<SEC-DOCUMENT>0001104659-25-110705.txt : 20251113
<SEC-HEADER>0001104659-25-110705.hdr.sgml : 20251113
<ACCEPTANCE-DATETIME>20251112220002
ACCESSION NUMBER:		0001104659-25-110705
CONFORMED SUBMISSION TYPE:	PREM14A
PUBLIC DOCUMENT COUNT:		24
CONFORMED PERIOD OF REPORT:	20251112
FILED AS OF DATE:		20251113
DATE AS OF CHANGE:		20251112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AVADEL PHARMACEUTICALS PLC
		CENTRAL INDEX KEY:			0001012477
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PREM14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37977
		FILM NUMBER:		251475164

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		10 EARLSFORT TERRACE
		CITY:			DUBLIN 2
		PROVINCE COUNTRY:   	L2
		ZIP:			D02 T380
		BUSINESS PHONE:		636-449-1830

	MAIL ADDRESS:	
		STREET 1:		16640 CHESTERFIELD GROVE ROAD
		STREET 2:		SUITE 200
		CITY:			CHESTERFIELD
		STATE:			MO
		ZIP:			63005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FLAMEL TECHNOLOGIES SA
		DATE OF NAME CHANGE:	19960422
</SEC-HEADER>
<DOCUMENT>
<TYPE>PREM14A
<SEQUENCE>1
<FILENAME>tm2529379-1_prem14a.htm
<DESCRIPTION>PREM14A
<TEXT>
<html>
  <head>
    <title>tm2529379-1_prem14a - none - 24.996268s</title>
  </head>
  <body style="margin-left:auto;margin-right:auto;width:595.31pt;">
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">UNITED STATES</font>
          <br >
          <font style="letter-spacing:-0.24pt;">SECURITIES AND EXCHANGE COMMISSION</font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Washington, D.C. 20549</font><font style="font-weight:normal;font-size:12pt;">&#8203;<font style="letter-spacing:0.24pt;"> </font></font>
        </div>
        <div style="margin-top:16.833pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">SCHEDULE 14A</font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proxy Statement Pursuant to Section&#160;14(a) of the</font>
          <br >
          <font style="letter-spacing:-0.2pt;">Securities Exchange Act of 1934</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:16.5pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:16pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Filed by the Registrant&nbsp;&nbsp;&nbsp;&#9746; </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Filed by a Party other than the Registrant&nbsp;&nbsp;&nbsp;&#9744; </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Check the appropriate box: </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9746;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Preliminary Proxy Statement </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Confidential, for Use of the Commission Only (as permitted by Rule&#160;14a-6(e)(2)) </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Definitive Proxy Statement </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Definitive Additional Materials </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Soliciting Material under Rule&#160;14a-12</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:24pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">AVADEL PHARMACEUTICALS PLC</font>
        </div>
        <div style="margin-top:4.167pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Name of Registrant as Specified In Its Charter)</font><font style="font-size:14pt;">&#8203;<font style="letter-spacing:0.28pt;"> </font></font>
        </div>
        <div style="margin-top:24.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 451pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:3pt; text-align:center; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</font><font style="font-size:10pt;">&#8203;<font style="letter-spacing:0.2pt;"> </font></font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Payment of Filing Fee (Check the appropriate box): </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">No fee required. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Fee previously paid with preliminary materials. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9746;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Fee computed on table in exhibit required by Item&#160;25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;color:#FC0014;">
          <font style="letter-spacing:-0.2pt;">PRELIMINARY PROXY STATEMENT&#8201;&#8212;&#8201;SUBJECT TO COMPLETION</font><font style="font-weight:normal;color:#000000;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lg_avadel-4clr.jpg" alt="[MISSING IMAGE: lg_avadel-4clr.jpg]" height="56" width="232" >
        </div>
        <div style="margin-top:16.01pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AVADEL PHARMACEUTICALS PLC </font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Ten Earlsfort Terrace </font>
          <br >
          <font style="letter-spacing:-0.2pt;">Dublin 2, D02 T380 </font>
          <br >
          <font style="letter-spacing:-0.2pt;">Ireland</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TRANSACTION PROPOSED&#8201;&#8212;&#8201;YOUR VOTE IS VERY IMPORTANT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To Our Shareholders: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You are cordially invited to attend two special meetings of the shareholders of Avadel Pharmaceuticals plc (&#8220;Avadel&#8221;). The first, the special Irish High Court-ordered meeting, is to be held on [&#8226;], 2026 at [&#8226;] (Irish local time), at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland (the &#8220;Scheme Meeting&#8221;), and the second, the extraordinary general meeting of shareholders is to be held on&#160;[&#8226;], 2026 at [&#8226;] (Irish local time), at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin&#160;2, D02&#160;T380, Ireland (the &#8220;EGM&#8221;), or, if the Scheme Meeting has not concluded by [&#8226;] (Irish local time), as soon as possible after the conclusion of the Scheme Meeting (or any adjournment thereof). The Scheme Meeting and the EGM are referred to collectively as the &#8220;Special Meetings.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As previously announced, on October&#160;22, 2025, Avadel entered into a Transaction Agreement (the &#8220;Transaction Agreement&#8221;), by and between Avadel and Alkermes plc, a public limited company incorporated in Ireland (&#8220;Alkermes&#8221;). Under the terms of the Transaction Agreement, subject to the satisfaction or, where applicable, waiver of the Conditions (as set out in Appendix&#160;III to the joint announcement issued by Alkermes and Avadel on October&#160;22, 2025 pursuant to Rule&#160;2.7 of the Irish Takeover Rules), Alkermes will acquire Avadel (the &#8220;Transaction&#8221;) pursuant to a scheme of arrangement under Chapter 1 of Part&#160;9 of the Irish Companies Act 2014 (the &#8220;Companies Act&#8221;), the terms of which are set out in full in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Part&#160;3&#8201;&#8212;&#8201;The Scheme of Arrangement</font><font style="letter-spacing:0.2pt;">&#8221; &#8203;(the &#8220;Scheme&#8221;) of the accompanying proxy statement. If the Scheme becomes effective, Avadel will become a wholly owned subsidiary of Alkermes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As consideration for the Transaction, holders of ordinary shares of Avadel, nominal value $0.01 per share (each an &#8220;Avadel Share&#8221; and such holders, the &#8220;Avadel Shareholders&#8221;), will be entitled to receive at the effective time of the Scheme (the &#8220;Effective Time&#8221;), $18.50 in cash for each Avadel Share held by them as of the Effective Time (the &#8220;Cash Consideration&#8221;) and a non-transferrable contingent value right entitling the holder to a potential additional payment of $1.50 for each Avadel Share held by them as of the Effective Time, contingent upon the achievement of the specified milestone set forth in the CVR Agreement (as defined below) (such contingent value rights, the &#8220;CVRs&#8221; and, together with the Cash Consideration, the &#8220;Scheme Consideration&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel equity awards will be treated as set forth in the Transaction Agreement, such that at the Effective Time: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each option to purchase Avadel Shares (each, an &#8220;Avadel Option&#8221;) granted under any Avadel equity incentive plan, program or arrangement under which equity awards are outstanding (the &#8220;Avadel Share Plans&#8221;) or otherwise, including each option with vesting based all or partially on performance conditions (each, an &#8220;Avadel Performance-Based Option&#8221;) having an exercise price less than the Cash Consideration (each such option, an &#8220;Avadel Cash-Out Option&#8221;) that is outstanding as of immediately prior to the Effective Time, whether or not vested, will be cancelled and, in exchange therefor, the holder of such cancelled Avadel Cash-Out Option will be entitled to receive (without interest): (i)&#160;an amount in cash (less applicable tax and any other mandatory withholdings) equal to the product of (x)&#160;the total number of Avadel Shares subject to such Avadel Cash-Out Option immediately prior to the Effective Time, </font><font style="font-style:italic;letter-spacing:0.2pt;">multiplied</font><font style="letter-spacing:0.2pt;"> by (y)&#160;the excess of the Cash Consideration over the applicable exercise price per Avadel Share under such Avadel Cash-Out Option and (ii)&#160;one CVR for each Avadel Share subject to such Avadel Cash-Out Option immediately prior to the Effective Time (without regard to vesting); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each Avadel Option with an exercise price equal to or greater than the Cash Consideration that is outstanding immediately prior to the Effective Time, whether or not vested, will be cancelled for no consideration; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each award of restricted share&#160;units representing the right to receive one or more Avadel Shares or the cash value thereof upon vesting and settlement, whether granted pursuant to the Avadel Share Plans or otherwise (each, an &#8220;Avadel RSU Award&#8221;) that is outstanding will be cancelled and, in exchange therefor, the holder of such cancelled Avadel RSU Award will be entitled to receive (without interest): (i)&#160;an amount in cash (less applicable tax and any other mandatory withholdings) equal to the product of (x)&#160;the total number of Avadel Shares subject to such Avadel RSU Award immediately prior to the Effective Time </font><font style="font-style:italic;letter-spacing:0.2pt;">multiplied</font><font style="letter-spacing:0.2pt;"> by (y)&#160;the Cash Consideration and (ii)&#160;one CVR for each Avadel Share subject to such Avadel RSU Award immediately prior to the Effective Time (without regard to vesting); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each award of Avadel Shares subject to vesting restrictions or forfeiture back to Avadel (each, an &#8220;Avadel Restricted Stock Award&#8221;), whether granted pursuant to the Avadel Share Plans or otherwise that is outstanding immediately prior to the Effective Time will vest in full as of immediately prior to the Effective Time and will be treated in the same manner as all other Avadel Shares. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You are being asked to vote on a proposal to approve the Scheme at both the Scheme Meeting and the EGM, as well as an additional proposal being presented at the EGM to amend Avadel&#8217;s Articles of Association that Avadel Shareholders must approve in order to properly implement the Scheme and upon which the Transaction is conditioned. At the EGM, Avadel Shareholders are also being asked to approve, on a non-binding, advisory basis, certain specified compensatory arrangements between Avadel and its&#160;named executive officers. The Scheme is also subject to sanction by the Irish High Court. More information&#160;about the Transaction and the proposals is contained in the accompanying proxy statement. </font><font style="font-weight:bold;letter-spacing:-0.2pt;">You are urged to read the accompanying proxy statement, including the annexes and the documents incorporated by reference therein, carefully and in their entirety.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Your proxy is being solicited by the members of the Avadel Board of Directors (the &#8220;Avadel Board&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">After careful consideration, the members of the Avadel Board have unanimously determined that the Transaction Agreement and the transactions contemplated by the Transaction Agreement, including the Scheme, are in the best interests of Avadel and the Avadel Shareholders and that the terms of the Scheme are fair and reasonable. Additional information regarding interests in the transaction of the Avadel directors and officers may be found in the section of the accompanying proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201; Interests of Certain Persons in the Transaction</font><font style="letter-spacing:0.2pt;">.&#8221; </font><font style="font-weight:bold;letter-spacing:-0.2pt;">The Avadel Board unanimously recommends that you vote &#8220;FOR&#8221; all proposals. </font><font style="letter-spacing:0.2pt;">In considering the recommendation of the Avadel Board, you should be aware that certain directors and executive officers of Avadel may have interests in the proposed Transaction that are in addition to, or different from, any interests they might have as shareholders. See the section of the accompanying proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction</font><font style="letter-spacing:0.2pt;">&#8221; for more information. </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Your vote is very important. Please vote as soon as possible whether or not you plan to attend the Special Meetings, by following the instructions in the accompanying proxy statement.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On behalf of the Avadel Board, thank you for your consideration and continued support. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sincerely, </font>
        </div>
        <div style="margin-top:24pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Jerad G. Seurer </font> <br ><font style="font-style:italic;letter-spacing:0.2pt;">General Counsel &amp; Corporate Secretary</font><font style="letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying proxy statement is dated [&#8226;], 202[&#8226;], and is first being mailed to Avadel Shareholders on or about [&#8226;], 202[&#8226;]. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Neither the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of the Transaction, passed upon the merits or fairness of the Transaction Agreement or the transactions contemplated by it or if the information contained in the accompanying proxy statement is accurate or adequate. Any representation to the contrary is a criminal offense.</font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADDITIONAL INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The accompanying proxy statement incorporates by reference important business and financial information about Avadel from documents that are not included in or delivered with the accompanying proxy statement. Avadel files annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains an Internet site that contains reports, proxy statements and other information regarding issuers that file electronically with the SEC. The SEC&#8217;s Internet site can be found at http://www.sec.gov. Avadel also maintains an Internet site that contains the reports, proxy statements and other information that it files with the SEC. Avadel&#8217;s Internet site can be found at https://www.avadel.com. Information found on, or accessible through, Avadel&#8217;s website is not a part of and is not incorporated into, the accompanying proxy statement. The information incorporated into the accompanying proxy statement from other documents is also available to you without charge upon your written or oral request. The documents incorporated by reference will not be provided to you unless they are requested by you. You can obtain the documents incorporated by reference into the accompanying proxy statement by requesting them in writing or by telephone from Avadel at the following address or telephone number: </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel Pharmaceuticals plc </font>
          <br >
          <font style="letter-spacing:0.2pt;">Ten Earlsfort Terrace</font>
          <br >
          <font style="letter-spacing:0.2pt;">Dublin 2, D02 T380</font>
          <br >
          <font style="letter-spacing:0.2pt;">Ireland </font>
          <br >
          <font style="letter-spacing:0.2pt;">Attn: General Counsel &amp; Company Secretary </font>
          <br >
          <font style="letter-spacing:0.2pt;">+353 1 601 5201 (Ireland) </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, if you have questions about the Transaction or the Special Meetings, or if you need to obtain copies of the accompanying proxy statement, proxy cards or other documents incorporated by reference into the accompanying proxy statement, you may contact Avadel&#8217;s proxy solicitor for the Special Meetings using the contact information listed below. You will not be charged for any of the documents you request. </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Innisfree M&amp;A Incorporated </font>
          <br >
          <font style="letter-spacing:0.2pt;">501 Madison Ave Floor 20 </font>
          <br >
          <font style="letter-spacing:0.2pt;">New York, NY 10022 </font>
          <br >
          <font style="letter-spacing:0.2pt;">Shareholders in the US and Canada may call toll free: </font>
          <br >
          <font style="letter-spacing:0.2pt;">(877) 687-1874 </font>
          <br >
          <font style="letter-spacing:0.2pt;">Shareholders outside the US and Canada may call: </font>
          <br >
          <font style="letter-spacing:0.2pt;">+1 (412) 232-3651 </font>
          <br >
          <font style="letter-spacing:0.2pt;">Banks and Brokers may call collect: </font>
          <br >
          <font style="letter-spacing:0.2pt;">(212) 750-5833 </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If you would like to request documents, please do so by [</font><font style="font-weight:normal;letter-spacing:0.2pt;">&#8226;</font><font style="letter-spacing:-0.2pt;">] (US Eastern Time) on [</font><font style="font-weight:normal;letter-spacing:0.2pt;">&#8226;</font><font style="letter-spacing:-0.2pt;">], 202[</font><font style="font-weight:normal;letter-spacing:0.2pt;">&#8226;</font><font style="letter-spacing:-0.2pt;">] in order to receive them before the Special Meetings.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For a more detailed description of the information incorporated by reference into the accompanying proxy statement and how you may obtain it, see the section of the accompanying proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Where You Can Find More Information</font><font style="letter-spacing:0.2pt;">.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">THE ACCOMPANYING PROXY STATEMENT DOES NOT CONSTITUTE THE SOLICITATION OF A PROXY IN ANY JURISDICTION TO OR FROM ANY PERSON TO WHOM OR FROM WHOM IT IS UNLAWFUL TO MAKE SUCH PROXY SOLICITATION IN THAT JURISDICTION. YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED OR INCORPORATED BY REFERENCE INTO THE ACCOMPANYING PROXY STATEMENT TO VOTE YOUR AVADEL SHARES AT THE SCHEME MEETING AND EGM. WE HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH INFORMATION THAT IS DIFFERENT FROM WHAT IS CONTAINED IN THE ACCOMPANYING PROXY STATEMENT. THE ACCOMPANYING PROXY STATEMENT IS DATED [&#8226;], 202[&#8226;]. YOU SHOULD NOT ASSUME THAT THE INFORMATION CONTAINED IN THE ACCOMPANYING PROXY STATEMENT IS ACCURATE AS OF ANY DATE OTHER THAN THAT DATE, AND THE MAILING OF THE ACCOMPANYING PROXY STATEMENT TO AVADEL SHAREHOLDERS DOES NOT CREATE ANY IMPLICATION TO THE CONTRARY. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AVADEL PHARMACEUTICALS PLC </font>
          <br >
          <font style="letter-spacing:-0.2pt;">Ten Earlsfort Terrace </font>
          <br >
          <font style="letter-spacing:-0.2pt;">Dublin 2, D02 T380 </font>
          <br >
          <font style="letter-spacing:-0.2pt;">Ireland</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTICE OF SCHEME MEETING OF SHAREHOLDERS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">THE HIGH COURT, 2025 No. [</font><font style="font-weight:normal;letter-spacing:0.2pt;">&#8226;</font><font style="letter-spacing:-0.2pt;">] COS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">IN THE MATTER OF AVADEL PHARMACEUTICALS PLC</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8212; </font><font style="font-weight:bold;letter-spacing:-0.2pt;">and&#8201;&#8212;&#8201;</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IN THE MATTER OF THE COMPANIES ACT 2014</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">NOTICE IS HEREBY GIVEN </font><font style="letter-spacing:0.2pt;">that, by an order dated [&#8226;], 202[&#8226;] made in the above matter, the Irish High Court has (in accordance with section 450 of the Irish Companies Act 2014 (the &#8220;Companies Act&#8221;)) directed a meeting (the &#8220;Scheme Meeting&#8221;) to be convened of the holders of Avadel Shares (as defined in the proposed scheme of arrangement that is included in the document of which this Notice forms a part) in the capital of Avadel Pharmaceuticals plc (&#8220;Avadel&#8221;) for the purpose of considering and, if thought fit, approving (i)&#160;a resolution to approve (with or without modification) a scheme of arrangement pursuant to Chapter 1 of Part&#160;9 of the Companies Act proposed to be made between Avadel and the holders of the Scheme Shares (the &#8220;Scheme&#8221;) and (ii)&#160;any motion by the chair of the Scheme Meeting to adjourn the Scheme Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Scheme Meeting to approve the Scheme (together, the &#8220;Scheme Meeting Proposals&#8221;) and that such meeting will be held at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland on [&#8226;], 2026, commencing at [&#8226;] (Irish local time), at which place and time all holders of Avadel Shares are invited to attend. The Scheme Meeting Proposals may be voted on in such order as is determined by the Chair of the Scheme Meeting: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The resolution to approve the Scheme shall be in the following terms: </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Scheme Meeting Proposal 1:</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">That the Scheme in its original form or with or subject to any modification(s), addition(s) or condition(s) approved or imposed by the Irish High Court be agreed to</font><font style="letter-spacing:0.2pt;">.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To be passed, the resolution to approve the Scheme requires the approval at the Scheme Meeting (or any adjournment of such meeting) of a majority in number of Avadel Shareholders (as defined in the Scheme) of record as of [&#8226;] p.m. (US Eastern Time) on [&#8226;], 202[&#8226;] (the &#8220;Voting Record Time&#8221;) representing at least seventy-five&#160;percent (75%) in value of the Avadel Shares present and voting either in person or by proxy at the Scheme Meeting. The quorum for the Scheme Meeting shall be at least five or more registered holders of Avadel Shares present (in person or by proxy) holding not less than a majority of the issued and outstanding Avadel Shares entitled to vote at the Scheme Meeting. Registered holders of Avadel Shares who have submitted properly executed or transmitted proxies that are marked &#8220;abstain&#8221; will be treated as present for purposes of determining a quorum. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event that there is a motion by the Chair of the Scheme Meeting to adjourn the Scheme Meeting to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Scheme Meeting to approve the Scheme, such resolution shall be in the following terms: </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Scheme Meeting Proposal 2:</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">&#8220;</font><font style="letter-spacing:0.2pt;">That, any motion by the Chair to adjourn the Scheme Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Scheme Meeting to approve the Scheme, be approved.&#8221;</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To be passed, the resolution to adjourn the Scheme Meeting (or any adjournment of such meeting) requires the approval at the Scheme Meeting of at least a simple majority (being more than fifty&#160;percent (50%)) of the votes cast by the Avadel Shareholders (as defined in the Scheme) as of the Voting Record Time present and voting in person or by proxy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A copy of the Scheme and a copy of the explanatory statement required to be furnished pursuant to Section&#160;452 of the Companies Act are incorporated into the document of which this Notice forms part. Capitalized terms used in this Notice have the meanings given to them in the document of which this Notice forms part (save as otherwise defined in this Notice). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By the said order, the Irish High Court has designated Geoffrey Glass, Chair of the board of directors of Avadel, or, failing him, any other director of Avadel as the board of directors of Avadel may determine, to act as Chair of the Scheme Meeting and has directed the Chair to report the result thereof to the Irish High Court. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to, amongst other items, the approval of the resolution to approve the Scheme proposed at the meeting convened by this Notice and resolutions 1 and 2 to be proposed at the extraordinary general meeting of Avadel convened for [&#8226;], 2026, the prior satisfaction or, where applicable, waiver of the other Conditions (as defined in the Scheme) to the completion of the Scheme (other than those Conditions which by their nature cannot be satisfied prior to the hearing by the Irish High Court of the application to sanction the Scheme) and the availability of the Irish High Court, the hearing by the Irish High Court of the application to sanction the Scheme is anticipated to be heard in [&#8226;], 2026. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Scheme will be subject to the subsequent sanction of the Irish High Court. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Arthur Cox LLP </font> <br ><font style="letter-spacing:0.2pt;">Irish Legal Counsel for Avadel </font> <br ><font style="letter-spacing:0.2pt;">Ten Earlsfort Terrace</font> <br ><font style="letter-spacing:0.2pt;">Dublin 2, D02 T380, Ireland </font></div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Dated: [&#8226;], 202[&#8226;] </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Statement of Procedures</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Availability of documents and information in connection with the Scheme Meeting</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Information regarding the Scheme Meeting, including the full, unabridged text of the documents and resolutions to be submitted to the Scheme Meeting, will be available at [www.[&#8226;].com]. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Entitlement to attend and vote</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Only those Avadel Shareholders registered in the register of members of Avadel at the Voting Record Time (being [&#8226;] p.m. (US Eastern Time) on [&#8226;], 202[&#8226;]) are entitled to receive notice of, attend, speak and vote at the Scheme Meeting, or if relevant, any adjournment thereof. Changes in the register after that time and date will be disregarded in determining the right of any person to attend and/or vote at the meeting or any adjournment thereof. Attending the Scheme Meeting in person is not required in order to vote. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:7.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Scheme Meeting will be held at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin&#160;2, D02 T380, Ireland on [&#8226;], 2026 commencing at [&#8226;] (Irish local time). If you are an Avadel Shareholder of record and you wish to attend the Scheme Meeting in person, you are recommended to arrive at least 15 minutes before the time appointed for the holding of the Scheme Meeting to allow time for registration. You will be entitled to be admitted to the meeting as an Avadel Shareholder of record only if your shareholder status may be verified by checking your name against the register of members of Avadel. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Appointment of proxies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">An Avadel Shareholder of record who is entitled to attend, speak and vote at the Scheme Meeting is entitled to appoint a proxy (or more than one proxy as alternates) using the form of proxy card set out in section 184 of the Companies Act or the form of proxy card accompanying this Notice and proxy statement, to attend, speak and vote instead of the shareholder (please see notes 5 to 7 below). Beneficial owners of Avadel Shares who are not shareholders of record of such shares (for example those who hold their interests in Avadel Shares in &#8220;street name&#8221; through a bank, broker or other nominee) should see notes 8 to 10 below and consult with their bank, broker or other nominee at the earliest opportunity for further information on the processes and timelines for submitting proxy appointments and voting instructions for the Scheme Meeting. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5.</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To be valid, a proxy card and any power of attorney or other authority under which it is executed (or a duly certified copy of any such power or authority) must be delivered to Avadel&#8217;s Company Secretary, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland (if delivered by hand or by mail in accordance with the instructions on the voter instruction form or proxy card, during normal business hours) as soon as possible but, in any event, so as to be received no later than 11:59&#160;p.m. (Irish local time) on [&#8226;], 202[&#8226;]. Avadel Shareholders of record may also submit a proxy or proxies via the Internet by accessing the website [www.[&#8226;].com] or vote by telephone by calling [&#8226;] anytime up to 11:59&#160;p.m. (Irish local time) on [&#8226;], 202[&#8226;]. All proxies submitted by internet or by telephone will be forwarded to Avadel&#8217;s registered address electronically. If a proxy card for the Scheme Meeting is not lodged by the relevant time, it may also be handed to the Chair before the start of the Scheme Meeting. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">In the case of joint holders, the vote of the senior holder who tenders a vote (whether in person or by proxy) will be accepted to the exclusion of the vote(s) of the other joint holder(s) and, for this purpose, seniority will be determined by the order in which the names stand in the register of members of Avadel in respect of a joint holding. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">7.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Any Avadel Shareholder of record which is a corporation, limited liability company or partnership and wishes to attend, speak and vote at the Scheme Meeting must appoint a proxy or a corporate representative who may exercise on its behalf all of its powers. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A&#160;shareholder that is a corporation, limited liability company or partnership, may execute a proxy card either under its common seal or under the hand of an officer or attorney, duly authorized. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Further information for participants holding interests in &#8220;street name&#8221;</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">8.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Beneficial owners of Avadel Shares who are not the shareholders of record of such shares (for example, if such shares are held in &#8220;street name&#8221; through a bank, broker or other nominee), are advised to consult with their bank, broker or other nominee at the earliest opportunity for further information on the processes and timelines for submitting proxy appointments or voting instructions for the Scheme Meeting. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">9.</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">If your shares are held in &#8220;street name&#8221; in an account through a bank, broker or other nominee, you must likewise instruct the bank, broker or other nominee how to vote your shares by following the instructions the bank, broker or other nominee provides you along with this proxy statement. Your bank, broker or other nominee, as applicable, may have an earlier deadline by which you must provide instructions to it as to how to vote your shares, so you should read carefully the materials provided to you by your bank, broker or other nominee. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">10.</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Beneficial owners of Avadel Shares who are not the shareholder of record of such shares (for example, if such shares are held in &#8220;street name&#8221; through a bank, broker or other nominee) at the Voting Record Time are invited to attend the Scheme Meeting but may not vote their shares in person at the meeting unless they obtain a legal proxy from their bank, broker or other nominee. To request a legal proxy, please contact your bank, broker or other nominee holder of record. In order to be entitled to be admitted to the Scheme Meeting, holders of interests in Avadel Shares held in &#8220;street name&#8221; will need a form of photo identification and valid proof of ownership of their Avadel Shares. A recent brokerage statement or letter from a bank or broker are examples of proof of ownership. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Deadlines for receipt by Avadel of proxy voting instructions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">11.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">All proxy appointments and voting instructions (whether submitted directly or through a bank, broker or other nominee) must be received by Avadel&#8217;s Company Secretary, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland no later than 11:59&#160;p.m. (Irish local time) on [&#8226;], 202[&#8226;]. However, persons holding Avadel Shares through a bank, broker or other nominee will also need to comply with any additional voting deadlines imposed by such bank, broker or other nominee. All persons affected are recommended to consult with their bank, broker or other nominee at the earliest opportunity. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">12.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">If a proxy card is properly executed and returned, it will be voted in the manner directed by the shareholder executing it, by the Chair of the Scheme Meeting or by any other person duly appointed as proxy by the shareholder. If you sign and return your proxy cards appointing the Chair as your proxy but do not mark your cards to tell the proxy how to vote on a voting item, your shares will be voted in respect of such voting item at the discretion of the Chair. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">13.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">By Order of the Irish High Court made on [&#8226;], 202[&#8226;], the Irish High Court has appointed Geoffrey Glass, Chair of the board of directors of Avadel, or, failing him, any other director of Avadel as the board of directors of Avadel may determine, to act as Chair of the Scheme Meeting and has directed the Chair to report the result thereof to the Irish High Court. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">14.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The resolutions at the Scheme Meeting shall be decided on a poll. Every Avadel Shareholder of record as of the Voting Record Time will have one vote for every Avadel Share carrying voting rights of which he, she or it is the holder. An Avadel Shareholder of record as of the Voting Record Time (whether present in person or by proxy) who is entitled to more than one vote need not use all his, her or its votes or cast all his, her or its votes in the same way. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:40pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">15.</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">In order for the resolution to approve the Scheme at the Scheme Meeting to pass, it requires the approval at the Scheme Meeting by a majority in number of the Avadel Shareholders of record as of the Voting Record Time present and voting, either in person or by proxy, representing at least seventy-five percent (75%) in value of the Avadel Shares, voted at such meeting, either in person or by proxy. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">16.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">In order for the resolution to adjourn the Scheme Meeting (or any adjournment of such meeting) at the Scheme Meeting to pass, it requires the approval at the Scheme Meeting of at least a simple majority (being more than fifty&#160;percent (50%)) of the votes cast by the Avadel Shareholders of record as of the Voting Record Time present and voting in person or by proxy. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">17.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Because the votes required to approve the proposals at the Scheme Meeting are based on votes properly cast at the meeting, and because abstentions and broker non-votes are not considered votes properly cast, abstentions and broker non-votes, along with failures to vote, will have no effect on such proposals. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">YOUR VOTE IS IMPORTANT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IT IS IMPORTANT THAT AS MANY VOTES AS POSSIBLE ARE CAST AT THE SCHEME MEETING (WHETHER IN PERSON OR BY PROXY) SO THAT THE IRISH HIGH COURT CAN BE SATISFIED THAT THERE IS A FAIR AND REASONABLE REPRESENTATION OF AVADEL SHAREHOLDER OPINION. TO ENSURE YOUR REPRESENTATION AT THE SCHEME MEETING, YOU ARE REQUESTED TO COMPLETE, SIGN AND DATE THE ENCLOSED FORM OF PROXY (OR A FORM OF PROXY IN SUCH OTHER FORM AS MAY BE PERMITTED BY IRISH COMPANY LAW) AS PROMPTLY AS POSSIBLE AND RETURN IT IN THE POSTAGE PREPAID ENVELOPE ENCLOSED FOR THAT PURPOSE OR TO PROVIDE A PROXY AND VOTE BY INTERNET OR TELEPHONE IN THE MANNER PROVIDED ABOVE. IF YOU ATTEND THE SCHEME MEETING AS A SHAREHOLDER OF RECORD, YOU MAY VOTE IN PERSON EVEN IF YOU HAVE RETURNED A COMPLETED FORM OF PROXY. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-style:normal;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AVADEL THERAPEUTICS PLC </font>
          <br >
          <font style="letter-spacing:-0.2pt;">Ten Earlsfort Terrace </font>
          <br >
          <font style="letter-spacing:-0.2pt;">Dublin 2, D02 T380 </font>
          <br >
          <font style="letter-spacing:-0.2pt;">Ireland</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-style:normal;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTICE OF EXTRAORDINARY GENERAL MEETING</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-style:normal;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">OF</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-style:normal;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AVADEL PHARMACEUTICALS PLC</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:normal;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">NOTICE IS HEREBY GIVEN</font><font style="letter-spacing:0.2pt;"> that an </font><font style="font-weight:bold;letter-spacing:-0.2pt;">EXTRAORDINARY GENERAL MEETING</font><font style="letter-spacing:0.2pt;"> (&#8220;EGM&#8221;) of Avadel Pharmaceuticals plc (&#8220;Avadel&#8221;) will be held at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland on [&#8226;], 2026, commencing at [&#8226;] (Irish local time) or, if later, as soon thereafter as the special Irish High Court-ordered meeting (the &#8220;Scheme Meeting&#8221;) shall have been concluded or adjourned, for the purpose of considering and, if thought fit, passing the following resolutions of which resolutions 1, 3 and 4 will be proposed as ordinary resolutions and resolution 2 will be proposed as a special resolution (collectively, the &#8220;Avadel Proposals&#8221;). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">The Avadel Proposals may be voted on in such order as is determined by the Chair of the EGM: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:normal;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;font-style:normal;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Ordinary Resolution: Approval of the Scheme</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-style:normal;letter-spacing:0.2pt;">&#8220;</font><font style="letter-spacing:0.2pt;">That, subject to the approval by the requisite majority at the Scheme Meeting, the scheme of arrangement that is included in the document of which this Notice forms part (the &#8220;Scheme&#8221;) (a copy of which has been produced to the meeting and, for the purposes of identification, signed by the Chair thereof) in its original form or with or subject to any modification(s), addition(s) or condition(s) approved or imposed by the Irish High Court be approved and the directors of Avadel be authorized to take all such action as they consider necessary or appropriate for carrying the Scheme into effect</font><font style="font-style:normal;letter-spacing:0.2pt;">.&#8221; </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:normal;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;font-style:normal;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Special Resolution: Amendment of Articles of Association</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">That, subject to the Scheme becoming effective, the Articles of Association of Avadel be amended by adding the following new article 145:</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;145. Scheme of Arrangement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">In this article 145, the &#8220;Scheme&#8221; means the scheme of arrangement dated [</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8226;</font><font style="letter-spacing:0.2pt;">], 202[</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8226;</font><font style="letter-spacing:0.2pt;">] between the Company and the holders of the scheme shares (which comprise the ordinary shares of the Company that are transferred under the Scheme) (the &#8220;Scheme Shares&#8221;) under Chapter 1 of Part&#160;9 of the Act in its original form or with or subject to any modification(s), addition(s) or condition(s) approved or imposed by the High Court of Ireland. Unless otherwise defined, expressions defined in the Scheme shall have the same meanings in this article 145.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Notwithstanding any other provision of these articles or the terms of any resolution, whether ordinary or special, passed by the Company in any general meeting, if the Company allots and issues any ordinary shares (other than to Alkermes plc (&#8220;Alkermes&#8221;) and/or its nominee(s)) on or after the Voting Record Time and prior to the Scheme Record Time, such shares shall be allotted and issued subject to the terms of the Scheme and the holder or holders of those shares shall be bound by the Scheme accordingly.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Notwithstanding any other provision of these articles, if any new ordinary shares of the Company are allotted or issued to any person (other than to Alkermes and/or its nominee(s)) (a &#8220;new member&#8221;) on or after the Scheme Record Time, the new member shall, provided that the Scheme has become effective, have such shares transferred immediately, free of all encumbrances, to Alkermes and/or its nominee(s) in consideration of and conditional on the payment by Alkermes to the new member of the Scheme Consideration to which the new </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:80pt; width:376pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">member would have been entitled under the terms of the Scheme had such ordinary shares transferred to Alkermes hereunder been Scheme Shares at the Scheme Record Time.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(d)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">In order to give effect to any such transfer required by this article 145, the Company may appoint any person to act, and who shall be authorised, as attorney and/or agent for and in the name of, any new member, without the need for any further action being required to give effect thereto, to execute and deliver a form of transfer on behalf of, or as attorney for and in the name of, the new member in favour of Alkermes and/or its nominee(s). Subject to the Scheme becoming effective, pending the registration of Alkermes as a holder of any share to be transferred under this article 145, the new member shall not be entitled to exercise any rights attaching to any such shares unless so agreed by Alkermes and Alkermes shall be irrevocably empowered to appoint a person nominated by Alkermes to act as attorney or agent on behalf of any holder of that share in accordance with any directions Alkermes may give in relation to any dealings with or disposal of that share (or any interest in it), the exercise of any rights attached to it or receipt of any distribution or other benefit accruing or payable in respect of it and any holder(s) of that share must exercise all rights attaching to it in accordance with the directions of Alkermes.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(e)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">In the absence of bad faith or willful default, none of Alkermes, the Company, any person or nominee appointed by Alkermes, the Company or their respective agents shall have any liability for any loss or damage arising as a result of sale or transfer (including as a result of the timing or terms of such sale or transfer) or any instrument of transfer executed and/or delivered or any other thing done for or on behalf of any new member or otherwise pursuant to this article 145.&#8221;&#8221;</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:normal;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;font-style:normal;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Ordinary Resolution (non-binding, advisory): Advisory Vote on Compensatory Arrangements between Avadel and its Named Executive Officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;That, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction (as more particularly described in the section of the accompanying proxy statement entitled &#8220;The Transaction&#8201;&#8212;&#8201;Quantification of Payments and Benefits to Avadel&#8217;s Named Executive Officers&#8221;) be approved.&#8221;</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:normal;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;font-style:normal;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Ordinary Resolution: Adjournment of the EGM</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;That, any motion by the Chair to adjourn the EGM, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the EGM to approve resolutions 1 and/or 2 be approved.&#8221;</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">By order of the Avadel Board </font>
        </div>
        <div style="margin-top:24pt; width:456pt; line-height:12pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">Jerad G. Seurer </font> <br ><font style="letter-spacing:0.2pt;">General Counsel and Company Secretary </font> <br ><font style="letter-spacing:0.2pt;">Avadel Pharmaceuticals plc </font> <br ><font style="letter-spacing:0.2pt;">Ten Earlsfort Terrace, </font> <br ><font style="letter-spacing:0.2pt;">Dublin 2, D02 T380, Ireland </font></div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">Dated: [&#8226;], 202[&#8226;] </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Statement of Procedures</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Availability of documents and information in connection with the EGM</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Information regarding the EGM, including the full, unabridged text of the documents and resolutions to be submitted to the EGM will be available at [www.[&#8226;].com]. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Entitlement to attend and vote</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Only those Avadel Shareholders registered in the register of members of Avadel at the Voting Record Time (being [&#8226;] p.m. (US Eastern Time) on [&#8226;], 202[&#8226;]) are entitled to receive notice of, attend, speak and vote at the EGM, or if relevant, any adjournment thereof. Changes in the register after that time and date will be disregarded in determining the right of any person to attend and/or vote at the meeting or any adjournment thereof. Attending the EGM in person is not required in order to vote. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The EGM will be held at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin 2, D02&#160;T380, Ireland on [&#8226;], 2026, commencing at [&#8226;] (Irish local time), or, if later, as soon thereafter as the Scheme Meeting shall have been concluded or adjourned. You are recommended to arrive at least 15 minutes before the time appointed for the holding of the EGM to allow time for registration. You will be entitled to be admitted to the meeting as an Avadel Shareholder of record only if your shareholder status may be verified by checking your name against the register of members of Avadel. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Appointment of proxies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">An Avadel Shareholder of record who is entitled to attend, speak and vote at the EGM is entitled to appoint a proxy (or more than one proxy), using the form of proxy card set out in section 184 of the Companies Act or the form of proxy card accompanying this Notice and proxy statement, to attend, speak and vote instead of the shareholder (please see notes 5 to 7 below). Beneficial owners of Avadel Shares who are not shareholders of record of such shares (for example those who hold their interests in Avadel Shares in &#8220;street name&#8221; through a bank, broker or other nominee) should see notes 8 to 10 below and consult with their bank, broker or other nominee at the earliest opportunity for further information on the processes and timelines for submitting proxy appointments and voting instructions for the EGM. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5.</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To be valid, a proxy card and any power of attorney or other authority under which it is executed (or a duly certified copy of any such power or authority) must be delivered to Avadel&#8217;s Company Secretary, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland (if delivered by hand or by mail in accordance with the instructions on the voter instruction form or proxy card, during normal business hours) as soon as possible but, in any event, so as to be received no later than 11:59&#160;p.m. (Irish local time) on [&#8226;], 202[&#8226;]. Avadel Shareholders of record may also submit a proxy or proxies via the Internet by accessing the website [www.[&#8226;].com] or vote by telephone by calling [&#8226;] anytime up to 11:59&#160;p.m. (Irish local time) on [&#8226;], 202[&#8226;]. All proxies submitted by internet or by telephone will be forwarded to Avadel&#8217;s registered address electronically. If a proxy card for the EGM is not lodged by the relevant time, it may also be handed to the Chair of the EGM before the start of the EGM. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">In the case of joint holders, the vote of the senior holder who tenders a vote (whether in person or by proxy), will be accepted to the exclusion of the vote(s) of the other joint holder(s) and, for this purpose, seniority will be determined by the order in which the names stand in the register of members of Avadel in respect of a joint holding. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">7.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Any shareholder of record which is a corporation, limited liability company or partnership and wishes to attend, speak and vote at the EGM must appoint a proxy or a corporate representative who may exercise on its behalf all of its powers. A shareholder that is a corporation, limited liability company or partnership, may execute a proxy card either under its common seal or under the hand of an officer or attorney, duly authorized. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Further information for participants holding interests in &#8220;street name&#8221;</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">8.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Beneficial owners of Avadel Shares who are not the shareholder of record of such shares (for example, if such shares are held in &#8220;street name&#8221; through a bank, broker or other nominee) are advised to consult with their bank, broker or other nominee at the earliest opportunity for further information on the processes and timelines for submitting proxy appointments or voting instructions for the EGM. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">9.</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">If your Avadel Shares are held in &#8220;street name&#8221; in an account through a bank, broker or other nominee, you must likewise instruct the bank, broker or other nominee how to vote your shares by following the instructions the bank, broker or other nominee provides you along with this proxy statement. Your bank, broker or other nominee, as applicable, may have an earlier deadline by which you must provide instructions to it as to how to vote your shares, so you should read carefully the materials provided to you by your bank, broker or other nominee. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">10.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Beneficial owners of Avadel Shares who are not the shareholder of record of such shares (for example, if such shares are held in &#8220;street name&#8221; through a bank, broker or other nominee) at the Voting Record Time are invited to attend the EGM but may not vote their shares in person at the meeting unless they obtain a legal proxy from their bank, broker or other nominee. To request a legal proxy, please contact your bank, broker or other nominee holder of record. In order to be entitled to be admitted to the EGM, holders of interests in Avadel Shares held in &#8220;street name&#8221; will need a form of photo identification and valid proof of ownership of their Avadel Shares. A recent brokerage statement or letter from a bank or broker are examples of proof of ownership. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Deadlines for receipt by Avadel of proxy voting instructions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">11.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">All proxy appointments and voting instructions (whether submitted directly or through a bank, broker or other nominee) must be received by Avadel&#8217;s Company Secretary, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland no later than 11:59&#160;p.m. (Irish local time) on [&#8226;], 202[&#8226;]. However, persons holding Avadel Shares through a bank, broker or other nominee will also need to comply with any additional voting deadlines imposed by such bank, broker or other nominee. All persons affected are recommended to consult with their bank, broker or other nominee at the earliest opportunity. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">12.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">If a proxy card is properly executed and returned, it will be voted in the manner directed by the shareholder executing it, by the Chair of the EGM or any other person duly appointed as proxy by the shareholder. If you sign and return your proxy cards appointing the Chair as your proxy but do not mark your cards to tell the proxy how to vote on a voting item, your shares will be voted in respect of such voting item at the discretion of the Chair. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">13.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The resolutions at the EGM shall be decided on a poll. Every Avadel Shareholder of record as of the Voting Record Time will have one vote for each Avadel Share carrying voting rights of which he, she or it is the holder. An Avadel Shareholder of record as of the Voting Record Time (whether present in person or by proxy) who is entitled to more than one vote need not use all his, her or its votes or cast all his, her or its votes in the same way. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">14.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">At the EGM, the requisite approval of each of the resolutions depends on whether it is (a)&#160;an &#8220;ordinary resolution,&#8221; which requires the approval of at least a simple majority (being more than fifty&#160;percent (50%)) of the votes cast by the Avadel Shareholders of record as of the Voting Record Time present and voting (in person or by proxy) at the EGM, or (b)&#160;a &#8220;special resolution,&#8221; which requires the approval of at least seventy five&#160;percent (75%) of the votes cast by Avadel Shareholders of record as of the Voting Record Time present and voting (in person or by proxy) at the EGM. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The quorum for the EGM shall be at least five or more registered holders of Avadel Shares present either in person or by proxy holding not less than a majority of the issued and outstanding Avadel Shares entitled to vote at the EGM. Registered holders of Avadel Shares who have submitted </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">properly executed or transmitted proxies that are marked &#8220;abstain&#8221; will be treated as present for purposes of determining a quorum. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">15.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Because the vote required to approve each proposal at the EGM is based on votes properly cast at the meeting, and because abstentions and broker non-votes are not considered votes properly cast, abstentions and broker non-votes, along with failures to vote, will have no effect on any such proposal. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">YOUR VOTE IS IMPORTANT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IT IS IMPORTANT THAT AS MANY VOTES AS POSSIBLE ARE CAST AT THE EGM (WHETHER IN PERSON OR BY PROXY). TO ENSURE YOUR REPRESENTATION AT THE EGM, YOU ARE REQUESTED TO COMPLETE, SIGN AND DATE THE ENCLOSED FORM OF PROXY (OR A FORM OF PROXY IN SUCH OTHER FORM AS MAY BE PERMITTED BY IRISH COMPANY LAW) AS PROMPTLY AS POSSIBLE AND RETURN IT IN THE POSTAGE PREPAID ENVELOPE ENCLOSED FOR THAT PURPOSE OR TO PROVIDE A PROXY AND VOTE BY INTERNET OR TELEPHONE IN THE MANNER PROVIDED ABOVE. IF YOU ATTEND THE EGM AS A SHAREHOLDER OF RECORD, YOU MAY VOTE IN PERSON EVEN IF YOU HAVE RETURNED A COMPLETED FORM OF PROXY.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:620.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:427.33pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSUM"><font style="letter-spacing:0.2pt;">SUMMARY </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSUM">iii</a></font><a href="#tSUM"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPTTT"><font style="letter-spacing:0.2pt;">Parties to the Transaction </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPTTT">iii</a></font><a href="#tPTTT"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tTTPB"><font style="letter-spacing:0.2pt;">The Transaction </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tTTPB">iii</a></font><a href="#tTTPB"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tSOTT"><font style="letter-spacing:0.2pt;">Structure of the Transaction </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSOTT">iv</a></font><a href="#tSOTT"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tSCTA"><font style="letter-spacing:0.2pt;">Scheme Consideration to Avadel Shareholders </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSCTA">iv</a></font><a href="#tSCTA"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tTOAE"><font style="letter-spacing:0.2pt;">Treatment of Avadel Equity Awards </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tTOAE">iv</a></font><a href="#tTOAE"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tROTA"><font style="letter-spacing:0.2pt;">Recommendation of the Avadel Board and Avadel&#8217;s Reasons for the Transaction </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tROTA">v</a></font><a href="#tROTA"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tOOMS"><font style="letter-spacing:0.2pt;">Opinion of Morgan Stanley &amp; Co. LLC </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOOMS">v</a></font><a href="#tOOMS"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tOOGS"><font style="letter-spacing:0.2pt;">Opinion of Goldman Sachs &amp; Co. LLC </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOOGS">vi</a></font><a href="#tOOGS"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tIOCP"><font style="letter-spacing:0.2pt;">Interests of Certain Persons in the Transaction </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tIOCP">vii</a></font><a href="#tIOCP"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tCVRA"><font style="letter-spacing:0.2pt;">Contingent Value Rights Agreement </font> </a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <a href="#tCVRA"><font style="letter-spacing:0.2pt;">vii</font> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tMTCP"><font style="letter-spacing:0.2pt;">Material Tax Consequences of the Proposed Transaction </font> </a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <a href="#tMTCP"><font style="letter-spacing:0.2pt;">viii</font> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tNDRP"><font style="letter-spacing:0.2pt;">No Dissenters&#8217; Rights </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNDRP">ix</a></font><a href="#tNDRP"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tRARP"><font style="letter-spacing:0.2pt;">Regulatory Approvals Required </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRARP">ix</a></font><a href="#tRARP"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tCTTC"><font style="letter-spacing:0.2pt;">Conditions to the Completion of the Transaction </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCTTC">x</a></font><a href="#tCTTC"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tTOTT"><font style="letter-spacing:0.2pt;">Termination of the Transaction Agreement </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tTOTT">x</a></font><a href="#tTOTT"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tRPPB"><font style="letter-spacing:0.2pt;">Reimbursement Payment </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRPPB">xi</a></font><a href="#tRPPB"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tFRTT"><font style="letter-spacing:0.2pt;">Financing Relating to the Transaction </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tFRTT">xii</a></font><a href="#tFRTT"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:427.33pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tQAAA"><font style="letter-spacing:0.2pt;">QUESTIONS AND ANSWERS ABOUT THE TRANSACTION AND THE SPECIAL MEETINGS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tQAAA">xiii</a></font><a href="#tQAAA"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSRF"><font style="letter-spacing:0.2pt;">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSRF">xxii</a></font><a href="#tCSRF"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tP1TT"><font style="letter-spacing:0.2pt;">PART 1&#8201;&#8212;&#8201;THE TRANSACTION AND THE SPECIAL MEETINGS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tP1TT">1</a></font><a href="#tP1TT"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tTSMO"><font style="letter-spacing:0.2pt;">THE SPECIAL MEETINGS OF AVADEL&#8217;S SHAREHOLDERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tTSMO">1</a></font><a href="#tTSMO"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tOVE"><font style="letter-spacing:0.2pt;">Overview </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOVE">1</a></font><a href="#tOVE"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tDTAP"><font style="letter-spacing:0.2pt;">Date, Time and Place of the Special Meetings </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDTAP">1</a></font><a href="#tDTAP"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tATT"><font style="letter-spacing:0.2pt;">Attendance </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tATT">1</a></font><a href="#tATT"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPRO"><font style="letter-spacing:0.2pt;">Proposals </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPRO">1</a></font><a href="#tPRO"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tRDOO"><font style="letter-spacing:0.2pt;">Record Date; Outstanding Ordinary Shares; Ordinary Shares Entitled to Vote </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRDOO">2</a></font><a href="#tRDOO"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tQUO"><font style="letter-spacing:0.2pt;">Quorum </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tQUO">2</a></font><a href="#tQUO"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tOSOA"><font style="letter-spacing:0.2pt;">Ordinary Share Ownership and Voting by Avadel&#8217;s Directors and Officers </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOSOA">2</a></font><a href="#tOSOA"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tVRRO"><font style="letter-spacing:0.2pt;">Vote Required; Recommendation of the Avadel Board </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tVRRO">2</a></font><a href="#tVRRO"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tVYOS"><font style="letter-spacing:0.2pt;">Voting Your Ordinary Shares </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tVYOS">4</a></font><a href="#tVYOS"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tVOSH"><font style="letter-spacing:0.2pt;">Voting Ordinary Shares Held in Street Name </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tVOSH">4</a></font><a href="#tVOSH"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tRYP"><font style="letter-spacing:0.2pt;">Revoking Your Proxy </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRYP">5</a></font><a href="#tRYP"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tCOS"><font style="letter-spacing:0.2pt;">Costs of Solicitation </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCOS">5</a></font><a href="#tCOS"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tOTBU"><font style="letter-spacing:0.2pt;">Other Business </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOTBU">5</a></font><a href="#tOTBU"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tADJ"><font style="letter-spacing:0.2pt;">Adjournment </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tADJ">5</a></font><a href="#tADJ"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tASS"><font style="letter-spacing:0.2pt;">Assistance </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tASS">5</a></font><a href="#tASS"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tTHTR"><font style="letter-spacing:0.2pt;">THE TRANSACTION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tTHTR">6</a></font><a href="#tTHTR"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tTHTR1"><font style="letter-spacing:0.2pt;">The Transaction </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tTHTR1">6</a></font><a href="#tTHTR1"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tBOTT"><font style="letter-spacing:0.2pt;">Background of the Transaction </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tBOTT">6</a></font><a href="#tBOTT"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="TOC2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:197.5pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:415.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:427.33pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center; line-height:9pt;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tROTA1"><font style="letter-spacing:0.2pt;">Recommendation of the Avadel Board and Avadel&#8217;s Reasons for the Transaction </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tROTA1">16</a></font><a href="#tROTA1"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tOOMS1"><font style="letter-spacing:0.2pt;">Opinion of Morgan Stanley &amp; Co. LLC </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOOMS1">21</a></font><a href="#tOOMS1"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tOOGS1"><font style="letter-spacing:0.2pt;">Opinion of Goldman Sachs &amp; Co. LLC </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOOGS1">27</a></font><a href="#tOOGS1"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tAUPF"><font style="letter-spacing:0.2pt;">Avadel Unaudited Prospective Financial Information </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAUPF">33</a></font><a href="#tAUPF"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tFIN"><font style="letter-spacing:0.2pt;">Financing </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tFIN">37</a></font><a href="#tFIN"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tIOCP1"><font style="letter-spacing:0.2pt;">Interests of Certain Persons in the Transaction </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tIOCP1">38</a></font><a href="#tIOCP1"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tQOPA"><font style="letter-spacing:0.2pt;">Quantification of Payments and Benefits to Avadel&#8217;s Named Executive Officers </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tQOPA">42</a></font><a href="#tQOPA"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tRAR"><font style="letter-spacing:0.2pt;">Regulatory Approvals Required </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRAR">44</a></font><a href="#tRAR"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPOC"><font style="letter-spacing:0.2pt;">Payment of Consideration </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPOC">45</a></font><a href="#tPOC"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tNDR"><font style="letter-spacing:0.2pt;">NO DISSENTERS&#8217; RIGHTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNDR">46</a></font><a href="#tNDR"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMTCO"><font style="letter-spacing:0.2pt;">MATERIAL TAX CONSEQUENCES OF THE PROPOSED TRANSACTION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMTCO">47</a></font><a href="#tMTCO"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDADO"><font style="letter-spacing:0.2pt;">DELISTING AND DEREGISTRATION OF AVADEL SHARES </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDADO">53</a></font><a href="#tDADO"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPTTT1"><font style="letter-spacing:0.2pt;">PARTIES TO THE TRANSACTION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPTTT1">54</a></font><a href="#tPTTT1"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tTTA"><font style="letter-spacing:0.2pt;">THE TRANSACTION AGREEMENT </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tTTA">55</a></font><a href="#tTTA"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tFRTT1"><font style="letter-spacing:0.2pt;">FINANCING RELATING TO THE TRANSACTION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tFRTT1">74</a></font><a href="#tFRTT1"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSOOM"><font style="letter-spacing:0.2pt;">SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN BENEFICIAL OWNERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSOOM">75</a></font><a href="#tSOOM"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tASVO"><font style="letter-spacing:0.2pt;">AVADEL SHAREHOLDER VOTE ON SPECIFIED COMPENSATORY ARRANGEMENTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tASVO">78</a></font><a href="#tASVO"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tFSP"><font style="letter-spacing:0.2pt;">FUTURE SHAREHOLDER PROPOSALS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tFSP">79</a></font><a href="#tFSP"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tHOPS"><font style="letter-spacing:0.2pt;">HOUSEHOLDING OF PROXY STATEMENT </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tHOPS">80</a></font><a href="#tHOPS"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tWYCF"><font style="letter-spacing:0.2pt;">WHERE YOU CAN FIND MORE INFORMATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWYCF">81</a></font><a href="#tWYCF"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tP2ES"><font style="letter-spacing:0.2pt;">PART 2&#8201;&#8212;&#8201;EXPLANATORY STATEMENT </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tP2ES">82</a></font><a href="#tP2ES"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tP3TS"><font style="letter-spacing:0.2pt;">PART 3&#8201;&#8212;&#8201;THE SCHEME OF ARRANGEMENT </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tP3TS">96</a></font><a href="#tP3TS"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tP4AI"><font style="letter-spacing:0.2pt;">PART 4&#8201;&#8212;&#8201;ADDITIONAL INFORMATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tP4AI">105</a></font><a href="#tP4AI"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tANA"><font style="letter-spacing:0.2pt;">ANNEX A </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tANA">A-1</a></font><a href="#tANA"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tANB"><font style="letter-spacing:0.2pt;">ANNEX B </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tANB">B-1</a></font><a href="#tANB"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tANC"><font style="letter-spacing:0.2pt;">ANNEX C </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tANC">C-1</a></font><a href="#tANC"> </a>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAND"><font style="letter-spacing:0.2pt;">ANNEX D </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAND">D-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSUM">&#8203;</a><a name="tPTTT">&#8203;</a><a name="tTTPB">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">SUMMARY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">This summary highlights selected information contained in this proxy statement and may not contain all of the information that may be important to you. Accordingly, you should read carefully this entire proxy statement, including the annexes and the documents referred to or incorporated by reference into this proxy statement. The page references have been included in this summary to direct you to a more complete description of the topics presented below. See also the section of this proxy statement entitled &#8220;Where You Can Find More Information.&#8221; Unless otherwise specified, all references in this proxy statement to &#8220;Avadel&#8221; refer to Avadel Pharmaceuticals plc, a public limited company incorporated in Ireland; all references in this proxy statement to &#8220;Alkermes&#8221; refer to Alkermes plc, a public limited company incorporated in Ireland; all references to the &#8220;Transaction Agreement&#8221; refer to the Transaction Agreement, dated as of October&#160;22, 2025, by and between Avadel and Alkermes, a copy of which is included as Annex A to this proxy statement and all references to the &#8220;conditions appendix&#8221; refer to the conditions to the Transaction and the Scheme (each as defined herein), a copy of which is included as Annex B to this proxy statement. Unless otherwise indicated, all references to &#8220;dollars&#8221; or &#8220;$&#8221; in this proxy statement are references to U.S. dollars.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Parties to the Transaction (Page <a href="#tPTTT1">54</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Alkermes</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Alkermes is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. Alkermes has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy and idiopathic hypersomnia (&#8220;IH&#8221;). Alkermes is a public limited company incorporated in Ireland whose ordinary shares are listed on the Nasdaq Global Select Market (&#8220;Nasdaq Select&#8221;) under the ticker &#8220;ALKS.&#8221; </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Alkermes&#8217; principal executive offices are located at Connaught House, 1 Burlington Road Dublin 4, Ireland, D04 C5Y6, its telephone number is +353 1 722 8000 and its website is www.alkermes.com. Information on Alkermes&#8217; website is not incorporated by reference into or otherwise part of this proxy statement. For more information about Alkermes, see the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Parties to the Transaction&#8201;&#8212;&#8201;Alkermes.</font><font style="letter-spacing:0.2pt;">&#8221; </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Avadel</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Avadel is a biopharmaceutical company focused on transforming medicines to transform lives. Avadel&#8217;s approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel&#8217;s commercial product, LUMRYZ&#8482;, was approved by the U.S. Food &amp; Drug Administration (&#8220;FDA&#8221;) as the first and only once-at-bedtime oxybate for extended-release oral suspension for the treatment of cataplexy or excessive daytime sleepiness (&#8220;EDS&#8221;) in patients seven (7)&#160;years of age and older with narcolepsy. Avadel is a public company registered in Ireland whose ordinary shares are listed on the Nasdaq Global Market (&#8220;Nasdaq Global&#8221;) under the ticker &#8220;AVDL.&#8221; </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Avadel&#8217;s principal executive offices are located at Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland, its telephone number is + 353 1 901 5201 and its website is www.avadel.com. Information on Avadel&#8217;s website is not incorporated by reference into or otherwise part of this proxy statement. For more information about Avadel, see the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Parties to the Transaction&#8201;&#8212;&#8201;Avadel.</font><font style="letter-spacing:0.2pt;">&#8221; </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The Transaction (Page <a href="#tTHTR1">6</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">On October&#160;22, 2025, Avadel entered into the Transaction Agreement by and between Avadel and Alkermes, which is attached as Annex A to this proxy statement and incorporated by reference herein (the &#8220;Transaction Agreement&#8221;). Under the terms of the Transaction Agreement, Alkermes will acquire Avadel (the &#8220;Transaction&#8221;) pursuant to a scheme of arrangement under Chapter 1 of Part&#160;9 of the Irish Companies Act 2014 (the &#8220;Companies Act&#8221;) (the &#8220;Scheme&#8221;). As a result of the Scheme, as set forth in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Part&#160;3&#8201;&#8212;&#8201;the Scheme of Arrangement</font><font style="letter-spacing:0.2pt;">&#8221; of this proxy statement, Avadel will become a wholly owned subsidiary of Alkermes. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">iii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSOTT">&#8203;</a><a name="tSCTA">&#8203;</a><a name="tTOAE">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Structure of the Transaction (Page <a href="#tSTT1">55</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Pursuant to the Transaction, Alkermes will acquire the entire issued and to be issued ordinary share capital of Avadel, in accordance with the terms of the Transaction Agreement, by way of the Scheme. Upon the completion of the Transaction (the &#8220;Completion&#8221;), Avadel will be a wholly owned subsidiary of Alkermes. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Alkermes reserves the right, subject to the consent of the Irish Takeover Panel (if required), to effect the Transaction by way of an offer, in accordance with the Transaction Agreement, for the entire issued share capital of Avadel (other than any ordinary shares of Avadel, nominal value $0.01 per share (each an &#8220;Avadel Share&#8221;) beneficially owned by Alkermes or any member of the Alkermes group (being Alkermes and all of its subsidiaries) (if any) and any Avadel Shares held by any member of the Avadel group (being Avadel and all of its subsidiaries)), as an alternative to the Scheme, in the circumstances described in and subject to the terms of the Transaction Agreement (a &#8220;Takeover Offer&#8221;). In the event the Transaction is structured as a Takeover Offer, such offer will be implemented on terms and conditions that are at least as favorable to the holders of Avadel Shares (the &#8220;Avadel Shareholders&#8221;) and the Avadel equity award holders as those which would apply in relation to the Scheme (except for an acceptance condition set at eighty&#160;percent (80%) of the nominal value of the Avadel Shares to which such offer relates and which are not already beneficially owned by Alkermes, or such lesser&#160;percentage (being more than fifty&#160;percent (50%)), as Alkermes may, with the consent of Avadel and the Irish Takeover Panel (if required) decide). </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Scheme Consideration to Avadel Shareholders (Page <a href="#tCAS1">55</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At the effective time of the Scheme (the &#8220;Effective Time&#8221;), Avadel Shareholders will be entitled to receive $18.50 in cash for each Avadel Share held by them as of the Effective Time (the &#8220;Cash Consideration&#8221;) and a non-transferrable contingent value right entitling the holder to a potential additional payment of $1.50 for each Avadel Share held by them as of the Effective Time, contingent upon the achievement of the specified milestones set forth in the CVR Agreement (as defined below) (such contingent value rights, the &#8220;CVRs&#8221; and, together with the Cash Consideration, the &#8220;Scheme Consideration&#8221;). </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Treatment of Avadel Equity Awards (Page <a href="#tTAEA1">55</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Avadel equity awards will be treated as set forth in the Transaction Agreement, such that at the Effective Time: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">each option to purchase Avadel Shares (each, an &#8220;Avadel Option&#8221;) granted under any Avadel equity incentive plan, program or arrangement under which equity awards are outstanding (the &#8220;Avadel Share Plans&#8221;) or otherwise, including each option with vesting based all or partially on performance conditions (each, an &#8220;Avadel Performance-Based Option&#8221;) having an exercise price less than the Cash Consideration (each such option, an &#8220;Avadel Cash-Out Option&#8221;) that is outstanding as of immediately prior to the Effective Time, whether or not vested, will be cancelled and, in exchange therefor, the holder of such cancelled Avadel Cash-Out Option will be entitled to receive (without interest): (i)&#160;an amount in cash (less applicable tax and any other mandatory withholdings) equal to the product of (x)&#160;the total number of Avadel Shares subject to such Avadel Cash-Out Option immediately prior to the Effective Time, </font><font style="font-style:italic;letter-spacing:0.2pt;">multiplied</font><font style="letter-spacing:0.2pt;"> by (y)&#160;the excess of the Cash Consideration over the applicable exercise price per Avadel Share under such Avadel Cash-Out Option and (ii)&#160;one CVR for each Avadel Share subject to such Avadel Cash-Out Option immediately prior to the Effective Time (without regard to vesting); </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">each Avadel Option with an exercise price equal to or greater than the Cash Consideration that is outstanding immediately prior to the Effective Time, whether or not vested, will be cancelled for no consideration; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">each award of restricted share&#160;units representing the right to receive one or more Avadel Shares or the cash value thereof upon vesting and settlement, whether granted pursuant to the Avadel Share Plans or otherwise (each, an &#8220;Avadel RSU Award&#8221;) that is outstanding will be cancelled and, in exchange therefor, the holder of such cancelled Avadel RSU Award will be entitled to receive (without interest): (i)&#160;an amount in cash (less applicable tax and any other mandatory withholdings) equal to the product of (x)&#160;the total number of Avadel Shares subject to such Avadel RSU Award </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">iv</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tROTA">&#8203;</a><a name="tOOMS">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:30pt; width:426pt; line-height:11.5pt;font-weight:normal;">
            <font style="letter-spacing:0.2pt;">immediately prior to the Effective Time </font><font style="font-style:italic;letter-spacing:0.2pt;">multiplied</font><font style="letter-spacing:0.2pt;"> by (y)&#160;the Cash Consideration and (ii)&#160;one CVR for each Avadel Share subject to such Avadel RSU Award immediately prior to the Effective Time (without regard to vesting); and </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;font-weight:normal;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;font-weight:normal;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">each award of Avadel Shares subject to vesting restrictions or forfeiture back to Avadel (each, an &#8220;Avadel Restricted Stock Award&#8221;), whether granted pursuant to the Avadel Share Plans or otherwise that is outstanding immediately prior to the Effective Time will vest in full as of immediately prior to the Effective Time and will be treated in the same manner as all other Avadel Shares. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.2pt;">Recommendation of the Avadel Board and Avadel&#8217;s Reasons for the Transaction (Page <a href="#tROTA1">16</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.2pt;">The Board of Directors of Avadel (the &#8220;Avadel Board&#8221;) has unanimously approved the Transaction Agreement and determined that the Transaction Agreement and the transactions contemplated by the Transaction Agreement, including the Scheme, are in the best interests of Avadel and its shareholders and that the terms of the Scheme as contemplated by the Transaction Agreement are fair and reasonable.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:-0.2pt;">The Avadel Board unanimously recommends that Avadel Shareholders vote:</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">&#8220;FOR&#8221; the proposal to approve the Scheme at the special Irish High Court-ordered meeting (the &#8220;Scheme Meeting&#8221;) (such resolution, the &#8220;Scheme Meeting Resolution&#8221;);</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">&#8220;FOR&#8221; the proposal, at the Scheme Meeting, to approve any motion by the Chair of the Scheme Meeting to adjourn the Scheme Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Scheme Meeting to approve the Scheme (the &#8220;Scheme Meeting Adjournment Resolution&#8221;);</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">&#8220;FOR&#8221; the proposal, at the extraordinary general meeting of shareholders (the &#8220;EGM&#8221;) to approve the Scheme and authorize the directors of Avadel to take all such actions as they consider necessary or appropriate for carrying the Scheme into effect (the &#8220;Scheme Approval Resolution&#8221;);</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">&#8220;FOR&#8221; the proposal, at the EGM, to amend the Articles of Association of Avadel so that any Avadel Shares that are issued on or after [</font><font style="font-weight:normal;letter-spacing:0.2pt;">&#8226;</font><font style="letter-spacing:-0.2pt;">] on [</font><font style="font-weight:normal;letter-spacing:0.2pt;">&#8226;</font><font style="letter-spacing:-0.2pt;">], 202[</font><font style="font-weight:normal;letter-spacing:0.2pt;">&#8226;</font><font style="letter-spacing:-0.2pt;">] (&#8220;Voting Record Time&#8221;) to persons other than Alkermes or its nominees will either be subject to the terms of the Scheme or will be immediately and automatically acquired by Alkermes and/or its nominee(s) for the Scheme Consideration (the &#8220;Articles of Association Amendment Resolution&#8221;);</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">&#8220;FOR&#8221; the proposal, at the EGM, to approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction (the &#8220;Compensation Resolution&#8221;); and</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="font-weight:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">&#8220;FOR&#8221; the proposal, at the EGM, to approve any motion by the Chair of the EGM to adjourn the EGM, or any adjournments thereof, to solicit additional proxies in favor of the approval of the resolutions if there are insufficient votes at the time of the EGM to approve the Scheme Approval Resolution and the Articles of Association Amendment Resolution (the &#8220;EGM Adjournment Resolution&#8221;).</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:normal;">
            <font style="letter-spacing:0.2pt;">The Avadel Board considered many factors in making its determination that the Transaction Agreement and the transactions contemplated thereby, including the Scheme, are in the best interests of Avadel and Avadel Shareholders, and that the terms of the Scheme as contemplated by the Transaction Agreement are fair and reasonable. For a more complete discussion of these factors, see the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Recommendation of the Avadel Board and Avadel&#8217;s Reasons for the Transaction.</font><font style="letter-spacing:0.2pt;">&#8221; </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:normal;">
            <font style="letter-spacing:0.2pt;">In considering the recommendation of the Avadel Board, you should be aware that certain directors and executive officers of Avadel have interests in the Transaction that are in addition to, or different from, any interests they might have as shareholders. See the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction.</font><font style="letter-spacing:0.2pt;">&#8221; </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.2pt;">Opinion of Morgan Stanley &amp; Co. LLC (Page <a href="#tOOMS1">21</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:normal;">
            <font style="letter-spacing:0.2pt;">Avadel retained Morgan Stanley &amp;Co. LLC (&#8220;Morgan Stanley&#8221;) to provide it with financial advisory services in connection with a possible sale, merger or similar business combination, and, if requested by Avadel, a financial opinion with respect thereto. Avadel selected Morgan Stanley to act as its financial advisor </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-weight:normal;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">v</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tOOGS">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;font-weight:normal;">
            <font style="letter-spacing:0.2pt;">based on Morgan Stanley&#8217;s qualifications, expertise and reputation and its knowledge of the financial services industry, market and regulatory environment and business and affairs of Avadel. On October&#160;21, 2025, Morgan Stanley rendered its oral opinion, which was subsequently confirmed by delivery of a written opinion dated October&#160;21, 2025, to the Avadel Board, that, as of that date, and based upon and subject to the assumptions made, procedures followed, matters considered, and qualifications and limitations on the scope of review undertaken by Morgan Stanley as set forth therein, the Scheme Consideration to be received by the holders of Avadel Shares (other than Avadel Shares held by Alkermes or any persons deemed to be acting in concert with Alkermes pursuant to Rule&#160;3.3 of Part&#160;A of the Irish Takeover Rules (collectively, the &#8220;Excluded Shares&#8221;)) pursuant to the Transaction Agreement was fair from a financial point of view to such holders of Avadel Shares. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.2pt;">The full text of the written opinion of Morgan Stanley, dated October&#160;21, 2025, is attached as Annex C and incorporated by reference into this proxy statement. The opinion sets forth, among other things, the assumptions made, procedures followed, matters considered and qualifications and limitations on the scope of the review undertaken by Morgan Stanley in rendering its opinion. Avadel Shareholders are urged to, and should, read the opinion carefully and in its entirety. Morgan Stanley&#8217;s opinion was directed to the Avadel Board and addressed only the fairness, from a financial point of view to the holders of Avadel Shares (other than the holders of Excluded Shares) of the Scheme Consideration to be received by such holders pursuant to the Transaction Agreement as of the date of the opinion. Morgan Stanley&#8217;s opinion did not address any other aspect of the transactions contemplated by the Transaction Agreement. Morgan Stanley&#8217;s opinion did not address the relative merits of the transactions contemplated by the Transaction Agreement and the CVR Agreement as compared to other business or financial strategies that might be available to Avadel, nor did it address the underlying business decision of Avadel to enter into the Transaction Agreement or proceed with any other transaction contemplated by the Transaction Agreement and the CVR Agreement and does not constitute a recommendation to Avadel Shareholders as to how to act or vote in connection with the Transaction or any other matter or whether to take any other action with respect to the Transaction. The summary of Morgan Stanley&#8217;s opinion set forth in this proxy statement is qualified in its entirety by reference to the full text of the opinion. In addition, the opinion does not in any manner address the price at which the Avadel Shares will trade following the consummation of the Transaction or at any time.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.2pt;">For a description of the opinion that the Avadel Board received from Morgan Stanley, see the section of the proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:-0.2pt;">The Transaction&#8201;&#8212;&#8201;Opinion of Morgan Stanley &amp; Co. LLC</font><font style="letter-spacing:-0.2pt;">&#8221; beginning on page&#160;<a href="#tOOMS1">21</a>.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.2pt;">Opinion of Goldman Sachs &amp; Co. LLC (Page <a href="#tOOGS1">27</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:normal;">
            <font style="letter-spacing:0.2pt;">Goldman Sachs &amp; Co. LLC (&#8220;Goldman Sachs&#8221;) delivered its opinion to the Avadel Board that, as of October&#160;22, 2025 and based upon and subject to the factors and assumptions set forth therein, the Scheme Consideration to be paid to the holders (other than holders of Excluded Shares and their respective affiliates) of Avadel Shares pursuant to the Transaction Agreement was fair from a financial point of view to such holders of Avadel Shares. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.2pt;">The full text of the written opinion of Goldman Sachs, dated October&#160;22, 2025, which sets forth assumptions made, procedures followed, matters considered and limitations on the review undertaken in connection with the opinion, is attached as Annex D. Goldman Sachs provided advisory services and its opinion for the information and assistance of the Avadel Board in connection with its consideration of the Transaction. Goldman Sachs&#8217; opinion is not a recommendation as to how any holders of Avadel Shares should vote with respect to the Transaction or any other matter. Pursuant to an engagement letter between Avadel and Goldman Sachs, Avadel has agreed to pay Goldman Sachs a transaction fee of approximately $23&#160;million, $2&#160;million of which became payable upon the announcement of the Transaction, and the remainder of which is contingent on closing of the Transaction. Avadel has agreed to pay Goldman Sachs an additional $2&#160;million fee which is contingent upon the Milestone Payment (as defined below) being made. Goldman Sachs may receive an additional fee of up to $4&#160;million at Avadel&#8217;s sole discretion. Avadel has not yet determined whether to pay such additional fee to Goldman Sachs.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.2pt;">For a description of the opinion that the Avadel Board received from Goldman Sachs, see the section of the proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:-0.2pt;">The Transaction&#8201;&#8212;&#8201;Opinion of Goldman Sachs &amp; Co. LLC&#8221;</font><font style="letter-spacing:-0.2pt;"> beginning on page&#160;<a href="#tOOGS1">27</a>. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-weight:normal;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">vi</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tIOCP">&#8203;</a><a name="tCVRA">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Interests of Certain Persons in the Transaction (Page <a href="#tIOCP1">38</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In considering the recommendation of the Avadel Board with respect to the Transaction Agreement, you should be aware that certain of Avadel&#8217;s directors and executive officers have interests in the Transaction that are in addition to, or different from, any interests of Avadel Shareholders generally. Interests of Avadel&#8217;s directors and executive officers that may be in addition to, or different from, any interests of Avadel Shareholders include: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;font-style:italic;">
            <font style="font-style:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;font-style:italic;">
            <!--blacklining:none;-->
            <font style="font-style:normal;letter-spacing:0.2pt;">each Avadel equity award, including Avadel equity awards held by an executive officer or director, will receive the treatment described in the section entitled &#8220;</font><font style="letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction&#8201;&#8212;&#8201;Treatment of Equity Awards</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221;; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">each Avadel executive officer is party to an employment agreement that provides for severance benefits upon a qualifying termination of employment, including enhanced severance benefits if a qualifying termination of employment of the executive officer occurs in connection with a &#8220;change in control&#8221; &#8203;(which includes the Transaction) as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction&#8201;&#8212;&#8201;Severance Entitlements</font><font style="letter-spacing:0.2pt;">&#8221;; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">if the Completion occurs prior to the date that Avadel would normally pay annual bonuses for the 2025 fiscal year, each employee participating in Avadel&#8217;s corporate annual cash incentive program, including Avadel&#8217;s executive officers, will receive an annual bonus for the 2025 fiscal year as soon as practicable following the date of Completion at the greater of target or actual performance, as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction&#8201;&#8212;&#8201;2025 Annual Bonuses</font><font style="letter-spacing:0.2pt;">&#8221;; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Avadel may take certain tax-planning actions to mitigate potentially adverse tax consequences under the &#8220;golden parachute&#8221; provisions of Sections&#160;280G and 4999 of the U.S. Internal Revenue Code, as amended (the &#8220;Code&#8221;), that could arise in connection with Completion of the Transaction. The tax-planning and mitigation actions may include accelerating vesting of equity awards and/or payment of 2025 bonuses for Avadel executive officers, as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction&#8201;&#8212;&#8201;280G Mitigation Actions</font><font style="letter-spacing:0.2pt;">&#8221;; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">all Avadel employees, including Avadel executive officers, who continue as employees of Alkermes after the Completion are generally entitled to receive annual base salary or base wage rate (as applicable) and target annual cash bonus opportunity or target cash commission opportunity that are no less favorable, in the aggregate, than the annual base salary or base wage rate (as applicable) and target annual cash bonus opportunity or target cash commission opportunity in effect immediately prior to Completion (provided that each employee&#8217;s base salary or base wage rate (as applicable) shall also be independently no less than 95% of the annual base salary or base wage rate (as applicable) in effect immediately prior to Completion) and pension and welfare benefits that are, in the aggregate, no less favorable than the pension and welfare benefits provided to similarly situated employees of Alkermes through the earlier of the first anniversary of the Effective Time or the termination of the employee, as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction Agreement&#8201;&#8212;&#8201;Employee Matters</font><font style="letter-spacing:0.2pt;">&#8221;; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;font-style:italic;">
            <font style="font-style:normal;letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;font-style:italic;">
            <!--blacklining:none;-->
            <font style="font-style:normal;letter-spacing:0.2pt;">Avadel directors and executive officers are entitled to continued indemnification and insurance coverage under the Transaction Agreement as described in the section entitled &#8220;</font><font style="letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction&#8201;&#8212;&#8201;Directors&#8217; and Officers&#8217; Indemnification and Insurance.</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">These interests are discussed in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction.</font><font style="letter-spacing:0.2pt;">&#8221; The Avadel Board was aware of the additional or different interests set forth herein and considered such interests along with other matters in approving the Transaction Agreement and the Transaction. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Contingent Value Rights Agreement (Page <a href="#tCVR">64</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At or prior to the Effective Time, Alkermes and a duly qualified rights agent (the &#8220;Rights Agent&#8221;) will enter into a Contingent Value Rights Agreement (the &#8220;CVR Agreement&#8221;), in substantially the form included as Exhibit&#160;A to Annex&#160;A to this proxy statement, governing the terms of the CVRs issued pursuant to the </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">vii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMTCP">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Transaction Agreement. Pursuant to the Transaction Agreement, Alkermes will issue CVRs entitling the holder to receive the Milestone Payment (as defined below) upon the achievement of the Milestone (as defined below) to the record holders of (i)&#160;outstanding Avadel Shares, (ii)&#160;the Avadel Cash-Out Options, (iii)&#160;the Avadel RSU Awards and (iv)&#160;the Avadel Restricted Stock Awards. The Rights Agent will keep a register of the holders of CVRs. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Subject and pursuant to the terms of the CVR Agreement, each CVR will represent the contractual right to receive $1.50 per Avadel Share (the &#8220;Milestone Payment&#8221;), settleable in cash, with settlement conditioned upon the occurrence on or prior to 11:59&#160;p.m., U.S. Eastern Time on December&#160;31, 2028 (the &#8220;Milestone Expiration&#8221;) of each of: (1)&#160;final approval by the FDA of an application submitted to the FDA for the commercial marketing and sale of LUMRYZ</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> in the United States for the treatment of IH in adults (provided, that, such approval will be deemed achieved upon receipt of written notice from the FDA that LUMRYZ</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> has been approved for the treatment of IH in adults in the United States and which is not blocked by any third party orphan-drug exclusivity, regardless of whether any risk evaluation and mitigation strategies, or other conditions are imposed by the FDA, provided that such approval permits commercial marketing and sale of LUMRYZ</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> for the treatment of IH in adults in the United States) (the &#8220;LUMRYZ Approval&#8221;); and (2)&#160;the dismissal of certain specified claims with prejudice by the United States District Court for the District of Delaware pursuant to the Settlement and License Agreement, by and between Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited, on the one hand, and Avadel CNS Pharmaceuticals and Flamel Ireland Limited, on the other hand, dated October&#160;21, 2025 (the &#8220;Settlement Agreement&#8221;) (the &#8220;Legal Event&#8221; and, together with the LUMRYZ Approval, the &#8220;Milestone&#8221;). If the FDA has issued one or more orders that impose a clinical hold on the investigation of LUMRYZ for idiopathic hypersomnia, the Milestone shall not be deemed achieved unless or until no such order is in effect. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On October&#160;24, 2025, Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited, on the one hand, and Avadel CNS Pharmaceuticals and Flamel Ireland Limited jointly filed a stipulation to dismiss certain claims with prejudice, and on October&#160;27, 2025, the U.S. District Court for the District of Delaware entered the dismissal, thereby satisfying the Legal Event milestone under the CVR Agreement. Alkermes is obligated to use certain specified efforts and resources to achieve the Milestone until the earlier of achievement or the Milestone Expiration. However, there can be no assurance that the Milestone will be achieved or that the Milestone Payment will be made. CVRs are complex instruments and a number of factors will determine whether any amount will actually be paid to CVR holders in accordance with the terms of the CVR Agreement. If the Milestone is not achieved by the Milestone Expiration, then the CVRs will have no value. The minimum payment under each CVR is zero; if the Milestone Payment is made, the payment under each CVR is $1.50. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Material Tax Consequences of the Proposed Transaction (Page <a href="#tMTCO">47</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="font-style:normal;letter-spacing:0.2pt;">For Irish tax purposes, Avadel Shareholders that are neither resident nor ordinarily resident in Ireland for Irish tax purposes should not be liable for Irish capital gains tax, referred to as &#8220;Irish CGT,&#8221; on the disposal of their Avadel Shares pursuant to the Scheme unless such shares were used in or for the purposes of a trade carried on by the Avadel Shareholder in Ireland through a branch or agency, or were used or held or acquired for use by or for the purposes of the branch or agency. See the sections of this proxy statement entitled &#8220;</font><font style="letter-spacing:0.2pt;">Material Tax Consequences of the Proposed Transaction&#8201;&#8212;&#8201;Irish Tax Considerations&#8201;&#8212;&#8201;Taxation of Chargeable Gains</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="letter-spacing:0.2pt;">Part&#160;2&#8201;&#8212;&#8201;Explanatory Statement&#8201;&#8212;&#8201;Taxation.</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">For U.S. federal income tax purposes, the receipt of cash for Avadel Shares pursuant to the Scheme will be a taxable transaction, and a U.S. holder (as defined under the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Material Tax Consequences of the Proposed Transaction&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Considerations</font><font style="letter-spacing:0.2pt;">&#8221;) will generally recognize gain or loss equal to the difference, if any, between (i)&#160;the sum of the cash received in the Scheme and (ii)&#160;the U.S. holder&#8217;s adjusted tax basis in the Avadel Shares surrendered in exchange therefor. The amount of gain or loss a U.S. holder recognizes, and the timing and character of such gain or loss, also depends in part on the U.S. federal income tax treatment of the CVRs, with respect to which there is a significant amount of uncertainty. The potential treatment of the receipt of a CVR and the receipt of any cash pursuant to a CVR, by a holder of Avadel Shares is discussed in the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Material Tax Consequences of the Proposed Transaction&#8201;&#8212;&#8201;Irish Tax Considerations&#8221;</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">&#8220;Material Tax Consequences of the Proposed Transaction&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Considerations</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMTCO">47</a>. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">viii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tNDRP">&#8203;</a><a name="tRARP">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-indent:20pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Holders of Avadel Shares should read the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:-0.2pt;">Material Tax Consequences of the Proposed Transaction</font><font style="font-weight:normal;letter-spacing:0.2pt;">&#8221;</font><font style="letter-spacing:-0.2pt;"> for a more detailed discussion of certain Irish and U.S. federal income tax consequences of the Scheme. Tax matters can be complicated and the tax consequences to a particular holder will depend on such holder&#8217;s particular facts and circumstances. Holders of Avadel Shares are urged to consult their own tax advisors to determine the specific consequences to them of receiving cash pursuant to the Scheme.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">No Dissenters&#8217; Rights (Page <a href="#tNDR">46</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Under Irish law, Avadel Shareholders do not have appraisal or dissenters&#8217; rights with respect to the Transaction or any of the other transactions described in this proxy statement. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Regulatory Approvals Required (Page <a href="#tRAR">44</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Antitrust Matters</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the &#8220;HSR Act&#8221;), and the rules promulgated thereunder, certain transactions may not be completed until certain information and materials have been furnished to the Antitrust Division of the U.S. Department of Justice (&#8220;DOJ&#8221;) and the Federal Trade Commission (&#8220;FTC&#8221;) and the applicable HSR Act waiting period requirements have been satisfied. The waiting period under the HSR Act applicable to the Transaction is thirty (30) calendar days, unless the waiting period is terminated earlier or extended. If the DOJ or FTC issues a request for additional information and documentary materials (a &#8220;Second Request&#8221;), the parties must observe a second thirty (30)-day waiting period, which would begin to run only after both parties have substantially complied with such Second Request, unless the waiting period is terminated. The parties may also agree with the DOJ or FTC to not consummate the Transaction for a specified period of time. If any waiting period expires on a Saturday, Sunday or federal holiday, then the period is extended until 11:59&#160;p.m., U.S. Eastern Time on the next day that is not a Saturday, Sunday or federal holiday. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The Transaction is subject to the provisions of the HSR Act and therefore cannot be completed until each of Avadel and Alkermes file a notification and report form with the DOJ and the FTC under the HSR Act and the applicable waiting period (and any extension thereof) has expired or has been terminated. Avadel and Alkermes each filed a notification and report form with respect to the Transaction with the DOJ and the FTC under the HSR Act on November&#160;7, 2025. The waiting period with respect to the notification and report forms filed under the HSR Act is scheduled to expire at 11:59&#160;p.m., U.S. Eastern Time, on December&#160;8, 2025, unless extended or earlier terminated. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">At any time before or after consummation of the Transaction, notwithstanding the termination or expiration of the waiting period under the HSR Act, the DOJ, the FTC, state attorneys general or non-U.S. authorities could take such action under the Antitrust Laws as it deems necessary or desirable in the public interest, including seeking to preliminarily or permanently enjoin the Completion, seeking divestiture of substantial assets of Avadel and Alkermes, requiring the parties to license or hold separate assets or terminate existing relationships and contractual rights, or requiring the parties to agree to other remedies. Private parties may also seek to take legal action under the Antitrust Laws under certain circumstances, including by seeking to intervene in the regulatory process, to litigate to enjoin or overturn regulatory approvals, or to bring private actions to enjoin the Transaction. Any of these actions could impede or preclude obtaining regulatory approvals or consummating the Transaction. There can be no assurances that a challenge to the Transaction will not be made or that, if a challenge is made, Avadel will prevail. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Avadel and Alkermes have agreed to use reasonable best efforts to obtain the regulatory approvals required to consummate the Transaction, subject to certain limitations as set forth in the Transaction Agreement. Although Avadel expects that all required antitrust and foreign investment clearances and approvals will be obtained, there can be no assurances that these regulatory clearances and approvals will be timely obtained, obtained at all, or that the granting of these regulatory clearances and approvals will not involve the imposition of additional conditions, restrictions, qualifications, requirements or limitations on the Completion, including the requirement to divest assets, license or hold separate assets, or terminate existing relationships and contractual rights, or agree to other remedies, or require changes to the terms of the Transaction Agreement. These conditions or changes could result in the conditions to the Transaction not being satisfied.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ix</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCTTC">&#8203;</a><a name="tTOTT">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Irish High Court Approvals</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The Scheme requires the approval of the Irish High Court, which involves an application by Avadel to the Irish High Court to sanction the Scheme. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Conditions to the Completion of the Transaction (Page <a href="#CCTPP">69</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The Scheme and the closing of the Transaction are conditioned on the satisfaction (or waiver, as applicable) of among other things: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the passing of the Scheme Meeting Resolution at the Scheme Meeting; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the passing of the Scheme Approval Resolution and Articles of Association Amendment Resolution at the EGM; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the sanction of the Scheme by the Irish High Court; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">a copy of the order of the Irish High Court sanctioning the Scheme having been delivered for registration to the Irish Registrar of Companies; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the waiting period under the HSR Act having expired or having been earlier terminated and, to the extent applicable, any agreement between Avadel and Alkermes, on the one hand, and the FTC or the Antitrust Division of the DOJ, on the other hand, not to consummate the Scheme or the Transaction having expired or been earlier terminated; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">no government entity of competent jurisdiction having enacted, issued, promulgated, enforced or entered any law or order (whether temporary, preliminary or permanent) that is in effect and restrains, enjoins, makes illegal or otherwise prohibits the consummation of the Transaction; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the Transaction Agreement not having been terminated in accordance with its terms; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the accuracy of each of the parties&#8217; representations and warranties set forth in the Transaction Agreement, subject to certain materiality and material adverse effect exceptions; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the performance by each party, in all material respects, with all of such party&#8217;s covenants and agreements under the Transaction Agreement; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the CVR Agreement being in full force and effect. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Alkermes reserves the right, subject to the consent of the Irish Takeover Panel (if required), to effect the Transaction by way of a Takeover Offer. In the event the Transaction is structured as a Takeover Offer, such offer will be implemented on terms and conditions that are at least as favorable to the Avadel Shareholders and the Avadel equity award holders as those which would apply in relation to the Scheme (except for an acceptance condition set at eighty&#160;percent (80%) of the nominal value of the Avadel Shares to which such offer relates and which are not already beneficially owned by Alkermes or such lesser percentage (being more than fifty&#160;percent (50%)), as Alkermes may, with the consent of Avadel and the Irish Takeover Panel (if required) decide). </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The Transaction is also conditioned on the Scheme becoming effective and unconditional by not later than the End Date (as defined below) (or such earlier date as may be specified by the Irish Takeover Panel, or such later date as Alkermes and Avadel may, subject to receiving the consent of the Irish Takeover Panel and the Irish High Court, in each case if required, agree). In addition, the Scheme will lapse unless it is effective on or prior to the End Date (or such earlier date as may be specified by the Irish Takeover Panel, or such later date as Alkermes and Avadel may, subject to receiving the consent of the Irish Takeover Panel and the Irish High Court, in each case if required, agree). </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Termination of the Transaction Agreement (Page <a href="#tTOTTP">70</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The Transaction Agreement may be terminated and the transactions contemplated by the Transaction Agreement may be abandoned at any time prior to the Effective Time in any of the following ways: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">by mutual written consent of Avadel and Alkermes (subject to the consent of the Irish Takeover Panel, if required); </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">x</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRPPB">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:20pt; margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">by either Avadel or Alkermes: </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">if the Scheme Meeting has been completed and the Scheme Meeting Resolution has not been approved by the requisite vote and/or the EGM has been completed and the Scheme Approval Resolution and the Articles of Association Amendment Resolution have not been approved by the requisite votes; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">subject to certain exceptions, if the Transaction has not been consummated by 5:00&#160;p.m., New York City time, on July&#160;22, 2026 (or October&#160;22, 2026, if extended under certain circumstances in accordance with the Transaction Agreement) (the &#8220;End Date&#8221;); </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">if the Transaction is implemented by way of the Scheme, if the Irish High Court declines or refuses to sanction the Scheme, unless both parties agree in writing within thirty (30) days of such decision that the decision of the Irish High Court will be appealed (it having been agreed that Avadel will make such an appeal if requested by Alkermes and the counsel appointed by Alkermes and Avadel agree that doing so is a reasonable course of action); or </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">subject to certain exceptions, if there is in effect any applicable law or final and non-appealable order issued, promulgated, made, rendered or entered into by any governmental entity of competent jurisdiction, that permanently restrains, enjoins, makes illegal or otherwise prohibits the consummation of the Transaction; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">by Avadel: </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">if Alkermes breaches or fails to perform in any material respect any of its covenants or other agreements contained in the Transaction Agreement or if any of its representations or warranties set out in the Transaction Agreement are inaccurate such that the breach, failure to perform or inaccuracy (i)&#160;would result in the failure of certain closing conditions to be satisfied and (ii)&#160;is not reasonably capable of being cured by the End Date or, if curable, is not cured by the earlier of (x)&#160;the End Date and (y)&#160;thirty (30) days following written notice by Avadel; or </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">prior to obtaining the required approvals of the Avadel Shareholders at the Scheme Meeting and the EGM, if (i)&#160;the Avadel Board authorized Avadel to terminate the Transaction Agreement in response to an Avadel Superior Proposal (as defined below) and (ii)&#160;substantially concurrently with such termination, a definitive agreement providing for the consummation of the transaction contemplated by such Avadel Superior Proposal is duly executed and delivered by all parties thereto and Avadel pays Alkermes the Reimbursement Payment (as defined below); </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">by Alkermes: </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">if Avadel breaches or fails to perform in any material respect any of its covenants or other agreements contained in the Transaction Agreement or if any of its representations or warranties set out in the Transaction Agreement are inaccurate such that the breach, failure to perform or inaccuracy (i)&#160;would result in the failure of certain closing conditions to be satisfied and (ii)&#160;is not reasonably capable of being cured by the End Date or, if curable, is not cured by the earlier of (x)&#160;the End Date and (y)&#160;thirty (30) days following written notice by Alkermes; or </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">if, prior to obtaining the required approvals of the Avadel Shareholders at the Scheme Meeting and the EGM, an Avadel Board Change of Recommendation (as defined below) has occurred. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Reimbursement Payment</font><font style="font-weight:normal;letter-spacing:0.2pt;"> (</font><font style="letter-spacing:-0.2pt;">Page <a href="#tREIPAYP">71</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The Transaction Agreement also provides that, in the event of a termination of the Transaction Agreement under certain circumstances, Avadel will reimburse Alkermes for an amount equal to the documented, specific, quantifiable third-party costs and expenses incurred, directly or indirectly, by Alkermes or its subsidiaries, or on their behalf for the purposes of, in preparation for or in connection with the Transaction. The maximum amount payable by Avadel to Alkermes as expense reimbursement is equal to one&#160;percent (1%) of the aggregate value of the total Cash Consideration payable with respect to the Avadel Shares in connection with the Transaction. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">xi</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tFRTT">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Financing Relating to the Transaction</font><font style="font-weight:normal;letter-spacing:0.2pt;"> (</font><font style="letter-spacing:-0.2pt;">Page <a href="#tFRTT1">74</a>)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Alkermes estimates that it will need approximately $2.1&#160;billion in order to pay Avadel Shareholders the Cash Consideration due to them under the Transaction Agreement and to pay related fees, expenses and other transaction costs in connection with the Transaction. Alkermes anticipates that the funds needed to pay the foregoing amount will be derived from a combination of (i)&#160;cash on hand and (ii)&#160;borrowings under credit facilities, including as described in the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Financing</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Financing Relating to the Transaction</font><font style="letter-spacing:0.2pt;">&#8221;. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">xii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tQAAA">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">QUESTIONS AND ANSWERS ABOUT THE TRANSACTION AND THE SPECIAL MEETINGS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">The following questions and answers are intended to address briefly some commonly asked questions regarding the Transaction and the Special Meetings. These questions and answers highlight only some of the information contained in this proxy statement. They may not contain all the information that is important to you. You should read carefully this entire proxy statement, including the annexes and the documents incorporated by reference into this proxy statement, to understand fully the proposed transactions and the voting procedures for the Special Meetings. See also the section of this proxy statement entitled &#8220;Where You Can Find More Information.&#8221;</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">If you are in doubt about this offer, you should consult an independent financial advisor who, if you are taking advice in Ireland, is authorized or exempted under the European Communities (Markets in Financial Instruments) Regulations&#160;2017 (S.I. No. 375 of 2017).</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; line-height:12pt; margin-top:11.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:11.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">Why am I receiving this proxy statement?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">You, as an Avadel Shareholder, are receiving this proxy statement because Avadel and Alkermes entered into the Transaction Agreement on October&#160;22, 2025, pursuant to which, on the terms and subject to the conditions set forth therein, Alkermes has agreed to acquire the entire issued and to be issued share capital of Avadel, which Transaction will be implemented by means of the Scheme to be undertaken by Avadel under Chapter 1 of Part&#160;9 of the Companies Act. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The Irish High Court has ordered the convening of the Scheme Meeting in order to obtain shareholder approval of the Scheme. At [&#8226;] (Irish local time) on [&#8226;], 2026, or, if the Scheme Meeting has not concluded by [&#8226;] (Irish local time), as soon as possible after the conclusion of the Scheme Meeting (or any adjournment thereof), Avadel will hold the EGM in order to obtain shareholder approval of the resolutions necessary to implement the Scheme and related resolutions. </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">It will not be possible to complete the Transaction unless the requisite Avadel Shareholder approvals described above are obtained at each Special Meeting. However, as described below, the Transaction is not conditioned on approval of certain additional matters being presented at the EGM. For instance, the Completion is not conditioned on the approval of the Compensation Resolution or the EGM Adjournment Resolution. </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">This proxy statement includes important information about the Transaction, the Transaction Agreement (a copy of which is attached as Annex A) and the conditions appendix (a copy of which is attached as Annex B) and the Special Meetings. You should read this information carefully and in its entirety. If you are an Avadel Shareholder of record, the enclosed voting materials allow you to vote your Avadel Shares without attending each or either Special Meeting by granting a proxy or voting your shares by mail, telephone or over the Internet. If you hold your Avadel Shares through a bank, broker or other nominee (in &#8220;street name&#8221;), you should follow the instructions provided by your bank, broker or other nominee in order to instruct them how to vote such shares. </font>
          </div>
          <div style=" float:left; line-height:12pt; margin-top:11.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:11.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">When and where will each Special Meeting be held?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">The Scheme Meeting will be held at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland, on [&#8226;], 2026, at [&#8226;] (Irish local time). </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The EGM will be held at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland, on [&#8226;], 2026, at [&#8226;] (Irish local time) or, if the Scheme Meeting has not concluded by [&#8226;], as soon as possible after the conclusion of the Scheme Meeting (or any adjournment thereof). </font>
          </div>
          <div style=" float:left; line-height:12pt; margin-top:11.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:11.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">What will the Avadel Shareholders and holders of Avadel equity awards receive as consideration in the Transaction?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">As consideration for the Transaction, Avadel Shareholders will be entitled to receive the Scheme Consideration, which is (i) $18.50 in cash for each Avadel Share held by them as of the Effective Time, and (ii) a non-transferrable contingent value right entitling the Avadel Shareholder to a potential additional payment of $1.50 for each Avadel Share held by them as of the Effective Time, contingent </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">xiii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:20pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">upon the achievement of the specified milestone set forth in the CVR Agreement. Avadel&#8217;s equity awards will be treated as set forth in the Transaction Agreement, such that at the Effective Time: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">each Avadel Cash-Out Option (including each Avadel Performance-Based Option) that is outstanding as of immediately prior to the Effective Time, whether or not vested, will be cancelled and, in exchange therefor, the holder of such cancelled Avadel Cash-Out Option will be entitled to receive (without interest): (i)&#160;an amount in cash (less applicable tax and any other mandatory withholdings) equal to the product of (x)&#160;the total number of Avadel Shares subject to such Avadel Cash-Out Option immediately prior to the Effective Time, </font><font style="font-style:italic;letter-spacing:0.2pt;">multiplied</font><font style="letter-spacing:0.2pt;"> by (y)&#160;the excess of the Cash Consideration over the applicable exercise price per Avadel Share under such Avadel Cash-Out Option and (ii)&#160;one CVR for each Avadel Share subject to such Avadel Cash-Out Option immediately prior to the Effective Time (without regard to vesting); </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">each Avadel Option with an exercise price equal to or greater than the Cash Consideration that is outstanding immediately prior to the Effective Time, whether or not vested, will be cancelled for no consideration; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">each Avadel RSU Award that is outstanding will be cancelled and, in exchange therefor, the holder of such cancelled Avadel RSU Award will be entitled to receive (without interest): (i)&#160;an amount in cash (less applicable tax and any other mandatory withholdings) equal to the product of (x)&#160;the total number of Avadel Shares subject to such Avadel RSU Award immediately prior to the Effective Time multiplied by (y)&#160;the Cash Consideration and (ii)&#160;one CVR for each Avadel Share subject to such Avadel RSU Award immediately prior to the Effective Time (without regard to vesting); and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">each Avadel Restricted Stock Award, whether granted pursuant to the Avadel Share Plans or otherwise that is outstanding immediately prior to the Effective Time will vest in full as of immediately prior to the Effective Time and will be treated in the same manner as all other Avadel Shares. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">What is a CVR and how does it work?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Each CVR is a form of contingent consideration that will entitle the holder thereof to a payment from Alkermes equal to $1.50 per CVR (the Milestone Payment), in cash, without interest, subject to any applicable withholding taxes, if the Milestone is achieved by the Milestone Expiration, which is December&#160;31, 2028. If the Milestone is not achieved by such date, no payment will be made with respect to the CVR. If the FDA has issued one or more orders that impose a clinical hold on the investigation of LUMRYZ</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> for the treatment of IH in adults, the Milestone will not be deemed achieved unless or until no such order is in effect. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The right to payment described above is solely a contractual right governed by the terms and conditions of the CVR Agreement. The CVRs will not be evidenced by a certificate or other instrument, will not have any voting or dividend rights, will not represent any equity or ownership interests in Avadel or Alkermes and will not be transferable except in limited circumstances specified in the CVR Agreement. Any potential payout of the CVR is subject to various risks and uncertainties related to the development of LUMRYZ for the treatment of IH in adults and FDA clearances. Alkermes is obligated to use certain specified efforts and resources to achieve the Milestone until the earlier of achievement or the Milestone Expiration. There can be no assurance that the Milestone will be achieved prior to the Milestone Expiration or termination of the CVR Agreement, or that any payment will be required with respect to the Milestone and CVR. </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">For more information see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction Agreement&#8201;&#8212;&#8201;CVR Agreement.</font><font style="letter-spacing:0.2pt;">&#8221; </font>
          </div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">What proposals are being voted on at each Special Meeting and what shareholder vote is required to approve those proposals?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Scheme Meeting</font><font style="letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Among other proposals, Avadel Shareholders are being asked to vote on a proposal to approve the Scheme at both the Scheme Meeting and the EGM. The vote required for such proposal is different at each of the Special Meetings, however. As set out in full under the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Part&#160;2&#8201;&#8212;&#8201;Explanatory </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">xiv</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
            <font style="font-style:italic;letter-spacing:0.2pt;">Statement&#8201;&#8212;&#8201;Consents and Special Meetings,</font><font style="letter-spacing:0.2pt;">&#8221; in order for the Scheme Meeting Resolution to pass, it requires the approval at the Scheme Meeting by a majority in number of the Avadel Shareholders (as defined in </font><font style="font-style:italic;letter-spacing:0.2pt;">&#8220;Part&#160;3&#8201;&#8212;&#8201;The Scheme of Arrangement&#8221;</font><font style="letter-spacing:0.2pt;">), present and voting, either in person or by proxy, representing at least seventy-five percent (75%) in value of the Avadel Shares voted at such meeting, either in person or by proxy. The Scheme Meeting Adjournment Resolution requires the approval of at least a majority of the votes cast by the Avadel Shareholders (as defined in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Part 3&#8201;&#8212;&#8201;The Scheme of Arrangement</font><font style="letter-spacing:0.2pt;">&#8221;) present and voting either in person or by proxy, at the Scheme Meeting. </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Because the votes required to approve the proposals at the Scheme Meeting are based on votes properly cast at the meeting, and because abstentions and broker non-votes are not considered to be votes properly cast, abstentions and broker non-votes, along with failures to vote, will have no effect on such proposals. </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The Transaction is conditioned on approval of the Scheme at the Scheme Meeting. </font>
          </div>
          <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">EGM</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Set forth below is a table summarizing certain information with respect to the resolutions to be voted on at the EGM: </font>
          </div>
          <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:42.32pt;text-align:left;">
                <font style="letter-spacing:-0.16pt;">EGM </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Resolution # </font>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:261.44pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Resolution </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:65.99pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Ordinary or Special</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Resolution? </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:50.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Transaction</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Conditioned on</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Approval of</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Resolution? </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:1.917pt 0pt 0.833pt 0pt; width:42.32pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">1 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; width:261.44pt;white-space:normal;text-align:left;">
                <font style="letter-spacing:0.2pt;">Scheme Approval Resolution: To approve the Scheme and authorize the directors of Avadel to take all such actions as they consider necessary or appropriate for carrying the Scheme into effect. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; width:65.99pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Ordinary </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; width:50.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Yes </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:42.32pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">2 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:261.44pt;white-space:normal;text-align:left;">
                <font style="letter-spacing:0.2pt;">Articles of Association Amendment Resolution: To amend the Articles of Association of Avadel so that any Avadel Shares that are issued on or after the Voting Record Time to persons other than Alkermes or its nominee(s) will either be subject to the Scheme or will be immediately and automatically acquired by Alkermes and/or its nominee(s) for the Scheme Consideration. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:65.99pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Special </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:50.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Yes </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:42.32pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">3 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:261.44pt;white-space:normal;text-align:left;">
                <font style="letter-spacing:0.2pt;">Compensation Resolution: To approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:65.99pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Ordinary </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:50.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">No </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:42.32pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">4 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:261.44pt;white-space:normal;text-align:left;">
                <font style="letter-spacing:0.2pt;">EGM Adjournment Resolution: To approve any motion by the Chair of the EGM to adjourn the EGM, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the EGM to approve the Scheme Approval Resolution and the Articles of Association Amendment Resolution. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:65.99pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Ordinary </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:50.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">No</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
          <div style="margin-left:20pt; margin-top:7.5pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At the EGM, the requisite approval of each of the resolutions depends on whether it is (i)&#160;an &#8220;ordinary resolution&#8221; &#8203;(the Scheme Approval Resolution, the Compensation Resolution and the EGM Adjournment Resolution), which requires the approval of at least a majority of the votes cast by the registered holders of Avadel Shares present and voting (either in person or by proxy), or (ii)&#160;a &#8220;special resolution&#8221; &#8203;(the Articles of Association Amendment Resolution), which requires the approval of at least seventy-five&#160;percent (75%) of the votes cast by the registered holders of Avadel Shares present and voting (either in person or by proxy). </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As the votes required to approve each of the resolutions are based on votes properly cast at the EGM, and because abstentions and broker non-votes are not considered votes properly cast, abstentions and broker non-votes, along with failures to vote, will have no effect on the resolutions. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">xv</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As of the Voting Record Time, the Avadel directors and executive officers had the right to vote approximately [&#8226;] of the Avadel Shares then outstanding and entitled to vote at the Scheme Meeting and the EGM (representing [&#8226;]% of the Avadel Shares entitled to vote at each of the Special Meetings). The Avadel Board and executive officers who are shareholders of Avadel intend to vote &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; each of the proposals at the Scheme Meeting and each of the proposals at the EGM, although none of them have entered into any agreement or irrevocable commitment requiring them to do so. </font>
          </div>
          <div style=" float:left; line-height:12pt; margin-top:11.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:11.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">Why are there two Special Meetings?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Irish law requires that two separate shareholder meetings be held, the Scheme Meeting and the EGM. Both Special Meetings are necessary to cause the Scheme to become effective. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At the Scheme Meeting, Avadel Shareholders (excluding Alkermes and its affiliates, to the extent they hold Avadel Shares) will be asked to approve the Scheme for the purposes of satisfying the requirements of the Irish legislation upon which the Scheme is based. </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At the EGM, Avadel Shareholders (including Alkermes and any of its affiliates, to the extent they hold Avadel Shares) will also be asked to approve the Scheme, authorize Avadel&#8217;s directors to take whatever actions they deem necessary or appropriate for carrying the Scheme into effect and approve the Scheme and approve other related matters. For more detail on these matters, see the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Part&#160;1&#8201;&#8212;&#8201;The Transaction and The Special Meetings.</font><font style="letter-spacing:0.2pt;">&#8221; </font>
          </div>
          <div style=" float:left; line-height:12pt; margin-top:11.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:11.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">Is my vote important?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Yes. It is important that as many votes as possible are cast at the Scheme Meeting and the EGM (whether in person or by proxy) so that the Irish High Court can be satisfied that there is a fair and reasonable representation of the opinions of the Avadel Shareholders and to ensure that the views of the Avadel Shareholders are heard, in each case with respect to the matters prepared to be voted on at the Scheme Meeting. To ensure your representation at the Scheme Meeting and the EGM, you are requested to complete, sign and date the enclosed forms of proxy cards (or a form of proxy in such other form as may be permitted by Irish law) as promptly as possible and return them in the postage prepaid envelope enclosed for that purpose or vote by Internet or telephone in the manner provided below. If you attend the Scheme Meeting or the EGM in person, you may vote at such meeting even if you have previously returned a completed form of proxy or voted by Internet or telephone. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:11.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:11.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">What constitutes a quorum?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">A quorum is the minimum number of shares required to be represented, either by the appearance of the shareholder in person or through representation by proxy, to hold a valid meeting. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Five or more registered holders of Avadel Shares outstanding, present in person or by proxy, entitling them to exercise a majority of the voting power of Avadel at the Voting Record Time will constitute a quorum for each of the Special Meetings. Avadel does not hold any shares in treasury. Avadel&#8217;s inspector of election intends to treat as &#8220;present&#8221; for these purposes shareholders who have submitted properly executed or transmitted proxies that are marked &#8220;abstain.&#8221; The inspector will also treat as &#8220;present&#8221; shares held in &#8220;street name&#8221; by brokers that are voted on at least one proposal to come before the meetings. </font>
          </div>
          <div style=" float:left; line-height:12pt; margin-top:11.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:11.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">What is the recommendation of the Avadel Board regarding the proposals being put to a vote at each Special Meeting?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">The Avadel Board has unanimously approved the Transaction Agreement and determined that the Transaction Agreement and the transactions contemplated by the Transaction Agreement, including the Scheme, are in the best interests of Avadel and its shareholders and that the terms of the Scheme as contemplated by the Transaction Agreement are fair and reasonable. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The Avadel Board unanimously recommends that Avadel Shareholders vote: </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; the Scheme Meeting Resolution at the Scheme Meeting; </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">xvi</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:44pt; margin-left:12pt;width:456pt;">
          <div style="margin-left:20pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; any Scheme Meeting Adjournment Resolution at the Scheme Meeting; </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; the Scheme Approval Resolution at the EGM; </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; the Articles of Association Amendment Resolution at the EGM; </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; the Compensation Resolution at the EGM; and </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; any EGM Adjournment Resolution at the EGM. </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-style:italic;">
            <font style="font-style:normal;letter-spacing:0.2pt;">See the section of this proxy statement entitled &#8220;</font><font style="letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Recommendation of the Avadel Board and Avadel&#8217;s Reasons for the Transaction.</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">In considering the recommendation of the Avadel Board, you should be aware that certain directors and executive officers of Avadel have interests in the Transaction that are in addition to, or different from, any interests they might have as shareholders. See the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction.</font><font style="letter-spacing:0.2pt;">&#8221; </font>
          </div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">How will the Avadel Board and Executive Officers vote at the Special Meetings?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">As of the Voting Record Time, the full Avadel Board and executive officers had the right to vote approximately [&#8226;] of the then-outstanding Avadel Shares at the Special Meetings. The Avadel Board and executive officers who are shareholders of Avadel intend to vote &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; the Scheme Meeting Resolution at the Scheme Meeting, &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; any Scheme Meeting Adjournment Resolution at the Scheme Meeting, &#8220;FOR&#8221; the Scheme Approval Resolution at the EGM, &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; the Articles of Association Amendment Resolution at the EGM, &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; the Compensation Resolution at the EGM and &#8220;FOR&#8221; any EGM Adjournment Resolution at the EGM. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">Does the Avadel Board or executive officers have interests in the Transaction that are in addition to, or different from, any interests they might have as Avadel Shareholders?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">In considering the recommendation of the Avadel Board, you should be aware that certain directors and executive officers of Avadel have interests in the Transaction that are in addition to, or different from, any interests they might have as Avadel Shareholders. See the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction.</font><font style="letter-spacing:0.2pt;">&#8221; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">When is the Transaction expected to be completed?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">As of the date of this proxy statement, the Transaction is expected to be completed in the first quarter of 2026. However, no assurance can be provided as to when or if the Transaction will be completed. The required votes of Avadel Shareholders to adopt the required shareholder proposals at the Special Meetings, as well as the necessary regulatory consents and approvals, must first be obtained and other conditions specified in the conditions appendix must be satisfied or, to the extent applicable, waived. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">What happens if the Scheme is not completed?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">If the Scheme is not approved at the Special Meetings or the Transaction is not completed for any other reason, Avadel Shareholders will not be entitled to, nor will they receive, any Scheme Consideration. Instead, Avadel will remain an independent public company, Avadel Shares will continue to be listed and traded on Nasdaq Global and registered under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and it will continue to file periodic reports under the Exchange Act with the Securities and Exchange Commission (the &#8220;SEC&#8221;). Under certain specified circumstances, Avadel will be required to pay Alkermes for certain expenses following the termination of the Transaction Agreement, as described in the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction Agreement&#8201;&#8212;&#8201;Reimbursement Payment</font><font style="letter-spacing:0.2pt;">.&#8221; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">xvii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">Do you expect the Scheme to be taxable to Avadel Shareholders?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;">
            <font style="font-style:normal;letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;">
            <!--blacklining:none;-->
            <font style="font-style:normal;letter-spacing:0.2pt;">For Irish tax purposes, Avadel Shareholders that are neither resident nor ordinarily resident in Ireland for Irish tax purposes should not be liable for Irish capital gains tax, referred to as &#8220;Irish CGT,&#8221; on the disposal of their Avadel Shares pursuant to the Scheme unless such shares were used in or for the purposes of a trade carried on by the shareholder in Ireland through a branch or agency, or were used or held or acquired for use by or for the purposes of the branch or agency. See the sections of this proxy statement entitled &#8220;</font><font style="letter-spacing:0.2pt;">Material Tax Consequences of the Proposed Transaction&#8201;&#8212;&#8201;Irish Tax Considerations&#8201;&#8212;&#8201;Taxation of Chargeable Gains</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="letter-spacing:0.2pt;">Part&#160;2&#8201;&#8212;&#8201;Explanatory Statement&#8201;&#8212;&#8201;Taxation.</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The exchange of Avadel Shares for the Scheme Consideration pursuant to the Scheme generally will be a taxable transaction for U.S. federal income tax purposes. The amount of gain or loss a U.S. Holder (as defined in the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Material U.S. Federal Income Tax Consequences of the Scheme</font><font style="letter-spacing:0.2pt;">&#8221;) recognizes, and the timing and character of such gain or loss, depends in part on the U.S. federal income tax treatment of the CVRs, with respect to which there is a significant amount of uncertainty. We urge you to consult your tax advisor as to the particular tax consequences to you of the receipt of cash and CVRs in exchange for Avadel Shares pursuant to the Scheme. </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Holders of Avadel Shares should read the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:-0.2pt;">Material Tax Consequences of the Proposed Transaction</font><font style="font-weight:normal;letter-spacing:0.2pt;">&#8221; </font><font style="letter-spacing:-0.2pt;">for a more detailed discussion of certain Irish and U.S. federal income tax consequences of the Scheme. Tax matters can be complicated and the tax consequences to a particular holder will depend on such holder&#8217;s particular facts and circumstances. Holders of Avadel Shares are urged to consult their own tax advisors to determine the specific consequences to them of receiving cash pursuant to the Scheme.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">Who can attend and vote at the Special Meetings?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">The Avadel Board has fixed a record date as the Voting Record Time, which is [&#8226;] (U.S. Eastern Time) on [&#8226;], 202[&#8226;]. If you were an Avadel Shareholder of record at the Voting Record Time, you are entitled to receive notice of, attend, speak and vote at the Special Meetings and any adjournments thereof. Attending the Scheme Meeting and the EGM in person is a requirement to vote in person (as opposed to by proxy) at such meetings. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">What if I sell my Avadel Shares after the Voting Record Time?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">If you transfer your shares after the Voting Record Time but before either Special Meeting, you will retain your right to vote at both Special Meetings, but will have transferred the right to receive the Scheme Consideration. In order to receive the Scheme Consideration, you must hold your shares through the Completion. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">What if I buy Avadel Shares after the Voting Record Time?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">If you acquire additional Avadel Shares after the Voting Record Time, you will not have the right to vote in respect of those additional Avadel Shares at either Special Meeting. You will have the right to receive the Scheme Consideration in respect of those additional Avadel Shares if you hold such shares through the Completion. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">What is a proxy?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">A proxy is a legal authorization by a shareholder of record to vote shares he, she or it owns on his, her or its behalf. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">How do I vote?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">If you are an Avadel Shareholder of record, you will receive two proxy cards (one for the Scheme Meeting and one for the EGM). You may vote your Avadel Shares in one of the following ways: </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">by mailing your applicable completed and signed proxy card in the enclosed return envelope; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">by voting by telephone or over the Internet as instructed on the applicable enclosed proxy card; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">xviii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:42pt; margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">by handing your applicable completed and signed proxy card to the Chair of the applicable Special Meeting before the start of the applicable Special Meeting; or </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">by attending the applicable Special Meeting and voting in person. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">If you are an Avadel Shareholder of record, the Avadel Shares listed on your proxy cards will include, if applicable, Avadel Shares held in a book-entry account at Computershare Trust Company, N.A., Avadel&#8217;s transfer agent.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">If you hold your shares through a bank, broker or other nominee (i.e., in &#8220;street name&#8221;), you should follow the instructions provided by your bank, broker or other nominee in order to instruct them how to vote such shares. The bank, broker or other nominee, as applicable may have an earlier deadline by which you must provide instructions to it as to how to vote such shares, so you should carefully read the materials provided to you by your bank, broker or other nominee.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">In the case of joint holders, the vote of the senior holder who tenders a vote, whether in person or by proxy, will be accepted to the exclusion of the votes of the other joint holders of record and, for this purpose, seniority will be determined by the order in which the names appear in Avadel&#8217;s register of members in respect of the joint holding.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">What is the difference between holding shares as a record owner and as a beneficial owner?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">If your Avadel Shares are registered directly in your name with Avadel&#8217;s transfer agent, Computershare Trust Company, N.A., you are considered the shareholder of record with respect to such shares and access to the proxy materials is being provided directly to you. If your Avadel Shares are held by a bank, in a stock brokerage account or by another nominee, then you are considered the beneficial owner of such shares, which are considered to be held in &#8220;street name.&#8221; Access to proxy materials is being provided to you by your bank, broker or other nominee. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">If my shares are held in &#8220;street name&#8221; by my bank, broker or other nominee, will my bank, broker or other nominee automatically vote my shares for me?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">No. Brokers do not have discretionary authority to vote on any of the proposals at either the Scheme Meeting or the EGM. As a result, if you hold Avadel Shares in a stock brokerage account or if your shares are held by a bank, broker or other nominee, your bank, broker or other nominee will not vote your shares if you do not provide your bank, broker or other nominee with a signed voting instruction form with respect to your shares. Therefore, you should instruct your bank, broker or other nominee to vote your shares by following the directions your bank, broker or other nominee provides. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">A &#8220;broker non-vote&#8221; occurs when a broker submits a proxy that states that the broker does not vote for one or more of the proposals because (i)&#160;the broker has not received instructions from the beneficial owner on how to vote the applicable shares with respect to those proposals and (ii)&#160;the broker does not have discretionary authority to vote the shares in the absence of instructions. As brokers will not have discretionary authority to vote on any of the proposals at either the Scheme Meeting or the EGM, no &#8220;broker non-votes&#8221; can occur at either of the Special Meetings. </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-style:italic;">
            <font style="font-style:normal;letter-spacing:0.2pt;">Please see the section of this proxy statement entitled &#8220;</font><font style="letter-spacing:0.2pt;">Part&#160;1&#8201;&#8212;&#8201;The Transaction and The Special Meetings&#8201;&#8212;&#8201;The Special Meetings of Avadel&#8217;s Shareholders&#8201;&#8212;&#8201;Voting Ordinary Shares Held in Street Name.</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; </font>
          </div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">How many votes do I have?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">At each Special Meeting, you are entitled to one vote for each Avadel Share that you owned as of the Voting Record Time. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">xix</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">What do I need to do now?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Avadel Shareholders entitled to vote at the Voting Record Time have been sent a form of proxy card for each of the Special Meetings. Avadel Shareholders are strongly urged to complete and return their proxy cards as soon as possible and, in any event, no later than 11:59&#160;p.m. (Irish local time) (being 6:59&#160;p.m. U.S. Eastern Time) on [&#8226;], 202[&#8226;]. Even if you plan to attend either or both Special Meetings in person, you are encouraged to vote by proxy before the Special Meeting(s) that you plan to attend. After carefully reading and considering the information contained in this proxy statement, including the annexes and the documents incorporated by reference herein, please submit your proxy or proxies by telephone or over the Internet in accordance with the instructions set forth on the relevant enclosed proxy cards or mark, sign and date the applicable proxy card and return them in the enclosed prepaid envelope as soon as possible so that your Avadel Shares may be voted at the applicable Special Meeting. Your proxy card or your telephone or Internet directions will instruct the persons identified as your proxy to vote your Avadel Shares at the applicable Special Meeting as directed by you. Each proxy card may also be handed to the Chair of the Scheme Meeting or the EGM, as applicable, before the start of the applicable Special Meeting and will still be valid. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">If a shareholder signs and returns his, her or its proxy card appointing the Chair of the applicable Special Meeting as his, her or its proxy but does not mark the proxy card to tell the proxy how to vote on a voting item, such Avadel Shares will be voted in respect of such voting item at the discretion of the Chair of the applicable Special Meeting. </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">If you hold your Avadel Shares through a bank, broker or other nominee (i.e., in &#8220;street name&#8221;), you should follow the instructions provided by your bank, broker or other nominee in order to instruct them how to vote such Avadel Shares. </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">If you are a registered shareholder, please sign the relevant proxy cards exactly as your name appears on the card. In the case of joint holders, the vote of the senior holder who tenders a vote, whether in person or by proxy, will be accepted to the exclusion of the vote(s) of the other joint holder(s) and, for this purpose, seniority will be determined by the order in which the names stand in Avadel&#8217;s register of members in respect of the joint holding. If you are an Avadel Shareholder of record that is a corporation, limited liability company or partnership, the form of proxy must either be under the common seal of such entity or under the hand of an officer or attorney, duly authorized. If the relevant proxy cards are signed pursuant to a power of attorney or other authority, such power or authority (or a duly certified copy of such power or authority) must be deposited with Avadel together with the instrument of proxy. </font>
          </div>
          <div style=" float:left; line-height:12pt; margin-top:11.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:11.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">May I change my vote after I have mailed my signed proxy cards or voted by telephone or over the Internet?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Yes, you may change your vote at any time before your proxy is voted at the Scheme Meeting or at any time before your proxy is voted at the EGM. If you are a registered shareholder (i.e., a shareholder who holds shares directly with Avadel&#8217;s transfer agent in his, her or its own name), you may revoke your proxy before the applicable Special Meeting by: </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">submitting a new proxy with a later date; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">providing written notice that you have revoked your proxy to the Avadel Company Secretary, as applicable, so that it is received anytime up to 11:59&#160;p.m. (Irish local time) (being 6:59&#160;p.m. U.S. Eastern Time) on [&#8226;], 202[&#8226;] at the following address: </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Avadel Pharmaceuticals plc </font> <br ><font style="letter-spacing:0.2pt;">Ten Earlsfort Terrace </font> <br ><font style="letter-spacing:0.2pt;">Dublin 2, D02 T380, Ireland </font> <br ><font style="letter-spacing:0.2pt;">Attention: Company Secretary </font></div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">submitting a new vote by telephone or Internet up to 11:59&#160;p.m. (Irish local time) (being 6:59&#160;p.m. U.S. Eastern Time) on [&#8226;], 202[&#8226;]; or </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">voting in person at the applicable Special Meeting. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">xx</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:20pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">If you are a beneficial shareholder (i.e., your shares are held in the name of a bank, broker or other nominee, sometimes referred to as holding shares in &#8220;street name&#8221;), follow the voting instructions provided to you by your bank, broker or other nominee to determine how you may change your vote or revoke your proxy. </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Simply attending the applicable Special Meeting, however, will not revoke your proxy or change your voting instructions; you must vote by ballot at the applicable Special Meeting to change your vote. </font>
          </div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">Who can help answer my questions?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">If you have questions about the Transaction, or if you need assistance in submitting your proxy or voting your shares or need additional copies of this proxy statement or the enclosed proxy cards, you should contact Innisfree M&amp;A Incorporated, the proxy solicitation agent for Avadel, by mail at 501&#160;Madison Ave Floor 20 New York, NY 10022 or by telephone at (877) 687-1874 (for Avadel Shareholders in the U.S. and Canada) or +1 (412) 232-3651 (for Avadel Shareholders outside the U.S. and Canada). </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">If your shares are held by a broker, bank or other nominee, you should contact your broker, bank or other nominee for additional information. </font>
          </div>
          <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
            <!--blacklining:none;-->
            <font style="letter-spacing:-0.2pt;">Where can I find more information about Avadel?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">You can find more information about Avadel from various sources described under &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Where You Can Find More Information.</font><font style="letter-spacing:0.2pt;">&#8221;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">xxi</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCSRF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This proxy statement and the documents incorporated by reference herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, that is, statements related to future, not past, events that reflect Avadel&#8217;s current expectations regarding its future growth, results of operations, business strategy and plans, financial condition, cash flows, performance, development plans and timelines, business prospects and opportunities, as well as assumptions made by, and information currently available to, its management. Forward-looking statements include any statement that does not directly relate to a current or historical fact. These forward-looking statements are often identified by words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;seek,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;can,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;likely,&#8221; &#8220;depend,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;target,&#8221; and similar expressions, and may include references to assumptions and relate to Avadel&#8217;s future prospects, developments and business strategies, and the Transaction. Such forward-looking statements include, but are not limited to, statements relating to the Transaction involving Alkermes and Avadel, Avadel&#8217;s current expectations and estimates about the expected effects and anticipated benefits of the Transaction, the date of the Completion, including the parties&#8217; ability to satisfy the conditions to the consummation of the Transaction and the other conditions set forth in the transaction agreement, and Avadel&#8217;s business activities and strategies. Avadel&#8217;s expectations and beliefs regarding these matters may not materialize. Actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of uncertainties, risks, and changes in circumstances, including but not limited to risks and uncertainties related to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the failure to obtain the required vote of Avadel Shareholders to approve the Scheme Approval Resolution or Articles of Association Amendment Resolution; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the risk that the required regulatory approvals for the Transaction are not obtained, are delayed or are subject to conditions that are not anticipated that could reduce the anticipated benefits of or cause the parties to abandon the Transaction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the inability of the parties to satisfy the other conditions to, and to complete, the Transaction in a timely manner or at all; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the occurrence of any event, change or other circumstance that could give rise to the termination of the Transaction Agreement, including in circumstances that would require payment by Avadel of a termination fee; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the possibility that alternative acquisition proposals for Avadel&#8217;s business will be made; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">significant Transaction costs, fees, expenses and charges; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the risk of litigation and/or regulatory actions related to the Transaction or unfavorable results from litigation and proceedings that could arise in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">risks related to disruption of management&#8217;s attention from Avadel&#8217;s ongoing business operations due to the pendency of the Transaction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the effect of the announcement of the Transaction on Avadel&#8217;s business relationships, operating results and business generally; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the inherent uncertainty with financial or other forecasts or projections; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the impact of the Transaction not being completed on Avadel and its business and shareholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">uncertainties related to Avadel&#8217;s, Alkermes&#8217; or their affiliates ability to achieve the Milestone set forth in the CVR Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s ability to successfully commercialize LUMRYZ in the United States for the treatment of cataplexy or EDS in patients seven&#160;years of age and older with narcolepsy; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s plans with respect to our commercial infrastructure and marketing, market access and commercial activities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s ability to maintain and receive additional regulatory approvals for LUMRYZ in any other jurisdictions outside the U.S., and any related restrictions, limitations, and/or warnings in the label of LUMRYZ; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">xxii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:66pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s expectations regarding the rate and degree of market acceptance for LUMRYZ; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s ability to enter into strategic partnerships for the commercialization, manufacturing and distribution of LUMRYZ in the U.S.; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s reliance on a single marketed product, LUMRYZ; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s expectations regarding timing of and our ability to execute the pivotal REVITALYZ trial of LUMRYZ in IH; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s ability to seek, maintain and receive additional U.S. regulatory approvals as well as commercialize LUMRYZ for indications beyond narcolepsy, including IH; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s dependence on a limited number of suppliers for the manufacturing of LUMRYZ and certain raw materials used in LUMRYZ and any failure of such suppliers to produce LUMRYZ or deliver sufficient quantities of such raw materials, which could have a material adverse effect on our business, including commercialization of LUMRYZ in the U.S.; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s ability to finance our operations on acceptable terms, either through the raising of capital including the incurrence of convertible or other indebtedness, issuance of equity or royalty-based financings, or through strategic financing or commercialization partnerships; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s expectations regarding the pricing and reimbursement and the extent to which patient financial assistance programs are utilized for LUMRYZ; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s expectations about the potential market size and market participation for LUMRYZ; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s expectations regarding the continued profitability of LUMRYZ; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s expectations regarding our cash runway to support the commercialization of LUMRYZ in the U.S.; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the potential impacts of tariffs, inflation and rising interest rates on our business and future operating results; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s ability to hire and retain key members of our leadership team and other personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the potential impacts due to global political instability and conflicts, such as terrorism, civil unrest, war and natural disasters in foreign countries on our business, financial condition and results of operations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the potential impact of changes in political conditions or financial markets, including new or increased trade restrictions, tariffs, or policies, as well as disruptions in securities, credit, or capital markets in the U.S. or abroad, which could result from government shutdowns or other events; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">competition existing today or that may arise in the future. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Although Avadel believes that the expectations reflected in its forward-looking statements are reasonable, Avadel cannot guarantee future results, events, levels of activity, performance or achievement. Avadel undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The above list of factors is not exhaustive. You should carefully consider the factors and the other risks and uncertainties that affect the businesses described in Avadel&#8217;s most recent Annual Report on Form 10-K and other documents filed from time to time with the SEC or incorporated herein by reference.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">xxiii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tP1TT">&#8203;</a><a name="tTSMO">&#8203;</a><a name="tOVE">&#8203;</a><a name="tDTAP">&#8203;</a><a name="tATT">&#8203;</a><a name="tPRO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PART 1&#8201;&#8212;&#8201;THE TRANSACTION AND THE SPECIAL MEETINGS </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE SPECIAL MEETINGS OF AVADEL&#8217;S SHAREHOLDERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This proxy statement is being provided to Avadel Shareholders as part of a solicitation of proxies by the Avadel Board for use at the Special Meetings of Avadel Shareholders referred to below and at any adjournments of such meetings. This proxy statement is being furnished to Avadel Shareholders on or about&#160;[&#8226;], 202[&#8226;] and provides Avadel Shareholders with information they need to be able to vote or instruct their vote to be cast at the Special Meetings. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Date, Time and Place of the Special Meetings</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Scheme Meeting has been scheduled for [&#8226;], 2026 at [&#8226;] (Irish local time), at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin&#160;2, D02 T380, Ireland. Avadel has also convened the EGM for [&#8226;], 2026 at [&#8226;] (Irish local time), at the offices of Arthur Cox&#160;LLP, Ten Earlsfort Terrace, Dublin&#160;2, D02 T380, Ireland, or, if the Scheme Meeting has not concluded by [&#8226;] (Irish local time), as soon as possible after the conclusion of the Scheme Meeting (or any adjournment thereof). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Attendance</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Attendance at the Special Meetings is limited to Avadel Shareholders at the Voting Record Time. Please indicate on the enclosed proxy cards if you plan to attend the Special Meetings. If your shares are held through a bank, broker or other nominee and you would like to attend, please write to Avadel Pharmaceuticals plc, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland, Attention: Company Secretary, or bring to the applicable meeting a statement or a letter from the bank, broker or other nominee confirming your beneficial ownership of your Avadel Shares as of the Voting Record Time for the meetings. Any beneficial holder who plans to vote at either meeting must obtain a legal proxy from his or her bank, broker or other nominee and should contact such bank, broker or other nominee for instructions on how to obtain a legal proxy. Each Avadel Shareholder may be asked to provide a valid picture identification, such as a driver&#8217;s license or passport and proof of ownership as of the Voting Record Time. The use of cell phones, smartphones, pagers, recording and photographic equipment will not be permitted in the meeting rooms. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proposals</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme Meeting</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;Avadel Shareholders (excluding Alkermes or any of its affiliates, to the extent they hold Avadel Shares) are being asked to consider and vote on a proposal at the Scheme Meeting to approve the Scheme and, if proposed, to approve any motion by the Chair to adjourn the Scheme Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Scheme Meeting to approve the Scheme Meeting Resolution. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Transaction is conditioned on the approval of the Scheme Meeting Resolution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Transaction is </font><font style="font-weight:bold;letter-spacing:-0.2pt;">not</font><font style="letter-spacing:0.2pt;"> conditioned on the approval of the Scheme Meeting Adjournment Resolution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">EGM</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;Avadel Shareholders (including Alkermes and any of its affiliates, to the extent they hold Avadel Shares) are also being asked to consider and vote on a proposal at the EGM to approve the Scheme, in addition to certain other proposals as set forth in the resolutions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Transaction is conditioned on approval of the Scheme Approval Resolution and the Articles of Association Amendment Resolution. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Scheme Approval Resolution:&nbsp;&nbsp;&nbsp;To approve the Scheme and authorize the directors of Avadel to take all such actions as they consider necessary or appropriate for carrying the Scheme into effect. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Articles of Association Amendment Resolution:&nbsp;&nbsp;&nbsp;To amend the Articles of Association of Avadel so that any Avadel Shares that are issued on or after the Voting Record Time and prior to the Scheme Record Time will be issued subject to the terms of the Scheme and bound by it, and any </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRDOO">&#8203;</a><a name="tQUO">&#8203;</a><a name="tOSOA">&#8203;</a><a name="tVRRO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel Shares issued on or after the Scheme Record Time will be automatically transferred to Alkermes and/or its nominee(s) free of all encumbrances in exchange for the Scheme Consideration. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Transaction is </font><font style="font-weight:bold;letter-spacing:-0.2pt;">not</font><font style="letter-spacing:0.2pt;"> conditioned on approval of the remaining resolutions. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Compensation Resolution:&nbsp;&nbsp;&nbsp;To approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">EGM Adjournment Resolution:&nbsp;&nbsp;&nbsp;To approve any motion by the Chair to adjourn the EGM, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the EGM to approve the Scheme Approval Resolution and the Articles of Association Amendment Resolution. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Record Date; Outstanding Ordinary Shares; Ordinary Shares Entitled to Vote</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Only holders of Avadel Shares as of the Voting Record Time, which is [&#8226;] (U.S. Eastern Time) on [&#8226;], 202[&#8226;], will be entitled to notice of, and to vote at the Special Meetings or any adjournments thereof. At the Voting Record Time, there were [&#8226;] Avadel Shares outstanding, held by [&#8226;] holders of record. Each outstanding Avadel Share (other than, only in the case of the Scheme Meeting, any Avadel Shares held by Alkermes or any subsidiary of Alkermes) is entitled to one vote on each proposal and any other matter properly coming before the Special Meetings. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Quorum</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Five or more registered holders of Avadel Shares, present in person or by proxy, entitling them to exercise a majority of the voting power of Avadel at the relevant meeting will constitute a quorum for each of the Special Meetings. Avadel does not hold any shares in treasury. Avadel&#8217;s inspector of election intends to treat as &#8220;present&#8221; for these purposes shareholders who have submitted properly executed or transmitted proxies that are marked &#8220;abstain.&#8221; The inspector will also treat as &#8220;present&#8221; shares held in &#8220;street name&#8221; by brokers that are voted on at least one proposal to come before the meeting. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Ordinary Share Ownership and Voting by Avadel&#8217;s Directors and Officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the Voting Record Time, the full Avadel Board and executive officers had the right to vote approximately [&#8226;] of the then-outstanding Avadel Shares at the Special Meetings. The Avadel Board and executive officers who are shareholders of Avadel intend to vote &#8220;FOR&#8221; the Scheme Meeting Resolution at the Scheme Meeting, &#8220;FOR&#8221; any Scheme Meeting Adjournment Resolution at the Scheme Meeting, &#8220;FOR&#8221; the Scheme Approval Resolution at the EGM, &#8220;FOR&#8221; the Articles of Association Amendment Resolution at the EGM, &#8220;FOR&#8221; the Compensation Resolution at the EGM and &#8220;FOR&#8221; the EGM Adjournment Resolution at the EGM. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Vote Required; Recommendation of the Avadel Board</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Scheme Meeting</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Proposal to approve the Scheme</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;Avadel Shareholders (excluding Alkermes and any subsidiaries of Alkermes, to the extent they hold Avadel Shares) are being asked to vote on a proposal to approve the Scheme at both the Scheme Meeting and the EGM. The vote required for such proposal is different at each&#160;of the meetings, however. As set out in full under the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Part&#160;2&#8201;&#8212;&#8201;Explanatory Statement &#8212; Consents and Special Meetings</font><font style="letter-spacing:0.2pt;">&#8221; in order for the Scheme Meeting Resolution to pass, it requires the approval at the Scheme Meeting by a majority in number of the Avadel Shareholders present, and voting, either in person or by proxy, representing at least seventy-five&#160;percent (75%) in value of the Avadel Shares voted at such meeting, either in person or by proxy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Scheme Meeting Adjournment Resolution requires the approval of at least a majority of the votes cast by the Avadel Shareholders present and voting, in person or by proxy, at the Scheme Meeting. Because the votes required to approve the Scheme Meeting Resolution and the Scheme Meeting Adjournment Resolution are based on votes properly cast at the meeting, and because abstentions and broker non-votes </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">are not considered votes properly cast, abstentions and broker non-votes, along with failures to vote, will have no effect on such proposals. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Transaction is conditioned on the approval of the Scheme Meeting Resolution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Transaction is </font><font style="font-weight:bold;letter-spacing:-0.2pt;">not </font><font style="letter-spacing:0.2pt;">conditioned on the approval of the Scheme Meeting Adjournment Resolution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Avadel Board recommends that Avadel Shareholders vote &#8220;FOR&#8221; the proposals to approve each of the resolutions to be voted upon at the Scheme Meeting.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In considering the recommendation of the Avadel Board, you should be aware that certain directors and executive officers of Avadel have interests in the Transaction that are in addition to, or different from, any interests they might have as shareholders. See the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction.</font><font style="letter-spacing:0.2pt;">&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EGM</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Set forth below is a table summarizing certain information with respect to the resolutions to be voted upon at the EGM: </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:42.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Resolution # </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:261.44pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Resolution </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:65.99pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary or Special</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Resolution? </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:50.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Transaction</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Conditioned on</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Approval of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Resolution? </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:42.32pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:261.44pt;white-space:normal;text-align:left;">
              <font style="letter-spacing:0.2pt;">Scheme Approval Resolution: To approve the Scheme and authorize the directors of Avadel to take all such actions as they consider necessary or appropriate for carrying the Scheme into effect. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:65.99pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Ordinary </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:50.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Yes </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:42.32pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:261.44pt;white-space:normal;text-align:left;">
              <font style="letter-spacing:0.2pt;">Articles of Association Amendment Resolution: To amend the Articles of Association of Avadel so that any Avadel Shares that are issued on or after the Voting Record Time to persons other than Alkermes or its nominee(s) will either be subject to the Scheme or will be immediately and automatically acquired by Alkermes and/or its nominee(s) for the Scheme Consideration. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:65.99pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Special </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:50.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Yes </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:42.32pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:261.44pt;white-space:normal;text-align:left;">
              <font style="letter-spacing:0.2pt;">Compensation Resolution: To approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:65.99pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Ordinary </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:50.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">No </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:42.32pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">4 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:261.44pt;white-space:normal;text-align:left;">
              <font style="letter-spacing:0.2pt;">EGM Adjournment Resolution: To approve any motion by the Chair of the EGM to adjourn the EGM, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the EGM to approve the Scheme Approval Resolution and the Articles of Association Amendment Resolution. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:65.99pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Ordinary </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:50.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">No</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8.89pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the EGM, the requisite approval of each of the resolutions depends on whether it is (i)&#160;an &#8220;ordinary resolution&#8221; &#8203;(the Scheme Approval Resolution, the Compensation Resolution and the EGM Adjournment Resolution</font><font style="font-weight:bold;letter-spacing:-0.2pt;">)</font><font style="letter-spacing:0.2pt;">, which requires the approval of at least a majority of the votes cast by the registered holders of Avadel Shares present and voting in person or by proxy, or a &#8220;special resolution&#8221; &#8203;(the Articles of Association Amendment Resolution), which requires the approval of at least seventy-five&#160;percent (75%) of the votes cast by the registered holders of Avadel Shares present and voting, in person or by proxy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As the votes required to approve each of the resolutions are based on votes properly cast at the EGM, and because abstentions and broker non-votes are not considered votes properly cast, abstentions and broker non-votes, along with failures to vote, will have no effect on the resolutions. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tVYOS">&#8203;</a><a name="tVOSH">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Avadel Board recommends that Avadel Shareholders vote &#8220;FOR&#8221; the proposals to approve each of the resolutions to be voted upon at the EGM.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In considering the recommendations of the Avadel Board described above, you should be aware that certain directors and executive officers of Avadel have interests in the Transaction that are in addition to, or different from, any interests they might have as shareholders. See the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction.</font><font style="letter-spacing:0.2pt;">&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting Your Ordinary Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel Shareholders of record may vote by proxy or in person at each Special Meeting. Avadel recommends that you submit your proxy even if you plan to attend either or both of the Special Meetings. If you vote by proxy, you may change your vote, among other ways, if you attend and vote at the applicable Special Meeting. Completion and return of a form of proxy will not preclude an Avadel Shareholder of record from attending and voting in person at the Scheme Meeting or the EGM, or any adjournments thereof, if that Avadel Shareholder wishes to do so. Any alteration to the form of proxy must be initialed by the person who signs it. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you own shares in your own name, you are considered, with respect to those shares, the &#8220;shareholder of record.&#8221; If your shares are held in a stock brokerage account or by a bank or other nominee, you are considered the beneficial owner of shares held in &#8220;street name.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you are an Avadel Shareholder of record you may use the enclosed proxy cards to tell the persons named as proxies how to vote your shares. If you are an Avadel Shareholder of record, the shares listed on your proxy cards will include, if applicable, shares held in a book-entry account at Computershare Trust Company, N.A., Avadel&#8217;s transfer agent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you properly complete, sign and date your proxy cards, your shares will be voted in accordance with your instructions. The named proxies on your proxy card will vote all shares at the meeting for which proxies have been properly submitted and not revoked. If you sign and return your proxy cards appointing the Chair of the applicable Special Meeting as your proxy but do not mark your cards to tell the proxy how to vote on a voting item, your shares will be voted in respect of such voting item at the discretion of the Chair of the applicable Special Meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel Shareholders of record may also vote over the Internet at [www.[&#8226;].com] or by telephone at [&#8226;] anytime up to 11:59&#160;p.m. (Irish local time) (being 6:59&#160;p.m. U.S. Eastern Time) on [&#8226;], 202[&#8226;]. Voting instructions are printed on the proxy cards or voting instruction form you received. Either method of submitting a proxy will enable your shares to be represented and voted at the Special Meetings. You may also hand your applicable completed and signed proxy card to the Chair of the applicable Special Meeting before the start of the applicable Special Meeting. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting Ordinary Shares Held in Street Name</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If your shares are held in an account through a bank, broker or other nominee, you must likewise instruct the bank, broker or other nominee how to vote your shares by following the instructions that the bank, broker or other nominee provides to you along with this proxy statement. Your bank, broker or other nominee, as applicable, may have an earlier deadline by which you must provide instructions to it as to how to vote your shares, so you should read carefully the materials provided to you by your bank, broker or other nominee. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you do not provide a signed voting instruction form to your bank, broker or other nominee, your shares will not be voted on any proposal on which the bank, broker or other nominee does not have discretionary authority to vote. This is referred to in this proxy statement and in general as a broker non-vote. In these cases, the bank, broker or other nominee will not be able to vote your shares on those matters for which specific authorization is required. Brokers do not have discretionary authority to vote on any of the proposals at either Special Meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Accordingly, if you fail to provide a signed voting instruction form to your bank, broker or other nominee, your shares held through such bank, broker or other nominee will not be voted at either Special Meeting. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRYP">&#8203;</a><a name="tCOS">&#8203;</a><a name="tOTBU">&#8203;</a><a name="tADJ">&#8203;</a><a name="tASS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revoking Your Proxy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You may change your vote at any time before your proxy is voted at the Scheme Meeting or at any time before your proxy is voted at the EGM. If you are a registered shareholder (i.e., a shareholder who holds shares directly in his, her or its own name through Avadel&#8217;s transfer agent), you may revoke your proxy before the applicable Special Meeting by: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">submitting a new proxy at a later date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">providing written notice that you have revoked your proxy to the Avadel Company Secretary, as applicable, so that it is received up to 11:59&#160;p.m. (Irish local time) (being 6:59&#160;p.m. U.S. Eastern Time) on [&#8226;], 202[&#8226;] at the following address: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:30pt; margin-top:8pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel Pharmaceuticals plc </font> <br ><font style="letter-spacing:0.2pt;">Ten Earlsfort Terrace, </font> <br ><font style="letter-spacing:0.2pt;">Dublin 2, D02 T380, Ireland </font> <br ><font style="letter-spacing:0.2pt;">Attention: Company Secretary </font></div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">submitting a new vote by telephone or Internet up to 11:59&#160;p.m. (Irish local time) (being 6:59&#160;p.m. U.S. Eastern Time) on [&#8226;], 202[&#8226;]; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">voting in person at the applicable Special Meeting. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you are a beneficial shareholder (i.e., your shares are held in the name of a bank, broker or other holder of record, sometimes referred to as holding shares in &#8220;street name&#8221;), follow the voting instructions provided to you by your bank, broker or other holder of record to determine how you may change your vote or revoke your proxy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Simply attending the applicable Special Meeting, however, will not revoke your proxy or change your voting instructions; you must vote by ballot at the applicable meeting to change your vote. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Costs of Solicitation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel will bear the cost of soliciting proxies from Avadel Shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel will solicit proxies by mail. In addition, the directors, officers and employees of Avadel may solicit proxies from Avadel Shareholders by telephone, electronic communication, or in person, but will not receive any additional compensation for their services. Avadel will make arrangements with brokerage houses and other custodians, nominees and fiduciaries for forwarding proxy solicitation material to the beneficial owners of Avadel Shares held of record by those persons and will reimburse them for their reasonable out-of-pocket expenses incurred in forwarding such proxy solicitation materials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel has engaged Innisfree M&amp;A Incorporated, a proxy solicitation firm, to solicit proxies in connection with the Special Meetings at a cost of approximately $50,000 plus expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Business</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel is not aware of any other business to be acted upon at the Special Meetings. If, however, other matters are properly brought before the Special Meetings, the proxies will have discretion to vote or act on those matters (save where expressly directed otherwise), and they intend to vote the shares as the Avadel Board may recommend. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Adjournment</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any adjournment of the Scheme Meeting will result in an adjournment, as applicable, of the EGM. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Assistance</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you need assistance in completing your proxy cards or have questions regarding Avadel&#8217;s Special Meetings, please contact Innisfree M&amp;A Incorporated, the proxy solicitation agent for Avadel, by mail at 501 Madison Ave Floor 20, New York, NY 10022 or by telephone at (877) 687-1874 (for Avadel Shareholders in the U.S. and Canada) or +1 (412) 232-3651 (for Avadel Shareholders outside the U.S. and Canada). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTHTR">&#8203;</a><a name="tTHTR1">&#8203;</a><a name="tBOTT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE TRANSACTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Transaction</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;22, 2025, Avadel entered into the Transaction Agreement, by and between Avadel and Alkermes. Under the terms of the Transaction Agreement, Alkermes will acquire Avadel pursuant to a court-sanctioned scheme of arrangement under Chapter 1 of Part&#160;9 of the Companies Act. As a result of the Scheme, Avadel will become a wholly owned subsidiary of Alkermes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the Effective Time, Avadel Shareholders will be entitled to receive (i) $18.50 in cash for each Avadel Share held by them as of the Effective Time and (ii) a non-transferrable contingent value right entitling the holder to a potential additional payment of $1.50 for each Avadel Share held by them as of the Effective Time, contingent upon the achievement of the specified milestone set forth in the CVR Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel equity awards will be treated as set forth in the Transaction Agreement, such that at the Effective Time: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each Avadel Cash-Out Option (including each Avadel Performance-Based Option) that is outstanding as of immediately prior to the Effective Time, whether or not vested, will be cancelled and, in exchange therefor, the holder of such cancelled Avadel Cash-Out Option will be entitled to receive (without interest): (i)&#160;an amount in cash (less applicable tax and any other mandatory withholdings) equal to the product of (x)&#160;the total number of Avadel Shares subject to such Avadel Cash-Out Option immediately prior to the Effective Time, multiplied by (y)&#160;the excess of the Cash Consideration over the applicable exercise price per Avadel Share under such Avadel Cash-Out Option and (ii)&#160;one CVR for each Avadel Share subject to such Avadel Cash-Out Option immediately prior to the Effective Time (without regard to vesting); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each Avadel Option with an exercise price equal to or greater than the Cash Consideration that is outstanding immediately prior to the Effective Time, whether or not vested, will be cancelled for no consideration; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each Avadel RSU Award that is outstanding will be cancelled and, in exchange therefor, the holder of such cancelled Avadel RSU Award will be entitled to receive (without interest): (i)&#160;an amount in cash (less applicable tax and any other mandatory withholdings) equal to the product of (x)&#160;the total number of Avadel Shares subject to such Avadel RSU Award immediately prior to the Effective Time multiplied by (y)&#160;the Cash Consideration and (ii)&#160;one CVR for each Avadel Share subject to such Avadel RSU Award immediately prior to the Effective Time (without regard to vesting); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each Avadel Restricted Stock Award, whether granted pursuant to the Avadel Share Plans or otherwise that is outstanding immediately prior to the Effective Time will vest in full as of immediately prior to the Effective Time and will be treated in the same manner as all other Avadel Shares. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Alkermes reserves the right, subject to the prior written approval of the Irish Takeover Panel (if required), to effect the Transaction by way of a Takeover Offer. In the event the Transaction is structured as a Takeover Offer, such offer will be implemented on terms and conditions that are at least as favorable to the Avadel Shareholders and the Avadel equity award holders as those which would apply in relation to the Scheme (except for an acceptance condition set at eighty&#160;percent (80%) of the nominal value of the Avadel Shares to which such offer relates and which are not already beneficially owned by Alkermes, or such lower&#160;percentage (being more than fifty&#160;percent (50%)), as Alkermes may, with the consent of Avadel and the Irish Takeover Panel (if required) decide). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Background of the Transaction</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Avadel Board, together with Avadel&#8217;s senior management, and with the assistance of its financial and legal advisors, regularly reviews Avadel&#8217;s strategic and financial performance and prospects on a standalone basis in light of developments in Avadel&#8217;s business, developments in the biotechnology industry and the economy and financial markets generally. These reviews have included consideration, from time to time, of potential partnerships, collaborations and other strategic transactions to enhance shareholder value, including potential sale transactions. Such reviews have been accompanied by periodic conversations </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">between senior executives of Avadel and counterparts at other companies in the biotechnology industry regarding such potential transactions and opportunities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2025, Alkermes and Avadel discussed exploring a clinical development partnership. On February&#160;13, 2025, Avadel entered into a non-disclosure agreement with Alkermes (which did not include a standstill provision) to facilitate the parties continuing their ongoing discussions regarding Avadel&#8217;s programs and potential business development opportunities. Over the course of the next several&#160;months, members of Avadel&#8217;s and Alkermes&#8217; respective management teams met to discuss potential structures for collaboration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">On June&#160;30, 2025, Richard Pops, Chief Executive Officer of Alkermes, contacted Greg Divis, Chief Executive Officer of Avadel, via e-mail indicating that Mr.&#160;Pops would like to meet in person over the course of that week at Avadel&#8217;s U.S. headquarters in Chesterfield, Missouri. Mr.&#160;Divis responded that he would follow-up the next week. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;4, 2025, Alkermes sent an initial unsolicited non-binding indication of interest to Avadel for the acquisition of 100% of the fully diluted share capital of Avadel for $12.50 in cash per ordinary share, representing a transaction equity value of approximately $1.27&#160;billion (the &#8220;July&#160;4 Proposal&#8221;). This proposal represented a premium of approximately 40% to Avadel&#8217;s closing price of $8.93 on July&#160;3, 2025. Following receipt of the proposal, Mr.&#160;Divis and Mr.&#160;Pops engaged in a telephone discussion during which Mr.&#160;Divis confirmed receipt of the July&#160;4 Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Also on July&#160;4, 2025, the Financing Committee of the Avadel Board, comprised of Geoffrey M. Glass, Eric J. Ende, M.D. and Peter J. Thornton (which had previously been formed by the Avadel Board to provide focused oversight on strategic transactions), held a meeting to review the July&#160;4 Proposal, with representatives of Morgan Stanley &amp; Co. LLC (&#8220;Morgan Stanley&#8221;), one of Avadel&#8217;s financial advisors, and representatives of Goodwin Procter LLP (&#8220;Goodwin&#8221;) and Arthur Cox LLP (&#8220;Arthur Cox&#8221;), Avadel&#8217;s outside legal counsel, in attendance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;7, 2025, the Avadel Board held two meetings to review the July&#160;4 Proposal, with members of Avadel management and representatives of each of Morgan Stanley and Goldman Sachs &amp; Co LLC (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Goldman Sachs</font><font style="letter-spacing:0.2pt;">&#8221;), Avadel&#8217;s financial advisors, and Goodwin and Arthur Cox in attendance. Each of Morgan Stanley and Goldman Sachs had advised Avadel on strategic advisory matters from time to time over the last several years. During the first meeting, representatives of Arthur Cox reviewed with the Avadel Board its fiduciary duties under Irish law in connection with exploring a potential transaction involving the sale of Avadel. Avadel management also discussed with the Avadel Board preliminary forecasts related to Avadel&#8217;s future financial performance, as prepared by management, including the methodology utilized to prepare the forecasts and underlying assumptions. Representatives of each of Morgan Stanley and Goldman Sachs reviewed with the Avadel Board Morgan Stanley&#8217;s and Goldman Sachs&#8217; respective preliminary financial analyses of Avadel and the July&#160;4 Proposal. Following discussion and consideration of Avadel&#8217;s prospects on a stand-alone basis, the Avadel Board determined that the July&#160;4 Proposal was inadequate and that Avadel should seek improved terms from Alkermes as a condition to allowing Alkermes to conduct due diligence or to otherwise further explore a transaction. The Avadel Board also reviewed a list of potential strategic acquirors prepared by management with input from each of Morgan Stanley and Goldman Sachs in the event that the Avadel Board were to explore a potential transaction with a third party, which list included Party A, Party B and Party C, and the Avadel Board considered the risk of leaks that might arise from making contact with other parties in the industry and the potential impact on Avadel&#8217;s business of such leaks. Also at the meeting, the Avadel Board formed a Transaction Committee of independent directors to manage day-to-day matters related to the strategic process in order to provide an efficient manner in which to actively supervise the process and to have the ability to meet as often as needed on a more convenient basis than the Avadel Board (the &#8220;Transaction Committee&#8221;) consisting of Messrs. Glass, Ende and Thornton. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Later on July&#160;7, 2025, the Avadel Board held a subsequent meeting to discuss next steps and process considerations, instructed each of Morgan Stanley and Goldman Sachs to reflect various matters discussed during the meetings of the Avadel Board in their respective preliminary financial analyses of Avadel, and instructed Mr.&#160;Divis to contact Mr.&#160;Pops to convey that the July&#160;4 Proposal from Alkermes was inadequate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Later on July&#160;7, 2025, Mr.&#160;Divis called Mr.&#160;Pops to advise Mr.&#160;Pops of the Avadel Board&#8217;s determination that the July&#160;4 Proposal was inadequate. Mr.&#160;Divis further indicated that Avadel would not permit Alkermes to conduct due diligence unless Alkermes provided an improved proposal. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;11, 2025, Messrs. Divis and Pops had a telephone call regarding the potential transaction during which Mr.&#160;Pops indicated that Alkermes would be sending an updated non-binding offer. Following the call, Alkermes sent a non-binding indication of interest to Avadel for the acquisition of 100% of the fully diluted share capital of Avadel for $13.25 in cash per share, representing a transaction equity value of approximately $1.35&#160;billion (the &#8220;July&#160;11 Proposal&#8221;). This revised proposal represented a premium of approximately 36% to Avadel&#8217;s closing price of $9.77 on July&#160;10, 2025. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;13, 2025, the Avadel Board held a meeting to discuss the July&#160;11 Proposal, at which members of Avadel management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox were present. During the meeting, representatives of Arthur Cox reviewed with the Avadel Board its fiduciary duties, which had been previously reviewed at prior meetings of the Avadel Board, in connection with exploring a potential transaction involving the sale of Avadel. Management discussed further with the Avadel Board the preliminary forecasts related to Avadel&#8217;s future financial performance, as prepared by management, including the methodology utilized to prepare the forecasts and the underlying assumptions as previously discussed at the July&#160;7th meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;16, 2025, the Avadel Board held an additional meeting to review the July&#160;11 Proposal, at which members of Avadel management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox were present. Representatives of each of Morgan Stanley and Goldman Sachs reviewed with the Avadel Board Morgan Stanley&#8217;s and Goldman Sachs&#8217; respective preliminary financial analyses of Avadel and the July&#160;11 Proposal. Following discussion and consideration of Avadel&#8217;s prospects on a stand-alone basis, the Avadel Board again determined that the July&#160;11 Proposal was inadequate and that Avadel should seek improved terms from Alkermes, but the Avadel Board authorized Avadel management to conduct limited due diligence with Alkermes in order to facilitate Alkermes&#8217; ability to improve its position on value. The Avadel Board also discussed certain process considerations, including potential messaging to Alkermes regarding its proposal and providing Alkermes with a management presentation as a basis to increase its offer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;17, 2025, Mr.&#160;Divis called Mr.&#160;Pops to advise Mr.&#160;Pops of the Avadel Board&#8217;s determination that the July&#160;11 Proposal was inadequate. Mr.&#160;Divis, however, indicated that Avadel would permit Alkermes to conduct limited due diligence and that senior management of Avadel were willing to meet with Alkermes to provide a management presentation about Avadel if it would help Alkermes improve its offer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;25, 2025, representatives of management of each of Avadel and Alkermes held a call to discuss preliminary diligence matters. Alkermes also provided a list of key diligence items to Avadel management. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;29, 2025, Avadel held its annual general meeting of shareholders in Dublin, Ireland. Following the annual general meeting, the Avadel Board held a meeting in Dublin, Ireland, with members of Avadel management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox in attendance, at which matters relating to the proposed transaction with Alkermes were discussed. During the meeting, Avadel management further discussed with the Avadel Board the preliminary forecasts related to Avadel&#8217;s future financial performance, as prepared by management, including the methodology utilized to prepare the forecasts and the underlying assumptions as previously discussed at the July&#160;7th and 13th meetings of the Avadel Board. See the heading titled &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Avadel Unaudited Prospective Financial Information</font><font style="letter-spacing:0.2pt;">&#8221; for further information regarding the July Avadel Projections (as defined therein)</font><font style="font-style:italic;letter-spacing:0.2pt;">.</font><font style="letter-spacing:0.2pt;"> Following discussion of these matters, the Avadel Board approved the July Avadel Projections for use by each of Morgan Stanley and Goldman Sachs in connection with the financial analyses prepared in connection with any fairness opinion rendered by each of Morgan Stanley and Goldman Sachs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;14, 2025, Mr.&#160;Pops called Mr.&#160;Divis and delivered a verbal updated non-binding indication of interest for the acquisition of 100% of the fully diluted share capital of Avadel for $15.25 in cash per ordinary share, representing a transaction equity value of approximately $1.57&#160;billion (the &#8220;August&#160;14 Proposal&#8221;). This proposal represented a premium of approximately 11% to Avadel&#8217;s closing price of $13.77 on August&#160;13, 2025. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;14, 2025, the Transaction Committee held a meeting to discuss the August&#160;14 Proposal at which members of Avadel management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox were present. At the meeting, Mr.&#160;Divis provided an update to the Transaction </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Committee regarding the status of discussions with Alkermes and representatives of Goodwin summarized the terms of the August&#160;14 Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;16, 2025, the Avadel Board held a meeting, at which members of Avadel management and representatives of each of Goodwin and Arthur Cox were present, to review the status and proposed terms regarding a proposed transaction with XWPharma Ltd. to enter into an exclusive global license agreement granting Avadel a license to develop, manufacture and commercialize valiloxybate, a low/no sodium once nightly oxybate product (the &#8220;Amended and Restated XWPharma License&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;18, 2025, the Avadel Board held a meeting to review the August&#160;14 Proposal, at which members of Avadel management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox were present. During the meeting, representatives of Arthur Cox reviewed with the Avadel Board its fiduciary duties under Irish law, which had been previously reviewed at prior meetings of the Avadel Board, in connection with exploring a potential transaction involving the sale of Avadel. Also during the meeting, representatives of Avadel&#8217;s financial advisors reviewed the status of discussions with J.P. Morgan Securities LLC (&#8220;J.P. Morgan&#8221;), financial advisor to Alkermes. Representatives of each of Morgan Stanley and Goldman Sachs also reviewed with the Avadel Board Morgan Stanley&#8217;s and Goldman Sachs&#8217; respective preliminary financial analyses of Avadel and the August&#160;14 Proposal. A discussion ensued, including regarding the premium that the August&#160;14 Proposal represented to the current and historical trading prices of Avadel Shares. Following discussion, the Avadel Board again determined that the August&#160;14 Proposal was inadequate, but, in order to facilitate Alkermes&#8217; ability to improve its offer, the Avadel Board also authorized additional limited due diligence with Alkermes and instructed Avadel&#8217;s financial and legal advisors to engage with advisors to Alkermes as needed to complete such due diligence. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;21, 2025, representatives from Avadel and Alkermes management and their respective financial advisors held a meeting to discuss targeted due diligence. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;24, 2025, Avadel and Alkermes entered into a confidentiality agreement, which included a customary standstill provision that restricted Alkermes from publicly offering to acquire or acquiring Avadel, and from taking certain other actions, including soliciting proxies, without the prior consent of Avadel. The confidentiality agreement provided that the standstill would terminate in certain circumstances, including upon Avadel entering into a binding agreement related to the sale or a change of control of Avadel. This confidentiality agreement terminated the confidentiality agreement dated February&#160;13, 2025 between Avadel and Alkermes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;27, 2025, Avadel granted access to a limited virtual data room to representatives of Alkermes and its legal and financial advisors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Over the course of the next several weeks, representatives of management from both Avadel and Alkermes, together with their respective financial advisors, held additional meetings to discuss key diligence items, including research and development, regulatory, commercial and legal matters. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;30, 2025, Avadel and XWPharma Ltd. entered into the Amended and Restated XWPharma License. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;6, 2025, Mr.&#160;Pops contacted Mr.&#160;Divis and suggested meeting after the 2025 World Sleep Congress taking place in Singapore from September&#160;5 through September&#160;10, 2025. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;12, 2025, Messrs. Divis and Pops engaged in a brief telephone discussion following the World Sleep Congress, to discuss a possible transaction between Avadel and Alkermes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;26, 2025, Mr.&#160;Divis spoke telephonically with Mr.&#160;Pops. Mr.&#160;Pops reaffirmed Alkermes&#8217; continuing interest in a transaction with Avadel as well as a preference to execute a transaction in an expeditious manner. Mr.&#160;Pops also indicated that Alkermes intended to submit a revised proposal in the coming week. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;1, 2025, Alkermes sent to Avadel a non-binding proposal to acquire Avadel for up to $20.00 per ordinary share, representing a transaction equity value of up to approximately $2.1&#160;billion (the &#8220;October&#160;1 Proposal&#8221;), consisting of, per ordinary share, (i)&#160;$18.00 in cash, plus (ii)&#160;one non-tradeable CVR representing the right to receive $2.00 in cash upon FDA approval of LUMRYZ for treatment of idiopathic </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">hypersomnia (&#8220;IH&#8221;) in adults, with no legal or regulatory impediment to the sale or marketing in IH, by December&#160;31, 2027. The $20.00 per ordinary share nominal value of the October&#160;1 Proposal represented a premium of approximately 31% to Avadel&#8217;s closing price of $15.27 on September&#160;30, 2025. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;2, 2025, the Transaction Committee held a meeting to discuss the October&#160;1 Proposal at which members of Avadel management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox were present. At the meeting, Mr.&#160;Divis provided an update to the Transaction Committee regarding the status of discussions with Alkermes and representatives of Goodwin summarized the terms of the October&#160;1 Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;3, 2025, the Avadel Board held a meeting to review the October&#160;1 Proposal, at which members of Avadel management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox were present. At the meeting, representatives of each of Goodwin and Arthur Cox reviewed with the Avadel Board its fiduciary duties under Irish law, which had been previously reviewed at prior meetings of the Avadel Board, in connection with exploring a potential transaction involving the sale of Avadel. Members of Avadel&#8217;s management (i)&#160;provided an update regarding recent conversations between representatives of Avadel and Alkermes and (ii)&#160;described the October&#160;1 Proposal, in particular the milestones proposed for the CVR. Representatives of each of Morgan Stanley and Goldman Sachs reviewed with the Avadel Board Morgan Stanley&#8217;s and Goldman Sachs&#8217; respective preliminary financial analyses of Avadel and the October&#160;1 Proposal. The Avadel Board then engaged in discussions regarding the October&#160;1 Proposal, including the milestone proposed for the CVR in the October&#160;1 Proposal, in particular (i)&#160;the uncertainty and regulatory risks presented by the milestone tied to FDA approval, (ii)&#160;the desire for the CVR milestone period to be extended by one year, from the end of 2027 to the end of 2028, (iii)&#160;the inherent uncertainty of CVR payments as compared to upfront cash consideration and (iv)&#160;the no legal impediment component of the CVR in light of the ongoing litigation with Jazz Pharmaceuticals, Inc. (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Jazz</font><font style="letter-spacing:0.2pt;">&#8221;) and the potential settlement of same, which would satisfy such component of the CVR in relation to a third party legal impediment by Jazz. After discussion, the Avadel Board directed representatives of each of Morgan Stanley and Goldman Sachs to make a counterproposal, on Avadel&#8217;s behalf, to representatives of Alkermes on the CVR of (A)&#160;up to $2.00 payable, with (1)&#160;$1.00 per share payable upon FDA approval of LUMRYZ for treatment of IH and (2)&#160;$1.00 per share payable upon clearing of any legal, non-regulatory impediment to the sale or marketing of LUMRYZ in IH, in either case of (1)&#160;and (2), prior to the end of 2028 and (B)&#160;(x)&#160;if, prior to closing of a transaction with Alkermes, Avadel were to settle its litigation with Jazz, the per share consideration to be received by Avadel shareholders at closing would be adjusted such that Avadel shareholders receive 100% of any non-appealable recovery amount achieved through such settlement or the cash component of any settlement amount, in both instances net of costs, on a pro&#160;rata basis, in cash or (y)&#160;if Avadel&#8217;s litigation with Jazz were not settled prior to closing, an additional non-transferable contingent value right payable in cash, equal to 90% of any settlement&#160;/ recovery amount obtained by Avadel (or Alkermes as successor) from Jazz relating to the Jazz litigation, which amount would be payable in cash to Avadel shareholders on a pro&#160;rata basis and a target announcement date of the transaction no later than October&#160;27, 2025 (the &#8220;Avadel CVR Counterproposal&#8221;). The Avadel Board then discussed process and timing considerations, including whether to contact other third parties regarding their interest in a potential transaction with Avadel. The Avadel Board discussed with representatives of each of Morgan Stanley and Goldman Sachs which parties would be most likely to have an interest in an acquisition of Avadel, and would have the ability to consummate a transaction of this size and nature, as well as the ability to move quickly and efficiently in a process. The Avadel Board also discussed the importance of maintaining the confidentiality of a process involving the exploration of a potential transaction and the impact of a leak on the business of Avadel, including in connection with any settlement of litigation with Jazz or the impact of the upcoming trial between Avadel and Jazz. Following these discussions, the Avadel Board determined that Avadel should contact Party A, Party B and Party C, global biotechnology and pharmaceutical companies, with respect to their potential interest in an acquisition of Avadel based on the fact that such parties met the outreach criteria discussed by the Avadel Board earlier in the meeting. Following discussion and based on the consideration of the factors discussed at the meeting, the Avadel Board further directed representatives of each of Morgan Stanley and Goldman Sachs to (i)&#160;convey to Alkermes that Avadel would proceed to negotiate definitive transaction documents with Alkermes and (ii)&#160;engage in discussions with Party A, Party B and Party C to determine whether terms could be reached on a transaction that would be superior to a potential transaction with Alkermes, by the end of October&#160;2025. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Between October&#160;4 and October&#160;17, 2025, Avadel responded to numerous confirmatory diligence requests from, and conducted numerous due diligence meetings and teleconferences with, representatives of Alkermes, and granted representatives of Alkermes and its legal and financial advisors access to its comprehensive virtual data room. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;6, 2025, at Avadel&#8217;s direction, representatives of Morgan Stanley separately contacted Party A, and representatives of each of Morgan Stanley and Goldman Sachs contacted Party B and Party C regarding potential interest in a transaction to acquire Avadel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;7, 2025, at Avadel&#8217;s direction, representatives of each of Morgan Stanley and Goldman Sachs provided Party A with Avadel&#8217;s form of confidentiality agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;7, 2025, representatives of Paul, Weiss, Rifkind, Wharton &amp; Garrison LLP (&#8220;Paul, Weiss&#8221;) and McCann FitzGerald LLP (&#8220;McCann FitzGerald&#8221;), legal counsel to Alkermes, provided an initial draft of the Transaction Agreement and Conditions Appendix for review to representatives of Goodwin and Arthur Cox. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;9, 2025, Mr.&#160;Pops responded via e-mail to Mr.&#160;Divis regarding the Avadel CVR Counterproposal, proposing that the non-tradeable CVR represent (A)&#160;up to $2.00 payable, with (1)&#160;$1.00 per share payable upon FDA approval of LUMRYZ for treatment of IH plus a positive valiloxybate pivotal PK study showing bioequivalence to LUMRYZ and alignment with the FDA on the bioequivalence regulatory path to approval and (2)&#160;$1.00 per share payable upon clearing of any legal impediments to the sale or marketing of LUMRYZ in IH following FDA approval of LUMRYZ for the treatment of IH, and a positive valiloxybate pivotal PK study showing bioequivalence to LUMRYZ and alignment with the FDA on the bioequivalence regulatory path to approval, in either case of (1)&#160;and (2), prior to the end of 2028 and (B)&#160;(x)&#160;if, prior to closing of a transaction with Alkermes, Avadel were to settle its litigation with Jazz, the per share consideration to be received by Avadel shareholders at closing would be adjusted such that Avadel shareholders receive 100% of any non-appealable recovery amount achieved through such settlement or the cash component of any settlement amount, in both instances net of costs, on a pro&#160;rata basis, in cash or (y)&#160;if Avadel&#8217;s litigation with Jazz were not settled prior to closing, an additional non-transferable contingent value right payable in cash, equal to 90% of any settlement / recovery amount obtained by Avadel (or Alkermes as successor) from Jazz relating to the Jazz litigation, which amount would be payable in cash to Avadel shareholders on a pro&#160;rata basis, unless the Jazz litigation proceeded to court appeal, in which case the 90% would become 75% of any settlement / recovery amount obtained by Avadel (or Alkermes as successor) (the &#8220;Alkermes October&#160;9 CVR Proposal&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;10, 2025, representatives of Paul, Weiss and McCann FitzGerald, legal counsel to Alkermes, provided an initial draft of the CVR Agreement for review to representatives of Goodwin and Arthur Cox. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;12, 2025, the Transaction Committee held a meeting at which members of Avadel management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox were present. Representatives of Goodwin provided an overview of key terms of the draft Transaction Agreement and CVR Agreement and reviewed the terms of each of the financial advisors&#8217; proposed engagement letter with Avadel. Avadel management and representatives of each of Morgan Stanley and Goldman Sachs then discussed the Alkermes October&#160;9 CVR Proposal. Members of the Transaction Committee discussed with Avadel management the status of the Jazz litigation and that in the event Avadel reached agreement with Jazz, the CVR milestone criteria regarding legal impediments to the sale and marketing of LUMRYZ in IH and the Jazz settlement distribution to Avadel shareholders would become moot factors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;13, 2025, representatives of Party B contacted Morgan Stanley and Goldman Sachs to indicate that Party B was not interested in a transaction to acquire Avadel at this time. Party C did not respond to the outreach on October&#160;6, 2025 regarding interest in a transaction with Avadel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Later on October&#160;13, 2025, the Avadel Board held a meeting to review the Alkermes October&#160;9 CVR Proposal and other transaction updates, at which members of Avadel management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox were present. Representatives of Goodwin provided an overview of key terms of the draft Transaction Agreement and CVR Agreement and reviewed the terms of each of the financial advisors&#8217; proposed engagement letter with Avadel. Prior to the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">meeting, representatives of each of Morgan Stanley and Goldman Sachs had delivered to Avadel their respective relationship disclosure letters describing their respective relationships with Avadel and Alkermes and certain of Alkermes&#8217; affiliates, and the Avadel Board determined that there were no conflicts for either Morgan Stanley or Goldman Sachs. Following the Avadel Board&#8217;s review of such disclosures and a review of the terms of each financial advisor&#8217;s proposed engagement letter, and based on each of Morgan Stanley&#8217;s and Goldman Sachs&#8217; familiarity with Avadel and the biotechnology industry, as well as their respective experience with strategic transactions of the type contemplated by the Transaction Agreement, the Avadel Board approved entry into the respective engagement letters. Avadel management, members of the Transaction Committee and representatives of each of Morgan Stanley and Goldman Sachs then reviewed the Alkermes October&#160;9 CVR Proposal. Members of the Avadel Board discussed with Avadel management the status of the Jazz litigation. The Avadel Board further discussed that in the event Avadel reached agreement with Jazz, the CVR milestone criteria regarding legal impediments to the sale and marketing of LUMRYZ in IH and the Jazz settlement distribution to Avadel shareholders would become moot factors. Regarding the other milestones in the Alkermes October&#160;9 CVR Proposal, the Avadel Board determined that Avadel would counter-propose to Alkermes that the $2.00 per share prong for FDA approval would be achieved for either approval of LUMRYZ in IH or a positive valiloxybate pivotal PK study, but not both, with no outside time limitation to achievement (the &#8220;Avadel October&#160;13 CVR Counterproposal&#8221;). Representatives of each of Morgan Stanley and Goldman Sachs then provided an update on outreach to Party A, Party B and Party C, including that neither Party B nor Party&#160;C had expressed an interest in a potential acquisition of Avadel and that Party A had not made a proposal on value or ability or willingness to imminently execute a transaction. Following discussion, and consideration of the factors and reasons discussed at prior meetings of the Avadel Board, the Avadel Board directed members of Avadel&#8217;s management to proceed with final discussions with Alkermes and to seek to finalize a transaction and agreed to follow up on the CVR counter-proposal following certain October&#160;14 Jazz litigation discussions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Also later on October&#160;13, 2025, Goodwin delivered to Paul, Weiss a revised draft of the Transaction Agreement. Over the course of the subsequent days, the parties and their respective advisors, including their respective Irish co-counsel, negotiated and exchanged drafts of the Transaction Agreement and other transaction-related documents. The negotiations primarily focused on issues relating to the conditionality of the consummation of the proposed transaction, covenants and closing conditions with respect to regulatory approvals and the implications if regulatory approvals could not be obtained, the definition of &#8220;Company Material Adverse Effect,&#8221; the circumstances in which Avadel would be required to reimburse Alkermes for its expenses (subject to the one&#160;percent (1%) limit under Irish law), the treatment of equity awards and other employee compensation and benefits matters, provisions regarding Avadel&#8217;s ability to change its recommendation in favor of the proposed transaction, provisions restricting the solicitation of alternative transaction proposals, the grounds for terminating the Transaction Agreement, and the interim operating covenants of Avadel pending the consummation of the proposed transaction. Also during this process, the parties stayed in contact with the Irish Takeover Panel and raised issues with and received responses from the Irish Takeover Panel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;14, 2025, Avadel and Party A entered into a confidentiality agreement, which included a customary standstill provision that restricted Party A from publicly offering to acquire or acquiring Avadel, and from taking certain other actions, including soliciting proxies, without the prior consent of Avadel. The confidentiality agreement provided that the standstill would terminate in certain circumstances, including upon Avadel entering into a binding agreement related to the sale or a change of control of Avadel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Later on October&#160;14, 2025, members of Avadel management provided a management presentation to Party A. In follow-up to the management presentation, representatives of Party A&#8217;s financial advisor contacted representatives of Morgan Stanley to confirm next steps, and, at the direction of Avadel, representatives of Morgan Stanley conveyed to Party A that Party A would need to demonstrate the ability to negotiate and execute a definitive transaction agreement with Avadel in the immediately following days, and submit a written proposal with a proposed transaction value prior to Avadel granting access to its virtual data room and engaging in subsequent calls with management, but such representatives, at the direction of Avadel, indicated that legal counsel to Avadel would prepare a draft transaction agreement for Party A in order to facilitate Party A&#8217;s ability to submit a proposal on value to Avadel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Also on October&#160;14, 2025, the Avadel Board held a meeting to review the status of the Jazz litigation, at which members of Avadel management and representatives of each of Latham &amp; Watkins LLP and Morrison Foerster, as counsel to Avadel in the Jazz litigation, and Goodwin were present. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Also on October&#160;14, 2025, following the meeting of the Avadel Board, at the direction of Avadel, representatives of each of Morgan Stanley and Goldman Sachs communicated the Avadel October&#160;13 CVR Counterproposal to J.P. Morgan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October 15, 2025, representatives of each of Morgan Stanley and Goldman Sachs held a call with J.P. Morgan, during which J.P. Morgan conveyed an offer on behalf of Alkermes of a counterproposal to the Avadel October 13 CVR Counterproposal, lowering the CVR value to $1.50 from $2.00 per share for FDA approval of LUMRYZ in IH with a December 31, 2028 outside date to achievement, in connection with settlement of the Jazz litigation (the &#8220;Alkermes October 15 CVR Counterproposal&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Also on October&#160;15, 2025, the Transaction Committee held a meeting at which members of Avadel management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox were present, to discuss updates on the status of the transaction with Alkermes and the Jazz litigation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;16, 2025, the Avadel Board held a meeting to discuss the status of the transaction with Alkermes and the Jazz litigation, at which members of Avadel management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox were present. At the meeting, members of Avadel management and the Avadel Board discussed the Alkermes October&#160;15 CVR Counterproposal. Based on a discussion with Avadel management regarding the Jazz litigation, the Avadel Board discussed also increasing the upfront cash amount from the October&#160;1 Proposal from $18.00 per ordinary share to $18.50 per ordinary share, noting that such an increase would provide shareholders with an increase to immediate and certain liquidity, together with the terms of Alkermes October 15 CVR Counterproposal. After discussion, the Avadel Board directed representatives of each of Morgan Stanley and Goldman Sachs to make this updated proposal of a change from $18.00 per ordinary share to $18.50 per ordinary share and to otherwise agree to the Alkermes October&#160;15 CVR Counterproposal (the &#8220;Avadel October&#160;16 Proposal&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Later on October&#160;16, 2025, following the meeting of the Avadel Board, representatives of each of Morgan Stanley and Goldman Sachs communicated the Avadel October&#160;16 Proposal to J.P. Morgan, stating that Avadel accepted the CVR terms in the Alkermes October 15 Counterproposal, but asked for $18.50 upfront cash in connection with settlement of the Jazz litigation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Later on October&#160;16, 2025, at the direction of Avadel, representatives of each of Morgan Stanley and Goldman Sachs provided an initial draft of a transaction agreement for review to representatives of Party A and Avadel provided access to its virtual data room to representatives of Party A. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;17, 2025, Avadel entered into an engagement letter with each of Morgan Stanley and Goldman Sachs as previously approved by the Avadel Board. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Also on October&#160;17, 2025, at the direction of Avadel, representatives of each of Morgan Stanley and Goldman Sachs had a call with representatives of Party A&#8217;s financial advisor to discuss the status of a potential proposal to Avadel from Party A. Financial advisors of Party A updated representatives of Morgan Stanley and Goldman Sachs on Party A&#8217;s progress and indicated that Party A would submit a proposal early the week of October&#160;20 based largely on publicly available information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Also on October&#160;17, 2025, in a call between representatives of J.P. Morgan and representatives of each of Morgan Stanley and Goldman Sachs, J.P. Morgan communicated that Alkermes accepted the Avadel October&#160;16 Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Also later on October&#160;17, 2025, Paul, Weiss delivered a revised draft of the Transaction Agreement to Goodwin and Goodwin delivered to Paul, Weiss revised drafts of the Conditions Appendix and the CVR Agreement and the CVR Agreement reflected the terms of the Avadel October&#160;16 Proposal. Over the course of the subsequent days, the parties and their respective advisors, including their respective Irish co-counsel, continued to negotiate and exchange drafts of these and other transaction-related documents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;19, 2025, the Avadel Board held a meeting in Dublin, Ireland, attended by members of Avadel management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox to consider documentation for the proposed acquisition of Avadel by Alkermes. Mr.&#160;Divis summarized for the Avadel Board the discussions with Alkermes and Alkermes&#8217; advisors during the previous week and members of senior management of Avadel reviewed with the Avadel Board Alkermes&#8217; due diligence </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">process and the procedures undertaken by Avadel in connection with the proposed transaction. Members of Avadel&#8217;s management then presented management&#8217;s updated projections for Avadel, including revised assumptions underlying the same to account for the impact of a potential settlement of the Jazz litigation. See the heading titled &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Avadel Unaudited Prospective Financial Information</font><font style="letter-spacing:0.2pt;">&#8221; for further information regarding the Updated Avadel Projections (as defined therein). The Avadel Board determined the Updated Avadel Projections to be reasonably prepared on bases reflecting then-currently available estimates and judgments of the members of Avadel&#8217;s management as to the expected future performance of Avadel on a standalone basis, approved the Updated Avadel Projections and directed each of Morgan Stanley and Goldman Sachs to use and rely on the Updated Avadel Projections in performing financial analyses relating to advising the Avadel Board and the rendering of their respective fairness opinions to the Avadel Board. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Later on October&#160;19, 2025, the Avadel Board held a second meeting in Dublin, Ireland, attended by members of Avadel management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox to consider the proposed terms and documentation for the proposed acquisition of Avadel by Alkermes. Representatives of Goodwin and Arthur Cox discussed with the Avadel Board an overview of the fiduciary duties of directors and the Irish Takeover Rules in the context of the proposed transaction with Alkermes. In addition, a representative of Arthur Cox described to the Avadel Board the substance of the announcement required pursuant to Rule&#160;2.7 of the Irish Takeover Rules in connection with the proposed transaction. Following this, representatives of each of Morgan Stanley and Goldman Sachs reviewed with the Avadel Board their respective financial analysis of Avadel and the proposed transaction. A discussion by the Avadel Board with respect to the proposed transaction, as well as alternatives to it, including a potential transaction with Party A, ensued and members of Avadel management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox responded to comments and questions from the Avadel Board, including relating to the Avadel Board&#8217;s ability to change its recommendation in favor of the transaction with Alkermes. Prior to the meeting, representatives of each of Morgan Stanley and Goldman Sachs each provided to Avadel updated relationship disclosure letters describing their respective relationships with Alkermes and Party A and certain of their respective affiliates, and the Avadel Board determined there were no conflicts for either Morgan Stanley or Goldman Sachs. Following discussion, (i)&#160;Morgan Stanley rendered its opinion to the Avadel Board that, as of October&#160;19, 2025, and based upon and subject to the assumptions made, procedures followed, matters considered, and qualifications and limitations on the scope of review undertaken by Morgan Stanley as set forth in such opinion, the Scheme Consideration to be received by the holders of Avadel Shares (other than the Excluded Shares) pursuant to the Transaction Agreement was fair from a financial point of view to such holders of Avadel Shares and (ii)&#160;Goldman Sachs rendered its opinion to the Avadel Board that, as of October&#160;19, 2025 and based upon and subject to the factors and assumptions set forth in such opinion, the Scheme Consideration to be paid to the holders (other than holders of Excluded Shares and their respective affiliates) of Avadel Shares pursuant to the Transaction Agreement was fair from a financial point of view to such holders of Avadel Shares. Representatives of Goodwin then summarized the key terms of the proposed Transaction Agreement, which were summarized in writing in advance of the meeting, and also reviewed the regulatory processes the transaction would entail and related terms of the proposed transaction documents. Following this, and based upon the presentations and discussions at this meeting, the Avadel Board unanimously determined that the Transaction Agreement and the transactions contemplated thereby, including the Scheme, are in the best interests of Avadel and its shareholders and that the terms of the Scheme as contemplated by the Transaction Agreement are fair and reasonable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;20, 2025, Party A sent to Avadel a non-binding proposal (the &#8220;October&#160;20 Party A Proposal&#8221;) to acquire Avadel for up to $20.00 per ordinary share, consisting of (i)&#160;$18.00 in cash, plus (ii)&#160;one non-tradeable CVR representing the right to receive up to $2.00 in cash as follows: (a)&#160;$1.00 per share in cash upon the first commercial sale of LUMRYZ in IH patients by December&#160;31, 2028 and (b)&#160;$1.00 per share in cash upon LUMRYZ reaching annual net sales globally of at least $700&#160;million in any calendar year by December&#160;31, 2030. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of October&#160;21, 2025, there were no employment, retention or other arrangements or understandings between any of Avadel&#8217;s directors or executive officers, on the one hand, and Alkermes, on the other hand, and the transaction with Alkermes was not conditioned upon any of Avadel&#8217;s directors or executive officers entering into any such agreement, arrangement or understanding. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;21, 2025, the Transaction Committee held a meeting at which members of Avadel management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox were present. At the meeting, members of Avadel management and representatives of Goodwin provided an update on discussions with Party A and a description of the October&#160;20 Party A Proposal, noting that, among other things, (i)&#160;the October&#160;20 Party A Proposal provided insufficient upfront cash consideration relative to the October&#160;16 Proposal and that the October&#160;20 Party A Proposal CVR milestones, taken together, were less likely to be achieved relative to the October&#160;16 Proposal CVR milestones and (ii)&#160;Party A indicated that final terms could be reached on a transaction no earlier than the end of October in order for Party A to complete its due diligence. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Later on October&#160;21, 2025, the Avadel Board held a meeting, with members of Avadel&#8217;s management and representatives of each of Morgan Stanley, Goldman Sachs, Goodwin and Arthur Cox in attendance. Members of Avadel management and the Transaction Committee reviewed the October&#160;20 Party A Proposal and the various factors discussed at the Transaction Committee meeting earlier that day. In particular, the Avadel Board weighed prior discussions with representatives of Party A with respect to value and timing constraints of a transaction between Avadel and Party A. Following discussion, the Avadel Board determined that the time it would likely take for Party A to increase the value of its proposal beyond the value of consideration in the October&#160;16 Proposal with Alkermes would create significant risk that Alkermes would not be willing to execute a transaction with Avadel. The Avadel Board also discussed the status of executing a global settlement of the Jazz litigation and that it remained a precursor to executing a transaction with Alkermes based on the terms of the October&#160;16 Proposal. The Avadel Board then discussed the various reasons to approve the transaction with Alkermes and certain other considerations. For a detailed description of the various reasons considered by the Avadel Board, see &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Recommendation of the Avadel Board; Avadel Reasons for the Transaction.</font><font style="letter-spacing:0.2pt;">&#8221; After further discussion, including on the process that led to the proposed transaction, the alternatives available to Avadel, including remaining as a standalone public company or pursuing strategic collaborations with respect to LUMRYZ, and the risks and benefits associated with the proposed transaction, representatives of Arthur Cox provided an overview of the fiduciary duties of the Avadel Board under Irish law in connection with considering and approving the Transaction and representatives of Goodwin and Arthur Cox presented to the Avadel Board the final agreed terms of the Transaction Agreement, including the Scheme. Representatives of each of Morgan Stanley and Goldman Sachs then reviewed with the Avadel Board their respective updated financial analysis of Avadel and the proposed transaction, which reflected the CVR Estimates provided to each of Morgan Stanley and Goldman Sachs, which each of Morgan Stanley and Goldman Sachs used to calculate the net present value of the risk-adjusted Milestone Payment estimated to be made based on the probability and timing of achieving the Milestone, and which accounted for the updated projected commercialization date for LUMRYZ in IH of March 1, 2028. Thereafter, (i)&#160;Morgan Stanley rendered an oral opinion, which was subsequently confirmed by delivery of a written opinion dated October&#160;21, 2025, to the Avadel Board that, as of that date, and based upon and subject to the assumptions made, procedures followed, matters considered, and qualifications and limitations on the scope of review undertaken by Morgan Stanley as set forth therein, the Scheme Consideration to be received by the holders of Avadel Shares (other than the Excluded Shares) pursuant to the Transaction Agreement was fair from a financial point of view to such holders of Avadel Shares, and (ii)&#160;Goldman Sachs delivered to the Avadel Board an oral opinion, subsequently confirmed by delivery of a written opinion, dated October&#160;22, 2025, that, as of the date of such opinion and based upon and subject to the factors and assumptions set forth therein, the Scheme Consideration to be paid to the holders (other than holders of Excluded Shares and their respective affiliates) of Avadel Shares pursuant to the Transaction Agreement was fair from a financial point of view to such holders of Avadel Shares. For a detailed discussion of Morgan Stanley&#8217;s opinion and Goldman Sachs&#8217; opinion, please see the sections of this proxy statement entitled &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Opinion of Morgan Stanley &amp; Co. LLC</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Opinion of Goldman Sachs &amp; Co. LLC,</font><font style="letter-spacing:0.2pt;">&#8221; respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the evening of October&#160;21, 2025, Avadel entered into a global settlement of all litigation with Jazz. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Early on October&#160;22, 2025, Avadel and Alkermes executed and delivered the Transaction Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On the morning of October&#160;22, 2025, prior to the opening of trading on Nasdaq and the New York Stock Exchange, Avadel and Alkermes issued a joint announcement pursuant to Rule&#160;2.7 of the Irish Takeover Rules announcing the Transaction. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tROTA1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of the Avadel Board and Avadel&#8217;s Reasons for the Transaction</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At its meeting on October&#160;19, 2025, the Avadel Board unanimously approved the Transaction Agreement and determined that the Transaction Agreement and the transactions contemplated by the Transaction Agreement, including the Scheme, are in the best interests of Avadel and its shareholders and that the terms of the Scheme as contemplated by the Transaction Agreement are fair and reasonable. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Avadel Board unanimously recommends that Avadel Shareholders vote: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;FOR&#8221; </font><font style="letter-spacing:0.2pt;">the Scheme Meeting Resolution at the Scheme Meeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;FOR&#8221; </font><font style="letter-spacing:0.2pt;">any Scheme Meeting Adjournment Resolution at the Scheme Meeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;FOR&#8221; </font><font style="letter-spacing:0.2pt;">the Scheme Approval Resolution at the EGM; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;FOR&#8221; </font><font style="letter-spacing:0.2pt;">the Articles of Association Amendment Resolution at the EGM; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;FOR&#8221; </font><font style="letter-spacing:0.2pt;">the Compensation Resolution at the EGM; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;FOR&#8221; </font><font style="letter-spacing:0.2pt;">any EGM Adjournment Resolution at the EGM. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Avadel&#8217;s Reasons for the Transaction</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Background of the Transaction</font><font style="letter-spacing:0.2pt;">&#8221;, in evaluating the Transaction Agreement and Transaction, the Avadel Board held discussions with Avadel&#8217;s senior management and consulted with and received the advice of its outside legal and financial advisors, and carefully considered a number of factors that it believed supported its decision to enter into the Transaction Agreement, including (but not necessarily limited to) the reasons enumerated below (which are not in any relative order of importance). </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Financial Terms of the Transaction and Certainty of Value</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Avadel Board considered the aggregate value and form of the Scheme Consideration to be received in the Transaction by the Avadel Shareholders, and also considered: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the current and historical market prices of the Avadel Shares, including the market performance of the Avadel Shares relative to general market indices and the fact that the Scheme Consideration (assuming the Milestone Payment is made) represents a premium of: (i)&#160;approximately 38% to the weighted average trading price of Avadel over the three&#160;months prior to the announcement of the Transaction and (ii)&#160;a premium of 12% to Avadel&#8217;s closing price on Oct. 21, 2025 (being the last business day prior to announcement of the Transaction); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">that as a result of an active and robust negotiating process, Avadel was able to obtain multiple increases in the total consideration offered by Alkermes from the time of its initial expression of interest to the end of the negotiations and the Avadel Board&#8217;s belief that Alkermes&#8217; final offer of the Scheme Consideration (i)&#160;was its best and final offer and (ii)&#160;would be withdrawn if an agreement was not reached expeditiously; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">that the consideration to be paid in the Transaction will consist primarily of upfront Cash Consideration, which provides liquidity and certainty of value to the Avadel Shareholders, which the Avadel Board believed was compelling when compared to the uncertain long-term value of Avadel as a standalone business; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">challenges faced by the biopharmaceutical industry, which could impact Avadel, including macroeconomic trends and the fact that the industry is subject to complex regulatory and political regimes and evolving pricing environments, particularly with respect to generating revenue and profitability in light of the increasing scrutiny of pharmaceutical pricing and proposals to address the perceived high costs of pharmaceuticals, potential future competition from other companies and potential evolutions in the standard of care and the fact that Avadel currently has only one commercial product; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">challenges to achieving Avadel&#8217;s growth plans in light of current and foreseeable market conditions, including the risks and uncertainties in the U.S. and global economy and the biopharmaceutical industry generally; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:40pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(i) the oral opinion of Goldman Sachs rendered to the Avadel Board, subsequently confirmed in writing by delivery of its written opinion, dated October&#160;22, 2025, that, as of the date of such opinion and based upon and subject to the factors and assumptions set forth therein, the Scheme Consideration to be paid to the holders (other than holders of Excluded Shares and their respective affiliates) of Avadel Shares pursuant to the Transaction Agreement was fair from a financial point of view to such holders of Avadel Shares (as more fully described in the section of this proxy statement entitled &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Opinion of Goldman Sachs &amp; Co. LLC</font><font style="letter-spacing:0.2pt;">&#8221;) and (ii)&#160;the oral opinion of Morgan Stanley rendered to the Avadel Board, subsequently confirmed in writing by delivery of its written opinion, dated October&#160;21, 2025, that, as of the date of such opinion, and based upon and subject to the assumptions made, procedures followed, matters considered, and qualifications and limitations on the scope of review undertaken by Morgan Stanley set forth therein, the Scheme Consideration to be received by the holders of Avadel Shares (other than holders of Excluded Shares) pursuant to the Transaction Agreement was fair, from a financial point of view, to such holders of Avadel Shares (as more fully described in the section of this proxy statement entitled &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Opinion of Morgan Stanley &amp; Co. LLC</font><font style="letter-spacing:0.2pt;">&#8221;). The full text of the written opinion of Morgan Stanley, dated October&#160;21, 2025, and of the written opinion of Goldman Sachs, dated October&#160;22, 2025, have been included as Annex C and Annex&#160;D to this proxy statement, respectively, and are each incorporated herein by reference. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Opportunity to Realize Additional Value.&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">The Avadel Board considered the fact that, in addition to the Cash Consideration, the Avadel Shareholders have an opportunity to realize additional value, through an additional cash payment of $1.50 per CVR, if the Milestone set forth in the CVR Agreement is achieved by December&#160;31, 2028. The Avadel Board considered that Alkermes has agreed that it (i)&#160;will, and will cause its subsidiaries, licensees and rights transferees to, use commercially reasonable efforts to achieve the Milestone and (ii)&#160;will not take any action with the sole purpose of preventing or materially delaying the achievement of the Milestone. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Likelihood and Speed of Consummation of the Transactions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Avadel Board considered the likelihood that the Transaction will be consummated in a timely manner, including: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the financial strength of Alkermes and the fact that it has obtained fully committed financing for the Transaction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the business reputation and capabilities of Alkermes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the likelihood of obtaining required regulatory approvals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the anticipated timing of the consummation of the transactions contemplated by the Transaction Agreement, including the likelihood of consummation, based upon the scope of the conditions to the consummation of the Transaction, the remedies available to Avadel under the Transaction Agreement in the event Alkermes breaches its obligation to consummate the Transaction, including specific performance, and Alkermes&#8217; reputation in the biopharmaceutical industry and its financial capacity to complete an acquisition of this size, which the Avadel Board believed supported the conclusion that a transaction with Alkermes could be completed relatively expeditiously and in an orderly manner, as described in more detail in the section of this proxy statement entitled the &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Transaction Agreement</font><font style="letter-spacing:0.2pt;">;&#8221;; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Transaction being structured as a scheme of arrangement under Chapter 1 of Part&#160;9 of the Companies Act, pursuant to which Alkermes will acquire the entire issued and to be issued ordinary share capital of Avadel, with the expected result that a relatively short period will elapse before Avadel&#8217;s Shareholders receive the Cash Consideration, and Avadel Shareholders who do not attend or vote at the Special Meetings will receive the same Scheme Consideration received by those Avadel Shareholders who do attend or vote at the Special Meetings. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Opportunity to Receive Unsolicited Alternative Proposals, Terminate the Transaction Agreement in Order to Accept a Superior Proposal.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Avadel Board considered the following: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s right, subject to the terms of the Transaction Agreement, to respond to and negotiate unsolicited Avadel Superior Proposals that are received prior to the approval of the Transaction by Avadel Shareholders at the Scheme Meeting and the EGM; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:40pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the provision in the Transaction Agreement allowing the Avadel Board to, subject to its compliance with the applicable provisions of the Transaction Agreement, terminate the Transaction Agreement in order to accept and enter into a definitive agreement with respect to an unsolicited Avadel Superior Proposal, subject to Avadel reimbursing Alkermes for its documented, specific and quantifiable third-party costs and expenses incurred, directly or indirectly, by Alkermes or its subsidiaries or on their behalf, for the purposes of, in preparation for, or in connection with the Transaction, subject to a maximum reimbursement amount equal to 1% of the aggregate Cash Consideration (but excluding any Cash Consideration payable in respect of interests in Avadel Shares held by Alkermes and any person Acting in Concert with Alkermes), which the Avadel Board believed was reasonable relative to termination fees in transactions of a similar size and would not likely preclude competing bids; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the ability of the Avadel Board under the Transaction Agreement to withdraw or modify the Scheme Recommendation, including in connection with an Avadel Alternative Proposal, if the Avadel Board determines in good faith, after consultation with its financial advisors and outside legal counsel that such Avadel Alternative Proposal constitutes an Avadel Superior Proposal and that the failure to take such action would reasonably be expected to be inconsistent with its directors&#8217; fiduciary duties under applicable laws. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Terms of the Transaction Agreement</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Avadel Board considered the terms and conditions of the Transaction Agreement (including the terms of the Scheme of Arrangement), which was the product of robust negotiations with the assistance of Avadel&#8217;s legal and financial advisors, including the structure of the Transaction, the combination of the Cash Consideration and the CVR Consideration, the limited scope of the conditions to the consummation of the Transaction, and the customary nature of the representations, warranties, and the covenants and agreements of the parties. In addition to reasons detailed throughout this section, for the reasons noted below, the Avadel Board believed that the provisions of the Transaction Agreement were fair and reasonable to, and in the best interests of, Avadel and the Avadel Shareholders: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">End Date</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Avadel Board considered the fact that the End Date under the Transaction Agreement, on which either party, subject to certain exceptions, can terminate the Transaction Agreement, allows for sufficient time to consummate the transactions contemplated by the Transaction Agreement, but also provides that if specific conditions are not met as of the End Date, the End Date will be automatically extended by three&#160;months which provides for flexibility and also prevents the Transaction Agreement from being extended for an unreasonable amount of time; which could adversely impact Avadel&#8217;s operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Enforcement</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Avadel Board considered Avadel&#8217;s ability to seek an injunction or injunctions to prevent breaches or threatened breaches of the Transaction Agreement and to specifically enforce the terms and provisions of the Transaction Agreement against Alkermes without proof of actual damages, thereby ensuring that Avadel has an appropriate remedy in the event Alkermes were to fail to comply with their obligations under the Transaction Agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Avadel Shareholder Approval</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Avadel Board considered that the consummation of the Transaction would be subject to the approval of a majority in number of registered Avadel Shareholders, at the Voting Record Time who are present and voting, representing at least seventy-five&#160;percent (75%) in value of the Avadel Shares held by such Avadel Shareholders who are present and voting either in person or by proxy at the Scheme Meeting (or at any adjournment or postponement of such meting). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Conditions to Closing; Interim Operations</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Avadel Board considered the fact that the terms and conditions of the Transaction Agreement minimize, to the extent reasonably practical, the risk that a condition to consummation of the Transaction would not be satisfied and also provide reasonable flexibility to operate Avadel&#8217;s business prior to the consummation of the Transaction. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Future Development.&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">The Avadel Board, in consultation with members of Avadel&#8217;s management, also assessed Avadel&#8217;s prospects for substantially increasing shareholder value as a standalone company in excess of the Scheme Consideration given the risks and uncertainties in Avadel&#8217;s business,&#160;including, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">but not limited to the following (which are not listed in any relative order of importance) and&#160;those discussed in Avadel&#8217;s public filings with the SEC (see &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Where You Can Find More Information</font><font style="letter-spacing:0.2pt;">&#8221;): </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">that Avadel may need additional funding to successfully complete development and commercialization of LUMRYZ for idiopathic hypersomnia and to continue to commercialize LUMRYZ for cataplexy or EDS in patients seven years of age and older with narcolepsy; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">that currently, Avadel depends solely on the success of LUMRYZ for narcolepsy and that if Avadel is unable to continue to commercialize LUMRYZ for narcolepsy, or to successfully commercialize LUMRYZ for idiopathic hypersomnia or for other indications, its ability to generate revenue and its financial condition will be adversely affected; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">that Avadel may need additional funding, incur additional costs, be subject to technical or clinical risks or experience delays in completing, or ultimately be unable to complete, the development and commercialization of valiloxybate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">that LUMRYZ and valiloxybate to treat idiopathic hypersomnia or any other indication may have serious adverse, undesirable or unacceptable side effects which may delay or prevent marketing approval or limit their commercial success; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">that regulatory approval processes are lengthy, time consuming and inherently unpredictable, and if Avadel is ultimately unable to obtain regulatory approval for LUMRYZ to treat idiopathic hypersomnia or valiloxybate, its business could be harmed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">that Avadel operates in a highly competitive and rapidly changing industry, which may result in others, discovering, developing or commercializing competing products before or more successfully than it does and may include future competition from other companies that have established commercial presences and scale advantages that can operate in less-uncertain political, economic and regulatory environments which could negatively impact pricing or reimbursement by third party payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">that if LUMRYZ and valiloxybate do not gain market acceptance or if Avadel fails to accurately forecast demand or manage its supply chain and product inventories, its business will suffer and Avadel might not be able to fund future operations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">that potential legal and regulatory actions by competitors, including litigation or exclusivity strategies, could delay or materially affect anticipated product commercialization efforts; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">that Avadel&#8217;s commercial capabilities and infrastructure, including sales, marketing, operations, manufacturing, distribution, and reimbursement infrastructure, may not be adequate to successfully continue to commercialize LUMRYZ for cataplexy or EDS in patients seven years of age and older with narcolepsy or to successfully commercialize LUMRYZ for idiopathic hypersomnia or valiloxybate. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Avadel Board also considered a variety of risks and other potentially negative reasons in determining whether to approve the Transaction Agreement and the Transaction, including the following (which are not listed in any relative order of importance): </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Cash Consideration, while providing relative certainty of value, would not allow Avadel Shareholders to participate in future earnings or growth of Avadel, other than any payments in respect of the CVR, or to benefit from any other appreciation in value of Avadel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">although there is an obligation for Alkermes to use certain efforts to achieve the Milestone specified in the CVR Agreement, such Milestone might not be achieved at all or prior to December&#160;31, 2028, such that no payment would be made with respect to any CVR; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the fact that the pendency of the Transaction may cause Avadel to experience disruptions to its business operations and future prospects, including its relationships with employees, vendors, healthcare providers, partners, and others that do business or may do business in the future with Avadel, and the potential effects of such disruptions on Avadel&#8217;s operating results in the event that the Transactions are not consummated in a timely manner; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the fact that Avadel has incurred and will continue to incur significant transaction costs and expenses in connection with the Transaction, regardless of whether the Transaction is consummated; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the risk that the Transaction is not consummated in a timely manner or at all and the effect of a resulting public announcement of the termination of the Transaction Agreement (other than in connection with an Avadel Superior Proposal); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the potential effects of termination of the Transaction Agreement, if any, including on the trading price of Avadel Shares, which could be a result of (i)&#160;the reason the Transaction Agreement was terminated and whether such termination results from factors adversely affecting Avadel, (ii)&#160;the possibility that the marketplace would consider Avadel to be an unattractive acquisition candidate and (iii)&#160;the possible sale of Avadel Shares by investors following the announcement of a termination of the Transaction Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s ability to attract and retain key personnel and other employees and the possible loss of key management or other personnel during the pendency of the Transaction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s operating results, particularly in light of the significant transaction and opportunity costs expended attempting to consummate the Transaction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the effect of the non-solicitation provisions of the Transaction Agreement that restrict Avadel&#8217;s ability to solicit or, subject to certain exceptions, engage in discussions or negotiations with third parties regarding a proposal to acquire Avadel, and the fact that, upon termination of the Transaction Agreement under certain specified circumstances, Avadel will be required to reimburse Alkermes&#8217; transaction expenses up to 1% of the aggregate Cash Consideration; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the fact that the treatment of the consideration to be received by Avadel Shareholders in the Transaction will be taxable for U.S. federal income tax purposes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the effect of the restrictions in the Transaction Agreement on the conduct of Avadel&#8217;s business prior to the consummation of the Transaction, which may delay or prevent Avadel from undertaking business opportunities that may arise or other actions Avadel would otherwise take absent the pending Transaction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the fact that the consummation of the Transaction will require certain Irish High Court and applicable antitrust approvals, which approvals could subject the Transaction to unforeseen delays and risks; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the risk of Transaction-related litigation; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">other risks of the type and nature as further described in the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Cautionary Statement Regarding Forward-Looking Statements</font><font style="letter-spacing:0.2pt;">.&#8221; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the Avadel Board was aware of and considered the interests of its directors and executive officers that may be different from, or in addition to, the interests of Avadel Shareholders generally when approving the Transaction Agreement and recommending that Avadel Shareholders vote to approve each of the Proposals. See &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction</font><font style="letter-spacing:0.2pt;">&#8221;. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Avadel Board determined that, overall, these potential risks and uncertainties were outweighed by the benefits that the Avadel Board expects Avadel Shareholders to realize as a result of the Transaction and that the terms of the Transaction as contemplated by the Transaction Agreement were therefore fair and reasonable. The Avadel Board acknowledged that there can be no assurance about future results, including those considered or expected in connection with the foregoing reasons. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The foregoing discussion of the Avadel Board&#8217;s reasons for its recommendation that Avadel Shareholders approve the Transaction is not meant to be exhaustive but addresses the material information and reasons considered by the Avadel Board in connection with its recommendation. In view of the wide variety of factors considered in connection with the evaluation of the Transaction and the complexity of these matters, the Avadel Board did not find it practicable to, and did not, quantify or otherwise assign relative weights to the specific reasons considered in reaching its determination and recommendation. Rather, Avadel&#8217;s directors made their determinations and recommendations based on the totality of the information presented to them, and the judgments of individual members of the Avadel Board may have been influenced to a greater or lesser degree by different reasons. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tOOMS1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The foregoing description of Avadel&#8217;s consideration of the factors supporting the Transaction is forward-looking in nature. This information should be read in light of the factors discussed in the section entitled &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221;. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ACCORDINGLY, THE AVADEL BOARD UNANIMOUSLY RECOMMENDS THAT AVADEL SHAREHOLDERS VOTE &#8220;FOR&#8221; THE SCHEME MEETING RESOLUTION AT THE SCHEME MEETING, &#8220;FOR&#8221; THE SCHEME MEETING ADJOURNMENT RESOLUTION AT THE SCHEME MEETING, &#8220;FOR&#8221; THE SCHEME APPROVAL RESOLUTION AT THE EGM, &#8220;FOR&#8221; THE ARTICLES OF ASSOCIATION AMENDMENT RESOLUTION AT THE EGM, &#8220;FOR&#8221; THE COMPENSATION RESOLUTION AT THE EGM AND &#8220;FOR&#8221; ANY ADJOURNMENT RESOLUTION AT THE EGM.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Opinion of Morgan Stanley &amp; Co. LLC</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel retained Morgan Stanley to provide it with financial advisory services in connection with a possible sale, merger or similar business combination, and, if requested by Avadel, a financial opinion with respect thereto. Avadel selected Morgan Stanley to act as its financial advisor based on Morgan Stanley&#8217;s qualifications, expertise and reputation and its knowledge of the financial services industry, market and regulatory environment and business and affairs of Avadel. On October&#160;21, 2025, Morgan Stanley rendered its oral opinion, which was subsequently confirmed by delivery of a written opinion dated October&#160;21, 2025, to the Avadel Board, that, as of that date, and based upon and subject to the assumptions made, procedures followed, matters considered, and qualifications and limitations on the scope of review undertaken by Morgan Stanley as set forth therein, the Scheme Consideration to be received by the holders of Avadel Shares (other than holders of Excluded Shares) pursuant to the Transaction Agreement was fair from a financial point of view to such holders of Avadel Shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The full text of the written opinion of Morgan Stanley, dated October&#160;21, 2025, is attached as Annex C and incorporated by reference into this proxy statement. The opinion sets forth, among other things, the assumptions made, procedures followed, matters considered and qualifications and limitations on the scope of the review undertaken by Morgan Stanley in rendering its opinion. Shareholders are urged to, and should, read the opinion carefully and in its entirety. Morgan Stanley&#8217;s opinion was directed to the Avadel Board and addressed only the fairness, from a financial point of view to the holders of Avadel Shares (other than holders of Excluded Shares) of the Scheme Consideration to be received by such holders pursuant to the Transaction Agreement as of the date of the opinion. Morgan Stanley&#8217;s opinion did not address any other aspect of the transactions contemplated by the Transaction Agreement. Morgan Stanley&#8217;s opinion did not address the relative merits of the transactions contemplated by the Transaction Agreement and the CVR Agreement as compared to other business or financial strategies that might be available to Avadel, nor did it address the underlying business decision of Avadel to enter into the Transaction Agreement or proceed with any other transaction contemplated by the Transaction Agreement and the CVR Agreement and does not constitute a recommendation to Avadel Shareholders as to how to act or vote in connection with the Transaction or any other matter or whether to take any other action with respect to the Transaction. The summary of Morgan Stanley&#8217;s opinion set forth in this proxy statement is qualified in its entirety by reference to the full text of the opinion. In addition, the opinion does not in any manner address the price at which the Avadel Shares will trade following the consummation of the Transaction or at any time.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with rendering its opinion, Morgan Stanley, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reviewed certain publicly available financial statements and other business and financial information of Avadel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reviewed certain internal financial statements and other financial and operating data concerning Avadel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reviewed (i)&#160;certain financial projections, prepared by the management of Avadel and approved for Morgan Stanley&#8217;s use by the management of Avadel (the &#8220;Forecasts&#8221;), as discussed more fully in the section of this proxy statement captioned &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Avadel Unaudited&#160;Prospective Financial Information</font><font style="letter-spacing:0.2pt;">&#8221;, (ii)&#160;certain estimates as to the probability and timing of achievement of the Milestone, as prepared by the management of Avadel and approved for Morgan Stanley&#8217;s use by </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the management of Avadel (the &#8220;CVR Estimates&#8221;) and (iii)&#160;certain forecasts related to the expected utilization by Avadel of certain net operating loss carryforwards and tax credits, as prepared by the management of Avadel and approved for Morgan Stanley&#8217;s use by the management of Avadel (the &#8220;NOL Forecasts&#8221;); </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Discussed the past and current operations and financial condition and the prospects of Avadel with senior executives of Avadel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reviewed the reported prices and trading activity for the Avadel Shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Compared the financial performance of Avadel and the prices and trading activity of the Avadel Shares with that of certain other publicly-traded companies comparable with Avadel and their securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">7)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reviewed the financial terms, to the extent publicly available, of certain comparable acquisition transactions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">8)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Participated in certain discussions and negotiations among representatives of Avadel and Alkermes and their financial and legal advisors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">9)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reviewed the Transaction Agreement, the CVR Agreement and certain related documents; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">10)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Performed such other analyses, reviewed such other information and considered such other factors as Morgan Stanley deemed appropriate. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Morgan Stanley assumed and relied upon, without independent verification, the accuracy and completeness of the information that was publicly available or supplied or otherwise made available to Morgan Stanley by Avadel, and formed a substantial basis for its opinion. With respect to the Forecasts, the CVR Estimates and the NOL Forecasts, Morgan Stanley assumed that they had been reasonably prepared on bases reflecting currently available estimates and judgments of the management of Avadel of the future financial performance of Avadel. Morgan Stanley expressed no view as to the Forecasts, the CVR Estimates or the NOL Forecasts, or the assumptions upon which they were based. Morgan Stanley expressed no view as to the likelihood the Milestone is achieved or whether the CVR Consideration becomes payable. In addition, Morgan Stanley assumed that the Transaction will be consummated in accordance with the terms set forth in the Transaction Agreement without any waiver, amendment or delay of any terms or conditions, including, among other things, that the definitive Transaction Agreement and CVR Agreement would not differ in any material respect from the drafts thereof furnished to Morgan Stanley. Morgan Stanley assumed that in connection with the receipt of all the necessary governmental, regulatory or other approvals and consents required for the proposed Transaction, no delays, limitations, conditions or restrictions will be imposed that would have a material adverse effect on the contemplated benefits expected to be derived in the proposed Transaction. Morgan Stanley is not a legal, tax or regulatory advisor. Morgan Stanley is a financial advisor only and relied upon, without independent verification, the assessment of Avadel and its legal, tax and regulatory advisors with respect to legal, tax and regulatory matters. Morgan Stanley expressed no opinion with respect to the fairness of the amount or nature of the compensation to any of Avadel&#8217;s officers, directors or employees, or any class of such persons, relative to the Scheme Consideration to be received by the holders of Avadel Shares (other than holders of Excluded Shares) pursuant to the Transaction Agreement. Morgan Stanley did not express any view on, and its opinion did not address, any other term or aspect of the Transaction Agreement or the transactions contemplated thereby other than with respect to the fairness, from a financial point of view, of the Scheme Consideration to be received by the holders of Avadel Shares (other than holders of Excluded Shares) pursuant to the Transaction Agreement, or any term or aspect of any other agreement or instrument contemplated by the Transaction Agreement or the CVR Agreement or entered into or amended in connection therewith. Morgan Stanley&#8217;s opinion did not address the relative merits of the transactions contemplated by the Transaction Agreement and the CVR Agreement as compared to other business or financial strategies that might be available to Avadel, nor did it address the underlying business decision of Avadel to enter into the Transaction Agreement or proceed with any other transaction contemplated by the Transaction Agreement and the CVR Agreement. Morgan Stanley did not make any independent valuation or appraisal of the assets or liabilities of Avadel, nor was it furnished with any such valuations or appraisals. Morgan Stanley&#8217;s opinion is necessarily based on financial, economic, market and other conditions as in effect on, and the information made available to Morgan Stanley as of, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the date of its opinion. Events occurring after such date may affect Morgan Stanley&#8217;s opinion and the assumptions used in preparing it, and Morgan Stanley did not assume any obligation to update, revise or reaffirm its opinion. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Summary of Financial Analyses of Morgan Stanley</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of the material analyses performed by Morgan Stanley in connection with its oral opinion and the preparation of its written opinion letter, dated October&#160;21, 2025. The following summary is not a complete description of Morgan Stanley&#8217;s opinion or the financial analyses performed and factors considered by Morgan Stanley in connection with its opinion, nor does the order of analyses described represent the relative importance or weight given to those analyses. Except as otherwise noted, the following quantitative information, to the extent that it is based on market data, is based on market data as it existed on or before October&#160;17, 2025, the third to last trading day before the public announcement of the Transaction (referred to in this section of the proxy as the &#8220;Unaffected Date&#8221;), and is not necessarily indicative of current market conditions. Some of these summaries of financial analyses include information presented in tabular format. In order to fully understand the financial analyses used by Morgan Stanley, the tables must be read together with the text of each summary. The tables alone do not constitute a complete description of the financial analyses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In performing the financial analyses summarized below and in arriving at its opinion, Morgan Stanley utilized and relied upon the Forecasts, the NOL Forecasts and the CVR Estimates, which were prepared by the management of Avadel and which the Avadel Board directed Morgan Stanley to rely on and use in its financial analysis, as discussed more fully in the section of this proxy statement captioned &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Avadel Unaudited Prospective Financial Information</font><font style="letter-spacing:0.2pt;">.&#8221; In addition, Morgan Stanley utilized and relied upon the number of issued and outstanding Avadel Shares, on a fully diluted basis, as of October&#160;20, 2025, provided by management of Avadel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For purposes of its financial analyses, Morgan Stanley calculated the implied value of the Cash Consideration plus one CVR per Avadel Share to be paid to the holders of Avadel Shares (other than holders of Excluded Shares) pursuant to the Transaction Agreement to be $19.57 (which we refer to in this section of the proxy statement as the &#8220;Consideration NPV&#8221;) by adding the Cash Consideration of $18.50 per Avadel Share and the risk-adjusted net present value of one CVR of $1.07 per Avadel Share, which was calculated by discounting to the present value, as of September&#160;30, 2025, the risk-adjusted Milestone Payment estimated to be made based on the probability and timing of achieving the Milestone as reflected in the CVR Estimates, discounting back from date of achievement of the Milestone as forecasted by the management of Avadel at a discount rate of 10% (the midpoint of the discount rate range of 9.5% to 10.5% determined by Morgan Stanley), reflecting Morgan Stanley&#8217;s estimates of Avadel&#8217;s weighted average cost of capital as described in further detail below. However, there is no guarantee that any of the conditions for the Milestone Payment pursuant to the CVR Agreement will be satisfied, and if satisfied, when such conditions will be satisfied. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Historical Trading Analysis</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Morgan Stanley analyzed the consideration to be paid to holders of Avadel Shares pursuant to the Transaction Agreement in relation to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">$15.22, the closing price per Avadel Share on the Unaffected Date (referred to in this section of the proxy statement as the &#8220;current share price&#8221;); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">$15.23, the volume weighted average price (referred to in this section of the proxy statement as the &#8220;VWAP&#8221;) of the Avadel Shares during the 30 trading-day period ended on the Unaffected Date (referred to in this section of the proxy statement as the &#8220;30-day VWAP&#8221;); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">$14.33, the VWAP of the Avadel Shares during the 60 trading-day period ended on the Unaffected Date (referred to in this section of the proxy statement as the &#8220;60-day VWAP&#8221;); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">$12.61, the VWAP of the Avadel Shares during the 90 trading-day period ended on the Unaffected Date (referred to in this section of the proxy statement as the &#8220;90-day VWAP&#8221;); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">$16.66, the highest intraday trading price of the Avadel Shares for the 52-week period ended on the Unaffected Date (referred to in this section of the proxy statement as the &#8220;52-week high price&#8221;). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The analysis indicated that the Scheme Consideration NPV represented: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a premium of 29% based on the current share price of $15.22; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a premium of 29% based on the 30-day VWAP of $15.23; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a premium of 37% based on the 60-day VWAP of $14.33; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a premium of 55% based on the 90-day VWAP of $12.61; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a premium of 17% based on the 52-week high price of $16.66. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sum-of-the-Parts Discounted Cash Flow Analysis</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Morgan Stanley performed a sum-of-the-parts discounted cash flow analysis of Avadel, which is designed to provide an implied value of a company by calculating the present value of the estimated future cash flows of separate product lines or businesses of a company. The estimates of future unlevered free cash flows projected to be generated by Avadel&#8217;s existing products for selected indications for the last quarter of fiscal year 2025 and for fiscal&#160;years 2026 through 2045 were based on the Forecasts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with this analysis, Morgan Stanley performed separate discounted cash flow analyses with respect to the following indications: narcolepsy and IH. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this analysis, Morgan Stanley utilized the Forecasts, which included probability of success risk-adjusted estimates of net revenue and management&#8217;s allocation of related operating and other expenses, in each case for the last quarter of fiscal year 2025 and for fiscal&#160;years 2026 through 2045. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The cash flows were then discounted to present value as of September&#160;30, 2025, using a midyear convention, at discount rates ranging from 9.5% to 10.5%. This range of discount rates was based on Morgan Stanley&#8217;s analysis of Avadel&#8217;s weighted average cost of capital determined by the application of the capital asset pricing model. The sum-of-the-parts discounted cash flow analysis assumed an allocation of selling, general and administrative, contingency and stock-based compensation costs by annual sales mix between indications, as provided by the management of Avadel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From the foregoing analysis, Morgan Stanley derived a range of illustrative aggregate values for each indication. The resulting combined range of implied aggregate values, comprised of the sum of the aggregate values for each of the indications, was then adjusted by the net present value of estimated net operating losses, as provided by the management of Avadel, and by the expected net cash of Avadel as of September&#160;30, 2025, as provided by the management of Avadel, to derive a range of implied equity values. Morgan&#160;Stanley then divided the implied equity values by the number of fully diluted shares, as of October&#160;20, 2025 and calculated using the treasury stock method, of Avadel, as provided by the management of Avadel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This analysis resulted in a range of implied equity values per Avadel Share (rounded to the nearest $0.05) of approximately $16.15 to $17.35, as compared to the Scheme Consideration NPV. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Information</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Morgan Stanley observed additional factors that were not considered part of Morgan Stanley&#8217;s financial analyses with respect to its opinion, but which were noted as reference data for the Avadel Board, including the following information described in the sections of this proxy statement captioned &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Historical Trading Range</font><font style="letter-spacing:0.2pt;">,&#8221; &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Analysts&#8217; Price Targets</font><font style="letter-spacing:0.2pt;">,&#8221; &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Selected Comparable Company Analysis</font><font style="letter-spacing:0.2pt;">,&#8221; and &#8220;&#8212;&#160;</font><font style="font-style:italic;letter-spacing:0.2pt;">Precedent Transactions&#8201;&#8212;&#8201;Premia Paid Analysis.&#8221;</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Historical Trading Range</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For reference only, and not as a component of its fairness analysis, Morgan Stanley reviewed the historical trading data of Avadel Shares for the 52-week period ending on the Unaffected Date, and noted that the 52-week high price per Avadel Share was $16.65 and the lowest intraday trading price of the Avadel </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Shares for such period was $6.40 (each price rounded to the nearest $0.05). Morgan Stanley compared this range to the Scheme Consideration NPV. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Analysts&#8217; Price Targets</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For reference only, and not as a component of its fairness analysis, Morgan Stanley reviewed and analyzed future public market trading price targets for the Avadel Shares that were prepared and published by equity research analysts on or before the Unaffected Date. These price targets reflect each analyst&#8217;s estimate of the future public market trading price of the Avadel Shares. The range of undiscounted analyst price targets was $16.00 to $36.00 per Avadel Share, rounded to the nearest $0.05. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to better compare the equity analysts&#8217; stock price targets with the Scheme Consideration NPV, based on its professional judgment and experience, Morgan Stanley discounted each analyst&#8217;s price target for one year using a discount rate of 10%, which rate was selected by Morgan Stanley based on the midpoint of Avadel&#8217;s estimated cost of equity. This analysis resulted in a discounted analyst price target range of $14.55 to $32.70 per Avadel Share, rounded to the nearest $0.05. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Morgan Stanley compared each of the foregoing ranges to the Scheme Consideration NPV. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The public market trading price targets published by securities research analysts do not necessarily reflect current market trading prices for Avadel Shares and these estimates are subject to uncertainties, including the future financial performance of Avadel and future financial market conditions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Selected Comparable Company Analysis</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For reference only, and not as a component of its fairness analysis, Morgan Stanley performed a selected public trading comparables analysis, which is designed to provide an implied value of a company by comparing it to similar companies that are publicly traded. Morgan Stanley reviewed and compared the Forecasts with comparable publicly available consensus equity analyst research estimates for selected companies, that, in Morgan Stanley&#8217;s professional judgment, share certain similar business characteristics and have certain comparable operating characteristics including, among other things, product characteristics, similarly sized revenue and/or revenue growth rates, market capitalizations, profitability, scale and/or other similar operating characteristics. These companies are referred to in this section of the proxy statement as the &#8220;comparable companies.&#8221; The following is a list of the comparable companies: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Jazz Pharmaceuticals plc </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Axsome Therapeutics, Inc. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Alkermes plc </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">ACADIA Pharmaceuticals Inc. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Centessa Pharmaceuticals plc </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Supernus Pharmaceuticals, Inc. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Catalyst Pharmaceuticals, Inc. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Harmony Biosciences Holdings, Inc. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this analysis, Morgan Stanley analyzed the ratio of aggregate value (&#8220;AV&#8221;), defined as fully diluted market capitalization, plus total debt, less cash and cash equivalents, to estimated revenue for fiscal year 2029, for each of the comparable companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The multiples for each of the comparable companies were calculated using their respective closing prices on the Unaffected Date, and were based on the most recent publicly available information as of the Unaffected Date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Based on its analysis of the relevant metrics for each of the comparable companies, and the application of its professional judgment and experience, Morgan Stanley selected a reference range of AV/revenue multiples for estimated fiscal year 2029 of 2.0x to 2.7x. Morgan Stanley applied the selected reference range to Avadel&#8217;s estimated revenue for fiscal year 2029, as set forth in the Forecasts. Based on the number of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">fully diluted shares, as of October&#160;20, 2025 and calculated using the treasury stock method, and the expected net cash of Avadel as of September&#160;30, 2025, in each case, as provided by the management of Avadel, Morgan Stanley&#8217;s analysis resulted in an implied value per Avadel Share of $11.95 to $15.25, rounded to the nearest $0.05. Morgan Stanley compared this range to the Scheme Consideration NPV. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No company utilized in this analysis is identical to Avadel. In evaluating the comparable companies, Morgan Stanley made numerous assumptions with respect to industry performance, general business, regulatory, economic, market and financial conditions and other matters, many of which are beyond Avadel&#8217;s control. These include, among other things, the impact of competition on Avadel&#8217;s business and the industry generally, industry growth, and the absence of any adverse material change in the financial condition and prospects of Avadel and the industry, and in the financial markets in general. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Analysis of Precedent Transactions&#8201;&#8212;&#8201;Premia Paid Analysis</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For reference only, and not as a component of its fairness analysis, Morgan Stanley considered, based on publicly available information, transactions with public biopharmaceutical targets between $1&#160;billion and $10&#160;billion in AV, paid in all-cash Scheme Consideration since January&#160;1, 2025. For these transactions, Morgan Stanley noted (i)&#160;the&#160;percentage premia paid over the price on the date before transaction announcement or rumor (referred to in this section of the proxy statement as &#8220;the unaffected stock price&#8221;) and (ii)&#160;the&#160;percentage premia paid over the acquired company&#8217;s 52-week high price, for the period ended on the date of the transaction announcement or rumor, in each case, based on publicly available information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based on its analysis of the premia for these transactions and the application of its professional judgment and experience, (i)&#160;Morgan Stanley selected a range of premia to the unaffected stock price of 26%&#8201;&#8211;&#8201;47%, based on 25th and 75th&#160;percentiles, and applied such range to Avadel&#8217;s closing price of $15.22 on the Unaffected Date, which resulted in an implied price range per share of $19.20 to $22.30 (rounded to the nearest $0.05) and (ii)&#160;Morgan Stanley selected a range of premia relative to the 52-week high price of (2)% to 26%, based on 25th and 75th&#160;percentiles, and applied such range to Avadel&#8217;s 52-week high price of $16.66, for the period ended on the Unaffected Date, which resulted in an implied price range per share of $16.35&#8201;&#8211;&#8201;$21.00 (rounded to the nearest $0.05). Morgan Stanley compared these ranges to the Scheme Consideration NPV. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No company or transaction utilized in the premia paid analysis is identical to Avadel or the Transaction. In evaluating the precedent transactions, Morgan Stanley made judgments and assumptions with regard to industry performance, general business, market and financial conditions and other factors beyond the control of Avadel, such as the impact of competition on the business of Avadel or the industry generally, industry growth and the absence of any adverse material change in the financial condition of Avadel or the industry or in the financial markets in general, which could affect the public trading value of the companies and the AV and equity value of the transactions to which they are being compared. Mathematical analysis (such as determining the 25th and 75th&#160;percentiles) is not in itself a meaningful method of using precedent transaction data. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with the review of the Transaction by the Avadel Board, Morgan Stanley performed a variety of financial and comparative analyses for purposes of rendering its opinion. The preparation of a financial opinion is a complex process and is not necessarily susceptible to a partial analysis or summary description. In arriving at its opinion, Morgan Stanley considered the results of all of its analyses as a whole and did not attribute any particular weight to any analysis or factor it considered. Morgan Stanley believes that selecting any portion of its analyses, without considering all analyses as a whole, would create an incomplete view of the process underlying its analyses and opinion. In addition, Morgan Stanley may have given various analyses and factors more or less weight than other analyses and factors, and may have deemed various assumptions more or less probable than other assumptions. As a result, the ranges of valuations resulting from any particular analysis described above should not be taken to be Morgan Stanley&#8217;s view of the actual value of Avadel. In performing its analyses, Morgan Stanley made numerous assumptions with respect to industry performance, general business and economic conditions and other matters. Many of these assumptions are beyond the control of Avadel. Any estimates contained in Morgan Stanley&#8217;s analyses </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tOOGS1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">are not necessarily indicative of future results or actual values, which may be significantly more or less favorable than those suggested by such estimates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Morgan Stanley conducted the analyses described above solely as part of its analysis of the fairness of the Scheme Consideration pursuant to the Transaction Agreement from a financial point of view to holders of Avadel Shares and in connection with the delivery of its opinion to the Avadel Board. These analyses do not purport to be appraisals or to reflect the prices at which the Avadel Shares might actually trade. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Scheme Consideration was determined through arm&#8217;s-length negotiations between Avadel and Alkermes and was approved by the Avadel Board. Morgan Stanley provided advice to Avadel during these negotiations. Morgan Stanley did not, however, recommend any specific consideration to Avadel or that any specific consideration constituted the only appropriate consideration for the proposed Transaction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Morgan Stanley&#8217;s opinion and its presentation to Avadel Board was one of many factors taken into consideration by the Avadel Board in deciding to approve, adopt and authorize the Transaction Agreement. Consequently, the analyses as described above should not be viewed as determinative of the opinion of the Avadel Board with respect to the Scheme Consideration or of whether the Avadel Board would have been willing to agree to a different consideration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Avadel Board retained Morgan Stanley based upon Morgan Stanley&#8217;s qualifications, experience and expertise. Morgan Stanley is a global financial services firm engaged in the securities, investment management and individual wealth management businesses. Its securities business is engaged in securities underwriting, trading and brokerage activities, foreign exchange, commodities and derivatives trading, prime brokerage, as well as providing investment banking, financing and financial advisory services. Morgan Stanley, its affiliates, directors and officers may at any time invest on a principal basis or manage funds that invest, hold long or short positions, finance positions, and may trade or otherwise structure and effect transactions, for their own account or the accounts of its customers, in debt or equity securities or loans of Avadel, Alkermes, or any other company, or any currency or commodity, that may be involved in this transaction, or any related derivative instrument. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of its engagement letter, Morgan Stanley provided Avadel financial advisory services and a financial opinion in connection with the Transaction, and Avadel agreed to pay Morgan Stanley a fee of approximately $23&#160;million for its services, $2&#160;million of which became payable in connection with the delivery of Morgan Stanley&#8217;s opinion, and the remainder of which is contingent on closing of the Transaction. Avadel has agreed to pay Morgan Stanley an additional $2&#160;million fee which is contingent upon the Milestone Payment being made. Morgan Stanley may receive an additional fee of up to $4&#160;million at Avadel&#8217;s sole discretion. Avadel has not yet determined whether to pay such additional fee to Morgan Stanley. Avadel has also agreed to reimburse Morgan Stanley for its expenses incurred in performing its services. In addition, Avadel has agreed to indemnify Morgan Stanley and its affiliates, their respective directors, officers, agents and employees and each person, if any, controlling Morgan Stanley or any of its affiliates against certain liabilities and expenses, including certain liabilities under the federal securities laws, related to or arising out of Morgan Stanley&#8217;s engagement. In the two&#160;years prior to the date of its opinion, Morgan Stanley and its affiliates have provided financial advisory and financing services for Alkermes and have received aggregate fees of between $5&#160;million and $10&#160;million in connection with such services. In the two&#160;years prior to the date of its opinion Morgan Stanley and its affiliates have not provided financial advisory or financing services to Avadel, and have not received fees in connection with such services. As of October&#160;21, 2025, so far as Morgan Stanley was aware, Morgan Stanley and/or its affiliates held an aggregate interest of: (x)&#160;between 2% and 3% of the Avadel Shares and (y)&#160;less than 1% of the ordinary shares of Alkermes, which interests were held in connection with its and/or its affiliates&#8217; investment management business, wealth management business, including client discretionary accounts, or ordinary course trading activities, including hedging activities. Morgan Stanley may also seek to provide such services to Avadel and Alkermes and their respective affiliates in the future and would expect to receive fees for the rendering of these services. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Opinion of Goldman Sachs &amp; Co. LLC</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Goldman Sachs rendered its opinion to the Avadel board that, as of October&#160;22, 2025 and based upon and subject to the factors and assumptions set forth therein, the Scheme Consideration to be paid to the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">holders (other than holders of Excluded Shares and their respective affiliates) of Avadel Shares pursuant to the Transaction Agreement was fair from a financial point of view to such holders of Avadel Shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The full text of the written opinion of Goldman Sachs, dated October&#160;22, 2025, which sets forth assumptions made, procedures followed, matters considered and limitations on the review undertaken in connection with the opinion, is attached as Annex D. Goldman Sachs provided advisory services and its opinion for the information and assistance of the Avadel Board in connection with its consideration of the Transaction. Goldman Sachs&#8217; opinion is not a recommendation as to how any holder of Avadel Shares should vote with respect to the Transaction, or any other matter.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with rendering the opinion described above and performing its related financial analyses, Goldman Sachs reviewed, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Transaction Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the CVR Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">annual reports to stockholders and Annual Reports on Form 10-K of Avadel for the five&#160;years ended December&#160;31, 2024; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">certain interim reports to stockholders and Quarterly Reports on Form 10-Q of Avadel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">certain other communications from Avadel to its stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">certain publicly available research analyst reports for Avadel; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">certain internal financial analyses and forecasts for Avadel prepared by the management of Avadel as approved for Goldman Sachs&#8217; use by Avadel (the &#8220;Forecasts&#8221;), as discussed more fully in the&#160;section of this proxy statement captioned &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Avadel Unaudited Prospective Financial Information</font><font style="letter-spacing:0.2pt;">&#8221;; certain forecasts related to the expected utilization by Avadel of certain net operating loss carryforwards and tax credits, as prepared by the management of Avadel as approved for Goldman Sachs&#8217; use by Avadel (the &#8220;NOL Forecasts&#8221;); and certain estimates as to the probability and timing of the achievement of the Milestone prepared by the management of Avadel as approved for Goldman Sachs&#8217; use by Avadel (the &#8220;CVR Estimates&#8221;). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Goldman Sachs also held discussions with members of the senior management of Avadel regarding their assessment of the past and current business operations, financial condition and future prospects of Avadel; reviewed the reported price and trading activity for the Avadel Shares; compared certain financial and stock market information for Avadel with similar information for certain other companies the securities of which are publicly traded; reviewed the financial terms of certain recent business combinations in the biotechnology industry; and performed such other studies and analyses, and considered such other factors, as it deemed appropriate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of rendering this opinion, Goldman Sachs, with the Avadel Board&#8217;s consent, relied upon and assumed the accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by, it, without assuming any responsibility for independent verification thereof. In that regard, Goldman Sachs assumed with the Avadel Board&#8217;s consent that the Forecasts, the NOL Forecasts and the CVR Estimates were reasonably prepared on a basis&#160;reflecting then available estimates and judgments of the management of Avadel. Goldman Sachs did not make an independent evaluation or appraisal of the assets and liabilities (including any contingent, derivative or other off-balance-sheet assets and liabilities) of Avadel or any of its subsidiaries and it was not furnished with any such evaluation or appraisal. Goldman Sachs assumed that all governmental, regulatory or other consents and approvals necessary for the consummation of the Transaction will be obtained without any adverse effect on the expected benefits of the Transaction in any way meaningful to its analysis. Goldman Sachs also assumed that the Transaction will be consummated on the terms set forth in the Transaction Agreement, without the waiver or modification of any term or condition the effect of which would be in any way meaningful to its analysis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Goldman Sachs&#8217; opinion does not address the underlying business decision of Avadel to engage in the Transaction or the relative merits of the Transaction as compared to any strategic alternatives that may be available to Avadel; nor does it address any legal, regulatory, tax or accounting matters. Goldman Sachs&#8217; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">opinion addresses only the fairness from a financial point of view to the holders (other than holders of Excluded Shares and their respective affiliates) of Avadel Shares, as of the date of the opinion, of the Scheme Consideration to be paid to such holders pursuant to the Transaction Agreement. Goldman Sachs&#8217; opinion does not express any view on, and does not address, any other term or aspect of the Transaction Agreement, the CVR Agreement or the Transaction or any term or aspect of any other agreement or instrument contemplated by the Transaction Agreement or the CVR Agreement or entered into or amended in connection with the Transaction, or any consideration received in connection therewith by, the holders of any other class of securities, creditors, or other constituencies of Avadel; nor as to the fairness of the amount or nature of any compensation to be paid or payable to any of the officers, directors or employees of Avadel, or class of such persons in connection with the Transaction, whether relative to the Scheme Consideration to be paid to the holders (other than holders of Excluded Shares and their respective affiliates) of Avadel Shares pursuant to the Transaction Agreement or otherwise. Goldman Sachs&#8217; opinion is necessarily based on economic, monetary market and other conditions as in effect on, and the information made available to Goldman Sachs as of, the date of its opinion and Goldman Sachs assumes no responsibility for updating, revising or reaffirming its opinion based on circumstances, developments or events occurring after the date of its opinion. In addition, Goldman Sachs does not express any opinion as to the prices at which the Avadel Shares will trade at any time, as to the potential effects of volatility in the credit, financial and stock markets on Avadel, Alkermes or the Transaction, or as to the impact of the Transaction on the solvency or viability of Avadel or Alkermes or the ability of Avadel or Alkermes to pay their respective obligations when they come due. Goldman Sachs&#8217; opinion was approved by a fairness committee of Goldman Sachs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Summary of Financial Analysis</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of the material financial analyses delivered by Goldman Sachs to the Avadel Board in connection with rendering the opinion described above. The following summary, however, does not purport to be a complete description of the financial analyses performed by Goldman Sachs, nor does the order of analyses described represent relative importance or weight given to those analyses by Goldman Sachs. Some of the summaries of the financial analyses include information presented in tabular format. The tables must be read together with the full text of each summary and are alone not a complete description of Goldman Sachs&#8217; financial analyses. Except as otherwise noted, the following quantitative information, to the extent that it is based on market data, is based on market data as it existed on or before October&#160;17, 2025, the third to last trading day before the public announcement of the Transaction (the &#8220;Unaffected Date&#8221;), and is not necessarily indicative of current market conditions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For purposes of its financial analyses, Goldman Sachs calculated the implied value of the price per share to be paid to the holders of Avadel Shares pursuant to the Transaction Agreement to be $19.56 (the &#8220;Consideration NPV&#8221;) by adding to the Cash Consideration of $18.50 per Avadel Share the net present value of one CVR of $1.06 per Avadel Share, calculated by discounting to the present value, as of September&#160;30, 2025, the risk-adjusted Milestone Payment estimated to be made based on the timing of achieving the Milestone as reflected in the CVR Estimates, using the mid-year convention for discounting cash flows and a discount rate of 10.5% (the midpoint of the discount rate range of 9.5% to 11.5% determined by Goldman Sachs), reflecting estimates of Avadel&#8217;s weighted average cost of capital. Goldman Sachs derived such discount rates by application of the Capital Asset Pricing Model (the &#8220;CAPM&#8221;), which requires certain company-specific inputs, including Avadel&#8217;s target capital structure weightings, the cost of long-term debt, after-tax yield on permanent excess cash, if any, future applicable marginal cash tax rate and a beta for Avadel, as well as certain financial metrics for the United States financial markets generally. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Historical Stock Trading Analysis</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Goldman Sachs reviewed the historical trading prices and volumes for the Avadel Shares from January&#160;1, 2025 through the Unaffected Date. In addition, Goldman Sachs analyzed the Consideration NPV in relation to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">$15.22, the closing price per Avadel Share on the Unaffected Date (referred to as the &#8220;current share price&#8221;); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">$16.66, the highest intraday trading price of the Avadel Shares for the 52-week period ended on the Unaffected Date (referred to as the &#8220;52-week high price&#8221;). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The analysis indicated that the Consideration NPV represented: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a premium of 29% based on the current share price of $15.22; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a premium of 17% based on the 52-week high price of $16.66. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Illustrative Discounted Cash Flow Analysis.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Using the Forecasts and the NOL Forecasts, Goldman Sachs performed an illustrative discounted cash flow analysis on Avadel to derive a range of illustrative present values per Avadel Share. Using the mid-year convention for discounting cash flows and discount rates ranging from 9.5% to 11.5%, reflecting estimates of Avadel&#8217;s weighted average cost of capital, Goldman Sachs discounted to present value as of September&#160;30, 2025 estimates of (i)&#160;unlevered free cash flow for Avadel for the last quarter of fiscal year 2025 and for fiscal&#160;years 2026 through 2045 as reflected in the Forecasts and (ii)&#160;Avadel&#8217;s estimated net operating losses, as reflected in the NOL Forecasts. For a summary of the Forecasts and NOL Forecasts used by Goldman Sachs in performing this analysis, see the section of this proxy statement captioned &#8220;The Transaction&#8201;&#8212;&#8201;Avadel Unaudited Prospective Financial Information.&#8221; Goldman Sachs derived such discount rates by application of the CAPM, which requires certain company-specific inputs, including Avadel&#8217;s target capital structure weightings, the cost of long-term debt, after-tax yield on permanent excess cash, if any, future applicable marginal cash tax rate and a beta for Avadel, as well as certain financial metrics for the United States financial markets generally. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Goldman Sachs derived ranges of illustrative enterprise values for Avadel by adding the ranges of present values it derived above. Goldman Sachs then subtracted from the range of illustrative enterprise values it derived for Avadel the amount of Avadel&#8217;s total debt and debt-like items and added the amount of Avadel&#8217;s cash and cash equivalents, in each case, as provided by and approved for Goldman Sachs&#8217; use by the management of Avadel, to derive a range of illustrative equity values for Avadel. Goldman Sachs then divided the range of illustrative equity values it derived by the number of fully diluted outstanding shares of Avadel, as provided by and approved for Goldman Sachs&#8217; use by the management of Avadel, using the treasury stock method, to derive a range of illustrative present values per share ranging from $15.06 to $17.43. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Premia Paid Analysis.&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">Goldman Sachs reviewed and analyzed, using publicly available information, the acquisition premia for select transactions announced from January&#160;1, 2023 through the Unaffected Date involving a public company in the biotechnology industry as the target where the disclosed enterprise values for the transaction were between $1&#160;billion and $5&#160;billion. Using publicly available information, Goldman Sachs calculated the low and high premia of the price paid in the 14 transactions relative to the target&#8217;s last undisturbed closing stock price prior to announcement of the transaction or market rumors regarding a possible transaction. This analysis indicated a low premium of 17% and a high premium of 104% across the period. Using this analysis, Goldman Sachs applied a reference range of illustrative premia of 17% to 104% to the undisturbed closing price per Share of $15.22 on the Unaffected Date and calculated a range of implied equity values per Share of $17.76 to $31.12. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Goldman Sachs also calculated the low and high premia of the price paid in the transactions relative to the target&#8217;s undisturbed 52-week high price. The analysis indicated a low premium of (43)% and a high premium of 101% across the period. Using this analysis, Goldman Sachs applied a reference range of illustrative premia of (43)% to 101% to the undisturbed 52-week high price of $16.66 as of the Unaffected Date, and calculated a range of implied equity values per Share of $9.54 to $33.47. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table presents the results of this analysis: </font>
        </div>
        <table style="width:458.13pt;height:125.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Date Announced </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:141.16pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Target </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:135.39pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Acquirer </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Premium to </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Undisturbed </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Premium to </font>
                <br >
                <font style="letter-spacing:-0.16pt;">52-Week </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Intraday </font>
                <br >
                <font style="letter-spacing:-0.16pt;">High </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">October&#160;2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:141.16pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Akero Therapeutics, Inc. </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:135.39pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Novo Nordisk A/S </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">42<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">(8<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">September&#160;2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:141.16pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">89bio, Inc. </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:135.39pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Roche Holding Ltd </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">79<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">22<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">April&#160;2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:141.16pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">SpringWorks Therapeutics, Inc. </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:135.39pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Merck KGaA </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">17<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">(13<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">October&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:141.16pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Longboard Pharmaceuticals. Inc. </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:135.39pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">H. Lundbeck A/S </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">80<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">48<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">May&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:141.16pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Calliditas Therapeutics AB </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:135.39pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Asahi Kasei Corp. </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">83<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">47<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">April&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:141.16pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Deciphera Pharmaceuticals, Inc. </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:135.39pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">ONO Pharmaceutical Co., Ltd. </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">75<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">44<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:458.13pt;height:155.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Date Announced </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:141.16pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Target </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:135.39pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Acquirer </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Premium to </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Undisturbed </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Premium to </font>
                <br >
                <font style="letter-spacing:-0.16pt;">52-Week </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Intraday </font>
                <br >
                <font style="letter-spacing:-0.16pt;">High </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:141.16pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">CymaBay Therapeutics, Inc </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:135.39pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Gilead Sciences, Inc. </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">27<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">23<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:141.16pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">MorphoSys AG </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:135.39pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Novartis AG </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">87<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">59<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">December&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:141.16pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">RayzeBio, Inc. </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:135.39pt;text-align:left;">
              <div style="white-space:nowrap; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Bristol-Myers Squibb Company </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">104<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">101<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">October&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:141.16pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Mirati Therapeutics, Inc. </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:135.39pt;text-align:left;">
              <div style="white-space:nowrap; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Bristol-Myers Squibb Company </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">35<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">(43<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">June&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:141.16pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Chinook Therapeutics, Inc. </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:135.39pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Novartis AG </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">67<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">46<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">May&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:141.16pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">VectivBio Holding AG </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:135.39pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Ironwood Pharmaceuticals, Inc. </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">43<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">34<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">May&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:141.16pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">CTI BioPharma Corp. </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:135.39pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Swedish Orphan Biovitrum AB </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">89<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">17<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">April&#160;2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:141.16pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Bellus Health Inc. </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:135.39pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">GSK plc </font>
            </td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">103<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">16<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:15.9pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The preparation of a fairness opinion is a complex process and is not necessarily susceptible to partial analysis or summary description. Selecting portions of the analyses or of the summary set forth above, without considering the analyses as a whole, could create an incomplete view of the processes underlying Goldman Sachs&#8217; opinion. In arriving at its fairness determination, Goldman Sachs considered the results of all of its analyses and did not attribute any particular weight to any factor or analysis considered by it. Rather, Goldman Sachs made its determination as to fairness on the basis of its experience and professional judgment after considering the results of all of its analyses. No company or transaction used in the above analyses as a comparison is directly comparable to Avadel or Alkermes or the Transaction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Goldman Sachs prepared these analyses for purposes of Goldman Sachs&#8217; providing its opinion to the Avadel Board as to the fairness from a financial point of view of the Scheme Consideration to be paid to the holders (other than holders of Excluded Shares and their respective affiliates) of Avadel Shares pursuant to the Transaction Agreement. These analyses do not purport to be appraisals nor do they necessarily reflect the prices at which businesses or securities actually may be sold. Analyses based upon forecasts of future results are not necessarily indicative of actual future results, which may be significantly more or less favorable than suggested by these analyses. Because these analyses are inherently subject to uncertainty, being based upon numerous factors or events beyond the control of the parties or their respective advisors, none of Avadel, Alkermes, Goldman Sachs or any other person assumes responsibility if future results are materially different from those forecast. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Scheme Consideration was determined through arm&#8217;s-length negotiations between Avadel and Alkermes and was approved by the Avadel Board. Goldman Sachs provided advice to Avadel during these negotiations. Goldman Sachs did not, however, recommend any specific amount of consideration to Avadel or the Avadel Board or that any specific amount of consideration constituted the only appropriate consideration for the Transaction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As described above, Goldman Sachs&#8217; opinion to the Avadel Board was one of many factors taken into consideration by the Avadel Board in making its determination to approve the Transaction Agreement. The foregoing summary does not purport to be a complete description of the analyses performed by Goldman Sachs in connection with the fairness opinion and is qualified in its entirety by reference to the written opinion of Goldman Sachs attached as Annex D. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Goldman Sachs and its affiliates (collectively, &#8220;Goldman Sachs Affiliated Entities&#8221;) are engaged in advisory, underwriting, lending and financing, principal investing, sales and trading, research, investment management and other financial and non-financial activities and services for various persons and entities. Goldman Sachs and its affiliates and employees, and funds or other entities they manage or in which they invest or have other economic interests or with which they co-invest, may at any time purchase, sell, hold or vote long or short positions and investments in securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of Avadel, Alkermes, any of their respective affiliates and third parties (collectively, &#8220;Relevant Parties&#8221;) or any currency or commodity that may be involved in the Transaction. Goldman Sachs acted as financial advisor to Avadel in connection with, and participated in certain of the negotiations leading to, the Transaction. During the two-year period ended October&#160;22, 2025, Goldman Sachs Investment Banking has not been engaged by Avadel or its affiliates to provide financial </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">advisory or underwriting services for which Goldman Sachs has recognized compensation. During the two-year period ended October&#160;22, 2025, Goldman Sachs Investment Banking has not been engaged by Alkermes or its affiliates to provide financial advisory or underwriting services for which Goldman Sachs has recognized compensation. As of October&#160;22, 2025, Goldman Sachs Investment Banking was not mandated by Alkermes and/or its Related Entities (as defined below) to provide financial advisory and/or underwriting services. As of October&#160;22, 2025, Goldman Sachs Investment Banking was not soliciting Alkermes and/or its Related Entities (as defined below) to work on financial advisory and/or underwriting matters on which it had not been mandated. Goldman Sachs may also in the future provide financial advisory and/or underwriting services to the Relevant Parties and their respective affiliates for which Goldman Sachs Investment Banking may receive compensation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of October&#160;22, 2025, Goldman Sachs Affiliated Entities had (i)&#160;no direct GS Principal Investment (as defined below) in Avadel and/or its affiliates (excluding any significant shareholder and its other affiliates), (ii)&#160;no direct GS Principal Investment in Alkermes and/or its affiliates (excluding any significant shareholder and its other affiliates). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On the public side of Goldman Sachs&#8217; informational wall (the &#8220;Public Side&#8221;) and in the ordinary course of its various business activities, Goldman Sachs Affiliated Entities may also own equity securities in the Relevant Parties, and/or their respective affiliates arising from engaging in market making, trade execution, clearing, custody, margin lending and other similar financing transactions, securities lending, and related activities (including by acting as agent for third parties executing their transactions or as principal supplying liquidity to market participants, and any related hedging, other risk management or inventory management) (collectively, &#8220;Market Making Activities&#8221;), which positions change frequently. Regulatory, informational and operational barriers separate the Public Side from Goldman Sachs Investment Banking. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this section of the proxy statement, (x)&#160;Goldman Sachs relied on its books and records to (i)&#160;unless otherwise indicated, calculate all amounts and (ii)&#160;determine whether an entity is an affiliate, portfolio company, subsidiary or majority-owned subsidiary of another entity, and (y)&#160;the following terms have the definitions set forth below: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;GS Principal Investments&#8221; &#8203;(including any associated commitments) are (i)&#160;direct balance sheet investments in equity interests or equity securities held by Goldman Sachs Affiliated Entities for its own account or (ii)&#160;direct investments in equity interests held by a fund managed by a Goldman Sachs Affiliated Entity which fund is primarily for the benefit of Goldman Sachs Affiliated Entities and/or its current and former employees and not third party clients. GS Principal Investments do not include equity interests arising from Market Making Activities, equity derivatives, convertible debt instruments, or warrants or equity kickers received in connection with senior secured loans, mezzanine loans, warehouse loans, preferred equity with a fixed rate of return or other similar types of financing transactions (which may also be subject to hedging or other risk-mitigating instruments). GS Principal Investments also do not include investments by funds managed by Goldman Sachs Affiliated Entities which funds are almost entirely for the benefit of third party clients (&#8220;GS Client Funds&#8221;), which funds can co-invest alongside, and/or make Investments in, the Relevant Parties or their respective Related Entities (as defined below). As investment managers for GS Client Funds, Goldman Sachs Affiliated Entities are required to fulfill a fiduciary responsibility to GS Client Funds in making decisions to purchase, sell, hold or vote on, or take any other action with respect to, any financial instrument. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Related Entities&#8221; are, as applicable, a person or entity&#8217;s subsidiaries, affiliates, portfolio companies and/or funds managed thereby. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Avadel Board selected Goldman Sachs as its financial advisor because it is an internationally recognized investment banking firm that has substantial experience in transactions similar to the Transaction Agreement. Pursuant to a letter agreement dated October&#160;17, 2025, Avadel engaged Goldman Sachs to act as its financial advisor in connection with the contemplated Transaction. The engagement letter between Avadel and Goldman Sachs provides for a transaction fee of approximately $23&#160;million, $2&#160;million of which became payable upon the announcement of the Transaction, and the remainder of which is contingent on closing of the Transaction. Avadel has agreed to pay Goldman Sachs an additional $2&#160;million fee which is contingent upon the Milestone Payment being made. Goldman Sachs may receive an additional fee of up to $4&#160;million at Avadel&#8217;s sole discretion. Avadel has not yet determined whether to pay such additional fee to Goldman Sachs. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tAUPF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, Avadel has agreed to reimburse Goldman Sachs for certain of its expenses, including attorneys&#8217; fees and disbursements, and to indemnify Goldman Sachs and related persons against various liabilities, including certain liabilities under the federal securities laws. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Avadel Unaudited Prospective Financial Information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel does not as a matter of course make public long-term forecasts or projections as to future performance, revenues, earnings or other results, due to, among other reasons, the inherent difficulty of accurately predicting financial performance for future periods and the uncertainty of the underlying assumptions and estimates. However, in connection with its strategic planning process, and at the direction of the Avadel Board, Avadel&#8217;s senior management prepared long-range projections reflecting the currently available estimates and judgments of the senior management of Avadel on a standalone and risk-adjusted basis for the fiscal&#160;years 2025 through 2045. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The long-range plan included certain unaudited prospective financial information concerning Avadel on a standalone basis for the&#160;years 2025 through 2045, risk-adjusted to reflect Avadel management&#8217;s estimate of the probability of regulatory and commercial success for Avadel&#8217;s development and commercialization of LUMRYZ for idiopathic hypersomnia (&#8220;IH&#8221;) and the continued commercialization of LUMRYZ for cataplexy or EDS in patients 7&#160;years of age and older with narcolepsy, including in light of the potential launch in the near term of one or more generic versions of Xyrem, an oxybate used for the treatment of narcolepsy, as well as the potential for the approval and commercial launch of one or more orexin agonists for the treatment of narcolepsy and IH beginning in 2027. These unaudited risk-adjusted projections are referred to as the &#8220;July Avadel Projections.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the request of the Avadel Board, Avadel management updated the July Avadel Projections in October&#160;2025 to reflect Avadel&#8217;s assumptions regarding its go-forward business, as impacted by the Settlement Agreement. Accordingly, the July Avadel Projections were updated to reflect a projected commercialization date for LUMRYZ for IH of March&#160;1, 2028 (assuming FDA approval and award of Orphan Drug Exclusivity), revised royalty rates for LUMRYZ for narcolepsy and IH, and estimated cash settlement, net of legal fees and expenses, in accordance with the terms of the Settlement Agreement. The resulting updated unaudited risk-adjusted projections are referred to as the &#8220;Updated Avadel Projections&#8221; and, together with the July Avadel Projections, the &#8220;Avadel Projections.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with the consideration of a possible transaction, the Avadel Board authorized Morgan Stanley and Goldman Sachs, as Avadel&#8217;s financial advisors, to use the Updated Avadel Projections for purposes of their respective financial analyses and fairness opinions (as described in more detail in the sections captioned &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Opinion of Morgan Stanley and&#8201;&#8212;&#8201;Opinion of Goldman Sachs</font><font style="letter-spacing:0.2pt;">&#8221;), and the Updated Avadel Projections constituted the only financial projections with respect to Avadel used by each of Morgan Stanley and Goldman Sachs in performing such financial analyses. The Avadel Projections were considered by the Avadel Board in connection with their respective evaluation of the Transaction in the context of evaluating Avadel&#8217;s strategic alternatives. The Avadel Projections were not provided to Alkermes or any other prospective bidder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Avadel Projections are being included in this proxy statement to give Avadel Shareholders access to certain non-public information provided to the Avadel Board and its financial advisors. The inclusion of the Avadel Projections should not be regarded as an indication that the Avadel Board, Avadel, Morgan Stanley, Goldman Sachs, or any other recipient of this information considered, or now considers, it to be an assurance of the achievement of future results or an accurate prediction of future results, and they should not be relied on as such. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, the Avadel Projections were not prepared with a view toward public disclosure or with a view toward compliance with the published guidelines established by the SEC or the American Institute of Certified Public Accountants for preparation or presentation of prospective financial information, or U.S. Generally Accepted Accounting Principles (&#8220;GAAP&#8221;), but, in the view of Avadel management, were prepared on a reasonable basis, reflected the available estimates and judgments at the time of preparation, and presented as of the time of preparation, to the best of management&#8217;s knowledge and belief, the expected course of action and the expected future financial performance of Avadel and estimated outcomes of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">other future events. However, this information is not fact and should not be relied upon as being necessarily indicative of future results, and readers of this proxy statement are cautioned not to place undue reliance on the Avadel Projections. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Avadel Projections reflect estimates and assumptions made by Avadel senior management with respect to Avadel&#8217;s business, including with respect to general business, economic, competitive, regulatory and other market and financial conditions and other future events, all of which are difficult to predict and many of which are beyond Avadel&#8217;s control. The Avadel Projections were developed without giving effect to the Transaction, including any impact of the negotiation or execution of the Transaction Agreement or the consummation of the Transaction, the expenses that have already or may be incurred in connection with completing the Transaction or any changes to Avadel&#8217;s operations or strategy that may be implemented during the pendency of or following the consummation of the Transaction. The Avadel Projections also do not consider the effect of any failure of the Transaction to be completed, and they should not be viewed as accurate or continuing in that context, or any other. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In particular, the Avadel Projections, while presented with numerical specificity, necessarily were based on numerous variables and assumptions that are inherently uncertain. The Avadel Projections reflect numerous estimates and assumptions made by Avadel, based on information available to Avadel at the time the Avadel Projections were developed, with respect to industry performance and competition, regulatory conditions, general business, economic, market and financial conditions, and matters specific to Avadel&#8217;s products and product candidates, all of which are difficult to predict and many of which are beyond Avadel&#8217;s control. As a result, there can be no assurance that the Avadel Projections accurately reflect future trends or accurately estimate the future market for any of Avadel&#8217;s products or product candidates. The Avadel Projections also reflect assumptions as to certain business decisions that are subject to change. Important factors that may affect actual results and result in the Avadel Projections not being achieved include, but are not limited to: (1)&#160;the success of clinical trials (including the funding therefor, anticipated patient enrollment, clinical outcomes, timing or associated costs); (2)&#160;regulatory approvals and related timelines; (3)&#160;the market acceptance of Avadel&#8217;s products; (4)&#160;Avadel&#8217;s development of such products and product candidates for different indications; (5)&#160;the impact of existing and potential future competitive products and pricing, including other treatments for narcolepsy and IH that may be approved and commercialized in the future; (6)&#160;the effect of regulatory actions; (7)&#160;the availability of partnering arrangements on favorable terms or at all; (8)&#160;the effect of global economic conditions; (9)&#160;conditions in the financing markets and access to sufficient capital; (10)&#160;changes in applicable laws, rules and regulations; (11)&#160;accuracy of certain accounting assumptions; (12)&#160;changes in actual or projected cash flows; (13)&#160;potential legal (including intellectual property claims) and regulatory actions by competitors, regulators, or other parties, including litigation or exclusivity strategies, that could delay or materially affect anticipated product commercialization efforts; (14)&#160;the Company&#8217;s ability to attract and retain key personnel and other employees and the possible loss of key management or other personnel, especially with respect to the Company&#8217;s commercialization efforts; (15)&#160;any changes in political conditions (including the imposition of new or increased trade restrictions, tariffs or trade policies) and (16)&#160;other risk factors described in Avadel&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2024 and subsequent Quarterly Reports filed on Form&#160;10-Q and Current Reports on Form 8-K, as well as the section titled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Cautionary Statement Regarding Forward-Looking Statements</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement. In addition, the Avadel Projections may be affected by Avadel&#8217;s ability to achieve strategic goals, objectives and targets over the applicable period. Further, the Avadel Projections cover multiple&#160;years and, by their nature, become subject to greater uncertainty with each successive year. Accordingly, there can be no assurance that the Avadel Projections will be realized, and actual results may vary materially from those shown. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Avadel Projections contain certain non-GAAP financial measures, including unlevered free cash flow, that Avadel believes are helpful in understanding its potential future results. Such non-GAAP financial measures should not be viewed as a substitute for GAAP financial measures, and may be different from non-GAAP financial measures used by other companies. Furthermore, there are limitations inherent in non-GAAP financial measures, because they exclude charges and credits that are required to be included in a GAAP presentation. Accordingly, non-GAAP financial measures should be considered together with, and not as an alternative to, financial measures prepared in accordance with GAAP. The SEC rules, which otherwise would require a reconciliation of a non-GAAP financial measure to a GAAP financial measure, do not apply to non-GAAP financial measures provided to a board of directors or financial advisors in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">connection with a proposed business combination transaction such as the proposed Transaction. In addition, reconciliations of non-GAAP financial measures to a GAAP financial measure were not provided to or relied upon by the Avadel Board, Morgan Stanley or Goldman Sachs in connection with the Transaction. Accordingly, Avadel has not provided a reconciliation of the financial measures included in the Avadel Projections to the relevant GAAP financial measures. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, Deloitte &amp; Touche LLP has neither audited, reviewed, examined, compiled nor applied agreed-upon procedures with respect to the Avadel Projections and, accordingly, Deloitte &amp; Touche LLP does not express an opinion or any other form of assurance with respect thereto. The Deloitte &amp; Touche LLP report included in Avadel&#8217;s <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000101247725000010/avdl-20241231.htm">Annual Report on Form 10-K for the year ended December&#160;31, 2024</a> that is incorporated by reference into this proxy statement relates to Avadel&#8217;s previously issued financial statements. It does not extend to the Avadel Projections and should not be read to do so. None of Avadel, Alkermes, the combined company or their respective affiliates, advisors, officers, directors or other representatives can provide any assurance that actual results will not differ from the Avadel Projections and none of them undertakes any obligation to update, or otherwise revise or reconcile, the Avadel Projections to reflect circumstances existing after the date the Avadel Projections were prepared or to reflect the occurrence of future events, even in the event that any or all of the assumptions underlying the Avadel Projections are shown to be in error. Except as required by applicable securities laws, Avadel does not intend to make publicly available any update or other revision to the Avadel Projections. None of Avadel or its affiliates, advisors, officers, directors or other representatives has made or makes any representation to any Avadel Shareholder, Alkermes or other person regarding Avadel&#8217;s ultimate performance, including as compared to the information contained in the Avadel Projections, or that forecasted results will be achieved. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The July Avadel Projections</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Various judgments and assumptions were made when preparing the July Avadel Projections, including, among others (1)&#160;revenue estimates based on various assumptions, including with respect to (a)&#160;a 68% probability of success with respect to LUMRYZ to treat IH (which reflected management&#8217;s judgment regarding the likelihood of regulatory approval, including successfully overcoming potential litigation challenges, and successful commercial launch) and a commercial launch date of February&#160;1, 2028, (b)&#160;the expected commercial launch of one or more generic versions of Xyrem, (c)&#160;the expected approval and commercial launch of multiple orexin agonists with approvals in narcolepsy and IH beginning in 2027, (d)&#160;the expected loss of exclusivity with respect to LUMRYZ and (e)&#160;no successful commercial launch of a no or low sodium, once nightly oxybate, (2)&#160;assumptions with respect to cost of goods sold based on the costs of materials and production used in the manufacturing and distribution of Avadel&#8217;s products and estimated royalties to Jazz Pharmaceuticals of 4.75% of LUMRYZ revenue through the first quarter of 2036, (3)&#160;the rate of selling, general and administrative expense growth, (4)&#160;research and development expenses, including IH clinical trial and long-term maintenance costs, (5)&#160;a blended effective tax rate of 15.1% (taking into account the Irish corporate tax rate and U.S. corporate and state tax rates) and (6)&#160;no material capital expenditures or depreciation and amortization. In connection with the July Avadel Projections, Avadel&#8217;s management estimated $65&#160;million of Irish and $247&#160;million U.S. Federal net operating losses (&#8220;NOLs&#8221;); such NOLs were presented separately to the Avadel Board and are not reflected in the July Avadel Projections as summarized below. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table presents a summary of the July Avadel Projections: </font>
        </div>
        <table style="width:456pt;height:79pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:82.32pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="64">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fiscal Year Ending December&#160;31,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:82.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">(US$ in millions) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025E</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2026E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2027E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2028E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2029E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2030E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2031E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2032E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2033E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2034E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2035E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:82.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Revenue </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.165pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">273 </td>
            <td style="padding:0pt;padding-left:4.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">349 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">426 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">482 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">529 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">556 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">585 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">620 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">655 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">684 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">725 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:82.32pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EBIT</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font> </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.165pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">20 </td>
            <td style="padding:0pt;padding-left:4.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">60 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">106 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">133 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">172 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">187 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">203 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">225 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">246 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">262 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">287 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:82.32pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Unlevered Free Cash Flow</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(3)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.165pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">12 </td>
            <td style="padding:0pt;padding-left:4.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">22 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">74 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">96 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">134 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">156 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">166 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">184 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">202 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">214 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">232</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:79pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:122.65pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="58">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fiscal Year Ending December&#160;31,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:122.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">(US$ in millions) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2036E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2037E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2038E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2039E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2040E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2041E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2042E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2043E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2044E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2045E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:122.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Revenue </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">762 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">798 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">834 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">872 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">911 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">952 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">846 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">507 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">304 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">183 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:122.65pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EBIT</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font> </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">341 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">371 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">414 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">455 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">493 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">526 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">427 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">256 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">154 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">92 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:122.65pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Unlevered Free Cash </font>
                <br >
                <font style="letter-spacing:0.2pt;">Flow</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(3)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">277 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">300 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">332 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">365 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">396 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">422 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">357 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">214 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">129 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">77</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The first half of fiscal year 2025 reflects actual results of operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">EBIT, a non-GAAP financial measure, refers to Avadel&#8217;s earnings before interest and taxes, </font><font style="font-style:italic;letter-spacing:0.2pt;">minus</font><font style="letter-spacing:0.2pt;"> tax-effected share-based compensation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Unlevered Free Cash Flow, a non-GAAP financial measure, refers to EBIT </font><font style="font-style:italic;letter-spacing:0.2pt;">minus</font><font style="letter-spacing:0.2pt;"> 3.75% royalty on net revenue payable to RTW Royalty II DAC or its affiliates (for an aggregate payment of $63&#160;million during the projection period (the &#8220;RTW Payment&#8221;)), </font><font style="font-style:italic;letter-spacing:0.2pt;">minus</font><font style="letter-spacing:0.2pt;"> taxes, </font><font style="font-style:italic;letter-spacing:0.2pt;">minus</font><font style="letter-spacing:0.2pt;"> capital expenditures, </font><font style="font-style:italic;letter-spacing:0.2pt;">plus</font><font style="letter-spacing:0.2pt;"> depreciation and amortization, </font><font style="font-style:italic;letter-spacing:0.2pt;">minus</font><font style="letter-spacing:0.2pt;"> changes in net working capital. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The Updated Avadel Projections</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Updated Avadel Projections were prepared using the same underlying assumptions as the July Avadel Projections, except for, as a result of the Settlement Agreement, Avadel management assumed: (1)&#160;a 77% probability of success with respect to LUMRYZ to treat IH (which reflected management&#8217;s judgment regarding the likelihood of regulatory approval and successful commercial launch) and a commercial launch date of March&#160;1, 2028, (2)&#160;estimated royalties to Jazz Pharmaceuticals of 3.85% of narcolepsy LUMRYZ revenue and 10% of IH LUMRYZ revenue through the first quarter of 2036, and (3)&#160;$62&#160;million of Irish and $242&#160;million U.S. Federal NOLs as of September&#160;30, 2025. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table presents a summary of the Updated Avadel Projections: </font>
        </div>
        <table style="width:456pt;height:79pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:82.32pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="64">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fiscal Year Ending December&#160;31,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:82.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">(US$ in millions) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025E</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2026E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2027E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2028E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2029E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2030E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2031E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2032E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2033E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2034E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2035E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:82.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Revenue </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.165pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">273 </td>
            <td style="padding:0pt;padding-left:4.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">349 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">426 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">480 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">527 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">555 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">585 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">622 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">657 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">686 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">727 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:82.32pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EBIT</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font> </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.165pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">22 </td>
            <td style="padding:0pt;padding-left:4.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">63 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">110 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">135 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">171 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">185 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">200 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">221 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">241 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">256 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">281 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:82.32pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Unlevered Free Cash Flow</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(3)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.165pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">16 </td>
            <td style="padding:0pt;padding-left:4.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">32 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">84 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">102 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">140 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">163 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">173 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">188 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">198 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">209 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">227</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:79pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:122.65pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="58">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fiscal Year Ending December&#160;31,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:122.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">(US$ in millions) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2036E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2037E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2038E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2039E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2040E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2041E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2042E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2043E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2044E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2045E</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:122.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Revenue </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">764 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">801 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">837 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">875 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">914 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">955 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">849 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">509 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">306 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">183 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:122.65pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">EBIT</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font> </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">342 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">374 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">417 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">458 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">497 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">529 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">430 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">258 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">155 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">93 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:122.65pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Unlevered Free Cash </font>
                <br >
                <font style="letter-spacing:0.2pt;">Flow</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(3)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">278 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">302 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">334 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">367 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">398 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">424 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">359 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">215 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">129 </td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">78</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.31pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The first half of fiscal year 2025 reflects actual results of operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">EBIT, a non-GAAP financial measure, refers to Avadel&#8217;s earnings before interest and taxes, </font><font style="font-style:italic;letter-spacing:0.2pt;">minus</font><font style="letter-spacing:0.2pt;"> tax-effected share-based compensation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Unlevered Free Cash Flow, a non-GAAP financial measure, refers to EBIT </font><font style="font-style:italic;letter-spacing:0.2pt;">minus</font><font style="letter-spacing:0.2pt;"> the RTW Payment, </font><font style="font-style:italic;letter-spacing:0.2pt;">minus</font><font style="letter-spacing:0.2pt;"> taxes, </font><font style="font-style:italic;letter-spacing:0.2pt;">plus</font><font style="letter-spacing:0.2pt;"> tax savings from U.S. and Ireland NOLs, </font><font style="font-style:italic;letter-spacing:0.2pt;">minus</font><font style="letter-spacing:0.2pt;"> capital expenditures, </font><font style="font-style:italic;letter-spacing:0.2pt;">plus</font><font style="letter-spacing:0.2pt;"> depreciation and amortization, and </font><font style="font-style:italic;letter-spacing:0.2pt;">plus or minus</font><font style="letter-spacing:0.2pt;"> changes in net working capital. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AVADEL DOES NOT INTEND TO UPDATE OR OTHERWISE REVISE THE AVADEL PROJECTIONS TO REFLECT CIRCUMSTANCES EXISTING AFTER THE DATE WHEN MADE OR TO REFLECT THE OCCURRENCE OF FUTURE EVENTS, EVEN IN THE EVENT THAT ANY OR ALL OF THE ASSUMPTIONS UNDERLYING THE AVADEL PROJECTIONS ARE NO LONGER APPROPRIATE.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFIN">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Irish Takeover Panel considers the forward-looking financial information for Avadel for each of the financial&#160;years ending 31&#160;December from 2025 to 2045 as set out above and used by each of Morgan Stanley and Goldman Sachs in connection with their financial analyses for the purpose of preparing their respective fairness opinions, to be profit forecasts within the meaning of Rule&#160;28 of the Irish Takeover Rules. However, following consideration of the exceptional circumstances of publication of the matters, the Irish Takeover Panel decided to (i)&#160;waive the requirement under Rule&#160;28.1(a) of the Irish Takeover Rules to have the forecasts for the financial&#160;years ending 31 December&#160;2025 and 2026 reported on by an independent accountant and each of Morgan Stanley and Goldman Sachs, and (ii)&#160;the requirement under Rule&#160;28.2(a) of the Irish Takeover Rules for the Avadel Board to provide certain confirmations concerning the forecasts for the financial&#160;years ending 31 December from 2027 to 2045, given that the forward-looking financial information is included in this proxy statement only because it is required to be disclosed pursuant to SEC regulations.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Financing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Alkermes estimates that it will need approximately $2.1&#160;billion in order to pay Avadel Shareholders the Cash Consideration due to them under the Transaction Agreement and to pay related fees, costs, expenses and other transaction costs in connection with the acquisition. Alkermes anticipates that the funds needed to pay the foregoing amount will be derived from a combination of (i)&#160;cash on hand and (ii)&#160;borrowings under credit facilities, including as described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">J.P. Morgan Securities LLC, lead financial advisor to Alkermes, is satisfied that sufficient resources are available to satisfy in full the Cash Consideration payable to Avadel Shareholders under the terms of the Transaction Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Bridge Credit Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;22, 2025, Alkermes entered into a 364-day senior secured bridge term loan credit agreement (the &#8220;Bridge Credit Agreement&#8221;) among Alkermes, the other loan parties from time to time party thereto, certain lenders from time to time party thereto and JPMorgan Chase Bank, N.A. as administrative agent. Under the Bridge Credit Agreement, the lenders party thereto have committed to provide Alkermes with secured bridge financing in an aggregate principal amount of $1.23 billion. The commitments are intended to be available to finance, in part, the cash component of the Scheme Consideration and fees and expenses related to the Transaction. Subject to the conditions in the Bridge Credit Agreement, Alkermes intends to replace commitments or the borrowings, as applicable, under the Bridge Credit Agreement by accessing the loan markets prior to or following the closing of the Transaction. The entry by Alkermes into any credit facilities to replace the Bridge Credit Agreement would be subject to market and other conditions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Summary of Terms of the Bridge Credit Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The funding of the loans under the Bridge Credit Agreement is conditioned on, among other things, the consummation of the transaction and the absence of certain events of default described in the Bridge Credit Agreement. The commitments under the Bridge Credit Agreement will automatically terminate on the earliest of (a)&#160;11:59&#160;pm (Dublin time) on the date on which the consideration payable in respect of the Transaction has been paid in full without the making of any advances under the Bridge Credit Agreement, (b)&#160;11:59&#160;pm (Dublin time) on the Effective Date after giving effect to the making of advances under the Bridge Credit Agreement, and (c)&#160;the date on which certain mandatory cancellation events have occurred or first exist, including, subject to certain exceptions, if the Transaction has not been consummated by the End Date. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Advances under the Bridge Credit Agreement will bear interest as follows: </font>
        </div>
        <table style="width:456pt;height:65.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt; width:201.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Days after the first advance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">ABR Spread (applicable to</font>
                <br >
                <font style="letter-spacing:-0.16pt;">borrowings that bear interest at the</font>
                <br >
                <font style="letter-spacing:-0.16pt;">alternate base rate) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Term Benchmark and RFR Spread</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(applicable to borrowings that bear</font>
                <br >
                <font style="letter-spacing:-0.16pt;">interest at the Term SOFR rate) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:201.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">0&#8201;&#8211;&#8201;90&#160;days </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:48.955pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.00<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:48.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:48.745pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.00<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:48.745pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:201.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">91&#8201;&#8211;&#8201;180&#160;days </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:48.955pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.25<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:48.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:48.745pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.25<font style="position:absolute;">% </font></td>
            <td style="padding:0pt;padding-left:48.745pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:201.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">181&#8201;&#8211;&#8201;270&#160;days </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:48.955pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.50<font style="position:absolute;">% </font></td>
            <td style="padding:0pt;padding-left:48.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:48.745pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.50<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:48.745pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tIOCP1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Alkermes may voluntarily prepay the loans or reduce the commitments under the Bridge Credit Agreement at any time without premium or penalty. The Bridge Credit Agreement also requires mandatory prepayments and commitment reductions, as applicable, with the net cash proceeds received by Alkermes in connection with certain asset sales, debt or equity issuances and recovery events, subject to customary exceptions. The Bridge Credit Agreement also contains customary events of default, upon the occurrence of which, and for so long as such event of default is continuing, the amounts outstanding under the Bridge Credit Agreement could be accelerated by the lenders. In addition, the loan parties under the Bridge Credit Agreement are subject to certain affirmative and negative and, following the Certain Funds Period, also will be subject to certain financial maintenance covenants in the form of secured net leverage and consolidated interest coverage ratios tested at the end of each fiscal quarter. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.81pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The borrowers&#8217; obligations under the Bridge Credit Agreement will be guaranteed jointly and severally by each of Alkermes&#8217; direct and indirect subsidiaries that are or are designated as Material Domestic Subsidiaries and Material Irish Subsidiaries as defined therein subject to certain exceptions (collectively, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Subsidiary Guarantors</font><font style="letter-spacing:0.2pt;">&#8221; and together with the borrowers, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Loan Parties</font><font style="letter-spacing:0.2pt;">&#8221;). Within 45 days of the Effective Date Alkermes shall procure that Avadel and each of its restricted subsidiaries that is or is designated as a Material Domestic Subsidiary or a Material Irish Subsidiary become Subsidiary Guarantors. Alkermes&#8217; obligations under the Bridge Credit Agreement will be secured by way of security granted over substantially all assets of the Loan Parties, subject to permitted liens and assets customarily excluded from a financing of this nature. </font>
        </div>
        <div style="margin-top:10.92pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interests of Certain Persons in the Transaction</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In considering the recommendation of the Avadel Board with respect to the Transaction Agreement, you should be aware that some of Avadel&#8217;s directors and executive officers have interests in the Transaction that are in addition to, or different from, any interests of Avadel Shareholders generally. These interests are described in more detail below, and, with respect to the executive officers of Avadel, are quantified in the table below. The Avadel Board was aware of these interests and considered them when it adopted the Transaction Agreement and approved the Transaction. </font>
        </div>
        <div style="margin-left:20pt; margin-top:7.72pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s current executive officers and directors and their respective positions are as follows: </font>
        </div>
        <table style="width:416pt;height:194.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:202pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:202pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:-0.2pt;">Executive Officers</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Gregory J. Divis </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Chief Executive Officer and Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Thomas S. McHugh </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Chief Financial Officer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Susan Rodriguez </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Chief Operating Officer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Jerad G. Seurer </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">General Counsel &amp; Corporate Secretary </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:-0.2pt;">Directors</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Geoffrey M. Glass </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Chair of the Board of Directors </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Naseem S. Amin, M.D. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Eric J. Ende, M.D. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Mark A. McCamish, M.D., Ph.D. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Linda S. Palczuk </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Peter J. Thornton </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:5.71pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain other individuals who served since the beginning of Avadel&#8217;s last fiscal year would be considered executive officers for purposes of this disclosure, but as former employees of Avadel they are not entitled to the payments and benefits described below for executive officers in connection with the Transaction. None of the former executive officers are receiving any compensation in connection with the Transaction. Accordingly, such former executive officers are not included in this disclosure. </font>
        </div>
        <div style="margin-top:10.82pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Treatment of Equity Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each Avadel Cash-Out Option (including each Avadel Performance-Based Option) that is outstanding as of immediately prior to the Effective Time, (whether or not vested) will be canceled and converted at the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Effective Time into the right to receive (without interest): (i)&#160;an amount in cash (less applicable tax and other mandatory withholdings) equal to the product of (x)&#160;the total number of Avadel Shares subject to such Avadel Cash-Out Option immediately prior to the Effective Time, </font><font style="font-style:italic;letter-spacing:0.2pt;">multiplied</font><font style="letter-spacing:0.2pt;"> by (y)&#160;the excess of the Cash Consideration over the applicable exercise price per Avadel Share under such Avadel Cash-Out Option and (ii)&#160;one CVR for each Avadel Share subject to such Avadel Cash-Out Option immediately prior to the Effective Time (without regard to vesting). Each Avadel Option with an exercise price equal to or greater than the Cash Consideration that is outstanding immediately prior to the Effective Time, whether or not vested, will be cancelled at the Effective Time for no consideration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each Avadel RSU Award that is outstanding will be cancelled at the Effective Time and, in exchange therefor, the holder of such cancelled Avadel RSU Award will be entitled to receive (without interest): (i)&#160;an amount in cash (less applicable tax or any other mandatory withholdings) equal to the product of (x)&#160;the total number of Avadel Shares subject to such Avadel RSU Award immediately prior to the Effective Time multiplied by (y)&#160;the Cash Consideration and (ii)&#160;one CVR for each Avadel Share subject to such Avadel RSU Award immediately prior to the Effective Time (without regard to vesting). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each Avadel Restricted Stock Award, whether granted pursuant to the Avadel Share Plans or otherwise that is outstanding immediately prior to the Effective Time will vest in full as of immediately prior to the Effective Time and will be treated in the same manner as all other Avadel Shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following tables set forth the number of Avadel Options and Avadel Restricted Stock Awards held by Avadel executive officers and directors as of November&#160;7, 2025, the latest practicable date to determine these numbers before the filing of this proxy statement, and the estimated aggregate value of such Avadel Options and Avadel Restricted Stock Awards. For each individual, the estimated aggregate value of Avadel Options and Avadel Restricted Stock Awards equals the product of (a)&#160;the Cash Consideration plus the maximum amount payable for one CVR (i.e., a maximum total amount of $20.00 per share), less the applicable exercise price in the case of Avadel Options, multiplied by (b)&#160;the total number of Avadel Shares subject to the Avadel equity award. As of November&#160;7, 2025, no Avadel executive officers or directors held any Avadel Options with an exercise price per share that is equal to or greater than the Cash Consideration or any Avadel RSU Awards. </font>
        </div>
        <table style="width:456pt;height:251.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:142.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Unvested</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Time-Based</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Avadel </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Value of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unvested</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Time-Based</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Avadel </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Unvested </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Avadel</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Performance-</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Based</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options</font><font style=" position:relative; bottom:3.25pt;line-height:6pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font><font style="letter-spacing:-0.16pt;"> </font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Value of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unvested Avadel</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Performance-</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Based</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options</font><font style=" position:relative; bottom:3.25pt;line-height:6pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Vested</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Avadel </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Value of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Vested</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Avadel </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:142.65pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Executive Officers</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:142.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">527,500</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">3,808,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">77,500 </td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">940,075 </td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">2,265,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">30,814,725 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:142.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas S. McHugh </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">155,625</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,202,044</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">18,000 </td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">218,340 </td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">830,875 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">11,694,451 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:142.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Susan Rodriguez </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">300,000</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">3,123,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:142.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jerad G. Seurer </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">105,625</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">742,938</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">21,000 </td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">254,730 </td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">364,875 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">4,605,053 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:142.65pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Directors</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:142.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Geoffrey M. Glass </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">100,870</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">230,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,937,100</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:142.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Naseem S. Amin, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">44,000</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">234,850</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">27,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">107,470</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:142.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Eric J. Ende, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">100,870</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">238,057</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,086,235</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:142.65pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Mark A. McCamish, M.D., Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">100,870</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">280,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,438,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:142.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Linda S. Palczuk </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">36,000</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">327,620</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">230,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,937,100</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:142.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter J. Thornton </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:3.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">100,870</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">230,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,937,100</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Based on the value of the Scheme Consideration and the recommendation of the compensation committee of the Avadel Board, the Board determined that all outstanding Avadel Performance-Based Options will vest and have performance conditions satisfied immediately prior to the Effective Time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:209.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:282.11pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Avadel Restricted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Stock Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Value of Avadel </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Restricted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Stock Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:282.11pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Executive Officers</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:282.11pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,040,000</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:282.11pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas S. McHugh </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">12,600</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">252,000</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:282.11pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Susan Rodriguez </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:282.11pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jerad G. Seurer </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">14,700</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">294,000</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9pt 0pt 1pt 0pt; width:282.11pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Directors</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:282.11pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Geoffrey M. Glass </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">220,000</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:282.11pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Naseem S. Amin, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">220,000</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:282.11pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Eric J. Ende, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">220,000</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:282.11pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mark A. McCamish, M.D., Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">220,000</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:282.11pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Linda S. Palczuk </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">220,000</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:282.11pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter J. Thornton </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:15.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">220,000</td>
            <td style="padding:0pt;padding-left:5.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Treatment of Purchase Rights Under the Employee Share Purchase Plan</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Avadel Pharmaceuticals plc 2017 Employee Share Purchase Plan (the &#8220;Avadel ESPP&#8221;) allows Avadel&#8217;s regular full-time employees, including Avadel&#8217;s executive officers, to purchase up to a specified maximum number of Avadel Shares as determined by the compensation committee of the Avadel Board (which, in the absence of any contrary determination, is 3,000 Avadel Shares) per offering period under the Avadel ESPP, subject to a maximum of $25,000 per year of Avadel Shares. The purchase price for each offering period is established by the compensation committee of the Avadel Board, but in no event is less than 85% of the lesser of (i)&#160;the fair market value of Avadel Shares on the applicable offering date, or (ii)&#160;the fair market value of Avadel Shares on the applicable purchase date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prior to the Effective Time, the Avadel Board (or the appropriate committee thereof) will take all actions necessary to effect the following: (i)&#160;the Avadel ESPP will be frozen and suspended during the offering period in progress as of the date of the Transaction Agreement and no new offering periods will commence under the Avadel ESPP at any time on or after the date of the Transaction Agreement, (ii)&#160;no new participants will be permitted into the Avadel ESPP after the date of the Transaction Agreement, (iii)&#160;no current participants in the Avadel ESPP will be permitted to increase their payroll deduction elections or rate of contributions from those in effect on the date of the Transaction Agreement or make any separate non-payroll contributions to the Avadel ESPP, (iv)&#160;the then-current offering period in progress as of the Effective Time under the Avadel ESPP will be accelerated to a date on or prior to the Completion, and each participant&#8217;s accumulated payroll deductions will be used to purchase Avadel Shares in accordance with the terms of the Avadel ESPP, (v)&#160;any accumulated payroll deductions that are not used to purchase Avadel Shares will be promptly refunded to the applicable participant and (vi)&#160;the Avadel ESPP will terminate immediately prior to, and contingent upon, the Effective Time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Severance Entitlements</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each Avadel executive officer is a party to an employment agreement with Avadel&#8217;s U.S. subsidiary which provides for the severance benefits described below if the executive officer&#8217;s employment is terminated by the executive officer for &#8220;good reason&#8221; or by Avadel for any reason other than &#8220;cause&#8221; &#8203;(as such terms are defined in each Avadel executive officer&#8217;s employment agreement), including non-renewal by Avadel at the end of the employment term. Upon such a termination each Avadel executive officer is entitled to receive&#160;payment of accrued but unpaid bonuses for any completed fiscal year and vacation pay, expense reimbursement and other benefits due under Avadel benefit plans, and, subject to the Avadel executive officer&#8217;s execution and non-revocation of a separation and release agreement in favor of Avadel, (i)&#160;an amount equal to 1.0 </font><font style="font-style:italic;letter-spacing:0.2pt;">times</font><font style="letter-spacing:0.2pt;"> the executive officer&#8217;s then-current base salary (or, for Mr.&#160;Divis, 1.5 </font><font style="font-style:italic;letter-spacing:0.2pt;">times</font><font style="letter-spacing:0.2pt;"> his then-current base salary), payable in substantially equal installments in accordance with Avadel&#8217;s normal payroll&#160;practices; and (ii)&#160;if the Avadel executive officer elects continuation coverage under COBRA, payment of the Avadel </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">executive officer&#8217;s monthly COBRA premiums until (x)&#160;12&#160;months (or, for Mr.&#160;Divis, 18&#160;months) following the Avadel executive officer&#8217;s date of termination or (y)&#160;the date that the Avadel executive officer becomes covered under similar plans of any subsequent employer or otherwise ineligible for COBRA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to the severance benefits described above, if such a termination occurs (A)&#160;for Mr.&#160;Divis, within 6&#160;months prior to or 18&#160;months following a &#8220;change of control&#8221; &#8203;(as defined in Mr.&#160;Divis&#8217; employment agreement), or (B)&#160;for each other Avadel executive officer, within 18&#160;months following a &#8220;change of control&#8221; &#8203;(as defined in each such Avadel executive officer&#8217;s employment agreement), the Avadel executive officer is entitled to also receive (i)&#160;immediate vesting of 100% of such Avadel executive officer&#8217;s outstanding and unvested stock options and other stock-based awards, (ii)&#160;extension of such any outstanding and vested stock options held by such Avadel executive officer as of the date of termination, with such stock options remaining outstanding and exercisable until the 18-month anniversary of such date of termination (not to extend beyond the original maximum term of such stock option); and (iii)&#160;for Mr.&#160;Divis only, a lump sum payment equal to the higher of (x)&#160;the greater of (I)&#160;his target bonus in effect for the fiscal year in which the change of control occurs or (II)&#160;his target bonus in effect for the fiscal year in which the termination of employment occurs, or (y)&#160;his actual bonus for performance during the calendar year prior to the calendar year during which the termination of employment occurs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Completion of the proposed Transaction will qualify as a &#8220;change of control&#8221; under each Avadel executive officer&#8217;s employment agreement, and the payments and benefits provided under such employment agreements in connection with the proposed Transaction may be subject to an excise tax under Section&#160;4999 of the U.S. Internal Revenue Code of 1986, as amended (referred to hereinafter as the &#8220;Code&#8221;). These payments and benefits may also not be eligible for U.S. federal income tax deduction for Avadel&#8217;s U.S. subsidiary pursuant to Section&#160;280G of the Code. If the payments or benefits payable to each Avadel executive officer in connection with the proposed Transaction would be subject to the excise tax imposed under Section&#160;4999 of the Code, then those payments or benefits will be reduced if such reduction would result in a higher net after-tax benefit to the Avadel executive officer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The estimated value of such severance payments and benefits for each Avadel executive officer is set forth below under the section entitled &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Interests of Certain Persons in the Transactio</font><font style="letter-spacing:0.2pt;">n&#8201;&#8212;&#8201;</font><font style="font-style:italic;letter-spacing:0.2pt;">Quantification of Payments and Benefits to Avadel&#8217;s Named Executive Officers&#8201;&#8212;&#8201;Golden Parachute Compensation.&#8221;</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">2025 Annual Bonuses</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Completion occurs prior to the date that Avadel would normally pay annual bonuses for the 2025 fiscal year, each employee participating in Avadel&#8217;s corporate annual cash incentive program, including Avadel&#8217;s executive officers, will receive an annual bonus for the 2025 fiscal year as soon as practicable following the Completion at the greater of target or actual performance. The following table sets forth each Avadel executive officer&#8217;s target bonus for 2025 (assuming payout at 100%): </font>
        </div>
        <table style="width:416pt;height:77.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:341.4pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Target 2025 Bonus</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.445pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">390,960</td>
            <td style="padding:0pt;padding-left:12.445pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Susan Rodriguez</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.445pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">146,503 </td>
            <td style="padding:0pt;padding-left:12.445pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas S. McHugh </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.445pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">209,417</td>
            <td style="padding:0pt;padding-left:12.445pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jerad G. Seurer </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.445pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">189,000</td>
            <td style="padding:0pt;padding-left:12.445pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.31pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Pursuant to Ms.&#160;Rodriguez&#8217; employment agreement, her annual bonus for the 2025 fiscal year will be pro-rated based on the date she began employment with Avadel. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">280G Mitigation Actions</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel may take certain tax-planning actions to mitigate potentially adverse tax consequences under the &#8220;golden parachute&#8221; provisions of Sections&#160;280G and 4999 of the Code that could arise in connection with the Completion, which, for the avoidance of doubt, may not include paying or agreeing to pay any gross-ups or similar make-whole payments. The tax-planning and mitigation actions may include accelerating vesting of equity awards and/or payment of 2025 bonuses for Avadel executive officers if the date of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tQOPA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Completion is not reasonably expected to occur in 2025. However, any accelerated payments for Avadel executive officers will be subject to clawback in the event that the Avadel executive officer terminates employment for any reason other than death, disability or a severance-eligible termination, as described above under the section entitled &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Interests of Certain Persons in the Transaction&#8201;&#8212;&#8201;Severance Entitlements&#8221; </font><font style="letter-spacing:0.2pt;">prior to the date such vesting or payment would otherwise have occurred. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Employee Benefits Matters</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As further described in the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction Agreement&#8201;&#8212;&#8201;Employee Matters</font><font style="letter-spacing:0.2pt;">,&#8221; the Transaction Agreement generally requires Alkermes to, through the earlier of the first anniversary of the Effective Time or the termination of the employee, provide all Avadel employees, including Avadel executive officers, who remain employed following the Effective Time with annual base salary or base wage rate (as applicable) and target annual cash bonus opportunity that is no less favorable, in the aggregate, than the annual base salary or base wage rate (as applicable) and target annual cash bonus opportunity or target cash commission opportunity in effect immediately prior to the Effective Time (provided that each employee&#8217;s base salary or base wage rate (as applicable) shall also be independently no less than 95% of the annual base salary or base wage rate (as applicable) in effect immediately prior to the Effective Time), and pension and welfare benefits that are, in the aggregate, no less favorable than pension and welfare benefits provided to similarly-situated employees of Alkermes. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Director and Officer Indemnification Insurance</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the terms of the Transaction Agreement, Avadel&#8217;s directors and executive officers will be entitled to certain ongoing indemnification and coverage under directors&#8217; and officers&#8217; liability and fiduciary liability insurance policies following the Transaction. Such indemnification and insurance coverage is further described in &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction Agreement&#8201;&#8212;&#8201;Directors&#8217; and Officers&#8217; Indemnification and Insurance.</font><font style="letter-spacing:0.2pt;">&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Quantification of Payments and Benefits to Avadel&#8217;s Named Executive Officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The table below sets forth the information required by Item&#160;402(t) of Regulation&#160;S-K regarding the amount of payments and benefits that each of Avadel&#8217;s named executive officers may receive in connection with the transaction. While Richard J. Kim, Avadel&#8217;s former Chief Commercial Officer, was a named executive officer for Avadel&#8217;s fiscal year ended December&#160;31, 2024, he terminated employment on December&#160;31, 2024, prior to the date on which the Transaction Agreement was executed, and is not entitled to any payments or benefits that are based on or otherwise relate to the Transaction. Accordingly, Mr.&#160;Kim is not included in this disclosure. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Assumptions</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless otherwise noted, the estimates set forth in the table below assume the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the value of Avadel equity awards is calculated based on $20.00 per share (i.e., the Cash Consideration plus the maximum amount payable for one CVR); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">all outstanding Avadel Performance-Based Options will vest and have performance conditions satisfied immediately prior to the Effective Time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Effective Time of the Transaction occurs on November&#160;7, 2025 (which is the assumed date solely for purposes of this golden parachute compensation disclosure); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the consummation of the Transaction constitutes a change in control for purposes of the applicable compensation plan or agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Avadel named executive officer&#8217;s base salary and target bonus will remain unchanged from those in place on November&#160;7, 2025; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Avadel named executive officer&#8217;s outstanding equity award holdings will remain unchanged from those in place on November&#160;7, 2025; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each Avadel named executive officer experiences a termination without &#8220;cause&#8221; or resigns with &#8220;good reason&#8221; &#8203;(as such terms are defined in each Avadel named executive officer&#8217;s employment agreement) immediately following Completion. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The amounts set forth in the table below are based on multiple assumptions that may or may not actually occur or be accurate on the relevant date, including assumptions above and described in footnotes to the table. The amounts below do not reflect certain compensation actions that may occur before the Effective Time. The actual amounts payable to Avadel&#8217;s named executive officers, if any, will depend on whether the named executive officer incurs a qualifying termination, the date of termination of the named executive officer&#8217;s employment (if applicable), the closing date of the Transaction, the ultimate value of each CVR, the manner of termination and the terms of the plans or agreements in effect at such time. The amounts set forth in the table below do not include any value received in respect of Avadel Options or other equity awards that have vested prior to the assumed closing date of the Transaction in accordance with their existing terms. </font>
        </div>
        <div style="margin-top:10.42pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Golden Parachute Compensation</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:62.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:221.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Cash</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Perquisites/Benefits</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:221.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,759,320</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">5,788,075 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">81,797</td>
            <td style="padding:0pt;padding-left:18.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">7,629,192 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:221.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas S. McHugh </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">674,789</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,672,384 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">28,303</td>
            <td style="padding:0pt;padding-left:18.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">2,375,476 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:221.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jerad G. Seurer </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">609,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,291,668 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">54,532 </td>
            <td style="padding:0pt;padding-left:18.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,955,199</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:6.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:6.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Cash.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The amounts in this column represent the sum of (i)&#160;cash severance payments under each Avadel named executive officer&#8217;s employment agreement equal to (A)&#160;for Mr.&#160;Divis, 1.5 </font><font style="font-style:italic;letter-spacing:0.2pt;">times</font><font style="letter-spacing:0.2pt;"> his base salary, plus the higher of his 2025 target bonus or actual prior year bonus, and (B)&#160;for Messrs. McHugh and&#160;Seurer, 1.0 times such Avadel named executive officer&#8217;s base salary; and (ii)&#160;each Avadel named executive officer&#8217;s annual bonus for the 2025 fiscal year at the greater of target or actual performance. Such severance arrangements constitute &#8220;double trigger&#8221; arrangements that will become payable by reason of the proposed Transaction subject to a qualifying termination of the Avadel named executive officer&#8217;s employment, and the 2025 annual bonuses constitute &#8220;single trigger&#8221; arrangements that will become payable solely by reason of the proposed Transaction subject to each Avadel named executive officer&#8217;s continued employment. The estimated amount of each type of payment is shown in the following table: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:436pt;height:62.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:295.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Cash Severance</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025 Annual Bonus</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:295.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,368,360</td>
            <td style="padding:0pt;padding-left:5.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">390,960</td>
            <td style="padding:0pt;padding-left:15.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:295.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas S. McHugh </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">465,372</td>
            <td style="padding:0pt;padding-left:5.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">209,417</td>
            <td style="padding:0pt;padding-left:15.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:295.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jerad G. Seurer </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">420,000</td>
            <td style="padding:0pt;padding-left:5.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">189,000</td>
            <td style="padding:0pt;padding-left:15.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:1.09pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:1.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Equity</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The amounts in this column represent the estimated value of Scheme Consideration payable with respect to unvested Avadel Options and Avadel Restricted Stock Awards that will become payable in connection with the proposed Transaction, subject to each Avadel named executive officer&#8217;s continued employment through such date (or, for Mr.&#160;Divis, a qualifying termination of employment within 6&#160;months prior to the Completion as described above under the heading &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Interests of Certain Persons in the Transaction&#8201;&#8212;&#8201;Severance Entitlements&#8221;</font><font style="letter-spacing:0.2pt;">). The estimated payouts in respect of the Avadel named executive officer&#8217;s Avadel equity awards are &#8220;single trigger&#8221; arrangements that will become payable solely by reason of the proposed Transaction, subject to each Avadel named executive officer&#8217;s continued employment (or, for Mr.&#160;Divis, in the event of a qualifying termination within 6&#160;months prior to the Completion). The estimated value of such unvested Avadel Options and Avadel Restricted Stock Awards held by each Avadel named executive officer is shown in the table below. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:436pt;height:89.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:217.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Value of Unvested </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Time-Based</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Avadel Options</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Value of Unvested </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Avadel </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Performance-Based </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options </font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Value of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Avadel Restricted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Stock Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:217.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">3,808,000</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">940,075 </td>
            <td style="padding:0pt;padding-left:16.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,040,000</td>
            <td style="padding:0pt;padding-left:8.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:217.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas S. McHugh </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,202,044</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">218,340 </td>
            <td style="padding:0pt;padding-left:16.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">252,000</td>
            <td style="padding:0pt;padding-left:8.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:217.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jerad G. Seurer </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">742,938</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">254,730 </td>
            <td style="padding:0pt;padding-left:16.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">294,000</td>
            <td style="padding:0pt;padding-left:8.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tRAR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Perquisites/Benefits.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The amounts in this column represent the estimated value of continued health benefits (medical, dental and vision) for Mr.&#160;Divis for eighteen (18) months and for each other Avadel named executive officer for twelve (12) months, based on the costs of coverage and benefit elections in effect on November&#160;7, 2025. Such benefits continuation is a &#8220;double-trigger&#8221; benefit payable under each Avadel named executive officer&#8217;s employment agreement only in the event that such Avadel named executive officer experiences a qualifying termination of employment, as described above under the heading &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Interests of Certain Persons in the Transaction&#8201;&#8212;&#8201;Severance Entitlements&#8221;</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regulatory Approvals Required</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Antitrust Matters</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the HSR Act and the rules promulgated thereunder, certain transactions may not be completed until certain information and materials have been furnished to DOJ and the FTC and the applicable HSR Act waiting period requirements have been satisfied. The waiting period under the HSR Act applicable to the Transaction is thirty (30) calendar days, unless the waiting period is terminated earlier or extended. If the DOJ or FTC issues a request for additional information and documentary materials (a &#8220;Second Request&#8221;), the parties must observe a second thirty (30)-day waiting period, which would begin to run only after both parties have substantially complied with such Second Request, unless the waiting period is terminated. The parties may also agree with the DOJ or FTC to not consummate the Transaction for a specified period of time. If any waiting period expires on a Saturday, Sunday or federal holiday, then the period is extended until 11:59&#160;p.m., U.S. Eastern Time, on the next day that is not a Saturday, Sunday or federal holiday. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Transaction is subject to the provisions of the HSR Act and therefore cannot be completed until each of Avadel and Alkermes file a notification and report form with the DOJ and the FTC under the HSR Act and the applicable waiting period (and any extension thereof) has expired or been terminated. Avadel and Alkermes each filed a notification and report form with respect to the Transaction with the DOJ and the FTC under the HSR Act on November&#160;7, 2025. The waiting period with respect to the notification and report forms filed under the HSR Act is scheduled to expire at 11:59 p.m., Eastern Time, on December&#160;8, 2025, unless extended or earlier terminated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At any time before or after the consummation of the Transaction, notwithstanding the termination or expiration of the waiting period under the HSR Act, the DOJ, FTC, state attorneys general or non-U.S. authorities could take such action under the Antitrust Laws as it deems necessary or desirable in the public interest, including seeking to preliminarily or permanently enjoin the Completion, seeking divestiture of substantial assets of one (1)&#160;or both of the parties, requiring the parties to license or hold separate assets or terminate existing relationships and contractual rights, or requiring the parties to agree to other remedies. Private parties may also seek to take legal action under the antitrust laws under certain circumstances, including by seeking to intervene in the regulatory process, to litigate to enjoin or overturn regulatory approvals or to bring private actions to enjoin the Transaction. Any of these actions could impede or preclude obtaining regulatory approvals or consummating the Transaction. There can be no assurances that a challenge to the Transaction will not be made or that, if a challenge is made, Avadel will prevail. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:0.2pt;">Avadel and Alkermes have agreed to use their respective reasonable best efforts to obtain the regulatory approvals required to consummate the Transaction, subject to certain limitations as set forth in the Transaction Agreement. Although Avadel expects that all required antitrust and foreign investment clearances and approvals will be obtained, there can be no assurances that these regulatory clearances and approvals will be timely obtained, obtained at all, or that the granting of these regulatory clearances and approvals will not involve the imposition of additional conditions, restrictions, qualifications, requirements or limitations on the Completion, including the requirement to divest assets, license or hold separate assets, or terminate existing relationships and contractual rights, or agree to other remedies, or require changes to the terms of the Transaction Agreement. These conditions or changes could result in the conditions to the Transaction not being satisfied.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Irish High Court Approvals</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Scheme requires the approval of the Irish High Court, which involves an application by Avadel to the Irish High Court to sanction the Scheme. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tPOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:524pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Payment of Consideration</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Settlement of the Scheme Consideration to which any Avadel Shareholder is entitled will be paid to Avadel Shareholders of record within fourteen (14) days of the date on which the Scheme becomes effective in accordance with its terms (or, if the Transaction is implemented by way of a takeover offer (in accordance with Section&#160;3.6 of the Transaction Agreement), such date on which the takeover offer is completed in accordance with the provisions of the relevant documents and rules) (the &#8220;Effective Date&#8221;). For further information regarding the settlement of consideration, see the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Part&#160;2&#8201;&#8212;&#8201;Explanatory Statement&#8201;&#8212;&#8201;Settlement, Delisting and Dealings.</font><font style="letter-spacing:0.2pt;">&#8221; </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tNDR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:584pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">NO DISSENTERS&#8217; RIGHTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Under Irish law, holders of Avadel Shares do not have appraisal or dissenters&#8217; rights with respect to the Transaction or any of the other transactions described in this proxy statement.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tMTCO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MATERIAL TAX CONSEQUENCES OF THE PROPOSED TRANSACTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Irish Tax Considerations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">This is a summary of the principal Irish tax considerations for certain beneficial owners of Avadel Shares who receive the Cash Consideration and the CVR Consideration under the Scheme based on Irish taxation laws and the practices of the Irish Revenue Commissioners currently in force in Ireland (which may be subject to change). It deals with Avadel Shareholders who beneficially own their Avadel Shares as an investment. Particular rules not discussed below may apply to certain classes of taxpayers holding Avadel Shares, such as dealers in securities, collective investment schemes, insurance companies, trusts etc.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">This summary does not constitute tax or legal advice and the comments below are of a general nature only. Holders of Avadel Shares should consult their professional advisers on the tax implications of the Scheme under the laws of their country of residence, citizenship and / or domicile. If you are in doubt as to your tax position or are subject to tax in a jurisdiction other than Ireland, you should consult an appropriate professional adviser without delay.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Taxation of Chargeable Gains</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The current rate of tax on chargeable gains in Ireland is thirty-three&#160;percent (33%). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Non-resident shareholders</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel Shareholders that are neither resident nor ordinarily resident in Ireland for Irish tax purposes should not be liable for Irish capital gains tax, referred to as &#8220;Irish CGT,&#8221; on the disposal of their Avadel Shares pursuant to the Scheme unless such shares were used in or for the purposes of a trade carried on by the Avadel Shareholder in Ireland through a branch or agency, or were used or held or acquired for use by or for the purposes of the branch or agency. An Avadel Shareholder who is an individual and who is temporarily non-resident in Ireland may, under Irish anti-avoidance legislation, still be liable to Irish CGT on any chargeable gain realized on the disposal of their Avadel Shares pursuant to the Scheme during the period in which the individual is a non-resident. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Irish resident shareholders</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel Shareholders that are resident or ordinarily resident in Ireland for Irish tax purposes or that have used their Avadel Shares in or for the purposes of a trade carried on by the Avadel Shareholder in Ireland through a branch or agency, or whose Avadel Shares were used or held or acquired for use by or for the purposes of such a branch or agency (each an &#8220;Irish Holder&#8221;) will, subject to the availability of any exemptions and reliefs, generally be within the charge to Irish CGT to the extent that the amount of proceeds realised on the disposal of their Avadel Shares pursuant to the Scheme exceed the base cost of their Avadel Shares plus incidental acquisition and selling expenses. For the purpose of Irish CGT an Irish Holder should be treated as having made a disposal of their Avadel Shares for proceeds of an amount equal to the Scheme Consideration (i.e., the Cash Consideration and CVR Consideration received pursuant to the Scheme). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to Section&#160;563 of the Taxes Consolidation Act 1997 of Ireland (&#8220;TCA&#8221;), in the computation of a chargeable gain, consideration for the disposal shall be taken into account without any discount for postponement of the right to receive any part of the consideration and without regard to a risk of any part of the consideration being irrecoverable or to the right to receive any part of the consideration being contingent. Accordingly, where the value of the CVR Consideration is ascertainable at the time of disposal, the full amount should be included in computing the chargeable gain or allowable loss. This may require the maximum amount potentially payable in respect of the CVRs (i.e. US $1.50 per CVR) to be treated as proceeds arising on the disposal of Avadel Shares, such that the Irish Holders are subject to Irish CGT on the aggregate value of the Cash Consideration, plus the maximum amount payable pursuant to the CVR Agreement (i.e. US $1.50 per CVR) before any amounts are actually received or receivable pursuant to the CVR Agreement. If the maximum amount payable pursuant to the CVR Agreement (i.e. US $1.50 per CVR) is properly included in the computation of an Irish Holder&#8217;s chargeable gain for Irish CGT purposes pursuant to Section&#160;563 TCA and it is subsequently established that it is irrecoverable (i.e., the Milestone is </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">not achieved and the CVR payment is not made), the Irish Holder may seek an adjustment, whether by means of a discharge or repayment of tax, from the Irish Revenue Commissioners. Irish Holders are urged to consult their own tax advisors concerning the appropriate tax treatment of the CVRs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The amount of Irish CGT, if any, payable as a consequence of the disposal of the Avadel Shares by an Irish Holder pursuant to the Scheme will depend on his or her own personal tax position. In the case of individuals, an annual exemption from Irish CGT applies (&euro;1,270 for 2025). This annual exemption is not available to companies. Irish Holders are required, under Ireland&#8217;s self-assessment system, to file a tax return reporting any chargeable gains arising to them in a particular year. Irish Holders that realize a loss on the disposal of their Avadel Shares will generally be entitled to offset such capital losses against chargeable gains realized from other sources in determining their liability to Irish CGT. Capital losses which remain unrelieved in a year may generally be carried forward and applied against chargeable gains realized in future&#160;years. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stamp Duty</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">No Irish stamp duty should be payable by an Avadel Shareholder in relation to the disposal of their Avadel Shares for cash pursuant to the Scheme. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any holder of Avadel Shares who has any doubt about his or her own taxation position or who is subject to taxation in any jurisdiction other than Ireland is strongly recommended to consult his or her independent professional adviser immediately. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Considerations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following discussion describes certain material U.S. federal income tax consequences generally applicable to U.S. Holders (as defined below) whose Avadel Shares are exchanged for cash and CVRs in the Scheme. This discussion is for general information only and is not tax advice. This discussion is based on the Code, U.S. Treasury regulations promulgated under the Code (&#8220;Treasury Regulations&#8221;), published rulings and administrative pronouncements of the Internal Revenue Service (the &#8220;IRS&#8221;) and administrative and judicial interpretations thereof, all as available and in effect on the date hereof and all of which are subject to change or differing interpretations, possibly with retroactive effect. Any such change or differing interpretation could affect the statements set forth in this discussion. We have not sought, and do not expect to seek, a ruling from the IRS as to any U.S. federal income tax consequence described herein, and no assurance can be given that the IRS will not take a position contrary to the discussion below, or that a court will not sustain any challenge by the IRS in the event of litigation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This discussion addresses only U.S. Holders (as defined below) who hold their Avadel Shares as capital assets within the meaning of Section&#160;1221 of the Code (generally, property held for investment) and does not address all of the tax consequences that may be relevant to U.S. Holders in light of their particular circumstances or that may apply to certain types of U.S. Holders subject to special treatment under U.S. federal income tax laws, including, without limitation, partnerships, other entities or arrangements classified as partnerships for U.S. federal income tax purposes, &#8220;S corporations&#8221; or any other pass-through entities for U.S. federal income tax purposes and partners or investors who hold their Avadel Shares through such entities, banks and other financial institutions, brokers, dealers or traders in securities or other&#160;persons that generally mark their securities to market for U.S. federal income tax purposes, insurance companies, U.S. expatriates and former citizens or long-term residents of the United States, mutual funds, real estate investment trusts, regulated investment companies, cooperatives, tax-exempt organizations (including private foundations), retirement plans, controlled foreign corporations, passive foreign investment companies, persons who are subject to any alternative minimum tax, persons who hold their Avadel Shares as part of a straddle, hedge, conversion, constructive sale, synthetic security, integrated investment, or other risk-reduction transaction for U.S. federal income tax purposes, stockholders that have a functional currency other than the U.S. dollar, certain taxpayers that are required to prepare certified financial statements or file financial statements with certain regulatory or governmental agencies, persons that own or have owned within the past five (5)&#160;years (or are deemed to own or have owned within the past five (5)&#160;years) five&#160;percent (5%) or more of the outstanding Avadel Shares (by vote or value), U.S. Holders of Avadel Shares that exercise appraisal rights, persons required to accelerate the recognition of any item of gross income as a result of such income being recognized on an applicable financial statement and persons who </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">acquired their Avadel Shares upon the exercise of stock options or otherwise as compensation. This discussion does not address any U.S. federal estate, gift, or other non-income tax consequences, any tax consequences arising under the Medicare contribution tax on net investment income or the Foreign Account Tax Compliance Act of 2010 (including the Treasury Regulations promulgated thereunder and intergovernmental agreements entered into pursuant thereto or in connection therewith and any laws, regulations or practices adopted in connection with any such agreement), or any state, local or non-U.S. tax consequences. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As used in this summary, the term &#8220;U.S. Holder&#8221; means a beneficial owner of Avadel Shares that, for U.S. federal income tax purposes, is: (i)&#160;an individual who is a citizen or resident of the U.S.; (ii)&#160;a corporation, or other entity or arrangement treated as a corporation for U.S. federal income tax purposes, that is created or organized in or under the laws of the U.S. or any state thereof or the District of Columbia; (iii)&#160;an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or (iv)&#160;a trust if (a)&#160;a court within the U.S. is able to exercise primary supervision over the administration of the trust and one (1)&#160;or more U.S. persons has the authority to control all substantial decisions of the trust or (b)&#160;the trust has a valid election in effect under applicable Treasury Regulations to be treated as a U.S. person. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If a partnership (including any entity or arrangement treated as a partnership for U.S. federal income tax purposes) exchanges Avadel Shares for cash and CVRs in the Scheme, the tax treatment of a partner in the partnership will generally depend upon the status of such partner and the activities of such partnership. Partnerships and partners in partnerships holding Avadel Shares are urged to consult their tax advisors regarding the tax consequences of exchanging Avadel Shares for the Scheme Consideration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">THE FOLLOWING IS A GENERAL DISCUSSION OF CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE EXCHANGE OF AVADEL SHARES FOR CASH AND CVRS PURSUANT TO THE SCHEME UNDER CURRENT LAW AND IS FOR GENERAL INFORMATIONAL PURPOSES ONLY. ALL HOLDERS ARE URGED TO CONSULT THEIR OWN TAX ADVISORS TO DETERMINE THE PARTICULAR TAX CONSEQUENCES TO THEM OF EXCHANGING AVADEL SHARES FOR CASH AND CVRS PURSUANT TO THE SCHEME IN LIGHT OF THEIR PARTICULAR CIRCUMSTANCES, INCLUDING THE APPLICABILITY AND EFFECT OF ANY U.S. FEDERAL, STATE, LOCAL, NON-U.S. AND OTHER TAX LAWS. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">U.S. Holders</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The exchange of Avadel Shares for the Scheme Consideration pursuant to the Scheme generally will be a taxable transaction for U.S. federal income tax purposes. The amount of gain or loss a U.S. Holder recognizes, and the timing and character of such gain or loss, depend in part on the U.S. federal income tax treatment of the CVRs, with respect to which there is a significant amount of uncertainty. The installment method of reporting any gain attributable to the receipt of a CVR generally will not be available with respect to the disposition of Avadel Shares pursuant to the Scheme because the Avadel Shares are traded on an established securities market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There is no legal authority directly addressing the U.S. federal income tax treatment of the receipt of the CVRs in connection with the Scheme. The receipt of the CVRs as part of the Scheme Consideration might be treated as an &#8220;open transaction&#8221; or as a &#8220;closed transaction&#8221; for U.S. federal income tax purposes, each discussed below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to U.S. Treasury Regulations addressing contingent payment obligations that are analogous to the CVRs, if the fair market value of the CVRs were determined to be &#8220;reasonably ascertainable,&#8221; a U.S. Holder should treat the transaction as a &#8220;closed transaction&#8221; and treat the fair market value of the CVRs as part of the consideration received in the Scheme for purposes of determining gain or loss. On the other hand, if the fair market value of the CVRs cannot be reasonably ascertained, a U.S. Holder should treat the transaction as an &#8220;open transaction&#8221; for purposes of determining gain or loss. These Treasury Regulations state that only in &#8220;rare and extraordinary&#8221; cases would the value of contingent payment obligations not be reasonably ascertainable. There is no authority directly addressing whether contingent payment rights with characteristics similar to the rights under a CVR should be treated as &#8220;open transactions&#8221; or &#8220;closed </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">transactions,&#8221; and such question is inherently factual in nature. We urge you to consult your tax advisor with respect to the proper characterization of the receipt of, and payments made with respect to, a CVR. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following sections discuss certain U.S. federal income tax consequences of the Scheme if the exchange of Avadel Shares for cash and CVRs pursuant to the Scheme is treated as a &#8220;closed transaction&#8221; or, alternatively, as an &#8220;open transaction&#8221; for U.S. federal income tax purposes. Under either &#8220;open&#8221; or &#8220;closed&#8221; transaction treatment, gain or loss generally will be determined separately for each block of Avadel Shares (that is, Avadel Shares acquired at the same cost in a single transaction) exchanged pursuant to the Scheme. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Treatment as Closed Transaction</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the receipt of the CVRs is treated as part of a &#8220;closed transaction&#8221; for U.S. federal income tax purposes, then a U.S. Holder generally would recognize capital gain or loss on an exchange of Avadel Shares for the Scheme Consideration (i.e., cash and CVRs), in an amount equal to the difference, if any, between: (i)&#160;the amount of cash received plus the fair market value (determined as of the Effective Time) of any CVRs received; and (ii)&#160;the U.S. Holder&#8217;s adjusted U.S. federal income tax basis in the Avadel Shares sold or exchanged. The proper method to determine the fair market value of a CVR is not clear, but it is possible that the trading value of the Avadel Shares would be considered along with other factors in making that determination. Any capital gain or loss recognized will be long-term capital gain or loss if such Avadel Shares was held for more than one (1)&#160;year prior to the Scheme. The deductibility of capital losses is subject to significant limitations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A U.S. Holder&#8217;s initial U.S. federal income tax basis in a CVR received in the Scheme would equal the fair market value (as of the Effective Time) of such CVR as determined for U.S. federal income tax purposes. The holding period for a CVR would begin on the day following the Scheme. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There is no authority directly addressing the U.S. federal income tax treatment of receiving payments on the CVRs received in a &#8220;closed transaction&#8221; for U.S. federal income tax purposes and, therefore, the amount, timing and character of any gain, income or loss with respect to the CVRs would be uncertain. For example, if a payment is made with respect to a CVR, it could be treated as a payment with respect to a sale or exchange of a capital asset or as giving rise to ordinary income. It is also unclear how a U.S. Holder of the CVRs would recover its adjusted tax basis with respect to payments thereon. It is also possible that, were the payment to be treated as being made with respect to the sale of a capital asset, a portion of such payment may constitute imputed interest under Section&#160;483 of the Code (as described below under &#8220;&#8212;&#160;</font><font style="font-style:italic;letter-spacing:0.2pt;">Imputed Interest</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Treatment as Open Transaction</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the transaction is treated as an &#8220;open transaction&#8221; for U.S. federal income tax purposes, a U.S. Holder generally would recognize capital gain for U.S. federal income tax purposes on the exchange of Avadel Shares for the Cash Consideration received pursuant to the Scheme if and to the extent the amount of cash received in such exchange exceeds such U.S. Holder&#8217;s adjusted U.S. federal income tax basis in the Avadel Shares sold or exchanged. However, a U.S. Holder may not be able to recognize loss for U.S. federal income tax purposes in connection with the Scheme even if its adjusted U.S. federal income tax basis exceeds the amount of cash received as of the Effective Time and instead may be required to defer recognition of loss (and the determination of the amount of such loss) until the U.S. Holder&#8217;s right to receive further payments under the CVRs terminates (e.g., when the Milestone is achieved and all payments under the CVR Agreement have become due, the CVR Agreement lapses without achieving the Milestone, or, possibly, if the U.S. Holder abandons its CVRs), as discussed below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The fair market value of the CVRs generally would not be treated as additional consideration for the Avadel Shares at the time the CVRs are received in the Scheme, and the U.S. Holder would have no U.S. federal income tax basis in the CVRs. Instead, the U.S. Holder would take payments under the CVRs into account when made or deemed made in accordance with the U.S. Holder&#8217;s regular method of accounting for U.S. federal income tax purposes. A portion of such payments may be treated as interest income under Section&#160;483 of the Code (as discussed below under &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Imputed Interest</font><font style="letter-spacing:0.2pt;">&#8221;) and the balance, in general, would be treated as additional consideration for the disposition of the Avadel Shares in the Scheme. The portion </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">of payments on the CVRs not treated as imputed interest under Section&#160;483 of the Code will generally be treated as gain to the extent the sum of such payments (and all previous payments under the CVRs), together with the cash received upon the closing of the Scheme, exceeds such U.S. Holder&#8217;s adjusted U.S. federal income tax basis in the Avadel Shares surrendered pursuant to the Scheme. Subject to the imputed interest rules discussed below, a U.S. Holder that does not receive cash pursuant to the Scheme (including for this purpose any cash received as payments on the CVRs) in an amount at least equal to such U.S. Holder&#8217;s adjusted U.S. federal income tax basis in the Avadel Shares surrendered pursuant to the Scheme may be able to recognize a capital loss upon termination of the U.S. Holder&#8217;s right to receive further payments under the CVR (e.g., when the Milestone is achieved and all payments under the CVR Agreement have become due or the CVR Agreement lapses without achieving the Milestone), or possibly upon such U.S. Holder&#8217;s abandonment of its CVRs. Any such capital gain or loss will be long-term if the Avadel Shares were held for more than one (1)&#160;year prior to the Scheme. The deductibility of capital losses is subject to significant limitations. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Imputed Interest</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under either &#8220;closed transaction&#8221; or &#8220;open transaction&#8221; treatment, a portion of the payments made with respect to a CVR may be treated as imputed interest, which would be ordinary income to the U.S. Holder of a CVR. The portion of any payment made with respect to a CVR treated as imputed interest under Section&#160;483 of the Code will be determined at the time such payment is made and generally should equal the excess of: (i)&#160;the amount of the payment in respect of the CVRs; over (ii)&#160;the present value of such amount as of the Effective Time calculated using the appropriate applicable federal rate published by the IRS as the discount rate. A U.S. Holder must include in its taxable income interest imputed pursuant to Section&#160;483 of the Code using such U.S. Holder&#8217;s regular method of accounting for U.S. federal income tax purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The U.S. federal income tax treatment of the CVRs is not certain. There is no legal authority directly addressing the U.S. federal income tax consequences of the receipt of CVRs (or cash payments made with respect to the CVRs). Neither Alkermes nor Avadel intends to seek a ruling from the IRS regarding the tax treatment of the CVRs. Due to the legal and factual uncertainty regarding the valuation and tax treatment of the CVRs, holders of Avadel Shares are urged to consult their own tax advisors concerning the recognition, timing and character of any gain or loss resulting from the Scheme, including the receipt of the CVRs pursuant to the Scheme and the tax consequences of the receipt of payments with respect to the CVRs after the Scheme. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Passive Foreign Investment Company Considerations</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A non-U.S. corporation, such as Avadel, will be classified as a &#8220;passive foreign investment company&#8221; (referred to as a &#8220;PFIC&#8221;) for any taxable year if, after the application of certain &#8220;look-through&#8221; rules, (a)&#160;at least seventy-five&#160;percent (75%) of its gross income is &#8220;passive income&#8221; as that term is defined in the relevant provisions of the Code (e.g., dividends, interest, rents, royalties, or gains on the disposition of certain investment property) or (b)&#160;at least fifty&#160;percent (50%) of the average quarterly value of its assets consists of assets that produce, or are held for the production of, &#8220;passive income.&#8221; Avadel is not expected to be classified as a PFIC for U.S. federal income tax purposes, but this conclusion is a factual determination made annually and, thus, is subject to change. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Avadel were classified as a PFIC for any taxable year during which a U.S. holder held Avadel Shares, such classification could result in adverse tax consequences to such U.S. holder, and different U.S. federal income tax consequences from those described above may apply to the receipt of the Scheme Consideration by such U.S. holder in exchange for Avadel Shares. These consequences may include having gains realized on the receipt of Scheme Consideration in exchange for Avadel Shares treated as ordinary income rather than capital gain and being subject to interest charges on such gains. U.S. holders should consult their tax advisors regarding the potential application of the PFIC rules to their disposition of Avadel Shares in connection with the Scheme. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Information Reporting and Backup Withholding</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Information reporting generally will apply to payments to a U.S. Holder pursuant to the Scheme (including payments with respect to a CVR), unless such U.S. Holder is an entity that is exempt from </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:352pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">information reporting and, when required, properly demonstrates its eligibility for exemption. Any payment to a U.S. Holder that is subject to information reporting generally will also be subject to backup withholding (currently at a rate of 24%), unless such U.S. Holder: (i)&#160;provides the appropriate documentation (generally, IRS Form W-9) to the applicable withholding agent certifying that, among other things, its taxpayer identification number is correct, or otherwise establishes an exemption; and (ii)&#160;with respect to payments on the CVRs, provides the Rights Agent with the certification documentation in clause (i)&#160;of this sentence or otherwise establishes an exemption from backup withholding tax. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules generally will be allowed as a refund or a credit against a U.S. Holder&#8217;s U.S. federal income tax liability if the required information is properly and timely furnished by such U.S. Holder to the IRS. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Tax information provided to a U.S. Holder and the IRS on IRS Form 1099-B for the year of the Scheme may reflect the fair market value of the U.S. Holder&#8217;s interest in payments made (or to be made) on the CVRs, in addition to the cash amounts paid to a U.S. Holder in the Scheme. U.S. Holders are urged to consult their own tax advisors regarding how to accurately report their income under this method. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">THE FOREGOING SUMMARY DOES NOT PURPORT TO BE A COMPLETE DISCUSSION OF THE POTENTIAL TAX CONSEQUENCES OF THE SCHEME OR THE OWNERSHIP OF CVRS. EACH HOLDER IS URGED TO CONSULT ITS OWN TAX ADVISOR REGARDING THE U.S. FEDERAL, STATE, LOCAL AND NON-U.S. INCOME, ESTATE AND OTHER TAX CONSIDERATIONS RELATING TO THE SCHEME IN LIGHT OF ITS PARTICULAR CIRCUMSTANCES. NOTHING IN THIS SUMMARY IS INTENDED TO BE, OR SHOULD BE CONSTRUED AS, TAX ADVICE. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tDADO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:572pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">DELISTING AND DEREGISTRATION OF AVADEL SHARES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Following the consummation of the Transaction, Avadel Shares will be delisted from Nasdaq Global and deregistered under the Exchange Act and will cease to be publicly traded. As a result, Avadel would no longer file periodic or other reports with the SEC. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tPTTT1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:308pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PARTIES TO THE TRANSACTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Alkermes</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Alkermes is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuro science. Alkermes has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy and IH. Alkermes is a public limited company incorporated in Ireland whose ordinary shares are listed on Nasdaq Select under the ticker &#8220;ALKS.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Alkermes&#8217; principal executive offices are located at Connaught House, 1 Burlington Road, Dublin 4, Ireland, D04 C5Y6, its telephone number is +353 1 722 8000 and its website is www.alkermes.com. Information on Alkermes&#8217; website is not incorporated by reference into or otherwise part of this proxy statement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Avadel</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel is a is a biopharmaceutical company focused on transforming medicines to transform lives. Avadel&#8217;s approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel&#8217;s commercial product, LUMRYZ&#8482;, was approved by the FDA as the first and only once-at-bedtime oxybate for extended-release oral suspension for the treatment of cataplexy or EDS in patients 7&#160;years of age and older with narcolepsy. Avadel is a public company registered in Ireland whose ordinary shares are listed on Nasdaq Global under the ticker &#8220;AVDL.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s principal executive offices are located at Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland, its telephone number is + 353 1 901 5201 and its website is www.avadel.com. Information on Avadel&#8217;s website is not incorporated by reference into or otherwise part of this proxy statement. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tTTA">&#8203;</a><a name="tSTT1">&#8203;</a><a name="tCAS1">&#8203;</a><a name="tTAEA1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE TRANSACTION AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of certain material terms of the Transaction Agreement and the conditions appendix and is qualified in its entirety by reference to (i)&#160;the complete text of the Transaction Agreement, which is incorporated into this proxy statement by reference and attached as Annex A to this proxy statement, and (ii)&#160;the complete text of the conditions appendix, which is incorporated into this proxy statement by reference and attached as Annex B to this proxy statement. This summary is not intended to provide you with any other factual information about Avadel or Alkermes. You are urged to read carefully this entire proxy statement, including the Annexes and the documents incorporated by reference. You should also review &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Where You Can Find More Information</font><font style="letter-spacing:0.2pt;">.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Structure of the Transaction</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Transaction, Alkermes will acquire the entire issued and to be issued ordinary share capital of Avadel, in accordance with the terms of the Transaction Agreement, by way of the Scheme. Upon the closing of the Transaction, Avadel will be a wholly owned subsidiary of Alkermes. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Closing of the Transaction</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The closing of the Transaction will take place at 9:00&#160;a.m. New York City time, on a date to be selected by Alkermes in consultation with Avadel as promptly as reasonably practicable following, but not later than the third business day (or such shorter period of time as remains before 5:00&#160;p.m., New York City time, on the End Date) after the satisfaction or, in the sole discretion of the applicable party, waiver (where applicable) of conditions to the closing of the Transaction (other than those conditions that by their nature are to be satisfied at the closing, but subject to the satisfaction or waiver of such conditions at the Completion). For a description of the conditions to the closing of the Transaction, see the section of this proxy statement entitled &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Conditions to the Completion of the Transaction.</font><font style="letter-spacing:0.2pt;">&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Consideration to Avadel Shareholders</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the Effective Time, Avadel Shareholders will be entitled to receive the Scheme Consideration (which is $18.50 in cash for each Avadel Share held by them as of the Effective Time and a non-transferrable contingent value right entitling the holder to a potential additional cash payment of $1.50 for each Avadel Share held by them as of the Effective Time, contingent upon the achievement of the specified milestone set forth in the CVR Agreement). Within fourteen (14) days following the Effective Date, in respect of each Avadel Share subject to the Scheme (excluding Avadel Shares held by current or former employees of Avadel or its subsidiaries that are subject to unvested Avadel Restricted Stock Awards as of immediately prior to the Effective Time, which will be treated in accordance with the last sentence of this paragraph), Alkermes will pay, or cause to be paid, in respect of each holder of Avadel Shares at the Scheme Record Time (as specified in the Scheme), the Scheme Consideration in accordance with the terms and conditions of the Scheme. As soon as reasonably practicable after the Completion date (but no later than ten (10) business days after the Effective Time), Alkermes will pay or cause to be paid through payroll the aggregate Cash Consideration payable with respect to Avadel equity awards held by current or former employees of Avadel or its subsidiaries (net of withholding taxes required to be deducted and withheld). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Treatment of Avadel Options, Avadel RSU Awards and Avadel Restricted Stock Awards</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel equity awards will be treated as set forth in the Transaction Agreement, such that at the effective time: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each Avadel Cash-Out Option (including each Avadel Performance-Based Option) that is outstanding as of immediately prior to the Effective Time, whether or not vested, will be cancelled and, in exchange therefor, the holder of such cancelled Avadel Cash-Out Option will be entitled to receive (without interest): (i)&#160;an amount in cash (less applicable tax and any other mandatory withholdings) equal to the product of (x)&#160;the total number of Avadel Shares subject to such Avadel Cash-Out Option immediately prior to the Effective Time, </font><font style="font-style:italic;letter-spacing:0.2pt;">multiplied</font><font style="letter-spacing:0.2pt;"> by (y)&#160;the excess of the Cash Consideration over the applicable exercise price per Avadel Share under such Avadel Cash-Out Option and (ii)&#160;one </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">CVR for each Avadel Share subject to such Avadel Cash-Out Option immediately prior to the Effective Time (without regard to vesting); </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each Avadel Option with an exercise price equal to or greater than the Cash Consideration that is outstanding immediately prior to the Effective Time, whether or not vested, will be cancelled for no consideration; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each Avadel RSU Award that is outstanding will be cancelled and, in exchange therefor, the holder of such cancelled Avadel RSU Award will be entitled to receive (without interest): (i)&#160;an amount in cash (less applicable tax and any other mandatory withholdings) equal to the product of (x)&#160;the total number of Avadel Shares subject to such Avadel RSU Award immediately prior to the Effective Time multiplied by (y)&#160;the Cash Consideration and (ii)&#160;one CVR for each Avadel Share subject to such Avadel RSU Award immediately prior to the Effective Time (without regard to vesting); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each Avadel Restricted Stock Award, whether granted pursuant to the Avadel Share Plans or otherwise that is outstanding immediately prior to the Effective Time will vest in full as of immediately prior to the Effective Time and will be treated in the same manner as all other Avadel Shares. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Representations and Warranties</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel and Alkermes made customary representations and warranties set forth in the Transaction Agreement on behalf of themselves and their respective subsidiaries that are subject, in some cases, to specified exceptions and qualifications contained in the Transaction Agreement or in the disclosure schedules to the Transaction Agreement. The representations and warranties made by Avadel and Alkermes are also subject to and qualified by certain information included in filings Avadel and Alkermes have made with the SEC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Transaction Agreement contains representations and warranties of Avadel regarding, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">corporate organization, existence and good standing and requisite corporate power and authority to carry on business; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">corporate authority to enter into the Transaction Agreement and the CVR Agreement and the enforceability thereof; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the absence of certain material litigation, claims and actions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the absence of conflicts with, or violations of, organizational documents and other agreements or obligations in connection with the execution, delivery and performance of the Transaction Agreement and the consummation of the Transaction and required governmental filings and consents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the reliability and accuracy of information supplied for this proxy statement and any other documents filed or furnished to the Irish High Court, the SEC or pursuant to the Companies Act or the Irish Takeover Rules, in each case in connection with the Transaction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the due incorporation or organization, valid existence and good standing of its subsidiaries, the valid issuance and ownership of the equity securities of its subsidiaries, as well as their qualification to do business and good standing in each jurisdiction where such qualification is necessary; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">capital structure; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">SEC filings, financial statements contained in those filings and internal controls and procedures; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the absence of certain changes since December&#160;31, 2024, that have had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect (as defined below); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">title to material tangible assets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">title and rights to, and condition of, real property; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">ownership of or rights to intellectual property, and absence of infringement, and compliance with intellectual property laws; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">data privacy and information security matters; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">56</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the existence of and compliance with certain material contracts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the absence of undisclosed liabilities and off-balance-sheet arrangements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">compliance with applicable laws and listing requirements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">certain regulatory matters relating to the products, product candidates and businesses of Avadel and its subsidiaries, including compliance with applicable healthcare laws including the U.S. Food, Drug and Cosmetic Act of 1938, as amended, the U.S. Controlled Substances Act, and federal Medicare and Medicaid statutes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">compliance with anti-bribery, anti-corruption and anti-money laundering laws; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the absence of transactions with affiliates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the absence of regulatory inspections, investigations or liabilities since January&#160;1, 2023, and availability of regulatory reports, audits and submissions related to Avadel&#8217;s products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">compliance with applicable permits; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">certain tax matters; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">employee compensation and benefits matters and labor matters, and compliance with applicable employee benefits laws; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">compliance with environmental laws; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the existence and maintenance of insurance; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the absence of any pending or served legal proceedings and orders relating to the Transaction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the receipt of fairness opinions; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the absence of undisclosed brokers&#8217; fees, finders&#8217; fees or other similar fees or commissions relating to the Transaction. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, Alkermes has made representations and warranties, among other things, regarding: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">corporate organization, existence and good standing and requisite corporate power and authority to carry on business; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">corporate authority to enter into the Transaction Agreement and the CVR Agreement and the enforceability thereof; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the absence of certain material litigation, claims and actions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the absence of conflicts with, or violations of, organizational documents and other agreements or obligations in connection with the execution, delivery and performance of the Transaction Agreement and the consummation of the Transaction and required governmental filings and consents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the reliability and accuracy of information supplied for this proxy statement and any other documents filed or furnished to the Irish High Court, the SEC, or pursuant to the Companies Act or the Irish Takeover Rules, in each case in connection with the Transaction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Alkermes&#8217; ownership of Avadel shares; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the availability of financing to Alkermes. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the Transaction Agreement, the parties agreed that except for the representations and warranties contained in the Transaction Agreement, none of Avadel or Alkermes make any other representation or warranty. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Many of the representations and warranties made by each of Avadel and Alkermes are qualified by a material adverse effect standard. For the purpose of the Transaction Agreement, a &#8220;Material Adverse Effect&#8221; with respect to Alkermes means any event, change, effect, development or occurrence that, individually or together with any other event, change, effect, development or occurrence, would be reasonably expected to prevent, materially delay or materially impair the ability of Alkermes to consummate the Transaction. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">57</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the purpose of the Transaction Agreement, a &#8220;Material Adverse Effect&#8221; with respect to Avadel means any event, change, effect, development or occurrence that, individually or together with any other event, change, effect, development or occurrence, (a)&#160;would reasonably be expected to prevent, materially delay or materially impair the ability of Avadel to consummate the transaction or (b)&#160;has had or would reasonably be expected to have a material adverse effect on the condition (financial or otherwise), assets, liabilities, business, operations or results of operations of Avadel and its subsidiaries, taken as a whole, however, solely for the purposes of clause (b), excluding any event, change, effect, development or occurrence to the extent resulting from or arising out of: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any changes in conditions generally affecting the industry in which Avadel and its subsidiaries operate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any decline in the market price or change in trading volume of Avadel shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any general changes in political conditions (including the imposition of new or increased trade restrictions, tariffs or trade policies) or in securities, credit, financial, debt or other capital markets, in each case in the United States or any foreign jurisdiction, including any disruption thereof, due to a government shutdown or otherwise; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any failure, in and of itself, by Avadel or its subsidiaries to meet any internal or published projections, forecasts, estimates or predictions, revenues, earnings or other financial or operating metrics for any period (it being understood and agreed that the facts, events, developments or occurrences giving rise to or contributing to such failure that are not otherwise excluded from the definition of Material Adverse Effect pursuant to the Transaction Agreement may be taken into account in determining whether there has been, or would reasonably be expected to be, a Material Adverse Effect); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the execution, delivery and public announcement of the Transaction Agreement or the consummation of the transaction, or Alkermes&#8217; identity; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any adoption, implementation, promulgation, repeal, modification, amendment or change of any applicable law of or by any governmental entity (it being understood and agreed that any changes to the regulatory treatment of Avadel products may be taken into account in determining whether there has been, or would reasonably be expected to be, a Material Adverse Effect); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any changes or prospective changes in U.S. generally accepted accounting principles (&#8220;GAAP&#8221;); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any outbreak or escalation of hostilities, acts of war, sabotage, terrorism or any escalation or worsening of any such acts of war, sabotage or terrorism threatened or underway as of the date of the Transaction Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any action taken by Avadel or its subsidiaries which is expressly required by the Transaction Agreement or taken at Alkermes&#8217; written direction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any event, change, effect, development or occurrence resulting from Avadel&#8217;s entry, on October&#160;21, 2025 into the Settlement and License Agreement, by and between Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited, on the one hand, and Avadel CNS Pharmaceuticals and Flamel Ireland Limited, on the other hand (the &#8220;Settlement Agreement&#8221;), or the performance of Avadel&#8217;s obligations required thereunder; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any epidemic, plague, pandemic or other outbreak of illness or public health event, hurricane, earthquake, flood or other natural disasters, acts of God or any change resulting from weather conditions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">However, the exceptions laid out in the second, fourth, fifth and sixth bullets will not prevent or otherwise affect a determination that the underlying cause of any such decline or failure is a Material Adverse Effect, and, in the case of the first, third, sixth, seventh, eighth and eleventh bullets, to the extent that any such event, change, effect, development or occurrence has a disproportionate adverse effect on Avadel and its subsidiaries, taken as a whole, relative to the effect of such events on Avadel as compared to other companies operating in the industries in which Avadel operates, then only the incremental disproportionate adverse effect of such effect will be taken into account for the purpose of determining whether a Material Adverse Effect exists or has occurred. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">58</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">THE DESCRIPTION OF THE TRANSACTION AGREEMENT IN THIS PROXY STATEMENT HAS BEEN INCLUDED TO PROVIDE YOU WITH INFORMATION REGARDING ITS TERMS. THE TRANSACTION AGREEMENT CONTAINS REPRESENTATIONS AND WARRANTIES MADE BY AND TO THE PARTIES AS OF SPECIFIC DATES. THE STATEMENTS EMBODIED IN THOSE REPRESENTATIONS AND WARRANTIES WERE MADE FOR PURPOSES OF THE CONTRACT BETWEEN THE PARTIES AND ARE SUBJECT TO QUALIFICATIONS AND LIMITATIONS AGREED BY THE PARTIES IN CONNECTION WITH NEGOTIATING THE TERMS OF THE TRANSACTION AGREEMENT AND IN SOME CASES WERE QUALIFIED BY CONFIDENTIAL DISCLOSURES MADE BY THE PARTIES, WHICH DISCLOSURES ARE NOT REFLECTED IN THE TRANSACTION AGREEMENT. IN ADDITION, CERTAIN REPRESENTATIONS AND WARRANTIES WERE MADE AS OF A SPECIFIED DATE OR MAY HAVE BEEN USED FOR THE PURPOSE OF ALLOCATING RISK BETWEEN THE PARTIES RATHER THAN ESTABLISHING MATTERS AS FACTS. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Shareholders Meetings and Recommendations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel has agreed to (i)&#160;convene or seek an order of the Irish High Court convening a meeting of its shareholders to approve the Scheme in accordance with the requirements of the Companies Act (in other words, the Scheme Meeting) and (ii)&#160;convene the EGM, in order to approve the resolutions required to effect the Scheme, subject to the specified exception described in &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Conditions to the Completion of the Transaction.</font><font style="letter-spacing:0.2pt;">&#8221; Additionally, the Avadel Board has, subject to the specified exceptions described in &#8220;&#8212;&#160;</font><font style="font-style:italic;letter-spacing:0.2pt;">Third-Party Acquisition Proposals</font><font style="letter-spacing:0.2pt;">&#8221; recommended that Avadel Shareholders vote to approve the Scheme at the Scheme Meeting and vote to approve the resolutions required to effect the Scheme at the EGM. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Third-Party Acquisition Proposals</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel has agreed in the Transaction Agreement that it will not and it will cause its subsidiaries and its and their respective directors, officers and employees not to, and it will use its reasonable best efforts to cause its and its subsidiaries&#8217; other representatives not to, directly or indirectly: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">initiate or solicit any inquiry, proposal or offer with respect to, or take any action to knowingly facilitate or knowingly encourage (including by way of furnishing information to any person in connection with) the submission or announcement of any Avadel Alternative Proposal (as defined below) or any indication, proposal or inquiry that would reasonably be expected to lead to an Avadel Alternative Proposal; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">enter into, continue or otherwise participate in any discussions or negotiations with, furnish any non-public information relating to Avadel or any of its subsidiaries to, or afford access to the business, properties, assets, books or records of Avadel or any of its subsidiaries to, otherwise cooperate in any way with, or assist, participate in, knowingly facilitate or knowingly encourage any effort by, any third party that would reasonably be expected to seek to make, or has made, an Avadel Alternative Proposal (except Avadel may notify such a third party of the existence of the restrictions described in this section); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(A) fail to make or withdraw or qualify, amend or modify in any manner adverse to Alkermes, the recommendation of the Avadel Board in favor of the Scheme (the &#8220;Scheme Recommendation&#8221;) or the comparable recommendation if Alkermes should elect to implement the Transaction by way of a takeover offer, (B)&#160;fail to include the Scheme Recommendation in the document distributed to Avadel Shareholders or this proxy statement, (C)&#160;recommend, adopt or approve or publicly propose to recommend, adopt or approve any Avadel Alternative Proposal or (D)&#160;fail to reaffirm the Scheme Recommendation in a statement complying with Rule&#160;14e-2(a) under the Exchange Act with regard to an Avadel Alternative Proposal or in connection with such action by the close of business on the tenth business day after the commencement of such Avadel Alternative Proposal under Rule&#160;14e-2(a) (each of clauses A, B, C and D referred to as an &#8220;Avadel Board Change of Recommendation&#8221;); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">take any action to make any &#8220;moratorium&#8221;, &#8220;control share acquisition&#8221;, &#8220;fair price&#8221;, &#8220;supermajority&#8221;, &#8220;affiliate transactions&#8221; or &#8220;business combination statute or regulation&#8221; or other similar anti-takeover laws and regulations under applicable law inapplicable to any third party or any Avadel Alternative Proposal; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">59</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">waive, terminate, modify or fail to enforce any provision of any &#8220;standstill&#8221; or similar obligation of any person with respect to Avadel or any of its subsidiaries; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">enter into any agreement in principle, letter of intent, term sheet, merger agreement, acquisition agreement, option agreement or other agreement providing for or relating to an Avadel Alternative Proposal or any indication, proposal or inquiry that would reasonably be expected to lead to an Avadel Alternative Proposal (other than a confidentiality agreement with terms no less favorable in the aggregate to Avadel than those contained in the Confidentiality Agreement between Avadel and Alkermes). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel will, and will cause its subsidiaries and its and their respective directors, officers and employees to, and will use reasonable best efforts to cause its and their respective other representatives to, (i)&#160;immediately after the execution of the Transaction Agreement cease and terminate all activities, discussions or negotiations, if any, with any third party which could reasonably be expected to lead to, an Avadel Alternative Proposal, and (ii) terminate access to any physical or electronic data rooms to any such third parties.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">However, if at any time prior to the receipt of approval of the Transaction by Avadel Shareholders at the Special Meetings (and in no event after that time), the Avadel Board receives a </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> written Avadel Alternative Proposal made after the date of the Transaction Agreement which has not resulted from a material breach of Avadel&#8217;s non-solicitation obligations described in this section, the Avadel Board, directly or indirectly through its representatives, may: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">contact the third party that has made such Avadel Alternative Proposal solely to (i)&#160;inform the third party of the provisions described in this section and (ii)&#160;clarify the terms of such Avadel Alternative Proposal for the sole purpose of the Avadel Board informing itself about such Avadel Alternative Proposal, and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(i) engage in negotiations or discussions with any such third party that has made such an unsolicited bona fide written Avadel Alternative Proposal, and (ii)&#160;furnish to such third party and its representatives non-public information relating to Avadel or any of its subsidiaries pursuant to a confidentiality agreement with terms no less favorable in the aggregate to Avadel; than those contained in the Confidentiality Agreement between Avadel and Alkermes, so long as all such non-public information (to the extent that such information has not been previously provided or made available to Alkermes) is provided to Alkermes, substantially concurrently as it is provided to such third party, and so long as (prior to and as a condition of taking the actions described in this bullet), the Avadel Board determines in good faith, after consultation with its financial advisor(s) and outside legal counsel, that (a)&#160;the failure to take such action would be inconsistent with its fiduciary duties under applicable law and (b)&#160;such Avadel Alternative Proposal either constitutes or would reasonably be expected to result in an Avadel Superior Proposal (as defined below). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel must notify Alkermes promptly (but in any event within twenty-four (24) hours) if (i)&#160;any Avadel Alternative Proposal or any indication, proposal or inquiry by a third party that would reasonably be expected to lead to a Avadel Alternative Proposal, is received by Avadel, (ii)&#160;any non-public information is requested by any person and such request would reasonably be expected to lead to an Avadel Alternative Proposal or (iii)&#160;any discussions or negotiations are sought to be initiated or continued with, Avadel, its subsidiaries or their respective representatives with respect to a possible Avadel Alternative Proposal. Each such notice must be provided in writing and must identify the third party making, and, to the extent applicable, the material terms and conditions (including price) of, any such Avadel Alternative Proposal, indication, proposal, inquiry or request (including any changes thereto and, if applicable, copies of any written requests, proposals or offers, including proposed agreements). Following such initial notice, Avadel must keep Alkermes reasonably informed, on a current basis, of any changes in the status and details of any such Avadel Alternative Proposal, indication, inquiry, proposal or request by a third-party (including any changes thereto, other than changes that have a de </font><font style="font-style:italic;letter-spacing:0.2pt;">minimis</font><font style="letter-spacing:0.2pt;"> effect), including the status of any such discussions or negotiations, and will promptly (but in no event later than twenty-four (24) hours after receipt) provide to Alkermes copies of all material correspondence and written materials (including draft documentation) sent or provided by or to Avadel or any of its subsidiaries (or any of its or their respective representatives) that </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">60</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">describes any terms or conditions of any Avadel Alternative Proposal (as well as written summaries of any material oral communications addressing such matters). Neither Avadel nor any of its subsidiaries will enter into any agreement with any person which prohibits Avadel from providing any information to Alkermes in accordance with, or otherwise complying with, this section. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to Alkermes&#8217; right to negotiate with Avadel to amend the Transaction Agreement in light of any Avadel Superior Proposal, prior to the approval of the Transaction by Avadel Shareholders at the Special Meetings (and in no event after that time), the Avadel Board may (i)&#160;make an Avadel Board Change of Recommendation or (ii)&#160;terminate the Transaction Agreement in accordance with its provisions in order to substantially concurrently enter into a definitive agreement providing for an Avadel Superior Proposal if, with respect to clause (i)&#160;and clause (ii), (a)&#160;in the case of such an action taken in connection with an Avadel Alternative Proposal, the Avadel Alternative Proposal has not been withdrawn and the Avadel Board determines in good faith, after consultation with outside legal counsel and its financial advisor(s), that such Avadel Alternative Proposal constitutes an Avadel Superior Proposal or (b)&#160;in the case of an Avadel Board Change of Recommendation contemplated by clause (i)&#160;above involving or relating to an Avadel Intervening Event (as defined below) (and not involving any Avadel Alternative Proposal), the Avadel Board determines in good faith, after consultation with outside legal counsel and its financial advisor(s), that the failure to take such action would reasonably be expected to be inconsistent with its directors&#8217; fiduciary duties under applicable law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Avadel Board and Avadel, as applicable, will not take any of the actions contemplated in the preceding paragraph unless prior to taking such action (i)&#160;Avadel has notified Alkermes in writing at least five (5)&#160;business days before taking such action, that Avadel intends to take such action, and provides to Alkermes, in the case of an Avadel Board Change of Recommendation in response to an Avadel Superior Proposal or the termination of the Transaction Agreement, the most current version of each proposed contract providing for or related to such Avadel Superior Proposal (including any contract relating to financing or expense reimbursement) and the identity of the third party(ies) making the Avadel Superior Proposal or, in the case of an Avadel Intervening Event, a reasonably detailed description of the facts giving rise to the Avadel Board Change of Recommendation, (ii)&#160;if requested by Alkermes, during such five (5)-business day period, Avadel and its representatives will have discussed and negotiated in good faith with Alkermes (to the extent that Alkermes desires to so discuss or negotiate) regarding any proposal by Alkermes to amend the terms of the Transaction Agreement in response to such Avadel Superior Proposal or other potential Avadel Board Change of Recommendation and (iii)&#160;after such five (5)-Business Day period, the Avadel Board determines in good faith, after consultation with its financial advisor(s) and outside legal counsel and taking into account any proposal by Alkermes to amend the terms of the Transaction Agreement, that (A)&#160;in the case of any such action in connection with a Avadel Alternative Proposal, such Avadel Alternative Proposal continues to constitute a Avadel Superior Proposal and (B)&#160;the failure to take such action would be reasonably expected to be inconsistent with its fiduciary duties under applicable law (it being understood and agreed that in the event of any amendment to the financial terms or other material terms of any such Avadel Superior Proposal, a new written notification from Avadel consistent with that described in clause (i)&#160;of this paragraph will be required, and a new three (3)&#160;business days (as opposed to five (5)&#160;business days) notice period will begin, during which notice period Avadel will be required to comply with the requirements of this paragraph). After delivery of such written notice pursuant to this paragraph, Avadel will promptly inform Alkermes of all material developments affecting the material terms of any such Avadel Superior Proposal and will promptly provide Alkermes with copies of any additional written materials received or sent that are material to such Avadel Superior Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Transaction Agreement provides that a &#8220;Avadel Alternative Proposal&#8221; means any indication of interest, proposal or offer (including non-binding proposals or offers) from any person or group, other than Alkermes and its subsidiaries or any persons deemed to be Acting in Concert with Alkermes pursuant to Rule&#160;3.3 of Part&#160;A of the Irish Takeover Rules, relating to any (i)&#160;direct or indirect acquisition (whether in a single transaction or a series of related transactions) of assets of Avadel or any of its subsidiaries (including equity securities of subsidiaries) equal to twenty&#160;percent (20%) or more of the consolidated assets of Avadel, or to which twenty&#160;percent (20%) or more of the revenues or earnings of Avadel on a consolidated basis are attributable for the most recent fiscal year for which audited financial statements are then available, (ii)&#160;direct or indirect acquisition (including by scheme of arrangement or takeover offer) or issuance (whether in a single transaction or a series of related transactions) of twenty&#160;percent (20%) or more of any class of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">61</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">equity or voting securities of Avadel, (iii)&#160;scheme of arrangement, tender offer, takeover offer or exchange offer that, if consummated, would result in a person or group beneficially owning twenty&#160;percent (20%) or more of any class of equity or voting securities of Avadel or (iv)&#160;scheme of arrangement, merger, consolidation, share exchange, business combination, joint venture, reorganization, recapitalization or similar transaction involving Avadel or any of its subsidiaries, under which a person or group or, in the case of clause (B)&#160;below, the shareholders or equityholders of any person or group would, directly or indirectly, (A)&#160;acquire assets equal to twenty&#160;percent (20%) or more of the consolidated assets of Avadel, or to which twenty&#160;percent (20%) or more of the revenues or earnings of Avadel on a consolidated basis are attributable for the most recent fiscal year for which audited financial statements are then available or (B)&#160;immediately after giving effect to such transactions, beneficially own twenty&#160;percent (20%) or more of any class of equity or voting securities of Avadel or the surviving or resulting person (including any parent person) in such transaction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Transaction Agreement provides that a &#8220;Avadel Superior Proposal&#8221; means any bona fide, written Avadel Alternative Proposal (other than an Avadel Alternative Proposal which has resulted from a breach of the Transaction Agreement) (with all references to &#8220;twenty&#160;percent (20%)&#8221; in the definition of Avadel Alternative Proposal being deemed to be references to &#8220;fifty&#160;percent (50%)&#8221;) on terms that the Avadel Board determines in good faith, after consultation with its financial advisor(s) and outside legal counsel, and taking into account all the terms and conditions of the Avadel Alternative Proposal that the Avadel Board reasonably considers to be appropriate (including the financial terms of the proposal, the identity of the person making the Avadel Alternative Proposal and the expected timing and likelihood of consummation, any governmental or other approval requirements (including divestitures and entry into other commitments and limitations), break-up fees, expense reimbursement provisions, conditions to consummation and availability of necessary financing), would result in a transaction that (i)&#160;if consummated, is more favorable to the Avadel Shareholders (in their capacity as such) from a financial point of view than the Transaction (taking into account any proposal by Alkermes to amend the terms of the Transaction Agreement) and (ii)&#160;is reasonably capable of being completed on the terms proposed on a timely basis and (iii)&#160;for which financing, if a cash transaction (whether in whole or in part) is reasonably determined to be available by the Avadel Board. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Transaction Agreement provides that a &#8220;Avadel Intervening Event&#8221; means any material event, fact, change, effect, development or occurrence arising or occurring after the date of the Transaction Agreement that (i)&#160;was not known or reasonably foreseeable, or the material consequences of which were not known or reasonably foreseeable, in each case to the Avadel Board as of or prior to the date of the Transaction Agreement, (ii)&#160;does not relate to any Avadel Alternative Proposal, (iii)&#160;does not relate to Alkermes or any of its subsidiaries and (iv)&#160;does not relate to the achievement of, or failure to achieve, the Milestone (as defined in the CVR Agreement). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The obligations of the parties under the Transaction Agreement are subject in all respects to the parties&#8217; obligations under the Irish Takeover Rules. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Efforts to Consummate</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to the terms and conditions of the Transaction Agreement, each of Avadel and Alkermes agreed to, and agreed to cause its subsidiaries to, use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable, to the extent permitted by applicable law, to achieve satisfaction of the closing conditions described below and to consummate the Transaction and the other transactions contemplated by the Transaction Agreement as promptly as reasonably practicable and in any event on or before the End Date, including using reasonable best efforts to (x)&#160;prepare and file as promptly as reasonably practicable with any governmental entity or other third party all documentation to effect all filings (and thereafter make any other required or appropriate submissions) as are necessary, proper or advisable to consummate the Transaction and the other transactions contemplated by the Transaction Agreement, including Avadel and Alkermes as applicable each making as promptly as reasonably practicable, but in no event later than twenty (20) business days after the date of the Transaction Agreement (unless the parties mutually agree otherwise), an appropriate filing of a notification and report form pursuant to the HSR Act with the FTC and the Antitrust Division of the DOJ with respect to the Transaction and the other transactions contemplated by the Transaction Agreement and requesting </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">62</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">early termination of the waiting period under the HSR Act and (y)&#160;obtain prior to the End Date, and thereafter maintain, all clearances required to be obtained from any governmental entity in connection with any filing or submission to any governmental entity and any investigation or other inquiry (including any litigation) by or before any governmental entity that are necessary and advisable to consummate the Transaction or other transactions contemplated by the Transaction Agreement, and complying with the terms and conditions of each clearance. Each of Avadel, Alkermes, and their respective subsidiaries will promptly provide any supplemental information or documentation requested by any governmental entity (including, but not limited to, supplying as promptly as reasonably practicable any additional information and documentary material that may be requested pursuant to the HSR Act or other applicable antitrust law or foreign investment law). Avadel will provide all information reasonably required to enable Alkermes to make such filings and to achieve the fulfilment of the conditions precedent and cooperate with Alkermes in its efforts to comply with its obligations under the Transaction Agreement, including in seeking to obtain any required clearances, including defending (but without any obligation to commence) any action commenced by any governmental entity in connection with the transactions contemplated by the Transaction Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Alkermes and Avadel will jointly (i)&#160;direct, devise and implement the strategy for obtaining any necessary approval of and submitting filings to, for responding to any request from, inquiry or investigation by (including directing the timing, nature and substance of all such responses), and will have the right to co-lead all meetings and communications (including any negotiations) with, any governmental entity that has authority to enforce any antitrust law, and (ii)&#160;control the defense and settlement of any action brought by or before any governmental entity that has authority to enforce any antitrust law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding anything in the Transaction Agreement to the contrary, the parties agree that none of Alkermes nor any of its subsidiaries or affiliates will be required to propose, agree to, commit to or effect any action (or refrain or cause to refrain from taking any action) (including, in each case, any divestiture, hold separate arrangement, licensing of rights, or termination, assignment, novation or modification of contracts (or portions thereof) or other business relationships), restriction, commitment, condition, contingency, contribution, cost, expense, liability, limitation, loss, obligation, payment, requirement or term, with respect to any asset, operation, division, business, product line or business relationship of Alkermes, Avadel or any of their respective subsidiaries, in each case as a condition to, or in connection with, (i) the expiration or termination of any applicable waiting period relating to the Transaction under the HSR Act, (ii) obtaining any clearance under any other applicable antitrust laws or foreign investment laws or (iii) obtaining any other clearance from a governmental entity or otherwise.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The parties further agree that Avadel will not, and will cause its subsidiaries not to, take any of the foregoing actions with respect to Avadel or any of its subsidiaries unless consented to in writing by Alkermes, which includes taking or committing to take actions that limit Alkermes or any of its subsidiaries (including Avadel following the Effective Time), as applicable, freedom of action with respect to, or their ability to retain, any of the businesses, employees, or assets of Avadel, and Alkermes and its affiliates shall not be required to commit to any provision (in any consent decree or otherwise) requiring the prior approval of a governmental entity to engage, or agree not to engage in any present or future transaction involving Alkermes or any of its affiliates; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, notwithstanding the foregoing, Alkermes shall defend through litigation on the merits any claim asserted in court or through administrative tribunal by any governmental entity under any applicable antitrust law that would prevent the closing from occurring prior to the End Date, it being understood that, notwithstanding the foregoing, Alkermes shall have the right to direct, devise and control such litigation.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From the date of the Transaction Agreement through the earlier of the termination of the Transaction Agreement or the closing of the Transaction, Alkermes will not, and will cause its subsidiaries and affiliates not to, acquire or agree to acquire, by merging or consolidating with, or by purchasing a substantial portion of the assets of or equity interests in, or by any other manner outside the ordinary course of business, any person or entity that has an asset or program in clinical development or approved for narcolepsy or idiopathic hypersomnia and that would reasonably be expected to (i)&#160;materially delay or materially impede the receipt of any authorizations, consents, orders, declarations or approvals of any governmental entity necessary to close the Transaction and the other transactions contemplated by the Transaction Agreement or (ii)&#160;materially delay the closing of the Transaction and the other transactions contemplated by the Transaction Agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">63</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCVR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The CVR Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At or prior to the Effective Time, Alkermes and the Rights Agent will enter into the CVR Agreement governing the terms of the CVRs to be issued to Avadel Shareholders and holders of Avadel equity awards pursuant to the terms of the Transaction Agreement. Holders of CVRs will not be permitted to transfer CVRs (subject to certain limited exceptions). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each CVR represents a non-transferrable contractual right to receive the Milestone Payment, in cash, without interest, subject to any applicable withholding taxes, upon the occurrence prior to the Milestone Expiration of each of: (i)&#160;final approval by the FDA of an application submitted to the FDA for the commercial marketing and sale of LUMRYZ</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> in the United States for the treatment of idiopathic hypersomnia in adults; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that, such approval shall be deemed achieved upon receipt of written notice from the FDA that LUMRYZ</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> has been approved for the treatment of idiopathic hypersomnia in adults in the United States and which is not blocked by any third party orphan-drug exclusivity, regardless of whether any risk evaluation and mitigation strategies or other conditions are imposed by the FDA; and (ii)&#160;the dismissal of certain specified claims with prejudice by the United States District Court for the District of Delaware pursuant to the Settlement Agreement. If the FDA has issued one or more orders that impose a clinical hold on the investigation of LUMRYZ for the treatment of idiopathic hypersomnia in adults, the Milestone shall not be deemed achieved unless or until no such order is in effect. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;27, 2025, the Legal Event was deemed to have occurred pursuant to the dismissal with prejudice of the certain specified claims by the United States District Court for the District of Delaware, in accordance with the terms of the Settlement Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="font-weight:normal;letter-spacing:0.2pt;">The CVRs are contractual rights only and not transferable except under certain limited circumstances, will not be certificated or evidenced by any instrument and will not be registered with the SEC or listed for trading. The CVRs will not have any voting or dividend rights and will not represent any equity or ownership interest in Alkermes, Avadel or any of their affiliates. </font><font style="letter-spacing:-0.2pt;">There can be no assurance that the Milestone will be achieved prior to the Milestone Expiration or termination of the CVR Agreement, or that the Milestone Payment will be made. CVRs are complex instruments and a number of factors will determine whether any amount will actually be paid to Avadel Shareholders in accordance with the terms of the CVRs. If the Milestone does not occur by the Milestone Expiration then the CVRs will have no value. The minimum payment under each CVR is zero and the maximum payment under each CVR is $1.50, settleable in cash, without interest and subject to applicable withholding taxes.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Financing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel is required to use its reasonable best efforts, and to cause each of its subsidiaries to use its reasonable best efforts, and its and their respective officers, employees and advisors and other representatives, including legal advisors and accountants, to provide Alkermes and its subsidiaries such assistance as may be reasonably requested by Alkermes that is customary in connection with the offering, arranging, obtaining, syndication, consummation, issuance or sale of Alkermes&#8217; debt financing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The consummation of the Transaction is not conditioned upon the consummation of, or the receipt by Alkermes of proceeds from, any debt financing. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conduct of Business Pending the Completion</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From the date of the Transaction Agreement until the earlier of the Completion or termination of the Transaction Agreement, except as may be prohibited or required by law, the Transaction Agreement or as set forth in the disclosure schedules to the Transaction Agreement, without Alkermes&#8217; prior written consent (such consent not to be unreasonably withheld, conditioned or delayed), Avadel has agreed to, and will cause each of its subsidiaries to, conduct its business in the ordinary course of business consistent with past practice in all material respects and in compliance in all material respects with all applicable laws and to use commercially reasonable efforts to preserve intact its business organization and relationships with customers, suppliers, licensors, licensees, governmental entities and other third parties, keep available the services of its present officers and employees, and timely file all reports, schedules, forms, statements and other documents required to be filed with the SEC and by the Securities Act of 1933, as amended, and none </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">64</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of the documents filed by Avadel with the SEC after the date of the Transaction Agreement will, at the time filed (or, if amended or supplemented, at the time of such amendment or supplement), contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel has also agreed that, except as may be prohibited or required by law or the Transaction Agreement or as set forth in the disclosure schedules to the Transaction Agreement, without Alkermes&#8217; prior written consent (such consent not to be unreasonably withheld, conditioned or delayed), Avadel will not, and will not permit any of its subsidiaries to, undertake the following actions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">adopt or propose any change to its organizational documents (whether by merger, consolidation or otherwise); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">merge or consolidate with any other person, or acquire (including by merger, consolidation or acquisition of stock or assets) any interest in any corporation, partnership, other business organization or any division or business thereof or any assets, securities or property, other than (1)&#160;transactions (x)&#160;solely among Avadel and one or more of its wholly owned subsidiaries or (y)&#160;solely among Avadel&#8217;s wholly owned subsidiaries or (2)&#160;acquisitions of inventory or equipment in the ordinary course of business consistent with past practice or (B)&#160;adopt a plan of complete or partial liquidation, dissolution, recapitalization or restructuring; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(A) split, combine or reclassify any shares of its capital stock, (B)&#160;amend any term or alter any rights of any of its outstanding equity securities, (C)&#160;declare, set aside or pay any dividend or make any other distribution (whether in cash, stock, property or any combination thereof) in respect of any equity securities, other than dividends or distributions by a subsidiary of Avadel to Avadel or its wholly owned subsidiary, or (D)&#160;redeem, repurchase, cancel or otherwise acquire or offer to redeem, repurchase or otherwise acquire any of its equity securities or any equity securities of any subsidiary of Avadel, other than repurchases or withholding of Avadel Shares in connection with the exercise of Avadel Options or the vesting or settlement of Avadel RSU Awards or Avadel Restricted Stock Awards (including in satisfaction of any amounts required to be deducted or withheld under applicable law) in accordance with the terms of such Avadel equity awards outstanding as of the date of the Transaction Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">issue, deliver or sell, or authorize the issuance, delivery or sale of, any equity securities, other than (A)&#160;the issuance of any Avadel Shares upon the exercise of Avadel Options or any Avadel Shares in connection with any offering period in existence under the Avadel ESPP, the accrual of any dividend equivalents under any dividend equivalent rights applicable to any Avadel equity awards, or the vesting or settlement of the Avadel RSU Awards or Avadel Restricted Stock Awards or the withholding of Avadel Shares to satisfy tax (or other mandatory withholding) obligations pertaining to the exercise of Avadel Options or the vesting or settlement of Avadel equity awards or to satisfy the exercise price with respect to Avadel Options or to effectuate an optionee direction upon exercise of Avadel Options that, in each case, are outstanding as of the date of the Transaction Agreement (in accordance with their existing terms as of the date hereof), (B)&#160;transactions with respect to equity securities of any subsidiary of Avadel or (C)&#160;in connection with transactions (1)&#160;solely among Avadel and one or more of its wholly owned subsidiaries or (2)&#160;solely among Avadel&#8217;s wholly owned subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">make any capital expenditure or incur any obligations or liabilities in connection therewith in an aggregate amount in excess of $650,000; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">sell, lease, license, transfer or otherwise dispose of any subsidiary of Avadel or any division, assets, securities or properties of Avadel or its subsidiaries, other than (A)&#160;sales or dispositions of inventory, goods, services, tangible personal property (including equipment), in each case in the ordinary course of business consistent with past practice, (B)&#160;transactions (1)&#160;solely among Avadel and one or more of its wholly owned subsidiaries or (2)&#160;solely among Avadel&#8217;s wholly owned subsidiaries or (C)&#160;any non-exclusive license of intellectual property granted in the ordinary course of business consistent with past practice to (x)&#160;customers, (y)&#160;distributors and (z)&#160;service providers solely in connection with the performance of services or manufacture of products for Avadel or its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">65</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">sell, assign, license (including sublicense), fail to diligently prosecute or maintain, waive, abandon, allow to lapse, transfer or otherwise dispose of, or create or incur any lien (other than a permitted lien) on, any intellectual property, other than (A)&#160;non-exclusive licenses granted in the ordinary course of business consistent with past practice to (1)&#160;customers, (2)&#160;distributors and (3)&#160;service providers solely in connection with the performance of services or manufacture of products for Avadel or is subsidiaries or (B)&#160;for the purpose of abandoning, allowing to lapse or otherwise disposing of immaterial, obsolete or worthless assets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(A) make any loans, advances or capital contributions to, or investments in, any other person, other than (1)&#160;loans, advances, capital contributions or investments (a)&#160;by Avadel to or in, as applicable, one or more of its wholly owned subsidiaries or (b)&#160;by any subsidiary of Avadel to or in, as applicable, Avadel or any wholly owned subsidiary of Avadel or (2)&#160;capital contributions required under the terms of contracts in effect as of the date hereof or (B)&#160;incur, assume, guarantee or repurchase or otherwise become liable for any indebtedness for borrowed money, issue or sell any debt securities or any options, warrants or other rights to acquire debt securities (in each case, whether, directly or indirectly, on a contingent basis or otherwise) or enter into any interest rate or currency swaps, forward currency or interest rate contracts or other interest rate or currency hedging arrangements, other than (1)&#160;borrowings under Avadel&#8217;s or its subsidiaries&#8217; existing credit facilities (as in effect as of the date hereof) in accordance with the terms thereof, provided that any such activities incurred in accordance with this provision do not have a material adverse tax consequence, individually or in the aggregate, with respect to Avadel or any of its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">create or incur any lien (other than a permitted lien) on any material assets or properties, other than liens that may be discharged at or prior to the closing of the Transaction that are not material in amount or effect on the business of Avadel or its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(A) enter into any material contract (including by amendment of any contract or agreement that is not a material contract such that such contract or agreement becomes a material contract), other than in the ordinary course of business consistent with past practice (</font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that certain material contracts described in the Transaction Agreement must not be entered into without the prior written consent of Alkermes (which will not be unreasonably withheld, conditioned or delayed)) or (B)&#160;terminate, renew, extend or in any material respect modify or amend (including waiving, releasing or assigning any material right or claim thereunder) any material contract, other than in the ordinary course of business consistent with past practice or any termination, renewal, extension, modification or amendment that occurs automatically in accordance with the terms of any such material contract without any action by Avadel or its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">terminate, fail to renew, suspend, abrogate, amend or modify any material permit held by Avadel in a manner material and adverse to Avadel and its subsidiaries, taken as a whole; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">except as required pursuant to the terms of an existing employee plan or employee agreement, (A)&#160;grant (or increase the value of) any change in control, equity or equity-based awards, or severance, termination or similar pay, to (or amend any existing arrangement with) any current or former director, officer, employee or individual independent contractor of Avadel or any of its subsidiaries, (B)&#160;enter into any employment, deferred compensation, severance or other similar agreement (or any elective extension of, or amendment to, any such existing agreement) with any current or former director, officer, employee or individual independent contractor of Avadel, other than employment agreements with newly hired employees reviewed and approved by Alkermes (</font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that such approval will not be unreasonably withheld), (C)&#160;establish, adopt, enter into, amend or terminate any employee plan or employee agreement (or any plan, program, policy, scheme, trust, fund, practice, agreement or arrangement that would be an employee plan or employee agreement if in effect on the date hereof) (including any union or works council agreement), provided that, notwithstanding this clause (C), Avadel and its subsidiaries may renew any health and welfare plans in the ordinary course of business consistent with past practice, so long as such renewals will not materially increase the cost of administering or maintaining such employee plan or employee agreement, (D)&#160;increase or accelerate the payment, vesting or funding of, the incentive, equity or equity-based awards, bonus opportunity or other compensation payable under any employee plan or employee agreement or otherwise, (E)&#160;terminate (other than for &#8220;cause&#8221;) any individual who is at the time of termination </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">66</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">above the level of executive director or (F)&#160;increase the wages, salary or other compensation or benefits with respect to any current or former director, officer, employee or individual independent contractor of Avadel; </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">make any material change in any method of financial accounting or financial accounting principles or practices, except for any such change required by reason of (or, in the reasonable good-faith judgment of Avadel, advisable under) a change in GAAP or applicable law or SEC policy; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(A) make, change or revoke any material tax election; (B)&#160;file any amended tax return; (C)&#160;waive or extend any statute of limitations with respect to any assessment or determination of material taxes; (D)&#160;adopt or change (or request to change) any material method of tax accounting or tax accounting period; (E)&#160;enter into any material &#8220;closing agreement&#8221; as described in Section&#160;7121 of the Code (or any corresponding or similar provision of state, local or non-U.S. tax law) or other binding written agreement with any tax authority or any tax sharing, allocation or similar agreement; (F)&#160;apply for any material tax ruling; or (G)&#160;settle, compromise or surrender any material tax claim, liability, audit, assessment or refund for an amount in excess of reserves therefor on the financial statements of Avadel and its subsidiaries (</font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that no term of such settlement, compromise or surrender would increase the tax liability of Alkermes, Avadel or their respective subsidiaries following the closing); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">settle or compromise, or propose to settle or compromise, any legal action involving or against Avadel or any of its subsidiaries (including any action involving or against any officer or director of Avadel or any of its subsidiaries in their capacities as such); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">commence any legal action, other than in connection with a breach of the Transaction Agreement or any other agreements contemplated by the Transaction Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">fail to maintain in full force and effect Avadel&#8217;s insurance policies or replacement or successor policies providing coverage in at least such amounts and against such risks as are currently in effect; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">enter into any collective bargaining agreement or other agreement with any labor organization or recognize or certify any labor union, works council or other labor organization as the bargaining representative for any employees of Avadel or its subsidiaries; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">agree, commit or propose to do any of the otherwise prohibited actions described above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel has also agreed to use commercially reasonable efforts to conduct clinical site audits as promptly as reasonably practicable following the date of the Transaction Agreement, and in any event prior to the unblinding of any clinical data.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Directors&#8217; and Officers&#8217; Indemnification and Insurance</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For a period of not less than six (6)&#160;years from the Effective Date, Alkermes will cause Avadel or any applicable subsidiary thereof, to the fullest extent authorized or permitted by applicable law as now or hereafter in effect, to fulfill and honor in all respects the obligations of Avadel to each person who is at the date of the Transaction Agreement, was previously, or during the period from the date of the Transaction Agreement through the date of the Effective Time, serving as a director or officer of Avadel or any of its subsidiaries, or at the request or for the benefit of Avadel or any of its subsidiaries as a director, trustee or officer of any other entity or any benefit plan maintained by Avadel or any of its subsidiaries (each referred to as an &#8220;indemnified party&#8221;) pursuant to (i)&#160;each indemnification agreement in effect between Avadel and/or any of its subsidiaries and any indemnified party as of the date thereof and (ii)&#160;all rights to indemnification, advancement of expenses and exculpation from liabilities for acts or omissions contained in Avadel&#8217;s organizational documents (as in effect on the date of the Transaction Agreement). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For a period of not less than six (6)&#160;years from the Effective Date, Alkermes will cause the organizational documents of Avadel to contain provisions no less favorable with respect to indemnification, advancement of expenses and limitations on liability of directors and officers than are set forth in the organizational documents of Avadel as of the date of the Transaction Agreement, which provisions will not be amended, repealed or otherwise modified for a period of at least six (6)&#160;years from the Effective Date in any manner that would adversely affect the rights thereunder of any indemnified party, unless any modification or amendment is required by applicable law (but then only to the extent required by applicable law). At </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">67</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s option and expense, prior to the Effective Time, Avadel may purchase (and pay in full the aggregate premium for) a six (6)-year prepaid &#8220;tail&#8221; insurance policy (which policy by its express terms will survive the Transaction) of at least the same coverage and amounts and containing terms and conditions that are no less favorable to the directors and officers of Avadel or any of its subsidiaries as Avadel&#8217;s and its subsidiaries&#8217; existing directors&#8217; and officers&#8217; insurance policy or policies with a claims period of six (6)&#160;years from the Effective Time for claims arising from facts, acts, events or omissions that occurred on or prior to the Effective Time; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the premium for such tail policy will not exceed two hundred and fifty&#160;percent (250%) of the annual amount currently paid by Avadel and its subsidiaries for such insurance. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employee Matters</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From the date of Completion through the earlier of the first anniversary of the Effective Time and the termination of the relevant Avadel employee (the &#8220;Benefits Continuation Period&#8221;), Alkermes will provide, or will cause its subsidiaries to provide each continuing Avadel employee with (i) an annual base salary or base wage rate (as applicable) and target annual cash bonus opportunity or target cash commissions opportunity that are no less favorable, in the aggregate, than the annual base salary or base wage rate applicable, and target annual cash bonus opportunity or target commissions opportunity in effect immediately prior to the Effective Time (provided that each Avadel employee&#8217;s annual base salary or base wage rate (as applicable) will also independently be no less than 95% of the annual base salary or base wage rate (as applicable) in effect immediately prior to the Effective Time), and (ii)&#160;employee pension and welfare benefits that are, in the aggregate, no less favorable than those provided to similarly-situated employees of Alkermes. For purposes of determining whether such employee benefits are no less favorable in the aggregate under clause (ii), any defined benefit pension plan benefits, nonqualified deferred compensation plans, subsidized retiree health or welfare benefits, post-termination health or welfare benefits and retention or change in control payments or awards will not be taken into account. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Alkermes will recognize continuing Avadel employees&#8217; length of employment with Avadel and its subsidiaries and predecessors prior to the Effective Time for purposes of vesting, eligibility to participate and determining level of benefits under their benefit plans providing benefits to continuing Avadel employees to the same extent and for the same purpose as such service was recognized under the corresponding Avadel benefit plans in which the continuing Avadel employee participated or was eligible to participate immediately prior to the Effective Time, except that length of employment will not be recognized with respect to (i)&#160;any defined benefit pension plan or any retiree or post-termination health or welfare benefits, (ii)&#160;any benefit plan that is frozen or for which participation is limited to a grandfathered population, (iii)&#160;any equity-based compensation arrangements or (iv)&#160;to the extent that its application would result in a duplication of benefits or compensation for the same period of service. Service will only be credited to the extent service with Alkermes is credited for similarly situated Alkermes employees under Alkermes benefit plans. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each continuing Avadel employee will be immediately eligible to participate, without any waiting time, in any and all Alkermes benefit plans to the extent coverage under such Alkermes benefit plan is replacing comparable coverage under an Avadel benefit plan in which such continuing Avadel employee had already satisfied any such waiting period and participated immediately before the Effective Time (such plans, collectively, the &#8220;Old Plans&#8221;) and for purposes of each Alkermes benefit plan providing medical, dental, pharmaceutical, vision or disability benefits to any continuing Avadel employee, Alkermes will use its reasonable best efforts to cause (i)&#160;all pre-existing condition exclusions and actively-at-work requirements of such Alkermes benefit plan to be waived for such employee and his or her covered dependents, unless and to the extent the individual, immediately prior to entry in the Alkermes benefit plans, was subject to such conditions under the comparable Old Plans and (ii)&#160;any eligible expenses incurred by such continuing Avadel employee and his or her covered dependents under the Old Plans during the portion of the plan year of the Old Plans ending on the date such Avadel employee&#8217;s participation in the corresponding Alkermes benefit plan begins to be taken into account under the Alkermes benefit plan for the purpose of satisfying all deductible, co-insurance and maximum out-of-pocket requirements applicable to such continuing Avadel employee and his or her covered dependents for such plan year under any Alkermes benefit plan, as if such amounts had been paid in accordance with such new benefit plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel will use commercially reasonably efforts to coordinate in advance with Alkermes prior to the Effective Time regarding any communication with any continuing Avadel employee relating to compensation </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">68</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="CCTPP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or benefits to be provided subsequent to the Effective Time, and any such communication shall be subject to Alkermes&#8217; prior reasonable review and comment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prior to the Effective Time, the Avadel Board (or the appropriate committee thereof) will take all actions necessary to effect the following: (i)&#160;the Avadel ESPP will be frozen and suspended during the offering period that is in progress as of the date of the Transaction Agreement and no new offering periods will commence under the Avadel ESPP at any time on or after the date of the Transaction Agreement, (ii)&#160;no new participants will be permitted into the Avadel ESPP after the date of the Transaction Agreement, (iii)&#160;no current participants in the Avadel ESPP will be permitted to increase their payroll deduction elections or rate of contributions from those in effect on the date of the Transaction Agreement or make any separate non-payroll contributions to the Avadel ESPP, (iv)&#160;the then-current offering period that is in progress as of the Effective Time under the Avadel ESPP will be accelerated to a date on or prior to the Completion, and each participant&#8217;s accumulated payroll deductions will be used to purchase Avadel Shares in accordance with the terms of the Avadel ESPP, (v)&#160;any accumulated payroll deductions that are not used to purchase Avadel Shares shall be promptly refunded (without interest, to the extent permitted by applicable law) to the applicable participant and (vi)&#160;the Avadel ESPP will terminate immediately prior to, and contingent upon, the Effective Time. At the Effective Time, each outstanding Avadel Share issued under the Avadel ESPP will be treated the same as all other Avadel Shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conditions to the Completion of the Transaction</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Transaction is conditioned on the Scheme becoming effective and unconditional by not later than the End Date (or such earlier date as may be specified by the Irish Takeover Panel, or such later date as Alkermes and Avadel may, subject to receiving the consent of the Irish Takeover Panel and the Irish High Court, in each case if required, agree). In addition, the Scheme will lapse unless it is effective on or prior to the End Date (or such earlier date as may be specified by the Irish Takeover Panel, or such later date as Alkermes and Avadel may, subject to receiving the consent of the Irish Takeover Panel and the Irish High Court, in each case if required, agree). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Alkermes reserves the right, subject to the consent of the Irish Takeover Panel (if required), to effect the Transaction by way of a Takeover Offer. In the event the Transaction is structured as a Takeover offer, such offer will be implemented on terms and conditions that are at least as favorable to the Avadel Shareholders and the Avadel equity award holders as those which would apply in relation to the Scheme (except for an acceptance condition set at eighty&#160;percent (80%) of the nominal value of the Avadel Shares to which such offer relates and which are not already beneficially owned by Alkermes, or such lesser&#160;percentage (being more than fifty&#160;percent (50%)), as Alkermes may, with the consent of Avadel and the Irish Takeover Panel (if required) decide). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Mutual Conditions Precedent to the Scheme</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Scheme will be conditional upon: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the passing of the Scheme Meeting Resolution at the Scheme Meeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the passing of the Scheme Approval Resolution and Articles of Association Amendment Resolution at the EGM; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the sanction of the Scheme by the Irish High Court (the date on which this condition is satisfied, the &#8220;Sanction Date&#8221;); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a copy of the order of the Irish High Court sanctioning the Scheme having been delivered for registration to the Irish Registrar of Companies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Mutual Conditions Precedent to the Transaction</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel and Alkermes have agreed that the Transaction will also be conditional upon the following matters having been satisfied or waived on or before the Sanction Date: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the waiting period under the HSR Act having expired or having been earlier terminated and, to the extent applicable, any agreement between Avadel and Alkermes, on the one hand, and the FTC or the </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">69</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTOTTP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Antitrust Division of the DOJ, on the other hand, not to consummate the Scheme or the Transaction having expired or been earlier terminated; </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">no government entity of competent jurisdiction having enacted, issued, promulgated, enforced or entered any law or order (whether temporary, preliminary or permanent) that is in effect and restrains, enjoins, makes illegal or otherwise prohibits the consummation of the Transaction; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Transaction Agreement not having been terminated in accordance with its terms. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conditions Precedent to the Obligations of Alkermes to the Transaction</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Alkermes&#8217; obligation to effect the Transaction will also be conditional upon the following matters having been satisfied (or, to the extent permitted by applicable law, waived by Alkermes): </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">from the date of the Transaction Agreement to the Sanction Date, there having not been any event or occurrence that has or would reasonably be expected to have, a material adverse effect; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the accuracy of Avadel&#8217;s representations and warranties set forth in the Transaction Agreement, subject to certain materiality and material adverse effect exceptions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the performance by Avadel, in all material respects, with all of its covenants and agreements under the Transaction Agreement; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Alkermes having received a certificate from an executive officer of Avadel confirming the satisfaction of the conditions set forth in the second and third bullet notes above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conditions Precedent to the Obligations of Avadel to the Transaction</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s obligation to effect the Transaction will also be conditional upon the following matters having been satisfied (or, to the extent permitted by applicable law, waived by Avadel): </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">from the date of Transaction Agreement to the Sanction Date, there having not been any event or occurrence that has or would reasonably be expected to have, a material adverse effect; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the accuracy of Alkermes&#8217; representations and warranties set forth in the Transaction Agreement, subject to certain materiality and material adverse effect exceptions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the performance by Alkermes, in all material respects, with all of its covenants and agreements under the Transaction Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel having received a certificate from an executive officer of Alkermes confirming the satisfaction of the conditions set forth in the second and third bullet notes above; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the CVR Agreement being in full force and effect. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Survival of Representations and Warranties</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">None of the representations and warranties of the Transaction Agreement will survive the consummation of the Transaction or the termination of the Transaction Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Termination of the Transaction Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Transaction Agreement may be terminated at any time prior to the Effective Time in any of the following ways: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">by either Avadel or Alkermes: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if the Scheme Meeting has been completed and the Scheme Meeting Resolution has not been approved by the requisite vote and/or the EGM has been completed and the Scheme Approval Resolution and the Articles of Association Amendment Resolution have not been approved by the requisite votes (a &#8220;Non-Approval Termination&#8221;); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if the Transaction has not been consummated by 5:00&#160;p.m., New York City time, on the End Date (except that the right to terminate the Transaction Agreement pursuant to this provision is </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">70</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tREIPAYP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:50pt; width:406pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">not available to a party whose breach of any provision of the Transaction Agreement is the primary cause of the failure of the Transaction to be consummated by such date); </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if the Transaction is implemented by way of the Scheme, the Irish High Court declines or refuses to sanction the Scheme, unless both parties agree in writing within thirty (30) days of such decision that the decision of the Irish High Court will be appealed (it having been agreed that Avadel will make such an appeal if requested to do so in writing by Alkermes and the counsel appointed by Alkermes and Avadel agree that doing so is a reasonable course of action); or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if there is in effect any applicable law, or final and non-appealable order, writ, decree, judgment, award, injunction, ruling, settlement or stipulation issued, promulgated, made, rendered or entered into by any court or other tribunal of competent jurisdiction, that permanently restrains, enjoins or otherwise prohibits the consummation of the Transaction (except that the right to terminate the Transaction Agreement pursuant to this provision is not available to any party whose material breach of any provision of the Transaction Agreement was the primary cause of such law, order, writ, decree, judgment or injunction); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">by Avadel: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if Alkermes breaches or fails to perform in any material respect any of its covenants or other agreements contained in the Transaction Agreement or if any of its representations or warranties set out in the Transaction Agreement are inaccurate such that the breach, failure to perform or inaccuracy (1)&#160;would result in the failure of certain closing conditions and (2)&#160;is not reasonably capable of being cured by the End Date or, if curable, is not cured by the earlier of (x)&#160;the End Date and (y)&#160;thirty (30) days following written notice by Avadel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">prior to obtaining the required approvals of the Avadel Shareholders at the Scheme Meeting and the EGM, if (1)&#160;the Avadel Board authorized Avadel to terminate the Transaction Agreement in response to an Avadel Superior Proposal and (2)&#160;substantially concurrently with such termination, a definitive agreement providing for the consummation of such Avadel Superior Proposal is duly executed and delivered by all parties thereto and Avadel pays Alkermes the Reimbursement Payments (as defined below) (the &#8220;Superior Proposal Termination&#8221;); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">by Alkermes: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if Avadel breaches or fails to perform in any material respect any of its covenants or other agreements contained in the Transaction Agreement or if any of its representations or warranties set out in the Transaction Agreement are inaccurate such that the breach, failure to perform or inaccuracy (1)&#160;would result in the failure of certain closing conditions and (2)&#160;is not reasonably capable of being cured by the End Date or, if curable, is not cured by the earlier of (x)&#160;the End Date and (y)&#160;thirty (30) days following written notice by Alkermes thereof (an &#8220;Avadel Breach Termination&#8221;); or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">prior to obtaining the required approvals of the Avadel Shareholders at the Scheme Meeting and the EGM, if (1)&#160;an Avadel Board Change of Recommendation has occurred (an &#8220;Avadel Change of Recommendation Termination&#8221;). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">by mutual written consent of Avadel and Alkermes, subject to the consent of the Irish Takeover Panel (if required). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reimbursement Payment</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Transaction Agreement provides that, in the event of a termination of the Transaction Agreement as described in this section, Avadel will reimburse Alkermes for an amount equal to the documented, specific, costs and expenses incurred, directly or indirectly, by Alkermes or its subsidiaries in connection with the Transaction, together with any irrecoverable tax incurred by Alkermes or its subsidiaries and imposed by any member state of the European Union on the common system of value added tax (2006/112/EC) and any tax similar to or replacing the same, subject to a cap equal to one&#160;percent (1%) of the aggregate value of the total Cash Consideration payable with respect to the Avadel Shares in connection with the Transaction (the &#8220;Reimbursement Payment&#8221;), in immediately available funds within seven (7)&#160;business days following </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">71</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s receipt of invoices or written documentation supporting Alkermes&#8217; request for a Reimbursement Payment. The reimbursement payment is owed if one of the following events occurs: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Transaction Agreement is terminated by Alkermes pursuant to an Avadel Change of Recommendation Termination; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Transaction Agreement is terminated by Avadel pursuant to a Superior Proposal Termination; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">all of the following occur: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Transaction Agreement is terminated (x)&#160;by Alkermes pursuant to an Avadel Breach Termination as a result of a material breach or failure to perform any covenant or agreement in the Transaction Agreement such that certain conditions to closing would not be satisfied (except with respect to a breach of the provisions described in&#8201;&#8212;&#8201;</font><font style="font-style:italic;letter-spacing:0.2pt;">Third Party Acquisition Proposals</font><font style="letter-spacing:0.2pt;">) that first occurred following the making of an Avadel Alternative Proposal of the type referenced in the next bullet point below or (y)&#160;by Alkermes or Avadel pursuant to a Non-Approval Termination (but if such termination is by Avadel at such time Alkermes would be permitted to terminate the Transaction Agreement); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">prior to the date of such termination, an Avadel Alternative Proposal is publicly disclosed or announced and not withdrawn (or, in the case of an Avadel Breach Termination as a result of a material breach or failure to perform any covenant or agreement in the Transaction Agreement, was made publicly or privately to the Avadel Board), or any person has publicly announced an intention (whether or not conditional) to make an Avadel Alternative Proposal that has not been withdrawn at least three (3)&#160;business days prior to the EGM; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(x) an Avadel Alternative Proposal is consummated within twelve (12) months after such termination or (y)&#160;a definitive agreement providing for an Avadel Alternative Proposal is entered into within twelve (12) months after such termination and is subsequently consummated (it being understood that, for purposes of the foregoing provisions, references to &#8220;twenty&#160;percent (20%)&#8221; in the definition of Avadel Alternative Proposal will be deemed to refer to &#8220;fifty&#160;percent (50%)&#8221;). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Expenses</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in the Transaction Agreement, all costs and expenses incurred in connection with the Transaction will be paid by the party incurring such cost or expense, except the following: (i)&#160;the Irish Takeover Panel&#8217;s document review fees will be paid by Alkermes, (ii)&#160;the costs associated with the filing, printing, publication and posting of the Rule&#160;2.7 Announcement will be paid by Alkermes, (iii)&#160;the costs associated with the filing, printing, publication and proposing of the Scheme Document, proxy statement and any other materials required to be proposed to Avadel Shareholders pursuant to SEC rules, the Companies Act or the Irish Takeover Rules will be paid by Avadel, (iv)&#160;the filing fees incurred in connection with notifications with any governmental entities under any antitrust laws, will be paid by Alkermes and (v)&#160;the cost incurred in connection with soliciting proxies in connection with the Scheme Meeting and the EGM will be paid by Avadel. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Amendment and Waiver</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Transaction Agreement may not be amended except by an instrument in writing signed by each of the parties, except that following approval of the Scheme by the Avadel Shareholders there will be no further amendment which by applicable law would require further approval by the Avadel Shareholders without such further approval nor will there be any amendment or change not permitted under applicable law. Furthermore, certain provisions of the Transaction Agreement may not be amended without the prior written consent of sources of financing for the Transaction. No delay or omission by either party to the Transaction Agreement in exercising any right, power or remedy provided by law or under the Transaction Agreement will operate as a waiver. The exercise or partial exercise of any right, power or remedy provided by law or under the Transaction Agreement will not preclude any other or further exercise of it or the exercise of any other right, power or remedy. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">72</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:328pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Specific Performance; Third-Party Beneficiaries</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The parties agreed in the Transaction Agreement that irreparable harm would occur and that the parties would not have any adequate remedy at law for any breach of any of the provisions of the Transaction Agreement or in the event that any provisions of the Transaction Agreement were not performed in accordance with their specific terms. Except where the Transaction Agreement is validly terminated, as described above, each party is entitled to seek an injunction or injunctions to prevent breaches or threatened breaches of the Transaction Agreement and to specifically enforce the terms and provisions of the Transaction Agreement, without proof of actual damages, and each party agreed to waive any requirement for the securing or posting of any bond in connection with such remedy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Transaction Agreement is not intended to confer upon any person other than Avadel and Alkermes any rights or remedies, with the exception of the rights of the specified directors, officers and employees to certain indemnification and insurance, certain rights provided to the financing sources of Alkermes in the Transaction Agreement, the rights of CVR holders after the Effective Time to receive payment and the rights of Avadel Shareholders and equity award holders solely to the extent necessary to receive the Cash Consideration.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Governing Law</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Transaction Agreement and all actions based upon, arising out of or related to the Transaction Agreement or the transactions contemplated thereby will be governed by, and construed in accordance with, the laws of the State of Delaware; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that the Scheme and matters related thereto (including matters related to the Irish Takeover Rules) will to the extent required by the laws of Ireland, and the interpretation of the duties of directors of Avadel shall, be governed by, and construed in accordance with, the laws of Ireland. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">73</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFRTT1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:96pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">FINANCING RELATING TO THE TRANSACTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Alkermes estimates that it will need approximately $2.1 billion in order to pay Avadel Shareholders the Cash Consideration due to them under the Transaction Agreement and to pay related fees, costs, expenses and other transaction costs in connection with the acquisition. Alkermes anticipates that the funds needed to pay the foregoing amount will be derived from a combination of (i)&#160;cash on hand and (ii)&#160;borrowings under credit facilities, including as described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">J.P. Morgan Securities LLC, lead financial advisor to Alkermes, is satisfied that sufficient resources are available to satisfy in full the Cash Consideration payable to Avadel Shareholders under the terms of the Transaction Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Bridge Credit Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;22, 2025, Alkermes entered into the Bridge Credit Agreement among Alkermes, the other loan parties from time to time party thereto, certain lenders from time to time party thereto and JPMorgan Chase Bank, N.A. as administrative agent. Under the Bridge Credit Agreement, the lenders party thereto have committed to provide Alkermes with secured bridge financing in an aggregate principal amount of $1,231,459,813.22. The commitments are intended to be available to finance, in part, the cash component of the Scheme Consideration and fees and expenses related to the Transaction. Subject to the conditions in the Bridge Credit Agreement, Alkermes intends to replace commitments or the borrowings, as applicable, under the Bridge Credit Agreement by accessing the loan markets prior to or following the closing of the Transaction. The entry by Alkermes into any credit facilities to replace the Bridge Credit Agreement would be subject to market and other conditions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Summary of Terms of the Bridge Credit Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The funding of the loans under the Bridge Credit Agreement is conditioned on, among other things, the consummation of the transaction and the absence of certain events of default described in the Bridge Credit Agreement. The commitments under the Bridge Credit Agreement will automatically terminate on the earliest of (a)&#160;11:59&#160;pm (Dublin time) on the date on which the consideration payable in respect of the Transaction has been paid in full without the making of any advances under the Bridge Credit Agreement, (b)&#160;11:59&#160;pm (Dublin time) on the Effective Date after giving effect to the making of advances under the Bridge Credit Agreement, and (c)&#160;the date on which certain mandatory cancellation events have occurred or first exist including, subject to certain exceptions, if the Transaction has not been consummated by the End Date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The borrowers may voluntarily prepay the loans or reduce the commitments under the Bridge Credit Agreement at any time without premium or penalty. The Bridge Credit Agreement also requires mandatory prepayments and commitment reductions, as applicable, with the net cash proceeds received by Alkermes in connection with certain asset sales, debt or equity issuances and recovery events, subject to customary exceptions. The Bridge Credit Agreement also contains customary events of default, upon the occurrence of which, and for so long as such event of default is continuing, the amounts outstanding under the Bridge Credit Agreement could be accelerated by the lenders. In addition, the loan parties under the Bridge Credit Agreement are subject to certain affirmative and negative and, following the Certain Funds Period, also will be subject to certain financial maintenance covenants.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">74</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tSOOM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN BENEFICIAL OWNERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the name, address (where required) and beneficial ownership of each person (including any &#8220;group&#8221; as defined in Section&#160;13(d)(3) of the Exchange Act) known by us to be the beneficial owner of more than five&#160;percent (5%) of Avadel Shares, based on filings made under Section&#160;13 of the Exchange Act as of November&#160;7, 2025 and based on 97,817,589 Avadel Shares outstanding as of that date. </font>
        </div>
        <table style="width:456pt;height:217pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:348.92pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number and Percentage of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares Beneficially Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:348.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name and Address of Beneficial Owner</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Avadel Shares</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:348.92pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">5% or Greater Shareholders:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.550000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.550000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:348.92pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Entities Affiliated with Janus Henderson Group plc</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(1)</font> <br ><font style="letter-spacing:0.2pt;">201 Bishopsgate</font><br ><font style="letter-spacing:0.2pt;">EC2M 3AE, United Kingdom</font></div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.550000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">11,132,131 </td>
            <td style="padding:0pt;padding-left:0.550000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">11.38<font style="position:absolute;">% </font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:348.92pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Entities Affiliated with BlackRock, Inc.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(2)</font> <br ><font style="letter-spacing:0.2pt;">50 Hudson Yards,</font><br ><font style="letter-spacing:0.2pt;">New York, NY 10001</font></div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.550000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">6,742,480 </td>
            <td style="padding:0pt;padding-left:0.550000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.89<font style="position:absolute;">% </font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:348.92pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Entities Affiliated with Two Seas Capital LP</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(3)</font> <br ><font style="letter-spacing:0.2pt;">32 Elm Place&#8201;&#8211;&#8201;3rd Floor, Rye, New York 10580 </font></div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.550000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">6,155,074 </td>
            <td style="padding:0pt;padding-left:0.550000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.29<font style="position:absolute;">% </font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:348.92pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Entities Affiliated with Tontine Asset Associates, LLC</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(4)</font> <br ><font style="letter-spacing:0.2pt;">1 Sound Shore Drive, Suite 304</font><br ><font style="letter-spacing:0.2pt;">Greenwich, CT 06830-7251</font></div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.550000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">5,685,350 </td>
            <td style="padding:0pt;padding-left:0.550000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.81<font style="position:absolute;">% </font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:348.92pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">The Vanguard Group</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(5)</font> <br ><font style="letter-spacing:0.2pt;">100 Vanguard Blvd., Malvern, PA 19355</font></div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.550000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">5,564,259 </td>
            <td style="padding:0pt;padding-left:0.550000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.69<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.69pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Information herein is solely based on a Schedule&#160;13G/A filed with the SEC by Janus Henderson Group plc (&#8220;JHG&#8221;) on August&#160;14, 2025. JHG reports that it has shared voting power and shared dispositive power over 11,132,131 shares which are held directly by one or more funds or portfolios managed by JHG. The principal business address of JHG is 201 Bishopsgate, EC2M 3AE, United Kingdom. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Information herein is solely based on a Schedule&#160;13G filed with the SEC by BlackRock, Inc. (&#8220;BRI&#8221;) on July&#160;16, 2025. BRI reports that it has sole voting power and sole dispositive power over 6,742,480 shares. The principal business address of BRI is 50 Hudson Yards, New York, NY 10001. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Information herein is solely based on a Schedule&#160;13G filed with the SEC by Two Seas Capital LP (&#8220;TSC&#8221;), Two Seas Capital GP LLC (&#8220;TSC GP&#8221;) and Sina Toussi on August&#160;13, 2025. Consists of 6,155,074 shares held by Two Seas Global (Master) Fund&#160;LP (the &#8220;TSC Global Fund&#8221;). TSC has been granted investment discretion over portfolio investments, including Avadel&#8217;s ordinary shares, held by or for the account of the TSC Global Fund. TSC GP serves as general partner of TSC. Sina Toussi serves as the chief investment officer of TSC and managing member of TSC GP. The principal business address of TSC, TSC GP and Sina Toussi is 32 Elm Place &#8212; 3rd Floor, Rye, New York 10580. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Information herein is solely based on a Schedule&#160;13G/A filed by Tontine Capital Overseas Master Fund&#160;II, L.P. (&#8220;TCOM II&#8221;), Tontine Asset Associates, LLC (&#8220;TAA&#8221;) and Mr.&#160;Jeffrey L. Gendell on February&#160;13, 2024. Consists of (i)&#160;3,539,782 American Depositary Shares held by TCOM II, (ii)&#160;2,075,568 American Depositary Shares held by Tontine Financial Partners, L.P. (&#8220;TFP&#8221;) and (iii)&#160;70,000 American Depositary Shares, held by Mr.&#160;Gendell, which were automatically exchanged for ordinary shares on April&#160;15, 2024 when the Company&#8217;s ordinary shares became directly listed on Nasdaq. Mr.&#160;Gendell serves as the Managing Member of TAA and also serves as the Managing Member of Tontine Management, L.L.C., a limited liability company organized under the laws of the State of Delaware (&#8220;TM&#8221;), which serves as general partner of TFP. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:4.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Information herein is solely based on a Schedule&#160;13G filed with the SEC by The Vanguard Group on July&#160;29, 2025. Consists of 5,564,259 shares held by The Vanguard Group. The principal business address of The Vanguard Group is 100 Vanguard Blvd., Malvern, PA 19355.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">75</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Share Ownership of Directors and Executive Officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth, as of November&#160;7, 2025, based on 97,817,589 Avadel Shares outstanding as of that date, the beneficial ownership of Avadel Shares (including rights to acquire Avadel Shares within sixty (60) days of that date) by (i)&#160;each Avadel director, (ii)&#160;each Avadel named executive officer and (iii)&#160;all current directors and executive officers (including named executive officers) as a group. No Avadel Shares have been pledged as security by any of the Avadel directors or executive officers named below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless otherwise indicated in the footnotes to this table and pursuant to applicable community property laws, Avadel believes the persons named in this table have sole voting and investment power with respect to all Avadel Shares reflected in this table. The business address of each of Avadel&#8217;s directors and named executive officers is Ten Earlsfort Terrace, Dublin 2, D02 T380 Ireland. </font>
        </div>
        <table style="width:456pt;height:211pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:331.1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number and Percentage of Avadel </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares Beneficially Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:331.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name of Beneficial Owner</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:331.1pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Named Executive Officers:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">2,511,600 </td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.51<font style="position:absolute;">% </font></td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas S. McHugh</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">956,175 </td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jerad G. Seurer</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">385,545 </td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.1pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Directors (excluding Gregory J. Divis)</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Geoffrey M. Glass</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">385,979 </td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dr.&#160;Naseem S. Amin</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">38,500 </td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dr.&#160;Eric J. Ende</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(6)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">446,957 </td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dr.&#160;Mark A. McCamish</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(7)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">358,025 </td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Linda S. Palczuk</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(8)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">322,900 </td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter J. Thornton</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(9)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">334,055 </td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:331.1pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">All current executive officers and directors as a group (9&#160;persons)</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:-0.15pt;">(10)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">5,739,736 </td>
            <td style="padding:0pt;padding-left:5.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">5.59<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents beneficial ownership of less than one&#160;percent. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes (i)&#160;options to purchase 2,342,500 ordinary shares that are exercisable within 60&#160;days of November&#160;7, 2025, (ii)&#160;10,000 ordinary shares held by the Gregory J. Divis Jr. Revocable Trust, of which Mr.&#160;Divis is trustee and beneficiary and (iii)&#160;159,100 ordinary shares held by Mr.&#160;Divis. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes (i)&#160;options to purchase 868,675 ordinary shares that are exercisable within 60&#160;days of November&#160;7, 2025 and (ii)&#160;87,800 ordinary shares held by Mr.&#160;McHugh. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes (i)&#160;options to purchase 376,750 ordinary shares that are exercisable within 60&#160;days of November&#160;7, 2025 and (ii)&#160;8,795 ordinary shares held by Mr.&#160;Seurer. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes (i)&#160;options to purchase 230,000 ordinary shares that are exercisable within 60&#160;days November&#160;7, 2025 held by Mr.&#160;Glass, (ii)&#160;86,904 ordinary shares held by Geoffrey M. Glass Revokable u/t/d August&#160;26, 2020 and (iii)&#160;69,075 ordinary shares held by The Geoffrey Glass Trust of which Mr.&#160;Glass is a co-trustee and sole beneficiary. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes (i)&#160;options to purchase 27,500 ordinary shares that are exercisable within 60&#160;days of November&#160;7, 2025 and (ii)&#160;11,000 ordinary shares held by Mr.&#160;Amin. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes (i)&#160;options to purchase 238,057 shares that are exercisable within 60&#160;days of November&#160;7, 2025, (ii)&#160;208,900 ordinary shares held by Dr.&#160;Ende. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes (i)&#160;options to purchase 280,000 ordinary shares that are exercisable within 60&#160;days of November&#160;7, 2025, (ii)&#160;78,025 ordinary shares held by Matthew 5 LLC, of which The Mark &amp; Barbara McCamish Family Trust is the sole owner and Dr.&#160;McCamish serves as manager. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">76</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:564pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(8)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes (i)&#160;options to purchase 255,000 ordinary shares that are exercisable within 60&#160;days of November&#160;7, 2025, held by The Revocable Trust of Linda S. Palczuk, of which Ms.&#160;Palczuk serves as trustee and (ii)&#160;67,900 ordinary shares held by Ms.&#160;Palczuk. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(9)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes (i)&#160;options to purchase 230,000 ordinary shares that are exercisable within 60&#160;days of November&#160;7, 2025 and (ii)&#160;104,055 ordinary shares held by Mr.&#160;Thornton.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">77</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tASVO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:220pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AVADEL SHAREHOLDER VOTE ON SPECIFIED COMPENSATORY ARRANGEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Advisory Vote on Golden Parachute Compensation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In accordance with Section&#160;14A of the Exchange Act, Avadel is providing its shareholders with the opportunity to cast a non-binding, advisory vote at the EGM on the compensation that may be paid or become payable to its named executive officers in connection with the Transaction and the agreements and understandings pursuant to which such compensation may be paid or become payable. As required by those rules, Avadel is asking its shareholders to vote on the adoption of the following resolution: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;RESOLVED, that the compensation that may be paid or become payable to Avadel&#8217;s named executive officers in connection with the Transaction, as disclosed in the table in the section of the proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Quantification of Payments and Benefits to Avadel&#8217;s Named Executive Officers</font><font style="letter-spacing:0.2pt;">,&#8221; including the associated narrative discussion, are hereby APPROVED.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Required Vote</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The vote on executive compensation payable in connection with the Transaction is a vote separate and apart from the vote to approve the Transaction. Accordingly, you may vote to approve the executive compensation and vote not to approve the Transaction and vice versa. Because the vote is advisory in nature only, it will not be binding on Avadel or Alkermes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The affirmative vote of holders of a majority of Avadel Shares present or represented by proxy at the EGM and entitled to vote thereon is required to approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Avadel Board recommends that you vote &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; the proposal to approve, on a non-binding advisory basis, the specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IN CONSIDERING THE RECOMMENDATION OF THE AVADEL BOARD, YOU SHOULD BE AWARE THAT CERTAIN DIRECTORS AND EXECUTIVE OFFICERS OF AVADEL HAVE INTERESTS IN THE PROPOSED TRANSACTION THAT ARE DIFFERENT FROM, OR IN ADDITION TO, ANY INTERESTS THEY MIGHT HAVE AS SHAREHOLDERS. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">78</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFSP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:96pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">FUTURE SHAREHOLDER PROPOSALS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel held its 2025 annual general meeting of shareholders on July&#160;29, 2025. Avadel will hold an annual general meeting of shareholders in the year 2026 only if the Transaction has not already been completed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel Shareholders may submit proposals on matters appropriate for shareholder action at shareholder meetings in accordance with Rule&#160;14a-8 promulgated under the Exchange Act. For such proposals to be included in Avadel&#8217;s proxy materials relating to its 2026 Annual General Meeting of Shareholders, all applicable requirements of Rule&#160;14a-8 must be satisfied and, pursuant to Rule&#160;14a-8, such proposals must have been received by Avadel no later than February&#160;18, 2026. However, if the Scheme has not been completed, and Avadel&#8217;s 2026 Annual General Meeting of Shareholders is changed such that it is more than 30&#160;days from July&#160;29, 2026, the deadline will then be a reasonable time prior to the time that Avadel begins to print and mail its proxy materials. Such shareholder proposals must be delivered to the attention of Avadel&#8217;s Company Secretary at Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland. In addition to the requirements as to form and substance established by the SEC, shareholder proposals must be a proper subject for shareholder action under Irish law and Avadel&#8217;s Articles of Association to be included in the proxy materials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s Articles of Association sets forth advance notice procedures to be followed if an Avadel Shareholder wishes to propose a nomination of persons for election to the Avadel Board or present a proposal at an annual general meeting. All such nominations and/or proposals must be accompanied by certain background and other information specified in Avadel&#8217;s Articles of Association. To be considered timely, an Avadel Shareholder&#8217;s notice must be delivered by close of business on that day that is not less than 120&#160;days prior to the first anniversary of the day of release to shareholders of Avadel&#8217;s proxy statement in respect of the preceding year&#8217;s annual general meeting; provided, however, that in the event that the date of the annual general meeting is changed by more than 30&#160;days from the date contemplated at the time of the previous year&#8217;s proxy statement, notice by the member must be so delivered by close of business on the day that is not less than the later of (a)&#160;150&#160;days prior to the day of the contemplated annual general meeting or (b)&#160;ten (10) days after the day on which public announcement of the date of the contemplated annual general meeting is first made by Avadel. For Avadel Shareholders to submit proposals or nominees for election to the Avadel Board in line with the advance notice provisions set out in the Articles of Association, the required notice must be received no later than February&#160;18, 2026. All such proposals must be sent in writing to the Avadel Company Secretary at Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Eligibility to Submit a Proposal</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under Rule&#160;14a-8 promulgated under the Exchange Act, in order to be eligible to submit a proposal, you must have continuously held (i)&#160;at least $2,000 in market value of Avadel Shares entitled to be voted on the proposal at the meeting for at least three (3)&#160;years by the date you submit the proposal, (ii)&#160;at least $15,000 in market value of Avadel Shares entitled to be voted on the proposal at the meeting for at least two (2)&#160;years by the date you submit the proposal or (iii)&#160;at least $25,000 in market value of Avadel Shares entitled to be voted on the proposal at the meeting for at least one (1)&#160;year by the date you submit the proposal. You must continue to hold those Avadel Shares through the date of the meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Shareholder Nomination Procedures</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In addition, to comply with the universal proxy rules, Avadel Shareholders who intend to solicit proxies in support of director nominees other than Avadel&#8217;s nominees must provide notice that sets forth the information required by Rule&#160;14a-19 under the Exchange Act. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">79</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tHOPS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:372pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">HOUSEHOLDING OF PROXY STATEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for proxy statements and annual reports with respect to two (2)&#160;or more shareholders sharing the same address by delivering a single proxy statement or annual report, as applicable, to those shareholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for shareholders and cost savings for companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A number of brokers with account holders who are Avadel Shareholders will be &#8220;householding&#8221; proxy materials. A single copy of this proxy statement or other materials related to the Special Meetings will be delivered to multiple shareholders sharing an address unless contrary instructions have been received from the affected shareholders. Once you have received notice from your broker that they will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate proxy statement or materials related to the Special Meetings, please notify your broker or us. Direct your written request to Company Secretary, at Ten Earlsfort Terrace, Dublin 2, D02 T380, or contact the Company Secretary at +353 1 902 5201 (Ireland). Shareholders who currently receive multiple copies of the proxy materials or other materials relating to the Shareholder meetings at their addresses and would like to request &#8220;householding&#8221; of their communications should contact their brokers. In addition, Avadel will promptly deliver, upon written or oral request to the address or telephone number above, a separate copy of proxy materials to a shareholder at a shared address to which a single copy of the materials was delivered. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">80</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tWYCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WHERE YOU CAN FIND MORE INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel files annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains an Internet site that contains reports, proxy statements and other information regarding issuers that file electronically with the SEC. The SEC&#8217;s Internet site can be found at http://www.sec.gov. Avadel also maintains an Internet site that contains reports, proxy statements and other information that it files with the SEC. Avadel&#8217;s Internet site can be found at https://investors.avadel.com/sec-filings. Information found on, or accessible through, Avadel&#8217;s website is not a part of and is not incorporated into, this proxy statement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The SEC allows incorporation by reference of the information that Avadel files with it, which means that Avadel can disclose important information to you by referring you to another document that it has filed with the SEC. Avadel incorporates by reference the following information or documents that it has filed with the SEC: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2024 filed with the SEC on <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000101247725000010/avdl-20241231.htm">March&#160;3, 2025</a>; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Quarterly Reports on Form 10-Q for the quarter ended March&#160;31, 2025 filed with the SEC on <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000101247725000016/avdl-20250331.htm">May&#160;7, 2025</a>, the quarter ended June&#160;30, 2025, filed with the SEC on <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000101247725000024/avdl-20250630.htm">August&#160;7, 2025</a>, and the quarter ended September&#160;30, 2025 filed with the SEC on <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000101247725000031/avdl-20250930.htm">November&#160;4, 2025</a>; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Current Reports on Form 8-K (other than information furnished rather than filed) filed with the SEC on <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000110465925002035/tm252686d1_8k.htm">January&#160;8, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000110465925021773/tm258627d1_8k.htm">March&#160;7, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000110465925044999/tm2514119d2_8k.htm">May&#160;6, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000110465925047848/tm2514853d1_8k.htm">May&#160;13, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000110465925056674/tm2517242d1_8k.htm">June&#160;5, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000110465925063606/tm2519346d1_8k.htm">June&#160;27, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000110465925071732/tm2521996d1_8k.htm">July&#160;29, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000110465925087076/tm2525099d1_8k.htm">September&#160;3, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000110465925090694/tm2526334d1_8k.htm">September&#160;17, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000110465925101382/tm2529228d1_8k.htm">October&#160;22, 2025</a> (announcing the Settlement Agreement) and <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1012477/000110465925101430/tm2529228d2_8k.htm">October&#160;22, 2025</a> (announcing the Transaction Agreement); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The description of our ordinary shares contained in our registration statement on <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1012477/000110465924046963/tm2411820d2_8a12b.htm">Form 8-A filed with the SEC on April&#160;15, 2024</a>, including any amendments or reports filed for the purposes of updating this description. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any information in any of the foregoing documents will automatically be deemed to be modified or superseded to the extent that information in this proxy statement or in a later filed document that is incorporated or deemed to be incorporated herein by reference modifies or replaces such information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel also incorporates by reference any future filings (other than current reports or portions of current reports furnished under Item&#160;2.02 or Item&#160;7.01 of Form 8-K and exhibits filed on such form that are related to such items) made with the SEC by us pursuant to Section&#160;13(a), 13(c), 14 or 15(d) of the Exchange Act and prior to the Special Meetings. Information in such future filings updates and supplements the information provided in this proxy statement. Any statements in any such future filings will automatically be deemed to modify and supersede any information in any document that Avadel previously filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements in the later filed document modify or replace such earlier statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel will furnish without charge to each Avadel Shareholder to whom a proxy statement is delivered, upon written or oral request, a copy of any or all of the documents incorporated by reference, including exhibits to these documents. Any such request may be made by writing or telephoning us at the following address or phone number: </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel Pharmaceuticals plc </font>
          <br >
          <font style="letter-spacing:0.2pt;">Attention: Company Secretary </font>
          <br >
          <font style="letter-spacing:0.2pt;">Ten Earlsfort Terrace </font>
          <br >
          <font style="letter-spacing:0.2pt;">Dublin 2, D02 T380, Ireland+353 1 901 5201 (Ireland) </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The information contained in Parts 2, 3 and 4 of this proxy statement is not required to be included pursuant to the rules and regulations of the SEC but is included solely to comply with the requirements of the Companies Act and the Irish Takeover Rules in order to provide the information required under such laws to Avadel Shareholders.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">81</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tP2ES">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PART 2&#8201;&#8212;&#8201;EXPLANATORY STATEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The information contained in Parts 2, 3 and 4 of this proxy statement is not required to be included pursuant to the rules and regulations of the U.S. Securities and Exchange Commission but is included solely to comply with the requirements of the Irish Companies Act 2014 and the Irish Takeover Rules in order to provide the information required under such laws to Avadel Shareholders.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(IN COMPLIANCE WITH SECTION 452 OF THE IRISH COMPANIES ACT 2014) </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To Avadel Shareholders and, for information purposes only, to Equity Award Holders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">PROPOSED ACQUISITION OF AVADEL PHARMACEUTICALS PLC BY ALKERMES PLC BY MEANS OF A SCHEME OF ARRANGEMENT UNDER CHAPTER 1 OF PART 9 OF THE IRISH COMPANIES ACT 2014 </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">INTRODUCTION</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;22, 2025, Alkermes and Avadel announced that they had entered into a Transaction Agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Transaction Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) pursuant to which Alkermes agreed to acquire the entire issued and to be issued ordinary share capital of Avadel for cash and contingent value rights (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Transaction</font><font style="letter-spacing:0.2pt;">&#8221;), subject to the satisfaction of certain conditions, by way of a scheme of arrangement under Chapter 1 of Part&#160;9 of the Companies Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">Capitalized terms used but not defined in this </font><font style="letter-spacing:0.2pt;">&#8220;Part&#160;2&#8201;&#8212;&#8201;Explanatory Statement&#8221;</font><font style="font-style:normal;letter-spacing:0.2pt;"> have the meanings ascribed to such terms in </font><font style="letter-spacing:0.2pt;">&#8220;Part&#160;3&#8201;&#8212;&#8201;The Scheme of Arrangement.&#8221;</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The section of this proxy statement entitled </font><font style="font-style:italic;letter-spacing:0.2pt;">&#8220;The Transaction&#8201;&#8212;&#8201;Recommendation of the Avadel Board and Avadel&#8217;s Reasons for the Transaction</font><font style="letter-spacing:0.2pt;">&#8221; sets forth the reasons why the Avadel Board, which has been so advised by Morgan Stanley &amp; Co. LLC (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Morgan Stanley</font><font style="letter-spacing:0.2pt;">&#8221;) and Goldman Sachs &amp; Co. LLC (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Goldman Sachs</font><font style="letter-spacing:0.2pt;">&#8221;) as financial advisors and independent advisors for the purposes of Rule&#160;3 of the Irish Takeover Rules to the Avadel Board, as to the financial terms of the Transaction, considers the terms of the Transaction to be fair and reasonable and why the Avadel Board unanimously recommends that all Avadel Shareholders vote in favor of the Transaction and the Scheme, as well as the other resolutions proposed, at both the Scheme Meeting and the EGM as the Avadel directors intend to do in respect of their own beneficial holdings of, in the aggregate, &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; Avadel Shares, as of the Voting Record Time. In considering the recommendation of the Avadel Board, Avadel Shareholders should be aware that directors and executive officers of Avadel may have interests in the Transaction that are in addition to, or different from, the interests they might have as shareholders generally. See the section of this proxy statement entitled </font><font style="font-style:italic;letter-spacing:0.2pt;">&#8220;Part&#160;2&#8201;&#8212;&#8201;Explanatory Statement&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction&#8221;</font><font style="letter-spacing:0.2pt;">. In providing their advice to the Avadel Board, Morgan Stanley and Goldman Sachs have taken into account the commercial assessments of the Avadel Board. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">THE TRANSACTION</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Transaction will be effected by way of a scheme of arrangement between Avadel and Scheme Shareholders pursuant to Chapter 1 of Part&#160;9 of the Companies Act. The Scheme is set out in full in the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Part&#160;3&#8201;&#8212;&#8201;The Scheme of Arrangement</font><font style="letter-spacing:0.2pt;">&#8221;. Under the terms of the Scheme (subject to the satisfaction or, where applicable, waiver of the conditions set out in Annex B to this proxy statement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Conditions</font><font style="letter-spacing:0.2pt;">&#8221;)), Alkermes will pay, or cause to be paid, the Scheme Consideration to the Scheme Shareholders in consideration for the transfer to Alkermes of the Scheme Shares. Under the terms of the Transaction, subject to the satisfaction or, where applicable, waiver of the Conditions, at Completion, each Scheme Shareholder will be entitled to receive (i)&#160;a cash price of $18.50 per share (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Cash Consideration</font><font style="letter-spacing:0.2pt;">&#8221;) and (ii)&#160;one (1)&#160;non-transferable contingent value right (a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">CVR</font><font style="letter-spacing:0.2pt;">&#8221;) per share, representing a contractual right to receive $1.50 (a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Milestone Payment</font><font style="letter-spacing:0.2pt;">&#8221;), settleable in cash, without interest, subject to any applicable withholding taxes, conditioned upon the achievement of (a)&#160;LUMRYZ Approval (as defined in the Transaction Agreement) and (b)&#160;the Legal Event (as defined in the Transaction Agreement) (together, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Milestone</font><font style="letter-spacing:0.2pt;">&#8221;) prior to 11:59&#160;p.m., U.S. Eastern Time on December&#160;31, 2028 (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Milestone Expiration</font><font style="letter-spacing:0.2pt;">&#8221;) (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">CVR Consideration</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">82</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The CVRs will be constituted subject to the terms of the CVR Agreement to be entered into between Alkermes and the Rights Agent. Pursuant to the terms of the Transaction, each CVR will represent the contractual right to receive the Milestone Payment, upon the occurrence of the Milestone. There is no assurance that the Milestone will be achieved prior to the Milestone Expiration Date or termination of the CVR Agreement, or that any Milestone Payment will be made. The CVRs are complex instruments and a number of factors will determine whether any amount will actually be paid to Avadel Shareholders in accordance with the terms of the CVR Agreement. If the Milestone does not occur by the Milestone Expiration, then the CVRs will have no value. The minimum payment under each CVR is zero and the maximum payment under each CVR is $1.50, settleable in cash, without interest and subject to applicable withholding taxes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Scheme involves an application by Avadel to the Irish High Court to sanction the Scheme. If the Scheme becomes effective, all Scheme Shares will be automatically transferred to Alkermes and / or its nominee(s) in accordance with the terms of the Scheme. As a result of the Scheme, Avadel will become a wholly owned subsidiary of Alkermes. The Scheme and the Transaction are subject to the satisfaction or, where applicable, waiver of the Conditions (which are summarized in paragraph 3 below and set out in full at Annex B to this proxy statement). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Scheme will require, among other things, approval by Avadel Shareholders as of the Voting Record Time at the Scheme Meeting, approval by Avadel Shareholders as of the Voting Record Time at the EGM and the sanction of the Scheme by the Irish High Court at the Court Hearing.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Provided the Conditions are satisfied or, to the extent applicable and lawful, waived, the Scheme will become effective upon delivery to the Registrar of Companies of a copy of the Court Order of the Irish High Court sanctioning the Scheme. Upon the Scheme becoming effective, it will be binding on all Scheme Shareholders, irrespective of whether or not they attended or voted at the Scheme Meeting or the EGM. It is expected that the Scheme will become effective and that the Transaction will be completed during the first quarter of 2026, subject to satisfaction or waiver (if applicable) of the Conditions. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">THE CONDITIONS</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Conditions to the Transaction and the Scheme are set out in full at Annex B to this proxy statement. In summary, completion of the Transaction is subject to the satisfaction (or waiver, if applicable) of all of the following conditions on or before the End Date: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Mutual Conditions Precedent to the Scheme:</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the approval of the Scheme Meeting Resolution by a majority in number of Avadel Shareholders representing at least seventy-five&#160;percent (75%) in value of the Avadel Shares, at the Voting Record Time, present and voting either in person or by proxy, at the Scheme Meeting (or at any adjournment or postponement of such meeting); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each of the Required EGM Resolutions (as defined below) being duly passed by the requisite majority of Avadel Shareholders, at the Voting Record Time, at the EGM (or at any adjournment or postponement of such meeting); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the sanction of the Scheme by the Irish High Court (with or without material modification, but subject to any such modification being acceptable to each of Alkermes and Avadel) pursuant to Sections&#160;449 to 455 of the Companies Act; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">copies of the Court Order having been delivered for registration to the Registrar of Companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Mutual Conditions Precedent:</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the waiting period (or any extension thereof) applicable under the HSR Act having expired or having been earlier terminated and, to the extent applicable, any agreement between Avadel and Alkermes, on the one hand, and the Federal Trade Commission or the Antitrust Division of the U.S. Department of Justice, on the other hand, not to consummate the Scheme or the Transaction having expired or been earlier terminated; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">83</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">no Government Entity of competent jurisdiction having enacted, issued, promulgated, enforced or entered any Law or Order (whether temporary, preliminary or permanent) that is in effect and restrains, enjoins, makes illegal or otherwise prohibits the consummation of the Transaction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Transaction Agreement not having been terminated in accordance with its terms; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Conditions Precedent to the Obligations of Alkermes:</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the accuracy of Avadel&#8217;s representations and warranties, subject to certain materiality and material adverse effect exceptions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the performance by Avadel, in all material respects, of all of its covenants and agreements under the Transaction Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the absence of a Company Material Adverse Effect (as defined in the Transaction Agreement) that is continuing; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Alkermes having received a certificate from an executive officer of Avadel confirming the satisfaction of the conditions set forth in the first and second bullet notes above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Conditions Precedent to the Obligations of Avadel:</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the accuracy of Alkermes&#8217; representations and warranties, subject to certain materiality and material adverse effect exceptions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the performance by Alkermes, in all material respects, of all of its covenants and agreements under the Transaction Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the CVR Agreement being in full force and effect; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the absence of a Parent Material Adverse Effect (as defined in the Transaction Agreement) that is continuing; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel having received a certificate from an executive officer of Alkermes confirming the satisfaction of the conditions set forth in the first and second bullet notes above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Transaction is also conditioned on the Scheme becoming effective and unconditional by not later than the End Date. See the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction Agreement&#8201;&#8212;&#8201;Conditions to the Closing of the Transaction</font><font style="letter-spacing:0.2pt;">&#8221; for further information. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">CONSENTS AND SPECIAL MEETINGS</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Scheme Meeting is being convened at the direction of the Irish High Court to seek the approval of the Scheme by Avadel Shareholders as of the Voting Record Time. The EGM is being convened to seek the approval of Avadel Shareholders as of the Voting Record Time with respect to certain resolutions that are necessary or desirable to effect and to implement the Scheme, as described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Whether or not an Avadel Shareholder votes in favor of the Scheme at the Scheme Meeting and/or votes in favor of the resolutions at the EGM, if the Scheme becomes effective all Scheme Shares will be transferred to Alkermes and / or its nominee(s) in accordance with the terms of the Scheme and the Scheme Consideration will be paid to the Scheme Shareholders. In addition, if the Scheme becomes effective, any Avadel Shares issued after the Scheme Record Time will be transferred to Alkermes and/or its nominee(s) in accordance with the amendments proposed to Avadel&#8217;s Articles of Association at the EGM in consideration for the same aggregate Cash Consideration and CVR Consideration as is payable to the Scheme Shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Before the Irish High Court&#8217;s sanction of the Scheme can be sought, the Scheme will require approval by Avadel Shareholders as of the Voting Record Time at the Scheme Meeting and the passing of the Required EGM Resolutions (as defined below). The Scheme Meeting will start at &#8199;&#8199;&#8199;&#8199; a.m. (Irish local time) on &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2026 and the EGM will start at &#8199;&#8199;&#8199;&#8199; a.m. (Irish local time) on &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2026 or, if the Scheme Meeting has not concluded by &#8199;&#8199;&#8199;&#8199; a.m. (Irish local time), as soon as possible after the conclusion of the Scheme Meeting (or any adjournment thereof). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notices of the Scheme Meeting and the EGM, which contain the full text of the proposals to be presented to Avadel Shareholders for consideration, are set out at the front of this proxy statement. You are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">84</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">encouraged to read these notices and the full text of each proposal in detail. Entitlement to notice of and/or to vote at each meeting will be determined by reference to the Register of Members at the Voting Record Time. See the sections of this proxy statement entitled &#8220;</font><font style="letter-spacing:0.2pt;">Part&#160;1&#8201;&#8212;&#8201;The Transaction and the Special Meetings&#8201;&#8212;&#8201; The Special Meetings of Avadel&#8217;s Shareholders&#8201;&#8212;&#8201;Voting Your Ordinary Shares</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; and </font><font style="letter-spacing:0.2pt;">&#8220;Part&#160;1&#8201;&#8212;&#8201;The Transaction and the Special Meetings&#8201;&#8212;&#8201;The Special Meetings of Avadel&#8217;s Shareholders&#8201;&#8212;&#8201;Voting Ordinary Shares Held in Street Name.</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the Voting Record Time, Avadel held no ordinary shares in treasury. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the Voting Record Time, there were &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; Avadel Shares in issue, no preferred shares with par value of US$0.01 in issue and 25,000 deferred, non-voting, ordinary shares with par value of &euro;1.00 in issue and there were &#8199;&#8199;&#8199;&#8199;&#8199;&#8199; registered members whose names appeared in the Register of Members. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.1</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme Meeting</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Scheme Meeting has been convened at the direction of the Irish High Court for &#8199;&#8199;&#8199;&#8199; a.m. (Irish local time) on &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2026 to enable Avadel Shareholders as of the Voting Record Time to consider and, if thought fit, approve a resolution to approve the Scheme and to approve any motion by the Chair of the Scheme Meeting to adjourn the Scheme Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Scheme Meeting to approve the Scheme (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme Meeting Adjournment Resolution</font><font style="letter-spacing:0.2pt;">&#8221;). At the Scheme Meeting, voting will be by poll and not a show of hands, and each Avadel Shareholder as of the Voting Record Time who is present (in person or by proxy) will be entitled to one vote for each Avadel Share held as of the Voting Record Time. In order to conduct business at the Scheme Meeting a quorum must be present. The quorum for the Scheme Meeting shall be five or more Avadel Shareholders as of the Voting Record Time present in person or by proxy holding at least a majority of the issued and outstanding Avadel Shares entitled to vote at the Scheme Meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order for the Scheme Meeting Resolution to pass, it requires approval at the Scheme Meeting by a majority in number of Avadel Shareholders at the Voting Record Time who are present and voting, either in person or by proxy, representing at least seventy-five&#160;percent (75%) in value of the Avadel Shares voted at such meeting, either in person or by proxy. The Scheme Meeting Adjournment Resolution is proposed as an &#8220;ordinary resolution&#8221;, which means that it requires the approval of a simple majority (being more than fifty&#160;percent (50%)) of the votes cast by Avadel Shareholders as of the Voting Record Time present and voting (in person or by proxy) at the Scheme Meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Scheme is conditioned on the approval of the Scheme Meeting Resolution. The Scheme is not conditioned on the approval of the Scheme Meeting Adjournment Resolution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">It is important that, for the Scheme Meeting, as many votes as possible are cast so that the Irish High Court may be satisfied that there is a fair representation of the opinion of Avadel Shareholders as of the Voting Record Time when it is considering whether to sanction the Scheme. You are therefore strongly urged to complete and return your proxy card for the Scheme Meeting as soon as possible.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.2</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">EGM</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to the Scheme Meeting, the EGM has been convened for &#8199;&#8199;&#8199;&#8199; a.m. (Irish local time) on &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2026, or, if the Scheme Meeting has not concluded by &#8199;&#8199;&#8199;&#8199; a.m. (Irish local time), as soon as possible after the conclusion of the Scheme Meeting (or any adjournment thereof). A quorum must be present in order to conduct any business at the EGM. The quorum for the EGM shall be at least five or more Avadel Shareholders as of the Voting Record Time present in person or by proxy holding not less than a majority of the issued and outstanding Avadel Shares entitled to vote at the EGM. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the EGM, the following proposals will be voted on by Avadel Shareholders: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:42pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To approve the Scheme and to authorize the Avadel Board to take all such action as it considers necessary or appropriate to carry the Scheme into effect (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme Approval Resolution</font><font style="letter-spacing:0.2pt;">&#8221;); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:42pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To amend the Articles of Association of Avadel so that any Avadel Shares that are issued on or after the Voting Record Time to persons other than Alkermes will either be subject to the terms of </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">85</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:42pt; width:414pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the Scheme or will be immediately and automatically acquired by Alkermes for the Scheme Consideration (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Articles of Association Amendment Resolution</font><font style="letter-spacing:0.2pt;">&#8221;); </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:42pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To approve, on a non-binding, advisory basis, certain compensation arrangements proposed to be entered into between Avadel and its named executive officers (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Compensation Resolution</font><font style="letter-spacing:0.2pt;">&#8221;); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:42pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To approve any motion by the Chair of the EGM to adjourn the EGM, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the EGM to approve the Scheme Approval Resolution or the Articles of Association Amendment Resolution (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EGM Adjournment Resolution</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Scheme is conditioned on the approval of the Scheme Approval Resolution and the Articles of Association Amendment Resolution described above (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Required EGM Resolutions</font><font style="letter-spacing:0.2pt;">&#8221;). The Scheme is not conditioned on the approval of the Compensation Resolution or the EGM Adjournment Resolution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Scheme Approval Resolution, the Compensation Resolution and the EGM Adjournment Resolution are each proposed as &#8220;ordinary resolutions&#8221;, which means that they require the approval of at least a majority (being more than fifty&#160;percent (50%)) of the votes cast by the Avadel Shareholders as of the Voting Record Time present and voting (in person or by proxy) at the EGM. The Articles of Amendment Resolution is a &#8220;special resolution&#8221; which requires the approval of at least seventy-five&#160;percent (75%) of the votes cast by the Avadel Shareholders as of the Voting Record Time present and voting (in person or by proxy) at the EGM. The Transaction is conditioned on the approval of the Scheme Meeting Resolution and the Required EGM Resolutions by the requisite majorities of Avadel Shareholders as of the Voting Record Time. The Transaction is not conditioned on the approval of the Scheme Meeting Adjournment Resolution, the Compensation Resolution or the EGM Adjournment Resolution. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.3</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Avadel Court Hearing</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to the approval of the Scheme Meeting Resolution and the Required EGM Resolutions and the prior satisfaction or, where applicable, waiver of the Conditions (other than those Conditions which by their nature cannot be satisfied prior to the hearing by the Irish High Court of the application to sanction the Scheme), the Court Hearing is expected to take place in the first quarter of 2026. Each Avadel Shareholder as of the Voting Record Time is entitled to be represented by counsel or a solicitor (at his or her own expense), or to appear in person, at the Court Hearing to support or oppose the sanctioning of the Scheme. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.4</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Forms of Proxy</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel Shareholders as of the Voting Record Time are being sent a form of proxy card for each of the Scheme Meeting and the EGM. Avadel Shareholders are strongly urged to complete and return their proxy cards as soon as possible and, in any event, no later than 11:59&#160;p.m. (Irish local time) on &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2026. The proxy cards for the Scheme Meeting and the EGM may also be handed by an Avadel Shareholder to the Chair of the Scheme Meeting or the EGM, as applicable, before the start of the applicable special meetings on &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2026 and will still be valid. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.5</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Voting Your Ordinary Shares</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel Shareholders as of the Voting Record Time may vote by proxy and/or in person at each special meeting. Avadel recommends that Avadel Shareholders submit the proxy even if they plan to attend either or both special meetings. If an Avadel Shareholder votes by proxy, that Avadel Shareholder may change its vote, among other ways, if he, she or it attends and votes at the Scheme Meeting or the EGM, as applicable. Completion and return of a form of proxy will not preclude an Avadel Shareholder as of the Voting Record Time from attending and voting in person at the Scheme Meeting or the EGM, or any adjournments thereof, as applicable, if that Avadel Shareholder wishes to do so. Any alteration to the form of proxy must be initialed by the person who signs it. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If you own shares in your own name, you are considered, with respect to those shares, the &#8220;shareholder of record.&#8221; If your Avadel Shares are held in a stock brokerage account or by a bank or other nominee, you are considered the beneficial owner of shares held in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">street name</font><font style="letter-spacing:0.2pt;">.&#8221; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">86</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you are an Avadel shareholder as of the Voting Record Time, you may use the enclosed proxy cards to tell the named proxies how to vote your shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you properly complete, sign, date and return your proxy cards, your shares will be voted in accordance with your instructions. The named proxies will vote all Avadel Shares at the meeting for which proxies have been properly submitted and not revoked. If you sign and return your proxy cards appointing the Chair of the Scheme Meeting or EGM, as the case may be, as your proxy but do not mark the proxy card to tell the proxy how to vote on a voting item, your shares will be voted in respect of such voting item at the discretion of the Chair of the Scheme Meeting or EGM, as the case may be. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel Shareholders as of the Voting Record Time may also vote over the Internet at www.proxyvote.com or by telephone at &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; anytime up to 11:59&#160;p.m. (Irish local time on) &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2026. Voting instructions are printed on the proxy cards or voting information form you received. Either method of submitting a proxy will enable your shares to be represented and voted at the special meetings. You may also hand your applicable completed and signed proxy cards to the Chair of the Scheme Meeting or the EGM, as the case may be, before the start of the applicable special meeting. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.81pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.6</font>
          <br >
        </div>
        <div style=" margin-top:7.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Voting Ordinary Shares Held in Street Name</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If your shares are held in an account through a bank, broker or other nominee, you must likewise instruct the bank, broker or other nominee how to vote your shares by following the instructions that the bank, broker or other nominee provides to you along with this proxy statement. Your bank, broker or other nominee, as applicable, may have an earlier deadline by which you must provide instructions to it as to how to vote your shares so you should carefully read the materials provided to you by their bank, broker or other nominee. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you do not provide a signed voting instruction form to your bank, broker or other nominee, your shares will not be voted on any proposal on which the bank, broker or other nominee does not have discretionary authority to vote. This is referred to as a broker non-vote. In these cases, the bank, broker or other nominee will not be able to vote your shares on those matters for which specific authorization is required. Brokers do not have discretionary authority to vote on any of the proposals at either special meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Accordingly, if you are a shareholder who holds shares through a bank or other nominee and you fail to provide a signed voting instruction form to your bank, broker or other nominee, your shares held through such bank, broker or other nominee will not be voted at either special meeting. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">STRUCTURE OF THE SCHEME</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">It is proposed that, pursuant to the provisions of the Scheme, all Scheme Shares will be transferred to Alkermes and / or its nominee(s) in accordance with the terms of the Scheme. Please see the section of this proxy statement entitled </font><font style="font-style:italic;letter-spacing:0.2pt;">&#8220;Summary&#8201;&#8212;&#8201;Structure of the Transaction&#8221;.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">OPINIONS OF THE FINANCIAL ADVISORS TO AVADEL</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">Please see the section of this proxy statement entitled &#8220;</font><font style="letter-spacing:0.2pt;">Part&#160;1&#8201;&#8212;&#8201;The Transaction and the Special Meetings&#8201;&#8212;&#8201;The Transaction&#8201;&#8212;&#8201;Opinion of Morgan Stanley</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="letter-spacing:0.2pt;">Part&#160;1&#8201;&#8212;&#8201;The Transaction and the Special Meetings&#8201;&#8212;&#8201;The Transaction&#8201;&#8212;&#8201;Opinion of Goldman Sachs</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; beginning at pages <a href="#tOOMS1">21</a> and <a href="#tOOGS1">27</a> of this proxy statement. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.91pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
        <div style=" margin-top:7.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">ALKERMES&#8217; REASONS FOR THE TRANSACTION</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Alkermes believes there is a compelling strategic and financial rationale for undertaking the Transaction, which is expected to deliver the following benefits: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The acquisition of Avadel and its commercial product, LUMRYZ</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;">, positions Alkermes as a key player in the commercial sleep medicine market; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">LUMRYZ</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;">, the first and only once-at-bedtime oxybate for narcolepsy, is approved for the treatment of cataplexy or excessive daytime sleepiness in patients 7&#160;years of age or older with narcolepsy. Its once-nightly dosing offers a differentiated product profile with strong market uptake since its launch and significant growth potential. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">87</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s established and proven commercial infrastructure and experience in rare disease provide a strong foundation for the potential launch of alixorexton, Alkermes&#8217; orexin 2 receptor agonist candidate in development for the treatment of narcolepsy and idiopathic hypersomnia. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Transaction is expected to be immediately accretive and to enhance Alkermes&#8217; revenue growth profile and profitability upon Completion, expected in the first quarter of 2026. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The financial strength and capabilities of the combined organization will support a broad development strategy for Alkermes&#8217; portfolio of orexin 2 receptor agonists, including ALKS 4510 and ALKS 7290, which are currently in phase 1 studies. In addition, the combined resources will support the advancement of clinical studies to support potential label expansion opportunities for LUMRYZ</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;">, currently being studied in a phase 3 clinical trial in patients with idiopathic hypersomnia, and the potential advancement of valiloxybate, Avadel&#8217;s in-licensed salt-free, once-at-bedtime oxybate candidate in clinical development. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Integration of Avadel&#8217;s operations is expected to drive certain cost synergies and operational efficiencies, as Alkermes prepares for the potential commercial launch of alixorexton, its lead orexin development candidate. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">ALKERMES&#8217; INTENTIONS REGARDING AVADEL</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Alkermes believes there is a compelling strategic and financial rationale for undertaking the Transaction, which would position Alkermes and Avadel (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Combined Group</font><font style="letter-spacing:0.2pt;">&#8221;) as a leader in sleep medicine. Alkermes recognizes the skills, knowledge and experience of Avadel&#8217;s employees and is excited to work with them to further expand the commercial portfolio and development pipeline, and grow the value, of the Combined Group in the longer term. In the period prior to Completion, to the extent permitted by applicable Antitrust Laws, Alkermes intends to engage with Avadel&#8217;s senior management in integration planning, including a review of Avadel&#8217;s business. While the parameters of the review have not yet been finalized, Alkermes expects that it will involve evaluating the best way in which to further maximize the value of the Combined Group&#8217;s sleep disorder portfolio through commercial execution and investments in clinical development. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, the review will also include an assessment of how best to combine the operations of Alkermes and Avadel in order to achieve some of the expected benefits of the Transaction (including the cost synergies identified &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Part&#160;1&#8201;&#8212;&#8201;The Transaction&#8201;&#8212;&#8201;Recommendation of the Avadel Board and Avadel&#8217;s Reasons for the Transaction</font><font style="letter-spacing:0.2pt;">&#8221;). The review would aim to identify and assess integration benefit opportunities, and to ascertain any areas in which a reduction in the number of employees of the Combined Group may be appropriate. Alkermes has not yet carried out the review referred to above and, except as described below, has not reached any conclusions as to its likely outcome nor made any decisions in relation to specific actions that may be taken in relation to the integration of Alkermes and Avadel. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">8.1</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Management and Employees</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Alkermes attributes significant value to Avadel&#8217;s management and employees, whose contributions will be key to growing the value of the enlarged business of Alkermes in the longer term. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Alkermes will safeguard the existing employment rights, including pension rights, of Avadel management and employees as required by applicable law. Alkermes does not envisage any material change in the conditions of employment of the management and employees of the Combined Group as a result of the Transaction. Under the Transaction Agreement, Alkermes has given certain assurances in relation to the continuation of certain existing compensation and employment benefit arrangements of Avadel employees following the Transaction, further details of which are provided in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction Agreement&#8201;&#8212;&#8201;Employee Matters</font><font style="letter-spacing:0.2pt;">&#8221;. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While Alkermes has not yet carried out the review of Avadel&#8217;s business referred to above and has not reached any conclusions as to its likely outcome or made any decisions in relation to any specific actions that may be taken as a result of this evaluation in relation to employees of the Combined Group, Alkermes currently anticipates that there will be some operational and administrative reorganiziation of Avadel required following Completion. This will also facilitate the integration of the two businesses as part of the Combined Group. In particular, certain central corporate and support functions, including those relating to Avadel&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">88</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">status as a listed company, may no longer be required on a standalone basis or may be reduced in scope. No decisions have been made as to the number of employees or the roles and locations that may be affected. Alkermes also currently anticipates that there may be opportunities for the Combined Group to realize cost efficiencies from leveraging Alkermes&#8217; existing systems and processes across various functions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The current directors of Avadel intend to resign as directors of Avadel with effect from Completion. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">8.2</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Headquarters, Locations of Business and Assets</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Following Completion, the global headquarters of the Combined Group will be located at Alkermes&#8217; current global headquarters in Dublin, Ireland. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Alkermes will, as part of its review of Avadel&#8217;s business referred to above, evaluate the consolidation of some or all of Avadel&#8217;s locations of business, including functions currently undertaken at Avadel&#8217;s U.S. headquarters in St. Louis, Missouri, into Alkermes&#8217; global headquarters in Dublin, Ireland and other locations of Alkermes across the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">No material changes are envisaged by Alkermes with respect to the redeployment of Avadel&#8217;s fixed asset base. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">8.3</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Delisting and Deregistration of Avadel Shares</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As further described in the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Delisting and Deregistration of Avadel Shares</font><font style="letter-spacing:0.2pt;">&#8221; following Completion, the Avadel Shares will be delisted from Nasdaq Global Market and deregistered under the U.S. Securities of Exchange Act 1934 (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exchange Act</font><font style="letter-spacing:0.2pt;">&#8221;) and will cease to be publicly traded. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Management Incentivization</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Information in relation to transaction bonuses that Avadel may grant to Avadel employees is set out in paragraph 11.1 below. Otherwise, Alkermes has not entered into, and has not had discussions or proposals to enter into, any form of incentivization arrangements, with members of Avadel&#8217;s management. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.41pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
        <div style=" margin-top:7.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">BOARD, MANAGEMENT AND EMPLOYEES</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">9.1</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Generally</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the Scheme becoming effective, all of the directors of Avadel intend to resign from the Avadel Board and one or more persons nominated by Alkermes will be appointed to the Avadel Board. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.41pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">9.2</font>
          <br >
        </div>
        <div style=" margin-top:7.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Indemnification and Insurance</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Information in relation to existing and future indemnification and insurance arrangements for Avadel&#8217;s directors and executive officers is set out in paragraph 11.3 below. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">9.3</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Employment and Benefits Matters</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From the date of Completion through the earlier of (x)&#160;the first anniversary of the Effective Time and (y)&#160;the termination of the employment of any relevant Avadel employee (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Benefits Continuation Period</font><font style="letter-spacing:0.2pt;">&#8221;), Alkermes will provide, or will cause its subsidiaries to provide, each Avadel employee with (i)&#160;an annual base salary or base wage rate (as applicable) and target annual cash bonus opportunity or target cash commissions opportunity no less favorable, in the aggregate, than as provided immediately prior to the Effective Time (provided that each Avadel employee&#8217;s annual base salary or base wage rate (as applicable) shall also independently be no less than 95% of the annual base salary or base wage rate (as applicable) in effect immediately prior to the Effective Time), and (ii)&#160;employee pension and welfare benefits that are no less favorable in the aggregate than those provided to similarly situated employees of Alkermes. For purposes of clause (ii), any defined benefit pension plans, non-qualified deferred compensation plans, subsidized retiree health or welfare benefits, post-termination health or welfare benefits and retention or change-in-control payments or awards will not be taken into account. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Alkermes will recognize continuing Avadel employees&#8217; length of employment with Avadel and its subsidiaries and predecessors for purposes of determining vesting, eligibility to participate, and determining </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">89</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">level of benefits under Alkermes benefit plans providing benefits to continuing Avadel employees to the same extent and for the same purpose as such service was recognized under the corresponding Avadel benefit plans in which the continuing Avadel employee participated immediately prior to the Effective Time, except that length of employment will not be recognized (i)&#160;by any defined benefit pension plan or any retiree or post-termination health or welfare benefits, (ii)&#160;by any benefit plan that is frozen or for which participation is limited to a grandfathered population, (iii)&#160;any equity-based compensation arrangements, or (iv)&#160;to the extent it would result in a duplication of benefits or compensation for the same period of service. Service will only be credited to the extent such service is credited for similarly situated Alkermes employees. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each continuing Avadel employee will be immediately eligible to participate, without any waiting time, in any and all Alkermes benefit plans to the extent coverage under such Alkermes benefit plan is replacing comparable coverage under an employee plan in which such continuing Avadel employee had already satisfied any such waiting period and participated immediately before the effective time (such plans, collectively, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Old Plans</font><font style="letter-spacing:0.2pt;">&#8221;) and for purposes of each Alkermes benefit plan providing medical, dental, pharmaceutical or vision benefits to any continuing Avadel employee, Alkermes will use its reasonable best efforts to cause (1)&#160;all pre-existing condition exclusions and actively-at-work requirements of such Alkermes benefit plan to be waived for such employee and his or her covered dependents, unless and to the extent the individual, immediately prior to entry in the Alkermes benefit plans, was subject to such conditions under the comparable Old Plans and (2)&#160;any eligible expenses incurred by such continuing Avadel employee and his or her covered dependents under the Old Plans during the portion of the plan year of such plans ending on the date such Avadel employee&#8217;s participation in the corresponding Alkermes plan begins to be taken into account under the Alkermes plan for the purposes of satisfying all deductible, coinsurance and maximum out-of-pocket requirements applicable to such continuing Avadel employee and his or her covered dependents for the applicable plan year as if such amounts had been paid in accordance with such Alkermes plan. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">AVADEL EQUITY AWARD HOLDERS</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This section describes the treatment of Avadel equity awards. As is required by Rule&#160;15 of the Irish Takeover Rules, appropriate proposals will be made by Alkermes to the Equity Award Holders in connection with the Scheme. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the terms of the Transaction Agreement, the outstanding Avadel equity awards will be treated as follows: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each option to purchase Avadel Shares granted under any Avadel equity incentive plan, program or arrangement under which equity awards are outstanding (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Avadel Share Plans</font><font style="letter-spacing:0.2pt;">&#8221;), including each option with vesting based all or partially on performance conditions (each an &#8220;Avadel Performance-Based Option&#8221;) (each an &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Avadel Option</font><font style="letter-spacing:0.2pt;">&#8221;) having an exercise price less than the Cash Consideration (each such option, an &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Avadel Cash-Out Option</font><font style="letter-spacing:0.2pt;">&#8221;) that is outstanding as of immediately prior to the Effective Time, whether or not vested, will be cancelled and, in exchange therefor, the holder of such cancelled Avadel Cash-Out Option will be entitled to receive (without interest): (i)&#160;an amount in cash (less applicable tax and other mandatory withholdings) equal to the product of (x)&#160;the total number of Avadel Shares subject to such Avadel Cash-Out Option immediately prior to the Effective Time, </font><font style="font-style:italic;letter-spacing:0.2pt;">multiplied</font><font style="letter-spacing:0.2pt;"> by (y)&#160;the excess of the Cash Consideration over the applicable exercise price per Avadel Share under such Avadel Cash-Out Option; and (ii)&#160;one (1)&#160;CVR for each Avadel Share subject to such Avadel Cash-Out Option immediately prior to the Effective Time (without regard to vesting); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each Avadel Option with an exercise price equal to or greater than the Cash Consideration (and which is therefore not an Avadel Cash-Out Option) that is outstanding immediately prior to the Effective Time, whether or not vested, will be cancelled for no consideration; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each award of restricted share&#160;units representing the right to receive one or more Avadel Shares or the cash value thereof upon vesting and settlement, whether granted pursuant to the Avadel Share Plans or otherwise (each, an &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Avadel RSU Award</font><font style="letter-spacing:0.2pt;">&#8221;) that is outstanding will be cancelled and, in exchange therefor, the holder of such cancelled Avadel RSU Award will be entitled to receive (without interest): (i)&#160;an amount in cash (less applicable tax and any other mandatory withholdings) equal to the product of (x)&#160;the total number of Avadel Shares subject to such Avadel RSU Award immediately </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">90</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:26.72pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">prior to the Effective Time multiplied by (y)&#160;the Cash Consideration; and (ii)&#160;one (1)&#160;CVR for each Avadel Share subject to such Avadel RSU Award immediately prior to the Effective Time (without regard to vesting); and </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each award of Avadel Shares subject to vesting restrictions or forfeiture back to Avadel (each, an &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Avadel Restricted Stock Award</font><font style="letter-spacing:0.2pt;">&#8221;), whether granted pursuant to the Avadel Share Plans or otherwise that is outstanding immediately prior to the Effective Time will vest in full as of immediately prior to the Effective Time and will be treated in the same manner as all other Avadel Shares. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Further details regarding the procedures to be followed by the Equity Award Holders will be set out in the Rule&#160;15 proposal to be made by Alkermes to the Equity Award Holders. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">AVADEL DIRECTORS &amp; EXECUTIVE OFFICERS AND THE EFFECT OF THE SCHEME ON THEIR INTERESTS</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">11.1</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Interests of Certain Persons in the Transaction</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In considering the recommendation of the Avadel Board with respect to the Transaction Agreement, you should be aware that some of Avadel&#8217;s directors and executive officers may have interests in the Transaction that are in addition to, or different from, any interests of Avadel Shareholders generally. These interests are described in more detail below, and, with respect to the executive officers of Avadel, are quantified in the table below. The Avadel Board was aware of these interests and considered them when it adopted the Transaction Agreement and approved the Transaction. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel &#8216;s current executive officers and their respective positions are as follows: </font>
        </div>
        <table style="width:416pt;height:68.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:202pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:202pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Gregory J. Divis</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Chief Executive Officer and Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Thomas S. McHugh</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Chief Financial Officer</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Susan Rodriguez</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Chief Operating Officer</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Jerad G. Seurer</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">General Counsel &amp; Corporate Secretary</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13.19pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Treatment of Equity Awards</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth (i)&#160;the number of Avadel Shares underlying the Avadel Restricted Stock Awards and the Avadel Options whether vested or unvested, held by each Avadel executive officer and director as of November&#160;7, 2025, the latest practicable date to determine these numbers before the filing of this proxy statement and (ii)&#160;the estimated aggregate value of such equity awards as of such date, determined in each case by multiplying (a)&#160;the number of Avadel Shares subject to the Avadel equity award by (b)(i) in the case of the minimum value, $18.50, less the applicable exercise price for the Avadel Options and (b)(ii) in the case of the maximum value, $20.00, less the applicable exercise price for the Avadel Options. For information regarding the beneficial ownership of Avadel Shares held by each of Avadel&#8217;s directors and named executive officers and all of Avadel&#8217;s directors and executive officers as a group, see the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Security Ownership of Management and Certain Beneficial Owners</font><font style="letter-spacing:0.2pt;">.&#8221; Each of Avadel&#8217;s directors and executive officers shall be entitled to receive, for each Avadel Share he or she holds, the same consideration in the same manner as other Avadel Shareholders shall receive for an Avadel Share in connection with the Transaction. In addition, for information regarding the treatment in connection with the Transaction of the purchase rights granted to Avadel&#8217;s executive officers under the ESPP, see the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction&#8201;&#8212;&#8201; Treatment of Purchase Rights Under the Employee Share Purchase Plan</font><font style="letter-spacing:0.2pt;">&#8221;. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">91</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:239.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;height:22.75pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:126.07pt;text-align:left;" rowspan="2">
              <div style="white-space:nowrap; line-height:9pt; padding-bottom:0.333333333333333pt;">
                <font style="letter-spacing:-0.16pt;">Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" rowspan="2" colspan="4">
              <div style="text-align:center; line-height:9pt; padding-bottom:0.333333333333333pt;">
                <font style="letter-spacing:-0.16pt;">Avadel</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Restricted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Value for Avadel</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Restricted Stock Awards</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" rowspan="2" colspan="4">
              <div style="text-align:center; line-height:9pt; padding-bottom:0.333333333333333pt;">
                <font style="letter-spacing:-0.16pt;">Avadel</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Value for Avadel Options</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;height:22.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Minimum</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Maximum</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Minimum</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Maximum</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:126.07pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Directors</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.07pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter Thornton </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">203,500 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">220,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">241,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,676,470 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,037,970 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.07pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Linda Palczuk </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">203,500 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">220,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">266,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,865,720 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,264,720 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.07pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Geoffrey Glass </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">203,500 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">220,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">241,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,676,470 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,037,970 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.07pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Eric Ende </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">203,500 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">220,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">249,057 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,813,520 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,187,105 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.07pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">52,000 </td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">962,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,040,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">2,870,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">31,257,800 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">35,562,800 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.07pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mark McCamish </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">203,500 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">220,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">291,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,103,070 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,539,570 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.07pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Naseem Amin </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">203,500 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">220,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">71,500 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">235,070 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">342,320 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.07pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Executive Officers</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.07pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">52,000 </td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">962,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,040,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">2,870,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">31,257,800 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">35,562,800 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.07pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas S. McHugh </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">12,600 </td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">233,100 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">252,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,004,500 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">11,608,085 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">13,114,835 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.07pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Susan Rodriguez </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212; </td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">300,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,673,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,123,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.07pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jerad G. Seurer </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">14,700 </td>
            <td style="padding:0pt;padding-left:2.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">271,950 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">294,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">491,500 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">4,865,470 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">5,602,720</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.1pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Severance Entitlements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each Avadel executive officer is a party to an employment agreement with Avadel&#8217;s U.S. subsidiary which provides for the severance benefits described below if the executive officer&#8217;s employment is terminated by the executive officer for &#8220;good reason&#8221; or by Avadel for any reason other than &#8220;cause&#8221; &#8203;(as such terms are defined in each Avadel executive officer&#8217;s employment agreement), including non-renewal by Avadel at the end of the employment term. Upon such a termination each Avadel executive officer is entitled to receive payment of accrued but unpaid bonuses for any completed fiscal year and vacation pay, expense reimbursement and other benefits due under Avadel benefit plans, and, subject to the Avadel executive officer&#8217;s execution and non-revocation of a separation and release agreement in favor of Avadel, (i)&#160;an amount equal to 1.0 </font><font style="font-style:italic;letter-spacing:0.2pt;">times</font><font style="letter-spacing:0.2pt;"> the executive officer&#8217;s then-current base salary (or, for Mr.&#160;Divis, 1.5 </font><font style="font-style:italic;letter-spacing:0.2pt;">times</font><font style="letter-spacing:0.2pt;"> his then-current base salary), payable in substantially equal installments in accordance with Avadel&#8217;s normal payroll practices; and (ii)&#160;if the Avadel executive officer elects continuation coverage under COBRA, payment of the Avadel executive officer&#8217;s monthly COBRA premiums until (x)&#160;12&#160;months (or, for Mr.&#160;Divis, 18&#160;months) following the Avadel executive officer&#8217;s date of termination or (y)&#160;the date that the Avadel executive officer becomes covered under similar plans of any subsequent employer or otherwise ineligible for COBRA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to the severance benefits described above, if such a termination occurs (A)&#160;for Mr.&#160;Divis, within 6&#160;months prior to or 18&#160;months following a &#8220;change of control&#8221; &#8203;(as defined in Mr.&#160;Divis&#8217; employment agreement), or (B)&#160;for each other Avadel executive officer, within 18&#160;months following a &#8220;change of control&#8221; &#8203;(as defined in each such Avadel executive officer&#8217;s employment agreement), the Avadel executive officer is entitled to also receive (i)&#160;immediate vesting of 100% of such Avadel executive officer&#8217;s outstanding and unvested stock options and other stock-based awards, (ii)&#160;extension of such any outstanding and vested stock options held by such Avadel executive officer as of the date of termination, with such stock options remaining outstanding and exercisable until the 18-month anniversary of such date of termination (not to extend beyond the original maximum term of such stock option); and (iii)&#160;for Mr.&#160;Divis only, a lump sum payment equal to the higher of (x)&#160;the greater of (I)&#160;his target bonus in effect for the fiscal year in which the change of control occurs or (II)&#160;his target bonus in effect for the fiscal year in which the termination of employment occurs, or (y)&#160;his actual bonus for performance during the calendar year prior to the calendar year during which the termination of employment occurs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Completion of the Transaction will qualify as a &#8220;change of control&#8221; under each Avadel executive officer&#8217;s employment agreement, and the payments and benefits provided under such employment agreements in connection with the Transaction may be subject to an excise tax under Section&#160;4999 of the U.S. Internal Revenue Code of 1986, as amended (referred to hereinafter as the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Code</font><font style="letter-spacing:0.2pt;">&#8221;). These payments and benefits may </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">92</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">also not be eligible for U.S. federal income tax deduction for Avadel&#8217;s U.S. subsidiary pursuant to Section&#160;280G of the Code. If the payments or benefits payable to each Avadel executive officer in connection with the Transaction would be subject to the excise tax imposed under Section&#160;4999 of the Code, then those payments or benefits will be reduced if such reduction would result in a higher net after-tax benefit to the Avadel executive officer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">All severance benefits (other than due to death or complete disability) provided to Avadel&#8217;s named executive officers pursuant to their employment agreements are contingent upon the executive&#8217;s execution of a separation agreement and release of claims in Avadel&#8217;s favour.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Transaction Bonuses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to the Effective Time, Avadel may (subject, if required, to: (i)&#160;consent of the Irish Takeover Panel; and (ii) in accordance with Rule&#160;16.2 of the Irish Takeover Rules, Morgan Stanley and/or Goldman Sachs (as independent advisors to Avadel) having stated publicly that, in their opinion, the arrangements are fair and reasonable), grant transaction bonuses to employees of Avadel and the aggregate amount of such transaction bonuses shall not exceed $1&#160;million (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Transaction Bonuses</font><font style="letter-spacing:0.2pt;">&#8221;), though no executive officer of Avadel has received or will receive a transaction bonus in connection with the Transaction. The Transactions Bonuses shall be paid in three increments between Completion and the first anniversary of Completion (subject to the recipient&#8217;s continued employment or other service relationship with Avadel through the time of each payment; provided, that in the event that a recipient&#8217;s employment or other service relationship is terminated by Avadel without &#8220;cause&#8221; &#8203;(as defined in Avadel&#8217;s severance policy) prior to the applicable payment date, any portion of the transaction bonus not yet paid shall be paid in full to such employee within 30&#160;days after such termination date) </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Acceleration of 2025 Annual Bonuses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Completion occurs prior to the date that Avadel would normally pay annual bonuses for the 2025 fiscal year, each employee participating in Avadel&#8217;s corporate annual cash incentive program, including Avadel&#8217;s executive officers, will receive an annual bonus for the 2025 fiscal year as soon as practicable following the Completion Date at the greater of target or actual performance. The following table sets forth each Avadel executive officer&#8217;s target bonus for 2025 (assuming payout at 100%): </font>
        </div>
        <table style="width:416pt;height:86.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:363.82pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Target 2025</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Bonus</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:363.82pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.235pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">390,960 </td>
            <td style="padding:0pt;padding-left:1.235pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.82pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas S. McHugh </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.235pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">209,417 </td>
            <td style="padding:0pt;padding-left:1.235pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.82pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Susan Rodriguez</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.235pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">146,503 </td>
            <td style="padding:0pt;padding-left:1.235pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.82pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jerad G. Seurer </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.235pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">189,000</td>
            <td style="padding:0pt;padding-left:1.235pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.89pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8.4pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Pursuant to Ms.&#160;Rodriguez&#8217; employment agreement, her annual bonus for the 2025 fiscal year will be pro-rated based on the date she began employment with Avadel. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">280G Mitigation Actions</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel may take certain tax-planning actions to mitigate potentially adverse tax consequences under the &#8220;golden parachute&#8221; provisions of Sections&#160;280G and 4999 of the Code that could arise in connection with Completion of the Transaction. The tax-planning and mitigation actions may include accelerating vesting of equity awards and/or payment of 2025 bonuses for Avadel executive officers but may not, for the avoidance of doubt, pay any gross-ups or similar make-whole payments. However, any accelerated payments for Avadel executive officers will be subject to clawback in the event that the Avadel executive officer terminates employment for any reason other than death, disability or a severance-eligible termination, as described above under the heading &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Severance Entitlements&#8221;</font><font style="letter-spacing:0.2pt;"> prior to the date such vesting or payment would otherwise have occurred. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">93</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director and Officer Indemnification Insurance</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the terms of the Transaction Agreement, Avadel&#8217;s directors and officers shall be entitled to certain ongoing indemnification and coverage under directors&#8217; and officers&#8217; liability and fiduciary liability insurance policies following the Transaction. Such indemnification and insurance coverage is further described in paragraph 11.3. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.19pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">11.2</font>
          <br >
        </div>
        <div style=" margin-top:8.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Continuing Directors</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon the Scheme becoming effective, all of the current directors of Avadel intend to resign from the Avadel Board and one or more persons nominated by Alkermes will be appointed to the Avadel Board. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">11.3</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Indemnification and Insurance</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel and its subsidiary, Avadel US Holdings, Inc., are party to certain indemnification agreements that require Avadel, among other things, to indemnify the present and former directors, officers and certain employees against certain liabilities that may arise by reason of their status or service as directors or officers, to the extent permitted by law. In addition, pursuant to the terms of the Transaction Agreement, certain directors and officers of Avadel will be entitled to certain ongoing indemnification and coverage under directors&#8217; and officers&#8217; liability and fiduciary liability insurance policies following the Transaction. Such indemnification and insurance coverage is further described in the Transaction Agreement. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">TAXATION</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Your attention is drawn to the section of this proxy statement entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Material Tax Consequences of the Proposed Transaction</font><font style="letter-spacing:0.2pt;">&#8221; which provides a high-level summary of the principal Irish and U.S. tax consequences of the Transaction. If you are in any doubt as to your own position with respect to taxation, if you require more detailed information or if you are subject to taxation in any jurisdiction other than Ireland or the United States, you should consult an independent financial advisor or tax advisor immediately. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">13</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">SETTLEMENT, DELISTING AND DEALINGS</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Following the consummation of the Transaction, all Avadel Shares will be delisted from Nasdaq Global Market and deregistered under the Exchange Act and will cease to be publicly traded. The last day of dealings in Avadel Shares on the Nasdaq Global Market is currently expected to be on or about the Business Day prior to the Effective Date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Alkermes will (a)&#160;appoint the Paying Agent to effect the technical implementation of the settlement of the Cash Consideration to the Avadel Shareholders entitled thereto following effectiveness of the Scheme and (b)&#160;procure the Rights Agent (mutually acceptable to Avadel and Alkermes) to effect the technical implementation of the settlement of the CVR Consideration, if applicable, to Avadel Shareholders entitled thereto following effectiveness of the Scheme. Following the Effective Time, it is intended that Avadel will be re-registered as a private company limited by shares. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">13.1</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme Consideration</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to the Scheme becoming effective, settlement of the consideration to which any Avadel Shareholder (save as set out below) is entitled under the Transaction will be paid to such Avadel Shareholders within fourteen (14) days following the Effective Date whereupon (i)&#160;the Paying Agent appointed by Alkermes will deliver, or cause to be delivered, the cheques for the Cash Consideration to the persons entitled thereto, unless otherwise properly directed by the person entitled thereto and (ii)&#160;the Rights Agent will record the Avadel Shareholders entitled thereto as the owners of the CVR Consideration in the CVR Register in accordance with the terms of the CVR Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Settlement of the consideration (net of withholding taxes required to be deducted and withheld by applicable laws) to which any current or former employees of the Avadel Group are entitled in respect of Unvested Scheme Shares, will be paid through payroll within ten (10) business days of the Effective Date; provided, however, that to the extent that any such Holder of Scheme Shares is not, and was not at any time during the vesting period applicable to such Scheme Shares, an employee of the Avadel Group for </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">94</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:116pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">employment tax purposes, such Holder of Scheme Shares shall receive the consideration payable to them in accordance with the procedure set out above. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">13.2</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">General</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Alkermes has confirmed that, except as provided for in the Scheme or otherwise with the consent of the Irish Takeover Panel, any payment to which an Avadel Shareholder is entitled to receive from Alkermes will be implemented in full without regard to any lien, right of set-off, counterclaim or other analogous right to which Alkermes may be, or claim to be, entitled against any such Avadel Shareholder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All documents and remittances sent to Avadel Shareholders (or in accordance with their directions) will be dispatched at their own risk. It is intended that all cheques issued by the Paying Agent will be drawn on a clearing bank in the United States. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">13.3</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Certain Effects of the Scheme</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At Completion of the Transaction, which is expected in the first quarter of 2026, Avadel will become a wholly owned subsidiary of Alkermes. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">14.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">OVERSEAS SHAREHOLDERS</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As regards overseas shareholders of Avadel (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Overseas Shareholders</font><font style="letter-spacing:0.2pt;">&#8221;), the Transaction may be affected by the laws of the relevant jurisdictions. Such Overseas Shareholders should inform themselves about and observe any applicable legal requirements of such relevant jurisdictions. It is the responsibility of Overseas Shareholders to satisfy themselves as to the full observance of the laws of the relevant jurisdiction in connection therewith, including the obtaining of any governmental, exchange control or other consents which may be required, or the compliance with other necessary formalities which are required to be observed and the payment of any issue, transfer or other taxes due in such jurisdiction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This explanatory statement has been prepared for the purposes of complying with the laws of Ireland and the United States and the Irish Takeover Rules and the rules of the SEC, respectively (to the extent applicable), and the information disclosed may be different from that which would have been disclosed if this document had been prepared in accordance with the laws of jurisdictions outside Ireland and the United States. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Overseas Shareholders are encouraged to consult their local tax and legal advisors. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">15</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">ACTION TO BE TAKEN</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">Please refer to the section of this proxy statement entitled &#8220;</font><font style="letter-spacing:0.2pt;">Part&#160;1&#8201;&#8212;&#8201;The Transaction and the Special Meetings&#8201;&#8212;&#8201;The Special Meetings of Avadel&#8217;s Shareholders</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; for a summary of the actions to be taken. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:22pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">16</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:22pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">FURTHER INFORMATION</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The terms of the Scheme are set out in full in </font><font style="font-style:italic;letter-spacing:0.2pt;">Part&#160;3&#8201;&#8212;&#8201;The Scheme of Arrangement</font><font style="letter-spacing:0.2pt;"> of this proxy statement. Your attention is drawn to the conditions and further terms of the Transaction set out in the remaining parts of this proxy statement, all of which form part of this proxy statement.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">95</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tP3TS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PART 3&#8201;&#8212;&#8201;THE SCHEME OF ARRANGEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">THE SCHEME OF ARRANGEMENT </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2025 No. [&#8199;&#8199;] COS </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE HIGH COURT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">IN THE MATTER OF </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AVADEL PHARMACEUTICALS PLC</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">AND IN THE MATTER OF </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE COMPANIES ACT 2014</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SCHEME OF ARRANGEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(UNDER CHAPTER 1 OF PART 9 OF THE COMPANIES ACT 2014)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">BETWEEN </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AVADEL PHARMACEUTICALS PLC</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">AND </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE HOLDERS OF THE SCHEME SHARES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(AS HEREINAFTER DEFINED)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRELIMINARY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">A.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">In this Scheme, unless inconsistent with the subject or context, the following expressions bear the following meanings: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;margin-bottom:5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Alkermes</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Alkermes plc, a public limited company incorporated under the laws of Ireland (with registration number 498284) having its registered office at Connaught House, 1 Burlington Road, Dublin&#160;4, Ireland, D04 C576;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Alkermes Group</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">Alkermes and all its Subsidiaries from time to time;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Antitrust Laws</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the Sherman Act of 1890, the Clayton Act of 1914, the Federal Trade Commission Act of 1914, the HSR Act and all other federal, state and foreign applicable Laws in effect from time to time that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or the substantial lessening of competition;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Avadel</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Avadel Pharmaceuticals plc, a public limited company incorporated under the laws of Ireland (with registration number 572535) having its registered office at 10 Earlsfort Terrace, Dublin&#160;2, D02 T380, Ireland;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Avadel Board</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the board of directors of Avadel from time to time and for the time being;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Avadel Group</font><font style="letter-spacing:0.2pt;">&#8221; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">Avadel and all its Subsidiaries from time to time;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Avadel Shareholders</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">Holders of Avadel Shares;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Avadel Shares</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the ordinary shares issued in the capital of Avadel with a nominal value of US$0.01 per share;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">96</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Business Day</font><font style="letter-spacing:0.2pt;">&#8221; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">any day other than a Saturday, Sunday or public holiday in Dublin or New York;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Cash Consideration</font><font style="letter-spacing:0.2pt;">&#8221; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">$18.50 in cash per Scheme Share;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Circular</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the proxy statement dated [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;], 2025 sent to Avadel Shareholders (and for information only, to Equity Award Holders) of which this Scheme forms a part;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Companies Act</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">the Companies Act 2014, as amended;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Product</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">all products or product candidates that are being researched, tested, developed, labeled, handled, packaged, stored, supplied, promoted, imported, exported, commercialized, manufactured, sold, distributed, licensed, sublicensed or held for license or sublicense by any member of the Avadel Group and all products or product candidates, if any, with respect to which any member of the Avadel Group has royalty rights, including Avadel&#8217;s proprietary formulations of sodium oxybate known as (i)&#160;LUMRYZ</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> (sodium oxybate) for extended-release oral suspension and (ii)&#160;valiloxybate, an investigational, once-at-bedtime, salt-free and artificial sweetener-free, extended-release oxybate, as licensed pursuant to a license agreement between Avadel and XWPharma Ltd.;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Regulatory Agency</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">any Government Entity with jurisdiction related to the quality, identity, strength, purity, safety, efficacy, testing, manufacturing, labeling, storage, distribution, marketing, sale, pricing, import or export of any of the Company Products;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Restricted Stock Award</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">all awards of Avadel Shares subject to vesting restrictions or forfeiture back to Avadel, whether granted pursuant to the Company Share Plans or otherwise;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Share Plans</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">has the meaning given to it in the Transaction Agreement;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Completion</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">the completion of the Transaction;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Conditions</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the conditions to the Scheme and the Transaction set out in Appendix&#160;III of the Rule&#160;2.7 Announcement and &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Condition</font><font style="letter-spacing:0.2pt;">&#8221; means any one of the Conditions;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Court Hearing</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the hearing by the Irish High Court of the application to sanction the Scheme under Section&#160;453 of the Companies Act;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Court Order</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the order or orders of the Irish High Court sanctioning the Scheme under Section&#160;453 of the Companies Act;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">CVR Agreement</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the contingent value rights agreement to be entered into by and between Alkermes and the Rights Agent, substantially in the form attached to the Transaction Agreement;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">CVR Consideration</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">one (1)&#160;contractual non-tradeable contingent value right per Scheme Share which shall represent the right to receive a potential additional cash payment pursuant to the CVR Agreement;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">CVR Register</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">has the meaning given to it in the CVR Agreement;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Designated Shares</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">any Avadel Shares held from time to time by Alkermes, any other member of the Alkermes Group and / or any nominee of any member of the Alkermes Group;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Effective Date</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the date on which the Scheme becomes effective in accordance with clause 7 of this Scheme;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Effective Time</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the time on the Effective Date at which the Scheme becomes effective in accordance with clause 7 of this Scheme;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">97</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EGM</font><font style="letter-spacing:0.2pt;">&#8221; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the extraordinary general meeting of Avadel Shareholders (and any adjournment or postponement thereof) to be convened in connection with the Scheme on [&#8199;&#8199;], 2026 at [&#8199;&#8199;] a.m. (Irish time) or, if later, immediately after the conclusion of the Scheme Meeting (it being understood that, if the Scheme Meeting is adjourned or postponed, the EGM shall be correspondingly adjourned or postponed);</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">End Date</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the date that is nine (9)&#160;months from October&#160;22, 2025 (being July&#160;22, 2026), provided that, if Completion shall not have occurred as of the End Date and all the conditions to Completion, other than Conditions 1, 2.3, 2.4 and 3.1 (including as a result of a Government Shutdown), would be satisfied if Completion were to occur on such date, the End Date shall be automatically extended to the date that is twelve&#160;months (12) from October&#160;22, 2025 (being October&#160;22, 2026), and such date shall be the End Date;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Equity Award Holder Proposal</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">the proposal of Alkermes to the Equity Award Holders to be made in accordance with the Transaction Agreement, Rule&#160;15 of the Takeover Rules and the terms of the Company Share Plans (as defined in the Transaction Agreement);</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Equity Award Holders</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">holders of certain equity awards issued by Avadel;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EUR&euro;</font><font style="letter-spacing:0.2pt;">&#8221; or &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">&euro;</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">euro, the lawful currency of Ireland;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Forms of Proxy</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the </font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">BLUE</font><font style="letter-spacing:0.2pt;"> form of proxy for the Scheme Meeting and the </font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">YELLOW</font><font style="letter-spacing:0.2pt;"> form of proxy for the EGM, as the context may require;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Government Entity</font><font style="letter-spacing:0.2pt;">&#8221; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">United States, Irish or other foreign or supranational, federal, state or local government or any commission, board, body, division, political subdivision, bureau or other regulatory authority or agency thereof, and including courts and other judicial bodies, or any competition, antitrust, national security, foreign investment or supervisory body, central bank, public international organization or other governmental, trade or regulatory agency or body, securities exchange or any self-regulatory body or authority, including any instrumentality or entity designed to act for or on behalf of the foregoing, in each case, in any jurisdiction, and including the Irish Takeover Panel, the Irish High Court, the SEC and each Company Regulatory Agency;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Government Shutdown</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">any shutdown resulting from the lack of Congressional budget appropriations, prior to the End Date, of certain United States federal government services provided by the Federal Trade Commission and Department of Justice to review the transactions contemplated by the Transaction Agreement under the HSR Act;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Holder</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">in relation to any Avadel Share, the Member whose name is entered in the Register of Members as the holder of that share and &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Joint Holders</font><font style="letter-spacing:0.2pt;">&#8221; means the Members whose names are entered in the Register of Members as the joint holders of that share and includes any person(s) entitled by transmission;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">HSR Act</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Irish High Court</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">the High Court of Ireland;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Law</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">any federal, state, local, foreign or supranational law, statute, ordinance, rule, regulation, judgment, order, injunction, decree, executive order or agency requirement of any Government Entity;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">98</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:7pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Members</font><font style="letter-spacing:0.2pt;">&#8221; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the members of Avadel as entered in its Register of Members at any relevant date, and &#8220;Member&#8221; will be interpreted accordingly;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Order</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">any order, writ, decree, judgment, award, injunction, ruling, settlement or stipulation issued, promulgated, made, rendered or entered into by or with any Government Entity or arbitrator (in each case, whether temporary, preliminary or permanent);</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Parties</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Avadel and Alkermes; &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Party</font><font style="letter-spacing:0.2pt;">&#8221; shall mean Avadel or Alkermes (as the context requires);</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Paying Agent</font><font style="letter-spacing:0.2pt;">&#8221; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the bank or trust company appointed by Alkermes to act as paying agent for the payment of the Cash Consideration;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Register of Members</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Avadel&#8217;s register of members maintained pursuant to the Companies Act;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Registrar of Companies</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the Registrar of Companies in Dublin, Ireland (being the &#8220;Registrar&#8221; as defined in Section&#160;2 of the Companies Act);</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Relevant Authority</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">any Irish, United States or other foreign national or supranational, federal, state, local or other governmental or regulatory authority, agency, commission, board, body, bureau, arbitrator, arbitration panel or other authority or agency, including courts and other judicial bodies, or any competition, anti-trust foreign investment review or supervisory body, central bank or other governmental, trade or regulatory agency or body, securities exchange, stock exchange or any self-regulatory body or authority, including any instrumentality or entity designed to act for or on behalf of the foregoing, in each case, in any jurisdiction (provided it has jurisdiction over the applicable person or its activities or property) including, for the avoidance of doubt, the Irish Takeover Panel, the Irish High Court, and the SEC;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Restricted Jurisdiction</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">any jurisdiction where it would be unlawful to send or make available information concerning the Transaction to Avadel Shareholders;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Restricted Overseas Shareholder</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">an Avadel Shareholder (including an individual, partnership, unincorporated syndicate, limited liability company, unincorporated organisation, trust, trustee, executor, administrator or other legal representative) in, or resident in, or any Avadel Shareholder whom Avadel believes to be in, or resident in, a Restricted Jurisdiction;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Rights Agent</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the rights agent named in the preamble of the CVR Agreement, until a successor rights agent is appointed pursuant to the applicable provisions of the CVR Agreement, and thereafter &#8220;Rights Agent&#8221; will mean such successor rights agent;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Rule&#160;2.7 Announcement</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the joint announcement made by Alkermes and Avadel on October&#160;22, 2025, pursuant to Rule&#160;2.7 of the Takeover Rules;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme</font><font style="letter-spacing:0.2pt;">&#8221; or &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme of Arrangement</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">this proposed scheme of arrangement under Chapter 1 of Part&#160;9 of the Act to effect the Transaction, on such terms and conditions and in such form as is consistent with the terms agreed to by the Parties as set out in the Rule&#160;2.7 Announcement, including any revision thereof as may be agreed between the Parties in writing, and, if required, by the Irish High Court and the Irish Takeover Panel;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">99</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme Consideration</font><font style="letter-spacing:0.2pt;">&#8221; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the aggregate of (i)&#160;the Cash Consideration and (ii)&#160;the CVR Consideration to be paid pursuant to this Scheme in respect of each Scheme Share held by Scheme Shareholders at the Scheme Record Time;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme Meeting Resolution</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">the resolution to be considered and voted on at the Scheme Meeting proposing that the Scheme in its original form or with or subject to any modification(s), addition(s) or condition(s) approved or imposed by the Court be agreed to;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme Meeting</font><font style="letter-spacing:0.2pt;">&#8221; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the meeting of the Avadel Shareholders or, if applicable, any class or classes of the Avadel Shareholders (including, but not limited to, as may be directed by the Irish High Court pursuant to Section&#160;450(5) of the Companies Act) (and any adjournment of any such meeting or meetings) convened by order of the Irish High Court to consider and vote on the Scheme Meeting Resolution, including any adjournments thereof;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme Record Time</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">11.59&#160;p.m. (U.S. Eastern time) on the last Business Day prior to the Effective Date;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme Shareholder</font><font style="letter-spacing:0.2pt;">&#8221; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">each Holder of Scheme Shares;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme Shares</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the Avadel Shares in issue at the Scheme Record Time but excluding any Designated Shares;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">SEC</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">the United States Securities and Exchange Commission;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Subsidiary</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">has the meaning as in Section&#160;7 of the Companies Act;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Takeover Rules</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">the Irish Takeover Panel Act, 1997, Takeover Rules, 2022;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Transaction</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the proposed acquisition by Alkermes of Avadel by means of this Scheme (as described in the Rule&#160;2.7 Announcement);</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Transaction Agreement</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">the transaction agreement dated October&#160;22, 2025, and entered into between Avadel and Alkermes;</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">US$</font><font style="letter-spacing:0.2pt;">&#8221; or &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">U.S. dollars</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:284pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">U.S. dollars, the lawful currency of the United States of America; and</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Voting Record Time</font><font style="letter-spacing:0.2pt;">&#8221;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:284pt;">
              <font style="letter-spacing:0.2pt;">[&#8199;&#8199;] (U.S. Eastern Time) on [&#8199;&#8199;], 2025,</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:16.6pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">and, unless otherwise specified, references to clauses are to clauses of this Scheme. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.59pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">B.</font>
          <br >
        </div>
        <div style=" margin-top:8.59pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The authorised share capital of Avadel on the date hereof is US$5,500,000 divided into 500,000,000 ordinary shares with a nominal value of US$0.01 each and 50,000,000 preferred shares with a nominal value of US$0.01 each and &euro;25,000 divided into 25,000 deferred ordinary shares with a nominal value of &euro;1.00 each. As of [&#8199;&#8199;], 2025 (being the last practicable date prior to the publication of the Circular), there were [&#8199;&#8199;] Avadel Shares and 25,000 deferred ordinary shares issued and outstanding, all of which are validly issued and fully paid up. There are no preferred shares in issue and no Avadel Shares are held in treasury. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">C.</font>
          <br >
        </div>
        <div style=" margin-top:8.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The purpose of the Scheme is to provide for the transfer of the Scheme Shares to Alkermes (and / or its nominee(s)) in consideration for Alkermes paying or procuring the payment of the Scheme Consideration (without interest and less any applicable withholding taxes) to the Scheme Shareholders. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">D.</font>
          <br >
        </div>
        <div style=" margin-top:8.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As of [&#8199;&#8199;], 2025 (being the last practicable date prior to the publication of the Circular), no member of the Alkermes Group held any Avadel Shares. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.49pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">E.</font>
          <br >
        </div>
        <div style=" margin-top:8.49pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Alkermes has agreed to submit to the terms of the Scheme. Alkermes undertakes to the Irish High Court to be bound by and to execute and do and procure to be executed and done all such documents, acts and things as may be necessary or desirable to be executed or done by it for the purpose of giving effect to this Scheme. Alkermes will appear by solicitor and / or counsel at the Court Hearing to formally provide this undertaking to the Irish High Court. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">100</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">F.</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The explanatory statement required to be furnished pursuant to Section&#160;452 of the Companies Act is set out in Part&#160;2 (</font><font style="font-style:italic;letter-spacing:0.2pt;">Explanatory Statement</font><font style="letter-spacing:0.2pt;">) of the Circular. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE SCHEME</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">TRANSFER OF THE SCHEME SHARES</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.1</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Pursuant to Chapter 1 of Part&#160;9 of the Companies Act and upon and with effect from the Effective Time, Alkermes (and / or its nominee(s)) shall acquire all of the Scheme Shares (including the legal and beneficial interest therein) held by each Scheme Shareholder fully paid, free from all options, liens, equities, charges, encumbrances, rights of pre-emption and any other third party rights and other interests and together with all and any rights at the date of this Scheme or thereafter attached thereto including voting rights and the right to receive and retain in full all dividends and other distributions (if any) and any return of capital (whether by reduction of share capital or share premium account or otherwise) announced, declared, paid or made in respect of the Scheme Shares by reference to a record date on or after the Effective Time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.2</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">For the purposes of such acquisition, the Scheme Shares shall be transferred to Alkermes (and / or its nominee(s)) and such transfer shall be effected by means of a form of transfer or other instrument or instruction of transfer, and to give effect to such transfer(s) any person may be appointed by Alkermes as attorney and / or agent and / or otherwise and shall be authorised, as such attorney and / or agent and / or otherwise on behalf of the relevant Scheme Shareholder or Scheme Shareholders concerned, to: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">execute and deliver as transferor a form of transfer or other instrument or instruction of transfer (whether as a deed or otherwise) of such Scheme Shares in favour of Alkermes (and / or its nominee(s)) on behalf of the Scheme Shareholder; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">give a good receipt in respect of consideration received in respect of any such transfer; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">give such instructions and do all other things which he or she may consider necessary or expedient in connection with such transfer, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">and every form or instrument or instruction executed or delivered or other such thing so done shall be as effective as if it had been executed, delivered or done by the Scheme Shareholder to which such form, instrument, instruction or thing relates. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">SCHEME CONSIDERATION FOR THE TRANSFER OF THE SCHEME SHARES</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.1</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">In consideration for the transfer of the Scheme Shares pursuant to clause 1, Alkermes shall pay the Scheme Consideration (without interest and less any applicable withholding taxes) to each Scheme Shareholder in accordance with clause 3. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.2</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">If, prior to the Effective Date, any dividend and / or other distribution and / or other return of capital is proposed, authorised, declared, paid or made or becomes payable by Avadel in respect of the Avadel Shares by reference to a record date prior to the Effective Date, Alkermes reserves the right to reduce the consideration payable under the terms of the Scheme by an amount up to the amount of that dividend and / or other distribution and / or return of capital except where the Scheme Shares are or will be acquired pursuant to the Scheme on a basis which entitles Alkermes to receive the dividend, distribution or return of capital and to retain it. If any such dividend and / or other distribution or return of capital occurs, any reference in this Scheme to the consideration payable under the Scheme will be deemed to be a reference to the consideration as so reduced. The exercise of those rights shall not be regarded as constituting any revision or variation of the terms of the Scheme. Any exercise by Alkermes of those rights shall be the subject of an announcement. To the extent that Alkermes exercises those rights, Avadel Shareholders will be entitled to receive and retain that dividend, distribution or return of capital. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.3</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">None of Alkermes or Avadel or their respective agents shall be liable to any Scheme Shareholder for any cash payment, dividend or distribution with respect to Scheme Shares delivered to a public </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">101</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">official in compliance with any law relating to abandoned property, escheat or law permitting attachment of money or property or similar law. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">SETTLEMENT OF SCHEME CONSIDERATION</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.1</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Prior to the Effective Date, Alkermes will appoint the Paying Agent to effect the technical implementation of the settlement of the Cash Consideration. For this purpose, Alkermes shall deposit, or cause to be deposited, with the Paying Agent, for the benefit of the Scheme Shareholders, cash in an amount equal to the aggregate Cash Consideration payable under the Scheme. Such deposit shall be made promptly and in any event in sufficient time to allow Alkermes to comply with clause 3.2. Prior to the Effective Date, Alkermes will also appoint the Rights Agent to effect the technical implementation of issuance of the CVRs to the applicable Scheme Shareholders and, if any amounts become payable pursuant to the CVR Agreement with respect to the CVRs, the settlement of the CVR Consideration. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.2</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Subject to clause 3.3, not later than fourteen (14) days after the Effective Date Alkermes shall deliver or procure the delivery to the persons entitled thereto, cheques for the Cash Consideration payable to them in accordance with clause 2.1, or payment shall otherwise be made in accordance with any dividend mandate in place pursuant to clause 3.5. All payments shall be made in U.S. dollars. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.3</font>
          <br >
        </div>
        <div style=" margin-top:7.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">In the case of Scheme Shares held by current or former employees of the Avadel Group that are subject to unvested Company Restricted Stock Awards as of immediately prior to the Effective Time (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Unvested Scheme Shares</font><font style="letter-spacing:0.2pt;">&#8221;), as soon as reasonably practicable after the Effective Date (but no later than ten (10) business days after the Effective Date), Alkermes shall, or shall cause its subsidiaries or Avadel to, pay through payroll the aggregate Cash Consideration payable with respect to such Scheme Shares in accordance with clause 2.1 (net of withholding taxes required to be deducted and withheld by applicable Laws); provided, however, that to the extent that any Holder of such Scheme Shares is not, and was not at any time during the vesting period applicable to such Scheme Shares, an employee of the Avadel Group for employment tax purposes, Alkermes shall pay, or cause to be paid, the Cash Consideration payable to them, in accordance with clause 2.1, pursuant to and as set out in clause 3.2. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.4</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Alkermes shall procure that, not later than fourteen (14) days after the Effective Date, the Rights Agent will record the Scheme Shareholders as the owners of the CVR Consideration in the CVR Register in accordance with the terms of the CVR Agreement. All payments due in respect of the CVR Consideration shall be made strictly in accordance with the terms and conditions of the CVR Agreement and the Transaction Agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.5</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Each mandate in force on the Effective Date relating to the payment of dividends or other distributions on any Scheme Shares and other instructions given to Avadel by Holders shall, unless notice of revocation of such instructions is received by the Paying Agent prior to the Scheme Record Time, be deemed to be an effective mandate or instruction to Alkermes to pay and despatch any amount payable to any Scheme Shareholder under the Scheme in accordance with such mandate. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.6</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">All despatches of cheques pursuant to clause 3.2 shall be effected by sending each cheque by registered post (or international standard post / mail, if overseas) in pre-paid envelopes addressed to the persons entitled thereto at their respective addresses as appearing in the Register of Members at the Scheme Record Time (or, in the case of Joint Holders, at the address of that one of the Joint Holders whose name stands first in the said Register of Members in respect of such joint holding at the Scheme Record Time). None of Alkermes or Avadel or any person or nominee appointed by Alkermes or Avadel or their respective agents shall be responsible for any loss or delay in transmission or delivery of any cheque(s) sent in accordance with this clause 3 which shall be sent entirely at the risk of the persons entitled thereto. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.7</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">All cheques drawn in accordance with this clause 3 shall be in U.S. dollars drawn on a U.S. clearing bank and shall be made payable to the Holder of the relevant Scheme Shares (except that, in the case of Joint Holders, Alkermes reserves the right to make such cheques payable to that </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">102</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">one of the Joint Holders whose name stands first in the Register of Members in respect of such joint holding at the Scheme Record Time), and the despatch of any such cheque in accordance with 3.2 shall be a complete discharge of Alkermes&#8217; obligations under this Scheme to pay, or procure the payment of, the monies represented thereby. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.8</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">In the absence of bad faith or wilful default, none of Alkermes or Avadel, any person or nominee appointed by Alkermes or Avadel or their respective agents shall have any liability for any loss or damage arising as a result of sale or transfer (including as a result of the timing or terms of such sale or transfer) or any instrument of transfer executed and / or delivered or any other thing done for or on behalf of any Scheme Shareholder pursuant to this Scheme. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.9</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The provisions of this clause 3 shall take effect subject to any condition or prohibition imposed by Law. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">OVERSEAS SHAREHOLDERS</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.1</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The provisions of clauses 1, 2 and 3 shall be subject to any prohibition or condition imposed by Law. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.2</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Notwithstanding the provisions of clause 4.1, Avadel retains the right to permit the release, publication or distribution of the Circular and / or the Forms of Proxy to any Restricted Overseas Shareholder who satisfies Avadel (acting in its absolute discretion) that doing so will not infringe the Laws of the relevant Restricted Jurisdiction or require compliance with any governmental or other consent or any registration, filing or other formality that Avadel is unable to comply with or which Avadel regards as unduly onerous to comply with. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5.</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">CERTIFICATES FOR SCHEME SHARES</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">With effect from the Effective Time any certificates or other statements of ownership representing Scheme Shares shall cease to have effect as documents of title to the shares comprised therein and every holder thereof shall be bound at the request of Avadel to deliver up such certificate(s) and/or statements to Avadel or as it may direct. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">AUTHORITY PENDING REGISTRATION OF TRANSFER</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">With effect from the Effective Time and until the Register of Members is updated to reflect the transfer of the Scheme Shares pursuant to clause 1: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.1</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each Scheme Shareholder irrevocably appoints Alkermes (or such of its nominee(s) as are directed by Alkermes) to exercise on its behalf any votes and any or all other rights and privileges (including, without limitation, the right to requisition the convening of a general meeting of Avadel or of any class of shareholders of Avadel) attaching to the Scheme Shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.2</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each Scheme Shareholder authorises Avadel and / or its agents to send any notice, circular, warrant, document or other communication which may be required to be sent to such Scheme Shareholder as a Member of Avadel in respect of their Scheme Shares to Alkermes and / or such of its nominee(s) as are directed by Alkermes at Alkermes&#8217; registered office; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.3</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each Scheme Shareholder irrevocably appoints Alkermes (or such of its nominee(s) as are directed by Alkermes) and / or any one or more of its directors or agents to sign on behalf of such Scheme Shareholder such documents, and to do such things, as may, in the opinion of Alkermes and / or any one or more of its directors or agents, to be necessary or desirable in connection with the exercise of any votes or other rights or privileges attaching to the relevant Scheme Shares (including, without limitation, an authority to sign any consent to short notice of a general meeting of Avadel as attorney or agent for, and on behalf of, such Scheme Shareholder and / or to attend and / or execute a form of proxy in respect of such Scheme Shares appointing any person nominated by Alkermes and / or any one or more of its directors or agents to attend general meetings of Avadel (or any adjournment thereof), and to exercise or refrain from exercising the votes attaching to the Scheme Shares on such Scheme Shareholder&#8217;s behalf); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">103</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:176pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.4</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each Scheme Shareholder irrevocably undertakes from the Effective Time: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">not to exercise any votes or any other rights attaching to the relevant Scheme Shares without the prior written consent of Alkermes; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">not to appoint a proxy or representative for, or to attend any general meeting or separate class meeting of Avadel. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">7.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">THE EFFECTIVE TIME</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">7.1</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">This Scheme shall become effective immediately upon delivery to the Registrar of Companies of a copy of the Court Order in accordance with Section&#160;454 of the Companies Act. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">7.2</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Unless the Scheme shall have become effective on or before the End Date or such earlier date as may be specified by the Irish Takeover Panel, or such later date as Avadel and Alkermes may agree, with the consent of the Irish Takeover Panel (if required) or the Irish High Court (if required), it shall not proceed and all undertakings given to the Irish High Court in respect of the Scheme shall be deemed to have lapsed with immediate effect. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">7.3</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Avadel and Alkermes have agreed (pursuant to the Transaction Agreement) that in certain circumstances the necessary actions to seek sanction of this Scheme may not be taken. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">8.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">MODIFICATION</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel and Alkermes may jointly consent on behalf of all persons concerned to any modification of or addition to this Scheme or any condition that the Irish High Court may approve or impose. Any such modification or addition may require, and may be conditional upon, the consent of the Irish Takeover Panel. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">9.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">COSTS</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel is authorised and permitted to pay all of its costs and expenses relating to the negotiation, preparation, approval and implementation of this Scheme. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">10.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">GOVERNING LAW</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This Scheme is governed by and shall be construed in accordance with the Laws of Ireland and Avadel, Alkermes and the Scheme Shareholders hereby agree that the Irish High Court shall have exclusive jurisdiction to hear and determine any suit, action or proceeding or to settle any dispute which may arise in relation thereto and the sanction thereof. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Dated: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;], 2025</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">104</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tP4AI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADDITIONAL INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(as required by the Irish Takeover Panel Act, 1997, Takeover Rules 2022 </font>
          <br >
          <font style="letter-spacing:0.2pt;">(the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Irish Takeover Rules</font><font style="letter-spacing:0.2pt;">&#8221;)) </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">Capitalized terms used but not defined in this &#8220;</font><font style="letter-spacing:0.2pt;">Part&#160;4&#8201;&#8212;&#8201;Additional Information</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; have the meanings ascribed to such terms in &#8220;</font><font style="letter-spacing:0.2pt;">Part&#160;3&#8201;&#8212;&#8201;The Scheme of Arrangement</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221;. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Responsibility</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Avadel directors accept responsibility for the recommendation and related opinions of the Avadel directors contained in this proxy statement and the other information contained in this proxy statement other than that relating to Alkermes, its subsidiaries and the Alkermes directors and members of their immediate families, related trusts and persons connected with them, or the statements made by Alkermes in respect of Avadel or its subsidiaries (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Alkermes Avadel Statements</font><font style="letter-spacing:0.2pt;">&#8221;), but including any statements made by Avadel in respect of Alkermes (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Avadel Alkermes Statements</font><font style="letter-spacing:0.2pt;">&#8221;). To the best of the knowledge and belief of the Avadel directors (who have taken all reasonable care to ensure such is the case), the information contained in this proxy statement for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Alkermes directors accept responsibility for the information contained in this proxy statement relating to Alkermes, its subsidiaries and the Alkermes directors and members of their immediate families, related trusts and persons connected with them, including the Alkermes Avadel Statements but excluding the Avadel Alkermes Statements. To the best of the knowledge and belief of the Alkermes directors (who have taken all reasonable care to ensure that such is the case), the information contained in this proxy statement for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Directors and Registered Office</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.1</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The directors of Avadel are as follows: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:376pt;height:113.5pt;margin-left:40pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:182pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:182pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Position</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Geoffrey Glass</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Chairperson and Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Gregory J. Divis</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Chief Executive Officer and Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Peter Thornton</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Linda Palczuk</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Eric Ende</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Mark McCamish</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Naseem Amin</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:40pt; margin-top:7.8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel&#8217;s registered office is at Ten Earlsfort Terrace, D02 T380, Dublin 2, Ireland. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.2</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The directors of Alkermes are as follows: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:376pt;height:143.5pt;margin-left:40pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:182pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:182pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Position</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Richard F. Pops</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Chairman and Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Richard B. Gaynor, M.D. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Nancy L. Snyderman, M.D. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Shane M. Cooke </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Frank Anders Wilson </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Lead Independent Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Brian P. McKeon </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Cato T. Laurencin, M.D., Ph.D. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Christopher I. Wright, M.D., Ph.D. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Nancy S. Lurker </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:182pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">105</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Alkermes&#8217;s registered office is at Connaught House, 1 Burlington Road, Dublin 4, Ireland, D04&#160;C5Y6. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:7.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Market Quotations</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.1</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The following table shows the closing price of an Avadel Share as derived from the Nasdaq Global Market on: (i)&#160;the first business day in each of the six (6)&#160;months prior to the date of this proxy statement; (ii)&#160;21 October&#160;2025 (being the last business day prior to the Rule&#160;2.7 Announcement); and (iii)&#160;the latest practicable date prior to the posting of this proxy statement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:436pt;height:155.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:401.29pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Avadel</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Share</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(US$) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:401.29pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Latest Practicable Date</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:401.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">November&#160;3, 2025 </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">18.92</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:401.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">October&#160;21, 2025 </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">17.87</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:401.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">October&#160;1, 2025 </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">15.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:401.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">September&#160;2, 2025 </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">14.98</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:401.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">August&#160;1, 2025 </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">11.08</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:401.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">July&#160;1, 2025 </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.81</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:401.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">June&#160;2, 2025 </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9.49</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.2</font>
          <br >
        </div>
        <div style=" margin-top:7.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">For the purposes of Rule&#160;24.3(e) of the Irish Takeover Rules: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">assuming the Milestone Payment is made, the Transaction represents: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a premium of approximately 38% to the weighted average trading price of Avadel Shares over the three&#160;months to October&#160;21, 2025 (being the business day prior to the commencement of the offer period), being $14.54; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a premium of approximately 27% to the closing price of $15.80 per Avadel Share on October&#160;20, 2025; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a premium of approximately 12% to the closing price of $17.87 per Avadel Share on October&#160;21, 2025 (being the business day prior to the commencement of the offer period); or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in the event that the Milestone Payment is not made, the Transaction represents: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a premium of approximately 27% to the weighted average trading price of Avadel Shares over the three&#160;months to October&#160;21, 2025 (being the business day prior to the commencement of the offer period), being $14.54; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a premium of approximately 17% to the closing price of $15.80 per Avadel Share on October&#160;20, 2025; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a premium of approximately 4% to the closing price of $17.87 per Avadel Share on October&#160;21, 2025 (being the business day prior to the commencement of the offer period). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Disclosure of interests and dealings in shares</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.1</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">For the purposes of this paragraph 4 of &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Part&#160;4</font><font style="letter-spacing:0.2pt;">&#8201;&#8212;&#8201;</font><font style="font-style:italic;letter-spacing:0.2pt;">Additional Information</font><font style="letter-spacing:0.2pt;">&#8221;: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">two or more persons are deemed to be acting in concert if they co-operate on the basis of an agreement, either express or tacit, either oral or written, aimed at: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">either </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:80pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(A)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the acquisition by any one or more of them of securities in the relevant company concerned; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">106</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:80pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(B)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the doing, or the procuring of the doing, of any act that will or may result in an increase in the proportion of securities in the relevant company concerned held by any one or more of them; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">either </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:80pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(A)</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">acquiring control of the relevant company concerned; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:80pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(B)</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">frustrating the successful outcome of an offer made for the purpose of the acquisition of control of the relevant company concerned; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:80pt; margin-top:8pt; width:376pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">and &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">acting in concert</font><font style="letter-spacing:0.2pt;">&#8221; shall be construed accordingly; </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">arrangement</font><font style="letter-spacing:0.2pt;">&#8221; includes any indemnity or option arrangement and any agreement or understanding, formal or informal, of whatever nature, between two or more persons relating to relevant securities which may be an inducement to deal or refrain from dealing in such securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a company is an &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">associated company</font><font style="letter-spacing:0.2pt;">&#8221; of another company if that other company owns or controls 20% or more of the equity share capital of the first-mentioned company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(d)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">connected fund manager</font><font style="letter-spacing:0.2pt;">&#8221; means a fund manager controlled by, controlling or under the same control as Avadel or (as the case may be) Alkermes or any bank or any financial or other professional advisor (including a stockbroker) which is acting in relation to the Transaction for that company (excluding a bank which is only providing normal commercial banking services or activities such as cash confirmation, the handling of acceptances and other registration work); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(e)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">control</font><font style="letter-spacing:0.2pt;">&#8221; means the holding, whether directly or indirectly, of securities in a company that confer in aggregate 30% or more of the voting rights in that company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(f)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">derivative</font><font style="letter-spacing:0.2pt;">&#8221; includes any financial product whose value, in whole or in part, is determined directly or indirectly by reference to the price of an underlying security; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(g)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">disclosure date</font><font style="letter-spacing:0.2pt;">&#8221; means November&#160;7, 2025 (being the latest practicable date before the posting of this proxy statement); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(h)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">disclosure period</font><font style="letter-spacing:0.2pt;">&#8221; means the period commencing on October&#160;22, 2024 (being the date 12&#160;months before the commencement of the offer period) and ending on the disclosure date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">exempt fund manager</font><font style="letter-spacing:0.2pt;">&#8221; means a discretionary fund manager which has been recognized by the Irish Takeover Panel as an exempt fund manager for the purposes of the Irish Takeover Rules, has been notified in writing of that fact by the Irish Takeover Panel and has not been notified by the Irish Takeover Panel of the withdrawal of such recognition; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(j)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">exempt principal trader</font><font style="letter-spacing:0.2pt;">&#8221; means a principal trader which is recognized by the Irish Takeover Panel as an exempt principal trader for the purposes of the Irish Takeover Rules, has been notified in writing of that fact by the Irish Takeover Panel and has not been notified by the Irish Takeover Panel of the withdrawal of such recognition; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(k)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">for the purpose of determining whether a person has an &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">interest in a relevant security</font><font style="letter-spacing:0.2pt;">&#8221; or is &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">interested in a relevant security</font><font style="letter-spacing:0.2pt;">&#8221;; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">that person shall be deemed to have an &#8220;interest,&#8221; or to be &#8220;interested,&#8221; in a relevant security if and only if he or she has a long position in that security; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a person who has only a short position in a relevant security shall be deemed not to have an interest, nor to be interested, in that security; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(l)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">long position and short position:</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a person shall be deemed to have a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">long position</font><font style="letter-spacing:0.2pt;">&#8221; in a relevant security for the purposes of paragraph 4.1(k) if he or she directly or indirectly: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">107</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:80pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(A)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">owns that security; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:80pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(B)</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">has the right or option to acquire that security or to call for its delivery; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:80pt; line-height:12pt; margin-top:7.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(C)</font>
          <br >
        </div>
        <div style=" margin-top:7.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">is under an obligation to take delivery of that security; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:80pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(D)</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">has the right to exercise or control the exercise of voting rights (if any) attaching to that security </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:80pt; margin-top:8pt; width:376pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or to the extent that none of the sub-paragraphs (A)&#160;to (D)&#160;above applies to that person, if he or she: </font>
        </div>
        <div style=" float:left; margin-left:80pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(E)</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">will be economically advantaged if the price of that security increases; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:80pt; line-height:12pt; margin-top:7.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(F)</font>
          <br >
        </div>
        <div style=" margin-top:7.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">will be economically disadvantaged if the price of that security decreases, irrespective of: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:100pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(I)</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:120pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">how any such ownership, right, option, obligation, advantage or disadvantage arises and including, for the avoidance of doubt and without limitation, where it arises by virtue of an agreement to purchase, option or derivative; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:100pt; line-height:12pt; margin-top:7.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(II)</font>
          <br >
        </div>
        <div style=" margin-top:7.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:120pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">whether any such ownership, right, option, obligation, advantage or disadvantage is absolute or conditional and, where applicable, whether it is in the money or otherwise, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:100pt; margin-top:8pt; width:356pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">provided that a person who has received an irrevocable commitment to accept an offer (or to procure that another person accept an offer) shall not, by virtue only of sub-paragraph (B)&#160;or (C)&#160;above, be treated as having an interest in the relevant securities that are the subject of the irrevocable commitment; </font>
        </div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a person shall be deemed to have a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">short position</font><font style="letter-spacing:0.2pt;">&#8221; in a relevant security for the purposes of paragraph 4.1(k) if he or she directly or indirectly: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:80pt; line-height:12pt; margin-top:7.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(A)</font>
          <br >
        </div>
        <div style=" margin-top:7.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">has the right or option to dispose of that security or to put it to another person; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:80pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(B)</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">is under an obligation to deliver that security to another person; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:80pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(C)</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">is under an obligation either to permit another person to exercise the voting rights (if any) attaching to that security or to procure that such voting rights are exercised in accordance with the directions of another person </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:80pt; margin-top:8pt; width:376pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or, to the extent that none of sub-paragraphs (A)&#160;to (C)&#160;above apply to that person, if he or she: </font>
        </div>
        <div style=" float:left; margin-left:80pt; line-height:12pt; margin-top:7.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(D)</font>
          <br >
        </div>
        <div style=" margin-top:7.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">will be economically advantaged if the price of that security decreases; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:80pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(E)</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">will be economically disadvantaged if the price of that security increases, irrespective of: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:100pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(I)</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:120pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">how any such right, option, obligation, advantage or disadvantage arises and including, for the avoidance of doubt and without limitation, where it arises by virtue of an agreement to sell, option or derivative; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:100pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(II)</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:120pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">whether any such right, option, obligation, advantage or disadvantage is absolute or conditional and, where applicable, whether it is in the money or otherwise; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(m)</font>
          <br >
        </div>
        <div style=" margin-top:7.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">relevant Alkermes securities</font><font style="letter-spacing:0.2pt;">&#8221; in relation to Alkermes shall have the meaning assigned by Rule&#160;2.1 of Part&#160;A of the Irish Takeover Rules, meaning: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">equity share capital of Alkermes; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">securities or any other instruments of Alkermes, conferring on their holders rights to convert into, or to subscribe for, any new securities of the equity share capital of Alkermes. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">108</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:40pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(n)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">relevant Avadel securities</font><font style="letter-spacing:0.2pt;">&#8221; in relation to Avadel shall have the meaning assigned by Rule&#160;2.1 of Part&#160;A of the Irish Takeover Rules, meaning: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">securities of Avadel which are the subject of the Scheme or which confer voting rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">equity share capital of Avadel; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:9.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:9.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">securities or any other instruments of Avadel, conferring on their holders rights to convert into, or to subscribe for, any new securities of the foregoing categories; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:9.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(o)</font>
          <br >
        </div>
        <div style=" margin-top:9.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">relevant period</font><font style="letter-spacing:0.2pt;">&#8221; means means the period commencing on October&#160;22, 2025 and ending on the disclosure date; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:9.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(p)</font>
          <br >
        </div>
        <div style=" margin-top:9.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">relevant securities</font><font style="letter-spacing:0.2pt;">&#8221; means relevant Alkermes securities or relevant Avadel securities, as appropriate, and &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">relevant security</font><font style="letter-spacing:0.2pt;">&#8221; shall be construed accordingly. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:9.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.2</font>
          <br >
        </div>
        <div style=" margin-top:9.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Interests and short positions in relevant Avadel securities</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:12pt; width:416pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Disclosures by Avadel and persons acting in concert with Avadel</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, the Avadel directors (including persons connected with them (within the meaning of the Companies Act)) were interested in the following relevant Avadel securities (excluding options and other equity awards which are disclosed in paragraph 4.2(b) below): </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:396pt;height:122.5pt;margin-left:60pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:323.67pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Avadel</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:323.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter Thornton </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">104,055 </td>
            <td style="padding:0pt;padding-left:13.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:323.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Linda Palczuk </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">67,900 </td>
            <td style="padding:0pt;padding-left:13.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:323.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Geoffrey Glass </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">155,979 </td>
            <td style="padding:0pt;padding-left:13.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:323.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Eric Ende </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">208,900 </td>
            <td style="padding:0pt;padding-left:13.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:323.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">169,100 </td>
            <td style="padding:0pt;padding-left:13.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:323.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mark McCamish </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">78,025 </td>
            <td style="padding:0pt;padding-left:13.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:323.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Naseem Amin </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:13.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:6.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, the following options over or equity awards in respect of Avadel Shares had been granted to the following Avadel directors (including persons connected with them within the meaning of the Companies Act) under the Avadel Pharmaceuticals plc 2017 Omnibus Incentive Compensation Plan, as amended, and the Avadel Pharmaceuticals plc 2020 Omnibus Incentive Compensation Plan and remain outstanding: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:60pt; margin-top:12pt; width:396pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Avadel Options</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:396pt;height:122.5pt;margin-left:60pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:185.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Avadel</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares under Option</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exercise Price per</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Avadel Share</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Expiration</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Date</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7.25pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:185.76pt;text-align:left;" rowspan="7">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Peter Thornton </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="7">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:21pt; text-align:right; white-space:nowrap;">60,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.03</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">8/7/2029</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.48</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/7/2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.07</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/3/2031 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4.79</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/3/2032 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">33,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">14.10</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/1/2033 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">16.32</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">7/30/2034 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:19pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.83</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">7/29/2035 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">109</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:29.5pt;margin-left:69.66pt;width:456pt;">
        <table style="width:396pt;height:632.5pt;margin-left:60pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:185.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Avadel</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares under Option</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exercise Price per</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Avadel Share</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Expiration</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Date</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7.25pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:185.76pt;text-align:left;" rowspan="8">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Linda Palczuk </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="8">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:27.75pt; text-align:right; white-space:nowrap;">60,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:20.25pt; text-align:right; white-space:nowrap;">2.03</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">8/7/2029</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">8.48</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/7/2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">8.07</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/3/2031 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">4.79</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/3/2032 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">33,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">14.10</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/1/2033 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">16.32</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">7/30/2034 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">25,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">10.93</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">12/17/2034 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">10.83 </td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">7/29/2035 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.76pt;text-align:left;" rowspan="7">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Geoffrey Glass </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="7">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:27.75pt; text-align:right; white-space:nowrap;">60,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:20.25pt; text-align:right; white-space:nowrap;">2.03</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">8/7/2029 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">8.48</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/7/2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">8.07</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/3/2031 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">4.79</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/3/2032 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">33,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">14.10</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/1/2033 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">16.32</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">7/30/2034 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">10.83</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">7/29/2035 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.76pt;text-align:left;" rowspan="8">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Eric Ende </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="8">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8,057</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1.49</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">5/22/2029 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">60,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">2.03</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/7/2029 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">8.48</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/7/2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">8.07</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/3/2031 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">4.79</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/3/2032 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">33,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">14.10</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/1/2033 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">16.32</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">7/30/2034 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">10.83</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">7/29/2035 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.76pt;text-align:left;" rowspan="10">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="10">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:27.75pt; text-align:right; white-space:nowrap;">150,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:20.25pt; text-align:right; white-space:nowrap;">10.40</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">12/14/2026</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">100,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">8.95</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">12/12/2027 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">50,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">7.06</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3/22/2028 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">100,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1.85</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3/7/2029 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">400,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1.71</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">5/30/2029 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">500,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">6.79</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">12/8/2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">310,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">8.20</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">12/7/2031 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">350,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">4.69</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/4/2032 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">600,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">13.57</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2/20/2034 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">310,000 </td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">7.87</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3/4/2035 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:185.76pt;text-align:left;" rowspan="8">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Mark McCamish </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="8">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:27.75pt; text-align:right; white-space:nowrap;">60,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:20.25pt; text-align:right; white-space:nowrap;">5.92</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">12/5/2029</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">8.48</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/7/2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">50,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">5.30</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">9/13/2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">8.07</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/3/2031 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">4.79</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/3/2032 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">33,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">14.10</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8/1/2033</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">16.32</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">7/30/2034 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:19pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">10.83</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">7/29/2035 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">110</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:396pt;height:62.5pt;margin-left:60pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:185.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Avadel</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares under Option</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exercise Price per</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Avadel Share</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Expiration</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Date</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7.25pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:185.76pt;text-align:left;" rowspan="3">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Naseem Amin </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="3">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24pt; text-align:right; white-space:nowrap;">49,500</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:17.25pt; text-align:right; white-space:nowrap;">15.94</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">5/17/2034</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">16.32</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">7/30/2034 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:19pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:17.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.83</td>
            <td style="padding:0pt;padding-left:16.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:45.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">7/29/2035</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:40pt; margin-top:19.4pt; width:416pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Equity Awards</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:396pt;height:131.5pt;margin-left:60pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:321.51pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Avadel</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares subject to</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity Awards</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:321.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter Thornton </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:17.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:321.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Linda Palczuk </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:17.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:321.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Geoffrey Glass </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:17.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:321.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Eric Ende </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:17.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:321.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:17.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:321.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mark McCamish </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:17.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:321.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Naseem Amin </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:17.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:60pt; margin-top:11.91pt; width:396pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:60pt; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">For each director other than Mr.&#160;Divis, represents restricted Avadel Shares granted in accordance with Avadel&#8217;s non-employee director compensation policy that are subject to forfeiture and vest in full on the earlier of 29 July&#160;2026 (the first anniversary of the grant date) or Avadel&#8217;s next annual meeting of shareholders, subject to each director&#8217;s continued service relationship as a director through such vesting date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:3.41pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">For Mr.&#160;Divis, represents restricted Avadel Shares granted in respect of his employment as Avadel&#8217;s Chief Executive Officer that are subject to forfeiture and vest in equal annual installments on each of the four anniversaries of 5 March&#160;2025 (the grant date), subject to his continued service relationship through each such vesting date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Save as described in paragraph (a)&#160;and (b)&#160;above, as at the close of business on the disclosure date, no Avadel director (including persons connected with them (within the meaning of the Companies Act)) was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(d)</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, neither Avadel nor any subsidiary or associated company of Avadel was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(e)</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, no trustee of any pension scheme (other than an industry-wide scheme) in which Avadel or any subsidiary of Avadel participates were interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.41pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(f)</font>
          <br >
        </div>
        <div style=" margin-top:7.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, no fund manager (including an exempt fund manager) nor any persons controlling, controlled by or under the same control as such fund manager with any other person (including a collective investment scheme) where such fund manager manages investments on a discretionary basis on behalf of such other person, in respect of the relevant investment accounts, connected with Avadel or any subsidiary of Avadel was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(g)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, Goldman Sachs &amp; Co. LLC (financial advisor to Avadel) and persons controlling, controlled by, or under the same control as Goldman Sachs &amp; Co. LLC were interested in the following relevant Avadel securities: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:396pt;height:32.5pt;margin-left:60pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:323.67pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Avadel</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.167pt 0pt; width:323.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Folio Investments, Inc. </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:25.165pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:25.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">111</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:40pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(h)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, neither Morgan Stanley &amp; Co. LLC (financial advisor to Avadel) nor any person controlling, controlled by, or under the same control as Morgan Stanley &amp; Co. LLC, was interested, or held any short positions, in any relevant Avadel securities other than as exempt principal trader or an exempt fund manager. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, no partner or member of the professional staff of Arthur Cox LLP (Irish legal advisor to Avadel) who is actively engaged in relation to the Transaction or who is customarily engaged in the affairs of Avadel or who has been engaged in those affairs since October&#160;22, 2023 was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.09pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(j)</font>
          <br >
        </div>
        <div style=" margin-top:8.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, no partner or member of the professional staff of Goodwin Procter LLP (U.S. legal advisor to Avadel) who is actively engaged in relation to the Transaction or who is customarily engaged in the affairs of Avadel or who has been engaged in those affairs since October&#160;22, 2023 was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(k)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, neither Brunswick Group, LLC (public relations advisor to Avadel) nor any person controlling, controlled by, or under the same control as Brunswick Group, LLC was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(l)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, neither Stern Investor Relations, Inc., dba Precision AQ (public relations advisor to Avadel) nor any person controlling, controlled by, or under the same control as Stern Investor Relations, Inc., dba Precision AQ, was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(m)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, neither Innisfree M&amp;A Incorporated (proxy solicitor of Avadel) nor any person controlling, controlled by, or under the same control as Innisfree M&amp;A Incorporated, was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(n)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, neither Golden Parachute Tax Solutions LLC (280G advisor to Avadel) nor any person controlling, controlled by, or under the same control as Golden Parachute Tax Solutions LLC, was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(o)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Except as disclosed in this paragraph 4.2, as at the close of business on the disclosure date, no other person acting in concert (including deemed to be acting in concert) with Avadel or any person with whom Avadel, or any person acting in concert with Avadel, has any arrangement, was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:12pt; width:416pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Disclosures by Alkermes and persons acting in concert with Alkermes</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(p)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, neither Alkermes nor any subsidiary or associated company of Alkermes was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(q)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, none of the Alkermes directors (including persons connected with them (within the meaning of the Companies Act)) were interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(r)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, no trustee of any pension scheme (other than an industry-wide scheme) in which Alkermes or any subsidiary or associated company of Alkermes, participates in was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(s)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, no fund manager (including an exempt fund manager) nor any persons controlling, controlled by or under the same control as such </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">112</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">fund manager with any other person (including a collective investment scheme) where such fund manager manages investments on a discretionary basis on behalf of such other person, in respect of the relevant investment accounts, connected with Alkermes or any member of the Alkermes group (being Alkermes and all its Subsidiaries from time to time) was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(t)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, J.P. Morgan Securities LLC, together with its affiliate J.P. Morgan Securities plc, (together &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">J.P. Morgan</font><font style="letter-spacing:0.2pt;">&#8221;) (financial advisor to Alkermes) or persons controlling, controlled by, or under the same control as J.P. Morgan, were interested in the following Avadel securities: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:396pt;height:47.5pt;margin-left:60pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:323.67pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Avadel</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:323.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">55I, LLC </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">53 </td>
            <td style="padding:0pt;padding-left:16.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:323.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">JPMorgan Chase Bank, National Association </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">13,558</td>
            <td style="padding:0pt;padding-left:16.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(u)</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, no partner or member of the professional staff of McCann FitzGerald LLP (Irish legal advisor to Alkermes) who is actively engaged in relation to the Transaction or who is customarily engaged in the affairs of Alkermes or who has been engaged in those affairs since October&#160;22, 2023 was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(v)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, no partner or member of the professional staff of Paul, Weiss, Rifkind, Wharton &amp; Garrison LLP (U.S. legal advisor to Alkermes) who is actively engaged in relation to the Transaction or who is customarily engaged in the affairs of Alkermes or who has been engaged in those affairs since October&#160;22, 2023 was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(w)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, no partner or member of the professional staff of Cleary Gottlieb Steen &amp; Hamilton LLP (U.S. legal advisor to Alkermes for the financing) who is actively engaged in relation to the Transaction or who is customarily engaged in the affairs of Alkermes or who has been engaged in those affairs since October&#160;22, 2023 was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(x)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, no partner or member of the professional staff of PricewaterhouseCoopers Ireland (Irish tax advisor to Alkermes) who is actively engaged in relation to the Transaction or who is customarily engaged in the affairs of Alkermes or who has been engaged in those affairs since October&#160;22, 2023 was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(y)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As at the close of business on the disclosure date, no partner or member of the professional staff of FGS Global Inc. (public relations advisor to Alkermes) who is actively engaged in relation to the Transaction or who is customarily engaged in the affairs of Alkermes or who has been engaged in those affairs since October&#160;22, 2023 was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(z)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Except as disclosed in this paragraph 4.2, as at the close of business on the disclosure date, no other person acting in concert (including deemed to be acting in concert) with Alkermes was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(aa)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Except as disclosed in this paragraph 4.2, as at the close of business on the disclosure date, no other person with whom Alkermes or any person acting in concert with Alkermes, has any arrangement, was interested, or held any short positions, in any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(bb)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The information in this paragraph 4.2 in respect of Avadel and all persons controlling, controlled by, or under the same control as Avadel has been included subject to the Avadel directors&#8217; knowledge, information and belief as of the disclosure date, having made due and careful enquiries. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">113</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:40pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(cc)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The information in this paragraph 4.2 in respect of Alkermes and all persons controlling, controlled by, or under the same control as Alkermes has been included subject to the Alkermes directors&#8217; knowledge, information and belief as of the disclosure date, having made due and careful enquiries. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:13.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">4.3</font>
          <br >
        </div>
        <div style=" margin-top:13.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Dealings in relevant Avadel securities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:12pt; width:416pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Disclosures by Avadel and persons acting in concert with Avadel</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the disclosure period, save as set out below, there have been no dealings in relevant Avadel securities by the directors of Avadel or persons connected with them (within the meaning of the Companies Act): </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Avadel Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:206.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:152.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:138.29pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nature of Transaction</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Price per</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Avadel Share</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(US$)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:152.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter Thornton </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:138.29pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Purchase of shares in the market</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">01/13/2025 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">10,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8.045 </td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.95pt;text-align:left;" rowspan="3">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Linda Palczuk </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="3">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.29pt;">
              <div style="white-space:nowrap; text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Purchase of shares in the market</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:37.5pt; text-align:right; white-space:nowrap;">12/06/2024 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24pt; text-align:right; white-space:nowrap;">3,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:27.75pt; text-align:right; white-space:nowrap;">10.1892 </td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:138.29pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Bona fide gift </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">12/24/2024 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">3,500 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">0 </td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.29pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Purchase of shares in the market </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">01/21/2025 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">5,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7.928 </td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.95pt;text-align:left;" rowspan="2">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Geoffrey Glass </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.29pt;">
              <div style="white-space:nowrap; text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Purchase of shares in the market</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:37.5pt; text-align:right; white-space:nowrap;">12/10/2024 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24pt; text-align:right; white-space:nowrap;">10,075 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:27.75pt; text-align:right; white-space:nowrap;">9.89 </td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.29pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Purchase of shares in the market </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">12/10/2024 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">10,204 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">9.80 </td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Eric Ende </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.29pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Purchase of shares in the market</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">01/13/2025 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">30,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7.8406 </td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.95pt;text-align:left;" rowspan="2">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.29pt;">
              <div style="white-space:nowrap; text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Purchase of shares in the market</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:37.5pt; text-align:right; white-space:nowrap;">12/06/2024 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24pt; text-align:right; white-space:nowrap;">9,598 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:27.75pt; text-align:right; white-space:nowrap;">9.977 </td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.29pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Purchase of shares in the market </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">12/09/2024 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">402 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">9.82 </td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mark McCamish </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.29pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212; </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212; </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Naseem Amin </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.29pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212; </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212; </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:152.95pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.29pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212; </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212; </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.86pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13.2pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Avadel Options</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:233.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:145.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:115.98pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nature of Transaction</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:68.17pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Price per</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Avadel Share</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(US$)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:145.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter Thornton </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:115.98pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Grant of option award</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">07/29/2025 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:68.17pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$10.83 </font>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">(Exercise Price) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:19pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:145.53pt;text-align:left;" rowspan="4">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Linda Palczuk </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="4">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:115.98pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Grant of option award </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; line-height:12pt; min-width:37.5pt; text-align:right; white-space:nowrap;">12/17/2024</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">25,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:68.17pt;white-space:normal;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">$10.93 </font>
              </div>
              <div style="margin-top:2pt; text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">(Exercise Price) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:115.98pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Transfer of options to trust </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">01/24/2025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">25,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:68.17pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:27pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:115.98pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Grant of option award </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">07/29/2025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:68.17pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$10.83</font>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">(Exercise Price) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:115.98pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Transfer of options to trust </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">09/15/2025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:68.17pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:19pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:145.53pt;text-align:left;" rowspan="2">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Geoffrey Glass </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:115.98pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Grant of option award </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; line-height:12pt; min-width:37.5pt; text-align:right; white-space:nowrap;">07/29/2025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:68.17pt;white-space:normal;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">$10.83</font>
              </div>
              <div style="margin-top:2pt; text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">(Exercise Price) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:115.98pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Transfer of options to trust </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">09/15/2025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:68.17pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:145.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Eric Ende </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:115.98pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Grant of option award </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">07/29/2025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:68.17pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$10.83</font>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">(Exercise Price) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:145.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:115.98pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Grant of option award </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">03/05/2025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">310,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:68.17pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$7.87</font>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">(Exercise Price)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">114</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:80.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:145.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:115.98pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nature of Transaction</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:68.17pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Price per</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Avadel Share</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(US$)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:145.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mark McCamish </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:115.98pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Grant of option award </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">07/29/2025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:68.17pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$10.83</font>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">(Exercise Price) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:145.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Naseem Amin </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:115.98pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Grant of option award </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">07/29/2025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:68.17pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$10.83</font>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">(Exercise Price)]</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:19.8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Avadel Equity Awards</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:131.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:150.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:140.85pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nature of Transaction</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Price per</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Avadel Share</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(US$)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:150.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter Thornton </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:140.85pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Grant of Restricted Stock Award</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">07/29/2025 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">0 </td>
            <td style="padding:0pt;padding-left:16.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:150.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Linda Palczuk </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:140.85pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Grant of Restricted Stock Award</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">07/29/2025 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">0 </td>
            <td style="padding:0pt;padding-left:16.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:150.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Geoffrey Glass </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:140.85pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Grant of Restricted Stock Award</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">07/29/2025 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">0 </td>
            <td style="padding:0pt;padding-left:16.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:150.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Eric Ende </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:140.85pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Grant of Restricted Stock Award</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">07/29/2025 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">0 </td>
            <td style="padding:0pt;padding-left:16.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:150.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gregory J. Divis </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:140.85pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Grant of Restricted Stock Award</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">03/05/2025 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">52,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">0 </td>
            <td style="padding:0pt;padding-left:16.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:150.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mark McCamish </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:140.85pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Grant of Restricted Stock Award</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">07/29/2025 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">0 </td>
            <td style="padding:0pt;padding-left:16.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:150.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Naseem Amin </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:140.85pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Grant of Restricted Stock Award</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">07/29/2025 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.715pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:16.715pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the disclosure period, Avadel has not redeemed or purchased any relevant Avadel securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:3.11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:3.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the disclosure period, there were no dealings in relevant Avadel securities by Avadel or any subsidiary or associated company of Avadel. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:3.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(d)</font>
          <br >
        </div>
        <div style=" margin-top:3.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the relevant period, there were no dealings in relevant Avadel securities by Morgan Stanley &amp; Co. LLC or Goldman Sachs &amp; Co. LLC (financial advisors to Avadel) or any person (other than exempt principal traders or exempt fund managers) controlling, controlled by, or under the same control as either of Morgan Stanley &amp; Co. LLC or Goldman Sachs &amp; Co. LLC. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:3.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(e)</font>
          <br >
        </div>
        <div style=" margin-top:3.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the relevant period, there were no dealings in relevant Avadel securities by any trustee of any pension scheme in which Avadel or any subsidiary of Avadel participates (other than an industry-wide pension scheme). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:3.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(f)</font>
          <br >
        </div>
        <div style=" margin-top:3.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the relevant period, there were no dealings in relevant Avadel securities by any partner or member of the professional staff of Arthur Cox LLP (Irish legal advisor to Avadel) who is actively engaged in relation to the Transaction or who is customarily engaged in the affairs of Avadel or who has been engaged in those affairs since October&#160;22, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:3.11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(g)</font>
          <br >
        </div>
        <div style=" margin-top:3.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the relevant period, there were no dealings in relevant Avadel securities by any partner or member of the professional staff of Goodwin Procter LLP (U.S. legal advisor to Avadel) who is actively engaged in relation to the Transaction or who is customarily engaged in the affairs of Avadel or who has been engaged in those affairs since October&#160;22, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:3.11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(h)</font>
          <br >
        </div>
        <div style=" margin-top:3.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the relevant period, there were no dealings in relevant Avadel securities by Brunswick Group, LLC (public relations advisor to Avadel) nor any person controlling, controlled by, or under the same control as Brunswick Group, LLC. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:3.11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:3.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the relevant period, there were no dealings in relevant Avadel securities by Stern Investor Relations, Inc., dba Precision AQ (public relations advisor to Avadel) nor any person controlling, controlled by, or under the same control as Stern Investor Relations, Inc., dba Precision AQ. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:3.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(j)</font>
          <br >
        </div>
        <div style=" margin-top:3.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the relevant period, there were no dealings in relevant Avadel securities by Innisfree M&amp;A Incorporated (proxy solicitor to Avadel) or any persons controlling, or controlled by, or under the same control as Innisfree M&amp;A Incorporated. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(k)</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the relevant period, there were no dealings in relevant Avadel securities by Golden Parachute Tax Solutions LLC (280G advisor to Avadel) or any persons controlling, or controlled by, or under the same control as Golden Parachute Tax Solutions LLC. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">115</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:40pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(l)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the relevant period, there were no dealings in relevant Avadel securities by any person that had an arrangement with Avadel or with any person acting in concert with Avadel. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:2.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(m)</font>
          <br >
        </div>
        <div style=" margin-top:2.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Save as disclosed in this paragraph 4.3, during the relevant period, there were no dealings in relevant Avadel securities by any other person acting in concert (or deemed to be acting in concert) with Avadel. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:10.62pt; width:416pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Disclosures by Alkermes and persons acting in concert with Alkermes</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(n)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the disclosure period, there were no dealings in relevant Avadel securities by Alkermes or any subsidiary or associated company of Alkermes. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(o)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the disclosure period, there were no dealings in any relevant Avadel securities by Alkermes directors or persons connected with them (within the meaning of the Companies Act). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(p)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the disclosure period, there were no dealings in relevant Avadel securities by any partner or member of the professional staff of McCann FitzGerald LLP (Irish legal advisor to Alkermes) who is actively engaged in relation to the Transaction or who is customarily engaged in the affairs of Alkermes or who has been engaged in those affairs since October&#160;22, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(q)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the disclosure period, there were no dealings in relevant Avadel securities by any partner or member of the professional staff of Paul, Weiss, Rifkind, Wharton &amp; Garrison LLP (US legal advisor to Alkermes) who is actively engaged in relation to the Transaction or who is customarily engaged in the affairs of Alkermes or who has been engaged in those affairs since October&#160;22,2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(r)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the disclosure period, there were no dealings in relevant Avadel securities by J.P. Morgan (financial advisor to Alkermes) nor any person (other than exempt principal traders or exempt fund managers) controlling, controlled by, or under the same control as J.P. Morgan. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:3.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(s)</font>
          <br >
        </div>
        <div style=" margin-top:3.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the disclosure period, there were no dealings in relevant Avadel securities by any partner or member of the professional staff of Cleary Gottlieb Steen &amp; Hamilton LLP (U.S. legal advisor to Alkermes for the financing) who is actively engaged in relation to the Transaction or who is customarily engaged in the affairs of Alkermes or who has been engaged in those affairs since October&#160;22,2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:2.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(t)</font>
          <br >
        </div>
        <div style=" margin-top:2.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the disclosure period, there were no dealings in relevant Avadel securities by any partner or member of the professional staff of PricewaterhouseCoopers Ireland (Irish tax advisor to Alkermes) who is actively engaged in relation to the Transaction or who is customarily engaged in the affairs of Alkermes or who has been engaged in those affairs since October&#160;22,2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:2.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(u)</font>
          <br >
        </div>
        <div style=" margin-top:2.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the disclosure period, there were no dealings in relevant Avadel securities by any partner or member of the professional staff of FGS Global Inc. (public relations advisor to Alkermes) who is actively engaged in relation to the Transaction or who is customarily engaged in the affairs of Alkermes or who has been engaged in those affairs since October&#160;22,2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:2.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(v)</font>
          <br >
        </div>
        <div style=" margin-top:2.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the disclosure period, there were no dealings in relevant Avadel securities by any trustee of any pension scheme (other than an industry-wide pension scheme) in which Alkermes or any subsidiary of Alkermes participates. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:2.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(w)</font>
          <br >
        </div>
        <div style=" margin-top:2.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">During the disclosure period, there were no dealings in relevant Avadel securities by any person that had an arrangement with Alkermes or with any person acting in concert with Alkermes. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:2.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(x)</font>
          <br >
        </div>
        <div style=" margin-top:2.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Save as disclosed in this paragraph 4.3, as at the close of business on the disclosure date, no other person acting in concert (including deemed to be acting in concert) with Alkermes dealt in any relevant Avadel securities during the disclosure period. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">4.4</font>
          <br >
        </div>
        <div style=" margin-top:8.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Interests and short positions in relevant securities of Alkermes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As of the close of business on the disclosure date, Avadel was not interested in any relevant Alkermes securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">116</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:40pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As of the close of business on the disclosure date, Avadel did not hold any short positions in any relevant Alkermes securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As of the close of business on the disclosure date, the following director of Avadel (including persons connected with him (within the meaning of the Companies Act)) was interested in the following relevant Alkermes securities: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:396pt;height:68.5pt;margin-left:60pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:273.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Alkermes</font>
                <br >
                <font style="letter-spacing:-0.16pt;">ordinary shares</font>
                <br >
                <font style="letter-spacing:-0.16pt;">of $0.01 each</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">total issued</font>
                <br >
                <font style="letter-spacing:-0.16pt;">ordinary share</font>
                <br >
                <font style="letter-spacing:-0.16pt;">capital of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Alkermes</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(rounded) (%)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.167pt 0pt; width:273.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter Thornton </font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:20.365pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">18 </td>
            <td style="padding:0pt;padding-left:20.365pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:14.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:60pt; margin-top:8.1pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Save as described above, as at the close of business on the disclosure date, no director of Avadel (including persons connected with them (within the meaning of the Companies Act)) was interested or held any short positions in any relevant Alkermes securities. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.5</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Dealings in relevant securities of Alkermes</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the relevant period: </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">there were no dealings in relevant Alkermes securities by Avadel; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">there were no dealings in relevant Alkermes securities by the directors of Avadel (or persons connected with them (within the meaning of the Companies Act)). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5.</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Material Contracts</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5.1</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Save as disclosed in this paragraph 5.1, neither Avadel nor any of its subsidiaries has, since October&#160;22, 2023, being the two&#160;years prior to the commencement of the offer period, entered into any contracts (other than contracts entered into in the ordinary course of business) that are, or may be, material save for: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Transaction Agreement</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;On October&#160;22, 2025, Avadel entered into the Transaction Agreement with Alkermes, for the purposes of implementing the Transaction. Further details regarding the Transaction Agreement are set forth in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Part&#160;1&#8201;&#8212;&#8201;The Transaction and the Special Meetings of Avadel&#8217;s Shareholders&#8201;&#8212;&#8201;The Transaction</font><font style="letter-spacing:0.2pt;">&#8221; of this proxy statement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Confidentiality Agreement</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;Avadel and Alkermes entered into a confidentiality agreement on August&#160;24, 2025 (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Confidentiality Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which Avadel and Alkermes have undertaken, amongst other things, to: (a)&#160;keep confidential information relating to the Transaction and not to disclose it to third parties (other than certain permitted parties) unless required by law or regulation; and (b)&#160;use the confidential information for the sole purpose of evaluating and participating in discussions regarding the Transaction. The Confidentiality Agreement also includes standstill provisions, pursuant to which Alkermes agreed to certain restrictions in respect of dealings in Avadel Shares, and solicitation or engagement in respect of competing transactions, subject to customary standstill termination provisions, for a period of one year from the date of the Confidentiality Agreement. Such standstill provisions became ineffective following the Rule&#160;2.7 Announcement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Settlement Agreement</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;Avadel entered into a settlement and license agreement with Jazz Pharmaceuticals, Inc. (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Jazz</font><font style="letter-spacing:0.2pt;">&#8221;) on October&#160;21, 2025 (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Settlement Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), in respect of the actions captioned: </font><font style="font-style:italic;letter-spacing:0.2pt;">Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC</font><font style="letter-spacing:0.2pt;">, C.A. No. 21-691; </font><font style="font-style:italic;letter-spacing:0.2pt;">Jazz Pharmaceuticals, Inc. et al v. Avadel CNS Pharmaceuticals, LLC</font><font style="letter-spacing:0.2pt;">, C.A. No.&#160;21-1138; </font><font style="font-style:italic;letter-spacing:0.2pt;">Jazz Pharmaceuticals, Inc. et al v. Avadel CNS Pharmaceuticals, LLC</font><font style="letter-spacing:0.2pt;">, C.A. No.&#160;21-1594; </font><font style="font-style:italic;letter-spacing:0.2pt;">Avadel CNS Pharmaceuticals, LLC et al v. Jazz Pharmaceuticals, Inc. et al</font><font style="letter-spacing:0.2pt;">, C.A. No. 22-487; </font><font style="font-style:italic;letter-spacing:0.2pt;">Avadel CNS Pharmaceuticals, LLC v. Jazz Pharmaceuticals, Inc</font><font style="letter-spacing:0.2pt;">., C.A. No.&#160;22-941; </font><font style="font-style:italic;letter-spacing:0.2pt;">Avadel CNS Pharmaceuticals, LLC et al v. Jazz Pharmaceuticals, Inc.,</font><font style="letter-spacing:0.2pt;"> et al, C.A. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">117</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No. 25-09; </font><font style="font-style:italic;letter-spacing:0.2pt;">Avadel CNS Pharmaceuticals, LLC et al v. Jazz Pharmaceuticals, Inc. et al</font><font style="letter-spacing:0.2pt;">, C.A. No.&#160;25-57; </font><font style="font-style:italic;letter-spacing:0.2pt;">Avadel CNS Pharmaceuticals, LLC et al v. Jazz Pharmaceuticals, Inc</font><font style="letter-spacing:0.2pt;">., et al, C.A. No. 25-221; and </font><font style="font-style:italic;letter-spacing:0.2pt;">Avadel CNS Pharmaceuticals, LLC et al v. Jazz Pharmaceuticals, Inc</font><font style="letter-spacing:0.2pt;">. et al, C.A. No. 25-435, each brought in the United States District Court for the District of Delaware (together, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Lawsuits</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Settlement Agreement further provides, among other things, for: (i)&#160;a payment by Jazz of $90&#160;million (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Settlement Payment</font><font style="letter-spacing:0.2pt;">&#8221;) to Avadel CNS Pharmaceuticals, LLC (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Avadel CNS</font><font style="letter-spacing:0.2pt;">&#8221;) (a subsidiary of Avadel) and a waiver by Jazz of its right to receive royalties and/or damages on sales of LUMRYZ through September&#160;30, 2025; (ii)&#160;subject to and contingent upon payment of the Settlement Payment, each of Avadel CNS and Jazz agreed to dismiss their respective Lawsuits with prejudice; (iii)&#160;the payment by Avadel CNS to Jazz of royalties with respect to (1)&#160;LUMRYZ sold for narcolepsy at a rate of 3.85% of net sales, starting October&#160;1, 2025, (2)&#160;LUMRYZ for indications (including any indications related to idiopathic hypersomnia (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">IH</font><font style="letter-spacing:0.2pt;">&#8221;) other than cataplexy or excessive daytime sleepiness in patients with narcolepsy) at a rate of 10% of net sales, starting March&#160;1, 2028 and (3)&#160;LUMRYZ sold for other certain indications as set forth in the Settlement Agreement; (iv)&#160;a grant by Jazz to Avadel CNS of a worldwide, non-exclusive, perpetual, irrevocable, non-terminable, non-transferrable (except as expressly provided in the Settlement Agreement) royalty-bearing license, without the right to sublicense (except as provided in the Settlement Agreement), to any past, present, or future patents that could be asserted against LUMRYZ for any indication; (v)&#160;agreement by JAZZ not to challenge the approval or approvability of LUMRYZ; and (vi)&#160;a grant by Avadel CNS to Jazz of a worldwide, non-exclusive, perpetual, irrevocable, non-terminable, non-transferrable (except as expressly provided in the Settlement Agreement), royalty-free, fully paid-up covenant not to sue, without the right to sublicense (except as expressly provided in the Settlement Agreement), Avadel CNS&#8217; patents in connection with XYWAV and XYREM. Royalties payable by Avadel CNS under the Settlement Agreement are subject to certain step-down adjustments as set forth therein. Jazz and Avadel CNS have also agreed to, among other things, a customary mutual release of all claims arising out of or relating to the Lawsuits. </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(d)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">XW Agreement</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;On August&#160;30, 2025, Avadel entered into an exclusive global license agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">License Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) with XWPharma Ltd. (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">XWPharma</font><font style="letter-spacing:0.2pt;">&#8221;) for the development and commercialization of valiloxybate, a GABAB receptor agonist, in all indications, including the treatment of sleep disorders, such as narcolepsy and IH. Under the terms of the License Agreement, XWPharma grants Avadel an exclusive global license to develop, manufacture and commercialize valiloxybate worldwide, excluding mainland China, Hong Kong and Macau. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">XWPharma has already received an upfront payment of $15&#160;million and will be due to receive an additional upfront payment of $5&#160;million from Avadel in the fourth quarter of 2025. XWPharma is eligible to receive milestone payments associated with certain development milestones of up to $30&#160;million. Avadel also agreed to pay XWPharma up to an aggregate of $155&#160;million in performance-based tiered sales milestones for first achievement of annual net sales up to $750&#160;million. For first achievement of annual net sales exceeding $750&#160;million and up to $3.5&#160;billion, Avadel will pay XWPharma certain performance-based sales milestone payments equal to 10% of each of those sales milestones. In addition, Avadel agreed to pay tiered royalties ranging from high-single digit to mid-teens, as a&#160;percentage of annual net sales of the licensed products, and also an additional $10&#160;million milestone payment after the first commercial sale in the U.S. for each indication beyond narcolepsy and IH following the U.S. Food and Drug Administration&#8217;s approval for same. </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless earlier terminated, the term of the License Agreement will continue until expiration of the last royalty term for the applicable product in the applicable country. The License Agreement is subject to customary termination provisions, including termination by a party for the other party&#8217;s uncured, material breach. Additionally, subject to a notice period, Avadel may terminate the License Agreement for convenience. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">118</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The License Agreement also includes customary representations and warranties, covenants and indemnification obligations. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">DIRECTORS AND SERVICE CONTRACTS</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.1</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The following are particulars of the service contracts of the Avadel directors with Avadel or any of its subsidiaries: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Gregory J. Divis has served as Avadel&#8217;s Chief Executive Officer and director of Avadel since 3&#160;June&#160;2019 pursuant to the terms of an employment agreement dated 3 June&#160;2019 between Mr&#160;Divis and Avadel Management, LLC (formerly known as &#8220;Avadel Management Corporation&#8221;) (a subsidiary of Avadel) (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Employer</font><font style="letter-spacing:0.2pt;">&#8221;), which was amended by way of an agreement dated 28 September&#160;2022 (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Divis Employment Agreement</font><font style="letter-spacing:0.2pt;">&#8221;). Pursuant to the Divis Employment Agreement, Mr Divis is employed as Chief Executive Officer of Avadel and of the Employer. The Divis Employment Agreement replaced an employment agreement dated September&#160;5, 2017 between Mr Divis and the Employer. The Divis Employment Agreement has a one-year term, subject to automatic one-year extensions unless either the Employer or Mr Divis gives notice of non-renewal before the end of the applicable term. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Divis Employment Agreement provides for: (i)&#160;an annual base salary of $500,000, subject to annual review and increase in the sole discretion of the Employer; (ii)&#160;an annual bonus with a target payout of no less than 60% of the base salary based on achievement by Mr.&#160;Divis of certain business and individual performance objectives as well as the performance of Avadel against its objectives; and (iii)&#160;a sign-on bonus in the form of the grant of options to purchase 400,000 of Avadel&#8217;s American Depositary Shares (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">ADSs</font><font style="letter-spacing:0.2pt;">&#8221;) with each such ADS representing one ordinary share of Avadel; such options become exercisable in four equal amounts on each of the first four anniversaries of the date of grant at an exercise price equal to the fair market value of the ADSs on the date of grant (note that Avadel&#8217;s ADS programme was terminated on July, 15 2024, at which time all ADSs were exchanged for underlying Avadel Shares). The Divis Employment Agreement also provides that Mr.&#160;Divis will receive an automobile allowance of $1,000 per month and is entitled to participate in future equity awards that may be granted to executive management. The Employer shall also facilitate the participation by Mr Divis and his family in any group medical, health, vision, dental, hospitalization, and accident insurance, retirement, pension, disability, or similar welfare or pension plan or program of the Employer existing in accordance with the terms and conditions of such plans or programs. </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event that Mr Divis wishes to resign from the Employer, he must provide no less than 30&#160;days&#8217; notice. If Mr Divis desires to resign for &#8216;Good Reason&#8217; (as defined in the Divis Employment Agreement), he must provide written notice of the facts constituting Good Reason within 90&#160;days of the initial occurrence of the Good Reason condition and providing that Employer can cure the acts within 30&#160;days of receipt of such notice. If not remedied, any termination for Good Reason must occur within 90&#160;days after the period for remedying the condition has expired. In the event that the Employer wishes to terminate the Divis Employment Agreement, the Employer must give Mr Divis at least 30&#160;days notice (save in the event of Mr Divis death or Incapacity (as defined in the Divis Employment Agreement), in which case no notice is required). </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Divis Employment Agreement, in the event that Mr Divis&#8217; employment is terminated by the Employer for any reason other than &#8216;Cause&#8217; (as defined in the Divis Employment Agreement) or Mr Divis terminates his employment for &#8216;Good Reason&#8217;, Mr&#160;Divis will, subject to his execution of a separation and release agreement acceptable to the Employer and Mr.&#160;Divis&#8217; release of all claims against the Employer, Avadel and Avadel&#8217;s subsidiaries (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Release Requirement</font><font style="letter-spacing:0.2pt;">&#8221;), be entitled to the following severance payments and benefits: (i)&#160;an amount equal to 1.5 times Mr Divis&#8217; then-current annual base salary, (ii)&#160;all accrued but unpaid bonuses for any completed fiscal year and vacation pay, expense reimbursement and other benefits due to Mr Divis under any Employer-provided benefit plans, policies and arrangements and any other benefits payable in accordance with the applicable terms of the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">119</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">benefit plans, policies and arrangements, and (iii)&#160;if Mr Divis elects continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">COBRA</font><font style="letter-spacing:0.2pt;">&#8221;), then the Employer each month will pay for Mr Divis&#8217; COBRA premiums for such coverage (at coverage levels in effect immediately prior to Mr Divis&#8217; termination) until the earlier of: (A)&#160;the expiration of a period of eighteen (18) months from the date of termination or (B)&#160;the date upon which the Executive becomes covered under similar plans of any subsequent employer or is otherwise ineligible for COBRA (the payments pursuant to items (i), (ii)&#160;and (iii), together the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Severance Indemnity</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Divis Employment Agreement, if Mr Divis terminates his employment for Good Reason or if his employment is terminated by the Employer other than for Cause and such termination occurs during a &#8216;Change in Control&#8217; period (as defined in the Divis Employment Agreement), then in lieu of the payments and benefits described above, Mr&#160;Divis will, subject to the Release Requirement, be entitled to: (i)&#160;a change of control indemnity equal to the sum of: (A)&#160;the Severance Indemnity; and (B)&#160;a lump-sum payment equal to one hundred&#160;percent (100%) of the higher of: (x)&#160;the greater of (I)&#160;Mr Divis&#8217; target bonus as in effect for the fiscal year in which the Change of Control occurs or (II)&#160;Mr Divis&#8217; target bonus as in effect for the fiscal year in which Mr Divis&#8217; termination of employment occurs; or (y)&#160;Mr Divis&#8217; actual bonus for performance during the calendar year prior to the calendar year during which the termination of employment occurs; (ii)&#160;all accrued but unpaid bonuses for any completed fiscal year and vacation pay, expense reimbursement and other benefits due to Mr Divis under any Employer-provided benefit plans, policies and arrangements; (iii)&#160;upon the later of the Change in Control or the termination of Mr Divis&#8217; employment, Mr&#160;Divis shall become immediately vested in full in all outstanding unvested Avadel options and any other equity awards held by Mr.&#160;Divis; and (iv)&#160;outstanding and vested stock options held by Mr.&#160;Divis as of his termination of employment date will remain exercisable until the 18 month anniversary of the termination of employment date (not to extend beyond the original maximum term of such options). </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Divis Employment Agreement, in the event that Mr Divis&#8217; employment is terminated by the Employer for Cause or if Mr Divis terminates his employment other than for Good Reason or as a result of Mr Divis&#8217; Incapacity (or if Mr Divis dies while employed by Employer), the Employer shall pay to Mr Divis all accrued or awarded but unpaid bonuses for any completed fiscal year and vacation pay, expense reimbursement and other benefits due to Mr Divis under any Employer-provided benefit plans, policies and arrangements. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.2</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">None of the other directors of Avadel has a service contract with Avadel or its subsidiaries or associated companies or has had such a contract in the six&#160;months prior to the date of this document. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.3</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Save as disclosed in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Part&#160;1</font><font style="letter-spacing:0.2pt;">&#8201;&#8212;&#8201;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction and the Special Meetings of Avadel&#8217;s Shareholders&#8201;&#8212;&#8201; The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction</font><font style="letter-spacing:0.2pt;">&#8221;, no proposal exists in connection with the Transaction that any payment or other benefit will be made or given by Alkermes (or any persons acting in concert with Alkermes) to any director (or recent directors) of Avadel as compensation for loss of office or as consideration for or in connection with retirement from office. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">7.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Irish Taxation</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Your attention is drawn to &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Material Tax Consequences of the Scheme&#8201;&#8212;&#8201;Irish Tax Considerations</font><font style="letter-spacing:0.2pt;">&#8221; of this proxy statement. If you are in any doubt as to your own position with respect to Irish taxation, or if you require more detailed information or if you are subject to taxation in any jurisdiction other than Ireland, you should consult an independent financial advisor immediately. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">8.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">U.S. Federal Income Tax Consequences</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">Your attention is drawn to &#8220;</font><font style="letter-spacing:0.2pt;">Material Tax Consequences of the Scheme&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Considerations</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; of this proxy statement. If you are in any doubt as to your own position with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">120</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">respect to U.S. federal income tax, or if you require more detailed information or if you are subject to taxation in any jurisdiction, you should consult an independent financial advisor immediately. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">9.</font>
          <br >
        </div>
        <div style=" margin-top:7.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Material Changes</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">9.1</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Save as disclosed in Avadel&#8217;s reports as filed or furnished with the SEC under the Exchange Act from time to time, the Avadel directors are not aware of any material change in the financial or trading position of Avadel since September&#160;30, 2025 (the date to which the last published unaudited interim financial statements were prepared). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">9.2</font>
          <br >
        </div>
        <div style=" margin-top:7.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Save as disclosed in this proxy statement there has been no material change in information previously published by Alkermes or Avadel in connection with the Transaction since October&#160;22, 2025 (being the date on which the Rule&#160;2.7 Announcement was made). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">10.</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Consents</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.31pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">10.1</font>
          <br >
        </div>
        <div style=" margin-top:7.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Goldman Sachs &amp; Co. LLC has given and not withdrawn its written consent to the inclusion in this proxy statement of the references to its name in the form and context in which they appear and to the inclusion of its fairness opinion in this proxy statement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">10.2</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Morgan Stanley &amp; Co. LLC has given and not withdrawn its written consent to the inclusion in this proxy statement of the references to its name in the form and context in which they appear and to the inclusion of its fairness opinion in this proxy statement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">10.3</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">J.P. Morgan Securities LLC has given and not withdrawn its written consent to the inclusion in this proxy statement of the references to its name in the form and context in which they appear. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">10.4</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">J.P. Morgan Securities plc has given and not withdrawn its written consent to the inclusion in this proxy statement of the references to its name in the form and context in which they appear. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">11.</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Appraisal Rights</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Avadel Shareholders approve the Scheme at the Scheme Meeting and the resolutions required to implement the Scheme at the EGM, the Irish High Court sanctions the Scheme and the Court Order is delivered to the Registrar of Companies, then the Scheme will be binding on all Avadel Shareholders, including those Avadel Shareholders who did not attend the Scheme Meeting and/or the EGM and who did not vote or who voted against the relevant resolutions at the Scheme Meeting and/or the EGM. If Avadel Shareholders approve the Scheme and the High Court sanctions the Scheme, no Avadel Shareholder will have &#8220;dissenters&#8221; or &#8220;appraisal&#8221; rights under Irish law or otherwise have any right to seek a court appraisal of the value of the Avadel Shares. If the Scheme becomes effective, all Avadel Shareholders who hold Avadel Shares will receive the same Scheme Consideration per Avadel Share. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">12.</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Sources and Bases of Information</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In this proxy statement, unless otherwise stated or the context otherwise requires, the following sources and bases have been used: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">12.1</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the historical share prices for Avadel are sourced from Nasdaq; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">12.2</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the value of the whole of the existing issued share capital of Avadel is based upon the entire issued ordinary share capital (excluding treasury shares), namely 97,817,589 Avadel Shares as of November&#160;7, 2025, the latest practicable date prior to the posting of this proxy statement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">12.3</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the value of the entire issued and to be issued share capital (fully diluted share capital) of Avadel is calculated on the basis of the following numbers as at November&#160;7, 2025, the latest practicable date prior to the posting of this proxy statement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of issued Avadel Shares, as set out in paragraph 12.2 above; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">218,675 Avadel Shares subject to issued Avadel RSU Awards; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">11,953,785 Avadel Shares subject to Avadel Options, other than Avadel Performance-Based Options; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">121</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:43pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(d)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">466,000 Avadel Shares subject to Avadel Performance-Based Options; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">12.4</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">references to the arrangements in place between Avadel and Alkermes regarding expense reimbursements are sourced from the terms of the expenses reimbursement provisions within the Transaction Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">12.5</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">save where otherwise stated, financial and other information concerning Avadel and Alkermes has been extracted from published sources or from audited financial results of Avadel and Alkermes; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">12.6</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">references to the Transaction related arrangements in place among Avadel and Alkermes are sourced from the Transaction Agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">13.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Concert Parties</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">13.1</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">For the purpose of the Irish Takeover Rules, each of the following persons is regarded as acting in concert with Avadel in connection with the Transaction: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the directors of Avadel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the subsidiaries and associated companies of Avadel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:7.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">partners and members of the professional staff of Goodwin Procter LLP (U.S. legal advisor to Avadel), having its principal executive offices at 100 Northern Avenue, Boston, MA 02210, United States, actively engaged in relation to the Transaction or who are customarily engaged in the affairs of Avadel or who have been engaged in those affairs since October&#160;22, 2023; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(d)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">partners and members of the professional staff of Arthur Cox LLP (Irish legal advisor to Avadel), having its registered offices at Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland actively engaged in relation to the Transaction or who are customarily engaged in the affairs of Avadel or who have been engaged in those affairs since October&#160;22, 2023; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(e)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Morgan Stanley &amp; Co. LLC (financial advisor to Avadel), having its registered offices at 1585&#160;Broadway, New York City, NY 10036, United States and any person (other than exempt principal traders or exempt fund managers) controlling, controlled by, or under the same control as Morgan Stanley &amp; Co LLC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(f)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Goldman Sachs &amp; Co. LLC (financial advisor to Avadel), having its registered offices at 200&#160;West Street, New York, NY 10282, United States, and any person (other than exempt principal traders or exempt fund managers) controlling, controlled by, or under the same control as Goldman Sachs &amp; Co. LLC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(g)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Brunswick Group, LLC (public relations advisor to Avadel) having its registered offices at 1114 Avenue of the Americas, 24</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> Floor, New York, NY 10036, United States; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(h)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Stern Investor Relations, Inc., dba Precision AQ (public relations advisor to Avadel) having its registered offices at 2 Bethesda Metro Ctr Ste 850, Bethesda, Maryland 20814, United States; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Innisfree M&amp;A Incorporated (proxy solicitor to Avadel) having its registered offices at 501&#160;Madison Avenue, 20</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> Floor, New York, NY 10022, United States; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(j)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Golden Parachute Tax Solutions LLC (280G advisor to Avadel) having its registered offices at 1501 Broadway, 12</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> Floor, New York, NY 10036, United States. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">13.2</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">For the purpose of the Irish Takeover Rules, each of the following persons is regarded as acting in concert with Alkermes in connection with the Transaction: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the directors of Alkermes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the subsidiaries and associated companies of Alkermes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">122</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:43pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">partners and members of the professional staff of Paul, Weiss, Rifkind, Wharton &amp; Garrison LLP (U.S. legal advisor to Alkermes), having its principal executive offices at 285 Avenue of the Americas, New York, NY 10019-6064, United States, actively engaged in relation to the Transaction or who are customarily engaged in the affairs of Alkermes or who have been engaged in those affairs since October&#160;22, 2023; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(d)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">partners and members of the professional staff of McCann FitzGerald LLP (Irish legal advisor to Alkermes), having its registered offices at Riverside One, Sir John Rogerson&#8217;s Quay, Dublin 2, D02 X576, Ireland, actively engaged in relation to the Transaction or who are customarily engaged in the affairs of Alkermes or who have been engaged in those affairs since October&#160;22, 2023; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(e)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">partners and members of the professional staff of Cleary Gottlieb Steen &amp; Hamilton LLP (U.S. legal advisor to Alkermes for the financing), having its principal office at One Liberty Plaza, 1 Liberty Pl, New York, NY 10006, United States, actively engaged in relation to the Transaction or who are customarily engaged in the affairs of Alkermes or who have been engaged in those affairs since October&#160;22, 2023; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(f)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">partners and members of the professional staff of PricewaterhouseCoopers Ireland (tax advisor to Alkermes), having its principal office at One Spencer Dock, North Wall Quay, Dublin 1, Ireland, actively engaged in relation to the Transaction or who are customarily engaged in the affairs of Alkermes or who have been engaged in those affairs since October&#160;22, 2023; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(g)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">partners and members of the professional staff of FGS Global Inc. (public relations advisor to Alkermes), having its principal office at 909 3rd Avenue, 32nd Floor, New York, NY 10022, United States, actively engaged in relation to the Transaction or who are customarily engaged in the affairs of Alkermes or who have been engaged in those affairs since October&#160;22, 2023; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(h)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">J.P. Morgan (financial advisor to Alkermes), having its principal offices at 270 Park Avenue, New York, NY 1001, United States of America and any person (other than exempt principal traders or exempt fund managers) controlling, controlled by, or under the same control as J.P. Morgan. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">14.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Other Information</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">14.1</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">No agreement, arrangement or understanding (including any compensation arrangement) having any connection with or dependence upon the Transaction exists between Alkermes, or any person acting in concert with Alkermes and any of the directors or recent directors, shareholders or recent shareholders of Avadel or persons interested or recently interested in, relevant Avadel securities. In this paragraph 14.1, &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">recent</font><font style="letter-spacing:0.2pt;">&#8221; means within the disclosure period. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">14.2</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">No arrangement (as defined below) exists between Alkermes and/or any other person acting in concert with Alkermes and any other person. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">14.3</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">No arrangement (as defined below) exists between Avadel, or any other person acting in concert with Avadel and any other person. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">14.4</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">No agreement, arrangement or understanding exists whereby ownership of any Avadel Shares acquired in pursuance of the Transaction will be transferred to any other person, but Alkermes reserves the right to transfer any Avadel Shares to any other member of the Alkermes group. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">14.5</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Save as disclosed in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Part&#160;1</font><font style="letter-spacing:0.2pt;">&#8201;&#8212;&#8201;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Transaction and the Special Meetings of Avadel&#8217;s Shareholders&#8201;&#8212;&#8201; The Transaction&#8201;&#8212;&#8201;Interests of Certain Persons in the Transaction</font><font style="letter-spacing:0.2pt;">&#8221;, the emoluments of the directors of Avadel will not be affected by the Transaction or automatically as a consequence of the Transaction. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">123</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">14.6</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">For the purposes of this paragraph 13.2(e), &#8220;arrangement&#8221; includes any indemnity or option arrangement and any agreement or understanding, formal or informal, of whatever nature, between two or more persons relating to relevant securities which may be an inducement to deal or refrain from dealing. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">15.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Documents Available for Inspection</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.81pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">15.1</font>
          <br >
        </div>
        <div style=" margin-top:7.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Copies of the following documents will be available from the date of this proxy statement (except in the case of the letter and documents referred to in paragraph 15.1(o), which will be available from the date on which they are provided to the holders of Avadel equity awards) until completion of the Transaction online at https://avadelpharmaceuticalsplc.gcs-web.com/transaction-overview (except in the case of the documents referred to in paragraph 15.1(k)) and https://www.alkermes.com/acquisition (except in the case of the documents referred to in paragraph 15.1(b) and 15.1(j)): </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Rule&#160;2.7 Announcement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the letter from Avadel to Avadel&#8217;s shareholders and convertible security holders, pursuant to Rule&#160;2.10, and the letter from Avadel to Avadel&#8217;s employees pursuant to Rule&#160;2.10; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">this proxy statement dated &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199; 2025; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(d)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Constitution of Avadel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(e)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Constitution of Alkermes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(f)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Transaction Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(g)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the CVR Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(h)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Form of Proxy&#8201;&#8212;&#8201;Scheme Meeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Form of Proxy&#8201;&#8212;&#8201;EGM; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(j)</font>
          <br >
        </div>
        <div style=" margin-top:7.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Rule&#160;8.1 disclosure made by Avadel on November, 5 2025; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(k)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Rule&#160;8.1 disclosure made by Alkermes on November, 5 2025; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(l)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the material contracts referred to in paragraph 5, save for the Settlement Agreement and the License Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(m)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the letters of consent referred to in paragraph 10; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(n)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the bridge credit agreement dated October&#160;22, 2025 entered into between Alkermes, JPMorgan Chase Bank N.A. and certain lenders from time to time party thereto; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(o)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the letter and associated documents provided to the holders of Avadel equity awards in accordance with Rule&#160;15 of the Irish Takeover Rules. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">16.</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Financial Information Relating to Avadel</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The financial information in respect of Avadel as required by Rule&#160;24.3(c) of the Irish Takeover Rules is incorporated into this proxy statement by reference pursuant to Rule&#160;24.15 of the Irish Takeover Rules and your attention is drawn to &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Where You Can Find More Information</font><font style="letter-spacing:0.2pt;">&#8221;. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">17.</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Financial Information Relating to Alkermes</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As required by Rule&#160;24.3(a)(i) of the Irish Takeover Rules, Alkermes&#8217; audited consolidated financial statements as of and for the financial&#160;years ended 31 December&#160;2024 and 31 December&#160;2023 each of which can be found on Alkermes&#8217;s website at https://investor.alkermes.com/annual-reports, and Alkermes&#8217; unaudited condensed consolidated financial statements as of and for the quarterly periods ended September&#160;30, 2025, June&#160;30, 2025 and March&#160;31, 2025 each of which can be found on Alkermes&#8217; website at https://investor.alkermes.com/quarterly-reports, (together, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Alkermes Financial Statements</font><font style="letter-spacing:0.2pt;">&#8221;) are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">124</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">incorporated into this proxy statement by reference pursuant to Rule&#160;24.15 of the Irish Takeover Rules. Alkermes will furnish without charge to each person to whom this proxy statement is delivered, upon written or oral request, a copy of any or all of the Alkermes Financial Statements, including exhibits to these documents. A hard copy of the Alkermes Financial Statements will not be sent to any person unless requested pursuant to this process. Any Avadel Shareholder may request a hard copy of the Alkermes Financial Statements by application to: </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Alkermes plc </font>
          <br >
          <font style="letter-spacing:0.2pt;">Connaught House </font>
          <br >
          <font style="letter-spacing:0.2pt;">1 Burlington Road </font>
          <br >
          <font style="letter-spacing:0.2pt;">Dublin 4, Ireland, D04 C5Y6 </font>
          <br >
          <font style="letter-spacing:0.2pt;">Attention: Company Secretary </font>
          <br >
          <font style="letter-spacing:0.2pt;">+35317728000 </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any such request must include the identity of the Avadel Shareholder and any hard copy documents will be posted to the address of the Avadel Shareholder provided in such application. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">18.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Alkermes&#8217; Current Trading and Prospects</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">18.1</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. Alkermes has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy and idiopathic hypersomnia. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">18.2</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">On October&#160;28, 2025, Alkermes announced its financial results for the quarter ended September&#160;30, 2025, the principal highlights of which are as follows: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">total revenues were $394.2&#160;million; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">total proprietary product net sales revenues were $317.4&#160;million, reflecting growth of 32%, 16% and 7% for LYBALVI</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, ARISTADA</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">/ARISTADA INITIO</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> and VIVITROL</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, respectively, compared to the same period in the prior year; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">GAAP net income was $82.8&#160;million and diluted GAAP earnings per share were $.049; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:43pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(d)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:63pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">as of September&#160;30, 2025, Alkermes recorded cash, cash equivalents and total investments of $1.14&#160;billion. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">18.3</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The information set forth above is only a summary and should be read in conjunction with Alkermes&#8217; audited consolidated financial statements as of and for the financial&#160;years ended 31&#160;December&#160;2024 and 31 December&#160;2023, and Alkermes&#8217; unaudited condensed consolidated financial statements as of and for the quarterly periods ended 30 September&#160;2025, 30 June&#160;2025 and 31 March&#160;2025, all of which are incorporated into this proxy statement by reference pursuant to Rule&#160;24.15 of the Irish Takeover Rules. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">19.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Ratings and Outlooks</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the close of business on the disclosure date, there are no publicly available analyst ratings, outlooks or credit ratings with respect to Avadel. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">20.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">No Profit Forecast or Merger Benefit Statement</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No statement in this proxy statement is intended to constitute a profit forecast or profit estimate for any period, nor should any statements be interpreted to mean that earnings or earnings per share will, for the current or future financial&#160;years or other periods, necessarily match or be greater or lesser than those for the relevant preceding financial periods for Avadel. No statement in this proxy statement constitutes an asset valuation or a quantified financial benefits statement within the meaning of the Irish Takeover Rules. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">125</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:520pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">21.</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Governing Law</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Scheme shall be governed by, and construed in accordance with, the laws of Ireland and the Scheme and matters related to the sanction thereof shall be subject to the jurisdiction of the Irish High Court. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">22.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Irish Takeover Rules and Irish Takeover Panel</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Transaction is subject to the provisions of the Irish Takeover Rules and the jurisdiction of the Irish Takeover Panel.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">126</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tANA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:496pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Annex&#160;A</font>&#8203;</div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">TRANSACTION AGREEMENT </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">dated as of October&#160;22, 2025 </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">among </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Alkermes plc </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">and </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avadel Pharmaceuticals plc </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="TOC3">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:611.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:422.96pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:422.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tARI"><font style="letter-spacing:0.2pt;">ARTICLE I INTERPRETATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tARI">A-4</a></font><a href="#tARI"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tS1D"><font style="letter-spacing:0.2pt;">Section&#160;1.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tS1D">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Definitions </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS1D">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS1D">A-4</a></font><a href="#tS1D"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tS1CT"><font style="letter-spacing:0.2pt;">Section&#160;1.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tS1CT">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Construction </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS1CT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS1CT">A-16</a></font><a href="#tS1CT"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tAI2A"><font style="letter-spacing:0.2pt;">ARTICLE II RULE 2.7 ANNOUNCEMENT, SCHEME DOCUMENT AND COMPANY EQUITY AWARD HOLDER PROPOSAL </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAI2A">A-17</a></font><a href="#tAI2A"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tS2R2"><font style="letter-spacing:0.2pt;">Section&#160;2.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tS2R2">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Rule&#160;2.7 Announcement </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS2R2">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS2R2">A-17</a></font><a href="#tS2R2"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tS2SS"><font style="letter-spacing:0.2pt;">Section&#160;2.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tS2SS">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Scheme </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS2SS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS2SS">A-17</a></font><a href="#tS2SS"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tS2CI"><font style="letter-spacing:0.2pt;">Section&#160;2.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tS2CI">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Change in Shares </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS2CI">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS2CI">A-17</a></font><a href="#tS2CI"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC"><font style="letter-spacing:0.2pt;">Section&#160;2.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Company Equity Award Holder Proposal </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC">A-18</a></font><a href="#tSEC"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:422.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAIOT"><font style="letter-spacing:0.2pt;">ARTICLE III IMPLEMENTATION OF THE SCHEME </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAIOT">A-18</a></font><a href="#tAIOT"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tS3RO"><font style="letter-spacing:0.2pt;">Section&#160;3.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tS3RO">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Responsibilities of the Company in Respect of the Scheme </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS3RO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS3RO">A-18</a></font><a href="#tS3RO"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tS3RO1"><font style="letter-spacing:0.2pt;">Section&#160;3.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tS3RO1">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Responsibilities of Parent in Respect of the Scheme </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS3RO1">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS3RO1">A-21</a></font><a href="#tS3RO1"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tS3MR"><font style="letter-spacing:0.2pt;">Section&#160;3.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tS3MR">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Mutual Responsibilities of the Parties </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS3MR">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS3MR">A-22</a></font><a href="#tS3MR"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC1"><font style="letter-spacing:0.2pt;">Section&#160;3.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC1">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Dealings with the Panel </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC1">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC1">A-22</a></font><a href="#tSEC1"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC2"><font style="letter-spacing:0.2pt;">Section&#160;3.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC2">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">No Scheme Amendment by the Company </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC2">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC2">A-23</a></font><a href="#tSEC2"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC3"><font style="letter-spacing:0.2pt;">Section&#160;3.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC3">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Switching to a Takeover Offer </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC3">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC3">A-24</a></font><a href="#tSEC3"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:422.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAIA"><font style="letter-spacing:0.2pt;">ARTICLE IV EQUITY AWARDS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAIA">A-25</a></font><a href="#tAIA"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC4"><font style="letter-spacing:0.2pt;">Section&#160;4.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC4">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Treatment of Company Equity Awards </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC4">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC4">A-25</a></font><a href="#tSEC4"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC5"><font style="letter-spacing:0.2pt;">Section&#160;4.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC5">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Treatment of Company ESPP </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC5">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC5">A-26</a></font><a href="#tSEC5"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tS4RB"><font style="letter-spacing:0.2pt;">Section&#160;4.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tS4RB">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Reasonable Best Efforts </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS4RB">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS4RB">A-27</a></font><a href="#tS4RB"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC6"><font style="letter-spacing:0.2pt;">Section&#160;4.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC6">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Amendment of Articles </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC6">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC6">A-27</a></font><a href="#tSEC6"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:422.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAVC"><font style="letter-spacing:0.2pt;">ARTICLE V COMPANY CONDUCT </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAVC">A-27</a></font><a href="#tAVC"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC7"><font style="letter-spacing:0.2pt;">Section&#160;5.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC7">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Conduct of Business by the Company </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC7">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC7">A-27</a></font><a href="#tSEC7"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC8"><font style="letter-spacing:0.2pt;">Section&#160;5.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC8">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Non-Solicitation </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC8">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC8">A-30</a></font><a href="#tSEC8"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:422.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAVAW"><font style="letter-spacing:0.2pt;">ARTICLE VI REPRESENTATIONS AND WARRANTIES </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAVAW">A-33</a></font><a href="#tAVAW"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC9"><font style="letter-spacing:0.2pt;">Section&#160;6.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC9">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Company Representations and Warranties </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC9">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC9">A-33</a></font><a href="#tSEC9"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC10"><font style="letter-spacing:0.2pt;">Section&#160;6.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC10">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Parent Representations and Warranties </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC10">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC10">A-52</a></font><a href="#tSEC10"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:422.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAVA"><font style="letter-spacing:0.2pt;">ARTICLE VII ADDITIONAL AGREEMENTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAVA">A-54</a></font><a href="#tAVA"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC11"><font style="letter-spacing:0.2pt;">Section&#160;7.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC11">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Access to Information; Confidentiality; Notices of Certain Events </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC11">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC11">A-54</a></font><a href="#tSEC11"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC12"><font style="letter-spacing:0.2pt;">Section&#160;7.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC12">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Consents and Regulatory Approvals </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC12">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC12">A-56</a></font><a href="#tSEC12"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC13"><font style="letter-spacing:0.2pt;">Section&#160;7.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC13">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Directors&#8217; and Officers&#8217; Indemnification and Insurance </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC13">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC13">A-58</a></font><a href="#tSEC13"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC14"><font style="letter-spacing:0.2pt;">Section&#160;7.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC14">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Employment and Benefit Matters </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC14">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC14">A-59</a></font><a href="#tSEC14"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC15"><font style="letter-spacing:0.2pt;">Section&#160;7.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC15">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Stock Exchange Delisting </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC15">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC15">A-60</a></font><a href="#tSEC15"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC16"><font style="letter-spacing:0.2pt;">Section&#160;7.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC16">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Financing </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC16">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC16">A-60</a></font><a href="#tSEC16"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC17"><font style="letter-spacing:0.2pt;">Section&#160;7.7</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC17">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Financing Cooperation </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC17">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC17">A-61</a></font><a href="#tSEC17"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC18"><font style="letter-spacing:0.2pt;">Section&#160;7.8</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC18">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Transaction Litigation </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC18">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC18">A-64</a></font><a href="#tSEC18"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC19"><font style="letter-spacing:0.2pt;">Section&#160;7.9</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC19">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">State Takeover Statutes </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC19">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC19">A-65</a></font><a href="#tSEC19"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC20"><font style="letter-spacing:0.2pt;">Section&#160;7.10</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC20">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">CVR Agreement </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC20">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC20">A-65</a></font><a href="#tSEC20"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="TOC4">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:225.5pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:353.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:422.96pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:422.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAVOA"><font style="letter-spacing:0.2pt;">ARTICLE VIII COMPLETION OF ACQUISITION AND MERGER </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAVOA">A-65</a></font><a href="#tAVOA"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC21"><font style="letter-spacing:0.2pt;">Section&#160;8.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC21">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Completion </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC21">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC21">A-65</a></font><a href="#tSEC21"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC22"><font style="letter-spacing:0.2pt;">Section&#160;8.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC22">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Payment of Consideration </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC22">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC22">A-66</a></font><a href="#tSEC22"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tART"><font style="letter-spacing:0.2pt;">ARTICLE IX TERMINATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tART">A-66</a></font><a href="#tART"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC23"><font style="letter-spacing:0.2pt;">Section&#160;9.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC23">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Termination </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC23">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC23">A-66</a></font><a href="#tSEC23"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC24"><font style="letter-spacing:0.2pt;">Section&#160;9.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC24">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Certain Effects of Termination </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC24">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC24">A-68</a></font><a href="#tSEC24"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tART1"><font style="letter-spacing:0.2pt;">ARTICLE X GENERAL </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tART1">A-70</a></font><a href="#tART1"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC25"><font style="letter-spacing:0.2pt;">Section&#160;10.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC25">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Announcements </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC25">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC25">A-70</a></font><a href="#tSEC25"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC26"><font style="letter-spacing:0.2pt;">Section&#160;10.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC26">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Notices </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC26">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC26">A-70</a></font><a href="#tSEC26"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC27"><font style="letter-spacing:0.2pt;">Section&#160;10.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC27">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Assignment </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC27">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC27">A-71</a></font><a href="#tSEC27"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC28"><font style="letter-spacing:0.2pt;">Section&#160;10.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC28">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Counterparts </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC28">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC28">A-71</a></font><a href="#tSEC28"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC29"><font style="letter-spacing:0.2pt;">Section&#160;10.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC29">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Amendment </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC29">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC29">A-71</a></font><a href="#tSEC29"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC30"><font style="letter-spacing:0.2pt;">Section&#160;10.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC30">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Entire Agreement </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC30">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC30">A-72</a></font><a href="#tSEC30"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC31"><font style="letter-spacing:0.2pt;">Section&#160;10.7</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC31">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Inadequacy of Damages </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC31">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC31">A-72</a></font><a href="#tSEC31"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC32"><font style="letter-spacing:0.2pt;">Section&#160;10.8</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC32">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Disclosure Schedule&#160;References and SEC Document References </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC32">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC32">A-72</a></font><a href="#tSEC32"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC33"><font style="letter-spacing:0.2pt;">Section&#160;10.9</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC33">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Remedies and Waivers </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC33">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC33">A-72</a></font><a href="#tSEC33"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC34"><font style="letter-spacing:0.2pt;">Section&#160;10.10</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC34">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Severability </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC34">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC34">A-73</a></font><a href="#tSEC34"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC35"><font style="letter-spacing:0.2pt;">Section&#160;10.11</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC35">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">No Partnership and No Agency </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC35">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC35">A-73</a></font><a href="#tSEC35"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC36"><font style="letter-spacing:0.2pt;">Section&#160;10.12</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC36">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Costs and Expenses </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC36">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC36">A-73</a></font><a href="#tSEC36"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC37"><font style="letter-spacing:0.2pt;">Section&#160;10.13</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC37">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Governing Law and Jurisdiction </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC37">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC37">A-73</a></font><a href="#tSEC37"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC38"><font style="letter-spacing:0.2pt;">Section&#160;10.14</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC38">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Third-Party Beneficiaries </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC38">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC38">A-74</a></font><a href="#tSEC38"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC39"><font style="letter-spacing:0.2pt;">Section&#160;10.15</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC39">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Waiver of Claims Against Financing Sources </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC39">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC39">A-75</a></font><a href="#tSEC39"> </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:422.96pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:63pt;white-space:nowrap;">
                <a href="#tSEC40"><font style="letter-spacing:0.2pt;">Section&#160;10.16</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:73pt;">
                <a href="#tSEC40">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:0.2pt;">Non Survival of Representations and Warranties </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSEC40">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:18pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEC40">A-75</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:20pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exhibits</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:72pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Exhibit&#160;A</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:72pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Form of CVR Agreement </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tARI">&#8203;</a><a name="tS1D">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TRANSACTION AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This TRANSACTION AGREEMENT (this &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), dated as of October&#160;22, 2025, is by and among Alkermes plc, an Irish public limited company with registered number 498284 having its registered office at Connaught House, 1 Burlington Road, Dublin 4, Ireland D04 C5Y6 (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;) and Avadel Pharmaceuticals plc, an Irish public limited company with registered number 572535 having its registered office at 10 Earslfort Terrace, Dublin 2, Ireland (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, Parent has agreed to make a proposal to acquire the Company on the terms set out in the Rule&#160;2.7 Announcement; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, this Agreement sets out certain matters relating to the conduct of the Acquisition that have been agreed by the Parties; and </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, the Parties intend that the Acquisition will be implemented by way of the Scheme, although this may, subject to the consent (where required) of the Panel, be switched to a Takeover Offer in accordance with the terms set out in this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">NOW, THEREFORE, in consideration of the foregoing and the representations, warranties, covenants and agreements contained in this Agreement, the Parties agree as follows: </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE I</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INTERPRETATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;1.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Definitions</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As used in this Agreement the following words and expressions have the following meanings: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Acquisition</font><font style="letter-spacing:0.2pt;">&#8221; means the proposed acquisition by Parent of the entire issued, and to be issued, ordinary share capital of the Company in accordance with the terms of this Agreement, to be effected by means of the Scheme or, should Parent elect, subject to the terms of this Agreement and the consent of the Panel (if required), a Takeover Offer (and any such Scheme or Takeover Offer as it may be revised, amended or extended from time to time, subject to the consent of the Panel and the High Court (if required)), including the settlement by Parent of the aggregate Scheme Consideration payable pursuant to the Scheme or the Takeover Offer, in each case, as described in the Rule&#160;2.7 Announcement and provided for in this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Companies Act 2014 of Ireland, all enactments which are to be read as one with, or construed or read together as one with, the Act and every statutory modification and reenactment thereof for the time being in force. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Acting in Concert</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meaning given to that term in the Takeover Panel Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Actions</font><font style="letter-spacing:0.2pt;">&#8221; means any civil, criminal or administrative actions, litigations, arbitrations, suits, demands, claims, hearings, notices of violation, investigations, proceedings, demand letters, settlement or enforcement actions by, from or before any Governmental Entity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Affiliate</font><font style="letter-spacing:0.2pt;">&#8221; means, in relation to any Person, any other Person that, directly or indirectly, controls, is controlled by, or is under common control with, such first person (as used in this definition, &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">control</font><font style="letter-spacing:0.2pt;">&#8221; means the possession, directly or indirectly, of the power to direct or cause the direction of management or policies of a Person, whether through the ownership of securities or partnership or other ownership interests, by Contract or otherwise and the terms &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">controlled</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">controlling</font><font style="letter-spacing:0.2pt;">&#8221; shall have correlative meanings). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Alternative Financing</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning ascribed to it in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.6(b)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Antitrust Laws</font><font style="letter-spacing:0.2pt;">&#8221; means the Sherman Act of 1890, the Clayton Act of 1914, the Federal Trade Commission Act of 1914, the HSR Act and all other federal, state and foreign applicable Laws in effect from time to time that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or the substantial lessening of competition. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Bribery Legislation</font><font style="letter-spacing:0.2pt;">&#8221; means all and any of the following: the FCPA; the Organization For Economic Co-operation and Development Convention on Combating Bribery of Foreign Public Officials in International Business Transactions and related implementing legislation; the relevant Law in England and Wales relating to bribery or corruption, including, the Public Bodies Corrupt Practices Act 1889; the Prevention of Corruption Act 1906 as supplemented by the Prevention of Corruption Act 1916 and the Anti-Terrorism, Crime and Security Act 2001; the United Kingdom Bribery Act of 2010; the Proceeds of Crime Act 2002; the relevant Laws in Ireland relating to bribery or corruption including the Criminal Justice (Corruption Offences) Act 2018 of Ireland; and any anti-bribery or anti-corruption related provisions in criminal and anti-competition laws or anti-bribery, anti-corruption or anti-money laundering Laws of any jurisdiction in which the Company Group operates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Business Day</font><font style="letter-spacing:0.2pt;">&#8221; means any day, other than a Saturday, Sunday or a day on which banks in Dublin, Ireland or in New York, USA are authorized or required by applicable Law to be closed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Cap</font><font style="letter-spacing:0.2pt;">&#8221; means an amount equal to one&#160;percent (1%) of the aggregate value of the total Cash Consideration payable with respect to the Company Shares in connection with the Acquisition (excluding, for clarity, any interest in such share capital of the Company held by Parent or any Concert Parties of Parent) as ascribed by the terms of the Acquisition as set out in the Rule&#160;2.7 Announcement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Cash Consideration</font><font style="letter-spacing:0.2pt;">&#8221; means $18.50 in cash per Company Share. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Clearance Date</font><font style="letter-spacing:0.2pt;">&#8221; means the Business Day next succeeding the date upon which the later occurring of (i)&#160;the Panel confirming that (x)&#160;it has no comments on the Proxy Statement or the Scheme Document or (y)&#160;its comments on the Proxy Statement or the Scheme Document have been adequately responded to or resolved and (ii)&#160;in respect of the SEC, (x)&#160;the SEC review period has expired with no comments or (y)&#160;the SEC confirming that its comments on the Proxy Statement have been adequately responded to or resolved. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Clearances</font><font style="letter-spacing:0.2pt;">&#8221; means all consents, clearances, approvals, permissions, licenses, variances, exemptions, authorizations, acknowledgements, permits, nonactions, Orders and waivers to be obtained from, and all registrations, applications, notices and filings to be made with or provided to, any Governmental Entity in connection with the implementation of the Scheme or the Acquisition. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Code</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Internal Revenue Code of 1986. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Alternative Proposal</font><font style="letter-spacing:0.2pt;">&#8221; means any indication of interest, proposal or offer (including non-binding proposals or offers) from any Person or Group, other than Parent and its Subsidiaries or any of its Concert Parties, relating to any (i)&#160;direct or indirect acquisition (whether in a single transaction or a series of related transactions) of assets of the Company or any of its Subsidiaries (including equity securities of Subsidiaries) equal to twenty&#160;percent (20%) or more of the consolidated assets of the Company, or to which twenty&#160;percent (20%) or more of the revenues or earnings of the Company on a consolidated basis are attributable for the most recent fiscal year for which audited financial statements are then available, (ii)&#160;direct or indirect acquisition (including by scheme of arrangement or takeover offer) or issuance (whether in a single transaction or a series of related transactions) of twenty&#160;percent (20%) or more of any class of equity or voting securities of the Company, (iii)&#160;scheme of arrangement, tender offer, takeover offer or exchange offer that, if consummated, would result in a Person or Group beneficially owning twenty&#160;percent (20%) or more of any class of equity or voting securities of the Company or (iv)&#160;scheme of arrangement, merger, consolidation, share exchange, business combination, joint venture, reorganization, recapitalization or similar transaction involving the Company or any of its Subsidiaries, under which a Person or Group or, in the case of clause (B)&#160;below, the shareholders or equityholders of any Person or Group would, directly or indirectly, (A)&#160;acquire assets equal to twenty&#160;percent (20%) or more of the consolidated assets of the Company, or to which twenty&#160;percent (20%) or more of the revenues or earnings of the Company on a consolidated basis are attributable for the most recent fiscal year for which audited financial statements are then available or (B)&#160;immediately after giving effect to such transactions, beneficially own twenty&#160;percent (20%) or more of any class of equity or voting securities of the Company or the surviving or resulting Person (including any parent Person) in such transaction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Benefit Plan</font><font style="letter-spacing:0.2pt;">&#8221; means each employee welfare benefit plan within the meaning of Section&#160;3(1) of ERISA (whether or not such plan is subject to ERISA), each employee pension benefit plan within the meaning of Section&#160;3(2) of ERISA (whether or not such plan is subject to ERISA), and each employment, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">individual consulting, compensation, salary contribution, change-in-control, bonus, incentive, equity or equity-based, phantom equity, deferred compensation, vacation, paid time off, stock purchase, stock or stock-based, severance, termination pay or indemnity, retention, employment, change of control or fringe benefit or other material benefit or compensation plan, program, policy, scheme, arrangement or agreement, whether or not written, that in each case, is sponsored, maintained or contributed to by any member of the Company Group or to which any member of the Company Group has or would reasonably be expected to have any material liability (whether current or contingent), excluding any arrangements maintained by any Governmental Entity or otherwise required by applicable Law. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Board</font><font style="letter-spacing:0.2pt;">&#8221; means the board of directors of the Company. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Directors</font><font style="letter-spacing:0.2pt;">&#8221; means the members of the board of directors of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Employees</font><font style="letter-spacing:0.2pt;">&#8221; means the employees of the Company or any Subsidiary of the Company as of immediately prior to the Effective Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Equity Awards</font><font style="letter-spacing:0.2pt;">&#8221; means the Company Options, Company Performance Options, Company Restricted Stock Awards, Company RSU Awards and any other Company equity-based awards granted under a Company Share Plan or otherwise. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Equity Award Holder Proposal</font><font style="letter-spacing:0.2pt;">&#8221; means the proposal of Parent to the Company Equity Award Holders to be made in accordance with this Agreement (including </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IV</font><font style="letter-spacing:0.2pt;">), Rule&#160;15 of the Takeover Rules and the terms of the Company Share Plans. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Equity Award Holders</font><font style="letter-spacing:0.2pt;">&#8221; means the holders of Company Equity Awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Equity Compensation Plans</font><font style="letter-spacing:0.2pt;">&#8221; means, collectively, the Company Share Plans and the Company ESPP. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company ESPP</font><font style="letter-spacing:0.2pt;">&#8221; means the Avadel Pharmaceuticals plc 2017 Employee Share Purchase Plan. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Group</font><font style="letter-spacing:0.2pt;">&#8221; means the Company and its Subsidiaries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Intellectual Property</font><font style="letter-spacing:0.2pt;">&#8221; means the Owned Intellectual Property and the Licensed Intellectual Property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Intervening Event</font><font style="letter-spacing:0.2pt;">&#8221; means any material event, fact, change, effect, development or occurrence arising or occurring after the date of this Agreement that (i)&#160;was not known or reasonably foreseeable, or the material consequences of which were not known or reasonably foreseeable, in each case to the Company Board as of or prior to the date of this Agreement, (ii)&#160;does not relate to any Company Alternative Proposal, (iii)&#160;does not relate to Parent or any of its Subsidiaries and (iv)&#160;does not relate to the achievement of, or failure to achieve, a Milestone (as defined in the CVR Agreement). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Material Adverse Effect</font><font style="letter-spacing:0.2pt;">&#8221; means any event, change, effect, development or occurrence that, individually or together with any other event, change, effect, development or occurrence, (a)&#160;would reasonably be expected to prevent, materially delay or materially impair the ability of the Company to consummate the transactions contemplated hereby (including the Acquisition) prior to the End Date or (b)&#160;has had or would reasonably be expected to have a material adverse effect on the condition (financial or otherwise), assets, liabilities, business, operations or results of operations of the Company and its Subsidiaries, taken as a whole; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that, solely for the purposes of clause (b), no event, change, effect, development or occurrence to the extent resulting from or arising out of any of the following shall be deemed to constitute a Company Material Adverse Effect or shall be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect: (i)&#160;any changes in conditions generally affecting the industry in which the Company or any of its Subsidiaries operate, (ii)&#160;any decline, in and of itself, in the market price or change in trading volume of Company Shares (it being understood and agreed that the facts, events, developments or occurrences giving rise to or contributing to such decline or change that are not otherwise excluded from the definition of Company Material Adverse Effect may be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect), (iii)&#160;any general changes in political conditions (including the imposition of new or increased trade restrictions, tariffs or trade policies) or in securities, credit, financial, debt or other capital </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">markets, in each case in the United States or any foreign jurisdiction, including any disruption thereof, due to a Government Shutdown or otherwise, (iv)&#160;any failure, in and of itself, by the Company or any of its Subsidiaries to meet any internal or published projections, forecasts, estimates or predictions, revenues, earnings or other financial or operating metrics for any period (it being understood and agreed that the facts, events, developments or occurrences giving rise to or contributing to such failure that are not otherwise excluded from the definition of Company Material Adverse Effect may be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect), (v)&#160;the execution and delivery of this Agreement, the public announcement of this Agreement or the consummation of the transactions contemplated hereby, including the Acquisition, or the identity of Parent (it being understood and agreed that the foregoing shall not apply with respect to any representation or warranty that is intended to address the consequences of the execution, delivery or performance of this Agreement or the consummation of the transactions contemplated hereby (including the Acquisition)), (vi)&#160;any adoption, implementation, promulgation, repeal, modification, amendment or change of any applicable Law of or by any Governmental Entity (it being understood and agreed that any changes to the regulatory treatment of any Company Product may be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect), (vii)&#160;any changes or prospective changes in GAAP, (viii)&#160;any outbreak or escalation of hostilities, acts of war, sabotage, terrorism or any escalation or worsening of any such acts of war, sabotage or terrorism threatened or underway as of the date of this Agreement, (ix)&#160;any action taken by the Company or any of its Subsidiaries which is expressly required by this Agreement or the taking of any action at the written direction of Parent (except for any obligation to operate in the ordinary course of business), (x)&#160;any event, change, effect, development or occurrence resulting from the Company&#8217;s entry into the Settlement and License Agreement, by and between Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited, on the one hand, and Avadel CNS Pharmaceuticals and Flamel Ireland Limited, on the other hand, dated October&#160;21, 2025 (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Settlement Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) or the performance of the Company&#8217;s or its Affiliates&#8217; obligations required thereunder, or (xi)&#160;any epidemic, plague, pandemic or other outbreak of illness or public health event, hurricane, earthquake, flood or other natural disasters, acts of God or any change resulting from weather conditions, except in the case of each of clauses (i), (iii), (vi), (vii), (viii)&#160;or (xii), to the extent that any such event, change, effect, development or occurrence has a disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to the adverse effect such event, change, effect, development or occurrence has on other companies operating in the industries in which the Company and its Subsidiaries operate, then only the incremental disproportionate adverse effect of such effect shall be taken into account for the purpose of determining whether a Company Material Adverse Effect exists or has occurred. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Options</font><font style="letter-spacing:0.2pt;">&#8221; means all options to purchase Company Shares, whether granted pursuant to the Company Share Plans or otherwise, other than the Company Performance Options and an option granted under the Company ESPP. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Performance Options</font><font style="letter-spacing:0.2pt;">&#8221; means all options to purchase Company Shares, for which vesting is based all or partially on performance conditions that have not been achieved prior to the Effective Time, whether granted pursuant to the Company Share Plans or otherwise. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Preferred Shares</font><font style="letter-spacing:0.2pt;">&#8221; means the preferred shares of the Company, nominal value $0.01. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Product</font><font style="letter-spacing:0.2pt;">&#8221; means all products or product candidates that are being researched, tested, developed, labeled, handled, packaged, stored, supplied, promoted, imported, exported, commercialized, manufactured, sold, distributed, licensed, sublicensed or held for license or sublicense by any member of the Company Group and all products or product candidates, if any, with respect to which any member of the Company Group has royalty rights, including the Company&#8217;s proprietary formulations of sodium oxybate known as (i)&#160;LUMRYZ</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> (sodium oxybate) for extended-release oral suspension and (ii)&#160;valiloxybate, an investigational, once-at-bedtime, salt-free and artificial sweetener-free, extended-release oxybate, as licensed&#160;pursuant to a license agreement between the Company and XWPharma Ltd. as disclosed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(t)(i)(I)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Regulatory Agency</font><font style="letter-spacing:0.2pt;">&#8221; means any Governmental Entity with jurisdiction related to the quality, identity, strength, purity, safety, efficacy, testing, manufacturing, labeling, storage, distribution, marketing, sale, pricing, import or export of any of the Company Products. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Regulatory Permits</font><font style="letter-spacing:0.2pt;">&#8221; means authorizations, permits, approvals, clearances, licenses, certifications, and registrations (i)&#160;under the FDCA or the Public Health Service Act, (ii)&#160;under the CSA, and (iii)&#160;of any applicable Company Regulatory Agency necessary for the lawful operation of the businesses of the Company or any of its Subsidiaries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Restricted Stock Awards</font><font style="letter-spacing:0.2pt;">&#8221; means all awards of Company Shares subject to vesting restrictions or forfeiture back to the Company, whether granted pursuant to the Company Share Plans or otherwise. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company RSU Award</font><font style="letter-spacing:0.2pt;">&#8221; means an award of restricted share&#160;units representing the right to receive one or more Company Shares or the cash value thereof upon vesting and settlement, whether granted pursuant to the Company Share Plans or otherwise. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Share Award</font><font style="letter-spacing:0.2pt;">&#8221; means an award denominated in Company Shares (including Company Restricted Stock Awards and Company RSU Awards), other than a Company Option and a Company Performance Option. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Share Plans</font><font style="letter-spacing:0.2pt;">&#8221; means, collectively, the Avadel Pharmaceuticals plc 2017 Omnibus Incentive Compensation Plan, as amended, the Avadel Pharmaceuticals plc 2020 Omnibus Incentive Compensation Plan, the Avadel Pharmaceuticals plc 2021 Inducement Plan, as amended, and any other equity-based incentive plan maintained by the Company or assumed by the Company in connection with prior acquisitions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Shareholder Approval</font><font style="letter-spacing:0.2pt;">&#8221; means (i)&#160;the approval of the Scheme by a majority in number of members of each class of Company Shareholders (including as may be directed by the High Court pursuant to Section&#160;450(5) of the Act) representing, at the relevant voting record time, at least seventy-five&#160;percent (75%) in value of the Company Shares of that class held by Company Shareholders who are members of that class and that are present and voting either in person or by proxy, at the Court Meeting (or at any adjournment or postponement of such meeting) and (ii)&#160;each of the Required EGM Resolutions being duly passed by the requisite majorities of Company Shareholders at the EGM (or at any adjournment or postponement of such meeting). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Shares</font><font style="letter-spacing:0.2pt;">&#8221; means the ordinary shares of the Company, nominal value $0.01 per share. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Shareholders</font><font style="letter-spacing:0.2pt;">&#8221; means the holders of Company Shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Superior Proposal</font><font style="letter-spacing:0.2pt;">&#8221; means any bona fide, written Company Alternative Proposal (other than a Company Alternative Proposal which has resulted from a breach of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;">) (with all references to &#8220;twenty&#160;percent (20%)&#8221; in the definition of Company Alternative Proposal being deemed to be references to &#8220;fifty&#160;percent (50%)&#8221;) on terms that the Company Board determines in good faith, after consultation with its financial advisor(s) and outside legal counsel, and taking into account all the terms and conditions of the Company Alternative Proposal that the Company Board reasonably considers to be appropriate (including the financial terms of the proposal, the identity of the Person making the Company Alternative Proposal and the expected timing and likelihood of consummation, any governmental or other approval requirements (including divestitures and entry into other commitments and limitations), break-up fees, expense reimbursement provisions, conditions to consummation and availability of necessary financing), would result in a transaction that (i)&#160;if consummated, is more favorable to the Company Shareholders (in their capacity as such) from a financial point of view than the Acquisition (taking into account any proposal by Parent to amend the terms of this Agreement) and (ii)&#160;is reasonably capable of being completed on the terms proposed on a timely basis and (iii)&#160;for which financing, if a cash transaction (whether in whole or in part) is reasonably determined to be available by the Company Board. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Completion</font><font style="letter-spacing:0.2pt;">&#8221; means the completion of the Acquisition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Concert Parties</font><font style="letter-spacing:0.2pt;">&#8221; means such Persons as are deemed to be Acting in Concert with Parent pursuant to Rule&#160;3.3 of Part&#160;A of the Takeover Rules. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Conditions</font><font style="letter-spacing:0.2pt;">&#8221; means the conditions to the Scheme and the Acquisition set out in paragraphs 1 through&#160;5 of Appendix&#160;III of the Rule&#160;2.7 Announcement, and &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Condition</font><font style="letter-spacing:0.2pt;">&#8221; means any one of the Conditions. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Confidentiality Agreement</font><font style="letter-spacing:0.2pt;">&#8221; means the letter agreement by and between the Company and Parent dated as of August&#160;24, 2025. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Contract</font><font style="letter-spacing:0.2pt;">&#8221; means any legally binding contract, agreement, obligation, understanding or instrument, lease, license or other legally binding commitment or undertaking of any nature. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">CSA</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Controlled Substances Act, 21 U.S.C. &#167;&#167;&#160;801 et seq., and all regulations promulgated thereunder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Court Hearing</font><font style="letter-spacing:0.2pt;">&#8221; means the hearing by the High Court of the Petition to sanction the Scheme under Section&#160;453 of the Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Court Meeting</font><font style="letter-spacing:0.2pt;">&#8221; means the meeting or meetings of the Company Shareholders or, if applicable, the meeting or meetings of any class or classes of Company Shareholders (and, in each case, any adjournment or postponement thereof) convened by (i)&#160;resolution of the Company Board or (ii)&#160;order of the High Court, in either case, pursuant to Section&#160;450 of the Act to consider and, if thought fit, approve the Scheme (with or without amendment). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Court Meeting Resolution</font><font style="letter-spacing:0.2pt;">&#8221; means the resolution to be proposed at the Court Meeting for the purposes of approving and implementing the Scheme. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Court Order</font><font style="letter-spacing:0.2pt;">&#8221; means the Order or Orders of the High Court sanctioning the Scheme under Section&#160;453&#160;of the Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">CVR Agreement</font><font style="letter-spacing:0.2pt;">&#8221; means that certain Contingent Value Rights Agreement by and between Parent and the Rights Agent, substantially in the form attached hereto as </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Exhibit&#160;A</font><font style="letter-spacing:0.2pt;"> (subject to changes permitted by </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.10</font><font style="letter-spacing:0.2pt;">). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">CVR Consideration</font><font style="letter-spacing:0.2pt;">&#8221; means one (1)&#160;contractual contingent value right per Company Share which shall represent the right to receive certain payments pursuant to the CVR Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Data Privacy Requirements</font><font style="letter-spacing:0.2pt;">&#8221; means, to the extent applicable to the Company or any Subsidiary, any and all: (i)&#160;Laws in any jurisdiction regulating the Processing of Personal Data by or on behalf of the Company Group, including any predecessor, successor or implementing legislation of the foregoing, and any amendments or re-enactments of the foregoing; (ii)&#160;binding obligations of any member of the Company Group concerning its Processing of Personal Data under any Contract; (iii)&#160;current and published privacy notices and privacy policies of any member of the Company Group; and (iv)&#160;binding industry standards relevant to any member of the Company Group&#8217;s Processing of Personal Data. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">DEA</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Drug Enforcement Administration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Debt Agreement</font><font style="letter-spacing:0.2pt;">&#8221; means that certain Bridge Term Loan Credit Agreement, dated as of the date hereof, among Parent, as the TopCo Borrower, Alkermes, Inc., as the U.S. Borrower, JPMorgan Chase Bank, N.A., as Administrative Agent, Sole Lead Arranger and Sole Bookrunner, and the lenders party thereto, an executed copy of which has been provided to the Company on the date of this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Effective Date</font><font style="letter-spacing:0.2pt;">&#8221; means the date on which the Scheme becomes effective in accordance with its terms or, if the Acquisition is implemented by way of a Takeover Offer, the date on which the Takeover Offer has become (or has been declared) unconditional in all respects in accordance with the provisions of the Takeover Offer Documents and the Takeover Rules. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Effective Time</font><font style="letter-spacing:0.2pt;">&#8221; means the time on the Effective Date at which the Court Order is delivered to the Registrar of Companies or, if the Acquisition is implemented by way of a Takeover Offer, the time on the Effective Date at which the Takeover Offer becomes (or is declared) unconditional in all respects in accordance with the provisions of the Takeover Offer Documents and the Takeover Rules. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EGM</font><font style="letter-spacing:0.2pt;">&#8221; means the extraordinary general meeting of the Company Shareholders (and any adjournment or postponement thereof) to be convened in connection with the Scheme, expected to be held as soon as the preceding Court Meeting shall have been concluded (it being understood that if the Court Meeting is adjourned or postponed, the EGM shall be correspondingly adjourned or postponed). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EGM Resolutions</font><font style="letter-spacing:0.2pt;">&#8221; means, collectively, the following resolutions to be proposed at the EGM: (i)&#160;an ordinary resolution to approve the Scheme and to authorize the Company Board to take all such action as it considers necessary or appropriate to implement the Scheme; (ii)&#160;a special resolution amending the Company Memorandum and Articles of Association in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;"> of this Agreement (the resolutions described in the foregoing clauses (i)&#160;and (ii), the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Required EGM Resolutions</font><font style="letter-spacing:0.2pt;">&#8221;); (iii)&#160;an ordinary resolution that any motion by the Chairperson of the Company Board to adjourn or postpone the EGM, or any adjournments or postponements thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the EGM to approve the Scheme or any of the Required EGM Resolutions to be approved; and (iv)&#160;any other resolutions as the Company reasonably determines to be (A)&#160;required under applicable Laws or (B)&#160;otherwise necessary or desirable for the purposes of implementing the Acquisition as have been approved by Parent (such approval not to be unreasonably withheld, conditioned or delayed). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">End Date</font><font style="letter-spacing:0.2pt;">&#8221; means the date that is nine (9)&#160;months from the date of this Agreement, provided, that if the Completion shall not have occurred as of the End Date and all the conditions to Completion, other than Conditions 1, 2.3, 2.4 and 3.1 (including as a result of a Government Shutdown), would be satisfied if the Completion were to occur on such date, the End Date shall be automatically extended to the date that is twelve&#160;months (12) from the date of this Agreement, and such date shall be the End Date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Environmental Law</font><font style="letter-spacing:0.2pt;">&#8221; means each applicable Law relating to (i)&#160;the protection, preservation or restoration of the environment (including air, surface water, groundwater, drinking water supply, surface land, subsurface land, plant and animal life or any other natural resource) or (ii)&#160;the exposure to, or the use, storage, recycling, treatment, generation, transportation, processing, handling, labeling, production, release or disposal of, Hazardous Substances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Environmental Permits</font><font style="letter-spacing:0.2pt;">&#8221; means all consents, clearances, approvals, permissions, licenses, variances, exemptions, authorizations, acknowledgements, approvals, permits and orders of Governmental Entities required by Environmental Law for the operation of the business of the Company or any of its Subsidiaries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Equitable Exceptions</font><font style="letter-spacing:0.2pt;">&#8221; means (i)&#160;applicable bankruptcy, insolvency, examinership, reorganization, moratorium or other similar Laws, now or hereafter in effect, relating to creditors&#8217; rights generally and (ii)&#160;general equitable principles, whether considered in a proceeding at law or equity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Equity Securities</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to any Person, (i)&#160;any shares of capital or capital stock (including any ordinary shares) or other voting securities of, or other ownership interest in, such Person, (ii)&#160;any securities of such Person convertible into or exchangeable for cash or shares of capital or capital stock or other voting securities of, or other ownership interests in, such Person or any of its Subsidiaries, (iii)&#160;any warrants, calls, options or other rights to acquire from such Person, or other obligations of such Person to issue, any shares of capital or capital stock or other voting securities of, or other ownership interests in, or securities convertible into or exchangeable for shares of capital or capital stock or other voting securities of, or other ownership interests in, such Person or any of its Subsidiaries or (iv)&#160;any restricted shares, stock appreciation rights, restricted&#160;units, performance&#160;units, contingent value rights, &#8220;phantom&#8221; stock or similar securities or rights issued by or with the approval of such Person that are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any shares of capital or capital stock or other voting securities of, other ownership interests in, or any business, products or assets of, such Person or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">ERISA</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Employee Retirement Income Security Act of 1974. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">ERISA Affiliate</font><font style="letter-spacing:0.2pt;">&#8221; means any Person that, together with any member of the Company Group, is (or at any relevant time has or would be) treated as a single employer under Section&#160;414 of the Code. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exchange Act</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Securities Exchange Act of 1934. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FCPA</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Foreign Corrupt Practices Act of 1977. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FDA</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Food and Drug Administration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FDCA</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Federal Food, Drug and Cosmetic Act of 1938, 21 U.S.C. &#167;&#167;&#160;301 et seq., and all regulations promulgated thereunder. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Filing</font><font style="letter-spacing:0.2pt;">&#8221; means any registration, petition, statement, application, schedule, form, declaration, notice, notification, report, submission or other filing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Financing</font><font style="letter-spacing:0.2pt;">&#8221; means debt financing provided by the Debt Agreement and any other debt financing provided by any Third Party that is necessary, or that is otherwise incurred or intended to be incurred by Parent or any of the Subsidiaries of Parent, to refinance, replace or refund the Debt Agreement and/or any existing indebtedness for borrowed money of the Company, Parent or any of their respective Subsidiaries, in each case in connection with the transactions contemplated hereby, or to fund the Cash Consideration payable by Parent in the Scheme or (as the case may be) the Takeover Offer, including the offering or private placement of debt securities or the incurrence of credit facilities. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Financing Amounts</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning ascribed to it in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.2(A)(e)(i)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Financing Information</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning ascribed to it in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.7(a)(ii)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Financing Sources</font><font style="letter-spacing:0.2pt;">&#8221; means (i)&#160;the Persons that have committed to provide or arrange or otherwise entered into agreements in connection with the Financing, including the parties to any joinder agreements, commitment and engagement letters, indentures or credit agreements entered into pursuant thereto or relating thereto, and any initial purchasers, underwriters, or syndication agents in connection with any notes offering contemplated by any engagement letter, but excluding in each case, for clarity, the Parties and their Subsidiaries, (ii)&#160;the Affiliates of the Persons set forth in clause (i)&#160;above and (iii)&#160;the Representatives and the respective successors and assigns of the Persons set forth in clauses (i)&#160;and (ii)&#160;above. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">GAAP</font><font style="letter-spacing:0.2pt;">&#8221; means U.S. generally accepted accounting principles. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Government Official</font><font style="letter-spacing:0.2pt;">&#8221; means (i)&#160;any official, officer, employee or representative of, or any Person acting in an official capacity for or on behalf of, any Governmental Entity, (ii)&#160;any political party, party official or candidate for political office or (iii)&#160;any company, business, enterprise or other entity owned or controlled by any Person described in the foregoing clause (i)&#160;or (ii)&#160;of this definition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Government Shutdown</font><font style="letter-spacing:0.2pt;">&#8221; means any shutdown resulting from the lack of Congressional budget appropriations, prior to the End Date, of certain United States federal government services provided by the Federal Trade Commission and Department of Justice to review the transactions contemplated by this Agreement under the HSR Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Governmental Entity</font><font style="letter-spacing:0.2pt;">&#8221; means any United States, Irish or other foreign or supranational, federal, state or local government or any commission, board, body, division, political subdivision, bureau or other regulatory authority or agency thereof, and including courts and other judicial bodies, or any competition, antitrust, national security, foreign investment or supervisory body, central bank, public international organization or other governmental, trade or regulatory agency or body, securities exchange or any self-regulatory body or authority, including any instrumentality or entity designed to act for or on behalf of the foregoing, in each case, in any jurisdiction, and including the Panel, the High Court, the SEC and each Company Regulatory Agency. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Governmental Healthcare Program</font><font style="letter-spacing:0.2pt;">&#8221; means any federal healthcare program as defined in 42&#160;U.S.C.&#160;&#167;&#160;1320a-7b(f), including Medicare, Medicaid, TRICARE, CHAMPVA, the United States Department of Veterans Affairs and any other healthcare reimbursement programs funded or regulated by a Governmental Entity. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Group</font><font style="letter-spacing:0.2pt;">&#8221; means a &#8220;group&#8221; as defined in Section&#160;13(d) of the Exchange Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Hazardous Substance</font><font style="letter-spacing:0.2pt;">&#8221; means any substance, material or waste that is listed, defined, designated or classified as hazardous, toxic, radioactive, dangerous or a &#8220;pollutant&#8221; or &#8220;contaminant&#8221; or words of similar meaning under any Environmental Law or that is otherwise regulated by any Governmental Entity with jurisdiction over protection of the environment or natural resources, including petroleum or any derivative or byproduct thereof, radon, radioactive material, asbestos or asbestos-containing material, urea formaldehyde foam insulation or polychlorinated biphenyls. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Healthcare Laws</font><font style="letter-spacing:0.2pt;">&#8221; means any healthcare Law, including (a)&#160;the FDCA; (b)&#160;the CSA; (c)&#160;the federal Medicare statute and federal and state Medicaid statutes (Title XVIII and Title XIX of the Social Security </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Act); (d)&#160;the Physician Payments Sunshine Act (42 U.S.C. &#167;&#160;1320a-7h); (e)&#160;the federal Anti-Kickback Statute (42 U.S.C.A &#167;&#160;1320a7b(b)), Stark Law (42 U.S.C.A &#167;&#160;1395nn), False Claims Act (31 U.S.C.A &#167;&#160;3729 et seq.) and state analogues and civil monetary penalties law (42 U.S.C. &#167;&#167;&#160;1320a-7a and 1320a-7b); (f)&#160;state licensing, disclosure and reporting regulatory requirements; (g)&#160;the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information and Technology for Economic and Clinical Health Act; (h)&#160;all applicable Laws governing government pricing or price reporting programs and regulations promulgated thereunder, including the VA Federal Supply Schedule (38 U.S.C. &#167;8126) or any state pharmaceutical assistance program or U.S. Department of Veterans Affairs agreement, and any successor government programs; (i)&#160;regulations regarding any advertising, marketing and promotional activities; (j)&#160;all other applicable Laws administered by the FDA and other applicable Company Regulatory Agencies, including those governing or relating to good clinical practices, good laboratory practices, good manufacturing practices, development, manufacture, approval, processing, and use of any Company Product; (k)&#160;regulations promulgated pursuant to any of the statutes in subclauses (a)&#160;through (j); and (l)&#160;any comparable non-U.S. Laws. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">High Court</font><font style="letter-spacing:0.2pt;">&#8221; means the High Court of Ireland. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">HSR Act</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Intellectual Property</font><font style="letter-spacing:0.2pt;">&#8221; means any and all rights in or associated with any of the following, whether or not registered, including all rights therein and associated therewith, arising in the United States or any other jurisdiction throughout the world: (i)&#160;trademarks, service marks, brand names, certification marks, collective marks, trade names, trade dress, logos, symbols, slogans, Internet domain names, Internet account names (including social networking and media names) and other indicia of origin, together with all goodwill associated therewith or symbolized thereby, and all registrations and applications relating to the foregoing; (ii)&#160;patents and pending patent applications, and all divisions, continuations, continuations-in-part, renewals, reissues and reexaminations, and any extensions thereof; (iii)&#160;works of authorship (whether or not copyrightable), registered and unregistered copyrights (including those in Software), all registrations and applications to register the same, and all renewals, extensions, reversions and restorations thereof, including moral rights of authors, and database rights; (iv)&#160;trade secrets, rights in technology, confidential or proprietary information and other know-how, including inventions (whether or not patentable or reduced to practice), concepts, methods, processes, protocols, assays, formulations, formulae, technical, research, clinical and other data, databases, compilations, prototypes, designs, specifications, techniques, schematics, drawings, algorithms, models and methodologies (collectively, &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Trade Secrets</font><font style="letter-spacing:0.2pt;">&#8221;); (v)&#160;rights in Software; and (vi)&#160;other similar types of proprietary rights or other intellectual property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Ireland</font><font style="letter-spacing:0.2pt;">&#8221; means Ireland, excluding Northern Ireland, and the word &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Irish</font><font style="letter-spacing:0.2pt;">&#8221; shall be construed accordingly. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Irrecoverable VAT</font><font style="letter-spacing:0.2pt;">&#8221; means in relation to any Person, any amount in respect of VAT which that Person (or a member of the same VAT Group as that Person) has incurred and in respect of which neither that Person nor any other member of the same VAT Group as that Person is entitled to a refund (by way of credit or repayment) from any relevant Tax Authority pursuant to and determined in accordance with applicable VAT Laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">IT Assets</font><font style="letter-spacing:0.2pt;">&#8221; means any and all computers, Software, firmware, middleware, servers, workstations, routers, hubs, switches, data communications lines and other information technology equipment, and all associated documentation, owned by, licensed or leased to, or otherwise used by any member of the Company Group. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">knowledge</font><font style="letter-spacing:0.2pt;">&#8221; means (i)&#160;in relation to the Company, the actual knowledge, after due inquiry, of the Persons listed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.1(a)(i)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule and (ii)&#160;in relation to Parent, the actual knowledge, after due inquiry of the Persons listed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.1(a)(ii)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule. None of the individuals set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.1(a)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule shall have any personal liability or obligations regarding such knowledge. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Law</font><font style="letter-spacing:0.2pt;">&#8221; means any federal, state, local, foreign or supranational law, statute, ordinance, rule, regulation, judgment, order, injunction, decree, executive order or agency requirement of any Governmental Entity. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Licensed Intellectual Property</font><font style="letter-spacing:0.2pt;">&#8221; means any and all Intellectual Property owned by a Third Party to which any member of the Company Group receives a license, covenant not to sue or other similar rights with respect to such Intellectual Property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Lien</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to any property or asset, any mortgage, lien, license, pledge, charge, security interest or encumbrance of any kind in respect of such property or asset (including in each case any license to, or covenant not to sue in respect of, Intellectual Property). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Lookback Date</font><font style="letter-spacing:0.2pt;">&#8221; means January&#160;1, 2023. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Nasdaq</font><font style="letter-spacing:0.2pt;">&#8221; means the Nasdaq Global Market, any successor stock exchange operated by the Nasdaq Global Market, or any successor thereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Northern Ireland</font><font style="letter-spacing:0.2pt;">&#8221; means the counties of Antrim, Armagh, Derry, Down, Fermanagh and Tyrone on the island of Ireland. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Order</font><font style="letter-spacing:0.2pt;">&#8221; means any order, writ, decree, judgment, award, injunction, ruling, settlement or stipulation issued, promulgated, made, rendered or entered into by or with any Governmental Entity or arbitrator (in each case, whether temporary, preliminary or permanent). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Organizational Documents</font><font style="letter-spacing:0.2pt;">&#8221; means memorandum of association, articles of association, articles of incorporation, certificate of incorporation, constitution, by-laws, limited liability company agreement, operating agreement or other equivalent organizational document, as appropriate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Owned Intellectual Property</font><font style="letter-spacing:0.2pt;">&#8221; means any and all Intellectual Property owned or purported to be owned, whether solely or jointly, by any member of the Company Group. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Panel</font><font style="letter-spacing:0.2pt;">&#8221; means the Irish Takeover Panel. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Parent Board</font><font style="letter-spacing:0.2pt;">&#8221; means the board of directors of Parent. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Parent Group</font><font style="letter-spacing:0.2pt;">&#8221; means Parent and all of its Subsidiaries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Parent Material Adverse Effect</font><font style="letter-spacing:0.2pt;">&#8221; means any event, change, effect, development or occurrence that, individually or together with any other event, change, effect, development or occurrence, would be reasonably expected to prevent, materially delay or materially impair the ability of Parent to consummate the transactions contemplated hereby (including the Acquisition) prior to the End Date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Parties</font><font style="letter-spacing:0.2pt;">&#8221; means the Company and Parent and &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Party</font><font style="letter-spacing:0.2pt;">&#8221; shall mean either the Company, on the one hand, or Parent (whether individually or collectively), on the other hand (as the context requires). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Permitted Lien</font><font style="letter-spacing:0.2pt;">&#8221; means (i)&#160;any Liens for Taxes that are either (A)&#160;not yet due and payable or (B)&#160;being contested in good faith by appropriate proceedings and with respect to which adequate reserves have been established in accordance with GAAP, (ii)&#160;carriers&#8217;, warehousemen&#8217;s, mechanics&#8217;, materialmen&#8217;s, repairmen&#8217;s or other similar Liens, (iii)&#160;pledges or deposits in connection with workers&#8217; compensation, unemployment insurance and other social security legislation, (iv)&#160;easements, rights-of-way, covenants, restrictions and other encumbrances of record as of the date of this Agreement, (v)&#160;easements, rights-of-way, covenants, restrictions and other encumbrances incurred in the ordinary course of business that do not materially detract from the value or the use of the property subject thereto, (vi)&#160;statutory landlords&#8217; liens and liens granted to landlords under any lease, (vii)&#160;any purchase money security interests, equipment leases or similar financing arrangements, (viii)&#160;any Liens which are disclosed on the Company Balance Sheet, or the notes thereto, (ix)&#160;any Liens that are not material to the Company and its Subsidiaries, taken as a whole, and (x)&#160;Liens listed and described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.1(a)(iii)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Person</font><font style="letter-spacing:0.2pt;">&#8221; means any individual, corporation, partnership, limited liability company, association, trust or other entity or organization, including a government or political subdivision or an agency or instrumentality of such government or political subdivision. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Personal Data</font><font style="letter-spacing:0.2pt;">&#8221; means any data or information relating directly or indirectly to an identified or identifiable natural person or household that constitutes &#8216;personal data,&#8217; &#8216;personally identifiable information&#8217; or any other such equivalent or similar defined term under relevant Laws applicable to the Company. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Process</font><font style="letter-spacing:0.2pt;">&#8221; means the creation, collection, use, storage, recording, maintenance, distribution, transfer, transmission, receipt, import, export, access, disposal, disclosure and any other processing of Personal Data (whether electronically or in any other form or medium), and &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">processing</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">processed</font><font style="letter-spacing:0.2pt;">&#8221; shall be construed accordingly. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Petition</font><font style="letter-spacing:0.2pt;">&#8221; means the petition to the High Court seeking the Court Order. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Proxy Statement</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning ascribed to it in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Registrar of Companies</font><font style="letter-spacing:0.2pt;">&#8221; means the Registrar of Companies in Dublin, Ireland. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Regulatory Information Service</font><font style="letter-spacing:0.2pt;">&#8221; means a regulatory information service as defined in the Takeover Rules. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Reimbursement Amount</font><font style="letter-spacing:0.2pt;">&#8221; means an amount equal to the documented, specific, quantifiable Third Party costs and expenses incurred, directly or indirectly, by Parent or its Subsidiaries, or on their behalf, for the purposes of, in preparation for, or in connection with the Acquisition, including Third Party costs and expenses incurred in connection with exploratory work carried out in contemplation of and in connection with the Acquisition, legal, financial and commercial due diligence, the arrangement of financing and the engagement of Third Party Representatives to assist in the process together with any Irrecoverable VAT thereon. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Representatives</font><font style="letter-spacing:0.2pt;">&#8221; means, in relation to any Person, the directors, officers, employees, agents, investment bankers, financial advisors, legal advisors, accountants, brokers, finders, consultants or other representatives of such Person. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Resolutions</font><font style="letter-spacing:0.2pt;">&#8221; means the EGM Resolutions and the Court Meeting Resolution, which will be set out in the Scheme Document. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Rule&#160;2.7 Announcement</font><font style="letter-spacing:0.2pt;">&#8221; means the announcement to be made by the Parties pursuant to Rule&#160;2.7 of the Takeover Rules in respect of the Acquisition, in the form agreed to by or on behalf of the Parties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Sanctioned Country</font><font style="letter-spacing:0.2pt;">&#8221; means any country or territory that currently is or in the last five (5)&#160;years has been the target of comprehensive sanctions pursuant to Sanctions Laws, including the Crimea region, Cuba, Iran, North Korea, Syria, the so-called Donetsk or Luhansk People&#8217;s Republics, or the Kherson or Zaporizhzhia regions of Ukraine. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Sanctioned Person</font><font style="letter-spacing:0.2pt;">&#8221; means any Person with whom dealings are restricted or prohibited under any Sanctions Laws, including the Sanctions Laws of the United States, the United Kingdom, the European Union or the United Nations, including (i)&#160;any Person identified in any list of Sanctioned Persons maintained by (A)&#160;the United States Department of Treasury, Office of Foreign Assets Control, the United States Department of Commerce, Bureau of Industry and Security or the United States Department of State, (B)&#160;His Majesty&#8217;s Treasury of the United Kingdom, (C)&#160;any committee of the United Nations Security Council or (D)&#160;the European Union, (ii)&#160;any Person located, organized, or ordinarily resident in, organized in, or a Governmental Entity of, any Sanctioned Country and (iii)&#160;any Person which is directly or indirectly fifty&#160;percent (50%) or more owned or controlled by, or acting for the benefit or on behalf of, a Person described in clause (i)&#160;or (ii). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Sanctions Laws</font><font style="letter-spacing:0.2pt;">&#8221; means all applicable Laws concerning economic sanctions, including embargoes, export/import controls and other restrictions, the ability to make or receive international payments, the freezing or blocking of assets of targeted Persons, the ability to engage in transactions with specified Persons or countries or the ability to take an ownership interest in assets of specified Persons or located in a specified country, and any applicable Laws threatening to impose economic sanctions on any person for engaging in proscribed behavior, including, without limitation, the Sanctions Laws of the United States, the United Kingdom, the European Union and the United Nations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme</font><font style="letter-spacing:0.2pt;">&#8221; means the proposed scheme of arrangement under Chapter 1 of Part&#160;9 of the Act to effect the Acquisition pursuant to this Agreement, on such terms and in such form as is consistent with the terms agreed to by the Parties as set out in the Rule&#160;2.7 Announcement, including any revision thereof as may be agreed between the Parties in writing, and, if required, by the High Court. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme Consideration</font><font style="letter-spacing:0.2pt;">&#8221; means (i)&#160;the Cash Consideration and (ii)&#160;the CVR Consideration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme Document</font><font style="letter-spacing:0.2pt;">&#8221; means a document (or relevant sections of the Proxy Statement comprising the Scheme Document) (including any amendments or supplements thereto) to be distributed to Company Shareholders and, for information only, to Company Equity Award Holders containing (i)&#160;the Scheme, (ii)&#160;the&#160;notice or notices of the Court Meeting and EGM, (iii)&#160;an explanatory statement as required by Section&#160;452&#160;of the Act with respect to the Scheme, (iv)&#160;such other information as may be required or necessary pursuant to the Act, the Exchange Act or the Takeover Rules and (v)&#160;such other information as the Company and Parent shall agree. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme Recommendation</font><font style="letter-spacing:0.2pt;">&#8221; means the recommendation of the Company Board that Company Shareholders vote in favor of the Resolutions. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Scheme Record Time</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meaning given to it in the Scheme. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">SEC</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Securities and Exchange Commission. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Securities Act</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Securities Act of 1933. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Software</font><font style="letter-spacing:0.2pt;">&#8221; means all (i)&#160;computer programs and other software including any and all software implementations of algorithms, models, methodologies, assemblers, applets, compilers, development tools, design tools and user interfaces, whether in source code or object code form, (ii)&#160;databases and compilations, including all data and collections of data, whether machine readable or otherwise and (iii)&#160;updates, upgrades, modifications, improvements, enhancements, derivative works, new versions, new releases and corrections to or based on any of the foregoing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Subsidiary</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to any Person, any entity of which securities or other ownership interests having ordinary voting power to elect a majority of the board of directors or other persons performing similar functions are directly or indirectly owned by such Person. For purposes of this Agreement, a Subsidiary shall be considered a &#8220;wholly owned Subsidiary&#8221; of a Person if such Person directly or indirectly owns all of the securities or other ownership interests (excluding any securities or other ownership interests held by an individual director or officer required to hold such securities or other ownership interests pursuant to applicable Law) of such Subsidiary. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Takeover Offer</font><font style="letter-spacing:0.2pt;">&#8221; means an offer in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6</font><font style="letter-spacing:0.2pt;"> for the entire issued share capital of the Company (other than any Company Shares beneficially owned by Parent or any member of the Parent Group (if any) and any Company Shares held by any member of the Company Group) including any amendment or revision thereto pursuant to this Agreement, the full terms of which would be set out in the Takeover Offer Document or (as the case may be) any revised offer documents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Takeover Offer Document</font><font style="letter-spacing:0.2pt;">&#8221; means, if, following the date of this Agreement, Parent elects to implement the Acquisition by way of the Takeover Offer in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6</font><font style="letter-spacing:0.2pt;">, the document to be sent to Company Shareholders and others by Parent containing, among other things, the Takeover Offer, the Conditions (except as Parent determines pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6</font><font style="letter-spacing:0.2pt;"> not to be appropriate in the case of a Takeover Offer) and certain information about Parent and the Company and, where the context so requires, includes any form of acceptance, election, notice or other document reasonably required in connection with the Takeover Offer. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Takeover Panel Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Irish Takeover Panel Act 1997. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Takeover Rules</font><font style="letter-spacing:0.2pt;">&#8221; means the Irish Takeover Panel Act 1997, Takeover Rules, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Third Party</font><font style="letter-spacing:0.2pt;">&#8221; means any Person or Group, other than the Company or any of its Affiliates, in the case of Parent, or other than Parent or any of its Affiliates, in the case of the Company, and the Representatives of such Persons, in each case, acting in such capacity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Treasury Regulations</font><font style="letter-spacing:0.2pt;">&#8221; mean the United States Treasury regulations promulgated under the Code. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">U.S.</font><font style="letter-spacing:0.2pt;">&#8221; or &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">United States</font><font style="letter-spacing:0.2pt;">&#8221; means the United States, its territories and possessions, any State of the United States and the District of Columbia, and all other areas subject to its jurisdiction. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tS1CT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:52pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">VAT</font><font style="letter-spacing:0.2pt;">&#8221; means any tax imposed by any member state of the European Union in conformity with the directive of the Council of the European Union on the common system of value added tax (2006/112/EC) and any tax similar to or replacing the same. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">VAT Group</font><font style="letter-spacing:0.2pt;">&#8221; means a group as defined in Section&#160;15 of the Value Added Tax Consolidation Act 2010 and any similar VAT grouping arrangement in any other jurisdiction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Willful Breach</font><font style="letter-spacing:0.2pt;">&#8221; means a material breach of this Agreement that is the consequence of an act or omission by a breaching party with the actual knowledge that the taking of such act or such omission to take action would be a material breach of this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;1.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Construction</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The following rules of interpretation shall apply to this Agreement: (i)&#160;the words &#8220;hereof&#8221;, &#8220;hereby&#8221;, &#8220;herein&#8221; and &#8220;hereunder&#8221; and words of like import used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement; (ii)&#160;the table of contents and captions in this Agreement are included for convenience of reference only and shall be ignored in the construction or interpretation hereof; (iii)&#160;references to Articles and Sections are to Articles and Sections of this Agreement unless otherwise specified; (iv)&#160;all schedules annexed to this Agreement or referred to in this Agreement, including the Company Disclosure Schedule, are incorporated in and made a part of this Agreement as if set forth in full in this Agreement; (v)&#160;any capitalized term used in any schedule annexed to this Agreement, including the Company Disclosure Schedule, but not otherwise defined therein shall have the meaning set forth in this Agreement; (vi)&#160;any singular term in this Agreement shall be deemed to include the plural, and any plural term the singular, and references to any gender shall include all genders; (vii)&#160;whenever the words &#8220;include&#8221;, &#8220;includes&#8221; or &#8220;including&#8221; are used in this Agreement, they shall be deemed to be followed by the words &#8220;without limitation&#8221;, whether or not they are in fact followed by those words or words of like import; (viii)&#160;&#8220;writing&#8221;, &#8220;written&#8221; and comparable terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form; (ix)&#160;references to any applicable Law shall be deemed to refer to such applicable Law as amended from time to time and to any rules or regulations promulgated thereunder; (x)&#160;references to any Contract are to that Contract as amended, modified or supplemented from time to time in accordance with the terms hereof and thereof; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that with respect to any Contract listed on any schedule annexed to this Agreement or referred to in this Agreement, including the Company Disclosure Schedule, all such amendments, modifications or supplements must also be listed in the appropriate schedule; (xi)&#160;references to any Person include the successors and permitted assigns of that Person; (xii)&#160;references &#8220;from&#8221; or &#8220;through&#8221; any date mean, unless otherwise specified, &#8220;from and including&#8221; or &#8220;through and including&#8221;, respectively; (xiii)&#160;references to &#8220;dollars&#8221; and &#8220;$&#8221; means U.S. dollars; (xiv)&#160;the term &#8220;made available&#8221; and words of similar import mean that the relevant documents, instruments or materials were (A)&#160;except as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.2(xiv)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, posted and made available to Parent on the Company virtual data room at least forty-eight (48) hours prior to the date hereof; or (B)&#160;filed or furnished to the SEC at least two (2)&#160;Business Days prior to the date hereof and not subject to any redactions or omissions; (xv)&#160;the word &#8220;extent&#8221; in the phrase &#8220;to the extent&#8221; shall mean the degree to which a subject or other theory extends and such phrase shall not mean &#8220;if&#8221;; (xvi)&#160;any reference to an Irish legal term for any action, remedy, method of judicial proceeding, legal document, legal status, court, official or any legal concept or thing shall, in respect of any jurisdiction other than Ireland, be deemed to include a reference to what most nearly approximates in that jurisdiction to the Irish legal term; (xvii)&#160;references to times are to New York City times unless otherwise specified; (xviii) unless otherwise indicated, the word &#8220;or&#8221; shall not be exclusive (</font><font style="font-style:italic;letter-spacing:0.2pt;">i.e.</font><font style="letter-spacing:0.2pt;">, &#8220;or&#8221; shall be deemed to mean &#8220;and/or&#8221;); and (xix)&#160;the Parties have participated jointly in the negotiation and drafting of this Agreement and, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the Parties and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any provision of this Agreement. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tAI2A">&#8203;</a><a name="tS2R2">&#8203;</a><a name="tS2SS">&#8203;</a><a name="tS2CI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE II</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RULE 2.7 ANNOUNCEMENT, SCHEME DOCUMENT AND COMPANY EQUITY AWARD HOLDER PROPOSAL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;2.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Rule&#160;2.7 Announcement</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Each Party confirms that its respective board of directors (or a duly authorized committee thereof) has approved the contents and release of the Rule&#160;2.7 Announcement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Following the execution of this Agreement, the Company and Parent shall jointly, in accordance with, and for the purposes of, the Takeover Rules, procure the release of the Rule&#160;2.7 Announcement to a Regulatory Information Service by no later than 5:00&#160;pm, New York City time, on October&#160;22, 2025, or such later time as may be agreed between the Parties in writing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The obligations of the Company and Parent under this Agreement, other than the obligations under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1(b)</font><font style="letter-spacing:0.2pt;">, shall be conditional on the release of the Rule&#160;2.7 Announcement to a Regulatory Information Service. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;The Company confirms that, as of the date hereof, the Company Board unanimously considers that the terms of the Scheme as contemplated by this Agreement are fair and reasonable and that the Company Board has unanimously resolved to recommend to the Company Shareholders that they vote in favor of the Resolutions. The recommendation of the Company Board that the Company Shareholders vote in favor of the Resolutions, and the related opinions of the financial advisors to the Company Board, are set out in the Rule&#160;2.7 Announcement and, subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;">, shall be incorporated in the Scheme Document and, to the extent required by applicable Laws, any other document sent to the Company Shareholders in connection with the Acquisition. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;The Conditions are hereby incorporated in and shall constitute a part of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;2.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Scheme</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6</font><font style="letter-spacing:0.2pt;">: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;the Company agrees that, unless this Agreement has been terminated in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">, it will propose the Scheme to the Company Shareholders in the manner set out in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;III</font><font style="letter-spacing:0.2pt;"> and, subject to the satisfaction or, in the sole discretion of the applicable Party, waiver (where permissible under the provisions of the Rule&#160;2.7 Announcement or the Scheme Document) of the Conditions (with the exception of Conditions 2.3 and 2.4 and any other Conditions that by their nature are to be satisfied on the Sanction Date (as defined in Appendix&#160;III of the Rule&#160;2.7 Announcement), but subject to the satisfaction or waiver (where permissible under the provisions of the Rule&#160;2.7 Announcement or the Scheme Document) of such Conditions), will, in the manner set out in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;III</font><font style="letter-spacing:0.2pt;">, petition the High Court to sanction the Scheme so as to facilitate the implementation of the Acquisition; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent agrees that it will participate in the Scheme and agrees to be bound by its terms, as proposed by the Company to the Company Shareholders, and that it shall, subject to the satisfaction or, in the sole discretion of the applicable Party, waiver (where permissible under the provisions of the Rule&#160;2.7&#160;Announcement or the Scheme Document) of the Conditions, effect the Acquisition through the Scheme on the terms set out in this Agreement and the Scheme; and </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;each of the Parties agrees that it will perform all of the obligations required of it in respect of the Acquisition on the terms set out in this Agreement or the Scheme, and each will, subject to the terms and conditions of this Agreement, including </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2</font><font style="letter-spacing:0.2pt;">, use its reasonable best efforts to take such other steps as are within its power and are reasonably required of it for the proper implementation of the Scheme, including those required of it pursuant to this Agreement in connection with the Completion. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;2.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Change in Shares</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Notwithstanding anything in this Agreement to the contrary, if at any time during the period between the date of this Agreement and the earlier of (i)&#160;the Effective Time and (ii)&#160;the valid termination of this Agreement pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">, the number of outstanding Company Shares or securities convertible or exchangeable into or exercisable for Company Shares shall have been changed into a different number of Company Shares or securities, or a different class, by reason of any subdivision, reclassification, reorganization, stock split (including a reverse stock split), </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tSEC">&#8203;</a><a name="tAIOT">&#8203;</a><a name="tS3RO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">stock dividend, combination or distribution, recapitalization or other similar transaction, the Scheme Consideration and any payments to be made under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IV</font><font style="letter-spacing:0.2pt;"> shall be equitably adjusted to provide the holders of Company Shares and Company Equity Awards the same economic effect as contemplated by this Agreement prior to such event. Nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.3</font><font style="letter-spacing:0.2pt;"> shall be construed to permit the Company or any of its Subsidiaries to take any action that is otherwise prohibited or restricted by any other provision of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;2.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Company Equity Award Holder Proposal</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Subject to the posting of the Scheme Document to the Company Shareholders in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1</font><font style="letter-spacing:0.2pt;">, the Parties agree that the Company Equity Award Holder Proposal will be made to Company Equity Award Holders in respect of their respective holdings of Company Options, Company Performance Options or Company Share Awards in accordance with Rule&#160;15 of the Takeover Rules and the terms of the Company Share Plans. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Company Equity Award Holder Proposal shall be sent to the Company Equity Award Holders as a joint letter from the Company and Parent, and the Parties shall reasonably agree to the final form of the letter to be issued in respect of the Company Equity Award Holder Proposal and all other documentation necessary to effect the Company Equity Award Holder Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Except as required by applicable Law, the High Court or the Panel, no Party shall amend the Company Equity Award Holder Proposal after it has been sent to the Company Equity Award Holders without the consent of each other Party (such consent not to be unreasonably withheld, conditioned or delayed). </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE III</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IMPLEMENTATION OF THE SCHEME</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;3.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Responsibilities of the Company in Respect of the Scheme</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Company shall: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;(i) be responsible for the preparation of a proxy statement to be sent to the Company Shareholders in connection with the matters to be submitted at the Court Meeting and the EGM (such proxy statement, as amended or supplemented, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Proxy Statement</font><font style="letter-spacing:0.2pt;">&#8221;) and the Scheme Document and all other documentation necessary to effect the Scheme and to convene the EGM and Court Meeting, including any materials required to be filed with the SEC in connection with the foregoing, (ii)&#160;provide Parent with drafts of the Proxy Statement and the Scheme Document and afford Parent reasonable opportunity to review and comment on the Proxy Statement and the Scheme Document and such other documents and shall consider such comments in good faith and (iii)&#160;subject to the foregoing clauses (i)&#160;and (ii), as promptly as reasonably practicable after the date hereof (but in no event later than November&#160;12, 2025), cause the preliminary Proxy Statement and the Scheme Document to be filed with the SEC and the Panel (to the extent required by Rule&#160;41.1(b) of the Takeover Rules); </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;for the purpose of implementing the Scheme, instruct a barrister (of senior counsel standing) and provide Parent and its Representatives with the opportunity to attend any meetings with such barrister to discuss matters pertaining to the Scheme and any issues arising in connection with it (except to the extent the barrister is to advise on matters relating to the fiduciary duties of the directors of the Company or their responsibilities under the Takeover Rules, a Company Alternative Proposal or the termination of this Agreement pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">); </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;as promptly as reasonably practicable, notify Parent upon the receipt of any comments from the Panel or the SEC on, or any request from the Panel or the SEC for amendments or supplements to, the Proxy Statement, the Scheme Document, the Company Equity Award Holder Proposal and the related forms of proxy and provide Parent with copies of all material written correspondence between it and its Representatives and the Panel or the SEC relating to such documents; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;use its reasonable best efforts to respond to and resolve all Panel and SEC comments with respect to the Proxy Statement and the Scheme Document as promptly as reasonably practicable after receipt thereof; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;as promptly as reasonably practicable, notify Parent of any other matter of which it becomes aware which would reasonably be expected to materially delay or prevent filing of the Proxy Statement or the Scheme Document with the SEC and the Panel, as applicable, or implementation of the Scheme as the case may be; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;prior to filing or sending any amendment or supplement to the Proxy Statement or the Scheme Document requested by the Panel or the SEC, or responding in writing to any comments of the Panel or the SEC with respect thereto, the Company shall provide Parent with a reasonable opportunity to review and comment on such document or response and consider in good faith such comments; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;subject to sub-paragraph (j)&#160;below, cause the definitive Proxy Statement to be mailed as promptly as reasonably practicable after the latter of (i)&#160;the date on which the SEC confirms that it will not review the Proxy Statement (which confirmation will be deemed to occur if the SEC has not affirmatively notified the Company on or prior to the tenth (10th) calendar day after filing the Proxy Statement) or that it has no further comments on the Proxy Statement and (ii)&#160;the date on which the Panel confirms that it has no further comments on the Proxy Statement and Scheme Document; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;to the extent that clearance of the Proxy Statement or the Scheme Document by the Panel might require that waivers or derogations in respect of the Takeover Rules be sought and obtained from the Panel in relation to matters that relate to the Company and/or any of its Concert Parties, make a submission for (and use reasonable best efforts to have approved) such waiver or derogation as promptly as reasonably practicable after having provided Parent with a reasonable opportunity to review and comment on such submission and considering in good faith such comments and support any submissions to the Panel made by Parent pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.2(h)</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;provide Parent with drafts of any and all pleadings, affidavits, orders, originating notices of motion or other originating pleadings or notices of motion, petitions and other filings prepared by the Company for submission to the High Court in connection with the Scheme prior to their filing, and afford Parent reasonable opportunities to review and comment on all such documents and consider in good faith such comments; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;as promptly as is reasonably practicable following the Clearance Date, as promptly as reasonably practicable (taking into account any requirements of the Panel with respect to the Scheme Document and the SEC review (if any) with respect to the Proxy Statement, that must be satisfied prior to the release of the Scheme Document), the Company shall file the originating notice of motion, the notice of motion for entry to the commercial division of the Irish High Court and any ancillary court papers with the Central Office of the Irish High Court for the purpose of commencing the court application to seek directions under Section&#160;450(5) of the Act as to the appropriate meetings to be held and to order that the Court Meeting be convened as promptly as is reasonably practicable following the Clearance Date and seek such directions of the High Court as it considers necessary or desirable in connection with the Court Meeting and thereafter comply with such directions; provided that if (x)&#160;the Company Board determines to convene the Court Meeting directly pursuant to Section&#160;450(1) of the Act and (y)&#160;Parent has provided its prior written consent (not to be unreasonably withheld, conditioned or delayed) to such action, this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1(j)</font><font style="letter-spacing:0.2pt;"> shall not apply and the Company Board shall convene the Court Meeting; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;if the Company Board determines, to convene the Court Meeting directly pursuant to Section&#160;450(1) of the Act and Parent has provided its prior written consent to such action in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1(j)</font><font style="letter-spacing:0.2pt;">, the Company shall make all necessary applications to the High Court in connection with the implementation of the Scheme following the Court Meeting, and use its reasonable best efforts to ensure that the hearing of such proceedings occurs as promptly as is reasonably practicable and seek such directions of the High Court as it considers necessary or desirable in connection with the implementation of the Scheme and thereafter comply with such directions; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;procure the publication of the requisite advertisements and sending the Scheme Document (in a form acceptable to the Panel), Proxy Statement and the related forms of proxy for the use at the Court Meeting and the EGM (the form of which shall be agreed between the Parties, acting reasonably) (i)&#160;to Company Shareholders on the register of members of the Company on the record date, as promptly as reasonably practicable after the Clearance Date and (ii)&#160;to the holders of the Company Options, Company </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Performance Options and the Company Share Awards as of such date, for information only, as promptly as reasonably practicable after the Clearance Date, and thereafter shall publish or post such other documents and information (the form of which shall be agreed between the Parties, acting reasonably) as may be required by applicable Law or as the High Court or the Panel may approve or direct from time to time; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(m)&nbsp;&nbsp;&nbsp;unless the Company Board has effected a Company Board Change of Recommendation pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;">, and subject to the obligations of the Company Board under the Takeover Rules, procure that the Proxy Statement and the Scheme Document include the Scheme Recommendation; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(n)&nbsp;&nbsp;&nbsp;include in the Proxy Statement a notice convening the EGM to be held immediately following the Court Meeting to consider and, if thought fit, approve the EGM Resolutions; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(o)&nbsp;&nbsp;&nbsp;prior to the Court Meeting, keep Parent reasonably informed on a reasonably current basis of the number of proxy votes received in respect of resolutions to be proposed at the Court Meeting or the EGM, and in any event provide such number promptly upon the request of Parent or its Representatives and, unless the Company Board has effected a Company Board Change of Recommendation pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;">, use reasonable best efforts to solicit proxies as may be necessary to pass the Resolutions at the Court Meeting or the EGM; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(p)&nbsp;&nbsp;&nbsp;notwithstanding any Company Board Change of Recommendation, unless this Agreement has been validly terminated pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">, hold the Court Meeting and the EGM on the dates set out in the notices of the Court Meeting and the EGM respectively, or such later date as may be agreed in writing by the Parties, and in such a manner as shall be approved, if necessary by the High Court or the Panel, and propose the Resolutions without any amendments, unless such amendments have been agreed to in writing by Parent, such agreement by Parent not to be unreasonably withheld, conditioned or delayed; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(q)&nbsp;&nbsp;&nbsp;subject to the terms of this Agreement, afford all such cooperation and assistance as may reasonably be requested of it by Parent in respect of the preparation and verification of any document or in connection with any Clearance or confirmation required for the implementation of the Scheme, including the provision to Parent in a timely manner of such information and confirmations relating to it, its Subsidiaries and any of its or their respective directors or employees as Parent may reasonably request; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(r)&nbsp;&nbsp;&nbsp;assume responsibility for the information relating to it or any of its Subsidiaries contained in the Scheme Document, the Proxy Statement or any other document sent to Company Shareholders (or Company Equity Award Holders, as applicable) or filed with the High Court or in any announcement issued in connection with the Acquisition, other than statements made by Parent in relation to their intentions with respect to the Company and its Subsidiaries; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(s)&nbsp;&nbsp;&nbsp;review and provide comments (if any) in a reasonably timely manner on all documentation submitted to it by Parent; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(t)&nbsp;&nbsp;&nbsp;following the Court Meeting and EGM, assuming the Resolutions are duly passed (including by the requisite majorities required under Section&#160;453 of the Act in the case of the Court Meeting) and all other Conditions are satisfied or, in the sole discretion of the applicable Party, waived (where permissible under the terms of the Rule&#160;2.7 Announcement or the Scheme Document) (with the exception of Conditions&#160;2.3 and 2.4 and any other Conditions that are by their nature to be satisfied on the Sanction&#160;Date, but subject to the satisfaction or waiver (where permissible under the provisions of the Rule&#160;2.7&#160;Announcement or the Scheme Document) of such Conditions), take all necessary steps on the part of the Company to prepare and issue, serve and lodge all such court documents as are required to seek the sanction of the High Court to the Scheme as soon as possible thereafter; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(u)&nbsp;&nbsp;&nbsp;give such undertakings as are required by the High Court in connection with the Scheme as are reasonably necessary or desirable to implement the Scheme; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;keep Parent reasonably informed as to the performance of the obligations and responsibilities required of the Company pursuant to the Scheme; and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tS3RO1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(w)&nbsp;&nbsp;&nbsp;use its reasonable best efforts to ensure the Proxy Statement and Scheme Document comply in all material respects with applicable Law and do not, at the time mailed and at the time of the Court Meeting and EGM, contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances, not misleading, except that no covenant is made by the Company with respect to statements made in the Proxy Statement and Scheme Document based on information supplied in writing by or on behalf of Parent specifically for inclusion or incorporation by reference therein. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;3.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Responsibilities of Parent in Respect of the Scheme</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Parent shall: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;either (i)&#160;instruct counsel to appear on its behalf at the Court Hearing and undertake to the High Court to be bound by the terms of the Scheme insofar as it relates to Parent or (ii)&#160;provide a written undertaking to the High Court to be bound by the terms of the Scheme insofar as it relates to Parent; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;if, and to the extent that, it or any of its Concert Parties owns or is interested in Company Shares, exercise all of its rights and, insofar as lies within its powers, procure that each of its Concert Parties shall exercise all of their respective rights, in respect of such Company Shares so as to implement, and otherwise support the implementation of, the Scheme, including by voting (and, in respect of interests in the Company held via contracts for difference or other derivative instruments, insofar as lies within its powers, procuring that instructions are given to the holder of the underlying Company Shares to vote) in favor of the Resolutions or, if required by Law, the High Court or the Takeover Rules, refraining from voting, at any Court Meeting or EGM as the case may be; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;provide the Company in a reasonably prompt manner with such information regarding Parent and/or its Concert Parties as is reasonably required for inclusion in the Scheme Document, the Proxy Statement, the Company Equity Award Holder Proposal and any necessary court application, paper, filing or other document; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;keep the Company reasonably informed as to the performance of the obligations and responsibilities required of Parent pursuant to the Scheme; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;subject to the terms of this Agreement (including </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2</font><font style="letter-spacing:0.2pt;"> hereof) and the Scheme, afford all such cooperation and assistance as may reasonably be requested of it by the Company in respect of the preparation and verification of any document or in connection with any Clearance or confirmation required for the implementation of the Scheme, including the provision to the Company in a reasonably timely manner of such information and confirmations relating to it, its Subsidiaries and any of its or their respective directors or employees as the Company may reasonably request (including for the purposes of preparing the Scheme Document); </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;assume responsibility for the information relating to it or any of its Subsidiaries, or any statements made by it or any of its Subsidiaries with respect to the Company and its Subsidiaries, contained in the Scheme Document, the Proxy Statement or any other document sent to Company Shareholders or filed with the High Court or in any announcement issued in connection with the Acquisition; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;review and provide comments (if any) in a reasonably timely manner on all documentation submitted to it by the Company; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;to the extent that clearance of the Proxy Statement or the Scheme Document by the Panel might require that waivers or derogations in respect of the Takeover Rules be sought and obtained from the Panel in relation to matters that relate to Parent and/or any of its Concert Parties, make a submission for (and use reasonable best efforts to have approved) such waiver or derogation as promptly as reasonably practicable after having provided the Company with a reasonable opportunity to review and comment on such submission and considering in good faith such comments and support any submissions to the Panel made by the Company pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1(h)</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;as promptly as reasonably practicable, notify the Company of any other matter of which it becomes aware which would reasonably be expected to materially delay or prevent filing of the Proxy Statement or the Scheme Document with the SEC and the Panel, as applicable, or implementation of the Scheme, as the case may be. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tS3MR">&#8203;</a><a name="tSEC1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;3.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Mutual Responsibilities of the Parties</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;If any of the Parties becomes aware of any information that, pursuant to the Takeover Rules, the Act, the Securities Act or the Exchange Act, should be disclosed in an amendment or supplement to the Scheme Document or the Proxy Statement, then such Party shall promptly inform the other Party thereof and the Parties shall cooperate with each other in submitting or filing such amendment or supplement with the Panel, the SEC or the High Court, as applicable, and, if required, in mailing such amendment or supplement to the Company Shareholders and, for information only, if required, to the holders of the Company Options, Company Performance Options or Company Share Awards. Each of the Parties agrees to promptly (i)&#160;correct any information provided by it for use in the Scheme Document or the Proxy Statement, as applicable, if and to the extent that such information shall have become false or misleading in any material respect and (ii)&#160;supplement the information provided by it specifically for use in the Scheme Document or the Proxy Statement, as applicable, to include any information that shall become necessary in order to make the statements in the Scheme Document or the Proxy Statement, as applicable, in light of the circumstances under which they were made, not misleading. The Company further agrees to cause the Scheme Document or the Proxy Statement, as applicable, as so corrected or supplemented promptly to be filed with the Panel and the SEC and to be sent to its shareholders and, for information only, if required, to the holders of the Company Options, Company Performance Options or Company Share Awards in each case as and to the extent required by applicable Law. For purposes of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3(a)</font><font style="letter-spacing:0.2pt;">, any information concerning the Company Group will be deemed to have been provided by the Company, and any information concerning the Parent Group will be deemed to have been provided by Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Each Party shall provide the other Party with reasonable prior notice of any proposed material oral communication with the SEC or the High Court and, except to the extent prohibited by the SEC or the High Court, afford the other Party reasonable opportunity to participate therein, other than with respect to any such communication to the extent related to a Company Alternative Proposal or the termination of this Agreement pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;3.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Dealings with the Panel</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Each of the Parties will (i)&#160;give the other reasonable prior notice of any proposed meeting or material substantive discussion, communication or correspondence between it or its Representatives with the Panel, or any amendment to be proposed to the Acquisition or the Scheme in connection therewith, and, except to the extent any such meeting, discussion, communication or correspondence relates to a Company Alternative Proposal or the valid termination of this Agreement pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">, afford the other reasonable opportunities to review and make comments and suggestions with respect to the same and consider in good faith such comments and suggestions and (ii)&#160;except to the extent any such meeting, discussion, communication correspondence or submission relates to a Company Alternative Proposal or the valid termination of this Agreement pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">, keep the other reasonably informed of all such meetings, discussions, communications or correspondence that it or its Representative(s) have with the Panel and not participate in any meeting or discussion with the Panel concerning this Agreement or the transactions contemplated by this Agreement unless it consults with the other Party in advance, and, unless prohibited by the Panel, gives such other Party the opportunity to attend and provide copies of all written submissions it makes to the Panel and copies (or, where verbal, a verbal or written summary of the substance) of the Panel responses thereto provided always that any correspondence or other information required to be provided under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.4</font><font style="letter-spacing:0.2pt;"> may be redacted: </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;to remove references concerning the valuation of the businesses of the Company; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;to prevent the exchange of confidential information as required by applicable Law (</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the redacting Party shall use its reasonable best efforts to cause such information to be provided in a manner that would not result in such confidentiality concerns); and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;as necessary to address reasonable privilege concerns (</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the redacting Party shall use its reasonable best efforts to cause such information to be provided in a manner that would not result in such privilege concerns). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Company undertakes, if so reasonably requested by Parent to, as promptly as practicable, provide its written consent to Parent and to the Panel in respect of any application made by Parent to the Panel: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tSEC2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;to redact any commercially sensitive or confidential information specific to Parent&#8217;s financing arrangements for the Acquisition (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Parent Financing Information</font><font style="letter-spacing:0.2pt;">&#8221;) from any documents that Parent is required to display pursuant to Rule&#160;26.3(v) of the Takeover Rules; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;for a derogation from the requirement under the Takeover Rules to disclose Parent Financing Information in the Scheme Document, any supplemental document or other document sent to Company Shareholders or the holders of the Company Options, Company Performance Options or Company Share Awards pursuant to the Takeover Rules; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;for a derogation from Rule&#160;16.1 or Rule&#160;20.1 of the Takeover Rules to permit Parent to implement, and to pay fees to lenders in connection with, its Financing and syndication arrangements with respect to its Financing, and to provide information to lenders and prospective lenders on such terms as the Panel may permit; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;for a derogation from the disclosure requirements of Rule&#160;24.4 of the Takeover Rules, seeking consent to the aggregation of dealings for purposes of disclosure in the Scheme Document. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent undertakes, if so requested by the Company to, as promptly as practicable, provide its written consent to the Company and to the Panel in respect of any application made by the Company to the Panel: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;to permit entering into and effecting the retention, bonus or benefit arrangements contemplated by </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.1(b)(xii)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;for a derogation from the disclosure requirements of Rule&#160;25.4 of the Takeover Rules, seeking consent to the aggregation of dealings for purposes of disclosure in the Scheme Document; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;to the extent applicable, requesting consent or, as the case may be, a derogation from, Rule&#160;16.1 and/or 16.2 of the Takeover Rules in respect of any matter which Parent and the Company have agreed to on the date hereof or Parent otherwise consents to; and </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Parent and the Company undertake, if so requested by the other Party to, as promptly as reasonably practicable, issue its written consent to the other Party and to the Panel in respect of any application reasonably requesting any derogation, permission or consent from the Panel in connection with the Takeover Rules (other than any derogation, permission or consent relating to the termination of this Agreement or the invoking of any Condition to the Acquisition). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.4</font><font style="letter-spacing:0.2pt;">, neither the Company nor Parent shall be required to take any action pursuant to the foregoing provisions (a)&#160;through (d)&#160;if such action is prohibited by the Panel (unless the Panel decision is successfully appealed by either the Company or Parent). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Nothing in this Agreement shall in any way limit the Parties&#8217; obligations under the Takeover Rules. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;3.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">No Scheme Amendment by the Company</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except as required by applicable Law, the High Court or the Panel, the Company shall not take any of the following actions after sending the Scheme Document to the Company Shareholders, in each case, without the prior written consent of Parent (such consent not to be unreasonably withheld, conditioned or delayed): </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;amend the Scheme; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;adjourn or postpone (or propose an adjournment or postponement of) the Court Meeting or the EGM; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that the Company may, without the consent of, but after consultation with, Parent, and shall, upon the written request of Parent, adjourn or postpone (or propose to adjourn or postpone) the Court Meeting or EGM if (i)&#160;in the case of adjournment, such adjournment was requested by the Company Shareholders (but only to the extent the proposal for such adjournment was not proposed by the Company or any of its Affiliates or their respective Representatives), (ii)&#160;reasonably necessary to ensure that any required supplement or amendment to the Scheme Document or Proxy Statement is provided to the Company Shareholders or to permit dissemination of information which is material to the Company Shareholders voting at the Court Meeting or the EGM (but only for so long as the Company Board determines in good faith, after having consulted with outside counsel, as is reasonably necessary or advisable to give the Company Shareholders sufficient time to evaluate any such disclosure or information) or (iii)&#160;as </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tSEC3">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of the time the Court Meeting or EGM is scheduled (as set forth in the Scheme Document or Proxy Statement), there are insufficient Company Shares represented (either in person or by proxy) (A)&#160;to constitute a quorum necessary to conduct the business of the Court Meeting or the EGM (but only until a meeting can be held at which there are a sufficient number of Company Shares represented to constitute a quorum) or (B)&#160;voting for the approval of the Court Meeting Resolutions or the EGM Resolutions, as applicable (but only until a meeting can be held at which there are a sufficient number of votes of Company Shareholders to approve the Court Meeting Resolutions or the EGM Resolutions, as applicable); </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, that, notwithstanding the foregoing, (x)&#160;other than any adjournments or postponements required by applicable Law, including adjournments or postponements to the extent reasonably necessary or advisable to ensure that any required supplement or amendment to the Proxy Statement is provided or made available to Company Shareholders or to permit dissemination of information which is material to shareholders voting at the Court Meeting and EGM and to give the Company Shareholders sufficient time to evaluate any such supplement or amendment or other information, no such adjournment or postponement pursuant to clause (i)&#160;or (iii)&#160;shall, without the prior written consent of Parent (such consent not to be unreasonably withheld, conditioned or delayed), be for a period exceeding fifteen (15) Business Days and the Company shall not adjourn or postpone the Court Meeting or the EGM pursuant to clause (i)&#160;or (iii)&#160;more than two (2)&#160;times and (y)&#160;without the prior written consent of the Company (such consent not to be unreasonably withheld, conditioned or delayed), Parent may not require any adjournments or postponements of the EGM or Court Meeting that in the aggregate with all other such adjournments and postponements required by Parent would exceed fifteen (15) Business Days; or </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;amend the Resolutions (in each case, in the form set out in the Scheme Document). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;3.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Switching to a Takeover Offer</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Subject to the terms of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6</font><font style="letter-spacing:0.2pt;">, in the event that Parent reasonably determines that a competitive situation (as that term is defined in the Takeover Rules) exists or, based on facts known at the time, may reasonably be expected to arise in connection with the Acquisition, Parent may elect (subject to receiving the Panel&#8217;s consent, if required) to implement the Acquisition by way of the Takeover Offer (rather than the Scheme), whether or not the Scheme Document has been posted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Except in the event the Company Board has made a Company Board Change of Recommendation pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;">, if Parent elects to implement the Acquisition by way of the Takeover Offer, the Company undertakes to provide Parent and its Representatives as promptly as reasonably practicable with all such information about the Company Group (including directors and their connected persons) as may reasonably be required for inclusion in the Takeover Offer Document and to provide all such other assistance as may reasonably be required by the Takeover Rules in connection with the preparation of the Takeover Offer Document, including reasonable access to, and ensuring the provision of reasonable assistance by, its management and Representatives. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;If Parent elects to implement the Acquisition by way of a Takeover Offer: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Parent and the Company agree that the Takeover Offer Document will contain provisions consistent with the terms and conditions set out in the Rule&#160;2.7 Announcement, the relevant Conditions and such other further terms and conditions as agreed (including any modification thereto) between Parent and the Panel; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that the terms and conditions of the Takeover Offer shall be at least as favorable to the Company Shareholders and the holders of Company Options, Company Performance Options and Company Share Awards as those which would apply in relation to the Scheme (except for the 80% acceptance condition contemplated by paragraph 9 of Appendix&#160;III of the Rule&#160;2.7 Announcement, which acceptance condition shall not be reduced or waived without the prior written consent of the Company); </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;except in the event the Company Board has made a Company Board Change of Recommendation pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;">, the Company agrees to reasonably co-operate and consult with Parent in the preparation of the Takeover Offer Document or any other document or filing which is required for the purposes of implementing the Acquisition; and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tAIA">&#8203;</a><a name="tSEC4">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;that, subject to the obligations of the Company Board under the Takeover Rules and the compliance of Parent with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6(c)(i)</font><font style="letter-spacing:0.2pt;">, and unless the Company Board has made a Company Board Change of Recommendation pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;">, the Takeover Offer shall incorporate a recommendation to the Company Shareholders from the Company Board to accept the Takeover Offer and such recommendation shall not subsequently be withdrawn, adversely modified or qualified except as contemplated by </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;If Parent elects to implement the Acquisition by way of the Takeover Offer in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6(a)</font><font style="letter-spacing:0.2pt;">, the Parties mutually agree: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;to prepare and file with, or submit to, the SEC, the Panel and the High Court, all documents, amendments and supplements required to be filed therewith or submitted thereto pursuant to the Takeover Rules, the Securities Act, the Exchange Act or otherwise by applicable Law in connection with the Takeover Offer and to make any applications or initiate any appearances as may be required by or desirable to the High Court for the purpose of discontinuing, cancelling or terminating the High Court proceedings initiated in connection with the Scheme and, unless the Company Board has made a Company Board Change of Recommendation, each Party shall have reasonable opportunities to review and make comments on all such documents, amendments and supplements and, following good faith consideration of such comments by the other Party and approval of such documents, amendments and supplements by the other Party, which approval shall not be unreasonably withheld, conditioned or delayed, file or submit, as the case may be, such documents, amendments and supplements with or to the SEC, the Panel and the High Court (as applicable); </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;to provide the other Party with any comments received from the SEC, the Panel or the High Court on any documents filed by it with the SEC, the Panel or the High Court promptly after receipt thereof, other than with respect to any such documents to the extent related to a Company Alternative Proposal; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;to provide the other Party with reasonable prior notice of any proposed material oral communication with the SEC, the Panel or the High Court and, except to the extent prohibited by the SEC, the Panel or the High Court, afford the other Party reasonable opportunity to participate therein, other than with respect to any such communication to the extent related to a Company Alternative Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;If the Takeover Offer is consummated, Parent shall (or cause its respective designees) to effect as promptly as reasonably practicable, following it becoming entitled under the Act to do so, a compulsory acquisition of any Company Shares under Section&#160;457 of the Act not acquired in the Takeover Offer for the same consideration per share as provided for in the Takeover Offer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;For clarity and except as may be required by the Takeover Rules (and without limiting any other provision of this Agreement), nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6</font><font style="letter-spacing:0.2pt;"> shall require the Company to provide Parent with any information with respect to, or to otherwise take or fail to take any action in connection with the Company&#8217;s consideration of or response to, any actual or potential Company Alternative Proposal. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE IV</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EQUITY AWARDS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;4.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Treatment of Company Equity Awards</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;At the Effective Time, each Company Option having an exercise price less than the Cash Consideration (a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Cash-Out Option</font><font style="letter-spacing:0.2pt;">&#8221;), whether or not vested, will be cancelled, and, in exchange therefor, the holder of such cancelled Company Cash-Out Option will be entitled to receive (without interest), in consideration of the cancellation of such Company Cash-Out Option, (A)&#160;an amount in cash (less applicable Tax and any other mandatory withholdings) equal to the product of (1)&#160;the total number of Company Shares subject to such Company Cash-Out Option immediately prior to the Effective Time </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">multiplied by</font><font style="letter-spacing:0.2pt;"> (2)&#160;the excess of the Cash Consideration over the applicable exercise price per Company Share under such Company Cash-Out Option (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Option Cash Consideration</font><font style="letter-spacing:0.2pt;">&#8221;) and (B)&#160;the CVR Consideration </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tSEC5">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">for each Company Share subject to such Company Cash-Out Option immediately prior to the Effective Time (without regard to vesting). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;At the Effective Time, each Company Option that is not a Company Cash-Out Option and any Company Option with an exercise price equal to or greater than the Cash Consideration, whether or not vested, shall be cancelled for no consideration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;At the Effective Time, each Company Performance Option (x)&#160;having an exercise price less than the Cash Consideration and (y)&#160;that is outstanding immediately prior to the Effective Time (a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Cash-Out Performance Option</font><font style="letter-spacing:0.2pt;">&#8221;), whether or not vested, will be cancelled, and, in exchange therefor, the holder of such cancelled Company Cash-Out Performance Option will be entitled to receive (without interest), in consideration of the cancellation of such Company Cash-Out Performance Option, (A)&#160;an amount in cash (less applicable Tax and any other mandatory withholdings) equal to the product of (1)&#160;the total number of Company Shares subject to such Company Cash-Out Performance Option immediately prior to the Effective Time </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">multiplied by</font><font style="letter-spacing:0.2pt;"> (2)&#160;the excess of the Cash Consideration over the applicable exercise price per Company Share under such Company Cash-Out Performance Option (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Performance Option Cash Consideration</font><font style="letter-spacing:0.2pt;">&#8221;) and (B)&#160;the CVR Consideration for each Company Share subject to such Company Cash-Out Performance Option immediately prior to the Effective Time (without regard to vesting). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;At the Effective Time, each Company RSU Award that is outstanding will be cancelled and, in exchange therefor, the holder of such cancelled Company RSU Award will be entitled to receive (without interest), in consideration of the cancellation of such Company RSU Award, (A)&#160;an amount in cash (less applicable Tax and any other mandatory withholdings) equal to the product of (1)&#160;the total number of Company Shares subject to such Company RSU Award immediately prior to the Effective Time multiplied by (2)&#160;the Cash Consideration and (B)&#160;the CVR Consideration for each Company Share subject to such Company RSU Award immediately prior to the Effective Time (without regard to vesting). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;At the Effective Time, each Company Restricted Stock Award that is outstanding immediately prior to the Effective Time will vest in full as of immediately prior to the Effective Time and will be treated in the same manner as all other Company Shares in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8.1(c)(i)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Each Company Equity Compensation Plan shall be terminated effective as of the Effective Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;The actions contemplated by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.1</font><font style="letter-spacing:0.2pt;"> shall be taken in accordance with Section&#160;409A of the Code and, if applicable, Section&#160;422 of the Code. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;The Company shall take all actions prior to the Effective Time necessary to effectuate the terms of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.1</font><font style="letter-spacing:0.2pt;"> and to ensure that no Company Equity Awards are outstanding following the Effective Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;4.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Treatment of Company ESPP</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Prior to the Effective Time, the Company or the Company Board (or the appropriate committee thereof) shall take all actions necessary to effect the following: (i)&#160;the Company ESPP shall be frozen and suspended during the offering period that is in progress as of the date of this Agreement and no new offering periods shall commence under the Company ESPP at any time on or after the date hereof, (ii)&#160;no new participants shall be permitted into the Company ESPP after the date hereof, (iii)&#160;no current participants in the Company ESPP shall be permitted to increase their payroll deduction elections or rate of contributions under the Company ESPP from those in effect on the date of this Agreement or make any separate non-payroll contributions to the Company ESPP on or following the date of this Agreement, (iv)&#160;the then-current offering period that is in progress as of the Effective Time under the Company ESPP will be accelerated to a date on or prior to the Completion Date, and each participant&#8217;s accumulated payroll deductions shall be used to purchase Company Shares in accordance with the terms of the Company ESPP, (v)&#160;any accumulated payroll deductions that are not used to purchase Company Shares shall be promptly refunded (without interest, to the extent permitted by applicable Law) to the applicable participant and (vi)&#160;the Company ESPP shall terminate immediately prior to, and contingent upon, the Effective Time. At the Effective Time, each outstanding Company Share issued under the Company ESPP shall be treated the same as all other Company Shares in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8.1(c)(i)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tS4RB">&#8203;</a><a name="tSEC6">&#8203;</a><a name="tAVC">&#8203;</a><a name="tSEC7">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;4.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Reasonable Best Efforts</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Each of the Parties shall use its reasonable best efforts to take all actions reasonably necessary to effectuate the transactions contemplated by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IV</font><font style="letter-spacing:0.2pt;">, including having the applicable board or committee administering the plans governing the affected awards, adopt resolutions necessary to effect the foregoing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;4.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Amendment of Articles</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Company shall procure that a special resolution be proposed to the Company Shareholders at the EGM proposing that the Company Memorandum and Articles of Association be amended so that any Company Shares allotted following the EGM will either be subject to the terms of the Scheme or acquired by Parent for the same consideration per Company Share as shall be payable to the Company Shareholders under the Scheme (depending upon the timing of such allotment); </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that nothing in such amendment to the Company Memorandum and Articles of Association shall prohibit the sale (whether on a stock exchange or otherwise) of any Company Shares issued on the exercise of Company Options or Company Performance Options or vesting or settlement of Company Share Awards or in settlement of participant rights under the Company ESPP, as applicable, following the EGM but prior to the sanction of the Scheme by the High Court, it being always acknowledged that each and every Company Share will be bound by the terms of the Scheme. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE V</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">COMPANY CONDUCT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;5.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Conduct of Business by the Company</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;From the date of this Agreement until the earlier of the Completion and valid termination of this Agreement pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">, except (x)&#160;as prohibited or required by applicable Law, (y)&#160;as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.1(a)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule or (z)&#160;as otherwise required or expressly contemplated by this Agreement, unless Parent shall otherwise consent in writing (which consent shall not be unreasonably withheld, conditioned or delayed), the Company shall, and shall cause each of its Subsidiaries to, (i)&#160;conduct its business in the ordinary course of business consistent with past practice in all material respects and in compliance in all material respects with all applicable Laws and (ii)&#160;use commercially reasonable efforts to preserve intact its business organization and relationships with customers, suppliers, licensors, licensees, Governmental Entities and other Third Parties, keep available the services of its present officers and employees, and timely file all reports, schedules, forms, statements and other documents required to be filed with the SEC and Securities Act, and none of the Company SEC Documents filed after the date hereof shall, at the time filed (or, if amended or supplemented, at the time of such amendment or supplement), contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Without limiting the generality of the foregoing, from the date of this Agreement until the earlier of the Completion and termination of this Agreement pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">, except (A)&#160;as prohibited or required by applicable Law, (B)&#160;as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.1</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule or (C)&#160;as otherwise required or expressly contemplated by this Agreement, without Parent&#8217;s prior written consent (which shall not be unreasonably withheld, conditioned or delayed), the Company shall not, and shall cause each of its Subsidiaries not to: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Adopt or propose any change to its Organizational Documents (whether by merger, consolidation or otherwise); </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;(A) merge or consolidate with any other Person, or acquire (including by merger, consolidation or acquisition of stock or assets) any interest in any corporation, partnership, other business organization or any division or business thereof or any assets, securities or property, other than (1)&#160;transactions (x)&#160;solely among the Company and one or more of its wholly owned Subsidiaries or (y)&#160;solely among the Company&#8217;s wholly owned Subsidiaries or (2)&#160;acquisitions of inventory or equipment in the ordinary course of business consistent with past practice or (B)&#160;adopt a plan of complete or partial liquidation, dissolution, recapitalization or restructuring; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;(A) split, combine or reclassify any shares of its capital stock, (B)&#160;amend any term or alter any rights of any of its outstanding Equity Securities, (C)&#160;declare, set aside or pay any dividend or make any other distribution (whether in cash, stock, property or any combination thereof) in respect of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">any Equity Securities, other than dividends or distributions by a Subsidiary of the Company to the Company or a wholly owned Subsidiary of the Company, or (D)&#160;redeem, repurchase, cancel or otherwise acquire or offer to redeem, repurchase or otherwise acquire any of its Equity Securities or any Equity Securities of any Subsidiary of the Company, other than repurchases or withholding of Company Shares in connection with the exercise of Company Options or Company Performance Options or the vesting or settlement of Company Share Awards (including in satisfaction of any amounts required to be deducted or withheld under applicable Law) in accordance with the terms of such Company Equity Awards outstanding as of the date of this Agreement; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;issue, deliver or sell, or authorize the issuance, delivery or sale of, any Equity Securities, other than (A)&#160;the issuance of any Company Shares upon the exercise of Company Options, Company Performance Options or any Company Shares in connection with any offering period in existence under the Company ESPP, the accrual of any dividend equivalents under any dividend equivalent rights applicable to any Company Equity Awards, or the vesting or settlement of the Company Share&#160;Awards or the withholding of Company Shares to satisfy Tax (or other mandatory withholding) obligations pertaining to the exercise of Company Options or Company Performance Options or the vesting or settlement of Company Equity Awards or to satisfy the exercise price with respect to Company Options or Company Performance Options or to effectuate an optionee direction upon exercise of Company Options or Company Performance Options that, in each case, are outstanding as of the date of this Agreement (in accordance with their existing terms as of the date hereof), (B)&#160;transactions with respect to Equity Securities of any Subsidiary of the Company or (C)&#160;in connection with transactions&#160;(1)&#160;solely among the Company and one or more of its wholly owned Subsidiaries or (2)&#160;solely among the Company&#8217;s wholly owned Subsidiaries; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;make any capital expenditures or incur any obligations or liabilities in connection therewith in an aggregate amount in excess of $650,000; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;sell, lease, license, transfer or otherwise dispose of any Subsidiary of the Company or any division, assets, securities or properties of the Company Group, other than (A)&#160;sales or dispositions of inventory, goods, services, tangible personal property (including equipment), in each case in the ordinary course of business consistent with past practice, (B)&#160;transactions (1)&#160;solely among the Company and one or more of its wholly owned Subsidiaries or (2)&#160;solely among the Company&#8217;s wholly owned Subsidiaries or (C)&#160;any non-exclusive license of Intellectual Property expressly permitted under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.1(b)(vii)</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;sell, assign, license (including sublicense), fail to diligently prosecute or maintain, waive, abandon, allow to lapse, transfer or otherwise dispose of, or create or incur any Lien (other than a Permitted Lien) on, any Intellectual Property, other than (A)&#160;non-exclusive licenses granted in the ordinary course of business consistent with past practice to (1)&#160;customers, (2)&#160;distributors and (3)&#160;service providers solely in connection with the performance of services or manufacture of products for the Company Group or (B)&#160;for the purpose of abandoning, allowing to lapse or otherwise disposing of immaterial, obsolete or worthless assets; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(viii)&nbsp;&nbsp;&nbsp;(A) make any loans, advances or capital contributions to, or investments in, any other Person, other than (1)&#160;loans, advances, capital contributions or investments (a)&#160;by the Company to or in, as applicable, one or more of its wholly owned Subsidiaries or (b)&#160;by any Subsidiary of the Company to or in, as applicable, the Company or any wholly owned Subsidiary of the Company or (2)&#160;capital contributions required under the terms of Contracts in effect as of the date hereof or (B)&#160;incur, assume, guarantee or repurchase or otherwise become liable for any indebtedness for borrowed money, issue or sell any debt securities or any options, warrants or other rights to acquire debt securities (in each case, whether, directly or indirectly, on a contingent basis or otherwise) or enter into any interest rate or currency swaps, forward currency or interest rate contracts or other interest rate or currency hedging arrangements, other than (1)&#160;borrowings under the Company&#8217;s or its Subsidiaries&#8217; existing credit facilities (as in effect as of the date hereof) in accordance with the terms thereof, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that any such activities incurred in accordance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.1(b)(viii)</font><font style="letter-spacing:0.2pt;"> do not have a material adverse Tax consequence, individually or in the aggregate, with respect to the Company or any of its Subsidiaries; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ix)&nbsp;&nbsp;&nbsp;create or incur any Lien (other than a Permitted Lien) on any material assets or properties, other than Liens that may be discharged at or prior to the Completion that are not material in amount or effect on the business of the Company or its Subsidiaries; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(x)&nbsp;&nbsp;&nbsp;(A) enter into any Company Material Contract (including by amendment of any Contract or agreement that is not a Company Material Contract such that such Contract or agreement becomes a Company Material Contract), other than in the ordinary course of business consistent with past practice (except that no Company Material Contract of the type described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(t)(i)(A), Section&#160;6.1(A)(t)(i)(C), or Section&#160;6.1(A)(t)(i)(F)</font><font style="letter-spacing:0.2pt;"> shall be entered into) or (B)&#160;terminate, renew, extend or in any material respect modify or amend (including waiving, releasing or assigning any material right or claim thereunder) any Company Material Contract, other than in the ordinary course of business consistent with past practice or any termination, renewal, extension, modification or amendment that occurs automatically in accordance with the terms of any such Company Material Contract without any action by the Company or its Subsidiaries; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(xi)&nbsp;&nbsp;&nbsp;terminate, fail to renew, suspend, abrogate, amend or modify any material Company Permit in a manner material and adverse to the Company and its Subsidiaries, taken as a whole; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(xii)&nbsp;&nbsp;&nbsp;except as required by the terms of an Company Benefit Plan as in effect on the date hereof, (A)&#160;grant (or increase the value of) any change in control, equity or equity-based awards, or severance, termination or similar pay, to (or amend any existing arrangement with) any current or former director, officer, employee or individual independent contractor of the Company or any of its Subsidiaries (each, a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Covered Individual</font><font style="letter-spacing:0.2pt;">&#8221;), (B)&#160;enter into any employment, deferred compensation, severance or other similar agreement (or any elective extension of, or amendment to, any such existing agreement) with any Covered Individual, other than employment agreements with newly hired employees reviewed and approved by Parent; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that such approval shall not be unreasonably withheld, (C)&#160;establish, adopt, enter into, amend or terminate any Company Benefit Plan (or any plan, program, policy, scheme, trust, fund, practice, agreement or arrangement that would be a Company Benefit Plan if in effect on the date hereof) (including any union or works council agreement), provided that, notwithstanding this clause (C), the Company and its Subsidiaries may renew any Company health and welfare plans in the ordinary course of business consistent with past practice, so long as such renewals will not materially increase the cost of administering or maintaining such Company Benefit Plan, (D)&#160;increase or accelerate the payment, vesting or funding of, the incentive, equity or equity-based awards, bonus opportunity or other compensation payable under any Company Benefit Plan or otherwise, (E)&#160;terminate (other than for &#8220;cause&#8221;) any individual who is at the time of termination above the level of Executive Director or (F)&#160;increase the wages, salary or other compensation or benefits with respect to any Covered Individual; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(xiii)&nbsp;&nbsp;&nbsp;make any material change in any method of financial accounting or financial accounting principles or practices, except for any such change required by reason of (or, in the reasonable good-faith judgment of the Company, advisable under) a change in GAAP or applicable Law or SEC policy; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(xiv)&nbsp;&nbsp;&nbsp;(A) make, change or revoke any material Tax election; (B)&#160;file any amended Tax Return; (C)&#160;waive or extend any statute of limitations with respect to any assessment or determination of material Taxes; (D)&#160;adopt or change (or request to change) any material method of Tax accounting or Tax accounting period; (E)&#160;enter into any material &#8220;closing agreement&#8221; as described in Section&#160;7121 of the Code (or any corresponding or similar provision of state, local or non-U.S. Tax Law) or other binding written agreement with any Tax Authority or any Tax sharing, allocation or similar agreement; (F)&#160;apply for any material Tax ruling; or (G)&#160;settle, compromise or surrender any material Tax claim, liability, audit, assessment or refund for an amount in excess of reserves therefor on the financial statements of the Company and its Subsidiaries; provided that no term of such settlement, compromise or surrender would increase the Tax liability of Parent, the Company or their respective Subsidiaries following the closing; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(xv)&nbsp;&nbsp;&nbsp;settle or compromise, or propose to settle or compromise, any Action involving or against the Company or any of its Subsidiaries (including any Action involving or against any officer or director of the Company or any of its Subsidiaries in their capacities as such); </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tSEC8">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(xvi)&nbsp;&nbsp;&nbsp;commence any Action, other than in connection with a breach of this Agreement or any other agreements contemplated hereby; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(xvii)&nbsp;&nbsp;&nbsp;make any material change in any method of financial accounting or financial accounting principles or practices, except for any such change required by reason of a change in GAAP or applicable Laws; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(xviii)&nbsp;&nbsp;&nbsp;fail to maintain in full force and effect the Company Insurance Policies or replacement or successor policies providing coverage in at least such amounts and against such risks as are currently in effect; or </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(xix)&nbsp;&nbsp;&nbsp;enter into any collective bargaining agreement or other agreement with any labor organization or recognize or certify any labor union, works council or other labor organization as the bargaining representative for any employees of any member of the Company Group; or </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(xx)&nbsp;&nbsp;&nbsp;agree, commit or propose to do any of the foregoing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The Company shall use commercially reasonable efforts to conduct clinical site audits as promptly as reasonably practicable following the date hereof, and in any event prior to the unblinding of any clinical data. For the avoidance of doubt completion of the clinical site audits shall not be deemed a condition to closing and none of the representations, warranties or covenants of the Company or Subsidiaries of the Company shall be deemed to apply to, or be deemed to be breached or violated by, the transactions or cooperation contemplated by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.1(c)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;5.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Non-Solicitation</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Solicitation or Negotiation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to any actions which the Company is required to take so as to comply with the requirements of the Takeover Rules, from the date of this Agreement until the earlier of the Effective Time and the valid termination of this Agreement pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">, except as otherwise set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;">, the Company shall not, and it shall cause its Subsidiaries and its and their respective directors, officers and employees not to, and it shall use reasonable best efforts to cause its other Representatives not to, directly or indirectly: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;initiate or solicit any inquiry, proposal or offer with respect to, or take any action to knowingly facilitate or knowingly encourage (including by way of furnishing information to any Person in connection with) the submission or announcement of any Company Alternative Proposal or any indication, proposal or inquiry that would reasonably be expected to lead to a Company Alternative Proposal; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;enter into, continue or otherwise participate in any discussions or negotiations with, furnish any non-public information relating to the Company or any of its Subsidiaries to, or afford access to the business, properties, assets, books or records of the Company or any of its Subsidiaries to, otherwise cooperate in any way with, or assist, participate in, knowingly facilitate or knowingly encourage any effort by, any Third Party that would reasonably be expected to seek to make, or has made, a Company Alternative Proposal (except to notify such Person as to the existence of the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2)</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp; (A)&#160;fail to make or withdraw or qualify, amend or modify in any manner adverse to Parent, the Scheme Recommendation or the recommendation contemplated by </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6(c)(iii)</font><font style="letter-spacing:0.2pt;">, if applicable, (B)&#160;fail to include the Scheme Recommendation in the Scheme Document or the Proxy Statement, (C)&#160;recommend, adopt or approve or publicly propose to recommend, adopt or approve any Company Alternative Proposal or (D)&#160;fail to reaffirm the Scheme Recommendation in a statement complying with Rule&#160;14e-2(a) under the Exchange Act with regard to a Company Alternative Proposal or in connection with such action by the close of business on the tenth (10th) Business Day after the commencement of such Company Alternative Proposal under Rule&#160;14e-2(a) (any of the foregoing in this clause (iii), a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Board Change of Recommendation</font><font style="letter-spacing:0.2pt;">&#8221;); </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;take any action to make any &#8220;moratorium&#8221;, &#8220;control share acquisition&#8221;, &#8220;fair price&#8221;, &#8220;supermajority&#8221;, &#8220;affiliate transactions&#8221; or &#8220;business combination statute or regulation&#8221; or other similar anti-takeover laws and regulations under applicable Law inapplicable to any Third Party or any Company Alternative Proposal; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;waive, terminate, modify or fail to enforce any provision of any &#8220;standstill&#8221; or similar obligation of any person with respect to the Company or any of its Subsidiaries; or </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;enter into any agreement in principle, letter of intent, term sheet, merger agreement, acquisition agreement, option agreement or other agreement providing for or relating to a Company Alternative Proposal or any indication, proposal or inquiry that would reasonably be expected to lead to a Company Alternative Proposal (other than a Company Alternative Proposal NDA). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Nothing contained herein shall prevent the Company Board from (x)&#160;complying with Rule&#160;14e-2(a) under the Exchange Act with regard to a Company Alternative Proposal, so long as any action taken or statement made to so comply is consistent with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(a)</font><font style="letter-spacing:0.2pt;"> or (y)&#160;making any required disclosure to the Company Shareholders if the Company Board determines in good faith, after consultation with outside legal counsel, that the failure to take such action would be inconsistent with applicable Law; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that any Company Board Change of Recommendation involving or relating to a Company Alternative Proposal may only be made in accordance with the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(b)</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(c)</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(d)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(e)</font><font style="letter-spacing:0.2pt;">. For clarity, a &#8220;stop, look and listen&#8221; disclosure or similar communication of the type contemplated by Rule&#160;14d-9(f) under the Exchange Act shall not constitute a Company Board Change of Recommendation. Additionally, the Company shall, and shall cause its Subsidiaries and its and their respective directors, officers and employees to, and shall use reasonable best efforts to cause its and its Subsidiaries&#8217; other Representatives to, cease immediately and cause to be terminated any and all existing activities, discussions or negotiations, if any, with any Third Party conducted prior to the date of this Agreement with respect to any Company Alternative Proposal or with respect to any indication, proposal or inquiry that would reasonably be expected to lead to a Company Alternative Proposal. The Company will promptly (and in each case within twenty-four (24) hours from the date of this Agreement) request from each Person (and such Person&#8217;s Representatives) that has executed a confidentiality agreement in connection with its consideration of making a Company Alternative Proposal to return or destroy (as provided in the terms of such confidentiality agreement) all confidential information concerning the Company or any of its Subsidiaries and shall promptly (and in each case within twenty-four (24) hours from the date of this Agreement) terminate all physical and electronic data access previously granted to each such Person. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Responding to Company Alternative Proposals</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Notwithstanding </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(a)</font><font style="letter-spacing:0.2pt;">, if at any time prior to the receipt of the Company Shareholder Approval (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Approval Time</font><font style="letter-spacing:0.2pt;">&#8221;) (and in no event after the Company Approval Time), the Company Board receives a </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> written Company Alternative Proposal made after the date hereof which has not resulted from a material breach of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;">, the Company Board, directly or indirectly through its Representatives, may (i)&#160;contact the Third Party that has made such Company Alternative Proposal solely to (A)&#160;inform the Third Party of the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;"> and (B)&#160;clarify the terms of such Company Alternative Proposal for the sole purpose of the Company Board informing itself about such Company Alternative Proposal and (ii)&#160;subject to the proviso at the end of this clause (ii), (x)&#160;engage in negotiations or discussions with any such Third Party that has made such an unsolicited bona fide written Company Alternative Proposal, and (y)&#160;furnish to such Third Party and its Representatives non-public information relating to the Company or any of its Subsidiaries pursuant to a confidentiality agreement with terms no less favorable in the aggregate to the Company than those contained in the Confidentiality Agreement, a copy of which shall be provided, promptly after its execution, to Parent for informational purposes (such confidentiality agreement, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Alternative Proposal NDA</font><font style="letter-spacing:0.2pt;">&#8221;); </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that all such non-public information (to the extent that such information has not been previously provided or made available to Parent) is provided or made available to Parent, as the case may be, substantially concurrently with the time it is provided or made available to such Third Party; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, that prior to and as a condition of taking any actions described in this clause (ii), the Company Board determines in good faith, after consultation with its financial advisor(s) and outside legal counsel, that (A)&#160;the failure to take such action would be inconsistent with its fiduciary duties under applicable Law and (B)&#160;such Company Alternative Proposal either constitutes or would reasonably be expected to result in a Company Superior Proposal. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notice</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company shall notify Parent promptly (but in any event within twenty-four (24) hours) if (i)&#160;any Company Alternative Proposal or any indication, proposal or inquiry by a Third Party that would reasonably be expected to lead to a Company Alternative Proposal is received by the Company, (ii)&#160;any non-public information is requested by any Person and such request would reasonably be expected to lead to a Company Alternative Proposal or (iii)&#160;any discussions or negotiations are sought to be initiated or continued with, the Company, its Subsidiaries or their respective Representatives with respect to a possible Company Alternative Proposal. Each such notice shall be provided in writing and shall identify the Third Party making, and, to the extent applicable, the material terms and conditions (including price) of, any such Company Alternative Proposal, indication, inquiry, proposal or request (including any changes thereto and, if applicable, copies of any written requests, proposals or offers, including proposed agreements). Following such initial notice, the Company shall keep Parent reasonably informed, on a current basis, of any changes in the status and details of any such Company Alternative Proposal, indication, inquiry, proposal or request (including any changes thereto, other than changes that only have a </font><font style="font-style:italic;letter-spacing:0.2pt;">de minimis</font><font style="letter-spacing:0.2pt;"> effect), including the status of any such discussions or negotiations and shall promptly (but in no event later than twenty-four (24) hours after receipt) provide to Parent copies of all material correspondence and written materials (including draft documentation) sent or provided by or to the Company or any of its Subsidiaries (or any of its or their respective Representatives) that describes any terms or conditions of any Company Alternative Proposal (as well as written summaries of any material oral communications addressing such matters). Neither the Company nor any of its Subsidiaries will enter into any agreement with any Person which prohibits the Company from providing any information to Parent in accordance with, or otherwise complying with, this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Fiduciary Exception to Company Board Change of Recommendation Provision</font><font style="letter-spacing:0.2pt;">.&#8194; Notwithstanding anything to the contrary in this Agreement, but subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(e)</font><font style="letter-spacing:0.2pt;">, prior to the Company Approval Time (and in no event after the Company Approval Time), the Company Board may (A)&#160;make a Company Board Change of Recommendation or (B)&#160;terminate this Agreement in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(a)(ii)</font><font style="letter-spacing:0.2pt;"> in order to substantially concurrently enter into a definitive agreement providing for a Company Superior Proposal if, with respect to clause (A)&#160;and clause (B), (x)&#160;in the case of such an action taken in connection with a Company Alternative Proposal, the Company Alternative Proposal has not been withdrawn and the Company Board determines in good faith, after consultation with outside legal counsel and its financial advisor(s), that such Company Alternative Proposal constitutes a Company Superior Proposal or (y)&#160;in the case of a Company Board Change of Recommendation contemplated by clause (A)&#160;above involving or relating to a Company Intervening Event (and not involving any Company Alternative Proposal), the Company Board determines in good faith, after consultation with outside legal counsel and its financial advisor(s), that the failure to take such action would reasonably be expected to be inconsistent with its directors&#8217; fiduciary duties under applicable Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Last Look</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company Board and the Company, as applicable, shall not take any of the actions contemplated by </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(d)</font><font style="letter-spacing:0.2pt;"> unless prior to taking such action (i)&#160;the Company has notified Parent, in writing at least five (5)&#160;Business Days before taking such action, that the Company intends to take such action, which notice attaches, in the case of a Company Board Change of Recommendation pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(d)(A)</font><font style="letter-spacing:0.2pt;"> in response to a Company Superior Proposal or the termination of this Agreement pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(d)(B)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(a)(ii)(B)</font><font style="letter-spacing:0.2pt;">, the most current version of each proposed Contract providing for or related to such Company Superior Proposal (including any Contract relating to financing or expense reimbursement) and the identity of the Third Party(ies) making the Company Superior Proposal or, in the case of a Company Intervening Event, a reasonably detailed description of the facts giving rise to the Company Board Change of Recommendation, (ii)&#160;if requested by Parent, during such five (5)-Business Day period, the Company and its Representatives shall have discussed and negotiated in good faith with Parent (to the extent that Parent desires to so discuss or negotiate) regarding any proposal by Parent to amend the terms of this Agreement in response to such Company Superior Proposal or other potential Company Board Change of Recommendation and (iii)&#160;after such five (5)-Business Day period, the Company Board determines in good faith, after consultation with its financial advisor(s) and outside legal counsel and taking into account any proposal by Parent to amend the terms of this Agreement, that (A)&#160;in the case of any such action in connection with a Company Alternative Proposal, such Company Alternative Proposal continues to constitute a Company Superior Proposal and (B)&#160;the failure to take such action would be reasonably expected to be inconsistent with its fiduciary duties under applicable Law (it being understood and agreed that in the event of any amendment to the financial terms or other material terms of any such </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tAVAW">&#8203;</a><a name="tSEC9">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Company Superior Proposal, a new written notification from the Company consistent with that described in clause (i)&#160;of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(e)</font><font style="letter-spacing:0.2pt;"> shall be required, and a new notice period under clause (i)&#160;of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(e)</font><font style="letter-spacing:0.2pt;"> shall commence, during which notice period the Company shall be required to comply with the requirements of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(e)</font><font style="letter-spacing:0.2pt;"> anew, except that such new notice period shall be for three (3)&#160;Business Days (as opposed to five (5)&#160;Business Days)). After delivery of such written notice pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(e)</font><font style="letter-spacing:0.2pt;">, the Company shall promptly inform Parent of all material developments affecting the material terms of any such Company Superior Proposal and shall promptly provide Parent with copies of any additional written materials received or sent that are material to such Company Superior Proposal. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE VI</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">REPRESENTATIONS AND WARRANTIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;6.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Company Representations and Warranties</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp;Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10.8</font><font style="letter-spacing:0.2pt;"> and except as disclosed (i)&#160;in any publicly available Company SEC Document filed on or after the Lookback Date, and prior to the date hereof (but excluding any risk factor disclosures contained under the heading &#8220;Risk Factors,&#8221; any disclosure of risks included in any &#8220;forward-looking statements&#8221; disclaimer or any other statements that are similarly cautionary, predictive or forward-looking in nature) or (ii)&#160;in the disclosure schedule delivered by the Company to Parent immediately prior to the execution of this Agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Disclosure Schedule</font><font style="letter-spacing:0.2pt;">&#8221;), the Company represents and warrants to Parent as follows: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Qualification, Organization, Subsidiaries, etc</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company is duly incorporated and validly existing under the Laws of Ireland. The Company has all requisite corporate power and authority required to own or lease all of its properties or assets and to carry on its business as now conducted. The Company is duly qualified to do business and is in good standing in each jurisdiction where such qualification is necessary, except for those jurisdictions where failure to be so qualified or in good standing has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Prior to the date of this Agreement, the Company has made available to Parent true and complete copies of the Memorandum and Articles of Association of the Company, as in effect as of the date hereof (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Memorandum and Articles of Association</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Subsidiaries</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp; Each Subsidiary of the Company is a corporation or other entity duly incorporated or organized, validly existing and in good standing (except to the extent such concept is not applicable under applicable Law of such Subsidiary&#8217;s jurisdiction of incorporation or organization, as applicable) under the Laws of its jurisdiction of incorporation or organization and has all corporate or other organizational powers and authority, as applicable, required to own, lease and operate its properties and assets and to carry on its business as now conducted, except for those jurisdictions where failure to be so organized, validly existing and in good standing or to have such power has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Each such Subsidiary is duly qualified to do business and is in good standing in each jurisdiction where such qualification is necessary, except for those jurisdictions where failure to be so qualified or in good standing has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(b)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule sets forth a true and complete list of all Subsidiaries of the Company, including their respective jurisdiction of incorporation or organization. The Company has made available true and correct copies of the Organizational Documents of all Subsidiaries of the Company that, in each case, are in full force and effect as of the date hereof. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;All of the outstanding Equity Securities of each Subsidiary of the Company have been validly issued and are fully paid and nonassessable (except to the extent such concepts are not applicable under applicable Law of such Subsidiary&#8217;s jurisdiction of incorporation or organization, as applicable) and are owned by the Company or one of its wholly-owned Subsidiaries, directly </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or indirectly, free and clear of any Lien (other than Permitted Liens or any restrictions imposed by applicable Law) and free of preemptive rights, rights of first refusal, subscription rights or similar rights of any Person and transfer restrictions (other than transfer restrictions under applicable Law or under the Organizational Documents of such Subsidiary). There are no outstanding obligations of the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire any Equity Securities of any Subsidiary of the Company. Except for the Equity Securities of its Subsidiaries, the Company does not own, directly or indirectly, any capital stock or other Equity Securities of any Person. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Capitalization</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;The authorized capital of the Company consists of 500,000,000 Company Shares nominal value $0.01 per share and 50,000,000 Company Preferred Shares nominal value $0.01 per share. As of October&#160;20, 2025 (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Capitalization Date</font><font style="letter-spacing:0.2pt;">&#8221;), there were outstanding (A)&#160;(x)&#160;97,403,364 Company Shares (145,300 of which were subject to outstanding Company Restricted Stock Awards), (y)&#160;zero (0)&#160;Company Preferred Shares, (B)&#160;816,109 Company Shares available under the Company ESPP, (C)&#160;Company Options to purchase an aggregate of 12,369,710 Company Shares, (D)&#160;Company Performance Options to purchase an aggregate of 466,000 Company Shares, (E)&#160;218,900 Company Shares were subject to outstanding Company RSU Awards and (F)&#160;17,030,075 additional Company Shares were reserved for issuance pursuant to the Company Share Plans. Except as set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(c)(i)</font><font style="letter-spacing:0.2pt;"> and for changes since the Company Capitalization Date resulting from (x)&#160;the exercise or vesting and settlement of Company Equity Awards outstanding on such date (in accordance with their existing terms in effect as of the date hereof) or issued on or after such date pursuant to the Company ESPP to the extent permitted by </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.1</font><font style="letter-spacing:0.2pt;"> or (y)&#160;the issuance of Equity Securities of the Company on or after the date hereof to the extent permitted by </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.1</font><font style="letter-spacing:0.2pt;">, there are no issued, reserved for issuance or outstanding Equity Securities of the Company. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;All outstanding Equity Securities of the Company have been, and all Equity Securities that may be issued pursuant to the Company ESPP or any other employee stock option or other compensation plan or arrangement will be, when issued in accordance with the respective terms thereof, duly authorized and validly issued, fully paid and nonassessable and free of preemptive rights. No Subsidiary of the Company owns any Equity Securities of the Company. There are no outstanding bonds, debentures, notes or other indebtedness of the Company having the right to vote (or convertible into, or exchangeable for, securities having the right to vote) on any matters on which shareholders of the Company have the right to vote. As of the date of this Agreement, other than obligations arising in the ordinary course under the Company Share Plans or Company Benefit Plans, there are no outstanding obligations of the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire any Equity Securities of the Company or its Subsidiaries. Neither the Company nor any of its Subsidiaries is a party to any agreement with respect to the voting of any Equity Securities of the Company. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;As of the date hereof, the Company has made available to Parent a true and complete list, as of the Company Capitalization Date, of all outstanding Company Equity Awards, including, the date of grant, the type of the award, the vesting schedule, whether subject to performance conditions and, for Company Performance Options, a description of such performance conditions, the number of Company Shares subject to such type of award (based on the aggregate number of shares granted on the grant date and vesting on the applicable vesting date), and, for Company Options and Company Performance Options, the applicable exercise price. As of the Company Capitalization Date, the aggregate amount of any accrued but unpaid dividend equivalent rights relating to outstanding Company Equity Awards was $0. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Corporate Authority Relative to this Agreement; No Violation</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;The Company has all requisite corporate power and authority to enter into this Agreement and, subject to receipt of the Company Shareholder Approval, to consummate the transactions contemplated hereby, including the Acquisition. The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby (including the Acquisition) have </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">been duly and validly authorized by the Company Board and, except for (A)&#160;the Company Shareholder Approval and (B)&#160;the filing of the required documents and other actions in connection with the Scheme with, and to receipt of the required approval of the Scheme by, the High Court, and the filing of the Court Order with the Registrar of Companies, no other corporate proceedings on the part of the Company are necessary to authorize the consummation of the transactions contemplated hereby (including the Acquisition). On or prior to the date hereof, the Company Board has determined that the transactions contemplated by this Agreement are fair to and in the best interests of the Company and the Company Shareholders and adopted a resolution to make, subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;"> and to the obligations of the Company Board under the Takeover Rules, the Scheme Recommendation and the recommendation contemplated by </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6(c)</font><font style="letter-spacing:0.2pt;"> in the Proxy Statement. This Agreement has been duly and validly executed and delivered by the Company and, assuming this Agreement constitutes the valid and binding agreement of Parent, constitutes the valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, subject to Equitable Exceptions. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;The execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the transactions contemplated hereby (including the Acquisition) require no action by or in respect of, Clearances of, or Filings with, any Governmental Entity other than (A)&#160;compliance with the provisions of the Act, including the sanction of the Scheme by the High Court, (B)&#160;compliance with the Takeover Panel Act and the Takeover Rules,&#160;(C)&#160;compliance with any applicable requirements of the HSR Act, (D)&#160;compliance with and Filings under any applicable Antitrust Laws of any non-U.S. jurisdictions, (E)&#160;compliance with any applicable requirements of the Securities Act, the Exchange Act and any other applicable U.S. state or federal securities laws or pursuant to the rules of the Nasdaq and (F)&#160;any other actions, Clearances or Filings the absence of which has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;Assuming compliance with the Scheme, the Act and any directions or orders of the High Court, the execution, delivery and performance by the Company of this Agreement and the consummation of the transactions contemplated hereby (including the Acquisition) do not and will not (A)&#160;contravene, conflict with, or result in any violation or breach of any provision of the Organizational Documents of the Company, (B)&#160;assuming compliance with the matters referred to in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(d)(ii)</font><font style="letter-spacing:0.2pt;"> and receipt of the Company Shareholder Approval, contravene, conflict with or result in any violation or breach of any provision of any applicable Law, (C)&#160;assuming compliance with the matters referred to in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(d)(ii)</font><font style="letter-spacing:0.2pt;"> and receipt of the Company Shareholder Approval, require any Clearance or other action by any Person under, constitute a default, or an event that, with or without notice or lapse of time or both, would constitute a default, under, or cause or permit the termination, cancellation, acceleration or other change of any right or obligation or the loss of any benefit to which the Company or any of its Subsidiaries is entitled under, any provision of any Company Permit or any Contract binding upon the Company or any of its Subsidiaries or any Clearance (including Clearances required by Contract) affecting, or relating in any way to, the assets or business of the Company and its Subsidiaries or (D)&#160;result in the creation or imposition of any Lien on any asset of the Company or any of its Subsidiaries, except, in the case of each of clauses (B)&#160;through (D), as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Reports</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;The Company has timely filed with or furnished to the SEC all reports, schedules, forms, statements, prospectuses, registration statements and other documents required to be filed with or furnished to the SEC by the Company since the Lookback Date (collectively, together with any exhibits and schedules thereto and other information incorporated therein, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company SEC Documents</font><font style="letter-spacing:0.2pt;">&#8221;). No Subsidiary of the Company is required to file any report, schedule, form, statement, prospectus, registration statement or other document with the SEC. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;As of its filing date (or, if amended or superseded by a filing prior to the date of this Agreement, on the date of such amended or superseding filing), the Company SEC Documents filed or furnished prior to the date of this Agreement complied, and each Company SEC Document </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">filed or furnished subsequent to the date of this Agreement (assuming, in the case of the Proxy Statement, that the representation and warranty set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.2(A)(d)</font><font style="letter-spacing:0.2pt;"> is true and correct) will comply, in all material respects with the applicable requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act of 2002 (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Sarbanes-Oxley Act</font><font style="letter-spacing:0.2pt;">&#8221;), as the case may be. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;As of its filing date (or, if amended or superseded by a filing prior to the date of this Agreement, on the date of such amended or superseding filing), each Company SEC Document filed or furnished prior to the date of this Agreement did not, and each Company SEC Document filed or furnished subsequent to the date of this Agreement (assuming, in the case of the Proxy Statement, that the representation and warranty set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.2(A)(d)</font><font style="letter-spacing:0.2pt;"> is true and correct) will not, contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;The Company is, and since the Lookback Date, has been, in compliance in all material respects with (A)&#160;the applicable provisions of the Sarbanes-Oxley Act and (B)&#160;all current listing and corporate governance requirements of Nasdaq. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;The Company and its Subsidiaries have established and maintain disclosure controls and procedures (as defined in Rule&#160;13a-15 under the Exchange Act). Such disclosure controls and procedures are designed to ensure that material information relating to the Company, including its consolidated Subsidiaries, is made known to the Company&#8217;s principal executive officer and its principal financial officer by others within those entities, including during the periods in which the periodic reports required under the Exchange Act are being prepared. For purposes of this Agreement, &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">principal executive officer</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">principal financial officer</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meanings given to such terms in the Sarbanes-Oxley Act. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;The Company and its Subsidiaries have established and maintain a system of internal controls over financial reporting (as defined in Rule&#160;13a-15 under the Exchange Act) (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">internal controls</font><font style="letter-spacing:0.2pt;">&#8221;) designed to provide reasonable assurance regarding the reliability of the Company&#8217;s financial reporting and the preparation of the Company&#8217;s financial statements for external purposes in accordance with GAAP. The Company&#8217;s principal executive officer and principal financial officer have disclosed, based on their most recent evaluation of such internal controls prior to the date of this Agreement, to the Company&#8217;s auditors and the audit committee of the Company Board (A)&#160;all significant deficiencies and material weaknesses in the design or operation of internal controls which are reasonably likely to adversely affect the Company&#8217;s ability to record, process, summarize and report financial information and (B)&#160;any fraud, whether or not material, that involves management or other employees who have a significant role in internal controls. The Company has made available to Parent prior to the date of this Agreement a true and complete summary of any disclosure of the type described in the preceding sentence made by management to the Company&#8217;s auditors and audit committee since the Lookback Date. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;Since the Lookback Date, each of the principal executive officer and principal financial officer of the Company (or each former principal executive officer and principal financial officer of the Company, as applicable) has made all certifications required by Rules 13a-14 and 15d-14 under the Exchange Act and Sections&#160;302 and 906 of the Sarbanes-Oxley Act and any related rules and regulations promulgated by the SEC and Nasdaq, and the statements contained in any such certifications are true and complete. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Financial Statements</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;The audited consolidated financial statements and unaudited consolidated interim financial statements of the Company included or incorporated by reference in the Company SEC Documents present fairly in all material respects, in conformity with GAAP applied on a consistent basis during the periods presented (except as may be indicated in the notes thereto), the consolidated financial position of the Company and its Subsidiaries as of the dates thereof and their consolidated results of operations and cash flows for the periods then ended (subject to normal and recurring year-end audit adjustments </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">in the case of any unaudited interim financial statements). Such consolidated financial statements have been prepared in all material respects from the books and records of the Company and its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Since the Lookback Date, the Company has not received written notice from the SEC or any other Governmental Entity indicating that any of its accounting policies or practices are or may be the subject of any review, inquiry, investigation or challenge by the SEC or any other Governmental Entity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Undisclosed Liabilities</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;There are no liabilities or obligations of the Company or any of its Subsidiaries of any kind whatsoever, whether accrued, contingent, absolute, determined, determinable or otherwise, that would be required by GAAP to be reflected on the consolidated balance sheet of the Company and its Subsidiaries, other than (i)&#160;liabilities or obligations disclosed and provided for in the Company&#8217;s consolidated balance sheet (or the notes thereto) as of June&#160;30, 2025 (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Balance Sheet</font><font style="letter-spacing:0.2pt;">&#8221;), (ii)&#160;liabilities or obligations incurred in the ordinary course of business consistent with past practice since the date of the Company Balance Sheet, (iii)&#160;liabilities arising in connection with the transactions contemplated hereby and (iv)&#160;other liabilities or obligations that have not had and would not reasonably be expected to have, individually or in the aggregate, a material effect on the Company Group. There are no off-balance sheet arrangements of any type pursuant to any off-balance sheet arrangement required to be disclosed pursuant to Item&#160;303(a)(4) of Regulation&#160;S-K promulgated under the Securities Act that have not been so described in the Company SEC Documents. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Compliance with Law; Permits</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;The Company and each of its Subsidiaries are, and since the Lookback Date have been, in compliance with all applicable Laws, except for failures to be in compliance as have not been and would not reasonably be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp; Except as has not been and would not reasonably be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole, the Company and each of its Subsidiaries hold all consents, clearances, permits, approvals, permissions, licenses, variances, exemptions, authorizations, acknowledgements, approvals and orders of any Governmental Entity necessary for the operation of its respective businesses, other than Company Regulatory Permits (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Permits</font><font style="letter-spacing:0.2pt;">&#8221;). The Company and each of its Subsidiaries are, and since the Lookback Date, have been, in compliance with the terms of the Company Permits, except for failures to be in compliance as have not been and would not reasonably be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole. There is no Action pending, or, to the knowledge of the Company, threatened, that seeks or would reasonably be expected to result in (nor is there, to the knowledge of the Company, any existing condition, situation or set of circumstances that would reasonably be expected to result in) the revocation, cancellation, termination, non-renewal or adverse modification of any Company Permit, except where such revocation, cancellation, termination, non-renewal or adverse modification has not been and would not reasonably be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Environmental Laws and Regulations</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;no written notice, notification, demand, request for information, citation, summons or order has been received, no complaint has been filed, no penalty has been assessed, and no claim, action, suit, proceeding or investigation is pending or, to the knowledge of the Company, threatened by any Governmental Entity or other Person relating to the Company or any of its Subsidiaries that relates to, or arises under, any Environmental Law, Environmental Permit or Hazardous Substance; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;the Company and its Subsidiaries are, and since the Lookback Date, have been, in compliance with all Environmental Laws and all Environmental Permits and hold all applicable Environmental Permits; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;to the Company&#8217;s knowledge, as of the date hereof, there is no existing condition, situation or set of circumstances that would reasonably be expected to result in Parent or any of its Subsidiaries incurring any liability or obligation pursuant to any applicable Environmental Laws. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Employee Benefit Plans</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(j)(i)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule sets forth a true and complete list as of the date of this Agreement of each material Company Benefit Plan. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Except with respect to a Company Benefit Plan listed on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(j)(i)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, neither the Company nor any of its Subsidiaries nor any of their respective ERISA Affiliates sponsors, maintains or contributes to (or has any obligation to contribute to), or has any current or contingent liability or obligation under or with respect to any multiemployer plan, as defined in Section&#160;3(37) of ERISA, any plan that is or was subject to Section&#160;412 or 430 of the Code or Section&#160;302 or Title IV of ERISA (each, a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Title IV Plan</font><font style="letter-spacing:0.2pt;">&#8221;), or any post-employment or post-retirement medical, dental, disability, hospitalization, life or similar welfare benefits (whether insured or self-insured) to any director, officer, employee or individual independent contractor (including any former director, officer, employee or individual independent contractor) of the Company or any of its Subsidiaries or any of their respective survivors, dependents or beneficiaries or any other Person (other than coverage mandated by applicable Law for which the covered Person pays the full cost of coverage). Except as specifically described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(j)(ii)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, and except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect with respect to each Title IV Plan: (A)&#160;no reportable event (within the meaning of Section&#160;4043 of ERISA) has occurred within the last three (3)&#160;years, or, to the knowledge of the Company, is expected to occur whether as a result of the transactions contemplated by this Agreement or otherwise; (B)&#160;the minimum funding standard under Section&#160;430 of the Code has been satisfied and no waiver of any minimum funding standard or extension of any amortization periods has been requested or granted; (C)&#160;all contributions required under Section&#160;302 of ERISA and Section&#160;412 of the Code have been timely made; (D)&#160;all amounts due to the Pension Benefit Guaranty Corporation (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">PBGC</font><font style="letter-spacing:0.2pt;">&#8221;) pursuant to Section&#160;4007 of ERISA have been timely paid; (E)&#160;with respect to each Title IV Plan for which there has been a significant reduction in the rate of future benefit accrual as referred to in Section&#160;204(h) of ERISA, the requirements of Section&#160;204(h) of ERISA have been complied with; (F)&#160;no liability under Title IV of ERISA has been incurred by the Company, its Subsidiaries or any ERISA Affiliate that has not been satisfied in full; (G)&#160;there has been no event described in Section&#160;4062(e) of ERISA, and the transactions contemplated by this Agreement will not result in any event described in Section&#160;4062(e) of ERISA; (H)&#160;to the knowledge of the Company, no event has occurred or circumstances exist that could result in a liability under or with respect to Section&#160;4069 of ERISA; and (I)&#160;no notice of intent to terminate any Title IV Plan has been filed and no amendment to treat a Title IV Plan as terminated has been adopted and no proceeding has been commenced by the PBGC to terminate any Title IV Plan. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;Except as has not been, and would not reasonably be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole, each Company Benefit Plan that is intended to be qualified under Section&#160;401(a) of the Code has received a current favorable determination from the Internal Revenue Service or may rely upon a current opinion or advisory letter from the Internal Revenue Service and, no circumstances exist that would reasonably be expected to result in any such letter being revoked or not being reissued. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;Except as has not been, and would not reasonably be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole: (1)&#160;each Company Benefit Plan has been established, maintained, funded, and administered in accordance with its terms and in compliance with all applicable Laws, including ERISA and the Code; (2)&#160;no Action (other than routine claims for benefits) is pending or, to the Company&#8217;s knowledge, is threatened against, with respect to any Company Benefit Plan; (3)&#160;there has been no &#8220;prohibited transaction&#8221; within the meaning of Section&#160;4975 of the Code or Section&#160;406 of ERISA and no breach of fiduciary duty (as determined under ERISA) has occurred with respect to any Company Benefit Plan; (4)&#160;all contributions (including all employer contributions and employee salary reduction contributions), distributions, reimbursements and premium payments that are due have been timely made in accordance with the terms of the Company Benefit Plan and the requirements of applicable Law; (5)&#160;all Company Benefit Plans that are required to be funded are fully funded, and amounts have been accrued for any unfunded Company Benefit Plans to the extent required under applicable international accounting standards; (6)&#160;no events have occurred with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">respect to any Company Benefit Plan that would reasonably be expected to result in the assessment of any excise Taxes or penalties against the Company or any of its Subsidiaries; and (7)&#160;neither the Company nor any of its Subsidiaries has incurred (whether or not assessed), or is reasonably expected to incur or to be subject to, any Tax or other penalty with respect to the reporting requirements under Sections&#160;6055 and 6056 of the Code, as applicable, or under Section&#160;4980B, 4980D or 4980H of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;Except as described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(j)(v)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, with respect to each Covered Individual, neither the execution and the delivery of this Agreement nor the consummation of the transactions contemplated hereby could (either alone or together with any other event), directly or indirectly: (A)&#160;result in any payment or benefit or increased payment or benefit (including any bonus, retention, severance, retirement or job security payment or benefit or otherwise) or (B)&#160;accelerate the time of payment or vesting or trigger any payment or obligation to fund (through a grantor trust or otherwise) or otherwise set aside assets to secure to any extent any compensation or benefits under, or increase the amount payable or trigger any other obligation under, any Company Benefit Plan or otherwise. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;Except as described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(j)(vi)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby will result in any amount paid or payable by the Company or any of its Subsidiaries that could, individually or with any other such payment, be classified as an &#8220;excess parachute payment&#8221; within the meaning of Section&#160;280G of the Code not deductible by the Company or any of its Subsidiaries under Section&#160;280G of the Code or result in any excise Tax on any Covered Individual under Section&#160;4999 of the Code. Neither the Company nor any of its Subsidiaries has any obligation to gross-up, indemnify or otherwise reimburse any Person for any Tax incurred by such Person, including under Section&#160;409A or 4999 of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;Each Company Benefit Plan that constitutes a &#8220;nonqualified deferred compensation plan&#8221; (within the meaning of Section&#160;409A of the Code) has been operated and maintained, in form and operation, in all material respects in accordance with all applicable requirements of Section&#160;409A of the Code and all applicable guidance of the Department of Treasury and Internal Revenue Service. No amount under any Company Benefit Plan is subject to the interest and additional tax set forth under Section&#160;409A(a)(1)(B) of the Code. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Absence of Certain Changes or Events</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Since December&#160;31, 2024, through the date hereof, the business of the Company and its Subsidiaries has been conducted in all material respects in the ordinary course of business consistent with past practice. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Since December&#160;31, 2024, there has not been any event, effect, development, occurrence or change that has had, or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Investigations; Litigation</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;As of the date hereof, there is no Action pending or, to the knowledge of the Company, threatened against or affecting the Company or any of its Subsidiaries, any present or former officers, directors or employees of the Company or any of its Subsidiaries in their respective capacities as such, or any of the respective properties or assets of the Company or any of its Subsidiaries, before (or, in the case of threatened Actions, that would be before) any Governmental Entity (i)&#160;that has been or would reasonably be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole or (ii)&#160;that would reasonably be expected to materially impair or delay the Company&#8217;s ability to perform its obligations under this Agreement or consummate any of the transactions contemplated hereby. As of the date hereof, there is no Order outstanding or, to the knowledge of the Company, threatened against or affecting the Company, any of its Subsidiaries, any present or former officers, directors or employees of the Company or any of its Subsidiaries in their respective capacities as such, or any of the respective properties or assets of any of the Company or any of its Subsidiaries, that has been or would reasonably be expected to be, individually or in the aggregate, material to the Company </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Group, taken as a whole or that would reasonably be expected to materially impair or delay the Company&#8217;s ability to perform its obligations under this Agreement or consummate any of the transactions contemplated hereby. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Except as described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(l)(ii)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, there are no fees, costs and expenses (including attorneys&#8217; fees and expenses) incurred or accrued, whether before or after the date hereof, by the Company and its Affiliates in prosecuting, defending and settling any and all claims, counterclaims and defenses asserted (whether on or after the date hereof) in </font><font style="font-style:italic;letter-spacing:0.2pt;">Avadel CNS Pharmaceuticals, LLC v. Jazz Pharmaceuticals, Inc.</font><font style="letter-spacing:0.2pt;">, No. 1:22-cv-00941 (D. Del.) (including defending against any claims brought by Jazz Pharmaceuticals, Inc. or its Affiliates), including amounts paid or payable in settlement or in judgment of any such claims against the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(m)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Information Supplied</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The information relating to the Company and its Subsidiaries to be contained in the Scheme Document, the Proxy Statement and any other documents filed or furnished with or to the High Court, the SEC, the Panel or pursuant to the Act and the Takeover Rules in each case in connection with the Acquisition will not, on the date the Scheme Document and the Proxy Statement (and any amendment or supplement thereto) is first proposed to Company Shareholders and at the time of the Court Meeting, contain any untrue statement of any material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, at the time and in light of the circumstances under which they were made, not false or misleading. The Proxy Statement and any related documents will comply in all material respects as to form with the requirements of the Exchange Act and the rules and regulations promulgated thereunder. The parts of the Scheme Document and any related documents for which the Company Directors are responsible under the Takeover Rules and any related filings for which the Company Directors are responsible under the Takeover Rules will comply in all material respects as to form with the requirements of the Takeover Rules and the Act. Notwithstanding the foregoing provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(m)</font><font style="letter-spacing:0.2pt;">, no representation or warranty is made by the Company with respect to information or statements made or incorporated by reference in the Scheme Document or the Proxy Statement which were not supplied by or on behalf of the Company. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(n)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Regulatory Matters</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Each Company Product is being, and since the Lookback Date has been, manufactured and commercialized, as applicable, and each member of the Company Group is, and since the Lookback Date has been, in material compliance with all applicable Laws governing the Company Group, as such Laws pertain to the Company Group, including any and all Healthcare Laws. Neither Company nor any of its Subsidiaries has received written notice of any pending or threatened Action, and there is not pending any allegation or investigation by any Governmental Entity that any operation or activity of Company or any of its Subsidiaries is in violation of any Healthcare Laws, except where such violation has not been, and would not reasonable be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole. Neither the Company nor any of its Subsidiaries is party to any material corporate integrity agreements, monitoring agreements, deferred prosecution agreements, consent decrees, settlement orders, corrective action plans, or similar agreements, obligations, or Orders with or imposed by any Governmental Entity and, to Company&#8217;s knowledge, no such agreement, decree or order is currently contemplated, proposed, or pending. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Except as has not been, and would not reasonably be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole, each Company Product is being or since the Lookback Date has been developed, manufactured, stored, distributed or marketed, where applicable, in compliance with all applicable Laws administered, issued, or enforced by the applicable Company Regulatory Agencies, including those relating to investigational use, marketing approval, current good manufacturing practices, packaging, labeling, advertising, record keeping, reporting, and security. There is no Action pending or, to the knowledge of the Company, threatened, including any prosecution, injunction, seizure, civil fine, debarment, suspension or recall, in each case alleging any violation applicable to any Company Product by the Company or any of its Subsidiaries of any applicable regulatory Law, except as has not been, and would not reasonably be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;Since the Lookback Date, Company has filed, maintained or furnished all material applications, reports (including adverse experience reports and annual reports), documents, claims, Governmental Authorizations, amendments, modifications and notices required to be filed, maintained or furnished to the FDA, DEA or any other Company Regulatory Agency in connection with the Company Products or the Company. All such applications, reports, documents, claims, Company Regulatory Permits, amendments, modifications and notices were complete and accurate in all material respects on the date filed (or were corrected in or supplemented by a subsequent filing). Any material updates, changes, corrections or modifications to such documents required under applicable Law or Order have been submitted in a timely and complete manner. The Company holds all Company Regulatory Permits required for the Company business as currently conducted, and each such Company Regulatory Permit is valid and in full force and effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;To Company&#8217;s knowledge, all nonclinical studies and clinical trials, and other studies and tests, with respect to any Company Product have been conducted in material compliance with all applicable protocols, procedures, Company Regulatory Permits and Laws, including the FDCA, CSA, and other Healthcare Laws. To Company&#8217;s knowledge, no clinical trial with respect to any Company Product has been terminated or suspended prior to completion, and neither the FDA nor any other applicable Governmental Entity, clinical investigator or contract research organization that has participated or is participating in, or institutional review board that has or has had jurisdiction over, a clinical trial with respect to any Company Product has commenced, or threatened to initiate, any action to place a clinical hold order on, or otherwise terminate or suspend, any proposed or ongoing clinical trial, or alleged any material violation of any Healthcare Laws in connection with any such clinical trial. To the extent required by applicable Laws, the clinical studies conducted by or on behalf of the Company have been registered on, and trial results have been reported on, the United States National Institutes of Health Website, www.clinicaltrials.gov, in accordance with 42 U.S.C. &#167;&#160;282(j), or in accordance with any other applicable Healthcare Laws. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;Company has made available to Parent all internal and third party audits and audits by a Company Regulatory Agency related to compliance with applicable requirements by Company with respect to the Company Products in the possession, custody or control of Company or any of its Subsidiaries that report material non-compliance of any such applicable requirements. Company has made available to Parent accurate and complete copies of all material correspondence, minutes of meetings, memoranda of meetings, or material regulatory contacts with a Governmental Entity that concerns any Company Product or the Company business in the possession, custody or control of Company. To Company&#8217;s knowledge, all information, reports, statistics, and other data, if any, submitted in connection with each investigational new drug application (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">IND</font><font style="letter-spacing:0.2pt;">&#8221;), new drug application (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">NDA</font><font style="letter-spacing:0.2pt;">&#8221;) or similar regulatory submission or Company Regulatory Permit were true, complete and correct in all material respects as of the date of submission, and no material updates, changes, corrections, supplements, amendments or modifications necessary to such IND, NDA or such submission or Company Regulatory Permit have failed to be submitted to the FDA or applicable Governmental Entity since the Lookback Date. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;Since the Lookback Date, neither Company nor any of its subsidiaries has been convicted of, charged with, or is subject to any investigation that is pending and of which Company Group has been notified in writing or, to Company&#8217;s knowledge, which has been threatened, in each case by (i)&#160;any Governmental Entity or (ii)&#160;the U.S. Department of Health and Human Services Office of Inspector General or Department of Justice pursuant to any Healthcare Law, including the U.S. Federal Healthcare Program Anti-Kickback Statute (42 U.S.C. &#167;1320a-7b(b)) or the U.S. Federal False Claims Act&#160;(31 U.S.C.&#160;&#167;3729) or comparable non-U.S. statute with respect to the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;Since the Lookback Date, neither the Company nor any of its Subsidiaries, nor, to the knowledge of the Company, any officer, employee, agent or distributor of the Company or any of its Subsidiaries, has made an untrue statement of a material fact or a fraudulent statement to the FDA or any other Company Regulatory Agency, failed to disclose a material fact required to be disclosed to the FDA or any other Company Regulatory Agency, or committed an act, made a statement, or failed to make a statement, in each such case, related to the business of the Company or any of its Subsidiaries, that, at the time such disclosure was made, would reasonably be expected to provide a basis for the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">FDA to invoke its policy respecting &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#8221;, set forth in 56 Fed. Reg. 46191 (September&#160;10, 1991) or for any other Company Regulatory Agency to invoke any similar policy, except for any act or statement or failure to make a statement that has not been, and would not reasonably be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(viii)&nbsp;&nbsp;&nbsp;To Company&#8217;s knowledge, neither Company nor any Subsidiary has been, or is, or is employing or utilizing the services of any individual who has been (i)&#160;debarred or excluded from participating in any federal or state healthcare programs or is listed on the U.S. General Services Administration/System for Award Management or the Department of Health and Human Services Office of Inspector General excluded individuals and entities listings or on any FDA debarment list; or (ii)&#160;convicted under any criminal Laws or engaged in any conduct that would reasonably be expected to result in (A)&#160;debarment under 21 U.S.C. &#167;335a or any similar state or foreign applicable Law or (B)&#160;exclusion under 42 U.S.C. &#167;1320a-7 or any similar state or foreign applicable Law; nor has Company received written notice of an impending or potential exclusion, debarment or listing. Company and its Subsidiaries have in place current agreements for the marketed Company Products to participate in federal healthcare programs in the U.S. and similar programs under the Laws in any other country or jurisdiction in where Company Products are commercialized and is in compliance with all such agreements. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ix)&nbsp;&nbsp;&nbsp;Except as set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(n)(ix)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, since the Lookback Date, Company has not received any FDA Form 483 or other notice of inspectional observations or adverse findings, Warning Letter, Untitled Letter, Letter of Admonition, Order to Show Cause, or similar written correspondence or notice from the FDA, DEA, or other Company Regulatory Agency alleging or asserting material noncompliance with any applicable Healthcare Law or Company Regulatory Permits. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(x)&nbsp;&nbsp;&nbsp;Except as set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(n)(x)</font><font style="letter-spacing:0.2pt;">, since the Lookback Date, neither the Company nor any of its Subsidiaries has voluntarily or involuntarily initiated, conducted or issued, or caused to be initiated, conducted or issued, any material recall, field correction, market withdrawal or replacement, safety alert, &#8220;dear doctor&#8221; letter, investigator notice, or other notice or action to wholesalers, distributors, retailers, healthcare professionals or patients relating to an alleged lack of safety, efficacy or regulatory compliance of any Company Product, including any facilities where any such products are produced, processed, packaged or stored, other than notices or actions that are not, individually or in the aggregate, material to the Company and its Subsidiaries, taken as a whole. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xi)&nbsp;&nbsp;&nbsp;To the knowledge of the Company, and since the Lookback Date, there are no facts as of the date hereof which are reasonably likely to cause, and neither the Company nor any of its Subsidiaries has received any written notice from the FDA, any other Company Regulatory Agency, or any third party that provides or supports healthcare-related coverage (including, but not limited to, any health insurer, public or private payor, third-party administrator, pharmacy benefit manager, broker or agent) regarding, (i)&#160;the recall, market withdrawal or replacement of any Company Product sold or intended to be sold by the Company or its Subsidiaries (other than recalls, withdrawals or replacements that are not material to the Company or its Subsidiaries, taken as a whole), (ii)&#160;a material change in the marketing classification or a material change in the labeling of any such Company Products, (iii)&#160;a termination or suspension of the manufacturing, marketing, or distribution of such Company Products, or (iv)&#160;a material negative change in reimbursement or coverage status of a Company Product. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xii)&nbsp;&nbsp;&nbsp;Since the Lookback Date, the Company and its Subsidiaries have been in compliance in all material respects with all applicable Healthcare Laws. The Company and its Subsidiaries maintain a compliance program having the elements of an effective corporate compliance and ethics program identified in U.S.S.G. &#167;&#160;8B2.1 in all material respects that (i)&#160;governs all employees and contractors; (ii)&#160;is consistent with the current guidance from the United States Department of Justice on Evaluation of Corporate Compliance Programs, and General Compliance Program Guidance issued by the U.S. Department of Health and Human Services Office of Inspector General; (iii)&#160;is consistent with the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals; and (iv)&#160;includes reasonably appropriate policies, procedures, and trainings, designed to promote compliance with applicable Healthcare Laws and industry codes and standards. Company and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">its subsidiaries operate in material compliance with such healthcare compliance program. There are no outstanding compliance complaints or reports, ongoing internal compliance investigations, or outstanding compliance corrective actions, except where such complaints, reports, investigations, or corrective actions have not been, and would not reasonably be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiii)&nbsp;&nbsp;&nbsp;Except as set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(n)(xiii)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, neither Company nor any of its Subsidiaries has received from DEA any notice of material noncompliance with the federal CSA, adverse findings with respect to any Company Product, including any Order to Show Cause, inspectional observations, notices of violations, letters of admonition, Memorandum of Agreements, civil complaints or notice of demand for civil penalties, criminal proceeding notices pursuant to the CSA or regulations promulgated by DEA or any other similar communication from any Company Regulatory Agency. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiv)&nbsp;&nbsp;&nbsp; As of the Effective Date, the following documents, reports, filings, data, information, audits, regulatory documentation and correspondence will be available, accessible and downloadable by Parent from IT Assets in the possession, custody or control of the Company: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp;each annual report and each other material report and filing submitted by Company or its Subsidiaries to the FDA or any similar state or non-U.S. Governmental Entity with respect to each Company Product or the Company business; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(B)&nbsp;&nbsp;&nbsp;in an accurate and complete manner, all clinical data from completed clinical trials (including all adverse events, patient complaints, and medical incident reports) regarding the Company Products in the possession, custody or control of Company or its Subsidiaries; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(C)&nbsp;&nbsp;&nbsp;all internal and third party audits and audits by a Company Regulatory Agency related to compliance with applicable requirements by Company with respect to the Company Products in the possession, custody or control of Company or its Subsidiaries; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(D)&nbsp;&nbsp;&nbsp;accurate and complete copies of (A)&#160;each IND and each similar non-U.S. regulatory submission, including all related supplements and amendments, (B)&#160;each NDA and each similar non-U.S. regulatory submission, including all related supplements and amendments and (C)&#160;each Company Regulatory Permit which, in each case of clauses (A)&#8201;&#8211;&#8201;(C), concerns any Company Product or the Company in the possession, custody or control of Company or its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(o)&nbsp;&nbsp;&nbsp; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Tax Matters</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;All income and other material Tax Returns that are required to be filed by, or on behalf of the Company and its Subsidiaries have been timely filed with the appropriate Tax Authority on or before the applicable due date (taking into account any valid extensions of such due date), and all such Tax Returns are true, accurate and complete in all material respects. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;The Company and its Subsidiaries have, within the time and manner prescribed by applicable Law, paid all material Taxes required to be paid by them, including all material Taxes required to be withheld from amounts owing to any employee, creditor or third party (in each case, whether or not shown on any Tax Return). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;All material Taxes of the Company and its Subsidiaries due and payable (whether or not shown on any Tax Return) have been timely paid by the Company and its Subsidiaries, as applicable. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;The Company and its Subsidiaries have made provision for all material Taxes payable by the Company and its Subsidiaries for which no Tax Return has yet been filed. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;There are no Liens for Taxes (other than Permitted Liens) upon any property or assets of the Company or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;No material deficiency for any Tax has been asserted, threatened in writing or assessed by a Tax Authority against the Company or any of its Subsidiaries which deficiency has not been paid when due, settled or withdrawn. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries is a party to any agreement or arrangement relating to the apportionment, sharing, assignment or allocation of Taxes (other than (x)&#160;an agreement or arrangement solely between or among the Company or one or more of its Subsidiaries or (y)&#160;customary Tax indemnification provisions in ordinary course commercial agreements that are not primarily related to Taxes), or has any liability for Taxes of any Person (other than the Company or any of its Subsidiaries) under Treasury Regulations&#160;Section&#160;1.1502-6 (or any similar provision of state, local or non-U.S. Law) or as a transferee or successor. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(viii)&nbsp;&nbsp;&nbsp;No claim has been made in writing by a Tax Authority against the Company or any of its Subsidiaries in a jurisdiction where the Company or such Subsidiary does not file Tax Returns that such Person is or may be subject to any material Tax by such jurisdiction. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ix)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has entered into any &#8220;listed transaction&#8221; within the meaning of Treasury Regulations&#160;Section&#160;1.6011-4(b), or any similar provision of state, local or non-U.S. Law. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(x)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries will be required to include any material item of income in, or exclude any material item of deduction from, Taxable income (including any Company or Subsidiary item that may be included in the computation of the Taxable income of Parent or any of its Affiliates) for any period (or portion thereof) ending after the Completion Date as a result of (A)&#160;a change in method of accounting pursuant to Section&#160;481 of the Code (or any corresponding or similar provision of state, local or non-U.S. Tax Law) made prior to the Completion Date, (B)&#160;a &#8220;closing agreement&#8221; as described in Section&#160;7121 of the Code (or any corresponding or similar provision of state, local or non-U.S. Tax Law) or other binding written agreement with any Tax Authority or any Tax sharing, allocation or similar agreement executed prior to the Completion Date, (C)&#160;an installment sale or open transaction disposition made prior to the Completion Date or (D)&#160;any prepaid amount received prior to the Completion Date. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xi)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has been a member of any consolidated, combined, affiliated, unitary or similar group of companies for any Tax purposes (other than a group the common parent of which was the Company). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xii)&nbsp;&nbsp;&nbsp;Within the past two (2)&#160;years, neither the Company nor any of its Subsidiaries has constituted a &#8220;distributing corporation&#8221; or a &#8220;controlled corporation&#8221; &#8203;(within the meaning of Section&#160;355(a)(l)(A) of the Code) in a distribution of stock intended to qualify for tax-free treatment under Section&#160;355 of the Code (or any similar provision of state, local or non-U.S. Law). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiii)&nbsp;&nbsp;&nbsp;Except to the extent otherwise listed on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(o)(xiii)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, each of the Company and its Subsidiaries is, and at all times since its formation has been, properly treated as a foreign corporation for U.S. federal income Tax purposes. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiv)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has a permanent establishment in any country other than its jurisdiction of formation. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xv)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries is subject to any material private letter ruling of the IRS or comparable rulings of any Tax Authority. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xvi)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, neither the Company nor any of its Subsidiaries has requested any extension of time within which to file any Tax Return, which Tax Return has since not been filed (other than extensions requested in the ordinary course of business). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xvii)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries is the beneficiary Tax exemption, Tax holiday or other Tax reduction agreement or order of any Tax Authority. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xviii)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its non-U.S. subsidiaries are treated as domestic corporations or surrogate foreign corporations under Section&#160;7874 of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xix)&nbsp;&nbsp;&nbsp;As used in this Agreement, (A)&#160;the term &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Tax</font><font style="letter-spacing:0.2pt;">&#8221; &#8203;(including the plural form &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Taxes</font><font style="letter-spacing:0.2pt;">&#8221; and, with correlative meaning, the terms &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Taxable</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Taxation</font><font style="letter-spacing:0.2pt;">&#8221;) means any and all taxes (including customs duties or fines), fees, levies, imposts, duties or other similar assessments in the nature of a tax, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">imposed by or payable to any federal, state, provincial, local or non-U.S. Tax Authority, and includes all U.S. federal, state, local and non-U.S. gross or net income, gain, profits, windfall profits, franchise, gross receipts, estimated, capital, documentary, transfer, ad valorem, premium, environmental, customs duty, capital stock, severances, stamp, payroll, sales, employment, unemployment compensation, social security, disability, use, property, unclaimed property, withholding or backup withholding, excise, production, value added and occupancy taxes, together with all interest, penalties and additions imposed with respect thereto, (B)&#160;the term &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Tax Return</font><font style="letter-spacing:0.2pt;">&#8221; means all returns and reports (including elections, declarations, disclosures, schedules, notices, notifications, forms, certificates, estimates, claims for refunds and information returns) filed or required to be filed with a Tax Authority relating to Taxes, including all attachments thereto and any amendments or supplements thereof and (C)&#160;the term &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Tax Authority</font><font style="letter-spacing:0.2pt;">&#8221; means any Governmental Entity responsible for the assessment, collection or enforcement of Laws relating to Taxes (including the United States Internal Revenue Service (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">IRS</font><font style="letter-spacing:0.2pt;">&#8221;) and the Irish Revenue Commissioners and any similar state, local, or non-U.S. revenue agency). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(p)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Labor Matters</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;No member of the Company Group is a party to, or bound by, any collective bargaining agreement, Contract or other agreement or binding understanding with a labor union, labor organization, works council, or similar employee representative. No member of the Company Group is or, since the Lookback Date, has been subject to a labor dispute, strike or work stoppage except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. To the knowledge of the Company, there are and, since the Lookback Date, there have been no organizational efforts with respect to the formation of a collective bargaining unit being made or threatened to be made involving employees of the Company Group, except for those the formation of which has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;The Company has made available to Parent a schedule listing each of the employees of the Company Group as of the date hereof, together with each such employee&#8217;s (1)&#160;name (to the extent permitted by applicable Law) or anonymous identifier, (2)&#160;employer, (3)&#160;base salary or hourly wage, (4)&#160;title, (5)&#160;start date, (6)&#160;location, (7)&#160;whether full- or part-time, (8)&#160;whether active or on leave (and, if on leave, the nature of the leave and the expected return date), and (9)&#160;whether exempt from the Fair Labor Standards Act, which schedule will be updated within ten (10) Business Days prior to the Effective Time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;The transactions contemplated by this Agreement will not require the consent of, or advance notification to, any works councils, unions or similar labor organizations with respect to any employees of the Company Group, except for where the failure to obtain any such consent or make any such advance notifications (A)&#160;has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect or (B)&#160;would not materially delay or frustrate the consummation of the transactions contemplated hereby (including the Acquisition). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;Each member of the Company Group is and, since the Lookback Date, has been in compliance, in all material respects, with all Laws relating to labor and employment, including all such Laws relating to wages and hours (including minimum wage and overtime wages), human rights, discrimination, harassment, retaliation, pay equity, employment equity, paid sick days/leave entitlements and benefits, family and medical leave and other leaves of absence (including the federal Emergency Family and Medical Leave Expansion Act), workers&#8217; compensation, safety and health, immigration and work authorization (including with respect to the completion of Forms I-9 for all employees and the proper confirmation of employee visas), worker classification (including with respect to employee-independent contractor classification and the proper classification of employees as exempt employees and non-exempt employees), plant closures and layoffs (including the Worker Adjustment and Retraining Notification of 1988, as amended, and any similar foreign, state, provincial or local &#8220;mass layoff&#8221; or &#8220;plant closing&#8221; Laws (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">WARN</font><font style="letter-spacing:0.2pt;">&#8221;)), terms and conditions of employment, whistleblowing, disability rights or benefits, employee trainings and notices, labor relations, employee leave issues, and unemployment insurance. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;There has been no &#8220;mass layoff&#8221; or &#8220;plant closing&#8221; &#8203;(as defined by WARN or any similar foreign, state, provincial or local Laws) with respect to the Company or its Subsidiaries between the Lookback Date, and the date of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp; All employees employed in the United States are employed on an &#8220;at-will&#8221; basis and their employment can be terminated at any time for any reason without any material amounts being owed to such individual other than with respect to wages accrued before termination, other amounts ordinarily due on termination, and severance under Company Benefits Plans disclosed on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(j)(i)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule or amounts required by applicable Law. The relationships with all individuals engaged directly by the Company who act on their own as contractors or as other service providers can be terminated for any reason with no greater than sixty (60) days&#8217; prior written notice, without any material amounts being owed to such individuals, other than with respect to payments earned before the notice of termination. As of the date hereof, no employee is on disability or other leave of absence, other than short-term absences of less than three (3)&#160;weeks. Except as disclosed on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(j)(vi)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, no member of the Company Group sponsors any employee for, or otherwise knowingly engages any employee working pursuant to, a visa. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;Since the Lookback Date, each member of the Company Group has reasonably investigated all sexual harassment and other discrimination, retaliation or material policy violation allegations relating to its employees, of which it is aware. With respect to each such allegation with potential merit, each of the Company and its Subsidiaries have taken prompt corrective action that the Company or such Subsidiary has determined is reasonably calculated to prevent further improper action. No member of the Company Group reasonably expects any material liabilities with respect to any such allegations and is not aware of any allegations relating to officers, directors, employees, contractors or agents of the Company Group, that, if known to the public, would bring the Company Group into material disrepute. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(q)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Intellectual Property</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(q)(i)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule contains a complete and accurate list of all registrations (including for patents, trademarks, copyrights and domain names) and applications for registration for Owned Intellectual Property or for material Licensed Intellectual Property that is exclusively licensed to the Company or any of its Subsidiaries (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Registered IP</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Except as has not been, and would not reasonably be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole: (1)&#160;none of the Company Registered IP has lapsed, expired, or been cancelled or abandoned and (2)&#160;the Company Intellectual Property has not been adjudged invalid or unenforceable, and, to the knowledge of the Company, is valid and enforceable. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;Except for such failures of each of the following clauses (1)&#160;through (3)&#160;to be true and correct as have not been, and would not reasonably be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole, (1)&#160;members of the Company Group solely and exclusively own all right, title and interest in and to the Owned Intellectual Property and hold all of their right, title and interest in and to all of the Owned Intellectual Property free and clear of all Liens (other than non-exclusive licenses granted by Company or one of its Subsidiaries in the ordinary course of business and other Permitted Liens), (2)&#160;the Owned Intellectual Property and the Licensed Intellectual Property include all of the Intellectual Property necessary to conduct the respective businesses of the Company Group as currently conducted, and as currently contemplated to be conducted in the ordinary course of business (it being understood that this clause (2)&#160;does not constitute a representation as to absence of infringement which is addressed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(q)(iv)</font><font style="letter-spacing:0.2pt;"> below), and (3)&#160;there exist no material restrictions on the use of any of the Owned Intellectual Property. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;Except for such failures of each of the following clauses (1)&#160;through (3)&#160;to be true and correct as have not been, and would not reasonably be expected to be, individually or in the aggregate, material to the Company Group taken as a whole, (1)&#160;neither the Company nor any of its Subsidiaries nor the conduct of their respective businesses nor any Company Product has infringed, misappropriated, diluted or otherwise violated any Intellectual Property rights of any Third Party, (2)&#160;there is no claim, action, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">suit, investigation or proceeding pending or, to the knowledge of the Company, threatened against or affecting the Company or any of its Subsidiaries, and, since the Lookback Date, no member of the Company Group has received any written notice of such a claim, action, suit, investigation, proceeding or threat (A)&#160;alleging that the Company or any of its Subsidiaries or any Company Product has infringed, misappropriated, diluted or otherwise violated any Intellectual Property rights of any Third Party or (B)&#160;based upon, or challenging or seeking to deny or restrict, the rights of the Company or any of its Subsidiaries in any Company Intellectual Property (including any challenges to the validity, enforceability, registrability, ownership or use of any Company Intellectual Property) and (3)&#160;to the knowledge of the Company, no Third Party has infringed, misappropriated, diluted or otherwise violated any Company Intellectual Property. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;The Company Group has taken commercially reasonable measures to maintain the confidentiality of the Trade Secrets included in the Owned Intellectual Property. To the knowledge of the Company, such Trade Secrets included in the Owned Intellectual Property that are material have not been disclosed to any Person except pursuant to written non-disclosure agreements or in forms that have previously been disclosed to Parent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;The Company Group has obtained from all parties (including current or former employees, officers, directors, consultants and contractors) who have created or developed (or are creating or developing) Intellectual Property for or on behalf of the Company Group, written, valid and enforceable non-disclosure and assignment-of-rights agreements for the benefit of the Company Group pursuant to which each such party presently assigns to the Company or one of its Subsidiaries all rights, including Intellectual Property rights, in work product created by such party in connection with such party&#8217;s employment, engagement or other affiliation with the Company Group, except with respect to any Intellectual Property that is not material to the conduct of the Company Group&#8217;s business as currently conducted (including research of products in development). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;Each member of the Company Group has complied in all material respects with any and all obligations to the extent applicable pursuant to the Bayh-Dole Act, 35 U.S.C. &#167;&#160;200-212, or other similar obligations under the Laws of any jurisdiction, including with respect to any patents that are part of the Company Intellectual Property. Except as identified on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(q)(vii)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, no funding, facilities, personnel or other resources of any Governmental Entity, university, college, educational institution, research institution or center or other private funding agency were used in the development of any material owned or exclusively licensed Company Intellectual Property, and no Governmental Entity, university, college, educational institution, research institute or center or other private funding agency has any right in or to such Intellectual Property. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(viii)&nbsp;&nbsp;&nbsp;Each member of the Company Group complies and, since the Lookback Date, has at all times complied with the Data Privacy Requirements in all material respects, and since the Lookback Date, no member of the Company Group (or, to the knowledge of the Company, any Person Processing or that has Processed Personal Data on behalf of any member of the Company Group) has: (1)&#160;been subject to any breach, loss, destruction or damage of, unlawful or unauthorized disclosure, use or access to, Personal Data that has given rise to a legal obligation to notify any Person or Governmental Entity; or (2)&#160;received or been subject to any written claim, action, suit, investigation, proceeding complaint, notice or dispute with or by any Person (including any Governmental Entity) in relation to its compliance with the Data Privacy Requirements, and, to the knowledge of the Company, there are no circumstances likely to give rise to any such event. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ix)&nbsp;&nbsp;&nbsp;The Company and its Subsidiaries, where required by the Data Privacy Requirements, provide reasonable notice of their Personal Data Processing on their websites and, to the knowledge of the Company, other customer and public communications and during the past three&#160;years, the Company and its Subsidiaries have complied in material respects with such policies. Neither this Agreement nor the consummation of the transactions contemplated hereby (including the Acquisition) will violate any Data Privacy Requirements in any material respect; and the Company and its Subsidiaries have taken commercially reasonable steps consistent with commercially reasonable industry practice designed to protect the Personal Data that they process against loss and unauthorized access, use, modification, disclosure or other misuse. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">(x)&nbsp;&nbsp;&nbsp;Except as has not been, and would not reasonably be expected to be material to the Company Group, taken as a whole, (1)&#160;the IT Assets operate in accordance with their specifications and related documentation and perform in a manner that permits the Company Group to conduct its business as currently conducted, (2)&#160;each member of the Company Group takes commercially reasonable actions, consistent with current industry standards, designed to protect the confidentiality, integrity and security of the IT Assets (and all data and other information and transactions stored or contained therein or processed or transmitted thereby) against any unauthorized use, access, interruption, modification or corruption, including the implementation of commercially reasonable data backup, disaster avoidance and recovery procedures and business continuity procedures, (3)&#160;(x)&#160;there has been no unauthorized use or access or security breaches, or interruption, modification, loss or corruption of any of the IT Assets (or any data or other information or transactions stored or contained therein or processed or transmitted thereby) (y)&#160;the IT Assets have not malfunctioned or failed (except for malfunctions or failures that have been fully remediated and did not give rise to material liability to the Company) and (z)&#160;the IT Assets are free from bugs and other defects and do not contain any &#8220;virus,&#8221; &#8220;worm,&#8221; &#8220;spyware,&#8221; &#8220;ransomware,&#8221; or other malicious Software. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">(r)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Real Property</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries owns any real property. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i)&#160;each lease, sublease or license (each, a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Lease</font><font style="letter-spacing:0.2pt;">&#8221;) under which the Company or any of its Subsidiaries leases, subleases or licenses any real property is, subject to the Equitable Exceptions, a valid and binding obligation of the Company or a Subsidiary of the Company (as the case may be) and, to the knowledge of the Company, each of the other parties thereto, and in full force and effect and enforceable in accordance with its terms against the Company or its Subsidiaries (as the case may be) and, to the knowledge of the Company, each of the other parties thereto (except for such Leases that are terminated after the date of this Agreement in accordance with their respective terms, other than as a result of a default or breach by the Company or any of its Subsidiaries of any of the provisions thereof), (ii)&#160;neither the Company nor any of its Subsidiaries, nor, to the knowledge of the Company, any of the other parties thereto has violated or committed or failed to perform any act which (with or without notice, lapse of time or both) would constitute a default under any provision of any Lease and (iii)&#160;neither the Company nor any of its Subsidiaries has received written notice that it has violated or defaulted under any Lease. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">(s)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Required Vote of Company Shareholders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company Shareholder Approval is the only vote of holders of Equity Securities of the Company which is required to consummate the transactions contemplated hereby. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(t)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Material Contracts</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(t)(i)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule sets forth a list as of the date of this Agreement of each Contract to which the Company or any of its Subsidiaries is a party or by which it is bound (each such Contract, and each of the following types of Contracts (other than any Company Benefit Plan) described below to which the Company or any of its Subsidiaries becomes a party or by which it otherwise becomes bound after the date of this Agreement, a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Material Contract</font><font style="letter-spacing:0.2pt;">&#8221;): </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp;each acquisition or divestiture Contract (including any Contracts pursuant to which any member of the Company Group has transferred or agreed to transfer ownership of any Intellectual Property) that (x)&#160;has a maximum potential value (or which otherwise requires the receipt or making of payments) in excess of $250,000 (including pursuant to any &#8220;earn-out&#8221;, contingent value rights, milestone payments, license fees, royalty payments, development costs or other contingent payment or value obligations) and pursuant to which the Company or its Subsidiaries has any current or future obligations, (y)&#160;involves the issuance of any Equity Securities of the Company or any of its Subsidiaries to a Third Party following the date of this Agreement or (z)&#160;grants to any Person (other than any member of the Company Group) any right of first refusal, right of first negotiation, right of first offer, option to purchase, option to license, or any other similar rights with respect to any Company Product or any owned or exclusively licensed Company Intellectual Property; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(B)&nbsp;&nbsp;&nbsp;any Contract with any Governmental Entity that is material to the Company and its Subsidiaries, taken as a whole, and involving or that would reasonably be expected to involve payments to or from any Governmental Entity in an amount having a maximum potential value in excess of $250,000; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; text-indent:20pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(C)&nbsp;&nbsp;&nbsp;any Contract that (x)&#160;limits or purports to limit, in any material respect, the freedom of the Company or any of its Subsidiaries to engage or compete in any line of business or with any Person or in any area or that would so limit or purport to limit, in any material respect, the freedom of Parent or any of its Affiliates to take such actions after the Effective Time, (y)&#160;contains exclusivity or &#8220;most favored nation&#8221; obligations or (z)&#160;contains any other provisions materially restricting or purporting to materially restrict the ability of the Company or any of its Subsidiaries to sell, market, distribute, promote, manufacture, develop, commercialize, test or research any Company Products through Third Parties, or to solicit any potential customer, supplier or other business relation in any material respect or that would so limit or purport to limit Parent or any of its Affiliates after the Effective Time; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(D)&nbsp;&nbsp;&nbsp; any Contract relating to third-party indebtedness for borrowed money in excess of $250,000 (whether incurred, assumed, guaranteed or secured by any asset) of the Company or any of its Subsidiaries; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(E)&nbsp;&nbsp;&nbsp;any Contract restricting the Company or any of its Subsidiaries from (x)&#160;the payment of dividends (y)&#160;the making of distributions to shareholders or (z)&#160;the ability to repurchase or redeem Equity Securities; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(F)&nbsp;&nbsp;&nbsp;any joint venture, profit-sharing, partnership, collaboration, co-promotion, commercialization, research, development or other similar agreement, which is material to the Company Group, taken as a whole; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(G)&nbsp;&nbsp;&nbsp;any collective bargaining agreements or other agreements with any labor organization, labor union, or works council; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(H)&nbsp;&nbsp;&nbsp;any Contracts or other transactions with any (A)&#160;executive officer or director of the Company or (B)&#160;affiliate (as such term is defined in Rule&#160;12b-2 promulgated under the Exchange Act) or &#8220;associates&#8221; &#8203;(or members of any of their &#8220;immediate family&#8221;) (as such terms are respectively defined in Rule&#160;12b-2 and Rule&#160;16a-1 of the Exchange Act) of any such executive officer, director or beneficial owner; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(I)&nbsp;&nbsp;&nbsp;any Contracts pursuant to which the Company or any of its Subsidiaries (A)&#160;receives any license (including any sublicense) to, or covenant not to be sued under, any Intellectual Property (other than non-exclusive licenses for generally commercially available off-the-shelf Software with annual payments of less than $250,000), (B)&#160;grants a Third Party any license (including any sublicense) to, or covenant not to sue under, any Intellectual Property or (C)&#160;has transferred or agreed to transfer ownership of any Owned Intellectual Property; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(J)&nbsp;&nbsp;&nbsp;any Contract involving the settlement of any Action or threatened Action (or series of related Actions) (A)&#160;which (x)&#160;will involve payments by the Company or any of its Subsidiaries after the date hereof, or involved such payments, in excess of $250,000 or (y)&#160;will impose, or imposed, materially burdensome monitoring or reporting obligations by the Company or any of its Subsidiaries outside the ordinary course of business or material restrictions on the Company or any Subsidiary of the Company (or, following the Completion, on Parent or any Subsidiary of Parent) or (B)&#160;which impose material restrictions on the use of any material Intellectual Property; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(K)&nbsp;&nbsp;&nbsp;any stockholders, investors rights, registration rights or similar agreements or arrangements with respect to the Company or any of its Subsidiaries; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(L)&nbsp;&nbsp;&nbsp;any other Contract required to be filed by the Company pursuant to Item&#160;601(b)(10) of Regulation&#160;S-K. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;All of the Company Material Contracts are, subject to the Equitable Exceptions, (A)&#160;valid and binding obligations of the Company or a Subsidiary of the Company (as the case may be) and, to the knowledge of the Company, each of the other parties thereto and (B)&#160;in full force and effect and enforceable in accordance with their respective terms against the Company or its Subsidiaries (as the case may be) and, to the knowledge of the Company, each of the other parties thereto, in the case of (A), except for such Company Material Contracts that are terminated after the date of this Agreement in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">accordance with their respective terms, other than as a result of a default or breach by the Company or any of its Subsidiaries of any of the provisions thereof, and except where the failure to be valid and binding obligations and in full force and effect and enforceable has not had and would not reasonably be expected to have, individually or in the aggregate, an effect that is material to the Company Group, taken as a whole. To the knowledge of the Company, as of the date hereof, no Person is seeking to terminate or challenging the validity or enforceability of any Company Material Contract, except such terminations or challenges which have not had and would not reasonably be expected to have, individually or in the aggregate, an effect that is material to the Company Group, taken as a whole. Neither the Company nor any of its Subsidiaries, nor, as of the date hereof, to the knowledge of the Company, any of the other parties thereto has violated any provision of, or committed or failed to perform any act which (with or without notice, lapse of time or both) would constitute a material default under any provision of, and as of the date hereof neither the Company nor any of its Subsidiaries has received written notice that it has violated or defaulted under, any Company Material Contract, except for those violations and defaults which have not had and would not reasonably be expected to have, individually or in the aggregate, an effect that is material to the Company Group, taken as a whole. The Company has made available to Parent true and complete copies of each Company Material Contract as in effect as of the date hereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(u)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Insurance</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company and its Subsidiaries maintain insurance coverage with reputable insurers in such amounts and covering such risks reasonably adequate for the businesses and operations of the Company and its Subsidiaries (taking into account the cost and availability of such insurance). Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i)&#160;all insurance policies for which the Company or any of its Subsidiaries is a policyholder or which cover the business, operations, employees, officers, directors or assets of the Company or any of its Subsidiaries as of the date hereof (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Insurance Policies</font><font style="letter-spacing:0.2pt;">&#8221;) are in full force and effect and (A)&#160;are sufficient for compliance by the Company and its Subsidiaries with all Company Material Contracts and (B)&#160;will not terminate or lapse by their terms (other than any change of control provisions in claims-made policies) by reason of the consummation of the transactions contemplated hereby (including the Acquisition) and (ii)&#160;the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby (including the Acquisition) do not and will not constitute a default under, or cause or permit the termination, cancellation, acceleration or other change of any right or obligation or the loss of any benefit to which the Company or any of its Subsidiaries is entitled under, any provision of the Company Insurance Policies. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Opinions of Financial Advisors</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;The Company Board has received the oral opinion, to be confirmed in writing by delivery of a written opinion, of Goldman Sachs &amp; Co. LLC, financial advisor to the Company, to the effect that, as of the date of such opinion and based upon and subject to the various assumptions, limitations, qualifications and other matters set forth therein, the Scheme Consideration to be paid to the Company Shareholders (other than Parent and any Concert Parties of Parent and their respective affiliates) pursuant to this Agreement is fair, from a financial point of view, to such holders. A written copy of such opinion will be delivered promptly to Parent after the date hereof for informational purposes only. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;The Company Board has received the oral opinion, to be confirmed in writing by delivery of a written opinion, of Morgan Stanley &amp; Co. LLC, financial advisor to the Company, to the effect that, as of the date of such opinion and based upon and subject to the various assumptions, limitations, qualifications and other matters set forth therein, the Scheme Consideration to be paid to the Company Shareholders (other than Parent and any Concert Parties of Parent) pursuant to this Agreement is fair, from a financial point of view, to such holders. A written copy of such opinion will be delivered promptly to Parent after the date hereof for informational purposes only. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(w)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Finders or Brokers</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except for Goldman Sachs &amp; Co. LLC and Morgan Stanley &amp; Co. LLC, there is no investment banker, broker or finder who might be entitled to any fee or commission from the Company or any of its Affiliates in connection with the transactions contemplated by this Agreement. Correct and complete copies of all agreements between the Company and Goldman Sachs &amp; Co. LLC and Morgan Stanley &amp; Co. LLC, have been delivered to Parent. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(x)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">FCPA and Anti-Corruption</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Except as has not been and would not reasonably be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole, neither the Company nor any of its Subsidiaries, nor any director, manager or employee of the Company or any of its Subsidiary has, in the past five (5)&#160;years in connection with the business of the Company or any of its Subsidiaries, itself or, to the Company&#8217;s knowledge, any of its agents, representatives, sales intermediaries, or any other third party, in each case, while acting on behalf of the Company or any Subsidiary of the Company, taken any action in violation of the FCPA or other applicable Bribery Legislation (in each case to the extent applicable). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries nor, to the knowledge of the Company, any director, manager or employee of the Company or any its Subsidiaries (in each case, while acting on behalf of the Company or any of its Subsidiaries), are, or in the past five (5)&#160;years have been, subject to any actual or pending or, to the knowledge of the Company, threatened civil, criminal, or administrative actions, suits, demands, claims, hearings, notices of violation, investigations, proceedings, demand letters, settlements, or enforcement actions or made any voluntary disclosures to any Governmental Entity, involving the Company or any of its Subsidiaries relating to applicable Bribery Legislation, including the FCPA. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;In the past five (5)&#160;years, the Company and each of its Subsidiaries has made and kept books and records, accounts and other records, which, in reasonable detail, accurately and fairly reflect in all material respects the transactions and dispositions of the assets of the Company and each of its Subsidiaries as required by the FCPA. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;The Company and each of its Subsidiaries has instituted policies and procedures reasonably designed to promote compliance with the FCPA and other applicable Bribery Legislation and maintain such policies and procedures in force. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;To the knowledge of the Company, no officer, director, or employee of the Company or any of its Subsidiaries is a Government Official. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;Except for such failures of each of the following clauses (A)&#160;through (C)&#160;to be true and correct as has not been and would not reasonably be expected to be, individually or in the aggregate, material to the Company Group, taken as a whole, none of the Company or any of its Subsidiaries, nor any of their respective directors, managers or employees (A)&#160;is a Sanctioned Person, (B)&#160;has, since April&#160;24, 2019, engaged in direct or indirect dealings with any Sanctioned Person or in any Sanctioned Country on behalf of the Company or any of its Subsidiaries in violation of any Sanctions Law or (C)&#160;has, since April&#160;24, 2019, violated, or engaged in any conduct in violation of any Sanctions Law, nor to the knowledge of the Company, been the subject of an investigation or allegation of such a violation or sanctionable conduct or any voluntary or involuntary disclosure to any Governmental Entity regarding any such actual or potential violation of Sanctions Laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(y)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Takeover Statutes</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;No &#8220;fair price&#8221;, &#8220;moratorium&#8221;, &#8220;control share acquisition&#8221; or other similar anti-takeover statute or regulation or any anti-takeover provision in the Company Memorandum and Articles of Association is, or at the Effective Time will be, applicable to Parent or any of its Subsidiaries, the CVR Agreement, the Acquisition or the Scheme. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(z)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Transactions with Affiliates</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;To the knowledge of the Company and as of the date of this Agreement, since the Lookback Date, there have been no transactions, or series of related transactions, agreements, arrangements or understandings in effect, nor are there any currently proposed transactions, or series of related transactions, agreements, arrangements or understandings, that would be required to be disclosed under Item&#160;404 of Regulation&#160;S-K that have not been otherwise disclosed in the Company SEC Documents filed prior to the date hereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(B)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Other Representations</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except for the representations and warranties made by the Company in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)</font><font style="letter-spacing:0.2pt;"> (as qualified by the applicable items disclosed in the Company Disclosure Schedule in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10.8</font><font style="letter-spacing:0.2pt;"> and the introduction to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;">), neither the Company nor any other Person makes or has made any representation or warranty, expressed or implied, at law or in equity, with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tSEC10">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">respect to or on behalf of the Company or its Subsidiaries, Parent acknowledges that it has conducted its own independent investigation of the Company and the Company Group and, in making its determination to proceed with the transactions contemplated by this Agreement, Parent has relied on the results of its own independent investigation and on the representations and warranties of the Company expressly set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)</font><font style="letter-spacing:0.2pt;">. Nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(B)</font><font style="letter-spacing:0.2pt;"> shall be construed as a waiver (or an admission of non-reliance with respect to) any claims based on fraud. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;6.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Parent Representations and Warranties</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp;Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10.8</font><font style="letter-spacing:0.2pt;">, and except as disclosed in any publicly available report, schedule, form, statement, prospectus, registration statement or other document required to be filed with or furnished to the SEC by Parent on or after the Lookback Date (collectively, together with any exhibits and schedules thereto and other information therein, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Parent SEC Documents</font><font style="letter-spacing:0.2pt;">&#8221;), and prior to the date hereof Parent represents and warrants to the Company as follows: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Qualification, Organization etc</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent is a legal entity duly organized, validly existing and in good standing under the laws of its jurisdiction of organization. Parent has all requisite corporate power and authority required to own or lease all of its properties or assets and to carry on its business as now conducted. Parent is duly qualified to do business and is in good standing in each jurisdiction where such qualification is necessary, except for those jurisdictions where failure to be so qualified or in good standing has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Corporate Authority Relative to this Agreement; No Violation</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Parent has all requisite corporate power and authority to enter into this Agreement and the CVR Agreement and to consummate the transactions contemplated hereby and thereby. The execution and delivery of this Agreement, the CVR Agreement and the consummation of the transactions contemplated hereby (including the Acquisition) and thereby has been duly and validly authorized by the Parent Board and, except for the filing of the required documents in connection with the Scheme with, and to receipt of the required approval of the Scheme by, the High Court, no other corporate proceedings on the part of Parent are necessary to authorize the consummation of the transactions contemplated hereby (including the Acquisition). This Agreement has been and, at the Completion, the CVR Agreement will be, duly and validly executed and delivered by Parent and, assuming this Agreement and the CVR Agreement constitute the valid and binding agreement of the Company and the Rights Agent (solely with respect to the CVR Agreement), constitute and will constitute valid and binding agreements of Parent, enforceable against Parent in accordance with their terms, subject to the Equitable Exceptions. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;The execution, delivery and performance by Parent of this Agreement and the CVR Agreement (and the consummation by Parent of the transactions contemplated hereby (including the Acquisition)) require no action by or in respect of, Clearances of, or Filings with, any Governmental Entity other than (A)&#160;compliance with the provisions of the Act, (B)&#160;compliance with the Takeover Panel Act and the Takeover Rules, (C)&#160;compliance with any applicable requirements of the HSR Act, (D)&#160;compliance with and Filings under any applicable Antitrust Laws of any non-U.S. jurisdictions, (E)&#160;compliance with any applicable requirements of the Securities Act, the Exchange Act and any other applicable U.S. state or federal securities laws or pursuant to the rules of the Nasdaq Global Select Market and (F)&#160;any other actions, Clearances or Filings the absence of which has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;Assuming compliance with the Scheme, the Act and any directions or orders of the High Court, the execution, delivery and performance by Parent of this Agreement, the CVR Agreement and the consummation of the transactions contemplated hereby and thereby (including the Acquisition) do not and will not (A)&#160;contravene, conflict with, or result in any material violation or material breach of any provision of the Organizational Documents of Parent, (B)&#160;assuming compliance with the matters referred to in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(d)(ii)</font><font style="letter-spacing:0.2pt;"> contravene, conflict with or result in any violation or breach of any provision of any applicable Law, (C)&#160;assuming </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">compliance with the matters referred to in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1(A)(d)(ii)</font><font style="letter-spacing:0.2pt;">, require any Clearance or other action by any Person, constitute a default, or an event that, with or without notice or lapse of time or both, would constitute a default, under, or cause or permit the termination, cancellation, acceleration or other change of any right or obligation or the loss of any benefit to which Parent or any of its Subsidiaries is entitled under, any provision of any Parent permit or any Contract binding upon Parent or any of its Subsidiaries or any Clearance (including Clearances required by Contract) affecting, or relating in any way to, the assets or business of Parent and its Subsidiaries, except, in the case of each of clauses (B)&#160;and (C), as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Investigations; Litigation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As of the date hereof, (i)&#160;there is no Action or Order pending or, to the knowledge of Parent, threatened against or affecting Parent, any of its Subsidiaries or any of the respective properties or assets of Parent or any of its Subsidiaries, before (or, in the case of threatened Actions or Orders, that would be before) any Governmental Entity and (ii)&#160;to the knowledge of Parent there is no Action pending or threatened against any present or former officers, directors or employees of Parent or any of its Subsidiaries in their respective capacities as such, in the case clause (i), that has had or would reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Information Supplied</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The information provided by and relating to Parent and its Subsidiaries to be contained in the Scheme Document, the Proxy Statement and any other documents filed or furnished with or to the High Court, the SEC, the Panel or pursuant to the Act and the Takeover Rules in each case in connection with the Acquisition will not, on the date the Scheme Document and the Proxy Statement (and any amendment or supplement thereto) is first proposed to Company Shareholders and at the time of the Court Meeting, contain any untrue statement of any material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, at the time and in light of the circumstances under which they were made, not false or misleading. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Financing</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp; At the Effective Time, Parent will have sufficient cash, available lines of credit or other sources of immediately available and cleared funds to enable Parent to make all required payments payable at the Effective Time in connection with the transactions contemplated under this Agreement (such amounts collectively, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Financing Amounts</font><font style="letter-spacing:0.2pt;">&#8221;). If the Milestone (as defined in the CVR Agreement) is achieved, on the date the Milestone Payment (as defined in the CVR Agreement) is made, Parent will have cash resources in immediately available funds and in an amount sufficient to satisfy Parent&#8217;s cash payment obligations under the CVR Agreement. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, Parent has delivered to the Company true, correct and complete copies, dated as of the date of this Agreement, of the fully executed Debt Agreement, together with all attached exhibits, schedules and annexes, and the fee letters (which may be redacted solely to the extent described below) associated therewith (but excluding any side letters or other similar agreements which do not impact the amount or availability of the Financing at the Effective Time or amend or, waive any of the terms of the Debt Agreement or impose any additional conditions or expand the conditions to obtaining the Financing on or before the occurrence of Completion), to provide to Parent the amount of financing set forth in the Debt Agreement, in order to consummate the Acquisition. As of the date of this Agreement, a true, correct and complete copy of each fee letter related to the Debt Agreement as in effect on the date of this Agreement has been provided to the Company, except that the fees and other customary &#8220;flex&#8221; terms (including provisions in such fee letter related to fees and economic terms) may have been redacted; provided, however, that no redacted term provides that the aggregate amount or net cash proceeds of the Financing set forth in the unredacted portion of the Debt Agreement could be reduced or adds or modifies any conditions or contingencies that affect the availability of all or any portion of the Financing at the Effective Time. Parent has fully paid (or caused to be paid) all commitment and other fees, if any, required by the Debt Agreement that are due and payable on or before the date of this Agreement. As of the date of this Agreement and other than as set forth in the Debt Agreement and assuming the satisfaction or waiver of each of the Conditions, there are no </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tAVA">&#8203;</a><a name="tSEC11">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">conditions precedent to the funding of the full amount of the Financing as necessary to consummate the transactions contemplated by this Agreement and to satisfy all of the payment and other obligations of Parent under this Agreement, and there are no contractual contingencies or other provisions under any agreement (including any side letters) relating to the Acquisition to which Parent or any of its respective Affiliates is a party that would permit the Financing Sources to reduce the total amount of the Financing or impose any additional conditions precedent to the availability of the Financing or that could affect the timing, termination or availability of the Financing necessary to consummate the Acquisition. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, the Debt Agreement is a valid and binding obligation of Parent and, to the knowledge of Parent, each other party thereto, and is enforceable in accordance with its terms, subject, in each case, to Equitable Exceptions, and in full force and effect, and has not been amended, modified, withdrawn, terminated or rescinded in any respect. No such amendment, modification, withdrawal termination, or rescission is contemplated by Parent or, to the knowledge of Parent, any other party thereto (other than with respect to &#8220;flex&#8221; rights and/or to add additional lenders, arrangers, bookrunners, syndication agents and similar entities who had not executed the Debt Agreement as of the date of this Agreement). Other than customary engagement letters, the redacted fee letters provided in accordance with clause (ii)&#160;above or nondisclosure or non-reliance agreements which do not impact the conditionality, aggregate amount or availability at the Effective Time of the Financing, as of the date of this Agreement, there are no other contracts or side letters, or arrangements to which Parent or any of its Affiliates is a party related to the Financing, other than as expressly contained in the Debt Agreement or otherwise delivered to the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Ownership of Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Neither Parent nor any of Parent&#8217;s Subsidiaries directly or indirectly owns, beneficially or otherwise, any Company Share or any securities, contracts or obligations convertible into or exercisable or exchangeable for Company Share. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(B)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Other Representations</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company acknowledges and agrees that, except for the representations and warranties made by Parent in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.2(A)</font><font style="letter-spacing:0.2pt;">, neither Parent nor any other Person makes or has made any representation or warranty, expressed or implied, at law or in equity, with respect to or on behalf of Parent or its Subsidiaries. The Company acknowledge that it has conducted its own independent investigation of Parent and, in making its determination to proceed with the transactions contemplated by this Agreement, the Company has relied on the results of its own independent investigation and on the representations and warranties of Parent expressly set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.2(A)</font><font style="letter-spacing:0.2pt;">. Nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.2(B)</font><font style="letter-spacing:0.2pt;"> shall be construed as a waiver (or an admission of non-reliance with respect to) any claims based on fraud. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE VII</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADDITIONAL AGREEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;7.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Access to Information; Confidentiality; Notices of Certain Events</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Upon reasonable notice, the Company shall, and shall cause its Subsidiaries to, afford to Parent, its Subsidiaries and its and their respective Representatives and Financing Sources, reasonable access during normal business hours, during the period from the date of this Agreement to the earlier of Completion and the date, if any, on which the Agreement is validly terminated pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">, to (i)&#160;its and its Subsidiaries&#8217; properties, employees, contracts, commitments and books and records and financial and operating data and (ii)&#160;all other information not made available pursuant to clause&#160;(i)&#160;of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1(a)</font><font style="letter-spacing:0.2pt;"> concerning its and its Subsidiaries&#8217; businesses, properties and personnel as Parent may reasonably request (in the case of each of clause (i)&#160;and (ii), in a manner so as to not unreasonably interfere with the normal business operations of the Company or any of its Subsidiaries). During such period described in the immediately preceding sentence, upon reasonable notice and subject to applicable Law and during normal business hours, the Company shall instruct its pertinent Representatives to reasonably cooperate with Parent in its review of any such information provided or made available pursuant to the immediately preceding sentence. Any such access shall be conducted at Parent&#8217;s expense and shall be subject to the Company&#8217;s reasonable security measures and insurance requirements and shall not include invasive </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">testing. No information or knowledge obtained in any review or investigation pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> shall affect or be deemed to modify any representation or warranty made by the Company pursuant to this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Without limiting the generality of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1(a)</font><font style="letter-spacing:0.2pt;">, during the period from the date of this Agreement to the earlier of Completion and the date, if any, on which the Agreement is validly terminated pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">, the Company agrees to, and to cause its Subsidiaries to, subject to applicable Law, (i)&#160;reasonably assist and cooperate with Parent and its Subsidiaries to facilitate the post-Completion integration of the Company and its Subsidiaries with Parent and its Subsidiaries (including, at the request of Parent from time to time, reasonably assisting and cooperating with Parent and its Subsidiaries in the planning and development of a post-Completion integration plan) and (ii)&#160;provide reasonable access to key personnel identified by Parent to facilitate Parent&#8217;s efforts with respect to the post-Completion retention of such key personnel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2</font><font style="letter-spacing:0.2pt;">, neither the Company nor any of its respective Subsidiaries shall be required to provide access to, disclose information to or assist or cooperate with Parent, in each case if and to the extent such access, disclosure, assistance or cooperation (i)&#160;would, as reasonably determined based on the advice of outside counsel, jeopardize any attorney-client privilege or other privileges and immunities with respect to such information or (ii)&#160;would contravene any applicable Law to which the Company or any of its Subsidiaries is subject, including the Protective Orders in the Actions set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1(f)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the Company shall, and shall cause its Subsidiaries to, use reasonable best efforts to make appropriate substitute disclosure arrangements under circumstances in which such restrictions apply (including redacting such information (A)&#160;as necessary to comply with applicable Law and (B)&#160;as necessary to address reasonable attorney-client, work product or other privilege concerns, or entering into a joint defense or other arrangement) and to provide such information as to the applicable matter as can be conveyed. Each of the Company and Parent may, as each deems advisable and necessary, reasonably designate, and the other Party shall treat, any competitively sensitive material provided to the other under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2</font><font style="letter-spacing:0.2pt;"> as &#8220;Outside Counsel Only Material.&#8221; Such materials and the information contained therein shall be given only to the outside counsel of the recipient and, subject to any additional confidentiality or joint defense agreement the Parties may mutually propose and enter into, will not be disclosed by such outside counsel to employees, officers, directors, other advisors or representatives of the recipient unless express permission is obtained in advance from the source of the materials (the Company or Parent, as the case may be) or its legal counsel. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;The Company shall promptly notify and, if applicable, provide copies to Parent of: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;any material written notice from any Person alleging that the approval or consent of such Person is or may be required in connection with the Scheme, the Acquisition or the other transactions contemplated hereby; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;any Action (other than any investigation), or to the knowledge of the Company, investigation, commenced or, to its knowledge, threatened against, relating to or involving or otherwise affecting the Company or any of its Subsidiaries or Parent or any of its Subsidiaries, as the case may be, that, if pending on the date of this Agreement, would have been required to have been disclosed pursuant to any of the Company&#8217;s representations or warranties, as the case may be, or that relate to the consummation of the Scheme, the Acquisition or the other transactions contemplated hereby. A failure by the Company to provide information pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1(d)</font><font style="letter-spacing:0.2pt;"> shall not constitute a breach of this Agreement for the purpose of any Condition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp; Each Party shall promptly notify and, if applicable, provide copies to the other Party of the occurrence of any event which would or would reasonably be expected to (A)&#160;prevent or materially delay the consummation of the Scheme, the Acquisition or the other transactions contemplated hereby or (B)&#160;result in the failure of any Condition; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the delivery of any notice pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1(d)</font><font style="letter-spacing:0.2pt;"> or this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1(e)</font><font style="letter-spacing:0.2pt;"> shall not in and of itself (i)&#160;affect or be deemed to modify any representation, warranty, covenant, right, remedy, or condition to any obligation of any Party hereunder or (ii)&#160;update any section of the Company Disclosure Schedule. A failure by either Party to provide information pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1(e)</font><font style="letter-spacing:0.2pt;"> shall not constitute a breach of this Agreement for the purpose of any Condition. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tSEC12">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;To the fullest extent permitted by applicable Law and without limiting the Company&#8217;s obligations pursuant to any other provision of this Agreement, with respect to the Actions set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1(f)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, the Company shall (i)&#160;keep Parent reasonably informed (on a timely basis) regarding the status of and any developments with respect to such Actions following the date hereof and provide such additional information with respect to such Actions as Parent may reasonably request and (ii)&#160;consult and cooperate with Parent, and consider in good faith Parent&#8217;s views, as to the strategy, defense and settlement discussions with respect to such Actions. The Company and Parent will operate under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1(f)</font><font style="letter-spacing:0.2pt;"> pursuant to a common interest agreement, whereby any information shared pursuant to the foregoing sentence remains subject to the protection of the attorney-client privilege, attorney work product doctrine, common interest privilege, joint defense privilege and any and all other applicable rights, privileges, protections or immunities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Until the earlier of Completion and the date, if any, on which the Agreement is validly terminated pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">, the Company shall, to the extent permitted by applicable Law, (i)&#160;promptly provide Parent with a copy of all material written correspondence received after the date hereof from the FDA, DEA, or any similar Governmental Entity and inform Parent of any material oral communications with the FDA, DEA, or any other Governmental Entity with respect to (x)&#160;any allegations of violations or infractions involving any Company Products, (y)&#160;the recall, removal or market withdrawal of any Company Products sold in the U.S. by the Company or its Subsidiaries or (z)&#160;any warning letter issued to the Company or any of its Subsidiaries by the FDA or any other Governmental Entity with respect to Company Products, in the case of each of clauses (x), (y)&#160;and (z), if the applicable Company Products are material to the Company and its Subsidiaries, taken as a whole and (ii)&#160;promptly provide Parent with such information as Parent may reasonably request on any side effects, adverse effects, or the results of any pre-clinical testing with request to any Company Product. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;The Parties hereby agree that all information provided to them or their respective Representatives pursuant to this Agreement shall be subject to the Confidentiality Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;7.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Consents and Regulatory Approvals</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The terms of the Acquisition at the date of publication of the Scheme Document shall be set out in the Rule&#160;2.7 Announcement and the Scheme Document, to the extent required by applicable Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Subject to the terms and conditions of this Agreement, including </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2(c)</font><font style="letter-spacing:0.2pt;">, each Party shall, and each shall cause its Subsidiaries to, use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable, to the extent permitted by applicable Law, to achieve satisfaction of the Conditions and to consummate the Acquisition and the other transactions contemplated hereby as promptly as reasonably practicable and in any event on or before the End Date, including using reasonable best efforts to (x)&#160;prepare and file as promptly as reasonably practicable with any Governmental Entity or other third party all documentation to effect all Filings (and thereafter make any other required or appropriate submissions) as are necessary, proper or advisable to consummate the Acquisition and the other transactions contemplated hereby, including the Company and Parent as applicable each making (A)&#160;as promptly as reasonably practicable, but in no event later than twenty (20) Business Days after the date hereof (unless the Parties mutually agree otherwise), an appropriate Filing of a notification and report form pursuant to the HSR Act with the Federal Trade Commission and the Antitrust Division of the United States Department of Justice with respect to the Acquisition and the other transactions contemplated hereby and requesting early termination of the waiting period under the HSR Act and (B)&#160;as promptly as reasonably practicable, but in no event later than twenty (20) Business Days after the date hereof (unless the Parties mutually agree otherwise), any other Filing, either finally or in draft as is appropriate in the relevant jurisdiction, that is required and advisable under any other Antitrust Law or foreign investment Law, including making all required Filings under the Antitrust Laws in the jurisdictions listed on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2(b)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule and (y)&#160;obtain prior to the End Date, and thereafter maintain, all Clearances required to be obtained from any Governmental Entity in connection with any Filing or submission to any Governmental Entity and any investigation or other inquiry (including any litigation) by or before any Governmental Entity that are necessary and advisable to consummate the Acquisition or other transactions contemplated hereby, and complying with the terms and conditions of each Clearance. Each Party shall promptly provide any supplemental information or documentation requested by any Governmental Entity (including, but not limited to, supplying as promptly </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-56</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">as reasonably practicable any additional information and documentary material that may be requested pursuant to the HSR Act or other applicable Antitrust Law or foreign investment Law). The Company will provide all information reasonably required to enable Parent to make such Filings and to achieve the fulfilment of the conditions precedent and cooperate with Parent in its efforts to comply with its obligations under this Agreement, including in seeking to obtain any required Clearances, including defending (but without any obligation to commence) any Action commenced by any Governmental Entity in connection with the transactions contemplated hereby. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Notwithstanding </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2(b)</font><font style="letter-spacing:0.2pt;"> or anything else in this Agreement to the contrary, nothing in this Agreement or otherwise shall obligate or otherwise require Parent nor any of its Subsidiaries or Affiliates to propose, agree to, commit to or effect any action (or refrain or cause to refrain from taking any action) (including, in each case, any divestiture, hold separate arrangement, licensing of rights, or termination, assignment, novation or modification of Contracts (or portions thereof) or other business relationships), restriction, commitment, condition, contingency, contribution, cost, expense, liability, limitation, loss, obligation, payment, requirement or term, with respect to any asset, operation, division, business, product line or business relationship of Parent, the Company or any of their respective Subsidiaries, in each case as a condition to, or in connection with, (i)&#160;the expiration or termination of any applicable waiting period relating to the Acquisition under the HSR Act, (ii)&#160;obtaining any Clearance under any other applicable Antitrust Laws or foreign investment Laws or (iii)&#160;obtaining any other Clearance from a Governmental Entity or otherwise. In addition, the Company shall not offer or commit to take any of such actions without Parent&#8217;s prior written consent, which includes taking or committing to take actions that limit Parent or any of its Subsidiaries (including the Company following the Effective Time), as applicable, freedom of action with respect to, or their ability to retain, any of the businesses, employees, or assets of the Company, and Parent and its Affiliates shall not be required to commit to any provision (in any consent decree or otherwise) requiring the prior approval of a Governmental Entity to engage, or agree not to engage in any present or future transaction involving Parent or any of its Affiliates; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, notwithstanding the foregoing, Parent shall defend through litigation on the merits any claim asserted in court or through administrative tribunal by any Governmental Entity under any applicable Antitrust Law that would prevent Completion from occurring prior to the End Date, it being understood that, notwithstanding </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2(d)</font><font style="letter-spacing:0.2pt;"> below, Parent shall have the right to direct, devise and control such litigation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Parent and Company shall jointly (i)&#160;direct, devise and implement the strategy for obtaining any necessary approval of and submitting filings to, for responding to any request from, inquiry or investigation by (including directing the timing, nature and substance of all such responses), and shall have the right to co-lead all meetings and communications (including any negotiations) with, any Governmental Entity that has authority to enforce any Antitrust Law, and (ii)&#160;control the defense and settlement of any Action brought by or before any Governmental Entity that has authority to enforce any Antitrust Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;To the extent permitted by applicable Law, the Company and Parent shall, as promptly as reasonably practicable, (i)&#160;upon request from a Governmental Entity, furnish to such Governmental Entity, any information or documentation concerning themselves, their Subsidiaries, directors, officers and shareholders information or documentation concerning the Acquisition, the Scheme and the other transactions contemplated hereby and such other matters as may be requested and (ii)&#160;make available their respective Representatives to, upon reasonable request, any Governmental Entity, in the case of each of clauses&#160;(i)&#160;and (ii), in connection with (A)&#160;the preparation of any Filing made by or on their behalf to any Governmental Entity in connection with the Acquisition, the Scheme or any of the other transactions contemplated hereby or (B)&#160;any Governmental Entity investigation, review or approval process. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2(d)</font><font style="letter-spacing:0.2pt;">, applicable Laws relating to the sharing of information and the terms and conditions of the Confidentiality Agreement and all other agreements entered into by the Parties, and subject to the proviso at the end of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2(f)</font><font style="letter-spacing:0.2pt;">, Parent and the Company shall, and shall cause their respective Subsidiaries to: (i)&#160;(A)&#160;as far in advance as reasonably practicable, notify the other of, and provide the other party with an opportunity to consult with respect to, any Filing or material or substantive communication or inquiry it or any of its Subsidiaries intends to make with any Governmental Entity relating to the matters that are the subject of this Agreement, (B)&#160;prior to submitting any such Filing or making any such communication or inquiry, provide the other Party and its counsel a reasonable opportunity to review, and shall consider in good faith the comments of the other Party&#8217;s Representatives in connection </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-57</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tSEC13">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">with any such Filing, communication or inquiry (except HSR filings), and (C)&#160;promptly following the submission of such Filing (except HSR filings) or making of such communication or inquiry, provide the other party with a copy of any such Filing or, if in written form, a summary of any communication or inquiry; (ii)&#160;as promptly as reasonably practicable following receipt, furnish the other party with a copy of any Filing (except HSR filings) or, if in written form, material or substantive communication or inquiry, it or any of its Subsidiaries receives from any Governmental Entity relating to matters that are the subject of this Agreement; and (iii)&#160;coordinate and reasonably cooperate with the other Party in sharing such information and provide such other assistance as the other Party may reasonably request in connection with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2</font><font style="letter-spacing:0.2pt;">. Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2(c)</font><font style="letter-spacing:0.2pt;">, none of the Company, Parent or their respective Representatives shall agree to participate in any material or substantive meeting or conference (including by telephone) with any Governmental Entity, or any member of the staff of any Governmental Entity, in respect of any Filing, Action (including the settlement of any investigation) or other inquiry regarding the Acquisition or the Scheme unless it consults with the other party in advance and, to the extent permitted by such Governmental Entity, allows the other party to participate. Any such disclosures or provision of copies by one Party to the other may be designated as &#8220;outside counsel only&#8221; basis, if appropriate and, if so designated, shall be given only to the outside legal counsel of the recipient and shall not be disclosed to employees, officers or directors of the recipient unless express permission is obtained in advance from the source of the materials or its legal counsel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;In the event that the latest date on which the High Court or the Panel would permit Completion to occur is prior to the End Date, the Parties shall use their respective reasonable best efforts to obtain consent of the High Court or the Panel, as applicable, to an extension of such latest date (but not beyond the End Date). If (i)&#160;the High Court or the Panel require the lapsing of the Scheme prior to the End Date or (ii)&#160;Condition 1 fails to be satisfied, the Parties shall (unless and until this Agreement is validly terminated pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">) take all reasonable actions required in order to re-initiate the Scheme process as promptly as reasonably practicable (it being understood that no such lapsing described in subclause (i)&#160;or (ii)&#160;shall, in and of itself, result in a termination of, or otherwise affect any rights or obligations of any Party under, this Agreement). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;From the date of this Agreement through the earlier of the termination of this Agreement or Completion, Parent shall not, and shall cause its Subsidiaries and Affiliates not to, acquire or agree to acquire, by merging or consolidating with, or by purchasing a substantial portion of the assets of or equity interests in, or by any other manner outside the ordinary course of business, any Person that has an asset or program in clinical development or approved for narcolepsy or idiopathic hypersomnia and that would reasonably be expected to (i)&#160;materially delay or materially impede the receipt of any authorizations, consents, orders, declarations or approvals of any Governmental Entity necessary to close the Acquisition and the other transactions contemplated by this Agreement or (ii)&#160;materially delay the closing of the Acquisition and the other transactions contemplated by this Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;7.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Directors&#8217; and Officers&#8217; Indemnification and Insurance</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;For a period of not less than six (6)&#160;years from the Effective Date, Parent shall cause the Company or any applicable Subsidiary thereof (collectively, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">D&amp;O Indemnifying Parties</font><font style="letter-spacing:0.2pt;">&#8221;), to the fullest extent each such D&amp;O Indemnifying Party is so authorized or permitted by applicable Law, as now or hereafter in effect, to fulfill and honor in all respects the obligations of the Company to each person who is at the date hereof, was previously, or during the period from the date hereof through the date of the Effective Time, serving as a director or officer of the Company or any of its Subsidiaries, or at the request or for the benefit of the Company or any of its Subsidiaries as a director, trustee or officer of any other entity or any benefit plan maintained by the Company or any of its Subsidiaries (collectively, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">D&amp;O Indemnified Parties</font><font style="letter-spacing:0.2pt;">&#8221;) pursuant to (i)&#160;each indemnification agreement in effect between the Company and/or any of its Subsidiaries and any D&amp;O Indemnified Party as of the date thereof and set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(a)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule and (ii)&#160;all rights to indemnification, advancement of expenses and exculpation from liabilities for acts or omissions contained in the Organizational Documents of the Company (as in effect on the date of this Agreement). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;For a period of not less than six (6)&#160;years from the Effective Date, Parent shall cause the Organizational Documents of the Company to contain provisions no less favorable with respect to indemnification, advancement of expenses and limitations on liability of directors and officers than are set </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-58</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tSEC14">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">forth in the Organizational Documents of the Company as of the date of this Agreement, which provisions shall not be amended, repealed or otherwise modified for a period of at least six (6)&#160;years from the Effective Date in any manner that would adversely affect the rights thereunder of any D&amp;O Indemnified Party, unless any modification or amendment is required by applicable Law (but then only to the extent required by applicable Law). At the Company&#8217;s option and expense, prior to the Effective Time, the Company may purchase (and pay in full the aggregate premium for) a six (6)-year prepaid &#8220;tail&#8221; insurance policy (which policy by its express terms shall survive the Acquisition) of at least the same coverage and amounts and containing terms and conditions that are no less favorable to the directors and officers of the Company or any of its Subsidiaries as the Company&#8217;s and its Subsidiaries&#8217; existing directors&#8217; and officers&#8217; insurance policy or policies with a claims period of six (6)&#160;years from the Effective Time for claims arising from facts, acts, events or omissions that occurred on or prior to the Effective Time; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the premium for such tail policy shall not exceed two hundred and fifty&#160;percent (250%) of the annual amount currently paid by the Company and its Subsidiaries for such insurance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;If Parent or the Company or any of their respective successors or assigns (i)&#160;consolidates with or merges with or into any other Person and shall not be the continuing or surviving company, partnership or other Person of such consolidation or merger or (ii)&#160;liquidates, dissolves or winds-up, or transfers or conveys all or substantially all of its properties and assets to any Person, then, and in each such case, proper provision shall be made so that the successors and assigns of Parent or the Company, as applicable, assume the obligations set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;The provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3</font><font style="letter-spacing:0.2pt;"> are intended to be for the express benefit of, and shall be enforceable by, each D&amp;O Indemnified Party (who are intended to be third party beneficiaries of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3</font><font style="letter-spacing:0.2pt;">), his or her heirs and his or her personal Representatives, shall be binding on all successors and assigns of Parent, and following the Effective Time, the Company. The exculpation and indemnification provided for by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3</font><font style="letter-spacing:0.2pt;"> shall not be deemed to be exclusive of any other rights to which a D&amp;O Indemnified Party is entitled, pursuant to applicable Law or Contract made available to Parent prior to the date hereof. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;7.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Employment and Benefit Matters</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;From the date of Completion through the earlier of (x)&#160;the first (1st) anniversary of the Effective Time, and (y)&#160;the termination of the relevant Company Employee (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Benefits Continuation Period</font><font style="letter-spacing:0.2pt;">&#8221;), Parent shall provide(or cause its Subsidiaries to provide), to each Company Employee (i)&#160;an annual base salary or base wage rate (as applicable) and target annual cash bonus opportunity or target cash commissions opportunity that are no less favorable, in the aggregate, than the annual base salary or base wage rate applicable, and target annual cash bonus opportunity or target cash commissions opportunity in effect immediately prior to the Effective Time (provided that each Company Employee&#8217;s annual base salary or base wage rate (as applicable) shall also independently be no less than 95% of the annual base salary or base wage rate (as applicable) in effect immediately prior to the Effective Time) and (ii)&#160;employee pension and welfare benefits that are, in the aggregate, no less favorable than the employee pension and welfare benefits provided to similarly situated employees of Parent; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that for purposes of determining whether such employee benefits are no less favorable in the aggregate, any defined benefit pension plan benefits, nonqualified deferred compensation, subsidized retiree health or welfare benefits, post-termination health or welfare benefits, and retention or change in control payments or awards shall not be taken into account. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;For purposes of vesting, eligibility to participate and determining level of benefits under the employee benefit plans of Parent providing benefits to any Company Employees (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">New Plans</font><font style="letter-spacing:0.2pt;">&#8221;), each Company Employee shall be credited with his or her&#160;years of service with the Company Group and its predecessors before the Effective Time, to the same extent and for the same purpose as such Company Employee was entitled, before the Effective Time, to credit for such service under the corresponding Company Benefit Plan in which such Company Employee participated or was eligible to participate immediately prior to the Effective Time; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the foregoing shall not apply with respect to (i)&#160;any defined benefit pension plan or any retiree or post-termination health or welfare benefits, (ii)&#160;any benefit plan that is frozen or for which participation is limited to a grandfathered population, (iii)&#160;any equity-based compensation arrangements or (iv)&#160;to the extent that its application would result in a duplication of benefits or compensation with respect to the same period of service, and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, that such service shall only be credited to the extent service with Parent is credited for similarly situated employees of the Parent </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-59</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tSEC15">&#8203;</a><a name="tSEC16">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Group under the New Plans. In addition, and without limiting the generality of the foregoing, (A)&#160;each Company Employee shall be immediately eligible to participate, without any waiting time, in any and all New Plans to the extent coverage under such New Plan is replacing comparable coverage under a Company Benefit Plan in which such Company Employee had already satisfied any such waiting period and participated immediately before the Effective Time (such plans, collectively, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Old Plans</font><font style="letter-spacing:0.2pt;">&#8221;) and (B)&#160;for purposes of each New Plan providing medical, dental, pharmaceutical, vision or disability benefits to any Company Employee, Parent shall use its reasonable best efforts to cause (1)&#160;all pre-existing condition exclusions and actively-at-work requirements of such New Plan to be waived for such employee and his or her covered dependents, unless and to the extent the individual, immediately prior to entry in the New Plans, was subject to such conditions under the comparable Old Plans and (2)&#160;any eligible expenses incurred by such employee and his or her covered dependents during the portion of the plan year of the Old Plan ending on the date such employee&#8217;s participation in the corresponding New Plan begins to be taken into account under such New Plan for purposes of satisfying all deductible, coinsurance and maximum out-of-pocket requirements applicable to such employee and his or her covered dependents for the applicable plan year as if such amounts had been paid in accordance with such New Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent hereby acknowledges that a &#8220;change of control&#8221; &#8203;(or similar phrase) within the meaning of any Company Benefit Plan will occur at or prior to the Effective Time, as applicable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;The Company shall use commercially reasonably efforts to coordinate in advance with Parent between the date of this Agreement and the Effective Time regarding any communication with any Company Employee relating to compensation or benefits to be provided subsequent to the Effective Time, and any such communication shall be subject to Parent&#8217;s prior reasonable review and comment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Nothing contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.4</font><font style="letter-spacing:0.2pt;"> (whether express or implied) shall (i)&#160;create or confer any rights, remedies or claims upon any employee of the Company or any of its Affiliates or any right of employment or engagement or continued employment or engagement or any particular term or condition of employment or engagement for any Company Employee or any other Person, (ii)&#160;be considered or deemed to establish, amend, or modify any Company Benefit Plan or any other benefit or compensation plan, program, policy, agreement, arrangement or Contract, (iii)&#160;prohibit or limit the ability of Parent or any of its Affiliates to amend, modify or terminate any benefit or compensation plan, program, policy, agreement, arrangement, or contract at any time assumed, established, sponsored or maintained by any of them or (iv)&#160;confer any rights or benefits (including any third-party beneficiary rights) on any Person other than the Parties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Stock Exchange Delisting</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Prior to the Effective Time, each of the Parties shall cooperate with the other Party in taking, or causing to be taken, all actions, and do or cause to be done all things, necessary, proper or advisable on its part under applicable Laws and rules and policies of Nasdaq to enable the de-listing of Company Shares from Nasdaq and the deregistration of Company Shares and other securities of the Company under the Exchange Act as promptly as practicable after the Effective Time; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that such delisting and deregistration shall not be effective until after the Effective Time. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;7.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Financing</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;From and after the date hereof until the earlier of the Completion or the termination of this Agreement pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">, in a timely manner so as not to delay the Completion, Parent shall use its reasonable best efforts to (i)&#160;take, or cause to be taken, all appropriate action, and to do, or cause to be done, all things necessary, proper or advisable to consummate, no later than the date the Completion is required to occur pursuant to this Agreement, the Financing on the terms set forth in the Debt Agreement and (ii)&#160;satisfy or cause to be satisfied (or waived) on a timely basis all conditions to funding described in the Debt Agreement. Parent shall not, without the prior written consent of the Company, agree to, or permit, any amendment, restatement, amendment and restatement, replacement, supplement, or other modification of, or waiver or consent under, any provision of the Debt Agreement that would (i)&#160;reasonably be expected to adversely affect the occurrence of Completion, (ii)&#160;reduce the aggregate amount of the Financing below the amount required at Completion, (iii)&#160;impose new or additional conditions precedent to the funding of the Financing or expand upon any existing conditions precedent to the funding of the Financing described in the Debt Agreement that would make the funding of the Financing less likely to occur in any material respect or (iv)&#160;affect the ability of Parent to enforce its rights against the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-60</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tSEC17">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">other parties to the Debt Agreement. Upon the Company&#8217;s written request, Parent shall deliver to the Company copies of any amendment, restatement, amendment and restatement, replacement, supplement, modification, waiver or consent with respect to the Debt Agreement promptly following the effectiveness thereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;In the event any portion of the Financing contemplated by the Debt Agreement becomes unavailable regardless of the reason therefor (as determined by Parent in its reasonable discretion), (i)&#160;Parent shall notify the Company in writing of such unavailability and the reason therefor and (ii)&#160;Parent shall use its reasonable best efforts, and shall cause each of its Subsidiaries to use their reasonable best efforts, to obtain as promptly as practicable following the occurrence of such event, alternative debt financing for any such portion from alternative sources (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Alternative Financing</font><font style="letter-spacing:0.2pt;">&#8221;) in an amount sufficient, when taken together with cash of Parent and its Subsidiaries and the other sources of funds immediately available to Parent at the Completion to pay the Financing Amounts and on terms and conditions that, in respect of certainty of funding, either (x)&#160;are equivalent to (or more favorable to Parent than) the conditions set forth in the Debt Agreement or (y)&#160;would not be expected to prevent, delay or impede Completion. Upon the Company&#8217;s written request, Parent shall deliver to the Company true, correct and complete copies of all contracts pursuant to which any alternative financing source shall have committed to provide any portion of the Alternative Financing promptly following the effectiveness thereof (with any fee letters or &#8220;flex&#8221; rights redacted in a customary manner as described in Section&#160;6.2(A)(e)(ii)). In addition to the foregoing, the Parent may also obtain Alternative Financing at its sole discretion which replaces the Financing, so long as the Parent is able to give the representations set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.2(A)(e)</font><font style="letter-spacing:0.2pt;"> with respect to such Alternative Financing as at the date such Alternative Financing becomes effective (with references to &#8220;date hereof,&#8221; the &#8220;Financing,&#8221; &#8220;Financing Sources&#8221; and &#8220;Debt Agreement&#8221; &#8203;(and other like terms) in that section deemed to have been replaced with references to the date such Alternative Financing, the commitments thereunder and the agreements with respect thereto becomes effective). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent shall provide the Company prompt written notice (i)&#160;of any expiration or termination of, or any material breach, default or violation by any party to, the Debt Agreement and (ii)&#160;of the receipt by Parent of any notice or other communication, in each case from any Financing Source with respect to any (x)&#160;material breach, default, violation, termination or repudiation by any party to the Debt Agreement or (y)&#160;material dispute or disagreement between or among Parent, on the one hand, and the Financing Sources, on the other hand, including any dispute or disagreement with respect to the obligation to fund the Financing or the amount of the Financing to be funded at Completion. To the extent requested in writing by the Company from time to time, Parent shall promptly provide the Company with updates on a reasonably current basis on the status of the Financing. Parent shall, to the extent not publicly filed, provide copies of all executed credit agreements and indentures and any amendments, modifications, replacements or waivers relating to the Financing or any Indebtedness that is a takeout to the Financing (or notice that such documents have been publicly filed). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Notwithstanding anything contained in this Agreement to the contrary, Parent expressly acknowledges and agrees that its obligations under this Agreement, including its obligations to consummate the Completion, are not conditioned in any manner upon Parent obtaining the Financing or any other financing. To the extent Parent obtains Alternative Financing pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.6(b)</font><font style="letter-spacing:0.2pt;"> or amends, replaces, supplements, modifies or waives any of the Financing, references to the &#8220;Financing,&#8221; &#8220;Financing Sources&#8221; and &#8220;Debt Agreement&#8221; &#8203;(and other like terms in this Agreement) shall be deemed to refer to such Alternative Financing, the commitments thereunder and the agreements with respect thereto, or the Financing as so amended, replaced, supplemented, modified or waived. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;7.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Financing Cooperation</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Until the earlier of the Completion and the termination of this Agreement pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;IX</font><font style="letter-spacing:0.2pt;">, the Company shall use its reasonable best efforts, and shall cause each of its Subsidiaries to use its reasonable best efforts, and shall use its reasonable best efforts to cause its and their respective officers, employees and advisors and other Representatives, including legal and accounting advisors, to provide to Parent and its Subsidiaries such assistance as may be reasonably requested by Parent that is customary in connection with the offering, arranging, obtaining, syndication, consummation, issuance or sale of the Financing, including with respect to: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-61</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;participating in and assisting with the due diligence, syndication or other marketing of the Financing, including with respect to (A)&#160;the participation by members of management of the Company with appropriate seniority in a reasonable number of meetings, presentations, road shows, drafting sessions, due diligence sessions and sessions with prospective lenders, investors and rating agencies, at times and at locations reasonably acceptable to the Company and upon reasonable notice, (B)&#160;assisting with Parent&#8217;s preparation of customary materials for registration statements, offering documents, private placement memoranda, bank information memoranda, prospectuses, rating agency presentations, syndication documents and other syndication materials, including information memoranda, lender and investor presentations, bank books and other marketing documents and similar documents required in connection with any portion of the Financing (collectively, &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Marketing Material</font><font style="letter-spacing:0.2pt;">&#8221;) and due diligence sessions related thereto, (C)&#160;delivering and consenting to the inclusion or incorporation in any SEC filing related to the Financing of the historical audited consolidated financial statements and unaudited consolidated interim financial statements of the Company included or incorporated by reference into the Company SEC Documents (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Historical Financial Statements</font><font style="letter-spacing:0.2pt;">&#8221;) and (D)&#160;delivering customary authorization letters, management representation letters, confirmations, and undertakings in connection with the Marketing Material (in each case, as applicable, subject to customary confidentiality provisions and disclaimers); </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;timely furnishing Parent and its Financing Sources with historical financial and other customary information (collectively, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Financing Information</font><font style="letter-spacing:0.2pt;">&#8221;) with respect to the Company and its Subsidiaries as is reasonably requested by Parent or its Financing Sources and customarily required in Marketing Material for Financings of the applicable type, including all Historical Financial Statements and other customary information with respect to the Company and its Subsidiaries (A)&#160;of the type that would be required by Regulation&#160;S-X and Regulation&#160;S-K under the Securities Act if the Financing were incurred by Parent and registered on Form S-3 under the Securities Act, including audit reports of annual financial statements to the extent so required (which audit reports shall not be subject to any &#8220;going concern&#8221; qualifications), or (B)&#160;reasonably necessary to permit Parent to prepare pro&#160;forma financial statements in accordance with Regulation&#160;S-X in order to comply with Parent&#8217;s obligations under the Exchange Act and the rules and regulations thereunder or as customary for Financings of the applicable type; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;providing to Parent&#8217;s legal counsel and its independent auditors such customary documents and other customary information relating to the Company and its Subsidiaries as may be reasonably requested in connection with their delivery of any customary negative assurance opinions and customary comfort letters relating to the Financing; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;causing the Company&#8217;s independent auditors to provide customary cooperation with respect to the Financing, including by using reasonable best efforts to cause the Company&#8217;s independent auditors to provide customary comfort letters (including &#8220;negative assurance&#8221; comfort, if customary and appropriate) in connection with any capital markets transaction comprising a part of the Financing or contemplated as part of any refinancing of the Financing, including at the time of pricing and closing, to the applicable Financing Sources, and by providing customary representation letters to the extent required by such independent auditor in connection with the foregoing; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;obtaining the consents of the Company&#8217;s independent auditors to use their audit reports on the audited Historical Financial Statements of the Company and to references to such independent auditors as experts in any Marketing Material and registration statements and related government filings filed or used in connection with the Financing; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;obtaining the Company&#8217;s independent auditors&#8217; customary assistance with the due diligence activities of the Financing Sources; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;causing the Financing to benefit from the existing lender relationships of the Company and its Subsidiaries; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(viii)&nbsp;&nbsp;&nbsp;cooperating with internal and external counsel of Parent in connection with providing customary back-up certificates and factual information regarding any legal opinion that such counsel may be required to deliver in connection with the Financing; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-62</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ix)&nbsp;&nbsp;&nbsp;providing documents reasonably requested by Parent or the Financing Sources relating to the repayment or refinancing of any indebtedness for borrowed money of the Company or any of its Subsidiaries to be repaid or refinanced on the Completion Date and the release of related Liens or guarantees (if any) effected thereby, including customary payoff letters delivered to Parent in draft form at least four (4)&#160;Business Days prior to the Completion Date and in executed form at least one&#160;(1) Business Day prior to the Completion Date and (to the extent required) evidence that notice of any such repayment has been timely delivered to the holders of such indebtedness or waived by the requisite holders, in each case in accordance with the terms of the definitive documents governing such indebtedness (provided that any such notice or payoff letter may be expressly conditioned on the Completion); </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(x)&nbsp;&nbsp;&nbsp;procuring consents to the reasonable use of all of the Company&#8217;s logos in connection with the Financing (provided, that such logos are used solely in a manner that is not intended to and is not reasonably likely to harm or disparage the Company or its Subsidiaries or the reputation or goodwill of the Company or any of its Subsidiaries); </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xi)&nbsp;&nbsp;&nbsp;providing at least four (4)&#160;Business Days in advance of the Completion Date such documentation and other information about the Company and its Subsidiaries as is reasonably requested in writing by Parent at least nine (9)&#160;Business Days in advance of the Completion Date in connection with the Financing that relates to applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including without limitation, the USA PATRIOT ACT; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xii)&nbsp;&nbsp;&nbsp;assisting with the preparation of and entry into (as of the Completion Date) definitive Financing agreements (including review of any disclosure schedules related thereto for completeness and accuracy) including credit agreements, note purchase agreements, indentures, schedules, exhibits, guarantees, pledge and security documents, perfection certificates, customary officers&#8217; certificates and corporate resolutions, as applicable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, in connection with any marketing efforts of the Parent Parties&#8217; Financing, the Parent may reasonably request the Company to file a Current Report on Form 8-K pursuant to the Exchange Act that contains material non-public information with respect to any member of the Company Group, which Parent, in consultation with the Financing Sources and upon the advice of outside counsel, reasonably determines is necessary to include in a registration statement, customary offering memorandum or other offering document for the Financing (each an &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Offering Document</font><font style="letter-spacing:0.2pt;">&#8221;) in order to (i)&#160;correct any untrue statement of a material fact or an omission of a material fact necessary in order to make the statements therein not misleading or (ii)&#160;to cause such Offering Document to comply with the requirements of the Securities Act. The Company shall consider such request promptly, and if the Company approves of such request (such approval not be unreasonably withheld), then the Company shall promptly file such Current Report on Form 8-K in a form reasonably satisfactory to the Company. Notwithstanding anything to the contrary in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.7</font><font style="letter-spacing:0.2pt;">, the Company shall not be obligated to effect any such filing of a Current Report on Form&#160;8-K pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.7</font><font style="letter-spacing:0.2pt;"> if in the good faith judgment of the Company Board it would be detrimental to the Company and its shareholders for such Current Report on Form 8-K to be filed at such time or in the near future, in which case the Company shall not be obligated to file such Current Report on Form 8-K. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding anything to the contrary in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.7(a)</font><font style="letter-spacing:0.2pt;">, (A)&#160;none of the Company nor any of its Subsidiaries shall be required to take or permit the taking of any action pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.7(a)</font><font style="letter-spacing:0.2pt;"> to (i)&#160;pay any commitment or other fee or incur any liability (other than third-party costs and expenses that are to be promptly reimbursed by Parent upon request by the Company pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.7(b)</font><font style="letter-spacing:0.2pt;">), (ii)&#160;execute or deliver any definitive financing documents or any other agreement, certificate, document or instrument, or agree to any change to or modification of any existing agreement, certificate, document or instrument, in each case that would be effective prior to the Completion Date or would be effective if the Completion does not occur (except (x)&#160;customary officers&#8217; certificates relating to the execution thereof that would not conflict with applicable Law and would be accurate in light of the facts and circumstances at the time delivered and (y)&#160;the authorization letters and management representation letters delivered pursuant to the clause (i)(D) above), (iii)&#160;provide access to or disclose information that the Company or any of its Subsidiaries reasonably determines would jeopardize any attorney-client privilege of the Company or any of its Subsidiaries (provided, that the Company shall, and shall cause its Subsidiaries to, use their respective </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-63</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tSEC18">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">reasonable best efforts to cause any such information to be disclosed in a manner that would not result in the loss of any such privilege), (iv)&#160;deliver or cause its Representatives to deliver any legal opinion, (v)&#160;be an issuer or other obligor with respect to the Financing that is effective prior to the Completion or (vi)&#160;prepare any pro&#160;forma financial information or projections, (B)&#160;none of the Company Board, officers of the Company, or directors and officers of the Subsidiaries of the Company shall be required to adopt resolutions or consents approving the agreements, documents or instruments pursuant to which the Financing is obtained, and (C)&#160;neither the Company nor any of its Subsidiaries shall be required to take or permit the taking of any action that would (i)&#160;interfere unreasonably with the business or operations of the Company or its Subsidiaries, (ii)&#160;cause any representation or warranty in this Agreement to be breached by the Company or any of its Subsidiaries (unless waived by Parent), (iii)&#160;cause any director, officer or employee or shareholder of the Company or any of its Subsidiaries to incur any personal liability, (iv)&#160;result in a material violation or breach of, or a default under, any material Contract to which the Company or any of its Subsidiaries is a party, the Organizational Documents of the Company or its Subsidiaries or any material applicable Law, (v)&#160;cause any covenant, representation or warranty in this Agreement to be breached or condition to this Agreement to fail to be satisfied or (vi)&#160;deliver any certificate that it reasonably believes in good faith contains any untrue certifications. Parent shall cause all non-public or other confidential information provided by or on behalf of the Company or any of its Subsidiaries or Representatives pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.7</font><font style="letter-spacing:0.2pt;"> to be kept confidential in accordance with the Confidentiality Agreement; provided, that the Company acknowledges and agrees that the confidentiality undertakings that will be obtained in connection with syndication of the Financing will be in a form customary for use in the syndication of acquisition-related debt during a takeover offer period in compliance with the requirements of the Panel and the Takeover Rules. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If the Completion does not occur and following the valid termination of this Agreement in accordance with its terms, Parent shall reimburse the Company promptly upon written demand for all reasonable and documented third-party out-of-pocket costs and expenses (including reasonable attorneys&#8217; fees) actually incurred by the Company Group in connection with its obligations under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.7</font><font style="letter-spacing:0.2pt;"> (and, for the avoidance of doubt, if Completion does occur, such costs and expenses may be paid by the Company or Parent at or following Completion) provided that the Company Group (and not Parent) shall be responsible for any amounts that would otherwise have been incurred in the absence of the financing cooperation contemplated by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.7</font><font style="letter-spacing:0.2pt;">, and shall indemnify and hold harmless the Company, its Subsidiaries and their respective Representatives from and against any and all liabilities, losses, damages, claims, expenses (including attorneys&#8217; fees), interest, judgments and penalties suffered or incurred by them, in connection with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.7</font><font style="letter-spacing:0.2pt;"> (other than to the extent resulting from (x)&#160;information provided by the Company or its Subsidiaries in writing in accordance with the terms hereof to the extent such information, as provided, is inaccurate or misleading or (y)&#160;the Company&#8217;s or its Subsidiaries&#8217; or Representatives&#8217; willful misconduct or gross negligence, as determined by a final non-appealable judgment of a court of competent jurisdiction), in each case whether or not the Completion is consummated or this Agreement is terminated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Transaction Litigation</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to the last sentence of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.8</font><font style="letter-spacing:0.2pt;">, the Company shall promptly notify Parent of any stockholder Actions (including class actions or derivative claims) commenced against it, its Subsidiaries or its or its Subsidiaries&#8217; respective directors, officers or Representatives relating to this Agreement or any of the transactions contemplated hereby or any matters relating hereto (collectively, &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Transaction Litigation</font><font style="letter-spacing:0.2pt;">&#8221;) and shall keep Parent informed regarding any Transaction Litigation. Other than with respect to any Transaction Litigation where the Parties are adverse to each other, the Company shall reasonably cooperate with Parent in the defense or settlement of any Transaction Litigation, and shall give Parent the opportunity to consult with it regarding the defense and settlement of such Transaction Litigation and shall consider in good faith Parent&#8217;s advice with respect to such Transaction Litigation and the Company shall give Parent the opportunity to participate in, at Parent&#8217;s expense, the defense and settlement of such Transaction Litigation (to the extent that the attorney-client privilege between the Company and its counsel is not undermined or otherwise adversely affected). Prior to the Effective Time, other than with respect to Transaction Litigation where the Parties are adverse to each other, neither the Company nor any of its Subsidiaries shall settle or offer to settle any Transaction Litigation without the prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed). The Company shall notify Parent promptly of the commencement or written threat of any Transaction Litigation of which it has received notice or become aware and shall keep Parent reasonably informed regarding any such Transaction Litigation. Notwithstanding anything to the contrary in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.8</font><font style="letter-spacing:0.2pt;">, in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-64</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tSEC19">&#8203;</a><a name="tSEC20">&#8203;</a><a name="tAVOA">&#8203;</a><a name="tSEC21">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the event of any conflict with any other covenant or agreement contained in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2</font><font style="letter-spacing:0.2pt;"> that expressly addresses the subject matter of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.8</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2</font><font style="letter-spacing:0.2pt;"> shall govern and control. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">State Takeover Statutes</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Each of Parent and the Company shall (a)&#160;take all action necessary so that no &#8220;moratorium&#8221;, &#8220;control share acquisition&#8221;, &#8220;fair price&#8221;, &#8220;supermajority&#8221;, &#8220;affiliate transaction&#8221; or &#8220;business combination&#8221; statute or regulation or other similar state anti-takeover Law, or any similar provision of the Organizational Documents of the Company or the Organizational Documents of Parent, as applicable, is or becomes applicable to the Scheme, the Acquisition or any of the other transactions contemplated hereby and (b)&#160;if any such Law or provision is or becomes applicable to the CVR Agreement, the Scheme, the Acquisition or any other transactions contemplated hereby, cooperate and grant such approvals and take such actions as are reasonably necessary so that the transactions contemplated hereby may be consummated as promptly as practicable on the terms contemplated hereby and otherwise act to eliminate or minimize the effects of such Law on the CVR Agreement, the Scheme, the Acquisition or the other transactions contemplated hereby. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">CVR Agreement</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;At or prior to the Effective Time, Parent shall authorize and duly adopt, execute and deliver, and will ensure that a duly qualified Rights Agent executes and delivers, the CVR Agreement, subject to any reasonable revisions to the CVR Agreement that are requested by such Rights Agent; provided, that such revisions are not, individually or in the aggregate, detrimental or adverse, taken as a whole, to any holder of a CVR. Parent and the Company shall reasonably cooperate, including by making any changes to the form of CVR Agreement, as necessary to ensure that the CVRs are not subject to registration under the Securities Act, the Exchange Act, any applicable state securities or &#8220;blue sky&#8221; laws or any applicable foreign securities laws. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE VIII</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">COMPLETION OF ACQUISITION AND MERGER</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;8.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Completion</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Completion Date</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Completion shall take place at 9:00&#160;a.m., New York City time, on a date to be selected by Parent in consultation with the Company as promptly as reasonably practicable following, but not later than the third (3rd) Business Day (or such shorter period of time as remains before 5:00&#160;p.m., New York City time, on the End Date) after, the satisfaction or, in the sole discretion of the applicable Party, waiver (where applicable) of all of the Conditions (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Completion Date</font><font style="letter-spacing:0.2pt;">&#8221;) (other than those Conditions that by their nature are to be satisfied at the Completion Date, but subject to the satisfaction or waiver of such Conditions at the Completion Date) with the exception of Condition 2.4 (but subject (where applicable) to the satisfaction or waiver (where applicable) of such Condition) or at such other date or time as may be mutually agreed to by Parent and the Company in writing, it being agreed that, only if reasonably practicable, Completion shall take place on the date that Condition 2.3 is satisfied. Completion shall take place at such place as may be mutually agreed to by Parent and the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;On or prior to Completion, the Company shall cause a meeting of the Company Board (or a duly authorized committee thereof) to be held at which resolutions are passed (conditional on registration of the Court Order with the Registrar of Companies occurring and effective as of the Effective Time) approving: </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;the removal of the directors of the Company as Parent shall determine; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;the appointment of such persons as Parent may nominate as the directors of the Company; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;the registration of the transfer to Parent (or its nominee(s)) in accordance with the Scheme of the relevant Company Shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;On or substantially concurrently with the Completion and subject to and in accordance with the terms and conditions of the Scheme: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;in respect of each Company Share subject to the Scheme (for the avoidance of doubt, excluding any Company Shares held by Parent or any Concert Parties of Parent), Parent shall pay, or cause to be paid (or deliver, or cause to be delivered in the case of the CVR Consideration), the Scheme </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-65</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tSEC22">&#8203;</a><a name="tART">&#8203;</a><a name="tSEC23">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:2pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Consideration, net of applicable withholding Taxes and without interest, on the terms and subject to the conditions set forth in this Agreement and the CVR Agreement; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;the Company shall deliver to Parent: </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp;a certified copy of the resolutions referred to in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8.1(b)</font><font style="letter-spacing:0.2pt;">; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(B)&nbsp;&nbsp;&nbsp;letters of resignation from the directors that are removed from the Company in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8.1(b)(i)</font><font style="letter-spacing:0.2pt;"> (each such letter to contain an acknowledgement that such resignation is without any claim or right of action of any nature whatsoever outstanding against the Company or the Company Group or any of their officers or employees for breach of contract, compensation for loss of office, redundancy or unfair dismissal or on any other grounds whatsoever in respect of the removal); and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;the Company shall cause an office copy of the Court Order to be delivered to the Companies Registration Office and use all reasonable endeavors to obtain from the Registrar of Companies a receipt in respect of the delivery of such Court Order and shall cause a copy of such receipt to be provided to Parent immediately following the Company&#8217;s receipt thereof. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;8.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Payment of Consideration</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Payment</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Within fourteen (14) days following the Effective Date, in respect of each Company Share subject to the Scheme (excluding Company Shares held by current or former employees of the Company Group that are subject to unvested Company Restricted Stock Awards as of immediately prior to the Effective Time), Parent shall pay, or cause to be paid, in respect of each holder of Company Shares at the Scheme Record Time, the Scheme Consideration in accordance with the terms and conditions of the Scheme. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Payroll</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As soon as reasonably practicable after the Completion (but no later than ten (10) Business Days after the Effective Time), Parent shall, or shall cause its Subsidiaries or the Company to, pay through payroll the aggregate Option Cash Consideration, Performance Option Cash Consideration, and Cash Consideration payable with respect to Company Equity Awards held by current or former employees of any member of the Company Group (net of withholding Taxes required to be deducted and withheld by applicable Laws); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that to the extent the holder of a Company Equity Award is not, and was not at any time during the vesting period of the Company Equity Award, an employee of the Company Group for employment tax purposes, Parent shall pay, or cause to be paid, the Option Cash Consideration and Cash Consideration payable pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.1</font><font style="letter-spacing:0.2pt;"> with respect to such Company Equity Award in the manner described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8.2(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Withholding</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Notwithstanding anything herein to the contrary, each of Parent, the Company and their respective Affiliates shall be entitled to deduct and withhold from any amount payable pursuant to this Agreement to any Person such amounts as Parent, the Company or such Affiliate is required to deduct and withhold with respect to the making of such payment under the Code or any other provision of federal, state, local or non-U.S. Tax Law. To the extent that amounts are so deducted and withheld and timely paid over to the appropriate Tax Authority, such deducted and withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of whom such deduction and withholding was made. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE IX</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TERMINATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section 9.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Termination</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;This Agreement may be terminated and the Acquisition and the other transactions contemplated hereby may be abandoned at any time prior to the Effective Time, in the case of: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-66</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;by either the Company or Parent: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp;if the Court Meeting or the EGM shall have been completed and the Court Meeting Resolution or the Required EGM Resolutions, as applicable, shall not have been approved by the requisite majorities (a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Non-Approval Termination</font><font style="letter-spacing:0.2pt;">&#8221;); </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(B)&nbsp;&nbsp;&nbsp;if the Effective Time shall not have occurred by 5:00&#160;p.m., New York City time, on the End Date; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the right to terminate this Agreement pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.1(a)(i)(B)</font><font style="letter-spacing:0.2pt;"> shall not be available to a Party whose breach of any provision of this Agreement shall have been the primary cause of the failure of the Effective Time to have occurred by such time; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(C)&nbsp;&nbsp;&nbsp;if the Acquisition is implemented by way of the Scheme, the High Court shall decline or refuse to sanction the Scheme, unless both Parties agree in writing within thirty (30) days of such decision that the decision of the High Court shall be appealed (it being agreed that the Company shall make such an appeal if requested to do so in writing by Parent and the respective counsels appointed by Parent and by the Company agree that doing so is a reasonable course of action); or </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(D)&nbsp;&nbsp;&nbsp;if there shall be in effect any applicable Law or final and non-appealable Order issued, promulgated, made, rendered or entered into by any Governmental Entity of competent jurisdiction, that permanently restrains, enjoins, makes illegal or otherwise prohibits the consummation of the Acquisition; provided that such right to terminate this Agreement shall not be available to any Party whose material breach of any provision of this Agreement shall have been the primary cause of such Law, order, writ, decree, judgment or injunction; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;by the Company: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp;if Parent shall have breached or failed to perform in any material respect any of its covenants or other agreements contained in this Agreement or if any of its representations or warranties set forth in this Agreement are inaccurate, which breach, failure to perform or inaccuracy (1) would result in a failure of Condition 5.2 or 5.3 as applicable and (2) is not reasonably capable of being cured by the End Date or, if curable, is not cured by the earlier of (x) the End Date and (y) thirty (30) days following written notice by the Company thereof (a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Parent Breach Termination</font><font style="letter-spacing:0.2pt;">&#8221;); or </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(B)&nbsp;&nbsp;&nbsp;prior to obtaining the Company Shareholder Approval, if (1) in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 5.2</font><font style="letter-spacing:0.2pt;">, the Company Board shall have authorized the Company to terminate this Agreement under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.1(a)(ii)(B)</font><font style="letter-spacing:0.2pt;"> in response to a Company Superior Proposal and (2) substantially concurrently with such termination, a definitive agreement providing for the consummation of the transactions contemplated by such Company Superior Proposal is duly executed and delivered by all parties thereto and, prior to or substantially concurrently with such termination, the Company pays Parent the applicable Reimbursement Amounts in accordance with this Agreement (it being understood that, without limiting the Company&#8217;s obligations under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.2(a)</font><font style="letter-spacing:0.2pt;"> of this Agreement, only such costs and expenses accrued prior to such termination and for which Parent submits to the Company in writing a request for such amounts and written invoices or written documentation supporting such request in accordance with the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.2</font><font style="letter-spacing:0.2pt;"> of the Agreement shall be due substantially concurrently with such termination (with respect to such written requests submitted prior to the termination) or within seven (7) Business Days following the submission of such amounts by Parent to the Company (with respect to such written requests submitted after the termination), subject at all times to the Cap) (a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Superior Proposal Termination</font><font style="letter-spacing:0.2pt;">&#8221;); </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;by Parent: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp;if the Company shall have breached or failed to perform in any material respect any of its covenants or other agreements contained in this Agreement or if any of its representations or warranties set forth in this Agreement are inaccurate, which breach, failure to perform or inaccuracy (1) would result in a failure of Condition 4.2 or 4.3 as applicable and (2) is not reasonably capable of being cured by the End Date or, if curable, is not cured by the earlier of (x) the End Date and (y) thirty (30) days following written notice by Parent thereof (a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Breach Termination</font><font style="letter-spacing:0.2pt;">&#8221;); or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-67</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tSEC24">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; text-indent:20pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(B)&nbsp;&nbsp;&nbsp;if, prior to the receipt of the Company Shareholder Approval, a Company Board Change of Recommendation shall have occurred (a &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Change of Recommendation Termination</font><font style="letter-spacing:0.2pt;">&#8221;); and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;by mutual written consent of the Company and Parent, subject to the consent of the Panel (if required). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The valid termination of this Agreement pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.1(a)</font><font style="letter-spacing:0.2pt;"> (1)&#160;shall not give rise to any liability of the Parties except as provided in the proviso to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.1(c)</font><font style="letter-spacing:0.2pt;"> and in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.2</font><font style="letter-spacing:0.2pt;"> and (2) the provisions set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article IX</font><font style="letter-spacing:0.2pt;"> (other than </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.1(a)</font><font style="letter-spacing:0.2pt;">) and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article X</font><font style="letter-spacing:0.2pt;"> (other than </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.1</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.2</font><font style="letter-spacing:0.2pt;">) of this Agreement shall survive, and continue in full force and effect, notwithstanding its termination. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Subject to the proviso in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.1(c)</font><font style="letter-spacing:0.2pt;">, upon valid termination of this Agreement pursuant to and in accordance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article IX</font><font style="letter-spacing:0.2pt;">, neither Party nor any of its Affiliates or its and their Representatives or shareholders shall have any liability in connection with this Agreement or the transactions contemplated hereby (including the Acquisition), other than the obligation of the Company (if applicable) to reimburse Parent for the Reimbursement Amount, subject to the Cap; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that nothing herein shall release any Party from liability (including any monetary damages or other appropriate remedy) for Willful Breach or for fraud or as provided for in the Confidentiality Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section 9.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Certain Effects of Termination</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;In the event of a Parent Payment Event, the Company shall reimburse Parent for the Reimbursement Amount, subject to the Cap (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Reimbursement Payment</font><font style="letter-spacing:0.2pt;">&#8221;), in immediately available funds within seven&#160;(7) Business Days following the Company&#8217;s receipt of invoices or written documentation supporting Parent&#8217;s request for a Reimbursement Payment. The Reimbursement Amount will be exclusive of any VAT but shall include any Irrecoverable VAT incurred by Parent or its Subsidiaries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;&#8221;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Parent Payment Event</font><font style="letter-spacing:0.2pt;">&#8221; means where the Parties have issued the Rule 2.7 Announcement and this Agreement is terminated in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.1(a)</font><font style="letter-spacing:0.2pt;">: </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;by Parent pursuant to a Change of Recommendation Termination; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;by the Company pursuant to a Superior Proposal Termination; or </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;all of the following occur: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp;this Agreement is terminated (x) by Parent pursuant to a Company Breach Termination as a result of a material breach or failure to perform any covenant or agreement in this Agreement described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.1(a)(iii)(A)</font><font style="letter-spacing:0.2pt;"> that (except with respect to a breach of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 5.2</font><font style="letter-spacing:0.2pt;">) first occurred following the making of a Company Alternative Proposal referenced in the following </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">clause (B)</font><font style="letter-spacing:0.2pt;"> or (y) by Parent or the Company pursuant to a Non-Approval Termination pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.1(a)(i)(A)</font><font style="letter-spacing:0.2pt;">, but if such termination is by the Company at such time Parent would be permitted to terminate this Agreement; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(B)&nbsp;&nbsp;&nbsp;prior to the date of such termination, a Company Alternative Proposal was publicly disclosed or announced and not withdrawn (or, in the case of a Company Breach Termination as a result of a material breach or failure to perform any covenant or agreement in this Agreement, was made publicly or privately to the Company Board), or any Person shall have publicly announced an intention (whether or not conditional) to make a Company Alternative Proposal that has not been withdrawn at least three (3) Business Days prior to the EGM; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(C)&nbsp;&nbsp;&nbsp;(x) a Company Alternative Proposal is consummated within twelve (12) months after such termination or (y) a definitive agreement providing for a Company Alternative Proposal is entered into within twelve (12) months after such termination and is subsequently consummated (it being understood that, for purposes of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.2(b)(iii)(C)</font><font style="letter-spacing:0.2pt;"> references to &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">20%</font><font style="letter-spacing:0.2pt;">&#8221; in the definition of Company Alternative Proposal shall be deemed to refer to &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">50%</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-68</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:28pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">VAT.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">VAT on the Reimbursement Payment.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Parent and the Company consider that any amounts payable under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.2</font><font style="letter-spacing:0.2pt;"> do not represent consideration for a taxable supply for VAT purposes and agree to use all reasonable efforts to secure that any Reimbursement Payment should not represent consideration for a taxable supply for VAT purposes (including not taking any contrary position in any Tax filing or return or in any correspondence with any Tax Authority). If and to the extent that any relevant Tax Authority determines that any Reimbursement Payment is consideration for a taxable supply made to the Company and that the Company (or any member of a VAT Group of which the Company is a member) of Parent is liable to account to a Tax Authority for VAT in respect of such supply, then: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp; the Reimbursement Payment shall be deemed to be exclusive of any such applicable VAT and any such VAT shall be due and payable by the Company (or any member of a VAT Group of which the Company is a member) in addition to the Reimbursement Payment to Parent (where Parent is liable to account to a Tax Authority for the VAT) immediately upon receipt of a valid VAT invoice; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(B)&nbsp;&nbsp;&nbsp;to the extent that the VAT is Irrecoverable VAT for the Company (or any member of a VAT Group of which the Company is a member) the sum of the total amount payable by the Company by way of any Reimbursement Payment, together with any Irrecoverable VAT arising in respect of the supply for which the Reimbursement Payment is consideration (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Irrecoverable VAT</font><font style="letter-spacing:0.2pt;">&#8221;), shall not exceed the Cap and the total amount of the Reimbursement Payment shall be reduced to ensure such; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(C)&nbsp;&nbsp;&nbsp;to the extent that the Company has already paid amounts in respect of any Reimbursement Payment the sum of which, when combined with any Company Irrecoverable VAT, exceeds the Cap, Parent shall repay to the Company, by way of a reduction in the amount of the Reimbursement Payment, an amount necessary to ensure that the sum of the total remaining Reimbursement Payment combined with any Company Irrecoverable VAT arising in connection with such does not exceed the Cap; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(D)&nbsp;&nbsp;&nbsp;the Company shall (and shall procure that any applicable member of the Company Group shall) accommodate any reasonable action that Parent requests, in writing and without delay, to avoid, dispute, defend, resist, appeal or compromise any determination of a Tax Authority that any Reimbursement Payment is consideration for a taxable supply for VAT purposes or that all or any part of such VAT is Irrecoverable VAT. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Recovered VAT</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If the Reimbursement Payment is reduced in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.2(c)(i)(B)</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">(C)</font><font style="letter-spacing:0.2pt;"> and the Company (or any member of a VAT Group of which the Company is a member) subsequently becomes entitled to recover all, or any part, of the Company Irrecoverable VAT amount as originally applied to the calculation in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.2(c)(i)(B)</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">(C)</font><font style="letter-spacing:0.2pt;"> whether by way of credit or refund from the relevant Tax Authority, the Company shall notify Parent without delay and the Reimbursement Payment shall be increased to reflect the correct amount of Company Irrecoverable VAT subject to a maximum of the original Reimbursement Payment. However, the increase of the Reimbursement Payment shall be subject to a maximum to ensure at all times that the sum of the total increased Reimbursement Payment combined with any remaining Company Irrecoverable VAT arising in connection with such does not exceed the Cap. Where there is an increase in the Reimbursement Payment in accordance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.2(d)</font><font style="letter-spacing:0.2pt;">, as soon as practicable (and, in any event, within five (5) Business Days of recovering whether by way of credit or refund any such VAT from the relevant Tax Authority), the Company (or the relevant member of a VAT Group of which the Company is a member) shall pay to Parent the appropriate amount by way of an increase in the Reimbursement Payment. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-69</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tART1">&#8203;</a><a name="tSEC25">&#8203;</a><a name="tSEC26">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE X</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">GENERAL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section 10.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Announcements</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to the requirements of applicable Law or the applicable rules of any securities exchange or Governmental Entity (including the Panel), the Parties shall consult with each other as to the terms of, the timing of and the manner of publication of any formal public announcement which either Party may make primarily regarding the Acquisition, the Scheme or this Agreement. Parent and the Company shall each give the other a reasonable opportunity to review and comment upon any such public announcement and shall not issue any such public announcement prior to such consultation, except as may be required by applicable Law or the applicable rules of any securities exchange or Governmental Entity (including the Panel). For clarity, the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.1</font><font style="letter-spacing:0.2pt;"> do not apply to any announcement, document or publication in connection with a Company Alternative Proposal, Company Superior Proposal or a Company Board Change of Recommendation or any amendment to the terms of the Scheme proposed by Parent that would effect an increase in the Scheme Consideration whether before or after an Company Board Change of Recommendation. Notwithstanding the foregoing: (a) each Party may, without such consultation or consent, make any public statement in response to questions from the press, analysts, investors or those attending industry conferences, make internal announcements to any officer or other employee, or individual who is an individual independent contractor, consultant or director, of or to any of the Company Group and make disclosures in Company SEC Documents, so long as such statements are consistent in tone and substance with previous press releases, public disclosures, public statements or statements to such Persons made jointly by the Parties (or individually, if approved by the other Party); and (b) a Party may, without the prior consent of the other Party hereto but subject to giving advance notice to the other Party, issue any such press release or make any such public announcement or statement as may be required by applicable Laws. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section 10.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Notices</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Any notice or other document to be served under this Agreement may be delivered by overnight delivery service (with proof of service) or hand delivery, or sent in writing (including email transmission), to the Party to be served as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;if to Parent, to: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Alkermes plc </font> <br ><font style="letter-spacing:0.2pt;">Connaught House </font> <br ><font style="letter-spacing:0.2pt;">1 Burlington Road </font> <br ><font style="letter-spacing:0.2pt;">Dublin 4, Ireland, D04 C5Y6 </font></div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Attention:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Secretary </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Email:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[***] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy (which shall not constitute notice) to: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Paul, Weiss, Rifkind, Wharton &amp; Garrison LLP </font> <br ><font style="letter-spacing:0.2pt;">1285 Avenue of the Americas </font> <br ><font style="letter-spacing:0.2pt;">New York, New York 10019-6064 </font></div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Attention:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">James E. Langston; Chelsea N. Darnell </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Email:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[***] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:68pt; margin-top:2pt; width:388pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[***] </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy (which shall not constitute notice) to: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">McCann FitzGerald </font> <br ><font style="letter-spacing:0.2pt;">Riverside One, Sir John Rogerson&#8217;s Quay </font> <br ><font style="letter-spacing:0.2pt;">Dublin 2, D02 X576, Ireland </font></div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Attention:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Stephen FitzSimons; Jack Kelly </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Email:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[***] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:68pt; margin-top:2pt; width:388pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[***] </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-70</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tSEC27">&#8203;</a><a name="tSEC28">&#8203;</a><a name="tSEC29">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;if to the Company, to: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Avadel Pharmaceuticals plc </font> <br ><font style="letter-spacing:0.2pt;">Ten Earlsfort Terrace </font> <br ><font style="letter-spacing:0.2pt;">Dublin 2, D02 T380, Ireland </font></div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Attention:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Greg Divis </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Email:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[***] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with copy (which shall not constitute notice) to: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Goodwin Procter LLP </font> <br ><font style="letter-spacing:0.2pt;">100 Northern Avenue </font> <br ><font style="letter-spacing:0.2pt;">Boston, Massachusetts 02210 </font></div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Attention:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Robert Puopolo; Blake Liggio; Caitlin Tompkins; </font>
          <br >
          <font style="letter-spacing:0.2pt;">Stephanie Isaia </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Email:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[***] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:68pt; margin-top:1.9pt; width:388pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[***] </font>
        </div>
        <div style="margin-left:68pt; margin-top:1.9pt; width:388pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[***] </font>
        </div>
        <div style="margin-left:68pt; margin-top:1.9pt; width:388pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[***] </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with copy (which shall not constitute notice) to: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Arthur Cox LLP </font> <br ><font style="letter-spacing:0.2pt;">Ten Earlsfort Terrace </font> <br ><font style="letter-spacing:0.2pt;">Dublin 2, D02 T380, Ireland </font></div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Attention:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Christopher McLaughlin; David Vos </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Email:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[***] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:68pt; margin-top:1.9pt; width:388pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[***] </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or such other postal or email address as it may have notified to the other Party in writing in accordance with the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.2</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;All such notices, requests and other communications shall be deemed received on the date of receipt by the recipient thereof if received prior to 5:00&#160;p.m. (addressee&#8217;s local time) on a Business Day. Otherwise, any such notice, request or communication shall be deemed to have been received on the next succeeding Business Day. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section 10.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Assignment</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Neither Party shall assign all or any part of its rights or obligations under this Agreement without the prior written consent of the other Party; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that Parent may assign any or all of its rights and obligations hereunder, in whole or from time to time in part, to one or more of its Subsidiaries (</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the prior consent in writing has been obtained from the Panel in respect of each such assignment), but no such assignment shall relieve Parent of its obligations hereunder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section 10.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Counterparts</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Agreement may be executed in any number of counterparts, all of which, taken together, shall constitute one and the same agreement, and each Party may enter into this Agreement by executing a counterpart and delivering it to the other Party (by hand delivery, e-mail or otherwise). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section 10.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Amendment</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;No amendment of this Agreement shall be binding unless the same shall be evidenced in writing duly executed by each of the Parties, except that, following approval by the Company Shareholders, there shall be no amendment to the provisions hereof which by applicable Law would require further approval by the Company Shareholders without such further approval nor shall there be any amendment or change not permitted under applicable Law. Notwithstanding anything to the contrary herein, this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.5</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.13(c)</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.13(d)</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.14</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.15</font><font style="letter-spacing:0.2pt;"> (and any provision of this Agreement and definitions of defined terms used herein (including the definition of &#8220;Financing Source&#8221;) to the extent a modification, waiver, or termination of such provision would modify the substance of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.5</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.13(c)</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.13(d)</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.14</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.15</font><font style="letter-spacing:0.2pt;">) may not be amended, supplemented, waived or otherwise modified in any manner adverse to the Financing Sources without the prior written consent of such Financing Sources party to any definitive agreement relating to the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-71</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tSEC30">&#8203;</a><a name="tSEC31">&#8203;</a><a name="tSEC32">&#8203;</a><a name="tSEC33">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Financing (it being expressly agreed that the Financing Sources in their capacities as such shall be third-party beneficiaries of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.5</font><font style="letter-spacing:0.2pt;"> and shall be entitled to the protections of the provisions contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.5</font><font style="letter-spacing:0.2pt;"> as if they were a party to this Agreement). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section 10.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Entire Agreement</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Agreement, together with the Confidentiality Agreement, the Rule 2.7 Announcement, the CVR Agreement and any documents delivered by Parent and the Company in connection herewith (including the Company Disclosure Schedule), constitutes the entire agreement and supersedes all prior agreements and understandings, both written and oral, between Parent and the Company with respect to the subject matter hereof, it being understood that the Confidentiality Agreement shall survive the execution and delivery of this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section 10.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Inadequacy of Damages</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Parties acknowledge and agree that irreparable harm would occur and that the Parties would not have any adequate remedy at Law (i) for any breach of any of the provisions of this Agreement or (ii) in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms. It is accordingly agreed that, except where this Agreement is validly terminated in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.1</font><font style="letter-spacing:0.2pt;">, the Parties shall be entitled to seek an injunction or injunctions to prevent breaches or threatened breaches of this Agreement and to specifically enforce the terms and provisions of this Agreement, without proof of actual damages, and each Party further agrees to waive any requirement for the securing or posting of any bond in connection with such remedy. Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.1(c)</font><font style="letter-spacing:0.2pt;">, the Parties further agree that (x) by seeking the remedies provided for in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.7</font><font style="letter-spacing:0.2pt;">, a Party shall not in any respect waive its right to seek any other form of relief that may be available to a Party under this Agreement and (y) nothing contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.7</font><font style="letter-spacing:0.2pt;"> shall require any Party to institute any proceeding for (or limit any party&#8217;s right to institute any proceeding for) specific performance under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.7</font><font style="letter-spacing:0.2pt;"> before exercising any termination right under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.1</font><font style="letter-spacing:0.2pt;"> (and pursuing damages after such termination), nor shall the commencement of any action pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.7</font><font style="letter-spacing:0.2pt;"> or anything contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.7</font><font style="letter-spacing:0.2pt;"> restrict or limit any Party&#8217;s right to terminate this Agreement in accordance with the terms of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.1</font><font style="letter-spacing:0.2pt;"> or pursue any other remedies under this Agreement that may be available then or thereafter. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section 10.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Disclosure Schedule References and SEC Document References</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Parties agree that each section or subsection of the Company Disclosure Schedule shall be deemed to qualify the corresponding section or subsection of this Agreement, irrespective of whether or not any particular section or subsection of this Agreement specifically refers to the Company Disclosure Schedule. The Parties further agree that (other than with respect to any items disclosed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 6.1(A)(k)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, for which an explicit reference in any other section shall be required in order to apply to such other section) disclosure of any item, matter or event in any particular section or subsection of the Company Disclosure Schedule shall be deemed disclosure with respect to any other section or subsection of the Company Disclosure Schedule to which the relevance of such disclosure would be reasonably apparent on its face, notwithstanding the omission of a cross-reference to such other section or subsections. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Parties agree that in no event shall any disclosure contained in any part of any Company SEC Document or Parent SEC Document entitled &#8220;Risk Factors&#8221;, &#8220;Forward-Looking Statements&#8221;, &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221;, &#8220;Special Note Regarding Forward Looking Statements&#8221; or &#8220;Note Regarding Forward Looking Statements&#8221; or any other disclosures in any Company SEC Document or Parent SEC Document that are cautionary, predictive or forward-looking in nature be deemed to be an exception to (or a disclosure for purposes of or otherwise qualify) any representations and warranties of any Party contained in this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section 10.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Remedies and Waivers</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;No delay or omission by either Party in exercising any right, power or remedy provided by Law or under this Agreement shall affect that right, power or remedy or operate as a waiver of it. The exercise or partial exercise of any right, power or remedy provided by Law or under this Agreement shall not preclude any other or further exercise of it or the exercise of any other right, power or remedy. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-72</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tSEC34">&#8203;</a><a name="tSEC35">&#8203;</a><a name="tSEC36">&#8203;</a><a name="tSEC37">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section 10.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Severability</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;If any term, provision, covenant or condition of this Agreement or the Acquisition is held by a court of competent jurisdiction or other Governmental Entity to be invalid, void or unenforceable, the Parties shall negotiate in good faith to modify this Agreement or, as appropriate, the terms and conditions of this Agreement and the Acquisition, so as to effect the original intent of the Parties as closely as possible in an equitable manner in order that the transactions contemplated hereby may be consummated as originally contemplated to the fullest extent possible in accordance with applicable Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If at any time any provision of this Agreement is or becomes illegal, invalid or unenforceable in any respect under the Law of any jurisdiction, that shall not affect or impair (i) the legality, validity or enforceability in that jurisdiction of any other provision of this Agreement; or (ii) the legality, validity or enforceability under the Law of any other jurisdiction of that or any other provision of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section 10.11&nbsp;&nbsp;&nbsp; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">No Partnership and No Agency</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Nothing in this Agreement and no action taken by the Parties pursuant to this Agreement shall constitute, or be deemed to constitute, a partnership, association, joint venture or other co-operative entity between any of the Parties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Nothing in this Agreement and no action taken by the Parties pursuant to this Agreement shall constitute, or be deemed to constitute, either Party the agent of the other Party for any purpose. No Party has, pursuant to this Agreement, any authority or power to bind or to contract in the name of the other Party to this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section 10.12&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Costs and Expenses</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except as otherwise provided in this Agreement (including </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.7(b)</font><font style="letter-spacing:0.2pt;"> hereof), all costs and expenses incurred in connection with this Agreement shall be paid by the Party incurring such cost or expense, except that (a) the Panel&#8217;s document review fees shall be borne by Parent, (b) the costs associated with the filing, printing, publication and proposing of the Rule 2.7 Announcement shall be borne one hundred&#160;percent (100%) by Parent, (c) the costs associated with the filing, printing, publication and proposing of the Scheme Document, Proxy Statement and any other materials required to be proposed to Company Shareholders pursuant to SEC rules, the Act or the Takeover Rules shall be borne one hundred&#160;percent (100%) by the Company, (d) the filing fees incurred in connection with notifications with any Governmental Entities under any Antitrust Laws, shall be borne one hundred&#160;percent (100%) by Parent and (e) the cost incurred in connection with soliciting proxies in connection with the Court Meeting and the EGM shall be borne one hundred&#160;percent (100%) by the Company. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section 10.13&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Governing Law and Jurisdiction</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;This Agreement and all Actions based upon, arising out of or related to this Agreement or the transactions contemplated hereby shall be governed by, and construed in accordance with, the Laws of the State of Delaware; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that the Acquisition and the Scheme and matters related thereto (including matters related to the Takeover Rules) shall, to the extent required by the Laws of Ireland, and the interpretation of the duties of directors of the Company shall, be governed by, and construed in accordance with, the Laws of Ireland. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Each of the Parties irrevocably agrees that the state and federal courts sitting in the State of Delaware, and any appellate courts therefrom, are to have exclusive jurisdiction to settle any Action based upon, arising out of or related to this Agreement or the transactions contemplated hereby and, for such purposes, irrevocably submits to the exclusive jurisdiction of such courts and waives, to the fullest extent permitted by Law, any objection which any of them may now or hereafter have to the laying of venue of, and the defense of an inconvenient forum to the maintenance of, any such Action in any such court. Any Action based upon, arising out of or related to this Agreement or the transactions contemplated hereby shall therefore be brought in the state and federal courts sitting in the State of Delaware, and any appellate courts therefrom. Notwithstanding the foregoing, the Scheme and matters related to the sanction thereof shall be subject to the jurisdiction of the High Court and any appellate courts therefrom. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-73</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tSEC38">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Notwithstanding anything in this Agreement to the contrary, each of the Parties, on behalf of itself, its Subsidiaries and its Affiliates, acknowledges and irrevocably agrees (i) that any Action (whether at Law, in equity, in contract, in tort or otherwise) arising out of, or in any way relating to, the Financing or the performance of services thereunder or related thereto against or by any Financing Source in its capacity as such shall be subject to the exclusive jurisdiction of any state or federal court sitting in the Borough of Manhattan, New York, New York, and any appellate court therefrom, and each Party hereto irrevocably submits for itself and its property with respect to any such Action to the exclusive jurisdiction of such courts, (ii) not to bring or support anyone else in bringing, or permit any of its Affiliates to bring or support anyone else in bringing, any such Action against or involving any of the Financing Sources in any other court, (iii) to irrevocably, knowingly, intentionally and voluntarily waive and hereby waive, to the fullest extent permitted by Law, any objection which any of them may now or hereafter have to the laying of venue of, and the defense of an inconvenient forum to the maintenance of, any such Action in any such court, (iv) that a final judgment in any such Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law, (v) that any such Action shall be governed by, and construed in accordance with, the Laws of the State of New York, (vi) that service of process in any such Action shall be effective if notice is given in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.2</font><font style="letter-spacing:0.2pt;"> and (vii) that no Financing Sources shall be subject to any special, consequential, punitive or indirect damages or damages of a tortious nature (it being expressly agreed that the Financing Sources in their capacities as such shall be third-party beneficiaries of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.13(c)</font><font style="letter-spacing:0.2pt;"> and shall be entitled to enforce the provisions contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.13(c)</font><font style="letter-spacing:0.2pt;"> as if they were a party to this Agreement). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;EACH PARTY HERETO, ON BEHALF OF ITSELF, ITS SUBSIDIARIES AND ITS AFFILIATES, HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, THE FINANCING, OR THE PERFORMANCE OF SERVICES THEREUNDER OR RELATED THERETO (INCLUDING ANY ACTION, PROCEEDING OR COUNTERCLAIM), INCLUDING IN ANY ACTION AGAINST OR BY ANY FINANCING SOURCE IN ITS CAPACITY AS SUCH, INCLUDING ANY ACTION DESCRIBED IN </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">SECTION 10.13(C)(I)</font><font style="letter-spacing:0.2pt;"> IN ANY SUCH COURT DESCRIBED IN </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">SECTION 10.13(C)</font><font style="letter-spacing:0.2pt;"> (IT BEING EXPRESSLY AGREED THAT THE FINANCING SOURCES IN THEIR CAPACITIES AS SUCH SHALL BE THIRD-PARTY BENEFICIARIES OF THIS </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">SECTION 10.13(D)</font><font style="letter-spacing:0.2pt;"> AND SHALL BE ENTITLED TO ENFORCE THE PROVISIONS CONTAINED IN THIS </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">SECTION 10.13(D)</font><font style="letter-spacing:0.2pt;"> AS IF THEY WERE A PARTY TO THIS AGREEMENT). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section 10.14&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Third-Party Beneficiaries</font><font style="letter-spacing:-0.2pt;">.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except to the extent: </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp; As expressly provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 7.3</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;as expressly provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 7.7(b)</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;as expressly provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.5</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;as expressly provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.13(c)</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;as expressly provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.13(d)</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;as expressly provided in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.14</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;as expressly provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.15</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;following the Effective Time, the rights of holders of CVRs solely to the extent necessary to receive payment in accordance with the CVR Agreement; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;following the Effective Time, the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 8.2</font><font style="letter-spacing:0.2pt;"> shall be enforceable by holders of Company Shares solely to the extent necessary to receive the Cash Consideration and the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 4.1</font><font style="letter-spacing:0.2pt;"> shall be enforceable by holders of awards under Company Stock Plans to the extent necessary to receive the amounts to which such holders are entitled thereunder, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-74</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tSEC39">&#8203;</a><a name="tSEC40">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:372pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">this Agreement is not intended to confer upon any person other than the Company and Parent any rights or remedies under or by reason of this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section 10.15&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Waiver of Claims Against Financing Sources</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Notwithstanding anything in this Agreement to the contrary and without limiting in any respect the liabilities of the Financing Sources to Parent or its Affiliates, or the remedies of Parent or its Affiliates against the Financing Sources under any other agreement to which they are both parties, none of the Financing Sources shall have any liability to the Parties or their Affiliates relating to or arising out of this Agreement or the Financing, whether at Law or equity, in contract, in tort or otherwise, and neither the Parties nor any of their Affiliates will have any rights or claims against the Financing Sources under this Agreement or the Financing. Notwithstanding anything herein to the contrary, in no event shall the Company or its Affiliates be entitled to seek the remedy of specific performance of this Agreement or any of the agreements entered into in connection with the Financing against any of the Financing Sources (it being expressly agreed that the Financing Sources in their capacities as such shall be third party beneficiaries of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.15</font><font style="letter-spacing:0.2pt;"> and shall be entitled to enforce the provisions contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 10.15</font><font style="letter-spacing:0.2pt;"> as if they were a party to this Agreement). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Section 10.16&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Non Survival of Representations and Warranties</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The representations, warranties, covenants and agreements contained in this Agreement and in any certificate or other writing delivered pursuant hereto shall not survive the Effective Time or the valid termination of this Agreement pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article IX</font><font style="letter-spacing:0.2pt;">, except that (i) </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 7.3</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article VIII</font><font style="letter-spacing:0.2pt;"> shall survive the Effective Time and (ii) </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 7.7(b)</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 9.2(b)</font><font style="letter-spacing:0.2pt;">-</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">(d) </font><font style="letter-spacing:0.2pt;">and this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article X</font><font style="letter-spacing:0.2pt;"> shall survive the valid termination of this Agreement pursuant to and in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article IX</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-75</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">IN WITNESS</font><font style="letter-spacing:0.2pt;"> whereof, the Parties have entered into this Agreement on the date specified above. </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">SIGNED</font><font style="letter-spacing:0.2pt;"> for and on behalf of </font>
          <br >
          <font style="font-weight:bold;letter-spacing:-0.2pt;">AVADEL PHARMACEUTICALS PLC</font><font style="letter-spacing:0.2pt;"> by its authorized signatory: </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:18pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:18pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">/s/ Declan O&#8217;Connor</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:240pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:33pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Name:</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:273pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Declan O&#8217;Connor</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:240pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:33pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Title:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:273pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Board Authorized Signatory </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">[Signature Page to Transaction Agreement]</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">IN WITNESS</font><font style="letter-spacing:0.2pt;"> whereof, the Parties have entered into this Agreement on the date specified above. </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">SIGNED</font><font style="letter-spacing:0.2pt;"> for and on behalf of </font>
          <br >
          <font style="font-weight:bold;letter-spacing:-0.2pt;">ALKERMES PLC</font><font style="letter-spacing:0.2pt;"> by its authorized signatory: </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:18pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:18pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">/s/ Gregory J. Divis</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:240pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:33pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Name:</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:273pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Gregory J. Divis</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:240pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:33pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Title:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:273pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">CEO </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">[Signature Page to Transaction Agreement]</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Exhibit A </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of CVR Agreement </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT A</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">FORM OF CONTINGENT VALUE RIGHTS AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [&#8226;], 2025 (this &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), is entered into by and among Alkermes plc, an Irish public limited company with registered number 498284 having its registered office at Connaught House, 1 Burlington Road, Dublin 4, Ireland D04 C5Y6 (&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;) and [RIGHTS AGENT] as the Rights Agent (as defined herein). Capitalized terms used but not defined herein shall have the meaning assigned to such terms in the Transaction Agreement (as defined herein). </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">RECITALS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, Parent and Avadel Pharmaceuticals plc, an Irish public limited company with registered number 572535 having its registered office at 10 Earslfort Terrace, Dublin 2, Ireland (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;), have entered into a Transaction Agreement, dated as of October 22, 2025 (as it may be amended, supplemented or otherwise modified from time to time pursuant to the terms thereof, the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Transaction Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), relating to a recommended offer (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Offer</font><font style="letter-spacing:0.2pt;">&#8221;) to be made by Parent for the entire issued and to be issued ordinary shares, nominal value $0.01 per share, of the Company (&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Company Shares</font><font style="letter-spacing:0.2pt;">&#8221;) to be implemented by the Scheme or, at the election of Parent and subject to the terms of the Transaction Agreement, by means of a takeover offer (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Acquisition</font><font style="letter-spacing:0.2pt;">&#8221;); and </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, as an integral part of the consideration of the Offer and the Acquisition, pursuant to and subject to the terms and conditions of the Transaction Agreement and the Rule 2.7 Announcement, (a)&#160;holders of Company Shares (other than any Company Shares beneficially owned by Parent or any member of the Parent Group (if any) and any Company Shares held by any member of the Company Group) (i)&#160;as of the Scheme Record Time or (ii) issued after the Scheme Record Time but prior to Completion and transferred to Parent on Completion pursuant to the Company Amended Articles, and (b) holders of Company Restricted Stock Awards, holders of Company Cash-Out Options, holders of Company Cash-Out Performance Options and holders of Company RSU Awards, at the Effective Time (any such holders in sub-paragraphs (a) and/or (b), the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Initial Holders</font><font style="letter-spacing:0.2pt;">&#8221;), will become entitled to receive one contingent cash payment, such payment being contingent upon, and subject to, the achievement of the Milestone (as defined below) prior to the earlier of the Milestone Expiration (as defined below) and the Termination (as defined below), subject to and in accordance with the terms of this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">NOW, THEREFORE, in consideration of the foregoing and the consummation of the transactions referred to above, the parties agree, for the equal and proportionate benefit of all Holders (as defined herein), as follows: </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE I</font>
          <br >
          <font style="letter-spacing:-0.2pt;">DEFINITIONS; CERTAIN RULES OF CONSTRUCTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section 1.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Definitions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As used in this Agreement, the following terms will have the following meanings: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Acquisition</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the preamble hereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Companies Act 2014 of Ireland, all enactments which are to be read as one with, or construed or read together as one with, the Act and every statutory modification and reenactment thereof for the time being in force. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Acting Holders</font><font style="letter-spacing:0.2pt;">&#8221; means, at the time of determination, Holders of not less than forty&#160;percent (40%) of outstanding CVRs as set forth in the CVR Register. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Agreement</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the preamble hereto. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Assignee</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 6.3(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Change of Control</font><font style="letter-spacing:0.2pt;">&#8221; means (a) a sale or other disposition of all or substantially all of the assets of Parent on a consolidated basis (other than to any Subsidiary (direct or indirect) of Parent), (b) a merger or consolidation involving Parent in which Parent is not the surviving entity, and (c) any other transaction </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">involving Parent in which Parent is the surviving or continuing entity but in which the shareholders of Parent immediately prior to such transaction (as shareholders of Parent) own less than 50% of Parent&#8217;s voting power immediately after the transaction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;font-style:normal;letter-spacing:0.2pt;">Claims</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; means all claims, counterclaims and defenses asserted (whether on or after the date hereof) in the following cases: </font><font style="letter-spacing:0.2pt;">Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC</font><font style="font-style:normal;letter-spacing:0.2pt;">, C.A. No. 21-00691; </font><font style="letter-spacing:0.2pt;">Jazz Pharmaceuticals, Inc. et al v. Avadel CNS Pharmaceuticals, LLC</font><font style="font-style:normal;letter-spacing:0.2pt;">, C.A. No. 21-01138; </font><font style="letter-spacing:0.2pt;">Jazz Pharmaceuticals, Inc. et al v. Avadel CNS Pharmaceuticals, LLC</font><font style="font-style:normal;letter-spacing:0.2pt;">, C.A. No. 21-01594; </font><font style="letter-spacing:0.2pt;">Avadel CNS Pharmaceuticals, LLC et al v. Jazz Pharmaceuticals, Inc. et al</font><font style="font-style:normal;letter-spacing:0.2pt;">, C.A. No. 22-00487; </font><font style="letter-spacing:0.2pt;">Avadel CNS Pharmaceuticals, LLC v. Jazz Pharmaceuticals, Inc.</font><font style="font-style:normal;letter-spacing:0.2pt;">, C.A. No. 22-00941; </font><font style="letter-spacing:0.2pt;">Avadel CNS Pharmaceuticals, LLC et al v. Jazz Pharmaceuticals, Inc., et al</font><font style="font-style:normal;letter-spacing:0.2pt;">, C.A. No. 25-00009; </font><font style="letter-spacing:0.2pt;">Avadel CNS Pharmaceuticals, LLC et al v. Jazz Pharmaceuticals, Inc. et al</font><font style="font-style:normal;letter-spacing:0.2pt;">, C.A. No. 25-00057; </font><font style="letter-spacing:0.2pt;">Avadel CNS Pharmaceuticals, LLC et al v. Jazz Pharmaceuticals, Inc., et al</font><font style="font-style:normal;letter-spacing:0.2pt;">, C.A. No. 25-00221; and </font><font style="letter-spacing:0.2pt;">Avadel CNS Pharmaceuticals, LLC et al v. Jazz Pharmaceuticals, Inc. et al</font><font style="font-style:normal;letter-spacing:0.2pt;">, C.A. No. 25-00435, each brought in the United States District Court for the District of Delaware. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Commercially Reasonable Efforts</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to a particular task, activity or obligation, those commercially reasonable efforts that are at least commensurate with the level of efforts that a pharmaceutical company of comparable size and resources as those of Parent and its Affiliates would devote to the development and seeking of regulatory approval for pharmaceutical products, which are of similar market potential at a similar stage in their development or product life (&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Relevant Products</font><font style="letter-spacing:0.2pt;">&#8221;), taking into account issues of safety, tolerability and efficacy, product profile, the competitiveness of other products in development and in the marketplace, market exclusivity, supply chain management considerations, the proprietary position of the Relevant Products (including with respect to patent or regulatory exclusivity), and the regulatory structure involved, the projected cost, the profitability or expected profitability of the Relevant Products (including pricing and reimbursement status achieved or expected to be achieved), such pharmaceutical company&#8217;s product portfolio at the time of consideration, and, in each case, other relevant technical, commercial, strategic, legal, scientific or medical factors. For clarity, &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Commercially Reasonable Efforts</font><font style="letter-spacing:0.2pt;">&#8221; shall be determined on an indication-by-indication, product-by-product and country-by-country basis, and it is anticipated that the level of efforts for different indications, products and countries may differ or change over time, reflecting changes in the status of the products, indications and country(ies) involved. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the recitals hereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Company Amended Articles</font><font style="letter-spacing:0.2pt;">&#8221; means the Articles of Association of the Company, as amended or adopted pursuant to the EGM. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Company Shares</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the recitals hereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">CVR Product</font><font style="letter-spacing:0.2pt;">&#8221; means the Company&#8217;s proprietary formulation of sodium oxybate known as LUMRYZ</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> (sodium oxybate) for extended-release oral suspension approved for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7&#160;years of age or older with narcolepsy, pursuant to New Drug Application (&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">NDA</font><font style="letter-spacing:0.2pt;">&#8221;) No. 214755, including amendments and supplements thereto. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">CVR Register</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 2.3(b)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">CVRs</font><font style="letter-spacing:0.2pt;">&#8221; means the rights of Holders hereunder (granted to Initial Holders as part of the consideration of the Acquisition pursuant to the terms of the Transaction Agreement and the Rule 2.7 Announcement) to receive a contingent cash payment on the terms and subject to the conditions of this Agreement, the Transaction Agreement and the Rule 2.7 Announcement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Depositary</font><font style="letter-spacing:0.2pt;">&#8221; means [&#8226;]. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">DTC</font><font style="letter-spacing:0.2pt;">&#8221; means The Depository Trust Company or any successor thereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Equity Award CVR</font><font style="letter-spacing:0.2pt;">&#8221; means a CVR received by an Initial Holder in respect of Company Cash-Out Options, Company Cash-Out Performance Options, Company Restricted Stock Awards (excluding a CVR received in respect of a Company Restricted Stock Award to which an election under Section 83(b) of the Code has been timely made and provided to Parent), or Company RSU Awards. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Final Determination</font><font style="letter-spacing:0.2pt;">&#8221; means with respect to (a) U.S. federal income Taxes, a &#8220;determination&#8221; within the meaning of Section 1313(a) of the Code or execution of an IRS Form 870-AD and (b) Taxes other than U.S. federal income Taxes, any final determination of liability in respect of a Tax that, under applicable Law, is not subject to further appeal, review or modification through proceedings or otherwise (including the expiration of a statute of limitations or a period for the filing of claims for refunds, amended returns or appeals from adverse determinations). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Funds</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 2.6</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Holder</font><font style="letter-spacing:0.2pt;">&#8221; means a Person in whose name a CVR is registered in the CVR Register as of the applicable date and time of determination. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Indication</font><font style="letter-spacing:0.2pt;">&#8221; means the treatment of idiopathic hypersomnia in adults. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Initial Holders</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the recitals hereto. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">IRS</font><font style="letter-spacing:0.2pt;">&#8221; means the Internal Revenue Service. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Legal Event</font><font style="letter-spacing:0.2pt;">&#8221; means the dismissal of the Claims with prejudice by the United States District Court for the District of Delaware pursuant to the Settlement and License Agreement, by and between the Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited, on the one hand, and Avadel CNS Pharmaceuticals LLC and Flamel Ireland Limited, on the other hand, dated October 21, 2025. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">LUMRYZ Approval</font><font style="letter-spacing:0.2pt;">&#8221; means approval by the United States Food and Drug Administration (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">FDA</font><font style="letter-spacing:0.2pt;">&#8221;) of an application submitted to the FDA for the commercial marketing and sale of the CVR Product in the United States for the Indication; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that, &#8220;LUMRYZ Approval&#8221; shall be deemed achieved upon receipt of written notice from the FDA that the CVR Product has been approved for the Indication in the United States and which is not blocked by any third party orphan-drug exclusivity, regardless of whether any risk evaluation and mitigation strategies or other conditions are imposed by the FDA, provided that such approval permits commercial marketing and sale of the CVR Product for the Indication in the United States. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Milestone</font><font style="letter-spacing:0.2pt;">&#8221; means the occurrence of (a) LUMRYZ Approval and (b) the Legal Event. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Milestone Expiration</font><font style="letter-spacing:0.2pt;">&#8221; means 11:59&#160;p.m., Eastern Time on December 31, 2028. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Milestone Notice</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 2.4(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Milestone Payment</font><font style="letter-spacing:0.2pt;">&#8221; means (a) if the Milestone is achieved before both (i) the Milestone Expiration and (ii) the Termination, an amount equal to $1.50, in cash, without interest, per CVR, and (b) if the Milestone is achieved at or after (i) the Milestone Expiration or (ii) the Termination, $0 per CVR. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Milestone Payment Amount</font><font style="letter-spacing:0.2pt;">&#8221; means, for a given Holder, with respect to the achievement of the Milestone, the product of (a) the Milestone Payment and (b) the number of CVRs held by such Holder as reflected on the CVR Register as of the close of business on the date of the Milestone Notice. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Milestone Payment Date</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 2.4(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Offer</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the recitals hereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Officer&#8217;s Certificate</font><font style="letter-spacing:0.2pt;">&#8221; means a certificate signed by an authorized officer of Parent, in his or her capacity as such an officer, and delivered to the Rights Agent. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the preamble hereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Permitted CVR Transfer</font><font style="letter-spacing:0.2pt;">&#8221; means: a transfer of CVRs (a) by will or intestacy upon death of a Holder; (b) by instrument to an inter vivos or testamentary trust in which the CVRs are to be passed to beneficiaries upon the death of the settlor; (c) pursuant to a court order; (d) by operation of law (including by consolidation or merger of the Holder) or if effectuated without consideration in connection with the dissolution, liquidation or termination of any Holder that is a corporation, limited liability company, partnership or other entity; (e) in the case of CVRs held in book-entry or other similar nominee form, from a nominee to a beneficial owner, and if applicable, through an intermediary; (f) if the Holder is a partnership </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or limited liability company, a distribution by the transferring partnership or limited liability company to its partners or members, as applicable (</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that such distribution or transfer does not subject the CVRs to a requirement of registration under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended); or (g) as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 2.7</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Qualified Pharmaceutical Company</font><font style="letter-spacing:0.2pt;">&#8221; means a company that, together with its Affiliates, in the good faith determination of Parent, has sufficient capabilities and experience in the development, manufacture, distribution and commercialization of pharmaceutical products as well as the financial resources to achieve the Milestone. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Rights Agent Account</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 2.4(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Rights Agent</font><font style="letter-spacing:0.2pt;">&#8221; means the Rights Agent named in the preamble of this Agreement, until a successor Rights Agent is appointed pursuant to the applicable provisions of this Agreement, and thereafter &#8220;Rights Agent&#8221; will mean such successor Rights Agent. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Scheme Record Time</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meaning given to it in the Scheme. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Scheme</font><font style="letter-spacing:0.2pt;">&#8221; means the proposed scheme of arrangement under Chapter 1 of Part 9 of the Act to effect the Acquisition pursuant to the Transaction Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Termination</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 6.8</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Transaction Agreement</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the recitals hereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section 1.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Rules of Construction</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;When reference is made in this Agreement to an Article, Section or Exhibit, such reference will refer to Articles and Sections of, and Exhibits to, this Agreement unless otherwise indicated. The word &#8220;extent&#8221; in the phrase &#8220;to the extent&#8221; shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply &#8220;if.&#8221; All references to &#8220;dollars&#8221; or &#8220;$&#8221; shall refer to the lawful currency of the United States. Whenever the words &#8220;include,&#8221; &#8220;includes,&#8221; or &#8220;including&#8221; are used in this Agreement, they will be deemed to be followed by the words &#8220;without limitation.&#8221; The words &#8220;hereof,&#8221; &#8220;herein,&#8221; &#8220;hereby,&#8221; &#8220;hereto,&#8221; and &#8220;hereunder&#8221; and words of similar import when used in this Agreement will refer to this Agreement as a whole and not to any particular provision of this Agreement. The word &#8220;or&#8221; will not be exclusive. The word &#8220;will&#8221; shall be construed to have the same meaning and effect as the word &#8220;shall.&#8221; Unless otherwise indicated, the word &#8220;or&#8221; shall not be exclusive (</font><font style="font-style:italic;letter-spacing:0.2pt;">i.e.</font><font style="letter-spacing:0.2pt;">, &#8220;or&#8221; shall be deemed to mean &#8220;and/or&#8221;). Whenever used in this Agreement, any noun or pronoun will be deemed to include the plural as well as the singular and to cover all genders. Any reference to any Person shall be construed to include such Person&#8217;s successors and assigns. The words &#8220;ordinary course of business&#8221; shall mean the ordinary course of business consistent with past practice. This Agreement will be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting or causing any instrument to be drafted. The parties hereto have participated jointly in the negotiation and drafting of this Agreement and, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the parties hereto and no presumption of burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of this Agreement. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE II</font>
          <br >
          <font style="letter-spacing:-0.2pt;">CONTINGENT VALUE RIGHTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section 2.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">CVRs</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each CVR represents the contractual right of a Holder (granted to each Initial Holder as part of the consideration of the Offer and the Scheme pursuant to the terms of the Transaction Agreement and the Rule 2.7 Announcement) to receive the Milestone Payment pursuant to, and subject to the terms and conditions of, this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section 2.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Nontransferable</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than through a Permitted CVR Transfer; the foregoing restrictions shall apply notwithstanding that certain of the CVRs will be held through DTC. Any attempted sale, assignment, transfer, pledge, encumbrance or disposition of CVRs, in whole or in part, in violation of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 2.2</font><font style="letter-spacing:0.2pt;"> shall be void ab initio and of no effect. The CVRs will not be listed on any quotation system or traded on any securities exchange. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:32pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section 2.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Certificate; Registration; Registration of Transfer; Change of Address</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The CVRs will be issued in book entry form only and will not be evidenced by a certificate or other instrument. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Rights Agent will create and maintain a register (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">CVR Register</font><font style="letter-spacing:0.2pt;">&#8221;) for the purpose of (i)&#160;identifying the Holders of CVRs and (ii) registering CVRs in book-entry position and Permitted CVR Transfers thereof. The CVR Register shall set forth (x) with respect to holders of Company Shares that hold such shares in book-entry form through DTC as of the Scheme Record Time or, in respect of Company Shares issued following the Scheme Record Time but prior to Completion and transferred to Parent (or its nominee) on Completion pursuant to the Company Amended Articles, such holders as of immediately prior to Completion, one (1) position for Cede &amp; Co. (as nominee of DTC) representing all such Company Shares that were subject of the Scheme or transferred to the Parent pursuant to the Company Amended Articles, and (y) with respect to (A) holders of Company Shares that hold such shares in certificated form as of the Scheme Record Time or, in respect of Company Shares issued following the Scheme Record Time but prior to Completion and transferred to Parent (or its nominee) on Completion pursuant to the Company Amended Articles, such holders as of immediately prior to Completion, upon delivery to the Depositary by each such holder of the applicable share certificates, together with a validly executed letter of transmittal and such other customary documents as may be reasonably requested by the Depositary, in accordance with the Scheme or the transfer pursuant to the Company Amended Articles (as applicable), (B)&#160;holders of Company Restricted Stock Awards, (C) holders of Company RSU Awards, and (D) holders of Company Cash-Out Options, (E) holders of Company Cash-Out Performance Options, in each case of clauses (A), (B), (C), (D) and (E), the applicable number of CVRs to which each such holder is entitled pursuant to the Transaction Agreement. The CVR Register will be updated as necessary by the Rights Agent to reflect the addition or removal of Holders (pursuant to any Permitted CVR Transfer), upon the written receipt of such information by the Rights Agent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Subject to the restrictions on transferability set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 2.2</font><font style="letter-spacing:0.2pt;">, every request made to transfer a CVR must be in writing and accompanied by a written instrument of transfer, in form reasonably satisfactory to the Rights Agent pursuant to its guidelines, duly executed by the Holder thereof, the Holder&#8217;s attorney duly authorized in writing, the Holder&#8217;s personal representative duly authorized in writing, or the Holder&#8217;s survivor (with written documentation evidencing such person&#8217;s status as the Holder&#8217;s survivor), and setting forth in reasonable detail the circumstances relating to the requested transfer. Upon receipt of such written notice, the Rights Agent will, subject to its reasonable determination that the transfer instrument is in proper form and the transfer otherwise complies with the other terms and conditions of this Agreement (including the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 2.2</font><font style="letter-spacing:0.2pt;">), register the transfer of the CVRs in the CVR Register. As a condition of such transfer, Parent and the Rights Agent may require a transferring Holder or its transferee to pay to the applicable Governmental Entity any transfer, stamp or other similar Tax or governmental charge that is imposed in connection with any such registration of transfer. The Rights Agent shall have no duty or obligation to take any action under any section of this Agreement that requires the payment by a Holder of a CVR of such applicable Taxes or charges unless and until the Rights Agent is reasonably satisfied that all such Taxes or charges have been paid or that such Taxes or charges are not applicable. All CVRs duly transferred in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section 2.2</font><font style="letter-spacing:0.2pt;"> that are registered in the CVR Register will be the valid obligations of Parent and will entitle the transferee to the same benefits and rights under this Agreement as those held immediately prior to the transfer by the transferor. No transfer of a CVR will be valid until registered in the CVR Register in accordance with this Agreement, and any transfer not duly registered in the CVR Register shall be null and void ab initio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;A Holder may make a written request to the Rights Agent to change such Holder&#8217;s address of record in the CVR Register. The written request must be duly executed by the Holder. Upon receipt of such written notice, the Rights Agent will promptly record the change of address in the CVR Register. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section 2.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Payment Procedures; Notices</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;If the Milestone is achieved prior to the Milestone Expiration and before the Termination (it being understood that, if the FDA has issued one or more orders that impose a clinical hold on the investigation of the CVR Product for the Indication, the Milestone shall not be deemed achieved unless or until no such order is in effect), then on or prior to the date that is fifteen (15) Business Days following the achievement of the Milestone (such date, the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Milestone Payment Date</font><font style="letter-spacing:0.2pt;">&#8221;), Parent shall (A) deliver to the Rights Agent (x) a written notice indicating that the Milestone has been achieved (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Milestone Notice</font><font style="letter-spacing:0.2pt;">&#8221;) and an Officer&#8217;s Certificate certifying the date of such achievement and that the Holders are entitled to receive the Milestone Payment and (y) any letter of instruction reasonably required by the Rights Agent, which shall set forth the Milestone Payment in respect of the Milestone as of the date of the Milestone Notice and (B) deliver to Rights Agent for payment to the Holders who are not Holders of Equity Award CVRs, the aggregate amount in immediately available funds necessary to pay the Milestone Payment Amount to each Holder who is not a Holder of an Equity Award CVR to the account set forth on Annex I hereto, which account information may be updated from time to time by the Rights Agent by prior written notice to Parent (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Rights Agent Account</font><font style="letter-spacing:0.2pt;">&#8221;). For the avoidance of doubt, the Milestone Payment shall only be due once, if at all, subject to the conditions set forth herein. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Rights Agent will promptly, and in any event within ten (10)&#160;Business Days after receipt of the Milestone Notice, any letter of instruction reasonably required by the Rights Agent and the Milestone Payment as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">, send each Holder at its registered address a copy of the Milestone Notice and pay the Milestone Payment Amount to each Holder (other than a Holder of an Equity Award CVR) (i)&#160;by check mailed to the address of each Holder as reflected in the CVR Register as of the close of business on the date of the Milestone Notice, or (ii)&#160;with respect to any such Holder that is due an amount in excess of $100,000 in the aggregate who has provided the Rights Agent wiring instructions in writing as of the close of business on the date of the Milestone Notice, by wire transfer of immediately available funds to the account specified on such instruction. Parent will, or will cause its Affiliates to, pay the applicable Milestone Payment Amount to each Holder of an Equity Award CVR within ten (10)&#160;Business Days of delivery of the Milestone Notice to the Rights Agent, subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(c)</font><font style="letter-spacing:0.2pt;">&#160;of this Agreement, through the Company&#8217;s or the applicable Affiliate&#8217;s payroll. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Notwithstanding anything herein to the contrary, each of Parent, the Company, the Rights Agent and their respective Affiliates shall be entitled to deduct and withhold from the Milestone Payment Amount or any other amount payable pursuant to this Agreement to any Person such amounts as Parent, the Company, the Rights Agent or such Affiliate is required to deduct and withhold with respect to the making of such payment under the Code or any other provision of federal, state, local or non-U.S. Tax Law. With respect to Initial Holders who received Equity Award CVRs, any such withholding may be made, or caused to be made, by Parent through its Affiliates&#8217; payroll system or any successor payroll system. Prior to paying the Milestone Payment Amount to the Holders, the Rights Agent shall provide the opportunity for each Holder to provide a copy of a duly executed IRS Form&#160;W-9 or appropriate IRS Form&#160;W-8, as applicable, or any other forms or information that the Rights Agent may reasonably request in order to avoid or reduce any applicable withholding amount. Unless otherwise directed by Parent, the Rights Agent shall promptly and timely remit, or cause to be remitted, any amounts withheld in respect of Taxes to the appropriate Governmental Entity. To the extent that any amounts are so deducted and withheld and properly timely paid over to the appropriate Tax Authority, such deducted and withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of whom such deduction and withholding was made. The parties intend that each Equity Award CVR is exempt from or in compliance with Section&#160;409A of the Code, and this Agreement shall be interpreted and administered in accordance therewith. None of the parties to this Agreement nor any of their employees, directors or representatives shall have any liability to a Holder or transferee or other Person in respect of Section&#160;409A of the Code. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;It is intended that each payment provided under this Agreement with respect to an Equity Award CVR is a separate &#8220;payment&#8221; for purposes of Section&#160;1.409A-2(b)(2)(i)&#160;of the U.S. Treasury Regulations. The parties intend that each payment in respect of an Equity Award CVR is exempt from or in compliance with Section&#160;409A of the Code and the Treasury Regulations and other guidance issued thereunder and any state law of similar effect (collectively &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;409A</font><font style="letter-spacing:0.2pt;">&#8221;), and this Agreement shall be interpreted and administered in accordance therewith and, to the extent not so exempt, that the payments with respect to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Equity Award CVRs comply, and this Agreement be interpreted to the greatest extent possible, as consistent with Treasury Regulations&#160;Section&#160;1.409A-3(i)(5)(iv)(A)&#160;&#8201;&#8212;&#8201;that is, as &#8220;transaction-based compensation.&#8221; Therefore, payments under this Agreement may be earned or paid after the fifth (5th) anniversary of the Completion Date. The parties intend to treat each Milestone as a valid performance condition and each respective Milestone Payment as subject to a substantial risk of forfeiture as defined under Section&#160;409A. None of the parties to this Agreement nor any of their employees, directors or representatives make any representation or warranty and shall have no liability to a Holder or transferee or other Person in respect of Section&#160;409A. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Any portion of a Milestone Payment Amount delivered to the Rights Agent that remains undistributed twelve (12) months after the date of the delivery of the Milestone Notice will be returned by the Rights Agent to Parent, upon demand, and any Holder will thereafter be entitled to receive, subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(f)</font><font style="letter-spacing:0.2pt;">, payment of the applicable Milestone Payment Amount, only from Parent, without interest, but such Holder will have no greater rights against Parent than those accorded to general unsecured creditors of Parent under applicable Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;None of Parent, any of its Affiliates or the Rights Agent will be liable to any person in respect of any Milestone Payment Amount or portion thereof delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law. If, despite efforts by the Rights Agent to deliver the Milestone Payment Amount to the applicable Holder pursuant to the Rights Agent&#8217;s customary unclaimed funds procedures, such Milestone Payment Amount has not been paid prior to the date on which such Milestone Payment Amount would otherwise escheat to or become the property of any Governmental Entity, such Milestone Payment Amount will, to the extent permitted by applicable Law, become the property of Parent, free and clear of all claims or interest of any person previously entitled thereto. In addition to and not in limitation of any other indemnity obligation herein, Parent agrees to indemnify and hold harmless the Rights Agent with respect to any liability, penalty, cost or expense the Rights Agent may incur or be subject to in connection with transferring such property to Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;The Rights Agent shall be responsible for information reporting required under applicable Law with respect to the CVRs to the extent required under applicable Law. Parent shall use commercially reasonable efforts to cooperate with the Rights Agent to provide any information in Parent&#8217;s possession and not otherwise available to the Rights Agent as is reasonably necessary for the Rights Agent to carry out its obligations in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(g)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;2.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Voting, Dividends or Interest; No Equity or Ownership Interest in Parent or any of its Affiliates</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The CVRs will not have any voting or dividend rights, and interest will not accrue on any amounts payable on the CVRs to any Holder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The CVRs will not represent any equity or ownership interest in Parent, any constituent corporation party to the Transaction Agreement or any of their respective Affiliates or Subsidiaries. The rights of the Holders and the obligations of Parent are contract rights limited to those expressly set forth in this Agreement, and such Holders&#8217; sole right to receive property hereunder is the right to receive cash from Parent, if any, through the Rights Agent in accordance with the terms hereof. It is hereby acknowledged and agreed that the CVRs shall not constitute securities of Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;No fiduciary or similar duties are owed by Parent, its Affiliates, or their respective officers, directors, employees, or agents to any Holder by virtue of this Agreement or the CVRs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;2.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Holding of Funds</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;All funds received by the Rights Agent under this Agreement that are to be distributed or applied by the Rights Agent in the performance of its services hereunder (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Funds</font><font style="letter-spacing:0.2pt;">&#8221;) shall be held by the Rights Agent as agent for Parent and deposited in one or more segregated bank accounts to be maintained by the Rights Agent in its name as agent for Parent. Until paid pursuant to the terms of this Agreement, the Rights Agent will hold the Funds through such accounts in deposit accounts of commercial banks with Tier 1 capital exceeding $1&#160;billion or with an average rating above investment grade by S&amp;P (LT Local Issuer Credit Rating), Moody&#8217;s (Long Term Rating) and Fitch Ratings,&#160;Inc. (LT Issuer Default Rating) (each as reported by Bloomberg Finance L.P.). The Rights Agent shall have no responsibility or liability for any diminution of the Funds that may result from any deposit made </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">by the Rights Agent in accordance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6</font><font style="letter-spacing:0.2pt;">, including any losses resulting from a default by any bank or financial institution; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that in the event the Funds are diminished below the level required for the Rights Agent to make the Milestone Payment Amount (to the extent remaining due) to Holders that are not Holders of Equity Award CVRs, as required under this Agreement, including any such diminishment as a result of investment losses, Parent shall promptly pay additional cash to the Rights Agent in an amount equal to the deficiency in the amount required to make such payments. The Rights Agent may from time to time receive interest, dividends or other earnings in connection with such deposits. The Rights Agent shall not be obligated to pay such interest, dividends or earnings to Parent, any Holder or any other Person. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;2.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Ability to Abandon CVR</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A Holder may at any time, at such Holder&#8217;s option, abandon all of such Holder&#8217;s remaining rights in a CVR by transferring such CVR to Parent without consideration therefor, which a Holder may effect via delivery of a written abandonment notice to Parent. Nothing in this Agreement shall prohibit Parent or any of its Affiliates from offering to acquire or acquiring any CVRs for consideration from the Holders, in private transactions or otherwise, in its or their sole discretion. Any CVRs acquired by Parent or any of its Affiliates shall be automatically deemed extinguished and no longer outstanding or entitled to any Milestone Payment or to count for the purpose of any vote or determination of Acting Holders for purposes of this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;2.8&nbsp;&nbsp;&nbsp; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Tax Treatment</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;For U.S. federal, and applicable state and local, income Tax purposes, except to the extent that any portion of any Milestone Payment Amount is required to be treated as imputed interest under applicable Tax Law, the parties hereto intend to treat the Milestone Payments made in respect of the CVRs (other than the Equity Award CVRs) issued in exchange for Company Shares as additional consideration for, or in respect of, such Company Shares pursuant to the Transaction Agreement (and not to treat the issuance of such CVRs to holders of Company Shares as a payment itself), and none of the parties hereto will take any position to the contrary on any Tax Return, or any other filing with a Governmental Entity related to Taxes or for other Tax purposes, except as otherwise required by a Final Determination. The parties hereto intend to treat the Milestone Payments made in respect of Equity Award CVRs as additional compensation for or in respect of the applicable Company Equity Awards (and not to treat the issuance of the CVR to holders of Company Equity Awards as a payment itself). The parties hereto will report imputed interest on such CVRs to the extent required by applicable Law. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE&#160;III</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE RIGHTS AGENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;3.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Liability</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Rights Agent will not have any liability for any actions taken or not taken in connection with this Agreement, except to the extent such liability arises as a result of its willful or intentional misconduct, bad faith or gross negligence (in each case as determined by a final non-appealable judgment of a court of competent jurisdiction). Notwithstanding anything in this Agreement to the contrary, other than in the case of willful or intentional misconduct, bad faith, fraud or gross negligence (in each case as determined by a final non-appealable judgment of a court of competent jurisdiction), any liability of the Rights Agent under this Agreement will be limited to two (2)&#160;times the amount of fees paid (but not including reimbursable expenses) in the twelve (12) months preceding the event for which recovery is sought in connection with this Agreement. Anything to the contrary notwithstanding, in no event will the Rights Agent be liable for special, punitive, indirect, incidental or consequential loss or damages of any kind whatsoever (including, without limitation, lost profits), even if the Rights Agent has been advised of the likelihood of such loss or damages, and regardless of the form of action. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;3.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Certain Duties and Responsibilities</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Rights Agent shall not have any duty or responsibility in the case of the receipt of any written demand from any Holder with respect to any action or default by any person or entity, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make any demand upon Parent; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.2</font><font style="letter-spacing:0.2pt;"> shall not affect the Rights Agent&#8217;s obligation to make payments in accordance with and subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;3.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Certain Rights of the Rights Agent</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Rights Agent undertakes to perform such duties and only such duties as are specifically set forth in this Agreement, and no implied covenants or obligations will be read into this Agreement against the Rights Agent. In addition: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;the Rights Agent may rely and will be protected and held harmless by Parent in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order or other paper or document reasonably believed by it in good faith to be genuine and to have been signed or presented by the proper party or parties; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;whenever the Rights Agent will deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Rights Agent may rely upon an Officer&#8217;s Certificate, which certificate shall be full authorization and protection to the Rights Agent, and the Rights Agent shall, in the absence of bad faith, gross negligence or willful or intentional misconduct (each as determined by a final non-appealable judgment of a court of competent jurisdiction) on its part, incur no liability and be held harmless by Parent for or in respect of any action taken, suffered or omitted to be taken by it under the provisions of this Agreement in reliance upon such certificate; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;the Rights Agent may engage and consult with counsel of its selection and the written advice of such counsel or any written opinion of counsel will be full and complete authorization and protection to the Rights Agent and the Rights Agent shall be held harmless by Parent in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon and that does not constitute gross negligence or willful or intentional misconduct; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;the permissive rights of the Rights Agent to do things enumerated in this Agreement will not be construed as a duty; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;the Rights Agent will not be required to give any note or surety in respect of the execution of such powers or otherwise in respect of the premises; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;the Rights Agent shall not be liable for or by reason of, and shall be held harmless by Parent with respect to, any of the statements of fact or recitals contained in this Agreement or be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by Parent only; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;the Rights Agent will have no liability and shall be held harmless by Parent in respect of the validity of this Agreement or the execution and delivery hereof (except the due execution and delivery hereof by the Rights Agent and the enforceability of this Agreement against the Rights Agent assuming the due execution and delivery hereof by Parent); nor shall it be responsible for any breach by Parent of any covenant or condition contained in this Agreement; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(viii)&nbsp;&nbsp;&nbsp;Parent agrees to indemnify the Rights Agent for, and hold the Rights Agent harmless against, any loss, liability, damage, judgment, fine, penalty, claim, demands, suits or expense arising out of or in connection with the Rights Agent&#8217;s performance of its duties under this Agreement (excluding any Taxes, interest, penalties or other costs or expenses imposed on the payment of fees hereunder), including the reasonable and documented out-of-pocket costs and expenses of defending the Rights Agent against any claims, charges, demands, suits or loss arising out of or in connection with the execution, administration, exercise and performance of its duties under this Agreement, including the reasonable and documented out-of-pocket costs and expenses of defending against any claim of liability arising therefrom, directly or indirectly, or enforcing its rights hereunder, unless such loss has been determined by a court of competent jurisdiction to have resulted from the Rights Agent&#8217;s willful or intentional misconduct, bad faith or gross negligence; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ix)&nbsp;&nbsp;&nbsp;Parent agrees (x)&#160;to pay the fees and expenses of the Rights Agent in connection with this Agreement, as agreed upon in writing in a fee schedule by the Rights Agent and Parent on or prior to the date hereof, which shall include reimbursement from Parent, for all reasonable, documented and necessary out-of-pocket expenses and disbursements paid or incurred in the preparation, delivery, negotiation, amendment, administration and execution of this Agreement and the exercise and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">performance by the Rights Agent of its duties hereunder and (y)&#160;to reimburse the Rights Agent for all Taxes and governmental charges (other than Taxes imposed on or measured by the Rights Agent&#8217;s net income and franchise or similar Taxes imposed on it (in lieu of net income Taxes)); </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that if the Rights Agent determines in good faith that it has received a refund of any Tax or governmental charge borne by Parent pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">clause (y)</font><font style="letter-spacing:0.2pt;">, the Rights Agent shall promptly repay such refund to Parent; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(x)&nbsp;&nbsp;&nbsp;no provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of its rights if it reasonably believes that repayment of such funds or adequate indemnification against such risk or liability is not reasonably assured to it; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xi)&nbsp;&nbsp;&nbsp;in the event the Rights Agent reasonably believes any ambiguity or uncertainty exists hereunder or in any notice, instruction, direction, request or other communication, paper or document received by the Rights Agent hereunder, the Rights Agent shall, as soon as practicable, provide written notice to Parent describing in detail the ambiguity or uncertainty it believes exists, and the Rights Agent shall seek clarification. Parent will respond to such request for clarification as promptly as reasonably practicable, and in any event within ten (10)&#160;Business Days. If such clarification is not provided within ten (10)&#160;Business Days, the Rights Agent may, in its sole discretion, refrain from taking any action, and shall be fully protected and shall not be liable in any way to Parent or any Holder or any other Person for refraining from taking such action, unless and until the Rights Agent receives written instructions from Parent which reasonably eliminate such ambiguity or uncertainty; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xii)&nbsp;&nbsp;&nbsp;the Rights Agent shall not be deemed to have knowledge of any event of which it was entitled to receive notice pursuant to the terms of this Agreement, and the Rights Agent shall be fully protected and shall incur no liability for failing to take action in connection with such event, in each case, unless and until such notice has been given in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiii)&nbsp;&nbsp;&nbsp;subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.3</font><font style="letter-spacing:0.2pt;">, the Rights Agent may perform any of its duties hereunder either directly or, with the prior written consent of Parent, by or through nominees, correspondents, designees, or subagents; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that in the event the Rights Agent performs any of its duties hereunder by or through any nominee, correspondent, designee, or subagent, the Rights Agent shall not be liable hereunder for any act, omission, default, neglect or misconduct of such nominee, correspondent, designee, or subagent, as applicable, to the Company resulting from any such act, default, neglect or misconduct, absent gross negligence, bad faith or willful or intentional misconduct (each as determined by a final, non-appealable judgment of a court of competent jurisdiction) in the selection or continued employment thereof; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiv)&nbsp;&nbsp;&nbsp;the Rights Agent shall neither be responsible for, nor chargeable with, knowledge of, nor have any requirements to comply with, the terms and conditions of the Transaction Agreement, nor shall the Rights Agent be required to determine if any Person has complied with the Transaction Agreement, nor shall any additional obligations of the Rights Agent be inferred from the terms of the Transaction Agreement even though reference thereto may be made in this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xv)&nbsp;&nbsp;&nbsp;the Rights Agent shall act hereunder solely as agent for Parent and shall not assume any obligations or relationship of agency or trust with any of the owners or holders of the CVRs; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xvi)&nbsp;&nbsp;&nbsp;the recitals or statements of fact contained herein shall be taken as statements of Parent (other than the Rights Agent&#8217;s representations, warranties and statements under this Agreement), and the Rights Agent assumes no responsibility for their correctness nor shall it be required to verify the same (other than the Rights Agent&#8217;s representations, warranties and statements under this Agreement). The Rights Agent shall be under no responsibility for the validity or sufficiency of this Agreement with respect to any other party hereto or the execution and delivery hereof (except the due execution hereof by the Rights Agent) or in respect of the validity or execution of the CVRs, nor shall it be responsible for any breach by Parent of any covenant or condition contained in this Agreement or any CVR. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The obligations of Parent and the rights of the Rights Agent under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.2</font><font style="letter-spacing:0.2pt;"> shall survive the Milestone Expiration and the Termination and the resignation, replacement or removal of the Rights Agent. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;3.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Resignation and Removal; Appointment of Successor</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Rights Agent may resign at any time by giving written notice thereof to Parent specifying a date when such resignation will take effect, which notice will be sent at least sixty (60) days prior to the date so specified and such resignation will become effective on the date so specified. Parent has the right to remove Rights Agent at any time by specifying a date when such removal will take effect and such removal will become effective on the date so specified. Notice of such removal will be given by Parent to Rights Agent, which notice will be sent at least sixty (60) days prior to the date so specified. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If the Rights Agent provides notice of its intent to resign, is removed pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.4(a)</font><font style="letter-spacing:0.2pt;">&#160;or becomes incapable of acting, Parent will as soon as is reasonably possible, appoint a qualified successor Rights Agent who, unless otherwise consented to in writing by the Acting Holders, shall be a stock transfer agent of national reputation or the corporate trust department of a commercial bank. The successor Rights Agent so appointed will, forthwith upon its acceptance of such appointment in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.5</font><font style="letter-spacing:0.2pt;">, become the successor Rights Agent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent will give notice of each resignation and each removal of a Rights Agent and each appointment of a successor Rights Agent by mailing written notice of such event by first-class mail to the Holders as their names and addresses appear in the CVR Register. Each notice will include the name and address of the successor Rights Agent. If Parent fails to send such notice within ten (10)&#160;Business Days after acceptance of appointment by a successor Rights Agent in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.5</font><font style="letter-spacing:0.2pt;">, the successor Rights Agent will cause the notice to be mailed at the expense of Parent; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that failure to give any notice provided for in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.4(a)</font><font style="letter-spacing:0.2pt;">, shall not affect the legality or validity of the resignation or removal of the Rights Agent or the appointment of the&#160;successor Rights Agent, as the case may be, in each case, in accordance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.4</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;The Rights Agent will reasonably cooperate with Parent and any successor Rights Agent as reasonably requested in connection with the transition of the duties and responsibilities of the Rights Agent to the successor Rights Agent, including transferring the CVR Register to the successor Rights Agent, but such predecessor Rights Agent shall not be required to make any additional expenditure without compensation or reimbursement by Parent or assume any additional liability in connection with the foregoing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;3.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Acceptance of Appointment by Successor</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Every successor Rights Agent appointed pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.4(b)</font><font style="letter-spacing:0.2pt;">&#160;hereunder will execute, acknowledge and deliver to Parent and to the retiring Rights Agent an instrument accepting such appointment and a counterpart of this Agreement, and thereupon such successor Rights Agent, without any further act, deed or conveyance, will become vested with all the rights, powers, trusts and duties of the retiring Rights Agent and all references to the &#8220;Rights Agent&#8221; herein shall be deemed to refer to such successor Rights Agent. On request of Parent or the successor Rights Agent, the retiring Rights Agent will execute and deliver an instrument transferring to the successor Rights Agent all the rights, powers and trusts of the retiring Rights Agent, except such rights which survive its resignation or removal under the terms hereunder. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE&#160;IV</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">COVENANTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;4.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">List of Holders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent will furnish or cause to be furnished to the Rights Agent in such form as Parent receives from the Company&#8217;s transfer agent (or other agent performing similar services for the Company with respect to the Company Shares, Company Performance Options, Company Restricted Stock Awards, Company RSU Awards or Company Options), the names and addresses of the Initial Holders of CVRs within fourteen (14) days after the Effective Time. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;4.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Additional Covenants</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;From the Effective Time through the earlier of the Milestone Expiration and achievement of the Milestone (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Milestone Efforts Period</font><font style="letter-spacing:0.2pt;">&#8221;), Parent (i)&#160;shall, and shall cause its Subsidiaries, licensees and rights transferees to, use Commercially Reasonable Efforts to achieve the Milestone and (ii)&#160;shall not take any action with the sole purpose of preventing or materially delaying the achievement of the Milestone; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">provided that use of Commercially Reasonable Efforts does not guarantee that Parent will achieve the Milestone by a specific date or at all. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;In the event that the Milestone has not yet been achieved and Parent desires to consummate a Change of Control prior to the Milestone Expiration, solely in the event that the obligations set forth in this Agreement would not continue to be obligations of Parent, Parent will reconfirm its obligations, duties and covenants under this Agreement and, if applicable, will cause the Person acquiring Parent to assume Parent&#8217;s obligations, duties and covenants under this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Subject to the other provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.2</font><font style="letter-spacing:0.2pt;">, Parent and its Affiliates shall have the right, in their sole and absolute discretion, to direct and control the research, development (including the clinical trial process), commercialization and other exploitation of the CVR Product and all of the Company&#8217;s other pharmaceutical products in all respects, including any determination to test, develop, pursue, market, make any regulatory filings or seek regulatory approval with respect to, commence or continue any sale of, or make any other strategic decisions affecting, the CVR Product and all of the Company&#8217;s other pharmaceutical products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Notwithstanding anything in this Agreement or otherwise to the contrary (including in any agreement between any of Parent, the Company, any subsidiaries or Affiliates thereof, any shareholder, equity holder or any other counterparty) but without prejudice to the application of the Takeover Rules&#160;(to the extent applicable), the only rights and interests of the Holders (or any person seeking the benefit of any CVR) in respect of a CVR shall be those set forth in this Agreement and no Holder (or any person acting on their behalf or for their benefit) may enforce any other right or interest against any person in respect of a CVR. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE&#160;V</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AMENDMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;5.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Amendments without Consent of Holders</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent and the Rights Agent, at any time and from time to time, may enter into one or more amendments hereto, without the consent of any Holders, for any of the following purposes: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;to evidence the succession of another Person to Parent and the assumption by any such successor of the covenants of Parent herein as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.2(b)</font><font style="letter-spacing:0.2pt;">&#160;or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.3</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;to add to the covenants of Parent such further covenants, restrictions, conditions or provisions as Parent and the Rights Agent will consider to be for the protection of the Holders; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that, in each case, such provisions do not adversely affect the interests of the Holders; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;to cure any ambiguity, to correct or supplement any provision herein that may be defective or inconsistent with any other provision herein, or to make any other provisions with respect to matters or questions arising under this Agreement; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that, in each case, such provisions do not adversely affect the interests of the Holders; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;as may be necessary or appropriate to ensure that the CVRs are not subject to registration under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, and the rules&#160;and regulations promulgated thereunder, and to ensure that the CVRs are not subject to any similar registration or prospectus requirement under applicable securities laws outside of the United States; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that, in each case, such provisions do not change the Milestone, the Milestone Expiration or the Milestone Payment; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;to evidence the succession of another Person as a successor Rights Agent and the assumption by any such successor of the covenants and obligations of the Rights Agent herein in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.4</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.5</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;any other amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement, provided that such amendments do not adversely affect the interests of the Holders; or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;if required, to reduce the number of CVRs in the event any Holder agrees to abandon or renounce such Holder&#8217;s rights under this Agreement in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.7</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.4</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Promptly after the execution by Parent and the Rights Agent of any amendment pursuant to the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.1</font><font style="letter-spacing:0.2pt;">, Parent will mail (or cause the Rights Agent to mail at the expense of Parent) a notice thereof by first class mail to the Holders at their addresses as they appear on the CVR Register, setting forth the terms of such amendment. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;5.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Amendments with Consent of Holders</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp; Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.1</font><font style="letter-spacing:0.2pt;"> (which amendments pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.1</font><font style="letter-spacing:0.2pt;"> may be made without the consent of the Holders), with the consent of the Acting Holders, whether evidenced in writing or taken at a meeting of the Holders, Parent and the Rights Agent may enter into one or more amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement, even if such addition, elimination or change is materially adverse to the interest of the Holders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Promptly after the execution by Parent and the Rights Agent of any amendment pursuant to the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;">, Parent will mail (or cause the Rights Agent to mail) a notice thereof by first class mail to the Holders at their addresses as they appear on the CVR Register, setting forth the terms of such amendment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;5.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Execution of Amendments</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As a condition precedent to executing any amendment permitted by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;V</font><font style="letter-spacing:0.2pt;">, the Rights Agent will be entitled to receive, and will be fully protected in relying upon, an opinion of counsel selected by Parent stating that the execution of such amendment is authorized or permitted by this Agreement. Notwithstanding anything to the contrary herein, the Rights Agent may, but is not obligated to, enter into any such amendment that materially and adversely affects the Rights Agent&#8217;s own rights, privileges, covenants or duties under this Agreement or otherwise. Each amendment to this Agreement shall be evidenced by a writing signed by each of the Rights Agent and Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;5.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Effect of Amendments</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Upon the execution of any amendment under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;V</font><font style="letter-spacing:0.2pt;">, this Agreement will be modified in accordance therewith, such amendment will form a part of this Agreement for all purposes and every Holder will be bound thereby. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE&#160;VI</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">OTHER PROVISIONS OF GENERAL APPLICATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notices</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Any notice or other document to be served under this Agreement may be delivered by overnight delivery service (with proof of service) or hand delivery, or sent in writing (including email transmission, to the extent that no &#8220;bounce back&#8221; or similar message indicating non-delivery is received with respect thereto), to the party to be served as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If to the Rights Agent, to it at: </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">[&#8226;] </font> <br ><font style="letter-spacing:0.2pt;">[&#8226;] </font> <br ><font style="letter-spacing:0.2pt;">[&#8226;] </font> <br ><font style="letter-spacing:0.2pt;">Telephone:</font><br ></div>
        <div style=" margin-top:34pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Email:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Attention:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If to Parent, to it at: </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Alkermes plc </font> <br ><font style="letter-spacing:0.2pt;">Connaught House </font> <br ><font style="letter-spacing:0.2pt;">1 Burlington Road </font> <br ><font style="letter-spacing:0.2pt;">Dublin 4,&#160;Ireland, D04 C5Y6 </font></div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Attention:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Secretary </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Email:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[***] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy (which shall not constitute notice) to: </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Paul, Weiss, Rifkind, Wharton&#160;&amp; Garrison LLP </font> <br ><font style="letter-spacing:0.2pt;">1285 Avenue of the Americas </font> <br ><font style="letter-spacing:0.2pt;">New York, New York 10019 </font></div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Attention:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">James E.&#160;Langston; Chelsea N. Darnell </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Email:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[***] </font> <br ><font style="letter-spacing:0.2pt;">[***] </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy (which shall not constitute notice) to: </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">McCann FitzGerald </font> <br ><font style="letter-spacing:0.2pt;">Riverside One, Sir John Rogerson&#8217;s Quay </font> <br ><font style="letter-spacing:0.2pt;">Dublin 2, D02 X576,&#160;Ireland </font></div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Attention:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Stephen FitzSimons; Jack Kelly </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Email:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:100pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[***] </font> <br ><font style="letter-spacing:0.2pt;">[***] </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or such other postal or email address as it may have notified to the other party in writing in accordance with the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;">. All such notices, requests and other communications shall be deemed received on the date of receipt by the recipient thereof if received prior to 5:00&#160;p.m.&#160;(addressee&#8217;s local time) on a Business Day. Otherwise, any such notice, request or communication shall be deemed to have been received on the next succeeding Business Day. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notice to Holders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Where this Agreement provides for notice to Holders, such notice will be sufficiently given (unless otherwise herein expressly provided) if in writing and mailed, first-class postage prepaid, to each Holder affected by such event, at the Holder&#8217;s address as it appears in the CVR Register, not later than the latest date, and not earlier than the earliest date, if any, prescribed for the giving of such notice. In any case where notice to Holders is given by mail, neither the failure to mail such notice, nor any defect in any notice so mailed, to any particular Holder will affect the sufficiency of such notice with respect to other Holders. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Successors and Assigns</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent may assign any or all of its rights, interests and obligations under this Agreement in its sole discretion and without the consent of any other party, (i)&#160;to any controlled Affiliate of Parent, but only for so long as it remains a controlled Affiliate of Parent, (ii)&#160;to any purchaser, transferee, licensee, or sublicensee that is a Qualified Pharmaceutical Company, of substantially all of the Intellectual Property and other rights (including, without limitation, all data, marketing authorizations and applications for marketing authorization), assets, rights, powers, privileges and contracts, in each case, (A)&#160;held, owned or entered into by Parent or its Subsidiaries immediately after the Effective Time and (B)&#160;necessary for the production, development or sale of the CVR Product in the United States; (iii)&#160;in compliance with ; or (iv)&#160;with the prior written consent of the Acting Holders, to any other Person (any permitted assignee under clause (i), (ii), (iii)&#160;or (iv), an &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Assignee</font><font style="letter-spacing:0.2pt;">&#8221;), in each case, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that the Assignee agrees in writing to assume and be bound by all of the terms of this Agreement and, in the case an assignment described in clause (i), Parent agrees to remain liable for the performance by each Assignee of all obligations of Parent hereunder with such Assignee substituted for Parent under this Agreement. Any Assignee may thereafter assign any or all of its rights, interests and obligations hereunder in the same manner as Parent pursuant to the prior sentence. This Agreement will be binding upon, inure to the benefit of and be enforceable by each of Parent&#8217;s successors and each Assignee. Subject to compliance with the requirements set forth in with respect to a Change of Control, this Agreement shall not restrict Parent&#8217;s, any Assignee&#8217;s or any of their respective successors&#8217; ability to merge or consolidate with, or sell, issue, license or dispose of its stock or other equity interests or assets to, any other Person, or spin-off or split-off any business unit or subsidiary. Each of Parent&#8217;s Assignees, shall expressly and unconditionally assume by execution of an assumption agreement, executed and delivered to the Rights Agent, all of Parent&#8217;s obligations under this Agreement (including the obligation to pay such unpaid Milestone Payment Amounts if and when due hereunder and the obligations of Parent pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.2(a)</font><font style="letter-spacing:0.2pt;">&#160;with respect to the Milestone) and upon delivery of such assumption agreement in compliance with this Section&#160;6.3 to the Rights Agent, Parent shall have no further obligations under this Agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Rights Agent may not assign this Agreement without Parent&#8217;s written consent other than as permitted by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.3(b)</font><font style="letter-spacing:0.2pt;">. Any attempted assignment of this Agreement or any such rights in violation of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.3(b)</font><font style="letter-spacing:0.2pt;">&#160;shall be void and of no effect. Any Person into which the Rights Agent or any successor Rights Agent may be merged or with which it may be consolidated, or Person resulting from any merger or consolidation to which the Rights Agent or any successor Rights Agent shall be a party, or any Person succeeding to the stock transfer or other shareholder services business of the Rights Agent or any successor Rights Agent, shall be the successor to the Rights Agent under this Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that such Person would be eligible for appointment as a successor Rights Agent under the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.4(b)</font><font style="letter-spacing:0.2pt;">. The purchase of all or substantially all of the Rights Agent&#8217;s assets employed in the performance of transfer agent activities shall be deemed a merger or consolidation for purposes of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.3(b)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Benefits of Agreement</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Nothing in this Agreement, express or implied, will give to any Person (other than the Rights Agent, Parent, Parent&#8217;s successors and Assignees, the Holders and the Holders&#8217; successors and assigns pursuant to a Permitted CVR Transfer) any benefit or any legal or equitable right, remedy or claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the foregoing. The rights of Holders and their successors and assigns pursuant to Permitted CVR Transfers are limited to those expressly provided in this Agreement. Notwithstanding anything to the contrary contained herein, any Holder or Holder&#8217;s successor or assign pursuant to a Permitted CVR Transfer may agree to renounce, in whole or in part, its rights under this Agreement by written notice to the Rights Agent and Parent, which notice, if given, shall be irrevocable. Except for the rights and immunities of the Rights Agent set forth herein, the Acting Holders are intended to be third-party beneficiaries hereof, and will have the sole right, on behalf of all Holders, by virtue of or under any provision of this Agreement, to institute any action or proceeding with respect to this Agreement, and no individual Holder or other group of Holders will be entitled to exercise such rights (</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that the foregoing shall not limit the ability of an individual Holder to seek a payment due from the applicable party pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4</font><font style="letter-spacing:0.2pt;"> solely to the extent such payment amount has been finally determined in accordance with this Agreement and has not been paid within the period contemplated by this Agreement). Reasonable expenditures incurred by such Holders in connection with any enforcement action hereunder may be deducted from any damages or settlement obtained prior to the distribution of any remainder to Holders generally. The Acting Holders acting pursuant to this provision on behalf of all Holders shall have no liability to any of the Holders for such actions. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Governing Law; Jurisdiction; Waiver of Jury Trial</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;This Agreement will be governed by, and construed in accordance with, the Laws of the State of Delaware, regardless of the Laws that might otherwise govern under applicable principles of conflicts of laws thereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;In the event any dispute arises out of this Agreement or the transactions contemplated hereby, each of the parties hereto hereby expressly and irrevocably submits to arbitration under the Rules&#160;of Arbitration (&#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Rules</font><font style="letter-spacing:0.2pt;">&#8221;) of the International Chamber of Commerce by an arbitral tribunal consisting of three (3)&#160;arbitrators appointed in accordance with the Rules, except as otherwise modified herein. No award or procedural order made in the arbitration shall be published. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Each arbitrator shall be a member in good standing of the Bar of the Supreme Court of Delaware for at least 10&#160;years. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;The arbitration shall be held, and the award shall be rendered, in New York, New York, in the English language. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;For the avoidance of doubt, by submitting their dispute to arbitration under the Rules, the parties expressly agree that all issues of arbitrability, including all issues concerning the propriety and timeliness of the commencement of the arbitration, the jurisdiction of the arbitral tribunal (including the scope of this agreement to arbitrate and the extent to which a dispute is within that scope), and the procedural conditions for arbitration, shall be finally and solely determined by the arbitral tribunal. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;The arbitral tribunal shall have the power to grant any remedy or relief that is in accordance with the terms of this Agreement, provided, however, that the arbitral tribunal shall have no authority or power to limit, expand, alter, amend, modify, revoke or suspend any condition or provision of this, nor any right or power to award indirect, special, punitive, consequential, exemplary, enhanced or treble damages. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;The parties shall share equally the arbitration administrative fees, the arbitral tribunal member fees and costs, and any other costs associated with the arbitration. Each party shall bear its own costs and attorneys&#8217; fees. The arbitral tribunal shall have no authority to award damages in excess of any limitations set forth in this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Arbitration under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.5</font><font style="letter-spacing:0.2pt;"> shall be the sole and exclusive remedy for any dispute, and any award rendered thereby shall be final and binding upon the parties as from the date rendered. Judgment on the award rendered by the arbitral tribunal may be entered in any state or federal court within the State of Delaware (which courts the parties hereby agree have jurisdiction over them to enforce any such award) and any other court having jurisdiction over the relevant party or its assets. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Severability</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;If any term, provision, covenant or condition of this Agreement is held by a court of competent jurisdiction or other Governmental Entity to be invalid, void or unenforceable, the parties shall negotiate in good faith to modify this Agreement or, as appropriate, the terms and conditions of this Agreement and the Acquisition, so as to effect the original intent of the parties as closely as possible in an equitable manner in order that the transactions contemplated hereby may be consummated as originally contemplated to the fullest extent possible in accordance with applicable Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If at any time any provision of this Agreement is or becomes illegal, invalid or unenforceable in any respect under the Law of any jurisdiction, that shall not affect or impair (i)&#160;the legality, validity or enforceability in that jurisdiction of any other provision of this Agreement; or (ii)&#160;the legality, validity or enforceability under the Law of any other jurisdiction of that or any other provision of this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Counterparts</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement may be executed in any number of counterparts, all of which, taken together, shall constitute one and the same agreement, and each party may enter into this Agreement by executing a counterpart and delivering it to the other party (by hand delivery, facsimile process, e-mail or otherwise). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Termination</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement will automatically terminate and be of no force or effect, the parties hereto will have no liability or obligations hereunder (other than with respect to monies due and owing by Parent to the Rights Agent in respect of the Rights Agents&#8217; services hereunder and any services to be performed by the Rights Agent under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(g)</font><font style="letter-spacing:0.2pt;">&#160;hereof), and no payments will be required to be made, upon the earliest to occur of (such time, the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Termination</font><font style="letter-spacing:0.2pt;">&#8221;) (a)&#160;the failure to achieve the Milestone before the Milestone Expiration, (b)&#160;(i)&#160;the mailing by the Rights Agent to the address or (ii)&#160;the payment by the Rights Agent by wire transfer of immediately available funds to the account, of each Holder as reflected in the CVR Register the last of the Milestone Payment Amounts (if any) required to be paid under the terms of this Agreement, and (c)&#160;the delivery of a written notice of termination duly executed by Parent and the Acting Holders. For the avoidance of doubt, the right of any Holder to receive the Milestone Payment with respect to the Milestone, and any covenants and obligations of Parent (other than pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(d)</font><font style="letter-spacing:0.2pt;">), shall be irrevocably terminated and extinguished if the Milestone is not achieved before the earlier of the Milestone Expiration and the Termination (it being understood for purposes of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.8</font><font style="letter-spacing:0.2pt;"> and solely with respect to the Milestone, that, if the FDA has issued one or more orders that impose a clinical hold on the investigation of the CVR Product for the Indication, the Milestone shall not be deemed achieved unless or until no such order is in effect). Notwithstanding the foregoing, no termination shall affect any rights or obligations accrued prior to the effective date of such termination (including the right of any Holder to receive the Milestone Payments under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4</font><font style="letter-spacing:0.2pt;"> to the extent earned prior to the earlier of the Milestone Expiration and the Termination) or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;6.4</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.5</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.6</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.7</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.9</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.12</font><font style="letter-spacing:0.2pt;"> or this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.8</font><font style="letter-spacing:0.2pt;">, which shall survive the termination of this Agreement, or the resignation, replacement or removal of the Rights Agent. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:240pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Entire Agreement</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement and the Transaction Agreement (including the schedules, annexes and exhibits thereto and the documents and instruments referred to therein) contain the entire understanding of the parties hereto and thereto with reference to the transactions and matters contemplated hereby and thereby and supersede all prior agreements, written or oral, among the parties with respect hereto and thereto. If and to the extent that any provision of this Agreement is inconsistent or conflicts with the Transaction Agreement, then solely with respect to the Rights Agent, this Agreement will govern and be controlling. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Further Assurances</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to the provisions of this Agreement, Parent and the Rights Agent will, from time to time, do all commercially reasonable acts and things and execute and deliver all such further documents and instruments, as Parent and the Rights Agent may reasonably require for the carrying out or performing by the Rights Agent of the provisions of this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.11&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Force Majeure</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary contained herein, none of the Rights Agent, Parent or any of its Subsidiaries will be liable for any delays or failures in performance resulting from acts beyond its reasonable control including acts of God, pandemics, epidemics, terrorist acts, shortage of supply, breakdowns or malfunctions, interruptions or malfunctions of computer facilities, or loss of data due to power failures or mechanical difficulties with information storage or retrieval systems, labor disputes, strikes, or shortages, war or civil unrest, it being understood that such parties shall use commercially reasonable efforts to resume performance as soon as reasonably practicable under the circumstances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.12&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Legal Holiday</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In the event that the Milestone Payment Date shall not be a Business Day, then, notwithstanding any provision of this Agreement to the contrary, any payment required to be made in respect of the CVRs on such date need not be made on such date, but may be made on the next succeeding Business Day with the same force and effect as if made on the Milestone Payment Date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.13&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Confidentiality</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Rights Agent and Parent agree that all books, records, information and data pertaining to the business of the other party, which are exchanged or received pursuant to the negotiation or the carrying out of this Agreement shall remain confidential, and shall not be voluntarily disclosed to any other person, except as may be required by a valid order of a Governmental Entity of competent jurisdiction or is otherwise required by law or regulation. </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Remainder of Page&#160;Left Blank Intentionally</font><font style="letter-spacing:0.2pt;">] </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its behalf by its duly authorized officers as of the day and year first above written. </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ALKERMES PLC</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:18pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:18pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name: </font>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Title: </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Signature Page&#160;to Contingent Value Rights Agreement</font><font style="letter-spacing:0.2pt;">] </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its behalf by its duly authorized officers as of the day and year first above written. </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">[RIGHTS AGENT]</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:18pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:18pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name: </font>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Title: </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Signature Page&#160;to Contingent Value Rights Agreement</font><font style="letter-spacing:0.2pt;">]</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tANB">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Annex B</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONDITIONS OF THE ACQUISITION AND THE SCHEME</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Acquisition and the Scheme will comply with the Takeover Rules and, where relevant, the rules and regulations of the Exchange Act, the Act and the Nasdaq, and are subject to the terms and conditions set out in this Announcement and to be set out in the Scheme Document. The Acquisition and the Scheme are, to the extent required by the Laws of Ireland, governed by the Laws of Ireland. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Acquisition and the Scheme will be subject to the conditions set out in this Appendix&#160;III (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Conditions</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">1.&nbsp;&nbsp;&nbsp;The Acquisition will be conditional upon the Scheme becoming effective and unconditional on or prior to the End Date (or such earlier date as may be specified by the Panel, or such later date as Parent and the Company may, subject to receiving the consent of the Panel and the High Court, in each case if required, agree). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.&nbsp;&nbsp;&nbsp;The Scheme will be conditional upon: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.1&nbsp;&nbsp;&nbsp;the Scheme having been approved by a majority in number of members of each class of Company Shareholders (including as may be directed by the High Court pursuant to Section&#160;450(5) of the Act) representing, at the relevant voting record time, at least seventy-five&#160;percent (75%) in value of the Company Shares of that class held by Company Shareholders, in each case present and voting either in person or by proxy at the Scheme Meeting (or at any adjournment or postponement of such meeting); </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.2&nbsp;&nbsp;&nbsp;each of the Required EGM Resolutions having been duly passed by the requisite majority of Company Shareholders at the EGM (or at any adjournment or postponement of such meeting); </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.3&nbsp;&nbsp;&nbsp;the High Court having sanctioned (with or without material modification, but subject to any material modification being acceptable to each of Parent and the Company) the Scheme pursuant to Sections&#160;449 to 455 of the Act (the date on which the condition in this paragraph 2.3 is satisfied, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Sanction Date</font><font style="letter-spacing:0.2pt;">&#8221;); and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.4&nbsp;&nbsp;&nbsp;copies of the Court Order having been delivered for registration to the Registrar of Companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.&nbsp;&nbsp;&nbsp;Parent and the Company have agreed that, subject to paragraph 6, the Acquisition will also be conditional upon the following matters having been satisfied or waived on or before the Sanction Date: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.1&nbsp;&nbsp;&nbsp;the applicable waiting periods (and any extension thereof) under the HSR Act in connection with the Acquisition having expired or been earlier terminated, and, to the extent applicable, any agreement between the Company and Parent, on the one hand, and the Federal Trade Commission or the Antitrust Division of the United States Department of Justice, on the other hand, not to consummate the Scheme or the Acquisition having expired or been earlier terminated; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.2&nbsp;&nbsp;&nbsp;no Governmental Entity of competent jurisdiction having enacted, issued, promulgated, enforced or entered any Law or Order (whether temporary, preliminary or permanent) that is in effect and restrains, enjoins, makes illegal or otherwise prohibits the consummation of the Acquisition; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.3&nbsp;&nbsp;&nbsp;the Transaction Agreement not having been terminated by the applicable Party or Parties as set forth below as a consequence of an event set forth below (such events being the events set out in the Transaction Agreement following the occurrence of which the Transaction Agreement may be terminated in accordance with its terms): </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.3.1&nbsp;&nbsp;&nbsp;termination by either the Company or Parent if the Scheme Meeting or the EGM shall have been completed and the Scheme Meeting Resolution or the Required EGM Resolutions, as applicable, shall not have been approved by the requisite majorities; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.3.2&nbsp;&nbsp;&nbsp;termination by either the Company or Parent if the Effective Time shall not have occurred by 5:00&#160;p.m., New York City time, on the End Date; provided, that such right to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">terminate the Transaction Agreement shall not be available to a Party whose breach of any provision of the Transaction Agreement shall have been the primary cause of the failure of the Effective Time to have occurred by such time; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.3.3&nbsp;&nbsp;&nbsp;termination by either the Company or Parent if the High Court shall have declined or refused to sanction the Scheme, unless both Parties shall have agreed in writing within thirty (30) days of such decision that the decision of the High Court shall be appealed (it being agreed that the Company shall make such an appeal if requested to do so in writing by Parent and the respective counsels appointed by Parent and by the Company in accordance with the Transaction Agreement agree that doing so is a reasonable course of action); </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.3.4&nbsp;&nbsp;&nbsp;termination by either the Company or Parent if there shall be in effect any applicable Law or final and non-appealable Order issued, promulgated, made, rendered or entered into by any Governmental Entity of competent jurisdiction that permanently restrains, enjoins, makes illegal or otherwise prohibits the consummation of the Acquisition; provided that such right to terminate the Transaction Agreement shall not be available to any Party whose material breach of any provision of the Transaction Agreement shall have been the primary cause of such Law, order, writ, decree, judgment or injunction; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.3.5&nbsp;&nbsp;&nbsp;termination by the Company if Parent shall have breached or failed to perform in any material respect any of its covenants or other agreements contained in the Transaction Agreement or if any of its representations or warranties set forth in the Transaction Agreement are inaccurate, which breach, failure to perform or inaccuracy (1)&#160;would result in a failure of Condition 5.2 or 5.3, as applicable, and (2)&#160;is not reasonably capable of being cured by the End Date or, if curable, is not cured by the earlier of (x)&#160;the End Date and (y)&#160;thirty (30) days following written notice by the Company thereof; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.3.6&nbsp;&nbsp;&nbsp;termination by the Company prior to obtaining the Company Shareholder Approval, if (1)&#160;in accordance with Section&#160;5.2 of the Transaction Agreement, the Company Board shall have authorized the Company to terminate the Transaction Agreement in response to a Company Superior Proposal and (2)&#160;substantially concurrently with such termination, a definitive agreement providing for the consummation of the transactions contemplated by such Company Superior Proposal shall have been duly executed and delivered by all parties thereto; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that the Company shall not be entitled to terminate the Transaction Agreement pursuant to the termination right summarized in this paragraph 3.3.6, and no such purported termination shall have any effect, unless, prior to or substantially concurrently with such termination, the Company shall have paid Parent the applicable Reimbursement Amounts (as defined in the Transaction Agreement) under Section&#160;9.2(a) of the Transaction Agreement (it being understood that, without limiting the Company&#8217;s obligations under Section&#160;9.2(a) of the Transaction Agreement, only such costs and expenses accrued prior to such termination and for which Parent, prior to the termination, submits to the Company in writing a request for such amounts and written invoices or written documentation supporting such request in accordance with the provisions of Section&#160;9.2 of the Transaction Agreement shall be due substantially concurrently with such termination, subject at all times to the Cap); </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.3.7&nbsp;&nbsp;&nbsp;termination by Parent if the Company shall have breached or failed to perform in any material respect any of its covenants or other agreements contained in the Transaction Agreement or if any of its representations or warranties set forth in the Transaction Agreement are inaccurate, which breach, failure to perform or inaccuracy (1)&#160;would result in a failure of Condition 4.2 or 4.3, as applicable, and (2)&#160;is not reasonably capable of being cured by the End Date or, if curable, is not cured by the earlier of (x)&#160;the End Date and (y)&#160;thirty (30) days following written notice by Parent thereof; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.3.8&nbsp;&nbsp;&nbsp;termination by Parent if, prior to the receipt of the Company Shareholder Approval, a Company Board Change of Recommendation (as defined in the Transaction Agreement) shall have occurred; or </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.3.9&nbsp;&nbsp;&nbsp;termination by mutual written consent of the Company and Parent, subject to the consent of the Panel (if required). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">4.&nbsp;&nbsp;&nbsp;Parent and the Company have agreed that, subject to paragraph 6, Parent&#8217;s obligation to effect the Acquisition will also be conditional upon the following matters having been satisfied (or, to the extent permitted by applicable Law, waived by Parent) on or before the Sanction Date: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">4.1&nbsp;&nbsp;&nbsp;from October&#160;22, 2025 (being the date of this Announcement) to the Sanction Date, there having not been any event, change, effect, development or occurrence that has had, or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">4.2&nbsp;&nbsp;&nbsp;(a) the representation and warranty of the Company set forth in Section&#160;6.1(A)(k)(ii) (</font><font style="font-style:italic;letter-spacing:0.2pt;">Absence of Certain Changes or Events</font><font style="letter-spacing:0.2pt;">) of the Transaction Agreement having been true and correct in all respects at and as of the date of the Transaction Agreement and at and as of the Sanction Date as though made at and as of the Sanction Date, (b)&#160;the representation and warranty of the Company set forth in Section&#160;6.1(A)(c)(i)&#8201;&#8211;&#8201;(ii) and the last sentence of 6.1(A)(c)(iii) (</font><font style="font-style:italic;letter-spacing:0.2pt;">Capitalization</font><font style="letter-spacing:0.2pt;">) of the Transaction Agreement having been true and correct in all respects, except for any </font><font style="font-style:italic;letter-spacing:0.2pt;">de minimis </font><font style="letter-spacing:0.2pt;">inaccuracies, at and as of the date of the Transaction Agreement and at and as of the Sanction Date as though made at and as of the Sanction Date (except to the extent that any such representation and warranty speaks as of a particular date, in which case such representation and warranty shall have been true and correct in all respects, except for any </font><font style="font-style:italic;letter-spacing:0.2pt;">de minimis</font><font style="letter-spacing:0.2pt;"> inaccuracies, as of such particular date), (c)&#160;each of the representations and warranties of the Company set forth in Sections&#160;6.1(A)(a) (</font><font style="font-style:italic;letter-spacing:0.2pt;">Qualification, Organization, Subsidiaries, etc.</font><font style="letter-spacing:0.2pt;">), 6.1(A)(b)(i) (</font><font style="font-style:italic;letter-spacing:0.2pt;">Subsidiaries</font><font style="letter-spacing:0.2pt;">), the first sentence of 6.1(A)(c)(iii) (</font><font style="font-style:italic;letter-spacing:0.2pt;">Capitalization</font><font style="letter-spacing:0.2pt;">), 6.1(A)(d) (</font><font style="font-style:italic;letter-spacing:0.2pt;">Corporate Authority Relative to this Agreement; No Violation</font><font style="letter-spacing:0.2pt;">), 6.1(A)(s) (</font><font style="font-style:italic;letter-spacing:0.2pt;">Required Vote of Company Shareholders</font><font style="letter-spacing:0.2pt;">), 6.1(A)(v) (</font><font style="font-style:italic;letter-spacing:0.2pt;">Opinions of Financial Advisors</font><font style="letter-spacing:0.2pt;">), 6.1(A)(w) (</font><font style="font-style:italic;letter-spacing:0.2pt;">Finders or Brokers</font><font style="letter-spacing:0.2pt;">) and 6.1(A)(y) (</font><font style="font-style:italic;letter-spacing:0.2pt;">Takeover Statutes</font><font style="letter-spacing:0.2pt;">) of the Transaction Agreement having been true and correct (read for the purpose of this paragraph 4.2(c) without any qualification as to materiality or Company Material Adverse Effect therein) in all material respects at and as of the date of the Transaction Agreement and at and as of the Sanction Date as though made at and as of the Sanction Date (in each case except to the extent that any such representation and warranty speaks as of a particular date, in which case such representation and warranty shall have been true and correct in all material respects as of such particular date), and (d)&#160;each of the representations and warranties of the Company set forth in Section&#160;6.1 of the Transaction Agreement (other than those specifically listed in paragraphs 4.2(a), 4.2(b) or 4.2(c)) having been true and correct (read for the purpose of this paragraph 4.2(d) without any qualification as to materiality or Company Material Adverse Effect therein) in all respects at and as of the date of the Transaction Agreement and at and as of the Sanction Date as though made at and as of the Sanction Date (in each case except to the extent that any such representation and warranty speaks as of a particular date, in which case such representation and warranty shall have been true and correct in all respects as of such particular date), except for such failures to be true and correct as have not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.3&nbsp;&nbsp;&nbsp;the Company having performed and complied, in all material respects, with all of the covenants and agreements that the Transaction Agreement requires the Company to perform or comply with prior to the Sanction Date; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.4&nbsp;&nbsp;&nbsp;Parent having received a certificate from an executive officer of the Company confirming the satisfaction of the conditions set forth in paragraphs 4.2 and 4.3. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.&nbsp;&nbsp;&nbsp;Parent and the Company have agreed that, subject to paragraph 6, the Company&#8217;s obligation to effect the Scheme and the Acquisition will also be conditional upon the following matters having been satisfied (or, to the extent permitted by applicable Law, waived by the Company) on or before the Sanction Date: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.1&nbsp;&nbsp;&nbsp;from October&#160;22, 2025 (being the date of this Announcement) to the Sanction Date, there having not been any event, change, effect, development or occurrence that has had, or would reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.2&nbsp;&nbsp;&nbsp;(a) each of the representations and warranties of Parent set forth in Section&#160;6.2(A)(a) (</font><font style="font-style:italic;letter-spacing:0.2pt;">Qualification, Organization, etc.</font><font style="letter-spacing:0.2pt;">) and Section&#160;6.2(A)(b) (</font><font style="font-style:italic;letter-spacing:0.2pt;">Corporate Authority Relative to this Agreement; No Violation</font><font style="letter-spacing:0.2pt;">) of the Transaction Agreement having been true and correct (read for the purpose of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:32pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">this paragraph 5.2(a) without any qualification as to materiality or Parent Material Adverse Effect therein) in all material respects at and as of the date of the Transaction Agreement and at and as of the Sanction Date as though made at and as of the Sanction Date (in each case except to the extent that any such representation and warranty speaks as of a particular date, in which case such representation and warranty shall have been true and correct in all material respects as of such particular date), and (b)&#160;each of the representations and warranties of Parent set forth in Section&#160;6.2 of the Transaction Agreement (other than those specifically listed in paragraph 5.2(a)) having been true and correct (read for the purpose of this paragraph 5.2(b) without any qualification as to materiality or Parent Material Adverse Effect therein) in all respects at and as of the date of the Transaction Agreement and at and as of the Sanction Date as though made at and as of the Sanction Date (in each case except to the extent that any such representation and warranty speaks as of a particular date, in which case such representation and warranty shall have been true and correct in all respects as of such particular date), except for such failures to be true and correct as have not had, and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.3&nbsp;&nbsp;&nbsp;Parent having performed and complied, in all material respects, with all of the covenants and agreements that the Transaction Agreement requires Parent to perform or comply with prior to the Sanction Date; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.4&nbsp;&nbsp;&nbsp;the Company having received a certificate from an executive officer of Parent confirming the satisfaction of the conditions set forth in paragraphs 5.2 and 5.3; and </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.5&nbsp;&nbsp;&nbsp;the CVR Agreement shall be in full force and effect. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6.&nbsp;&nbsp;&nbsp;Subject to the requirements of the Panel: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6.1&nbsp;&nbsp;&nbsp;Parent and the Company reserve the right (but neither Party shall be under any obligation) to waive (to the extent permitted by applicable Law), in whole or in part, all or any of the conditions in paragraph 3 (provided that no such waiver shall be effective unless agreed to by both Parties); </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6.2&nbsp;&nbsp;&nbsp;Parent reserves the right (but shall be under no obligation) to waive (to the extent permitted by applicable Law), in whole or in part, all or any of the conditions in paragraph 4; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6.3&nbsp;&nbsp;&nbsp;the Company reserves the right (but shall be under no obligation) to waive (to the extent permitted by applicable Law), in whole or in part, all or any of the conditions in paragraph 5. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7.&nbsp;&nbsp;&nbsp;The Scheme will lapse unless it is effective on or prior to the End Date (or such earlier date as may be specified by the Panel, or such later date as Parent and the Company may, subject to receiving the consent of the Panel and the High Court, in each case if required, agree). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.&nbsp;&nbsp;&nbsp;If Parent is required to make an offer for Company Shares under the provisions of Rule&#160;9 of the Takeover Rules, Parent may make such alterations to any of the Conditions as are necessary to comply with the provisions of that rule. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9.&nbsp;&nbsp;&nbsp;Parent reserves the right, subject to the consent of the Panel, to effect the Acquisition by way of a Takeover Offer in the circumstances described in and subject to the terms of Section&#160;3.6 of the Transaction Agreement. Without limiting Section&#160;3.6 of the Transaction Agreement, in the event the Acquisition is structured as a Takeover Offer, such offer will be implemented on terms and conditions that are at least as favorable to the Company Shareholders and the holders of Company Options, Company Performance Options and Company Share Awards as those which would apply in relation to the Scheme (except for an acceptance condition set at 80% of the nominal value of the Company Shares to which such an offer relates (and which are not already in the beneficial ownership of Parent) or such lesser&#160;percentage being more than 50%, as Parent may, with the consent of the Panel (if required) decide).</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tANC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Annex C</font>&#8203;</div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;">
          <tr style="height:27pt;white-space:normal;text-align:left;vertical-align:top;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:222pt;">
              <div style="position:relative;">
                <img src="lg_morganstanley-bw.jpg" alt="[MISSING IMAGE: lg_morganstanley-bw.jpg]" height="20" width="133" >
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 0pt 0pt; width:222pt;text-align:right;">
              <div style="position:relative;text-align:right;">
                <img src="lh_morganstanley-bw.jpg" alt="[MISSING IMAGE: lh_morganstanley-bw.jpg]" height="25" width="89" >
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:7.9pt; text-align:right; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">October&#160;21, 2025</font>&#8203;</div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Board of Directors </font> <br ><font style="letter-spacing:0.2pt;">Avadel Pharmaceuticals plc </font> <br ><font style="letter-spacing:0.2pt;">10 Earlsfort Terrace </font> <br ><font style="letter-spacing:0.2pt;">Dublin 2, Ireland </font> <br ><font style="letter-spacing:0.2pt;">D02 T380 </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Members of the Board:</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We understand that Avadel Pharmaceuticals plc (the &#8220;Company&#8221;) and Alkermes plc (the &#8220;Buyer&#8221;) propose to enter into a Transaction Agreement, substantially in the form of the draft dated October&#160;21, 2025 (the &#8220;Transaction Agreement&#8221;), which provides, among other things, for the acquisition (the &#8220;Acquisition&#8221;) of the issued and outstanding ordinary share capital of the Company by the Buyer by means of the Scheme (as defined in the Transaction Agreement). At the effective time of the Acquisition, each holder of outstanding ordinary shares of the Company, nominal value $0.01 per share (the &#8220;Company Shares&#8221;), other than Company Shares held by the Buyer or any Concert Parties (as defined in the Transaction Agreement) of the Buyer (collectively, the &#8220;Excluded Shares&#8221;), will receive per Company Share (a)&#160;$18.50 in cash (the &#8220;Cash Consideration&#8221;) plus (b)&#160;one contractual contingent value right, representing the right to receive $1.50 in cash, if the Milestone (as defined in the CVR Agreement (as defined in the Transaction Agreement and in the form attached as Exhibit&#160;A to the Transaction Agreement)) is achieved prior to the Milestone Expiration (as defined in the CVR Agreement) and before the Termination (as defined in the CVR Agreement), subject to and in accordance with the terms of the CVR Agreement (the &#8220;CVR Consideration&#8221; and, together with the Cash Consideration, the &#8220;Consideration&#8221;). The terms and conditions of the Acquisition are more fully set forth in the Transaction Agreement and the CVR Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You have asked for our opinion as to whether the Consideration to be received by the holders of Company Shares (other than the holders of the Excluded Shares) pursuant to the Transaction Agreement is fair from a financial point of view to such holders of Company Shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">For purposes of the opinion set forth herein, we have:</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reviewed certain publicly available financial statements and other business and financial information of the Company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reviewed certain internal financial statements and other financial and operating data concerning the Company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reviewed (i)&#160;certain financial projections, as prepared by and approved for our use by the management of the Company (the &#8220;Financial Projections&#8221;), (ii)&#160;certain estimates as to the probability and timing of achievement of the Milestone, as prepared by and approved for our use by the management of the Company (the &#8220;CVR Estimates&#8221;) and (iii)&#160;certain forecasts related to the expected utilization by the Company of certain net operating loss carryforwards and tax credits, as prepared by and approved for our use by the management of the Company (the &#8220;NOL Forecasts&#8221;); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Discussed the past and current operations and financial condition and the prospects of the Company with senior executives of the Company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reviewed the reported prices and trading activity for the Company Shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Compared the financial performance of the Company and the prices and trading activity of the Company Shares with that of certain other publicly-traded companies comparable with the Company and their securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">7)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reviewed the financial terms, to the extent publicly available, of certain comparable acquisition transactions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">8)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Participated in certain discussions and negotiations among representatives of the Company and the Buyer and their financial and legal advisors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">9)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reviewed the Transaction Agreement, the CVR Agreement and certain related documents; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">10)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Performed such other analyses, reviewed such other information and considered such other factors as we have deemed appropriate. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have assumed and relied upon, without independent verification, the accuracy and completeness of the information that was publicly available or supplied or otherwise made available to us by the Company, and formed a substantial basis for this opinion. With respect to the Financial Projections, the CVR Estimates and the NOL Forecasts, we have assumed that they have been reasonably prepared on bases reflecting the best currently available estimates and judgments of the management of the Company of the future financial performance of the Company. We express no view as to the Financial Projections, the CVR Estimates or the NOL Forecasts, or the assumptions upon which they were based. We express no view as to the likelihood the Milestone is achieved or whether the CVR Consideration becomes payable. In addition, we have assumed that the Acquisition will be consummated in accordance with the terms set forth in the Transaction Agreement without any waiver, amendment or delay of any terms or conditions, including, among other things, that the definitive Transaction Agreement and CVR Agreement will not differ in any material respect from the drafts thereof furnished to us. Morgan Stanley has assumed that in connection with the receipt of all the necessary governmental, regulatory or other approvals and consents required for the proposed Acquisition, no delays, limitations, conditions or restrictions will be imposed that would have a material adverse effect on the contemplated benefits expected to be derived in the proposed Acquisition. We are not legal, tax or regulatory advisors. We are financial advisors only and have relied upon, without independent verification, the assessment of the Company and its legal, tax and regulatory advisors with respect to legal, tax and regulatory matters. We express no opinion with respect to the fairness of the amount or nature of the compensation to any of the Company&#8217;s officers, directors or employees, or any class of such persons, relative to the Consideration to be received by the holders of Company Shares (other than the holders of the Excluded Shares) pursuant to the Transaction Agreement. We do not express any view on, and this opinion does not address, any other term or aspect of the Transaction Agreement or the transactions contemplated thereby other than with respect to the fairness, from a financial point of view, of the Consideration to be received by the holders of Company Shares (other than the holders of Excluded Shares) pursuant to the Transaction Agreement, or any term or aspect of any other agreement or instrument contemplated by the Transaction Agreement or the CVR Agreement or entered into or amended in connection therewith. This opinion does not address the relative merits of the transactions contemplated by the Transaction Agreement and the CVR Agreement as compared to other business or financial strategies that might be available to the Company, nor does it address the underlying business decision of the Company to enter into the Transaction Agreement or proceed with any other transaction contemplated by the Transaction Agreement and the CVR Agreement. We have not made any independent valuation or appraisal of the assets or liabilities of the Company, nor have we been furnished with any such valuations or appraisals. Our opinion is necessarily based on financial, economic, market and other conditions as in effect on, and the information made available to us as of, the date hereof. Events occurring after the date hereof may affect this opinion and the assumptions used in preparing it, and we do not assume any obligation to update, revise or reaffirm this opinion. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have acted as financial advisor to the Board of Directors of the Company in connection with this transaction and will receive a fee for our services, a substantial portion of which is contingent upon the closing of the Acquisition, and the Company has agreed to reimburse certain of our expenses arising, and indemnify us against certain liabilities that may arise, out of our engagement. In the two&#160;years prior to the date hereof, we have provided financial advisory and financing services to the Buyer for which we have received fees in connection with such services, and have not provided financial advisory or financing services to the Company for which we have received fees in connection with such services. As of the date hereof, so far as we are aware, we and/or our affiliates hold an aggregate interest of: (x)&#160;between 2% and 3% of the ordinary shares of the Company and (y)&#160;less than 1% of the ordinary shares of the Buyer, which interests are held </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:210pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">in connection with our and/or our affiliates&#8217; investment management business, wealth management business, including client discretionary accounts, or ordinary course trading activities, including hedging activities. Morgan Stanley may also seek to provide financial advisory and financing services to the Company and the Buyer and their respective affiliates in the future and would expect to receive fees for the rendering of these services. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Please note that Morgan Stanley is a global financial services firm engaged in the securities, investment management and individual wealth management businesses. Our securities business is engaged in securities underwriting, trading and brokerage activities, foreign exchange, commodities and derivatives trading, prime brokerage, as well as providing investment banking, financing and financial advisory services. Morgan Stanley, its affiliates, directors and officers may at any time invest on a principal basis or manage funds that invest, hold long or short positions, finance positions, and may trade or otherwise structure and effect transactions, for their own account or the accounts of its customers, in debt or equity securities or loans of the Company, the Buyer, or any other company, or any currency or commodity, that may be involved in this transaction, or any related derivative instrument. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This opinion has been approved by a committee of Morgan Stanley investment banking and other professionals in accordance with our customary practice. This opinion is for the information of the Board of Directors of the Company and may not be used for any other purpose or disclosed without our prior written consent, except that a copy of this opinion may be included in its entirety in any filing the Company is required to make with the Securities and Exchange Commission in connection with this transaction if such inclusion is required by applicable law. In addition, Morgan Stanley expresses no opinion or recommendation as to how the shareholders of the Company should vote at the shareholders&#8217; meeting to be held in connection with the Acquisition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based on and subject to the foregoing, we are of the opinion on the date hereof that the Consideration to be received by the holders of Company Shares (other than the holders of Excluded Shares) pursuant to the Transaction Agreement is fair from a financial point of view to such holders of Company Shares. </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Very truly yours, </font>
        </div>
        <div style="margin-left:220pt; margin-top:12pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">MORGAN STANLEY &amp; CO. LLC </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">/s/ Edward A. Smith</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Edward A. Smith</font>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Managing Director</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tAND">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Annex D</font>&#8203;</div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">200 West Street | New York, NY 10282-2198</font> <br ><font style="letter-spacing:0.2pt;">Tel: 212-902-1000 | Fax: 212-902-3000 </font></div>
        <div style="position:relative;margin-top:9.8pt; text-align:right; width:456pt;">
          <img src="lg_goldmansachs-bw.jpg" alt="[MISSING IMAGE: lg_goldmansachs-bw.jpg]" height="35" width="83" >
        </div>
        <div style="margin-top:16.61pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">PERSONAL AND CONFIDENTIAL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">October&#160;22, 2025</font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Board of Directors </font> <br ><font style="letter-spacing:0.2pt;">Avadel Pharmaceuticals plc </font> <br ><font style="letter-spacing:0.2pt;">10 Earlsfort Terrace </font> <br ><font style="letter-spacing:0.2pt;">Dublin 2, Ireland </font> <br ><font style="letter-spacing:0.2pt;">D02 T380 </font></div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Ladies and Gentlemen: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You have requested our opinion as to the fairness from a financial point of view to the holders (other than Alkermes plc (&#8220;Alkermes&#8221;) and any Concert Parties (as defined in the Agreement (as defined below)) of Alkermes and their respective affiliates) of the outstanding ordinary shares, nominal value $0.01 per share (the &#8220;Shares&#8221;), of Avadel Pharmaceuticals plc (the &#8220;Company&#8221;) of the Consideration (as defined below) to be paid to such holders pursuant to the Transaction Agreement, dated as of October&#160;22, 2025 (the &#8220;Agreement&#8221;), by and between Alkermes and the Company. The Agreement provides that pursuant to the Scheme (as defined in the Agreement), Alkermes will acquire the entire issued, and to be issued, ordinary share capital of the Company in accordance with terms of the Agreement and each holder of Shares (other than Alkermes and any Concert Parties of Alkermes) will have the right to receive $18.50 per Share in cash (the &#8220;Cash Consideration&#8221;) and one contractual contingent value right per Share (the &#8220;CVR Consideration&#8221;, together with the Cash Consideration, the &#8220;Consideration&#8221;). The CVR Consideration represents the right to receive $1.50 per Share in cash if the Milestone (as defined in the CVR Agreement (as defined in the Agreement)) is achieved prior to the Milestone Expiration (as defined in the CVR Agreement) and before the Termination (as defined in the CVR Agreement), subject to and in accordance with the terms and conditions of the CVR Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Goldman Sachs &amp; Co. LLC and its affiliates are engaged in advisory, underwriting, lending, and financing, principal investing, sales and trading, research, investment management and other financial and non-financial activities and services for various persons and entities. Goldman Sachs &amp; Co. LLC and its affiliates and employees, and funds or other entities they manage or in which they invest or have other economic interests or with which they co-invest, may at any time purchase, sell, hold or vote long or short positions and investments in securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of the Company, Alkermes, any of their respective affiliates and third parties, and any of their respective affiliates or any currency or commodity that may be involved in the transactions contemplated by the Agreement (the &#8220;Transaction&#8221;). We have acted as financial advisor to the Company in connection with, and have participated in certain of the negotiations leading to, the Transaction. We expect to receive fees for our services in connection with the Transaction, the principal portion of which is contingent upon consummation of the Transaction, and the Company has agreed to reimburse certain of our expenses arising, and indemnify us against certain liabilities that may arise, out of our engagement. Goldman Sachs &amp; Co. LLC and/or its affiliates may also in the future provide financial advisory and/or underwriting services to the Company, Alkermes and their respective affiliates for which Goldman Sachs Investment Banking may receive compensation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with this opinion, we have reviewed, among other things, the Agreement; the CVR Agreement; annual reports to stockholders and Annual Reports on Form 10-K of the Company for the five&#160;years ended December&#160;31, 2024; certain interim reports to stockholders and Quarterly Reports on Form&#160;10-Q of the Company; certain other communications from the Company to its shareholders; certain publicly available research analyst reports for the Company; certain internal financial analyses and forecasts </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">for the Company, as prepared by the management of the Company and approved for our use by the Company (the &#8220;Forecasts&#8221;); certain forecasts related to the expected utilization by the Company of certain net operating loss carryforwards and tax credits, as prepared by the management of the Company and approved for our use by the Company (the &#8220;NOL Forecasts&#8221;); and certain estimates as to the probability and timing of the achievement of the Milestone (as defined in the CVR Agreement), as prepared by the management of the Company and approved for our use by the Company (the &#8220;CVR Estimates&#8221;). We have also held discussions with members of the senior management of the Company regarding their assessment of the past and current business operations, financial condition and future prospects of the Company; reviewed the reported price and trading activity for the Shares; compared certain financial and stock market information for the Company with similar information for certain other companies the securities of which are publicly traded; reviewed the financial terms of certain recent business combinations in the biotechnology industry; and performed such other studies and analyses, and considered such other factors, as we deemed appropriate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For purposes of rendering this opinion, we have, with your consent, relied upon and assumed the accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by, us, without assuming any responsibility for independent verification thereof. In that regard, we have assumed with your consent that the Forecasts, the NOL Forecasts and the CVR Estimates have been reasonably prepared on a basis reflecting the best currently available estimates and judgments of the management of the Company. We have not made an independent evaluation or appraisal of the assets and liabilities (including any contingent, derivative or other off-balance-sheet assets and liabilities) of the Company or any of its subsidiaries and we have not been furnished with any such evaluation or appraisal. We have assumed that all governmental, regulatory or other consents and approvals necessary for the consummation of the Transaction will be obtained without any adverse effect on the expected benefits of the Transaction in any way meaningful to our analysis. We have assumed that the Transaction will be consummated on the terms set forth in the Agreement, without the waiver or modification of any term or condition the effect of which would be in any way meaningful to our analysis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our opinion does not address the underlying business decision of the Company to engage in the Transaction, or the relative merits of the Transaction as compared to any strategic alternatives that may be available to the Company; nor does it address any legal, regulatory, tax or accounting matters. This opinion addresses only the fairness from a financial point of view to the holders (other than Alkermes and any Concert Parties of Alkermes and their respective affiliates) of Shares, as of the date hereof, of the Consideration to be paid to such holders pursuant to the Agreement. We do not express any view on, and our opinion does not address, any other term or aspect of the Agreement, the CVR Agreement or the Transaction or any term or aspect of any other agreement or instrument contemplated by the Agreement or the CVR Agreement or entered into or amended in connection with the Transaction, including, any allocation of the Consideration, the fairness of the Transaction to, or any consideration received in connection therewith by, the holders of any other class of securities, creditors, or other constituencies of the Company; nor as to the fairness of the amount or nature of any compensation to be paid or payable to any of the officers, directors or employees of the Company, or class of such persons, in connection with the Transaction, whether relative to the Consideration to be paid to the holders (other than Alkermes and any Concert Parties of Alkermes and their respective affiliates) of Shares pursuant to the Agreement or otherwise. We are not expressing any opinion as to the prices at which the Shares will trade at any time or, as to the potential effects of volatility in the credit, financial and stock markets on the Company, Alkermes or the Transaction, or as to the impact of the Transaction on the solvency or viability of the Company or Alkermes or the ability of the Company or Alkermes to pay their respective obligations when they come due. Our opinion is necessarily based on economic, monetary, market and other conditions as in effect on, and the information made available to us as of, the date hereof and we assume no responsibility for updating, revising or reaffirming this opinion based on circumstances, developments or events occurring after the date hereof. Our advisory services and the opinion expressed herein are provided for the information and assistance of the Board of Directors of the Company in connection with its consideration of the Transaction and such opinion does not constitute a recommendation as to how any holder of Shares should vote with respect to such Transaction or any other matter. This opinion has been approved by a fairness committee of Goldman Sachs &amp; Co. LLC. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:530pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Based upon and subject to the foregoing, it is our opinion that, as of the date hereof, the Consideration to be paid to the holders (other than Alkermes and any Concert Parties of Alkermes and their respective affiliates) of Shares pursuant to the Agreement is fair from a financial point of view to such holders of Shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Very truly yours, </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">/s/ GOLDMAN SACHS &amp; CO. LLC</font>
        </div>
        <div style="margin-right:252pt; margin-top:2.5pt; width:204pt;">
          <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-right:252pt; margin-top:2pt; width:204pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(GOLDMAN SACHS &amp; CO. LLC)</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">D-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="position:relative;padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-8pt;margin-left:0pt;width:595.31pt;">
        <div style="position:relative;z-index:-1;text-align:center; width:595.31pt;">
          <img src="px_25avadelpxy01pg01-4c.jpg" alt="[MISSING IMAGE: px_25avadelpxy01pg01-4c.jpg]" height="982" width="759" >
        </div>
        <div style="margin-top:13pt; width:595.31pt; line-height:3pt;color:#FFFFFF;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">Using a black ink pen, mark your votes with an X as shown in this example. Please do not write outside the designated areas.Scheme Meeting Proxy Cardq IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.q Please sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please give full title. Signature 1 &#8212; Please keep signature within the box. Signature 2 &#8212; Please keep signature within the box. Date (mm/dd/yyyy) &#8212; Please print date below. Authorized Signatures &#8212; This section must be completed for your vote to count. Please date and sign below. B 1. That the Scheme in its original form or with or subject to any modification(s), addition(s) or condition(s) approved or imposed by the Irish High Court be agreed to. 2. That, any motion by the Chair to adjourn the Scheme Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Scheme Meeting to approve the Scheme, be approved. For Against Abstain For Against Abstain Proposals &#8212; The Board of Directors recommends a vote FOR Proposals 1 and 2. A Full details of the resolutions to be proposed at the Scheme Meeting are set out in the notice of the Scheme Meeting contained in the proxy statement.1UPX047JXB668043</font><font style="color:#000000;letter-spacing:0.02pt;"> </font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="position:relative;padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-8pt;margin-left:0pt;width:595.31pt;">
        <div style="position:relative;z-index:-1;margin-top:8pt; text-align:center; width:595.31pt;">
          <img src="px_25avadelpxy01pg02-4c.jpg" alt="[MISSING IMAGE: px_25avadelpxy01pg02-4c.jpg]" height="982" width="759" >
        </div>
        <div style="margin-top:13pt; width:595.31pt; line-height:3pt;color:#FFFFFF;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">THIS IS THE BLUE SCHEME MEETING PROXY CARD. NOTE THAT YOU ARE ALSO RECEIVING A SEPARATE YELLOW PROXY CARD FOR THE EXTRAORDINARY GENERAL MEETING. PLEASE COMPLETE AND RETURN BOTH PROXY CARDS. Important notice regarding the Internet availability of proxy materials for the Scheme Meeting of Shareholders. The material is available at: www.edocumentview.com/AVDL q IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.qProxy &#8212; Avadel Pharmaceuticals plc2026 Scheme Meeting of Shareholders Proxy Solicited by Board of Directors for Scheme Meeting &#8212; [&#8226;], 2026 The undersigned being a shareholder of Avadel Pharmaceuticals plc (&#8220;Avadel&#8221;) hereby appoints Mr. Gregory J. Divis and Mr. Thomas S. McHugh, and each or either of them, as proxies of the undersigned, with full power of substitution or revocation, and authorizes them, and each of them, to vote all the ordinary shares of Avadel that the undersigned is entitled to vote at the Scheme Meeting and any adjournment or postponement thereof upon the matters described in the notice of the Scheme Meeting and the proxy statement, receipt of which is hereby acknowledged, subject to any direction indicated on the reverse side of this proxy card and upon any such other matters as may properly come before the Scheme Meeting or any adjournment or postponement thereof, and hereby revoking any proxy heretofore given. Any Avadel shareholder of record entitled to attend and vote at the Scheme Meeting may appoint one or more proxies, who need not be an Avadel shareholder of record. If you wish to appoint as proxy any other person or persons, please contact the Company Secretary by writing to Avadel Pharmaceuticals plc, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland or by email at [&#8226;]. Shares represented by this proxy will be voted as directed herein by the shareholder. If no such directions are indicated, the proxies will have authority to vote FOR Proposals 1 and 2. In their discretion, the proxies are authorized to vote upon such other business as may properly come before the meeting. The proposals shall be decided on a poll. On a poll, a person entitled to more than one vote need not use all his, her, or its votes or cast all of the votes he, she or it uses in the same way. (Items to be voted appear on reverse side)</font><font style="color:#000000;letter-spacing:0.02pt;"> </font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="position:relative;padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-8pt;margin-left:0pt;width:595.31pt;">
        <div style="position:relative;z-index:-1;margin-top:8pt; text-align:center; width:595.31pt;">
          <img src="px_25avadelpxy02pg01-4c.jpg" alt="[MISSING IMAGE: px_25avadelpxy02pg01-4c.jpg]" height="982" width="759" >
        </div>
        <div style="margin-top:13pt; width:595.31pt; line-height:3pt;color:#FFFFFF;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">1UPX 047JWB 1. That the Scheme in its original form or with or subject to any modification(s), addition(s) or condition(s) approved or imposed by the Irish High Court be agreed to. 2. That, any motion by the Chair to adjourn the Scheme Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Scheme Meeting to approve the Scheme, be approved. Full details of the resolutions to be proposed at the Scheme Meeting are set out in the notice of the Scheme Meeting contained in the proxy statement. For Against Abstain For Against Abstain Scheme Meeting Proxy Card Using a black ink pen, mark your votes with an X as shown in this example. Please do not write outside the designated areas. q IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.q Please sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please give full title. Signature 1 &#8212; Please keep signature within the box. Signature 2 &#8212; Please keep signature within the box. Date (mm/dd/yyyy) &#8212; Please print date below. Authorized Signatures &#8212; This section must be completed for your vote to count. Please date and sign below. B Proposals &#8212; The Board of Directors recommends a vote FOR Proposals 1 and 2. AMMMMMMMMMMMMMMMMMMMMM 1234 5678 9012 345 668043 If no electronic voting, delete QR code and control # 000001 MR A SAMPLE DESIGNATION (IF ANY) ADD 1 ADD 2 ADD 3 ADD 4 ADD 5 ADD 6 ENDORSEMENT_LINE______________ SACKPACK_____________ MMMMMMMMMMMMMMM C123456789 MR A SAMPLE (THIS AREA IS SET UP TO ACCOMMODATE 140 CHARACTERS) MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND C 1234567890 J N T MMMMMMM 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext You may vote online or by phone instead of mailing this card. Online Go to www.envisionreports.com/AVDL or scan the QR code &#8212; login details are located in the shaded bar below. Your vote matters &#8211; here&#8217;s how to vote! Votes submitted electronically must be received by 11:59 pm, Irish Local Time, on [&#8226;], 202[&#8226;]. Save paper, time and money! Sign up for electronic delivery at www.envisionreports.com/AVDL Phone Call toll free 1-800-652-VOTE (8683) within the USA, US territories and Canada</font><font style="color:#000000;letter-spacing:0.02pt;"> </font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="position:relative;padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-8pt;margin-left:0pt;width:595.31pt;">
        <div style="position:relative;z-index:-1;margin-top:8pt; text-align:center; width:595.31pt;">
          <img src="px_25avadelpxy02pg02-4c.jpg" alt="[MISSING IMAGE: px_25avadelpxy02pg02-4c.jpg]" height="982" width="759" >
        </div>
        <div style="margin-top:13pt; width:595.31pt; line-height:3pt;color:#FFFFFF;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">Proxy &#8212; Avadel Pharmaceuticals plc q IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.q Non-Voting Items C Change of Address &#8212; Please print new address below. Comments &#8212; Please print your comments below. 2026 Scheme Meeting of Shareholders Proxy Solicited by Board of Directors for Scheme Meeting &#8212; [&#8226;], 2026 The undersigned being a shareholder of Avadel Pharmaceuticals plc (&#8220;Avadel&#8221;) hereby appoints Mr. Gregory J. Divis and Mr. Thomas S. McHugh, and each or either of them, as proxies of the undersigned, with full power of substitution or revocation, and authorizes them, and each of them, to vote all the ordinary shares of Avadel that the undersigned is entitled to vote at the Scheme Meeting and any adjournment or postponement thereof upon the matters described in the notice of the Scheme Meeting and the proxy statement, receipt of which is hereby acknowledged, subject to any direction indicated on the reverse side of this proxy card and upon any such other matters as may properly come before the Scheme Meeting or any adjournment or postponement thereof, and hereby revoking any proxy heretofore given. Any Avadel shareholder of record entitled to attend and vote at the Scheme Meeting may appoint one or more proxies, who need not be an Avadel shareholder of record. If you wish to appoint as proxy any other person or persons, please contact the Company Secretary by writing to Avadel Pharmaceuticals plc, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland or by email at [&#8226;]. Shares represented by this proxy will be voted as directed herein by the shareholder. If no such directions are indicated, the proxies will have authority to vote FOR Proposals 1 and 2. In their discretion, the proxies are authorized to vote upon such other business as may properly come before the meeting. The proposals shall be decided on a poll. On a poll, a person entitled to more than one vote need not use all his, her, or its votes or cast all of the votes he, she or it uses in the same way. (Items to be voted appear on reverse side) Small steps make an impact. Help the environment by consenting to receive electronic delivery, sign up at www.envisionreports.com/AVDL Important notice regarding the Internet availability of proxy materials for the Scheme Meeting of Shareholders. The material is available at: www.envisionreports.com/AVDL THIS IS THE BLUE SCHEME MEETING PROXY CARD. NOTE THAT YOU ARE ALSO RECEIVING A SEPARATE YELLOW PROXY CARD FOR THE EXTRAORDINARY GENERAL MEETING. PLEASE COMPLETE AND RETURN BOTH PROXY CARDS. Avadel Pharmaceuticals plc 2026 Scheme Meeting of Shareholders [&#8226;], 2026, [&#8226;] (Irish Local Time) Ten Earlsfort Terrace, Dublin 2, D02 T380 Ireland</font><font style="color:#000000;letter-spacing:0.02pt;"> </font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="position:relative;padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-8pt;margin-left:0pt;width:595.31pt;">
        <div style="position:relative;z-index:-1;margin-top:8pt; text-align:center; width:595.31pt;">
          <img src="px_25avadelpxy03pg01-4c.jpg" alt="[MISSING IMAGE: px_25avadelpxy03pg01-4c.jpg]" height="982" width="759" >
        </div>
        <div style="margin-top:13pt; width:595.31pt; line-height:3pt;color:#FFFFFF;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">1UPX047K0BExtraordinary General Meeting Proxy CardUsing a black ink pen, mark your votes with an X as shown in this example. Please do not write outside the designated areas.q IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.qForAgainstAbstainForAgainstAbstainPlease sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please givefull title.Signature 1 &#8212; Please keep signature within the box.Signature 2 &#8212; Please keep signature within the box.Date (mm/dd/yyyy) &#8212; Please print date below.Authorized Signatures &#8212; This section must be completed for your vote to count. Please date and sign below.BProposals &#8212; The Board of Directors recommends a vote FOR Proposals 1, 2, 3 and 4.AFull details of the resolutions to be proposed at the Extraordinary General Meeting are set out in the notice of the Extraordinary General Meeting contained in the proxy statement.1. Ordinary resolution to approve the Scheme and authorize the directors of Avadel Pharmaceuticals plc (&#8220;Avadel&#8221;) to take all such actions as they consider necessary or appropriate for carrying the Scheme into effect.2. Special resolution to approve an amendment to the Articles of Association of Avadel so that any Avadel Shares that are issued on or after the Voting Record Time to persons other than Alkermes or its nominee(s) will either be subject to the Scheme or will be immediately and automatically acquired by Alkermes plc and/or its nominee(s) for the Scheme Consideration.4. Ordinary resolution to approve any motion by the Chair to adjourn the Extraordinary General Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Extraordinary General Meeting to approve resolutions 1 and 2.3. Ordinary resolution to approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction.MMMMMMMMMMMMMMMMMMMMM668043</font><font style="color:#000000;letter-spacing:0.02pt;"> </font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="position:relative;padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-8pt;margin-left:0pt;width:595.31pt;">
        <div style="position:relative;z-index:-1;margin-top:8pt; text-align:center; width:595.31pt;">
          <img src="px_25avadelpxy03pg02-4c.jpg" alt="[MISSING IMAGE: px_25avadelpxy03pg02-4c.jpg]" height="982" width="759" >
        </div>
        <div style="margin-top:13pt; width:595.31pt; line-height:3pt;color:#FFFFFF;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">THIS IS THE YELLOW EXTRAORDINARY GENERAL MEETING PROXY CARD.NOTE THAT YOU ARE ALSO RECEIVING A SEPARATE BLUE PROXY CARD FOR THE SCHEME MEETING.PLEASE COMPLETE AND RETURN BOTH PROXY CARDS.Important notice regarding the Internet availability of proxy materials for the Extraordinary General Meeting of Shareholders.The material is available at: www.edocumentview.com/AVDLq IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.qProxy &#8212; Avadel Pharmaceuticals plc2026 Extraordinary General Meeting of Shareholders Proxy Solicited by Board of Directors for Extraordinary General Meeting &#8212; [&#8226;], 2026 The undersigned being a shareholder of Avadel Pharmaceuticals plc (&#8220;Avadel&#8221;) hereby appoints Mr. Gregory J. Divis and Mr. Thomas S. McHugh, and each or either of them, as proxies of the undersigned, with full power of substitution or revocation, and authorizes them, and each of them, to vote all the ordinary shares of Avadel that the undersigned is entitled to vote at the Extraordinary General Meeting and any adjournment or postponement thereof upon the matters described in the notice of the Extraordinary General Meeting and the proxy statement, receipt of which is hereby acknowledged, subject to any direction indicated on the reverse side of this proxy card and upon any such other matters as may properly come before the Extraordinary General Meeting or any adjournment or postponement thereof, and hereby revoking any proxy heretofore given. Any Avadel shareholder of record entitled to attend and vote at the Extraordinary General Meeting may appoint one or more proxies, who need not be an Avadel shareholder of record. If you wish to appoint as proxy any other person or persons, please contact the Company Secretary by writing to Avadel Pharmaceuticals plc, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland or by email at [&#8226;]. Shares represented by this proxy will be voted as directed herein by the shareholder. If no such directions are indicated, the proxies will have authority to vote FOR Proposals 1, 2, 3 and 4. In their discretion, the proxies are authorized to vote upon such other business as may properly come before the meeting. The proposals shall be decided on a poll. On a poll, a person entitled to more than one vote need not use all his, her, or its votes or cast all of the votes he, she or it uses in the same way. (Items to be voted appear on reverse side)</font><font style="color:#000000;letter-spacing:0.02pt;"> </font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="position:relative;padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-8pt;margin-left:0pt;width:595.31pt;">
        <div style="position:relative;z-index:-1;margin-top:8pt; text-align:center; width:595.31pt;">
          <img src="px_25avadelpxy04pg01-4c.jpg" alt="[MISSING IMAGE: px_25avadelpxy04pg01-4c.jpg]" height="982" width="759" >
        </div>
        <div style="margin-top:13pt; width:595.31pt; line-height:3pt;color:#FFFFFF;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">1UPX 047JZB Extraordinary General Meeting Proxy Card Using a black ink pen, mark your votes with an X as shown in this example. Please do not write outside the designated areas. q IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.q 1. Ordinary resolution to approve the Scheme and authorize the directors of Avadel Pharmaceuticals plc (&#8220;Avadel&#8221;) to take all such actions as they consider necessary or appropriate for carrying the Scheme into effect. 2. Special resolution to approve an amendment to the Articles of Association of Avadel so that any Avadel Shares that are issued on or after the Voting Record Time to persons other than Alkermes or its nominee(s) will either be subject to the Scheme or will be immediately and automatically acquired by Alkermes plc and/or its nominee(s) for the Scheme Consideration. 4. Ordinary resolution to approve any motion by the Chair to adjourn the Extraordinary General Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Extraordinary General Meeting to approve resolutions 1 and 2. For Against Abstain For Against Abstain 3. Ordinary resolution to approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction. Please sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please give full title. Signature 1 &#8212; Please keep signature within the box. Signature 2 &#8212; Please keep signature within the box. Date (mm/dd/yyyy) &#8212; Please print date below. Authorized Signatures &#8212; This section must be completed for your vote to count. Please date and sign below. B Proposals &#8212; The Board of Directors recommends a vote FOR Proposals 1, 2, 3 and 4. A Full details of the resolutions to be proposed at the Extraordinary General Meeting are set out in the notice of the Extraordinary General Meeting contained in the proxy statement. MMMMMMMMMMMMMMMMMMMMM 1234 5678 9012 345 668043 If no electronic voting, delete QR code and control # 000001 MR A SAMPLE DESIGNATION (IF ANY) ADD 1 ADD 2 ADD 3 ADD 4 ADD 5 ADD 6 ENDORSEMENT_LINE______________ SACKPACK_____________ MMMMMMMMMMMMMMM C123456789 MR A SAMPLE (THIS AREA IS SET UP TO ACCOMMODATE 140 CHARACTERS) MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND C 1234567890 J N T MMMMMMM 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext You may vote online or by phone instead of mailing this card. Online Go to www.envisionreports.com/AVDL or scan the QR code &#8212; login details are located in the shaded bar below. Your vote matters &#8211; here&#8217;s how to vote! Votes submitted electronically must be received by 11:59 pm, Irish Local Time, on [&#8226;], 202[&#8226;]. Save paper, time and money! Sign up for electronic delivery at www.envisionreports.com/AVDL Phone Call toll free 1-800-652-VOTE (8683) within the USA, US territories and Canada</font><font style="color:#000000;letter-spacing:0.02pt;"> </font>
        </div>
      </div>
      <hr >
    </div>
    <div style=" width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="position:relative;padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-8pt;margin-left:0pt;width:595.31pt;">
        <div style="position:relative;z-index:-1;margin-top:8pt; text-align:center; width:595.31pt;">
          <img src="px_25avadelpxy04pg02-4c.jpg" alt="[MISSING IMAGE: px_25avadelpxy04pg02-4c.jpg]" height="982" width="759" >
        </div>
        <div style="margin-top:13pt; width:595.31pt; line-height:3pt;color:#FFFFFF;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">Avadel Pharmaceuticals plc2026 Extraordinary General Meeting of Shareholders[&#8226;], 2026, [&#8226;] (Irish Local Time)Ten Earlsfort Terrace, Dublin 2, D02 T380 IrelandTHIS IS THE YELLOW EXTRAORDINARY GENERAL MEETING PROXY CARD.NOTE THAT YOU ARE ALSO RECEIVING A SEPARATE BLUE PROXY CARD FOR THE SCHEME MEETING.PLEASE COMPLETE AND RETURN BOTH PROXY CARDS.Important notice regarding the Internet availability of proxy materials for the Extraordinary General Meeting of Shareholders.The material is available at: www.envisionreports.com/AVDLSmall steps make an impact.Help the environment by consenting to receive electronicdelivery, sign up at www.envisionreports.com/AVDLq IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.qProxy &#8212; Avadel Pharmaceuticals plc2026 Extraordinary General Meeting of ShareholdersProxy Solicited by Board of Directors for Extraordinary General Meeting &#8212; [&#8226;], 2026The undersigned being a shareholder of Avadel Pharmaceuticals plc (&#8220;Avadel&#8221;) hereby appoints Mr. Gregory J. Divis and Mr. Thomas S. McHugh, and each or either of them, as proxies of the undersigned, with full power of substitution or revocation, and authorizes them, and each of them, to vote all the ordinary shares of Avadel that the undersigned is entitled to vote at the Extraordinary General Meeting and any adjournment or postponement thereof upon the matters described in the notice of the Extraordinary General Meeting and the proxy statement, receipt of which is hereby acknowledged, subject to any direction indicated on the reverse side of this proxy card and upon any such other matters as may properly come before the Extraordinary General Meeting or any adjournment or postponement thereof, and hereby revoking any proxy heretofore given.Any Avadel shareholder of record entitled to attend and vote at the Extraordinary General Meeting may appoint one or more proxies, who need not be an Avadel shareholder of record. If you wish to appoint as proxy any other person or persons, please contact the Company Secretary by writing to Avadel Pharmaceuticals plc, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland or by email at [&#8226;].Shares represented by this proxy will be voted as directed herein by the shareholder. If no such directions are indicated, the proxies will have authority to vote FOR Proposals 1, 2, 3 and 4. In their discretion, the proxies are authorized to vote upon such other business as may properly come before the meeting.The proposals shall be decided on a poll. On a poll, a person entitled to more than one vote need not use all his, her, or its votes or cast all of the votes he, she or it uses in the same way.(Items to be voted appear on reverse side)CNon-Voting ItemsChange of Address &#8212; Please print new address below.Comments &#8212; Please print your comments below.</font>
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>tm2529379d1_ex-filingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
  <head>
    <title>EX-FILING FEES</title>
  </head>
  <body>
    <div style="display: none">
      <ix:header>
        <ix:hidden>
          <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-150">SC 14A</ix:nonNumeric>
          <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-151">PREM14A</ix:nonNumeric>
          <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-152">EX-FILING FEES</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-153">0001012477</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-154">AVADEL PHARMACEUTICALS PLC</ix:nonNumeric>
          <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"></ix:nonNumeric>
          <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ix:nonNumeric>
          <ix:nonNumeric name="ffd:Rule011Flg" contextRef="offrl_1" format="ixt:booleantrue" id="ixv-157">0-11</ix:nonNumeric>
        </ix:hidden>
        <ix:references>
          <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
        </ix:references>
        <ix:resources>
          <xbrli:context id="rc">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-11-12</xbrli:startDate>
              <xbrli:endDate>2025-11-12</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_1">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-11-12</xbrli:startDate>
              <xbrli:endDate>2025-11-12</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:unit id="USD">
            <xbrli:measure>iso4217:USD</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="pure">
            <xbrli:measure>xbrli:pure</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="Shares">
            <xbrli:measure>xbrli:shares</xbrli:measure>
          </xbrli:unit>
        </ix:resources>
      </ix:header>
    </div>
    <div>
      <table style="width: 99%; text-align: center; font-size: 20pt; font-family: Arial, Helvetica, sans-serif;">
        <tr>
          <td colspan="4" style="padding-bottom: .6em;">
            <p>
              <b>Calculation of Filing Fee Tables</b>
            </p>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: center; width: 90%; word-wrap: break-word">
            <p style="margin: 0pt; text-align: center;">
              <b>Table 1: <span style="text-decoration: underline;">Transaction Valuation</span></b>
            </p>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 80%; text-align: center; border: 1px solid black; margin-left:auto; margin-right:auto;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 40%;">
            <!-- BLANK -->
          </th>
          <th style="width: 20%;">
            <!-- BLANK -->
          </th>
          <th style="width: 15%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Proposed Maximum Aggregate Value of Transaction</b>
            </p>
          </th>
          <th style="width: 15%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Rate</b>
            </p>
          </th>
          <th style="width: 10%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount of Filing Fee</b>
            </p>
          </th>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="width: 40%; text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_1" format="ixt:booleanfalse" id="ixv-182">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
		1
	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:TxValtn" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-183">2,101,825,233.00</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-184">0.0001381</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-185">290,262.06</ix:nonFraction>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="width: 40%; text-align: left;">
		Fees Previously Paid
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p style="margin: 0pt; text-align: left">Total Transaction Valuation:</p>
          </td>
          <td style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlTxValtn" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-186">2,101,825,233.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p style="margin: 0pt; text-align: left">Total Fees Due for Filing:</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; border-bottom: 1px black">
            <p id="TotalFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-187">290,262.06</ix:nonFraction>
            </p>
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p style="margin: 0pt; text-align: left">
					Total Fees Previously Paid:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalPreviouslyPaidAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-188">0.00</ix:nonFraction>
            </p>
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p style="margin: 0pt; text-align: left">
					Total Fee Offsets:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalOffsetAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-189">0.00</ix:nonFraction>
            </p>
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p style="margin: 0pt; text-align: left">
					Net Fee Due:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="NetFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:NetFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-190">290,262.06</ix:nonFraction>
            </p>
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table style="width: 80%; margin-left:auto; margin-right:auto; text-indent: 0px;">
        <tbody>
          <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
            <td>
              <p style="margin:0pt;text-align:left; margin-bottom: 5px;">
                <b>Offering Note</b>
              </p>
            </td>
            <td/>
          </tr>
        </tbody>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="width: 80%; margin-left:auto; margin-right:auto; text-indent: 0px;">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">1</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_1" id="ixv-191">(i) Title of each class of securities to which transaction applies:
Ordinary shares, nominal value $0.01 per share, of Avadel Pharmaceuticals plc.

(ii) Aggregate number of securities to which transaction applies:
As of the close of business on November 7, 2026, the maximum number of ordinary shares to which this transaction applies is estimated to be 110,456,049, which consists of (a) 97,817,589 outstanding ordinary shares (including restricted stock awards); (b) 12,419,785 ordinary shares subject to outstanding stock options to purchase ordinary shares; (c) 218,675 ordinary shares subject to outstanding time-based restricted stock unit awards; and (d) 44,029 shares of ordinary shares estimated to be issuable pursuant to Avadel's Employe Stock Purchase Plan (the "ESPP").

(iii) Per unit price of other underlying value of transaction computed pursuant to Rule 0-11 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"):
Estimated solely for the purpose of calculating the filing fee, as of November 6, 2025, the underlying value of the transaction was calculated based on the sum of: (a) the product of 97,817,589 outstanding ordinary shares (including restricted stock awards) and the per share transaction consideration of $20.00; (b) the product of 12,419,785 ordinary shares subject to outstanding stock options to purchase ordinary shares and $11.29 (which is the difference between the per share transaction consideration of $20.00 and the weighted average exercise price of $8.71); (c) the product of 218,675 ordinary shares subject to outstanding restricted stock unit awards and the per share transaction consideration of $20.00; and (d) the product of 44,029 shares of ordinary shares estimated to be issuable pursuant to the ESPP and the per share transaction consideration of $20. In accordance with Section 14(g) of the Exchange Act, the filing fee was determined by multiplying the sum calculated in the preceding sentence by 0.0001381. </ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 2: <span style="text-decoration: underline;">Fee Offset Claims and Sources</span></b>
          </th>
          <th style="vertical-align: bottom; word-wrap: break-word; text-align: right;">
            <span style="-sec-ix-hidden: hiddenrcOffsetTableNa">&#9745;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; text-align: center; border: 1px solid black;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 10%; text-align: left;">
            <!-- BLANK -->
          </th>
          <th style="width: 8%; text-align: left;">
            <!-- BLANK -->
          </th>
          <th style="width: 16%;">
				Registrant or Filer Name
			</th>
          <th style="width: 6%;">
				Form or Filing Type
			</th>
          <th style="width: 7%;">
				File Number
			</th>
          <th style="width: 6%;">
				Initial Filing Date
			</th>
          <th style="width: 6%;">
				Filing Date
			</th>
          <th style="width: 6%;">
				Fee Offset Claimed
			</th>
          <th style="width: 6%;">
				Fee Paid with Fee Offset Source
			</th>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Claims
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Sources
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
        </tr>
      </table>
    </div>
  </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>lg_avadel-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_avadel-4clr.jpg
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M%!04%!04_\  $0@ 6 %K P$1  (1 0,1 ?_$ +T   (" @,!
M   )!P@$!@$#!0(! 0 # 0$! 0$            !!@<%! ,""!   0,# P(#
M P8&"PH/     0(#!  1!2$&!S$201,(46$B<8$R0A0)4M(C)'05H6*"L[1U
M%C=7&#B1P9)#TY0EE387L7*B,V-SH\,TA*15)G8H$0$  @$" P,*!00#
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M7H@LWU@^I*#SAN#'83:0>1L3;Q<7'>?3Y:YLUT!*Y!;ZI0E([&@K6Q43;NL
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MNMV3Y=BEN2QL[$Y"5BLBR6,A"<+,AE6EEI-M/:D]4GQ%:OBRUR5B]9UBW&&
MY\%\.2V.\:6K.DQY=G;'F;YP=E8V)Y'@_:U);;GL/04.*-@EU8"T?.HH[?GK
MC==Q3DVDZ?3,2LWVKGKBZA7Q?76:^GG[EO4VMI68MN<T!0% 4&+DI\?%8^5D
MI:PB-$:6\ZI1L.U"237QS9:XJ3>W*L:OMAQ6RWK2O.TZ*;.N^>ZZ_;M\Y:W.
MWK;O456^:]8-EMXK3+^@*5\-8CNAL^P=G2-YYQ$0@IQ44I=R3XZ!L&X;!_"7
MT]PN:['1^F6WF:(^B.-I\WQGRY./UCJ==C@FWUVX5CS]_P"$+4M-H:;0TTD(
M;; 2A %@$IT  ]PK9:UBL:1RAB=IF9UGG+7N0=WP=@;)SV]<E;[)@X3TU25&
MW>II!*$?*M7:D>-SI7Z?DC3-YB?N#,Y#/91TOY+)R7ILQX]5O2%EQ9^<J- S
M3[OCCU.V^)YN]I3/9DMWS%*:4H648$ J9:^8N%U0]VOC06[H"@7=]X]QZF+F
MMK\FPT?#D6EX7*6&@>C7>CK)OU4A3B>GU![:"JG!W(3W%O*VU][(41%Q\Q",
M@D$#N@R 69";E*O\6M7A0.7WAM7%<@[+S&U,@XEW#[A@.Q%/HLL!$ANR'46-
MB4GM6G7PH$=;DP.0VON#*;;RK:FLGB);\&6VM)20['<+:M#KU30&VL!D=U;@
MQ>VL0T7LGEI3,*(TGQ<?6$"_L O<GP% \O96U\;LG:^'VAB$]N-PD-F#'L.W
MN2R@)*R+G51NHZ]30>_0+9]5/HPS6W<G.Y XCQR\EM625RLGMZ*"N5CE_26M
MA%RIUA1NKM2.YOV=O0*5.M.LN+9>0IMULE*T+!2I*AH00=010?4:-)F/MQ8C
M*Y$IT]K3+22XXM1\$I2"2?DH)YSGI>W7L7@_+<L<ALO8;)F5"B8' +[0_P!D
MAT!Q^6-2@=OPMMZ*OJJVER4 T0?#LO79FWK>.,A6_P W104#]5?HOST+,Y/D
MCB/'B=@)9^U9/;$-!^TQ'2/RKD9NY\QM2OC*$?$BYL.T:!1YYEZ.ZMB0VII]
MLE+C3@*5I4.H(.H(H!EAZ2ZB/';4Z^X0EMIM)6M2CT  N2:"?%^F+=FU>%MQ
M<N<APW<1Y;<5K;>&>^"4M<J0E"I$A /<TE*+]B%BZB;D  7"O] \KB/7B78E
MM+[=Q%O\Q9H*@^J_T79'.Y2;R7P_#0]D)BER,]M9KM;+CI!4Y)B7(!6LBZV>
MJE&Z;DVH* 9'&Y7!3W(&5B/X[)QE%+L>2VMA]M:3;5*P% @B@Z79<I](0^^X
MZ@&X2M94+^VQ-!)/$/ /)7-.4;B;2Q:T8D*2)N?F!3..CH)()4Z1\:M#\#84
MKW4#9>$.&]L\'[)9V?MU1E/%9DY;+.H#;\V8H *<4D$]J0 $H1<]J1U)N2%)
M/O)OYP=E_P 3/?PI5!"'I'('J)V)[YRA_P!@Y0,_Y>5NQAW;#NVMTRMO-Y/,
M1,++:C1HDA*T3E*N[>2TX0M'99-M*)A#>^^>.2=L_P L\!!>#F6@YUHX'**B
MMK2SMV&]&AY K'E]A6E]:$!2[DJD"U@D6@6W[1^Q;YJE#GK0:!R-Q7A-_,_:
M5?F.X66^R+DFQ>X!N$.I^NB_SCPKL].ZKDVDZ?NI/.OP[I5SK'0</4*ZS\N2
M(X6C\I[X\H5?W;L;=FR)7;F(;K3+:P6,I&[EQU%)!"DN)^B0;&RK$5H6UWV#
M=5^28U_MGGZF/]1Z5NMA?YZSI$\+UUT]?9Z4U\:<^8W(1&,-OB2F'ET6;:RQ
M3:+)'0%9&C;GMO\ ">NG2J5U+H]L=IMBC6O=VQ\8:/T3[GIFI&/<SX;\O%]-
MOA;OCEW=R;8LN+-:2_#?;D,*%TNLK2X@^&A22*K4Q,<)7JMHM&L3J[ZA^A0>
M5F-Q8/ ,F1F,BQ#:2+V=6 LCI\*!=2OF%?#+GQXHUO,0^V+#?).E8F4 <C\J
M/;N_T-APN-MX$%TK':]+6DW'<GP0#J$]2=3[*SWK75YW$?QX^%/;/Z-%Z'TB
M-O/\E^-_97]?.Z]G\3[AW(MN5D&U8K#7!4\\FS[J-"0TV=1<?65^S7.Z=]O9
M]S/BO\E//SG\(\H=7J7W#M]K'AI/\E^Z.4?C/NA83 ;?Q6VL:UBL0P&(C?Q&
MY[EK6>JUJ.JE'Q/]ZM/VNTQ[;'%,<:1Y<V6;S>9=UDG)DG69]GFCS/4KUO$Z
M942).85%FL-R8R[=[+R$N-J[2%"Z5 @V(O08/\F=N?\ L\'_ #9K\6@SV(\>
M*TAB,TAEAL!+;3:0A"4CH D6 %!VT!0=$J%#GM%B=':DL$A1:>0EQ%T]#VJ!
M%Q08)VSMLBQP\$@^'V9G\6@]-MMMI"6FDA#2 $H0D62E(T  '0"@\]W;V ?=
M6^_BH;K[I*G'5QVE+4H]2HE-R:#Z8P."BO(D1L9$9D-F[;K;#:%I)%KA24@C
M0T&>$I3T%!S0<$ ]?"@UG.<;\>[F?<E[AVKB,G,=':Y*EP8[SY -[>8I!7U]
M]!]X'C[8>UWA)VWMC%8F4$>7]I@PH\=[L]A<;0%'YS0>[)A0YK1CS8[<E@D$
MM/(2X@D&X-E C2@P3MG;9T.'@V_1F?Q:#U$I2A(0@!*$@!*0+  = !0! /6@
MUO.<=[ W,\J5N+:V)RLM:>Q4F9!COO\ :3>WF+05#77K0<8+CGC_ &P^B7MW
M:V)Q4QM/8B5#@QV'PDF]O,0@+Z^^@]^3#B3&E,3&&Y#"K=S3R0X@VU%PH$&@
MP3MG;9T.'@D?HS/XM!Z;;;;3:6FDA#2 $H0D )2D"P  Z 4')2"03X=*#QLY
MM#:>YO+_ )28''9GR3=K]8Q&)?8;6NGSD*MI0>#&X8XBAE18V+@05D*)5C(J
M]1TMWMFWS4&YLQH\9I+$=I++"!9#3:0A"1[DBP%!V!(3TH,29B,5D%I<GP8\
MIQ LA;[2'5)!\ 5@V%!U,8#!1G4R(V,B,OHU0ZVPVA:3[E)2"*#-4PRYV^8V
ME?:H+3W#NLH="+]"/;0=2\=CW2HN1&5E5PHJ;2;A2@I5[C6Y2DGW@4&18?WJ
M#F@*#X=:0\VIIU*5MK!2M"P%)4#U!!ZBIB=)UA$Q$\)1YGN#N.L\I;RL9^KI
M+ANM_'+5'O>Y(*!=%B3^#74Q]4W%(T\7BCS\5>W'V]L<TZ^#PS_Q^7\N#3VO
M3BYBU]^WMW3(%TE*[-!*CK>UV5M#M]UJ9>H3D_=6'PV_0(V_^/):/5[M':CC
M/F=A(99WX/(1\+84Z_?M'2]T'_AKFY)BW+@[.+!FKSOJ[4\4\H9%26\YOE?V
M9%RDL+?6H*^3\D/V:YV3!>_U:.MBO%><:LB#Z>\0'A(S6:ESG3W%WRTI9*E*
M\>Y1<5UZZZUSYZ/2\ZWM,NG3JEZ1I6L-_P %L':6VU)=Q.+9;E)&DIP%YZ_M
M"W+D?-7MP=.V^&=:5C7OYS[7FS]1W&:-+6G3NY1[&RC05T7/% 4!0% 4!0%
G4!0% 4!0% 4!0% 4!0% 4!0% 4!0% 4!0% 4!0% 4!0% 4!0?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>lg_goldmansachs-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_goldmansachs-bw.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    1@  _^$$ &AT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@.2XQ+6,P,#(@-SDN9C,U-&5F8S<P+" R,#(S+S$Q+S Y+3$R.C U
M.C4S(" @(" @(" B/B \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N
M=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B \<F1F.D1E<V-R
M:7!T:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+VUM+R(@>&UL;G,Z<W12968](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B('AM;&YS.GAM
M<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(@>&UL;G,Z9&,](FAT
M=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(B!X;7!-33I/<FEG:6YA
M;$1O8W5M96YT240](G5U:60Z-40R,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q
M-3 X0S@B('AM<$U-.D1O8W5M96YT240](GAM<"YD:60Z-C8U,D)#1#9"-C)#
M,3%&,#A$,41$14(U,#@R.3DW.4,B('AM<$U-.DEN<W1A;F-E240](GAM<"YI
M:60Z-C8U,D)#1#5"-C)#,3%&,#A$,41$14(U,#@R.3DW.4,B('AM<#I#<F5A
M=&]R5&]O;#TB061O8F4@26QL=7-T<F%T;W(@,C@N,R H36%C:6YT;W-H*2(^
M(#QX;7!-33I$97)I=F5D1G)O;2!S=%)E9CII;G-T86YC94E$/2)X;7 N:6ED
M.C8P-C<U,C8T+3@Q8F$M-#)A,RTX861D+3@V-V)C,3%E-F4X,R(@<W12968Z
M9&]C=6UE;G1)1#TB>&UP+F1I9#HV,#8W-3(V-"TX,6)A+30R83,M.&%D9"TX
M-C=B8S$Q939E.#,B+SX@/&1C.G1I=&QE/B \<F1F.D%L=#X@/')D9CIL:2!X
M;6PZ;&%N9STB>"UD969A=6QT(CY0<FEN=#PO<F1F.FQI/B \+W)D9CI!;'0^
M(#PO9&,Z=&ET;&4^(#PO<F1F.D1E<V-R:7!T:6]N/B \+W)D9CI21$8^(#PO
M>#IX;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^T 2%!H;W1O<VAO<" S
M+C  .$))300$       /' %:  ,;)4<< @   @ " #A"24T$)0      $/SA
M'XG(M\EX+S1B- =8=^O_[@ .061O8F4 9,     !_]L A  $ P,# P,$ P,$
M!@0#! 8'!00$!0<(!@8'!@8("@@)"0D)" H*# P,# P*# P-#0P,$1$1$1$4
M%!04%!04%!04 00%!0@'" \*"@\4#@X.%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  U ( # 1$  A$!
M Q$!_\0 B0   04! 0$!            !P $!08( P(!"0$! 0$
M          $"$  ! P,# P("!0<("P$    " 0,$$04& !('(1,(,2)!%%$R
M(Q4687&!D:%T"4)B<K1U-A<XP9*BLD.3LR2$)2<8$0$! 0$!
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M*-I)F0V)#NP:J@[W ):)7HE=!A+S8XORRV\@ERI;HSTC&[BQ%&1/C(1+!EQ
M%E$<V]0$D " _3=5/7U-1.\.^<LB$W%L'+L4I3 (+0Y/"&KZ(B4W26$^O^4V
MJ+_,)="QJ*:_&Q[A^[WCA2(S<2.%.NV.L1%*4R]*F&Y)(FQ524JN.$:-)\?8
MB)Z:(Q_B%EO.6<*<J9OR]:9RY3;025CN77A^5&EK(V$OR\<7# 1!MP1HC8HA
M*ZH=:(B%%7PEY+R"_P"#Y7!S"Z.SH.+.L/1ILPR==:B/M.D8$X2J2@'94AKZ
M55/2B(*H&'Y[?_)'D/-;U>H3]YQ+%;+.N6+8"+CC423*!4"($@&B'NN'U4MU
M?<M!]J4T/#CQOF\GEQGRW;<ICSVL/CV.:=L"X@\(QYA1GT<9C*_[MFVBF-50
M50?B2U%4?PWX^M_(UWR^SWVX3V,?"#&.7;K=*=A)*=)PT:5XV5$B%KW$(5VJ
M2HJUI31:L7A;G>36_E6Y<=/W&1.QJ9&EF$62X3@LR81HHNMH2KM4AW":#];I
M7T31*E\DY2L66^45RQ+F2<Y&XRLKK]KM5J<>=CVQ)K.U&WYB-J.\7"0UW.>T
M:BB^Q%T,'7#.$(&"\TAG&"MHQQ_=+ ^Q(AA*)YAFX.2&' -D3,E[;K8JJ;:H
M*HM*(J)HG1TT0M M M M +<6SR1?>7^2>,;V;#T.S,6J79H9-AN.%-A!\VA]
M/>*.D-=WP-$]-%9T\LO&;#<?Q*=RC@<4;,[;W6BO-H9Z0W&9#HL(XRW_ ,(A
M,QJ(^Q1KT14ZEE-O'GE2[\7>+>79=(CK/:M%Y*+CL9]2[2OS CHHK147M XX
MKI(*I7W(BHJZ%]1N*+=^8^$>4>7>4)[M_NUL8FPL<AR5VVZWN-Q1=)Z/&&C0
MN_;"(N;=R;?6JKH.?A[$DS^+.;(,(5.9)M8,QP&NY77(4\11*?%570KQ_#^=
M!,YRUE5^T.TM&(_2(2115_VDT*U]SGD,#&.'\TNMP-!9^Z9<1I%6F]^:VL9D
M$_I.."FB1DW^'U_>3-_W&%_UG=%JF^('^9!S]WNW^G1:T'REP3Q_Y'2LBON)
MON6#D''KD[8;I->:I&ER83;94?;%54A4' 0'Q]U.BB6U$0SW@.^-&5<F\3\W
ML\'92X\MJENOQ)-I>-7F8[PQRDM28JKZ":"B^V@D!55*HE"U^@FC):!:!:!:
M#!O)3><EYF3%XQDOAF2MP-H)' X21?N]CO?-$3PHK.WZ_MK6FWW[=&L7_P A
MVN5WN/O_ *]+@PN-PE1OQ"F!QG)L]U$<3M=W[TD1@:95[MTV=Q4/;6J:$2F?
M!PH?B(\%@=D,<<E'CI:WH+0OSPG_ #8;5<;=<:0G4?K\PA.#TW47TT36=>,&
MLV/QNY#&'*;9XN&<XMT=BQN]?3D(S']H@;[;(1E^P5\MY&@[T$5]4-:+7\/X
M(@P<]^4><=%7;7N[K0M*B[97IM<<K^S1*K/'X6H/)6\/^,SR/GVIOWS;[VUV
M+!\JCH=Y8TN,XZ_VU>[?93Y;HM/4- 6N5QOI@KW-CK#$5RWW-,.A6=OOXZQ?
M$@O]DIDF4;3STQ0W_*B4=IE%^J2N+T(%_@$$$<CS18C[KJ_(PMZ.LBU3[5ST
M477*Z+5.\1FX ^11JQ(><?\ E[KN$V!;#XUH2/&O[-"C#QX/+8<\<N.<<' >
ML?WK_P"ZCY #S,%9*U[7R[L8G'.\@UW?9;5'ZU%V:"1XV:L >3M_+DR4;_-Q
IQ!6UM1XP,6)F)\J%1@FK[KSKG8K4G@;7;O\ ;71,:JT0M M M M!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>lg_morganstanley-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_morganstanley-bw.jpg
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M%!04%!04%/_  !$( !\ T0,!$0 "$0$#$0'_Q ")   " @,! 0
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MM63K1;H"2>TPDKD-D(!]/E:;3_0D:%6GS-PIC/-%CC6^\NNV^\6QQ3]FO<4
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(=#H5<NB/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>lh_morganstanley-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lh_morganstanley-bw.jpg
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M<VAO<" S+C  .$))300$       /' %:  ,;)4<< @   @ " #A"24T$)0
M    $/SA'XG(M\EX+S1B- =8=^O_[@ .061O8F4 9,     !_]L A  $ P,#
M P,$ P,$!@0#! 8'!00$!0<(!@8'!@8("@@)"0D)" H*# P,# P*# P-#0P,
M$1$1$1$4%!04%!04%!04 00%!0@'" \*"@\4#@X.%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  H (L#
M 1$  A$! Q$!_\0 ;P   @,! 0$               0" P4& 0@! 0$
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M%YJR1F(\E\"&0E67ST%"]I4XHJ[5IGBR=:S-?7(;*TC6+083%UVXE7#;<?(
M;> U19!V_/0KUZ^*R4M54DFGN,T<4S69;+<W=RZ[AN1)'';Z;;:@#VO3B7&O
M0D>K;Q9E^-8'K+"SUF$BGHWN'U'_ +;$:H6_2L;[/L>_/PY_)^Y=_G>][_RM
.^/\ Z<O_ )VZ;:4?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>px_25avadelpxy01pg01-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 px_25avadelpxy01pg01-4c.jpg
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M_\0 \P !  (" P$!              8'! 4! P@""0$! 0 # 0$! 0
M      $" P0%!@<($   !@$# 0((!PH'# <$ 14  0(#! 4&$1('(3$302(4
M5)05"!A1D=$RU!9687&2TB-3D]/5%Z%",[1U-U>!4F)SLR0T=#65-G:Q<K)5
MM98XP8)#)84)XR='&:+$Q88F9W?P8X.C1(2E9B@1 0 ! P$% P4)# <' P4!
M 0 !$0(#!"$Q41(%01,4<9$R%0:!H;$B<I(S4W-AT5*"LM(CD[,T5%7PP4)#
M=)0UX6*BXB1%%L)CH_'#A*0E1#;_V@ , P$  A$#$0 _ /?P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M>#O.\QS;W7+S_P"[S^C7RI$-+R0
M
M
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MV2P>'?\ [2/^)RW_ "ICDU?][^(^5]I?^Y>72_ ]2CP7XN
M
M
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MX+\7
M
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ME?:7_N7ETOP/4H\%^+@
M                   #!MKFJHH:K"YF-0H:3))O/*)"=RCT(BU[3,_ 0"!.
M<ZX(C>I*ICC#9Z*=1&5V:Z:[#,G-->GS!:)5+\=R_'<K:6Y1SD2%M:=\P>J'
MF]>S<VHB41'\.@BMX
M                        ")<B<EX?Q91(R+,YWD5<X^W%9)"%.O..NGV(
M;3JI6U)&M6G8DC^\ D%1;U=]61;FEF,SZJ:V3T29&63C3C:NPTJ3J1@,T
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M?1[OW-M?>6<.%\<
M               C^7YC3855*M+=:E&H]D6&R6^0^X9D6UM':>FOC'V)+J8#
MR]D^5V^:69V-P\VMM&[R:,V9DS'96?BH;+4C->O13BDZ]A'H6A#-BT)+-O1P
MU&XX@B2M"E)[PE)7H1EIH7C$>A:ET4 R*VSF4<]JUJIBX4V/T3*C&C1!&?4E
MD?BK2YXFY)ET_N@/3/'7)D+,VE5TY*(.412TE024>UPD=%.L[B(]IF1^*?C)
M\/30SQF%3X10
M               &OO+RIQJGFW][+1!IZYE<F9+=/1#;39:F?3J9^ B+J9]"
MZ@/R\Y3Y#S#VF^5(<"CB.N1G7CKL3HR/^296K53KNA[26LD]X\OL2DM-=J",
M&>Y^A_"G%%;PY@</$H3ZI<PU'+MIJE*-+\YU*2<4A*CT0@B224)(BZ%J>JC,
MS,96("
M
M                     C^89?5X74+M;+5Q9GW<6(V9=Z^Z?\5.ID1$7:I1
M]$EU >6<@R6SRBX<NK=_669&2&V_Y)J,9ZDAHE&2DDG3<9]JCZ_<&;%J.J>Y
M(B[Q2%)+4S(R7J1$V22/MUZ_./3J6NO: (T:<(E;5QTK4DTI(T'N,M-"UZ(,
MM#,E*U21]/" X+H2>_,U.H)3<AY9&@M2,T;C2GH1>!:>NG:70!VQI<N!(CRX
M\A469%,W6Y*C)MQEQOH9IVFHNS0NNI*\)=0'ICC'DAC,H1U]D:6<GAITE,D6
MQ+R4Z%WS:? 1_P 9/@/[F@QF%6"(H     HWEGVI^/\ B'*4XC=1+"QM2CHE
M2?5Z&E(8)W4T(6;KC?C*26[IKT,@*(C6>W3Q196L*M567$5N8^VP<QYJ.337
M>*).]>U\U;2UZZ$"T>H",C+4NI'V&"                   Q;)UV/73'V5
MI;>:8<6VM?S4J2@S(SU\!& _+]7M=\_-K-/UI0O:K34H<,TGH?\ B>P&5'O;
MV=,PR+/.(J'*<JE^6WDXY1R)'=(8(R;DN-H(DMD2="2DBUTZ@Q6H      /"
M7M.>T+RWQ[R]:8QB=\4&D8BPG&8WDT=W:IYA*UGN<;4H]5&?A!8A//8]YIY$
MY6N,MC9Q9^L6:^/#>ADB.RPAI3JW4K+5I*?G$DM"/7L,"8>L00
M         !^='M=>T$KD*Z5QSA\DUX;4/Z3I+!ZILI[9Z=#+YS+1]$>!:O'Z
MD2#!E$/0GLG>SX7%]!]<,JBD6?W;1?D7"\:NA+T43!$?8ZOHIX_!T1X#W$F7
MI,$
M
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M4?EW,XFM5#<W8M >3T?D-G_IBB/^(VHM&OA7XW3:6X3+WH#$
M
M
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MW&1>!)'N/X"(&2V_:NXP@\8\HJBT<1,/&[:''F5K+1;6T&A!,/(27^,;-?\
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ME"$)3H1)21$1$0,'>
M
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M-D:GU@PCV]=#T>=Z_P!S4$E3/M2Y?*S#F[)GGEDJ+4/>IH"4GJ26()FD^O\
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M*CVD:BUT(P2CTV"
M
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MJE73J70!88(
M
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MCQ_E JMK@SV=*7@R;<S:JZE6RKEIAEU,IIMLFRCJ6HC3L[==X),KI!
M
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MG4^\/0M3 H]#@@
M
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MVET[3\)F)54R$4
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MDJ+QNTC+4"JS@0
M
M                       8,^EI[0C*SKXTPCTU\H90[V$9%\XC[-3 1.=P
M]Q_.-Q2:HHCCA=5Q'%LF1_"1$>TC_N"U2C5_N#XZU3I&E$T@C)+7E3FTB4K<
M?77=U,OA^\%2C.B<+<=Q3(UU9RE)-)I5(>=49&C70_%4DNTS/[Y_>"I1):O#
ML5I2(JNFB1E$9J):&4&LC,B(_&,C5UT+PB55NP
M                                  &!*HZ2>\<F=6Q9,@R))O/,-N+-
M*>PMRDF>A .CZKXS_P!S0?16?Q0#ZKXS_P!S0?16?Q0#ZKXS_P!S0?16?Q0#
MZKXS_P!S0?16?Q0'8QCU!&>1(C54-F0T>YMUN.TA:5=FI*))&1@-D
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                      Q;.6]
MKI<V/%<G/QF7'FH3&G>O+;2:B;1N,BW*,M"U,96Q68C<W8,<9,EMEUT61=,1
MS3NBO;/W(5U^]++/[,K_ /"B_K!V>&L^LM]]]9Z@TG\;A_XOO'[TLL_LRO\
M\*+^L#PUGUEOOGJ#2?QN'_B^\?O2RS^S*_\ PHOZP/#6?66^^>H-)_&X?^+[
MR28AEEQDCTINTQ6QQU$=*%-N6!M&EXU&9&2>[4H]2TZZC3EQ6V;KHN\CR.I=
M.PZ6+9QY[,U?P*[/+6$K'.\0
M
M
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M5@
M
M
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M^4]H;M;-MGB-3CU$5FD67Q=R[M](BE5H#A?&
M
M
M
M #5Y,TX_CELPRW)>><AR$-M0'28EK4II1$EAP]"0X?\ $4?8?4;,<TNCR]KM
MT-T6ZC',S;$1=;MNBMN_^U';;QCMAYT^J^1?9_D3_P Q1_E'L=Y;^%C^:_5_
M'Z?ZW1?J+G/U7R/[/\B?^8H_RAWEOX6/YIX_3_6Z+_+W'U7R/[/\B?\ F*/\
MH=Y;^%C^:>/T_P!;HO\ +W+(XAJK*MEVJI]=DL$G&V20K)+)NQ;49*5J3)-F
M>T^OC&?;T'%JKHF(I-L_)BCY'VDU&/+99R7X+Z3/T..;)[/2KO\ N+6' ^)
M
M
M
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MK[<ZC5Y,>'Q&GC!$3=2E]M]=W"(H]$#QWY2
M
M
M
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M56@.%\8
M
M
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M"^DS]%CG'/9Z5=_W%LCSWPX
M
M
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M"Z^8MYK>7W:OS7VYS:S)CP^(P6X8K=3EOBZN[A$4>B!X[\I
M
M
M
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M[(I59PX7QP
M
M
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MDU6/-9CBS+BR4F?H\4XZ;M]=ZUAP/B0
M
M
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M"[),6\\1'NU?F?MUFUN3'A\3BMQ16ZG+?S5W?<BCT6/&?DX
M
M
M
M            UF1>3?5^U\LKW+6)Y(_W]6R@G793?=JW,H09EN4X7BDG7KJ,
M\=>:*33;O=FBYN_LY;XQW<UM+YFD6S7TIGLB-Z@=W'/]A%__ +G3^M'K_I?K
MK?G/U"G4?YIA_6_\INXY_L(O_P#<Z?UH?I?KK?G%.H_S3#^M_P"4W<<_V$7_
M /N=/ZT/TOUUOSBG4?YIA_6_\JP^*3QDY5GZ@X_L<*7W;7?O6,(H29):JVI0
M9+5N-/4S^^./4\](YKXO\DU?*>T/B>6SOM79JMLTBR_FY=V_9%*K.'"^.
M
M
M
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M[NF[?Q6P//?#@
M
M
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MW)CP^)Q6XHK=3EOYJ[ON11Z+'C/R<
M
M
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MW5VZK;-(MNF[EW<>*RQQ/CP
M
M
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MHBET3Y+:/C_:368\]F.+<V/+29]##.*F[?7>M@>>^(
M
M
M
M       $=SY$!S!LE;M7G(]8NKFIF2&4DXZVP;"R6I"3,MRB3J9%J-V"O>6T
MWUAZO1YR1KL,XXBZ_O+.6)V1,\T4B9>'/4G!GVKO/]UM?KA]3SZC\&WSOZ0\
M5UOZC%^LG\T]2<&?:N\_W6U^N#GU'X-OG/%=;^HQ?K)_-/4G!GVKO/\ =;7Z
MX.?4?@V^<\5UOZC%^LG\U?/LRP<!AV.1'AEO/LW5LQ?*TSXB(J4));FTTFE:
M]3,]=1Y/4;LDQ;SQ$>27YG[=Y=??CP^*QV616ZG+=-U=D5KLAZ,'C/R8
M
M
M
M                     :Z_-E-%9JD5ZK:.45\W:MM"75RD=VK5E*%=%&X7
MBD1]NHSL]*-M/NNO1Q,Y[.6_NYYH^/6G+M]*O93>HKRG#?[ [+_<\3Y1ZM+_
M *Z//+]*Y-9_-;/UMYY3AO\ 8'9?[GB?*%+_ *Z/G2<FL_FMGZV\\IPW^P.R
M_P!SQ/E"E_UT?.DY-9_-;/UMZ?<8.TCDFR*IX\E80HD-=Z])A,PRDEJK1)&T
M?C;.WK\(Y-3%U(K?S^[5\QUZW-%MG>:NW5;9V1?-W+NX[JK('$^1
M
M
M
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MIN[9]+^I;@\]\*
M
M
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MR/S'V[R:Z_'A\3999%;J<ETW=D5K6(>CAXS\E
M
M
M
M  &NO^Z*BL^^KSMF?)7N\JDI2M4I/=GJR25^*9N%XNA].HSL]*-M/NNO1U[^
MRE_=SS1\?\';Z6SAO47KC7]@,K_=\$>K\?ZZ//+])_ZG^:V_/O<ZXS_8#*_W
M?!#X_P!='GD_ZG^:V_K+S7&?[ 97^[X(?'^NCSR?]3_-;?UEZ>\8G5^4V/J[
MCM[!SV-=X\['8CE)ZJT27<]3V=O7X1R:BM(K?SOF.O=[RV<^KC5;9V1===R[
MOPN*QQQ/D@
M
M
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M]9&>S'$:B-129_N)P\N[YU?>6\/.?!@
M
M
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MZC.28MYXB/(_,_;K)K[L>'Q5F.V*W4Y+IGLBM:Q#T8/&?DP
M
M
M
M            U]Z:2I+$UU_K9!1GMU41(4<HN[/5G1?BGWGS=%=.O49V>E&V
MGW75I/IK*7]W\:/C_@[?2V;=F_8I+O:W^P!7HE;^*/3I/UWOR_1>7)_-?^+*
M=[6_V *]$K?Q0I/UWOR<N3^:_P#%E.]K?[ %>B5OXH4GZ[WY.7)_-?\ BRIU
MQJN,J18%'XZ/!_$;W/FS%9\IZJT3_FY$9[.WK\(Y=16D?'Y_.^;ZY%T6V<VL
M\5MG96^>7YW%88XWR@
M
M
M                                           U&5,>58S<QO)?+N^@
MR6_(O*/(^_W-*+N_*/\ X6[YO>?Q>T;,<TOCLV^5W=/OY-3CNYN2E]OQN7FI
MMW\O]JGX/;N>9"PIO3^JP_\ STW^,/<[[_W/_C?L7K2?X[_]*7/U*1_98?\
MYZ;_ !@[[_W/_C/6D_QW_P"E)]2D?V6'_P">F_Q@[[_W/_C/6D_QW_Z4K1X6
MHTU$RX6G$_JT;K;!&YZ_3?=]HI?3:DS[O;\/AU^X.#5W\T1\;F_%Y7QGM1JY
MS68X[_OZ3/\ <=S3=V_VJ^\N ><^"
M
M
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M;SQ'N/S/VZOZA./#XNW';%;N7NYNGLBM>:(>C!XS\F
M
M
M
M       &!>*)%-8+.O.V),9XSJR)"CE:(/\ (Z.>*>_YOC=.O49V>E&VGW75
MI8KFLCG[OXT?'V_%V^ELV[-^Q3'K"/\ V"K]%K/Q1Z7+/UWPOT#N;OYK'SLI
MZPC_ -@J_1:S\4.6?KOA.YN_FL?.RGK"/_8*OT6L_%#EGZ[X3N;OYK'SLJ;<
M<R6WY$\F^/583HALS?-J*UY3U5XO^;D1GM[?&^$<N>*1'Q^?SOG>M63;;975
M^*VSLK?/+\[BL <CY<
M
M
M                                           8EI6P[FLF5%@@W($]
MAR+*;2I2#4T\DT+(E),E%J1]I'J,K;IMF)C?#?I\]^#);DLV763%T=NV-L*T
M]W'B3_NB1Z?-_7#N\?FX^]#[#_S;JWUD?,L_-/=QXD_[HD?[PF_K@\?FX^]!
M_P";=5^LCYEGYI[N/$G_ '1(_P!X3?UP>/S<?>@_\VZK]9'S+/S4HPSC+#L
M>EOXO#<BN3DH1)-R0_(W):,S3H3RUZ:;C[!SY=1?EIS3N>+U/KNLZC%L:BZ+
MHLK3XMMN_P D0EPYWA
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     C.>9_BW&N/KR?,)BH-*AUN.I]#3L@^\>,R26QE*
MU==/@ 5;[Y'L^?:9[_=L_P#4 M#WR/9\^TSW^[9_Z@"A[Y'L^?:9[_=L_P#4
M 4/?(]GS[3/?[MG_ *@"A[Y'L^?:9[_=L_\ 4 4957[6W!%S9PJBOR)UV?8/
MM1(K9U\Y!*>?63:"W*9(BU49=3,"B[@0
M
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M;M"UT(BI?:E0A-!Q\:4D1_7NAZD1%X7P6%\@@
M
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ME&:=H)":>T=539\; I[.-3,JK:7*(UE<55?%*>ZJ$S&D$L^Y5T5U41:'VGT
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MI$"+VDEMO0B5M^<9>$B(P25N BB/:F_X?X^_Y[H?^E\%A>X(
M
M
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M@,:'80+%+JZ^4S+0PZN,^IAQ+I(?:/1;:C29Z*2?123ZD R0
M            &#64M33%+*IA,P_+Y+L^=W""0;TN1H;CSFGSEJT+51_  S@
M!1/M9_U80?\ F&G_ )R0+"]@1J\DR*GQ&AL<FOY*8=-5L+DS)"_XJ$%KH1=I
MJ4?BI2752C(BZF \3-2\DI>0Z'VNLQH(L3"LFL?(5P#9-4NMJI#*8T*R=/K^
M44E.XUD75.A%_*)(C)[K;<;>;0ZTLG&G")2%I,E)4E1:D9&70R,@8OH!1'M3
M?\/\??\ /=#_ -+X+"]P0
M
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M\<;-W$+-WQ4VU!U[DT:]#<826TTD?1*3+KW:C!97^"*(]J;_ (?X^_Y[H?\
MI?!87N"
M
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M27@(!)0$#Y)XDQGDY-5(M7IE7?44@I5-?U#J8UC%7J1J)MQ2'"VJT+5*DGV
M)TV@VVT-FI2S2DDFM>FY6A::GH1%J8"BO:F_X?X^_P">Z'_I?!87N"
M
M
M
M                 AO)_&U+RMBYXI>RYD*$<EF8F36N(9DI=C*-2#2IQMPB
MZG_>@*V]UR*?4^5>0]?Z>3]'!:GNN1/[5.0O]^I^C@5/=<B?VJ<A?[]3]' J
M>ZY$_M4Y"_WZGZ.!4]UR)_:IR%_OU/T<"KAOV5,?785DZVSW-+M%3-CV<6%:
MVK<N+Y3%62T*-M<?[Y:EH>AGU JOP$
M
M
M
M
M
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M]]O@KSNS] 7^,!1*>/?:;XLY.R=C$<5D3G+B2VZ\TF1$6RWL80:U:K,S(NA
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M2K5)-I\'W1S:G36665AV:/6Y,N3ENW/28\I[@          -'EG^R3_QB/\
MVCNT7TGN/,ZE]#[J"#WGR[#L[6KI8BI]Q-8KX*.BY,IU##1'V]5+,B\ DS$;
MUBV9V0^*F[IKZ-Y91V,:RB=G?PWFY#>I]=-S9J(2)B=RW6S;OAGC)BP;:YJ:
M&&=A=3F*^$2DM]_)<2TC>X>U*2-1EJI1GH1=IC&9B-[*VV;II#.&3$
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M8C>RMMFZ:0SADQ
M
M                                       &ZQ7_ &PW_P!1?_0.+6_1
MR]+IWTT>24]'@/J0          :/+/\ 9)_XQ'_M'=HOI/<>9U+Z'W4$'O/E
MWBOG54/,/:/JL)SVW=J<$8;CMLNI43;:._CFZ:B-9&A)N/&32G#+Q2^\/.R[
M<E)W/6P?%Q5MBLKCXQ]G2LXRSF1E>.Y%.<Q]^*3;-2I23)Q;FNO?K01)=;26
MBF_%(]WAZ=>BS#RW5B=CERZGGMI,;6NRSVN^/,9R*10Q84ZY:A.&S-L(1-$P
ME:%;5$WWBTFYM/INZ)/P&?:)=J+8FC*S1W3%=RO/:=S''\F8XGS&GF]_CDB3
M+E$^DE>*EEV)WA*;+KO;T4E2=-2/4AISW1/+,-^ELFWFB=ZT,*]JC \US-C#
MX\*= 5/<-FKL)26R9?<Z["-*5&I'>:>)J1]>AZ#?;J+;IHYK]+=;;5F<G>TM
MA7&M\>,+B2[N[903DYB#L)$8C3O)+BUJ+Q]OC;4D>A=ID+DSQ;-$Q::Z^*[H
M;J+SMA5AQC.Y2K2DRJBLVIL*]"4%.9>4XAONU(4LDZEWB5:[]#3U(Q>]CEYF
M'<71?RJ^<]L_C=,J VW5VJX<E*3F23;:3Y,I1Z&DT=X9K-)=5;3^]J-?B;6_
MP5W&&:W[7_&KN5-4+<6>=0\\49%^:$)C&I1[=_=J43G=D9]5::Z==HOB;:T3
MP=]*]J8\K\[XCQ,]$K;-J19W\Y).L54$DFZ31J-)+<-9D2249&2>TS,NP9Y,
ML6-6+!=DV]C/XIYCQ3ERODR:+O8EE -*;"KEDE+[1+UVK+:9DI"M#T41_?(A
M<>6+]S'+ANQSM:SVDTI5PCEQ*(C+N(YZ'UZE,8,OB,3/Z$LM-])'].Q5/L6Y
MFAW&<AQ"<]M*H>*SC&LR(DQI*=KI$?P(6WN/_KC3IKMDPZ=99MB56<792YFW
MM50<K<U-NSL;!V/J1](Z8;Z&4]?[UM*"&G'=S9*NC+;RX:?<>CN0O:BP? \B
MD8PW!FWEE7F96BH*4$S&-)$:DFM:BW*3KXVG1)]#/74AU7Y[;9HX<>ENOBNY
M/*?E?![K GN28MCW>+1FW')CSR32ZPMD]%-+;+4^\U,B)):[M2VZZEKLC);-
MO-V-,X;HNY>U6>.^UWQY>9"Q32H-A4P)KO<0+>8AOR=:S62"-PD+4:$F9_.Z
MDG^-H-4:FV9HZ+M'=$5WJA]ISDRFG<K8Y!;C2TKP:;K:;B027MSD>07<>.>I
M[4&7C[>HT9[XFZ/N.G38YBR?]Y-N6>0N(^5>*JK,<G@WT>E:NG*V$=?Y(F<B
M23!N+-277%-&VI"=.TU$>@V9+[;[:S7>U8L=^.^8BFY.;KGCCKB)&+8;,@63
M-8]20Y=>^VA#Z&81H4TRAPS<)9K(FM#T(^WM&R<UME(^XTQI[LE9V;V5Q9[2
M&(<I9"]C$.#,J;<FUOQ&YI-FE]#759)-M1Z+(O&VGX->HN//%\T3+IKL<5:B
M_P#:WXWH,KDXVJ-/FQ(+CC$RWBH0IA+S1FE1(2I9*6DE%MW=GP:EU&,ZBV)H
MRMTE\VU6#Q5RK2<N4<N^H8<N'%ARS@N-SB;2X;B6T.F9=TMPM-'"\(VX\D7Q
M6&C+BG'-)4-[<:4^K<*5H6XG[ B/PZ&B/K_T#FU78[=#_:]Q".7N%BX&JJ'D
M3!,DG(F',;C*[\VT/)<<:4\A2#;2DC1^24E:%),CU+P:C7DQ=W$3$MN'-WLS
M;,+QN/:HPS%)$:JR6OL"M5U,.S<7%;;7'6[-BMR$M(,W"41GOVZJ21%\(Z)U
M$1O<D:2Z=L3VLB)[4N#*P%6>6<"=7LKFNUD&M6EMR3+?9;0ZLV=JR+NTDM)+
M6K0DJZ=NFMC/;RU2=+=S<L,[B[VD<*Y/MSQR-'DT^0J2MR)"G;-LA+:=ZB;6
M@S(U$DC4:3(CT(S+70Q<>>+YHF737617?#.QKG_$+]W+8LR)-I)^%LNR;B)8
M(:)WNHQJ2Z;9-N+W;5))/@U-2=.T6W-$U^XEVGNBG;5'GO:GQ2-B<#-I6.W+
M./V4YVMBOJ;C;E.L)2M:M"?^9U,B,CZFE1:=!AXB*5I+/PLUI6*IKRAS%C7%
M5-675Q'E6#%N]W,-J 3:W%%W?>;_ ,HMLMNFG8?A(;,F6+(JTXL,Y)F([$]B
M/JE1&)*VEL+>;0XIAS3>V:TD9I5H9EJ6NAC;#3,4EXJH<87[4/,663\GLI4;
M%<?W,0&(BDDM#)NJ:CMH-Q*TIW$VMUP]IZJ^_P!//MM[V^:[GK77=QCB(C:M
M'A[C/,^"I^8SK>Q1,XS::>DQ8C7>2)Z_)O'0^EAM.U*C:W)<2D]5&1=-"(;L
M=DXZUW.?-DMRQ$1Z3H8]LS USV42J*WBTC[AMMVSC;1IT2>AJ[M*S,R+PDDS
M,O@$\3;P)T5U-\)QR#[0N#\;W5357;4R0Q<0D64>QA(;>CE'<4M*3/5Q*CUV
M?Q4GVD-M^:VV6K'I[KXF8[$?H_:LPBUQ:_RV766%=74;L>,VEXF5.3)$PG%-
M,L;5Z&YM:4I9&>B4]=1A&HB8F6=VDNB8BN]0W+W-6/\ ,-M@+E1$EUTRJLUE
M+A2]II-$AR*;;B%(4:5?,474B,OO&.;+EB^CLPX9QQ-7O(>F\8
M
M
M               ;K%?]L-_]1?\ T#BUOT<O2Z=]-'DE/1X#ZD
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M.>6/,=XTVE"C::=B;$&9$7BIU/:7@U,-1&V#23,Q<]8CN>8
M
M
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M]OBEJ?@+GG%DNI5UVY\5M8MA[ '>\L
M
M                                                       ;K%?]
ML-_]1?\ T#BUOT<O2Z=]-'DE/1X#ZD          &@S!UMFG-;JTMH[U!;E&
M22ZZ^$QW:+Z3W'F=2^A]U7_E\'SEK](GY1[KY>AY?!\Y:_2)^4"AY?!\Y:_2
M)^4"AY?!\Y:_2)^4"AY?!\Y:_2)^4"AY?!\Y:_2)^4"AY?!\Y:_2)^4"AY?!
M\Y:_2)^4"AY?!\Y:_2)^4"AY?!\Y:_2)^4"AY?!\Y:_2)^4"AY?!\Y:_2)^4
M"AY?!\Y:_2)^4"AY?!\Y:_2)^4"AY?!\Y:_2)^4"AY?!\Y:_2)^4"AY?!\Y:
M_2)^4"AY?!\Y:_2)^4"AY?!\Y:_2)^4"AY?!\Y:_2)^4"AY?!\Y:_2)^4"AY
M?!\Y:_2)^4"BM>2N'\#Y5M*NRR>QDI16-K:\CB2D-,O$I6Y/>$9*,C3JK0T;
M3Z]O8--^*+YK+HQ9KL<3$)OC];B^*T\6@QY$:OJ(231&BLK224D9FHS/4S,S
M49FI2C/4SZF-ML1$4AJNNFZ:RV?E\'SEK](GY16%#R^#YRU^D3\H%#R^#YRU
M^D3\H%#R^#YRU^D3\H%#R^#YRU^D3\H%#R^#YRU^D3\H%&-8.0)\"5!.<E@I
M3+C!OLN()Q'>)-.Y!GJ1*+74N@3M91LFJ*\9X!AW%- [CV-RU.QGY*YC[\QY
MIQY;JTI1U-"4%H24$1%H->.R+(I#9ER79)K*9^7P?.6OTB?E&QIH>7P?.6OT
MB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P
M?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E
M H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6
MOTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>
M7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB
M?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?
M.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E
MH>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6O
MTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7
MP?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?
ME H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.
M6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H
M>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OT
MB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P
M?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E
M H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6
MOTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>
M7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB
M?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?
M.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E H>7P?.6OTB?E
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MQ^>8]Z7)^B!S3Q*6\#W"^8_/,>]+D_1 YIXE+>![A?,?GF/>ER?H@<T\2EO
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MI;P/<+YC\\Q[TN3]$#FGB4MX'N%\Q^>8]Z7)^B!S3Q*6\#W"^8_/,>]+D_1
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M"^\Z_N?:-"=$K8;+34^OC!62D=D/9@@
M
M
M
M
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M,.1+9RDPO(&[>T985+=899D)V,(4E!K4IQI*2+<M)=OA HGH(
M
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MI4:EEX%K4781 DRO<$
M
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M)+[Y=#U(S($;0
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MN:_'3EFD1NGFC9$4WM;B/#/'F#6Y7N-5BXEF3:V"=5)D/%W;FFXMKCBBZZ?
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M?FK:'GOA@
M
M
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MLG\,_D /K0YYLG\,_D ;>JL%6+"WE-DV:5[-"/7P$?\ [1%9P
M             #S[[:/]0=S_ *Y7_P Y0"QO?F(#-:LK@G(HO"47FY<MKU/)
MD]QZM[M9/I9.0N*3QJ/Q=IN)(B^^0)7:JH%>U_8@_P"$<P_I&'_D'!887+4]
MH++LAP7BJRR;%I?D%W'F0F6I/=MNZ-ON*2LMKJ5)ZD7P D(QC69\J85R/CV
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M/8?"SVSN$?5:R[LJR5'0IYV4M[71MEHM%*66U6])Z;=#W: ,.#S%QM889.Y
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MSBTY'XSILONV&V+:4J1&E=RG8TZN(Z;??(3V))>G4BZ;B/0"4^
M
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MF6OPD8#D
M                    !*<8_P!"=_QI_P#92 W8B@
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M?S3<02-J]O\ %W%T\ #YFT5!9JCN6=1 G.1-/)%RHK+RF=OS20:T'M(O 1=
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MPF6X[9K/M4:6R21G]TP':[#AOOLRGXK+TN,9G%D.-(6ZR:NTVUJ(U(U\.TR
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M4=J.;J^W59MI3N_N@/F+2T<&:_9P*J%#LY);9,V-%99?<(^TE.(22CU\/7J
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M?1 .,SY,EY)[B<)K;L)1'UW::B#.,S,S,^IGVF
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M!ZEK/-T_&KY0#U+6>;I^-7R@'J6L\W3\:OE /4M9YNGXU?* >I:SS=/QJ^4
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M ]2UGFZ?C5\H!ZEK/-T_&KY0#U+6>;I^-7R@'J6L\W3\:OE /4M9YNGXU?*
M>I:SS=/QJ^4 ]2UGFZ?C5\H!ZEK/-T_&KY0#U+6>;I^-7R@'J6L\W3\:OE /
M4M9YNGXU?* >I:SS=/QJ^4 ]2UGFZ?C5\H#)CQ8\1!HCH)M"CW&1:GU[/" [
M@
M
M
M                                      !I,PRFLPC&+3+;DG55=1'7
M*EICI)QTVT=NU)FDC/\ ND AW$G.N$\TG;EAR)R/4OD_EGE["6-?*^]V;-KB
M]?Y)6H+19@(
M
M
M                                        *R]HG^H[//Z(D?\ 00+#
MS;_]3T_^V'_]$?\ X:"R]O@Q
M
M
M                                                    >-O:.]YO
M]YTG]UGU@^J7D<7NO5FODO?[#[S;IX=>T&4449EOO>?5BV^N/UF^JODR_6_E
MFOD_DNGC]Y_@Z=H+L0SB+]^6EQ^YGUOM_P V]=>I]=-?RO<=[I__ !-O]T"5
MF?\ _</_ /MW_P!\";'Z.Q.]\D8[_7ON[1WF[MW;2UU^[J#%W
M
M
M
M                 K+VB?ZCL\_HB1_T$"P\V_\ U/3_ .V'_P#1'_X:"R]O
M@Q
M
M
M                               &CS+%:W.,6M<1N%O-UEQ'7$E+C*2A
MXFW.TT*4E1$?WTF A?$' ^%\)G<'B,BP?]=^3>6>L7FWM/).]V;.[::T_E5:
MZZ^ %JM $
M
M
M
M
M
M
M
M
M
M
M
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M$>.-)<8W$;;I$1Z&E:4JT,CU2>FA^ P1)@
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M),)1QYC.NU6Q1H41DHB4DR41D9*(C($;@
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M^'6SK"G57/N,J98?0U!-*S949$E9)/HHT^'M!%S @
M                                                      C/(K$B
M5Q]ED:&TM^6]36+;##236XXXN*X24I26IFHS/0B(!Y=3PBUC?LX55KBN,S5Y
M-/<QZ\S6B,WW9<]NK=4ZZR49\S)*B[U:N[2@M=--#,B!E5K[O'L@RUO+\XJ\
M5LHF,97FV*.U--*@+;DG'JFU-3);D4DJ-+3JE:FI1:'UU >U6668[9-,-I::
M+4R0A))21F>I]"Z=3,&+[  'EKF_#>2>4>5IE)B,.*Q34F)RX+EA=QWU0W9%
M[JAY$1:$[>_)M+>U>OB&74%A"'YV30ZW%,ZRK$KJ;#?XTLL/DQDUSK[\6VA.
MJ0IZ6VX1=RVZTCO.]7H6W4^PC!6HO7<[D<7XCC45O)CPV?QVDZF/C,!,QN;>
MNJ63C$]9-K63'=&E1D1EXOC)\;H8;N[Q/+'*;*$)H;%3K_$U!7MI3$?4:YS*
MFN\CI\74W4Z'N1\XM.I -[8X>V[;9XSDV+7<O$Y>"XW#>C44,_+''F%MZE%2
MHDH4['41.*1X"3U+3H U-DWR3E' V0MW%597T"DR*LD8]/EU)0KN=5176>]<
M<AI(U*-M);.\[5I(]3T(P'KS&K2-=T-?;PX,BMB3&4O,09K'DLEI"^I)<9_B
M'I_%!BI3GJIS[,.0..\7PB%'--:Y-R&=8W$9Y^F;=9:[B.AXVTF1J/>Z1(UU
MZD?8"PJ*M@YCC> <7UN1XO;V;O&N<38=DU"KWY;CT&*3CR)3#9HU6R1.:-N=
MA[.G4%'\?G5N Q\LDU&54>1SLMR+)<#G4]3Y<Y51YQ-H:9L(:_F-RB3XJ=OW
M?FZZA-K%[+XV7\%9[G.(2W92*N?7W\>IK_*3C3IC3;<<G6D%^2+^/M/HV>XB
M[#!$.R?]YF1\M4\?)(F32)=/R77R8L%FOUQB-C;#R4QYA/M-:]\:5'N6IS39
MNW:&0*V&.XEDA7N+JET$WR=GE;(+%XW8;NQ$-ULNZD*W(T)M1EXCA^+J70P%
MQ^S/4V=-@%G$M8#]=(5D-P\W'E-+86;3DDS0I*5D1[3+YIET,$E<H(
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MTZ^$"B18EF.,YW2MY#B5BW:5#JUM)D-$M!DXV>BD+0XE*T*+PI4DC!%>\?\
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M&-65L=N+7PVD1XD5E)(::9:22$(0DNA)2DB(B(!D
M        CN?L/RL$RB-%:6_)>J)[;++236XMQ<9PDI2DNIF9GH1$ AO$60.U
MN.8%QU/I+6/:LX;5V,BP=B*17,J;9:CJBN/*,C3)2HM3:-'0O#X 5\\MUMC.
MR[BA^##?DL0<F-^:ZRVMQ##/D$E.]PTD9(3J9%N5TU 5AFV-7DJ5R<INGF.H
MG9OB4F,XU%<6IZ+&1 [UUHR29J0WM7N4GHGKKX0&OL'LYR+EJA:R!62R9M/G
MCCGJ@ZTT8S#HV&Y2(,MN2VQXSBT++QU/==5$I):)U*M+V?7)=? R[%;.MG0+
M6LR.VE/+E17&(SK-A->=87'>41(>)2"W&:#/0C+7M+4DH7DT6WBY;[150=-9
M.OY;C#,G'Y,>(\]&DIAT3L1Q"7D)-/>]\HD);^<H^P@$8R[ <RR&'9U--4RF
MYC_$5+7QS-E;*%3(L]3SL(E&1))XT)V]V9Z]2UZ JR^"JZ+89!D&;IL<HG6,
MN'!K):\GJ6*5!IC]XM"&D,,,$XMC<IM:M#(M=",RT!)1KFN2]-S=E6&8C?0N
M:*B37MXQD\2*LJNQ@.O-JDM2Y#1J;.,A!N$XA_0TGIIT,P(;SCV>YA>>Y;A.
M18U:SK?(LPFY!47#$!4BN37SH[9M2%RU:-M]P2%,*+7<1Z$1'J8"O,1PS+'J
MSA6"FJFP)L=?(34N2]&>:\A78)FHC.2#-)&V3AJ0:#5\[IIKT!6!@^)3IF)3
M8LY67+S#$<'N:4J2?3LPZUAZ1$[AR&Q)880J2:W$)<8_*.&I);M=VH#9VF*Y
M$Y5V:$T4U2U<'P:EM)1'#/U@A;QG$21(_EB\4^Z+QNSIV ,#*L(L7<NR6GRA
M>3P,9S^MQIJ'&QVI:LVY10(;<9QB2XZPZJ,Y'=2;OST>*HU=H"\?:#J;.PXJ
M76UD>19SD65&?=L-J>?6EBSC*6LTMD9]$I-2CTZ%U!(5C:XUD#CEHM%-,4I?
M--7:(449PS.O:;A$J41[?Y%.BORGS2Z]>T!:/-=;96-AQ<NOAORTPLVKI4PX
M[:W29CHBRTJ=<VD>U"341&I73J!"L8$&M7@/)&)YG2Y)'<K\SFVR)M/7OKE,
M>6V*I$*?#4E)D\EO83BS;)6U)]2T,@%M\'W69WV"^59JTZ4YN=,CUME)B>K9
M5C7-.:1YK\,].X<>+4S1I]WP@2I3BZFR!JPXHP*1C=C!R'CBPO9>573T5Q$%
M+,EN4VE3,I9$E_RU3Z%$39F?0S/HG4%;*!CM\S[-7&%2=-,3:0KJA>G5Q1G$
MR&D-6I..+<:).Y)$GQE&HONF"(U:.RZ3*:?"K6EGP;1WF?ZQ-63D1TJZ5 L%
M/N1W$RR3W2G%H62.[)6[Q%:EXI@K?X+C>11\UXY?E4\UJ-$S#/I4MUV,ZEME
MF6S(*.ZX9IT2ETS+NU'T5X 1$J<N0J+BO"\6G,Y-C^,/UV2*>9QZK.3:/W:K
M60<6');6PZIIAQE:EIZ()>O56A:D597"E#>5V;XE(L*R7$C,<4T5>^\^PXTA
MN:U-=4N.I2TD1.I(]5-GXQ%X 26=R!BN29#R[F#%1#>2FVXLETU?9J0IN+ZR
MD3Y!-M=_IM)9;TJTUU)/4!72(=SE='-548G;5!XKQ/:XG;)E078ZWK9Z.VAJ
MOCI6DEO[%,K62FR,O&+PJ!5J6E-9JL>!.[K7S9JG5G8DEA1HB%ZB>;+OB).C
M>BS));M/&Z=H(@7%N,Y!"E\$KF4LR-ZLEYXJQ6[%<;\E3,??-COMR2[LG2V]
MWNTW=- 5,^4Y$C#^6*_/[6@L,BQ.3BMACK<:KAKL5M6;TIN0E*VD$9I3);2;
M)+TTUZ'H0(TG">%Y3BV=X=&R*OD(<K^-&8,J6MM2F69BK;OO)#=T-/>MMF1&
M@E=A? !*5>TU694[@]?D.#1'IF68_9MOPF8S:GGE-SV'JUXB2@C5H296]1EV
M;=3Z$!"H:_BW)<9@<R8U'KYCU%BN*S<?P@R8=4J:S?DNSD)9T(^]4ETD(/9K
MH9Z=H*L'$V;*CY69CV-38(;R' ZB!7S$1'5Q42J]N2X^U(>2G:RM)&1;5F6I
MFDNTR!&GXBQR^K[GA%<RGEQ&Z[$+:/8K=C.,ICR'78YI;>,TEL6K0S)*^I]3
M^$!NN63FXMRC,S&PQVPR'';S"96+P45<1VP6FS.6M\XSC;25;$R4+2DG%=#-
M.A@._AK%,@QK-:N)>P'FGZWCK':F3+6WJRF9'DRC=CI>+5"E-DI*5$E7@(_@
M ELO:%;@,,8[?-%?0<PIG9DC%\CQ^M7;HA27&4MK9ELI2HC:E),F]II\;3YQ
M%KJ(53G\O,6TVMKDV*6QWN=<7LTZ8]/7OS&6KU+DA3L9:626;.U+J%F2_FEJ
M6IF0*Q<PC7$1C/L47BMS96F:XIBE/CZHU<\]%.?&CNH<0[(-)-LFTIQ+BMZB
M(MAF>AD S<XH+^VM>3U4OECTG'LMPZVLSJV4R;!<6OJXW?.1F'24AUU!_EDM
MK(R5MZD8#-]1+A4%1R-7,Y)E%9'SR+DN2%;U28=@MMB"N%Y=&@L,M*6V@W&U
MGM:W'M,]/%,P$LR6\\NSKAGD2OQ:YAXPU(R.')CG6.(EL.VC3;,9UZ,T2E-H
M?6A3A+5IXI[E: B5>T/'FJPZELXD&3/8I,EH[:P9@L*ER$PX<Q*W5H901J7M
M+KH7@^X!"I.2XMR[8\KUJ,4M+>3RW74'U,=:A.K;)3$5+"VI:U)),149S60H
MG33H74^H*NKEN9FN/\:(7BKLI5FP[7Q[BQKHY3;!FM-U")LF*PI*B<=2WN4D
MC2?A/P BA*"@OI?D\R/#R*TAN\K4-DS97\!R/8OUS$!"#F/H[EHB:29='-B>
MFF[10*^\DB9+@^"YIR;#K7(U]B')]S>5B)C2VCE0+115QFWN(MS;OE*5DI.I
M*V /2_&&((P+CS&L/2E).U->PQ*-'S5RC3OD++_KNJ6K^Z#%+0    %"<Y^T
M-=\2Y=0XA0X<O*["^BJD1VF)#C;YN$ZIONT--L/*6>B=>@+$(5[TG-W]@5W\
M4_\ 9X+0]Z3F[^P*[^*?^SP*,"Y]K_E3':]VVR#A*RJJIDTD].G.S(["#<42
M$DIQR E):J,B+4^T"CU%A.1*R[#<?RM<<H:[RMB62HA+[PFCEL(>-&_1.[;N
MTUT+4&+>@ "E_:!YTG\*,XV==CGUCE9#(?BMQBD*CK2MDFMI()+3IK-9N:$6
M@+$*W]Z3F[^P*[^*?^SP6A[TG-W]@5W\4_\ 9X%&+8^UKR[3P7[.VX,MH-;%
M0;LF9)7-99:;3VJ6M< DI(OA,P*/1'%&=.<E\>T><NP2K7+AIQU4%+O?DWW;
MRVM"6:4:Z[-?FD#%,@ !6'//+;W"^#HS!FI3<K7.8@>2+?.*1$^AQ6_>3;G9
MW>FFWP@L*;:]JGFE]I#S/ MTXRXDEMN(.<I*DJ+4C(RK]#(R!:/OWI.;O[ K
MOXI_[/ H^'?:IYI8:6\]P+=-LMI-;CBSG)2E*2U,S,Z_0B(@*+DX&Y;>YHP=
M>8/5*:9:)S\#R1#YRB,F$-JW[S;;[>\TTV^ $E9X(  " \U9)DV*<97]QAD)
M^?E*6FX]8S$CKEO(=E.H9-Y+2$K-7<I6IW3:9>+UZ L(+QUF&&8%Q_9.8YB>
M7R?5C\5VZ=F4\DKJVGV;G=N3#\H-*GU[D[W3)7B)T(BTVD MS,VGI&'Y Q';
M4Z^[63$---I-2UK5'61)2DNIF9]"($4A0T-VW2^S:T]5RDKJ$%ZV0N.YK$,J
M)ULN_(T_DS)9DDM^GC=.T%0JN7G&-X)B-&\>3X[C,R7E3EJO&ZPY5JJR.U=7
M7QU-N,.&VR\VI2DF2=JSZ&9)\8BMMQI#N,2N.#YMU26349S%9E \IJ"^Z<6P
MDRHRT(E$2=6$[24HU.:$6A^ C!'H7"<UK\\J)-U41I#$%B=,K6ERTH1WZZ]Y
M4=QUO8M>K9K0HDF>A].P@1Y5Q[]X659WBUOES>23LJ@Q<L9R6'.K%1J6IDOP
MG68[->ZVRE*B=0E):]\YO\4]248,DHPS [2YD8-CUM5RX-9/XFE8_;/KC.-)
M8?EN1D*9<4:4[72\9>Q7C=#/X01)/93KKN907F<9.G2\L78>/)T4:TG$Q6*F
MN):5'X7'TR%JTZ;C E&.2<:R"99<U+C4LR2BRO,%<@J;BN.%)9B)A]^;1DD^
M\2UM5WFW4D]=?" ^\GH;V)>Y#DWU>FS:FBY.J<EF,L1G''7JQBH;CKDQFDIU
M?[EU9.&3>OS3/P -585UXW0-\AIQRS9Q^1RU&S%%:W"=58)ID1O)ES%1$I[T
MC=<+?L-.[0R5X05FYSC>3V61<NWD.@L)U:FXP6[*N*,LG+2!5QVG9;#"5D1.
MK01>,@NNY.WYW0!CS:J\RO)YN?U5#9LXQD/(F%2*Z-*A/1Y!QZ=HF9DYR.I.
MYMDU'IWBR+4DZGH"+=X,K+&L=Y..Q@OPBFYY<S(?E#2F2?C.M120\WN(MR%&
M1Z++H>A@2J'&XES:7]!A<7'K:'=4W)EME4ZTE5[T:!ZE)R;JXB6M))63W>H;
M21'XQ_<T!6_X$Q*PKN4LJJIC244'&29F/XPDCWZM7\]=N:]3[%ML&PT>G\4P
M24VS)<JGY^P2^?KILFGF5%C1IF0HKDIIF;*DQ5H)]3:3[I&U*E;U]-"/P$8"
MO,+QK(8LKB@WJB9&7$RG-7IKZHKB3CMS$V"6'G3-);4K-:-BE=%=-/  P> <
M*E1;_#*O)I&4L9-QY'M&DU,FJ8CT,54PCCO)3.;80;Z9!*2\U^56:MN[P LK
M'Y+D3<%Y=QGE-VGL;C&ETL_'+551&7-D1'7'VI<=Q3+1&LTN*0IO<1:$>FNF
MI:D:*V/+,NRNIRFVQ273RIO'V0M/UBTJE^2R9#['<L+=)M)$\XV6[N]I*+JG
M3H8"L\P3GK?&=)A4DLI@5"N/(#=-44-6J44^[7&6U,C62C8<<:2VG81MZHT1
MJHCW%M,K?Y1B^1OQ>4VVZ2:Z4Z+QHB&VF*ZLG_(9:#DI;+:>_N2_E2+7:7SM
M 'K&6VMV(^TV1;UMK2@C[-329$#%Y(Q-=M4<?\.7UCCERY XUM)D'+J@ZU\Y
M;3TB&\RW+:8-.YYN.XZDS6V2M->G4CT,ER\!U5O7X==V4VO>JD9%D-S?4U1-
M1Y._%@6$DUQVW6O_ (9F1;S1X-P)*A*.%R/GN6T3M^K)).9G39= O$VU><&F
MI[.=$[B.U =0RA&U9)3JHWG"46U6I&9D"NMEZ?/QZ4RK&[>H1BO#%WCMQ(LJ
MY^%'*TC,L)<9;=<227#U;4OH?4CU[== V=PQ:4]5D,>1C5GD'[Q^/:.FQ"37
M0E36F9K,%UA<9U9=&?RC[<G<O1.B===2 :ODNBRK'8')N'2J*VM[G+Z/#6::
M76P9$Z,^[1MI9FJ<>:0I+>Q23/QSU,C+X2 7-"IK9#'/YG72"<M)$@ZP^X62
MY:?43#:>Y/35PMY&DMNOC:EV@C3<34%U Y&P"7,JI46+%XCKJZ5(>CN--M3D
M2XRE1G%*21)>(B49MGXQ=>@"2V7EM1[3M;;2*R:[3W>'E2P[*-&<?C(G,63D
MI:'G$$9-$31DK<O0@.Q4>&83ELC&>%JA%3,K[!K&\W@R77X[K!0I5@VE$<Y!
MFDC;-:CU3OT-7:0*D7L\XXXN\QZ3<2LJ1DF'8\=+)KK>I8KZJ)N[IMV(W):9
M;.1HMLG6C-:]4%N,]=026\]HY^KF*;K%XGD3^;0H3DW LPQZ*XZIBY,U)1&[
MZ.9J;(U$@W4NIV*09F7C$1@0PZ.QOL&Y(OIO(N,65W99[78KY*NG@'8Q$SX$
M<X\UE:RT:92R^HY&JU$6S56O0@&AF8SD2GI"RI9JC/G2';$KR9TS]6H:CD<L
MCV_R!:'^5^;V]05T<9X;/9SBJQ;*IN5-76-9);7<>(W5,%0F;SLEU$KUD3/>
M*:E-/;3);QJ[PS2:2T(!]<:8QD,5G@TIU',8]6U^<ILDOQ'$^3+F.D;)/;D^
M(;I:[-VF_P &H")L8KDE'68'<72,CI:"?@'U5G%15*+.<4ORQQYV')C2([QM
M)D-N)VKVI,U(T,R(!Z$R[%W*KV;;?#Z5N=/7$Q)ZNKF'VM;!PFX1MM-K:;+^
M5T(D[4EV] 10T3B7):'+\8MFZJ>[00<KQ=O'8ILJ<*OKY[#EI;K,DI,VVRF*
M2A:E:$DRT/M!:M]AF%3T\AHQ7+9>5,S:O-9^50(<:J851.FIQZ0Q.<L4L&ON
MWFW#96E3^I+/9M+0M ^>%\+LH648QC66S,H;R3"+"YF,P?5;*,?:.4Y(W/)L
MNX)QQN6V]N21O*,UZEH1$0$NC%ZV_7Q3QAB2Z"T9N\2Y(@'>,N07T(;:.TFR
M5/I6:=%LI;=0:G4^*6O: WD+';YNPHG%4TPDHYBO+-Y?DKA:07O+2;E*/;_(
MJW)T</Q3Z=>P$1?C)V72Y?P3@=Y43JB_P]S,&+AV9%=9B.N.17W-\>0M)(?)
M9&3RC;,R+<1GVEJ5ZHP+,H/(.(U695D23"KK=I3\6/.2AN031+4A*E);6XDM
MQ)W)T4?BF0,4C   !YWYE]I+(N-.1X7'6-X,YEME/KV[%A$60ZF2LUK?)2$,
M-1WE*VI9-1F7@^\"Q"+^])S=_8%=_%/_ &>"T/>DYN_L"N_BG_L\"C67OMC<
MG8O!*SR3A>PIZXUI9*78/RXK/>+(S2G>[!26ID1Z%J!1ZXJIIV57"L31W1RX
M[4@V]=VWO4$O37IKIJ#%E@ "B>>/:"N.(,BQO&Z3$E9389&VZJ.PU(6T\;K;
MB6TMMMML/&LU;O "Q""^])S=_8%=_%/_ &>"T/>DYN_L"N_BG_L\"C!N/:]Y
M6Q^N>M[[A&SJZJ/M[^=-=F1X[>]1(3N<<@)26JE$DM3[3 H].8%DZLTPG'LN
M7&*$N\KXUBJ(2^])HY+27-A+VIW::Z:[2!BD0  I_P!H+FV5PC24UM#HBOGK
M>:<$HQR#C&DR;-9&1I:=-1F9::: L0J_WI.;O[ KOXI_[/!:'O2<W?V!7?Q3
M_P!G@4=,OVKN9($5^=.X(N(T*,VMZ3(>5.;:;:;2:EK6I5>1)2DB,S,^P"B]
M.$^3'>7./8&</5J:E<UV2T<)#QR"3Y,\IK7>:&]==NOS025A @
M         "(/\G88S*5#3.<??1>,XJZ4>-(?)NWD-DZEE9MMF22))D:W#\1/
M8:B,!AES!@JYMU"9ER7SH+"/2V<AB%*>CHL93I,DPEQ#1I6M"C+O=IGL_C:
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M9)FV#ER9@-)?WEM%B7^)55;.DSDO7,=G(6$.2R9FRO$;4XHMC2UZ(;->O3M
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M]6@Q $0Y6_JNS?\ H"U_F3H"K_8Q_J!HO]:L?YVX"RO\$
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M\K)<IVV0I;273BDC0HSCR%,I7WFO\8R+70"B[00
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MCQC84LS:22'#4>I)T(__ &]ID2
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MR-225X5* E%<.X0O,;_=AY5:1'_J+/R*=/[M#A>4)OO*>Z)K7L-'?EOW?!T
MJEG,&"Y!G%10*Q69#B9%C-["R*O]9I=7"==@I=1W3W<^.23)TS\7KT\':!"'
M9GP?DV5,<GDBW@L2<\^K2X:C;>V1ET!M*?[PM3,R<-!]WM[/"!5V-<*6]5R9
M8Y'5P\5L,5O;9%[8O7E8J7>Q'E(;3(9AOD9))#BF^\0:S_)J,_%5X15FN<(/
M67'G(V!V]DV2<UO;6]A2XZ%'Y+Y=)1*C$XE1EO-MQM)K(C(E%TU\(%6^XIPN
M_P 4CSUY-5XI76$A3:&/J?7+@(4TV1[C?4YH:U*5XQ)))$GX5 +&!
M
M
M                     &MO\@I<6J)5_D4YFMIH227*FR5$AILE*)!:F?A-
M1DDB\)GH0"-'S#Q>G&6,S5E=<G%Y,A4%FT4\263E)0IPV3,^I.;4*5M,M=/O
MD [%\M\:-3:&M>R> U/R=EJ50QW'20N4Q)/1E:25IH3A]&]VF\^B=3 9F?9!
M.QG''+:NDU<22F1%9)Z]>=C023(D(:42ELH6HEJ)6C?30U::] &*7*_&YY2G
M"?K/ ^MBGUQ"J3>(I'E""(S;-)]BCU\4C^=V%J -<K\;OW%Q0,Y/ 7<8^R_)
MN8B7B-<9F(6KZE^#1K_XFA^+X= &/DG+6%4%!/ND6T66]&H593$AH=)*Y-:>
MB67D'H?B.N*0VE6G:H@54E1[1]W9-<6UYOXWZ]Y#DN.R74/2_)(4)M;:$1MI
M^.<QQ:EQT]>[[U!EV 46C#Y4Q^GPY.69_?TE?$<GRH#4RODN/0UJ9D.-H:0I
MQ"5J=2EO\JE*>BB5_%(!GP\W8G98J+'MJ-[$5T#=\P\W+4JQ-MQ]2/*33IW/
MD9H3T=)S7<7P CFNY;XTML?L<JK<IKY&/5+B6;.P0\GNHZW%$A'>&>AI)1J(
MDF?0_  B6<^T+@]%Q[(SK%;BNO&&K.)3(_+J)GRF0ZGO",T)-6J&.\?[/&2G
MH8+18+^;XE%Q5.<2;>,UB*VFI";A:](W<OJ2AM>X_ I2DD7WP1\VF=8=2*MT
M6]U$A*H8[,RY[]PD%%8E&I+*G#/H7>&DR07:H^P@%>YW[0^%8Q28?D5-:5]I
M291=LU;L_P H-+4>"G<<R3HE*C-3'B)-"M.JRU!:)O(Y-X^B7U7C$G)(#.07
M3;;U77K>2EU]M\M6C21]G>?_  R/0U?Q=01]%R5@2LP_=^G(81YGH9^IB=(Y
M&I-]Z:=.S<2/'VZ[MO730!WYAGV&\?PF+#,[J-31)+G<QW)2]O>.$6II0DB,
MST+J>A= $,M.=,4K^2L4P9-C 57Y/6'91;(WS5WKDIUIJ TR24FE7E&Y:DJW
M==OQEHR^6N8*;BJ5B+%J_$8:R*T*'*=F.*;*/ ::4M^2DDI/78HVD=="U60#
M%@<Y8JGDC(>/LBL8%1+A2ZV'CR77]'[!5C":E;MID1$6YY+:.OC']WH!1+G.
M1<%:R]& N9!"3F3B"<13&\GRDR-'>$G;_?&CQ]GSMOC:: B.<P\N5O$L3&I-
M@J.2;VZB5;ZY3BFTQX+BM94K1*3-7<HT/3IVD"PR&>3J>)9Y3,O[ZAC8=3MU
M#L.6S+6<QE%LUN2J>E:4MM)=4:?)]JCW)ZGH [*CF[B2_L*VIILQJYEG;J4W
M7Q&I"3=<6@S3MVGH:5&9>(2M#5_%U HW#'(F#2LM=P./D$)S,&$&X[3)>2<D
MB2G>9;?"HD^,:"\8D]=- 1EY5F&+X/4JO,NM8]/5)6EGRF4LD)4ZO7:A)=JE
M&1&>U)&>A&?81@*SY(YU@8_88'4XA8TLEW-Y"E,6MD^ZJ W ;3KO(XQ&I2WE
M_D6NNF_YWW"T;OF'EZLXF;Q5RP5&2C(+J/6R7)3JFBC5YDI4J61)2HU=T6PM
M.G59 0PJ_GC$_P!X]_@E_8P*DHKM2SC3KLC1VS.UAHE&I*3(B2DE.(;3UZG]
MWH!1,Y7(F#0<LCX++R"$SE\I)+8IUO)*0K>6Y);? I1=4I/QC+J1 C3<L<@V
M& UE(BDKF;+(<EMH]#4-37_)(2),I+BR<?=)*C)!$V?BI(U*/0B!79'Y!5C.
M&-Y+S$W!PJ8A]420V<U$J,XLEJ2VMA:2)2N]2GO$M[=Z4Z[NPP1';OG_  S'
MLUJ:FVM:^+A5O0*O(63+D;FGY!S&XS;#6TC(R-!K<,]>FG@T,%HF=]R5@&+S
M*J!D&25]=+N]IU33[Z$F^A9D25I/738HST)9Z)/X01BWO+O&.,7AXUD65UM7
M>I4A*X4R0AE:#=03B#6:S(DDI)D9*49$ [(/*W'%GBTW-H.30'L4KEFU.M2>
M(F674[?$7KH9*/>G:G356XM-=2 ;O',EH,OIX]_C%BQ:TTHC[B9%63C:C09I
M46I=AI,M%)/J1]H"GV/:.@EBW+%[.KFV)W&=G+K$PB?-29:4N&Q"6I6PC;-]
MY*D&1$K;IX>P%HFL?F#"X&.8A;YI<P,=L<M@0YL2!)D$7CRF6W%)2I1%XB%.
M;>\424_#H W5_P B8+BUS6X]D600JR[MS(JZ#)>2AUW<K8DR(^PE*\5)JT)1
M]"Z@B"QN=*F?G^?\?,2JV+9XK#;>IW9DA:&Y<A,5Y^7WQI0?=MQE(0EPT[C(
MM3^X"T;H^9L#Q^IH3SO*J6MO;>MAV6QB2HXCS<Q)DEZ,IPDJ4PI25;%J(NA=
M= *-KD_+'&V%V4>HRK)Z^JLY3)26(TEXDK4R9FE*].NA*,C).OSM#T[ 1K^:
MN3&N)./YV8FTQ)FM/1HL"')=-E#STEY*#+<E*C\1OO'3(BZD@P6&5/YBXNJH
M-+8V665T6#D);J9]YXD)D(W;36G7L01]#6K1)>$P2B;$9&1&1ZD?4C(!R
M
M
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M%6[?K*CQFVW3W?QO'2?7P@B1@
M
M
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M)D=)/O++&X<U#UW3MQWK2&C4UQT326I@UGIH1K)"C(M==/[@#:
M           (QEN T&;OU:LC.5)@53WE)5*)+K5?*=2I#C9RV$&27R:6VE;:
M7-4D?@/4!)P
M
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MDA2/@Z&%D<,8ZYBG,G*U([<V-\;$/&%%973R9,Y9.,3%;5NI0@E$1_-\7LZ
MDK[!
M
M
M&AS##<?SNE70Y)'4_!-UJ2RMIQR.^Q)CJ);3S+K2DK;<0HM4J2?\&H"K\G]G
M?'95/08OC#2X= UE;>5Y&<B?-7+?6F$[&<6U(-Q;Q/+4;2M2<3U(U:Z]#+5V
MY-[/U%:+P.AIVS@X9C4RRGVJ6YLIBR>?FQEI;=1);/O5.F^LG%J4X6I%IU+Q
M0*IS2\7X1CJL9535A1"Q"/,AT*4.N[66K+8<DU$:C[Q3AH)2EN:JW:GKJ9@C
M#5PWQXK-"SQ54?KXI)6&SOW_ "+UB2.Z*9Y)O[GR@D=.]V;O#\[J"U;6OX]Q
M"KR;(<OAUJ$WV4ML,7CZU+<0^W&;[I">[69H21I^=M26[^-J",#!^)\*X[ER
MIF+1I+"Y391DMOS94MEB,E9K2RPV^ZM+;9*,S(DD S;3CW%KC,:G/9D9PLHI
MF5Q(DQE]YDE1UJ-?=/(;6E+J$J,UI2LC(E=0&#3\28%1'C!UM8;?U.38HQ\E
M/O.$PFYU\K)1+6?>;]?_ (FNG@T!:OG">(L&X]L95GBL21%=DMJCH8<F2I$:
M/'6YWRFH[#KBFVD&OQM$)_@!'1F_"W'?(=NS>9/6N/633'D3SL>5)B>4PR7O
M\GD$PX@G6]QZ[5 M7.3<+<<Y;;5UU;U1E,K668C28DA^&R[%B.$ZPP^TPM"'
M6VUD2D)61D7WN@%64YQ/@KJE*77*,UY&WFJOR[W^W6B2E,CY_81(3^3^9]P$
M=,#A_ ZO-'L\KX3\:]D2'ISC;4R4B"<V2V;3TGR1+A,]ZX@]%J-'7M^=U =U
M-Q-@M [C3U77*9<Q [-5 9OOK[@[Q9KF:[EGO[PU'IOUV_Q= &IG\"<9V%'1
MT"ZZ1&A8ZP[#JW8<Z7%DIB2#W.QUOM.I<<:</YR5J/[F@+5ML<X[AX[FU]F+
M4DWO6L"LJ8$)2#_S*)5H<2:"<4M1K[U2R4>I%IM+M!&NRK@SC;-,C<RG(JUZ
M59R"C(FH*9*;BRFH2M[+<B.AQ+3J$J(E;5H/4RZ@M67;</X'<YDWGDN$^C(2
M7%>D.19DJ*Q)=@'K&<DLLN(0ZIKL0:TGTZ'J70$;G-,'QW/Z=%+DL=;T9F0U
M.B/,.N1I,:7'/5I]AYI25MN)U/123[#,NPP%8Y#[.>-RE8I28^VY!Q*NNIM_
M>I.PFE/=DR82F$N,R=ZGN\[W8M1FZ78?;KH9:NS)?9[HK:RX]J:IOU9@.&Q[
MA#\6-+E1IYO626>Z6R^RHG-QK2XMY2W/&W==VH%5A4_'&&X_/I[&EK$PGZ"M
M<I*I+3CG=LP'G$.K;V&HR49J;2HUJU5KKUZF"-7!X8X[K<U=SZ'5&WD#LAZ?
MIW[YPT3I2.[>E(BFON4O.)Z+<)&I]O;U!:MG7<;8556.4VL2I:\KS4T_6;O3
M4\W+2AM;6U3;AJ2232XO<E)$2MQZ@C3T/"''&/4UQCT2N?DTU[&17SX<^=,F
MM^1-$HFF&B?=7W2&]ZMG=[5%\/0M"U:Z-[._%L:COL?]7S'H63>0>O'9%C->
MDR#JEFY&,WEO&M.PST\0RZ:%X *K32DDI)*>PBT+[Q CD
M
M
M
M
M
M
M
M
M
M
M
M
M
M                    '!F1&1&9$9]A?" $9*+5)D9'V&74@#4M=->I]2+P
MZ$ Y,R(C,ST(NIF8!V]2[ 'SWC>Y2-Y;TD2E)U+4DGKH9E\'0P'UV]2[  !U
MO/L1R2;[J&B6HFT&M1)W+5V)+7M,_ 0#[,R+M/3P=?A, U(S,B/J7:7AZ@.0
M     !P1DHM4F1E\)?< -2UTUZGU(O#H0#A"T.H)QM1+0KJE23(R,ON&0#Z
M '!F22U4>A?"8#D!P9DDC-1Z$7:9]" <@         #@S))&9GH1=3,^S0!R
M X,R(M3/0NSK]WH Y,R(C,ST(NIF8#C<G4BU+4^S[H#D  <$9&6I'J7PD &9
M%IJ9%J>A:_" Y
M
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MKW%[J;1V]C4QXL]BXQ94DZYUF4:T.,J3*U6EQE:.W=HM*B/1/4@)A=((
M
M
M                         (?RE@:.3,&L\*<GJK$62HJSG(:)]3?DDMF5
MT0:D$>[NMO;TUU :WD?C>SS&WQC)\;R$\:RK%7)OD$]4-%BRIBS9)B0A;#CC
M9&9DE)H5NZ&788*B6/>SJQC]52U3>1./HI\;NL8)TXB4J<*\?[\Y&G>GH;?9
MLZ[OA("J<M<;5R^)F.)K.4N56HHFL>>G-H)IU2&HI1N^2DS625=-Z2,U$1_"
M"*]B>SI.LHV01^0<R<R55Y01<9;>9KVJU<9BO>.1&>(T.N[W$.:.&:NU7W.A
M%JWUGQ+EV6\=9+@F?YSZ\?O6V6XEE'JH]<F&<=274J[EIQ7>FMQ"5N;G"^!.
MT!J\MX,RK*'W+,L[*'>6^..8EELLJAEUJ=#6MQS>PT;Q>3+_ "JTGHM9&G3L
M46H%7S?>SHQ=TV14WUB<CMW]#0X[WJ8B5FRG'W>\)XB-TMW>]FWIM^$P*MU?
M<27^4Y_3Y/?Y=Y5C6/VB+NFHVZUAB7'?;:-M+)6#:R6J.9GO6VIO5?89]"T#
M;<B<<V>66M#E.+9 >,9ECOE34*R5%181UQ;!"4/LO1UK;)?S$*0>_P 51=AZ
M@-5C7"-=BLSCQ^NMGEL8#%N&.[?;)QR>_?;%R'EN;_$/O$J<VDE7SM.FG45;
MGDWCZPSIO'Y=)>%CV08U9IM:ZP7$38-;NY<86A;"W&B,E)</0]W0R!&BN.$6
M[5V_=3>+8.\R>KROI&)?<JJ4QT]Q_*%N[SN-=_3;K\T].I:LJCXNR/&,RL+;
M'<P5#PFVM'[ZRQARO8D.N39I:R$HFN+-;;3CGY78EO5)]BM# 2/+<)3E-YB%
MTJ<<4\4LEVB62;)PI!KBNQN[-6Y.S3O=VNA]FF@(CC_%V10<]GY;A^7'1U%_
M)B3<DHUUS$[REZ(A+*C8?=41L=^TA*'?$4?\9)D?85T2N)+^XY(K<TR;+4VM
M)1RIDRCI2JHT:2P4UE;'DRYS:M[K"4N*\0VR-?3>9Z --C/L^2*2;6E:9:_<
M46+0;*MP>O<AMLNUS=N@V7%O/H69R5(:_)-ZI01)\'4"K L?9ML5U-1 H,T7
M52HV)JP.\DJK6Y:9U2I1K\1M;Z>X<U4OQB4OH?W-0*I33\/3:'+:#(JO(S;@
M5V,Q<2NJQR$A9SX\!#G<.H>-W<PHEN;E$25:D6GW0*H^S[/5K2TF*L8;FSM%
ME&.T\G&I-X5>U*3,K);O?F@X[CI=VMMPB6TM+AZ'VDH"K8%[/53%B3:^JMW8
MM?)P57'K32V$NK0A3CSAS5*):-RS-XS4V24EKX2\ J^,@X/O\B+'J2=FF[!J
M,JE94QU4;RPGZ9+>CD:>2R=8-Y39&OHHR(S2D]# JE_*?'TCD2DK(5?;G1W-
M);0KZILCCIF-MS*]9J1WC"EMDM)[CZ;R_P#8"(9E7 $K)K:W6>6O1,8R_P!7
M.9U2(AMF=B_5I0DEQWR<2<4GDMH2Z24KU^$%JG/*&!O<B8I]78ELJBEMS(5A
M%LFV$2C:>KY")#9DTM24J\9!=IZ?<,$0=7 D^523GK/+G)/(\N^C94UE;<%M
MEEFPKV"BQD%!)PTJ92QN;4A3GC;C/7LT+59V(U614],B'E-Z617/>.+=LD0V
MJY&U:M4MH89-1$E!>*1FI2C\)@BD.*.(<LDSH=]F%N_'QRER6\O:7#W8#;"T
MRY$F2VQ)7*W]XMONW5.H0:"\97SC3H0*EK7!+,?BBBXYCW[K=OC$]-S0Y*49
MLUL63,QV6RZJ,I9H6E/>J;4@U>,GX *H9FG#V7UM3C;=/;R+G/;?/8617F5)
M@-]W$-N%(82_Y'WFPHS"4MM]VIWKN^=J9 521O@"=!KJVQJ,M7$Y,@75CDCF
M5K@-OL/3+ION)K9P5.DE+2VB0A*2=U1M(R,"KF=P1D",!CX!C^;>1U\MNP+*
MWK"IC61VLBV=-YZ2:5K;[EQ*C5W6U1DDM-=QD1@59;/"5WCMO$L>.\T=QUAR
MMJ:B_:DUT:U=G-T3?<1GDN/*233QLFII:MBDJ+0]NI 5869>S_99)?WLRIS%
M=/B^3SJVWO* Z]J7WDZI4T:5M2%.MJ;2X3*#6G:9[BUUT\4"J<<G<?N\@5=2
MU M3I;S'[6+?4UB<=,QIN9#):4DZPI2"<0:7%D9;TF1Z&1] 1 U>S]<EC!0&
M,T-.7MY>K/&LA56-*:]8.-&TMM4/OB2;9DI1EHX6G3X.I:K#Y)P-ODCCZWP2
M=/7$.UCMM'8H;):D/,N(=0YW>J2,M[9&:=Q=.FI B-3N(+*[L)%WD&3>67<[
M#9V%39+4%$=M:K!\GE3$MDZ9)VZ;2:[#_O@5K&>#\BH'Z:9@><*QZ=&HZK'+
MYU=7&GIGM4J.[8D(0\O1E[:I:=?'3M,O%Z:F*K,RZBL,CQN;255W*QVRD)1Y
M-<P"0<AAQM:5D9)61I-*MNU:>FJ3,B,NT$5;^X"QLJO)I&39D]/S[(953/:R
M>- 8AH@R,>4:X"FHA+6D]AJ5WFY?CDK3Q>T%JD-=Q?D;EMB&09=F*\@N\7L+
M*Q4]Y S":=19PEPTQVVVEGW2&27N(U&XI1ZZGV:!'HG 5G14.+1\3R\ZS*\4
M<MTQ;MZN:E,2(=[+7+>8>BJ=21[5&C8HG.AIUTZZ$*M_:\1S+R<Y:6^2+E6D
MC#I^%S)1PVFS=<L7&W%SMC:DH2HC;_DDIV]>T@*M.][.]//AE6VUN[*KU8/!
MP!QM#*6EF5<Z;S<Y*C6LB62]%$V:321EVGV 53? L<S?'H\MO-<O++9#IM%$
M<161ZI+"&TF2C-+*W#6MP_&6I2M-?FI($3
M
M
M     5]S?G%QQMQ;D&:T+,>1;52(RHS,U*UL*-Z6RPHE);6A1^*X>FBBZZ L
M(HOG8['DCBG#Z!F.Y6YY4/WUFZ\2U/LQE0W'XJ632M*24;C+B7-Z5=$^ P*)
MECO,/'V4Y&_BU+:F]9M>4&PM;#S,664)?=R?))#B$M/]RKHYW2CT[>SJ!1HT
M^T%QY:U62RL9L5S9U!6RK9IM<24AN7'BFILWXQFVGOV2=+8I;1F1?>Z@4:G
M>7WLXIN-++URQ7S\@6]%NJV15S&SG36*\I;K4-Q6B6VVC/>3JC4A9%H2MVI
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M.HQQ]$S/XZ(*VHRXLB3"CE/DMMH\J>9(FVE+:-Q;27'$[M"\!EJ(A=0(
M
M
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M4V(V]W&S4\6D8]<P6D26$,4:(C+[<UTUI-MQ)1C-!:*->[7H6I@/7@,0
M
M
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M:8ZUF1]XELU=WO(RU2LT[D_Q3(!OP
M
M
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M(M ]?T3./X_'A8?5S$FY#BDN+!?E')F'$2K9WBC=6MU:=WB[U&?7IJ#%N@
M
M
M
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M6$&VJJ:-$LJRM110)3:-'&:QI6],=)G_ !"5U 2(
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M/)_,(^,P#ZSR?S"/C, ^L\G\PCXS /K/)_,(^,P#ZSR?S"/C, ^L\G\PCXS
M/K/)_,(^,P#ZSR?S"/C, ^L\G\PCXS /K/)_,(^,P#ZSR?S"/C, ^L\G\PCX
MS /K/)_,(^,P#ZSR?S"/C, ^L\G\PCXS /K/)_,(^,P#ZSR?S"/C, ^L\G\P
MCXS /K/)_,(^,P#ZSR?S"/C, ^L\G\PCXS /K/)_,(^,P#ZSR?S"/C, ^L\G
M\PCXS /K/)_,(^,P#ZSR?S"/C, ^L\G\PCXS /K/)_,(^,P#ZSR?S"/C, ^L
M\G\PCXS /K/)_,(^,P#ZSR?S"/C, ^L\G\PCXS /K/)_,(^,P#ZSR?S"/C,
M^L\G\PCXS /K/)_,(^,P#ZSR?S"/C, ^L\G\PCXS /K/)_,(^,P#ZSR?S"/C
M, ^L\G\PCXS /K/)_,(^,P#ZSR?S"/C, ^L\G\PCXS /K/)_,(^,P#ZSR?S"
M/C, ^L\G\PCXS /K/)_,(^,P#ZSR?S"/C, ^L\G\PCXS /K/)_,(^,P#ZSR?
MS"/C, ^L\G\PCXS /K/)_,(^,P#ZSR?S"/C, ^L\G\PCXS /K/)_,(^,P#ZS
MR?S"/C, ^L\G\PCXS /K/)_,(^,P#ZSR?S"/C, ^L\G\PCXS /K/)_,(^,P#
MZSR?S"/C, ^L\G\PCXS /K/)_,(^,P#ZSR?S"/C, ^L\G\PCXS /K/)_,(^,
MP#ZSR?S"/C, ^L\G\PCXS /K/)_,(^,P#ZSR?S"/C, ^L\G\PCXS /K/)_,(
M^,P#ZSR?S"/C, ^L\G\PCXS /K/)_,(^,P#ZSR?S"/C, ^L\G\PCXS /K/)_
M,(^,P#ZSR?S"/C, ^L\G\PCXS /K/)_,(^,P#ZSR?S"/C, ^L\G\PCXS /K/
M)_,(^,P#ZSR?S"/C, ^L\G\PCXS 9E9=O3Y11UM)2DTF>I:Z]/O@K=B
M      //OMH_U!W/^N5_\Y0"QO?F3$8\JE,1MVSOG$-[M-=-ZB+73^Z#-Z@N
M_8U3%LK'%L=Y%K+C/X$0YQ8L[&5"DNM$DEEL4;SO51&6G33KU,BZ@QYGEM:%
M-J4A:32M)FE25%H9&70R,C!D]K>Q!_PCF'](P_\ (."PPN>HMS:$K=?5L8:2
MIUY?]ZVVDU*5_<(C,&*K>$^9HO,D*^DMU[=7)I93;2(R'5/*=B2$K-MY6XB-
M)F:%$9=@+,+%]<4QQTS"M(1PEN=PB5Y2SW"GOS9.;MIK_P '745$+5RG 3S
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MJZ$3VJB[LS\&_34!V%+AJDG"3)95.2@GE1$N(-\FE=BS;(]Q)/P*TT =P
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M;??I);AD6JW4H/0"7HHR,CT/M!
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MZGITU(CT[ *M@YQSARYF(S6X*X[F";BQ=IAY:&8Y+VZDM)[N\+Q"^<8#06_
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M(_A /5%;YLC^$!BRF\<A/Q8LU<:-)G+-F$R\XEM;[J4FLT-)4HC6HDD:M$^
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M?,;E+E/)I&(X16V\"FRR5?Y-BN0WOJ_RR.M[&V%/)D,1UNHT[Q*2\4UZ;C^
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M(&5W%QB,#+?5=Q;QL[R#%SMCKFT+;15PW20_%)2EFPM2D>,:3UVGM,!TP?:
MS1-'!GV)1"M<;QK);K-J\FO%>L*B:=7#82I)ZL]X^E3BOA1X *)-P9RCEV69
M+-QS(IIY!#74L73-ZW23*%F++6[W4BNTE)+OB02VUM.I^<G=KKX!*^@0
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MWDY;1Y7;TE=9RV+.\QR$ICR&;-C(0T3AFXTM;9.H;0E]+9EWA$6ID?4!I8_
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MXKKAN HD2%0'MQFX3>NI[DI/;XQ:EU HLH$
M
M
M                                                         !#^
M6*2TR7C'+\>I&/*;>TJ)L.#'WI;[Q]]A:$)W+-*2U,]-5&1 *:SK!.2(=A!M
ML>QE60+L^.G\$F169D6*J#/>4APGG%2'$)6W\Y/Y,S/4ONEJ5IK;ASD9_$+Z
MICTY.39G'&.8U&1Y3&3OM:U:CD,ZFYH6PC^>9[#\!F N3FC$;S,N&,CQ&B92
M]?3:]MN+&4M*"<=96VX;9*49)(U;#21F>FO:8$(M<XGG&:9?'RA^A52LS\#N
M**0Q*E1WEQ;*<^V;+3ALK5NU2G<:D$:2[#Z] &MQ;#L^F5_"#=QC;U0K!TRJ
MR^0[+BNK0PBE57MR4&TXK4G'#\5*=5)\/3J T/$?$]Y@TR =O@,Z9DV$0K+U
M-D:\B4Y63)2VULM(APG'UDP4II>U9K:2EL^T@)>CL:GW%I05UAD%7ZDNY+"'
M)]3WR)7DSRB\9OO6R)*]/A($;4
M
M
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M42T*T/0]%),R/J6@#M   !U.28S3K4=UY"'Y!J)AI2B);AH+<K:1GJ>A=3T
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M74M0': ZGI,:,;12'D-&\LFF2<42=[BM3)"=3+51Z'T(!V@
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M*=Q,J$W#[MYPW:$UP]'N\/;W#1]VOQ3[Q6JO%UT!6; Y@SSB_%K^)DCE=?\
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M9NH]%7,Y'):F7Z(S16<F.CNF7)6TN]-M'@3NUV_<!&R
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M0R/L%5H1651XS+"W5R%M(2A3[NG>.&DB(U*VD1:GVGH0([0
M          512<)KKLJKK^XS*ZR*LH9,N?CM+:K:>;B2IR5H6M;^SO7]B7%I
M:)Q7B%V M4%S3@][#,"HX^!3,@EY335<W%HZZ=$ WYT&U6I_NI9RR)MEE#Q)
MU>1XS9'J1&>AD*I11<"L)QN-$N[-UJWD<?Q^/+-N*2%QT(2A9N/M&I)*-1*<
M42=>AD1= *L6^]FN%<(GPXF76E937<.IBY%7,MQ7$3WJ%IMF*\I;K2E-^(T@
MG$-&E*M.H%4KE\/P)N4YI=OW$SU'GM<5=D./I2R3#CB8A04OH>V&ZA1,D:=I
M*TW'N/P:!#VO9H8>K+BOO<SM+AVTQ]C$FI+[,1M46MAOD^RELFFT[C3IH:EZ
MFK4S,]0*IUG/&CN56E7D=#D4W%,LJF'X#=O7H8>-V!+-"G8[S4A"T+3N;2M!
MF7B*+4NH":5D-RNK8<!V6]/=BLML+G2C2J0^IM))-QTT)0DUJTW*VI(M? 0(
MCW&N"PN-,)JL(KY;TZ'4I>0U*DD@G5D\^X^>XD$2>AN:%H78 E8"*9S@L+.D
MXZF;+>B%CM[ R-CN"0?>O5JE*0TO<1^(K=XVG4!SF>#P\T?QA^7+=BJQBZC9
M!&)DDGWKT5MULFU[B/1)DZ>NG4!'\=XD<QB^DO5N5618,^_-F(PE28QUZ'[/
M>I]).FUWW<[W%N(:)9$E9Z_#J5H<:]GTL=L*V0G-;B5!Q^!95&+1%(AMJK(=
MHA*#-IU+.Y;K>U)I<=W?-26FA: 5=K/ +$N%D9Y3EMI=Y'D#=<TC(=L:#+AE
M2O>405LE&;0DW6W?'-Q>IJ[/AU%5@89CUWCE:]&R#)IF564A]3Z["<U&C["-
M*4DVTU%;;0A!$G73J>XS/7P$1#(O!5)"O6,DC6<DK=C*++*T/J;95XEVP4>9
M ,C3H;#B$I+4_'+0NH+5D8;P\>)LRJ%[*;*YX_.'(K:[$9R8ZHL:'+5JMI3R
M6R?>)"3-MO>YXJ#TZ@-!/XCR+&^,,SQBMR>URF*_C<ZCQ7'IB8B&X[:HRVX[
M1+:;;4XX6J6R<<7\W^ -WQ3Q1)PUYO)LENIE]EKM/!I$.SDQT^0U\0C=\D;.
M,A!.:.J4:G5:J5H7W3,,C+^)I.9Y+&LK3+;+ZJ-3(-F[B1-Q51#E5AI6R;;Y
MM=^TA2TDIQ*5^,9GU+IH$:RGAR)14DS(J.QNSR>!D=EE]9)I&(DFR;?O#-J5
M%98E:,N-J0LRT</P:Z^ Q5U\0<,V5)0<>6V72'HV58H60/.0"<:D$H\E?-U2
M7W4IT4XVG;N-OQ37KIJ6@#K]V6#$IJRHH\PM:E4:A?Q*UE,-Q7%SZ=^0[))I
M27FUI:4E;R]'&B)6T]-0*I;5\0,4F58QE%3?3(RJ"@C8K-@DVPMFQKX.Y3).
M&I!FVHG%;S-O37LZ%KJ$8H/9L@44N 7ULM)E'1Q+BMQRG?;B]U AWJ#2\E+B
M6R<<4DSU)3BC["+L("J3V7#\.3AN(8W5W<RHN\%:BHQW)8J6E2VEQ8OD:C6V
MXE3:T/-&I+K9EM5J FF,U$VAHXE797$J^G,$HY%M/)I,AY;BU+,S2RAM"2+=
MM2DD]$D1=>T$59+]FK#)D>QC.RY/=V68HSIXB2V6DA&I>2D6W^1,EN%\);@6
MK;9-P;1Y1^\7RRSEM?O$*I5+[LF_\S>HVT)CK9Z:GJIM*U$O[W0"K[L.&6;I
MZTGWF0S)]O<X>O![&:IIALW&G7'G5RR0VA*4N&IY6B2\70"K6V_L]T=O5W=6
M[=36F[NFHZ%YU"&=[;6/.DZTXG5)EN<,M%ZEI\ %4WH,%A8_F>89HQ+>>EY@
MJN7+BN$@FF#JXODJ.[,B)1[T^,K<?;V B-VW#4:SO,\M&[Z9&K>0JI57=5"&
MV%LID>1E!;EMK4C>2D-%ILW;34>I^#0KKL."<7N'+)-Q+DRX-IC,+$9$;Q$:
M,U[BGFI*%$D]'B69*+IM(R[ *I/@V*7V+193>09=89;*D*;[M^P;C,)9;:3M
M2EM$9M'57:M2C,U'U^'4B%9%P%#R3*[N[EY/8MX[D\VML,BQ9MN,<.6NF;93
M'1WBFS=0G<PE3FQ9;NSP$9%J[I_ M1.RQZZ*\L&,6FW#&46>'MDSY!)NXQ))
M,A3AH[TD*-M"W&MVU2BU/P$0J[:G@RIJ,HAYRS<3',Q:M["WL;59-[IK%FTE
MA<%Q.FA1VT-M$RG_ .&:-R>I@53;"\=GXM0,TUG?3<DF-./+5;69H.2LG7%+
M2E6PB+1!'M+[W]P$2           ?+B.\;4V9FDED:=R3T46I::D?@,!3U9P
M$VS:-V.0YE=9,FK@V-;BZ+13#CE:U;M&S(<-Y+9+?=[OQ$J=,]"\'9H6J'<I
M\*V%5A]3%P.1>3,E3C?[O5HK403:FUJFEJ:.P.69)892X1[WF?RA$O:7;J0J
MF7[A8$W'+&ILK5YJ5=8I58C/5&0@VFT52%EWK.\M3-1K/HKP 5?-_P  HNK>
M?)8R^SKJ"WF5UM<8^PU%5&E655W!-O*<6V;B4K*.V:VTJT-9;O 1 5;"?PA6
MV4K/FI-W-/&^065>LJ)*&":CSEM-,^5LNF@W-Y$RDTH49HU[2/IH*M+[NK<V
MJRF%D>96EW8Y8W2LS;-]J*TXTC'Y/E#!-(:;2@B5H25;B,SZGKJ8%4KS;BY_
M)LDB9ACN3S\2R5N"JGFSJY$=_P JK%N]\32D26W$I6A9J4VZDMR=RNWP!(LJ
MQ5&587:X9(GOL,VU>[5R+!.Q4CNWVC:6OJ1)-2DF>O33J"(YQSQM?8&XVS,S
MBRR&DC045\"GFQX;,>.EKNR;6@X[2%ZH0C81&K30SUZZ JQ 0 1#CW (/'>!
M5V P)CTV#7-/LMS)!()Y127G'C,R01)Z&X9%T\ "%,< ,U%+BL3$\KLL?R+%
MJ]ZE:R",U&=>E5LIPGG&'FGFU-F1+(EMF1:H/KV@M79F7 _UIDRI$+,;:F.Z
MI6L=RI3"(CSEM%C)6EM;RW&3V.'WBR<4T2=Z3VZ)Z@59MMPT_=7E1)GY?9N8
MG42:VQ9Q7NHGDQ3*9"$L+;?[KOFT&I!..(2OQE&KJ1&6@JSL9XLEXGDSUE4Y
M;9MX>N7,LF<-V1C@MRK%2W'M'3:-[NN\<4ZAHED25GK\.H9V;<84F>7E+;W;
MSIL5$*YK5P$$CNI$>_C(BODLS(U$:4(\4TZ=H(BC?!4VO;IG<=SNXH[6!4QL
M=M;"(U$4NQKH"U'&[Q#S3B$/M)4I"'TIW:&>NNH+5N;GB9^5F<C,L;RNSQA^
MV1#;R>+ 1%<19%7>*PLU/M.&TX2#[M2V_G(T+3X0A#7"UUE7(F=6626<ZNP.
MRO:RP+'VBC'%MTU<2*IM:U&E3S:4OM:+))IWDG[A&!5;N9X[<Y)6,Q:')9N*
MV4>0B2W8P&X[YJ)*5)-IUJ2VXA;9[MVWIXQ$>O@,B$5' .-5<?'(;L^5.AT4
M&\@267R;(IQY,I*YJW>[2G9JHCV);(B(CT!:J[PSA3(Y&5Y-3VLZY5@D3#9O
M'=597:(3,DV9+Z22<)J*7CL-,MIT>?T6XI1%IHGH*K$O.!*2^1/1(N)K/EM!
M58ZA;/=I6TJCE>6Q923VGJLG229I^:9%IX0*L)7L^M3:/,(%[EMC:7N9/U<Z
M=?N,1&7V9=*:#CK::9:0T22[M!;#3\WIKKU J[,SX&=S%Y,US-+2OLYU 6+Y
M/+C,P];:$2E.:N(4T:6E&M:S4;1%XI[2T("J3XUQ72X[9Y)8*D.V#.3UU543
MX4E*.Y*/3Q7(B2+:1&?>I=5OU_N .OCKC2QX_5Y']<+2[QR'&37T5).3&)B#
M$;41H3WC327'5(2DFT*6KHCIIV:!EY-QG2Y3G>'Y[.=<38X=Y>46,E*#9D%8
MLDS^5W$:OR9EO1M/M[01%:+V?,;Q_#L.PV!92RAX=D+>4QY2B:[Z3)9<?6EM
M[Q=-FCVS5)$>B2!:OM_@B&_6YC1*R*=ZARVY9R), VXYE!G)GMV#YM+V;E$\
MXTE.BS,DI[.NI@595IPC46MS;W3EK*;=M\AILH=:2ELT(?H4-H;:3J6NQS9X
MQ]OP 5$<(4[:HZBM9?\ F^;/\@IU2UUF2.]W1OF_R1=Z?7YWW0*M[R1QZ7($
M*G1'N)-!<4-DU<55K#;9><:D--N-:&V^E:%)-+JNAEVZ?>,C27G"=1=KR5;E
MI*9/);FIOI&Q+9]T]2I82A"-2ZDYW!&HS^'H"U9%?Q.]29I,R/'\JLJK';2P
M5=VV*,(C*AR+)U!)=<[UQI3R4.F1+<;2K0U:GJ7@#8\D<=KY 8HU1;V7CUIC
MUBFWK;&"AEUQ,A#+K*24A]*T*3HZ>Y)EU[ 1%E<!0(]+2(ILCL*[-Z.?/N&,
MR2W'>EO3KG=ZP4\RXV;*D/DK39M\7:GKT/4M74OV;L-DT]'C=G-F6&.T<"TB
MM09"D+4_879+*38O.&G54@B<7W1Z:-FK5.@%4QQO!K:ALJB;)RVRLX=72-4:
MZV1L*-)>9<W%.=(B,SD&DB0I6O7XP1-                     $>S3.,5X
M]I%9'F-BFLI4.ML*E*;==(G'CT06UE"U==/@ 5U[V'L^?;5GT.?]&!:'O8>S
MY]M6?0Y_T8"A[V'L^?;5GT.?]& H>]A[/GVU9]#G_1@*'O8>SY]M6?0Y_P!&
M H>]A[/GVU9]#G_1@*'O8>SY]M6?0Y_T8"A[V'L^?;5GT.?]& H>]A[/GVU9
M]#G_ $8"A[V'L^?;5GT.?]& H>]A[/GVU9]#G_1@*'O8>SY]M6?0Y_T8"A[V
M'L^?;5GT.?\ 1@*'O8>SY]M6?0Y_T8"A[V'L^?;5GT.?]& H>]A[/GVU9]#G
M_1@*'O8>SY]M6?0Y_P!& H>]A[/GVU9]#G_1@*'O8>SY]M6?0Y_T8"A[V'L^
M?;5GT.?]& H>]A[/GVU9]#G_ $8"A[V'L^?;5GT.?]& H>]A[/GVU9]#G_1@
M*'O8>SY]M6?0Y_T8"A[V'L^?;5GT.?\ 1@*'O8>SY]M6?0Y_T8"A[V'L^?;5
MGT.?]& H>]A[/GVU9]#G_1@*'O8>SY]M6?0Y_P!& H>]A[/GVU9]#G_1@*'O
M8>SY]M6?0Y_T8"A[V'L^?;5GT.?]& H>]A[/GVU9]#G_ $8"A[V'L^?;5GT.
M?]& H>]A[/GVU9]#G_1@*'O8>SY]M6?0Y_T8"A[V'L^?;5GT.?\ 1@*'O8>S
MY]M6?0Y_T8"A[V'L^?;5GT.?]& H>]A[/GVU9]#G_1@*'O8>SY]M6?0Y_P!&
M H>]A[/GVU9]#G_1@*'O8>SY]M6?0Y_T8"A[V'L^?;5GT.?]& H>]A[/GVU9
M]#G_ $8"A[V'L^?;5GT.?]& H>]A[/GVU9]#G_1@*'O8>SY]M6?0Y_T8"A[V
M'L^?;5GT.?\ 1@*'O8>SY]M6?0Y_T8"A[V'L^?;5GT.?]& HLS$\MQ[.:")E
M&*SDV-#.[SR68E#C9+[EQ32_%=2A1:+0I/5/@!&Z =4J2Q#C/3)*^[C1T*=>
M</4R2ALC4H^FI]"(!3I>UC[/AEK]=&?0[#Z,"T<^]A[/GVU9]#G_ $8"A[V'
ML^?;5GT.?]& H>]A[/GVU9]#G_1@*'O8>SY]M6?0Y_T8"A[V'L^?;5GT.?\
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ML^?;5GT.?]& H>]A[/GVU9]#G_1@*'O8>SY]M6?0Y_T8"A[V'L^?;5GT.?\
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M[@.$_L%2>A-?(!4_<!PG]@J3T)KY *G[@.$_L%2>A-?(!4_<!PG]@J3T)KY
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M_8*D]":^0"I^X#A/[!4GH37R 5/W <)_8*D]":^0"I^X#A/[!4GH37R 5/W
M<)_8*D]":^0"I^X#A/[!4GH37R 5/W <)_8*D]":^0"I^X#A/[!4GH37R 5/
MW <)_8*D]":^0"I^X#A/[!4GH37R 5/W <)_8*D]":^0"I^X#A/[!4GH37R
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MC@LO3 (
M    (/S-_5#GO_+UM_,G0(5_[&__ *?,9_QUE_/WP65\ B(<K?U79O\ T!:_
MS)T!5_L8_P!0-%_K5C_.W 65_@@
M                        JOVD_P"HK.OZ,7_VT L.GV8_ZA<'_P!15_EW
M0)6T"           \Z>VW_45+_I.!_VU L+IP#_@3%_Z(@?S9L$2(
M        'RM:&T*<<42&T$:EK4>A$1=3,S/L(@'G_@I"^2<]S/GR:DU5TYU6
M-8.2R/1--7K_ "KR"/L[]TMWPI42R[#!9>@@0               !YZS+_[+
M7M!X_@+?Y;$.-$-Y-DI=K3MP\7^81U=I:H2?>Z=AI-:3!7H4$
M               !7W.O]3&?_P! 67\V6"PB/LA?^GK$/_I'_P 2D@2N\$:G
M*/\ AFY_U&5_D5 //OL+?U)O?TW-_P E'!9>F 0
M                                    0?F;^J'/?^7K;^9.@0K_ -C?
M_P!/F,_XZR_G[X+*^ 1$.5OZKLW_ * M?YDZ J_V,?Z@:+_6K'^=N LK_!
M                                                       !5?M)
M_P!16=?T8O\ [: 6'3[,?]0N#_ZBK_+N@2MH$          !YT]MO^HJ7_2<
M#_MJ!873@'_ F+_T1 _FS8(D0               *6]I;*+.!A<3 <85_P#G
MGR)+1CE2@CT-#$C0I;YZ=20AI6U2OXN\E> %A9V'8M681BU1B5,G;6T\5J&P
M9D1*7W:=%.*T_C+5JM1^%1F"-V               "/YSEU;@6'W68VY_P"8
M4T5R4M&I)-Q:2T;:29_QG%FEM/W3(!77LUXA94>!N9=DQ;LUSZ4YDMZZHM%)
M\L,UQV=#ZDE#:B5L/YJE*(%E<H(                          "ON=?ZF
M,_\ Z LOYLL%A$?9"_\ 3UB'_P!(_P#B4D"5W@C4Y1_PS<_ZC*_R*@'GWV%O
MZDWOZ;F_Y*."R], @
M              @_,W]4.>_\O6W\R= A7_L;_P#I\QG_ !UE_/WP65\ B(<K
M?U79O_0%K_,G0%7^QC_4#1?ZU8_SMP%E?X(
M                                *K]I/^HK.OZ,7_VT L.GV8_ZA<'_
M -15_EW0)6T"           \Z>VW_45+_I.!_P!M0+"Z< _X$Q?^B('\V;!$
MB               !YZX_P#_ ++//.3<G.?EL4P%*\3Q$^UMR>9:V$I'734B
M4;9*+HI"T_ "O0H(                \]\UFKD_DS#>"(I]Y3)465YT2?F^
MK82](\=>A]CSO11=I:H4"P]!D1)(DI+1)="(NPB!'(
M         *^YU_J8S_\ H"R_FRP6$1]D+_T]8A_](_\ B4D"5W@C4Y1_PS<_
MZC*_R*@'GWV%OZDWOZ;F_P"2C@LO3 (
M                            (/S-_5#GO_+UM_,G0(5_[&__ *?,9_QU
ME_/WP65\ B(<K?U79O\ T!:_S)T!5_L8_P!0-%_K5C_.W 65_@@
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M'_TC_P")20)7>"-3E'_#-S_J,K_(J >??86_J3>_IN;_ )*."R], @
M                                                   @_,W]4.>_
M\O6W\R= A7_L;_\ I\QG_'67\_?!97P"(ARM_5=F_P#0%K_,G0%7^QC_ % T
M7^M6/\[<!97^"
M          "J_:3_ *BLZ_HQ?_;0"PZ?9C_J%P?_ %%7^7= E;0(
M  #SI[;?]14O^DX'_;4"PNG /^!,7_HB!_-FP1(@             !YZ+3EW
MVDS5_+87P^QH7A:>R6>77[A^3H3]]#B/\(%>A00               !0?M'S
MY>62<4X&HWE-V6=S$NWKS1^/&H("N^D+/X#6:-$:]%;5)\(+"]($"'5P8M97
M,IC5\)EN-%CMEHAMEE)(0A)? E)$1 C(
M 5]SK_4QG_\ 0%E_-E@L(C[(7_IZQ#_Z1_\ $I($KO!&IRC_ (9N?]1E?Y%0
M#S[["W]2;W]-S?\ )1P67I@$
M                     $'YF_JASW_EZV_F3H$*_P#8W_\ 3YC/^.LOY^^"
MRO@$1#E;^J[-_P"@+7^9.@*O]C'^H&B_UJQ_G;@+*_P0
M                                         57[2?\ 45G7]&+_ .V@
M%AT^S'_4+@_^HJ_R[H$K:!           >=/;;_J*E_TG _[:@6%TX!_P)B_
M]$0/YLV")$             ^5D:D*2E1H49&1++0S(S\/74N@"$\5<9UW%F-
MO44.:]:39LZ5:6MO*(DR)<N6O<;CFW4M222$=.W;KX0$X
M  06JXR@5_*%]RG*GO3[BV@QJJ%&>2DFZ^(QXSC;)EU,G5DE9Z]AZ_WP*G0(
M                             *^YU_J8S_\ H"R_FRP6$1]D+_T]8A_]
M(_\ B4D"5W@C4Y1_PS<_ZC*_R*@'GWV%OZDWOZ;F_P"2C@LO3 (
M                                                (/S-_5#GO_+U
MM_,G0(5_[&__ *?,9_QUE_/WP65\ B(<K?U79O\ T!:_S)T!5_L8_P!0-%_K
M5C_.W 65_@@
M        JOVD_P"HK.OZ,7_VT L.GV8_ZA<'_P!15_EW0)6T"
MJCVB>,K[EOC9_#L<D1(MD[,C22=GK<;8V,*,U%JTVXK7KT\4%A3\+BSVUZZ%
M&KH7)5&U#AM-QX[1)2>UII)(0G5569GH1%U,P78[_P!W/MP_VG4GX"/V4!L/
MW<^W#_:=2?@(_90&P_=S[</]IU)^ C]E ;#]W/MP_P!IU)^ C]E ;#]W/MP_
MVG4GX"/V4!L/W<^W#_:=2?@(_90&P_=S[</]IU)^ C]E ;#]W/MP_P!IU)^
MC]E ;#]W/MP_VG4GX"/V4!L/W<^W#_:=2?@(_90&P_=S[</]IU)^ C]E ;#]
MW/MP_P!IU)^ C]E ;#]W/MP_VG4GX"/V4!L/W<^W#_:=2?@(_90&P_=S[</]
MIU)^ C]E ;#]W/MP_P!IU)^ C]E ;#]W/MP_VG4GX"/V4!L/W<^W#_:=2?@(
M_90&P_=S[</]IU)^ C]E ;#]W/MP_P!IU)^ C]E ;#]W/MP_VG4GX"/V4!L/
MW<^W#_:=2?@(_90&P_=S[</]IU)^ C]E ;#]W/MP_P!IU)^ C]E ;#]W/MP_
MVG4GX"/V4!L/W<^W#_:=2?@(_90&P_=S[</]IU)^ C]E ;#]W/MP_P!IU)^
MC]E ;#]W/MP_VG4GX"/V4!L/W<^W#_:=2?@(_90&P_=S[</]IU)^ C]E ;#]
MW/MP_P!IU)^ C]E ;#]W/MP_VG4GX"/V4!L/W<^W#_:=2?@(_90&P_=S[</]
MIU)^ C]E ;#]W/MP_P!IU)^ C]E ;#]W/MP_VG4GX"/V4!L/W<^W#_:=2?@(
M_90&P_=S[</]IU)^ C]E ;#]W/MP_P!IU)^ C]E ;#]W/MP_VG4GX"/V4!L/
MW<^W#_:=2?@(_90&P_=S[</]IU)^ C]E ;#]W/MP_P!IU)^ C]E ;#]W/MP_
MVG4GX"/V4!L/W<^W#_:=2?@(_90&P_=S[</]IU)^ C]E ;#]W/MP_P!IU)^
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M4?\ 98&P^IOMV_;Z@_11_P!E@;#ZF^W;]OJ#]%'_ &6!L/J;[=OV^H/T4?\
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MKH0#R=AG#'MC\?8_'Q?$<QH*^BBJ<<8B^(_M4\LW%^.]7+4>JE&?S@95AO\
MZF^W;]OJ#]%'_98&P^IOMV_;Z@_11_V6!L/J;[=OV^H/T4?]E@;#ZF^W;]OJ
M#]%'_98&P^IOMV_;Z@_11_V6!L/J;[=OV^H/T4?]E@;#ZF^W;]OJ#]%'_98&
MP^IOMV_;Z@_11_V6!L/J;[=OV^H/T4?]E@;#ZF^W;]OJ#]%'_98&P^IOMV_;
MZ@_11_V6!L/J;[=OV^H/T4?]E@;#ZF^W;]OJ#]%'_98&P^IOMV_;Z@_11_V6
M!L/J;[=OV^H/T4?]E@;#ZF^W;]OJ#]%'_98&P^IOMV_;Z@_11_V6!L/J;[=O
MV^H/T4?]E@;#ZF^W;]OJ#]%'_98&P^IOMV_;Z@_11_V6!L/J;[=OV^H/T4?]
ME@;#ZF^W;]OJ#]%'_98&P^IOMV_;Z@_11_V6!L/J;[=OV^H/T4?]E@;#ZF^W
M;]OJ#]%'_98&P^IOMV_;Z@_11_V6!L/J;[=OV^H/T4?]E@;#ZF^W;]OJ#]%'
M_98&P^IOMV_;Z@_11_V6!L/J;[=OV^H/T4?]E@;#ZF^W;]OJ#]%'_98&P^IO
MMV_;Z@_11_V6!L/J;[=OV^H/T4?]E@;#ZF^W;]OJ#]%'_98&P^IOMV_;Z@_1
M1_V6!L/J;[=OV^H/T4?]E@;#ZF^W;]OJ#]%'_98&P^IOMV_;Z@_11_V6!L/J
M;[=OV^H/T4?]E@;#ZF^W;]OJ#]%'_98&P^IOMV_;Z@_11_V6!L/J;[=OV^H/
MT4?]E@;#ZF^W;]OJ#]%'_98&P^IOMV_;Z@_11_V6!L:K).*O;4RZBG8UD&:T
M$NELFC8FQMK37>-F9&9;VZU*B[/XJB V/1?#6'VN <88WAUXMERVJ8QL2EQ5
M*6R:C=6OQ%*2@S+11=J2!BG0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                #!F75/7NDQ/L8T5\TDLFGWFVEFD^
MA'HI1'IT 8_UHQG_ +Y@^E,_C 'UHQG_ +Y@^E,_C !Y3C)%J=U (B[3\J9_
M& ;1"T.(2XVHEMK(E(6D]2,CZD9&7:1@/H
M
M
M                                    =4F3'AL.2I;R(\9HMSKSJB0V
ME)>%2E&1$7WP&/77-1;DX=381IY,Z$Z<5YM_9NUTW;#/370]-0&:
M             _.#V[_ZZ(/] 0_YS+!G#S""@  _9KC\B+ \6(BT(JBO(B__
M +9L&M(P
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MI%T/4>A9I:X9ON]R'W&D]FXNZ7EUF:Z;;HMYL=NS;;6G-=&_EF=EN[=7=1;
M\]\.X4HDI-2CT21:F?W"!8BJG*[-^7<W8EY)@=53QL58>=:K8]T<E,^P3'4:
M%+3L-*&B49&227V*[>G4>E=APXZ6WS/-]RE(??9NE=)T%UN#5Y,EV:8B;IQ\
MO)CKMB-M9NIVT[-R><>9K$Y!Q.#D\5A414C>W)AK/<IF0RHT.(W:%J6I:I/3
MJ6G0NP<F?#.*^;9?-=9Z7?TW578+IYN6DQ/&)VQ/].U*!H>*
M                                                     *Q]HHB/
M@[.]2U_^4R#^(B!8>=O_ *GJE)0>05:%N-VI(U>$R),S0OX067M<&(
M             #\X/;O_ *YX'] 0_P"<RP9P\P@H  /V;P#_ ($Q?^B('\V;
M!K2(
M           %*>T?04E;PQR1=0*Z/&N+:$TJSL&FDID2#:<9;1WCA%N424I)
M*2,]"!86?A?_  =CW]&0OYN@$:WE8C/B[-B(M3.@M2(B_P!2= 1GV;#(^"L%
MT/7_ .6H_@6L%E#(_C>VG*V]=F"EOTZZ?Y\CM^#M ['H<$>/\&N.6ZOESF=/
M&F-5M^PY?MG8KL9OD:FEI2[W9(+^,1D:M09)P7'?,G*F;XMD'+C5/08EA\Q-
MM!H*AUR7(EV#>BFE/.J\4DH41=A]FJ=/&W$1Z(!%/>TY981#XBN86;1U3D6A
M)AT=='ZS'[9?6-Y/T,R6A1;S/3YI&6BM=IEA6WLI;J#*<QQ3DEE]KG5119-A
M-L7DRGI=.AAM+"6'2-1&EHMI.$E77Q>I[=$"7JH$      !0W*Y9%)YGP*NQ
MN0U"M)<&P9BV#[??)B$XD_*'VT&9$IQ+*5;4JZ:Z:CUM-RQ@OF[;%8]U^F>S
MWA[>C:J_/$W66WXYFV)IS4]&V9[+9NG;3:[[CZX\07^-63^53LGQ6_LF:6TA
M6VQ;S+TLC-MYA:2+0BVJ,T::=-.NNJ<;.3/;='+%MUL5BC7IO!]:P9K(P68,
MV''.2RZRL1,6[[;H\VW[VV\AY;\W51[2*W4<.WYMZ[37")TD]-4'-9U(S+P&
M/0Z?]/'N_ ^W]B(B>KXJ_P"_^1<TMABG**,45G3.<2(V3QX?K)-"PTTFD0VV
MWWODB6=#,]$EL[Q1F9GU&RW+BY^3DV5I7M\KT,/4.F3JO"3IK;L5UW)WDS/>
MUF:<_-Y=O+"S\"R?ZYX=390IDH[EE&0\\PG4TH=+5+A),^NW<1[=? .'/C[N
M^;>#X[J^@\#K,FGK6++J1/W.SWDB&EY+SSC-=EV8Y7EV7\7VC>'X])EN0I"I
M#2;$K*?%U)<I+#A$EDCW%U29Z^$M=2'L9+K,=EMN2.::>2D</NOU77Y])HM+
MI]-K[)U.2VV+HI/)W=EVZSFC;=_5V2D_!;C56>4X7913:S:GGE)R2>;RI";%
MZ<DUHEI6HDFDEI3_ ">GB]O:HQHUGQN6^/1F-GW*=CQO:RV<O<:JRZN#)93%
M;3E[N+-DV4^Y/;V^2%OCSGP:GE$?O-I\H["Q _)?@_T[KIK_ .]V#T?_ /+^
M/_4^]C__ )K9_$[?U?\ ]'URCI^]3B3NO]+\NL]-.WN>X:[SLZ]@:;Z')Y(3
MH'^EZ^N[DQ^?FNHM\><^#5YR_P AIP+'V$1'V8^0W;Q5]0]+42(S"UZ$N2\H
MR,B;92K<?0]3T+3M'9I<'>W;=T;9^][KZKV;Z-/4=1,W1,X\4<U\6^E=PLM^
M[=N\ZG9=[QEC5UQ="H\FB3XM383IF06IN[EN29+"=\E]74]SB]2+4ST+0M="
M'I19EOMR3-LQ6(I']3[_ !Z3J6JPZZ_+ANLG)99;CLINMMNV66_)C[[T]"F1
M;&''L(+R9$&6TA^,^V>Y#C3J26A:3\)&1D9#PIB8FDOQK+BNQ7S9?%+K9F)C
MA,;X=XC6AG(%)G60UJ8N#9&QCZU-O)D/+C]^XZI6TD$AW75K316JDI4KKT[!
MTX+\=LUOMYGT'1]5H=-DYM7AG-MBD<U(CC6/[79LF8AHN!K.LD84N@@U?J:;
MC,V146L'O3D%Y8RK<XZ3AZ&KO%*,_N'J1="(;=;;,9.:9KS16/(]/VNP9;=;
M&:^_O+<]MN2RZE/BSNBG93_;OJM <+XP
M                                   !Y2YT]KB[XBY$FX3"QF)9QHK$
M9],MZ2XTX9R&R<,C2E!D6FH,HA2V>^VQ?9WAMWATG$H<1BZB.0URD2W5J;)P
MM-Q)-!$9E]\"B <#^T19\%,7K%=1Q[@KQ<9;BI#ZV.[\D)TB(MB5:Z][_ "S
M"X?_ +H+DWV)@^F/?JP2CW?%>.1&9?,MINH2LR+J1;B(P8NT
M      ?G![=_]<\#^@(?\YE@SAYA!0  ?LW@'_ F+_T1 _FS8-:1
M
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M:[Z=E7VMO4^B1J/&1CR][7G[JMO=\]:^EZ7+7;2GN4V+7QVB@8Q15V/5B33
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MU&;O;JTI$;(C[CYWKG5YZCGB^+>2RRV+++?P;8W0F YG@
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MC@5?H?BM;)IL7I*B9M\LKX$6)([L]R.\890VK:9D6I:ETZ P;<
M
M
M                                                    0WEG%K+-
M^-LFQ*G4TBTN(#L2*N2I2&2<<+IO4E*C(OO),!4_LI\&9EPI&RIG+WX#RKIR
M"N)ZN=<>(BBI?)>_O&FM/Y5.FFOA!9EZ*!
M
M
M
M
M
M
M
M                      &ARO-<3P6O:M,OMXU-7O/)C,ORUDA*WED9DE/A
M,]"-1_ 1&9]" 9<_(Z&K16N6%C'CMW$AJ%5+6XG23(?2I;;;1E\Y2DI4HM/
M0#3XIR9@><2WX&*7L:TFQFB??CLFHG$M&K82]JTI/;NZ:_" ZBY5XY.*<TLF
M@'%**BP[TGBT.([+. EU/PI.07<]/X_B]ID R:CD;!;[(I^)4]_#F9+6*=1.
MJVW2.0VJ.K8Z6T]-3;5T7MUVGV@).
M
M
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MMU >M@8@
M
M
M
M
M
M
M
M
M
M
M
M
B                                          __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>px_25avadelpxy01pg02-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 px_25avadelpxy01pg02-4c.jpg
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M_\0 V0 !  (" P$!              4&! <! P@""0$! 0$! 0$! 0
M      $" P0%!@<0   & 0,"! 0!" <$ PH!'0 ! @,$!081$@<A$S$B% A!
M43(587%"(],65A<8@=%2DE24E9%B,R2A<K2QP4-SLS1T)35U-SB"LE-CA#9V
MX9.U)J+21$55A?"CQ-2E)T=WAPD9$0$  @(  @H! P,"! ,&!P   1$" Q($
M(3%!46&A4A0%%09Q(A.!,C/P(['1<C210D/!X?&RTC6"DE-STQ8V_]H # ,!
M  (1 Q$ /P#W\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M5\N0F8U+C$6JC;=2TSYB(C/0DF6B5>;5)D!3=((
M
M
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MN(?9<(C,C-*T&:3ZEIT,$90
M
M                                                 J5CQQB]IG]/
MR7+9>5E5'%=@U[R7EI92P^EQ*R4T1[5'H\OJ?_>( >XWQ:1R'&Y0<9=_:V+
M.J:>)Y1,^E4I:M#:^DSU6KJ @6^!^/&L<RS%419)5&:S#L;U'J7-ZY"G$NF;
M:M=4%N270@6V'F?MRXJSJKI*V[K'4NX]"8JZNRC/K9G(A14;&V5N]>XDO'SD
M>AF9EIJ>HM<,"X]Q+C/'F\8PVO37U2%J><+<IQUY]9$2G77%F:EK,DD6I^!$
M1%H1$0(QG^,L2DY__$J1&<<R<ZY5.I:W%*CJAJ,S-"F3\IZZGX@*%7^TWA"L
MREO*HM$YW6'REL5:Y#JZYM\CW$HF%'H9$9:DA1FCX;=.@+;=H(J6+\;XOA^1
M9/E-(RZW;Y<^U*NENO+<0MUGN&G8E71!?I5=" 1D'AC!:^%FU?&C2"C<@NR)
M&2)5(<4;BY9.$YVS,_T9'W5?2"VALB]N/%^4XIC>&7$.6[18HAUNG;1+=0XE
M+^W?O6D]5?27CX 6F.+^%\$X?1:(PB-(C)N#85-*1(<D:G%)PF]N\SV_\56N
MGC_0!;#Y,X$XZY;M(5QF<63(FU[!Q(RH\IR.DFE+-?4D'H9ZF?4"W8QP/QA#
MX]L.,*ZG.%B=JI#EBTP\Z4A]UIQMU*UOJ4IPSU;3XJTTZ> %HS O;5Q1QO<O
M7N,UTA,V1$>KWT2I+DEE<:1M[B%-N:I,CVEX@6Z,0]KW#N$9:C,Z*G=*UCK4
M[7LR)+C\:(XK\YEM9GU+7RFLU;?$NNA@6XSCVO<1\AY1/S#)H$MZ[LNUZIQJ
M8\R@^PRAA&B$GH7D0D"VR,.Q*FP7&J[$L?;<:IJMLV8B'G%.K)*EJ6>JU=3Z
MJ,$:POO:APGD63NY3.I'&Y4I[U,Z#&DNL09#QJW&I;2#+3<?U$@TD?RZF"VL
M_)'!_'/*E=6UN4UADFG+95R(*SBO1VC(DFV@T%IVS)*?(:3(M.F@%L:7P#QC
M*XZ9XL35KC8@R^B8;$=]QMYR2@]3=<>U-2U*^)F?AH1:$1:"T[/XSQ2RS>@Y
M!E,O*R3&HSL*J=2\M+267T.-J)39=%'M<5U,$:UMO9[PC=6DZXGULY4ZQD.R
MY*TSGDD;LA9N+,B(]"+51] 6U^7P]@SM]/R-^&Z]/LZ$\3FH<>6IERI4224T
M:#/34R21&KQ MDPN+<.KLOA9O"BN,WE?3HQR)M=7V$5K1[D-DWKIJ7]H$:SC
M>S/@N)*9F,5L]+\=Q#S:ON#YZ+0HE%\?F0+;>%W3PLAI;&@LTJ776L5^#,0A
M1H4;$EM33A$I/4C-*CT,O $5>JXEPBFIX-+#@K]/74\K'(KSCJU/IK9ZDK>;
M[FNNJC0D]WB7P!5;N_;=Q;D&'8[@EG#EN8]BYOJJ6DRW4.).2HU.;UD>JM3/
MIKX? "W7C_MHXIQC&LFQ.IA2VZ;+6X[-RVN8ZM:T0U+6UL49ZHT-:M=/$"W5
M@_M>XCX\RB!F&,P);-W6]WTKCLQYY!=]E;"]4*/0_(M0%KO$XWQ>%R%.Y/89
M=++;& FJDO&\LV3BH-M1$37TD>K2.O\ 6",<N*L/++\BSCL/_?\ *:\JBW<[
MZ^VJ(EMMK1"-=$*VMI\Q?]\P$)8^W[C2VXYJN+)\!]W$Z5\Y5<@Y#A26WE+=
M6I7>(]QZ]YPC+PT/\"!;9/)G!G'?+,:O9RZ XN35)[<&PBNJ8E-M'IJV:RUW
M),RUT41Z'U+34P+6# N/L3XSQYK&,-KTU]4VM3RT[E..NOK(B4ZZXLS4M9DD
MBU/X$1%H1$0(Z;'CC%[3/Z?DN6R\K*J.*[!KWDO+2REA]+B5DIHCVJ/1Y?4_
M^\0#LY!X^QODW&GL3RMIUZG?=:?<;8=4PO>PK<GS)Z^(#"/BG#_V\K.2&F'V
M,IJX/VII]I]:&G8A)6@D/MD>US0E]#5UZ)_LEH%/G^UCA:SS1S.)E":[!Z0<
MV1 [RRKG9)GN-Q<?P/57F-&NP_BGJ8+:ZP^,,2A\@67)I,/2,LLXB:YU^0\M
MUEJ*DD%VV6E>5LC[9:[2^?\ :5J1\8+Q;B7'-'98WBS3\>CLY#TIV$Z^MY#2
MY""0LF=W5"3(BZ$ R^/N/L;XRQIG$\4:=9IV'77VVWW5/KWOJW*\RNOB SLN
MQ''LZQZ;BV4PD6%)8()$F,LS3])DI*DJ29*2I*B)25)/4C 4##O;?Q9@M-?T
M]! D-GDL1VMM+!V0M<TX3R=JF6W>G;2?^X1&9Z:ZZ%H6TS.X6P"PXS8XDD0G
M?V,C);2PPEY:7TFT]WR5W2\VXUZF9_'4P+94?B?#H^91<\[#[V11:I-"AY]]
M;K:X*2TT<0K4E*,O%1^((K?\MW%Y8&_QKZ6;^R+]C]X*$<UXS;D[23HVLS-2
M4:%]'AKU\06V9B'M\XGP>DNZ*@HB;CY%$=KKF0\\Z]*?AOH-"VNZI6Y"3(_!
MO;UT/Q(@+6CC_ <;XSQ>+B.*,N,T\13CB"><4\ZIQY9K6I2E>)F9_#H"+.
M
M
M
M
M
M
M
M
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M236E1Z$*>H(LEF;%8F1S,V)#:'6C4E2%&AQ)*+5*B(R/0_ RU!'<
M                                              -'^[[_ .)YR_\
M_-W_ -DHP+#S360)&!\X\>\5(9<5CD?(8N48Q*>49J*%=1&B=9(O[*'6E)+_
M 'DJ^8*VEP=<5&.'[A8.22&HT^!=VD^Q1(625*AN$^25^;0U)49'H?\ O%\R
M E4::',B?_Z_[54M*DID*6_&2KQ[*KIHB,B/P(S2HR_V@=JZ^XK_ .(_I/\
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M0B0CU#*#6YV-QK2C>HR(SZ?#4&5F
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MUC\3X5&Y)D<L,PW$YC*B)@NO]U?9[:4):)1-:[25VT)1KX:%X:]01=@
M
M
M
M
M
M
M
M
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MMNY/4M%&>I$&R 0
M
M                                    >-LGB<K3?=CF\;B.;65UZYCT
M),R7<$M3;<12(A&IHDMN_I"6:#+5)EX@UV,#DKB]CA_"^&<2]=]PFGF\:?:V
M"B[:'9<A2=ZDDHST2DB2DM3ZZ:GIJ VY[PWV'_;YD_9=0YM>K25L42M#]>QX
MZ D+#P?C-YAV,'(R?/7\L:L(<*5$9F)0TFN8:CFI:$&3CAJ29*+4ST^DN@$O
M$+7)L5-NURB=)9_>SY 5D:\A5&,JW[$LB:]&3^N[?J1IVZ::?'4&GJOF/C*)
ME&;JSCBS-X^,<T4U8F3(BE(;)$ROT/MG(09GM29%MWK2I!IV[DZ:&#+3&?\
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M.JM%:[B7J9:@DO13#[,EEN3&<2]'>2EQIUM1+0M"RU2I*BU(R,CU(R!'8
M
M
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MXWQ?.[/&[7(FGGY&*SDVE2VV\MIHI:%(4E3B$GHO::"T)7X_ S!"PXWQ>SY
MJN39++Q993PW*V*^V\M#2HKO=U0XT1[5D1O+,M?CU^! *Y_+]QF?&Q\4+@/K
MQ#U)S6VER'%2&Y!N=S>AXSW$>NI?D,R^(+;'SCVY<7\B'2GD\*4^5!!;JJXF
MI;K6V*S])*VGYC_WCZ@6O.&X3BW'U"QC6'UK573,&I:6&MRE*<7]2W%K-2UK
M/0M5+49Z$1>!$",'(>-\6R?+<<S:V9=7?8J;JJAQMY3;:#?(B7O0717A\0%?
M3P+QVB#FE8S%E-5N?/%)R"&W*<2R;Q.*=-;*==&C-2CUV_#0O B(%M$8/[7N
M(^/,H@9AC,"6S=UO=]*X[,>>07?96PO5"CT/R+4!:[Q.-\7A<A3N3V&72RVQ
M@)JI+QO+-DXJ#;41$U])'JTCK_6"*QR9[>.,.6;6->Y97O?>(S91SFPGU1G'
M6$F9I0[MU)1%J>AZ;M.FN@+:4O\ A;CW(L+I^/Y5:J-BE#(8EUD*&\XQVW8Q
M+))FLCW*U[BS5N,S4H]QGKU MEJXJQ \\G<D-L/LY/:0#JK)UI]:&9$8TI01
M.-ET-1$A&BO]TOD"(21[?>,Y?&L7BB1 ><Q"#(.;$:5(<.0U(4XMPUI=UW:F
M;JR_ZJC(%MLF%$9@0X\&,1E'BM(89(S-1DAM))3J9^/0@1I*/[0N"V;<[F11
MOSGU/*DK8ES)#D=3JU&K539*(E%J?TGT/XZ@MKER9PGQ[RU!@0LNKE*75Z_;
MI<-PXTAA"B(E(2I/38>TO*HC+IT M+X9QQA_'^*_L;BE>4"D43AO()2E.O./
M))+CKCBC-2EJ(B+<9]"(B+0B(@1CXEQ;B.$X0_Q[0L/-XU)3*;=9=>6XZ:9I
M&3NCA]2U)1Z:> "#D\ \<R^.:OBQZ+*/$:B5Z^$R4IQ+Q/\ <==,U.D>XRW/
M+Z?U$"VV8ZTAYI;+G5#B30HBZ=%%H8(J_'G'>,\7XXC%<29=8IT/.R4MONJ?
M7W'C(U>9773H Q5<4X6YF5]G3\1Q^\R6M^R6Y.NK5&=@FEM!H[1GM+5+:2,R
M_P"^8"*C\#\;L\<*XI?KW9N&]U<B/%ER''78[SBS<WL.ZDILR4I2BVG^<K74
ME&1EMA8E[=.,<)QJ^QG'X<F.SDK"H=Q8G)6J>[&61I-I+W38@R,]201:Z]=0
M+9ECP-QO8X=CN#J@/1J;%)"9M$Y$D.,2X\E)J4;A/I/=JI2S6KYJT/Q(@+3V
M8<;XOG5CC=KD++SLS%)R+6G4T\IHDRFU(61K)/19:MIZ&"+: U7R5[=^+>5K
MB-D&65CIW#"$LN2X;ZXRWV4'JE#VSHK3P)7U:=-=- 6TRKA[ OON)7S->IA_
M"(ZXF-Q&75HB1VW$&@S[6NBE:?G*ZF9$9ZF!;[E\38;,R^YSAQA]%]?U2Z*V
M6V^M#3T)Q*4&1H(]"41(21*+J6@"%<]O?&J\3QG#BB2FZS$)BK*@D-RG$3(\
MEQU3ZC)XCW:&M>[3\"^1 6P<Q]L?$6>Y?+S;*:N1,N9RF52R*8^TPYZ=I#*"
MV-J3H6UM.NAD!:?S/A'C//,8KL1O:)I-13)[=*4,SC.PDZ)(R86WH:2422W)
M/4E:%J1F1 6@ZSVT<2U.#76 0ZMXJC(E,N7$I4EPYSZXKA/,&I[74NVLMR4D
M6WQU(]3U%ME8[05>*T-;C5*T;%14QFH<)I2E.*2RRDD)(U*,S,]"ZF8(DP
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M           !A6ES44<9,RZL(U;$4M+29$QYN.V;B_I02G#26X].A ,T
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MTC5JA!F712O'X ,ZLLZZYKXUM42FIU9,;2_$F1UI=9=:66J5(4DS(R,@&4
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M="Z@.;6WJJ* [:74YBNK6"U>ERW4,,H(ST+5:S(BU/P 9A&1D1EX'U(!R
M
M   /-_O:2E?$5<2B)1?M#7]#+7Q0^0+#&Y,YBYFK^3,PP?CR)1+@8QCZ<D>D
M6J)'>)AEM#CR4=IS:M:S5M0DTD7S40"/P7W \LVF7<;OY?4TL7!^3$RF:F/
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ME_L!5JY)5RN7N7P16$1:%J6FB66&,2R>1'3"]"KU29*4'JDTJ-XFB1TV[?Q
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M%%H7D/Q+11A'>QBFM8O'4JYFU=1'JYSAMU=I#:VV\GLOOI?3.<_.2VK:3!?
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M- N[=HZYS)6H[&0KC-*M&81J5&1*-!&XEHUZJ-!*U(C,$2(
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M- M\(@T_9S&[>>UE-3$]S1IK<M*E(;+M(:,FU;RW;MO30-X@@
M                                                      A\<Q3'
M,1B/P<:K6*V+*D.S92&$Z&[)?/<XZXH]5*4?S49]-"\"(!,
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MT'ECD(JM5F:EJ<*$3G=[1)-1H26[KJ2=?Q 3@#A2DITW*(MQZ%J>FIG\ '(
M         X2I*T[D*)23\#(]2Z .%K0VA3CBB0V@C4M:CT(B+J9F9^!$ Y(R
M41*2>J3ZD9=2,C <@        ("HS7%KZ]N,9I[-J9>8^;:+F&T2C5&4]KL2
MM1IVZGM/H1_ !/@                *KCW&V"8I=VN2X]0Q8-_=NNR+.R0@
MU2'5OK[CGG6:C2E2_,:$:)U^ "U
M
M                            /#O(?!>*5WN#P7!X]I=E29DBRFV^L\S>
M)UM#SR2:5LT26Y):ZD?0&K3&2W64\8^X9%5@E!*S+]FL!8@5]8_-2R3$1AQL
MW93KCA:&K:T1*VI)2UJ(OP ;.?\ <JF7QW@V38QC+UKF7(+[T*AQCU"&B]1#
M<4S)4Y(4DDDTVM/U&DM241GM+4R)2[<0\IGR97V[-G3N8[E^-3EU6143KJ9'
M8D(+4E(=01$MM>A[3T\4GXEHHPJ?*'.F5X9R-'XVQ#"#RNVF4BKMA:9R(>S8
MZ\A9+)QLT[$I9W:[R-1F22Z@4J6*^[.YR"=A,R;@#]9A&83VZ%J^7-;<,K9:
MNVI+31()2F4K,BWJVZ^;3JDT@4LG*G/.=\76LZ=8<>%(X\K'F&Y-ZFVBE+>:
MD*0@GF8>AN;24LD>;H:NFXNN@IK;DW/.0H_NCQ:1CF).WL>#4.JQV F>EEFR
MC2XZU.S$DM.UI3?<6V9*+56SQ\ 7L;$Y ]QMUCF3Y'48;A+V54F"-,R,XMT2
MVXI1$/IW[64*2HW#0@E*5IX;5:D1%N!*?>:>XNVKLDQ3'>.\/7F3V9497U,I
M$Q,)>UPEJ22TN-J224H1N7JLM/#Q I&P+*OL/<KADK(<9DUG(-AA96$I:;-2
MXT(W%OI7%5')HB<4C11&K>2=3UVZI)0"0;]P&;T^=T6-Y_Q\6.T6367V6KL&
M[:-/DHEK426N^PR1["<W)/J9=#U+=H!3J]OLB3*Y4YU7*><?6WD+++:G5J6:
M6F_4DA"=QGHE)=$D70@)9>9+QHO=-QTS+JI+^2/4U@<*U1/6U&8;:;DJVKB$
MV9.&?G+=W$_46I'M(#L<<;\^Y?R;DY?8, <7QHY/D5B,I^XL=YE<5)K-Q^)M
MWH2HM-$_B6BC,"FY<EL;6HH;"SHZE=[;165.Q*AMY$9<EQ/@V3KFJ4Z_,P1I
M#'/<-ETRRR?%,HPAJISBFH9&35,"/9LSXL^/'Z=GOL)427#5Y2,MQ=#UTTZE
MI)U?N%^^M\2(IZ-,B=R:<E4ACU)Z5[-<1>K61DU^DV&2]",DZ[3 I@95[@,W
MP7+&(V7<?%7X%)N&Z-J^1;1I$O\ 3K6EF2<1LC6EMPD*61*TZ%XZZ$8I0L@G
MT<.^]S*\?@3:O)H5,TN;<?<7'4O*>C*61M,DA'9T_P#&+T\$[2Z JYXEF7(>
M*<(<8E@>&-Y4[-IH_JWY%G&JV8ZDM-[$F<C3>MTU'M))^) C77+W,3_)'%_&
M&:TU9+8D.YE&C6.--/:J>EP36KTQ+VI)9+4230:D>)ETU(%I:,LYKO<SXJY?
MQC(J%["N0,2@H.77M3$R?^7FZ*;6A]HDZGMZ+V]#)1&1]3(B4EJSEVXPS ^)
ML!P;%UY=GUYBU?/9K/4MP6&8,>$WN==>=Z>8TJ)!=-3(^NNTE!MGB;DN!RMA
MK&4PX;E;*2\]!M*I\R6[$G15;76E*(BU\24D]"\IEJ1'J1$4GEWF7D/C2?.F
M0./D6^$U3#4J;>.6T:*ZZTK;W>Q%-*G3[1JT4>T_GT+J"TU'S7R3F=ERSP[<
MXEB\BVI7HZKO&89S"83;NS(K3BD*3YDM+C(47F5K]1_ %AOV-R-FCG*%5@LK
M!)K%!.J4V,W*"6:XD66;9K4PI1(V'M47:^O>:C(]NWJ",_DOD63Q[+PTBJRG
MUV3W\/')<DWNT<14\S)MW38HE$1I/4C-/Y0&MV_= S,CV15E"F18Q\Y8P2OC
M>J,BD(E*6EJ6:B:\NXFG#[>A^!>8"GU<^YU&/5DZ7;T*&Y=?G:\%D1TRCT],
MVCNG8$:FB/0T>#>GR\P%,JP]Q4Z)/LS9QM#V/U6;Q,$DV'JS)1&^1D_*V=DR
M_1+VI[>[KN+S$!3!L/=$AMC,6JK'TS+C&\KBX? AJE[$S7)CKC*'MQ-*V:J8
M=T21*U(BZ@4V;RWR;"XHQ$\DDP7;6?)DL5M14QU;')<^49DVT2C)6WHE2C/0
M^A=",^@(I.->X1U,/-HG)F-.XGEV"02MK*H;DM3DR83C9K;7'=;T29F9I09:
MZ$I2?-XDDM-30N2LWY'YUX4LLFQ1_%*J8W:V5,V<U,R/.B28"U-/;4I3L<0G
MQ)9;M%$>A$8*N$KW:OL6+U^UA4EWAF+;_8).;E)1N*02M#>3&))J-KXD>O4O
MB2_("4L?(WN R#'<TLL+X^P>1FLW&H35IE;C,@HQ16'DI<0VTG8LW7#0I*]$
MD9]>B3T5H*3T7F>3*Y3QSCE>.O04WV-)R9QZ<YV9D1:E.D<1Z.2%$2T]O11]
MSH9@4UX7NPLU\9XSGT7"_5SLBR!>.M4C4[S[DD>U2'#8T4M9EM))I(M?B!2-
MD^[+D&#$R0I?%+B++"9#?[8(*U95'A1'U$EK1Q+9FXXL]W1!*+1.[PUVBE\S
M+GZWCVE'C?&&'O9ED]M2MY3*@G)1"3%J72(T&I2B42G5&>TD%\33IN-1$!2+
MO/=$TWB''V5X?B[N0.9W,=K6Z@Y28LEB:RHFE,DHVUI4?=/:2CVD:=%?$"E;
MROG7-<NX9Y-C(P]ZFSC%UN5&00X\]*RA1I#+IJF-OH).[M$A6J4>/U$K0^@I
M\<?<SY5QYP'AE[D&%G&I69E51HEKFI_35,IC7[F1);4:?,1)[2O$U?4!2?Y>
MY/@9#"Y@X]LL?<G8OAE-#D6DZ-/5$>?ES3;?:82:6E["(B,U*\VNPTFG0P':
MWS!)Q'$N,<'XRPY_(<MR+'8MI74#T]#:(=8W&0O<_+?2DEG]2$GHDC-)^'E2
M82=#[D&,@9X^FQJ!4:'EUM,QR\1(D;7JBVB()2&3(F]'>YU,CU0>W3IKJ1"D
M;CGNA3EM5CTRCQY+TR_S%>(IC*EF1-16VTOJF[B:U5HTM"C;T+X^;H!2_<P\
MLGQA"I8M73.9%F&3S2K<=HVG$Q^\_P!-RUNJ(R2A&Y.IZ>*B\"U40A3I'N-L
MZ'C>;E>98+8TN71[8L<@XTXK5-A9+UV>F?V>=H]JM5I0HO+HG?TU%/BB]Q=N
MY59[!S'#UX[R'@=2Y>2*!<M#[$N(EKNI4W(;29%XH2OHHBW%H9]22*52M]UW
M(-C,Q^"CB=\Y.9P%R<.9;M&%*FO,EJXI9K;033)$2E;EZ'M(E::*U(4VEQES
M7%SCC.WY!NZQ5"[C;L^/?P#=)Y+3M8V3SNQ>B=2V&7B70]2Z^)BGF>"=Y"]L
M]QD1J-O/><LI0S&6E1I=TFRS)*"TZ[3)IXR_!P%=MI.OK3VF0;,WW/VOXDR,
MHLY;;J]^L&4;6U1D>II)N0T9_P#4U [6V*F<KD'W9,VL5YS['AV)1Y#;1+5V
M_5W">XC<DCVF:F91G_\ &D"=CSGA^)7M7PC=<]XKE5M6YIC%VXV<?U)KA2(:
M'6&S0MM1:F?Z8U'O4I*B+::>NH*WRG(W\F]S_$E\E:V8]Y@QV:HJ%K[)'*9E
MO%Y==#TW>)_(OD"/4H(
M
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MN-+)#=Y7N3)K1RC,O*]OE(;)*NOC\C M9N56>2>>^+)LJ;Q]84EMAV3M2XM
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M\C!'HSC_ "JSS/&(]_;X[-Q:<^XZA=-9I-,ILFEF@E*(TH/19%N+IX BT
M
M
M
M                     P9M-3V4F',L:^-,F5ZS=KY$AEMUR.X>FJFE+(S0
MH]"ZIT\ &<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M3T/8A):J,O#X@4ZZ;F_B3(9Z*NDS"LG6+C;KR(S+Y&LVX[2GG5$7^ZVA2S_
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M6SE)A>0-V]HRPJ6ZPRS(3L80I*#6I3C24D6Y:2\?B!2^@@
M
M                           P;FGK<@J9U%<1TRJJR8<B38R_I<9>2:%I
M/3KU(_@ _*G*.!,JI>;"X;@-JD39TM*:>:M)[':Y[5:92M"^EMM*E.[?I-"R
M+P!NWZB8/AU/Q_B51AU"WVZNHCICM&9$2G%]5..KTZ;W%FIQ?^\9@P\?<N:?
ML][I-?\ \IXIX?/NQM :AZBXCI\DK,;6[F%%C]'D,AW12,7:-J*[$0A/94X9
MD1FLC4OXZ%\/$$><.6J]$7EG*>)EI<.)R[:8A8L,MEY$QHS[C=DLS+XZQB<,
M%8^3UE!:X?[FKC)XT9S)(5V;4:6^E)R68T9+2:PD*5YD$HRVIV_5X=0%Y:HJ
MR?SGQ8J[J(;TZQPV7,N$O1FEF].-+2EN.[D>9>XS\RNOB"-<\BUJ+JHYKJ'7
M>PW89_11%OZ:]M+YM-FK3\"5J"JZ]>9 ]C7--;*0I&5XQBM3BET\DU&3_P!K
ML'(+[Y&?4TNQB)9G^)_ !OO"+#%J/F?'\5J^/XE>4G&&SQW-X<ULSFU#3#+J
MB5#:1Y2[JC1O=5N5MU+H"(;G&IRVZY[QZ!A<2CFW"\1L#6QE#*Y%>;'J=%Z)
M01Z.=2VFKR^.O0"&I["H>_@;Q3F''4IR'96;$SC:X=LMJW7&+V0^VYHML].T
MS(2Z;&WJE*T_%)@KV?\ L[78CQJYBU0C964],Y!C$>FXT,1C02E:>*E:;E'\
M3!E^<\]>6L<'L<;OD?V6"RSR.FPU_1JKIW:@-1227Q*8ZZ?CU/K\ ;;=]U&<
MUT/E^#*7/<9MN.*^KL:. VVXLG[:18L2'T+6@C2VGT:"5Y]-3+0$A=N3Y<>P
MY1Y+GQ%DY%E<*V#[#A>"FW7G5),ORD8#=O"+S,7A/ GI+B6648_6J6XXHD)2
M1QF^IF>A$"2[.:L-A<C<6W^)R;9JGCV3+*FK1U228;=9?;?9[AF9%L6M"4JZ
M^!].H$/,6>W\M/#G,&#9;B=5CG)-+'H7;JPHVVD1+6*N;'3&?_1I29&E)?0K
MPW="3U214_?JA)Y)YUM+?$HV;NT])CK<&EFR6H1IH7("G;!UE]Y*MA(,B<4;
M9;MWTGNT 4_++J2WR#@?*N)5OVR#B/'=/D'[-H,Y))HG9S\&5'2M6PU$U'D&
MHE*+P3J ]$>UI^,QP+@L=UY"'GH\KL-J425KTF/GY4F>I]#ZZ DH/FB!"M.?
M>#*^RB,SH#ZLF3(B2FD/LK04!DSW(<)23TTUZET\0(>?&XEA(Q'%:?$6J^5%
MC\LVL+"X]L2WZE<'82F4N$C<I3!N*7KM_'X@K=ON5QM%?[7K5=Y3TT7)X35;
MWU4T8FX;$E^RBE(](;B2<0A9^/@9EX@D=:@>[VPQ.';8[@Z9)8\Q24UCD\"/
M61?(Y;N*2U!;-#"-&R-33NJS(B+7J8+"ZPK"BY-Y]Q&TRJ-%F8Y9\9_=ZJ),
M)+D=,N=*(I6A+Z$XEDUI7\220(A\F8G5/,G&T?V]L4<R(SBM@5*B;(>=JSB'
M)6;AI>96I:E:F>GF/KKJ"MC>T#?_  $Q_N$1.>IM-Y)\-?N,C70$EH;!>1::
M3[JU9<BS6JPR2_M\6E0S;<)K[0S&CL5CB73(FS-Q]CJ@E&9:$8+V*1F+UOCK
MG*$E)&_CF=YK.HY"=G2+;4-U'GL*-1GT)UAUY/A\#!6Q^1ZC&9[_ +H+"_C1
MERJY="[4S'D([[$PXIDUV7#+<DUKVI,DGYBZ'T!&[^87K"1[6[J1;;ONKN-Q
MG)V_7=ZA3;)N:Z_'=J"1UO/%-'FW5/RKDLZBK\1F8OQVWB\W'X:D.2):YK")
MC-B\II"$&2VT%L\3\"U\O4KT1[?,2LU<95G[=4.,''L*ZN56_:(BM\BN*,TX
MT=AZA&BW]VBU;?+NZD"2T3'JJ]OV097/BP&&[!V7(;>DM,H2\MIJ_;,DJ6DB
M4:4D70C/H1 O:L_*#K3_ "+R.ZPM+K1<,22-Q!DI)&N0I22U+YI/4OP 4'CI
MF7D59D=M)I(.)R,&XM<KW8L=1*EWC5G5FZQ.=-M"$*;-""</JI25J(C,S\ [
M^"56]1R?PQ@EN:W6*NOM,CH9*DDE"ZK*J1$K874^K4EM]!_E/Y 2WO[P:RM?
MX4N;%^%'=L6'ZUN/+<:0M]M"[&.2DH<41J22BZ'H?4$A6^7X>3TG/'%\3BFN
MJ&[IFJNC@P+!*XU:E"TZO&:8VTR,R-1EM\5>(#3=;$R*?QYQ+$JXU7(R=[.K
MI+,:U2MVI5*-Q>J7DHU6;6NOAU!7NG$*R748U6PK&'70+9+"%6<:D:-BN*8I
M)&\;"5$2MAKUV[O-IX@R\,\90;:$7$>09+%JT8([FTJ#2S*MHV\C5:2),E#*
M)CJR)*XINEYR;/781$?YH-)%J! +@&ORI4=A/)Q\BDZN<DD^N.Y.S41M]S3?
MKVO-L^770!NR@QO'"]U&4QRIX),,8O7R66RBLDE$A4M6KJ2V]%G\5%U!.Q78
M5+7U7*ON&>Q^JB1[*HH*J10]B,TA4:6JG?42F#2G5M2EZ&9HTU,!6,5JL>JJ
M7VOVN+QH[&03)CJ),B,E*7WF'HR_N/<4DM5[5&9*W?3KIT!6D8JLT_A7D. P
MF5?L_E2Y^<%,U/M-PL>=ELS&E%\5+>BQ=#\"^/B0*]KYH>OM:MC^>$*/_P#A
MA SVO.M/B>;O<92^3EXC$Q*IJ.,WJ2%)B26G9MV4N*U_S[R6$IV))DE.Z.><
ME:=3_-*NL>JQNFSK@)S#X\>,FSP^X1=+AH0@Y$!%.AUA;YH(C5J^:U;E=37^
M(#7?MRKGLPR3B['9U%7T+>+5UID";HS0Y-R"#+D/1#9(DH(MB%J6VXAQ2CVI
M,^A&!+<?'E'21[GW /QZR(R_ L)+4%UJ.TA;#:ZQ1*2TI*2-!'J>I)^9@BE<
M40:^YRO@6KR&,S,IF\+LY%5&EI2ZRJP4ZHGM$+(TJ4322/P^&OP!5$>Q>QRS
M!\4Q'%Y90B1GV4-X7(2K1M#<-A4J,3:O DF\DR(R^>H#T![3<H;S6)R'EC<=
M415OD?JWXJB,C:?<@QS>1UZZ$YN(OP!):HY+@MV=;S[6O.=EJ9E^,QW'B+4T
M)=6R@U:?'0CU!5Q]MME:R.7\EH+YO;?X?C<+%K-_S:2'*B<\RT^1JZF3K)-+
MU^.H$KCSM14<CDGA]Z161'GI^1.-3G'([2UOMHB&24NFI)FLBT+0E?(@2&I>
M52SB%R7SE&P2'4G1HPZ(SD*+ W&EL5B:U23]$EDR3W"1NVDHMO@"OBHJ<GN>
M3>*8F(P*&RE)XDHG)K&5,N2(902DZ.*:2T2C)_4TD@_#0U:@/3'-S#,;A'.X
MT9M+,=G';!MEEM)(0A"(JR2E*2T(B(BT(B!(:)JZ'(J[VCY!99+68]$.7B<4
MZ.91,.-37JU<1I:3L%N)+<^?E4O8>TU:F"]JBX/*O<<RTL"W+?R'!\'R/[+9
M(W?\S#LH[-E7J29_G([RFM$^&TB ;>XHQKBJ/Q#Q]=)C5C.=GCEFY0ODM#4Y
M]]R*HK'8DE$;ZD;E$O<2NV1GIIU!%:BOV$;V#*<K=Q2%4[K:]FNOIW;-2'_#
MX=I2]?P!>UD7>(XH[R9BF+XR<:FILGXUM:V]FPTMH0W4O,$3$E>FU*B)?4EK
M/S:=3 5U:['$<*SKB?+\<IF\JA8!*DT&;4B6B3:4$/\ 1I2Z:2)9+U/?UZ+,
MC,R^E2@G#H<BK?:1D<_)JO'8;\O&X1U$K'V'&I+M<IAA:/7+=21J?,^J]A[=
M0.U*<?UU32>X#"V<7CLPWK/CMF1E,:&A+2%&E;1,O.H01%W#424[CZZ:?,$<
M\QU>57'N5Q:'AT&AL+7]E9"W(^4M.OU_IRFKWF262-7=ZEL/\H$*YSGZ_%_<
M'6YKC;*4M\?8?"MI%4RT6QVG.SD0)C:$I-)))#$@UD7@1),%A"4=HQQWQ'P/
MS ^2_1X_]^JIIM)U4INW;F]C>1>))=92?Y3 +3#<AI,>]M&.8Y$K)64R6KF<
MB+D;:WJU4BQC-37BE)01K/;W5::=241?(!M3+:]RLYZ]OE>[%API3,/(SEQ:
MMOLP4255A+?["#(C)!N&HTZEK\^H(Z[BKQ_(/<9GL7-XT>7!B8,R5:W.2E:&
MX#CBSE.()9:)T6HR-9=2U\0&D,:E9(Y#X =BXDSG-V=!D,=G'9SS$=EZ*F0Z
MTRI2Y25-DEMDDJ(C+J1:$"IU_C?/<.R'A? *V'CT[-(U9D<I<*^0[)I&BFOJ
ME*9,FB-9]I*]$F73?\= 'M:M9BUT2)5M-QHCC;)&F%$2EII))T)?:;+31!*5
M\OB#+\\O>GP[^Q6:HY!I8^S&\L<4J8E!:(CVVAK=(_D3Y$;R?FKN? B!J)>I
M/:GP[_"KCEJ5:L=O,,E)N?<;RT<9;VGZ>*>NAEVTJ-2R^"UJ+P(@29;W!
M
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MKB76E_#JE22_*70]2,R!$H
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MW/-XY5MRNYJ.WKZ*KR,,XVP_ (TZ)BT%4-BQ-"I:5///[C;)24]75J,NBC\
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MX#%A*1BSZ7$.0S>=4HTO+-Q?Z0UFOJH]?J$RWYSGQS/[F-OS?-[.<CG,LO\
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ML?\ Y,/_ *6VA\]^&
M
M
M
M
M
M
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M?ZM"_6@4?QFXA_?W'O\ 5H7ZT"C^,W$/[^X]_JT+]:!1_&;B']_<>_U:%^M
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M$/[^X]_JT+]:!1_&;B']_<>_U:%^M H_C-Q#^_N/?ZM"_6@4?QFXA_?W'O\
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M6]/+<_\ S9\-4]C#P/I@          @\L_\ 9)_^,1_WQ[N2_P G]'S/DO\
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M&$WDM"WH]=W$G(6VT6JU["ZDDB/Q,9XHNFN&:OL20TR
M
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M+R1BT/+*'N)A2MR%LOIVNM/-GM6VK34C-)_%)Z&.V&<91</-LUSAE4K0.CF
M
M
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MZTH-,@
M
M             )O%/_:Z?_%K_P"X/#SO^/\ J^E\=_F_I*^#X+]2
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MCHB,KMURYJ<L:F.GO6ZFX=@4W+-ORPW:/.S[=A4=RN4V@F4)4EE.I+(]Q_\
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M&$8Q4/-LV3GE<K*-N8
M
M                         ";Q3_VNG_Q:_P#N#P\[_C_J^E\=_F_I*^#X
M+]2          "#RS_V2?_C$?]\>[DO\G]'S/DO\/]5$'WGY<         1M
M?CU#4S9ME5U<6'86*NY82X[#;3TA>IJU=6DB4L]5&?F/XC,8Q'4U.4S%3*2&
MF0                                                !BR*ZOE28T
MV5%:>EPS4<1]Q"5N,FX1$HVU&1FDS(M#,A*A8F890J
M
M                                                       ";Q3_
M -KI_P#%K_[@\/._XWTOCO\ -_25\'P7ZD          &H/<LSG\CBV4QQHS
M,>RE<R)VBK2UDI9)9FXHOPT+0_RC>&<X3<.>>K'9%9=3Q7]D]YG^$RG^Z?\
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M>RT>D^R>\S_"93_=/^H/=;.\]EH])]D]YG^$RG^Z?]0>ZV=Y[+1Z3[)[S/\
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M&+)C2^^NQ+2,3ILF3>[\=WA^(YY[\\XJ9=,.6UZYO&*E[9'%W
M
M
M
M
M
M
M
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M3T/Q+0!A0,OQ.TN9>.5E[7S<@@$LYU5'E,NRV";42%FXRA1K1M4HDGN+H9Z
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M^.Z6I$MIU)*2HM=#ZD>H#O
M
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MA&@MIJ)2/SBT,P);4!
M
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M_#:NTS;%'<'<:@/8O$6KTSJ5(B*;98);4$E*<0T:T+;WJZI/74T@+/[QHTR
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MO0"W5[8"+^83G,]"U^YR=#TZ_P#M*3\0)77W$\(6G(]_1Y?@&1-4?*6/QU'
M8<>-E4B*TX:TFA2-5MFA;BBW;32>_:K0$B7Q[9.9\VSJ;DW'O)D5",WP]9-2
MIK24)[Q)<6PZEY+6K9.-K3]3?E41^'34Q,/18(
M
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MDI.TNCA^ %IGD/@>EY$RS#,ML+:7#E88XT[#CL);-M\V7VWR[AJ(S+4VR(]
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MIY*C,XMK,QG*5H2U-FP"2M,E*$=M*EI,TF2R1^CW)66J>AD8%K3QYP3A_&F
MVN"X\M\RO&7F[:X>-"I;SC[)L[^B221(2?Z-!%H7XF:C,6P\#]OF)X7QA=<4
M29<F[QV]>D/S%RB0VZDY+33>B#;(B(T&TE:%>)* MJ8O87AKD!<&9F-R^EEP
MU5A:,DU&:69FXGMF2B,UGM,U)V^'@"VW#R=P)B'*F%5.(W[C[4BB:;;J+EC8
M4IE2&TM*U(R-*DN$A/<1IUT+30R(P2U?X>]L.-<49&]F+MY89'DZV516)DU7
M;;:861)41-I4HU&9%IYU&1%X$1]0)E8^.^$:?CK.<QSF!:2IDS,I#DJ7%?2V
M33"G9#D@R;-!$9D1N&1:_ "T%S-[;:7E^_@Y4K(K.@R&OCE"8?AJ2XR3)*6L
MM&SVJ2K5:M5)66OQ(")3?"W!&*\)U]@U32)%G=6ZT+M+>::>ZZ31J-"$I3T0
MDMZC^)F9ZF9]-!,MI@@
M
M
M                 ,*UIJB^AJKKR!&LJ]2D.*B3&42&36VHE(4:'"4G5)D1
MD>G0P&2Q'8BLMQHK2&([220TRVDD(2DO DI3H1$0#L
M
M
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M($86"<@XCR70EDN%V*;*H[SD93Q(<94AYK0U(6VZE"TGHI*NI>!D?@8"S
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M?P ?.,Y-0YC21<CQF<BRHYO<]+-:)1(<[+BFEZ;B(^BT*3X? !+
M
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M6A:24LO,;F_<E1DK7QUU(B2V8"
M
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M[O5G^2C_ /W@"2@5E;5,JCU<-B#'4HUJ:C-(90:S(B-1I01%KH1=0&I^=O\
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MIH"2]/@@
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ML-*3,E&1&9>!_$ )*2,S(B(S\3 =:8T=+ZY264)DN$25O$DB<4DO C5IJ9$
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MO R)1'U =P
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M !3V^+\*1G;O)+L!4G+UH)N/-DOO/HBI[1,J],RM9MLFM)>8T)(SU/YGJ%P
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M2>JBUZ?$!]8SD]!F5'$R3&)S=E1SB6<6:SNV+[2U-+TW$1EM6E23U+Q(!+
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MJ/P (>245C=6>.09[,B\ID1W+6"TK<Y&*8E2V>Z1?2:TI-22/KIU\#(!*
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M<FRBFH<MPW(YF+/Y9.CF5>]Z)UDC>].E2?TBTN*2VA)=5$7E\014\>Y[S9_
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MWC.67DF&N!74BC:CE$B2X[Y%+>)LDJ=+8[H:"VZ&7@>H#T.@C2A*3\2(B/\
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M.P>^P+&[JKR%+*9<[(+2UCE'<[J?33'26V9GH6BM"ZD!*(Y4PWD&5R1@?(F
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M[=#U(!8P     !7++.*&KS&DP62MT\AOV94J"TALU-DQ"3N<6XOH2?DGQ,S
M6,       %6M>0,?I\LAX3(-]W(9U?*MVH\=E3I%$AGHI1F7BI1^5"4ZF9@,
MO"\L@YQC,#*:V+,A0K G%-1;)@XLM':<4T>]HS/34T&9=>I:'\0$\
M   *YA.<4/(%0]>8XMUVL:ER8!//-FUW'(;AM+4E)]=IJ+H9D1_@ L8
M  *YDV;T6)V./5-JIWU^3SBK*IEELW-SVPUJ4L^A)0DBZGK^0C 6,
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ME*4H_ OGH0!)SFAC9S"X\6MU62SJ]VW;:2V?:3#9<)HU+</0M37T)):GTZZ
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M6OP\=02'FR#R-F4+BSG&)6Y%DJFL353+QV=DVZ/DD0YZT^H;?5H2BT-.U/\
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MO%L9[L*/DD-]IIUS<VXZ4M&U&B9!%^A,U$9DDM%%NUU"PY/19EEO-=AQQ Y
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MA)9O+\S(\CY-P3B>HR&?B]1=1[*UNK.F=*/8N(@-I[++3QI5L+>9FOH>XOR
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M1 )N=Q5+F<BY#G*;1M#%WBW[+HA&R9K:<[AN=\U[]#+K].G]("IEP%D=/C&
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MLTPF/!<8<PLZYN3-<6DTR'+-A;Y$A">I$A*2(S4?4S\.@!Q7R'&Y2PN'FL2
MY6Q)[TMN/%?6E;NR))<C[E&DM-5&V9Z%KIX:F N>I$9$9]3\"^8#D!QJ6NFO
M4_ OR !F1>)Z:]"U^8!J6NW7S>.GQT ",CUT,CTZ& $9'X'J Y <:D1D6O4_
M @%-IN0HUUR1DW';$%QM_&(D"5*GK6G8ZJQ2IQ"&T%J>B4EU49^/P^)A<M2U
MVZ^;QT^.@"F8SR'%R?.LTPF/!<8<PLZYN3-<6DTR'+-A;Y$A">I$A*2(S4?4
MS\.@"Z:EKIKU\= '&I>&O7P_I\0 C(]=#UTZ'^4 U(S,B/J7B0!N+4BU+4_
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MZ&:E*4?7PT+Y@+D1$DM"+0OD7X@&I$9$9]3\" <ZEKI\?D I60\B1:#/\.P
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MR%A]MAW%TR+&EU5/<24RTQK-"NV^4=1.NJ)+J3WJ(U'U3^0@27HH$
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M"V!QCP*=GP@G#L_;FU5E.N)&20%MR25;U<E;NZ*YZDB,CD)06JU:?G&1D1^
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M\06V3+X.PVR9S^);JDSH/(C[$FWCN+0DF'8J"2TJ.:4$:30I*7"-6[S$7PZ
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MO62BV)TU/7H [:O,,3O+*934M[7V-O7:_<($.6R_(CZ*VGW6VUJ4C0^GF+Q
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MT9D7Y 682E/SMQ3?9FY@%3D34C)T..QTL$V\EAU^.6KK34A2"9<6DO%*%G^
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MI): B[
M
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MC(^I&6A@B2
M
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MOJ?D5T 9-34U=%6QJ>EALU]5#0346'&0EIEI!>"4H21$1 ,P
M
M
M
M
M
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MR;%\=GY$>=278%?6,+:8ELRV"42V72</:2DN)4A1[MI$1JU,M-13B%[C:<L
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M<ER'V1+PN- >9R5^)8J8KI#:F7UN,VSTE+>QPDF2G"1HC7YD!VN_A"JX_O\
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MV-.SJ?U?AO A0./:*[CX/P6PY4V$=R'G,]Z4Q)CND^PRIU_13Y&G5/0^JE=
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M0"6U00             8$6]I)UA*J85E%DVL'0YL%E]MR0QNZ%W6TJ-2-?\
M>(! 6F 5UQR#0<@SI3ZY>-Q)D2JK_)Z9MVP(D/2/IW;S;+M_5IH MP
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MC2DSU/;J6NG@ X;EQ77WHK3[:Y,?:<AE*TJ<;)PM4[TD>J=Q%TU\0'<
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MST0;JTMD9EUT+<9:@$:="F[O1R6I&S0E]E:7-NOAKM,]-0'>
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MCH16T\PY2Y&5G%E@7$V-P+N?BU='LLD<M9*XQ*5+2:V(<8D:%WEH+<2W#V?
M]-.I&XJU^9*KHDFPB>@GO,MN2H/<2]V'EH(UM=Q'E7L49IW)Z'IJ"-;^X'!L
M4S'C+(IF2UJ)\F@J;2QIW%K<0<>4W#<4EQ/;4G4R-)=%:ET!8:?P&?!XJP+C
M:FXGQNO7R=RE5Q9<Z192'VH.RMA=]Z5*42E*+0WE;$-[=34K3P(C*M$_W%9-
M$XUGWZ<>B%G]#DC.)W=(J0HX9R7'"23C#Q=>VX2DF@U>'774BU,E+CQ?R1FE
M]F65\?<AU$"MR7'6H<YIZG>=?B/1)Z5*26KQ$HEHT(E'TW'KT+3J&V00
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M,O$2.!.4*GCG-G8$&2O,*2_A,8,V2FS?<IZIR0RA3*C5IL4U8/*\QD9DGYZ
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MBWD>9Q_(M["B6WE66<B0\OET+#C;JZ^N[I;4NK(R2:D)3JO3YEJ1&1@J\6&
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M'Y-WTGX ,N!DU!:75KCM=8,R;JC*.JWAM*W+B^L2I;).:="-:4*41>.@"5
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M12[24),]3T22=O4-VG/3EP9QPS'8G+<SJYC"-FK*,L9[83 XO2      #'3
M@HFN62(S2;%UM+#LLFTD\MILS4E"EZ;C2DU*,B,]"U,!%Y#A^/95)I95_#*8
MYC\YNVJB6I:4-3F4J2V]M29$HT;C-.[4B/KX@)P
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M<_\ Y\FP!^??KP
M
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MENX?!?K
M
M
M                    !C6-?!MH$JKLX[<NMFM+CRXKR26TZRZDTK0M)]#2
MHC,C(P'U!@PZR%&K:Z.W$KX;2(\2*PDFVFF6DDA"$)3H24I21$1%X$ [P
M
M
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M)SL;5%L)9O[5FC3=H MRUK<]QZG'%*6XOBTU+6LS4I2C+4S,SZF9@+_[-_\
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MC,P.QJFHY#Y#R!1<IT,/.[;D7[\N27H8SLG%/LS:M%U^UM2C\J3T/R:%^7S
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M\QET!;8>/87$N/>#E6;,5[K,3'J:*R[,6VI+3]M,92SO:4HB)6V,2FU;?SB
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MY *-CWML>Q/)FI6-<@WM3@3%D=RSAD)9,L)?4>XVC>)6IQS^E31M^9/B>OF
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MV(5L7-[[?8)>NW:;F[:1Z]--0&<VXV\VAYE:7&G$DMMQ!DI*DJ+4C(RZ&1D
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M*C2DS,B/4M#!'PY>4K+[L9ZRBMR6%(0\RM]M*T+=^A*DFK4C5^:1^(#/
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M8<N'(K2>Q$<E/+43:75.K/X))7F(N@$-E>V;$L_P_(,VC7.(N87@=HY&GT-
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MEH!:T4G&V-X_G&1\@UY2/V@RA$=NT[CNYC;$0EMOMHT+;T26O4P1GYMA>/\
M(6+V&(9/'.3362"0^A*C0XE2%$M"T*+Z5(4DE)/\.NI= &O<+]M/'."V4RYJ
M7+21:6%6]23I4Z:J0MV-(VDI1ZI+19)0E*=NA$1> +;KL?;'QS88EC.((D6\
M&)B)S#HY\*<IF:U]R=-Z01KV&E6XSTZHU(NA?$"TH][>N+W^-VN+%5KA8VP_
MZYEXGE>N1.,S,Y1/GJ?=/<:==--OETV] +1;/M@XO:P>=@:D6#L"UFM6=K9.
MRS58RY4?7MJ=>VZ&1:GY221=3/Q,S M=.1N,,2Y3H&\>RMAU;$9Y$J!,BN&Q
M+BR&R,B<9<(CT/0S+J1D?R\ 1#8SP3Q_B^$7F Q6)<VGR7NJO7Y\E;\N4Z^@
MD*<4YY22LB(M#0E/4M?$%M#1_;-QTS@"^.'9%M*H5V#5J;LB;NE$['03;3:7
M$H226D)+1*$I+Y^(%LSDCV[<=<H7K>27R)T*X-@H4U^KDG$];%2>I,R2VJ):
M?AJ6BM-"UT(M!::>X<P==YAM[&BNPGL#9<BX[%C.FB,VRZV39I6DR4:^A>)J
MUUZGJ!;7^<^VBIM<8<Q;$W.S!O,NC91E!V3RUFICSE)3'V-GYC(RV)5H7S4!
M;>TB#$EPG:V0RAR ^TJ.[',M$*96DT*1H7P-)Z C4%-[8>-J/#\DP:*]:NX_
MDYQBF-/S36MAN&^<EMN,>PB;3W#,U=#-7YQF"VMC'$>(Q\OH,V04H[K&Z=./
M5Q*>-3!P4I6DB<09>9>CBM5:_P#<!%4QSVP<68KF$?,:AFP;=@R5SJRH5,6=
M9$DN:ZN,LD1&7CIHI9I_ %MT^Z7!\DY$XVBXQBU<JRLI%Q!6MDEI:0AA'<[C
MCBUF1)01'U/Q^1 0DL4]N?'.(5N4UU<5A)5ET)=5:3ITM4B6F XVIKL,N&DM
MB4I5TZ&?0M3/:0%K-'XLPUKC='%,B(N;AR(GH#C2G#6Z;1*WI,W$[3):5:*2
MI.AI,B,O $53"_;=QY@D>Z*D>M%6=W!<J'+J3,-R?&@.)V]F*Z2$DT22).TR
M3N+:77H"VD*K@3C^B=PJ12MRX$G TR&Z9]B1M6XW,6;CZ))[3[B7%*6:BZ?4
MK3Q LC<!<<,8GDV%/0WYE#E=@[;V;4EXU.)FNF@^XRM))-!I-"33_P!.I&9
M6P<6]M_'&*T>24;!V5BC*XR8%U-L)SKLIR*@C2AI*V^V2221F1:)UTZ&9ET
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MIN4DC/<9Z>"=I= 1>@0
M
M
M
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M\P6DEFW/'%''=BU59=D3<"P?@IM(S26)$@G8CBU(0MM;#:T*-1H5M3NUZ:^
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MX;JZJ<<J9E[>S&H%1 :4_,F/JV-MMI\3,_\ H(BZF?0NH(U]C_N%XERN@O\
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M*Y!E)H;P2#;3464B06L1F6XADXZWM?*6AH4HC5X$E1_,"&DLDD5MG@?N=O\
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M
M
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ML^B=IZ@=C9/N>K)]OP-FD*MCKDRSBLODRTDUK-N-*9><,B+J>U"%*_H AH+
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M:3&G()#I*86:#,C2:DJ2>G123_#Q(P970
M
M
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MR'&B9[3*2-+$9)$I6J624HDJ,_CX J]I2E"22DB2DO BZ$0(Y
M
M
M
M                                       '6Z^RSL[SB6^XHFV]ZB3N
M6KP26OB9_(!\'-A$T^^<EHF8N[U3AK3M:[9:JWGKHG0NIZ^ #M;<;>;0\RM+
MC3B26VX@R4E25%J1D9=#(R ?0    #J:E1GW'F67FW'HZB1(;0HE*;4I)*(E
MD1ZI,R,CZ_ !V@.F5*BPF%RIK[<>,WH;CSRTMMIU/0M5*,B+J8#N      '5
M&E19K")4-YN1&<+5MYE1.-J(CTZ*29D?4@': ZG949AUEAYY#;TE1HCMK425
M.*2DU&2",]5&22,ST^ #M                         8T^QKZJ(Y/M);,
M&"UIW9,EQ++2=QDDMRUF1%J9D1=?$!DD9&6I>'S =4:5%FL(E0WFY$9PM6WF
M5$XVHB/3HI)F1]2 ?2WF6W&V5N)2Z[J33:E$2E[2U/:1]3T+J>@#[
M
M
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ME
M
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M8J3==W=&]-%'\01Z+QFD9QK&Z?'(ZS<8IX,:O:6?0U(B,I:(_P"DD@B5
M
M
M                                 =3T:-)[?J&4/=E9.L]Q)+V.)\%I
MU(]%%KT,@':                       "&RS%J;-<>FXOD+*I%-8I0B8PE
M:FS6AMQ+FW<G0R(S26NGP 9ZZ^*JN55(1VH1L'%2VWY=K6S81)^6A> #!Q3%
MJ/"<=K\5QN*4.DK&NS$CD9JT(S-2C-1ZF:E*4:E&?B9@)@
M         '4Y&CNNM2'64+?8-1L.J21K;-9;5;3,M2U+H>@#M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
B                                          ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>px_25avadelpxy02pg01-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 px_25avadelpxy02pg01-4c.jpg
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M_\0! 0 !  (" P$!              4&! <" P@!"0$!  (# 0$!
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M #\ ]_
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                            "MP\^PZPD5\6%;LO2+5^5$KVT[]7GX!$
M<A"=4]J",M=1FG!?$3,QR^^Z^7H^\QVWW78YB,<6W7>Y%_HS[[K5R-A"+F?C
MZ[IA-S6-.R)\0]^YIJ.CO'%*/;IHE/4]#$^KY-,74X2M'1-[.&W-&.=%\Q%L
M\.,W32/AEQK.2<&N8L2;673$F+/G>J8CB261.3C03O<EJDO.VF1]>@7;?);,
MQ,<HK[R<_0][@NNMR8YMFRS7/+A96FKGRJ[H6?8=8NUC$*W9>>N'9,>L0G=J
M^[!_ATIU3]AY=1$X+XK6.7/WU,O1]YBB^;\<Q&.+9N_JQ?Z/PNM?(V$-VUE1
M+NF$VU0R]*LHI[]S+,=!..+4>W31*3U/0Q/J^2D74X2M'1-[.*S+&.=&28MM
MGAQFZ:1'ORXUO)6"W$>%*K;MB1'L9IU<):"7HY-)!.=T6J2\[:HCZ^R)NV^2
MV9B8Y17WEL_0]]ANNMR8IMFRW7=RX6UIJ^%WP<]Q"S?K(T"V9??N7);%8A)+
MU?<KRUD)3JG_ +,NW7]@5NP7Q6L<J5]_DQ9>D;O%;?=?CF(QQ;-W+S8O]'X7
M2?(^$)L[2F.Z8*SI6'I=K&T7N88BD2G5J/;IHDCZZ&)]7R4B:<)Y,G[DWOA6
M9?#G1EF+;)X>=-W*/?*ODC![IB%)J[IB2Q83%5D):"7HY,2V3IM%JDO.VF2N
MH7;?);6L<HK[QN.B;W!==;DQS;-ENN[EPMK2OPN^NSS$+9RJ9KK9F0Y>*E(J
M4HW?[0J!_O!(U27\'IUU_8$78;[:UCES]]CS=(W>&,DWXYB,6G7_ %=?HU\K
MH/D?"$V=I3'=,%9TK#TNUC:+W,,12)3JU'MTT21]=#$^KY*1-.$\F3]R;WPK
M,OASHRS%MD\/.F[E'OOM5R-A%VW >JKEB4W9R7($!2"7]UE,MDZMLM4EU))D
M?4+MODMK6.7%&XZ)O<$W1DQS;-EL77<N%LS2)^%VUN>XA;JIT5MLS(5?^E>I
MB1N_VGT#7TC9JDO>:'KJ(NP7VUK'H\_?4S](W>'Q->.;?!TZ_P"KK]&OE=/Z
M2,'.QMJDKICUC1,/RK>/HO='8BZ$ZM7FZ:)W%KIJ)]7R4B:<)Y,G[DWOAX\G
MASIRS%MD\/.F[E$>5]K.1L(N45SE9<L246\AV'7&@E_=I#"26XA.J2ZI29'U
M"[;Y+:UCDC/T3>X)OC)CFWPXBZ[EPB>$3[[NK,\Q"Y74MUELS)7>IDKJ21N_
MVA,(S2^:-4E[PR/741=AOMK6.7/WU,_2-W@C).3'-OA:=?\ 5U^C7RL8N2\%
M.?;U97;!SZ%IZ1;L:+W1VHJB0ZI7FZ>::B(]-1;U?)2)IPNY,O[CWWAX\GA3
MIRS$63P\Z;N,4X]KLJN1,*NTURZJY8E)MGWHE<:"7]V?C()QU"=4EU2DR,]1
M%V#);6L<E=QT7>X)OC)CFWPXBZ[EPBZ:1/OR[:K/,0NUU;55;,RG+IN0]5)0
M2R-]N&LT/&G5)>\4DR/41=AOMK6.7-3<=(W>"+YR8YM\*;8OY>;-T5M^%C%R
M5@ISK>L*[8.?0-/2+AC1>Z.U&42'5*\W3S5*(CTU%O5\E(FG"[DR_N/?:,>3
MPITYIB+)X>=-W&*<>UVU?(>%W15AU=PQ)*X<D,UFPE_=W(2.\?).J2]XD]3U
M$78,EM:QRY^^IN.C;S!K\3'-OAQ;-W+A%TTM^&795YYB%VY5M55LS*<NFWWZ
MI*-WW=N(HT/&G5)>\4DR/7V!%V&^VM8Y<U=QTC=X(OG)CFV,4VQ?_5F[C;\+
M%+DW SF7%>5Y'.90-O/7#/G[H[<9PFG35YO7:M1)/37J+>KY*1-/2Y,W[BWV
MC'?X4Z<TQ%D\/.FZ*Q3RQQ=U;R'A=QZJ]6W#,CUVJ2W5;27]W5!3N?).J2]X
M74]1%V#);6L<N?OL>?HV\P^)XF.;?"TZ^7FZ_1^%V5.>8A>NUK%1;,RW;=EZ
M36I1NU>9BK-IU2=4E[U23(]?8$78;[:UCDKN.D;O;Q?.3'-L8YB+O<FZ*Q\,
M,1/)^ KEV\%-['.70MO/7#6B]T=N,X33IJ\WKM69)/346]7R4B:>ER9YZ#OX
MLQW^%-,TQ%D\/.FZ*QV]L<7=7<B85;)K%5URQ(3<G*35[267?G7HWR-NJ2_@
MT]3U$78,EM:QRY^_R8\W1=[AUZ\<QX6G5R\W7-+?AEW5.=8E>OU\6IM694BT
MCN3:]M&[5V.PX;2UEJDNB5I-/41=AOMK,QR8]QTG=[>V^[)CFV,=T6W>Y=,5
MB/@81<GX"<BXBE>Q_2*!+B[AO1>L=++A,K-7F]=JS))Z:]1;U;)2)IZ7)L?N
M'?Z<=WA33-31R\ZL5CM[N+O@\B859-U;L&X9>;NBEG5J22]'RKD[Y.W5)?P9
M%J>HB<&2*UCE2OO\F/+T7>XIOB_',>%IU\O-U\+?[3OJ\XQ.ZD5\2KM&9,FU
MC+G5[:-VKL9I9MK<+5)="41EU$78;[8F9CDQ;CI6ZP6WW9+)MC'=%MWN73%8
MCX& GE' %+MVTWT<UT)*5;IT7_LY(=)E6[S>NBSV]->HMZMDX</2Y-F>@;^(
MQSX4_IO0Y>=PU=_=Q9$'D3"K)NL>@W+#S=R4M56I)++ORKD[Y.W5)?P9=3U$
M3@R16L<J5]_DQY>B[W%-\7XYB<6G5R\W7Z/]IWU6<8G>2H,*IM694JRB*L8+
M2-VYV(APVE.%JDNA+(T]>HB[#?;$S,<IHQ;CI6ZV]MUV2R;8LNT7>Y=2M/@1
M[?*?'SIVR6[Z.HZ)*EVQ:.?[.E#A,F:O-ZZ+,D]-1?U;)PX<^3:GV?W\>'7%
M=^E]#EYW"O?W<6=69WB-R=059;,R3OBDG4$@EEZ04$]']FJ2]YIUU%+L-]M:
MQZ//WVOGZ1N\'B>)CFWPM.O^KK]&OE6(87)
M
M
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M_DO+M?D>I1P7Q<
M
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M-N?0P^6/D>GN^S=+^EC_ &4ISCK^CN&O\S-OQ90Q9^>7\CY7.ZU]9U'R[/\
M.A9^(/SFXQ_Y2G_CJA@W7H9/I1\CC>TGV;>_\39^8UM#_P!^YV_U4O\ XJ0W
M9Y8?>^1Z_)Z'2_+;^R6;C?\ HKB#_4YM^ &'<<\OY#C];^MZAY=G^<L?#7YV
M\>?\E2O^(K&#=^A?]/[SD>TWV3=_\5;^SAK&J_A></YO)_XHD;UW^J^[L>RW
M'+IGEM_9-@\._P#TD?\ 4Y;^%,:F[_UOY#ROM+_^2\NU^1ZE'!?%P
M
M
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M]=O/^'Q_M$UQ5_OG"'_\8?Z;@Q[GEE_(<[V@]#J?_P"T^2%</]:O-W_+E_\
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M#N_1R?2CY'+]I_L^]_XC'^SA06?SEYX_FMI_Q- VY]##Y8^1Z>[[-TOZ6/\
M92G..OZ.X:_S,V_%E#%GYY?R/E<[K7UG4?+L_P Z%GX@_.;C'_E*?^.J&#=>
MAD^E'R.-[2?9M[_Q-GYC6T/_ '[G;_52_P#BI#=GEA][Y'K\GH=+\MO[)9N-
M_P"BN(/]3FWX 8=QSR_D./UOZWJ'EV?YRQ\-?G;QY_R5*_XBL8-WZ%_T_O.1
M[3?9-W_Q5O[.&L:K^%YP_F\G_BB1O7?ZK[NQ[+<<NF>6W]DV#P[_ /21_P!3
MEOX4QJ;O_6_D/*^TO_Y+R[7Y'J4<%\7
M                                &#;7-510U6%S,:A0TF23>>42$[E'
MH1%KVF9^0@%"<YUP1&]253'&&ST4ZB,KLUTUV&9.::]/>":(JM^.Y?CN5M+<
MHYR)"VM.^8/5#S>O9N;41*(C]G00E.
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M]QYK)QQ;XV2V_G6FFW33EQ0:/#Y#18YQ8E?N[LU:DM.M^C(TC>E22DF9'O\
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M^]QK\39PT7C@
M           %?R_,:;"JI5I;K4HU'LBPV2WR'W#,BVMH[3TU\X^Q)=3 >7LG
MRNWS2S.QN'FUMHW>C1FS,F8[*S\U#9:D9KUZ*<4G7L(]"T(750)+-O1PU&XX
M@B2M"E)[PE)7H1EIH7G$>A:ET4 R*VSF4<]JUJIBX4V/T3*C&C1!&?4ED?FK
M2YYFY)ET_9 >F>.N3(69M*KIR40<HBEI*@DH]KA(Z*=9W$1[3,C\T_.3Y>FA
MG682OPA(
M           "/O+RIQJGFW][+1!IZYE<F9+=/1#;39:F?3J9^0B+J9]"Z@/R
M\Y3Y#S#Q-\J0X%'$=<C.O'78G1D?\$RM6JG7=#VDM9)[QY?8E)::[4$8+\GZ
M'\*<45O#F!P\2A/JES#4<NVFJ4HTOSG4I)Q2$J/1"")))0DB+H6IZJ,S,K+8
M@(
M
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M9^L6:^/#>ADB.RPAI3JW4K+5I*??$DM"/7L,"8>L00
M  _.CQ=>()7(5TKCG#Y)KPVH?TG26#U393VSTZ&7OF6CZ(\BU>?U(D&"T0]"
M>$[P^%Q?0?+#*HI%G]VT7W%PO.KH2]%$P1'V.KZ*>/R=$>0]Q$R])@@
M
M
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MM >3T?D-G_OBB/[!M1:->ROSNFTMPF7O0%0
M
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M
M
M               UYS+D3M'B*X<1PV["W64-E23VJ[LRW.F1EJ9>81EV>43"
M)>:M-I)2T32"U/NTI,M2)OH22TZ%J1]#]DM>NHL@,]B6CT02="4C;J1EWIDD
MB4C0].JNA_7TZ ,_'J*TR*WB4M.PE<B69K-:U*-MIA&I*=49=B$&6WIYW86A
M@/5.'8A6894)K*_5QU9][-F.?PK[YEH:U>0O:270B[!198 &-/@1+2%(KI[2
M7X4IM33[2NI*0LM#(!Y7SW 9F"V10R2Y*H)A_P"QSEJ,]R=%;F%ZJT)PDEVI
M[2+<774BO$JJH1K7JLR)9N;.\(U:)]Z6BE[NFI&70_+NZ]4F Y%T(^A=TA>]
M*B,S41]2,S(]#(DG[XNNNOL=0&Y> LB4W)LL2D/[R42K&&A1]4F2^[?(M.FA
MF:5Z%V&9_LQ*8;U%4@#\Z/'/GJ[_ )*AX7&>W5N+Q4]\VD^GI\TB=<,_;)ON
MB^N"T.CP.8(K(N4I&726=]=BD53C;AJ4G2=-)3+1$1=%:-]\9D9^P!+?/CFP
M-S(>-(680VR5+Q:42Y)DG59PIAI:7U(M?-<[M7L::@B'A+C+,7^/^0,=S%A9
MH*IFM/2-I;E*C*/8^DBZ:[FE+3^R"TOUGS;'*[DKCZXQSO$K@Y%7+;C2.U!&
M\WO8=Z:]$JVK_8!1^.UE7RJFQEU4]LVIT%YR+):/M2ZRLT+3^P9&#(_57PQ9
MT>?<,X[8R'>]LZULZBQ,S(U=]!T;2H]/*MO8O]D&-3_&OFR<9X>=H65D4_*I
M3<!"?+Z,R9/O*_\ F$(_ZP)A^>F 8E-SO-:+$("35(N)C48S3IJAI2M77.OD
M0@E+/VB!:7K?QU7WR?H\'XLI?]FHVF53'8R%&1&U#2F-%0?LDDN\/KY=#\@*
MP\K\48!+Y/Y H\)BN=P5F_I*D=AM164FZ^LM2,MQ-I5M(^U6A M+]9,%X^Q'
MCBC8H,0K&:^&RVA#CJ$I](D*1K]T?=TW.+,S,]5>STT(%&#R5Q5AG*U"]199
M7MOFI)^AV"4DF7%=T/:XTX7G%H9]4Z[5=AD9 /R;Y!PRPX\S2[PJS6EV9325
M1S?06B76]"4VX1=="6A25Z>370%X>I?_ *GTK3),V1J?6#"/;UT/1YWK^QJ"
M):9\4N7RLPYNR9YY9*BU#WJ: E)ZDEB"9I/K_E.&XO\ 9 A<?"'P76<IY)-R
M;*V2D8EC:VB. K79,G.:K0VOV6T)3N<3]EJDCZ&8$R_2&%!A5L5J#71FH<)D
MMK,:.A+32$]NB4((B(OJ$"KSQXIO#_CV>8;:9A0UK47/:9E<Y$F,E+2IS+7G
MO-/Z:$M6PE*;4?G;BTUT,P3$T?FB"[]*^!,D^1OA*C94XI*55-?:S&3>/<@W
M&GWS;(]-.AKT+02QR_-N=-E64V38S75/39;JWY#RSU4MUU1J4HS/M,S/40R/
MTI\,N(\9\7\=UED_:U)9C=QFYUS8.RXQO([U!.)CI4:]4(:2HB41=JM3,2QS
M+=2\VP*4AR,YD50\VO<T\RJ;&6D]2\Y"DFL_(?4C$#\T_%-@&(X'R4?R&?BJ
MQRZC)L68<-Y#S<5Y2U(=:22#/:C5.Y"=>A'H70B!:)7WP(9A*JN2[+$%+,Z_
M(("W2;-1Z%*@GWB5$79J;9N$?[ $J?XR3(^?;_1LF_\ 9X&ID1EN/T5OSCU(
MNI@0VG_]3X3K>YTK<9:1*\MFOFGJX_U,O9+3H!+W>"H          /+G/GBX
M_15F<7"Z"D5/G0GH[^0R)J5LMG$<(EFU%[#4M2#_ (8]4)/IHKKM)B$3A>5T
MN;>,&-E>-RTRZ:WP]#["T*(U$1I1JVZE)GL<0HM%H/J1D">QZY!4 5GD#.\?
MXUQ.QS#)7^YK:]O<3:=.]?>5T;9:29EN6M70OKGH1&8#\R%*Y!\5G,9:?TE9
MJT27G*B554P?[&C;1*]HW'%?NE@OR>L9OB%X.\-]!$XSPIE[))M01M3$UQMD
MVJ7_ -LY)E*\U3JE%YQ-I7M][YI)))%:55NN_P#J@]*Y*)%M@LJ-"-75Z+8-
MR723[/=K89(S_P"N0)H],<:\N8'RU5KL\+LTRE,:%-@.EW,R,:NPG6E=2(].
MBDZI/R&8*M3YSXS>/<"RZWPZTH[F384T@XLA^,B*;*UI(C,T&N0A6G7RI($T
M5_Z?G%WS=O\ ^+A?E0)H?3\XN^;M_P#Q<+\J HOG(GBFPGC>MQ.TMZFTE,9?
M6-W$!,1$<U-,.H;627>\>01*T<+WIF7M@BBA_3\XN^;M_P#Q<+\J!-$KC'C>
MXWRK):?&(5#=LS+J=&K8[SS<0FD.RW4LH4O;)4>TC46NA&"*/38(
M
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M1T/J>I@F&S?_ *GRG6_SE>B-"AP"W'KO+5U[H7M'IU_8 E[Q!4
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M_95RVY#<BLB5[CT=Q*MS;A*92:D&2DZI5TZET ;#!
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MS=\4O,]9Z;@VVWQ7XXFM]^>V:S7ACOB+?BGCWMAC3>4
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MBOYZDLL]8MU<&A55*0\6V%(L*Z4TVY/TZZKE;E*:5NZMI/H0#<0A(
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M+V]G"J8:K4Y<]]J*P2H1$GO'UDA.I]X>A:F!1Z'!
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MK]6]/J'TMG_==><_^E'$/YU'_P!*2)P_;+ON[E^E?^Z=Q]&[^XPGOUN<*?\
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M/O,F/_W-M_U4?LKFO;?\W.$OJRO^+#;L]++]WXKU.V^T=2_)_9-CS?Z7<_\
MED@_@U#3CT?_  I>3Q?51_\ IE_RI!7ZC.6/^8+?\:9%/_,8_HQ\C4C^-[#]
M3B_-N:?R+]6?#G\XN_\ B30Z./ZW+^3\CWNR_B74?)A_92VGD7].9%_\H]%^
M"&AC]&W]7<\7LOJ,/_ YOE2;'ZKN=?\ F:__ /N(I/UN'Z-K3O\ XGTO]1@_
MO-)9)^I+C_\ K.X_"-CJ8_K[_):^B['^-;O]7B^26WL\_.+D7_F7$/P"1SL/
MHV?1O>#Z1]GV?ZC=?G2FHOYF<^?UE<?BA#%/IX?);\KGY/MG2OH8OSV@+/\
M4-0?\QS_ ,5:'7M^T3]&/E?4,'\=R_J+/S[FS\^_W/EC_,P?\$0T<'/'_P"(
M\;TCT]A_^\^5L"O_ -WYZ_SY7_#%#3NYX?N[7ELWI=*\EO[5YR>_]/47_G%[
M_AC8[4?:?R/OOK5O_N"[_AH_:RV9F7YN<D?\M8?_ *;8T<7I6?2O>/Z9]HV?
MZ_=_)+8M+^=/.W\U@_\ "WAIW^AA]_Y7D]U]EZ7]*_\ :VO-S/\ Z>I7_.+/
M_#'!VI^T_D???7+O_<%O_#3^UALK(/Z&R'_Y.:#\*T-''Z5OZRYY#9_78?\
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MMS4B=473HNLF><5\V9BMD=G&D1$MT#F/GH
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M%UT,*H;WPGC:BPM!R&2.;<N;N\L7R3O22R22D,D1>8@]I=.T_*9B*I7(0D
M                                                   >,<_Y(Q?B
MSQA2\IRUUYNJ3CK47=&:-]??/)2:2-)&730CZ@MV+K<^,/P[9#4S:*Z5/FU-
MBRN--B.P'#0XRZG:I)Z*(RZ'VEU+R BCA0>+[PYXO2P<>H#GP::M91&A1&H#
MFU#39:$6IJ,S,^U2E&9J/J9F8%$C]-O@KX79_$%_; 4/IM\%?"[/X@O[8"C2
MG(>><4^(GG7C&!51W9]*MQZ!>M2F5PENI=,E-I[Q"DK,BT/311:>3M!+T%7>
M#_@&NEIEEC*Y2D'JEJ5-ENM:^V@W2)7U%:D"*MSU%-4T%>Q4T<%BMJXR=D>'
M$:0PRVGV$H01$0(9H"IY#QC@&67T')\CH(MC?UB6D0+!])FZTEAU3S9),C+H
ME:E*+VS 6P!4<QXNX^Y D1969X_%N9$)"FHKDI*C4VA9DI1%H9=#,@%9^C9P
M5\Q:S]XO[<$U=T3P[\)093$Z)A-<U+C.(>8=2A>J'&U$I*B\[M(RU JV<"
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M%T:;8TQS[^+2W_4L>;%;@P8_"Q1=-]-4WS-T\*S,TX1'"V*<.-:S*W#7<(
M                             !@SZ6GM",K.OC3"/37TAE#O81D7OB/L
MU,!4YW#W'\XW%)JBB..%U7$<6R9'[)$1[2/]@35%$7^@/CK5.D:432",DM>E
M.;2)2MQ]==W4R]GZ@5*,Z)PMQW%,C75G*4DTFE4AYU1D:-=#\U22[3,_JG]0
M*E%EJ\.Q6E(BJZ:)&41FHEH90:R,R(C\XR-770O*(JE-@
M                                         ,"51TD]XY,ZMBR9!D23
M>>8;<6:4]A;E),]" ='R7QG_ ,&@_%6?M0#Y+XS_ .#0?BK/VH!\E\9_\&@_
M%6?M0#Y+XS_X-!^*L_:@.QC'J",\B1&JH;,AH]S;K<=I"TJ[-2422,C 20
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MDHTD1&9)+1)'I['D"JLW3/.7,0J
M
M
M
M
M
M                                (/,,GAX;C-CDLYM3S$!LEI8;]^ZZ
MXHFVFD]#ZK<4E!?5&7%CG)?%L=KI=-V%^^W-F"R:3?//NB.,S[T1,JS0YMD\
M6_3CG(E9"J9,V"[:5<NOD+D1E-1324B.Z;B4&3S)+2LS3JA1&>A].N>_#9-N
MK',S2:35U]YTO;7X/'V5]V2+;XLOBZV(NK=73=%)GS;J3''SHE%TW*&327:*
M]N:)B%@F52T0*22V^MRQ:7)-11')36S82)&TMNQ9[-Q:B]^VLBML36ZV*SW>
M[3R-W<]!VUL9<.++-VXV]LW7Q2(LG3Z<636M;.VL<:30NN3\F8>O[JAHX]A@
M^)2EPKV0N0MNP>7&)*I:XC>S8:8Y*/=WBBW[3)(6;:R:1=-+KN7=[E?*;7H.
MVNMQ8LV6ZS<;BV+L<:8FR-7H1?-:UO[*1PK%4I?9ODLN]1CO'=;"M9;$!JWL
M9E@^MB*EB2HRCLMFVA:C>>)*E)-6B4I+KV]*68;8MU9)F.-.#2VG2MM9@\;>
MWW8XF^<=L66Q-U;?2NFLQYMM8B:<9EC/<IR+:BQ9W$:Y#^39<J0W @6"U,L1
M3KR5Z:J0M"35M84G9YJ=5&9:"8VT6W7:IX6]WN\J>5FMZ!;ASYXW-],6WTS=
M=9%9NU_5Q;$S2M\37CRCF^)Y4F0<8NY5W4$C,Z&<U3/4<5XEHE3IAM^B&PXL
MB,FGR=0HC4G<DMW0].L^K1-\1$^;=%:^YV_ F?9^S)N<5N+)^@RV3DC)='&V
MRVNO5$?C6:9CA-)FG'BR:?/KBMGVU'R+"B5MG65B\@3*K''9$-ZM94:7C(W4
M(4EQI6A*2?;J1ET%;\%LQ$XYF8F:<>=6'<]'PY<>/+LKKK[+\GA4OB+;HOGT
M>4S%+NR?<XL.@Y&RMZQQ]_*J*-6XUF&J:&3'D*=DQW5LG(8:FH6A*24\VE1I
M[LSVJ+:KVK7X+*7:9K-O/^CR-C>=%VMN/+&WRW7Y=M]9$VTMNBNFZ[',3,TM
MNI75SCC#%F<K9#'*PRQFECKXPJIZJR78&^OUDM++Q1WIC324&V;#;AFG0U;S
M))JZ>2T;:V:6U\^8K[GD\K-B]GMO=HV\Y+O6\EFN+=,:(K;JMLNNK77-ON4B
M9HE,BSC+E9!:T.!4L2V=QN.S*O3G2'(YK<DH4ZU$C;$*(WE-IW;E^86XM1CQ
MX;-,77S,:N7X9:>RZ5M(V]F;>9+L<9KIMQZ;8NI%LTF^^LQYL3PI'&:2N&-7
M\'*L?K<CK=WH5G';DM)7IO23B=30K0S+<D]4JT\I#7R639=-L]C@;[9W[3<7
MX+_2LNF)][M\D\X:Z5ROD!(7F'J>+^BMNQ.J59>DJ]8F@I/H9SB:V[/1R>\W
M;N[S3SM-!N>K6^A6==*T[.^GE>LCV>V]?5O$N];FS7IT^9Z.OPZUKKT\:TTU
MX)+(L]RQ-W=5^%T<:TAXHTT]?N3'W([CSCS7I!1H9(;61N$UHHU+/;JHDBF/
M!9IB;YIJY?AEJ;+I&TG#COW66['=N)F,>FV)B(B=.N^LQYNKA2./"KE9<BV5
MLO':WCN%&GW&0UQWB7+1U<>+$K4D@B6]W25K-:UN$VE*"/16NO0A%N"+=4Y)
MI%LTX=LJX.BX\,9K][==99AO\/S(B;KK^/"VM(I$1JF9[*4=/Z59#N*1IL:H
MUS.5;*Q@J)3VK35PTI9.DX\A)_<4(0I[>2>J=/*8MZM&NE?-IJK[C)_T_;&Z
MNMNR?H+<?C>)3C.*:4I;\Z9G33O<X_)TNFK,I+/(#,*^Q*.U,EMU[BG8LR/*
M2HV%QE.I0K5:TFT:5ET5Y>O2)V\73;HFL7=_9Y5;^@V9\N#U2^;L>XNFV-<4
MNLNM]*+Z5CA$ZN'.'=CV:Y8UD4''>0*F'4R+R*].I78$E<A)'%)*GXLC>E.C
MS:%DLU(\Q1:Z'T$9,-FF;K)F:<Z_*Q[SI>TG;W9MGDNR1BNBV_5;3TJZ;[:3
M/FS,4I/G1PJBJWE3(9)U63S:1ACC>^G(K:R:E]9V37?N&S'DR&5()"675D1:
M)7N22B,]?+DNVUL5MB?/MBL]WDANY_9_;V^)@MRS.ZPV3?=;2-$TC5=9;=6N
MJV/<I-);8'/>(8<6WJIRI"84Z/)5#/;+)EU#ALJZ]'-IGM/H?OA:;9CG#8R;
M;+CIJMNMU<JQ,5\G>Y^L:\H[4LY;/HLA24,/]XCNW%+/1))5KH9F?9H&F:TH
MKX&35-NF:QSBG&/*@,,S>OS3UT<)*&SI[.35FE+R'5.)BJV$_HGWJ'#W;/:+
MM&7-AG'2O;%73ZGTK)L?#U<?$QVW\IBFKCI\L=JT# XP       "HYOEEC0N
M4])CT-F?E>0ON1ZN/*<4S&0B.V;S[[RTDI6QM)%J22W&9D1#8PXHNK-TTMMY
MN[TKIV/<1DRYKILPX8B;YMBMTZII;;;'*MT]_"*35 M\J2J[&\@D9%5)1E^-
M2V:R530GN\;E2IO=^AJCN*(C)M_O4F6].Y/G:ETZYO5HFZW3/FW16ODY_ Z<
M^S]N7<XK<.3]#GMF^+[HI-MME?$U1\ZS3/*:3PI/%E4N>7<"TL*'D6#$K+&)
M6N7S,RM=<D0G*]A6Q\C-U"%)<9,T[BZZD>I"M^&V8B[',S%:<>=6'==(PY,5
MF;9777VW7QBF+XB+HOGT>4S&F[C3NIQ1]#R3E3TW'9V3T<6NQ/,5DU026)*G
M9;#KK2GXR)B%)2G5]M)FGNC/:?10O?M[*71;-;K.?WZ>1M;OH>UMLS68,MU^
M;;17)$VTMNB)TW39-:^9,\=5*QQATV'*N0QCM,GB4C#W&U%.76V,XWE^LG.X
M<)E^4PRE!MJ9:69EH:]RB29EIY)MVULTMF?/F*^YY&3#[/[>[1@NRS&ZRV1?
M;;2-$5C5;9==6NJZ/<I%8A*Y#FV6NY%88]@%1#MGZ&*S-NW)TE<<C5*)2V8L
M?8A6KRT(->Y?F%J6O:,>/#9IBZ^9C5R_"TMETO:1M[,V\R78XRW3;9IMB[T:
M1=?=68\V)FE(\Z>-'3)Y.EW-=BR<"@LS;W+8[DZ*BQ<4U%AQHR4F^N2IE*U:
MI6I+1)0757EZ=9C;Q;-VN:1;W=OD7Q]!LP9,_KETVX]O=%LZ(K=?==Z,65I'
M&(U5GE'E</TJR&L4D39%3IF<>V3C'J(GM&G+AQ22;)#RDE]Q4A9/;S3T1KY2
M$^K1KI7S::J^XM_T_;.ZBV,GZ"<?C>)3C&**UK;\Z)C33O=U=R-95)Y%7<B0
MHU?<X[7E=K76.J?BRZY1++>QWI(62DK;4TI*R+SM-.AB+L$7:9QS6+IIQ[)8
M\_1,>;P;]E==?9FO\/SXI=;?PX74K%)B=43'96O)QQS/,M5=TU=FM)&JXV5-
M.OT+D-]R0XRXRUZ0<:82VT$3IM:J)2/-U29!DPV:9FR:Z>?X83O>D;2,.2_:
MY;LD[>8C)JMB(F)G3KLI,^;JX4GCQJC6^5\@4AK,#IXOZ*WK$JM%F4E7K$D*
MD^AIG*:-)(]'-[S=N[O-/.TT%_5K?0K.NE:=G?3RMR?9[;Q,[;Q+O6XLUZ=/
MF>CK\.M:Z]/&M-->#8F3Y!!Q3'K+([+4X59'<DNI1IO7L+4D)UT+<H]$IU\I
MC3QV3?=%L=KRFPV=^\W%F"STK[HCX>WR1S5#'<WRY&0U=!GU-$J7LCCO2J-4
M&0N1L7&0EUV))WH1H\AM6[<CS#T/3L&QDPV:9NLF9T\_PP[N]Z5M)V]^;9Y+
MLD8;HMR:K8M]*:6WV4F?-F>%)XQ6*HN#RMD$CU?E;]+';XRMYZ:R%8$^OUDV
M3SQQV9CS*D$@F''"(M"5N22B/KY<D[:V*VU\^(K[GD\K=R^SVWMU[>,ET[K'
M9KNMTQHFENJZRVZM==MON4FE&3?\C96S89#)Q:CC66+X<9(OY+\A34J0ZADI
M#[4)"4*2:F&U)-7>&6Y1[4BMFWLI;JFEUW+^GRL6SZ)M;L>*W<9;K,NY^KB+
M:VVQ73;.2:UI?=RT\HXRS;C/KFQL*NCXYA1+*RL:Q&0+E6;KL>&U6O*)#)ZM
M(6I3CRM227DVF9]!6S!;$3=DF8B)IP[VMMNCX<6._+O;KK+;,DXJ61$W3?'I
M<YB*6]O?7@QE\IRY^,T<FBJ"5F5_-=J&*26]L;BS89N>F*?<01F;3!-*49H3
MN46W0BUZ6]6B+YU3YML5K[D\OA9H]G[,>YRVYLGZ##9&2;[8XW6W4T:8G\:_
M5$<9I''CP?6N4Y%50Y0]EM:AG*,16PS/KJ]Q3S,I5@2?0E1UJ22MKZEDCSDZ
MI,CU[!$[:+KK=,^;=W^YS^ N]G[<V?!&VOKBW&J;;KXI-NCZR+HK2MD17A-)
MX49^,Y?E7RE+$L[JXE=:38:[.ID5KZY$9UII:4/,+-U*%$\UO09[=4J(^G9U
MKDQ6:=5DS,5I-6KONF[7U;UG:7W7V6W:+XOMB+HF8K;=%)F--U)]V)A>'WV(
MK+DB2ZAF.TDUNNN*)"$I+J9J4>A$1#5B*O-V677S%ML5F>R&,W<5+L)%DU/C
M+KG#)+<Q+R%,*,U;2(ED>TS,^G;VB=%U:4XLT[;+%^B;+M4=E)K\'-B9'D==
MC5386DQQ!K@0WY_HAN(;==1'2:C))+,NT]$D?9J9"V/'-\Q$=LT9]ELLFZRV
M8[8GS[K;:TF8C5W_ "N6,7L?)L>K+^,24MV,9F2;2'$NDTIU!+4V:D]#-!GM
M/VR#)9-ETV]R-_M+MKN+\-WXETQRI6D\Z>[S2PQM$
M
M
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ME&:E'VF8YFXNF<EU>^7SKKN:_+U#/-]TW3&2^.,UX1=,1'DB.2UC7<0
M
M
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MD@E+Z[4]B4^0A&3).2[5/-BZAO\ )O<TYLD1JNYZ8TQY:1VSVID8G/
M
M
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M,S&$NEM<)N0@G$DHB,]#T5U+4+[9MNF)[$[G!=@RWXKN=ETVS3E6)HS15K@
M
M
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M6W3$<O<[><]JX#6<$
M
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MB2))'VC'ER:[INI2K2ZGO;=YN+LT61CU\9B*TKVSQ[YXIX8G,
M
M
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M/-,Q,[:^+=7Q=M/(R9?9[=X\'C3%O"(NNLU1XEML\KKK.<1R\G;1=AJO.@
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MB6R\DEH41&1&6J3(^HFZV;9I/.$YL-^')=COBEULS$QW3'"62*L(
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MPXKBOOQ8\EM9\V^Z+;IX\Z7VW5M\EW<[<CRZZ5D='52<ZCX572<>9M'9LAF
M:9,UQTD*02II;2T3YVU C'BMTS.C7.JG;R]YCV73<,;?+DMVL[JZW--D6Q.3
MS;8BM?,X\^%9;*PUQ;U P^O)&\L2XIQ2+ME,9#;J26:=J?1")H]AD:>GL=1H
MY?2]'3[G_:\AU.(MSS$89V]*>9.JL</Z_G<>:?&)S
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ME@MDB-U,1]M\T$K70U$VI6FNG345NLNMYQ,,.?9Y\%)RV765Y:K9CY4B*-0
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MST(M"\@:I[R,^2.5T_#+);;;90EMI"6VTEHE"2)*2+VB(58;KIF:SS<@0
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MF?*[A#&
M
M(S(RA*QZU390G;*N.(^4NNCH-YZ0SW:M[3:$F1J4LM4I21]3,7QUU12:35N;
M+7ZQCT719=JMI=,TBV:\+IGLB.<R\^^B\.?X+Y3_ &-(_*!V*Y_\6W^U_0^I
M>)U?_F6W_P ZW_0/1>'/\%\I_L:1^4!7/_BV_P!K^@\3J_\ S';_ .=;_H'H
MO#G^"^4_V-(_* KG_P 6W^U_0>)U?_F.W_SK?]!L7B=K"FY5H>)X/;8BZ;;/
MI+MM!<A)D)U5M2V;CCFXTGJ9]G:-+=3DI&J^+O)-7E/:&[>S;9ZQN<>XBLTB
MR^+M/+G2(I5M :+Q@          *=RCFSW'F%3\L8AIGN0EL)**M9M)5W[R&
MC\XDJTTW:]@V=MA\7)%M:._T#I<=2WMFWF[1%VKC2O*V9^\PIG(<B+EF1XV5
M>A;5'1%>MR.\,E.K/=]R-.WH73WVO[ M&")LMNKSNHV,71;;]KASZYKES>%2
MG+W?Z$]@^1N9=B-/DST=,5VTC(DJCH4:TH-?D)1D6OUABS8_#OFWN<SJNRC9
M[O)@B=48[IBO>P./\S>S2/?/O0TPSIKJ;2H)"S<[Q$+9HX>J4Z&K=[T6SX?#
MF./.(GX6UUCID;&[%$7:O$Q69.5*:J\/>HMXUW!5&XS-ZKS_ !K"TPTNLWT>
M=(<F&LTJ:.$V2R(D:&2MVNG:-BS%JQW7U]&GQN[MNF1EV&;=:J3BFR*4YZII
MS]Q;AKN$@LTR!S%,3N<D:8*2Y5Q'9:8ZE&A*S:2:MIJ(CTU^H,N&S7?%O?+I
M=+V<;S=8\$SIC)=%M>ZK,Q^S5=4-7<K:)E=C#CRU,D>XD&^TEPTD>A:Z;M-=
M!6^W3=,=TL&\P1@SWXHFNBZZVO?2:)$4:@         J-7F3UCR%?X2J(EMB
MFAPY:)A+,U.'+(S-)HTT+;I[(V+L5,<7UYS+N[CIEN/I^+=:JSENOMTTY:?=
M6X:[A*CQYF3V;U-A9/Q$PU0K.96I;0LW"4F(LDDLS,BT,]>P;&?%X<Q%:UB)
M=WK73+=AELLB[5JQV7\J>E')(YID#F*8G<Y(TP4ERKB.RTQU*-"5FTDU;341
M'IK]04PV:[XM[Y:G2]G&\W6/!,Z8R71;7NJK55R1)L<APZD57(;;RBB]>.O$
MZ:C87W:%]TDMI;B\[3=T&>[;Q%MTU]&ZCL;CHEN+;[C+KF? R^'2GI<9BON<
MDIQKF;V>XJUD;\-,%QR1)CG'0LW4D49Y31'N,D]NW7L&/<8O"OTUJTNN=,CI
MVZG!%VN(BV:TIZ5L2S,]R5W#L/N,G9CIENUD<WT1UJ-"5F1D6AJ(C,NWV!7#
MC\2^+>]@Z1L8WN[QX)G3%\TKW(%CD:2]FE7BAUZ$M6&.ED2I7>F:D+-9H[DD
M[>I=/?:_L#-.WCPYNKRNTNG?T2VW9W[C7-;,_A4IV4KJY_$AJ?F*9:8]Q_=J
MJ6VEYI8N5SS)/*449+;CJ-Z3V%N,^[UT,B&2_:Q;=?%?0BK?W/LU9BW&[Q>)
M,^K61?$T]*L6S3GPYEQS%,J\>Y NTU+;J\+L6ZYEDWE)*2EQQI&]1[#VF7>:
MZ$1A9M8NNLBOIQ4VWLU9EW&TQ>),>LV3?,T]&D733GQY+/#S=^3R.O!#A)2P
MFB;O/3>\,U;W)!,=ULVZ::'KNU_8&"<-,6NOXU''R=*MLZ=ZWJX^+./33NMU
M5K]Y]RS-7\;RC$,>;AID-Y/*D177U+-!L%';2X1I21'NUU]D@Q8==EUU?11T
M[I=NZVVXS3=2<%MMU*<ZS3WG+ LT=S/Y2][#3$]07DVC1M6;G>IA;-'3U26T
MU;O>]?JB,^'P]/'TK8GX4=7Z7&Q\&EVKQL5F3E2FJO#WJ<T]D%FJEH;2Y0T3
MRZZ'(EI9,]I+-AI3A),]#TUVZ:Z#%9;JNB.^7,V>",^>S%,TUW6VU[JS1AX7
MD#F5XG39(ZP49RTB-2U1TJ-:4&ZDE;249%KI]06S6:+YM[I9^J;.-GNLF")U
M1CNFVO?1'<>YF]FT"WF/PTPSK+>94I0A9N$M,-22)PS,DZ&K7L%\^+PYB*\X
MB6WUGID;#)CMB[5KQV9.5*:NQ*9A>KQC%;K(VV2DN54)^8F.I6PG#8;->TU$
M1Z:Z>P*8K-=\6]\M/INTC=[K'@F=/B76VU[JS1W8S;+O\;I[UQHF'+2#&FK8
M2K>39R64NFDE:%KINTUT$9+=-TV]TL>^V\;?<9,,37P[[K:]^F9BJ$Y S-["
MX]"^S#3,.YNH5*LEK-ONT3=^KA:)5J:=OO1DP8?$F>/*)GX'1Z/TR-]=EB;M
M/AXK\G*M=-.'OU9N>Y*[AV'W&3LQTRW:R.;Z(ZU&A*S(R+0U$1F7;[ KAQ^)
M?%O>U^D;&-[N\>"9TQ?-*]R&B<@R).:4V*' 0EJUH/7ZI7>&:D+WDCNB3MZE
MU]]K^P,LX(C'-U>5U&_DZ-;;L\FXU\<>;PJ4Y\*U_H9O&.9N\@X169:_$3!=
MGG()45"S=2CN)#C'11DG779KV"FXQ>%DFVM:-?KW3(Z;O;]M%VN+-/&E.=L7
M??6X:[A*=FV:OXG:8I7LPTRDY':MU;CBEF@V4N%KO(B(]QE['0;.'#KBZ:^C
M%7?Z7TNW>8L]\W:?!QS?RYT[%7N.8IE7CW(%VFI;=7A=BW7,LF\I)24N.-(W
MJ/8>TR[S70B,9[-K%UUD5].*NSMO9JS+N-IB\28]9LF^9IZ-(NFG/CR;,E3E
M1ZEZR)!*4U'5()O70C-*#7IJ-&(K-'C\>+5EBRO.ZGQT0_'V4NYKAM1E+\9,
M-VS9-U49"S<2@R6I&A*,B,_>Z]@RY\?AWS;W.AUG81L=YDV\7:HLFE>5>%6'
MR?FS_'V(2<FCPTSW6'H[)1EN&TD_2'4MF>XDJ[-VO8+;;#XM^FM&?H/2[>I;
MN,$W:(F+IK2O**N=?F3TWD2YP=41*&*N!&GHF$LS6M4E1D:31IH1%IVZB+L5
M,47UYS17-TRW'T_'N]7')?=;IIRT]M5N&NX0 A<PO5XQBMUD;;)27*J$_-3'
M4K83AL-FO::B(]-=.W09<5FN^+>^71Z;M(W>ZQX)G3XEUMM>ZLT<L4NEY)B]
M+D+C)1UVT&-.4PE6\FSDM)<-)*,BUTW::Z",MFB^;>Z5>H;6-KNLF&)KX=]U
MM>_3,Q5$\;YD]G>.*O7XB83A3)43N$+-PM(KIMDK4R3VZ#)N,7A7::UX-[K?
M3+>G[CPHNU>;;=6E/2BKYC69O7V8YAB[D-+#6+N06VI*5FI3_IS"GCW)-);=
MNFG:>H9,.FRVZOI5^).^Z9&WV>WW$75G/%_"GHZ+J>_5;E'M2:O8(S^L-=PH
M5+C',W>0<(K,M?B)@NSSD$J*A9NI1W$AQCHHR3KKLU[!L;C%X62;:UH[G7NF
M1TW>W[:+M<6:>-*<[8N^^MPUW"                              !#9-
MEN,X97)M\KM8U/6+=3'3+F.$TT;JR-24[E=-3))@.U&28^YC_P K$6<96,^B
MG/\ 6Q.I]%]$2CO#=[S7;L)):F8#HQ?,,7S6 Y:8E;1KFM:=.,Y*A.$ZTEY*
M4K-!J3TU(EI/3VP$V          *]:YUB-+D%5BEE;QV<FNE&BLJ25OE.Z)4
MHU=V@C-*-$*\]>B>FFNH"P@        *]<9UB-#>U6+VMO'8R.[7W=75;M\I
MX]#/=W:",TH\T_/5HGIIKJ R\ERC'L.J'[[*+*/4T\;3O9<I9-H(S[$EKU4H
M_L4IU,_(0#+J[.%=5D*XK7.^KK!AJ7$>T4G>R^@G$*T41&6J3(]#+4!E@
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M9_,+R'2,S%*;BKG/)92XI!$:B2:CZZ$9:@)]"TN(2X@R4A1$I*B[#(^I& Y
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MS4?4D$9]1T(Q1BNRVQV6O<8NF6=.S=1V]DS=;9@YSSXVVW=GE1&6_F%SM_S
MQ^'BC)B^LP_1_"W^G?;NE_J;OS;VV9N8SW,NL\!..SZL9Q-5R4KSN_[Y3G<;
M.W;MTZ]FNHY\8HT1?VZJ/#8NF8XVEF\K.N=QX=.RE-5>^JI<;YC/QW">(Z.)
M'9=C9(J3$EN.[M[:&>\<(V]ID6IG^ZU&QN,47Y,DS^*[O6^FX]SO>H9;IF)P
MZ;HIVUI'%$\IYC/RWC+/&9T=EA./Y0W31C9W:N,QI3.U:]QGYQ[NNG09-MBB
MS+93\:VOQ-[H'3,>SZEM9LF9\;;SDFO9-UMW"/<69ZR>IN7.1;B.A+DBOQ:-
M+:;<U)"EL)<<22M.NAFGKH,,6ZL-D=]SCVX(S])V>*Z:1?N+K9]^D).JY1MY
MT[BZ*[#C)3G4.;*L5)[S5A42(F0DF=5=AFK0]VO08[MM;$9)KZ$Q\K2W'0,.
M.S?71==_LEUEMO+CJOFWSOZ*(YSF&^1A]AD10(?I43*CQMMH^][M48GTM=X?
MG:[]%>SI[7D%_5;=<6UGT=3<M]FL$[NS#KNI=M_&[*ZM,S3ER^-RS[,9]G'Y
M9PUZ.RB!18^E^-(1N[YQ4V(M:B7J>W0C+IH08,41.._MNN^25>D=,QXKMAN8
MF=67-28[(TWQ$4=N"9C/KT\686U'977W&,-RY$A6[OD+B1&C22-#VZ'KUU(1
MFQ1/B7]L7??4ZMTW'DG?;J9G5CSS;$=GG7W<U5P',9^&<:T+T".S(5<9D[3/
MD_NT0S,E/;EHVF7G%M+37H,^?%&3+->RROQ.WU?IF/?=1RQ?,QX>UC)%.V;;
M+>$^YQ2#.0RL3RCG7)(+3;\NL14266GMW=J4B$OHK:9'I]0Q6<<7V8;9[:_*
MU;ME;O-MTO!?,Q%_BQ,QS].%QA<AVLS-,<Q=R)'3#N\<]>R'DFOO4/F>FQ&I
MZ;/JEJ-:<$1CNNKRNHX&7HV*S9YMQ%UVK%G\*(X4F.^?=8/AM_4SCGU9WX_(
M%NH?7W>]\D-GVX_C&;\C]G:VL-!X@                              %
M+Y:P.-R7QUD&%ODGOK**HH+J^QJ:U]TCKU\A)<2G=I]CJ0#P&QR_9Q/#),X8
M6M99@5_ZE17=?2DU3BCE+21=NOI"38-/[E6@+]KT99\@0?"IQWA'%5%2JR7D
MFSCI653'49$N5)6??.K-"5K7O?4IME"4ZJ).FI;05YK3PCXCG>2,FL^/LSQU
MW$N0*Q"GCKG36:'FVS3O(B=2A:%I)25;3UW)\XCT F'=Q;X@9_(CW);3]"U
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MYF1BF"R&%I<9=F2UM.(,E)4A3#1D9&7:1D!#V)7?T?$_U+?^B0*LD
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M8.J]2R=0W-VXR1$77TKIY<(BWMF>[O6 87*
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M3[Y+227K_P!;4%7E[Q*N1N.^<N*>8Y!FU7-J>JK=Y!=4LM;CU/V34W)=(O\
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M\+IGLB.<R\^?_FJ_P,RG^Q%_RX['Z;_&M_M?T/J?_P!T_P"9[?\ SH_T3_\
M-5_@9E/]B+_EP_3?XUO]K^@_^Z?\SV_^='^B?_FJ_P #,I_L1?\ +A^F_P :
MW^U_0?\ W3_F>W_SH_T6QN)RQ'TFT/&<!ML,<[MKTAZV@*@IDIU5M2V9N+W&
MGJ9^QJ-+<ZZ1JOB_R35Y/VB];TV>/NL>YBLTBR_7IY<^$4JV@-%XP
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M;#M\N"VFC-IU</F36*=W%.#$YH
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M(I-L_1BCQ_M+N,66S'HOP7TF?JL<XY[/2KS]QMD<]X<
M
M
M
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MF^+J\NZ(H]$#COE(
M
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MV+%9PNNFM([.^/*[>XZ;TW;:;,N7+KFRRZ=..V8\^V+J5F^._N;,&B\>
M
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MDK2E:3U2HB,C[.ACBOD<Q2:/H(
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MWKW:GJ.5U"[),6ZXB/?J^9^W6;>Y,>'UG%;BBMU--^JO+W(H]%CC/DX
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MKU41?LA22VRZZ*Q$S1VB%
M
M
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MRZO:I7O)3FY1*22B/748<>:_)JMOFL3$SY)CBY73^J;GJ'CX=S?.6R['DO\
M.FNB^RV;[;K?F\8I2VD4FE%!K)<O&\5S"OE.J>Q_-&LK57&K4RC7$)V8TY'U
M).A)D,-$ZWJKWZ%D7:-NZ(OOMF.=FCX)IQ]Z7I\^.S=;K;WVQ3)MIVVK^MBO
MC',7>6R^[3/#E=;W-G7UU+Q[A,K.N4;=@BDB,0W4GH;;\IIJ.VLO\Q3A*_8&
MC99%^>D\JR\;M-K9N>M>'?QM\6Z;O=BV9NF/?B**5FU1"H[?**>O03<.!QA)
MBL%[#;3SZ2UT[3/3J-G#=-UMLSVY'HNE[F_<8L&6_C=?O[;I\LVVK+Q954B9
M$24QQN>,3&8"%MWCC4)/>J4E"%)2IA:G-5DHU><79KKU&'<W74F->KCRXN1U
M_<9M-UL[SQ[9O^KB;^'.?QHB.'+Y%8YPR6M3DC<-ZWCUT_$*P\BJ6WGMAR+D
MWTJ8:V?9GW+#J=/_ +,D9]GCG36E8NG3/D_[9^)V/938Y/5INC'=?;N<GA7T
MCT<6F=5U>SSKK9_(EVY?<3)&?U/(&+F[(358JU>'!;(M9M5(E_[2R>IEYY,J
M[UK_ .R(+H(Q61&.;+NVZGDFG!3INVLMV&39YZ1XFXG'JG\3)%GF7>35&F[^
MK,LQBF7F2,XM,7E-KN85[#O\4GH5JRJ0FIAN-D9D:=6WVU&TX1]-JNI=!6;_
M  ]$7<IMF+O[4_(U[MU&QG;8]Q;.B[#?BRV]NGQLD3^59/G6^['NLNFICY)Q
MC(N0+5CT>=D]>J+CK"U)6Y70(NJXYDI)%HXN2GTE1D?[@OL16^_P;[;(Y6SQ
M]V?^S@P[K=?NO<X=GCFMN"_5DGLR7W<+N'S8L\R/RN]L;"KIW),0H;]_0I%G
M7Q9;Y)+1).O-)4LB+V"49C2S6:+YM[I>2ZIM8VN[RX8Y67W6QY(F:?$G1B<T
M
M
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MMU.YW&3-/"<EUUW]J:I08VD
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M<X^Y0/'LEY[RC/KF2]CV*6[,>(AU9NICQD*D(:CQVM221K4:4)(M-RC+<?E
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M;T22CZ BC>#;C;S:'F5I<:<22VW$&2DJ2HM2,C+H9&0(<@
M      %>SUN"[@^2M6<A<2N75S4RY32.]<:9-A9+6E&I;C2G4R+7J,V"OB6T
MYUAU>D3?&]PSCB+KO$LI$\(F=44B9[*O#OJ#A7Y]6W]D'_+CU&O/\R/A?H_U
MSK/^ZX_\W_X3U!PK\^K;^R#_ )<->?YD?">N=9_W7'_F_P#PGJ#A7Y]6W]D'
M_+AKS_,CX3USK/\ NN/_ #?_ (6^/#-7X-!L<B/$+^9=.K9C%*1,A'#)M)+<
MVFD]Z]VIZCE=0NR3%NNV(]^KYG[=9M[DQX?6<5N**W4TWZJ\O<BCT6.,^3@
M   #4608[R13<F6&;X975UM%M:V/ =9FR51ELJCK,SZ$1ZZ].O\ ^A]&S)BN
MQ19?,Q2:O=[/>].S]-LVNZOOQSCONNK;;JK6&3Z^Y^^:-'_:*_M171M_G7?
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M]T]JT# XP
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MVKR-5YL
M                                          !H_([7.N3.4;OC;$,B
M<Q#&,,CP7LFMH33;MG+FVC:GV(["G24EMM+9;UK(MV[S>PP2S/T(Y;_C#E_\
M;"_)P*GZ$<M_QAR_^,A?DX%3]".6_P",.7_QD+\G J?H1RW_ !AR_P#C(7Y.
M!4_0CEO^,.7_ ,9"_)P*NJ1PIGS;"W*GF7)VK))&J*Y,3"E1B<+WO>,]RC>G
M7M3N("JQ<+YS>9MC5DSE;#3.7XM;3,;OU1=2C/3(&PS>9(^I(<0XA6GLZ^0"
M6QP0    ^:$9D9EU+L, ,B/M+73J7U0 R(]-2UTZEK[(#Z9$?:  &A:ZZ=>S
M4 T+77R^R  !$1%H70B["   !\T+7=IU[-?+H ^Z%KKIU/M,!\T(C,R+J?:8
M#[H6NOE]D  -"UU\OL@ #X1$786FO4_J@&A:F>G4^TP#0M=VG7LU\N@#Z ^:
M$1F9%U/M,!]  'S0M3/3J?:8#[H6NNG4^TP !1N6>-F.5\3+#YUF]6U;TR-*
ML.X0E:I#$5?>=P>XRVDI1)5N+LV@+NA"&T);;22&T$24I26A$1="(B(!R  #
M0M==.I]I@/FA&9&9=2[# #(C[2UTZE]4!] -"UUTZ]FH#YH1F1F74NPP'T
M                    163,.2L<MXS49V8Z]#D-HB1WBBO.J4THB0AXS(FU
M*["6?O3ZC)CFET>5N["^+-QCNF8MB+K>,QJB./.;?QHCN[7G+Y#7O^'N1?\
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MLE^.ZR:71,3[KN$,8
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M>%\O\C4?)UVJ/C]4_ @XS7Q8BW32E2%KD.K-E"E'IN;W&M7M)("CTU7SX=K
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MV+O"R5CC27@K<W[OW\W61%_A7W1;JXQPK%L^]Z4>["L<:PJAW*,BO<*B-5^
M.,QJZ(F(A+4.=80UNE(EL(21)V))2&.\26CBD&>IZ:C/N)NT6VWS6[GY(GL^
M^[/7,N:-MAQ;JZ;]Q$W7SJFMUEET6Z;+I[YXWZ9XVQ,<JMH#1>,
M
M                           :2XN_7]SK_KL7_P"%+!+=H(:@R?\ ]1V
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M1F6I:J(C^J1>P0#T]P8M2^&< 4H]Q_)^L+7VDQ6R+ZV@(E?P0
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M[B
M                                      -)<7?K^YU_UV+_ /"E@ENT
M$-/Y09)\1N &HR(BQ^^ZF>G_ &D0$MN]ZU^[3]<@0P+MQLZ6Q(EIU.*_Y2^]
MJ :\\-7ZB<&_JY/X18)EM4$-,^'_ /WWES_Y0;C\!$!,MS @ <7&T.H4TZDE
MMK(TK0HB-*DF6AD9'VD8#&K*JKI8;==3PF*^O:W&U$B-(892:C-2MJ&R2DM3
M,S/0@&#3XEBN/2I4V@HZ^KFSCUFR(,1F,Z\>NOW132$FKKUZ@.3>*8NU>KRA
MJD@(R5Q!MKN$Q62FJ09:&DWR3O,M.GO@'&7B.*3[F/D<ZCKY.01-/1;5Z(RY
M,:V]FQY2#6G3R:* 9B*>H;M'+Q$",FZ=:*.[9)9;*4IDC(R;4Z1;S21D1[==
M 'R'24U?,EV,"NBQ;"P,E3Y;##;3TA2==#=6E)*69:G[XS 8A8AB:;T\I*BK
MRR8T[#N2B,^G;3+33O\ 9O[.GO@'RRP[$KJ<5I<4-=861,JBE,EQ&'W_ $=?
MOF][B#5L/RIUT 2L:-&A1F8<-E$>)'0EIB.RDFVVVT%M2E"4D1$DB+0B(!!H
MP/!V[!BV;QFJ1:Q7ERHTY,&.F0V^YU6XAPD;B6KRJ(]3 57-N-;/,^3,"RN1
M-81B^&+ESG*TTK.1(L'VR0RLE>])+1I2HO+V^ST);+!#"CT]1$L)5M%KXS%K
M.)*9LYIEM$A\FRT23CB2)2]I=FX^@#"<P[$7:R52NT%<NGFNG)F5ZH;!QGGS
M,E&XXT:-JEZI(]RBUZ$ XW>%X?DI1RR+'ZVV*)H44I\-B5W1)["1WJ%;2^H
MS)E%26-85)/K8LJF(FTE7/L-N1=K)DILNZ4DT:(-*33TZ:%H S666H[2&([:
M6F&DDAMI!$E"4I+0B21="(B\@#6O+7%"^4+#"7')S4.NQBY;NIK3K/I!R4L%
MJE@DJ,DZ+,MJS5KT\A]@)7.+A^)0:9W'(5#71\>?4I;]2U$81#6I9DI1J92@
MD&9F1&>J00R4T%$B7'GHJXB9T2/Z%%E%':)UJ+]Y0O;JEO\ R"/0!5KKB7$+
MBRQ*<B*FMBX=8.6U;65[3,>(N6XC:2G$);^Q5YY;=/.[0%V?89DLN1I+:7H[
MR5-O,N)):%H66BDJ2>I&1D>AD8"-1BV,-LU\9NE@(CU#AO5328K)(B.F>XUL
M)).C:M>NJ-# 9,RGJ;&3#FV$"/+F5ZS=@2'V4.NQW%:$:FE*(S09Z%J:= &
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MA%(,T_="(CZ;]0&=$B18$9F%!8;C0XZ$M1X[*$MM-MH+1*4)21$DB+L(@'<
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MUW"
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MDUS;,:M6FV)F*\:5X<>#8@\\]D
M                        "NY^B Y@N3-VKKC%8JJFIFO,))QU#!QU[U(2
M9D2E$G4R(S&;!7Q+:<ZPZW1YR1OL,XXB;_$LTQ/")G5%*SW/#'JG@[YR9!_9
ML?\ *!ZG5N/FV_#_ $/TEZQUO_!P_P"9=_H'JG@[YR9!_9L?\H#5N/FV_#_0
M>L=;_P '#_F7?Z)ZIX.^<F0?V;'_ "@-6X^;;\/]!ZQUO_!P_P"9=_HM]^&*
M'@<6QR,\-L[&P=4S%]+38Q6XR4));FTT&VXYJ9GKKKH.3U&<DQ;KB(\CYC[=
MY-]?CP^LV6616ZFBZ;NR*UK$/1PXSY*     *#E?$6.99?'DKLZTJK=QA$60
M_4S%1.^:;,S23FB5:Z:C;Q;JZRW32)CW8>HZ?[1[C9X/ BW'DLB=41DLU4F>
M=$1^@:D^=65?VNY]H,GKMWS;?@;W_5V;_ V_^5'X5TPS#*;!*;U)2=\IA;SD
MI]^4X;S[S[QD:W'%F1:J/0B[/(-;+FNRW5EY[J?5,W4,WBY:5I%L1;%(B(Y1
M$+",+E-?<O-3[B@@X75F:)N53V*];^PW4,0VM94EQ:2-.Y/=M&@T[BW;M-1N
M;68MNF^?Q8K]Z'J?9N['ASW;K)Z.WLFZE:5NGS;(CW=5U:TFE&MLWJ<MHF,_
MK+J2BX/+Z [)B7"BKB-%-J31'<:)KO'_ #UL+:5NW==G9T&[ANLNT3'#3=3W
MI_I>NZ5N-IN+MIDQ1./U?-HF+KHNG3DK=$ZJ6\(OBZ*4X:ELM,GI^3K;$Z3#
ME2)S-5;QKJWL3B2(\6-'KT+4E"EOH;U<=<-"$I3N/3<9Z$0U[<=V&VZ;^%8I
M''O<3;[#-TK%GR[G39.3'=CLMU6W773?,<:6S/"V*S,S3LHJ6/YG6M\3S^.H
M3$N;G<_UU7L4S4.1J3MC-E$VMQU39-);2AU+BU*<T).OE&Q?BGQHR32+8TS6
MO=$.YO.F9)ZK9O;IMMV]G@WS?-]O*RRRL1%=4W3-NF(IS;DE2)&"X.PN/!?N
MG*.'%8<BQ-._=:8)MIU:"/M-*"4YM[5::%U,<V(C)DYTK+Y_CLMZAO9B;HQ1
MENNFMW*)FLQ$^6:17LK54.,EU3V79-,PE;LC!9K,:4_,?[Y:7+Q:G"?[EV06
M]229)K>G4TH5T+3J0V-Q71;%_I1\CO==C+;M,-NZI&XMFZV(C3PQ<-.J+>$3
MJU4GG,<9JVL-!XD
M                                                  !#9+B6+YC
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MQC=O%M'J>0<*S1%=2ZJ/(3KJA9$?3L/KV'H?L&/,/=)L
M                                          1U_P!T5%9]]7G;,^BO
M=Y5)2E:I2>[/5DDK\TS<+S=#Z=1>STHXT]UM[.OCV4O\.=4>?\WCZ7#NYM%Z
MXU_@#*_L^".KY_\ C1\,OI/^T_\ -;?[=[[KC/\ @#*_L^"'G_XT?#)_M/\
MS6W_ #+S7&?\ 97]GP0\_P#QH^&3_:?^:V_YEZ^\8G5^DV/J[CM[!SV-=X\[
M'8CE)ZJT27<]3V=O7V1J;BM(K?K>8Z]XNFS7NXW7&>$777:>7SN]L<:3R0
M         #J](CFSZ3WJ/1R(S-[<6S0NT]VN@FDKZ+JZ:37N<8\R',)1Q)#;
MY(T)9M+2O37LUVF>@3$QS3?BOL]*)CRPXMV$!Y[T=F4RY(Z_<D.)4OS>WS2/
M7H)TSW+78<EL:IMF([Z,D587%*T*4I*5$:D'HLB/4R,RUT/V.A@F8F'($
M
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MK:DC6HTH1HDMQZ%U'">K6@
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M1C/N^5DTI%/OR[/M1$S9MKHQSBL\.;;;9B8I%N2^(K_6FVEUWNS5M@<]X<
M
M
M
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MQT^H=7S[W'BLR3,^%;,<;IFLS=,ZIKV\:>2(6@8'%
M
M
M                                              $?>FDJ2Q-=?ZV0
M49[=5$2%'*+NSU9T7YI]Y[W173KU%[/2CC3W6UM/KK*7^'YT>?\ -X^EPX\.
M?!I+O:W_   5\4K?M1TZ3_C?'+Z+IR?\U_[V4[VM_P  %?%*W[4*3_C?')IR
M?\U_[V4[VM_P 5\4K?M0I/\ C?')IR?\U_[V5>N-5QE2+ H_'1X/YC>Y\V8K
M/I/56B?]G(C/9V]?9&KN*TCS]?PO-]<BZ+;-6\]:XSPK?.G^UWMAC3>4
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MP9+[Y[=5FCR4\Z:U]Y91@<<
M
M             %*?Y?XQC966#OY57MY6;I1_5BGB[PGU=C1J]Z3A]FPU;M>F
MFH"Z@(7),NQO$6(DC([)FO1826H$!+I^>_+?/1MIM!$:E*/V"+VSZ ,2CY P
M_)<AN\5H[5J9D&.+2W<PD$LE,*7T(M5))*M#(TJV&>A]#T,!90
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M]OL^77VAH;N_5$>=J_)TO&>U&[G-9CCQ_'I,_P"H\&G+M_&K\3< YSP0
M      -?<O-3[B@@X75F:)N53V*];^PW4,0VM94EQ:2-.Y/=M&@T[BW;M-1N
M;68MNF^?Q8K]Z'J?9N['ASW;K)Z.WLFZE:5NGS;(CW=5U:TFE&MLWJ<MHF,_
MK+J2BX/+Z [)B7"BKB-%-J31'<:)KO'_ #UL+:5NW==G9T&[ANLNT3'#3=3W
MI_I>NZ5N-IN+MIDQ1./U?-HF+KHNG3DK=$ZJ6\(OBZ*4X:ELM,GI^3K;$Z3#
ME2)S-5;QKJWL3B2(\6-'KT+4E"EOH;U<=<-"$I3N/3<9Z$0U[<=V&VZ;^%8I
M''O<3;[#-TK%GR[G39.3'=CLMU6W773?,<:6S/"V*S,S3LHJ6/YG6M\3S^.H
M3$N;G<_UU7L4S4.1J3MC-E$VMQU39-);2AU+BU*<T).OE&Q?BGQHR32+8TS6
MO=$.YO.F9)ZK9O;IMMV]G@WS?-]O*RRRL1%=4W3-NF(IS;3RBIAUG%[E)9U<
MC(J^!!BQ9M?#6IN1(8C&TEQ2#2:5'M2DW-I'JHBVEU,:&.Z;LM8G3,S+Q>PW
M%^7J<9<=\8;K[[KK;KN,6S=6E>SG-*\HYJ]QJB@?S6\L>/&4Q^/W*Z&T^4=E
M<>&[<H<=-2V4+2DMR6#0EXT%VZ;O.(QFW&J,<1D]*L^6G_;R=3KDY[=EBLWL
MUW,7WS%9B;HQ4BD73'9-U9MKV5IP;9'/>'
M
M                       $3E$]^JQFYM(O^\P8,J2SKU+O&65+3^V0#P_5
M<;XE9>"^QSV9"8>S9]V3<JR%1$J>4EBR-DD]^>J]%(2:33KIJHS]]U!/:V/-
MY YGR;,N/<)PO)XM"628#"R*PE3H34U2)CJ7#==3N2:C6>U)$1^:74]#,2A1
M\BY"O^3.*>%LERA;;M^G/8T*9(9032751G5I2O8G1)&:=N[;TU["+L!*YS^1
MLFH[WQ'S*;T*#88LQ7OU4UB!%1(-QQ"]5/K[O5XR(NG>[M 0R^..3>7H7(F
M5W(610;F@Y#QYZ[:B182(IP38AG*+1:$DI:C2GS]3VZF>A=" 4.H\5>9.V-5
MGLW+*AW'K.Z]72>-$1THGPZEUU3:91R=NY3J2(E&6_:?0^P]")>Y1"
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MKKKJ.5U&<M+=<1[SYG[=7]0G'A];MQVQ6[3X<W3V16NJ(>C!QGR8
M   !U>D1S9])[U'HY$9F]N+9H7:>[70325]%U=-)KW.,>9#F$HXDAM\D:$LV
MEI7IKV:[3/0)B8YIOQ7V>E$QY8<6[" \]Z.S*9<D=?N2'$J7YO;YI'KT$Z9[
MEKL.2V-4VS$=]&2*L+JCRHTM!NQ7D/MDHT&MI1+22DGH9:I,^I'VD)F)CFO?
MCNLFET3$^Z[1"@
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MZ'UW:>8 ]2"
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MCPK,<&T!HO&@
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M  &/'GP9;\F-%DM/R(:B;EM-K2M;*U%N)+A$9FDS(]=#\@#(
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MU#J6//CMPX<?@XK9F[3JFZ9NNI$S-T^Y$1$4X1WS*V#7<,
M
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MT]0&'E/B@M*J7RS IJ^#*DX6JI9Q<E=XHYKL]]N*_P!Z27"W;''-4$WMZ%U
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M:9@/2WAW(BX/P/3I_P#"(_[9&(0V:
M
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ME1MJ[EI:SU<624F7DUU\@@>B@
M
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M?8
M
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M-9#5Y;C]9D]*X;U3;QFIL-Q1;5&T^@EIW)\BBUT47D,!*
M
M
M             \XW6:\)8].SK&IUE<1YV03G/7IM-JW-267%;O1UDCHG=KIK
MKJ0O&.Z[L^1]9VO2^M;FS:Y[+,4VX;(\.LQQMF/QHKS^!#9%GO >31*6#-O,
MA9:HXB8$547O&UN-I))$IT]A[U^;VB?"O^;\CH;+H_7MK?DOMQ89G+=JG52:
M3QY<>$<7V SQ[68E=<H<<V-M:3\7-"4Q;QQ3L);D@TM&3C1I0:R)#AF6BBT5
MH8KIFNF8I[T(S7=0R[O'L-[9CQVY^W'$1=$6\>%W&G&/@JUS#N^1;SB[-[%M
M$%>)S;!M^Y6XI92677'6EI1&0:S)+>Y2-"T/0M1LS;99?$15ZW)M.G;?JFVL
MF;_&MLF+*4TS$1=%;YIZ5*M@Y%Q=C;%?2XWC5M<?I%R" S-IV)$Q10#)"2<?
MWK)&B=&TN;2U[="\HUK+N-9BL>2'E=EU[<79,F?/CQ>K8;YMOF+(U]UM(KQX
MS%??57$>',@J^2ZG"LXFO1HUS'E3E>JYADM1LMK,E*5H9:FI/74AGR9+;HX0
M[?4O:;;YNFY-UM+8NG%=;;Y]G?,?>9O(&"<:/<>7N88G.MYMA13VJIP[-W>E
M+O>MI<225((S+1?0R/M%<-UT71'9/D:_1NK=2MZABVVXMQVVY;)O\R.RDT[?
M<;3P=2<_Y#I.2<:43N*T]0J@FNOZL/E-0DW#)+2BZHVNH\[7V?8&&8FV-,QQ
M>*ZK$].Z?DV.?AFR9/%MIQC1RY]_FSP_"VCA668]F-9)L<:2M,*-+=AO$XR<
M<_2&B2I>B3(M??%U]P12CQG5.G;C99+;,]-5UL71QU<)K3Y%D!R4;D58NZQ^
MVIFUDTY8PY$1#BNI)4^TILC/ZFX!Y,H49;E5%Q-PHYB5M5WV"WL"RRNSF15(
MK6(E&IPTJ9DZ['#D$I/=[?;[2ZB1N+@ZKM*[(N6G;&#(AM3LPER82Y#2VDOL
M*9:(G&C41$M!F712>@"5YU5BCN%E6YMBEGE>-SY*&9C=-&5*D02)*C3+T;4E
MQ)(/IN1J?7L,M2$#035+R3:<1UUXY77EW68%GD+(L5@V[6F03<:K2VDDV^BE
M*+O%&C<6XTD>A:;1*5\Y.S;).4.*;6=B>-9)744.UKBLDFPJ#:6=(E9*G%#:
M2KO2VZ;3_=)(^TMQ$0UI18G"2CF5?'N'7]-B5IA'HU#'M8TWOI4C:\2BCE*4
MXX9*5[Q&[7RD6AD V;1T5XWG_ $IRKEHC5>(2XUF\IAPD17U5T=!-OJTT;6:
MDFG:K0]0%H\3L"SF\9MR*R!(LE5=S564N-";-^1Z+%E)6ZI#:>JMI=>GU>P(
M$=8O3LKYMXDS*!3V4>D747JWW)D1QA4;OVD$TF01D9-*7IYJ5GJ8#3T[CW))
M?&#%K)H;>0SCO(=K<6M3 )Z);/5$AQ;:WX>FQ:E$2DJ1L]\6O70!NO@+'L'9
M=O\ *L1I<FK5V!L0W9^6*D=[.9CI-2%L%)<6O8@U*1JHB]H!@\RMY#A/).+\
MQT]3)N:F'5V&/W;4%E<M^,4G[M$D&PV9+6T3Q:.[3U2GVS(!J>K@99G?#7./
M(=G1OQ,PS-Z)#5CK$>0J2UZH:9;))-K03AFKO%*VD1Z%Y0&QZ#%IG''-^+W5
M'1.,8KGF.HJ[XH4/:Q"MJY"76GG^Z21-=XG1KSM-5:F?9T"Y^(O&;_)N-'DX
MS"59W-185]RQ6-_PLE-?(2ZMIO\ RC1N-)=IZ:%U,!1^0\BO.>N*LK@X=B-S
M ?IW:V?6'=1O03L7XCZ)+\=EM2C7N02#3KIHI70C 83*KSG;D&3DU5CMGCV/
M5>'V=#Z1?1E0G';>W3M-A"%]5)9+WZRZ:EIY2U"I8G:7]RO@O#G<.OX%E@5G
MZ)DLN57NH@,+8C.,)T?T-*MY)WZET(O+U(!&QN.,<JLBR7 N1<4S2UL+6_DR
M:I>/NRE4TVJGR"=0^LD.H90;1&9O$KLT+M/L#VHB#%3!36J:2["2T4<V72)Q
M*FB3LVJ)6NI&7;J($;\CL1_\ K?B;'V@#/ELH;K'X\=LDMH86VTTV6A$1(,D
MI2DOK$1 /(.+T.4X?QCP/GLO';.2W@DRY3D5,Q%<.R9B6[C[/?\ HZB)9DWH
ME1EIKHHC[.HE+G=8EFF<8?RUR75X[.C+R*[H[7'Z":T;%A*@8V;9*<)GJI)N
MIW*0G3<>WIKJ6I#/:RM/(W+V>V]32VU>F1Q?)BPX=I#7%ER%G)49*:9/51I-
M2N[3^Z4D]-2T,!)X3CN0QLC\-KLBIFM-5&.6[%LXN.ZE,-URO;2A$@S27=J4
MHMI$O0S,!L'PY5=I58[E[5K"D077\PO)+")32V5.,.O)-#B261&:%%[U1=#"
M1K;.)%[@6;\T5[V+W-U'Y.J(YXO+IH3DUM4EBN=A.LO*1T0:5+WGK]@6OE(@
M%;N\'?KZSA_+\OI,B>Q>%AS%!>(QTY,>TKIB$MNM*>;8-#QMJ,U(4G[$RZ]=
M",)_*<2K:K@2ML\(Q;(84#Y60,HM:BV0[)NR0U)2AY]31K<6>]+:%Z:ZZ'JK
M3J RN7'&,NS;$LASC&<HMN()]"X==1U<>8U,;R)R22FSEL17&W$*4P1=UN46
MBO\ K *UQ_BF30\-X3BOT%E$=K<WL),Z-)C/=]$C*<D;5R-4ZI3H9>>KH?L@
M+3%K85=2\RM9YA-OD>,7>:O;Z^##<=D*AN-M&4UE.J%J;;4C<3C)ZD?8 MWA
MF3D;-7DT1[URKCR/8(3@B\F;4U9^A&WJ\DR<T6;*5Z$T:O)K]0@UKS;0.6?)
M6:)SS&LDR:++IXR.*T4*)CD2/*3&<3*-PHSB$)<[XR4HW-2[O74C+0@$[QOC
MV01,LX'>E5,QABLPR=%LG78[J$1GU--$EMXU)(FUF9=$JT,!7^2</K,=YBS2
M[S6@RVWH<O8@RL?D8>N7M7)BQO1GH<E$5:"WJ,B-LW.FW7V3 >H,"H:K&<,H
MZ*DAR:^JAQ&TQ8,Y6Z4PA9;^[>/57GI-6BNI]1 L0
M
M
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M5FXRA!F>GEZ*+J*Z9MX2^6]8Z;N-AG\/<4US&KA->$S*U XH
M                   #X9:D9=FO34NT!1L#XKI,$GVEXBPL;[)[G8BQOKN1
MZ7-6RR9FVRDTI0A#:->B4(+V]=" 7H
M
M
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MQHEE(<0E,=;TIGOR2RHE&:MB3+?JDM#/RB!90
M
M
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M1":2HT%YJ"[DM#_RM2Z /3@@
M
M
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MALT,*)QA)H3HA9:D2DEIT,M3ZD [@
M
M
M
M
M
M
M
M
M
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M<5N_2;EM*W([3K#T=,IMHS):XZG4I)PDZ'J1==",]-",P*-G @
M
M
M
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MTJVQMI;E+A\:G./,8:0R1S(KLIHDD9FE!^<]_"><I.NI@2]Y J
M
M
M                                                           -
M$7ZLIY<Y6R3CROR:PQ+"L&CUZKEVB=*+:6%A:M');2F3M4;;+;:=%$DM34?7
M7IM)2/T=87^)/(/_ )D?^T J?1UA?XD\@_\ F1_[0"I]'6%_B3R#_P"9'_M
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M&6)#VIZGWCC:"4KKUZF F0
M
M
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MKN222/WQ;3/;VZ==- %U
M
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MU)LVFD(E.H5/F(-*W2+<HC2VVG0S[$I]@![S!4
M
M
M&DN+OU_<Z_Z[%_\ A2P2W:"&E\UL*^L\0V R[.6Q"BIH+U)O274,HW*=B$1;
MEF1:G[ );+^6N&_.*L^.Q_MP0PKG,L/<J+!M&0UAK7&>2DO38_4S;,B^S 53
MPU?J)P;^KD_A%@F6U00TSX?_ /?>7/\ Y0;C\!$!,MS @  &OHW!O$\/-5<A
MQL6B-Y<IU4GTXC<V%(69J-Y+!K[DG3,]W>$WNUZZZ]035CY+P!P_F&02\HR/
M%8TZ[G-DU,D*<?;2[HDDDM3;;B4=X1%H3FW?[8%5B/CS##LI=P=0T=E.JBQZ
M4_N<U75%V1S+=H2?;(MWM@A+4%#48O30L>H8J85-7-)CPHJ#4I+;2>Q)&LU*
M/]DP%?K.*^/Z?,;3/JVC98RRZ:6Q9SR4ZHGFW32IS5I2S:(UFE)K4E!&KR^4
M!A8=PGQ9@%Y+R3$,9C5=U,)2')3:G7#0A>AJ2REQ:TM)/3J31)+]@$U99<3\
M>%5MTI43/JQJW^4;<?>]H5MN-?I&N_7=J?9KM\FF@(6N?!B6<&36SVB?@S&G
M(\IE6I$MIU)H6D]-#T,C,@%</C3!CJL<I#IFCJL2DL3\=C&MTTQ)437N7$GO
MU4:=Q^_,P'#/N,,$Y0KV*S.J9JVC15F[%4I;C+S2E:;N[>86VXDE:%N(E:*T
M+7L <7>*^/'\)3QR[CT16%(+1NHVJ)I)[S<WI41[R7N,U=X2MVIF>H#OP7CG
M"N-*I=+A%0U4U[KG?/H;4XZXXYIIN<<>4M:CTZ%N5T 2%QB>.W]G37-O 1*L
M\?>7*IY"E+)4=YU&Q:DDE1$>J>GG$8"84DE$:5$1I,M#(^I&1@->8QP3Q)AN
M3.YAC.*Q*_(7-VR4@W5)9-9&E7<-+6IMG4C,C[I">AZ=@)J[<HX1XJS/)XN9
M9/C$6QR*+LVRW#<2EWNB(D=^TA:6WMI$1%WJ%=.G8!5+YSQUA7)52BCS>G:M
MJYI??,(<4MIQIS33<VZRI#B#T/0]JBU\H(2.,8MCV&4D7',6KVJNDAD91X;!
M&24[C-2C,S,S4I1GJI2C,S/M 8.<<?8;R13^H<VJ6K:K2X3S;;IK;6VZ1&DE
MMN-*0M"M#,M4J+H C8G#_&<'"G..XV-0RPYY7>/5BDJ<2X[J1]ZMQ:C<4X6U
M.CAKW%H77H ZL*X8XRX\@V%?B&/,US-JVIBQ<[QY]]YE1&1MJ>?<6YMZGYI*
MT!-4% \,O!=7/BV<##H[,Z$\W)BO$_+,T.LJ):%:*>,CT,B/J0%6V00AJ/%,
M=QJ1;2Z*O;A2;V8NSMG&]VLB8X1$IQ6XST,].PM"UZ]IF K".#^*49O^D9&+
MQ"S W3D^GZN;/23/<;_<;^Y[W=YW>=WNW===>H)JL]QB>.W]G37-O 1*L\?>
M7*IY"E+)4=YU&Q:DDE1$>J>GG$8(5[..&N,^2+"/:YMCS-O81&?18[[CK[:D
MLDM2]OW)Q!&6Y1GU]D"J<P_"\8P&E;QW$*Y%72M.+>1$;4XXDG'3W+/5U2U=
M3]L!&(X_C1.2'.1JF:N#(LH!5V15J4)4Q8>CF7HCZSU(TNL$:D$KKN0>WIIU
M",J^">(Z7+U9W5XI#C90:U/)EI[PVVWE&9FXVP:S90O4_?(;(P35SS+@[BGD
M"]CY+E^,QK*[C)2A,I2WFC<2CWJ7DM.(2Z1=A=Z2NG3L JD<VXLX^Y%J(M'F
M-#'L:V!_N#9;XZXY:$G1EQA3:T),DD1I2HB/0M2Z$"'6]Q'QK(PQOCU[&82L
M.9\YFKV&24.:F9N)<(^\)PS,]7"7O/4^H#&Q_B3%,#Q6WQSC"*WB4JT9<0FV
M90J9);D*0I+;RE25K4[W1JW(0M>TOV3!*;P7#*?CW$ZO#Z)*BKJMGNR<</5U
MYU1FMUYP_*MQ:E+5[9].@(=]CA^-6V14^66-<W(R*@2^BHGJ-1+CIEH[MTDD
M1DD]R>GG$>GDT 84/CG":^IR&CA4[+-5E;TN3D$9*G-LIZP1W<A2CW:IWIZ:
M(,B+R: (S)>&>,LOHJ/&LBQYF;2XTEMNDC*<>;]&;:0ELD)6VXE9H-*$DI*E
M&2M"UUT JEG^/L-DSLALGZEI<W*X::S(734Y_M<-MI3"6ED2M"(FU&GS2(]
M'"NXZPNIGTEI7U+;$_&X!U%(\2W3.- 41$;224LR,M"[5:G[8#$C<3\>0Z2D
MQR+1,MTF.6*+NDADM[9&L6W%NI>29KU,R4XL]%&:>O8 N8
M
M
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M:5[$J7MUTUT(!,
M
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MM$");5!
M
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M(9;9LJZ++-JLG'':-EE<I@DZN&VD_,+?M(R(]-02KM5X:N.:C*XV31G+1R#
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M-F*J2LG'C2:U+/<HDI(SU4?D($+
M
M
M
M
M
M
M
M
M
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M8!*\LNI?9;>1KL<22TZ]#T46I:@AS
M
M
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MD[(DF2EHCR8\Q,9"="+S3;V*^JH".;WE"0MN'';<+:M#2$J+V#))$9 J[P
M
M
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MKQ/Q!97QY1>&B;@KU7%JK$CFYD\HSKS@M.N.(T422;5L->[5#AJ424D2=QF
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M+:Y,9*B<)IU22-:"6716T]2U\H(9
M
M
M #0V4\EYIR-E,_C+@UQF,56HV,LY DH[Z'7+[#CQ$=CTGH9'Y$G^RI)*QX;X
M>>.,5D'<V4)669@\9.3,ER-7K&:X]IU4GOMR&_:V)UTZ&9@5;40A#:$H;22$
M)+1*4EH1$7D(B!"+O\7QO*H:J_)JB';PE$9&Q.8;D(+7V"<2>A^V0#25IPKE
M7%;SV4>'JQ<8:2HWY_'=D\I^GFIU-2RC*=5NCNG]B>[0ST+5*>ADU;)XMY2H
MN5*)VSK6G:ZXKW3AW]!,+9-KYJ-24TZDR(]-2/8O0MVA]BB4DB%Z
M     41/$^-'RFYR[(7(?R?T%%;$;4LDQH[*4J2HTH21&I2R69&:U&1>0B 7
ML  47#N*,9PK*\JS6N5(?R'+I)R;)^0LC0A&XU)::0DDD24F?:>JC]D!>@ !
MBV=; N:Z746L=$NLGLN19D5TMS;K#R30M"B\I*29D8#C555;15D2FIXK<*K@
MM(CPXC*=K;339;4I21>0B 9@                       -?Y-Q/3Y7R1BO
M(]I.E*DXBV\FMJ4]WZ&IY\E$;R]4FO<6J3+11=4)!+8 (
M
M
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MLTJ,E>7S2&P\GY8XVPNWCT.5Y17U%O)1WS466\EM1-GKHI9GT01Z'M-9EKY
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MUF\R:)703R932DFZS.D,[EI=2E*22HU$LM"+3H>@$MF @
M
M               %9SS/\6XUQ]>3YA,5!I4.MQU/H:=D'WCQF22V,I6KKI[
M#5OTR/#Y\YGO[-G_ ,@":'TR/#Y\YGO[-G_R %#Z9'A\^<SW]FS_ .0 H?3(
M\/GSF>_LV?\ R %#Z9'A\^<SW]FS_P"0 HRJOQ;<$7-G"J*_(G79]@^U$BMG
M7SD$IY]9-H+<IDB+51EU,P*-W @
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MARQ+&L=XGQ:THZJ/76%[35DNXD,(VKE/E&2?>.&9GJ9FM1_LF");9!
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M$7M)+;>A$K;[XR\I$1@B6W 0T1XIOS?X^_Y[H?\ I?!,-[@@
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MIJ [(UI639$B)#FL2)<0]LIAIU#CC2M3+1:4F9I/4C[0&6
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MMW:::] &2 QH=A L4NKKY3,M##JXSZF'$NDA]H]%MJ-)GHI)]%)/J0#)
M                     8-92U-,4LJF$S#]/DNSYW<()!O2Y&AN/.:>^6K0
MM5'[ #.  &B?%G^K"#_S#3_C) F&]@0B\DR*GQ&AL<FOY*8=-5L+DS)"_L4(
M+70B[34H_-2DNJE&1%U,!XF:EY)2\AT/BZS&@BQ,*R:Q]!7 -DU2ZVJD,IC0
MK)T^OW124[C61=4Z$7\(DB+/=;;C;S:'6EDXTX1*0M)DI*DJ+4C(RZ&1D"KD
M T1XIOS?X^_Y[H?^E\$PWN"
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MLEYM@5#F=E 34O7,-$\X1.]\EII[539]X:4:ZHVJ]Z7:"'G^9XPK,GYN5U.
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MULA,7N7W.\;DZH)9K9W)2>U)&DM?.29]BNAD08G-W,T+AZDKGVZQV]R>^E%
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M]@!B13(\D\6O7_\ !DG\'* ;/X@IY^2>#)JAJ=5V=E07D.&A/:MYU^8A"/\
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M]"(M3 :*\4WYO\??\]T/_2^"8;W!
M                          BF\9QQF99V#51"1/ND);N)*8[1.S$(2:$I
MD+).KA$DS21+UZ ,FJJ:JBKV*FD@QZVKC$:8T*&TAAALE*-1DAMLB26IF9]"
M[0$=\B<-]3R\=^3U;Z@GNG)G5?H;'HC[ZE)6;CC.S8I9J0E6Y1:ZD7L )1^N
MKY->Y4R(K+M6\RJ*[!6VE4=<=2=AM*;,MIH-/FFG333H C5X=B3D2K@+H:]4
M&C=0_2QCB,FU">:ZH7'3LT:4GR&C0R <BQ+%RR,\P*GAEE1L>BG<]PWZ8;'[
MCO=-VFG3M[.G8 P)W&W'UGD#>5V.+U<K)&C)2+1Z&RN3N3[U1K-)F:D_8J/J
M7D 2<[&<<L[6%>651"F75;KZNL9$=IV3'U/4^Z=4DU(_ZID ^P<:QVKLYUW6
MU,.'<V9D=E81X[34F2:>SOG$I)2]/\HS ==3B>+4,Z=9T=) K;*S4;EE,AQ6
M8[TE9J-9J>6VDE+/<I2M5&?4P'V/BF,1+.?<Q:6"S;VJ>[LY[<9I$B4CIYKS
MA)W.%T+HHS 15)QAQSC5PN_Q[%*JKNG-VL^)#99>+O-25M4A)&G=KYVW34!+
MQL9QR%=R\DAU$*/D4]!-3K9J.TB8^VG;HEQY*26HBV)Z*/R%[ ",=XWX_?R1
M&8/8Q6+RE"B<3;JB,G*)U/8YWFW7>7D7[[VP$G-QG'+&WA7]A40I5[7$::^S
M?CM.2HY'KJ33JDFM':?O3 =!87AZ7+=XJ"N)Z_2;=ZX41G=.0HC(TR3V:ND>
MX^B]>T!GU-14T->Q4T<&/6U48E%'@PVD,,-DI1K,D-MD22U49F>A=I@(-/&O
M'R<D/,4XO5EE)K[X[<H;/I7>_?.\VZ[_ /+]][8#5V2<&3<P\0K7(=_%KIF!
M1J0JM^MG(*2N6\XE\C(FE)-*4H-Q*MRCUU+S2\I$U;II*&DQJL8I<>KX]74Q
MB,F(4-I##*-3U/1""(M3/J9^4$(BCXWX_P 9MG[['L8K*NYD[N^GPXC++QDO
MJHB4A)&1*^R(NWR@)-C&<<BWDG)XU1"9R28V3$NW;CM)FO-))!$AQXD[U)(F
MT=#5]B7L .&2XGC.95WJG*ZB)<UI+)U,:<RA]"7$ZD2TDLCVJ(C,M2Z@,.RX
M^P6YHXV-6N-ULO'X221"K7HC*H["4]")I!IT1I_DZ .V%@^&UV.O8C H*^-B
M\A*T2*=J,TB(XETM%[VB3M4:M.IF6I@.PL-Q(L;+#BHX/R42WW!4IQFCA=WK
MNT[DT[??>=V=O7M <\;Q/&<.K_5.*5$2FK=QN*C064,(4XKM4HD$6Y1Z=I]0
M$?5\;\?TE\[E%/C%9!R)_<;EG&B,M2#-PM%F2TI(R-6OG&7OO* DTXSCB;U6
M4)J(19*MKT==P4=HIILZ$6PW]N_;H1=-V@# ;X]P)FFE8ZSB]2W03G2DS:M,
M&.41]])I,G'&21L4HC0GSE%KT+V %5_0AC:N5ZSE9<I_TRCKDU-'2(2RW7PX
MZ&EM))I"4$9:$XX9%KH6[IV$":KPK%L95?)RI5/"5DR&^Y1<G&:.<EK::=A/
MFG>2=#,M-P(?)F+8S8W,3(Y]-"E9!7IV0;5Z,TY,81JH]K;RDFM)>>KHE7E/
MV0'U&+8RW?.94W304Y.ZWW+MRF,T4Y31)).Q3^WO#+1)%IN[" =&0X5AV7*C
MKRK'ZZ\5$)915641B6;1.:;R1WR%;=VTM=.W0!FTU#1X["36X_6Q:JN29J3$
M@L-QF24?0SV-)2G7I[ "OS^*.+[2;(LK/"J*982W%/2I<BMB.O.NN'N4M:U-
MF:E&9ZF9F LE54U=%7L5-+"8KJN,1IC0HC2&&&TF9J,D-MD24D9F9]" 9@
M
M                                IO)_&U+RMBYXI>RYD*$<EF8F36N(
M9DI=C*-2#2IQMPBZG^Y :V^BY%/J?*O(>O\ 7R?R<$U/HN1/\5.0O[=3^3@5
M/HN1/\5.0O[=3^3@5/HN1/\ %3D+^W4_DX%3Z+D3_%3D+^W4_DX%7QOPJ8^N
MPK)UMGN:7:*F;'LXL*UM6Y<7TF*LEH4;:X_U2U+0]#/J!5OP$
M
M
M
M
M
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MKX1*2WW\EQ+2-[A[4I(U&6JE&>A%VF*S,1S6MMFZ:0SA94
M
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MB2ZZ956:REPI>TTFB0Y%-MQ"D*-*O>*+J1&7U#&MERQ?1N8<,XXFKWD.FXP
M
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M(M'H5F1]T;GM-+2:B]O3V"&MD\VZ+O>;F'SK+K??;K&RTP
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M,-Q'&#:3,Q<]8C><P
M                                      :VY_JY%QPWF$.*DUO)@^DD
ME):F:8CB)"M"_P ULQAS16R6QMYIDA;<,N(N08C17<%1+BSX$:0V9>0G&DF9
M'[9'T/VQ>R:Q$L62*73"<%U&K.?RTP$]/AL?_H6+6>E'W=CZY_*K^,S^JO\
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M?-+4_(6O.+)=2K;MSXK:Q;#V -]RP
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M/!=UWRWD^1U\CZ?Y)GVEM,8;(FZ[5/O-G+=%ENB/?;J&RTP
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MWAU\*G(W%')\',LCD5#E5'C2F'$P7WG7]S[1H3HE;#9::GU\X*R4CLA[,$
M
M
M
M
M                            A<KRW'L'HY&2Y3-*OHXAMIDS%-N.I;-Y
M:6T;B:2M1$:E$6NGE :Y^E-P#\]HO\1+_D 31?,+SW$N1*MR[PRR3:U+3RHJ
MY:&W6D=\A*5*27>H09Z$I.IET!#KG\CX)5M7SUC?PXS6,+CM9 MQS0H2YAD3
M"7?8-PU$2?9 ?<0Y%P;/CF%AE]#NSK^[]-*&X3G==_N[O=[&[8K3Z@ ]R+@\
M>NO;9Z^B(K<9D*A7\E3FB(<E"DI-MWV%:J(M/9 8UGRKQQ37E;C5KDT")>VR
M6EU\%UXDN.)D?P1^PGO/L-^F[R (RRYWX=I[*73V>:5<6S@/N1)D5U\DK:?9
M4:%H47D-*B,C]@$T2]CR;@%2Q;2;/(846/12FJ^X==<VIBRGR(VVW#/L-1&"
M$JWE6..V\^A19QSMZN.W-L8AK(EL1GB,T.KUZ$DR(SUU 1>(<F8!GSTR/AN0
MPKJ17F7I;41TEK01GH2M#T,T&9:$LM4^V XY9RAQ[@LR/7YAD<*EFRV^^CLS
M'2;4MK=LW%KY-2T 9T/.,/L+1VF@W<.19,P6[=;#;J5:USNFR2E1>:IH]2\]
M)F74!WTN58[D= C*:.R9G8ZZEUQNR95JPI$=2D.*)1Z=$J0HC^H C5\E8$WB
M+>>KR&$G#73)+=T;I>C*4;IL;25[/>$:-/9(!)6F58Y26-146]G'AV=\XMBF
MBO+)+DIQHB4I+9'VF1*3]<O9 =-AFV)U5E.I[&XC1K.LK7+V?%<7M<9JV3-*
MY*R\C:3+0U )*JM*Z\K8EQ4243*N>TB3#E-'N;=9=22D+2?E(R/4!]L[.NI:
M^3;6\IJ#60FU/RYDA:6F6FD%JI2U*,B(B(!4J_F+BZUQRPRVORNO?QVI6VW9
MSR>(D1E/+)MLG241*3O4HDHU+SO(!1E95RCQY@[\"+EN20:B19EOA-2G20I;
M9GIOTZ[4:]-ZM$^V DUYAB[=^WBR[:,60O0CM&:[O"[Y<$E&GODEY4:I/J7L
M ,F@R"ERFHC7^.SFK*FF$I46;'5O:<)"S0K:?M*29'[9 (K+^1<&P$X99G?0
MZ0[#O/0BF.$WWO<[>\V^SMWIU^J Z[ODWC['*>OR&[R2!#HK8]*RQ6^E4>1Y
MN_[FXG4E="UZ (F1SGQ!$KX-M)S*L:K;(WDP9*GB)#QQ5$ATDGI]B:B(P31)
M1^4^.I5/7Y!'R6 NEM9R:FNG$\7=/SU&9$P@S[5]#!#+S#/\,X_B1YV9W<6E
MC2W.YC*E+VFXLBU,D)+51Z%[XR+0O* [V<TQ.3:UM'&N(K]K<0SLZJ,TX3BI
M,(NO?M&G4E(TZD9'U 9&.Y+0Y=4LWN,V#-I3R%+2Q-C*WM+4TLVUD1^7123(
M!Q8RG').1RL0CV<=S)X4=$V75)61R&XSAD27%)_<F9E]<O9(!%N\F\?LP+>S
M=R*$B!03?5=S(-TML6:;A-=R[^Y5O,D_5 =3_*W&\7)SPN5E%='RI+B6#JGI
M"&G^^<22DHT69%N42BVIUU/7H L-W=U.-U4J\O9C<"H@H[V7,?/:VVC4BU4?
MU3 5RIY9XUOJFSO:;*:Z;54K9O6TEA]*RC-$1GO=(O.2D]#T,RT/0!@1.<^(
M)\*PL8>95CT&J;;>L7T/D:&&WG4L(4L].A*<6E'U3($T?8?.7$-A#L;"%F58
M_"J6D2+)]#Y&EAIUU+"%+/3H1N+2CZID!1/S\[PZLG3*VPNHL:?7UJKV;'<<
M(EM5:%;525%][(^AJ!".HN6>-,FAV<^@RJNL(M,PN9:K8D)4<>,VDU*=<3[X
MD$1'JK30!(0L]PRQ<H&H-W$D.92V^]CR6W",YK<1'>/&S^Z[M/57L ,3+>3^
M/L$EQX.8Y%"I9DMLWX[,QTFU+;2K::B+V->@#G3\E8'D#M0Q2Y!#G.WZ9+E,
MAES<<I, S3(-OV>[,CW ,&;S%Q=75$:_G957QZ:7(>A1IJW=&G),4]'6TGIV
MH/M!-%@QG*\<S.J3>8K9L6U0M:VD3(JM[9K;/12=?9(P0@\=Y<XQRRW]08YE
M=;8W6BS3 9D)-]7=Z[]B3T-6W0S/;KTZ]@#(3R?Q\K+SP%.1P3S$M2.G)XN_
MWDG>:/8W[?.V:[M/( A8W/G#,V:U71<WJG9K[I1V64R"W+=4K:E)>V9]"!-'
M=3\Y<17]I$I:7,:R=;3G"8AQ&7B4XXXKL2DM.TP*).BY/X]R?()N*X_DD&QR
M&OW^EU\=XENI[I6U>GD5L/HK89[?*"':QR/@DG&)F:1[^&YBM>M;4VV2Z1QV
MG&E$A25*\ADI1%IY=2T[0$M)OZ6)1+R>3.::Q]N+Z>Y8J5HP439WG>FK]SM\
M[7V $/B?)6 9T<E&(9' N7(227+:B/I6XV@^Q2D:[B3_ )6F@#KQKE'CS,9%
ME$Q;)8%K)J"4NP;BO)6;;:3T-S_*01]-Z=4^V PJ?FGB?("F^ILPJYAUT5VP
MFI;D(W-1(Z36Z\:3T/8A):J,NSR@4==-S?Q)D,]%729A63K%QMUY$9E\C6;<
M=I3SJB+_ "6T*6?M$8)HS[/E7CJEQB#F=IDD*+C%F9%76+CGW.0:M=";(B-2
MC\T]2)/33J"&8[R!A++%#*<OH11<H=1'QY\GDJ;FO.Z;$,J+4E&>I$7M].T!
M(5.1T5\_91:>>S-D4\E4"T;95N./*01*4TOV%$1D B+'DS *EFYD660PXK&/
M/LQ+MQUS:421)T[I#OL&K7H EHV34$R\D8U%L67KZ+&:G2("%:NHC/F:6W#+
M]RHRZ& K61<S\5XE;R*#),MKJRZB$@Y,&0\276^]0EU&Y/DU0I*B]HP31(Q^
M2,#EHGN1L@ANMU=<U=V"T.$:6:V0SZ0U)49=.[4WYY'[ (1UUS/Q5COJ_P!>
M9;70/6L)FUK>^>)/?P9.O=/HZ=4+VGM/V@3195Y+0MX[\K5V#!8SZ(5EZTWE
MZ/Z$IOO2>W?N#0>[7V 0J]9S9Q-=-6+]5E];+:J8JK"R4T\2NXB-J2A3J^GO
M24I)']4@31/P\TQ2PG5=;!MXTB==PO6M2PVLE*DP/-/OV].AH\XNH(1M1RKQ
MQ?7%G04V30)MQ3H<=L8C+R5+:;8/1U7L*)!]%FDSV^4!-TN2T&143.34MBQ-
MQ^0VMYFQ;67<*;:-25JW'H1$DTJ(]>S0!#XKR?Q[FZ;!6)Y)!M4U7G6)QWB/
MN4=?/5NT\SH?G^]Z=H##I^9.+,@B6TZFRRNFQ:)I4FV<:>(^X81T4ZHCT,VR
M_=IU3[8%'76\V<37$>QEU>7ULJ-41_3;)QIXE$Q&)9([Q?3WNY22^J9 FB;Q
M//,,SN._*PZ]A7;,51(DG">2ZII2M=I+21ZIUT/34NOD!#"RSE+CO!)S-;F&
M20::?(:](8CRW>[6MG<:-Y%[&Y)E^P RX6?X78V$&J@WD1^QLZU-Y7QD.$;C
M]8LS),A!>5!Z'U]H!PIN1<'R&36PZ2^B3I5Q%=L*MIES<<B*PX;+CC?LDE:3
M2?MD BYW-'%597QK6PRVNC5TQ^3$B27'MK;K\%24OH0>G4VS4DE?5($T2=9R
M/@ERJB357\.6K)RE'CY-.;O32KS,I/<_NNZVGN]C0$&8<CX)@'H?RSOX=*=@
MHT0TRW"0IPTZ;C)):GM3J6Y7O2UZF Z,FY3XZPTX)91DT"K*S:])KU2'DDE]
MGI]T;46I&GSBZ@.J]Y<XRQEFND7N5UL*-;L^E5;ZY"3;DL%H7>-K3J2D]>TC
M HL=-?4^14\:_HIC=A33&S>BS(Y[VW$$9EJG3MZD9 -8J\4O :3-*\UC)6D]
M%)5'F)41EVD9&QJ1@FBQ87S5QAR);.4F%Y W;VC+"I;K#+,A.QA"DH-:E.-)
M21;EI+M\H%%]!
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MN\PR4FY]QO+1QEO:?H\4]=#+NTJ-2R\BUJ+L(@1,M[@@
M
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MGU!"1Q# ,6P1R[<QB&</Y06#MO9([Q:T*EOZ;U(2HS)"3TZ)3H1>0!"V?"^
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M93!16Y% :L8#<AB8AA\MR2?BN)=:7Y.J5)+ZI=#U(S($)0
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M5$3![D?="62ST/V5"MN>^V_7$\6##UO=XMW.[MNIENK6:1V\^%*?$89QMA^
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MO?\ 7/5_\6/[%G^BVT.>\,
M
M
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MH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X
M?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[
M@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^
M?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?
MWY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#
M)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*AS
MX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J
M'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N '
MRH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X
M ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G
M[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]
M^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R
M?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^
M#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*A
MSX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\
MJ'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N
M'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^
MX ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?
MG[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G
M]^?N 'RH<^#)_?G[@!\J'/@R?WY^X ?*ASX,G]^?N 'RH<^#)_?G[@!\J'/@
MR?WY^X ?*ASX,G]^?N )>JL%6+"WE-DV:5[-"/7R$?\ [1"6<
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M1^,Z;+[MAMBVE*D1I7<IV-.KB.FWWR$]B27IU(NFXCT E?@
M
M!:<8_P!R=_UI_P"BD!-B$@                       //OC1_4'<_SRO\
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M,!]
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MVT]"1W1D:=I>0M.GD <6(-?&@IJHT*.S4H;-E->VRVF*32NU'=$G9H?E+3J
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M4A1&1E[1D (CQFHY0VH[2(1(-DHB6T$QW1]#1W>FW:?[G30!TUM95TL8H=+
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MQ.$UMV$HCZ[M-1 SC,S,S/J9]I@
M                                        "TXQ_N3O^M/_ $4@)L0D
M                       !!Y=AV-9Y2.XYEM>BSI7EMNNQ'%+0DUM*):#U
M;4E70R]D!KOZ+/ /S)B_Q\O^7!-3Z+/ /S)B_P ?+_EP*GT6> ?F3%_CY?\
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M4M9\'3]=7N@'J6L^#I^NKW0#U+6?!T_75[H!ZEK/@Z?KJ]T ]2UGP=/UU>Z
M>I:SX.GZZO= /4M9\'3]=7N@'J6L^#I^NKW0#U+6?!T_75[H!ZEK/@Z?KJ]T
M ]2UGP=/UU>Z >I:SX.GZZO= /4M9\'3]=7N@'J6L^#I^NKW0#U+6?!T_75[
MH!ZEK/@Z?KJ]T!DQXL>(@T1T$VA1[C(M3Z]GE =P
M
M
M
M                  A,PRFLPC&+3+;DG55=1'7*EICI)QTVT=NU)FDC/]D@
M%.XDYUPGFD[<L.1.1ZE]'],]/82QKZ7WNS9M<7K_  2M031LP$
M
M
M
M                   #67B)_4=GG]42/^@@3#S;_P#4]/\ Z8?_ -"/_?03
M+V^"H
M
M
M                                #QMXCOI-_I.D_HL^4'R2]#B]UZLU
M]%[_ &'WFW3RZ]H+11HS+?I>?)BV^6/RF^2OHR_6_IFOH_HNGG]Y_DZ=H)X*
M9Q%^G+2X_0SZWV_[-ZZ]3ZZ:_=>X[W3_ .V;?V0);,__ .X?_P"KO_F@1P?H
M[$[WT1CO]>^[M'>;NW=M+77V]05=P
M
M
M                                                        -9>(
MG]1V>?U1(_Z"!,/-O_U/3_Z8?_T(_P#?03+V^"H
M
M
M
M        @\RQ6MSC%K7$;A;S=9<1UQ)2XRDH>)MSM-"E)41']5)@*7Q!P/A?
M"9W!XC(L'_7?HWIGK%YM[3T3O=FSNVFM/X56NNOD!-6T 0
M
M
M
M
M
M
M
M
M
M
M
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MCU2>FA^0P0LP
M                          A\MN7<=Q6\R!AI+[]37RY[3#AFE"UQ6%ND
ME1D1F1&:=#,@&I>/N6^1K:EC9[R)346-\92*TK1=TU8J=>;0ZE*F24THNAJW
M;=NN[7IV] 2NC'-O%,C%$YPUE4,\5.4FO58F:TH1+66XFG$J22T*T\[1:2Z=
M>P"BQXGE^.9S2,9)BD]%G225.(8F-I6A*E,K-M9$3B4JZ*29=@(38  T]S_S
M>GA2MQZ6U 192;FP[AZ.M2DFW 81ODO)V$9F:-R/:Z]03$+CF/*?'O'Y5RLQ
MR"+4E;;O5W?&I7>I01&I1=VE6B2W%YQZ)Z]H(1=SSMQ'CT.EL+G*HL2'D+)2
MJ=Y27E)?8-6WO/-;/:G7IN7H0)HQI/*#=1G-_$O;6CCX%44<:Y3):?><M$=^
MXE'>NH2DV^X42O--&I^][=Q[0DJ/F?BS)*ZZMZ3*8,JMQU!.W4HEJ0B.VHC-
M*U&XE.J3VF1&G4C/H74$447D'Q-X31\=-YQA%K!NRDV;51&[\I#;1.[FUR-R
M-B%ZM,K[S3IVE]0R:-RT5Y4Y+40[ZBE(G4]@V3\.6WKL<;5V*+<1']<@0HW.
MO*2^(>/I.6Q8:+&T5)C0:V ZI2$//R%]4ZHU5T;2XOI[ )A 9CSW!QC&N-<M
M-,5F@S>3$]8SY;BR;A0GXOI+JBV%J:T^]+7R^0"BTSN;>*:W$H&<S<IAMXM:
M.*8KY_W17?.H,R4A+24&YN2:3WEL\WRZ 45+*O$;B6/\AX1BK=E!5C^3PG+&
M;;.&\:FF7VB57]V24[?]H6?:K7I[':!1=?TP\9EFOZ.E9'%3F>_N?52N\2KO
M33N)OO#03>\R[$;]Q^P"**O1<X4E726-MRA?T-:EN]L*>N=JG9#[!MP22LFW
MC6C4I"2,]Z2+3WNG4]H)HV/B^58]FM'%R3%K!JSI)A*./,9UVJV*-"B,E$2D
MF2B,C)1$9 A,
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MV5&1)623Z*-/E[00W,"
M                                !6>16)$KC[+(T-I;\MZFL6V&&DFM
MQQQ<5PDI2DM3-1F>A$0#RZGA%K&_#A56N*XS-7DT]S'KS-:(S?=ESVZMU3KK
M)1GS,DJ+O5J[M*"UTTT,R(%JH^[Q[(,M;R_.*O%;*)C&5YMBCM332H"VY)QZ
MIM34R6Y%)*C2TZI6IJ46A]=0'M5EEF.V33#:6FBU,D(224D9GJ?0NG4S!5S
M 'EKF_#>2>4>5IE)B,.*Q34F)RX+EA=QWU0W9%[JAY$1:$[>_)M+>U>OF&74
M$PI#\[)H=;BF=95B5U-AO\:66'R8R:YU]^+;0G5(4]+;<(NY;=:1WG>KT+;J
M?81@E$7KN=R.+\1QJ*WDQX;/X[2=3'QF F8W-O75+)QB>LFUK)CNC2HR(R\W
MSD^=T,)N[Q/+'*;*$)H;%3K_ !-05[:4Q'U&N<RIKO(Z?-U-U.A[D>^+3J0"
M=L</;=ML\9R;%KN7B<O!<;AO1J*&?ICCS"V]2BI424*=CJ(G%(\A)ZEIT 1-
MDWR3E' V0MW%597T"DR*LD8]/EU)0KN=5176>]<<AI(U*-M);.\[5I(]3T(P
M'KS&K2-=T-?;PX,BMB3&4O,09K'HLEI"^I)<9^P/3[$%6E.>JG/LPY X[Q?"
M(4<TUKDW(9UC<1GGZ9MUEKN(Z'C;29&H][I$C77J1]@)AJ*M@YCC> <7UN1X
MO;V;O&N<38=DU"KWY;CT&*3CR)3#9HU6R1.:-N=A[.G4$C^/SJW 8^62:C*J
M/(YV6Y%DN!SJ>I].<JH\XFT-,V$-?O&Y1)\U.WV_>ZZA=K%[+XV7\%9[G.(2
MW92*N?7W\>IK_23C3IC3;<<G6D%]R+[/:?1L]Q%V&"%.R?\ 29D?+5/'R2)D
MTB73\EU\F+!9K]<8C8VP\E,>83[36O?&E1[EJ<TV;MVAD"4ACN)9(5[BZI=!
M-]'9Y6R"Q>-V&[L1#=;+NI"MR-";49>8X?FZET,!N/PSU-G38!9Q+6 _72%9
M#</-QY32V%FTY),T*2E9$>TR]Z9=#!$MR@@           !6N0,DM,0PVYR6
MGIUWMA61ER6ZU#S<;>39:J4IQTR(DH3JM6FJM"\TC/0@'9@>1/9=A&-Y7)91
M'D7E7"LG6&C-3;:Y;"'C2DU=3(C5H6H"@<H9YRIB.58_48Q54$VIR>8BJJG[
M&7,9D(F=PX^LWTM,J23>C9DDT&H]=.@)?:GGC'6>0KSCO,[&!47<2= K*:,D
MWC5*?EP6'W-5J3M(C>=-MK=MW:>R!1:T\M<=*S17'A7['RR2:D'6&ETE=XAO
MO5()PT=V:R1YVPE[M/("$!PIS/3<O0;IR')C*L*JPD,G%BD]YM?WSC<-Y9NI
M+4WD-FOI]8@3,*](\0\%.4<KXM%3$>L\$K7)U#$U>[VP>A0'),Q+A[22E+3R
M4L^:>I]3Z@46[CSF?!L\QURTBWL%4^I@1YV3M(4MIF$IQCO75;GB3JT@R67>
M$9I+3J8%$_A/(N%<C0I%AA5RS;QHCA,RC:):%MK46Y.YMU*%D2BZH5MT47O3
M,$*')Y-Y"MN3[O#L(HZF93XB]7,9"BQFN1K1Y%DVE[OXB$H4V3;2%=>\]^9:
M)!*YO\J<>QLU;X[?R"*C,W"3MJC-6_<M'>);4O;W:7%)\Y+:E[S+J1 A4N'N
M>,:Y*C1ZF?.B0N0%JG*E8\R;NK3426ZR@DK<225K[I"'%I2K4MVNTB!,PLM)
MS%QCD;EXU29-#FKQQEV7<=T:]&HT?7O'DF:2)UM)I,C<:W)UZ:Z@A _27X*)
M)K/-H.A.H8/S7]=SA:DK3N]>[]EWWA'T-1&":+-?\J\=XOD%;BU_D42#?6Y(
M7 AN*49J0ZK8VI2DD:&TK5YJ%.*22CZ%J"'9R-D4_%L7<MZV;5U\I$J&QZ3>
MF^4$D2)+;2TGZ,1KWJ2HTM^3>9;NFH#!/F7C!.7)P-62Q4Y:J2<$JU1.$LI1
M$1DT:S1L):M?,(U><?1.I@FC/S7(;"ADXNU F5<-%O=1ZV6FV-\EOL/-NK4U
M#[@C+TE6S5'>^9H1Z]= 0H/'WB-PC*J#+<ANK>#7P,8LI#+KB"?)*:PY!L07
MU[TZFN1IYJ4%J9]-NH)HV?BF78[G%(QD6*ST65-(-:&I2$K1JII1H6DTN)2I
M)I,M#)22,$(BFY6XZR'*9^%4N119F3UO>%+KVS5N)3!Z.I0LTDAQ39^_2VI1
MI\N@"KRN<,2R&K<D\;Y12S)$&PJHUF]9)F%%0S:/FVEM"FFR,WW"2M+1=A*]
M_H0)HL$KF/C*%F"<!DY)&1ERWFHB:W1Q2CD2--C6]*#;WGN+5&_4M>N@(0D3
MFC&,?H7+;D;)::,;MI90(#M4F8XRM%>\:>Z-+B%.'(0DTDZ22VFKWNH)HF;O
MF?B_':"GRBWR2,S0WZ5+IYB$NOID)01&LTI90M1$@C\_<DMOV6@%'35\CG=<
MHIPVL3&DXV]BL7*8=NRLUJ?],F+8;V&1[#:-"-Y'VGJ KUUS%(9Y[J.'ZR16
MQXIUQV-N]-1)<E//*):TQ8W=FEM"TLH](4MS<DT].A@46>BYGXNR:)>3J+)X
MDZ)CC+DNY=;WD3,9DE&MXB4DC<;+:?W1O<GVP*,(^?>'RHE9-\JXIT*9KE64
MTD/FA<UIE,A339$WJM7=J2HMA&1ZZ%UZ 49N*\S\79O<IQ_%,FB6EPN/Z6B,
MSWA&IHB(U;5*0E)J22BWMD>]/V1$!1(9MR5@O'#$.1FUVQ4-SUJ;AI=):W'3
M;(C6:4-)6K:@C+>O3:G4M3($,._Y@XTQB;55UWDD6/-O&H\BH93O?.4S,7W;
M+C1LI62DK5V*[/+V +'/R*EJ[6JI+"8B/:WBGT549>[<^J(T;[Q),BT\QLC4
M>IET 5&UY6QB9B3]SA^05;LZ746-S22I_?G 4S5GW;S[_<I[PF6G#)+FGG>0
MNH)5ZFYS@2^4G>,)LFO7:(HX4^-Z)Z09R[21'7,>::4M.TFDL$AU.[KHKMUU
M(A1F\,\Y8MRK45\=%G#^7*X";"VHXO>EW"5*VF23=+SR09I2O:I6A]N@$PM.
M;<G8%QSZ"6:WL>H79+4B$A[>M;FS3>K:VE9DA.I;EJ(DI\I@ACW'+G'%!?5>
M,6N0QF;ZZ]%.JA()QY<A,]9MQU(-I"TFE:DF1*UV^R8#/S;D/#..:]FTS2W:
MJ84EWN(ZG$N.+<<))J,DMM)6LR21:J,DZ)+J>@#J7R7@B&7Y"KR/W$:G;R9Y
MPMZDE3/:FB5J23U0K:>FG7V@%)7X@L.J^1+3$<GM8534^B4TG&YSAN[IQVR'
M5K6I6TT-MHVM$2E[2\_J?4B!-%B:Y#AU,[.I677=-%QO%7XJ27'5(3*B-2(Z
M%[9W>EL-Q:U?<28UW),B]]T 92.7.-G,,7R"C(XIX@VON5V/GD:7R42>Y-DT
M]Z3NIE]RV;_:!"D9!XD,*KLJX\KZRU@R\5S-N>])N?NRC92P1-14MI2CWSLC
M<THE]4;3U(@318N:.6(7$M)36LM<='K2WA5KBY7>FAJ*\X1R7R)HC,S::)2]
M/^GL,0D++F;B^GL*.KL\GB19V1L,3*AIPUEWL:7IW+JE;=&DN&>B3=-.I].T
M"BT7]_38M33,@R"8B!30&^]F3'==C:-2+4]I&?:9%T($*BUSAQ0]BWRT1D\4
ML9*9ZL7.6EYO9.V&YW"VUH)Q*]I;MJD%T!-$A1<J<?9*="5)?1Y:\F],*C;(
MEH7)56$2I2"2M*5)6T1D:D+(E:== 0F\>R2CRNL3<X[-185:W7F$2V=W=J<C
MN*:<))J(M=JTJ3J73H E0             !'7U+#R.GF4=@M]N%/;-E]41]R
M*_L5V[765)6G7L\T^P!T8MBN/830P\9Q: W64<%)IBQ&MQDG<HU*,U+-2E*4
MHS-2E&9F?: F                 $/E4S(X%!-E8E6,V^1(2DH%?*D>AL+6
MM:4F:W=JM"0DS69::JTVEIKJ I7%F?Y5DMUEV&9S7P(F68<]!1-DTKKKU:^W
M9QSD-=T;Z4N$M!),G$J+V/9!*Q\B6N74>+R[C#(M=,LH)*DR6;=YYA@XC+:W
M'-BF&W%&YYI$DC(D]NI@AJF+SY?TN+X%EW(L:GIJ7-91N^E0W9<E,:K56JF-
M;TFV2O2%ND3>Q!+3UZ:GV$T;$M>:>+J7&*O,[')([>,W1J35SVT//I?-O7>2
M4-(6LMFU6_5);=#W:: 45VTY[Q:#R=B.$MV,-=1E565C$L/NRUO/3'FVH#;1
MH3LT>U</<K]SY/**-O A1Z[F+C.VR*RQ.OR*.]D-2F0J="VNI-)0M2?)*U()
M#AMZ'O)M2C+3J":,"MY\X?N(UK,K<LB2(U+'3.LEI2\7=15K2WWI$;9&M!+6
ME*C1KM4>BM# HN+&3T$J^<QB-/;=OF8;=F["1JI28;RS;0Z9D6W12B/3KK^P
M"%6R+F[BG$K]W%\DRF'6WK"D(D19!N)[HW6B?1WB]AH02D*(R-2B(]=.WH":
M.V'S+QA/P^9GL7)8JL3KWCBS+!1.([J01I+NE-+03G>'O3M1LW*U+0C!%%0S
M_P 1F&XOC^&911V<*PH<HNV:Z1/<[XDQZYO<<U_8E&\G&=$)[M9$>JNP$T6>
M!R37M6V;R;Z]I&L2QIFLE,N,+D(FQ6)\7OS58=\1-ZNF9'')G4S3T/SN@#L:
MYLXK>Q/Y<(R>)\EO2O5R[!1.H)$S3=W+C:D$XA>GG;5H+IU\H%%BQ+,<9SNE
M;R'$K%NTJ'5K:3(:):#)QL]%(6AQ*5H47E2I)&"&O>/^?,4RFWM<6NK*' S"
M'9W$2-3-$\IU<.I><02S-232ITVVS<4A)ZZ=23H":+Q!Y"PNR7CC<"X8D+RU
MI]_'$HW&<QJ(V3KRD>;T)"3U5NT]CM!"HY-S12XSS#CO%]A)C1TW4);RG72>
M4_Z:^^VQ#802$["[TS</57[GR>4FCIXNYVQC.I:\:LK&'"STIEFP6/M=[O)F
MNE/-)\]9;5.&TV3JDI5KM/70B HM>/<I\>Y9D5CB>.Y!%L,AJB4<V"R:MQ$V
MONUFA2DDEPD*/:HVU*))]#!""Y'SW+:K)*/ >.:R!99G<QY=FXY;O.L0(E?!
MV)4MSN$J<-3JW$MMDDM->JN@)5N7X@48M:8I&Y/@M85%NJ2796;4U3DB0Q81
M9+4=,=OT<ED:%)6MW<9:["Z[=# HNV3<R\88<BI<R/)8L)F\91+JGM''FGHS
MFW:]O90M*6SW)T6LR3U[0*,=_DFOI+W,7<HO::+A^.,U#A+95(.=%5:[DDJ:
M9I-K8ZLT=P;6O37< FJWD3#[O#).?T]FW+Q.,S*DN61(=0WW<'>3RM%()>B3
M0KL3UTZ:@A0\ \0^%9!Q5$Y&RNWA51H<3#N&F2?4AB>YJI$9M!I4XXX;>BMK
M9*\I]@)HVCCV0TF5TT3(<<G-65+/1WD2;'5N;6DC-)^V1DHC2I)]2,C(^H(5
MZBY;XYR;)IN'4>01Y>2UW>^E0"2ZA1>C*V.[%N(2AS8KHONU*T\H"@2/$11W
M^3VU!Q[:U,^#58Q;WLF[EG).''FUKC;;9/&VDC5&\\UK6SO-1%YOMDT7&;S'
M@.+P\::S?)JR!<Y!#C2F>Y4Z<5PGTI(WD&I)FW'4LS)MQ_:7MZZ@)BUY*P6C
M^4/K:\CQ?DH4-61;]_\ L967^Z]YHD_X77S=-00PI/+_ !M$RF1A4C(8Z,HB
M(?=E5NUU3C3<6/Z6ZI9D@TI)+7G]5=?)J?0!VX7ROQWR'+F0<+OX]O+@(0[*
M:9)Q*B;</0EI[Q*=Z=?--2-2(^A]0%;E\U5,'G1KB"6]&9;>J&Y;3ZN].2Y;
M/O'LB$1)V$7HY=]N,_+H":.GA;G?&N4ZF!$DSH<;/G(SLRRQ^.;OW!MM]39$
ME;J2)9I3L-9)49EKU(B F%NQ'E+C[/9]A5X?D$6VGU9_[8S'-6I)W&CO$&I*
M2<;W%M[QO<C7IJ"%/SODK/(G(;7'/'-/53[F/4%D,Y-W+<AG*C*D*CE'A$VE
M6KNJ#-2W/,3J6H)6J]Y6P+$[BIQK+;R)49-<(;7'K'5J<,C=5L+>M*=J$&O5
M"5N;249= 0JV'\\8U;YID. Y).B5.40K^72T=81NFY*BQFFE-NK6I.PG'5*<
M)*-Q:[=$D8)HMT#E+CZTS&5@%?D$5_+X?>$_5H-6\ELEN<;2LT[%N-EU<;0H
MU(^R(M#!"L.^)7@QGTCO,TA:Q4DMU)(D*49&K;HV26C-PR/WR6]QI+J>A FB
M?R#F'C+%JZEM[[)H<2NR)"7:609K<3(94E*N]23:5&39$I)J<41)3KU,@11(
M9YE:L4P#(,TKFVIZJFLD6<5LU_<7NX9-U);T:^:K3M(!K!7B)8D5/#\NL@L/
M6')TQF-)CJ=5LB-M[6IIH,BU4IIY9(1N(M=#U!-&QV.4^/96:.<>1\@BN9DV
M2MU41JW[VT=XMM*]O=J<2GSE-I7O274R!#HB\O\ &DZ_ML7B9)$>OJ-M]ZSA
MH-9FVF(6KY)5MVN*:+^$0VI2D^4B!-&N<%\01Y_A.-Y!73Z*LO9V21J2\KIY
MS#;;9ER7T-1XJD)U5+>9;0MK?]SU,]VG8!1L.#S'QE99<>!P<DC/9:E^3$.L
M(G"64F$I27FMQH)&]!H5YN[4R+4M2 H57,?&5YEJ\%J<DC2\K;=>CG7-DYN4
M[%0IQY*%F@D+V)0K=M4>FAEV@BB\@             "NYIA./\@4WR?R=IZ1
M3J>0^_%8DOQ$O=V1EW;IL+0:VSW><@SVGT]@@$U @0JN#&K*V.W%KX;2(\2*
MRDD--,M))"$(270DI21$1$ R                            5W/V'Y6"
M91&BM+?DO5$]MEEI)K<6XN,X24I274S,ST(B 4WB+(':W',"XZGTEK'M6<-J
M[&18.Q%(KF5-LM1U17'E&1IDI46IM&CH7E\@)<>6ZVQG9=Q0_!AOR6(.3&_-
M=9;6XAAGT"2G>X:2,D)U,BW*Z:@-89MC5Y*E<G*;IYCJ)V;XE)C.-17%J>BQ
MD0.]=:,DF:D-[5[E)Z)ZZ^4!'V#V<Y%RU0M9 K)9,VGSQQSU0=::,9AT;#<I
M$&6W);8\YQ:%EYZGNNJB4DM$ZDMI>'UR77P,NQ6SK9T"UK,CMI3RY45QB,ZS
M837G6%QWE$2'B4@MQF@ST(RU[2U(E2\FBV\7+?$54'363K^6XPS)Q^3'B//1
MI*8=$[$<0EY"33WO?*)"6_?*/L(!6,NP',LAAV=335,IN8_Q%2U\<S96RA4R
M+/4\[")1D22>-"=O=F>O4M>@);+X*KHMAD&09NFQRB=8RX<&LEKR>I8I4&F/
MWBT(:0PPP3BV-RFUJT,BUT(S+0$2K7-<EZ;F[*L,Q&^A<T5$FO;QC)XD595=
MC =>;5):ER&C4V<9"#<)Q#^AI/33H9@0G./9[F%Y[EN$Y%C5K.M\BS";D%1<
M,0%2*Y-?.CMFU(7+5HVWW!(4PHM=Q'H1$>I@->8CAF6/5G"L%-5-@38Z^0FI
M<EZ,\UZ"NP3-1&<D&:2-LG#4@T&KWW337H"6!@^)3IF)38LY67+S#$<'N:4J
M2?3LPZUAZ1$[AR&Q)880J2:W$)<8^Z.&I);M=VH"3M,5R)RKLT)HIJEJX/@U
M+:2B.&?K!"WC.(DB1_#%YI]T7G=G3L 8&5818NY=DM/E"\G@8SG];C34.-CM
M2U9MRB@0VXSC$EQUAU49R.ZDW??H\U1J[0&\?$'4V=AQ4NMK(\BSG(LJ,^[8
M;4\^M+%G&4M9I;(SZ)2:E'IT+J"(:QM<:R!QRT6BFF*4OFFKM$**,X9G7M-P
MB5*(]O\  IT5]T]Z77KV@-H\UUME8V'%RZ^&_+3"S:NE3#CMK=)F.B++2IUS
M:1[4)-1$:E=.H$-8P(-:O >2,3S.ER2.Y7YG-MD3:>O?7*8]-L52(4^&I*3)
MY+>PG%FV2MJ3ZEH9 -M\'W69WV"^E9JTZ4YN=,CUME)B>K95C7-.:1YK\,].
MX<>+4S1I[?E EI3BZFR!JPXHP*1C=C!R'CBPO9>573T5Q$%+,EN4VE3,I9$E
M_P!-4^A1$V9GT,SZ)U!*2@8[?,^&KC"I.FF)M(5U0O3JXHSB9#2&K4G'%N-$
MG<DB3YRC47MF"%:M'9=)E-/A5K2SX-H[S/\ *)JR<B.E72H%@I]R.XF62>Z4
MXM"R1W9*W>8K4O-,$I_!<;R*/FO'+\JGFM1HF89]*ENNQG4MLLRV9!1W7#-.
MB4NF9=VH^BO("%2IRY"HN*\+Q:<SDV/XP_79(IYG'JLY-H_=JM9!Q8<EM;#J
MFF'&5J6GH@EZ]5:%J1+97"E#>5V;XE(L*R7$C,<4T5>^\^PXTAN:U-=4N.I2
MTD1.I(]5-GYQ%Y 1+.Y Q7),AY=S!BHAO)3;<62Z:OLU(4W%]92)\@FVN_TV
MDLMZ5::ZDGJ UTB'<Y71S55&)VU0>*\3VN)VR94%V.MZV>CMH:KXZ5I);^Q3
M*UDILC+SB\J@2VI:4UFJQX$[NM?-FJ=6=B26%&B(7J)YLN^(DZ-Z+,DENT\[
MIV@A0N+<9R"%+X)7,I9D;U9+SQ5BMV*XWZ*F8^^;'?;DEW9.EM[O=INZ: E<
M^4Y$C#^6*_/[6@L,BQ.3BMACK<:KAKL5M6;TIN0E*VD$9I3);2;)+TTUZ'H0
M(0G">%Y3BV=X=&R*OD(<K^-&8,J6MM2F69BK;OO1#=T-/>MMF1&@E=A>P!*U
M>)JLRIW!Z_(<&B/3,LQ^S;?A,QFU//*;GL/5KQ$E!&K0DRMZC+LVZGT("&H:
M_BW)<9@<R8U'KYCU%BN*S<?P@R8=4J:S?DNSD)9T(^]4ETD(/9KH9Z=H);!Q
M-FRH^5F8]C4V"&\AP.H@5\Q$1U<5$JO;DN/M2'DIVLK21D6U9EJ9I+M,@0A^
M(L<OJ^YX17,IY<1NNQ"VCV*W8SC*8\AUV.:6WC-);%JT,R2OJ?4_9 37+)S<
M6Y1F9C88[89#CMYA,K%X**N([8+39G+6^<9QMI*MB9*%I23BNAFG0P'?PUBF
M08UFM7$O8#S3];QUCM3)EK;U93,CR91NQTO%JA2FR4E*B2KR$?L 2DO$*W 8
M8QV^:*^@YA3.S)&+Y'C]:NW1"DN,I;6S+92E1&U*29-[33YVGOB+740U3G\O
M,6TVMKDV*6QWN=<7LTZ8]/7OS&6KU+DA3L9:626;.U+J%F2_>EJ6IF0)8N81
MKB(QGV*+Q6YLK3-<4Q2GQ]4:N>>BG/C1W4.(=D&DFV3:4XEQ6]1$6PS/0R 9
MN<4%_;6O)ZJ7TQZ3CV6X=;69U;*9-@N+7U<;OG(S#I*0ZZ@_NR6UD9*V]2,!
MF^HEPJ"HY&KF<DRBLCYY%R7)"MZI,.P6VQ!7"].C06&6E+;0;C:SVM;CVF>G
MFF8"V9+>>G9UPSR)7XM<P\8:D9'#DQSK'$2V';1IMF,Z]&:)2FT/K0IPEJT\
MT]RM 0M7B'CS58=2V<2#)GL4F2T=M8,P6%2Y"8<.8E;JT,H(U+VEUT+R>T!#
M4G)<6Y=L>5ZU&*6EO)Y;KJ#Y&.M0G5MDIB*EA;4M:DDF(J,YK(43IIT+J?4$
MMU<MS,UQ_C1"\5=E*LV':^/<6-='*;8,UINH1-DQ6%)43CJ6]RDD:3\I^0$-
M"4%!?2_1YD>'D5I#=Y6H;)FROX#D>Q?KF("$',?1W+1$TDRZ.;$]--VB@2YY
M)$R7!\%S3DV'6N1K[$.3[F\K$3&EM'*@6BBKC-O<1;FW?24K)2=25L >E^,,
M01@7'F-8>E*2=J:]AB4:/>KE&G?(67^>ZI:OV056T    !H3G/Q#7?$N74.(
M4.'+RNPOHJI$=IB0XV^;A.J;[M#3;#REGHG7H"8A2OI2<W?X!7?UI_\ =X)H
M?2DYN_P"N_K3_P"[P*,"Y\7_ "ICM>[;9!PE9554R:2>G3G9D=A!N*)"24XY
M 2DM5&1%J?:!1ZBPG(E9=AN/Y6N.4-=Y6Q+)40E]X31RV$/&C?HG=MW::Z%J
M"J=  &E_$#SI/X49QLZ['/E'*R&0_%;C%(5'6E;)-;2026G36:S<T(M 3$-;
M_2DYN_P"N_K3_P"[P30^E)S=_@%=_6G_ -W@48MCXM>7:>"_9VW!EM!K8J#=
MDS)*YK++3:>U2UK@$E)%[)F!1Z(XHSISDOCVCSEV"5:Y<-..J@I=[\F^[>6U
MH2S2C779K[T@57(  :PYYY;>X7P=&8,U*;E:YS$#T1;YQ2(GT.*W[R;<[.[T
MTV^4$PTVUXJ>:7VD/,\"W3C+B26VX@YRDJ2HM2,C*OT,C($T<_I2<W?X!7?U
MI_\ =X%'!WQ4\TL-+>>X%NFV6TFMQQ9SDI2E):F9F=?H1$0%&Y.!N6WN:,'7
MF#U2FF6B<_ ]$0^<HC)A#:M^\VV^WO---OD!$MG@@  %!YJR3)L4XRO[C#(3
M\_*4M-QZQF)'7+>0[*=0R;R6D)6:NY2M3NFTR\WKT!,*+QUF&&8%Q_9.8YB>
M7R?5C\5VZ=F4\DKJVGV;G=N3#](-*GU[D[W3)7F)T(BTVD VYF;3TC#\@8CM
MJ=?=K)B&FFTFI:UJCK(DI274S,^A$"&D*&ANVZ7PVM/5<I*ZA!>MD+CN:Q#*
MB=;+OR-/W,R69)+?IYW3M!*E5R\XQO!,1HWCR?'<9F2\J<M5XW6'*M561VKJ
MZ^.IMQAPVV7FU*4DR3M6?0S)/G$2EN-(=QB5QP?-NJ2R:C.8K,H'E-07W3BV
M$F5&6A$HB3JPG:2E&IS0BT/R$8(>A<)S6OSRHDW51&D,06)TRM:7+2A'?KKW
ME1W'6]BUZMFM"B29Z'T["!#RKCWZ0LJSO%K?+F\DG95!BY8SDL.=6*C4M3)?
MA.LQV:]UME*5$ZA*2U[YS?YIZDHP66C#,#M+F1@V/6U7+@UD_B:5C]L^N,XT
MEA^6Y&0IEQ1I3M=+SE[%>=T,_9!"R>%.NNYE!>9QDZ=+RQ=AX\G11K2<3%8J
M:XEI4?E<?3(6K3IN,"58Y)QK()EES4N-2S)*+*\P5R"IN*XX4EF(F'WYM&23
M[Q+6U7>;=23UU\H#GD]#>Q+W(<F^3TV;4T7)U3DLQEB,XXZ]6,5#<=<F,TE.
MK_<NK)PR;U]Z9^0!%6%=>-T#?(:<<LV<?D<M1LQ16MPG56":9$;T9<Q41*>]
M(W7"W[#3NT,E>4$LW.<;R>RR+EV\AT%A.K4W&"W95Q1EDY:0*N.T[+882LB)
MU:"+SD%UW)V^^Z ,>;57F5Y/-S^JH;-G&,AY$PJ171I4)Z/(./3M$S,G.1U)
MW-LFH].\61:DG4] 0V[P966-8[R<=C!?A%-SRYF0_2&E,D_&=:BDAYO<1;D*
M,CT670]# EJ'&XES:7]!A<7'K:'=4W)EME4ZTE5[T:!ZE)R;JXB6M))63W>H
M;21'YQ^UH"4_P)B5A7<I9553&DHH.,DS,?QA)'OU:OYZ[<UZGV+;8-AH]/L3
M!$KMF2Y5/S]@E\_739-/,J+&C3,A17)33,V5)BK03ZFTGW2-J5*WKZ:$?D(P
M&O,+QK(8LKB@WJB9&7$RG-7IKZHKB3CMS$V"6'G3-);4K-:-BE=%=-/( P>
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MGV 4;TX3Y,=Y<X]@9P]6IJ5S79+1PD/'()/HSRFM=YH;UUVZ^]!$MA @
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M/7&J8S[?08OX%((2H"*R<],:N3+M]!E?@5 //G@6_4F]_7<W\%'!,O3 (
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M>K05 %0Y6_5=F_\ 4%K^).@-7^#']0-%_.K'\;<!,M_@@
M!Y?YZF9'\M,P=K<INJ:/BV",9%6PJJ<Y$C+LD3Y:$N/MIZ.)VH2E2#Z*+M["
M!,(2;D&8811\B5L#,+:5WL##)#%M;R?3'Z][)92XLY]I:R23:=O5*4D24*T-
M)$"7?>W658K<9/Q%7Y7;RJ)>2895-7<F8M^[@1,G[TYK:9J]5DH^X2;2C+5!
M.=/( P:-=MA,QVGIKNR6EWFF#53ILF4IZ7,@N5B#6S)=/JZE6B=V[MT+7J Z
M,;8L\.Q;-YU)?VK<B7RVU3/*=F.++T9JU;0XHNS[H^ETRD+_ .T(D[NP!L[
M"L<JRG,>1+_+[:&6+95;TC-#%E&BH]5U+1(0T[#-*DK<41G(4XGSSZ:'H"&M
M:"[R2\R1P^^RJNPC/<7R*?#=N[UN>Y)8:2TXP_%89_W!;9.Z$GJ1H4DO(8)3
M?'C=GB> \ Q*R[M/1LEM69%DS)EN.H-EVI=7Z*@CT),8E-I4AGWI'U[00X<8
M9)EDF;Q9GTS*;&QG<F3[J+D.//2%.5K3,=N4XUZ'&46C'HAQT)6:.JM3W'U!
M*O8)D6<TE+A^0L95=W5OE^%9/9SHMK,<FQRG5+:%PU1FEZDVI)GH9IZJ\O74
M!/6--D-=PGQ-<8Y(N6N/*NB38YG$Q*>5;<FN9$:?.:VKIWQ,NJ?<<9W%N4K4
M]=.A"^0K*"_SC@=SCDUR=79#@\I<^:ZH][]='>C/PI+R=$D2S4\OSC21^>HN
MG8 VKEF35&/8=<97/D.>IJZ"_,>D032MTVFFS49LGKM-9Z>9UTU!#R(]G')6
M"4G(2DR+ZI->+U-M5,Y);HR&6T=G:' 58-O-D1,:-*-2F=/-6G7LV@LE+2+9
M\;WG,%-09';JD27L#JE9+83#F6<2-:OOLON%)=(SU2A:B;4?5&XMNFA .;*+
M/C_+LCIZ2\M'=>2L+@2I\Z8Y(G2H<R(T;C$A\]%.-F2MFBOL2(CU 8SD&QP[
MCSQ#9CC^0W4:XAY+.@15>GNFT@R<KW3?2DM-)!DX;9NZ[N[T3Y %@Y3R3*V;
M'E?-H65V%3,XP?I&<<HV9!M5SB)+,=]TYL9/FR/2E/*;0:^SIIV .N^L<HCY
MQ;Y6SEMVVJJY*IL;C4R9J_5'JR>U$](:7%,C2K=WRNI^]T(TZ'J9D).MK<UR
M/#.8I6%2G"SJ3GD^-*4W(*OG/UM4['9;A,3#(S84<1))9</WN_R:Z@,:UO*J
M?Q=A-MCTZZD9#C^?5T!+.22#D746T5,.-*KGG>AK(FGEM[=3U;TUZ@-G<Y6=
MLAK"<5KK231Q,NR.+46MK!<]'E(B&P^^;++Q><TX\II*$K3UTU]D"&HV9^4W
M::KCMW,[INO@<D6N)%=09JV;9^IBU:IB&7Y1:FXM"U=VIPRU\WR*+4$MO<UW
M%OQQP?;2L;L7V[*MC0*V-<S%G)DMHD28\)<IUQ?5;B4.*<-9_9><8(A4\XH+
M7!Z[%L#JLVR!RMS+*HE;8V\^P.191(BHCCRXL>8:2=;5(6TG:K<9EN,D]# 4
MV#.R>]G4W'$G,KI-5 Y!O<6.W@SG&+615P:HYK34B46JG%H<4;2G#\[IY%=0
M2Y8C995G%9Q9@MOEUW$AV!9<N?;09AQ;6<J@G'%AMKE(+>9MMJWK_=Z$:M00
MKW'EA:2,!PK%T64N)16/'&3O2HL5Y;*3>9ED2'B(NA.$1F1*TUT,R\H)7#CA
MNSQ2C\/%97W=JY7Y(4B=9Q9<QQY"TG0&\B,A)Z$4="T$IIKWJ3Z^V"$;Q]DN
M6+5QIFTG,+"QG<G-Y"605+TDW*]GT.))DLG!CF>V-Z*ME+:C1VZGJ"45A]]F
M^/5%=;QLKO+NSR;C*YR-^/;3%S6T6T%+:HRXJ%?P9IWFGS??%[[574!.7E/?
M5'$'%-S02;EGC&GQYN;EC&(SBJ[="I$1EXK!/W]#:E.N.M:EU5N,E>0A?HUA
M#D<[X+;XW+7/@9'A,I<Z6I1F<BO8?C/PI#B=$EN-3R]%&DC\\R 5WQ)Y):G*
MF4V(GD9Y%C>/3,CG/4EPBE@0HI[TM29"3\Z6I"V%'W"3ZHW>4RT$*;E5WF5M
M!SG,D9I<UECAV*8I?53$&6J/7.3Y\9UY]3\738X3IM;=AEM\X]2/IH2S.1+S
M+H=KRCG\')[F%.PFQQ-5+CS4UQ-3I9QJ_P!)9>B=2<)TWEEH?8KJ74S 2%W;
M9155'-G*$7)+I^XQ&UL:B@ISF+741FG(<31[T0R-*EM'(4XG?JDMI>;VZD,#
M*G<WP%69XMBV87.1(J,7J,^BV-E.<E/M28-@I,QDG4Z'W$N.RI9LJU3[!:=H
M=%YGV991']8X_-NIE'G><2:RH;IK!NO><HZ2 :4-0GY*D-QSDR&G'%J2M*ED
MDR+J8)3,4N4)TSC?BK/+6ZQMBZGY*ZJ6S9-?*"36U+#;]:V_/@J4DW22^??&
MGW_=:F"%S\.,UZK\-U/8,-G*D06;IYMKM4\MBQFJ(CT[36:>NGE,"6ML:R',
M*1G!+\\QM;V3R9BV0V=^Q-E&]%AS(,%,UEV$TDB3&[I:S8-*-"[.FI ENK@.
MDE1..J+)+'(+B_M<HJZVTGNW4U<U+3ST5+BDQTJ(B;1JL^A=3T+4S/J"):=3
M;Y5E-@G&Y>574&'/Y7R&D=D5TUR-*15Q8;KK<1MPM32TDT%H1>]^QT/0P2P^
M+K3+8=WQG92,OO+4LGDY=2VT.SFJE1E1J%J04-2&S(B2ZDXZ5+=ZK69JU/0]
M &!C669M@^+XGFC&5V]_8Y7@^3W5E$NY:["(S.HXC<J*ZRTOHWHI>Q>A^<7;
MJKJ M&/HSZ#/3B&*YQ/N+;->/'<C8EV\HYB8MYWC*&Y3"UZFPP[WZDI0@C2D
MR(R(] 0@IF9W]/Q\UAU/)RMG.Y>75&.Y=26MNW)N(2+",M[NZZR=-*$-R^Y+
MN7E+[5JTT\T$IUH^445N(\<YI/O,8A9'E\R+$GKLF'[T\?C5RIC$9VPB+=/>
MN02FS7N)PT)(NSM(; \,D3T#CZT@&^]*.+DM\P<J4OO)#O=SW$[W5Z%N6K35
M2M.I@2W," !Y2YN_]6'#/^K/\,Z"8Y/5H( &A_&1_P"GS)O]=6_C[ )AL#AG
M]4.!?\O5/XDT")7@  >4O&1^</#G_,*OPL0%H>K05 &LO$3^H[//ZHD?]! F
M$9X6?U X3_-7_P ;? EN $ #S/XZ?U)L_P!=POP4@$P]!8O^;--_,8OX%((2
MP")RC\V;G^8ROP*@'GWP+?J3>_KN;^"C@F7I@$     #5W/=W<U&&UT*EL'J
M9[(;VIH)5W%,D2(,2QE):>>;6HC)"B1JDE_8[M2ZZ&"8:7O;3+*F3<\6P\OO
M'*JOS_%J6'D1SEJN$P,AC)=DQ?2]#-?=*4>PU[C+H1ZZ$0#T#D,NIXMXNLY=
MI96DJJH:YXW;%U\Y=NX1D9),GG??/&I1$A2^A'IKT!#R_,R/DG%,5Y4K9,S(
MZ&5#JL<L:QJZNTW=C&<GV*H[CS4MK3NR<0G1;7D41^0P666SLLMPF;R)"AY5
M=SZ/C+(<2O"5/F.S)C]98,(.SCOO*ZK8-#BG>[TT3MU(M0&Y.#;&TR/'+K-;
M"QD3X63WMG/H$2%+VQZ9I\XL-MM"CT0E3;/>^;V[]?*"):8QW/,@LN6L;S#'
M%9(>!Y5+R1N*=K<-3*ZS160I3A-QZU);HB6WX_W(S\XT^^[>I*$QM-P5GQYR
M!.R:UN<BR?#LKMI+\V6;K$264=ES2$T1$F.2#42#2CIYB>FI )=%ME684M5%
MG9K;TOR>XM@9BQ)AS%QWI=O(0Z:Y4MPCW/M-]RE*FW.AFH]>T!]M.1,ULL5S
MS(%74N).7QMC5\PW%>6PW%L)[3KC[L=*3+NU*/M-/7L]H!=,81=WW*7(=Q.R
M:Z*-AL:H744C4YQNK4Y.H4.NJ?CET<,W#WEJ>A*Z]H(:SQR^S+'L:9MTYA>V
MDS)N+;S(YGK2>Y*3'LX3;:F'HI'IW*D;S3JGM[3U5U!+$N&LMKJZ[>C\@96;
MM7@%;G3!N6SB]UU(6XE9JU+4V-$$7H^NSJ?3LT"RYC>\T97R+EC. MV\ZUQ%
M%#ZB9KK.%7T[2YD-J=(.QB2'VCE$_O<0GIHE*="T,!VY;:91%S3*,NB99=M+
MH<[H*2!2)FK*H]"GM0_26G(OO5DOOE=I].U.AZF89>(X-E3T?GB1Q]D5E$S%
M^^G5E4<R:M<(G%-0Y"G"09:)DFE2F6W^U"33[ (;1X&MH4W&[2K)V_1>U%BN
M/>5&5S#LK"OE*:;5W*))E]TCFG[HTO4]VXSZ=A"7GB=C**SB/Q 6;=K9R5EF
M,BJ*/+EK?CEW5A7+*3W2NAR3->BG3ZF24EY 2L&29)FV#ER9@-)?WEM%B7^)
M55;.DSDO7,=G(6$.2R9FRO,;4XHMC2UZ(;->O3M 9=@WRS5XS48OD,W(L:J[
MG/*>MII\JWCS+\JBQ8=*2PN9$6X2B0ZE1MFYJHDF6NNT@&/EZ>6Y&>Y)AO'3
MN36DC (%*SCLAFYC,,')F-+E.2+=,]U!SN^-)M=AI2E"BT)1@,KDC*<N;>Y.
MY&BY+95EIQO8TD2CQ=F2INM6B0B(M]$N,@M)'I2I#B$*5U+0MI] 0N_#U+"I
M>4^8[9VWG*:*[89-B=-4N&1RXD>3N[M6B=Z5*[IM7:ELB1Y )9GBKJD6O$YH
M7*EQ>YN:92?0GC8-9NV#+&B]"/<22=-:2\CB4*^Q A0,]7DK5ER1&A9M?4S7
M$.-5<S&ML]1G82WF'Y3C]@;A'Z6:U,HCZ.:IZGTU,$MQ9[F;5=P^>1VZ;"+,
MMX4)AJ/2.IC6)3[7NVFVX[KFJ6U=XX1;U>]+KU,$//\ #N.08U9=X5:VV08^
M\UG6*U!-/W)6EO"AW;32I#:+)!&3B5DOO&R,C).NAEKJ"4Q N,J5#_1FO*[A
MNJ?Y.FXH>0.3%*MD5$:O3.1$*:K[H2W73V)<UW[?-+H A+.#99@C%,;NLDN7
MDXKRG98?6V\><XS/=KVXBWD///I+5<I@R[E+_:1;_P!T8#.RANUI<\Y!S:FR
M"UKIU3F6*U[==&E*;K9#4R- CO'+CD6CZEMJT,U]G:6G74)"FN>9,JY0N,@Q
M^/=2X5'F[U#+-NSA,X\UCT!U##[*ZYYY+BI!MJ[_ +XD&K<:=O3H V+P;63[
M2PRK-[3);JUD%?7]-$K)DYQVK8AQK%26NZC'YI+2E!$2SZDDS270$2@8>.$W
MXCN1,B9MK5N178_7S$143%E"6Y)8EL['62+12&]A.-(,_,<U47: UAZ]S+),
M9I'I&8WT-^NXHL,O[V#8O1UR;>!)VM.25$9FX6BO.(S\[0B,] 2S)^:YUQ]B
MF36-9D]K:S[/CZ@RGO;>0<TXMM<SUQ'WHI+(DLMI0K<EM);$F1>0@&X^$*WD
MREM<AKLK@W<?#UMQ'J)>3VL.ZLD2R):)2>_C.NJ-M>C:TI7T2>NWH8(EKOD_
M,+]_D55]AJ\D;J\=R2DQVWLRN&H] B4\_'3(C%5:;WR6W()+CA]269:>:6H#
M$:NLMC9DUEB<KN5N.<N/87ZG=FN+J2I7&W%&T44_,W:^]7]CTTT!+#PX[7(\
MQX>Y*O;NTF7&2Y%E"95/*E*<K828;4Z.RW%C&6C.QMI*5;??=35KT ;9Y?C6
M=_R=QGA+.06U#2WC&0N69T<URO?>.#'BN,D;C?7S5*,_K^0S!$-38+GDR2[@
MW(.9SGY;M9@>6.VEC'T.4]'JK-$=+R-VA*=6AI*B,^U1ZF"44O.>2\"IN07$
M/7M8H\6JK>H8R6W;R&4TJRLU03L&W4%HSHTHU*9T\U:-=-- &Q>3ZS(^-,;H
ML5Q;),FR)&69+#KY1R+9H[=N.<1UY46+/D=V;*Y"FB5N4YT+<2--00V3P@QR
M%#Q.97\B19<:5$LY3=%ZSEQ[&Q73*)"XQRI$9QQ+CJ34MM2C/4]I:@2T&^U9
M9RKCAV]OK<I3/(V15C,F+.<9=1&2J2ILB66IZMDR3;9_8MJ6DNB@2]C J
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M 4]GPZ\=/T\2AR",_<UM2[,30H=DR8RX=;-=[XZ\UQG6U/,(5T23V[S=$GV
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M)PMGV.@%1[A+C%_$6L&>H]^.,3/6C+2I4LY")^IGZ0F5WW?DYU/SB=UT,R[
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M\7]N!5LBIJ:ZBJX=+41D0ZJ RB-#BM%HAIEI))0A.OD(BT!#,  %;S# ,-Y
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MK;6&1LRBT:6<\G0;#(">>4N35LKCQC84LS:22'#4>I)T(_\ V]ID+
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MU*5YQ)))$GV5 -C @
M
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M%V(R,B,CU(^I&0#Z
M
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M!Z)X]J[2CP'%J6[5NN:VHKX=BK=OUE1XS;;I[OLO/2?7R@A8P
M
M
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M?*=2I#C9RV$&27R:6VE;:7-4D?D/4!9P
M
M
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M9RR<8F*VK=2A!*(C][YO9T!$M]@@
M
M
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M["+0OJ$"'T
M
M
M
M
M
M
M
M
M
M
M
M
M                                             'PS(C(C,B,^PO9
M",E%JDR,C[#+J0!J6NFO4^I%Y=" ?3,B(S,]"+J9F =O4NP!Q[QO<I&\MZ2)
M2DZEJ23UT,R]CH8#EV]2[  !UO/L1R2;[J&B6HFT&M1)W+5V)+7M,_(0#F9D
M7:>GDZ^R8!J1F9$?4NTO+U ?0     !\(R46J3(R]DO: -2UTUZGU(O+H0#X
MA:'4$XVHEH5U2I)D9&7M&0#D  /AF22U4>A>R8#Z ^&9)(S4>A%VF?0@'T
M        ?#,DD9F>A%U,S[- 'T!\,R(M3/0NSK[?0!],R(C,ST(NIF8#YN3J
M1:EJ?9[8#Z  /A&1EJ1ZE[) !F1::F1:GH6OL@/H
M
M
M               -.^*=QQK@?*UM+6A6M:1]TI2'%)59Q24A)I,CU61FGM\H
M)A7L&FT>!9?@^,X3A,G$:SD%5TN\AWBWUV3:J&,AR.IM)RY*$I6;JM>O5/L&
M HL?/+GD5>.9K;(;A65GQWF+SD:"IU+#3C$I+"5-[U*4E6U!:JUU!+<&)Y:S
M@OAGQ[,I#)R4TN'0)WH^[8;SC=>VI"#5H>F]6B=VAZ:Z@AJ=7(F<8'F6:\B<
MBQZV7=U^"U4N'74IR&HA%-L7$,M.'(6M1+)Y>UQ:#T-!$9%KT!*$Y$YDR+D#
MAGDG'7+*@L+&C;J),B[QQ4PH$B!.E)2MIHG5&M#S3J"2HU*-*VU=A -H\N<N
MYMQ7CU0NQN\0CY7Z#*F658\S9NG-=CGJVW";97N:;<(C1WLA>W?H7LZ$-><R
M90U?XKRC,:J(]982L3Q*R>L6%O%.6FPF$KT=U9+V&ALBVEM0G74]VI=A+;L#
MDW,++FVRX\)='4T]4MHTU5DF6W=6$%R+WIS(+J3]'<23FJ#;))FDDJ-1D?0$
M)KDC-<PKLFQK >/F*Y649"W.G.3KHGG(,6%6H;-1J;CJ0XI3JW4H1HK0NIF
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M/R7FDO$<"PSB:AH:V[EXU*RF;#G>F>K6(3$KT=MB,E#IN[WGE^^<<,D%J?G
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MK5:7&5H[=VBTJ(]$]2 F&Z00
M
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M
M
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MHW%M)<<3NT+R&6HB&Z@0
M
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M"TU"OYSQ=G65QLDK(%4^V],XYH:^&Z]HVVY8UL\Y;L(EF>TG%$G;UZ$9]3T
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MVXDHQF@M%&O=KT+4P'KP%0
M
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MX3BM]>U.2W58U.NJ(U*J)#YK6F.M9D?>);-7=[R,M4K-.Y/V)D GP
M
M
M                          !J;Q)SYU;P_<3*V4]"EHF4Z428SBV74I<M
MHB%$2T&1EJDS2?7L!,--9 U)8S.]S9FSLF[ZLY/IJ*"29\DH;==,:AE(8*+O
M[HTNDXHEZIU/IV==26R?$]05=]38$S:=]W*\THXBS9D.QM&9K_=.^<VI.A[?
M>K[4'U29 B&J.7J&+67'+N1U4V?"M\&H\0<QN5%GR6S;<)3Z$N/:.:2%DE.T
ME/;^BE>4]03"3R4N3LGY8S&?C+'_ ,=QB]JX5+82<B.NC5\(F([QQU56PTOH
MGI6YJM9^<:M$^\,C#:WB,WNX_AU><R1!AVF8T5=8O0Y#L-TX<IY3;R>^94A2
M2-)]NH(AJ)NO3/:B<>%<V;F)0N5Y6/1.YL9")":OU.Y)7"])2OO5-MNJ4D]R
MS5Y-=02Q^04G4'RC=0[RPKL@XI5CE=@,%,Z0I,:,IF.I&]DG-))S5+6VXI\E
MJ4737H L5E*4?B3CX4N[FM8$_90\@G1R4^EAO+?077&:OTDED1-/-MIF&P>J
M5++81== 0X\?OY!-Y8KN(I,V:J'QQ<Y#>6!O//*5(K97<JI2<=-6J_\ ?G%;
M%:]&_8 6_P 1M192#I\C43UQB>.1K"=D6*P;5VFL%1TH0?K*.MIQOO5PR)2N
M[</:>NA=5 0KV/-8;(YTN^3FESWH$?":C):]STF3WCK#K$A!J5'WD3AFPVG[
MFLC(EZJTWGJ UU"])LG,B<772*7&LQXWNLC1 /(YEV_*-M;#T63()TR-ATB6
M9;4>:9&I'[L@2E9M?-K<%X(PC&8,BYH<L@/6MY3+O)-2F;/;JHKS;)SR-:V4
M)4XMY$=&B5&@B(BT 9TS'<BLXW'&)<BVLV1-CX]ETF6=?;O*3)3!<857J>E1
M#:[]339I(S/WRDZJUU,C"OT5QD>)8V]DM#;VLB\ON)YF26CTR=(G&JV8EQFD
MS4D^M9(4RVZO;MT222[.W4.ZUA<@XGQ1R#8L[J3%)./ULJ(EO)EY%+.U5,:(
MY[3Y$A32);2M5$D]IJ1JGH>A!PY+QR%6TW-.$-S)[N,XU98/95,:582I"V9-
MLZAF6M3KKJEJ)PE&HTK4:4KT41$9%H'K^B9Q_'X\+#ZN8DW(<4EQ8+\HY,PX
MB5;.\4;JUNK3N\W>HSZ]-0530
M
M
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MNH"Q
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MG[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7,
M^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?
M7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_
M>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'R
MGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY
M@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[P
MCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\
MG[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7,
M^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?
M7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_
M>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'R
MGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY
M@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[P
MCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\
MG[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7, ^4\G[PCZY@'RGD_>$?7,
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M2IZ&^W(02B\AFVI6A_5$#[.L*ZKC^EVLV/7Q-Q(*1,>;CMFL^Q)*<-)&?M$
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M+*IR4$\J(EQ!ODTKL6;9'N))^16F@#N
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M9ZEU/452F:<4X/R#=5N0Y/$?<N*I/=QI,20J*:V27WA-.D@CW()1GH73H9D
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MTM;3OOB2LO>F?L@../TM=B])6X[2H6U4U#*8L!MU9NK2T@S41*6>AJ/4^T!
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M6P&T(::;9:22&64(::078EMM)(277KT(B(!R
M                      $KCO\ 22?\Q7_0 MXA(          (++\;Q7*J
M)^IS.%'G8^9I>D,3#T8(VCW)4H]2TVGU[0&ND<#^'%V$]9M8M1KK8^O?S$N$
M;#>TM3WN$YM+3RZF":LXO#=P2HB4G!JPTGU(R0OL/_K@5/HV<%?,6L_>+^W
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M2U JL5=QQ&J\K:SRPM)MW>,8TC&):9"&-LMIJ0J6I]2&T(+O7%J,MI:(TZ:
M(/PXX%(X\XKKJFPKSJ[>=(E6EC 4HEJ9<E/'W3:E%VJ;82TV?MI EPY X'@9
MS:WMA'R:TQZ/E<&/793"K2C&B>B#N]'4I3[3BT&DEJ0KNS+>GH?EU%6=></)
MR++*V]M\IM9&.U5A#NX>**]'*"U8UK9(86VX31/);(RWJ:[S12C,SZ'H!59L
MUPB!F[=$U/DO1BH;J!D,<V-OW1^L<-Q#:]Q'YBC/SM.OM@A297 =83TFTI<A
ML:C)5Y+89;!NF$QG78LBWCIBRHZ&WFEMJ96TG3STFK7KKY 35DXWP928VYB3
MS=S8SG\1]?''?EJ:6[*5DJ^\D+D*2VG<I)]4FG3VP*N--P)BU77T52_,ESZV
MEQ^RQ549\T)3*@VZD*>-TVTI,E:(T+89 59-#P]Z#C-SA^299<93CUK7>I&(
MED<9)18!-J:3W:F64&I[:KJ\LS,]$^P A9?"V493B-3C.89Q.8:CUR:*_A4Y
M,^@VD&.XHFWE)ELN.,R76R1WRT*[=23TZF*K3AN 2J3,,DS*X>9=F6#<:GH8
MT;<IN#0UI'W#.YQ)*-QQQ:W7NIEKH1'TU,,'D'AR+G5\61Q,ALL;M)%2_C=L
M]6>CJ.942'#=-@_2&G2;4E9FI+C9$KJ9?4#7S_ %I:Y=-HCN;2GX[C8I18NZ
M[#7%2=O&@=^EYATE(6I!D@T$;B$I]^I):ZF!5WS>")^7<CYVY=2YE-QM9GCS
M"*F$N.4>YCU,5)J:=(TK=:2VXE*-4&C<G<GVP*M@KXH6QF\G+:/*[>DKK.6Q
M9WF.0E,>@S9L9"&B<,W&EK;)U#:$OI;,N\(BU,CZ@(6/P%7Q<FAW#&36J<?K
M;YS*JW%M(QP&;*3WAO*W&UWII4;JS0GO-$;E:=H%4W!XJ52X#'P;&LGM*5R)
M-D6,:ZB]P<GO)4MZ8IMQ#C2FUM;GC2:#3U(BU 3''F!P./*%VGARW[&5,F2;
M6TLY>PGI4^<YWCSJDM)0A.I]"2A)$1%^R"%<;X2HFU1U)LIFL?,W^0$Z]UUG
M2>]W1_>?P)=Z?^5[8)JR,0XE+"KMR139/:HP]+DN1 PTSC^K8SM@M3CQ$HFN
M]4V2U*6VV:]$&?EZ@,?]"5&GC2@XY8M)T<\6>8FT%^T;:9\6=%6M;;Y>8;9G
MHXM"DFC12%&7M@5?;7A]ZZQRI@6.7V[V7T4Y=M59B?HQ3F93I*0M)-):)GN%
M(6:#9-&FWH ^T'"./8]+P^PC6$U^?B<JVLERI"FUNV,^]96U*?E*V$9J/>:D
M[--.A=@%79A?$+6#1\3KZ?)K;U/BQ69+K%.-)C6"K5YQ_=*0A!;C94Z9MZ::
M=/;U#-Y#XT/.)=1;UV166+Y%2^D-Q+2J4C<<><E*'VG&W4J0HE$A)I,RU0HM
M2 0,_@.C;IL5KL/N[/%+'#XK]=5W%>MI<E<*81>DMODZ@T+-Q1=X2MI;%^<G
M3L JY'P!B#,%JKK9,N#6L8G/PAIALVU&4.T4E;L@U*1U?-1&K7WIF9] *N^9
MP9C<\I:)<^8MJ;A[.!NH(VRTA,*6M,@CV?PVJ_\ -_R0*KKAU!+Q?&Z^@G6\
MB]DP6S:5:3$M(?=22CV$:64H21(3H@M"["ZF9ZF"%#J.!J.HRR/>HN;&1CM;
M8R;ZFQ%Y31UL*UFDLG7V]$$X9$;BU-MFK:A2C,NT$U8;GANPEV,_$5)E]P_F
MA9^M/W+3TPB,O1/>?[OHI1:>^Z^^ JE<DX2HLE5FZI5E,8/.I-+,G]UW7W!=
M!W'<DSN0?1?<)W[M>WIH!5DQ^)O5N;2LIH,GM:>GLYR;FYQB(<<H,NQ)"6U.
MJ4MI3B4NDDN^0E7GGUU+H R8?&#57C618]2W]E5/Y!;S;X[:&IE$N-)GRBE*
M0UN;4DVR,MADI)F:#,M>NH#+X[X]CX!"M"59R;N[O9SEK=6\U+3;DB4XA#>I
M-L(0VA))0DB2E((0\WB([;-H.4W656UG3U=CZ\J\9D^CG$C6)-*:0M#J6DO=
MV@EF:&M^W7MUZ@EA4? F,4S&$Q53Y<V+A+-Y&C,R.Z-$QK(R,I"9&U!=$DHR
M1LT]O4"K&QOP]X_2G)9M[NTR*L332<7I(%DXT;=;332VO,,FVA)J4:22WWB]
M5$A))[" JBH/AFK&H%I"MLNM[=5CC:<-8>E)B).)4M/)=90T3;*=5(VZ;E[M
MVIF8%69F_ARILRF6KK>26M- R*)7Q,FKX7HRFK%5/H41UPWFEJ2I*2)*B09$
MHB+V]15M'*\8J,TQNTQ2^:-ZHMXZXLM"3VKVK+HI!Z'HI)Z*2?D,B,$*$OA>
M198I/QO*,WN[Z6^_"EU=O*.,B16R*M9.1G6";92DUDHB-U3FXW/+H?4$U89>
M'^OD5-PQ;Y1;6>26MM"R-K)GO1D38EO6M)98>82VREHDI2G839H,MGF^V!5.
MUG%"(UKA]_<9+:7MYB3EJ\B;/4RHY3ETV33I.)0VDD(;(ON*&]"273J FN.<
M%@<;835X/5RGYD"J2ZAF5*V=^HGWG'SW;$I3T-PR+0NP$*0G@-F4J]=R/,;G
M(95K1S<6@RK#T7OH5;8GN>(E-,M]ZX9D6BW"[.F@)JHW-/!EK8Q/57'SMQZR
MRR#74=Z;*X:*A;-(IM+,JR6\7?)-+1K)*8Q:N&G;T^R$2V=D?"U'DB\N<E6,
MMD\OL*:TFDUW>C+E"F.EI+>Y)]%^CIW[M>WH!5;,=QJ716-].DWMA;MW,STR
M/$GN)6S 1M)/<1B2DMK?ET/_ *=3,A"9/Q1CN69._E-FX]Z;(QZ=BCC2-G=^
MAV*MRU]4F>])&I*>NFBCZ .JMXEHZIOCMJ++D$WQPTZS6I/N_P#:>_@J@K4_
MHGM-*C7YFGG>T"5>;X @UM%CM?C.4VM%>8RNS*!?Q?1U2'(MW*5*E1WVW&S:
M<1O41HU3JA22474"J;L.'ZRSGNV<ZYL9,U_$I.#OR7U,K><BRUI<7*6HFTD<
M@S3VZ$G_ "0*K/2XJQ1X57X3"FR6XM;5LTT>Q0I*)B6X\=,=+R5$DTDZ1)W$
M>W3=Y 0UI*\.D"YJ<CAY3EEO>V^1,5T!RZDE%;DL0*B6F8PT@FF4H4:EI^Z.
M+2:E>T":JYR7Q!=V/(-<6&+N&ZF^O:S)LH:-R&C'F7*MQ!.O*WD<E4AQ#39)
M9;\U2O/4K1/0+XK@ZA4I"O6<W5O-CY$+^"_W\TFGT?WG\!U_SO\ * JYT'"=
M'C]KC%M'LICKV+3;ZQB-N=UL=<R0U&\ES1!'HWN^Y[=/;U JH>7<&%AW'U%#
MP*3D4O)\=ASZ.N>J%P&Y<R)<NK>6U+7*2EI#*732?>I+<V7G$1GU(5;6X]PQ
MS'>+<?P._)N2["IV*RT2V9FTM7<$V\E)]#-.IJ(CZ:EU!"HXWP$C'Y;$A6;7
MLQ%92S,:QY"U1&U5=?+)LD''6VP1]\T3222ZYNUT3J6B2($U67C[C).$V=YD
M-C?3LFR?("BM3[6P2PTHX]>A3<=M+<=MM!;26K<K351]H"M9]X?:S.;?(K!&
M2VE' R]B$UE%7 *,IF<Y6%MC.*4^TXM&U!$A:6U$2R(M?;%5@<XEK5YKE&6I
MMIK</,J]NOR&B2;7HDA;,<XC;Q*-!N)4EDS3HE6FO4P%>;X#*/CN+UD3,[>/
MD6&=\QCN2MIB^DL5TAE$94-31M=TXUW3:"(UIW$I)*(_(!5/XMPWC.'3\5ET
M;\EMG$ZN;40X[BDN$\5D\W(??>5M(S=6X@UF:="U4?0"K"5P=0J4A7K.;JWF
MQ\B%_!?[^:33Z/[S^ Z_YW^4!5EXSQ0O$\F=M*?*K=K%52I=@QANYCU:U*L#
M4M_11M&[W6]:G4-$LDI6>I>4@&O*KBG+CJ^9[#%FU8CEF;WRFZ6:ZZII:($9
MQ!*EI6QN6COU.2G4D6A]4]@#>]G15MU02\9M6U2ZF?$<KYC;JU&MV.\V;2R4
MO7=JI)GYVNOE!#6S'"<_Y&7.#V/(%_8U%K$8J6%OG$)V)6,*T6RV:&"W+>;,
MV777-RC3[!@FKLE\!XLY$R"NKILJIK;>P@7U3%KTLLHI;BM;0VF7!T;\U3G=
MH-Q*]Q'UTTU JR+3AYZ\Q6#47.86\W*:JS3>U66K]&1,BST$:2)MI#26>XVJ
M4DV5)-)DH_:T##N^#/7,2@5\M;V/D5-%GUTK)"7'=GSH5LLG)#+INLJ0DB41
M=SM3]S26A=A&0JR*KA&!0SL&L:2_L(4C"ZWU&HT)845C6[VW38D$IL]I&MI)
MFIO:?;[1D*L?%N :'%;Z%9Q[JRE4U"5@6(X^^IKT2H.WW%)-I2$)<<\U:D-]
MZI6Q)F74^H%653<87>+3.-J?'[V0C!\+B6+-M%<>4V[9.O--M0R=0TDD+2T9
MNN==-%;=",!-<@<<-9O+H+F)<2\>R?&7WWZBY@)8==;1-9./);-N2VXVI+C9
MZ=4ZD9$9>P9"H(\/5?"H<7JZ3++FKN,67:)B9$RJ.N<_&O9"Y$MI_>T;:C4I
M6J5[-4J+<74$U9=3P#CM161JMBTG+9C8G/PA"U=SN.'9/)?6^>B"+O4FG1/V
M/M 5<)WA\QR=6KK5VLY+:\-B8 :R[G=Z#!<-U$CJC^&,ST5]C[0%7??\#8_D
M,3-(<FTG-(S9-&F<IONM6/D[W?<]SJ@_X3NR[S=K[6@%6=*XF=0>12L<RNTQ
MZWR&Y1?NSX11EFAYN*F+W"FWFEI<8,DDLT*Z[B+KTT 1<7@&EK(N$IIKVR@6
MN%2YTQFU0;"WY?KA>^>AY*FS01/'^X26PNSV0*I"3PG02L4R?%56,U",DOI.
M4IGMJ;3)A64B2B6A3!DC3:TXVG:2B/4M2,"J(<\/T290Y176^5VMC>Y5-KK6
M5D+R8J)3,ZI[ON%M-M,H;)!=TDMAIZ)Z%[(%7=E/ <'*I/I,G*;>(NTKHE/F
M91%1VO7T:#KL5)T:^YN*W*2I;.WS%&@B(@*N[*>)[5JKY!E<=6[E1E>;HJVF
M7U.''8@)K&6H>K"F$]XG[@E1]OONS0!L6UH*V[Q^9C%LA4JHL(;E=,;<6HUN
M1WFS:61KUW;C29^=KKKU!#6<7@5@\1FXC?9E?7<910$T<N2ZPV]4^IU;X;D7
MNFDD3R3T[QU6IN$1$8)J[H? ]0W#C':WMA:Y"625^7VE]([E,B;-JM"8:6E#
M9(0PE"202$$6A=A@50>=\0W_ "!RS:S5VMC0X7.Q2+16,FO5&_V\G)LI<B&I
M+R'%$7=.%]T2DMN[34]3(!*Y1X>,8R&>\Y"M;&CHK6+7U^3T->MM,6TB4Y$F
M(VXM:%.-[4$32E-K(U-^;T[0*K*_Q1CTUS/BGNOOP^0FV&;:+JA"66XT%,!)
M,&E.I'L02M5:Z* 5>O\ #]")B_1DV5VV22,@Q\L4>DS"BM+CU[:EFUW),LH(
ME(WZZKW;E:J5KJ!5E2^$Y3\''7HN;6\',L?AOU7RKCHB)ERZV4X2U1GVS:-H
MTHVH[H]NJ#22NJNH%6S8M<VQ5,U,EYVP:;CIBO/S#2X](2E!(4IXTI22E++J
MO1)$9GV AJ_$. J7%+%F6N^M+B%40IE7B5?/6TMJGB6)EWZ65)02UJ,B)M*W
M%&9((D@FJ3J^&J6KK>/:QJQEK:X[=4]6K5W>Z0:X[D<R>T3V:.&?FZ 51DK@
M2I.,X]3WUA4Y*UD-GE55?QR87(AR;K5,IA*'&U(6PM"MII66I].H%7?:\**E
M.4UG4YI>U.4UM:='.R-#K$F=8URG.^-$@WVEIWI<-2FW$)(T;C_8%67DG&MG
MMS#(,1MWV<VR#'6L?@R9+O=(9>B)>)F3WK2-Z7-SQJ4I)=#+4B 7FHK%U]%
MIYDERP<BQ&HDB9(4:WI"FVR;4XXH^IJ7IN49^4P0USC7!E=CM-B]&O(+"Q@X
M=='=4)228)3+11W8Z(9FAM.YM).J7N/SC5Y=.@)JQ>1O#_6\@VUW8%DMK0Q,
MGAQ(.25]=Z.;,XJY:E1EK-YIQ231N-)D@RW%T]G452UMQ#Z^S.OR6[RFUGT5
M59M7U;BSWH_H4>SCM*::<0XEHGB;02C436_;N/4]>P!&,< U3.-V.+_*&S]
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M;26K6N:6I26G>\0HT*(EJ1WB-%;%&GL,$U67&^/JC%LIR+**QQQ*\ACU<1R
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M>NI[DI/;YQ:EU HV4"
M
M
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M$E>GLD"$J
M
M
M                               .#KK3#:GGUI;:06Y;BS)*4D7E,SZ$
M X1I468WWT-]N0SJ:>\:6E:=2[2U29D Y//,QF7)$AQ+,=I)K==<42$)2DM3
M-2CT(B(O* YI4E:26@R4A1$:5$>I&1]AD8#Z X-/,ODHV7$N$A2FUFA1*VK0
M>BDGIV&1]I .8  BKK):/'G:MBYF)BOW4Q%95MJ)2E/RW4J6EM)()6GFH49J
M/1)>4P$AZ3&.2<,GD>ED@G3C[B[PFS/:2MNNNW4M-0!,F.M]R*AY"I+24K=9
M)1&M"5Z[34G74B/0]->W0!'T&2T>41I,R@F)G1(DI^O?>;)1(*3$6;;J"-1%
MNVJ+3<G5)^0P$J  .*UH:0IQQ1(;01J6M1Z)))=3,S/L(@!"T.H2XVHEMK(E
M(6D]4FD^I&1EVD8#D X//,QVE/2'$M,HZK<<424D7MF?0@'05G6G$7/*8QZ"
MWKOE=ZCN4Z=#U7KH7UP&4      .#SS,=ER1(<2TPTDW'77#)*$(26IJ49]"
M(BZF9@.,:5&FQFID-Y$B)(0EUB0RHG&W&UEJE25),R,C(]2,@#TF-Z2</OD>
MED@G3C[B[SNS/:2]NNNW4M-0': ZH\F/,91)B/(?CN=6WFE$M"B(].BDF9'U
M /28WI)P^^1Z62"=./N+O.[,]I+VZZ[=2TU =H#J])C>D%#[Y'I9H[TF-Q=Y
MW9'MW;===NO34!V@.I$F.X^Y&;>0J2R25/,I41K03FNTU)(]2W:'IKV@.T
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MV9"V_P"$2TXE9I^J23/0!V1I,:8RF3$>1(CKUV/-*):%:'H>BDF9'U+0!V@
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MM<0ER%.7$GNUM2'DFE;K:"5H@OL0&S>*LKS.?E>>X)FTV):V.(2*TV+>#%.
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M+\/EV[+>?E96[D*\DNJ&PS>3;-,L*DUV-]XXS&8:B-)07>.&T2MVG1)GJ:C
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M46I^0B%7;4\&5-1E$/.6;B8YF+5O86]C:K)O=-8LVDL+@N)TT*.VAMHF4_\
M9FC<GJ8%5VPO'9^+4#--9WTW))C3CRU6UF:#DK)UQ2TI5L(BT01[2^I^P"%@
M          '%Q'>-J;,S22R-.Y)Z*+4M-2/R& T]6<!-LVC=CD.9763)JX-C
M6XNBT4PXY6M6[1LR'#>2V2WW>[\Q*G3/0O)V:$U4[E/A6PJL/J8N!R+R9DJ<
M;_1ZM%:B";4VM4TM31V!RS)+#*7"/>\S]T(E[2[=2%5R_0+ FXY8U-E:O-2K
MK%*K$9ZHR$&TVBJ0LN]9WEJ9J-9]%>0"KC?\ HNK>?)8R^SKJ"WF5UM<8^PU
M%5&E655W!-O*<6V;B4K*.V:VTJT-9;O(1 52$_A"MLI6?-2;N:>-\@LJ]942
M4,$U'G+::9]+9=-!N;R)E)I0HS1KVD?3050OT=6YM5E,+(\RM+NQRQNE9FV;
M[45IQI&/R?2&":0TVE!$K0DJW$9GU/74P*K7FW%S^39)$S#'<GGXEDK<%5/-
MG5R([_I58MWOB:4B2VXE*T+-2FW4EN3N5V^0+%E6*HRK"[7#)$]]AFVKW:N1
M8)V*D=V^T;2U]2))J4DSUZ:=00KG'/&U]@;C;,S.++(:2-!17P*>;'ALQXZ6
MN[)M:#CM(7JA"-A$:M-#/7KH"6Q 0 *AQ[@$'CO J[ 8$QZ;!KFGV6YD@D$\
MHI+SCQF9((D]#<,BZ>0!2F. &:BEQ6)B>5V6/Y%BU>]2M9!&:C.O2JV4X3SC
M#S3S:FS(ED2VS(M4'U[035V9EP/\J9,J1"S&VICNJ5K'<J4PB(\Y;18R5I;6
M\MQD]CA]XLG%-$G>D]NB>H%6;;<-/W5Y429^7V;F)U$FML6<5[J)Z,4RF0A+
M"VW^Z[YM!J03CB$K\Y1JZD1EH*L[&>+)>)Y,]95.6V;>'KES+)G#=D8X+<JQ
M4MQ[1TVC>[KO'%.H:)9$E9Z^SJ&=FW&%)GEY2V]V\Z;%1"N:U<!!([J1'OXR
M(KY+,R-1&E"/--.G:"%4;X*FU[=,[CN=W%':P*F-CMK81&HBEV-= 6HXW>(>
M:<0A]I*E(0^E.[0SUUU!-4S<\3/RLSD9EC>5V>,/VR(;>3Q8"(KB+(J[S6%F
MI]IPVG"0?=J6W[Y&A:>R%(:X6NLJY$SJRR2SG5V!V5[66!8^T48XMNFKB15-
MK6HTJ>;2E]K19)-.\D^T1@5;=S/';G)*QF+0Y+-Q6RCR$26[& W'?-1)2I)M
M.M26W$+;/=NV]/.(CU\AD*14< XU5Q\<ANSY4Z'10;R!)9?)LBG'DRDKFK=[
MM*=FJB/8ELB(B/0$U:[PSA3(Y&5Y-3VLZY5@D3#9O'=597:(3,DV9+Z22<)J
M*7GL-,MIT>?T6XI1%IHGH*MB7G E)?(GHD7$UGTV@JL=0MGNTK:51RO38LI)
M[3U63I),T^],BT\H%6$KP^M3:/,(%[EMC:7N9/U<Z=?N,1&7V9=*:#CK::9:
M0T22[M!;#3[WIKKU J[,SX&=S%Y,US-+2OLYU 6+Y/+C,P];:$2E.:N(4T:6
ME&M:S4;1%YI[2T("JSXUQ72X[9Y)8*D.V#.3UU543X4E*.Y*/3Q7(B2+:1&?
M>I=5OU_8 =?'7&ECQ^KT/Y86EWCD.,FOHJ2<F,3$&(VHC0GO&FDN.J0E)-H4
MM71'33LT#+R;C.ERG.\/SV<ZXFQP[T\HL9*4&S(*Q9)G[KN(U?<S+>C:?;V@
MA5:+P^8WC^'8=AL"REE#P[(6\ICRE$UWTF2RX^M+;WFZ;-'MFJ2(]$D":N;_
M  1#?K<QHE9%.]0Y;<LY$F ;<<R@SDSV[!\VE[-RB><:2G19F24]G74P*LJT
MX1J+6YM[IRUE-NV^0TV4.M)2V:$/T*&T-M)U+78YL\X^WV *B.$*=M4=16LO
M_9\V?Y!3JEKK,D=[NC>]_@B[T^OOO; JG>2./2Y A4Z(]Q)H+BALFKBJM8;;
M+SC4AIMQK0VWTK0I)I=5T,NW3ZAD(2\X3J+M>2K<M)3)Y+<U-](V);/NGJ5+
M"4(1J74G.X(U&?L] 35D5_$[U)FDS(\?RJRJL=M+!5W;8HPB,J'(LG4$EUSO
M7&E/)0Z9$MQM*M#5J>I>0)'DCCM?(#%&J+>R\>M,>L4V];8P4,NN)D(9=922
MD/I6A2='3W),NO8"%65P% CTM(BFR.PKLWHY\^X8S)+<=Z6].N=WK!3S+C9L
MJ0^2M-FWS=J>O0]2:NI?ANPV33T>-V<V988[1P+2*U!D*0M3]A=DLI-B\X:=
M52")Q?='IHV:M4Z 57'&\&MJ&RJ)LG+;*SAU=(U1KK9&PHTEYES<4YTB(S.0
M:2)"E:]?K@A=                     %>S3.,5X]I%9'F-BFLI4.ML*E*;
M==(G'CT06UE"U==/8 :Z^EAX?/GJS\3G_DP)H?2P\/GSU9^)S_R8"A]+#P^?
M/5GXG/\ R8"A]+#P^?/5GXG/_)@*'TL/#Y\]6?B<_P#)@*'TL/#Y\]6?B<_\
MF H?2P\/GSU9^)S_ ,F H?2P\/GSU9^)S_R8"A]+#P^?/5GXG/\ R8"A]+#P
M^?/5GXG/_)@*'TL/#Y\]6?B<_P#)@*'TL/#Y\]6?B<_\F H?2P\/GSU9^)S_
M ,F H?2P\/GSU9^)S_R8"A]+#P^?/5GXG/\ R8"A]+#P^?/5GXG/_)@*'TL/
M#Y\]6?B<_P#)@*'TL/#Y\]6?B<_\F H?2P\/GSU9^)S_ ,F H?2P\/GSU9^)
MS_R8"A]+#P^?/5GXG/\ R8"A]+#P^?/5GXG/_)@*'TL/#Y\]6?B<_P#)@*'T
ML/#Y\]6?B<_\F H?2P\/GSU9^)S_ ,F H?2P\/GSU9^)S_R8"A]+#P^?/5GX
MG/\ R8"A]+#P^?/5GXG/_)@*'TL/#Y\]6?B<_P#)@*'TL/#Y\]6?B<_\F H?
M2P\/GSU9^)S_ ,F H?2P\/GSU9^)S_R8"A]+#P^?/5GXG/\ R8"A]+#P^?/5
MGXG/_)@*'TL/#Y\]6?B<_P#)@*'TL/#Y\]6?B<_\F H?2P\/GSU9^)S_ ,F
MH?2P\/GSU9^)S_R8"A]+#P^?/5GXG/\ R8"A]+#P^?/5GXG/_)@*'TL/#Y\]
M6?B<_P#)@*'TL/#Y\]6?B<_\F H?2P\/GSU9^)S_ ,F H?2P\/GSU9^)S_R8
M"A]+#P^?/5GXG/\ R8"A]+#P^?/5GXG/_)@*'TL/#Y\]6?B<_P#)@*'TL/#Y
M\]6?B<_\F H?2P\/GSU9^)S_ ,F H?2P\/GSU9^)S_R8"A]+#P^?/5GXG/\
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MSU9^)S_R8"A]+#P^?/5GXG/_ "8"A]+#P^?/5GXG/_)@*'TL/#Y\]6?B<_\
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MF&R9&1]2,C(@*OOZ .$_F%2?$FO< J?H X3^85)\2:]P"I^@#A/YA4GQ)KW
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M .$_F%2?$FO< J?H X3^85)\2:]P"I^@#A/YA4GQ)KW *GZ .$_F%2?$FO<
MJ?H X3^85)\2:]P"I^@#A/YA4GQ)KW *GZ .$_F%2?$FO< J?H X3^85)\2:
M]P"I^@#A/YA4GQ)KW *GZ .$_F%2?$FO< J?H X3^85)\2:]P"I^@#A/YA4G
MQ)KW *GZ .$_F%2?$FO< J?H X3^85)\2:]P"I^@#A/YA4GQ)KW *GZ .$_F
M%2?$FO< J?H X3^85)\2:]P"I^@#A/YA4GQ)KW *GZ .$_F%2?$FO< J?H X
M3^85)\2:]P"I^@#A/YA4GQ)KW *GZ .$_F%2?$FO< J?H X3^85)\2:]P"I^
M@#A/YA4GQ)KW *GZ .$_F%2?$FO< J?H X3^85)\2:]P"I^@#A/YA4GQ)KW
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M, @
M4?F;]4.>_P#+UM^).@0U_P"#?_T^8S_KK+\??!,M\ A4.5OU79O_ %!:_B3H
M#5_@Q_4#1?SJQ_&W 3+?X(
M                   &J_$G^HK.OZL7_IH!,.GPQ_J%P?\ F*OP[H$MM @
M         'G3QM_J*E_UG _TU F&Z< _,3%_ZH@?BS8(6(
M '%:T-H4XXHD-H(U+6H]"(BZF9F?81 //_!2%\DY[F?/DU)JKISJL:P<ED>B
M::O7]U>01]G?NEN]E*B6788)EZ"!                #SUF7_YVO$'C^ M_
M=L0XT0WDV2EVM.W#Q?[!'5VEJA)][IV&DUI,$O0H(
M       !K[G7]3&?_P!067XLL$PJ/A"_]/6(?_1'_B4D"6[P0B<H_-FY_F,K
M\"H!Y]\"WZDWOZ[F_@HX)EZ8!
M                       H_,WZH<]_Y>MOQ)T"&O\ P;_^GS&?]=9?C[X)
MEO@$*ARM^J[-_P"H+7\2= :O\&/Z@:+^=6/XVX"9;_!
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M"_\ 3UB'_P!$?^)20);O!")RC\V;G^8ROP*@'GWP+?J3>_KN;^"C@F7I@$
M                                                       "C\S?
MJASW_EZV_$G0(:_\&_\ Z?,9_P!=9?C[X)EO@$*ARM^J[-_Z@M?Q)T!J_P &
M/Z@:+^=6/XVX"9;_  0
M                -5^)/]16=?U8O_30"8=/AC_4+@_\Q5^'= EMH$
M     \Z>-O\ 45+_ *S@?Z:@3#=. ?F)B_\ 5$#\6;!"Q
M \]<?_\ YV>><FY.<^[8I@*5XGB)]K;D\RUL)2.NFI$HVR4712%I]@$O0H(
M               >>^:S5R?R9AO!$4^\IDJ+*\Z)/O?5L)>D>.O0^QYWHHNT
MM4*!,/09$22)*2T270B+L(@0^@                           U]SK^IC
M/_Z@LOQ98)A4?"%_Z>L0_P#HC_Q*2!+=X(1.4?FS<_S&5^!4 \^^!;]2;W]=
MS?P4<$R], @
M        4?F;]4.>_P#+UM^).@0U_P"#?_T^8S_KK+\??!,M\ A4.5OU79O_
M %!:_B3H#5_@Q_4#1?SJQ_&W 3+?X(
M                           &J_$G^HK.OZL7_IH!,.GPQ_J%P?\ F*OP
M[H$MM @          'G3QM_J*E_UG _TU F&Z< _,3%_ZH@?BS8(6(
M        :O\ $!G\OC[C:?*IMR\MNEMT>,L-?PR[*PU;;-LOW3:=SA>R:2+R
M@F$WQ+@$7C'CRBPN/M4]7QR.>^GL>FO&;DAS4^IDIQ2MNO8G0O("%U
M         !A7-O7T%1/O;9XH]761W9DU]78AB.@W%J_821@-*^&JIL+J%D?-
M>1LFWD/(TTY<1ISJN-21=6H3):^3:6[4O?)V&"9;W!
M          #7W.OZF,__ *@LOQ98)A4?"%_Z>L0_^B/_ !*2!+=X(1.4?FS<
M_P QE?@5 //O@6_4F]_7<W\%'!,O3 (
M                            %'YF_5#GO_+UM^).@0U_X-__ $^8S_KK
M+\??!,M\ A4.5OU79O\ U!:_B3H#5_@Q_4#1?SJQ_&W 3+?X(
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MGK$/_HC_ ,2D@2W>"$3E'YLW/\QE?@5 //O@6_4F]_7<W\%'!,O3 (
M                                                   %'YF_5#GO
M_+UM^).@0U_X-_\ T^8S_KK+\??!,M\ A4.5OU79O_4%K^).@-7^#']0-%_.
MK'\;<!,M_@@
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MDWOZ[F_@HX)EZ8!
M             H_,WZH<]_Y>MOQ)T"&O_!O_ .GS&?\ 767X^^"9;X!"H<K?
MJNS?^H+7\2= :O\ !C^H&B_G5C^-N F6_P $
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M&L/M< XPQO#KQ;+EM4QC8E+BJ4MDU&ZM?F*4E!F6BB[4D"J]
M
M
M
M
M
M
M
M
M                         .M^0Q&;-Z2ZAEHNAN.*)"2U]L]"$Q%5[++K
MYI;%9]QS2I*DDI)DI*BU(RZD9&(5F*/H(?#4DC))F1*5T21GU/3KT!- S))&
MI1Z$74S/L(@0)4E1$I)D:3ZD9=2,@3,4-Z=VS<6_3=MUZZ=FN@%)I5]!!J7U
MNT   'Q*TK+<A1*+LU(]2U($S$QS?00 /B5H61FA1*(CT,R/7J7D!,Q,<PU)
M3IN,BW'HG4]-3]@@(B9?00^)6E6NU1*VGM5H>NAEY#!,Q,/H(
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M3$:;N/N2[X\J-+;[V(\V^UJ:=[2B6G4NTM4F9")B8YL5^.ZR:71,3[KM$*
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MQ;8.X].OO4^>9:;N@YV::W=OO\W@^K99R9ZS=ENX1QR^G\L\.Y91@<@
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M<Q;^:2?PB!QNE>C=Y7R;^6GU&?Z5OR2D?"%_0^<?]R_!R13JGI6>_P#>:O\
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MEEW]6WX'TSJ74[NG[_:9HXQ&WQ1='SK9B=4?!\=)=/#>3S,JY-O)5M'<BY%
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MUYBJOZ4@_P X:_TR'<NY2^Q[CZJ[R3\CTQXN_P X,+_S)7X5D<3I?HWOC_\
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M *!P'Q*[FY @
M             8[\&')D19<AE#DF$I3D1U1:J:6X@VU&D_(9I4:?J&)BZ8BG
M>RV9;[;;K8FD7<_=I-?E8L['J2S3/18069";-EN+/)Q.O?,LFLVTJ_S#6HT^
MP9ZD+6WW12D\F?%O,V+1HNFWPYFZWW)FE9]^D5[W;5U%;2US-35QD1JYA)H:
MCH+S2)1F:M==3,U&9FHSZF9ZGU$773=-9YL>?<Y,^2<F2Z;KI[?N^+N0D/CG
M!:]F='AT,1IBQV%,;)O5*T-K[Q""(]=J$K\Y*$Z)(_(,L[C)-*S/!T<O6]]D
MFVZ[+=,V>CQ[XI,^[,QPK/%+RJ&FG3V+29!:?L(QMFQ(6DC6@V36:#(_\DW%
M&7L:C'%]T12)X-''N\V/'..VZ8MNK6/+2OPTCX'Q6/TBK8KXX#)W!;3*;M+O
M=4-K:(]?9)#BT_4/0-=U-->"8WF:,7@ZIT?-[.<3\L1/EAQAXW0U]K+O(->S
M'MIQ&4N6VDDK<W;35KI^Z-"=WLZ%J)G)=,1$SPA.7?9\F*W%??,V6<H[(^ZL
MT[D=9<>X5;LLL6-)%?9CNOR&4&DTD2Y;ANOEYIEJEQ9[EH/S5'VD+VY\EO*6
MW@ZSO<,S-F6Z)F+8G\F*6^_;'")YQV2FE5=<J5#FG%;]*@(<:A.DDB-EMXDD
MM*-.PE$A.I>T,6J:3'>YT;C)%MUNJ:7S$W>[,5I7X90,?C?!HL]VSCTK#<Q[
MO^]66_:KTM*TO:HW;?/):M>GE&6=QDF*5=._K>]OQQCNR3-L:>[\6FGCSX4A
M*/8SC\A,!$BMCNHK&G(T!"VTJ2TP\UW#C:2/IL4WYJDGT,A2,ET5X\VE;OMQ
M;-TQ?=&N8F[CSF)U1/EB>,2@_P!&N+Q*IVEI(+-97S),9ZS0T@UJD,Q5DXED
MU*5JE&J221:Z)29Z$6HR^L7S-9FL]CI?OS=7Y8RY;IONMMNBVL^C-T4U4IS[
M>^9I6>"P65%37*VUVL%F8MEM]EHWDDO:U+;[IY):^1:/-5[)##;?=;RERL&[
MS8(F,=TVUFV>'?;-;9]Z>,.F/B^.Q'8[\6MCM.Q395&6A!$;9QF%Q6C3[&QI
MQ;:?\DS(3.2Z><_=S9+]_N+XF+KYF+JUX\]5T73\-T1,^[#D_C-!*;L69%>R
MXS;N(>LVU)\R0XT2$I4X789D3:2_8((R713CRY%F^SV39-M\Q..)BW^K$UY?
M#/PLMRN@NV#-JY'0JQCM.1V)6GW1++YH4M!'^Y4;:#,O:%=4TIV->,]\8YQQ
M,Z;IB9CLK%:3\<_"@U\>80Y8SK5=%$5/LD.MS731T<3(3M>,T^])3A=%J(B4
MKRF8R^/DI$5FD.E'6=[&.W'&6[39,3;QY:?1]VEO9'*.Q)VF.T=TIA=K 9EJ
MC)6B.;J25L2X:#41>T9MH/3_ "2]@8[<EUO*6G@WN?!$QCOFW5SIVTK^&?AE
MC.8=BSJ7T.5$52)2Y;LA/=EHXY8D125*]DW2+SS\HMXM_?W?%R98ZGNHF)C)
M=YL6Q''E%GH?V>QEW5#3Y%7JJKN&W-KUJ0LV'==N]M1*0HM#(R,C+4C(5LON
MLFL326':[O-MLGB8KIMN[X]WF@W^,,#DQ8D)^D97'@DZF(1J<W(2^LG'$DHE
M[C)2BW:&?:,L;C)$S->;I6=>WUMUUT99K?2O+C2*1PI3DG&J&G9.L4W#;)=,
MVIFK49&I4="VR:42#,S,M4%MU]@8IONX\>?-S;MWFNUUNG])-;_ZW&O'W^+X
MQC]+&M';J/!9;MG]YO2TI(G%&ZEI"]3_ ,HF&B/V=I!-]TQ2O OWF:[%&*;I
MFR*4CLX:ICX-5WPRA97&/'\U$5J3CT-;,)*VXS)-[6TMNNF^M&Q)DDT*<4:C
M29::F,L;C)'XT\71Q]>W^.;IMS75NI,S7C6(TQ->^G"O-8I-;7RX[423&;<B
ML.,O,LFDMB'(JTNLJ21=AH4A*D^QH,,73$U<FS/DLNFZV9B9B8F>^+HI=\,3
M,2P'L2QF1'5%>JHRXR_2-S1MEM/TQ]$E_I_]D=;0XKVR(7C+?$UK]T<&U;U'
M<VW:HR75\WM^;;-MOP6S,1[DLQ516+L_72HK?K;T<X7IA%H[Z,I9.&V:BZFG
M<6XB\ABFJ:4[&O&YR1B\+5.C5JT]FJE*^6CI^3E$4*NK2KV2@U#C+U8P2")$
M=R,6C:FR\AI(S(A/B75F:\9YLGKN?7??KG5DB8NGYT7<Z^5AV6$XG;W,?(+*
MHCR;F*:#9EK3YVK2MS>XB,B7L/JC>1[3ZEH+6YK[;=,3P9\'5=UAPSALR76V
M75K'EYT[J]M.?:RCQJ@55(HU5[)U+;A/-Q#3JVEU+O?DLO\ *[SS]?9$>)=6
MM>+#&^SQEG+KG7,4KVTIIIY*</(^-8OCS!))FMCM[40VD[4$7F5B^\B)^HRH
M]4>P$Y+I[>_X^:;M_N+N=\SQOGG_ (D4O_M1S[W<Q14\:H70L0FFZ9;;K*X*
M4D3)MOFHW$FGV%;E:_5$3?=-VJO%COW>:[+XTW3-]8G5VUCE\%$"CB_ 6Z]R
MK11L% <=;D*8W.&1.L)4AM23->J32E:D^;IT,9?6<E:UXNG/7]_.2,DY9U1$
MQ7ARFDSV<>,0E(6(XW7U2*.)7-(J4/HEIB*W.([]MQ+R5^>9]26E*B]LA2<M
MTS69XM/+U'<Y,OBW7SKIIKRX3%)CA[DT=\S':.PL&;6; 9?LH_=]S)6G5Q/<
M+-QO0_\ )4HU)]@S%8R71%(G@Q8M[GQXYQV7S%LUK'9QBD_#'"6%:X1B=VA]
M%I4L2"DR4SGST-"ERFVNX2Z:D&1[B;\S77L%[<U]O*6QM^J[O!,3CR3&FW3'
MT9G53CV:N/E2M95UM+ 8JZB*U"KHR=K$9A!-MH(S,ST(O9,S,S\I]1CNNFZ:
MSQEI9]QDSY)R9+INNNYS/&66*L                            #!F75/
M7NDQ/L8T5\TDLFGWFVEFD^A'HI1'IT 8_P J,9_\9@_&F?M@#Y48S_XS!^-,
M_; !Y3C)%J=U (B[3]*9^V 2B%H<0EQM1+;61*0M)ZD9'U(R,NTC <@ !5>3
M?U<9=_4UA^+.#8V_UMOECY7;Z%_$=O\ K<?YT/.O!GZ@^3/]58?\-(=C>?:,
M?O?*^K^UG\>V7EQ_M%J\'_YE7W]:?^[M#!U7ZR/(XG\R?MN+]7_>N4+Q@?GK
M0_U7_P"\.C;Z5]7/E>G_ );?8LOZS^[:G_#;^J7D#_O'XB8P]0^NL^[M<SVX
M_BNT_)_:/->,?G)3?SZ-^&2.WD]&?(^N[_[-D^A=\DO1_BF_6#@_^87XTD<7
MIOU=_P!W8^2^P'\/W7E_N2>(;]>> _YE=_Q)P-C]GO\ ?^0]C/X)NO+D_90Z
MO$?^NO!_]3 _XBZ)V'U%_O\ R+^Q/\&W/EO_ &</2><_F5DG]5SOQ=8XN'ZR
MWRP^0]*^VX?UEGYT/SBQC\Y*;^?1OPR1[/)Z,^1^M=_]FR?0N^26^O&%^=N/
M?U<O\.H<GI7H7>5\R_EK]DS?3C\V$UX6/S&SS_J_BSHQ=2^LL<_V_P#MVU^[
M\:U%^'O]4O*7\R>_$7QDWWUV/R_?;GME_%=C]*/VEK*\/WZE.2_]3-_X<H5W
MWU^/WOE8?;'^,[+RV?M%C\'OYI9#_6*/P"1AZKZ=OD<C^97VO#]"?SI4SQA?
MG;CW]7+_  ZAL]*]"[RO0_RU^R9OIQ^;"9\,7ZML^_Z_XHL8NH_6V?=VN?[>
M?Q':^]^?#S/0_P!.5G\[8_")';O]&?(^P;SZB_Z-WR/2GBP_/'"?\QS\8;'%
MZ9Z%[Y%_+S['N?+'YLGB1_7%@?\ F0_Q]0;#ZB_W_D/8C^$;KRW_ +-U>)K]
M;6$_ZF-^/*$]/^IO^[L7]A?X5N?+=^SAZ8S#\TK[^KIGX!8XF+TX\L/CW3?M
M>+Z=GYT/S8H?Z<K/YVQ^$2/:7^C/D?KO>?47_1N^1Z#\8GYRXU_,7OPPY'2O
M1N\KY9_+7[-F^G'R);PF_FOG7_=_P+XQ]3].QI?S$^U;7\K\ZU&>'#]6W*'\
MR/\ %)(R;_ZW'Y?OPW/;;^(['Z7]^QD^'3]4O)/^I?\ Q%P5W_UV/[NUA]M?
MXKL_+;^TA/>#O\V\E_GS/X$QAZKZ5OD<O^97VG#]"?E57QB?G+C7\Q>_##8Z
M5Z-WE=O^6OV;-]./D2WA8_,;//\ J_BSHQ]2^LL:7M_]NVOW?C6O,55_2D'^
M<-?Z9#N7<I?8]Q]5=Y)^1Z8\7?YP87_F2OPK(XG2_1O?'_Y<?9]SY;?DN/$W
M^M'!?\QG\=#IWU-_W=A["?PS=>6?S'5XI/UDX5_J6_QL3TWZJ[[NQ;V!_AVY
M\L_F/3N3_FU<_P QE?@5#AX_2CROCFP^TX_IV_+#\SZK^E(/\X:_TR'MKN4O
MV#N/JKO)/R/1GC&_IS%OYI)_"('&Z5Z-WE?)OY:?49_I6_)*1\(7]#YQ_P!R
M_!R13JGI6>_]YJ_S(^NVWY?RV(OPS?F-R?\ S)O\6EC)U#ZS'Y?P-SVZ^V[+
MZ4_G8V?X8?U?<A?YG_NKHIU'ZRS[NUK>WG\0VGE_OVI7P<_T'E/\[C?@UC'U
M7TK?(T?YE_7X/HW?+"O>,;^G,6_FDG\(@9NE>C=Y75_EI]1G^E;\DI'PF_FO
MG7_=_P "^*=3].QJ_P Q/M6U_*_.M>78?^^1_P#6H_TB'=GD^S9?0GR2].^,
M7^D,,_S)_P#I1AP^E<KO>^^^.?RT^KW/EL_OO5;?\&CZA?\ 0. ^)7<W($
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MKUZC5SQ'FS2E8>:ZQ99,XLMML63EQQ==;'"*ZKK:Q'9%T6Q=2.''AP7 :S@
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M,\8W].8M_-)/X1 XW2O1N\KY-_+3ZC/]*WY)2/A"_H?./^Y?@Y(IU3TK/?\
MO-7^9'UVV_+^6Q%^&;\QN3_YDW^+2QDZA]9C\OX&Y[=?;=E]*?SL;/\ ##^K
M[D+_ #/_ '5T4ZC]99]W:UO;S^(;3R_W[4KX.?Z#RG^=QOP:QCZKZ5OD:/\
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M^#L[U+7_ .$R#^L1 F'G;_ZGJE)0>05:%N-VI(U>4R),S0OVP3+VN"H
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MA?G;CW]7+_#J')Z5Z%WE?,OY:_9,WTX_-A->%C\QL\_ZOXLZ,74OK+'/]O\
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M_P#K@N3?,F#\<>_DP11[OBO'(C,OF6TW4)69%U(MQ$8*NT
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M)"-IDKO$IZZ^P*;S<VYIB8BE&I[6>T&'J^7'?BMNMT6S'G4[_<F4-SIPG?\
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MW+&6RZ[Q----.S5WS[K<R2VI2D^TB(AS7S^>;Z"
M
M                                   %-Y9Q:RS?C;)L2IU-(M+B [$B
MKDJ4ADG'"Z;U)2HR+ZB3 :G\*?!F9<*1LJ9R]^ \JZ<@KB>KG7'B(HJ7R7O[
MQIK3^%3IIKY03,O10(
M
M
M
M
M
M
M
M      0.5YKB>"U[5IE]O&IJ]YY,9E^6LD)6\LC,DI\IGH1J/V"(S/H0#+GY
M'0U:*URPL8\=NXD-0JI:W$Z29#Z5+;;:,O?*4E*E%IY" 0^*<F8'G$M^!BE[
M&M)L9HGWX[)J)Q+1JV$O:M*3V[NFOL@.V%R'@]BVR]!OH;[4CT4V%H=(R7ZP
ME.08VWV>]D-+93[*DF0#!7R[QDW95M0YE5>BQMS,JUE3Q)[\RD.1?-4?F]7F
MG&D]>JTF1:F N@
M
M
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MYAS[3#\32C$FH*WHU_.;N),V1$>E$V:HA(6X:U.)<;,B,]3/30P]Q@J
M
M
M
M
M
M
M
M
M
M
M
M
M
9                             #__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>px_25avadelpxy02pg02-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 px_25avadelpxy02pg02-4c.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !&
M  #_X0,Q:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 Y+C$M8S P,B W.2YF,S4T969C-S L(#(P,C,O,3$O
M,#DM,3(Z,#4Z-3,@(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T
M<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<#TB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(@>&UL;G,Z>&UP34T](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B('AM;&YS.G-T4F5F/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(B!X;7 Z
M0W)E871O<E1O;VP](D%D;V)E(%!H;W1O<VAO<" R-2XU("A-86-I;G1O<V@I
M(B!X;7!-33I);G-T86YC94E$/2)X;7 N:6ED.CA!.3=#.4)&0C@S1C$Q1C!!
M130W0CA!138Q,C<P,SDT(B!X;7!-33I$;V-U;65N=$E$/2)X;7 N9&ED.CA!
M.3=#.4,P0C@S1C$Q1C!!130W0CA!138Q,C<P,SDT(CX@/'AM<$U-.D1E<FEV
M961&<F]M('-T4F5F.FEN<W1A;F-E240](GAM<"YI:60Z.$$Y-T,Y0D1".#-&
M,3%&,$%%-#=".$%%-C$R-S S.30B('-T4F5F.F1O8W5M96YT240](GAM<"YD
M:60Z.$$Y-T,Y0D5".#-&,3%&,$%%-#=".$%%-C$R-S S.30B+SX@/"]R9&8Z
M1&5S8W)I<'1I;VX^(#PO<F1F.E)$1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME
M="!E;F0](G(B/S[_[@ .061O8F4 9,     !_]L A  $ P,# P,$ P,$!@0#
M! 8'!00$!0<(!@8'!@8("@@)"0D)" H*# P,# P*# P-#0P,$1$1$1$4%!04
M%!04%!04 00%!0@'" \*"@\4#@X.%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 9R!/L# 1$  A$! Q$!
M_\0 X0 !  (" P$!              8'! 4" P@!"0$! 0$! 0$! 0
M      $" P0%!@<0   & 0," P(("@4'!P8!'0 ! @,$!081$@<A$S$B"$$4
M46$RTA465AAQD=%"DB-3TY07@5)4E5=B,Y,DM%5UH7*R<S0W.+&"0[-T)36U
M-G;!8W?AA-2%HD3$129'"?"#HV1E*!FEQ68GAQ$!  (! 08% P,"! ,' @<
M  $1 @,A,4$2! 51H5(4%6$3!G$B,H$S\+$C-)%R-<'1\4*"LD/ATI)3<X/3
M%C;_V@ , P$  A$#$0 _ /?P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M4!OZRP8MJV':QB4F-.8:DLI<+:LD/():246IZ'H?4!E
M
M
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MS'>9O:<<\NX:=;:P8Z9B;BO;,H;:5EN0A]9.O-'W"U[:FW/%)I-/B9"7H4$
M
M
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MXZO\VD<?4UZQ.R:/&3,-F.?>96VHC4HD/(W(-2$Z*6G=J1*+X]"4G (
M
M
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M6UD@@
M
M
M
M
M
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M^M$F,N>U5$K=(]T;5L-U22UVHW="-6FIZZ:Z& W
M
M
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MMNFA /50(
M
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MTUZ@ML2%Z;N3&.**[#I*ZH[Z-G[>62%,/+1$.O3'-I7;_5$9*WGY6]OR?;[
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M&,0&,4M$V:LIHT/-VMA'8<);419'IJC0B1YR+:G7JKKN%O4H(
M
M
M                                                         PK>
MGJK^MDTUY"9L:J8GMRH4IM+K+B-2/12%$9'U+4!SK:RNIX+%940V8%;&3LC0
MXK:&&&T>.U"$$24EU]A ,H
M
M
M
M
M
M
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M/TY\B76;XA84V7+)><878/X_?O%_Z=R*>U$C\*R(TJ^%:5'H1&1 2N($
M
M
M                                            =4G_ +,]_P Q7_D,
M:P_E#GJ?QG]%6\.U<6ZXG^B9Z35#G*F,/$D]JMCBS29D?L,O8/U/?=;+2[AS
MX[\>67X/\4Z;#J.S_:S_ (Y\\3_66?@/#]5@ML_<HG.V$M:%,QNXA+26FUF1
MJU(C/<H]-->GX!Y^Y=\U.LTXT^6,8WSQMZ^R?BNCVW6G5C.<\JJ+BJC_ +9^
MODTM9=Q,7S;E7)+%*U0*>&S8RD-$1N&S%C*>42"4:2-1I3TU,AT[A_T_I_\
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M#Z5&W+BSY7Y$CITHLKRB0NG<Z[7F(SCRNZGX4J[Y%K\)&7L!)>CP0
M
M
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MEJ1Z#S/<WIQHQDX1LHT>ZNEM+S_\[IU_I ?5,LK:["VTJ9T(NV9$:="\"T\
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M^I@-H   !\0   !GIU/P
M
M                                                   !YO\ 6)BD
M3^6=MR-'GV4+(Z-F%%@^YS7H\;9(L&6UFME!DE2MKJBW>/A\ +#9.9'_ "7F
ML\5\5XO;9]D+\=W)K.+,MMJHD)1I8)7O,I+FJEJ;T;801=>OYW4,VU]1;:\<
MP&]PG%Y&32,_>DQ(%7[TU ?8E1$F3C3BG4J1JEQ*D+4:B21)-6IEH!28<2\G
M.<F5-L[84CN.9%CUF_2WE,\\B5V9<<DJ/8\V24N(,E=%$1=2/Q+0S"A^9I&
MO>HM5;RCD\['\5+$H[\,XDV3#0JP.>ZDB/L$K4S;W^)>P%A=]D61<5XA38]Q
MGB<W.%-K=:;;F6S4=;3:E*?-;\N9N,R,U*)!$1^Q/0M 1#I'J64WQ]19A&PZ
M5)O;;)"PV1C)2FT/L6OZTC0AXVS2YYFR271/RNNF@%-;=9%F%SR[P&[E5.YB
MME.=RQ5CC13D3VDG%@DAA:W&22VX9I,UIZ>7=^$!)\#YLR?D&^7]"8!(/C]4
MN= C9:=C&,S?KTKU[T/;W&DN*3L29J/Q("E,<,9J6(ERYS1R!B<B+.AVMC%E
M7IV29LCO*E,)11MQR5I^J<4@DOD6PR/3HE(+*Z<0YQM[.[LL5SO"Y.&Y7'J%
MY%5U[TQJ:W-KV]25HZVA!-NI5T4VI.I=?@!*0^1S7R+GW#F7976\=2J>E>QR
M7)J+<KB.3KCIZL/+:22$.(*.V;DA*ST-?;T26JB I.?39<9+;<1XV614*J5$
M2OA,5DE<MJ8=C$*,V:9FC?5KN&9_JW/,0$JXYXXTI7^3\#EE97,=6;W9P;IF
M-9/LL]EF)Y290D]&SU0DSV_'\($-[,YK5QY](X_BN&6F2\<\=*9J\KRTYS:G
MHJTI2;A-M/$;DI3"5%WC)2=OMT3HHQ3=YASGD5?F[6"\>X,YF]C(I(^2,2&;
M)BO9.'(>4UN,WVS(B+1)I,E&:C5II[0*=R^9\LG\HW''.+8"[<Q<=FUD:_O_
M *28C,18UFTATW^TXWO6;9*7^K09FHD&?3P IPON;,LQ3,:ZJR?CN5781;WC
M>-5V5'8Q7ENRI#BD,.^Y-D:TM.;342E+UV^S7R@4XVW.M]]<+>BPKC^PR['\
M8F,5F37<&2RVXQ+?V[FXT59;Y!M;OUNBD[>NNB?,8ITYIZ@;'';_ "&'C>#S
M<HQC"4MJS:_C2F8Y0C<03RDL,N$9R%--^=W:I.S\[0NH%+DJ[*%<UD.XK7BD
M5U@PU+AOIUVN,/H)Q"BU]AI,C!%(>J9ER=4\<TOO<F)#NLYIJN>N$^N*\J++
M1(;<02VS(RU(_P ?4%AH<=N[/@WD3.L!58V&1X? Q!W.Z"':2C?E1_<EK:?B
M(D+(SVNJ29IU+1.A=-=QJ"P87-C4R1Q/'^A%H_FE%D3$*]Y(R@>[0FYFT_U9
M=W=W-NI;/#7X@*4OQ7S/?X#76S]_BLV?@LS-;&#99LJ<TKW:3,E$TV7NJB-U
M3:"))+7N))>!:GT!:;#(;2"W<>IU[*8TJ[HJ^/CR%5:)CL11L>YK7VVG4[^T
M1K5N/:DR/VD8"<W/,MYB]GCG'N <?R<IL9.+1L@BQBM&XQLPT*[';<<D-K-1
MI))>?4U+49%IJ>H)2R>,<^KN4,%ILZJV%Q8ELVM7NKIDI;3K+JV'4&HB(E;5
MMJ(E:%J770@11/J/P3'L>K;GD&1E^0IY$LGVF\%KH]@YJW.)39-Q845DDFI)
MJ/5?B9$?];Y18>D,<.W/'JD\@))7QPH_TH2--I3.TGO:;>FF_=X BH?51W7,
M!HXC<F1%;G9-3PY+D-Y<9XV)#JFW$DM!D9:D8+".X\[.X-Y=LL$:M["YP"UQ
MB3DM=%MI*I;\*;6K43S;;J]3)M;:34?QF7P:F%;*AY#CG$5#ZI7LDM)&?.V,
M:TOVU2G%5TBJFSO=CA%&^0EM+:VR(B^2>NFGEVE6'ZCL#Q2NJ<CY(OLQOF,E
ME,)9P>LCV#C33%JAK1AF%'9(E*[SI$ISQ,BW'T\02%\8$K(E8/C:LN(RRDZR
M&=T2M"5[[V$=[=ITW;]=VG37P!'FNIX9QI/J(GX25MD!T5;CL6_8;5<2E+.:
MJ=VS-2]VIHVD1;0:MS]1F.XMCMA,NHN7Y OFJ^?BN8'41YSI$RX;S;*66&D$
MEI+)J)9J-T_^7Q$,[G.QAM9SA%9S7<RZ7C"31ONR%U3[[#3^3,J3W$O^ZZN]
MM#:B4T>FFX]/:8)".0,IS:?P?@F)IO)S+>>9<6/560.._P#O8\54^X9.&X1F
M9/&A&PM>NWH"K$XZK7^*>=;#B>ML9LW"+S'49'51K&0N6N'-CR?=7FVW'#-6
MUQ/ZQ7QZ C<\YRY<;,N'6XTEUAN1E;;4A#3BVTN-]A1[5DDR)2=2\# AVUO-
M.57G(=UAU)@3LJAQNU167V4+LX[#$9A;9.&_V7&R6LR+4S;09Z%IJKJ!35X_
MZDG+FWI)<S#)E;QGE5FJDQC-79+2TRIAK6VUW(9))QE#RT*2A:E'_P"704Z>
M,+RZ@W7.5K$@R<CLX&2K1!JD/)2\ZEJ.@D,MK>5M0E)'T+P(O !L*KGJ]:;S
MB!G&#NXUE>&4;F3?1)6+%@S+@H;6ORR66R2E6Y&SY*O^30"G'C[U 6^693C6
M/Y+@\C%X6:UKEKB-DY.9FIF-QV4ON$IMM"3:\A[T[CU,M-4EN I6/)W,^0<B
M5^,NTF+S8'&\G-:R%7Y@4YKMV/NDQ3;B%Q$$3B65J29H4HU),T==%= 6GK\&
M0
M
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M KW4#(
M
M
M #7,T%,Q=R<D9A-IO9D=J')GD7ZU<=A2EMMF?]5)K4>A?" V(          U
MA8[1ED1Y9[BU]9%0BJSL]OZ_W%+IODSN_J=P]^GP@-F
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MZ4AB7'(M5&TYL1YB(C/0MQ:)5YM4F0%+M!
M
M
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M:3ZEIT,$90
M
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M$!:4<?X#C?&>+Q<1Q1EQFGB*<<03SBGG5./+-:U*4KQ,S/V= 1)P
M
M
M
M
M
M
M
M
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M)*3Z:F236E1Z$*>H(LEF;%8F1S,V)#:'6C4E2%&AQ)*+5*B(R/0_ RU!'<
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MCZ=]U;;5)27_ ,W4LSU,M-'=WBDP7@GOK8Q-3J\,RJJFJK;>TEJPZ>\WKJ]
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M"/>&4&MSL;C6E&]1D1GT]FH,I,
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M(:A":NG)**8X9G%=A)0E*"2PI'R4[4I2:#(TGH734BT%MAQSQCAO%5">/87
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M4\.@Q^$U74U>V3,.&PG:VV@NO0O:9F9FHSZF?4^H(T:>-\61R&OE F7?K:Y
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M=M"4:^&A>&O4$38
M
M
M
M
M
M
M
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M7EE]&KJ#E*)MM/O$EC>3O;U,S[!'IM_.^("GH62Z;$9Y\BW&TA2R3X:[2,]
M1Y,Q[UD9.]40\TRKC=^%QM)EE ?R6!+.2EAW=M,S:-I)J(CZ>*=? C,^@-4E
MN;^HC.Z?DZUX^P3C_P"N2:F#&M'GHLPVGUQ9#3;AJ2CM+(]#=2E.W<9_ "4S
MIWJGQHN)*ODBFJ9,ZZNYWT)5XMN(I*K8CT4RI:4J\I%HHE)29JW)+0E*T(4^
MX-SUF616.2X'DF%ECW+5/6KMJFC>D[XMBT22-*4O)29)4:E)3T-1=3/\U1$*
M:NM]4R\CH^/4XSC[<O.,VLWZN71.25)37)@KVR7G%);-6U*5(=3J@O)N]J3
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MZZIGFV%FXXE^%*[J=^L=TM-VTM-VW<GJ6BC/4B"R 0
M
M
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MB2R/V@2U7J<9RU_FOB)O!'XL?+NW;*J79Y:QN\AM"MJR,E?*(C273Q,O %A
M,:C,7_IFY=Y5M;1RTS_*EG'R8G&DL)AN0)".TPA"?A;<2LST+H:4Z>74POKT
MT8I?X]AE-:7.=R,D@W5)5NU=%(0E#=8CW<G.TT9.K-1)2HF_DIZ)!):/'?\
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M^2/41?5:R=H),YN.P^TK<R[(81+[JD*+RJ\==2_K$"2^>FG_ ,)5I_[/?_\
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M&1D>I&0([
M
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M)"2-2C,S/0NIF"-F
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M4HB/I[0&U 85=<5-P4E53.8G)AO*B2E1G4/):D-D2E-+-!F1+22BU2?4@&:
M     ,&LNJ>Z0\Y36,:Q;C.JCR%Q'FWR;>1\IM9MJ5M46O5)]0"LNJ>[;>=I
MK&-8M1W51Y"X;S<A+;R--S:S;4K:HM>J3Z@,X  84:XJ9D^951)S$BSKR;5/
MB-.)6]')_<;?=0DS-&[:K;N\= '119+CV41GIN-VL2VB1WEQ7WX+S<AM#[7R
MVU*;,R)1:ET_I ;0    !H*#.,.RJ;85V-7L&VG52B;L8\*0V^MA1F:2)9(,
M].J3+\)& S+O),>QF.B7D=M"IXCBMC;]A(:BMJ7_ %24ZI)&?Q $K(\?A5T>
MWEVL1FKEJ;;B35OMDP\M\R2VEM>[19K,]$DDSU]@#9@    ,*NN*FX*2JIG,
M3DPWE1)2HSJ'DM2&R)2FEF@S(EI)1:I/J0#- 8,RYJ:^7"@3YS$:=9+4U7Q7
M74H>D.(2:U):09ZK,DD:CVET+J ^VMO544!VTNIS%=6L%J]+ENH8901GH6JU
MF1%J?@ S",C(C+P/J0#Z
M                          /-_K:2E?$5<2B)1?6&OZ&6OBA\@6&-R9S%
MS-7\F9A@_'D2B7 QC'TY(](M42.\3#+:''DH[3FU:UFK:A)I(OA40#7X+Z@>
M6;3+N-W\OJ:6+@_)B93-3'@+?7.8=@H22G7%N*VD2W%$:4=?(>GRBZBD>?\
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M7)WJ!QR\XYX[:BXV]R%ED:S.S<>3)*M0[%6M3+C:TN$HB2PDEK+:HU*Z$7L
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MC<2T:]5&@E:D1F"-B
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M>I_$"VET'A[.9!^H6+)B-1&\_498O(<?;6A_]3)(C639J4V6YQ!'O(CZGTZ
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MR\[_ (*FUF.5M7 P^182LHA4[R6X$)V=V7%=A#RB<62EI69[=VA_%U!$HS[
M,JO.?.,<XK(27L9QQBR1;S#>:0;2I+"T-D3:E$M6IJ+Y"3^,!4+WISY"MN*\
MNHI5=%;R).=O9CC]?+?:=C3XW;2SVG5-+,D$XA2_*LT]2(CVD>I%M87$''5Z
MF'E4NZXTH.-Y5I7N5-5]&.E)G*0^@^][PMI2T&V:TH4DBT5TT,CT(S(S_2_0
M<GX5A?U!SW'6*:NQXW&ZNP;EMRG)ZI4I^0XO8TI1(0@EI(MVAJU\.A@2TO-O
M&V<6'+F-\DXYB5=GU3'JG:.5CUL^RRQ&><<=4F492-4*3H]H>U*E>7PZD9"$
M=QC@C/V/3%=\>V->U!SQ%JY<43#4AA:"?COLO,FEPEJ0G>3:D%N5T(^N@%[7
MRSX#Y"L/34G%%L,N<D2[M>5WU:Z^V34V4Y(<4IA3J%=LS-LVSZKV[DZ:EX@M
MNC%.)^3I66<CY3.P*MPV'E.$RZ6JIJV7$4R5B\VVAMM?9-*4J7L,UKV$DNG4
MSU ;&JX<Y%C5OIZ8>J4)=P65+>RA/O4<_=4/.-J09:+,G-22?^;W=016>3^G
MCF)5%E&$5^"55P]+R)=[#SQR9%;GO1GE$1,()TTN)/IN<WJ(BU5H2C,E&6UD
M<@83SC5\M\C9=@F)1;VDS&EC43#[T^/&<;-41IA3R4..),^VM*MR5$6I=2,$
M9=7P5FN.6G ,>+':FP,"18JR>8V^VE#+]CM=42$N*2MQ)+-:2-*?9J9%J!:-
M7?!'*$SC/E['(].A=OE67_3-&Q[W%(GX/O9.]PU&X24>7\U9DKX@6TYY0POE
M2OY*XYY+P''H^22*"K?J)]8]+:ADTY(:4WW%+<46J"[I_(U/R^'4$1CU:X1)
MR+,^-&JR9[K;Y8\O$[9MD]%O5KCS,A:BUZ]MD]ZE?\X@6'J]F.Q'CMQ&&R;C
M-(2TVTGHE*$EM))?$1$#+Q<]P5S<WC4ST]Q*N$?&4N]^E$9L<ION-UANI=[1
MQC5W#>(TDKY.F[RZ[?,#5KJHN.LFK/4K;9Y[BEO"7<68IH<WO-*4<EIZ.KM]
MK=W"T2VKS&G3XP1K/6=_W WO_M5=_M;8$(KC7'W+><9A;<A9S00Z!R%A;^*X
M]!B3&I*9S\AMQ27R6E:MB#[JB_6&1EJGQT48"48SPSD=AZ56^'LB0BIR=V#)
M:-"G$/--22GN3(^];)K(TF9-[]NNA&?M XHMA> \TY-G&#9#R9CL:EJ>*ZV1
M%KVHLMF0_;S38)A*T;'#2VE6QM7G,BU+3\[RATX?QASACO(-3S;/B>]Y3DUE
M,C9YC29L8VXE$^;3<0F7#7L6<9+>_:E9J,B0G^L"NGE; ?IGU8X5#A2/_=N0
ML1+S)J]/@L\;6ZIAQTOZJR2AE/QD8'!ZKM6'9-7-C,%N>>CNMMI,]-5+09$6
MI^'4P9>2\9X,Y.KN/>&Z&73H;M,2S(KN^9][C*)B 4LW>X2DN&E?EZ[4&:OB
M!JW++^ N2\CK^<8T2(U'<RRZK+7&TN2FB1/8@N/..-KVJ/MZDM)I[NWSZ:Z%
MY@+;OA_C7D&'S9(Y$O\  JW \>EXV=6FNJI,5Y")).LF1K0P9>=26S,S).A)
MVD9FK4$:GCSAGE57$N:\#992Q*JE<;DO4N3)F(>*9/7);?8_5-FI2&2-HC6I
M225H9%MUU!;;C@GC/+Z7)8$C*.*,<Q5-#"4P62Q7T/64N?V^SWF"9<6E*7$*
M5W"61>.I'^:"2F'IUX\R[ N&9&(Y5!3"R!<BQ<1%2^T^1ID?YL][2E)Z_A_"
M!*FV>!>4ZKBGB]M>,1+N]P6ZL)]KADJ5&[,Z/-D$X@S<-:F#-))\%&?17@?5
M)EMVL<%\JO\ &7--.YB<*GN,TL:N=04=?+B^ZI;CS"D.MMJ):4()M'0MVS<9
M=" M*.;,%Y/RNAK,*C<9564U2*6+#@7JY[46QJK4F=CKN]3B#-I!DD^VCRKV
M^8S(]H)#T!QQ06^+8%C>.7\WZ0NJNOC1)TPE*62WFFR2K12M%*(M-I*5U,BU
M,$4[0<+Y-86'/E=D+":VIY#?2F@GDZV]N3VY)$ZIMM1J22%.-F:5Z&?4@5$L
M*XNYLR"^XQQ_D.DA4>(\3.=YFVC2VY*[1R,E"8O;;0I2DD1-HW;R3TW'XZ)
M6=Z?,"RO!3Y 5E,),,[[*)UM6[7FGN[$D:;%_JE*VZZ?)5H?Q 2D_..'V^?<
M3Y1B-"2%7-E%),)#JB0A;K+J'B1N/H6_9M(SZ$9]>@$*8RG!N9>0.#L/QNSQ
M-BJR;'KZJ_\ =B)\=PSJJR*;)R5N&O82E+,_U:5&>W3Q ;?(^$<JR_DWE^5,
M81"QC-,=AU=+;*>;61S8[4?3>TA1N$E#C7FU3U+P\0+:C@SBS+Z/)J9K+.)L
M;H(^.1NV]ES+Z7K"9,:;[;3\=+2UZ&LNKO<26NIF1D?D E>7*B>3CQ)U?$JX
M!9:T\TZENS+5MV.@]SC39F9)2M>A)U7TVZ]4GHHB*+QGB7DWDOD/(.0>3Z&#
M@S-CC4O%SKZ]YN2_+7.;6RJ2Z;2UI/:E9]5J(_*@M-"U!6[X3J?45B<C&N.\
M@I:NOP+%6Y4>QOBD(DKM&%;CBE&;0HEMJ09EJ;B2U+QZ]#$H'_(?E3^0WU)^
MA6_K+]=_IWW/WR-M^CM-.[W.YL\?S==VGL]@+;8\C\)YG7<J9/EF.\=TG(U/
MF/NST<[E]#2JF<TC8X:DN.-FMIPS-:B1U,MI:EM\PM.V^*LF@\R\69+74<*O
MQ3&*"7 MTUSZ2B1)<AA\NTPVZ:75H-QPMJMGAU/0$5NC@KE-/#N/XK]#-E?P
M.0"R*3%][C:)K")TN]O[FT^JB\A'NT]@+;NSG@_-JCD_*[W'^.:+D.FS*0W/
MA3;MY#1U,I6O?)U"G&U+;4I2E:-Z]-O74C(Q;U=CE2Q14%93QH<>O9A1FF"A
M0MQQ630@B-#1J))F@CUVZD1Z R\MXUZ;LGL:W'OK;7M1IM%R',R'M./M/$N@
MDI;<61=LU%^M>8;\AGKIJ9@U;[*]/6>9%Q=R7CEC&8A9#:YI+RS&VGGFG&)+
M9FC:3AM*42"=1W$D2]-#TW:$!;<\=\1WM]49C R;C*@XT3<TLBCA3*IU,BP4
MY,1M>6KM+<1V=Q)423,E=-/,1Z@C3\*\/YICN28_697Q/C,")C>JIF<)D)?F
MS'F",XS\5#:S4ES<236;J"U\?(9;0693+ ,1Y2P?GC.)*:"/+X^S>:W9O9*<
MMM*HR&&7E(:3'W=Q2U..DV>J2(OE:F0(K?\ D/RI_)WZJ?0K?T]_,3ZR>Z^^
M1M/HKM;.]O[FWY7YFN[3KI[ 6TURSA/,<LY&YCFKC-1J#,L;B5M#9./MFE<^
M,U'-*5MI-3B$DXUYE&CPZEJ"6K?%I'(ZN=N$,0SZEA5-EB-9.@ML0YK4Z2Y'
M8KEL^\R296M+27";3L29ZF>[XB(KT7ZA.-;7E+C>30X^\VSD4*3'M:CO'M:7
M)B*,R;4K0]-R5*(C/INTUZ:@D(!A&#\M9GR98\N<H4<7&9D/'G,<HZ.-);DJ
M<<=-:EO*6VM:4IU6X1$I6OF+^KJH)KZ9\'R;COB*JQ7+H90;R+(F./1DNM/D
M27I"W$'O94M)ZI,O P)8W*UCZ@:;)&9W'E!59?@\B$<29C\EQN-*3*6H]SRW
M'EMDI!IT024J,M-VY/@H!3=9Z<^2J7CO"J8H,5^Z;SUG,+R#$?9:CU\/MH:-
MMM3BR)>U+9&:6]?'0MVFIEMO,RX*Y$R>RYZ3#BM16,W;I7,:EN2&MLE54XAY
MUI1(4:F]^S81N$DM3^ $MKL"XGY.7R3"S"RX\K<)J&<3ET"H=;+B+[DPFEMH
M=>2TK7>Z:BT/S:().Y6I J=<=<+Y']U][B#*VT5&13(UBR9&XB0AEY^6[(CJ
M4IA2TFG4T&HDGX=/$$M'."^+,PHLFIF\LXFQO'X^.1C:>RYA]+UA,F--]II^
M.EI:]#675WN)+74S(R/R 2CG\A^5"X&^I7T*W]9OKO\ 3ON?OD;;]'Z:=WN=
MS9X_FZ[M/9[ 6V_SKCCFO&,NY*;XSI(=_C/+,=#4J;(E-QG:I]3+C#RU)<6D
MUD9/.*3M)7YOM+11&XKN#\KQC/.#W*UE$_'L#JY\._M"=;;),F7'<29H:6HG
M%)6XX>W:D]"\0+5?;\*\^PL(N^'*7%X4_$V\D^G*[(#L&&G7HJW$FAI#*UI-
M*DZ;W#7IIU(MW0P6TPY4X5S"-RS?YUCG'U-R-4Y;'C)*-;OML'5V$9I+/<,G
M'&][2R22UDD]3\-4Z%J+2QWB7*H_)O#%Y6T,"MQ[$8$]N_8JWD(A0Y4UA>Y$
M=MTTNK0IU9Z&23^,$/4AC'(.:J+'*CC:KS3&I$)3<*U?FMPK*MM'36DWD+<6
M@R;27;5L3\LR\QZ= (;?"JKG7")7&N$>[0+?"(-/V<QNWGM934Q/<T::W+2I
M2&R[2&C)M6\MV[;TT"\00
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M(BZ$1$0#Z   #1IP[&D9:O.BKT'ECD(JM5F:EJ<*$3G=[1)-1H26[KJ2=?C
M;P   '!IUIYM+K*TN-*^2M!DI)_@,@'U;B&R)3BB0DS))&HR(MRCT(NOM,ST
M(!R          'S<G=LW%OTUVZ]=/AT ?0       :&3FN*Q,LAX+(M&D9;/
MC*FQ*KS&\N,C?JYT(R(OU:_$R\ &^                 17'N-L$Q2[M<EQ
MZABP;^[==D6=DA!JD.K?7W'/.LU&E*E^8T(T3K[ $J
M
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MF6JEM[#7_E:@/=8,@
M
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M+=T_.($6""
M
M
M                   ".9WA%%R-C$O$,F0ZY1SUL*EM,.&RM91GT/I3O3U(
MC4V6[3KI[2 ;R'#C5\./ AMDU$BMH8CM%J9(;:224I+74^A%H [P
M !A6E14WD15?=0(]E 4I*U19C*)#)J0>J3-#A*3J1]2Z ,Q*4H2E"$DE"2(D
MI(M"(BZ$1$0#Z
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M/]R8)_I[+YX&P^D_6!_N3!/]/9?/ V'TGZP/]R8)_I[+YX&P^D_6!_N3!/\
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MCSFZC1XEE:'+)^/#):6$^[2WHZ=I.*6KJELC/51]0)6*"
M                                                          "A
M/3+_ -KY@_\ GA7G_2;!97V"
M
M                                     #&L?_@^5_U+G_1,!2WH^_\
M#QB/_.L__BI*!97D"
M                              "A/3+_ -KY@_\ GA7G_2;!97V"   Q
M;&SKJ>$]96\QB!71T[WY<IQ##+:?A4M9DDB_"8"D+KU<<5Q9SE5BK=KFUJWT
M./CL%<E.XST_SCAMDHM?SD;B!:8A>HW/'$]]G@[+E1/$E+9-#NG_ %9M:@4Y
MPO5W@$:4W SRCR#!I;BNV1WE<XAG=\2FMZ^GMU;("EV8]D^.Y;6HM\8M8MO6
M.=$RH3R'V]?':9H,]%%[4GU($;4
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M]VIEJ?EU+H6(7?07]/E%/$O\?F(GTT]'=B3&M=CB-33J6I$?B1D"-D
M                               ^*4E*34HR))%J9GT(B(!3V8>J#AW#
MYOT2=TJ^O-QH*LH&CL7C67YN]!DUNUZ;3<U^(%I'&_4MEEBGOT/"N83(2NK;
M\B-[KN3[#(MCA'_0HP*<3]6572KTY X^RS$F/$YLNO-R*DO#4UZH/3_FI,"E
MLX/RAQ_R1%.5A5_%MMJ=SL=M9HE-D>G5QAPDNH+KXJ0")<   #&L?_@^5_U+
MG_1,!2WH^_\ #QB/_.L__BI*!97D"
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M.E>-6T7'N<<KF9/B-I])8VVQ:T^%NK-AJ4VE/N[RVC224DILG/,2CU4:O;J
MXX0[BK^=>F9&#+KUW;%/,^LI5G:[R#]R+O>]=OJ2]WO&[?UW;OA =W'=A5<0
M\F8U0T5AC?(.!99=OM45E%*.[D53*EJ[!J6M)&LDD2MJU'J2DZF6S70PN#UG
M?]P-[_[57?[6V"0K"9B>*IYPRV"FD@%"C<5N2XT7W9KM-2"0TUW$(VZ)7L,T
M[BZZ&"H_B^:7S7''!G'U1-IJ!5XQ<RUY9?Q&)K,3W*3)(FVBDEVTJ6DC;4?B
M>Y)$9>T(,EV87IPR,H$J,_*;Y/0J')AI2W"4\<5&UQA&FU+2C(E(+30DZ J4
M2"R"E]/_ #9QW9$ESD"@OHTW*+!C<;T^'8267#D*6HB6M)FA:E'H7ZL^I=3U
M(L'@['+6;RYCV7%E6#NIB8V<1ZBQ%;K4IZK6G]2IYDT$1J;=-O>:E:IVI(R\
M )63ZG<WML6I,4I*A-;'?RJ\C5BKN[CMRX-:6I**0;;Q&WN0>BB4LC)))4>F
MO4B0\RL%)9Q3U-QI-M NW4(HB?LZ=IN- D.IE.$IQMIKR)/74E[>F[7Q!5IX
ME5U5-SYPFBH@QX"9> DN249I#7<6<9Y9J7L(MRC/J:CZF F?K-_[K:?_ .26
MK_\ (\"0K+/:JKL.5O4K)GPF)4F%A\=R&\\VAQ;*_HM@]S9J(]IZI3U+KT!7
M3@5;6U'(7IB>JH4>$].QVP=FN1VD-J><=@.FM;AI(C4HS4H]3]IF K!*\2<]
M/5A#A+KSY*7G9' :;[7TOU-)-F1%^MV:;R2?R=?C!4_YWS&[R^TY?KE6>/8_
M3XFW$KE5<Z#'7;W.[Y*VY#A=TE(4G5KM]$DI/3\X$AMJ%_&6^6>))'):X?U6
M<XMKRJGK@V_</?>R?>U-[]7W#;->N[X4_P"2 S.=4<52>+.)+;C^+ 3@B,LB
M1X<GLFVTB(:I*I3:U2$DLD*<0I3I+^4HM3U AZ4:Y$XNHY6.8M"NZR*Y?DI&
M-081H]W?2A9HT9-@C;21K(TIZD2E=$ZF#*;
M           TF7Y=C^"X[.RK*)B(-+7-]R0^OJ9F9Z)0A)=5+69DE*2ZF8#S
ME7U7)OJG_P#?.1R9>"\&O'_[NHHBNW:7+&O1R0OJ26EEU+Q3_52K_. NY?>#
M\88%QQ"3!PRABU:2227)+:-\IWIXNOKW.+_\Y0(EH#XI*5I-"R)2%$9*29:D
M9'XD9 *8Y ]-&!Y9)^L6,$O",\CF;L'(J'_55)?+P4ZRV:$+(_SC+:L_ZP+;
M0\?\QY=A^7Q>'>>VFHV2RO)C.8,%MK[E.NU*5'HDD/&9D1=$ZGHDTI4:=XIZ
M&! !C6/_ ,'RO^I<_P"B8"EO1]_X>,1_YUG_ /%24"RO($
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MFS:K(FV[)G63&UW''E-F:'V3/H?D61D1Z>9.BO:")>
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M )UG_P#%24"RO($
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M8L$I)]""_JH-;+9?\T%EZ-!
M
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M"
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M*94:M%IT41ZIZ:&")'&DQYD=F9#>1(B2$)=8?:42VW&UD2DJ2I)F1I,CU(R
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MU*4H]"(BZF9F8"/8[GN%Y>J:WB>05]V]7'MF-P)+4A31]=-Q-J/0C,CT5X&
MA7%/,$;*>'JWE3.Y4#'X\YR9[PM;G8B,H9FO1FD$MY1F:C2VGV^97@7L!5@U
MV48W;499/66\.7CAMK?.V9?;7$)IK7>I3I*VD2=#W:GY=.H(A64<TX7!XVR;
M/L5OJJZ;HHSQM;)2%LJGD@S8CK-M6I*=7HE*?%6O0%IV87R_AUSQU0YI>9+4
M12G-0XMI)*4TU$9N7XR'W8FY:SV+3N/]6I6XB\0*;I?*7'#>.(R]S*JM&+N.
MG&:ME2FBC+?29D;:%FK12BT/REU!&=*SG"X5'#R:9D-<QCE@MMN#;.RF40WE
MO:["0\:MAF>T_;[# 1ZZY%JKK +[).-<GQ^3)KD*0W:V$HE5,9])IU]Z<95J
M@MIZE_1[ 5M;#/<:Q.@J+//,@J:IVP::(I*I*68C\A3:5.'&-TR4IO4]4G_5
MT,P1)HLJ--C-3(3S<B)(0EUB0RHG&W&UEJE25),R,C+J1D [0
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M[E*\.OBA(+#T0",:Q_\ @^5_U+G_ $3 4MZ/O_#QB/\ SK/_ .*DH%E>0(
M
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MC/X01YVP%:<P]5O(N4L?K:W$:B'B[3WYOO+RTO.D7QH6TZ@__H@O!Z*!
M            'E@N/9&?^H_EEN/EU_B:J^-CIJ5CDLH2I/>@?^G,T+W;-OD_
M"8*JN$U9'P/Q/414Q)L*3GLIB0Q=N+16RGT291QVYJD$HS;6HC-2=ID?P J8
M9;@&;XCQISE=Y''H:NMR&)7.HH<:>><B1IT9:$O.=MUMLFU.I4A:]/E'U^ !
M*85!BN1>H=F%EU?"L*U/%\1?;L&VW6T:R]CBT]PC))DVI9&HNI),^H";^DIZ
M6_P#BAREK<2CW]J*MW7<<9N?(2UX^PDEHGXM 26EX6H<?8Y:YGEL5D)J;!N8
MR(+[;#27F$OPC-TFU$G<@EGJ:MNFX]=0)4C@%'2P^)?3QD<.NC1\AFY^VU,M
M6FD(EO-KGS&U)<=(MRB-#3:=#/P21 K*1@N=<DJYC@UU;BSLM_,9T>1D-[)D
M1[V N*\W[D4=:&E[&4I(DLGN+=JI/4@'K_(5W]?QK:K2Z;F41:.0HGX^IFJ>
MW$4>YOH1GJX6J>@,O*?#W'6;W=1P]DM+7XA4U=++:L"NX$J05[-BJ):+!A\C
M:-*W%I4ON(WGM,M",DZD#4M!E%'1KXDYRR;Z-C'D4/D^4W#MS:1[ZRVBQB$E
M*'M-Q$1/.="/3SJ^$!*^;2>QW.>1N/8+JF)O,C&,G1(2G5OWHYI5\TBTZ:J:
M2:U_A(P(2?((,6KY6Y6KH39-0X7%Z8\9LO!+32'4)27X"(@$8R.@Q^F](6*3
MH-;%K&+I&.MY981&4,//PG9+:W3D/((EJ(UF1F:C\3^,#BD6355!CG-^3UF$
MQ(U?72N,)[U[!K4(:B[VW5(C.+;:(DDYLVI2>FNS3V'U(C.$45)4N^ERTJJZ
M-!LY[=I[],C-(:>D=R!JKNK21&O4U*^49^)Z>(*B\G%\:F<2.V<NGAO63_*Z
MHTB8ME!ON1U3#;-I;FFXVS2HRV:Z )!R1&+''_5!78I'36QBK,4_U. VEEI+
M,ADD2C)MLB2DE-+<[FA=2,S,!->/N.<VB9WC^:KKL0H,=BXY*@28^*R9#CMA
M7/LDJ,M:'&DDLD.)0HG-VI^TSZ BML!HJ2OXV].&00*Z-%OIN8*:F6;+2&Y3
MS;DJ6A27'4D2ED:6T)\QGT21> *NG@JBQ^/R=S!+8K(34V%D2683[;#2766W
M8I&M#:B3N2E1ZFHD]#Z@DN[U.1*^>]Q-!M6&9-9)SRI:EQY*4K8<:6AXE(<2
MORJ29'H9*Z&!"K<EPF+:3_4MB^(QT1:ZK;Q^^JV(2$H:CV\.(J:\3"4%M2XX
M;:DKVEKJ>G0%65Z?[2/R9F^=<U,D:Z^P;J\>I%.)-"FVH4-I^:DB/KM5(=+]
M$$EW<J0ZRX]0W$M-E#+4K'EQ+R1"@S$I7%>LFV4;=R%D:5K0G12"470_#J T
M.:8[@+'*7"&(U4.O_EFY,R.0FMC]MVK<MVHY*:)9$:D&M+RE;$G^=Y2+V *N
MS*+71L YPI*1IM.&1LXJ45\5@B*(W(=?8]\::)/E21*))&E/1/0B!5G.83CC
MW-?*6$P$Q\9H+K X\>6Y";;C1V>\I;!OFVG8CR(/XBT($1>O?NN/L7SOBRWQ
MRIK^0ZC IDVCS3'D-MJLJ**1L$ITTDEU#Q*\W7Y2B-6A:)-163Q#QOG$FSXB
MS.NK\1I:"GKU*.72R9!6=G73(B4NIDH4RE+KA+5O7JKR.*/KJ AL>BI&>(*S
M)&*Z,UD2>4D$FV0TE,PB38J21=XBWZ$70DZZ?T@+LP:AQ]7J@Y3DKK(1R8D.
MBE1'E,-=QJ3)86;KK:C3JE;AGYU)ZJ]H)P4TF'$G\-XE G1VY4"7S"EB5%>2
M2VG67)<E*T+2?0TJ2>AE\ *[N3(R,>B>JFNQEA%;#:3A?;AP4$RTA$PD>];4
M((B(G$K7W-"ZZF M.IHL2H?5%C3.(5\&!7/8&ZX2:YMMM#B"EI2TM7;(MWZL
MDD2SZF1%UZ G!L/5%65<X^)E3X4:4:^0*.(XJ0TAS=%D=[NLJ-9'^K<VIWH/
MRJT+7P A@2<>Q"V]3=A0Y9707Z*JP9DL>JIC37N+,94I3<E;+2B[:="U0:B+
M4DZEX$ W_I+>==X4JTDXX]6,3K-BG==,U&J"W-=)K0U=3(NJ2_!I[ ):/BK'
M::=R3S5>N4\.;DE=?I.JG/QVGI++B8>Y!-+6DS1YCU\ID ISB+C[/\RP?C^^
MIH>*P_<,A*Y<RAR5)1DK\IF8Z<IF2?9,EJ<21D;1K,E(2G4%6GQMC7'^4Y#S
M1-Y,@ULZ>SF2X[TBW)LELU[':37));AD:$*,MJ-#+?\ )Z^ (@-SB&7\@YIS
ME4Q*G%IS\B>W!DV>3/OLV5?$**1078O;;6E#:2(EH5J6Y1==2(%6%4T$XN?\
M9QC+W$3[/^4Z*R^>2HUHD/%-)F0HE*(C42U;CU,O;X B"\/KG7^5X%@3JSE7
M?#$'*CM6E(_5G.*6=? 29'T,R;-*D?@,P5H>)>/>0<RP3 ;ZDAXI#5 R$KA6
M4.2I*,D?ELRW3E,R3[)DM3B2,C:-9DI"4Z@/37J5D6,;@G.7:M2TRCKC;6;7
MRO=W74(?_H[2E[OBU!(5GQ=QUFK&?X5FWT?B%#C4"AD0Y+>+R9"Y-E628Z3C
MJ<2XTDG"0\3:^YNZF9ZF?0!46,M7$WBKTX559$K;%B3;Y&Y]'WZUMT[U@S*D
M^Z%(-LE'N+<YVD[3W*Z::&"I/FN%9;A/%6>GE7T/68QDN54LB;48W(><@0F5
MOMMSR4;B$&T2U)9,TEX>'0M" 7/RIA_&=1Q9RE]6:FHC6C^/..VD>$VP2B*+
M%<5"<6RCHC;\II6TO#4O $5UGE!0-\$<%US59#376V18>Y:16V6TLRERH1I>
M4\E)$2S<+HLU=5%X@J69;C.*EZB>.,5GU$%K$6*2YETU.<=INO5:+61O*2P2
M2;4YVRW_ ">A^;Q!%-/PZU[CFPH(K3<G!V.:D0*6(HB<B'6J<+5EHNI&R>Y6
MFG0]3!6^SJLKJ2P]4573Q&:^L338ZZF%%;2RPEQ<4U*4EM!$DC,S,ST+Q/4!
M+:>IQ[).=Z:KSB+%L*N+QI#>IH-DA#D4C=>)$EU"'"-._9N2I7CLU]A="/1V
M,P<?K,?KJ_%$1V\;CL(;K$0U$N.4<B\O;4DU$HC^'4]01M0
M  5-ZF<;=RG@S,JZ.@W)+$,K%E*>JM:YU$M6A>TS2TH@6$HXGR=C,^-,4R9A
M>_Z0K(RWS(]=)"&R;?3K_DN)6G^@$4[G!IJO6/QU9V1[(%ICTRMKGE]$>^-G
M+6I)&?34R=0G\*B+V@O!L_5)C5E%IZ+F7%FM<KXWF(L5$GH;]4M22E-*TZFD
MB(E'J?1'<^$"$ PW!VO5KE-IROR-#E,<:14JJ<&HC>7'6M+:_P!=)6IE1==Q
M&2C29[E^771HM2[EZ\;<#<:<364RWPFM>ASY[!19#CLI^01LDLE[22ZM22\R
M2/734$M7O%[B<O\ 4_RKF4?1RMQV%#Q6,]XD;Q&E<A*3_P EV.LC_"7P@<'H
MP$>=N<%EE/./#/'T8NXY#L'LKLD>Q#%>1+94KXE*:=3U]O0%AZ)!&-8__!\K
M_J7/^B8"EO1]_P"'C$?^=9__ !4E LKR!
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M3TY\<V/'G'3)9&:EYID<AR^R5UWJ[[[-T5VUG_6;224K]F_<9>($K;!
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M#B%F@R21&E2C+^D%M,:>GJ\?JXE)21&H-3 :2Q#AL))#;;:"T)*2($9H
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MS\%$"R]&@C&L?_@^5_U+G_1,!2WH^_\ #QB/_.L__BI*!97D"
M
M  "A/3+_ -KY@_\ GA7G_2;!97V" "A>9.*<I8R:/S;PXI$?DJL:)JUJU=(]
MW 21$;#I:I(W"2DDIU,M2).ADI"#(L)1Q)SMB/*T=4%G?29M#W(M\4L/U4Z.
MZWT<VI623<01E\I):E^<E)] *6+;5%5?5LFGNX3-C53$&W*A2FTO,N(/V*0L
MC(P11L[T=\/NRWI=,=QCI/JW.,5%BXRT9F>NA$ZETR+XB/I[ 6V\Q#TN<+X?
M,59-4!75HK769>N'8J\Q:'^K=_5:]?E=O7XP+5#D%G,]&^6H=JGRN>&LJ?6X
MG%#D(^DZR8HC4:HJ'%:K:/;IKX'\E9DHDK47>F''N"9AS!FD+FOF*$JLK*LS
M7@.#NZG[FDU$I,N2E1%JZ9I2HMR24:B)6B4I0D$>D00
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M;_D;,N/45ZX[V(-UKKE@IU*D22M&#?(DH))&G9IM/4SU!$V
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M*2(B(&62 QK'_P"#Y7_4N?\ 1,!2WH^_\/&(_P#.L_\ XJ2@65Y @
M
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M  QK'_X/E?\ 4N?]$P%+>C[_ ,/&(_\ .L__ (J2@65Y @
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M^<H^IG\(%K5JX":JLA5B'WI*(3#49,F4ONR'2902"6ZL]-RU::J5[3!&6
M                              QK'_X/E?\ 4N?]$P%+>C[_ ,/&(_\
M.L__ (J2@65Y @
M                           \G\,<N\:\>77+-7F>1QJBQDY[=R6(SY.&
MM3!N)02RV(46AJ2HO'V LK6^\YP+]N(/Z+_[H"C[SG OVX@_HO\ [H"C[SG
MOVX@_HO_ +H"C[SG OVX@_HO_N@*/O.<"_;B#^B_^Z H^\YP+]N(/Z+_ .Z
MH^\YP+]N(/Z+_P"Z H^\YP+]N(/Z+_[H"C[SG OVX@_HO_N@*/O.<"_;B#^B
M_P#N@*/O.<"_;B#^B_\ N@*/O.<"_;B#^B_^Z H^\YP+]N(/Z+_[H"C[SG O
MVX@_HO\ [H"C[SG OVX@_HO_ +H"C[SG OVX@_HO_N@*/O.<"_;B#^B_^Z H
M^\YP+]N(/Z+_ .Z H^\YP+]N(/Z+_P"Z H^\YP+]N(/Z+_[H"C[SG OVX@_H
MO_N@*/O.<"_;B#^B_P#N@*/O.<"_;B#^B_\ N@*/O.<"_;B#^B_^Z H^\YP+
M]N(/Z+_[H"C[SG OVX@_HO\ [H"C[SG OVX@_HO_ +H"C[SG OVX@_HO_N@*
M/O.<"_;B#^B_^Z H^\YP+]N(/Z+_ .Z H^\YP+]N(/Z+_P"Z H^\YP+]N(/Z
M+_[H"C[SG OVX@_HO_N@*/O.<"_;B#^B_P#N@*/O.<"_;B#^B_\ N@*/O.<"
M_;B#^B_^Z H^\YP+]N(/Z+_[H"C[SG OVX@_HO\ [H"C[SG OVX@_HO_ +H"
MC[SG OVX@_HO_N@*/O.<"_;B#^B_^Z H^\YP+]N(/Z+_ .Z H^\YP+]N(/Z+
M_P"Z H^\YP+]N(/Z+_[H"C[SG OVX@_HO_N@*/O.<"_;B#^B_P#N@*/O.<"_
M;B#^B_\ N@*/O.<"_;B#^B_^Z H^\YP+]N(/Z+_[H"C[SG OVX@_HO\ [H"C
M[SG OVX@_HO_ +H"C[SG OVX@_HO_N@*/O.<"_;B#^B_^Z H^\YP+]N(/Z+_
M .Z H^\YP+]N(/Z+_P"Z H^\YP+]N(/Z+_[H"C[SG OVX@_HO_N@*/O.<"_;
MB#^B_P#N@*/O.<"_;B#^B_\ N@*/O.<"_;B#^B_^Z H^\YP+]N(/Z+_[H"C[
MSG OVX@_HO\ [H"C[SG OVX@_HO_ +H"C[SG OVX@_HO_N@*/O.<"_;B#^B_
M^Z H^\YP+]N(/Z+_ .Z H^\YP+]N(/Z+_P"Z H^\YP+]N(/Z+_[H"C[SG OV
MX@_HO_N@*/O.<"_;B#^B_P#N@*/O.<"_;B#^B_\ N@*/O.<"_;B#^B_^Z H^
M\YP+]N(/Z+_[H"C[SG OVX@_HO\ [H"C[SG OVX@_HO_ +H"C[SG OVX@_HO
M_N@*/O.<"_;B#^B_^Z H^\YP+]N(/Z+_ .Z H^\YP+]N(/Z+_P"Z H^\YP+]
MN(/Z+_[H"C[SG OVX@_HO_N@*/O.<"_;B#^B_P#N@*/O.<"_;B#^B_\ N@*/
MO.<"_;B#^B_^Z H^\YP+]N(/Z+_[H"C[SG OVX@_HO\ [H"C[SG OVX@_HO_
M +H"C[SG OVX@_HO_N@*/O.<"_;B#^B_^Z H^\YP+]N(/Z+_ .Z H^\YP+]N
M(/Z+_P"Z H^\YP+]N(/Z+_[H"C[SG OVX@_HO_N@*/O.<"_;B#^B_P#N@*/O
M.<"_;B#^B_\ N@*/O.<"_;B#^B_^Z H^\YP+]N(/Z+_[H"C[SG OVX@_HO\
M[H"C[SG OVX@_HO_ +H"C[SG OVX@_HO_N@*/O.<"_;B#^B_^Z ITR_4QP.]
M$D-(SB!N6VM*?*_XFDR_9 4UOH^_\/&(_P#.L_\ XIR@)7D"
M
M #3O8EBLEYR1(HJ]Z0ZHUNNN1&%K6M1ZFI2C09F9GXF8#K^I>'?9ZL_@H_S
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MP ^I>'?9ZL_@H_S #ZEX=]GJS^"C_, /J7AWV>K/X*/\P ^I>'?9ZL_@H_S
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MP ^I>'?9ZL_@H_S #ZEX=]GJS^"C_, /J7AWV>K/X*/\P ^I>'?9ZL_@H_S
M#ZEX=]GJS^"C_, /J7AWV>K/X*/\P ^I>'?9ZL_@H_S #ZEX=]GJS^"C_, /
MJ7AWV>K/X*/\P ^I>'?9ZL_@H_S #ZEX=]GJS^"C_, /J7AWV>K/X*/\P ^I
M>'?9ZL_@H_S #ZEX=]GJS^"C_, /J7AWV>K/X*/\P!M8<*'7QT0X$=J+$;U[
M;#"$M-IW&:CT2DB(M3/4!W@
M
M
M
M
M
M
M
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M+Z?)W*27X3(%IN\3SS#,[CORL.O85VS%42))PGDNJ:4K7:2TD>J==#TU+K[
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MD)V,(4E!K4IQI*2+<M)>/M I/00
M
M        8-S3UN05,ZBN(Z9559,.1)L9?R7&7DFA:3TZ]2/V /RIRC@3*J7F
MPN&X#:I$V=+2FGFK2>QVN>U6F4K0ODMMI4IW;\DT+(O &[?J)@^'4_'^)5&'
M4+?;JZB.F.T9D1*<7U4XZO3IO<6:G%_Y1F##Q]RYI]7O5)K_ +SQ3P^'NQM
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ME)N?<;RT<9;VG[O%/70R[:5&I9>Q:U%X$0),KW!
M
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ME22_"70]2,R!&T
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M02DJ^29'^ P*?-Z-=-Q:_!J!4OIJ2GY1D7X3 J3<DBW:EI\/L H)25?),C_
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MU$1_&8%2&I)%J9D1?"8%!*29:D9&1>)D!02T*/0E$9_$8%2^&M!'H:B(_@U
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M.^'T&[\'_;IGAX_M1Z?D-?Q\H?>__O/=_P#\V/\ \&'_ -JVA\]^&
M
M
M
M
M
M
M
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M,^Y7=?;"+_ N?OP^/^I\M/I\S[E=U]L(O\"Y^_#X_P"I\M/I\S[E=U]L(O\
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MI\S[E=U]L(O\"Y^_#X_ZGRT^GS/N5W7VPB_P+G[\/C_J?+3Z?,^Y7=?;"+_
MN?OP^/\ J?+3Z?,^Y7=?;"+_  +G[\/C_J?+3Z?,^Y7=?;"+_ N?OP^/^I\M
M/I\S[E=U]L(O\"Y^_#X_ZGRT^GS/N5W7VPB_P+G[\/C_ *GRT^GS/N5W7VPB
M_P "Y^_#X_ZGRT^GS/N5W7VPB_P+G[\/C_J?+3Z?,^Y7=?;"+_ N?OP^/^I\
MM/I\S[E=U]L(O\"Y^_#X_P"I\M/I\S[E=U]L(O\  N?OP^/^I\M/I\S[E=U]
ML(O\"Y^_#X_ZGRT^GS/N5W7VPB_P+G[\/C_J?+3Z?,^Y7=?;"+_ N?OP^/\
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M\EH6]'KNXDY"VVBU6O874DD1^)C/-%TURS5\&R&F0
M
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M^\5-E,@OQG--I[3-9&E1>Q23(TJ+V&0FOE&6%P=-C..K,2NOCO\ [O\ %/\
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M%H>64/<3"E;D+9?3M=:>;/:MM6FI&:3]J3T,=L,XRBX>;4TYPRJ4H'1S
M
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MWMWMH-,@
M
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M)1FZZ>YYYUP]RW7#(B+<H_@(B+P(B(AWPPC&*AYM34G/*Y24;<P
M
M                                             2;#/^U2O^K3_P"4
M?+Z_^,/M=J_EE^B8CX[]"    K+U$_\ <=GG_")'_D(%AYM__)Z?_C#_ /K1
M_P#=H++V^#(               #1Y9_\$G_UB/\ Y8]W1?W/Z/F=R_L_U00?
M>?EP        !K:_'J&IFS;*KJXL.PL5=RPEQV&VGI"]35JZM)$I9ZJ,_,?M
M&8QB-S4Y3,5,MD-,@
M     #%D5U?*DQILJ*T]+AFHXC[B$K<9-PB)1MJ,C-)F1:&9"5"Q,PRA4
M
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M?V3*?T3_ "![K4\3V6AZ3Z$]9G]DRG]$_P @>ZU/$]EH>D^A/69_9,I_1/\
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M?V3*?T3_ "![K4\3V6AZ3Z$]9G]DRG]$_P @>ZU/$]EH>D^A/69_9,I_1/\
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M?V3*?T3_ "![K4\3V6AZ3Z$]9G]DRG]$_P @>ZU/$]EH>D^A/69_9,I_1/\
M('NM3Q/9:'I/H3UF?V3*?T3_ "![K4\3V6AZ3Z$]9G]DRG]$_P @>ZU/$]EH
M>D^A/69_9,I_1/\ ('NM3Q/9:'I>@?2?7\ZP\LO5\L,7#=6JN2F JU+1KWCO
MH,R3_E;=?Z!RSU<L_P"4NNGH:>G_ !BK>LAR=@   %9>HG_N.SS_ (1(_P#(
M0+#S;_\ D]/_ ,8?_P!:/_NT%E[?!D
M
M
M                                                           :
M/,L5K<XQ:UQ&X6\W67$=<24N,I*'B;<\30I25$1_A28"%\0<#X7PF=P>(R+!
M_P"F_=O?/I%YM[3W3N[-G;::T_SJM==?8"VM $
M
M
M
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MDI(S,!WT5]3Y/3P[_'YK5A33VR>AS&#W-N(/IJ7M(R,C(R/J1]#Z@-B
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MZG[ &9"F1K&''L(3A/0Y;2'X[I:D2VG4DI*BUT/J1Z@.\
M
M
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MHA"W?33C_!N.5=NQPYD!WS\GW;Z<>??-4DU1R<)I:F%(:[:3-Q>ADV1'\)Z
MDKW!'YL</X]Q=R!R5F]/Z@YTB-FTZ8XW7.292H3?OG>=1(2;FI))U*MB6D.>
M734B(^A V]EX9BF'^F'BBQ]]MI4JAJE/64^;*/<M2W5$E+;+)*VH-1[$)0G3
M<L]3ZJ!G>J7'_6RN7>52\FP"?2X+?2#BU.0$MU_>:5DV:B1V$)=))F7<2RM2
MD^S<?0%I#^7<T<X^]8\3*(U/*OYS%2VS#IH!&<B5)E0WF&T)T2H_%>IF25'H
M70C X+TX&]0Y\OV=[C%WCKN,9=0$3DJO=<4X2FR<-I>I+;;6VMM>B5H4GV^/
MB1$F$#R3UG.1KFX<PG!)N3X'CCR6+K)VG5MLIW+-&].QEQ"4*,C[:G%EO+V)
M I8O(7J*I,3XAJ.8,<KCR&FN9#$>/&4^4):.\EW>2U=M[1;:VE-K21'YM>H%
M*K/UR_1]K">R/CJUK,0M8YOU-@I?^M2=J?E--N-MMN(-9[-4.]"\W^2"TF'$
M_JCF9UR1_+7+L+E8?<S&7)-0B4XXIU:6VC?)#K;K+*DFII*EI670]--/:"4X
M\G>J>1B^:3\#X\PV7F]U1MF_D#D5;B6HR&R)3B2)EEY1["41+6>B4J\O4P*6
MEQ!RQC_,F',Y;0H7&,G51;&N>,E.Q939$I39J+HHC2I*DJ+Q2?@1ZD0E%?5B
M1'Z?,TUZ_J8?_P 4(P$*0]&W*L7'>*LYJ;U>UO#$.9!';6>BE0I#*EJ0@O@)
MQK7\+I LH;Z(I\^XYUR:ZM3-5C9TDZ=)=41D:W)5A$=4HM?8HU:@2NC._5X_
M397=X_@.#S,QK<3-7UGN&''&V&"9/:Z:>TP]HA!DI)N.&1&:3T(T^8$I:E7S
MK@EEQ(YS(;[C&,QV%.2V%DGWIN2VLFCB[=2(W5.&E".NBMR3UVGJ!2G\8]9C
MLN\IOKM@LS%\'R5Y3%'DSSJW&5:+)&]6]EM"D$9EW%-K/9\8%*T];&=SY'(N
M,8XK'WFX^*2/>X=HI2^W8*F(BO+::+M$1;#;)![5KZ^P@6%NYQR95\A>FG(<
MVY%X_DL08DQEA>,OS'8D@U)E,--OMR3CH4@TF[N_S1D>TTGJ1F".I_G.@X5]
M/_'V48SAIE0W!E%BT?T@9*BDX3SZUJD*84;JE*2I2M4)U-0%.&)>L!ZZY#H\
M2R3!)^,T>4K::QZTFK6EYWWA7;8<-I;*$J;<69)W-K,DZ_G 4D7,GJ6=X\S2
M%QUAN*2<TS%UI,J;!B+6DV6E)-PD)2TT\M;AMI[A^71*=#Z^!"F5P5ZD$<V9
M)?T+>,NT*:1A#_=D2B?=6:G.V:%M$RWL,C+^L8$PNVQL(537R[6R?3&KH++D
MJ7)</1#;+*36M:C^!*2,S!'DF1ZY%)FNW,+CRQD\9,2_<5Y)W%(6;A]2Z&SV
M26:?,3*GM?C(&J:7UN<D-7V!8?4T,1R5C&0J8R%C(4&M+"DI:=0W'4@T:;E$
M[W-%+)2=NFWX!"Y/2G,IK+CM^;4X/]1E(E(AR8QFXI4Y4>*PHIFKC;9F2^X9
M>!^'RC!)0CUZ2;]GC"F8KU.)HI%LE%SVM22K:RM;"7-/S-Y&K0^FXD^W0"&O
MXM]/WIYSI.)YWQM=SFI%&IF3;PV9BO>W)*$$HDR4J/?'63A=3:T2I.I)\241
M;1;FG,3P#UBTN5-5,J]E0ZAMN+3P"UDRI$J+*CM-IT)1]5.%KHE1Z>!&8$;E
MX<#^HE?+EU>XC?8V]BV7T2.](KW7%.;FDN$TYN)QMI;:VUJ2E2%)]OX2!)A"
M<L]6F>8U-LYJN(+5&&TTQ<&PN)CCK)$MMSM&>]$9;*?-T+]8HCZ>;J!2<<B>
MI2IP[B3&^7*.F7>5>2268S,)V04)QDW67W%[U$V\1J;4PIM22+37P/0"FIXU
M]3EEG>0S2M,'F8S@$:HD7J,HL7%I;]SADGN.&1LI0M)FKIVW%="UZ]=!2((]
M;CAS$7[W'EDUQ0Y-^CDY4:U&KN>.NPFNT:]O7M$]K_E M-;ZWKFM<@<4Y)&<
M][JE3GY[+[&BN[&4F*\2FS/0CW)T,@(3/C[U8R<GY+@\>Y;@\[$_ITC702IJ
MUDZMM25K94ZRXRWY7209)6VI1;NG4M5$2FPY<]4!X/F9\=8)BDK-LPC-$_9Q
MXAN$B.DT$[L)++3RUK)!DI>B22DC+J9ZD0IM,/YNQ_F_B#,;2MBKK;>MK)L>
MYIGU$ZMA;D5TT*2LB3O;625;5&E)ZI41ET I6_I"RVHP3TW9)E]\M2*FGMYT
MF1L(E.*VQHA)0@C,B-:U&2$D9EU,@65/\_\ J)N.7N-HE?9X+,QZGDVS=A07
M;BUO192(K;[#B"6MEI)K+N=3;4KVD!$/56>\Y4W"W&^'O/P';O);J%$CTE'&
M5L<?6B.UN4I6U9I0DU(3Y4J4:E$1%XF1*=/#GJ-/D+*IO'N9XQ)PO/H;1R6Z
MN6I9D^T1$M6A.MM+2LDJ)>TTGJGS$8$P@M]ZS+2%E>4X10<<S+J_H)TJ%%*'
M)7(2\U!?6TZ^ZVU&-;:2))*(BW>/4R]I:23.?5+*Q&BPMF+A<NRY%S2O:LXV
M*M.J4J,R_P!&]RD,J<6I9D>U"6B/H>[;IU)2<\)<M7G*M?;N9!ATW$+.D?;B
M26)IJ-#CRTFLR03C;3A&@MIJ)2/SBT,P)6H"
M
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MR*A&;X>LFI4UI*$]XDN+8=2\EK5LG&UI^4WY5$?ATU,3#T6"
M
M
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M*4]$)+>H_:9F>IF?303*TP0
M
M
M                     &%:TU1?0U5UY C65>I2'%1)C*)#)K;42D*-#A*3
MJDR(R/3H8#)8CL166XT5I#$=I)(:9;22$)27@24IT(B(!V
M
M
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MV
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M%&MY#DIM,1*Y.]3!+4:"2WO)&IZ&:C0E2MIZ"7)'J=YTA4M?S+<8M6IX9LK
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MPGU'WEH6DE++S&YOW)49*U\==2(DK,!
M
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MH"2]/@@
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M5D2B\#(E$?4!W
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M]-=--0'< QIMC7UJ&W+&6S$;>=1'97(<2T2WG#T0VDUF6JE'X)+J8#)
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MVB0DM34:M=-"(O$!S:=:?:0^PM+C+B26VX@R4E25%J1D9=#(R <P
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M6>B4J+7HHSZ$0#( =*)45R0[$;>;7*8)*GV$J(W&R<UVFI)'J6[0]-?$!W
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MFV&=R4=QU1(3N<424EJHR+4S,B+X3 <UK0VA3CBB0V@C4M:CT(B+J9F9^!$
MX>\QO=_>^\CW7;W._N+M[--=V[7333V@.:%H<0EQM1+;61*0M)ZD9'U(R,O$
MC <@&(_:5D5TV9,UAEXB(S;<=0A1$?@>AF1@.16->HXY)ELF<PU%$(G$F;QH
M(U*[?7S:$1F>@#)       !C2["! -HITIF,;ZNVR3SB6]Z_ZJ=QEJ?Q$ R0
M'6_(8BM&])=0RRG3<XXHD)+4]"U,]"\0!^1'C([LEU#+>I)WN*)"=RCT(M3T
MZF?@ [ '7[PP3Y1C=1[R:>X3.XM^PCTW;?'37V@#4AA\W$LNH<4TK8Z2%$HT
M++\U6G@?Q& [  !TL2XLKNE&?;>-APV7NVM*]CJ=-4*T,]%%J6I'U =P
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M17JG-:%Z_P %R+%Z[:U(M*F;6Q#5T0E<F,ME&OQ$:B!EYIP6GY0M<HX/A7&
M6%#5<;1YU;;VTMZ.MIUURN*,E;:$+-7;,VD^?J1FK0O#4S3ZWQKGQ<.P:'Z
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M^O@8):WN-<ZSW,I4PLIP*5A]=$CLDB3/DMK=?G&9]Y#;*",^TDM#2X9]?@^
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M.D1*6?YO]'4,69QIGZ^.,KJDT$E5E.Y2<OXD8C;W.5:I3"RDEY_D:)/QZ]/
M%3BXP++;7D7F:3'KEH@91B+%123G5(2P_,.(\T:"/74MJED2M2!&'CTK*6N
M*3&\BXDG7J*QN)C]UC<MZ*B0]#B14DN<PVO7>1.I23:"-*]?,1EMU ;_ --.
M+Y5BN*W42[@3*3'9%J\_B..VD@I4V!5J2G:VM1&K:1JU,D&>I=3]NIB49Y<X
MIR7/<]SKW>N<556>!LPJB?N0AI5Y!LE38[1*-1&E6Y*?-IH1& Q\=XMR?&<@
MR"OBU#BJAGC.)C=?+1VR1)LVD+-QLO,7G6M2E&9].OB E.&S.1..N*>+J"OP
MM^XM'/<ZO(HYOH876QS(][R_E$>W\1>T^I +)Y%Q).>8)D6'*=)A5U ?ALOJ
M(S2V\X@^VM1%U,DKVJ,@1YNK,3Y.Y N.*\=RWCXJ&?QO.A2;S-GW&'$RH]*6
MC+,5:/.M,A1$M:2/:E?7P!I:G%N&W<*[Y?1?07H$#);^0]6OKV_KXCT<F^ZW
MH9]/P@BH>)>((V,7%#B>5\+'-R.FFF<OD%$Q*:U;++JG8\QM*G-5KZ-D;.W=
M[3T^2"VTG+L3-^.<%YKQ*9BTB;C&5WKF40\N0\RB"RS9R8QJ;=)2B6;B7$(:
M2A):J,]?D]3"S[J+R)QKR1+Y!Q?#Y.85N58Y KG(L-Q#;\.UKT[6B>2LRT86
MD_,LO ]?#0M2-5BO#V9X@C@*MD0E3'L9F7<[*94=2%,PW+1M3J4J/=UT4YV]
M4:D9IU]I ,WUAT-K*HL3O\:?2QDWTD_B\8E'H;T?*8KD)YM)%U4KHDR^#JKV
M 0]!XW10\8QZIQNN+2!3PX\"-KX]J*TEI.OQZ)!'FWE1'.^<U&6<+S\1.:S?
M6S7T)FL9;3-7'HD269*/>$FHU=ULFE)670SU\I'H6XJ\*#(<M?SJ\Q.?BSD'
M#ZB+%53Y2J0A:)SBT)WH)HB(TFDS47CTV]?E$"(-S[6Y:N\XWR;%L<E9-]6K
MEZ?.@PEMMN=HXYH+S.F1%J9@L(:[Q]R-E>-<Q<A9+1*K<MS>H^A\<Q-MYN1(
MC08C"D(2XXD]IN/+T6:=>G].A!T<T\;<AV/%W&TW":IU_.:*K5C]A 0I"7&X
M=U4>XR]QFLDGVUI27B>T_-[ (3.WXWMZODG@9-'!7(QC!X-S7V<]&WML)75M
M18YK(S(_UBD:="/KX@(7!QS,[_FS'LNI>-I_'EY&FO*SJX*:PY4V-;M46S1D
MR3(==,R/<2-25U5KH2DA:/J*Q7),PXQE5.,Q5V;[<R%,GTC;ONZ[&!&?2X_%
M)>I:&M):^/7;H77H!"EJ7CW(9EERO8X]QE(P>BR'!9-5152O=FU29ZVUI(C:
M9<-+;BS/3:?L(E'\H%3.FP#+F<D]/+\JH?1"Q;&9U=DKVJ-(4AZH9CI0YYO$
MW$F@MNO4$5S6XARW#Q+C_AV3@DU;.!YG$LY>5-NL>X2*YJ<^\EUI)K):M4OF
M:OZI)Z]3T(KU5R973K?CC,*FK85*LY])91845&A+=??B.H;0G<9%JI1D1:F#
M+S.OT_Y&B$YDJ*0UV2^)6Z#W S0;_P!:/<"KU$2==-Q1T]O=KX^T&K3['<)R
MV)GG"=E)J'FH..X:[6WCZC0:8DU4)ELF7-%'YMR33Y=01:6!9-E^2+R LLQ9
MS&4UMF]"J5./I?\ ?8;?R)!;2+0E?TD?L/H8(B?/.+9!E'\MOH" Y.^A\XI;
M:S[9I+L08O>[KRMQEY4[BUTZ@L/N88S?S^?>-LGAU[CV/U$"[9L[!.WML.2F
M$I:)6ID?F,M"T(!4D+C'D:KPF#D$*@=?R/$N0I^4M8^XXVT]/JGG#2OLJU-)
M+4D]4;O@/H9Z$961<83R+G=!S+GT_&)-/9YA5PJ?&<7>6VY8&Q (M[CQ)/:E
M3BNJ4ZZD6OCT,PG55A^4,\T8;D#U6\BE@8%]$39IFCMM6'?2KL*T5KNT+X-/
MC!%05/%N:4G'/#/UKP25E-/BCV0ED^%(-E;W>L93RH4@V%+[;Q)(]?,?E(_C
M,%2/ \5R;$.+<OJ[[B%ZWI\@S&=+=PA$B*IR'22([*F7&/,:7C:6A+2";-*N
MFXC+0!9/IIQC+<5PVU@Y#"ET](];27\2H+-\I4ROJ%DGM,N+(U;?,2C)&O3Q
M]H)+"YAR'DSNY%A7\L"S3"[V 4:DFPI"#-,EQHR<*<A[_-DEPR4A:=-I)(R4
M:C\@9W&R.1N/(/&_%T[&UVM2W3K3D.5(DI[-?):2M3<8D&1FLDZ):(]2U(R-
M/R3 ;'U&8[D&5<4V--C$%RQN7)E8\Q%8-).&F//8=69;C27E2DU>($*=SG@7
M(JYSD^SQNJ78N95D=#,JF6C0;B834A,^:I)*46Q/O#B]2^!!&"VF5\SR-Q;R
M]FN98KA<G-*KD"'6>[^Y/M,G#LJEA45#<CN&6UI:5;S<TT+\8(D;./99)]1=
M3FTRH7%I3P7Z-G24.(>CLV3ECWU1266TUFDNN[81&74!6>1\49[=\><Y4\2I
M<1;7F6G=X^P\I"2G18[\9XC;/=IYTM*V:Z=="Z K)1C?(7+'(&;7UMALW#:S
M(./9>+5KMHZRX9S79&Y)N):4:D>9:O*:=32G=TW$0(CV/VV9R>2?3SBF6XA+
MQN=BL>UK5/RGF7$S5Q*E#+CC"&E*/MI2TA1K/RF:]$Z[3,%;%SC3/CX=G4)4
M$D[ESD,[EN'^K[AUQSTN=_Y>FS:6OB O?$^0+/)N1\[PXZMN/2X<JOCM6I.J
M4Y*D3XQ2%I[>TB239'H?F/V?""*]YUQ&VL>0<.RJ;ACW(>#UT2="E8VP;2S8
ML))I-J4IE]24.),BV&:NB--?'340KS'.+,_C\>X-5KQ-ZIEUO*L;(I=.EQIT
MH5.A;AFX2TK,E-MD9)(RZGXZ K=YSQ'G.5.>H./ K5M.9*[C<W%WG5-I;G.4
M[9.NMH,U=#U;[9;]I;E%UTU!+2'!E<@9ESY#Y&R'!I^)T;.(NTIJGN,K-<PI
MR'U$26U;DD>Y1(W)\Q)W>T!NO4EQW89O38S;5U$G*BQ>V1/L<86YV53Z]QLV
MWVVE:I_6%Y5(+7KU\3T28A7MAQ?*NN%\RB\>\7/8%:V;\'=2OS$E,N:Z"\EY
MQI1DXHV#41N))!GYOP* 8N*\6VF2YIFKE1QT]QIB.28'+QV$F04="5V3[R2)
MYUJ.M1H5H>FFFJDHW'U4"K(XCR'E'Z)J>.\EX]DTL7'J7Z,LL@D2V#CO283*
M8\?W5"-QNDZ234HR41)^'X2(!B_&N>PN,>!*:50R&K3&,J]_OXIFWOB1/>Y:
M^ZYHO3;M<2KH9GU^$%73SU@EKR1Q3D&)T2D)NY"&)-<EQ1)0N1"D-R4MFI6A
M%O[>PC/H1GJ?0$A7=)"Y&Y.Y+B9_DN'R</K<7QZ=61HDUUMR1,MK$MKA-$@_
M\RE)>5:M-3T\=3VA/?3MCUWBG#&*8_D<)RNNH+#Z)<)[;W&S5*>6G7:9EU2H
MC\?:!*SP0           !\,R21J4>B2ZF9^PB 1.#R?Q_98_"RJ%D$1W'[*8
MFL@3=QI2_.<=-E+#:5$2E+-1'HDB\.OAU ;F1D=%%O8>,2)[*,@L&794.N-6
MK[C#&A..$DO!)&>FI_T -H     BV;\D8/QO#BSLWNF*>--<-F(;V]:W5I(C
M5M0VE:C))&6X]-"U+7Q 2&;/A5L&19V$AN+71&ER94MY1-M-,M)-:UK4K0DI
M2DC,S/P(!IY&<8E%H:W*)-M'9H;@XJ:N:M1I1)5/T]W2T1EN4;FI&DB+73KX
M )  A[?%^%(SMWDEV J3EZT$W'FR7WGT14]HF5>[,K6;;)K27F-"2,]3^$]0
MF           C6<X)CO(M(6.Y2T^_3F\B0['CR7XG=-!*3L<4PM"E-J)1DI!
MGH?X2(!N:JJK:.MB4]/%;A5<%I$>'$822&VFFRVI2DB\"(@&!BN88SF]6JZQ
M.S9MJM+SD54J.9F@GF3T6GJ1>&O])=2Z -V   #2Y7EV-X/2/Y'EEDS54L8T
MI=EOF>FY9[4I2E)&I2C/P2DC,!E4=W59)3PK^CDIF5%BRB3"E()24N,N%JE1
M$HB,M2^$@&!'SC$95'89-'N8KF/52Y#5A9DX7NS2X9Z/$;G@>PRT,RZ -O G
M1+2#%LX#I/P9K3<B*^G7:MEU)+0HM=#T,C(P&0     U>0Y'18E3R<@R6P9J
MZ6&23DS9*R;:1O42$D9G[5*,DI(NIF>A -H1ZD1_"   #2,9AC,G*96$L6;+
MF5PHJ;"55$9]]N*M24DX9::::J3[=>I?"0#=@    -9C^14>55;=WCD]FSJ'
MENMLSHRNXRXIAQ33FQ9=%$2T*3J73IT ;,  :0LPQD\I<PHK-GZTLPOI1VLU
M/NIA;R;[IGIMTW'IXZ_T ,5/(.$KQ)S/$WL0\-:)PU7?<+W0R9>..HTK\%?K
M4F@MORE="U 2)IQ#S2'FSW-N)):%>&J5%J1]0&FRW,<9P2D>R++K-FJIF%)0
MY*?,]#6L]$I2E)*4I1^Q*2,P&=37%9D-3!O::0F74V3#<N%*02B2XP\DEH41
M*(C+4C]I .JPR*CJK2JI+">S'M[M;K=3!6HN_)5&;-UWMH\3)""W+/P+IKXD
M 4>14>2L295!/9L8T22[!D/1U;VTR8YZ.-[BZ&:3/0] &S          $5QO
MDG!LON[?',9NV+.YHE;;6/'WJ)E6XT:;S22%:*2:3V*/0P&?B>(X]A%.BAQF
M&4&L0XZ^;1+6XI3SZS<<6I3BE*-2E'J>I_\ ( W8#5VV245#(K8EQ/9ARKB2
MF#5L.*T<D25$:B0VDM3,]"U/V%[0&Q>99D-.,2&TNL.I-#K2R)2%(46AI41]
M#(R\2 85S<T^,U$JZO)C-;35[?=E2WU$VRTVGIU,_CT(B]I]" 8%IF^)TLBB
MB6UJQ$DY,Z4:A:=,TJEO*2E1)06GB9*3XZ=3(O$R 9=;D=%<6-I4U<]F78TK
MC;%K'95N5'=>1O0A9ET)1IZZ>SV@-H T\3*L<G/W,>'9L/NX\OM79(7J45SM
M]TTN*\",D]5%KT]H#EC.3T&94<3),8G-V5'.)9Q9K.[8OM+4TO3<1&6U:5)/
M4O$@&V  '6\PQ()*9#2'4H6EQ!+22B)QL]R5%KX&DRU(_8 [        :K)<
M>K<LQ^RQFX)Q55;1W(<U#+BF5J8>+:M)+09&6XCT/3V ,FJJX-)5P:6K9*/6
M5T=J'"CIU,FV(Z";;06O71*4D0#HO,BH\:CQY5]/9@,2Y+,"(I]6TW9<E6QI
MELO%2U'X)+XS\",!&\F_EQ>YMC6,Y*^Q(S*M4K(L=JG%K2X2V"6V4DD)T2K9
MHO;N]I&9%Y=2#>Y9B=#G%#)QC)XA3J.8IE4N&:UMI<]W>0^@E&V:5:;VTF9$
M?7P ;A"$-H2VV1)0@B2E)>!$70B <@    &KGY)15EO54$^P98N[LWDU,!:B
M[\GW5LW7C;1XF2$%N4?@0#:    CK6>8:_C4K,F;N(O%81OE)N"<+W5/NJS:
M<T<\%:+2:?+KJ?AJ WL62Q-C,S(JR<C2&TO,N%J1*;<(E)/KUZD8#M ?#,DD
M:E'HDNIF?L(@%;?5SB?FUVCY!2I&3P*EQ952B??^C_>&'#(UKC&:6UK0K70W
M$'T^$M 590( (_D6%T&56%#97;"Y#^-S2M*I'<6AI$Q*#0AQ:$F1+-!&9IW>
M!@,RPR.BJK2JI+">S'N+Q;S=1!6K]=)5&;-UWMH\3)""W*/P+IKXD 1\CHI=
M[,QF-/9>OZYEJ3/@-JW.L,R->VIPB^3OTU(CZZ=? !M         &KGY)15E
MO54$^P98N[LWDU,!:B[\GW5LW7C;1XF2$%N4?@0#:     -719)19-'D2\?G
MLV,6))=@R'XZM[:9,<]KB-W@9I/H>G0!M  !%:'DG!LHR2UQ''[N/8Y#1Z_2
ML)C>HV-J^VHC7MV&:5^51)49D?0P&VFY'15UQ68]-L&6;RY[QU=>I1=^045'
M<=-"/$R0GJH_  AY)16-U9XY!GLR+RF1'<M8+2MSD8IB5+9[I%\DUI2:DD?7
M3KX&0#:     -7=9)18X4 [RP9@':3&:RN2\HDJD392MK3+9>*EJ/P(OP^ #
M:     -7*R.BA7<#&I4]EN^M&WGX%>:OU[K48B-Q9)+\U.OB8#:  "'4W%V%
MT>8VF?0X"W<NMMR7[*4^])6VTM6Y33!.K4EE!GUVMD7P>'0!ES>1,&K85Y8S
MK^$Q QMY,2]DK=(FHLE>W:TXKP[A[TEL+S:GIIKT ;V-!@Q')$B)&:CO3%D_
M+<;;2VMUTDDC>X9$1J5M22=5=="T :5O/L+>Q5_.&KR(K$(_>-VZ)PO=-([J
MF%FESP41.)-!;==Q^&H#?QWVI3#4EA6]AY"7&EEJ6J%EJ1]?A(P'8     TM
MEE^,5%DJGL[6/&M$07[=R(M9=Q%?%/1V0HB^2VD^FX^GCIX& [L=R.DRVEAY
M%CDUNQI)Z#<B3&==CB4J-!Z;B(RT4DR,C+4C(!M                 $3Y-
MS-/'F 9#FAL%*730W)#$8S,DN/?):2HRZDDUJ22C+V */XIYKRB5R#C.(9/F
M-!FK6:P),IM% EI#M+80V"E+C.]I:B6TIO>E*W/.:DGX:=2TKC(KK-,ZX3X;
MR&//KJB6_G*(SC<>N:;CE8^_R&X4E+3>B22R2'#<;T_6;^I].I5@9K3\DO\
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MBN'%>1N1L%S.RQ7D>R@Y#4,82O-HCM9$]Q5%1"7VEQ4%J9K29$>BU^;P\.I
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M;[+N,.1,XX,RO$G\:QO&<LO),-<"NI%&U'*)$EQWR*6\39)4Z6QW0T%MT,O
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MP\P;65PO?W7IOJ>+),IFNS"KA0EQ91*-V,W85[J7F]RB+JA1IV&9)/3770]
M+8V/XCS)9YI8\N9K65,3**G'WJ/$\:@REN1W93JS>5(D/JUV)6K1!)+7R^/5
M.J@U_%W"F=<897C64QY;=I+OX4MGE93LE6KU@^\J6Q+9)1;7%-+<4R9^7R%J
M1:J,"VL9]/\ FJ>*Z:K[=8YFV+Y1+R:N@35'(K)K#S[BCBOGMZ$ZVOQV]#(B
MZ:ZD+3_&ZOEFNQ"\GP,/P_&LU>=9^AZN*;GNRXS:DFZB8]'0C5:B[G:V>4C,
MMWM 8'"'&V68SEV99QD=16XHUDQ1&V<5I'C?C(<BDON25F24H);AJZ$@O:>O
MQB69R9A?($;D6CY:XRC0;6[A5DC'[:DLGCBH?@O.^\-+:=(C)*FW>JB/Q+P
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M(BU/4M"/J!##M>+<NF9;S+<M)BG$SC&X]/1&;QI-4MJ ['5W2VGL3O677KT
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MJ74 >SBA9SJ-QR:W59-)K'+PFDMGVD06WBC[U.'H6JEF9$DM3Z==.FH20
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M$1V3G-#&SF%QXM;JLEG5[MNVTEL^TF&RX31J6X>A:FOH22U/IUT 20
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MJKA=M-F-6ZY2FJR2XE<.#[M.E-&45!)(T$Z?ZQS4SU5UZ 2B7J^LL9NLEQC
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MBSY=?+;-:4/=U"#<<96A25+,M3U+H1: DH]R>SEF5\]2<&K<TNL7HXV"JO\
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M]Z:M5545?3K<)U<*(S$4\1;24;+26S5IJ>FNFN@(IW&^'N3<!XTQ/"\"SB)
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MRC(L@=C;6WI++R'#::90HMC:4HVH+=TZGH1'M(6D]QPO%R+,\XOKJ<3M'FE
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M] ?-2UTUZGX%^  ,R+Q/37H6OP@&I:[=?-XZ>W0 (R/70R/3H8 1D?@>H#Z
M^:D1D6O4_ @$-IN0HUUR1DW';$%QM_&(D"5*GK6G8ZJQ2IQ"&T%J>B4EU49^
M/L]IA,M2UVZ^;QT]N@"&8SR'%R?.LTPF/!<8<PLZYN3-<6DTR'+-A;Y$A">I
M$A*2(S4?4S\.@"::EKIKU\= 'S4O#7KX?T^( 1D>NAZZ=#_" :D9F1'U+Q(
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M?'J:NQQVSI+7WGZ6OFY#;35;V&R6WO:41J<[JO*6TRT^,!(]2UVZ^;QT]N@
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M 6?P%C>18GR/<0J3";C"N*I].V[]%W$M,QM%Y'D)1O8/O/*23K*S-9:]5)^
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M\SW@"CSC)YN4,Y#<XW)NH!5.2,4LAMANRB(+1"7NXVYH9)\AF7BCR]-3U%K
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M'U,"VUR#C!BZPFDPR!D5Q0?5],,JZVJ9)1IAJ@,]AOO&232XA1=5H-.TS_
MC4;TY8>>%7>)W%E:6UAD$Y%Q99/)?25K]),Z=E]IQ*-K9M::(+:?0S(]2,"T
MJX[X]E8(W8KL,LN\LGV:FE/2;R3WD-$PDT)2PTE*4MZD?G,NJCZF")N
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M0D)Z>'4P6EL C1U69X??29L.CR"MLI=;K](L0YC$AR.23T/NI;6HT:&6GFT
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M<"Y'Y%Q:_M,<QF@7EJ\LE3BSN9.4S>Q+.%/2LF]O;4:$DDB0EK?MT5NVZZ&
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M")L
M
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M1EH8(V0
M
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M^I^170!DU-35T5;&IZ6&S7U4-!-18<9"6F6D%X)2A)$1$ S
M
M
M
M
M
M                                                       #,B(S
M,]"+Q,!Y1]-_(>29!RQECMY-?D8]GD:5D>)-/NK6TS$K+1^O[325GH@S1H:B
M274DD8-2E,_U2?1TZZD/X+9*PO&\A=QB^RE$AA4>.^V^EA*R:Z+7J:DJ4GIM
MW)ZF:B($I,Y'-M37R.3HEK6O0Y/&<=J;*;4ZA1SHTF,N0PIGH1$;FW9H?@:B
MU I.<1O7LGQ>FR1^"NL<MX;$[W!U9..,IDMDXE"E$1%N(E%KT!'FOC3D#)IW
MJ3OY=C-==PS,';FEQ>$MY9L>\8I[NE2VFS,TIWH[BCVEJ>[4P:6+&]0U=)P/
M'\O1022M;_(D8BC'C?;[[-DJ0XR:5N:;3(B;W^'M(@2G;F?.%S@U^;5UQ_:-
MX*U81ZI_+S?C$T3LI:$(=1&(U.*9U61;]2Z]--W0"F@YKYKLZ^+GV$X5CME;
M3<?HGG,BR.O?;C)IG;"(XN,X6XR6XI"='E=LR-*2,R^2>@B'*@Y<FXGQ_P 7
MXM08[-S;/+C%H%HNLB/ML*;@M162<E/OOZD6]:MJ-?EJU+7734-;FW)D?/J_
MA;),:?F5]=<9K#BVE:XI4=Y+L8W4NQI*$&6NQQ'R5=#Z'\ "WN4>18/&&+_6
M*7!>LY#\J/6UM;&-*')$R8O8TWO69)07B9J/P(@13?.&>YA:<!WMK;8W:X/=
M1+6N@OP/>4..OM*E,&OW=^,I/<;62MFO0C/4@6%B8)S)+RJ]R+%+S#[#&LJH
M(;=FW42'6)+DN$_N[:FUM*)!+,R))H-6A*/3=T/04Q<1YKM[C-HF$9?@MCA\
M^WA2+&A=FR&)*93,7:;B5DS_ )IPB5J:%&>GMTU+44T^$^I%>5X[+SNSPJPH
M>.H5=+L'<EDR&'6G'(3O:4PRTG12U*5JE)]-5$:?8!3<X'S<_EF0,8ODV(V&
M&VMO7KN,9^D'&GD6$)&AKT-O3MO(2I*U,J+<2>I_&*5'Z=.;[BGPK ,?R['K
M1^KR:QF547.Y,E#[4JUDS9#B$&A1J=,NO;[BS^4E6A&23!9A8N4>I6'C]U>I
MB8E96^#8E-;J\KR^*MHH\*8M24K0A@_UCW:-9$Z:=-I^S0TF9*<&\I;B>H_(
M9\^T<^JE9@+5J1&ZM41IKWSN.OI;(S3J:$:FHBU,@$)?Y>R3D3D[AMT\:ML6
MQ.TL+"=6/2I+:H]M%*$9LN.-,J\BT?*2AS7HO<DS(P$ZE>I2OC7<ISZK6+G&
ME?;?5VPSY*VO<F;#N)9,^P?ZPXZ7%$@WR/;KX$9Z$8IL[3FRZ;Y,MN-L:P.P
MR"11N5I6EK'DL,QF(]FTETG5]PM2-)*/1'BK:H^A$!27<F\BUG&.-%?SXK]C
M+E2F*VHJ89$<F;82U&EEAO7IJ>AJ/XB/0C/H9%<3N<;FYP7D:&WBMA0<G8E7
M&[)QY4AA;[;4UH^W,8DIT;<0TDU.JV]?+H6IF0+3N])]>4;B:#8KI)M1-M#;
MERY-A-5.59N+CM&<]O<M7:0Z9F1-Z)TV]?A,2V5!S;=9/GUIAU)@=A)J:.Y>
MI+G)O>6$PXYLEKW-IEN5KXF@NJ2,NNIZ 4UM;ZE(%A=5[JL6L6.-;FU/'Z7/
M5K:.')GDXIE)]@OUB65N(4A#QGIKXD6BM!3.R'GM^ORZUQW%\'N,NK<:>C1<
MHMZGMK]UD2]-K3,<_/(4@C+N$@RV^WIU I\SWGX\4R.YQ_'</L<M+%(;5EF4
MV"ZTRW6QY"#=06CO5USMI-S8G3R^WHK:*<<G]02($_%Z["<4G9G(R^H5>TY0
M7FHWZA.AZ.]XO)H1^8S\#\NAF!37\B\XW$!JTQ7',/M+'(X>._2^3N09##:Z
M'WV.HVTFI1_K7FS\VUO\TMR=>I$*2[T^OORN%<(DRG5OR7JMEQYYU2G'%K7J
M:E*4HS,S,S]H$HM%]2E?)NXKAXM8M\:6%N>.U^>FMHX3UAW%,D?8+]8F.IQ)
MH2^9[=?$B/4B%,3*_4Q(QJXRV'&P*SMJ3!Y3,?([J-(CI:99?2E27$-KT4M7
MF^07@752B("FCR3D/+2]3= Q1X[8W>/'C1.0([$QIF,\Q/>:6Y9);6HB(FB5
MV5$O19[>G334<&AY+RENIPCG=_"8%TBZ1;L0+R<=D:T1^ZWN5)CI49&TUH?;
M4VC51[B_-3Y2M_D&4Y19Q>#/I*KG8JJ3D\6+*JGI273DQX\75IQQ3"M%(4?F
M)*_Z2!$HR7U(1*"[NRC8G96F!8K.1495F49;7NT*:HT)<0E@_P!8Z3)N))XT
M_)/V'JG44Y<J\V2ZB5?8;A6.6.1V5=1N6=Y;5;[+*:IB4ROW=Q)N&1N.:%W2
M0C0]O5.O4B%)!P/,EKX,PZ>LG9\]5.V^I*E[GGW3)2M#6X?RE'[5&!*L/3MR
M9?-4W(=MG%-80:"NMKRYL,BGRT2TQUQE-$NN[>IN;V6R/38G9Y="ZF0$IK@G
MJ"^M>24=#D&'V.*1\OBO3L,L9[K+K5DQ'03JB,FNK2S;,G"2K74M.O5.HI9&
M:9#;8S1KLZ/'I>3V?=;98J8"VFG%*=5MW*6\I*4(3^<KKI\&@(\_<H<V7^2<
M(<A(AXU9XYF5 ^U3W\%,MKNU[<I).E*)]LT]QI2?)^K+<>[7Y/4%IKN5^0,^
M9P3AU]K$;2KD2<JJFY-8F>R2Y:81$<>&XI!Z**:9FM&_RI[7G+P!5JY1S9;4
MDNCQNHP:PO>0;2K^G;+&(TAAMRM@I43:U//JU0I7<U;0E'RU%ITU3J2F':>H
MRJ1B^#Y-B^.S\B/.I+L"OK&%M,2V9;!*);+I.'M)27$J0H]VTB(U:F6FHI\A
M>HVG+ ,CR^_H)U3>8O9?0-CBQJ;D2UVBU(2RRRXC1*R6:R\VGL4>AD1:BF@X
MPR_*LK]0V2'E%+/QA^'B\-"<>G2D2FFE.2B4IUE3)]M1++351%KJ1D?@ M7D
M+,<JQ1N C$\)G9E-FF\;C<.1'ALQTL$E6KSKY]#62C[9$D]VTRZ'IJ1 7_4K
M7N87AN64V+6-I*S&Q>I8]&VXTU+8GQS6A3:C7H@RWH^5J7EZGIX M,B#ZCJ=
M&"95EF34$ZDNL0GE46F,J6W)E+GO&A+#;#C>B5DXI9$2M/89]4Z&8I'>-LQR
MS+/4;<_6FDL,6=AX@R2,=G2DRF4*<GI4;[)LGVS):=J35INU2:3\ %L2N1(\
M'E&%QG,@.-+L:=VZ@VYN)[+BXSW:=C[--Q*2G]8:M=- 1 6_4E#G8;CN14F+
M3K.]S*QFUV(XXR\TE^:W7+4AZ2IU1$EII.WS&HCV]/S=5$6D*YEYJL<J]/&7
M6./5-E1Y)76+6/Y/#[Z&9=.XE]"G%J6@R-QIPMK)&W\KN? 2@(A9%AS'9XUB
M.-N3\)L$Y[DDA==180F0PN6\<9)J6ZM\OU:&DMD2UK,O+J6I>)D*2GC+DF)R
M/5V#YULBCOJ2:Y5WU%--*GXDQDB4:=R/*M"DJ)2'$]% C1\H<KY-QX[*D0./
M[+(L=JX?TE<WD>3&C1X\=.XW-B7#-;JFTH-2TD1:)Z^ *K#-N3LGD\X<:V6*
M8W9WF/3:&3:5<)F6U&;G(L&$*-[MN*)!*CH61*[G7KY?C"U/4+=W5!PWEUC0
M1I+]@5>\V3T)XH[T5MQ!I7))>I'HT7F/9YO@^$"%(Y=F^8)X9X=LWZ.TJID?
M+,:A)J&Y:'95W"8AFZ@TJ;7HI,E:2(FWC^46JO88*M>E]0M2K&LXNLUHY>*6
MO'ZVD7]*^XU*=_UM.Z*33C9I0LWS\B/ M3+KH>H)39<>\QRLKR9["\LQ*?A6
M5' 3<UT"P<;?*77*7VS6E;9$27$*,M[2BW)_H/04A/J9M)$.\X^K\CM[*@XB
MLIDMC+;6G=7'<3)[23@MOO-D:D,J7NW>S0C,^J4F0A)_I^KX&XPC2I%[9Y^U
M.GHB8H3KK4N=,<L5:1(;+R>CB22DSWF9]-=.FU " \U<DY5><&9)+LL9N<'O
M:NUJX4R&MTC-]MZ2RM119+!I)Y"DJVJVZ%KT A86+<[QK";EE7F^-S<)LL2K
MRO)D><ZU*[E4I*E=Y*F-2W$2?,V6NAGH1F>N@ITX%SVK+,CIJ#(,0L<3;RN(
M]8X9.GN,O-V<>.@G5EHUU:<)M1.;%:^7KKU3J*1)'JQ>]WAVSG'%RK&["S>Q
MZ#9QWXSRI%PA2TLQV63-"E=PT:;]2(CU(MV@%);2^H.J5C&;WF;44K%+3 %M
M(OZ5YUJ6[_K:"5%)IQO:A9OF9(1X%J9==#U IL>/>8Y65Y,]A>68E/PK*C@)
MN:Z!8.-OE+KE+[9K2MLB)+B%&6]I1;D_T'H*5QZN<VO<!F\9Y#2R9+:85P_+
MGQ(SBT)DQ(J&W7FW4I,B4GMDO7=X$9@0Q,LY)L+SU;<?8G26#Y8O617#GML.
MK1&D2[&N?F))Q*3)*R)DF%IW$>FH'!,I7J4KXUW*<^JUBYQI7VWU=L,^2MKW
M)FP[B63/L'^L..EQ1(-\CVZ^!&>A&*9^>\]JQ+([F@H,0L<L;Q2(S8YG.@.,
MLMUL>0@W4%M=/5USM)[NQ.GEZZ]%:"D!Y,Y/R)WF'B&UPJBL<BQV;6V5K5Q8
MDQN*Q;>^02Z]MPR22XK:NX?>_KZ)T,!)UYYC&%9KSCD<6NL95MBL2EEW:'9N
M^+))V$IQI,5I1:,FE/1>NNI^&G@ VV#<^'D^41\9R3$9^(JM*A6044RP>8=;
MEP&]IK4HFC_5*(CW;5:^4M3V]",4TE1ZG';BTQDT8':1\/S*V33XUD[[["&9
M&KBFS=6SU6W\DU)0KY:2,R/H!2R.6.2(_%6(+RV36/V[:)4:&4**I*'E*EN$
MV1IW$9&9&?A[0%63/4_D$%V_K'^*KE-_B[/TGD$(YD/LQ*@VB>3)4^DS)2S0
M9GV4)/P/S=# I8-_RC>(QS&\BX_PFPS1C)8963"8[\>"B/&4TV\GOK?4>U:D
MN>5!)/4TF7CIJ&GQ_P!0E)D37'$V/426*OD-Z?!;E/+0GW"PKR41QW4D1[C<
M6A26U),OAT I+,#Y%CY[:Y?"@5[D>!B=LY0G8K<2I$J7&21R"0DBU239FDNI
M]=0$=Y/Y?R/CF1,DQ^/;.]Q6ICHF7&0QY$9AAIE>NXVFUF:W31IYRT3M\3Z=
M0&ORSGN9593"Q+#<*L,QLK#'F<KC^YOLQM(#SJFS-9.D9D9$DM--34I1)(M3
M ITS_4?7+QC \CQ3&IV1N9^Y(C5E9'=98D-2HA&3C3AN'M\JTJ2I6NTB2:O
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M0$0OB.OQMWFG!++"ZW)O<VZ.R1D%GD+<Y32K-;!=Q*').J2<)6O=[>B#,TZ
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M_%(K[_$O),3/7,@5>/LHJZ=<E=!)B/2NZQ8)0DNTEE)&2W%:[DF1J\>A!O\
M/L;I\<Y8Y 5R$C-&Z;+EQ9>/JPY<GW6R0J+V)$1]MCRJ=2KR$EP^J3ZZ$9:A
M*[),+A+EG#,L^AKA_ '<%3B$ X\5V=-CRX\PIC34A#9&HEK29((M/E:^Q)Z$
M3;THQ)\/AN U90I%?+586CBHDQI3#Z"<FNJ+<A9$9'H8$J7S"AOG^%/4-#9J
MYBY<_/7I$&.F.Z;C[/TC!5W&D;=5HT29[DD9:%J"M3ZAHV283S).RIS'IUG2
M7EKC^0P)<)E3J#.DKGX#L5:B(R2X:G$KT/\ - A?W'&,6N->EZ%CT]ESZ6+&
M9KKD78KO)<G-/2$M&C3=O3W20:=-=Q: G%3_ !Y83,X;X*P6LH[:)98(]]*9
M3)L(+T1B*S%CJ2V1..$1+[ZE?J]O]/Q%:"DP'%(TZTXIY+B9ZY<RK^0AFJI5
MR7*&9!DRB=8G$VDNR3:=26X9ZFDTZ^)&1!Z9]0WUQ;X>R+ZB'+^G$ML$HZ[4
MY_N??;]Z]W,NO<[._P .NFNGFT!(>><&J<<<Y)R^PXYJ<A3B#_&]E%;F7C$Y
M2Y%B<E!K3'7*W*41EH6Q/_I"7M+0%2;&JBW1&]+I+KY2?H]%A](:L.%[OK )
M*>]Y?)J?ANTU 3[U-5UOEM5AO&U.F0W]:\AB(LY[#*GDQ:^$??=<5T-!&E7;
M4DE]#V@D(%7<:9'6Y]RGQ?>V4_(X_(F*-V$;))L<FT*LHI.1&T*4T1-$XC<2
MB+IY4%K[ 5&L)B<KV?"7*7(U= G5O(]K&J:2#')IUJ<4+'XD>/)=CI41+);J
M5R%%L\V\NG4B =6$8SCU]R;/C<95N1-4%K@=M5_2>2-S"0Y9R5)0HDN2M2Z&
M9=S89(WZ[2 9&*Y)*NW.!,+^KMU#N\(L_<\E.57OM18KL>.I@DJ>-.TS61;R
MT\$^.@#61\%QBKO,GXYY+CYXNPMLBE/5M;CRY+E+95LZ0EUF3VT$;/D^4]NZ
MIV^U1:$%\8152H'J-Y!<**^BL^@:*/%E.(7VG.RA23)+AEM49>W0P1#?4S)Q
M)-VB6BNR:IY6J:[NX?EE!"?<9E/J4XI$!3K6XG"WEYT+26TEGH?4R,0W&-M9
M?.YWP&\RRO=8N'..MMZZEE28[=DY)2MUHU)+8E9*U\A'T_  IVGAV59Q'Q%#
MS&)?0^,2L\B/.8M6W+8E]U<EY5<3Z&"2^31J-1GI_P!+:"NJNH)Z.$\YC55)
M<QXDCD:)+JH5G&D_21P.[$-M;J7"-PSVEYE'KU\3 6[ZE\:=/,,!SR>F\+#J
M<K*!D$W%ENMVD),UI'8>2;&J^T:TFATR_-Z=3,B!(0[(,4QY'#?TM@4#)GTW
MF95,V8YDC;[MC)5'D)0<HB41K-I:>I+5U/V@K?YUA>09=R!SI454-XY%OB=6
MQ5N+0I#,B0RA3A-(<41(,U&G9\KH9]01U8O?3^6L_P"(FZG'K2L8XZB2W\OE
M6<-R(U&F.P41$1&U.$6]9N(/4OZO7V&1!#J2NO<9X[X^SB52SWJ_$<[M)MY$
M:C.G+:@3'G6_>"9-)*4E&I:Z%[2!7;94=[RSC7J$F8Q3632KV906-'%GQ'H4
MB8S7$EU?:0XDC,UI:,VR+J>J>A&8"5\9U''^1VEKDF/HSR=D=30S6?>LL5)>
MBL*EMFAR&A;Y:J>(SW;$=/:6H(M7TUQ)<'@W"XDZ.[%EM0EI=8?0IIQ)]]T_
M,E9$9= )6J"             # BWM).L)53"LHLFU@Z'-@LOMN2&-W0NZVE1
MJ1K_ )1 -!:8!77'(-!R#.E/KEXW$F1*JO\ )[LV[8$2'I'R=V\VR[?RM- $
MN      '2Q*BRB<.*\V^3+BF73;42]CJ#T4A6TST47M(^I .Q:T-H4XXHD-H
M(U+6H]"(BZF9F?@1 ,&QOJ.G@%:VUG$@5:C229LI]MB.9K^3HXM1)Z^SJ SD
M+0ZA+C:B6VLB4A:3U2:3ZD9&7B1@.0      QG[&OC2XT"3+99G3=_N<5QQ"
M'GNT6Y?;09D:MI=5;2Z$ R0'2Q*BR3=3&>;>5'6;+Y-J)9MN$1&:%:&>BB(R
M/0^H#N =,65%FL(E0GVY,9S7MO,K2XVK0S(]%),R/0RT =P       ,:+8U\
M]<AN#+9DN1'3CRT,N)<-EY)$9MN$DSVJ(C^2?4!D@.F+*BS6$2H3[<F,YKVW
MF5I<;5H9D>BDF9'H9: .X                  =2Y49M]J*X\VB4^2E,,J4
M1.+)O3<:4F>I[=2UT\ 'QN7%=?>BM/MKDQ]IR&4K2IQLG"U3O21ZIW$737Q
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M3)#4=*ST0;JTMD9EUT+<9:@$:="F[O<Y+4C9H2^RM+FW7PUVF>FH#O
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MO]GO+C5ER^\9E+DML&2C2MLTMD?PEJ74B(Q"76665?$F!8-A_$3;622\G?\
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MHS:3L[A+\/9KX:E3CT[8U?XK@]C79'7NULYV^MI;;#VW<IB1)-;:RVF?11>
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MO)_J1E6H9_6>;^N1EY=05Z+?9:DLN1WT$XP\E3;K:BU2I"BT,C+X#(P1Y/\
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MHMG68HEYK<M"B>6Q&:>)2D:*,NTA9]/;X J1YW395:8%SORMD]%(QEG)H-5
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M,-P.+T@      QTP(*)KEDB,TFQ=;2P[+)M)/+:;,U)0I>FXTI-2C(C/0M3
M:O(</Q[*I-+*OX93',?G-VU42U+2AJ<RE26WMJ3(E&C<9IW:D1]?$!O
M                        &CI\/QZANKW(JN&3-WDKK#]U,-2UK?5$:[+)
M'N,R2E"-22E)$74S\3 ;P  :C*,;K,PQZQQBZ2XJIM6%19J&7%,K4RYT4DEH
M,C(E%T/3V ,ZMKX=171*JN:)BO@LMQ8C"?DMLLH)"$E\1)(B 9(
M T68XC2YWC4_$\B0Z[2V24(F-,.KCK6AMQ+A)WMF2B(S01*T/J73P ;EAEJ,
MRW'CH)MAE*6VFTEHE*$%H1$7P$1 .P!'\NPN@SB%"KLC87)@P9T:T:82ZMI"
MY$-1K:[A(,MZ"/J:%=# 2         !#\4XOPO#+NWR6D@*+(;Q:EV-I*>=E
MR5(6ON=I"WE+-#1'IHVC0NA? 0"8
M  #1WF(8]DEC26MW#*7,QV2<^H-2EDEF4:-A.[4F1*4DC\NXCT/KX@-X  ,=
M,""B:Y9(C-)L76TL.RR;23RVFS-24*7IN-*34HR(ST+4P&0
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M],?_ &P]/XA_TS#]<_\ WY+ 'Y]^O
M
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MEH5J:EGT,M2+Q+0MO3>78Y%S#%;O%)RU-1+N#)KGG4%JM"932FC6DC]J=VI
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MX98=MPC*)QF\]D[)_G*[A\%^L
M
M
M                                      &-8U\&V@2JNSCMRZV:TN/+
MBO));3K+J32M"TGT-*B,R,C <H,&'60HU;71VXE?#:1'B16$DVTTRTDD(0A*
M="2E*2(B(O @'>
M
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MM1D9Z$"TL:LG?2=;#LO=WHGOC#4CW64CM2&NZ@E['4'KM6G712?88(R@
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M30VU4YL639A/R++LX@(J9^1R66VULQ&B(DI;9)2B,_*G<:E_FEIIUU+;=0^
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MK)_MJ0M3*]W@E:FD:F7P -9C_!M)CJN3785@Z;_)CTEZ<Z;:".(4I#Y&EO\
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ML^\NH9WJ+V)WF6I]?8".4FRKH2T-3);,=UQ*EMH><0VI26RU49$HRU))=3^
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M37?;WG(_9:;M=_\ D^(#NC6$":X^S#E,R'HJ^U*;9<2XIIPM?*LDF9I/IX&
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M=R2RZAQI.PM5:K29D6A>/4!P;O*5XU$S917#0Q[VLD/MJ,HQ?^E/171'^5X
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MU=4="\2PA%=25W(:O3%29DA=I6V$&XCS&ENK0IUF&LR:0:T&2MI$VA/0_ M
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M77PG$QU&;;B31L)E'R#3KIU!8W(_DV'XYR=GO/\ -SU3BI&!U++6)-J?<:1
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M +23D;CK&N4L7?Q'*VW5U3[K3^L=?:>0XPK<E25:'I[2/IX&8(UF3<,X'EF
M5O&]O"</'J9J,U4K:=-N5%5";[33C;O4]Y)U(S,CW:GJ0+;&PO@SC_!\7O<4
MKHK\V'DZ'&\BF6+QR)LY+S:FE$ZZ1)\$K5IM(M#49^)F8%M50^F[C:CP>YX]
M<1/M<=NU-KD(LI2GG6>P9J9*.I"4$UVU'N3M+Q^5J!;;<7\)89Q,[92\=<GS
M+2V2TW.L;64J4^MJ/KVF_!""2C7IHC7XP+;:VXSQJZY H>2YOO'UEQR.]$KM
MCNV/VY*'$+WMZ>8]'5:=?@^ $=W(G'.)\I8V[BN80SEUBW$/M*0HVWF'V]22
MZTLNJ5$2C+XR,R/4C,@$?XUX(P'BN#:1L<9DOSKI':LK:P>]XG.M:&1(WDE"
M4I+4ST2DM3\=="T+;5+]-/&B\#J^/$E8-T]+8JN*R8U*-$]B8K=JI#Z4EH7F
M\-/$B/Q(C M8N68M69GC%EB5V;JJJVCJB2S97VW3;7XZ*T/0_P"@$<\5QNMP
M[&ZO%J?N?1=1&;AP^\KN.=II.U.Y6A:GI\0#3X%QIC/',:YB8ZE\V+ZQ?MYZ
M93G>UDR22E>WREHG1)= $(QWTN<38QF$?,:R),-Z!)5.JJAZ2IRLA2EGJ;K#
M!EJ2B,B-.Y2B29$9>!:%M6]!Z8(>;Y[R3D/)4&P@U%GD*Y%*U%G>[HL82''%
MJ[[3>X^T:MBD&9I7[2T M;_)' /'O)[E7*N&95;8T[!PH4^G?]S?3"/H<8SV
MJ2;6AF1)V]-3TTU,"W1?>G;C>\P^@PIEJ=3U6,*<<I7JJ6N-)9=?(^ZX:SWD
MM:S,S4I:3/4STTU,"V._Z:>+GN/V>.T19;%;'GG<LVC4E2;0K,RVJE=\R,C<
M-)$D]4[="+IT+06Z:OTQ\9U-%E>/QCLUPLS;BMWCK\U3TAPX3ANH6EQ:3,E*
M6HU+,]==?@ MRS#TS\=YHY5/6$FWAO5-7'H$+@3U,F_612,D,/DI*R4D]3W:
M$1JUZ@6M#'L?J,5HX&.4,9,.FK&$1849!F9(:;+0M349F9GXFHSU,^I]01I,
M.XWQS!K;)[JC]X]]RZ>JUMO>'3=1[RM2U'VRT+:G59] $5S[T[<=<C9*K*[Q
M,^+:R(ON%E]&S%PVYT8BT2B2E!&:B3T\#+70B5J1$0+;)J.!<#I'\(D0BF]S
MC]$MO'^Y(W%I/4I3O>\OGZJ/3PT MC2/3IQK+Q?)<1DL2W:O*;15].6J1J^S
M8+,C[L=>WR:>PC(^AF1ZD8%LOC?@C!N++J=D.-+L';>RBHASY%A+5+4\E"B7
MW%;B+SF:2U,NGP$0%L;D[T]X!RU?0\CRI=BFR@Q2@1S@RSCH)DG%N?)VJ\QF
MXK4_:6GP 6P(OICXTB8%=<=(79KH+V2S-EK<F&N2A^-MV*;6:-I?)ZDI)D?X
M@+6A68[64^-P\4@(6W3P(3=9&0I:EN)C,M$RDC6K4S,DE\H^H(KF)Z<N.86+
MX[B+)3_HC%[8K^KUDZN^^DHU>=6SS(U/Y.A MI9C_&V-XUF62YW6^\?3N5]C
MZ5[KN]G_ %5.U';1H6WIX]3!&DY-X-PGE>QJ+?(E3HEI3$XW&F5<DXCRV'OE
MLN*)*C-!]?DZ*ZGH?4%MER>'<.E9%EN4.%**RS6J^@KDD/FEHH?83'T921>1
M6Q!>;7QZ@-%=^G#C>]PS'<+D(G1X^*=SZ MHTHVK*-WE;W"2]M,C)1Z:D:-.
MA:> %NU?IWXX5@E9QXEJ<B@JK-%XTM,M9R7)Z"61N..*(]25O/5*2(O@T M*
M*3C;&\?SC(^0:\I'U@RA$=NT[CNYC;$0EMOMHT+;T26O4P1GYMA>/\A8O88A
MD\<Y--9()#Z$J-#B5(42T+0HODJ0I)*2?Q==2Z *]POTT\<X+93+FI<M)%I8
M5;U).E3IJI"W8TC:2E'JDM%DE"4IVZ$1%X MNNQ],?'-AB6,X@B1;P8F(G,.
MCGPIRF9K7TDZ;T@C7L-*MQGIU1J1="]H%MH]Z>N+W^-VN+%5KA8VP_[\R\3R
MO?D3C,S.43YZGW3W&G733;Y=-O0"VK9],'%[6#SL#4BP=@6LUJSM;)V6:K&7
M*CZ]M3KVW0R+4_*22+J9^)F8%IIR-QAB7*= WCV5L.K8C/(E0)D5PV)<60V1
MD3C+A$>AZ&9=2,C^#P!&FQG@GC_%\(O,!BL2YM/DO=5>OSY*WY<IU]!(4XIS
MRDE9$1:&A*>I:^(+;31_3-QTS@"^.'9%M*H5V#5J;LB;NE$['03;3:7$H226
MD)+1*$I+X?$"V9R1Z=N.N4+UO)+Y$Z%<&P4*:_5R3B>^Q4GJ3,DMJB6GV:EH
MK30M="+06W3W#F#KO,-O8T5V$]@;+D7'8L9TT1FV76R;-*TF2C7T+Q-6NO4]
M0+5_G/IHJ;7&',6Q-SLP;S+HV490=D\M9J8\Y24Q]C9^8R,MB5:%\*@+7M(@
MQ)<)VMD,H<@/M*CNQS+1"F5I-"D:%[#2>@(J"F],/&U'A^28-%>M7<?R<XQ3
M&GYIK6PW#?.2VW&/81-I[AF:NAFK\XS!;2QCB/$8^7T&;(*4=UC=.G'JXE/&
MI@X*4K21.(,O,O1Q6JM?_("(ICGI@XLQ7,(^8U#-@V[!DKG5E0J8LZR))<UU
M<99(B,O'312S3\0+;I]4N#Y)R)QM%QC%JY5E92+B"M;)+2TA#".YW''%K,B2
M@B/J?C\! 0V6*>G/CG$*W*:ZN*PDJRZ$NJM)TZ6J1+3 <;4UV&7#26Q*4JZ=
M#/H6IGM("TFC\68:UQNCBF1$7-PY$3W XTIPUNFT2MZ3-Q.TR6E6BDJ3H:3(
MC+P!$4POTW<>8)'NBI'K15G=P7*ARZDS#<GQH#B=O9BNDA)-$DB3M,D[BVEU
MZ MMA5<"<?T3N%2*5N7 DX&F0W3/L2-JW&YBS<?1)/:?<2XI2S473Y2M/$"R
M-P%QPQB>384]#?F4.5V#MO9M27C4XF:Z:#[C*TDDT&DT)-/_ "ZD9D!;!Q;T
MW\<8K1Y)1L'96*,KC)@74VPG.NRG(J"-*&DK;[9)))&9%HG73H9F70"V9QKP
M%@?%MO)R"D586-Y(CE";L+>4<QUB)N)799\J"2C4B]AGT\?$"V1R1P=@_*-M
M5WN0>^Q+JJ0J.S/JY2H;[D5PS-4=Q:2,S;/<KPT5YCT,M3 MJJ[TV\:U=)08
M]#3/36XU=?62L2J4:E%.(TF1+,T^9!;"\O\ R@6D')_#V'<M1:]K)D26)]2X
MIZKMJYXXLV,IPB)9-N:*+16U.I*2?@0%MMQ]Q_C?&>-LXKBS;S=:TXX^M<EY
M<AYQ]X]5N+6L_%1_U2(OB!%<93Z4N*,MO+F\GHLXRKYSWJRKX,U3$)<S=N.3
MV229&X9FHSU,T^8SVZGJ"VS\Q]-/&>;VD"WMTV+,J%7-TKI0IBXR9<%E.UMN
M3M+5>GPD:=="W:D1$!;(M/3OQY;<:5'%CY3FZ"AD',J);4G;/CR%..N&M+QH
M,CZO++0T:::=-2(P+;.OX5PRMO</R-E4YRTPF&_ IW7Y*G=[<I#B'%/[BU<6
MKNJ/=J74"VN3Z=^-#PF[P&3$DRJ"]LW+V3WWS5(:L'20GNL.$1&@R)!$7CTU
M(]2,R M\QKT\<=XOBN28K#3.E(RUDX]_;S9)OV4AHTFA*3>VD1$DE'IHCV]=
M0+;^=Q1BEAQBGB61[S]4D0V*\MKVV5V(RT+1^MV^.J"U\H(B&2>F+CC)[&!:
MS)-Q&FUM9%HXSD*P6P?N4)&QM*C))F9F7RNO4^H+;+R'TY<>9+C&/XU.<LVW
M,7)Q-->,35)MFD/J-;B3D*2K<E1GX*3TT\N@%NV=Z=>,YW&\+B[W64QC];)]
M_@2FI*_?V9IJ4I3Z'EDK1:MZM2V[>O1)=-!;8\9<)83Q--N+#%/?3E7I,%9.
M3I*I2EJC[S)>JRUW*4XI2SU\3]@%N/)_"&%\L3*BRR-<Z)9TG<3#G5<GW1\V
MG]-[2U;5:I/3V:&6IZ&6I@6U&?>FKC+D6^1D=PU.AV*F&H=A]&RE143HS!$3
M;<DMJMY))*2U(TJT277H6@M:E55U]'60Z:ICHB5=>RW%A16BT0TRRDD(0DO@
M(BT!$-I^'L)HN2;CE:OCO)RR[8.-,4IW=')*NUN4VWIY5*[*=QZ_#\(*BEMZ
M6N);K,GLRFPI?<E2RLYU(W)--3)G),U=YV/MZJ,S,U$2B2>IZEU,"V]Y"X+P
M?DK)*C++U4^+=U#?NS;];*.*;\7>;G8>,DF9HW*5\@TGYCZ@6U.>>FCC'D/)
MWLKN6Y\6PG):1<,UTM46/8)8(B04E!$9GH24EJ@TGT+V@6M1RHKG:A5"['2Y
M4+C'!7%69J2J,;?:-!F9ZF1IZ>.H(IK&/2?Q7B=Y49#6KMG+"AE^^U129ZG6
MF/-O)I*-I%VR5J>GRC]JC!;5[QOZ5ZV^M,HR3E*NG1U3,HFV5=6)F$B+.KR>
M-;/O<=&[IN-9I\R5:'\'B6UO<D^GGCOE&Y9R"]1-@VZ(_N,J3523B'+AD>I,
M2"VJ):/9T(E:=-="+0EMO+X:P61-PB8S$=A)X][A8U%BNFAALG4MI43A&2C<
M_P TGJ:M3/4S,]3 ML,+XWQO K#);*A]X]YRNQ<N+7WAWNI]Z>4I2NV6A;4Z
MK/H"(3EWICXTS;+)F6W:[4W[-UE^WK&9[C=?-7'2E".\UH:M"2A)$2%IT]@+
M;)SOTW\:<AY"WDMRU.BS2A)K)3-;*5#8DQ&RT;;>0@M3)'33::? B/4B M]M
M_3EQO<X)08#(;G-0,76X[06C$DV[.*X\LW%FA_:9>8SZD:=.B>FJ2 MR8].?
M&D7&L>Q:+&E,5N.6R,ABN(D'WW[-'_II*S2?<,R(B/PZ$1%H1 6E6/\ &V-X
MUF62YW6^\?3N5]CZ5[KN]G_54[4=M&A;>GCU,$1[D_@+ >6+&)<Y"F;#NHC*
MH?TC52/=7W8:S,U,.F:5DIL]RO9KYCZ]06W?D7!7'F1\<P.+7H3L'%ZE33U7
M[BZ;<F,^SNT>0XLEZK5W%[U+)6[<9GU LA<'X7!GX59I<L'YV!HDHI7I$I3R
MUG-,S>7(-1&;BE&HS]GXN@%L='I^XV^K64XE)AR)=/EUBY<VB'WS4XB<X9*)
MQA:22;9I,M4^/P'J1F0%L+'?3;QUC>.9-CD==G,3ES"(=W93IJGYKL=HC)M"
M5[4H22",R(R1KIT/4M +63C./5^)8[58O4[_ *+IXK,&'WE;W.S'02$;E:%J
M>A=3!%:<@^FSCSDG)9677KUI&O9<9N$N17S#CD3#9;322=BB\R=4J)6I&1@M
MLG)O3MQMD^+8SB3D>760,0,SH9-9(./+8)S3NEW3)>O=-)*<,RW&KKJ1@6P(
MOI@XM@X?:8/$18LTEK8-6[AHG.%(:F1T[6U-N::^4O8O=UZ^.@%NVO\ 31QI
M7X1D&"I*PD0\I<C/7UI(EFY9250G4O,$I[:1:(4GH1(]I_"!:1Q^'\/C9:UF
MK7O7TTS2)QE!F_JU]'H+0M4[==_3Y6H%M ]Z;>,G^.X'&CC$SZ%JI3EA53DR
M338193JU+4XT\22TZJ/H:3+XM2(P+<6/37QK'P*5Q\DK)5;-GIN9=BJ<Z=@[
M8H+1,A3I:)W$1%TV;=>NF[J!;Y6>FGC*LPR^PG982XF3.1W[NSDS%KLI+D-9
M.1S4\DDEHVHMR4[=-?$C MN^,>%<,XI=LIM J;.N;;MIGV]M).9,<:9UV-[]
MJ2)*=?8GKTUUT+06P^1. ./^3,@C9/?%.BV[,8X$EZLEKA^]PU&9]B1L(S4C
MS'\DTF?@9F6A 6U$_P!,'&\W$\<Q%J1;P(F*+FN4D^%.-F:T=FYW9!&LD&E6
MX^G5&I%T+V@6L+ <!QGC3&H^*8G&5'JHZENF;JS=>=>=/<MQU:NJE*/_ )-"
M+0B(@1#YOIYX]L*3,<?D%.^C\YLTW5X29.B_>TO^\%VCV>1._P!FA] 6VUD\
M,X/-R>?E<]A^5-M*(\6GQG7C.*[5JVDI!H(B/<>TO,2O^4"T5Q#TM\:85D5-
ME-8_;R+:@6XJK5-G*?;:;<2I!,DC81$VDEJVD6A]>IF!;&PS K%[U)Y_R;94
MBZVM17PJBDF.DDO?G%-ME(D)(C/Y/82V1]-4F7Q@-EZGL.R//>(['%<4@JL+
MN=,@$Q'2I#9;424+6I2W%)2E*4D9F9F!#[@GIQX^PF)<JB-SGK'(JLZ6?(F3
M%278\%ULD.1HSAI2:$:D6FNI^4O@T M,*7C#$*7CQ'%R8JYN'IC/0EQ9KANK
M6Q(6MQ9*66T]=5GM-.AIZ::: B)8'Z>./N+Y<^^QYN?87;D)R##D6<DY:XL4
MR,^Q&+:@D)/P\#5ITUT,]2VK#T^>E>JI:#&\GY&KYD?,JR6[8HI5S2=@)?)>
ML9]QA&Y).H22>A+]A;B]A"969GGIHXQY"R=[*[EJ?%L)R6T7#-=+5%CV"62(
MD%)01&9Z$E):H-)]"]H%I8SQ;BD?/87(S")",@KZI-#%03QG'3"0HU)(T*(S
M-1;OE&H$=T;C?&XG(TWE)KWCZT3ZY-._N=UC>ZI6VLM&].BM6T]=0%=<*X#8
MUG)O*_(=O3.4YY!;%$IFGDDE3D*-JIR2DB,^DA:DKZ^T@65E<A<=XMRAC3V*
MY=%5)K''$/M+:6;3[#[6NQUI9=4K+4R^,C,CU(S($1&C].?&%)A=Y@ZH4BSK
M\E6AZ\G6,A3T^2\R>YIQ3R21HII7F1M(B(]3]IZEM\PWTZ<=815Y'75Q3YDG
M*8+E3:VUA*-^><%ULVNRVZ24DA))/IM3KT3KKM+06SX'!F#5OU$]V*9__KKW
MH\=W2-?^VFDW.]Y?/\DM/#0"W0CT_<;?5K*<2DPY$NGRZQ<N;1#[YJ<1.<,E
M$XPM))-LTF6J?'X#U(S("V9Q?PKAW$RK*1CKD^99V_:3865K*5+DN-QR,FD:
MZ(01((S(M$:_"?0@+8/)/I_P7E/((V49"]91KR%"^CH<JMF'%-IK>XX2DD25
M>?5U1:GT,NAD!;E*]/G&,OC6%Q6Y7.)QJN=]ZA/(>4F:U,W*4<DG]->X9K5J
M9EMT/;IMT("W''_3_@..X1D."Q%6$BORDC^G9\N6IZ=(4:=NXW#(DI,BZ>5!
M?'J!;(R7@G <KP:BP&S9E)KL90PBAL([_:L8BHR";0M#Q)/S&DBW:I,CZ'IJ
M1:"V WZ<>,VN.9O&+<>6FBLY2+"TF>\&JPE2VUI63CKQI/4_*1:$DB^+4S M
M*<ZXPQ'D;$T8;E,5<BJ9-IR(XVX;<EAZ.DT-NM.%U)9),RUTZD9D9:&",7C'
MB7%.)X,^)C:YLF1:.ID6=A9R52Y4AQM)I0:U&24EM(S+RH+X]05K^2^#,(Y4
MMJF\R)4^+;4Z%LL2ZN4<1QR.Z>JF7%$E1F@]5?)-*O,?7J!;*F<-X;.OLSR)
M\I?TCGE:FFO=K^UOW1,=,8NRG;Y%;$EUZ]0+:2^].''&08CCF(R$SXS6)H4W
M0V\24;-E'0X>JTD]M,C)1Z:D:/9TT M-< P''.-,9C8GBS3K55'4X[K(=6^Z
MMUY6YQ:UK/Q4?7IH7P$"(K-X"P&?7YS6/^_>[<ARV9^0[9)DKO1WO>$=D]OD
M+>?4NNI=/ %MMHW$6'QLR@9RE$ARZKZ9.-LH==WQU5Z-2)*VS3YE'N/4S/K\
M "+8GZ8N+L,RZ-F%*U8%)KW7I%16/37'*^"[((TN*8:Z'U(]-%K40%N.0^E_
MBO)<PDYC.8GL2+"0B;;5<.8N/7S93:MQ.O-(+=NW>8]BTZJ,S\3,P+;KD+@K
M!^2<DJ,KO%3XMU3M^[-OULHXIOQ26;G8>,DF9HU4KY)I/S'U MV67!^$6MGF
MUM**9[WG\5F!?[']J>S'0EM'9+;Y#T277J!;LB<*X7"ML(NF"EE-X_A*K<?U
M?U04=;)L'WBV^<]I^/0"WGG-O344KE"MJ>/<6L:^C;N8M_:Y'.L$?0T:.9]Q
M]F!#+S&XI6A>;4T["(M$'J1;>D,:XDQ#%,\R/D:I3)+(LH22;'NOJ<CI(E)6
MKMMF73<I)&>XST\$[2Z B= @
M
M
M
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MTU\ *8N1^HGAW$V*.1?9*W&1D41BRJT%'DNN*@RD[FGW$-M*4VA1>'<)/M^
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M-2_&0%.G ^?.)^2[I_'L-R%$^X80ITHJV)$93C;9Z*4T<AMLEZ>)DGKIUTT
MI0SGJ!Y,7P9,SI,V,WD4K-#Q]IY,9!MQH!I29):0>I&HM/E.;CZG\6A:>P@9
M>9N$_5#CUZVJEY*R.-'S>UO)<2JKVX[C3#48C;;CMFXA!H3N7N))NN;C]I^
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M\02D,X$Y3L^4[?D.<[8,S\<J[DH>,JC-=IOZ/V*4VHS,B6I2RT4HU^WP(BZ
MLM1ZD^=CXIDXE25EFU LK6RC/71KC+D.-T1.*2^ZV>U2"49IVZ:&O^J7M B$
M[R#G?BK&,4I\UNLA;CT&0([E*YV7UORD%IN4AA+9NZ)U+<9H+;J6OB0%)=B^
M58]FM'$R3%K!JSI)J35&ELF>U6TS2HC)1$I*DF1DI*B(R/Q($1?/>;.,N,K!
MJJS>]35V,B*<^/'5'DO&XPE2D:I-EI:=34DR).NH+33U7J6X2N[JFQZKRQB1
M:WW;*O:)J023<>5M;:<6ILDM.J5Y2;<,E:Z=.I:BFPS+GKB7 ,C8Q/+,D9@7
MKQ(4N-VWGB92Z1&@WUM(6AK<1D9=Q1=/-X=0*=V<<X<7<<3(]?F.0-U\R7#^
MD8C9,R)!/1MQI)2%,-K29J-)[2UU,"FOOO47PYC$2BFWF2HBM9)%9L*I!QY2
MW50I&O;?<;0T:VT*T/0W"3KH>G@8%++AS(EC#CV$!]$F#+;0_&DLJ);;C3J2
M4A:%%J1I41D9&0(\XVWJ8J*OU%%@4^\:BX1"AJ@R$HAO+=7D3CY-)96X3:E;
M4D?0T:(U\3/V%I\8]35-BW+G(>.\GWK%5CM-(@0,9B-1775J4XA:Y#JS8;<6
M>GDW&HR27L("EHYQSMQ7QTS5OY7?HC-W3*9=7V&7Y??C+(C)U/N[;A;#(_$_
M'V 4YW7.7%./T%'E%MDK#./9)O\ H:Q2V^\T\;1:K(^TVHT&GP43A)T/H?4"
MFTX^Y.PCE*J?N<'M4V<**Z<>3^K=8=:=TW$2VWDH66I=4GIH?]!@C)SGD#$.
M-J-619K:-U542R90XX2W%N/*(S)MMMM*EK49),]$I/H1GX$ T4;G#BV9@4KD
MR+D+3N&07$,3IZ&GU+8><6VVEMQ@FS>2HU.HZ&CP,C\.H+1@W.'%W)-S-Q_"
M\@:L[6"U[R\P33[.YG5*36V;S:"62341*VZZ:@4ZL:YZXDR_+7<'QW)H\W(V
MS6EN.E#J6WU,D:EDP\M!-NFDDF?ZM9]",RU(C I-<@OJO%Z2?D5V\<>GJV%R
MYTA+:W3;8:+<M>QM*E&22+4]J3!$>5RM@)(Q%96Y*+.M/JJE#+ZE3"-*%F>A
M-F;9))Q.[N[=NO4!J(G/_$,[-SX[BY/'<RKO'$3')#Q,JE$>TV$R#1V5.:^4
MDDOJKREUZ M*VI_4M43/45;X!/O&FL2;0U2449,-XG'\A7(:9=;<<-LU$:5]
MQM)GM;TZ]?$"EEV//?$M5G"..I^2L-96MU$8XVQU3*)#FA)97(2@VDN&9Z;5
M+Z'T/0^@%+(!%0RO5!P9"N#H966-LV:)KE:^VY%EH2U(97VU]QQ3)(2@E=.X
M:MOQZ$8+3?Y_S9QCQ?.A5N;W[=;83TDY'BDT])=)DU&DG5I80X:$:D9$I6FN
MAZ>!@4R\PY9X]P3&8>7Y+>L1J"R)LZR4T2Y)RB>1W$&PAA*U+(TGNW)+0BZF
M".+?+O'+N JY.1?L'A"$[EV>CGE5O)OMFUM[A.;C)/;V;M?8 KGC+G%/*7-5
MW38Q;,V''<''V9L!+4=3+IS7'FDN&\;R4N$I.JD[>B=/Q@M+6SCD'$.-ZEB]
MS6R355,B2W!:DK;==2<AU*UI29,H69%HA1[C+0M 1JL%YEXUY(9MI&'WS,UF
MCZV:G$.Q29;,E&3I^\(;U;,D*\Y>7H!3"PSGOB;D&YF8_B>1M3K:$AQY<<VG
MV#<:9^6MDWFT$Z2?$^WKTZ^'4%I6W"?J3JN1>3<MQ>=>-/,2YO;P""U$>9)Z
M!%:?=><4M3>I+-"$K43RDGT\I>P"87OEN64&#8]-RK*)?N-#7$A4R7VW'=A.
MN):3Y&DK6>JUI+HD$:UGDK"I&24^(LV9*R&_KBNJF'V7B[U>HE&3N\T;$]$*
M\JE$KX@&@QSU \19;EYX+CN2-3\D-3C;+#;,CM/*82I;A-/FV32]J4J/5*]#
M(NFH+3L>Y[XD8SDN.'<FCIRTWBB>Z['3:*6I6THYR"1VB=W>79OUW>7Y70"E
MC@BK:/U%\-Y'ER<'J,G:?R%QTXS#*F)+33KZ=2-M#SC26U*U+0B)7F/H6I@M
M*SLN;L]B1^?[!I^-K@#L.)C,<V$FVR3JW4+<<Z[G%JT2KS'M(R\-.@"^N/+.
M?=8#BMS:O>\6=C45\R:_M2CN/R(S;CBMJ2(BU4HST(M"!%%U'J=H\<Y,Y%H>
M4\@8K*JKM(U7BT-J*ZX9-H)[ONN*8;<4>OZO<I9Z%^:"TGL_*[I7/&-4$',J
M]&*V5$[8'BA1''9<PS[NR2U*2T;9(\I&6KQ=$&6P]Q* ;#'/4#Q%EN7G@N.Y
M(U/R0U.-LL-LR.T\IA*EN$T^;9-+VI2H]4KT,BZ:@4LL$4)S!S:]QERW@U+<
MV;%1Q]-AV%AD,A3"GGG#89=2PVDTI6LB-TD:$VG<9]-= 6(6%"YCXUGX&YR8
MQD#!84SJE^R<2XWVW$J)!M*:4DG.YN,B)&S<>I:$>I C%H.<>+LGQ"VSJEOT
M2,<HDFJX>[+Z7HR2+75;"FR=T,ODF2#W==-=#!:=F!\U\:<FVDRFP>[*UG0(
MZ)<E*8\EE"673(B,EO-(29D:B(TD>I'_ $@4GX(K6DY_XAR+,EX%39/'E9*E
MQ;+;"4.I8==;UW(9D*033BBTZ$A9Z^S4%ICVGJ+X=ILE<P^?D9(R5J>BI=KT
MQ)BW$RW%;23JEDTFG<>FXCV_&!2<9C+EP,2OIT">U538M=+?CV<AHWV8KC3*
MU)>6VDE&M*#+<:2(]2+P,$>7LQ]1=SA/%G&SB\QA7&5Y%,;=NKV-7NI;<I&I
M+S<AYEMQELDK1M0T>K1*5U4E)>)&J7A?<_\ $F-8O39C<9$AFCR%*G*5PF)"
MWY*&S(EJ2PELW2))F6XU((BZ?"0)2:XSDU%F-%"R;&IB;"CL$&Y#F-DI*5I2
MHT'Y5DE1&2DF1D9$>I C4M\F82Y<9/0?2A(ML.CIF9''<9>;]UC+:[Y.;E()
M*T]OS?JS4 C]UZ@>),?Q2GS2VR)$>AO^X=,LX\DY$E+*]CBD1R:[NU)^*E((
MNI?"6I:5_P _^HRLQ3C*ER/CF^C.V.5/Z4LXF%R4*B15I3,6DE)V)<:-:$FE
MTM2,S+;J701"QIG.W%5=@<'DB7D*&\0LG%QZZ:IF03LAYEQ;2T-L&V3QF2FU
M:^3V:^ %-C%Y<XXF8(ODQG((_P!26DF;UHHEI)M1*)';4V:2<)S<9))O9N,S
M+0NI C[QWRQ@/*T.7.P6V*S:KUH;FH-EZ.XTIW<:-R'T(/11)5H9=.@#8YOG
MF)<<T2\DS.S;JJA"TLI><)2UN.K(S2VVVV2EK69),]J4GT(S\",!H8/-_%UE
M@DWDJ%D#;V'5JDMV,U+3YN1W%K0V2'&";[J5&IQ'39X'KX=06F3@7+W'G)\J
MTAX-<%;.4Y,G/6AB0TVDI)*[9DMYM"5:[%%Y3]@(S<^Y)PKC"G1>YO:HK(#K
MA,,:I6\ZZZ9:[6VFDK6K0NIZ)T+V@-))YXXGBX*QR0[DK'U0DO\ N;,U#;SB
MSEFE2^P;*6S=2YM2:MBD$>G7PZ@M.^BYLXOR/#;#/ZO(F%8K4F:;2:\EUA4=
M?ET2XTXA+A&K<DD$2?.9Z)U,"D5L?4OQG8<;Y;F^'7K<M>/1]A$_$EH)$^6E
MQ$%#C2FT+-#KJ-NI=/'4R ID>G'EN)RM@,63)M2L\QKD)+)DICJC$R_)<=4T
MDBV(09;$:%V]2Z=>H$IKR!R7A?%U0U>9O9E65S[I1XZ^T\^MQXR-6Q*&4+49
MZ$9^ (J[E7G^"7!-OR=Q!;QI[T>1'@MRW&5*..\\\VA9+8>2DTN)2LE))Q.G
M4CT,@6F;1\DY7/\ 4%'XYD2&_JRQB+=TMM+22>>G.N,I-;CGCH1*5HE.TNO7
M4!<-U=5..5,R]O9C4"H@-*?F3'U;&VVT^)F?_(1%U,^A=017V/\ J%XERN@O
M\BQ_(42H6-1US+9"F)#+[4=!&?<)EQM+BT=--R$GUZ>(+2N?2?REE7*B,AN<
MJS!JUG)4A2\4:KBBHJD...$TM$DDD3J7$H,MNY1IV^8]3 EM?4GSL?%,G$J2
MLLVH%E:V49ZZ-<9<AQNB)Q27W6SVJ02C-.W30U_U2]H$0P^0_497X]FW&4R'
M=L1.*,DAS[6VM%QG5//,L,K["$I4V;J2-S;Y4MDLSZ> %+2@<S<9V."/<EQL
MA8+"XZC;DV+B7&S;=29)[2FE()PG-5)T1LW*U+374@*9G'O*&#<IUC]M@ULB
MSBQ7"9EHV.,/,K,M4DMIY*%D2B(]IZ:'UT/H8(EX            #S;Z7S(\
MYYTT/7_\,)/_ *^2"R\]0&(37IGQZP0RTF7_ #+:UDDA/</:AS356FI]"_$"
MMMF#,M')7-^.9%F='A\2ZE,JF(R"$J7)F5SB35&.&LB-6K25(,DMZJ(]#+Y/
M0/:_&E4]1<>8M3/V+=NN!5PXR;-G7M2$-,I2AQ.[4S)22(R,P9>,,FR#":N7
MZGZO(I4)C(+22RW1QY))]Y?6A;O1C4M3-*S;49)\/E'X TFN%U*7.>.'JS(8
MC<B7&XL@ID1Y;:7%-O(3(2>Y*R/11%JD_P"D!B7UIA6(\S\YL<EG%BIM,<C(
MQE$U"22_"*"39L1-Q::FI*$$A'4U(/3Y)@(C42H.-0?2Q-SQUF'7QTWDF1(L
M2+LMQ7Y"'(:UFLC(D[%M&E1]$]#^,!JLA)JRXWY6R*D;.3QXYR9'ENN14F<5
MVN2MWN*2E.A&@U.Q]-/A2 M&-/X_S'U#Y9:XQ-C?RT1Q](AYE;UNC<1+3O16
MKB$[=Z6>WX=2[9E^:9 -=PUG<WC[+8_'&/7--R3BIT5E/QFWK64MV<!J*VY+
M*)+-M.Y).K023;6:E;E)ZE\D!7L+-;[.+WA3(\ASRNN;&PS!AX\,A0HD1ZFU
ML&VS,UL?K-KI$D]KI%NU)7G/50"QJNKP^]:]3E1G5Q]!8S*R"*B3;Z&OW=TI
M3BHZ]B>JOUR6R-/YWAJ7B FWIHSRZEY7D?&=I84V5LT,"'(A9O0(;2W)BIT:
M98DJ:2E*G$)5T]J32LC-7B"2D_J<H<4O<;QXKW,(V%7\"V:G8K;3B)44[!A"
MEDAY*B-)-Z%J:U=$F1>.NU0AYWSCD*TY ]-UJWD$:M5/HLTC5<JWID)16V:D
MDI:I+9)2E)FLE:J41$2B,E:%KH14VR[()7'W.O,%]C,)@YE5@3$B+$)I/9):
M%Q$$M;:2+5+:5;E%_5+3P 17C2[LKSU!\.V5KGL+-9\NDG//,P8D6&=4;U=)
M<."Y[J1$KMF9Z)625)T/RI(R 1G<G[K>NI:?S*\=?\C7_P @'%^B8,OS4;M\
M5E^GR?B,"3$7R/+SLG:ZN;))V*MZDH;<21%O-.FY)*\-3T\3!M.^1$SXW-W,
M=5<Y=28A#OH$%#CV10CEJFU2H9(-,)>TS)3>A$:6SW*61;2,T="/6W#%,K'^
M*\3I_I9J]9B5S*8MM&)26)$96JF%-DOKM)HT$6OP DO)&67F*4DOU.TV8R8D
M?*K5^.=&Q-))R)#:DN*CICI41J,TDMM7E\-4J\"U!75=RKFHS/A:X8R&JQ>'
M(XVK8M9=Y!'*36IDH95[RWYO*AQ2'$%O,RZ&2?S@'7*H*W#^-N*K*=D$/*N,
MVN0#L[&RA1W6JYB.X;:3;<8=+4DH6W(,RVZ:*TTZ]0G_ #ODG%&2<#<G2.+T
MPUK:M:PL@FU\?M-29:YD=1.$\222\6FOF2H^NI^W4Q#"EWF*8QSY9S>1),2'
M43N-HS-*]9DE3"]Q-$II!+)1*4LT/:)(M5=4EXZ&%61EV4+AST^74:PBU%9!
MO;U$BWLF3DU\6<[.-45Q]O0R,B)MTR,_#0S]@#<Y=02&>$^7<CK\QJ\Q8N;V
MG?NOJ^PN-$CR&)"C?423(DF3JG65;V]4GMUU,!:N%Y#A.2^K>)/P.7"F4Z,'
M)AUVN)/:)]$@CV*-!$1K2V;9'\!:)/PT(<$N]9<:?(X.L%1&W'8<>? ?M6VM
M=3AH>+=J1>PEF@_B\?8"0K>5<8=E?/\ )N.+'(LG&X/'DYN^E5:4MQ2W(>)E
MI>TDEO22F"VGU+:1?F&1%0;&&8D;C#TRS([++4MW-'.[(0A!.+,[92#W*(M3
MZ$E/7X"^ @'MCDC(K'$< R;**F,4NSIZR7.B1UD:D*=CLJ6G<23(S21EJHB/
MP!EXFP[(K;)>7."[NXSV#EEC-]Z?>IX$.+"71FZSUBN'&).I*\"2LBV[5&1:
M*U,T]:>HG_N.SS_A$C_R$"0\U8-;8OD&=^FB%A<F)+N*6EF)R5$ DDY&-,!)
M+3)VD6BC43VN[Q-6OYQ&95>O6.,(].-O@<SM*YI5F)MG6FC_ -[JL/>$)-PB
MTWZ;"4UN\-WE\0%RW?>;YIYT1+62I2.-E$^HCZ&LH#.X_9[0$YX,Y,PG"^(.
M*,=R6U1!M\G87$IHYMN+[KI25HT-2$J2@C6M*"-9D6I_AT)*X.1J67D?'V5X
M_ +=.M:>PA14_"](C.-H+K\*E$"/$=ARGC%MZ1JWB."Z;O)+\J-1?5LFE^^$
M^S9D^2MID7124I21_P!=6WQU!KBL1ND9@>HRPI;-EF4Y5<7%&,W4)=23K"&F
ME*3N(]#,MQ:E[#,O P%C^CE:E^GS%R4>I(=LDI^(OI"0>G_*"2JGGOD+);+/
M^1<(D9E7X/CV/XX1Q(<R#%DO9 <N*3BXR79!;RW&ZIM)-*,TF6XDFHC,BPO3
MTQJ-7 V#F9Z_Z@HM?P/N%I_0"2\\97D&$TG+GJ/8RZ7"C2[+'6XU.W,)/=??
M56(+ML&HOEFHV_*D]==#_-U(K%Q*378EEWI^N^2EMPL5^I\IJ%,L]"AM3%F^
MXDU&YY4F;+K!$9_"D!$;)*%^G[-[2K1V<-L>2O>,;223;:.+J9;FDF1:(VDA
M/X4F7L,!Z%J;&'4^KOD&SG.=N'!PMB5)61&HTM,KBK6>B=3/0B]@)P7EA.;8
M[R'CD7+,5D+ET4U3J8LEQEV.:S8<4TLR0ZE*M"6E2==/8"/*?/?(62V6?\BX
M1(S*OP?'L?QPCB0YD&+)>R Y<4G%QDNR"WEN-U3:2:49I,MQ)-1&9&H7IZ8U
M&K@;!S,]?]046OX'W"T_H!)4#F&0831\X>H!O,)<*,[88LS%JT323O>>75LD
M;3!J+JM1FG1*3U/^@%0M)9+CY>GVWD7,'&&3QV<BLO+]CWFMCOO.O.$:TJ\J
M36PZR2%GX:D?L 9>2XW!I^ XAQLFK<MJ+KDB--)ZL85'A-..L.(?82TX1;4Z
MHU)*2V[3Z=# 7[ZC\7PI<'$UIRVMX\S"LL7;'$ILQMM$!V4TAOND\DTFV1$2
M6OUBR,BZ%HK70$A264Y[89_PW@N39770V,=QKD)F#E3M8R?T9,CL$2U32:2G
M0VW.ZXA7L4L_9NVD5G7]C0Y#FGJ%R'!76)6%_4E,>9-@;3A.V2F6]BDFCRJ/
M1#I:E[24 R<98C0\O]*KD1AJ.X]2S3>4TA*#6:X9;C4:2+4S-2C/7VF9^)@+
MY]4L6TF<!YJU4$I4E,5EYTF]=WNK$IEV1X>PFDK-7Q:@D*-X<A-Y%R)AN2KY
M$QVXF4>-2&48Y2PEQ)7T6J(MI+#ZDD2"6RXM*C0OS%IKIUU!95U1,QH_IYXB
MFL,M-35<BM&N2A"4NF:5O:;ED6I]$I\3]A? 0"\JNRQ+'_6-F",@=@P%V515
MLTR926VU/V,A48DDQN+S.J49_)\QGJ"<$9K&&I55ZM4*91(-#\UQ"%(2YM4B
M/-,E$1D>AITU(_$O$%:O)[K%K+T.JA4$N'(LZZ)1M7C4/9W6I*IK)$E_81'O
MT2?RNH'%A9P]:U7.$IZ3DU/B<*VPF S L,EB%,AOUYL-H?CM;B-*5J6EP]/S
MNI>W0P[6Z^FP!7IL7>9##N\!KY5\ZG(]%-5^LQQ+K!K[Y$:-BC(OUFFW:?AH
M8"U/2G.IK*^YAL,=6RY12LK>>KG(R20RJ.ON&A39$1$23+J70$EU^L#Z.B1N
M,;6R0PU#CYA7^^39"$&AN.DEK63BU$>B-$FI23Z'I\0$--FN28+"]2''.8W4
MV GC*5C,QB@M7-GT4F:V[()PT+,NV7D6A.[P\R?B!4B]'+>[#\RL:]LVL3L<
MKLI&-HVFA!P]&TDIM)D6B.FW\*3!),XCQ9?K"XZ9ELMOH+&[!1(=2E9$HBEZ
M&1*UZ@<'GBEC08G!G&<N.PRT_P#S/;WR$(23BDH-PBU7IJ9$24^)^PO@!4GR
M*YPS'W_4U3<@+C,Y?;2%+H&9R2.3(9=0ZJ#[MN(S/8:V5^7Y):*\"Z!(<.J'
MCYBX"J\HBI?F,8"9N1IB"6IM2&))MDI*RZ*0G0NI:EH T/)+<ZHY\Y+K)V44
M>&U5O10F(KE_"]Y9D4WNC;*V(9$GRFE:%%VT=5*3Y2,T@/4_!%']7.(\4IDW
M+.0,1XAJBW$9*T,OQ7G5NL&A+GF(DM+0CK\'L!)4UD5EB6-^LAN9E+L&MKY.
M)-DP[-0VA#TUR89-[#4GS.F:3))_*Z:?$!P0?((T1Z]]5[[\=IU]F#![+KB$
MK6C5ITSVJ,C-.II2?3VD7P$"N,SD#)6XO'O'R,XKN/L<9XVK[=5U8P8TQ4]Y
M^.EM4,CDEIL42-NQ'51H5T4>TB",86TQ+X\]-T68A#\9>:S$*9=(EH-)V"-4
MFE6I&1F?@ ] >GI+;7+G/4=E*6V47T-26T$24D:BE:GH7PF0)+#]2LB#5<G\
M*Y!E)H;P2#;3464B06L1F6XADXZWM?*6AH4HC5X$E1_"!"DLDD5MG@?J=O\
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M32#3HC:DMI;-.G3P 93N+XT_0GBKU/"7C)M%'.G5':.%V2/4D=G;LVD?4BT
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MN,DJVJ/0"F)&]4F R<N;QY%?;%0/V?T!'S147_W$Y;:Z=@I&[V^Q6G^5\CS
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MMD<_XG(@\<S($&=+7R6\;%-&:2SW&.T:4OKD:N:$EDU>?8:O ] *6P"
M
M
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M#I*86:#,C2:DJ2>G123^+Q(P930
M
M
M      '$D(2I2TI(EKTWJ(NIZ>&I^W0 V(W]S:7<TV[].NGCIK\ !L1O[FTN
MYIMWZ>;;XZ:_  &VA2TN*21K3KM49%J6OCH8#D  .)H0I25J21K1KL49:F6O
M0]#]@#0PL+QZORZUSF-'4627$:/"FRE.*47N\378A"#/:DM3U5M+J8#?J2E:
M30LB4DRT-)EJ1D $E*4DE)$22T(B+P(B\ 'WXP'$D(2I2TI(EKTWJ(M#/3H6
MI^T!R <4(0V1DA))(S-1DDM-3/Q/H Y  #B:$*4E:DD:T:[5&74M?'0_C <@
M'%"$-I)*$DE)>!)+0BU_  );;2I2TI)*E]5J(B(ST^'X0#8C?W-I=S3;OT\V
MWQTU^  -MLUDX:2-Q)&25F1:D1^.A@.0   .*T(<2:'$DM!^*5%J73KX& Y?
M& ^:%IIIT/Q+\(#XA"&TDAM)(0GH24EH1?@(@!;;;A;7$DM.I'HHB,M2\#Z@
M/JDI66U1$HNAZ&6I=.I /N@!I[?: XJ0A:#;6DE(,M#29:D9?@ <B(B+0NA%
MX$  !$1> #XE"$))*$DE)>!$6A$ @G'O&;."V^8W[MDNVN,RM56DN0XT3/:9
M21I8C)(E*U2R2E$E1G[? %3M*4H224D24EX$70B!'T
M
M
M
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MG123,CZD Y+>9;<;96XE+KNI--J41*7M+4]I'U/0NIZ .8
M
M
M                        I!]T\_\ 4@JCGGW,=XQJX]FQ!,SV+O[;7M2%
MI\%=F/N[6I:H6HU$?4%4EDB[AKASU%%3,L.(7GMHFT.0XILT0C6P:UM;2/<Y
MOV%M5H6AG^ RK>?Y.Y&Q/$,%QARDIG.3\N<7$H8:);J:EJO@1D/.2I#BB)?D
M;,M6T>.OE,]-#(PK+U%9-5<9Y/>S,?AHY!PVZC4-Q4(?6Y =7*>;2V^PZ6BN
MVXA>J-W4C+J!36V'-O/L"URG%UX=CGT_B5=]8[*2F?)5$55FV;B66D;$K7(/
M11;S4E&J3Z=2,Q3=7G/F5V<CCZGX\J:E-[G%*60-GD4MQB*1;4G[DRIHB-Q\
MS-1%[.A'IH?04O*C?N)5) DWT-J!>O1VW)\%EWOM,R%)(UMI=T+<25=-V@(\
MO<$97FV*KYBR;+X%8UBE5D%[9Y(]#?>=FHM8S;3CC$9"R)*V-I:-J7HK7H#4
MIGA7-O(DC(L,C\BXQ I\:Y'9<>Q67727'Y$9Q+)26F9Q.$1;G6S+::"+J>AE
M\K:2F5ZMU/)XA4IAHI#Q7-0;<=2MB7%%,1H@U'T(E'TU,"'*DYOR2BL\WH.7
M*:%67&)TWUH852ON2(\NK/<1I2;Y)5W4K)+>O0E*/P(BZBG1@?-6>3<IQ2FY
M&Q^MJ:SD"(_-Q215RER7F%QV4R?=IR7"(B6II6XE(T+7RZ:Z[12<<L<@6?',
M7&;:-"8ET]E?0*:\=>4M*HL2>HV_>$;>GD5IT5XZ@(/D_J"L<>F<D*9I6I]=
MB,RJH<=;:<4F197=HV1K949ZI0EE2O-H6NA?#T IJ[/D_D^16Y[QIF-#4P.1
M(^,NWU0N%*?.LE53IG'D&:U$;B'6=5$1>"U%^:DMQAJN-.2<MXV]-]%>7=-
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ML>1'4I*DZ[5;M#W;=3#T-C=TQDN.U&1QDFB-;PHU@R@^II1*:2ZDC_ 2@1M
M
M
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MT;TT4?M!'HO&:1G&L;I\<CK-QBG@QJ]I9]#4B(REHC_I)((VH
M
M
M                         #J>C1I/;]X90]V5DZSW$DO8XGP6G4CT46O0
MR =H                       -1E&,4F94,S&<CC>^4E@2$3(N];1.(0M+
MA)-3:DJ(C-):Z& SE5\0Z\ZM+?;@FS[LEIOR[6MFS:G3PT+P 8.+XQ18900<
M7QJ&F!1UK9M0XJ#4HD)-1K5JI9J49J4HU*,SU,S ;<
M     '4Y&CNNM2'64+?8-1L.J21K;-9;5;3,M2U+H>@#M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                       $+Y3Y*I^)L.E9I>Q9,RNBNLLK8A$VIXU2'";2
M9$XM"=",^OF 4']_SB[[.W_^CA?_ %4#5'W_ #B[[.W_ /HX7_U4!1]_SB[[
M.W_^CA?_ %4!2U>)_4%BO+U;9V=#6V$)FJ?:C/HG)82I2GD*61I[3KA:$2>N
MH,SL6!]9X7[)W\2?G"H?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>
M%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G
M'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$
MGYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?L
MG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9
MX7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^<
M ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\
M2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^
MR=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'U
MGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GY
MP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?
MQ)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7
M[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?
M6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?
MG 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=
M_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA
M?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!
M]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)
M^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)
MW\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>
M%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G
M'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$
MGYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?L
MG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9
MX7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^<
M ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\
M2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^
MR=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'U
MGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GY
MP!]9X7[)W\2?G 'UGA?LG?Q)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?
MQ)^< ?6>%^R=_$GYP!]9X7[)W\2?G 'UGA?LG?Q)^< R(5W&G/E':;6E1D9Z
MJTTZ?@,Q%;,           'GWUH_]P=S_P"V5_\ M* 6-[\Q ;7%#]+O-$_"
MDYW&H256.1_?681O-IL'(NF[N)CF>X]4^8D_*,O!/4@9M3H-/:_H@_\ C1S#
M_B,/_P!0X+#&2]LBY'Q?%,LQS#+MUUBWRKI4ND@CB[NZ;*4NN&HC2:EEM+H?
MB0,LJGS6DO<JR7#8)/E=8FIA%OW4$EG641FCM*)1FKPZZD0"2*;<01&M)I)7
M5)F1EK^ !]-ETB-1MJVD6IGH>A$8#@1*5T21J5H>B2\3,B\"^,P$#J^7\-M\
M M^28YRVL=HW'6+)E]DFYJ'F%-I-':W&6XS<3H1J^$!+Z&S:R.DK\@@,O(@V
M<9J:PV^C8\EE].Y'<21GM,R/734!JLIS2FQ"3C\*T2^Y-R>P14U#,=O>2I"S
M02E.*,R)*4$LC/Q,_80#KL\V@56>U''K]=8.V=S&=EM633!JKV4L[_(Z[[%'
MVSUT^3JG7Y1 )2;+I$:C;424_*,R/0M?A ?$MN+(U(0I22/0S(C,M3 ?-JMV
MPRT5KIH?3J AM7R=BEJC,W652F8^ K=1D;KK!Z)*.EQ3BF4I,S<(B:5\&O3X
M0&[Q;((>78U4Y76M.M5UTQ[U#;?(B>)LUJ06\DF9$9[=="/V@-PIMQ*B0I!I
M6?@DR,CZ_$ ^FRZ6FK:BU/:70_'X/P@.)H62^V:3)SPVF777\  M"T*VK2:5
M? HM#_Y0'P
M
M                                                          !M
M<=_^$D_\Q7_D 2\10          >??6C_P!P=S_[97_[2@%C>_-G%XL:;DU-
M"FD2H<B=%9D)5X&TX\E*B/\ H,&I>D/5+R%G6&^H>RDXK;RJIVOJXD& <8_*
MB&_&2ZZE*#(TD1K4H_#H9:^P$B'EQUQ;SBWG5;G'%&M:C\34H]3,&GM7T0?_
M !HYA_Q&'_ZAP6&,G=ZG<6L<OY"PNLIG5M7D;'[6SJ^UIO5*K77)2$%K[5=L
MR+X] 2$?P/E>3+1SORW2H)JU=J:24RE:=R6I[B/=G%;3+0R0Z:E)]G0@6DJP
MUO*^->0N)U2LLLLE@<H1E*R2!:NF^RB6II#R7(Q*/R$E3R=#\?*9'T/0B*Y9
MDYA#P&5RRC-KT[2ES4ZB'5*E*7 **XO<O>A1F:C/PT,]NWIIU >E+NRYY8SX
MT8W34#G'93(ZFYDATTV)0S[:GU;>\7G3JO86SV%X@CSOG*4T<WD[@^$;C+F6
MYC2RJA'M7%M%*>6:2Z:DDR:(_8#2:91"R?/LTY/AUV5V6,U7$<!AC%J^K>-A
ME;\:.I7<DDGY9*[!]?'J1>!:&1&\]BS^3Z[@G-;6]L8%IE#[51.1!<)EEB1&
M=-"YT=!:$B0YNU4HO@+X 5;%BNTQ_G;BS#6+B=*J&<>G,RRDOJ,YSD5M]*7Y
M22/:MT]J5*49>) BBZ:3F-=@..<L)S>]>M6\R.D15O2E.P/<U+W.$I"S,UFO
MP/<>W;TT]H":\@ED^8Y)S;?LY9;4,;C2.F-C]94R%1XZD[%D]WDEH:M^TSW$
M9*U/77RD0"^.)Y4F=QEA$V:\Y)F2::"[(D/*-QUQQ;9&I2U*,S4H_:9@DO/T
M2F^G,>]2L7WZ37^[6CUAWH:MBW/<T2G.PL_:TY\EPO:0*ZH\NZXK]+]/>4%_
M9NVF:NU\9MUU7?55,K4^3J("/%&]*-"(NNI].H'%VXED]Y61N3,9I9F5R\++
M$YUK36V5-.Q["':Q6B)TFG3(M-^XU)(CZ:%TU(S,-)CM)E\JTX>B'R)DC:>4
M:Z7'O7"F;E,1XRNC<;>2MIF1:;U;E:ZG[= 5N:*VY0M.!<PI\8L+2VL\9RIZ
MK>EL.*<NE4#226ZEESJHUDH]3TZDDSTZ= 1;/ -EC%CB$U6+9+=9#&:F$4B+
MDRR79U;AH_[,K;T-*C)2MZ?*9EITT E:H(
M
M
M                      VN._\ PDG_ )BO_( EXB@          \^^M'_N
M#N?_ &RO_P!I0"QO?F*E2D*):#-*TF1I41Z&1EX&1@V]4EZNJ!^!'RBSP&--
MYIBUBJ9K*'7".*IM230;JV33U,R4K<CVZFDE$D] 8IY8>=<?=<?=/<ZZHUK5
MH1:J4>IGH70&WM3T0?\ QHYA_P 1A_\ J'!88R7K;805IR3BG(I3S9=Q:)+A
MHK>T2TR/?-_F-S<6W;O\-IZZ RB>+< XOC+W(48Y3DS'>0$]EZJ)LF50F>XX
MZ26W2,]QH4YY#VEIM+Q!;=> \'/XIE-+DV3Y=+RXL287"PZ!(8*,U!861I(U
MF2U[U)2>B?9X?U2("V*OT_,KXXL.._K&LD3\A+)3LO="U09?^@)ON=?^?N\?
M8!:Z%'N/7XB+\1: BM[WA^KON7L?Y=>GJ;F43#;2JKLDMN0[&)PF7#<-1;=N
M\M2VGKM(%MILZX*?RC);C(L9R^7BB<LCMPLS@L,%);L&&R)!F@S6G8M22T5[
M/$_SC("VRS3AJ+?XIB&.8G<NXO,P1]M_'+(FREJ0;:2(S=2:D:J4I/<W%^=K
MTT,$;-7'#[V<X;G<Z^>G6.)U;U7([[*>Y8NR4.)7)6LE$2#,W#5M))_A 1-'
MI^91QQ7\=_6-9H@9">2E9>Z%JLS_ /0&WW.G_/W>/L!;0SU!89]#6F1WF-WU
MQ$L^2X_N\C#JFO5-193(NQ!;Y!=&6BW[UI,MRM5$GH9Z"%\\?4\[&<#Q3'[-
M))LZFJA1)K:3W$E]II)+3J7CM/R@B.4/$L"H+D9F99N3H7(SS[LQI#1,KB(D
M(=0I*%;E;S+N]#,B\ &CJ>"7BXSG\8Y;ETJ\K5.1UX[+983%74%#4M;1LIW*
MWJ-2SWZJZET+3Q!;;BGXWS L:RBBS7D2PRJ5DM>NJ;>D,DU$A-J;4V3K;&Y6
MYW17F/<6[VZGU!'14\-L5<WBV=]-*>5QDS(8;1[OM*?[R9F9F>\^UI_YP%L2
MKX7M\?QF\I<8SB926UOD"\F:N(D9)*;<6@T%&<0:SWM]=RM%%J9%TT ;_C3C
M=> IO+&TNG<CRW)Y2)M[<NLIBI<6T2B0EMI!F22\RC,_:8"=@
M
M
M                                     -KCO_PDG_F*_P#( EXB@
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M?VCOXT_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T
M^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT
M_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T ^K,']H
M[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS
M!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T ^K,']H[^-/S0
M#ZLP?VCOXT_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C
M3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP?V
MCOXT_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T ^K
M,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_-
M /JS!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T ^K,']H[^
M-/S0#ZLP?VCOXT_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_
M:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T ^K,']H[^-/S0#Z
MLP?VCOXT_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\
MT ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP?VCO
MXT_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T ^K,'
M]H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /
MJS!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T ^K,']H[^-/
MS0#ZLP?VCOXT_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:.
M_C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP
M?VCOXT_- /JS!_:._C3\T ^K,']H[^-/S0#ZLP?VCOXT_- /JS!_:._C3\T
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MTXZR[=04/,S&JMYM4EHE(L).TVHRB-6I/+W)V-_*/7H0#;@
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MJ1:%X /8F*914YICM?E-$MQ=39M=Z*M]I;#AHW&GS(<(E%U(_9U\2Z RW(
M
M  #HFQCF0Y$-+[L94AI;128YDEYHW$FG>VHR41*3KJDS(^H"-X#Q[0\<U4BM
MI%RI;\^2N?:VMD^J7/FS'2)*GGWE:;E&22+H1%\7B E8
M      T",/IT9J]GVCIY ]5MT9F;A]DH;,A<HB)OPW=QP_,?LZ$ WX
M            :%II[
M                  #0O#V         &A::>P  1_"<.IL Q>!B./DZ516D
MX4?WEPWG3[SJWEFI9^.JW%'\7@ D    (ZUAE4WG,CD%2WG;U^L;I&TK4DV&
M8;;ZI"B;222,E..&1K,U'KM3X: )$
M                                                   (#S#RE X?
MPQS,[*O>LXK<EF*<:,M#:]7S,B5JOIH6@+"CD>MV$XA+B.-L@4VLB4A2229&
ME1:D9&2.I&0%.7WVXG^&N0_B3\P"C[[<3_#7(?Q)^8!1]]N)_AKD/XD_, H^
M^W$_PUR'\2?F 4??;B?X:Y#^)/S */OMQ/\ #7(?Q)^8!1]]N)_AKD/XD_,
MH^^W$_PUR'\2?F 4??;B?X:Y#^)/S */OMQ/\-<A_$GY@%'WVXG^&N0_B3\P
M"C[[<3_#7(?Q)^8!1]]N)_AKD/XD_, H^^W$_P -<A_$GY@%'WVXG^&N0_B3
M\P"C[[<3_#7(?Q)^8!1]]N)_AKD/XD_, H^^W$_PUR'\2?F 4??;B?X:Y#^)
M/S */OMQ/\-<A_$GY@%'WVXG^&N0_B3\P"C[[<3_  UR'\2?F 4??;B?X:Y#
M^)/S */OMQ/\-<A_$GY@%'WVXG^&N0_B3\P"C[[<3_#7(?Q)^8!1]]N)_AKD
M/XD_, H^^W$_PUR'\2?F 4??;B?X:Y#^)/S */OMQ/\ #7(?Q)^8!1]]N)_A
MKD/XD_, H^^W$_PUR'\2?F 4??;B?X:Y#^)/S */OMQ/\-<A_$GY@%'WVXG^
M&N0_B3\P"C[[<3_#7(?Q)^8!1]]N)_AKD/XD_, H^^W$_P -<A_$GY@%'WVX
MG^&N0_B3\P"C[[<3_#7(?Q)^8!1]]N)_AKD/XD_, H^^W$_PUR'\2?F 4??;
MB?X:Y#^)/S */OMQ/\-<A_$GY@%'WVXG^&N0_B3\P"C[[<3_  UR'\2?F 4?
M?;B?X:Y#^)/S */OMQ/\-<A_$GY@%'WVXG^&N0_B3\P"C[[<3_#7(?Q)^8!1
M]]N)_AKD/XD_, H^^W$_PUR'\2?F 4??;B?X:Y#^)/S */OMQ/\ #7(?Q)^8
M!1]]N)_AKD/XD_, H^^W$_PUR'\2?F 4??;B?X:Y#^)/S */OMQ/\-<A_$GY
M@%'WVXG^&N0_B3\P"C[[<3_#7(?Q)^8!1]]N)_AKD/XD_, H^^W$_P -<A_$
MGY@%'WVXG^&N0_B3\P"C[[<3_#7(?Q)^8!1]]N)_AKD/XD_, H^^W$_PUR'\
M2?F 4??;B?X:Y#^)/S */OMQ/\-<A_$GY@%'WVXG^&N0_B3\P"C[[<3_  UR
M'\2?F 4??;B?X:Y#^)/S */OMQ/\-,A_$GY@%+-X.Y^J^;W<@9KZ.72NX\<9
M,E$U:%J6J4;Q:$2-#(T]D]=?A F%P C09QE3&#XA=Y?*CKEQJ2&[.=C-&25N
M)93N-*35T(ST >;(WKDK)C"),3CJ^?C.:['FC0M"M#T/124F1]0:IV_?;B?X
M:Y#^)/S 2C[[<3_#7(?Q)^8!1]]N)_AKD/XD_, H^^W$_P -<A_$GY@%'WVX
MG^&N0_B3\P"C[[<3_#7(?Q)^8!1]]N)_AKD/XD_, H^^W$_PUR'\2?F 4??;
MB?X:Y#^)/S */OMQ/\-<A_$GY@%'WVXG^&N0_B3\P"C[[<3_  UR'\2?F 4?
M?;B?X:Y#^)/S */OMQ/\-<A_$GY@%'WVXG^&N0_B3\P"C[[<3_#7(?Q)^8!1
M]]N)_AKD/XD_, H^^W$_PUR'\2?F 4??;B?X:Y#^)/S */OMQ/\ #7(?Q)^8
M!1]]N)_AKD/XD_, H^^W$_PUR'\2?F 4??;B?X:Y#^)/S */OMQ/\-<A_$GY
M@%'WVXG^&N0_B3\P"C[[<3_#7(?Q)^8!1]]N)_AKD/XD_, H^^W$_P -<A_$
MGY@%'WVXG^&N0_B3\P"C[[<3_#7(?Q)^8!1]]N)_AKD/XD_, H^^W$_PUR'\
M2?F 4??;B?X:Y#^)/S */OMQ/\-<A_$GY@%'WVXG^&N0_B3\P"C[[<3_  UR
M'\2?F 4??;B?X:Y#^)/S */OMQ/\-<A_$GY@%'WVXG^&N0_B3\P"C[[<3_#7
M(?Q)^8!1]]N)_AKD/XD_, H^^W$_PUR'\2?F 4??;B?X:Y#^)/S */OMQ/\
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MC[[<3_#7(?Q)^8!1]]N)_AKD/XD_, H^^W$_PUR'\2?F 4??;B?X:Y#^)/S
M*/OMQ/\ #7(?Q)^8!1]]N)_AKD/XD_, H^^W$_PUR'\2?F 4??;B?X:Y#^)/
MS */OMQ/\-<A_$GY@%)AQ/ZHZKE3./J*UBUC26/NKLQ3DY;>B4,DD]#01$KS
M;BT I?H(          #SIZV_^XJ7_P 3@?\ 34"PNG 3,\$Q<SZF=3 U/_Z6
M;!$B
M                                       !Y0])AFKE/GI2CU4>0),S
M/Q,SFV0-2]7@RKCG_P#[D\]_X)-_]48+#0>D_P#\/F%?]3,_V^2!*Y@0
M
M                              'E*K_\=]U\6/(_V6,#7!ZM!D
M    'G3UM_\ <5+_ .)P/^FH%A=. ?\ QB8O_P (@?[,V")$
M
M                       #R?Z2O^]'GG_CZ?\ ;;(&I>L 95QS_P#]R>>_
M\$F_^J,%AH/2?_X?,*_ZF9_M\D"5S @
M
M     /*57_X[[K_Y'D?[+&!K@]6@R          #SIZV_P#N*E_\3@?]-0+"
MZ< _^,3%_P#A$#_9FP1(@
M                                                        >3_2
M5_WH\\_\?3_MMD#4O6 ,JXY__P"Y//?^"3?_ %1@L-!Z3_\ P^85_P!3,_V^
M2!*Y@0
M                                        'E*K_P#'?=?_ "/(_P!E
MC UP>K09          !YT];?_<5+_P")P/\ IJ!873@'_P 8F+_\(@?[,V")
M$
M                                    #R?Z2O\ O1YY_P"/I_VVR!J7
MK &5<<__ /<GGO\ P2;_ .J,%AH/2?\ ^'S"O^IF?[?) E<P(
M
M                       #RE5_^.^Z_P#D>1_LL8&N#U:#(          /
M.GK;_P"XJ7_Q.!_TU L+IP#_ .,3%_\ A$#_ &9L$2(
M
M                  'D_P!)7_>CSS_Q]/\ MMD#4O6 ,JXY_P#^Y//?^"3?
M_5&"PT'I/_\ #YA7_4S/]OD@2N8$
M
M  !Y2J__ !WW7_R/(_V6,#7!ZM!D          'G3UM_]Q4O_B<#_IJ!873@
M'_QB8O\ \(@?[,V")$
M                                                     #R?Z2O^
M]'GG_CZ?]ML@:EZP!E7'/_\ W)Y[_P $F_\ JC!8:#TG_P#A\PK_ *F9_M\D
M"5S @
M                                       /*57_ ..^Z_\ D>1_LL8&
MN#U:#(          /.GK;_[BI?\ Q.!_TU L+IP#_P",3%_^$0/]F;!$B
M
M                                !Y/])7_>CSS_ ,?3_MMD#4O6 ,JX
MY_\ ^Y//?^"3?_5&"PT'I/\ _#YA7_4S/]OD@2N8$
M
M               !Y2J__'?=?_(\C_98P-<'JT&0          >=/6W_ -Q4
MO_B<#_IJ!873@'3!,7+_ /=$#_9FP1(@
M
M       >4/261EREST1^)9 DC_C;(&I>KP95QS__ -R>>_\ !)O_ *HP6&@]
M)_\ X?,*_P"IF?[?) E<P(
M                                                        #RE5
M_P#CONO_ )'D?[+&!K@]6@R          "!\O<75O+^&N8;:SWZZ(Y(9E*DQ
M4H4YJP9F2=%D9:'J"PHU/H9QQ*20G/<@2E)$E*24T1$1="(N@+;[]QO'OM]D
M/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM
M]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'
MOM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]Q
MO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9
M]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(
M!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:
M_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_
M3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OL
MA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]
MOLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X
M]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N
M-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +
M/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y
M +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;
M7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/
MZ;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]
MD/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'O
MM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO'OM]D/Z;7Y +/N-X]]OLA_3:_(!9]QO
M'OM]D/Z;7Y +/N-X]]OLA_3:_(!:T.$> :7A!R_=J+F;;KR XQR53B;(T'$[
MQD9&V1&9J[QZZ_ "3*W01H<VQ:-F^(W6(3'W(L6ZB.P7I#))-Q"'DFDU))6I
M:EK[0'FQGT*8Q':2S'SJ_:91\EMLV4I+7J>A$6A U;L^XWCWV^R']-K\@%GW
M&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%
MGW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\
M@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-
MK\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R'
M]-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^
MR']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCW
MV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XW
MCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^
MXWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D
ML^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?
MD L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_I
MM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0
M_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^W
MV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>
M^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&
M\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%G
MW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K\@
M%GW&\>^WV0_IM?D L^XWCWV^R']-K\@%GW&\>^WV0_IM?D L^XWCWV^R']-K
M\@%GW&\>^WV0_IM?D M,N)_2U0<49J6;PLDLK>P]U=AJ:GDT:30]MZFI);NF
MWH"6OL$
M
M
M
M
M
M
M
M
M
M
M !@S+JGKW28GV,:*^:2633[S;2S2?0CT4HCTZ ,?ZT8S_OF#_%,_. /K1C/^
M^8/\4S\X /*<9(M3NH!$7B?O3/S@&T0M#B$N-J);:R)2%I/4C(^I&1EXD8#D
M
M
M
M  .J3)CPV')4MY$>,T6YUYU1(;2DO:I2C(B+\(#'KKFHMR<.IL(T\F="=.*\
MV_LW:Z;MAGIKH>FH#-                     ?G!Z[_P#OH@_\ A_[3+!N
M'F$%  !^S7'Y$6!XL1%H15%>1%_]+-@YI&
M
M
M                                    *Q]11$?!V=ZEK_[ID'^(B!8>
M=O\ \GJE)0>05:%N-VI(U>TR),S0O^4%E[7!D                   !^<'
MKO\ ^^>!_P  A_[3+!N'F$%  !^S> ?_ !B8O_PB!_LS8.:1
M
M
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M('^S-@YI$
M
M
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M4O$&&X
M
M
M        $+Y<QBTS3C/*,4I>V=M;P'8L0GE=MON++IN5H>A?T *C])G"6;\-
M1<K9S,HA*N'(*X?N;QO](R9!+W>5.G^<3H"S+T@"
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
D                                            /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>px_25avadelpxy03pg01-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 px_25avadelpxy03pg01-4c.jpg
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M_\0 ]  !  (" P$!              4&! <" P@!"0$! 0 # 0$! 0
M      $" P0%!@<($   !@$# 0((!@L*"@@" !<  0(#! 4&$1('(3$302(4
M5)05"!A18=$R%E9QD4)2DM(CD]/4%X&A,U.T==4V-U=B<[,D=#65M78XL7*"
MLC0E599#A0G!X\0G1QFBQ89W\$0F9_%C@Z.$I68H$0$  0," P((" D)!P(&
M P   1$" Q($(3$%01-187&1,A05!H&AL2)RDC-3T5*RTG.3LS14P4*"(T-T
ME#55\.&BXB1%%F*CPF/#A*0E\40V_]H # ,!  (1 Q$ /P#W\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M[P=YWF.;>ZTZ_P#TZ_1KY5B&EY(
M
M
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M !.6_P"5,<F[_M?Z#Y7WE_[EY=K\CU*/!?BX
M
M
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M<NF>6W]DV#P[_P#:1_Q.6_Y4QR;O^U_H/E?>7_N7EVOR/4H\%^+@
M
M
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M]9_=NH?H]G\J#>_MCYC_ .'+W^3M#;'V&+Z5KTK?\HZ=^GP?E2<-_P!6>/\
M_CB3_NY(;OT[_H?RGO-^\[O^Z6_M)6'C#_6_#O\ I&9_])C3N?1R_P!!Y77O
MLNH^3:*\]_;'S'_PY>_R=H;H^PQ?2M>K;_E'3OT^#\J7;PS_ *EXU_XLL_\
M=R1-WZ63Z,?*P]Y_MMY_=\?[1-<5?^,X0_\ QP_[[@U[GEE_H/.]X/0ZG_\
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M[EY=K\CU*/!?BX
M               P;:YJJ*&JPN9C4*&DR2;SRB0G<H]"(M>TS/P$ H3G.N"(
MWJ2J8XPV>BG41E=FNFNPS)S37I\P6B56_'<OQW*VEN4<Y$A;6G?,'JAYO7LW
M-J(E$1_#H(J<
M                   !4N1.2\/XLHD9%F<[R*N<?;BLDA"G7G'73[$-IU4K
M:DC6K3L21_8 6"HMZN^K(MS2S&9]5-;)Z),C+)QIQM78:5)U(P&:
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M/9W>O3377XAJR[N;]7#TZ?$\OJ/O+=O/6:XXM]9[KM]'N_@XU^)LX<+XX
M                                                        !7\O
MS&FPJJ5:6ZU*-1[(L-DM\A]PS(MK:.T]-?&/L274P'E[)\KM\TLSL;AYM;:-
MWDT9LS)F.RL_%0V6I&:]>BG%)U["/0M"&;% DLV]'#4;CB")*T*4GO"4E>A&
M6FA>,1Z%J710#(K;.91SVK6JF+A38_1,J,:-$$9]261^*M+GB;DF73]T!Z9X
MZY,A9FTJNG)1!RB*6DJ"2CVN$CHIUG<1'M,R/Q3\9/AZ:&>,PJ_"*
M                                                         C[R
M\J<:IYM_>RT0:>N97)F2W3T0VTV6IGTZF?@(BZF?0NH#\O.4^0\P]IOE2' H
MXCKD9UXZ[$Z,C_@F5JU4Z[H>TEK)/>/+[$I+37:@C!GR?H?PIQ16\.8'#Q*$
M^J7,-1R[::I2C2_.=2DG%(2H]$((DDE"2(NA:GJHS,S&6Q 0
M
M
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M,JBD6?W;1?D7"\:NA+T43!$?8ZOHIX_!T1X#W$F7I,$
M
M                                                         !%Y
M#D%;C%2_<VKAHBL$7BH+<XXM1Z)0A/A4H^A$ \J93E%EE]VY;V2.[-1)[F&A
M??-QV6M=Q-),_GZ%JX:>JC[.FA#-BA$K>)LU[C0@TFX@]O>);3TU,E%J1D9E
MN+Q?&(!Q(T*[M"=#02DK29)-26U>-M46[4^NIET/H7Q .*$N+4E"F]KCI)0C
MNB-?C=22@S5HE789ETT/L[0'!)MN-I61$7>LJ2MM9FONUGHM*DEJ74O!K\/@
M["#M2X2%*<2:]J5$^:$&2S)+A&;:RU(R41$?A^=X=#+4!W0I<RIDQ94):V9L
M(^^A2FE:['$J->W3J6S3IMUTT/0!ZGX]SF)F].4@MK=K&)*+",A6Y)*/71:#
M\*%Z&9?!U(^P8S"K>(H  .J3(:B1WI4A6QAA"G75GV$A!&HS_<(@'XZ\HYF[
MR%R%D69.;N[M9KKT9"_G(C)/8P@_^JVE) SA405^M7LZY\?(W$..WTA9+LV&
M?5MGIV^50OR2E'J9]5I)+G_:!K7JTRW%*.24*ZO:^MF&DG"CS);,=PT*,R)1
M)<6D]#,CZ@.-=F6(7$M,"HR"MGSEDI2(L68P^ZHDEJHR0VLS/0NWH FP ! 3
M,YPJNE.P;#)*N)-85L?C/SH[3J%=NBD*61D?V2 953DV-WZW6Z*X@VCC!)4^
MB%)9DJ0E>I)-1-*5H1Z'IJ D7WV(K*Y$EU#+#9;G'7%$A"2^$S/0B 4&3SMP
MS$?7&D9W2(>;/:M/ES)Z']DE&0"WTF14&2Q/+L>M(EK#Z$;\)]N0@C/P&;9F
M1']D!CV.98A3RUP+;(*V!.;)*G(LJ8PPZDEEJDS0M9&6I=2Z .^IR7'+];K=
M%<0;1;!$I],*2U)-!*U(C432E::Z'IJ E $?;7U'0,%)O;.)61U&9)=FOMQT
M&9=="-Q22,!3X7.7#EC*;AP\ZI'9+QF3;?ES*=3(C/M4HB[" 6^Q?;E4<R1"
M6B0VY%=4RMLR=0O5!Z:::DHC ?BJYO[Q?>%M7N/<G3;H>O4M/ #8_4SV13(^
M <5T7OT\L+L(M/\ /'N@-;=X"!R'-\.Q-!KR>_KZ@B3OVS933"C3\))6HC/]
MP@%=A\Y<.6$E$2)G5(Y(<Z(1Y<PG73XU*(@%ZB2XD^.W+@OMR8KI;FGV5I<;
M4D_"E23,C+[ #N ?F'[:/]OES_H=?_)D RALW_Z'P2_7N=&1EL\DK]R=.IGW
MC^AD?VP)>[P8@                  \D>V)[0GT3K7N*\.E;<HLFB]?365>
M-"A.IU[E)EV.O)/KX4MGKVJ29&40H7L;>SUZXE1^7<SB:U4-S=BT!Y/1^0V?
M_C%$?W#:BT:^%?C=-I;A,O>@,0
M
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MEO*\;LZ((SZ@)[%<NSCBW(6;C'IDNCN6#2I;9DMI+J$GKL>:7H3C9Z=4K(R
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ME,OT\APXE=#CU\!A$:#$;0Q&C,I)#;;3222A"$IT(DI(B(B(&#O
M
M
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M:?&(5#=LS+J=&K8[SS<0FD.RW4LH4O;)4>TC46NA&"4>FP0
M
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MA::)\F1T/J>I@L-F_P#T/E.M_G*]$:%#@%N/7>6KKW0OB/3K^X!+WB#$
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MV5.1-Q3'\6?LJY;<AN161*]QZ.XE6YMPE,I-2#)2=4JZ=2Z -A@@
M
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MC\E;\;QB+][H"PVC_P#0^=/I%G!;",_(H.CFAZD7>N]-=-.OV? !+WD#$
M        !^<7M7X/:9)SUD;6*UR'I4.B8O+)EG:AQQJ.A*7G23TWK))I,R+Q
MC2GP@RA;O8W]H@ZU^+P_FDK6!)<)K$[!Y7\"^X?2$LS^X6H_R/P*\3L4G:)A
M\]LSV@SLI,CA_#I1E7Q'-F63FC_AI#9_^"29?<MJ+5[X5^+TVJW"(77V.?9[
M^B]>QRMF,3;DMBT9X]">3XT.&\G0WU$?8Z\D_%^];/X5F21,JA[:"DUO-O&]
MU:E_Y W'C&Z:OF:1;%3DC_[Q:-0(>Z4J2M)+09*0HB-*B/4C(^PR,&+Z \S^
MW/.@1^%FXDI2?+)EO$3!0>AJWMH=6M1%VZ$@E$9_'IX06&Q/9KC2HO!."M3"
M,GE5J74[BT/NGG%N-?N;%)T EYN]K'_F8XM_Q=1_OAT%A[E!B\(>WVT3^7X&
MPH]J78DI!F7:1*?:+4&4+9_]S\P_ZXV?H\?Y0*MM<&>SI2\&3;F;574JV5<M
M,,NIE--MDV4=2U$:=G;KO!)END$
M
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M[D5_/4EEGK%NK@T*JI2'BVPI%A72FFW)^G75<K<I32MW5M)]" ;B$4
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M*J_;1X7M[.%4PU6IRY[[45@E0B)/>/K)"=3[P]"U,"CT."
M
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MU%A:#D,D<VY<W=Y8ODG>DEDDE(9(B\1![2Z=I^$S$JJY"*
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M=$]G?A*#*8G1,)KFI<9Q#S#J4+U0XVHE)47C=I&6H%6S@0
M
M                                                       8,^EI
M[0C*SKXTPCTU\H90[V$9%\XC[-3 5.=P]Q_.-Q2:HHCCA=5Q'%LF1_"1$>TC
M_<%JE$7^P/CK5.D:432",DM>5.;2)2MQ]==W4R^'[ 5*,Z)PMQW%,C75G*4D
MTFE4AYU1D:-=#\522[3,_LG]@*E%EJ\.Q6E(BJZ:)&41FHEH90:R,R(C\8R-
M770O")54V
M      P)5'23WCDSJV+)D&1)-YYAMQ9I3V%N4DST(!T?1?&?_1H/HK/XH!]%
M\9_]&@^BL_B@'T7QG_T:#Z*S^* ?1?&?_1H/HK/XH#L8QZ@C/(D1JJ&S(:/<
MVZW':0M*NS4E$DC(P$D
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                    Q;.6] KI<V/%<G/QF7'FH3&G>O+;2:B;1N,BW*,M
M"U,96Q68CDW8,<9,EMEUT61=,1JGE%>V?%#77[4LL_NRO_PHOZ0=GJUGWEOQ
MOK/8&T_C</\ Q?@/VI99_=E?_A1?T@>K6?>6_&>P-I_&X?\ B_ ?M2RS^[*_
M_"B_I ]6L^\M^,]@;3^-P_\ %^!9,0RRXR1Z4W:8K8XZB.E"FW+ VC2\:C,C
M)/=J4>I:==1IRXK;.5T7>1Y'4NG8=K%LX\]F:OXE>'EK"UCG>(
M
M
M
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M>W!%;J4OMOKR\$12CT*/'?E8
M
M
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MS<:3U,^SM'%NIR4C5?%WDFKY3WANWLVV>L;G'N(K-(LOB[3RYTB*5;0'"^,
M
M
M
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M)G[''-D]GI5Y^)M8<#XD
M
M
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M[.S0>5U"Z^8MU6Z?AJ_-??G<;O)CP^L;>,$1-U*7VWUY>"(H]$#QWY2
M
M
M
M                    (S(_)#Q^U\O@.VL'R1_RFLCM]\]):[M6YEMO4MRE
MEXJ4Z]3,9XZZHI-./-V;+7ZQCT7QCNU6TNF:1;->%TSV1'.9>?/_ +%7]QF4
M_P"Q%_IQ[']=]];];_<_4_\ ]I_J>W_71^:?_8J_N,RG_8B_TX?UWWUOUO\
M<?\ [3_4]O\ KH_-/_L5?W&93_L1?Z</Z[[ZWZW^X_\ VG^I[?\ 71^:V-Q.
M6(^4VAXS@-MACG=M>4/6T!4%,E.JMJ6S-Q>XT]3/X-1Q;G72-5\7^2:OD_>+
MUO39W^ZQ[F*S2++]>GESX12K: X7Q@
M
M
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MNB8BDVS]&*/C_>7<8LMF/1?@OI,_98YQSV>E7GXFV1Y[X<
M
M
M
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MEX(BCT0/'?E(
M
M
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ME/>&-U%MG?[O'N8K-(LR:]/+GPBE6SAPOC@
M
M
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M]3/M'#NKXNB*3;/DBCY'WDW6/-9CBS+BR4F?L\4XZ<N=>;:PX'Q(
M
M
M
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M>,_)P
M
M
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M2++]6GESX12K9PX7QP
M
M
M                                           BLG8<DXW;QVHSTQUV
M%(;1$C/>3/O*4THB;;>/3NU*[$K^Y/J-F.:71Y7;L+XLW&.Z;HMB+K>,QJB.
M/.;>V([8[7G#Z%WW]W64_P#NM'RCV>^M_'M^H_6_:F#^,V_^&D^A=]_=UE/_
M +K;^4.^M_'M^H>U,'\9M_\ #2?0N^_NZRG_ -UM_*'?6_CV_4/:F#^,V_\
MAI;,X>H["HEVJYN-6] 3K;)(7;6Z;9#NBE:DA*3\0R\)^$<6ZOBZ(I=%WDBC
MX_WEW>/-9CBS-CS4F?0Q=W3ES\+; \]\.
M
M
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M%V28MUVQ'PU?F?OUFWN3'A]9Q6XHK=33?JKR\44>BQXS\G
M
M
M
M           $;D/<>H;3RJO7;1O)'^^JVT$XN4CNU;F4H5H2C<+Q2(^W49X_
M2BDTX\W7LM7?V:;^[G5;2^>&GCZ5?%S:&W83_<):_P"RF/QAZW]9]]'G?IM-
M[_JN/];=^ W83_<):_[*8_&#^L^^CSE-[_JN/];=^ W83_<):_[*8_&#^L^^
MCSE-[_JN/];=^!L#BTZ(Y-EZGX]F82K8UWKTN(W$*26JM$I-!GNV=O[HX]SJ
MI%;XO^%\OU^,^FSO=W;NN,TBVZ;M/+P^%LL<3X\
M
M
M
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M[X@
M
M
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M-U>$5KPAZ,'C/R8
M
M
M                                        1U^;*:*S5(KU6T<HKYNU
M;:$NKE([M6K*4*Z*-PO%(C[=1G9Z4<:>-U[.)G/9IO[N=4?/K33Q]*O93FT5
MY3AO]P=E_L>)\H]6E_WT>>7Z5HWG^JV?K;SRG#?[@[+_ &/$^4*7_?1]:31O
M/]5L_6WGE.&_W!V7^QXGRA2_[Z/K2:-Y_JMGZV]?N,':1R39%4\>2L(42&N]
M>DPF8922U5HDC:/QMG;U^$<FYBZD5OU_#5\QUZW-%MG>;NW=<9X1?-VGEX>5
M6R!Q/D0
M
M
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MC?>;=VYK,<1GMS4F>6"<-.7;/I?R-N#SWPH
M
M
M
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M^2@
M
M
M                           ".O\ NBHK/OJ\[9GR5[O*I*4K5*3W9ZLD
ME?BF;A>+H?3J,[/2CC3QNO9U[^RE_=SJCY_XO'TN'@YM%ZXU_<#*_P!GP1ZO
MS_OH\\OTG_J?]5M^O>^ZXS_<#*_V?!#Y_P!]'GD_ZG_5;?UEYKC/]P,K_9\$
M/G_?1YY/^I_U6W]9>OO&)U?E-CZNX[>P<]C7>/.QV(Y2>JM$EW/4]G;U^$<F
MXK2*WZWS'7N]TV:]W&ZXSPBZZ[3R_&\+8XXGR0
M
M
M
M   B<I8.5C-S&3#.P4]"DME 2_Y&;YK:47=$^>G=;_F]Y]SVC9CFE\36G%W=
M/OT;G'=JT4OM^=IU:>//3_.ISIV\GF7Z#2O[H7__ 'RU^./<[Z/O/_;?L/M:
MW_4(_P %/X'WZ#2O[H7_ /WRU^.'?1]Y_P"V>UK?]0C_  4_@/H-*_NA?_\
M?+7XX=]'WG_MGM:W_4(_P4_@;1X7H'::9;K<PUS%>];8(G'+]%[W^U2^A)2H
M^[VZ]OAU^(<&[OU1'SM7]'2^,]Y]Y&>S'$;B-Q29_L)PZ>7UJ_$V\/.?!@
M
M
M
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MD5K6(>C!XS\F
M
M
M                                     $?>FDJ2Q-=?ZV049[=5$2%'
M*+NSU9T7XI]Y\W173KU&=GI1QIXW5M/MK*7]W\Z/G_B\?2X<>'/@TEWM;_<
MKT2M_%'ITG[[XY?HNG)_JO\ Q93O:W^X!7HE;^*%)^^^.33D_P!5_P"+*=[6
M_P!P"O1*W\4*3]]\<FG)_JO_ !95ZXU7&5(L"C\='@_B-[GS9BL^4]5:)_S<
MB,]G;U^$<NXK2/GZ_.^;ZY%T6V:MYZUQGA6^=/UO"V&.-\H
M
M
M
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MP0
M
M
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M]D5KJB'HP>,_)@
M
M
M                                      !@7BB136"SKSMB3&>,ZLB0
MHY6B#_(Z.>*>_P";XW3KU&=GI1QIXW5M8KFLC7W?SH^?Q^;Q]+AQX<^#3'K"
M/_<*OT6L_%'I:9^^^5^@=S=_JL?6RGK"/_<*OT6L_%#3/WWRG<W?ZK'ULIZP
MC_W"K]%K/Q0TS]]\IW-W^JQ];*NW',EM^1/)OCU6$Z(;,WS:BM>4]5>+_FY$
M9[>WQOA'+GBD1\_7YWSO6K)MMLKN_6N,\*WSI^MX6P!R/EP
M
M
M
M           !B6E;#N:R946"#<@3V'(LIM*E(-33R30LB4DR46I'VD>HRMNF
MV8F.<-^WSWX,EN2SA=9,71V\8XPUI[N/$G_I$CT^;^F'=Z_F\/Q0^P_\VZM]
MY'U+/S3W<>)/_2)'^T)OZ8/7\WA^*#_S;JOWD?4L_-/=QXD_](D?[0F_I@]?
MS>'XH/\ S;JOWD?4L_-6C#.,L.P!Z6_B\-R*Y.2A$DW)#\C<EHS-.A/+7IIN
M/L'/EW%^6FJ>3Q>I]=WG48MC<71=%E:?-MMY^2(6X<[P@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                               5G/,_Q;C7'UY/
MF$Q4&E0ZW'4^AIV0?>/&9)+8RE:NNGP -6^^1[/GUF>_V;/_ $ +0]\CV?/K
M,]_LV?\ H *'OD>SY]9GO]FS_P! !0]\CV?/K,]_LV?^@ H>^1[/GUF>_P!F
MS_T %&55^UMP1<V<*HK\B==GV#[42*V=?.02GGUDV@MRF2(M5&74S HW<"
M
M
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M00
M
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M_P =T/\ TO@L-[@@
M
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M29*2I*BU(R,NAD9 Q<@&B/:F_J_Q]_QW0_\ 2^"PWN"
M
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M(T1[4W]7^/O^.Z'_ *7P6&]P0
M
M                                       $:S04T>[E9(Q#;1>SF&HD
MN<1?E7&(YJ4VA1_ DUJT^R @+KBGCO(:V=47./19=?96)W<UI1*2:[-2$MJD
MDM*B4EPT)))J29:ET[#,!CVG#?%]T_5R;/&(3[U+%9KZPS2I),Q(I[F6B2A1
M$I+9]4$HCV^#34"K)KN*>.JJXN;^#C<)NVR!M]FYD*1WOE#4M6]]"DN&I))=
M5U<2E)$L_G:@,W#<"P_CZO>J\-J6:B#(=[]]IG<K>YM).JE+4I1Z)(DD6O0N
MA (NNX?XQJ;:RO*_&(+-G<-R6+)TD&I+S,T]7VE-J,T$AP^JD$G:?7IU,!*X
M=@F(<?UKE1AM0Q45[KIOO-,$HS6Z9$G<I2S4I1D1$DM3Z$6A= '6QQYA$8H"
M6J*(3=6FP1 ;4WO0TBY4:YJ22K4C)\S_ "A&74!%Q>&>+H6+V.&1<7A-8S;.
M)?L8!)5H\XVI*D*4LU;_ !#26S17B_<Z 56&WQ/'+_'EXG=5K,[&W&VF5UKZ
M=[*FXZDK:(R/[U2$F7QD QI6!X=-79.2J:,ZY;RXMC9J4GJ_+@;/)W5]>JF^
M[1M^P XW7'^&9$W=M7=+'FHR-F-&NR=29^5-05*7')>AE_!*4:D&6AD?4!A'
MQ5QV=_590>/13OZ5EF-63]%=XTU&1W;.OC:+4VD]J%+(U)+L,!F9CQ[A7(#$
M2-F=)&N&8#IOPRDI,S;6HM%:*29'M41$2T:[5:%N(] &':\4\<W>0P<JM,<A
MR,@K"83!G&@T*:\C7O8,DH,DF;9_,,RU270N@#%LN%^+K>/:1;'&8KS%S8>N
M;).KB#=L=JDG((T+2:%F2UDHT::[CU[06K-E<7<>S:R72R<=AKJIT*)52HFP
MTMJA5RE+BM$23+:3*E&ILTZ&D^I'J"(Y_A#BB3CC6)/8K#5C[,E<]J'HLMLE
MQ)(6X3A+)>JTEM7XWC%T/4%JLUKB>-WF-N8A;5C$K&76$1%UBT_D.X:V]V@B
M+339M3MT[-"T!$:WQI@;33[***,2)2:U,G4E&;A4>GD&Y1GJ?<;2V:F Y5G&
M^"TV53LWJJ*+$RJS)93;)I)I<<-TTFXK;KM)2S21K4E)&L^JM0'1DO%?'F8W
M47(LFQZ+8W4-"&H\QTE$LD-+[Q!'M41*VJ,S3N(]NIZ=I@/B^*>.7+^SRA>-
MPU7MU'>AVDHT&??L2D=V\E:-=FKB2VN*).Y1=IF 8_Q3QWBT6'#H,?C0F($W
MUK$)&]2D3NY5')[>M2E&HFEJ;3N,]$]" 4NC]G3"X&4Y/=SZZN517T0JMG&X
M454>&40Y135KD;W7.\=4ZE&G=DVVA*=$IZF8+5=K_BSC[*$2F[^@C32FS$6<
MHU[TJ7,;83&2Z:D*2>O=))LR(]%)Z&1@C[&XOX^AS*>PBX_$:F4,-VKJ74I/
M\C!?2I*V--=%-F2U^*LCTW'IV@,"'PKQ77T%IB\/%X;-#<NMOV4-)+T<=8/5
MI1*-6Y/=F7Y/8HMGW.@+5.4F"XACF./8C2TT:)C,@GDOU:4;X[B9)&3I+2O=
MN)9&9*(^T$0U'PSQ?C;),4F,Q(B"E0K#5.]:O*JM2EQ'#4M2E&;)K5LZ]-=.
MP!(SN-\&L\MB9U.HHSV6P224:U-)DZ6PC2@S(C)*E))1DE2B,TET(P$&SP-P
M_':LF6,0@-LV[:F)Z$I61+96^B2:$^-^323J$N)2WM)*BU3H"U3=)QK@N..T
M[])1QH3U S(BU#C9*W1VIJM[Y),U'J;BNJU*U49^'J"+4
M        #17M9]>,()%V_2&F_E) L-Z@BM8;@>-X''M(^.QUM%<V,FXL777%
M/.NS)BMRU*6K4S(M"))> @%E 4/DGB3&>3DU4BU>F5=]12"E4U_4.IC6,5>I
M&HFW%(<+:K0M4J2?8 O3:#;;0V:E+-*22:UZ;E:%IJ>A$6I@-%>U-_5_C[_C
MNA_Z7P6&]P0
M
M
M                                 %-Y/XVI>5L7/%+V7,A0CDLS$R:U
MQ#,E+L91J0:5.-N$74_O0&MO=<BGU/E7D/7^?D_JX+4]UR)_>IR%_MU/ZN!4
M]UR)_>IR%_MU/ZN!4]UR)_>IR%_MU/ZN!4]UR)_>IR%_MU/ZN!5\;]E3'UV%
M9.ML]S2[14S8]G%A6MJW+B^4Q5DM"C;7'^R6I:'H9]0*M^ @
M
M
M
M
M
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MQ>[LVI<6DSU&=MEUW*)E*IEIUI]I#["TN,N));;B#)25)46I&1ET,C(8JY"
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M[5$:3T/M&5ULV\)&>,0
M
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M>_\ +_C7^.L?Y>^.;=_:RRMY-ZCC9
M
M                            [HW\*7V#'I=.^VCR2UY.3.'U#E
M    !TROX+]TAYG4OLOA;<?-@CYATO!?M-8K&SCVIL7Q"9(7%BW4*MANR62)
M3C:77Y!;DDKH9E\8]G;7:<,SX*M5W-Z?X1X.J>$:^WKZFUDVC=N\T^XJ4AML
MT*92I!$GN^W7=X1Y^?/.6G"E&<11XZ]K6#C5)S?*A5-JY!B9)'@NYM&C)-2&
M7#=2LU*0DR)9FA#<C9I\_P ;M5T]3:S,X^/9R:[N;T7[3E'CE1[,<R%C\=@Z
MFN8J(]0\E*'#3%\LC$DT.::^.DB,U%\[]T<.VNF<W'QL[N3GB$&"S['[LUF*
MRW,>PN>EV0AM*7%EY*]T4HB(S[/"%\SW]/'!'HHKV.:W'&."I-Q95\59>L)K
M\^0XPAQ:T1"0M)J,R,U;"3JGX/ ,MW-W>1$%O)KDN7N>.8J/.[_ \;IV.-F&
MY+%G!E-M>4/LKCF;AK<4M)N/I9T4HRT(O%(M1O[K'CFV+IG4QK,M(S9<GW;,
M?KS<,H#N:6+CQ> EM5T0D'^X3KGVQUQ'];,^*/EECV/1WMMXWC]1QAA$BJB,
MQGZR>W75SC*4H4F$J(XLT)-.A[=6FS^R.#9W3-]U6=\<$;6,,9![96-NWL9N
M:X]00YCS<E!.)\I*E[PE[5$9;DK\8O@/J,[OFX)IX?Y4_G,SVGX,%WGSB"C>
M8:9I'YL9Y]E*$I:6[+LVD/J4DBT,UDV@E&?:,=M,]U=/;_N6[FR^?(4.-[5G
M$,F/';9D2G8!R76T$E;IHGJ2DUF1>,9%T+7P!MY_J;OA^0NYJY@7]N7M%_S/
MD/\ *4C9?]GC\MJ1SEU\.5\#W-.2)GDC)S'G+%+L@VTFXLF8\=39*5IJ>PS,
MT_ ?8)EF>_M(]%%XAS%>\;^S_@&,8I51K;+\KM+'U44ULGVH_<3B;0:6S-)&
MZMU>C9F>B=#,_ ,K\,7Y)F>401-(8N5+Y<1[1G%*N78E>QD/K"K1$F5A-[9$
M15@1:.&A1EN0HUI["_\ IBVZ.ZNT<N/R)-:\6P/9YK:Z;[3O,DB9$9D2(LVQ
M.*Z\VE:FC<LUI4:#41[3,NAF0T[B9C#;\'R,K>;/]KVB1AMIQKRQ1QTQ48S9
M-09"(R"0A+27"EL)T01$2=6WDZ=GC:#':7:HNMGM+N'%]X89;Y$]J?D7DI+G
ME530M)@5D@BU;W/(3&;4@_@-IAT_^T&?YF&VWPD<9;J]HF*],X0SEF.1FXFK
M>>,B[=C!DZO_ .]28Y-M-,D,KN31/ \7.\D]EA-1Q3:M5>9Q;E]LY;CA-I0G
MODO.)4?=N::MN)^Y'9GFVW-6^.%&,5IP:E=Y'Y8N^.>9J+-,C=MU4+5?7N]6
MS:0M=PW&>4VIM"-Q+))HU\*3'3W=D76S$4K^!C6:2S8B.9,PX$J^-:3BE$C%
MG6VI==D$<]7UO$_WQR4D:R+<YXR%?X*C(2>[MR:INX^ XT9654MM$RWV;L>S
M6O-NSBM0:^PK)J4KT:9M2:0VXG5232;9)+3X!+9C3DFWQ_(=L+[R0RRS[;V!
M$RA+1*AQ#5L22=3),LNNG;T(D_8&G'^[RRGTFJ/9ZRWE*MCYA-P_CUG-WKU\
MF[^;(UW))PG%*846XO%6:U*47A\/8.G/99--5VFC&V9?).%9W@OLZ9]59G1R
M:*)(O*>95,232:5*<-QM[9HI1GM2ALC,_B#7;=EB;9KPDI-'J?%\@QSBSV8\
M<S]=/&<=IL?A36&FVT-+<GS66VM>\))FE3SCNCBRZZ&?;V#SKK9R9IMKSELY
M0\S\CYASYG'![V3Y#2TT7BBRD,JB,PV6V7XA-R=K3C*-YK2E3A=WJ>IF1GTT
M/4=^.S';DI$SJ:YK1TYJI2Z[V:#4>I^21R_<38,$7[Q"V<[_ /;L)['Z,#PF
MY^8BL9<NZ7FG((.Y-WAF10[B"XW_  B6W)LUE\R/_!+8Y_V1]#KI-L>&&BG-
MUY@Y99GQEEW-UTR35CE>5P:IALNJ$,Q8;[SA(-1:FG4FD$?^!H%E+;HLCL@G
MPKOR9:Y*USUQLY24B<GM*K&Z=RFH7M>[>6F*Z_J6AEU0K5S7X4%\ U8XCN[J
MS2LRL\UGJ:OFRXY]J^7K[ ',49C1)#5L]'\:.HD0I#9/.ZK,S,R4A/9]R7A&
MN9QQCT1=5>-:M?\ L^Y!R= PS*8&&\<-9K6W\A<6[LWU*-9D;!$<=1[BU(B<
M-?V5C=GMLFZ)NNI1(JN6,X+F>&>ROR=49[2.UKS+[<RG1-2A2TD^<=MU31ZJ
MVD9MEKIH-5U]MV:V;96G!NC@^O@(]EB#/1%93.<HK=*Y*6TDZHN\E%H:R+4^
MPO".7-,]_3QPRCD\JX[_ ,GF7_\ %\7^3QAZ$_;QY&'8V!S[!@Q?9,XB5%BL
ML*6JM<4IIM*#-;U8\MQ1F1=JU>,OX3ZF-&"9[ZY;N22Q5IJU]L3&6K1!/-U^
M.P%P$ND2B-2:%#A*(C\*5.+47QEJ%_#!-/#/Y1'--8]#B0O;QO&8<=N,R<%3
MAMLH)M!K=K&%K5HG0M5*,U*/PF>HPNFNVC_;M7^<WW[0?]B6=?S1)_[HXMO]
MI#*[D\6<.<8^T%R'QOZKPS)V*KC:PDR(TR([)4SUU23^Y+32G%)47W._178?
M0>KFRXK+JW1Q:XB96;VDN*JWAS@G#</KY*IKZ[UZ;:3E)[ORB:[$4E2R1J>U
M))2E"2U["ZZGJ->WRSDR3/B6Z*0VS[4\&#0^SDTW1P6(#:_5D!7DK26C3#4I
M+IM$:2(R0:VT&:>P].HY]M,SEFOC97<E7Y"QC&VO8?I)#<1AM^)7T]E%>2A.
M\ITQ]DGU$K37<OOG"4,\=\^L3\*3'S4+R%&IK+V,L$R&^EG$R6E**G&9!$??
M+>2ZMDF$GT,DFPWO^+NTGX!GCF8W%T1RGFD^BO/L456.6?'617[TCUIE5_8O
MM92N1XSI)(C-MM1F>JDN)=4Z:ONE+47W(T[V9BZ([(Y,K.30C=T_Q7QSSIQ!
M)>)J6U:0F*M"S\9UEZ2;3ZR+P[H[31_NCMTZ[K+_ !,.58>X>#<1^@W$N)XX
MMLFY3,!N1-21=DJ9K(>(_AT6X9?N#R,]^J^9;;8X/-?+AE3>VK@EE8'W4.:F
ML)AU?1!FXMZ*74^G\(._#QV\QY6N?2>PK/),?I9M?76]I%@3[53B*R/)>0RN
M0MDB4M+1+,MQI)1&9$/,BV9XQ#;5Y%9YHYRY9RG,%<-8]3EBU*9L3BL&6U/3
MVR[QMLGEN*3N4XA"MK9:$E/0S\)^GW./'$:YFK769Y-&XBHU>R[R0GL05]3*
M2GX#4K0_^@=5_P!K;Y)81R>ID5U?5>QFB?60(\><G$S?2^TTA#I/3(^Q]TE$
M6I+6E:]RM=3U'!69W%)\+9_-:_P*GJ7/8:R)]<1EY]Q-C+<4MM*E%)9DDAMS
M4RUW)2A.U7@&Z^9]8AC'HMR>Q[_R_P"-?XZQ_E[XY-W]K+.WDWJ.-D
M
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M'!N,D7WS,-D12&S1SJ
M
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M-Y]C_I<G]4#3!4]P[F;S['_2Y/ZH&F"I[AW,WGV/^ER?U0-,%3W#N9O/L?\
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MC0G1*V&RTU/KXPL1"3+V6*Q
M
M
M
M                                                    $+E>6X]@
M]'(R7*9I5]'$-M,F8IMQU+9O+2VC<325J(C4HBUT\(#7/O3< _7:+^8E_H 6
MB^87GN)<B5;EWAEDFUJ6GE15RT-NM([Y"4J4DN]0@ST)2=3+H".N?R/@E6U?
M/6-_#C-8PN.UD"W'-"A+F&1,)=^ W#41)^$!]Q#D7!L^.86&7T.[.O[ORTH;
MA.=UW^[N]WP;MBM/L #W(N#QZZ]MGKZ(BMQF0J%?R5.:(AR4*2DVW?@5JHBT
M^$!C6?*O'%->5N-6N30(E[;):77P77B2XXF1_!'\">\^XWZ;O  C++G?AVGL
MI=/9YI5Q;. ^Y$F177R2MI]E1H6A1> TJ(R/X 6B7L>3< J6+:39Y#"BQZ*4
MU7W#KKFU,64^1&VVX9]AJ(P1*MY5CCMO/H46<<[>KCMS;&(:R);$9XC-#J]>
MA),B,]=0$7B')F 9\],CX;D,*ZD5YEY6U$=):T$9Z$K0]#-!F6A++5/Q@..6
M<H<>X+,CU^89'"I9LMOOH[,QTFU+:W;-Q:^#4M &=#SC#["T=IH-W#D63,%N
MW6PVZE6M<[ILDI47BJ:/4O'29EU =]+E6.Y'0(RFCLF9V.NI=<;LF5:L*1'4
MI#BB4>G1*D*(_L (U?)6!-XBWGJ\AA)PUTR2W=&Z7DRE&Z;&TE?#WA&C3X2
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MS6XB.\>-G[[NT]5?  Q,MY/X^P27'@YCD4*EF2VS?CLS'2;4MM*MIJ(O@UZ
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MAEF0G8PA24&M2G&DI(MRTEV^$"B^@@
M
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M.39Z["(C^Y!DD6H$ N :_*E1V$\G'R*3JYR23Y<=R=FHC;[S3?KW7C;/@ZZ
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MGLI\._LJXY:E6K'=YADI-S[C>6CC+>T_)XIZZ&7=I4:EEX%K4781 DRWN"
M
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M&O4S4>I]01(XA@&+8(Y=N8Q#.'](+!VWLD=XM:%2W]-ZD)49DA)Z=$IT(O
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M2F^Z(]I^*6A:ET!$7R)PI@'*5A7VF7Q)#\VK:<8A.QI;\0T(>,C67Y%:===
M6KG0\-8'CEW0Y%61)!6^-5KE-52'I;[VR&\XMPTK):S)9D;J]%*\!_$G056N
M_P ;HLI@HK<B@-6,!N0Q,0P^6Y)/Q7$NM+\'5*DE]DNAZD9D")0
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M24_.,B^ST H;DZ;M2V_#X *!*2KYID?V# H^;T:Z;BU^#4"DOIJ2GYQD7V3
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MG3=J6WX? !0)25?-,C^P8%'S>C73<6OP:@4E]-24_.,B^R8%)-R2+=J6GP^
M"@2DJ^:9']@"CX2T&>A*(S^#4"DOIK01Z&HB/XS I(:DD6IF1%\)@4"4DRU(
MR,B[3("@2T*/0E$9_$8%)?#6@CT-1$?P:@4E]-24_.,B^R>@%#<G3=J6WX?
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MGJ-WX/\ QTSL[?XT=/M#/X?BA[W_ )SU?[V/J6?FMM#SWPP
M
M
M
M                        USSCR;(XBX]FYO%KD6KT1^,P4-UTV$J*0Z39
MGO2E9]-?@ >5_P#[H/=?42+_ +1<_5P94/\ [H/=?42+_M%S]7 H?_=![KZB
M1?\ :+GZN!1O/@CVB)W,=/=6DJA:J554EB,EIJ2I\G">;4O4S4VC33:*QG@V
MM]*'/-D_AG\@(?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_( ?2ASS9/X9_(
M EZJP58L+>4V39I7LT(]? 1__3$5G                         //OMH_
MV!W/^F5_\I0"QS?F(#-M65P3D47A*+S<N6UZGDR>X]6]VLGTLG(7%)XU'XNT
MW$D1?9($KQ:J!7M?V(/ZHYA_.,/_ "#@L,+FU/:"R[(<%XJLLFQ:7Y!=QYD)
MEJ3W;;NC;[BDK+:ZE2>I%\ )"L8UF?*F%<CX]@/*5I"R6MRZL?M*RTAQTQI4
M94=E;ZB<2E#>J=&U)T-)]I&1]# 6K%>?N*LUM&Z?'[62N6N/(F..R8;D:,Q'
MA-J=>6\\L]J"2A)J\)::==3T!*,[">:>->1+\\8Q2W6_=*2M<9B5'7$3)0V9
MDI4=;G1>FTSTZ'H1GIT,"B'9]I'AUZV12>N93,Y4SU:XIZ"\W'9D;^[+O7>J
M4I4HCT5U[#,]"!:)S/.8>/>,[%BGR^R=8M7VO*/(X<=<QQIC7:3KQ-GXB3/Y
MOA/MT!*._*>5L PVDJ,BN;4W:N_T51G7M*F/3$&DEFMIM&A[4D9;C5IH9Z=O
M0!T/<P\?L837\AG.E.XM:R/(:YUF$^Y)>E$I:#:)@BU)6YM1:F>T].AF J>>
M<SP)W"N4Y]Q=9GZQJG&(!N2HW=R8;[[[;2M[#I&1+V+,T*ZEK\9 M%@R+F;
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M+>P(
M          "TXQ_X)W_&G_W4@)L10                       'GWVT?[
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M(^G_ ,0OO@.QIITT4W"G']Y:-*A8])Y$?MH*'FST;JTI3JHD:'JGQ%]"+KX
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MII:5(/L-*TF1@B9
M                     %IQC_P3O^-/_NI 38B@
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MC;^:;B"1M7M^YW%T\ #C-HJ"S5'<LZB!.<B:>2+E167E,[?FD@UH/:1> BZ
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M(OL .T
M            6G&/_!._XT_^ZD!-B*                        @\NP[&
ML\I'<<RVO19TKRVW78CBEH2:VE$M!ZMJ2KH9?" UW[K/ /U)B_GY?Z<%J>ZS
MP#]28OY^7^G J>ZSP#]28OY^7^G JMV'\4\?8#%E0L0HVJN+.<0]*;:<>62W
M&R-*3/O%J/H1GV BQ^I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/VU?* >I:SS=/
MVU?* >I:SS=/VU?* R8\6/$0:(Z";0H]QD6I]>SP@.X
M
M
M
M                     0F893681C%IEMR3JJNHCKE2TQTDXZ;:.W:DS21G
M^Z0"G<2<ZX3S2=N6'(G(]2^3^6>7L)8U\K[W9LVN+U_@E:@M&S 0
M
M
M
M                     :R]HG^P[//YHD?]! L/-O\ ]#T_^V'_ /*/_KT%
ME[?!B
M
M
M                                 \;>T=[S?[3I/[+/I!]$O(XO=>K-
M?)>_V'WFW3PZ]H,HHT9EOO>?1BV^F/TF^BODR_6_EFOD_DNGC]Y_@Z=H+P4S
MB+]N6EQ^QGUOM_S;UUZGUTU_*]QWNG_\S;^Z!+9G_P#W#_\ [=_]\"<'Z.Q.
M]\D8[_7ON[1WF[MW;2UU^/4&+N
M
M
M                                                     !K+VB?[
M#L\_FB1_T$"P\V__ $/3_P"V'_\ */\ Z]!9>WP8@
M
M
M
M         "#S+%:W.,6M<1N%O-UEQ'7$E+C*2AXFW.TT*4E1$?V4F I?$' ^
M%\)G<'B,BP?]=^3>6>L7FWM/).]V;.[::T_A5:ZZ^ %JV@"
M
M
M
M
M
M
M
M
M
M
M
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M6AD>J3TT/P&"+,
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M)23)1&1DHB,@1,
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MTK-E1D25DD^BC3X>T$;F!
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M(!.V.'MNVV>,Y-BUW+Q.7@N-PWHU%#/RQQYA;>I14J)*%.QU$3BD> D]2TZ
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M8S;Y$A*2@5\J1Y&PM:UI29K=VJT)"3-9EIJK3:6FNH"E<69_E62W6789G-?
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M7)>T!7+SSDC!VO)5V&(5Y2Z*,1O=]82(\-Z3-0L]NU!,K0AOI\)GU["+1/\
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MQ:^&TB/$BLI)#33+220A"$ET)*4D1$1 ,@
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MDTE;I&;:E:;NT@12N+<<R%RVXNQT\+LJ6SXQAY*C,+"5$[F*XJQ8=:8;CO\
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M9]@%&].$^3'>7./8&</5J:E<UV2T<)#QR"3Y,\IK7>:&]==NOS026P@0
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M2+=KT[ %9S'FGC# +IK'LPR%FJMWF6Y*8[K4A9$PZM3:%J6VVI"$FI)EJI1
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M*5H24F&LVWD%O).NU1&G<70_ 8"7     >4N;O\ FQX9_P 6?^6>!8Y/5H(
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M(( /*7MR?U>P'_B%'^2,&4/5H,0!4.5O[+LW_F"U_D3H#5_L8_V T7^E6/\
M*W 66_P0               !Y;Y]]:Y9=<DT4F^M*JEQ#!SMH%36RCB,3I,O
MRGOG)24E^6:)+263;5XNAGIH9Z@L(/*<NRVNQGD%BJO9U>BNQ_CWU5Y,^MOR
M-5C)0S(6P1'HA3B3T5I\[P@J2Y$@9[6YO XDPN?EEXQ78U(R&-*BWK,6U=LY
M<]QA#\R5-=:)^.QM2DF$]/'ZEH"+##C9QR'FZ,<S'++?#K?%<6H;&5$HY3,1
M#MU.4XJ:^Z24N-/MH4R3.Q6YHB4>G4P%8L4V.$99[1^?4-I:+NZ-F&N#'<E*
M=B=[/JVW>^<841H6<8U?D-Q&2&RV]@*C<XNLNXTK,UQFDS2YN8SV$5N5,7,^
M<Y*EQ;)RS1#<5&?Z&VU(0>\FR/0C(]NA& N7*N)9/@L&EF-W^86W&E0S.D91
M/K+I:,BBONJ0XF>XM1$4B.PA"R[@DDE&IKT,B,@1?^;,TG8[PA;Y=B%B2'WH
MT!-=<F6_NV+*3'C^5%J1=4MO&X1Z=O4"&@^8JZRI\4Y3XY<R:YNZ"@1B=S ?
ML9RY4QB18SRCO1WWU%N<0K:F0VA71"B)2>P%>HLDLFN->,[2T.6_,3C-.\\W
M+L73DRGUQ&#-!O.JZK<<4DB-1_.,P8O'. 3\CP_",]HZ!FZQ[)8-)09_'C62
M7(3\E^N-"+MQ);C-V,_W6A&?SM>I> &39$G.K',*^TD0)>0VTC/,ME0\!K*"
MV*F[RIQZ(277$RW?%886:'7'"1XSA[?\($86(V.7YY4<<83?Y1?53$B)ETNP
ME1+ F[64_26)PHL=Z8T1FZ;#9FI>GBN:$:M055<;L\^NL9XUP#$D7CD5C"'K
MYIC&;*-3256"[!41MZ0]*<;2ZRQTU9(^JED:B,@&YN/W,D=YSA+S)DF,N_9G
M5E>M)4VHBG)M)!/&1LF:.JBW>(>G7H"(K.X6?6W/62TF"1Z9YVTPF%#LG;Y;
MY,M1GYLQLUH;90OO#+=U0O0C^$!KW.,7LL&7FYT63VU;:\;87BC5?)K)*H;4
MQZ(J0V2Y;1;B<3H2B2THS21*,CUZ JT<L9=DQYJ_=XHK(VFL6MJ&HN[-JX:C
MX^Q+EOQC=8]5:;Y*5MR20XL^Q9IT\4C 9S:L@DT7//(#F57I66+R\HJ:&N18
M.IK8K4>M;>:<;8+L=0MPS0K=XNA:$7A(H.1-9=3P,J?A\@Y6IV@PZGS&&;MJ
MXX2K:8M1.FX1I\9DR;(B8U[OJ?3LT*N').69,_R"W=XNO(V86/Y#0X_>6B+A
MIC'FY<AV,4B,55IO?2I$DDN.'U)9EIXI:@BVX4=YD-QFW)D[*;9VPQK([^G@
MXM&E;*AR'4H6TQ&=AZ*2;JM">4XG19F?P -<8-;<T/8E*SUQS(%45UB5U/O+
MJTMX,J&FQ.&J3"DU46.X;L78LEMF@D$1)V[D[DZ@KNOKW(L@Q]5397U@NOF<
M$JOIC29*R)ZR0;2U2'.OC+<+5MQ1_.0I23[0$]13+O!$<#UU/;VD^OL<=OK6
M?72Y;DA,IUFFC26&#(^UMI:C)A'W!="!&7BT[Z*<,2.9\NSK);AS(L>;>LZ]
MF8VXAF?9O(0VY7-J1I&=;<>3'1L,FT]JDGH UW/F9>SB7)N*96JVCHI;7!Y,
M*HO;5%_+B*GV"#=,IR-=Z'>[2HD?<'K\/4K;3#N18USOWO(-G?)JK^Q<9PB;
M!GG]&76UQ#)%9,@Z&3<A!H<<0[_\51=O0R,B9Y:@V62<H<=X6UD=Q04MO"R!
MZQ*BG.5[SRX:(:F=5HZ^(:U&7[I=AF TQC>?Y3*KJ7D>7).5E]?Q3DTMJ8M)
M+-R16V;;+3ZTJZ*U)M+J]?G=05Z*XBQ1W'Z5FT=RZXR9R]@0)SZ+>9Y<TV^X
MT:G'HVY.YM#QJUV;C06WQ016<0KHN3\L\W0[M2W'5MTU$A"5FAUBI?K%.[65
MIT4@G''G7#-)_.Z]I (SF?$\<XTXPOL@Q:(\62JQJ)Q]1(2ZXZYY%(?3&99:
M09GJX1NFO=\XS("&K<)R>1@V,R(U2NTQNAX\SZ"]:5-N2X<AG$\E0ELDRV"4
MHC)+KRG4;M2Z:]H*[K'+,JR+!ZB(U(RJ;G5O O<^<9I[Q-*U!I),M3<-QQQ[
MJZAI!-=S&0>G56O30!QR^RR/D;"[)-[DMK%9I.**W(RA0)/D;5G8645Y<E^6
MA"2[YL^Z)M3:O%+<K30S =UM:<O9-DEA3<?M7;TO#:+&?H\U46<.MK&I,Z$4
MIQVQCS'6_*T.FGNDD6Y*4I4711@-F8;CE7EW*_+<;(8IJ1%M\1M2BDX9)3-@
MU3$ALE&@R):4.I+5)^*K3KT!$OS%AF,X_P )<F)@LG&*R;L,EE.FZLUJN#-,
MEMXE*,S29.LM;"3V;2(@(<>:42[SV:\AD6SLB)8N8ZB=+\F6<=9R$,H>6VO0
MOF*66UQ'W2=4@0I#M':R[W$N)6\SR*CQV#A<O*3N&K)Q%A(GKDM,MMO25%N4
MS%2XI:6NB=-I'J1 +QCMS:\A>S,W<Y%(?9MK7&9"YTR*KR9];C;#B3=2I!%M
M-S9O/:6GC=.@#5U0R[5<.\68-1/99=93E<!%]$@5E\FH<1'8@,F^WY8\7Y**
MWWJ%,1T=-WATUU*H=ER!G98YQUEK,B9.M[#"K.+D>21RWSZVI3<142K!'4C4
M\VRC8E>NN]6_M 7K,++EZ\Y%RVJXT3=64C!DT4?&"B7$./5I0]$:EN.6C,J0
MA4WRE*EI)9Z]"[=P#>'-62L46"ICNE:%:Y%-A4=/%HI:*^Q=L9SI=TRW+7JA
M@E;5$MT^Q.NG70$AH*CGY)*J\3KLH=L%S:+F6/61HUQ.3:S8L=-4M\HZYB?X
M8DK=7M6?70]/ "MS^SG_ %-OO^*\B_WBZ"2V\"    /*7-W_ #8<,_XL_P#+
M.@L<GJT$ &A_;(_Y?,F_QU;_ "]@%AL#AG^R' O^'JG^1- DKP  /*7MD?UA
MX<_XA5_E8@,H>K08@#67M$_V'9Y_-$C_ *"!81GLL_V X3_HK_\ *WP);@!
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MK &( \S^W3_8FS_/<+_)2 6'H+%_ZLTW^@Q?\BD$2P  \I>T-_S)<&?Z;_\
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M !B91PQQCF;]7)R3'F9KU.PW"A'WC[)>2,J2M$=TF7$$\TE2243;VY.O@ZF
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MH([<VXSPCD4J_P"F%64]RK6XN"\EY^*ZV3Z20ZCO([C:C0XDB):#/:K0M2Z
M.J!Q3Q_6,,1H-*AEB-42,;803KZB34S'"=>C^,X>I*41'N/QB\!@(2TXK:D9
MAQI)K&8L7#..X\THL-:G'))NN16X<1MLUDK\FTE)K4I3FXU)1V@JZY)BU#ET
M%FMR*(4V Q*CSFV%+6A/E$1PG6E*[M2=Q)41'M5XI^$C!$==<<85D,ZULKBJ
M1*F7E9ZBM7#<=1W]<2S<)I24+(B,E*,R6DB67WP"-O\ AGC7)JJBI;BB2[78
MTSY)2MM/R8RV(IMI94SWC#J%K;4A*4K0M1DK3QM06K%N.">*;ZKIJ:SQY#E=
M01UP:MIN3+84W$<T-3"UM/(6XV9D1['5*("KLR#A#B[)V:>/=8^AYNAAMU=;
MW<B3'4FO9V[(SBF74*=:+:7B.FHOMF!5::_%J"JO;7):^&EB[NVXK-I+):S-
MY$!"D1R-*E&DMB5J+Q4EKX=016;3A3B^YR]&=V6.LO9.AUF2J5WCZ&G)$8C)
MIUV.APF75HU\5;C:C("J07QA@CAJ-=.V9JOD9>?Y5[_7K9)),O\ A/G$22\7
MYG^" CZWA3C*HRQ.;UU$EC)6Y,B:Q**3*-IF1,2I#ZVHYO&RWWA+5O)#9$9]
M>TB!:L]?%V!.8,CC9=*V>%-)V,U?>/:-Z.F\2D.[^]2HEGN2LE[B/L,$0TG@
M7BJ7CT+&'J-?JFND/S8>R=.1)1)EEM><.2E\GE&X716YP]2!:KM68_2TU''Q
MFL@M1J&+'*&Q7H3^23').S9H>NI&7;KV^$$5N@XCX^Q>/3Q:2H..Q03'[*G0
MN3*?\GDRF3CN*0;SJSVFV>TD'XI> B,!@6?!/%5Q5UU+/H"775+LQZ TW*EL
MJ0=FZ;TI!K;>2M3;JU&:VEJ-!_!H"U9_[)./4O8O(;IB;?PQLF<<<;D26U1V
M4FDR;4:72[U&J$GM>WD")#,^/<0Y CPXV65WEJ:]TY$%UMY^(^RXM)H7L>C.
M-.$2TGM6G=HHNT@'30\98-C!T9T-0B%]&V9D6D)#CRBC,V;I/24D2UJW=XM)
M'XVNG@T 8I<1\>)S3]H"*9+>5=[Y4<IM^0ADY)MFR;YQDN$P;IH,TFX;>X_A
M 78       'CGE?)J##O;2PO(\GGMUE)#H%>4S7B4:$=ZU9-(UVDH^JU)3V>
M$&78W9[SG OUX@_@O_H@2A[SG OUX@_@O_H@*-#>USS-Q?GW%#='B&2Q;:V3
M;19)Q6"=)?=-MO$I7CH26A&HO""P]>XO_5FF_P!!B_Y%(,4L  /(GM/W%9CW
M/G#%Y=240ZFO?5)F2G-=C;3<IHU*/:1GH1?$#*&X?><X%^O$'\%_]$"4/><X
M%^O$'\%_]$!1J?VEN=>(\RX4R;',9RN)8W<SR+R6$TEXEN=U.8=7IN;(NB$J
M5V^ %B&\>"O[&, _F"M_DR 26P00 >3_ &ZG6V,9P1]Y1(9;OR6XL^Q*4LF9
MGT^ @90VM[SG WUX@?@O_H@2A[SG OUX@_@O_H@**UR+[1G"5OQ]EE36YE"D
M6$ZFL8L1A*7MSCS\5Q"$%JV1:FHR("A[&/\ 8#1?Z58_RMP"6_P0
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M9RSRC'=I<;:P2$[R'>(F6;-,FW2<2-30DM:.ORNX(C><<=[E"$(-.OC&HBZ
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M2CC72(!N*A%*2:NZ-XDDO;H9?.V)U^P J?NV<%?46L_ 7^."U/=LX*^HM9^
MO\<"I[MG!7U%K/P%_C@5;!Q['J3%*>+C^.0FJZEA$I,6$P6C;9+6IQ6A'KVJ
M49_N@B3  $%EN%XMG=6FER^J8MZM#R9*(LDC4@GD)4E*RT,NI$I1?N@*1[MG
M!7U%K/P%_C@M3W;."OJ+6?@+_' J>[9P5]1:S\!?XX%5WQ+"\6P2K52XA5,5
M%6MY4E<6,1I0;RTI2I9ZF?4R2DOW 1.@     #7'-MM IL,8EV,23-CKN*F.
M3,.<[6.DN1.:;0LWF24HTI-6Y2--%%TU+M!81F-<N7N3\AY)C$&@C%CV+RY-
M=9OKL"3=H7&8)U$E-=W6JH[ZU$TRLG/&ZJ\&@"IP_:+R-_BW(N6'<6@+H:UM
MAVLCQ;=+\E2WI:8RXTQ!,$;#S:5DXHM%%UT^,"BQ99SRC%+'D*N?IDONX:J@
MC5FLM#!6$S(TJ[M"UNI)#"&U%X[BE*+9JKP:&*(B+[14IZAE1BI(<OD-J^@8
MK%JZ^Q1+JI$RV:.1&?3.;;/1GNDN*7XFY*D&D^H%$M[.]QDEY!Y!E96MPKIG
M-+2*[#7)5,:AI98BDF,PZHDZLH^XT2GM[-=0)8])SQ9VF1U;DG&4Q>-<BNY6
M,8]DQ3$N2'K&(;R4K<BD@MK3ZX[J&SWF9;=5$6H%&+Q_S[D&69)BL"YQ1FKQ
M[-57,?'[)B?Y4\J1CZE]^;[)LM]VA9-JV>,9ZE\!@46_D3D3(L?R"EPO!L>:
MR3+[B/+LE1Y,LH$:/ @;$K6MPT+,U.+<2TV1)TUZJ,B+J%2KN>\@S*RQ.NXZ
MQ5BS/(Z/Z12W+&P\B\A98FE!DMF1,K[U3;A[2VF6O;IH!1LKD3*)^'XR]=UR
M*Q4A#K31N7EBBGKVDNJVFX[(6A9$2?O2+57@!'GG+N0[_ER%Q6W#JFSJK?)+
M&MR"NA7;L6/)D5*'4D34V*E"G8ZDI5(0M/0U)2G0]24#).8]RGE.&VG-N59C
M7E)Q/'+1PX[B+!3[Z7T,Q&H<)EA3>U#;J7$N*<U(D+49&E74P1))]I"SC8OE
MTV=CT"5EF*KIU%6U5PS-@38]]+;BM&W+0@]CC:E*2XE:-",B,CVJZ"C;,&RS
MAW"9=E<4T.#F:8\MQBG9G&[%[U!+\G2J4;2="7HG<K9XNH(\TX_EW):N&.&[
M#R9<F[E95"8@I5;N$JXC+B3G-TU]2%&V1N%JMM7>?,(^W0B,FPGO:,FIQ^D:
M*CA1<]MK6VHW8%A9)BU$=['U&F8ZJ<IOJ@]4$V6S52EZ>#4R4;(P',H/+7'D
M;(X:':U%LS)BR6&WDK>BR&EN1GDMOM'HK:M)FVXG34M%=-01H+&>2,C17\?L
MY)<RENX#799<<C,LR%G)E)QATZV.AXU+2;JEN*)S:Y\X]/L@R6+)>9\ZLL$S
M6GL,9+&\O=PR1EN/+C6*G"*I<+N7G%/)9;-J7%)9.$A/SU:$2D]H)1F8]EM@
MQ(X=^EM.\WDDNAN9,1Z-</N1B8@0(RB<DM$V29"Y"%DK\I_!*ZD:CZ@.W%/:
M,N)L0[?-,2;I*:7BLS-*ER%8)L'G8=;L[UMQ!M,DA:R6E3?7_!/KKH*+'QKR
MOE^59>K$,QQ:-CTQR@C91#7%L#G[HDU\V6VW"[EK8XDR,E]3ZETZ& U1S?E=
M95<K9'#R7,,IQ^+$QR!(QR+C4B<AI=H\])07>-1TJ:-2U$VDN^VI5V:@0L=A
M[0.68/3TU1D%/#L,JI\;A7^=JG64>J?2IY*MT>*PM)]]+-+:W5MI(DET2751
M$!1=2Y?R#(,O<H^.<71D5+4M5,C(;%^<F XVW>ME(9\F;<;4EPVV%$^YN6GH
M>TNH".B<]6#^3QN^QHFN-K#)',*K<D*62Y3MLA2VDNG%)O0HSCR%,I7WFOW1
MD6N@%$>QSWF2L=M,MDX7&11E/<Q_&$-VA.2K*Y]9^KFD*0;*28:,R6I:E*,R
MV]"/4@*)7@VYRVXRCD]69H\EMXMS$C^K&IBY\6*A->R9)CN*2@B0K7O-"0GJ
MKKU E 1\2D->TRJD^EF3+I&L?1ER:M=U+5$.>NW6T;9M&K:<?8DD]SIMTZ ,
M+&^7KFJP[!Z[C_$CL).4?2F2W'N;QUPXB:"<:7%+E/,K6Z3F]1I3H6WHG4RU
M4 F<3]HR?:-/6^58J5)CC^+3,TJ)$:<B=(<@UJT-O-NH[MHDN*WI4V1*[#T/
MKV"B:XGYO<Y R%_%;JMA5MVNJ9R*O;K+)NV:.O>=)E3<A;:$$U(:6I!+1U(]
MVI 40\C*\QK/:3O8\F,VK"*_%HLJ4XNP62(\)+K[KDQ,4FU)-Y3J%,J3T/8E
M*MW7: E./>:KW*;^AKLGQ8L?J\VKY%QA4Q,Q,MR3&B=VM2)+:4)[IPV74/%H
MI2=IZ:ZD!1W\E\LY;B>5JQ/$,6CY!,8Q^3E,QR3/.!LB0GR9<0A/<.[UJU(D
M=2ZGUZ$ KF6>TRBJ173,>I8TVO/'8687/K*SCULE$&P2;C<:(TLE'(E=VA:S
M06B>A)U-2B HL$7F/(+S-[&DQ;&V;'$*2#6W%M?*F*1)\BMHCDMHH\,F3-QQ
M1-F22[S[.FH%$50^T#:RN,KCE2YQV&6/LM15T3-1:)L)$F5.>)A$&0GN4&P^
MAQQI+G11%N/IXO44)W.^64=3D<6\PUE&>XW.I(CE.Q8D<*4SD;Q-17&I:V2V
MF2B6A9*;T)2>W0^@HZ)_M"7M1BT^1;XW#A9A790QA\N.[8Z4[#TIDI+<M^:;
M)&VP2%;5&;>N_0NFO04;<K<AFLX:G)\OA-4TF/#=G6D2/(3.:9;82I:C0\A*
M"6DT)WEH7AT!&FVN<\SNJ:4Q-Q1%%)R?&)^28!*39)<.0Q&:2LT/J2T7</I:
M=;?+3<G0]-2,@6BIU65\I?0G@F0S!1(OYTDTQ:]=NX3-M%*D6XW*G/FV9I7N
M-3RFC)P]R>A[CZ%7)_VCI[V,8A+K*"$SEF4>M3?@VULS7UT--#(.+)-4M:3W
MFXZ1(8)*.NNJC(DF"494#GO(,RD8C&XUQ5BV5D]*[?/KL+$H*83<28B%(0>C
M+G>FAQ1H\737MTT HS/:0O,PI*?"SQ%KO7Y>6TT>0WY8J"3^Y\C;BN*2D]6G
MUD27#^Y+KHH"%&ON6LYX]Y#Y$R*94%;XW3PL3=R*"JR42:E,U#C;B(#:FC2\
MI;CBEJ5^3UV=>IEH%_SGFJ?A7(-5BS\&G?J+"=6UID5TTF]UM5I:3(16]V:^
MY:6K11FK51=2Z 41L'GO('\O;KIF*,L88[E\S FKI$_O):[*-WIMN^2]RDB:
M431DK5S4C^QU%&]00 4G+>(.,\[M$W67XU#M[5#*8R)4E*C63*%*4E'11="-
M2C_= 0/NV<%?46L_ 7^."U/=LX*^HM9^ O\ ' J>[9P5]1:S\!?XX%6SX\=F
M)':BQD$U'80EIEM/1*4(+:DB^(B($=H  J.8\7<?<@2(LK,\?BW,B$A345R4
ME1J;0LR4HBT,NAF0"L^[9P5]1:S\!?XX+4]VS@KZBUGX"_QP*GNV<%?46L_
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MDGM(W^-+O>WYH%6[P0
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MCBEIT+LT!:-H @
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M+1TQN5J*FA7UGGN0T-?70+^920)$*6XXE)1FR=0Q*-U"=DPDDHW&D:D730S
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M?W;I%KM670TF9'J6I=2ZD L
M        #S[FEC5X9S5<7V;8_-OJ'),:@U5%Y'6.6Q.2(LQU;]?W:$+(EN&X
MAXB<VH5IVZD"J/R);9?=\D^H[J3:,.UN;T"Z;&(-/WM8[2,/Q5ILGK%,<S)6
MJEDK\OXAELVZ:[2IJQHII<%\X--5;Q6L_(LI6PE$=12)#;L_5"DD2=SB5)(M
MIEJ1D")SVB&9^(X5BO)>*U[9WN&OG'CQVTDR28]]#55K2E*"+0R>=CJ(M/N0
M(57*<"G8B18K6PGI#=3PY?U)OQF5J0]//N=Q)-)&1N.KW+))=3U 0.9X=DMI
M66U;C]1)3+>X@HV&VF8ZV][T6Q-Y^,1$DM7C:2:>[^=X- 5LWAO(Z/+.:.2+
MO'8TB+5O5.-H;1*A.USFK;<I/\$\A"M"TV$K30]OBZI(C!)8-YNK>3^:H$F!
M**;E&*PW<>>:AO.MR"@5TYN1M?;0:4J):T)VJ41J/0BU 4%_#,HM($&IHZJ2
MS92>"F*Y)$PMHES3D,+7$4HR(N^66].Q1Z^,>OA!6QO9]K85AD=EF#.175O.
M8IX-%*BVE WCT=A#*U.M,$33+*'7HVBVU&G=M2HBW&G:"2B.>[2"65F_B5%?
MUW.5,4)O$+N!"=5"N&9#B%NQG76C4TY&;(U$Z4G9L/JG4M=1"<Q6QJL2Y0S#
M%LMQ^=8Y%DN5,W6/6"*QR9'."Y#9;9?\IV&AM,-3;J%*-1*1KXI'U 4[#**U
M9D<5*37/Q9B<HSE;\LXRTJ9.4W8(9==5M(R)1FWM-7SB(O@(!6^*\2?76P8-
MI<7WTKP/'+V(YB3E B##B*F1UL/,*G,LI*3WKFU]D^]6I>F[H9J!68G&;$JU
MA"*5\EEP ]#\6(LO_,%D@S8UV?PYF:CV?/ZGT 1U_BUD5H[7939W5'CN:8EC
M-="8K* KQ4WR2-W3\)2EL.N17FG5$Z1)-&N[<9[DI ;T]HRHGJX N:>&B3;3
MV4T[1=VVIZ2^;%E#W+-#9&9F9)-:M"^$$AKC,*2Q<FYY):JWUON\D8O(8?1&
M6;BH[#<'<XA9)U-"/'\8CT3U^$P5A9!4V4S%.=<+BTTR3D;F5IR4ZQ$1U/EU
M&3U:\I++^PD.*=0R[HTE9J5H9:=0&S>'Y+&3<F<B\@4$"3"PVX8I(4*5*BNP
M?+IE>P\3[J&7T-N$31.(9W&@B,RZ:Z DM69/B,V9RGF.*Y-?WE,WE>05=I3L
M5="BQ:G-,-Q_)GDV/<N.,'$<:-+I&XA*$EJ6I*4"I7-Z:R>Q+VDD,U;ZWI\Z
M(J"E$99JD$4*(1J:T3JO11&9FG7KU!$7REC$U7(N30<BM+>EQ7-J6F@5C-/0
MHO4S414K;>A$LV'517&W%$ZDFS1KNW:[DI!5XIIU9@_+N84N8T,^ULLJG8Z]
MC5BU6N3VY;4*"U$)Y3J$*;:.(ZVMUU3BDFC4UIU!#CS+*_C=SF1W(*JR\MA9
M;-NU1X=>^^\]6V9Q68SC*B02'"4K<HTI7JE)&H]"Z@/0C+I/LMO)2I*7$I62
M5I-"R)1:Z*2?4C^$C!',
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M*S;4HDGIT+4RT!);U!
M      $#E6'T^9,5D6[)Y<:KLHEPRRTX;:'),!?>,I>(NCC9+T4:%=#,B^ !
M/  "K8?@&/X2Y:2ZLY4JVNWDR+>WLI+LZ=)4RDT,I6\\9GL:0>QM!:)27874
M]0M(
M                                        "IPN3,'L7VHL2W0N2];2
M<=994V\VM=K!2:GV$DM"3/823,UEXGP* 3&/Y)1Y55(O,>FMSZEQQYIJ8UKW
M:EQG5,N[341:DE:%)U[.G0!]Q[(:;*Z:)D./2TSZ:>DW(DMLE$AQ!*-)F1*(
MC[2/P ),!#HRJA<REW"D2]<F9@HMG(/=N=(3CIL)<[S;W?5:33MW[OBT 3
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M%;'O&64$LC56S3,F'^J2(DK-)Z$?7X@$\
M
M
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M-[F9D=!*4O4T[S+751&6H>@ 0
M
M                                                   $-E>*T&;4
M$W&,GAIGTL]))D1U&I!F:%$M"DK0:5)4E224E23(R,M0%9J^%^/:FH@TL6N=
M7'@W+&3(??E2'I3MQ%42FY+[RUFMQ1:$6BS-.A::: M5^6A+B5(61*0HC2I)
M]2,CZ&1@BC4?#O'N._1+U14]Q]!RGEC.K[[GDWK;7RHSWK/O#7N,_P INT\&
M@+5W1.*<'@SHUC&KU(F0[F;DS"^_>/2TLT*1(=T->ADHEGXA^*7@(@1,XKB5
M%A5"SC6.1CBT\=<AUIA3BW3)4MY<AT]SBE*ZK<4?;T[" 5'#N$^+N-YJ)]#7
MJ8>4PNMAHG39$QIIJ2K>ZU';E.N)0;RBU62"\;[&H+5(X1Q)A''DZ588M%DQ
MG9+?DR6GILJ2Q'C=YWO<QVGG%H:1O\;1*?W@1D9)Q?A>63K6RO8"I$RZJ4X]
M8N)?>;WUJ7U2":(D+(DGWBC/>GQOC =-OQ+@EZG(T6=<IY.6-5S%Z12'T=\W
M3*W1"+:LMFP_O--WAU!:NR;Q9A-@_-DRJ]2WK"XAY)*43[R=UG7);0PZ1$LM
M"232?$+Q3\) C%M.&^/KBJM:>96K\GN+E63R7FI+[4ANY4E"/*F'DK);*R)!
M$7=F1::EIH9ZEJZ9_"G'UCC=1BTB'**!1/N2JN4B?,18,O2#4;ZBED[W_P"5
MWJ)PM^AZ_$6@J[:SACCBI@TU9#IR]74$.RK*V(Z\\\TF'=JW3&EI<6KO"<__
M (FNG@!*L/'.!^-,7*>5?72'RLZMS'YA3Y\R:2JAW3_-$D^ZLD-I(MJ21IH0
M+5PD\"<<2\;I,8=B3"B8ZMY=-,183$6$8I);76T2DNDZ3:T>(;>[;M(BTZ$!
M59:WC_%:6XKK^LA*;M*FG^CM>XI]YS96)<0Z31]XM6X]S:?'7JOXP1!<*8'-
MX]P9%3;M1F;^?.G6]NW ,U14R)\E;A(;-1),TMM=VWV?<@LN.2<&<;Y9D,C)
MKFN?792UQ7YB&)LN-&?D0#3Y.\ZPRZAM;C9)V)4I)^+T JE'N+,)?4\IR LU
M/Y SF#AD^\6MU&)LFW^B^A$32/R?S/B!$4QP7QK&S(L[8K7F[]$]RW:VS)11
M&Y\A)I>?3&)WN26[KJL]G4P6J9S?C3$N0E5KN21GE2JA;JX$R'*D09+:9*";
M?;)Z,MM?=NI(DN)W:&0(K]C[/_%MI24>/2*IYNKQUF1#K41YTN.Z428>Y^.X
MZTZEQQM9_.2M1_\ 3J6J4:X@P2/.Q2QBPGH\S"XJ:ZC<9ER&S3#1MVLO;7"[
MY!&A*MKN[K^Z!5TT'"G&^,W4R]IJDV)DIN2RVVJ0^Y&B-SU;Y*8;"UFW')U7
M5?=)3\!:%T J[XG$.!0F8;$>M6EJ!1OXK&2<A\]M1*-)N,GJOJ9FDO'/QOC!
M$/>>SSQ5D,>%#L:J04.%61J/R>//FQFWX%>G;%1))EY'?&SVH4YJ>O;KT!:I
MR;Q1A-AD<O*GX;Q6UA6G2SS:E2&F9$,VULD3K2%DA:TH6I*5F6XM>G@!$9><
M$<9Y#"HJ^QJW?)\>@-TL$X\R5'<75M$DBB/N-.)4\SXB3VN&?7KX3U+5SM>#
MN.+G*"R^=7/G;>61;7NVILMF&=C V=S*.,VZEHW22A*34:.I=O:8%4@SQ/@L
M=]$AJN4EUO(7\Q2??O'_ .=RDJ0X_H:^PR6?Y/YGQ B/P; IE'R#R)GEHTPU
M)RR7!:@-QU;S*!5Q$L(6LS2G1QU9K4M/7L3U!6?G'$^$<ARXL[)X3SDN*P["
M[Z)+DP5O0I&AN1GE1G&S<949$HT*/37[)ZD15SP)QA?-T35C5.FC'J]BEA$S
M+DL&Y6132IJ+)-MQ)O-)4DE$EPSZ_9,%J@N4. Z;+KJ'EN/,E"RU5Q46-E)<
ME26XCC58\E2W51FU&TM_ND]VA2D?NEV@56%[@KC9_+_IPNM?*\*Q;O$I1-E(
MAILVB(O*2BI=)GO%$DMZC1U^V!5*5?%6#T\NEG5]>IN5CTRRL:E9OO*[J3=D
MM,Q1DI9DHEDXK0E:DG[G0$=+O$."NYJ6?%"?9OS>1,=2Q,DLPW9C2.Z1(=BM
MN):6Z2/%W*1U\.I@,&/P5QK%S%.=1ZQYJ^;G.6[)(F2BB-SY"32\\B*3O<DI
MW759[.I@M4QG7&>)<BE6JR9F2J13K=>K)4*7(@OL.OH)"U(<C.-JU,BTZ] 1
M5,OX=@6%/QWA.,5T2#AF*7T.XEM+49J1&KD/.);;)1*-:WW5D3BU*U,C49F9
MF"U;%R7':K+J"PQF\;6]3VC*HTUEMQ;*ELK^<G>V:5%J70]#[ 1"7W&&%9(N
M(NUKC7Y#5S:".EIYUE)5EFR4=]@R;6G<1H26TSZI/JG0P&%/X8XZLZZ54SZD
MWZ^;30L;D,J??T.MJUF[%07C]%-K/<3A>/KX06KZ[P[@CN8-9TJ))3?MN,2'
M5-S93<=^5%0334A]A#A-N.I26W<M)Z^'4$9SO&6&O8UD&(N05'0Y/*F3[J/W
MSQ*>D6+G>OJ)9+W(W*ZZ(,B+P ,>WXEP2]3D:+.N4\G+&JYB](I#Z.^;IE;H
MA%M66S8?WFF[PZ@M778\08)9YHWG\B$^WD278TA]<:9)CQY$B#TC.R&&G$MN
MK:(M$FM)].AZD!5PJN',"I\Q5G42%(5?=[*E1_*)LJ3&C2;#7REV.P\ZIMI;
MNXR4:$ET/0M" JOH(
M
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M;<"^(S94U&<:-3BR(C5MWD6A'J:>FHHWN1DHB478?4@1]
M
M
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MC?F#+*--MD][4)SNIR"!DF,541+QT44ZUHV/)ENJ;3)4F2E;BG5&1FE1^+T
M?*CAW,_*JG(+ZPK5Y$[FAYGD+<7O_)FV4USE>S%BJ6@E+V)-'C.)1KU^ M15
M%6W"^?\ [/9N#0HN*WD6WM[RRL&;[RTDM)LI"G8;T5UALU(>9):M_B^'Q5EI
MU%7*\]GG(K^LLJF??,O*E8338PW:N=ZJ4Y<4DQ4U,ITC(_R:EDCKO4OX>O4Q
M5TS>#N0\SB<AS<[DX^Q?Y<G'WJQBN*5+KF9..+=6E,A,EM"EM/;B2LM#\52N
MAZ%J*I6+P[DDC'JR([28ABUG$RFFO9$?%H[T:*[7U#Z7C0XLV4*<?,S<V:H2
MDM=/A,!!\N>S[E^;Y+E]E2*H)47+XU8TW8WB7U65,NK+:I%>;;+A)0]IO49+
M2>XSZ'T JMEGQ=FKF8\I3JZ56'C/(]*W$)4A4@IL6QBURJ]HMJ$&@V5;MZU;
MMW@)("LSN#N2JRI;K,.M:9!7V&UF%9BJP*5^2571U13FP3:3JM7=NN)2VYL+
M7:9GVD0JR\B]GZ[EX]R!CE%80VX61T.-T%"J4ITE-%CR7$+5(V-GIO2HMIHW
M?&1 5;AHVLT;O\@]?NUR\6-<8L61#)XIJ6B:TD>6&YXAF;FG=]WX-=0180
M
M
M
M
M                            U_?[
M
M
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M(YFIEN4IM)NH;-74TDO4DZ^ $9P
M  (S(L@J<4H;');V046GJH[DN8^KKM::2:CT+M4H^Q*2ZJ/0BZ@-1\"YKG^6
MY'R&UGR%0I$*76OUE&I*4G70[*'Y6S'69)2HW2;6WWV[_P")KV LI[G_ #F]
MP/CQR;BRFVLGMIT.DJ)+R2<;8D3W21WIH,C)1H02C21D9;M-2,N@$-<T_(>8
M\-Y9FV%Y]>2,ZKJ/&49G66#C34:;W+;Q1I#"MI[3U<5N1N,]"(!:3]H=\J6G
ML58#=MVV3S"BXM0.*C)G6$=,4I;LI*3<VH;;09:[E:ZF7QF0HH'&/)619-^R
MZ9D5_=-6619#DS2X;*(Z([[4,MZ&)J%:&A+24[4):+H9GX2(P5>^.O:7J>0+
MS&JH\6M:6%E[5@K'+6:;"H\M^HU5*;1W2U*(D$1^.9?.\7XP2C*C>T(TS9W5
M/DV(6>/V%;2S\B@L2GH;RI<6K(S>;_S=YPFGNGS%G]D^S448]7[1:IE'4939
M8-<TV+W=E4UD"SFJCI0MNYWDB5M2LS[EM24DH_"2TF7;H0HV!@V?Q<[F94Q
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MIS>XQ6MQ2?ZGH9TBJM,G6[&3"1*CLH>)"4=YWJC42TET1XNI:]O0-B@@
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MRZ/).0LMM,881(KJWNF(L6GGM&RI$7O'3/;N<?>-2]OV"+4!:6."KB7(8O\
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M:[GN$V2TJ)@_&5NV;?G]-?@($4&?P5D=AE=K(>RM@L!O,CB95:8^FO+RM<B
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M#</LUYUDG(_$M7EF6242KN4_,;>>;:0PDTL2%MH+8V1)+0B^ $EML$
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M;YU"GL,L,8Q?NTD$F25N6RS&8>WN&HSU6I3I_-(B(M"^,%7L$    >4N;O\
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MI(M5$G70!FQ9\&=WQP9+4GR9U<:1W+B7.[?;^>VO:9[5IUZI/J0#(
M      >3\R_Y[<!_F!W^3V@,NQZP!B /,_MT_P!B;/\ /<+_ "4@%AZ"Q?\
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MB_$ WSP'C\JAXMI7;1)%?7O?9#<N$6BES+AU4M6__"0EQ+?_ &026RP0
M       !Y/S+_GMP'^8'?Y/: R['K &( \S^W3_8FS_/<+_)2 6'H+%_ZLTW
M^@Q?\BD$2P  \I>T-_S)<&?Z;_\ 7;0,HY/5H,0!I#VO?^7K+_\ Y=_O*,"P
MMW!7]C& ?S!6_P F0!+8(( /*7MR?U>P'_B%'^2,&4/5H,0!4.5O[+LW_F"U
M_D3H#5_L8_V T7^E6/\ *W 66_P0                   !"XOEE'F52=YC
MT@Y57Y1)B)?-M;>YR&\MAW:E9$9D2T*(CTZ@(&OY!PK(I&(I<9?;M,C.PDXW
M&L8#S$I!U:3;DN&EYLC8,DKVD:MIJ2OQ=2,%7@$17T;I#R0LO.&@\D*"=4FP
MU5WA05.D^;)%KMT-PB5V:@)4    !"XOE=)F->]:X^^J3 9E28"GE-K:(WX3
MJF7222R(S(EI,M=.O@ 30    "I+D87@5NQ#0WY%;YU:N*2EM+KJI=CY/O6M
M9^,2"2TQX=$]/A 2U3D<&YL;BKBM2FY%(^B-+7(CNL-+6XV3I&RM:22ZG0^J
MD:]0$N  .F5*CPHKTV6X346,VIY]U7S4-MD:E*/XB(M0&NH?.F%3Z['K&+'M
ME_2N:N#CL,ZR2F7,0TVEY<IIDT[CC);43BGOFDGKX#!:+MC^00LDA.SX#<AI
MAJ3(AJ*6PY%6;D5U32E)2Z23-!FG5*NPR!'7CV*T.*(LD4,0HI6]A)N+)6];
MBGY\TR4\ZHW%*/56A%H70B(B(B(@$R   # N[FNQRFL<@N'O)ZFJC/3IS^U2
M]D>,@W'%;4$:CT2DST26H"*LZG&>3</;B6;3LS&+V/'E=TEV1#6['=)+R"6;
M*VW")1:;T:]2Z'T 8=?EF&4Z<@Q>D0I">/H495G50(KI^31W(JI$=EA"$?E%
M&RC5*&MQ]A=IZ +'46<>ZJH-Q%0ZW%L([4IEN0VIA]*'T$M).-K(E(41'XR5
M%J1] &: A<LRNDPFADY+D3ZHU1$4RAYU#:WE;Y+R([220V2E&:G'$I[/#UZ
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M263+A)UVF25$K8KP&1^$!DO1D.M/(1HTX\V;9O)2E2B(R,B/11&1Z:]"41D
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M-6IZ 4;-]C=A^-P+1LR6ELO)E6&K;B30HM9;AET41&"2WV"
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MG%6+>M;EJ!'Q3(II3&+)]%@M2D0G^[7*(^\4VE2O%1KM(DI+YO0!4'<@Y0Y
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M,4FV\F33T.3^KJ-=O+7*D(1)B1W28)Y]1K7JXM1H29F?4$EN<$
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MLHS,?::#VK;,TN+\;QO&U(M#"!J>1.5LNJ^,**-EB::XO_I:Q>WS%;$D./\
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MN9*2DR03ID:_@(C,M.PR#TV"
M        (?*,6Q_-*23CF40&[*EF$GOXKVXB,T*):5$I)I4E25$1I4DR,C[
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M
M
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MCH[^+9$TF4:D%M-Q1,J6G1S3>GKV'U(NP$68
M
M
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M:+-<R>Q4W*B-#P/%<JR*^1D'EJ')$QY4N?'1'3%).YLTN/*-2E*VFA)&77H
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ML!&Y<!5D!X=3HRBJ327C,=$>56(DHFI:-C\FD^^;)*5;TI)?3LUTZZ BR
M
M
M                       #J>DQHYM%(>0T;ZR:9)Q1)-;AD9DE.I]5&1'T
M(!@S9V/MI5/LI,-"*MW14J0MHBBO+3MT-:S_ ":C2O3M(]#^,!6LCS_&:3.L
M/Q:>RT[9Y&U8/U]DIQ@D16HK;9J\9:MWY<UI0C9\[0_@ 6]%C7N3G*Q$ME5D
MT@G78:7$F^EM70E*;(]Q)/7M,@'&-:5DR3(APYK$B9$/;+CM.H6XTH_ XE)F
M:3^R Z%S*"A3&@./PZQ,A9IAQE+:C$XXM6IDV@S3J9J5J>TNTP$#3\C4MSGV
M1\?,:-VF.,P7GW%NM:/JL$.N;&D$HU'W26_RFI=-P#[<<AT]-GM#Q_)(BLKV
M+*FMOJ>:;0VF*IM"4&E2MRENJ<T01%UT/X #".0Z;-TV"8FD.9 L;"L*"^ZV
M<EPJR0J,MXFTF:B0I23T 65BRKI,N1 C2V7IT3;Y5&;<0MUK>6J>\01F:=2[
M-2 5?)N2*7%\UQ/"9Z3*=EA3U,2C<:;9CIKVDN&;N]1*U=4LD-DDNIZ_  SJ
MC*ER&K5_(X;>/-0+&5 AN2IL5U,N-&(E)E$;2S)LEEN/NG-%HV^,0"8C6]3-
M?*-#GQY$E3*9266GD.+..YIM=)*3,]BM>BNPP'.-8U\QZ1&B2V9$B&HD2V6G
M$K6RL^Q+B4F9I,].Q0#Y-LJZL2TNQF,0T/.$RRJ0XAHENJ[$)-9EJH].A$ I
M%UR@W7\H4O%M;5^L;2PA*M;.6<MF,W"@DYW*5$AS53SAJ_\ A(T5M\;J6H*D
M,BY%IL;S;%L'FI_S[*43G6)*G6FVF$P$(5XY+42C-U3A(;))=3(_@!'+"^0Z
M?,W+>/'(H<VJMK&G\C?=;.0\=4\;#CZ&TGNV&HCTZ?9 69NQKWICU<S+9<L(
MR4KD1$.)4\VE9:I-:"/<DC+LU(!2.1.4?H)<8YCT/';#);W)_+CKX-8J.A9)
MK6VW'C4<AQM)>*X1EU\ *LM%D16E7&F6L1=#:.QSER::>ZR<N,TE9I-3G=+6
MG;T^<1Z?N@B&:Y+H7^1BXX94E<Y5,U>MSB>9-AQ$A]3+;+9$HU*69(-WH6FS
M0_" L19#0&A]TK6&;<5"79*RD-;6FU_-4L]WBI/3H9@.U5S4(KO7"[",FH,B
M44\WFRC;3/:1][KMT,^G: 2KBH@L(DS9\:-&=0;C;SSR&T*06AFHE*,B,O&+
MK\8"JYMGV+X=,H')C;4ZZM[*!1P6V5,G)91</I:)X]3WDSJDC5M+QC(B^P$I
M495Y1#G2\BC-8\F-.EQ(Y29L5Y+[$11D4@EM+,D$M)&HVU^.C[H!*2;NEA0F
MK&98Q8]>_M-B6Z^VVRO>6J=JU*))ZEU+0P'*3<5,)3:)D^-'6[M-I+SR&S5W
MA[4[249:[CZ%\)@.965<IMEY,MDV9#G<,.$XC:X[J9;$'KHI6J5%M+KT,!5>
M0^1(N!1ZMEJLE7V27TDX-%05^SRF4\ALW7%;G%)2AMM"34XM1Z)(!D8?G]5E
MF+'E#[$B@;C.O1+2'<I*([#E1G.Z=;<-1[#(E=BDJT/[.I$$_)N*B%';ES)\
M:/%=0;K3[KS;;:FR(C-25*,B,M#(]0'V3:U<.,S,ESH\>)(4A#$AUU"&W%.E
MJ@DJ49$9J+YNG: 2[:J@.H8G3H\9YPT$VV\ZAM2C<4:4$1*,C/<9:%\)@,:3
MDE*PW9&W-9DR:IER1.AQW6W)#:&DFH]S9*U(STZ;M $-0Y]#O>-HW)2(;S-?
M)JU7*8)J2I\F4M&]LU(R3N,B^'34!5'/:!P].!X;GS;$EV#FUC%IZR&CNSD-
MRI+BVEDYXVW1I3:R69&?[X+1M!5C7HG(K%RV4V3C9O-PS<23ZFB/0UDWKN-.
MI=NF@(%95RIJZU,MD[%IOOW(9.([]+1GIO-&NXDZGVZ: -?U'+;.3XO:9#BE
M0=K(K+=RH.L*=#8=6AF7Y*<@W''";2E6BEH2I6JR+IV@J^%<5)S4UI3XQV*S
M6E$0GD=\9MD2ED2-=QFDCU/IT! [BH*<=6<^,5FG:2H7?-]^1K+<G5O7=U(M
M2Z *[F/(=-A=QB]+9Z=_E$UR#'=4ZTRVPEEA;ZW7#<41[?$)):%U49$ LIV5
M<F>FK.8P5FMOOD0C<1WYM:Z;R;UW&GIVZ: ,H
M
M
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M-F2$/()>NBDET2?@\ $L["L?L%\\JXUE,J^C> W-UF\7<DO)U-7S3!US2/\
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M3C7<;=OY3U?Y#NW:_D_OO "O:0,0
M
M                                                           '
M%QMMYM;+R$N-.)-#C:R)25)46AD9'T,C(!C2*JLEP?5<J$P_6$E*"A.M(6QM
M;TVEW:B-.B="TZ= 'U^LKI28Z),-AY$1:78B7&D+)EQOYJFR,CVFGP&78 ^%
M5UJ9ZK5,-@K1:.Z7.)I!2#;+[DW--QIZ=FH!#JZRO=D/P(3$5Z6KO)3C#2&E
M.K+7QG#21&H^I]3 <9E14V+K3]A CRWF26EEQ]E#JD)<+19)-9&9$HNAZ=H#
ML]75_E;=AY(SY>TWW#4KNT]\AHSUV)7IN).O@(] 'V3 @S%L.S(K4AV*LG8R
MW6TN*:<+L6@U$>U7QD XE6UR30:8C)&VZJ0V9-H\5Y>NYPNG11ZGJKM/4!\9
MJZV-,?L8\-AJPE$129;;2$O.DGL):R(E*TT\)@.JW*C)IAZ]*)W#+[2HSDTF
M]J)1JVM&@W.A.&H]$:==>P!WIKJ]*R<3$9):7524J)M!&3ZR,E.$>GSS(]#5
MV@(MRSPRMB'8NS*R' KI2XIRU.1VFH\QY?=K:-9F1(=6M>U2=24:CT[3 24>
MKK8<F1-B0V&)DLR5+D--(0Z\9=AN*21&K37P@/LVMKK-+2+&&Q,0RX3S*9#:
M'20ZGL6DED>BBUZ&0#M\FC^4>6=RCRO9W7?[2[SN]=VW=IKMUZZ ,::U3R9,
M.-8HC/2R6<FO9D$VMPG&-#-QI*]3W(U+QD]FH#L*MKB-)E$9U0\J4@^[1TD+
MUW.ETZ+/4]5=H W65S4YVS:AL(LGTDV_,2VA+[B$Z:)4X1;C(M"T(S 8]TQ0
M*B*F9$U#.#$(UJD6"6C9:(]"-1J=\5)=FI@/OD%#61W)7DL2'%:CFVZ]W;;+
M:(I&:S2I6A$39:FHR/IX0&/4GBES'A6M%ZOL(D,E-5LZ%W#[;*=-BD,N-:DD
MM.ADDP&:Y55;T ZIZ#'<JU%M5"6TA4<TZ[M#;,MNFO7L <5TU.["<K7*^,NN
M>/<]$4RV;*U:D>JD&6TSU(NT@'>4.&2F%E';)<5)HC*)"=6DJ(DF2#T\4C(B
M+0@'2[3U+TPK%Z!'<L")!%+6RA3Q$VK<CQS+=XI]2Z]# <T5M<VI"T1&4K;<
M6^A26T$:7G==ZR,BZ*5J>Y7:8#J=HZ5]EJ.]6Q7&&'3D,-+8;4A#QF9FXDC3
MH2M3,]Q=0'>S @QEH<CQFF5MMDPVIMM*32R1ZD@C(BT3KUV]@"O46$QJ7,<I
MS14QV799/Y"TIMTDDW%C5K2FVV6M.NAJ<<<49]JE +'+AQ+",Y#GQVY41TM'
M8[Z$N-K(CUT4E1&1]2\(#K=K:YZ!ZK>AL.5FPFO(EMH4QW:=-$]V9;="T+0M
M ')NO@-%&)J*R@H:31$)+:2[E)EM,F]"\4C(M-$^ !T/TE-)AMUTFNBO5[2B
M<:B.,-K90LC,R4E!I-)'J9]2(!E%&CE(\J)E!2MA-=_M+O.[(]Q)W::[=3UT
M 8S5+3,2'9;-=%;E/J6X\^AEM+BUN%HM2E$G4S470S/M 9#<2*U&*$TPVB&E
M'=)CI0DFB;TTVDDBTTT\ #@JO@*8;C*BLJC,]WW3)MI-".YZM[4Z:%LT\73L
M\ #XNLKG)S=HY#879LH-IJ:IM!OH;/75*7#+<1'J?0C ?/5=85@=L4)CUJ:.
MZ.=W2/*.[^][S3=M^+4!Q]3U!JD+.!&WRUH=EJ[EO5YQH]4*</3QC2?5)GV
M.9UM<K7=$9/<\4I6K:.LA.FCI]/GEH6BNT!3K#C"!;\BU^?VD]QY-07>U=,A
MB.RPB:;*HYR7G4-]\\HFU&EM+B]K?W) JYS8$&Q:)BPBLRV$J2XEJ0VEU!+3
MU2HB61EJ7@,$<3K:Y4]-JJ&P=FAON4S3;0;Y-&>NPG--VWKV:@,H
M
M
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MQ,)==::(D-/R?X5UI/S.B3/770LMR@@
M
M
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M;EQBA.&XI#*V8Z-$O:[725KJ1%\>I6S@0
M
M
M
M
M
M
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M)274P&8 P[.VJZ6+Y=;S&8,/O&V2?D.):0;KZR;;01J,M5+6HDI+M,ST 9@
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M_%)9=#,!.
M
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M.SJ>I'H6FCV$2GKXEM+\OM6(S+4Z=M2WW\A#9)<=VH)*4[U$:M$D1%J",X
M
M
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MBG$$N.<6/K&92VH]R^^?[LU;2\4F^O@ ;1!
M
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MA./FC60W"D+CF^C8:M$+4VK;KUT!%I
M
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MQ:/A&$X_B,;3NZ:!'AJ6G[MQILB<7]E:]RC^R"+$
M
M
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MDM(6AY"'D)<2EQL]R%D2B,B4DRU(_ 8#O
M
M
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M9ZGIV@Q7@
M
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M1D25=.I:&?0P'!BO@13:.-%99-AON&#;;2C8UJ1[$Z$6B=2+Q2Z ,D
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MPU23A)DLJG)03RHB7$&^32NQ9MD>XDGX%:: .X
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M(,<JH4Q%/D[*8MHRY,<<44=#ANI;84HOR9;CU,^IGX0*LK).&^/<LHJ+'KF
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M63I%KM-)F@DZ=$_'U JV VA#33;+220RRA#32"[$MMI)"2Z]>A$1 .0
M                                         E<=_P!9)_ZBO^@!;Q%
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MZ7QCD6(3FJ"^SK,,TR.+928OEK;#<V/+2E9L*6WO4<9I&S<HM.FO9H F7?:
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M90\K<F<B8Y@5-26L"FR._@W]G=W;]<J0VJ/0S506D(B+<1M.0>BG=3U1X"\
M"GX7F?(M5QKAM#@UQ#I8E;@%EETM4N F>I]RKF;>Y3JXC9WN_0U==I:GH9Z
MJ6G<J\A*Q')VLP=I\B:M./X.?5T-VK2B'$\N?-LX+C+CKI2&TD1'O</4S\ (
MD<UY8Y/Q^PS.UH[*NC8MQ\6*K70*KDJ7.;OD,(=:*03J>Y2@UFI)I09]A="+
MJ&;D.>YI1P^2IF'U\.$]6YC$K[>YKZI,J5$J'8;+LBQ>CMFE4QUK<23W'KLZ
M]B0$?=.93E7)/ EQ59O6VCLR'D+D:_B59''=[IILY"R94_JE3K.QA2-Q&TM*
MC\.T@LE5R%FSD+D?-<FS.OHL/QJXNL;JHQU"I2VGXLM#$60ZIMXG'E$:MA,M
MI+>9EU\ #6.59OG>=<;7]/8WA.RL<R[&X[=M.HSJY,AJ:MAU"'J]U>K2F7UI
M5KK^40G3L5J"MBYCR#RS7S\NB8]=5IEQ+1U]KDYRZ_\ U[+E,.RG4()+W^:M
M]RP9IV&I6\]-3+J1%APW,,^SWE/(FJ^[BUN XX5-(*G57I>F2V[BI;F&A4DW
M4]WL6O74D&9]G9VALCD#*?H1@^19>3)25TE=*GM1E&:4NN,-*6A!F1&9$I1$
M1GX 1J.=EG,N'8)%L[^[J+C(,RF4=7C"VX"XK5;.O'-CR7DI=43S3!*(VE=%
M*,O&Z'H"H6UY2Y4I6K# 7+>ODYU4YA08T>3>K]D5^#DK!/-.KB$[HEQO=HHD
M+TZ%I\(#*SO+.9\>N;7'JC*JYQ_$,*3EMG+D5"3.SELR9:5M)0E\B80XVRE)
MF2E&1]G:>@8-_P T\E6K&39CA[T"NQS :BCN+*CF1O*'+5=Q"18OM>4[TJ82
MTPXDD&E"C4OMZ=@HN%?FV8V?(F<S9.3P:;C+!TPY#\1^O)Q]UB=2MS36[(-U
M)MI:<7OT2@U*(C3TZ -07G)>:9A@?*F+2\C*Y@-8HB]A7,G'W:)?<//N-O,-
MQGUFIQEYE)&U)U\4U:]3+0%6?)^3LZPF'AV HRB/%NG,><R"5D#>/2;%,A"7
M4LPX"(4(W3929&:77U=/%(RT,]ID;TQ+-7[KC2NSVZKW*V4[5^LK*N4A:%M.
MM-&MY"4N:*TW)5MW==- 1I:BY'Y7GHQM.0V]=Y-RQ07%CCC42#H=%*AQ$RV$
MK4ITSE-J9<\;>23WEIKIVE:\QG%+Y["?9YA,VE6W#M+.1+3&73,N,DX<!:D+
M?0;A)>=2AMQ'>J(E&I25]J.I5_J>0,NFVGT!PSU5B]WE&<9;#3=,5C3C;$+'
MR)QQYR.E;:7Y3QFA*G5JU/J9EX2(Y\F\N\D8E=0,(*ZA0,FK<<]?64V'1SKA
MBULE/N,L04-,;E16G.Z4;CZCZ&HB3H L]!F7)F><@UL*NLXV,8\QC^/Y/;TT
MBO\ *YKBK13IOPN]6MLVM";-!K-)J2>FB>T!N/(&ISU#:,U<I$*R<B/IAS'6
MBD-LO&VHD.*:,TDLDJT,T:EKV CRSQO<\DX[PCQ/48]D,*/,S"V16P9;]:EQ
M%?7+BRG5-FV3I=^X3C6\G#-&NNA].H,EHS+E7D3$*SEF(=C$FVN TV,OP+ X
M:6DO3+%*RF.K:)9D1.*1N0C=HCLZ@B<3GF:+YRF89<9#&QNH7TQBCE52G4W,
M4X9*5)CV)NI2;S3ZO'C[?FEIUZF U7A&;YGQCP;!G*O8SOTERM^@J9":E;QU
M)NV4]<Z8IB.M3DQ2B:4MIDDD:3T3XQ JPO<]9FU@L&/*L$P[N=D\C'(^9+HI
MQF[51HA32L6Z<T$\;BB437=$1H)6X]= 2C<7"N:W6=88JQR!E2;2#.EUBYIQ
M'ZYN>U%7^1F-QI!$XVEYM2%&A78K4NG80ET<M93E%;,Q##<,FL560YE9.0D7
M,J.4QN'&AQ7);RTL&I"5N&2"0DE*TZF U[@?+7(-GD/'E%>S8<KUW=9?47CS
M$7N">1CS2CC*:+<?=^,G57;J70! /\X9A.XDQ;("RUJISF>S=SY<&!CSMTY*
MCUDUZ.VLVVEZ16$DV277EDKJ>I=B@*+=19[R3F^78G$K[J#0TDC"Z+-;]@H'
MEKK[DY]TI$=A:W4]VA2$:$L]QIZ:$?4!KZHR+,LTS_B3D3*YL.3 R&!F$['Z
M%F(E":QE,(D=TZ^:S.3O;)O<:D(T/4NI&"LBTYBNZ+B'#9V-7L/',C^C;V0R
M,7J<:78,.1V]W=&KN%I;@15+0;9NFGM/4NB3 HDLUY?Y6:;R#(\>M*ZLJL6Q
MK'\GE4[T'RLYCML3ANQR?[U)MMEM/QB(U=FFG4P1ZACN^41VGR+;WJ$KV]NF
MXM= 1H?DOD3D=K(\U8P2?7UM7QA21[^ZCSXARUVKLEM^3Y,2R<1W+9,QU>.C
MQMYZ=G85F8EFN?<A<G63%/<QJC!J2#CUN[5NP$R9<IJ]AN2%,^4&XGN]IH^<
M2#,!9N6<JR>KDXEAV&2F*W(\RLG(#5Q+8\K;A1HL9R4^ZE@U(2XYM;)*$J41
M=0%9E9MR3C63Q<0R"PKYM@SA=Q>S)<.*IIEVP@24MQW"2M9FDC;47>(UT-6N
MFA:$055?+G(+\CC"397\3%<<R:AK+&1>2:HYD"PNY:B-^O<>)U!0_P GHIM1
M]IF?7IT#$J,ARCCR_P#:!SZ1:1K"LI)BGD4WD),J>F+A1U0C5(2YN)#2#2RM
M))\?JO4C/0!DWG+O*G&4/)J3+)E=DF3)QZNR&@G,1/(6([]I9(J51GD)<7WC
M;+KJ'$K\4U)(]>I^*%4G/9'B-QS4O)9%;EV1M3<!9DS9E6TB%(3)=[I!G"4M
MQ!+;2OQ5$OYQ$HM#!5ZR;F2^K>8*JFQW)6KC'9&10\7M*(J-YJ)$=?;,GR.Y
M-9MN2FE:*[A)%T/0^J5 E'3B7)_*#^88U+NK>!-Q/)<EOL812-0.XD1VZHY1
MLR/*2</<LS9(E)V;=O\ A'J0>DP1YMPKD[E!^[Q.\R*V@3\0RW(+C%TTS$#R
M>1$7 7+*._Y03A[U*.-M6G:223\*NI%:XP3E*\Q+BCC+"<<MF\<=EU5O<RK9
M5/*OU*)BT=:9C)C1$J4DG5J4;CRB\4B+3J>AE7?/>>,I:P:@R&JN#QG,%4#N
M06V)%C\FW<4;.Y!'(=WI\BBK=;4@G'"UZD>NA&"43[W)F>2.4L=J;2YAX=BE
MQ$J)%&S)K538]\],03DV,B=WB"C/MF?=LH/4U:DK0]2(P@:#GW+[CD>.AA[R
MS'9N3/XPK%6*6;OB5[3CD=%HNUV]R:N]0DW6>I)0KX2,R%&V.7\KR6C8Q?'L
M/DL5^0Y?<LTS-K*9\J;A,=R[(>?)DU))Q9):VH0I1$>[MZ 0U=CO(&5W%QB,
M#+?5=Q;QL[R#%SMCKFT+;15PW20_%)2EFPM2D>,:3UVGM,!TP?: S1-'!GV)
M1"M<;QK);K-J\FO%>L*B:=7#82I)ZL]X^E3BOA1X *+-P9RCEV69+-QS(IIY
M!#74L73-ZW23*%F++6[W4BNTE)+OB02VUM.I^<G=KKX!+?0(          "O
M9UB,//,0N,.L'W8L*YC+B/R(^WO4)7IJ:=Y&6O3PD PLWP"NSG )_'L^4_&K
M9\9J(Y+8V=^E#"D*(RW)-.I["UZ (>;Q.M6<2,SH\KMZ%JT=AR<AIH*F#B3W
MZ]*6VEJ[YIQ36]M"6WNZ,N\21:Z'U!4(Y[/]:K*4W;62VC-$UDB<T:QA)1E0
MBNC5N=<-Q31O&A9F9DWWFU)F9E\0JRHG!L%^ZEVN89+;9='<KK"E@0K13"2C
M0+?0I2#=CM-..FI);$J6KQ4]G@,A5/\ 'G']E@K3L:9E]MDL)#+,*MC6AQ]D
M2+&U)!%W+3:EN&1Z+=69FHB(!A\D\5O\CJ.*]EEM44$N+ZONJ.%Y,J),C&X;
MBOX9E:FW5:[3<0K7:1%H B,GX1QZ9'R^T9E63=A<OU5Q!]7&SY5!G8U&0S#5
M"[TB2:S)HB,G5:'KIJGM(55?C#AJZFTWK7/)-C$LSSCZ=U[4QR*Y8K2Q%**P
MB?Y.CN4J<3N6MMGH@MJ2/H8%6V\)PB!@[-VQ DO24WMS/R"0;^W5M^S<[U;:
M-I%XB3^;KU!$!!XF*GS27DU!D]K54EE/5=6N+1CC^02;):"0XZ:EM*=2EW3<
MZVE>BE=>@*B(?L]8M&F,VC]A,E6\AZZ7D<U?=H5<1\B1LDQY1-I3^2026^Y2
MC3N]A:>$"KHQSV>:JI6ZB]R:UR2M5C<C"H]=.\F:98I)"FC)MOR9EM7>)2TE
M/>FHU'V^ @*N]/!"96"76"Y!FE[>1+-N"Q!E3'&"77MU+B78IL(;;2DUDI"3
M=6K4W-I:@56*NXXC5>5M9Y86DV[O&,:1C$M,A#&V6TU(5+4^I#:$%WKBU&6T
MM$:=- $'[..!2./.*ZZIL*\ZNWG2)5I8P%*):F7)3Q]TVI1=JFV$M-G\:0)<
M.0.!X&<VM[81\FM,>CY7!CUV4PJTHQHGH@[O)U*4^TXM!I):D*[LRWIZ'X=1
M5G7G#R<BRRMO;?*;61CM580[N'BBO)R@M6-:V2&%MN$T3R6R,MZFN\T4HS,^
MAZ 56;-<(@9NW1-3Y+T8J&Z@9#'-C;^4?K'#<0VO<1^(HS\;3K\8(I,K@.L)
MZ3:4N0V-1DJ\EL,M@W3"8SKL61;QTQ94=#;S2VU,K:3IXZ35KUU\ +5DXWP9
M28VYB3S=S8SG\1]?''?EJ:6[*5DJ^\D+D*2VG<I)]4FG3XP*N--P)BU77T52
M_,ESZVEQ^RQ549\T)3*@VZD*>-TVTI,E:(T+89 59-#P]Y#C-SA^299<93CU
MK7>I&(ED<9)18!-J:3W:F64&I[:KJ\LS,]$_  A9?"V493B-3C.89Q.8:CUR
M:*_A4Y,^0VD&.XHFWE)ELN.,R76R1WRT*[=23TZF*K3AN 2J3,,DS*X>9=F6
M#<:GH8T;<IN#0UI'W#.YQ)*-QQQ:W7NIEKH1'TU,,'D'AR+G5\61Q,ALL;M)
M%2_C=L]6>3J.942'#=-@_*&G2;4E9FI+C9$KJ9?8#7S_  !:6N73:([FTI^.
MXV*46+NNPUQ4G;QH'?I>8=)2%J09(-!&XA*?GJ26NI@5=\W@B?EW(^=N74N9
M3<;69X\PBIA+CE'N8]3%2:FG2-*W6DMN)2C5!HW)W)^,"K8*^*%L9O)RVCRN
MWI*ZSEL6=YCD)3'D,V;&0AHG#-QI:VR=0VA+Z6S+O"(M3(^H"%C\!5\7)H=P
MQDUJG'ZV^<RJMQ;2,<!FRD]X;RMQM=Z:5&ZLT)[S1&Y6G:!5-P>*E4N Q\&Q
MK)[2E<B39%C&NHO<')[R5+>F*;<0XTIM;6YXTF@T]2(M0$QQY@<#CRA=IX<M
M^QE3)DFUM+.7L)Z5/G.=X\ZI+24(3J?0DH21$1?N@BN-\)43:HZDV4S6/F;_
M " G7NNLZ3WNZ/\ ,_@2[T_\+XP6K(Q#B4L*NW)%-D]JC#TN2Y$##3./ZMC.
MV"U./$2B:[U39+4I;;9KT09^'J Q_P!B5&GC2@XY8M)T<\6>8FT%^T;:9\6=
M%6M;;Y>(;9GHXM"DFC12%&7Q@5?;7A]ZZQRI@6.7V[V7T4Y=M59B?DQ3F93I
M*0M)-):)GN%(6:#9-&FWH ^T'"./8]+P^PC6$U^?B<JVLERI"FUNV,^]96U*
M?E*V$9J/>:D[--.A=@%79A?$+6#1\3KZ?)K;U/BQ69+K%.-)C6"K5YQ_=*0A
M!;C94Z9MZ::=/CU#-Y#XT/.)=1;UV166+Y%2^4-Q+2J4C<<><E*'VG&W4J0H
ME$A)I,RU0HM2 0,_@.C;IL5KL/N[/%+'#XK]=5W%>MI<E<*81>4MODZ@T+-Q
M1=X2MI;%^,G3L JY'P!B#,%JKK9,N#6L8G/PAIALVU&4.T4E;L@U*1U?-1&K
M7YIF9] *N^9P9C<\I:)<^8MJ;A[.!NH(VRTA,*6M,@CV?PVJ_P#J_P""!5=<
M.H)>+XW7T$ZWD7LF"V;2K28EI#[J24>PC2RE"2)"=$%H7874S/4P10ZC@:CJ
M,LCWJ+FQD8[6V,F^IL1>4T=;"M9I+)U]O1!.&1&XM3;9JVH4HS+M!:L-SV;L
M)=C/Q%29?</YH6?K3^2T\L(C+R3YG_A]%*+3YW7YP%4KDG"5%DJLW5*LIC!Y
MU)I9D_NNZ_(+H.X[DF=R#Z+[A._=KV]- *LF/Q-ZMS:5E-!D]K3T]G.3<W.,
M1#CE!EV)(2VIU2EM*<2ETDEWR$J\<^NI= &3#XP:J\:R+'J6_LJI_(+>;?';
M0U,HEQI,^44I2&MS:DFV1EL,E),S09EKUU 9?'?'L? (5H2K.3=W=[.<M;JW
MFI:;<D2G$(;U)MA"&T))*$D24I!$/-XB.VS:#E-UE5M9T]78^O*O&9/DYQ(U
MB32FD+0ZEI+W=H)9FAK?MU[=>H*PJ/@3&*9C"8JI\N;%PEF\C1F9'=&B8UD9
M&4A,C:@NB249(V:?'J!5C8W[/>/TIR6;>[M,BK$TTG%Z2!9.-&W6TTTMKS#)
MMH2:E&DDM]XO51(22>P@*HJ#[,U8U M(5MEUO;JL<;3AK#TI,1)Q*EIY+K*&
MB;93JI&W3<O=NU,S JS,W]G*FS*9:NMY):TT#(HE?$R:OA>3*:L54^A1'7#>
M:6I*DI(DJ)!D2B(OCU%6T<KQBHS3&[3%+YHWJBWCKBRT)/:O:LNBD'H>BDGH
MI)^ R(P10E\+R++%)^-Y1F]W?2WWX4NKMY1QD2*V15K)R,ZP3;*4FLE$1NJ<
MW&YX=#Z@M6&7L_U\BIN&+?*+:SR2UMH61M9,]Y,B;$MZUI++#S"6V4M$E*4[
M";-!EL\7XP*IVLXH1&M</O[C);2]O,2<M7D39ZF5'*<NFR:=)Q*&TDA#9%^1
M0WH22Z=0$UQS@L#C;":O!ZN4_,@5274,RI6SOU$^\X^>[8E*>AN&1:%V BD)
MX#9E*O7<CS&YR&5:T<W%H,JP\E[Z%6V)[GB)33+?>N&9%HMPNSIH"U4;FG@R
MUL8GJKCYVX]999!KJ.]-E<-%0MFD4VEF59+>+ODFEHUDE,8M7#3MZ?=");.R
M/A:CR1>7.2K&6R>7V%-:32:[O1ERA3'2TEO<D^B_)T[]VO;T JMF.XU+HK&^
MG2;VPMV[F9Y9'B3W$K9@(VDGN(Q)26UOPZ'_ -.IF1"9/Q1CN69._E-FX]Y;
M(QZ=BCC2-G=^1V*MRU]4F>])&I*>NFBCZ .JMXEHZIOCMJ++D$WQPTZS6I/N
M_P#.>_@J@K4_HGM-*C7XFGC?$"J\WP!!K:+':_&<IM:*\QE=F4"_B^3JD.1;
MN4J5*COMN-FTXC>HC1JG5"DDHNH%4W8</UEG/=LYUS8R9K^)2<'?DOJ96\Y%
MEK2XN4M1-I(Y!FGMT)/^"!59Z7%6*/"J_"84V2W%K:MFFCV*%)1,2W'CICI>
M2HDFDG2).XCVZ;O "-:2O9T@7-3D</*<LM[VWR)BN@.74DHK<EB!42TS&&D$
MTRE"C4M/Y1Q:34KX@6JN<E\07=CR#7%AB[ANIOKVLR;*&C<AHQYERK<03KRM
MY')5(<0TV266_%4KQU*T3T"^*X.H5*0KUG-U;S8^1"_@O_'FDT^3_,_@.O\
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M)J+.CNX&SRB+*;2ILSVN)4A:%H6I*VUEHH@%2O."$746E,LUOHU]60)U//R
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M$B0J ]N,W";UU/<E)[?&+4NH%&R@0
M
M
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MY,\HO&;[ULB2O3X2!$J
M
M
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M2,C+H9&0#D ZFY,9UYZ.T\A<B/M[]I*B-;>\M4[DD>I:EU+4!V@
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MT8VBD/(:-Y9-,DXHD[W%:F2$ZF6JCT/H0#M
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M+$N\?G7WT<G4K5+*9;AJ*.XMP_6REFR[(:<01+:078KX25H&%C7-F:Q*W/\
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M7Q+,5![B@?EW-M;(;22I% ^VR=<PVWO,TO\ >/*2^K:1;4$9?.ZAO<$
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MG\G)KIAH;8DN$Z1J3()EEOO$[E)W[NID"OA^S]1JKFJX[B9L:PASCTE[6O\
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MC^:>H$&=8"YEG.?&^0G5K56XI%M)]A:*(NX6ZYW3<..1ZZFXATU/ETZ$7Q]
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M5'C,L+=7(6TA*%/NZ=XX:2(C4K:1%J?:>A CM
M!JBDX3779577]QF5UD590R9<_':6U6T\W$E3DK0M:W]G>O[$N+2T3BO$+L!:
MJ+FG![V&8%1Q\"F9!+RFFJYN+1UTZ(!OSH-JM3_=2SED3;+*'B3J\CQFR/4B
M,]#(56BBX%83C<:)=V;K5O(X_C\>6;<4D+CH0E"S<?:-224:B4XHDZ]#(BZ
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M?75GT.?^K 4/>P]GSZZL^AS_ -6 H>]A[/GUU9]#G_JP%#WL/9\^NK/H<_\
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MKT625I!8;OK*V#35L.GK&4QZVO8:B0XZ/FML,()M""U\"4D1 C+
M      !1.8^06>,..;S+U:+GQF>YJHYEN[ZPD'W4=&WM46]1*41?<D9@(_@;
MCU[C?C:LJ++5>2V!KM\DD+/<XY:3M''=ZO":"VM:^'9J"RV6"
M              #7W.O]C&?_ ,P67\F6"PJ/LA?\O6(?_,?]Y20);O!$3E']
M6;G_ $&5_D5 //OL+?V)O?SW-_R4<%EZ8!
M                               !1^9O[(<]_P"'K;^1.@0U_P"QO_R^
M8S_CK+^7O@LM\ BH<K?V79O_ #!:_P B= :O]C'^P&B_TJQ_E;@++?X(
M                                                     -5^TG_8
M5G7\V+_[Z 6'3[,?]@N#_P"@J_R[H$MM @          /.GMM_V%2_YS@?\
M?4"PW3@']1,7_FB!_)FP18@               <5K0VA3CBB0V@C4M:CT(B+
MJ9F9]A$ \_\ !2%\DY[F?/DU)JKISJL:P<ED>B::O7^5>01]G?NEN^%*B678
M8++T$"                //69?_ &6O:#Q_ 6_RV(<:(;R;)2[6G;AXO\PC
MJ[2U0D^]T[#2:TF"O0H(                          #7W.O]C&?_ ,P6
M7\F6"PJ/LA?\O6(?_,?]Y20);O!$3E']6;G_ $&5_D5 //OL+?V)O?SW-_R4
M<%EZ8!
M   !1^9O[(<]_P"'K;^1.@0U_P"QO_R^8S_CK+^7O@LM\ BH<K?V79O_ #!:
M_P B= :O]C'^P&B_TJQ_E;@++?X(
M                         -5^TG_85G7\V+_[Z 6'3[,?]@N#_P"@J_R[
MH$MM @          /.GMM_V%2_YS@?\ ?4"PW3@']1,7_FB!_)FP18@
M          :6]I;*+.!A<3 <85_^N?(DM&.5*"/0T,2-"EOGIU)"&E;5*^YW
MDKP L-G8=BU9A&+5&)4R=M;3Q6H;!F1$I?=IT4XK3[I:M5J/PJ,P1-@
M          K^<Y=6X%A]UF-N?^84T5R4M&I)-Q:2T;:29_=.+-+:?C,@&NO9
MKQ"RH\#<R[)BW9KGTIS);UU1:*3Y89KCLZ'U)*&U$K8?S5*40++<H(
M                    #7W.O]C&?_S!9?R98+"H^R%_R]8A_P#,?]Y20);O
M!$3E']6;G_097^14 \^^PM_8F]_/<W_)1P67I@$
M                                    %'YF_LASW_AZV_D3H$-?^QO_
M ,OF,_XZR_E[X++? (J'*W]EV;_S!:_R)T!J_P!C'^P&B_TJQ_E;@++?X(
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M .8_[RD@2W>"(G*/ZLW/^@RO\BH!Y]]A;^Q-[^>YO^2C@LO3 (
M                                               */S-_9#GO_#UM
M_(G0(:_]C?\ Y?,9_P =9?R]\%EO@$5#E;^R[-_Y@M?Y$Z U?[&/]@-%_I5C
M_*W 66_P0
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M\E'!9>F 0
M      4?F;^R'/?^'K;^1.@0U_[&_P#R^8S_ (ZR_E[X++? (J'*W]EV;_S!
M:_R)T!J_V,?[ :+_ $JQ_E;@++?X(
M                          -5^TG_ &%9U_-B_P#OH!8=/LQ_V"X/_H*O
M\NZ!+;0(          #SI[;?]A4O^<X'_?4"PW3@']1,7_FB!_)FP18@
M         !YZ+3EWVDS5_#87P^QH7A:>R6>77XC\G0G[*'$?X0*]"@@
M          #0?M'SY>62<4X&HWE-V6=S$NWKS1^/&H("N^D+/X#6:-$:]%;5
M)\(+#>D"!#JX,6LKF4QJ^$RW&BQVRT0VRRDD(0DO@2DB(@1D
M                 -?<Z_V,9_\ S!9?R98+"H^R%_R]8A_\Q_WE) EN\$1.
M4?U9N?\ 097^14 \^^PM_8F]_/<W_)1P67I@$
M                                  %'YF_LASW_ (>MOY$Z!#7_ +&_
M_+YC/^.LOY>^"RWP"*ARM_9=F_\ ,%K_ ")T!J_V,?[ :+_2K'^5N LM_@@
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M>F 0
M 4?F;^R'/?\ AZV_D3H$-?\ L;_\OF,_XZR_E[X++? (J'*W]EV;_P P6O\
M(G0&K_8Q_L!HO]*L?Y6X"RW^"
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M 'G4GX"/Z* X'[.?;A_O.I/P$?T4!P/V<^W#_>=2?@(_HH#@?LY]N'^\ZD_
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MJ#\U'_HL#@?0WV[?K]0?FH_]%@<#Z&^W;]?J#\U'_HL#@?0WV[?K]0?FH_\
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MQ;+EM4QC8E+BJ4MDU&ZM?B*4E!F6BB[4D#%>@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                             &#,NJ>O=)B?8QHK
MYI)9-/O-M+-)]"/12B/3H Q_I1C/_K,'TIG\8 ^E&,_^LP?2F?Q@ \IQDBU.
MZ@$1=I^5,_C )1"T.(2XVHEMK(E(6D]2,CZD9&7:1@.0
M
M
M                                              ZI,F/#8<E2WD1X
MS1;G7G5$AM*2\*E*,B(OL@,>NN:BW)PZFPC3R9T)TXKS;^S=KINV&>FNAZ:@
M,T                    !^<'MW_P!M$'^8(?\ *98,X>804  '[-<?D18'
MBQ$6A%45Y$7_ /;-@UK&
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M'B@
M       #6/M%$1\'9WJ6O_E,@_M$0+#SM_\ 0]4I*#R"K0MQNU)&KPF1)F:%
M^^"R]K@Q                    ?G![=_\ ;/ _F"'_ "F6#.'F$%  !^S>
M ?U$Q?\ FB!_)FP:UB
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MWNP9;=[&:^_O+<]MN2RZE/FSRBG93_?SJV@.%\8
M                                           \I<Z>UQ=\1<B3<)A8
MS$LXT5B,^F6])<:<,Y#9.&1I2@R+34&40TMGOML7V=X;=X=)Q*'$8NHCD-<I
M$MU:FR<+3<2301&9?9 HH' _M$6?!3%ZQ74<>X*\7&6XJ0^MCN_)"=(B+8E6
MNO>_O LPW#_]T%R;ZDP?3'OT8)1[OBO'(C,OF6TW4)69%U(MQ$8,7:
M            /S@]N_\ MG@?S!#_ )3+!G#S""@  _9O /ZB8O\ S1 _DS8-
M:Q
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M$1%^[VF.;<9N]NK2D1PB/$^=ZYU>>HYXOBW199;%EEOXML<H7 <SP
M                                                         %>M
ML"P6_G*L[W&*FTLEI2A<R; C27U)06B2-;K:E&1%V=0&K.>N../*OAK-K"LQ
M&EASX]4^Y'E1ZZ*R\VLB+12%H;)23+X2,%AH7V$<2Q7)X.<JR2BK[E49VL*,
M=C$8EFV3B96XD=\A6W7:6NG;H"R]?_LHXM^I%!_LJ%^B!BMR4I2DDI(DI26A
M$70B(@'T                  >0?:>]FGD;E[D2+E&*.5R:QFJCP%%-D+9=
M[YIY]Q7BI:66FCB>NH,HEI?W%N;/XZD]-=_5P6I[BW-G\=2>FN_JX%3W%^;/
MXZD]-=_5P*OT/Q6MDTV+TE1,V^65\"+$D=V>Y'>,,H;5M,R+4M2Z= 8)<
M
M
M                                                           4
MWEG%K+-^-LFQ*G4TBTN(#L2*N2I2&2<<+IO4E*C(OL),!J?V4^#,RX4C94SE
M[\!Y5TY!7$]7.N/$114ODO?WC36G\*G337P@LR]% @
M
M
M
M
M
M
M
M                             "!RO-<3P6O:M,OMXU-7O/)C,ORUDA*W
MED9DE/A,]"-1_ 1&9]" 9<_(Z&K16N6%C'CMW$AJ%5+6XG23(?2I;;;1E\Y2
MDI4HM/ 0"NTO+O&N1&\5+DD26J.J,V\E)J2I*ITA,1@M%I(S[QY:6TZ?='H
M[;/E7CFEAQ["VR:!#@RYSM3&D//$AMR;&<-IYM*CZ&3:R-*U_-2?:9 ,E?(V
M"MY<>!N7\-&8$2?_ "=;I)D&;C9/)21'T-1MGO).NIIZZ: +.
M
M
M
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M56"4%L.(HE*V$[M6I!)-*MP#V@#$
M
M
M
M
M
M
M
M
M
M
M
M
M
$  '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>px_25avadelpxy03pg02-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 px_25avadelpxy03pg02-4c.jpg
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M_\0 U0 !  (" P$!              8'! 4" P@!"0$! 0$! 0$! 0
M      $" P0%!@<0   & 0,"! ,#"04#" 0 'P ! @,$!081$@<A$S$B% A!
M43)A(Q5Q0E*2E196%QB!X3/3U)%B)*&Q<K0E=3<X@D.S-'3!T;)3<S6U-G9C
MDX3$)J-$)Z+25&24156%I4=WAQD1 0 " 0$&!@$# @4# P('   !$0(#(3%!
M$@0%H5)B$Q05!E%Q(H$R\$(C,S1AD;%RLG.24]'QPM*S1!;_V@ , P$  A$#
M$0 _ /?P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M9>*5$?3P(B;
M
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MS1<TV0< \(U- ^U(M;.QQ]NICLK2;J5Q8:HSI$23UU;<6EI7R4>@$(9RK?\
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M*R'C687,J:Q I,DS"86.)E+1&*2I2&]"82X:=QJ+1))3U\IE\ )>HP0
M
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M[;9J4E:TK))^=*U(2I9J\RE%KKU/46L@$
M
M
M
M
M
M
M
M
M                   !3&9\]L85SCBW$UE6H_"\EB,NINC>,EM2I3TAAEKM
M;-#)3C2$Z[R^O[.I:=E/SQ"6GE2?DL%-=2\:3EPU/L.&\[+0@E[=$*)!)6M2
M4I2G=IJKQ I#L,]SV2S\FQB#R!@;V*8IG:MF(7BI'?)U;FWLI>3L3IW=Z-JO
M+]1'H:3W$*:B;[E><(.7Q,$?X@0G*K".Y-@5QVJ#6[%:-9*<)1(V:%VU>*M>
M@%)#F//_ "72YU5\>8QQVB]R:711;V=!_$$L.1G'MQ/M;E(V*)I1;=V[J!2X
M>/+S+,BQ>-:YMCW[KY XXZE^G[Z9/;0A9I0KN)Z'N21*!%&YU[BN7\+S:/B*
MN+$/_C5A+@8I(59H0JR;BN$E+B4DA1(W)6A>BS+3<"TEI<V95 S#C/"\EQ1N
MJN,Y8F.VD=4KN+KUQ-YI2G:@TN;B21^)::@4WW'W+$K->1^0L$>JVX;.$OQF
M&9J'C<5)*3W.JD&DB3IV_@9^("/81[AF,TY;S7BZ)5MH<QEN2JLF)?-2IKT!
MU+#S9I-)$GSJ\NBCZ$9@4@:O<MSBG+DX$?#Z"R]</\236?BJ-YP]QI[N[9LT
MU+33=J"T])VD^^8Q25:5E:B1DC<%4F/4..;4.2TM;RCFXDCTU5Y-V@,J)<]U
M33W#E%R!4T*9N87MN6.Q\63(,C*Q)9[D]S9KIV]BR\OBXDC!:<\X]Q^85636
M^+\?X*K+Y.'1&Y6;S69)M1HSBF]ZV6#V&I9I(E==-QFE1$@]IF!3:9#[E(,;
M!>/\[QBK*Q@9O;,4[D>2\;+D-;BEH=)6U*MRFUH4GX$?CX&!24R^6)4;G>!P
MZ56VJ),I%72K8WC)Q*B6ZCMDUMT,ON_'=\0%D3YL:M@R;&8OMQ(;3DB0X?@E
MMI)K4?\ 81 BH_;SSJCG.BN;)VL13SZB:49<-MXY&L=YLEM.&HT(T-1DXG33
M\T%F%8,>[S-$-7>12N,GI?'^/V3M5;7M?-WJ86TXE.IMK:(C/1:#T,R+S%YB
M!:3'D'W"Y/49CC&)\:8@C,EY51M9#7+.7Z)Q3#INJ+1*T&G0FVR7U47CH"4M
M+C7(<SR;&_Q+.\9_=.]]0ZU^%>H3*^Y02=CF]'3S:GT^P$0_W#<X%P;C%9=,
M5B+BQM)Q0V8+CQQR[2&EN..;B0L_+HA.FGYP+$,GF#F4N..+(_)E-7MW,>8J
M$<:.ZZ;"5,3T[TKWI2O\TR^ %)?FN<5N"8+9YW<MK7 JXA2W6&=#<6I>U*&T
MF>A:J6I*2,^G4$5CQ9S3R=F=_50\JXQE4F-9'#594V01I*9<=N,2"<0<GHG;
MW"4DD_2HS,O)IJ9%I%LD]UV01;._ML/P%_(.+\2F_AU_DZ9!-*-U*B0XIA&T
MR-*=2,O'RFE2MA*("GHZ@O*W)J.NR*G=[]5:QF9L)[30U,R$$X@S+X'H?4O@
M"/-EQ[I\[KLDS6+6\:+N\4P6PD0KJVASC2XTQ'<6GO*0;*M/*VI9D70B\3(N
MH+3?9W[D[2N7Q\GC7%BRQ?(41Z96QWI/HGTFR2#-LRVK3N3N42]5:$:?$P*9
M\WGK*<*XUM<XY5PAS';=F<W6T6/LRT27;!Y]!*1M<21D@M26:NAGM29D1GH1
MBGWCWG;+KNXO,2Y"P9_%,KK*M=Y#;[AOQ9$4DF9(4X2=&UZE\SUT47E4G0Q2
M-\<>X7F?D9%-;U7%"%8?93$1G[MNS0:6F4O]E]TFUH2H^WHH]-.N@%)%-Y]N
MT6O+U57XXS)?XRBM38^LE9'-;4A3KN\B;/9M0E2BTUU ISO?<)(B83QAD=%2
M-3[GDB9"@LUJY"D(CKDIT?,EI;,U]IPR1])=.O0"F?%YPFR,RY4Q;\%:)OCJ
MN*QCR>^K=,5Z8W]BT[-$%J6FI&8%(=$]U_XCP@?*L*B97<1;=JDLJ14E1(:6
M\LC2M+G;W&2FU)47D\=2^ %)3RGSED&-9I$XTXTQ->9YRN&=I81N\4>/$AD>
MB36H_P Y7VFDBU3XFHB I+N'>3T<KX@61+J)-%9QY#L"TJY:5:M2F--Q-K4E
M&]'4O-M+0]4GU(P)87/'+:.%\"7ER8*+*:Y+8@0H+CILI<=>W*5JHDJ/RMH6
MKP^ $)?A.3Q<UP^BRZ&DFX]U!CSDM$>[MF^V2U-F>A:FA1FD_M($5KRWS9?8
M=EU-QOQ_BRLMSVXBKLO1+D)B,,PFU+3O4M70S4;:^AJ3IIX]2(%II<J]P^58
MKP]#Y'M<"D5>0.VR:5_';-XV#W:.$;S:R;-1H-2-J=Z$_'Q3HI0IL\>Y6Y?7
M5Y5<9YQJ6,0*"DF6\)Y5@W)3*DQ$=PHY]LC-)*21GNTZ: (3B'NTR&6YC5EG
M_'[V/X1EDE,&IRF/*]3&*0M1H3O0;:=$[DGJ>XC))&9)5H!2=95[@H>,\\8[
MPTJN0['N66O66YO&E<>5*)WL-$UL,E;C0WUW%]?V=13IYEYORWCW-L:P;#L0
M3E=QD<9^3'C^J.,[NC&I2DI+8HCT0E2C,S B$BX:YDC\KQ+N/,II&-Y7C,HH
M-_12UDZMAQ6[:I*]J-4J-"RZI(R-)_#0S$PAW%_N0E\K1.0DXWCR'KO%"4[0
M5R)76T:5WDLF:E(239J4TDE>)%O("D;Q_P!R'-%]FLS!F^)D(NJ=<4[Y@K1!
MKAQY9H-+AZH)*O(LE$25&!3/G^X;E>=G>7X?@/&:,F9Q&:4.7,18ICJT<W]I
M2DN(+JOMJZ),_ "GH6AEV,^CK)UQ"_#;>5$8?GUV\G?327&TJ=9WET5L49IW
M%XZ CS&7NQSAEO(,C>XS5-X\QFU?I[>\@V"#=96RXE&[LN-D9]%H/X)\WU$#
M5+1>YJ0[RO@V U->B719K2N7T>Y4ZI#B&B9>>;(F=G7<EI/BHOJ^P$IE\@\L
M2L*Y'X]P1FK;F,YL_)8>FK>-M48HW;ZI023)6O<^)EX -4YS?.1R%R7A/X*T
M;& TA74>9WU;I:SB-R>VI&S1!:N;=2,_#4"D5XRYXYEY%=Q^S9XK2QA-S(2V
M[D#=DA:6HQ.FTZ\32DI6>PTJZ:== *6]RKFKW'/'M]FT>&FP>IHY/HAN+-I+
MAFXA&AK(E&7U:^ (J+ ?<W?VV18O1<C8)(Q.'FZ$KQ2Z1(]5%E*=0E;:3(VT
M&6\EHT,C,]5)U21'J"TC[ONUS>-,R>P+C)VQP?$K.15W%U!FZK9)AXV]YMJ9
M\=-%&6NA:]5%X@4G6?\ N'56'B%+QAC[F99AFT!%S45W<**AJM6@W$O/&KP-
M1)61)U(BVJW*+0B4*:R-[D[FTXKRC,ZO$C1FF"RBBY=B4N0I"X[:#,G7FW$M
MF9I21*49*06FQ?CH1J%-Q7\^OYAG6/8=QY4,VK%ICI9/:63\G8B"A]LU,1UI
M;2K[PUFVA>I^7?X=# I'6_=6TGA:QY&F4!,9=7W'[MKQ8WE:JLS62B02^WN_
MP=R_H^I*D_:!3T%2/VDJFKY-W&;A7+T=IRPALK-UMF0M!&XVE9D6XDJ,T[M.
MH(\VV7NRO"LK*]QKC^7=\24ED5-8Y0P\7><D&M+>]ADDGJG5:=I&?FW)W*0:
MB(%I8_.W-;'#N P\RBP$VLBREQXD"$\XJ-O)]M;QK5Y%*+:A!]#3XF6H$0Y\
MA<S(Q'A1OF"HKT6;,B+6S(\%QXVDFBR6RG0W$I4>J"=_1\2 I%N//<9>W694
M^#<DX/(PRTR6,J7CDPY!2HLM*$&YMUV(V&:2Z=3ZZ$9%J0%(=%]X.3L*M+VX
MXX?7QU36SE+:9)72C>..ZVLDZJ:6TDC/1:.AK26JB+=J9$"T]3UMC"MZZ);5
MKR9-=/9;E1)"/I<8?02T++7X*29&0,O-$#W'\QY-;Y'"P;BI%]7X]:2:A^:W
M9H9U<CN*26J7$)/4TD2NFOB"TWF=^X;,*S+'\&XZP1S+,CHZ]JSRUM,CMMPN
MZVASL(-*3[CA$LO#KKT2E1ZZ"G+)O<_#B<)5',&*TQ61V4]JK?II+_97'DJ)
MPG$*6A"MQI4V6T]I;DJ)73P IM.,^>KK)<W5QKR+ADG"<S=AJLJUEUXI+$N.
M@S)1H42$:&6U1EIN(]JNI&6@%)'S)GN>\?U46VPK#BRR,A$I^Z4<M,0H<>,V
MEPEGN(S5N+?X%^;]H$*\P?W#\B9/A.0\B6_'S=5B%;13[JILRGDZW-DP%;?3
M[=A+02MKGF-/3;]H%-E<>XFPJ^.>-<Y30,NOYY8Q:Y^$<E2412DFLC6E?;,U
MZ;? R("F+F?/G)-=RK?<98#QZC*Y%'&BS'GRGIBK[,EEIPU&EQ&TM%.[>BC^
M8%+IPNTR"[Q>MM<JI_P#()+9KG5'=)_TZR6HB3W$]#U21*_M!%$VON6SB9DE
M^UQUQK*RS#,3GG575JQ(VRG)"%['/3QTH4I1)/J6A*\OF5M(P6DLY5YQML.M
M<=PK"\5?R7DC)8YSH]$XZB.46*@C-2GUD:BUU0M)$2MOD49J\-PI&++W1S87
M#4WDE>).P\AJ+9%%;X_.=6TA$C=M6IM[M^9)>'TZDHC2?AJ8I.[SER74<P81
MQ@BJ;=BY; DSWK(WC2N.J.R\Z24M[#)1'VM-=Q>/V *R@>X[F/)K?(X6#<5(
MOJ['K234/S6[-#.KD=Q22U2XA)ZFDB5TUTU I.I'.ZJ[G6IX:MJE$5-O6MS&
M;+OF:D3'&EN]@T;--/NU))6[JK0"G.HYU;NN>KKAJ#6MKB4D!4J1<=X]RI+:
M65+:)O9IHGO;3/=XD8%*_P "]R'-/(D6+;XYQ,B7CCLOT;]FU:()+>Q:4NGM
M<0A1["5KX 4]%9?>.8QB=]DK3!27::NEV*(RE;$NJB,+>)!J(CT)6W370$5+
MCGN0K;K@&TYIDUZ(\JI3(8E4Z7C4@I[;B6V&>Z:"/1WNLGKL\N_XZ M-#>>Y
MK(H'&O'6:U&),V5WGTQRO8I2EJ;)#Y.J9:2APV_,:U$7U$6FH%-T7,W*E+Q_
MFN:Y[QTG''<;CQGZJ(Y8(?3.-YQ2'2-;:5&CM^0_#KN IT<?\Q\VYDY!G3>*
M2K\8LJ]ZQA6R;)MPG-8BI$1)(-)*(GU]M'4NF[4_ "D1C^Y;G&5ELG V.'T+
MRZ%$38RJPK5!+1$6:$DX:C1LT,W$E]6O4"EH)YFFGRGGG'?X.WZ?#J-%VS/[
MZM\E:F&7NTI&S1!:NZ;B,_ "D KO=J5IP7;\KQJ%G\<H[%FMGT1RE;"]2XV3
M;I.=O=M4E?3R_4E1 4F'*7.=UBF0T6 <?XNK+N0KN)^)JK2?*.Q&A$2O.XX9
M::J-"B(C-)=-3/JDC%)+PWRFYRGC\R;844K',@J);E;<U,HE&3<EGHHVW#2C
M>G4C2?35*B,C^!F)6."
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M_ PG'LMF9U(F8_/A2X\3"G$)3&BNG-41.(7W3,U?=J/3ME]9_P!I)67[G/\
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MLPQ2_.@@YD>=2(N,Q["Q8=PG8CTC[BFNV3BG#<U(R4M+FA(\4EU EZ<Y7_\
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M1]?M!)>@B,C(C(]2/P,$
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M2BT/Y@CY?\;XOD>88[G=BT\628QW2JY3#RVB)$@MJT.)3T6DR,RT/YF C/\
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ME;"]4*/0_(M0%IO$XWQ>%R%.Y/89=++;& FJDO&\LV3BH-M1$37TD>K2.O\
M\4$8Y<58>67Y%G'8?_'\IKRJ+=SOK[:HB6VVM$(UT0K:VGS%_P##,!I+'V_<
M:6W'-5Q9/@/NXG2OG*KD'(<*2V\I;JU*[Q'N/7O.$9>&A_80+;+Y,X0X]Y9A
MU\7+X#CC]41IKY\5U3$II"B+<C>6NY)Z$>BB/KU+0"VLD^V_B61QZUQDFH6Q
MC#4U%IHR^XF2N<A)MF\MXS-2E*09H/7IMZ$1:%H+6E#B1X$2/!B([42*VAAA
MLC,R2VVDDI3J>I]"+X@CN
M
M
M
M
M
M
M
M
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MHVV$1WE)2E1K66BB+=L+S&9I,C,4Q^//<5D]OFM-AG)^$.X8_ED94S%)9O\
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M]4J(R+0"4:YLYLRGC7*,4Q+$L43E5QE*)1QHQR3C.;XIH/:GR*(]4J,]3,O
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MB;/<XS-JWAY[A$K#KJF>;86;CB7X4KNIWZQW2TW;2TW;=R>I:*,]2(+(!
M
M
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M$O1WDI<:=;42T+0LM4J2HM2,C(]2,@1V
M
M                                                     (E!XXQ>
MNY!M.38K+Q97;PFZV:\IY:F3CM=K:26C/:1_<HZ__%,!A\F\287RY70:O-([
MTB'7OJE1DQWUQS)Q2#0>IH\2T,%16K]L/$M/B-_A$&#+309*Y$>M&53'E+4N
M YW6=BS/5.BO'3Q MTXM[6.(L-FS+"@A3H\N; EU;SISGE&4><V;3NTS/RJV
MGY5%X>(%I0OA; 5\7%P\<)W]R$I))1B?63Y&4KUF[NZ[MW>\W_)X 6CN9>V#
MB/.G:^7=UTE-G BL0#L8TIQJ3)CQ6DLME)7U[JB0DD[U%OTZ:Z: 6S\D]NW%
M63XG181-J5QL:QU;CE7#AON,;5O$>]2U$9J6I1F:E*49F9]=0+9_&'"& <0.
MV;V$Q9$9=NEE$WU$AR02BC&LT:;SZ:=Q0%MGR3Q9A?+%(BAS2 <N,PYWXDAI
M9LR8[NFAJ;<3U+4NBDGJD_B70@1@XIPGQMAV%3\ JJ5#F-VQ+_%FI2E/NRS<
M2234ZX9[M2(BV[=-OBG0P6VJXV]NO%G%-R_D&*UCOXRZA3+4N:^N2N.TOZD,
M[NB=? U:;M.FNAF!;=5W#V"5LFZE-05O.7]TSD]@F0ZMU/XG&>*0VX@C/RDE
MPM=I=/AX= +8[W"N"/QLWB.1Y/9Y!=2_DA%(<U6M&IEVNOW?51^ %IACE!6X
MK05F-4Z%-U51&:A0FW%&XM++""0@C4KJ9Z%X@BF[GV@\)WUQ87MC6S5V-G*>
MG2UHG/H2;TAPW5F1$?0C4H^@+;:YW[8N)N1\HF9AE$&6_=SR93(<:F/,MF4=
MI+*-$)/0O*@O "TD7P[A#G&'\H%1Y'[E=LF>QZASO[4R2EE]]KN_Q"U_)T\
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MM&Q45,9J'":4I3BDLLI)"2-2C,S/0NIF"-F
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MMU_.TT 9P#"*XJ3M3HBG,'=$R<M5<3J#DE')1([IMD>XD;E$6XRTU 9H
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MEYES8HT*-*T&:5$2B,NA@,L
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MY*EF?51[_#IIIX'J1!-P0
M   %)9[Q]EEW[A>-<[K8*7<7QV+/:MIIO-(-I<AIY"")M2B6K4UI^E)@JHYG
M _*3G$>;XNW3-JO;G.OQ^NC>LC$3E<:F_O37W-J?I/RJ,E?8"VDG)^"93799
MSER#,A);Q*VP-^!7SB>:4IR2U%;)2.T2C6G3MJZJ3I_M!$8X8P_E+/W>&+*^
MI(E3Q]@$-VPK[EF6V^[8^I;2EE/9)1K;6DVT[R41%]1_HD"RZ)W!W-[./7/
M%75P7.-+B]_%D9JY);)QFN4\A[M*C;B<-U)MI/HGQU+7:>XA:Z,0XYR2B]P^
M5YHN"36%SL?@5=7-[[:UK>BICI-!MDKN%H32NJDZ?[01I<LP_E&D]R$'DO#L
M?CW]!;TS-#8OORVXI0$^I2MUY25*)2]J$$:20E6NIEXZ:A4W(/ W+#UCRC24
M^#U>2L9I9_C=5F<J5&;F0VCD=_TK27S):5D1]OH:$Z:]3(R(BVLVEXHSR'RL
MK)Y%:A%-_+QG&O4%(8/_ +40AHC9VDO=H1H/S[=OV@B'2.#>46/;1AF(QJAI
MW.,4R'\?>I%2F/OF42):R0EY*^WN-+R5?7X:E]70%MZFP^=DMEC5=/S"L:I<
MDD-FY/JF'BDHCJ-1[4=U/11DG;N,NFNN@,O-UMPSR/)Q[W!06:E"I6<VD>7C
M"/51R]4RW)4ZI1F:R)O1)^#FWKT!;9-KQ[S%Q[E>+\F<=4$3([8\1AXKD=!(
ME-QU,R(R&C)U#BEH0I!*;01[5?FG\%:I#76WMVSN'[948- )BRS]5NC)K"$E
MU"&G)"W/.PVXLT(W)1MU,S))J(]#ZD"VEV9XIRKR-*X:R>UQIBKM:'(?Q3):
MQJ:RZF##0\C8?<-1=U1MHW&3>NAGH"-#"POW!<89CE]+QC45D_&,UO?QZ)DL
M]]!(K/4.$N2V_'-:7'"V_=EL(ST+<7F/1(:;/^$<TJN4,IR3'N.J/D6GS)QB
M7%?NGD-*J9J4FE[>E;C:EM+4:EF2/AM+4C+S%MZGQ:H:H,<JJ9F%&K40HS32
MH$ U'$9622WH9-9)4:"5KM-1$>GB#*G^"^+,CQW L]Q/-XGX>>3WEN^P33S3
MZE0+&.TPEPC:4HB,]%:)5U^9 LJSXDX2SC$\CHL:R+BW&)-=0S%/RN1'7R5)
MDL-.F\PXPVA9N)>2K;IW&]-"(E;?J!;0[FK'>2>*<4Y9H'*VO>XZS:Z3=Q<@
M?G--RB7)E-.G%9BFLG7'2,DDH]FTDI4KP\!"99?Q!R0[F"\GI\*K<TK<GQ")
M1);MWV&/P66U%;;-S9(U/4C1N+M%KJHRU3\0V.+<+<DUL'V],S*A#;F"R[E[
M*$E*CJ]*W.D)<9,M%GW-R2/4F]VA]# M+^5<,Y-JN9L=Y>XRHXV1O%4NX]:U
MLF4B$3:5.+<;?4MQ1:I(W/-LU/RZ:==2(K:-P3RP7"V.8I)IF?WG@YZC(9\9
MN7&[::\DN$IY*S<VF6Y1:(UWZ? %M,[?B//I>8\^6K%:A4#.:)JOQITY+!>H
MDIA$R:32:]6_.6FKA)($M'/Y;<M\=/<6\BT%'!L;?&<85C63U4VPC0FHS:3=
M<2\J0M9-FA)NF:C0:C\NA:ZZD5,O9>J4_P 2V$V4E.^;D-G()QK7LN;NT2E-
MF?BC<2B(_L!)=O+.)<I0^;L3Y4X]Q^-DC$2I=HY<61+;A%'4\ZZKO+-9D9H)
M+VOD)1^4^G4@&)<\4YU+Y"YTO(U:E57FF,(J\<?.0PGU$PJY$<VS2:]S?WA&
M6YPB+X@(+>\ 9U'Q7BO(4XC RR^Q*J<ILCPJQD,I;>9<4XMM3;V_M;FS<49F
M2SZ[="5U!;>@.$<4G8MANVXQ.HPVZGR'),RGH5&MA*>B&C<49J(W201$K8M2
M?B1]=")**6/'67R/<N?(C4%*L1/%G*GUW?9(_6*6LR1VC5W/B7FVZ?: JFNX
M%Y2C\*\=X>[3(+(,?S)%W:1?5Q3)N E;IFX2R<V*^HO*E1J^P%M8\W$N4<;]
MS$K/,<Q^/<XAE<&!66=BY+;CG7,QUM$^LVU'O6LDM;D)2DR5N(M2T,$5E'X!
MS3%<NN*")QAC>:8[;W+EC7Y?=/I0J)7R5$:X[S:5DZ:FTEY30V>BC-1$HCT(
MMKGQ3CS)*;W&9=G"Z]$?"["A@UM7*0ZT>YZ,4=)MDT2MZ223:NJDZ> (B%OQ
M'GTO,>?+5BM0J!G-$U7XTZ<E@O424PB9-)I->K?G+35PDD!:(9'P%G,>@XMR
M9&'U^87.+494.2878R&4(<;(UK:6T\:^V:FU.+,S)1_#0E=06TJR;AC+K_VV
MW&(5V)4N+YO9RFK->/4KA(B+5'D-J)"G'%*03QM-Z&>\T&HB\Q$?0EKNXRFY
MG/P^"_GE&SCM\G5HZIB0F63;#1$ALUN(,T[E$6[0C/3I\=01Y;Y'X-Y4?R+E
M.'3815Y5#SMYJQJ<JF2HS4JN)I1K..TE\R62_-L3M-*="(S,R\I&K2CFKA'D
M?)^->-&,,B(_??&ZG\ N(_J66B*'85J(DM)N+6E"TI-!I\IGT49EJ"1+8\J\
M-95#NN+;S"\:A9Q38+7KI9.*6+[,9EQ"F$L-O_\ $ZMGH9;E:D9D:4GH?706
M@#/M_P"62X0R+$/W<BQ,BLLU;OHM5%EQDQ45Y-(29MK-S:E"3+:E"CW;2\ 6
MUDYAP[G&3\J<H6\5EN'0Y7A9T%3:K?1M5/43'W:VT&;B4'L42U;--OAKX B!
M<;\.<IQ,^XKM[7CNLQ6KP=F17W%I!F0W)-@?IU-E+?2TO<K>H]4EYE;E*,]"
M,M"VTT?A7GR;B$[AV;BT.'B619.N\F9*<^.X[%C$XC<1LH<,U;B;2I&TM?@9
M%XD+6Y9\69N]R=S)D$6M0=)E>)%38\^<ADN_-*"VP39I-6Y!;TF6Y9$7QU!&
M@I.&^18C7MY*14H0>".6*LI+U4<_2E)6VIO319]S4DG_ (6[0!(\5P_E+"_<
M1F5U"Q^-/P/.7H4F5D*Y;;:H;4-A>J"8W=Q;BEKV?3IX*UTUT"'HP-4GWH/1
MHLDW,;B1D9Q.KD_X35FJ/Z!!J^3BEJ2]^0P7@]"\K82KD;CK(L);?3&?MXBF
M8TA>NQ$A"B=:->A&>W>A.[0M= 94/@O'7-&5YOQS,Y/HXF/8]Q3$=C0WH\IN
M2[:2NRAA#J4M+7L3HTVM6XB\#T^K1)5@^WO ,JP3^8'[T0DP_P =RB;:UFUY
MI[N0W]-BS[2E;==/I5H?V 2@WN?DY!"Y6X2EXK!9L\@9G6JX%?*=*.T^X28A
M]LW3,B0:BU))G\= (16XX*Y:R/B;D.3.IF&.0.0<CC7)X\U+8-$6&PZ:TI4^
MI9-FHMZ]=%>!%\3,B+:X.=N.,NRJEP[(L';9D9I@=G&N(-9*63;,LFB3W&-Y
MFE)&9H3H9J(M",M2,R!(0C'\0YSCKY+YBDX^Q#Y2R^+%J<:QIB9'4F"RRE#)
MR'7UK[1FA*4NDG=U4DR,BW:$&YX%XKY X6R>5C;I*M^/[VNBV4RS5(:,X>1M
MM$B6DFE*2XI#QE]9)/H2",^B@)1+@C U0O<?R.XW).5C6%.R&:)@NK,61D3I
M2G&V_M;2A;:R!97)[C,.R+/N',CQ/%(A3;Z?Z/TL53K;!+[$UAY?G=4E):(0
MH^I@D(2WQ;G">6X>5'7(_!&N/"QMR1ZAGI:%N^ZV;]VG7Z]NW[0%9L<%<IT>
M \02EXA"R6WP.5='<X7-EQ2:D(M92G672<4I3)["VF>JCT,D^4]#!;;O%>"N
M2$\.<O8C8TD*BO,NLEV-%5Q)#*X1-DMM]+#2D*,FT%L[3>_;ITUT("V3E/%O
M*G(_#^''>8E7P\TP&?&.#BDR6W)C6E7$CLLN(>6E>Q"GE(UV]S0D%]6I@.1<
M29E<\,\@UT;C*CPG*<@;C1J:HJ9+9R7H[$A#JBE/*7V=2,C4@R66O@9%H6H3
M[E3CS+LE]M'\O*:"F1EQ5=-%.!WFFT]Z"[%4\DG5J2WY2:7H>[0].@(K;..&
M^2F\Z;R2LPNJS>#<XE'QMR+:R6&VZ>:RRA"GB)[7<1&@S2;74]RBU3XF5SQK
MA/DNNQC@&NEU"$3,(NY\[)F_51E>FCR)YOMJ(R<,G-4==&S49'T MQY$XRY<
MY%Y-@2_W"JL>E5=XW,A\EU\]")"JB,Z?;0\PE?<=>V$GJI'0RVEM3J8#U1?1
M7YM'9PHR=\F1$?9909DDC6XVI*2U/H6IF#+RU%X!Y#=]M6*X@49B#R5B%RO(
M:^ ^^TXPZZW+D+2TIUM2D%N;>W%YM-Q$1F74R-6SZWC7EO-[+DWDK-Z&-0Y)
MD.(R\2QK&6I;4A7W[)ZK=>2HT)W.)+::E?G'KH1$9D71PEC=SA_%&*8SD,<H
MEU604L38Q+0Z2'"4H]-[9J2?0_S3,"4+]R.$9ODK.#Y)@=8W>6^&W\>Y<IW'
MVXIR&VC2K1+CBDI+S((CZZZ'J7@!#IDX7R)?<X<8\D6U,S#@U=%,8R0F933B
M(<Z6P^1,)(U;W=%.)3O0DT^)^ "K"]N/(4WAZ542ZB&>756;2,JK*6;(:=B6
M,%;;;9L.+;7M23NA]%*+HG0]N[4BVMW@+#+>D=N;V^XUH^/'Y1-1JZ-4O%(G
M.,%JITI*VU*;VFLDJ1M,C^!IZ$9DEK/<1A/)E[F/&N8\;4C%Y*P^3.ERH\F4
MS$;W/>F[:3-UQLS)7;7]/AH!#)FWON4N^-LIC2<,A4V=2C:@8\4"Q86E#4DE
M)D2EN*?4E)LIZM^;4U:>70@&)PMQ3FW$MGDW'9I58<86D-J93WBWVE.1[5<=
M#,MI3&J7-KBM5I,D[2))?G*,"4+P'C;FFMX&S/AFZQ:+%[$*8Q0SVY[+B[*5
M,?4[Y2W[6VTI/HIS;KTZ%U!4EY"X>SC(O;7A^"UT1EW+<9:J),VD>>03,M5>
MP;3L4W2439ZFK4C-6T]OC\01%L7X.SS)\FY'L,DQ"OX_I<UQ<JJOAULB-(8C
M3=6=F]$;;J>YKN.&E!$?AJ9]06V5A'&?-F29-QE6<CTD.AQ7B5!^GL8\MN2Y
M:O,-MM1C0A"E&DDDRV:MQ)_.^)DD@G_!'&638MCO(=+F<,H)9/D-G-B;'FGS
M7!G-(;2Y]TI1),]#\JM#^P$E2E;P_P"X)K'L&XQFXO!5C&!94S;HOV[!CNRX
MWJG'C6VTIPC2A)/+,R46\_*1)Z&"VFUYPYR),F^X.1&JD+;SIB"WC'_$QR.4
MJ.2]Y'JX7;TU_P#6;0+9S'#^?+S#AB>N&46!BN(2:/()S<ADU0YSU6Y$22$D
MLE.:.++13>I?'4$5;C? /+T N/<>D\?5$-&$Y,S8V68Q9L0YEC$]63YKT,T.
M&VVCIM7YSVI(DEH8+;T-PU@>58EGG+-W?PDQ:S)[Q$ZD>2\TZ;\<C?,U&EM1
MFCZT]%D1@DJKSOCUNU]X^-,1'R55V4:%E^00$^!2:$GX\5U:?#12B0@O^DH%
MX/6,^%'LH,FNEIWQ);3D=]'AN;=2:%%_:1@R\5/<+^X*#ATOV_0Z&HL<'<G.
M+J\ZE.M=V) ?D)?7HT:^XE:C+59):,_,HB,RT41JTMY4X'R&MS.CS#%,-KN2
M:B/C\;&YV/V[S<9QMV"24LS&U.+0G4TI2DRZZ%NZ>;5)+;:SX?S-Z-PLNMQ2
MJI7\<R$KK+*VD?2W B)6ZTM2VR?42EGM1YDH-?FZ$9EH8#67/M]S7*XO.];,
MCM5_[XVD"SQ*6X^VMM]4!QUW[Q+9J4V2B42/.6I;M=#T MF\7<:9<A=W)NN)
M,<PB2S2RJ^OGU\A#MA)LGVC94ILVW'&T,.),_K,E)^:B,] R:GA?.I'M$5Q%
M+;;J\V4P^HHRGT+;-:;14Y#2G65*1]ZV1(,]VA;NOQ O:CO&/%?)C7*N-9G<
M<>UN%4E7CDBDDLULJ(XIV2AIQM+[R65:FMTU%I]6B2+<HP5:_MCP3*...)H.
M+9?#3!NV)<QUR.EUJ01(>=-2#WLJ6GJ7V@DH-R'PAF&<9KRZX<1MO'\KQZNC
MT$M;[9)=M:PV7FDJ02C6@B<:-)J4G30_CJ!;-I>#+R+R#?P'XY,\?S..V,(A
MVB76E.&Z2&F5EVB5OUT):S4HB(S^/4"T0X;X8SC&,DQZDR?BK&$0L<?-Z7GQ
MOI=ERC86;D5Z*A"S6EU*B3J;K?73KL,%F6M<X#S?&<ROZF#QCC><45]<NVE=
MEEW()M4*'+42G([[9+)T]A?2;:#\QFKS:[2%K%Y.PGDNFYDPSD?C/&HE]7U=
M*O'7:]R6W!;B$I;FUQ1K,C-M*7>FPE'Y3+3J0(Q<JXGSVTY"YKO(=8A=5F&)
MHI\>?.2PDY$TH;3)MFE2R4WYDJ+<LB3]H#"J>(.0XME[>Y+M6A+6"1)C&4'Z
MF.?IE/M-I21$2_O-=I_X>X"U*\FXQR9Q=Q[-XHM*F K#YN6HGT%TF:TJ;,0^
MX1ML,PTJ-S<G;N<4I.A:[2UZ&"O>F5T#&5XO=XO)<-J/=0)5<ZZDM5(1+94T
M:B+IJ9$K4&7E+&>(>;[MSCOC?-Z6#68+QK:)LW,BCRVWE6:8JS7';:92>]/0
MS0HUI3T/4]#+0S2W>)L"RK%^5N7,GO(28U+E,Z _1R">:<-]N.F02S-"%&I&
MG<3]9$")'RZ[R_%J*Z?P^S7S+*'+2_:U=@9(7,B)29=EI:S2A)F9^8S4D_#:
MKQ(P\_L\,<MY5&Y:S[(,=@T&49O3IJ:O$X4AE1+<);*G'WG26;1+5V2/4UZJ
M4I1GM^);2^%Q'GJ<VX4LW8)1Z[$L3?I<AFMR&#7$FNUCD4B0DE[G-'%EHIO4
MOCJ"*DI/;]R] B85BKG'M0P6'9,U9SLUC38GK;&(<DW3/12DN=M"-/*OS'M0
M1((R4"V]%\/X'E6*\D<N9!?0DQJG*+6++HWTO-.F^RT4C<HTH4:D:=Q/19$8
M(I*A]OF98GDTK$CXOQK+<9DVZY<;-K=])+:J7ED9LN-)63O=0GZ3)!D2M>BD
M]06U@V_%&=2>0.<[J-6(.IS/%T5.-/'(83ZB6FN1&[9IW[FR):33N<(B^((C
M4?B?E[!(7%7(.*T4>XS+$J1W'\@Q9Z6RR:V'E.J0IM_?VS-)NJ-6B_T=-W4%
M:^T]OG)[_"=M7NPH\SD?+,N1E5O7,2&FV(S:U*U;)UQ9(4:3,U'M4?U:%NTU
M,6DG(?'?,-/RCG=_QS00[ZEY+I$5DU^5+;B%7R68Q1C6I*U$I>J4ZI)):&:N
MIEIU(C5S[?LZ;P+B>W+%8&2Y)A,27!R#";*0UV9<>6M:D['B636]K<:B\Y^8
MR/KMVF6VRRCAC.K_ (-725. 4N+Y=/OXEB]0TLEM#:8,;<E"GW75]LW4DK17
M;69&74NIFDB+JYM9S*7B[,'%,,K<[B27]MY16KR&"<B$@]#9-TTH)PE[3)1G
MJG3H6O4A"G>/L)]P'%'&$EK"*" F^N<F.>UB4V:4J/4TKR-#:2\IY!*5N))+
M,G%'L\W59GH'JM&_8GN$1+T+<1=2U^.@(Y
M                   ,&YIZW(:F;1W,=,NIL65QIL59F27672VK09I,CT,C
MT/0P'965E=35\:IJ(K4&LAMI8B0XZ$M,M-(+1*4)21$1$0#*
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M         T%1FN+7U[<8S3V;4R\Q\VT7,-HE&J,I[78E:C3MU/:?0C^ #?@
M  T3&&XS&RR5G+-<A.638B*Z3:;EFXJ(VI*R:(C4:4IW)29[4EKIU ;T
M                !%9W&V"6F7QL]LJ&++RZ&TVQ$M'TFXMI+*E*0:$J,T$M
M)K/1>W<7SZ$ E0
M
M     /#O(?!>*5WN#P7!X]I=E29DBRFV^L\S>)UM#SR2:5LT26Y):ZD?0&K;
MC);K*>,?<,BJP2@E9E^[6 L0*^L?FI9)B(PXV;LIUQPM#5M:(E;4DI:U$7V
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M4Y&_DWN?XDODK6S'O,&.S5%0M?9(Y3,MXO+KH>F[Q/Y%\@1ZE!
M
M
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MMA6P.!D8MA%K1P8>4G;W5.\XJS=K$//,FI<A]):)0:4;_.2="Z*(E:D V$'
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M-,ILFEF@E*(TH/19%N+IX B4
M
M
M                                                P9M-3V4F',L:
M^-,F5ZS=KY$AEMUR.X>FJFE+(S0H]"ZIT\ &<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M+K7'+#+:_*Z]_':E;;=G/)XB1&4\LFVR=)1$I.]2B2C4O-\ *965<H\>8._
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MQI*2+<M)>/Q I/00
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M0^A:T$:6T^C02O/IJ9: D)MR?+CV'*/)<^(LG(LKA6P?8<+P4VZ\ZI)E^4C
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M1D_J:20?AH:M0'ICFYAF-PCG<:,VEF.SCM@VRRVDD(0A$59)2E):$1$1:$1
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M(8D&LB\"))@L-)1VC''?$? _,#Y+]'C_ ./54TVDZJ4W;MS>QO(O$DNLI/\
M*8!:8;D-)CWMHQS'(E9*RF2U<SD1<C;6]6JD6,9J:\4I*"-9[>ZK33J2B+Y
M+4RVO<K.>O;Y7NQ8<*4S#R,Y<6K;[,%$E582W^P@R(R0;AJ-.I:_/J".NXJ\
M?R#W&9[%S>-'EP8F#,E6MSDI6AN XXLY3B"66B=%J,C674M?$!2&-2LD<A\
M.Q<29SF[.@R&.SCLYYB.R]%3(=:94I<I*FR2VR25$1EU(M"!6]?XWSW#LAX7
MP"MAX].S2-69'*7"OD.R:1HIKZI2F3)HC6?:2O1)ETW_ !T >UJUF+71(E6T
MW&B.-LD:841*6FDDG0E]ILM-$$I7R^(,OSR]Z?#O[E9JCD&EC[,;RQQ2IB4%
MHB/;:&MTC^1/D1O)^:NY\"(&HEZD]J?#O\JN.6I5JQV\PR4FY]QO+1QEO:?I
MXIZZ&7;2HU++X+6HO B!)E>X(
M
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M!_8G06E=_C=%E,%%;D4!JQ@-R&)B&'RW))^*XEUI?PZI4DORET/4C,@1M
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MZS++_6BMM1PBHV57@Q<+XHP;CZ9)GXI7KARI;9,/K5(??W-DK<1:.K41=2^
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M9 5-57DXF(:7WF-I/;37_A+3KKL3XC&CU&>E?+-6\/:N_=9VV,HZ?+EYZO\
MCC.ZZWQ/ZNV'QSB,##7<!BPE(Q9]+B'(9O.J4:7EFXO[PUFOJH]?J$RU\YSY
MYG^3&KWOJ]3K(ZS++_6BMM1PBHV57@Q<+XHP;CZ9)GXI7KARI;9,/K5(??W-
MDK<1:.K41=2^ UK=3J:M<T[G;NGY#UO<L,<.HSYHQFX_CC&W^D0U:>!^,$Y
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MZS++_6BMM1PBHV57@Q<+XHP;CZ9)GXI7KARI;9,/K5(??W-DK<1:.K41=2^
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MJYZO'*M7*[FHX[]E5X&&<;8?@$:=$Q:"J&Q8FA4M*GGG]QMDI*>KJU&711^
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M[],\/'_Y*/3]AK_KX0^]_P#[GN__ -V/_HP__:MH?/?A@
M
M
M
M
M
M
M                                                       :Z[R"
MBQF =ID=G%J*Q*DMJF3WVXS!+7T2DUNJ2G4_@6H",?SFXA_CW'OVM"_S0*/Y
MS<0_Q[CW[6A?YH%'\YN(?X]Q[]K0O\T"C^<W$/\ 'N/?M:%_F@4?SFXA_CW'
MOVM"_P T"C^<W$/\>X]^UH7^:!1_.;B'^/<>_:T+_- H_G-Q#_'N/?M:%_F@
M4?SFXA_CW'OVM"_S0*/YS<0_Q[CW[6A?YH%'\YN(?X]Q[]K0O\T"C^<W$/\
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M4?SFXA_CW'OVM"_S0*/YS<0_Q[CW[6A?YH%'\YN(?X]Q[]K0O\T"C^<W$/\
M'N/?M:%_F@4?SFXA_CW'OVM"_P T"C^<W$/\>X]^UH7^:!1_.;B'^/<>_:T+
M_- H_G-Q#_'N/?M:%_F@4?SFXA_CW'OVM"_S0*/YS<0_Q[CW[6A?YH%'\YN(
M?X]Q[]K0O\T"C^<W$/\ 'N/?M:%_F@4?SFXA_CW'OVM"_P T"C^<W$/\>X]^
MUH7^:!1_.;B'^/<>_:T+_- H_G-Q#_'N/?M:%_F@4?SFXA_CW'OVM"_S0*/Y
MS<0_Q[CW[6A?YH%'\YN(?X]Q[]K0O\T"C^<W$/\ 'N/?M:%_F@4?SFXA_CW'
MOVM"_P T"C^<W$/\>X]^UH7^:!1_.;B'^/<>_:T+_- H_G-Q#_'N/?M:%_F@
M4?SFXA_CW'OVM"_S0*/YS<0_Q[CW[6A?YH%'\YN(?X]Q[]K0O\T"C^<W$/\
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M4?SFXA_CW'OVM"_S0*/YS<0_Q[CW[6A?YH%'\YN(?X]Q[]K0O\T"C^<W$/\
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M4?SFXA_CW'OVM"_S0*/YS<0_Q[CW[6A?YH%'\YN(?X]Q[]K0O\T"C^<W$/\
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M4?SFXA_CW'OVM"_S0*/YS<0_Q[CW[6A?YH%'\YN(?X]Q[]K0O\T"C^<W$/\
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MOVM"_P T"FQI.2./<EGHJL=RNHMK-:5+1"@SXTE]24%JHR0VM2C(B\>@"3@
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M;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U
M?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O
M[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z
M[K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>G
MQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_
MU ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.
M8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/
MZ [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:
M>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.
M<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K
M^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/
M;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U
M?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O
M[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z
M[K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>G
MQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_
MU ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.
M8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/
MZ [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:
M>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.
M<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K
M^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/
M;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U
M?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O
M[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z
M[K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>G
MQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_
MU ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.
M8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/
MZ [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:
M>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.
M<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K
M^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/
M;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U
M?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O
M[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z
M[K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>G
MQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_
MU ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.
M8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/
MZ [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:
M>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.
M<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K
M^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/
M;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U
M?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O
M[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z [K^.8O[.<_U ?:>GQ/;/Z
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MU,S%&+5W-1>1CF4MA&LHB5FVJ1#>;D-DXDB,TFILU%J1&1Z"SC,;QFC(
MUC>1T+UZYC#-E'<R%F/ZQ^L0ZE4EN-N)!.+01F:4FI1$1GXC7+-76P;,9&)9
MVE920'[2XF,P*V*@W),R4XEEEM!>)J6LR(B&HB9FH'*ML8-Q7Q+:L?1*K9S+
M<F');/5#K#R26A:3^)*29&0DQ,34C%MLCQZA-I-Y;0JQ3^XV"FR&HYN$C3=M
M[BDZZ:EKH-8XSENBRWVJR+'[WN?@EK#LNU_B^BD-2-FOAN[:E:?VA.,QO@M\
M>R*ACW47&WK&.B_FMN/1:PW$^I6TR6JUDWKNVD1^.F@<LU=;"VS&
M        !JZK)*"\EV$&FLH\^74N(9LFXSB738=<3N2A9I,R)6G73Q&YPF-\
M;RV)$SC#Y^32\,AW<-_*X+?>EU#;R526T:),S4C77H2DZE\-2U%G3RC'FK8E
MM^.:@  U<C)*"+=Q,:D64=&03T..PZPW$^I<;93N6LFR/=M(OSM-!N,9JZV%
MMH,    #5O9)01[R+C+UE'3D,UMQZ-6=Q)R5M,EJM?;(]221'XGT&^2:NMA;
M:#
M
M             #NC?XI?D,?2[=_O1^TN>IN9P_4/*          #IE?X7]I#
MYG<O]K^KKI[V"/S#TO)WOW_\.<9_[[_^U'Q]+H?[I_9C-57.?"F/<&XKA_*'
M'EQ/K<C<EQF^P\^A:R<<C+?-YHR0E1;31M6D]R3)6GY?3HZTZN4XY1L8F*7_
M )[[J:[C6SQBEO,;F6,J_I(=RMZ X@E)=F$XDF4LK+51[V]/K_.^.@\>'2\]
MS$[IIN<J9M)[G:U7&UYR/FN,S<7CU$XJJ/6O+[LF;,6V3J6FB6VR9*VJ(U;D
MZ$6IZ]#&<NEGGC&)LYMC4<>>[NFRO+:[$\KQ:;B#UZ:?P";,<-UB3WCT9UW-
M,FGNGY4*3N2:NFOQ&M3I)QQN)NB,DXD\XQJGF9KB#(:1VK5.CJET]^Y(0J)*
M;2RIW7;M2:.K;K?57U)T^)#E&A>GSQ/]%O;2/XU[DSRS",VY"IL/EN8UB!GZ
M=]R2A"K!+:MSQMI-O[OM,[75[M?J)/CJ-Y=-RY1C,[93FV-I_410'P8?-Y5K
MOHR/M'2]Y/?]1ZSTG:[FW3Q\^NWZ1GX\^YR6O-LM8''V5N9UA=+F#E>NJ*ZC
M)F-077">6AETS-LS624D>]&U?A\1PU,.3*8WTL3;,N,OQ/'7VXN07U=527D=
MUIF?+8BK6WKMW)2ZM)F6I::D)CAEENB9+:T^3^-"(S/,J,B+J?\ VG$_S1KV
ML_+/_8N$H9>9D,MR([B76'4DXTZV9*0M"BU)23+H9&74C(<U4W[K,I_=;@W)
M5H5ME6Z&Z:.6NF[URR0Z7_UDG3'JZ7'FU(_Z,Y3L4_[))5GBUWF_%E\@F;*.
MF'<M,;M=.XVE#IZ'IXI7''JZV(F(RAG!=_%7.==R5+S&NDU+E!887(]/9L2'
MTOF9)4\A:R-*4Z$E3"B,>35T.2JF[:B;:/$O<DSE?&&1<I,8?9%544HH;,&,
MXW)E2E:-FM:2T024-]U)K/S:%KIKH-Y]-RYQC>\C+9:/8K[MTS\RJ<1SK!+3
M##OW4,5$V<I9I6IY6QLUH=88,DJ4:4[D;B(SZ].HWGTE8S..5TD9)-S'[CZW
MBS(Z["ZK'IF69?/:*4JL@J-!M,*-6WJEMU2EJ)"U$A*.B2U,R(R'/1Z:=2+F
M:A9RI4?M=R>-F?N%Y-RF)%?A,6D0Y!0Y9$E]HSDM$I"R(S(C2HC(>GJL>72Q
MC]&,=Z6Y-[S*:KO;2-C>'6628I1/>GN<EBJV1FE;MFY&C:TFDU$9(4XXC=\.
M@YX]',QMFIG@USNKW79139K[;8>58\_ZFGM9U?(BNZ;5;3-PC2I/P4E1&E2?
M@HC(.EQG'5F)_1,IN%\\8_\ AKAO_<=9_P!4:'CU?[\OWEN-SRY[WJ]BUS+B
MFKE$HXTZ1,C/$@]%]MZ1"0K:?70]#Z#Z'136.3&:(\N\:5?MFY$P#)^,;::U
M)M)2VY%;)=2ZM33+C!+3JA*#4T\ETT*2HO'P/Y=='4G7QRC*$F*;K.\^:XV]
MX=]D9U,R\EJJ6(L&IKD[Y$B2]!CDA)=#,DZ$9J,DJ,M/ QG3T^?0B+K_ /,F
M:R>@N#N?:OF=BYCIIY%%D5"M";"J?63Q['#6E*D+-#9ZDI"DJ2I!&D]/F/#K
M]/.G6VXEN,K5Q=>\>=227ILSBR^CXC&DJB2+F69L&EU*S0:=O94UOU+3;ZCQ
M^([QT<3_ )HM.?\ Z)[R?[CL=X[PS%<ZBUC][1Y6:50U,N)C.(:6R3Q*4E:5
M>;0]#3TT,<=+IISRG&ZI9RIJL#]S#V<*RN4G![&KI<>I9&00ITQU*#FL,%N0
MV2%-D25.D1FE25K3T/4_#7>?2\M;=\TD96@I^^FN<K&+B+Q]:O5C;W8MIO?2
M4:,I1_=I2Z31I6M1==B^W^4_$=?@[:YDYVV3[U<=5DE9'/$;1G![9],6%E,G
M[DG%FLD+6ADT&E2&S/S;7C47RUZ#/PIK?M_1>=9/,/,]CQA,JJJGPFVRZUN&
MW7(J*Y)]@NPI)+2I;:'E[R)1*T[>FA^(X:.C&<3,S$4LS3IX3Y^J.87K:G<I
MY6.991[3L*:8>]1(-6PU)5M;/5*RVK2I"3+4O$-?IYTZF[B2,K5[E7O1HJ?(
M+.!C>)6&2XY1O=BWR&,YVX[:MVS<@NTXDT&HE$E3BT;M.G3J.^/13,;9J92<
MUBYA[B<#Q/C*JY.(W["NO]B*2O:03<N0\HCW(42^B";VJ[BNI%ITW:IUX8=/
MEEG./Z+.6RVEXH]R\#D#*SP3)\:FX5E[S)R:Z!8FI12FR2;ADDUM,J)6PC61
M&C122/0^F@UJ]-R8\T3<$96DF%\T1<RY1RWC%JG=B2,42M3MDM]+C;^QU#?E
M;))&G7?KXF,9Z'+A&5[R)VTB5![G8V283G.70\2F+/#)$:(Y6-/I>>EJE/=D
MS0:&_+L^I7E/H.N72\N41>](R4%[-.45XQ8O8*C'I<YO)K5K6V9,_3PR)DTZ
M.>16I]/TB'LZS2YHYKW,8S2X<+=XS/W8Y7 K,:EQLXCQGI$JX7,[D)2G&V#=
M6W'V$:5N$[HHS69>.A%J/-GS^Q%SL;BK=V?>\&EQ;*;3'<7Q:=ED?'U&C(+6
M*YVH\8VU;7=IDT[J2#(TFM9H3N+H>G433Z.<L;F:LG-/W^>*!WB%KE^@J;&[
MJG=B/PR*T7K&WE.]A:'",]")#GE4I&XOB6I#A&A/N<DS2\VRT*P;W5HOLYK<
M$S;"++"K*Z,D5#L]2U)=6Y_ADM#K#"DDLRVI4DE%NZ?:.V?25CS8S=)&6U%(
M1:>_*Q^VH3K^S&1TG_C?X_5/\R19M[NX5!E]MBN)8799:WCSJF+RQAK-#3*V
ME;7-J4,O&9(42D[EF@C,CTZ=1C#I+QB9FK6<E[X9DS69XI496Q"D5S%Q%;F-
M0YB4I?0ATM4[B2:BZEYBZ]2,AXL\>7*8_1N$$YQYRK^$(-+86-.];,6\AR,9
M1WD,J:)I*5FK1:5;M2/H73\H[:&A[M[:IF9I#\ ]V%3F'($3!;K%;'%SN4[\
M>F6)Z'))1&IO>T:$;"<))DA2%+2:NFOQ'74Z2<<>:)NDC)#* B+WXY(9?&K2
M9_LV(7_PAVR_XT?XXI_F2OD;W=4N(9798KB^,3<N=H=W[PSHCG:CQ.R>CQ:I
M:=,^T?E6I6U)*Z:CEI]).6-S-6LY+CXUY$H>4L0@YECO=1!E[D.,2$['F7VC
MVN-KTU(S2?Q29D9#RZNG.GE4M1-I:.2@
M
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M>Z-L,
M
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M/+J:DYY7+4124CDH
M
M                       #NC?XI?D,?2[=_O1^TN>IN9P_4/*
M #IE?X7]I#YG<O\ :_JZZ>]@C\P](         U5;C..4T^=:5-1#@V=HON6
M4V-';:?DKW&K<\XA)*6>JC/S&?B-SE,Q4R-J,
M                           Q)-76S)<6?+ALOS8)K.%(=;2MQ@W"(E&V
MI1&:341$1FD:B9@98R
M
M                               #NC?XI?D,?2[=_O1^TN>IN9P_4/*
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M8/\ ,]%_^Z)QI?J#LBTC$[VC[6[[=WA]HZ8=-IX3>,5*3E</9P]#F
M
M
M
M
M
M
M
M           "$3^8^*:JZ/'K',Z>+<I7VW(CLUE*D.:Z;%F:MJ%:_FJ,C I-
M4+0XA+C:B6VLB4E23U(R/J1D9 (?7<L\8VU\>+UF75,O(-YM)KV9C*W5.%T-
M"-%:*47Q2G4P$BNKVDQNN=M\AL8U55L?XLR:\B.RG7P(UN&1:G\" :?$^2,!
MSI;S6'Y'7W3\<M[[$.0AQY"-=-RFR/<2=>F[30!)EK0TA3CBB0V@C4M:CT22
M2ZF9F?@1 -+09GB6529\3&;N%<2*M3:+%$"0W)["G=VPEFV:B(SV*Z?88#>
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M<,B+4!J,3Y$P3.N\6'Y% NEQBUD-0I"'76TZZ$I2"/<1&?@9EH DP
M   TC&8XO*R9W#8MM&?RF/&5.DU33A./LQT+0V:W$IUV>9Q):*T,]0&Z4I*$
MFM9DE*2,U*/H1$7Q,!IL>R_%,M;?=Q6]K[MJ*I*9*ZV4S+)I2R,TDLV5*VZZ
M'IJ 3\OQ.JN8F.V=[7P\@GD@X-5(E,M2WR<4:$&VRI1+5N4DTEM+J9 -T
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M+-M>Q7@HB4DRW%T/X -L
M
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M;RGSW69C[9;;,\.K9,QN]2]CUG%W&EZK<D1W">6\;:5D:4)VG^:2DK2>J==
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M:4I4@U:F?@1 3"_P0
M
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MJILXGV\W-KU<]R@:==:]"U)G-&RT6Q]>Y*S<6A'E3T1X 0RLIA\FR/>9E,3
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M4BV3/CF=)<)63[Z4(;<6TOO$1*=:7V5H^]3W$J\3T+0%EZ]!D
M
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M29Z$!:^P0
M
M                                    !KZBAHZ!ER/0UD2KCO+[KK4%
MAN,A;AD1;E):2DC/0O$P&P                             =<B.Q*8=B
MRFD/QGT*:>9=22VUMK+:I*DJU(R,CT,C 8U535%#"16T<"-6U[?^'$ALHCLI
MZ$71#9)270OD S0
M
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M!AX'R;@W)L2=-P>W;MH];(.),4A#C1H<TU(]KJ4&:5%U2LBVJ^!]# 2T
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MLU-Q&J#\W0R)6I )2
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MY$_@>#8W9XOF#T?0GL@013K)EHN\>Y:7%D2]OWIMDE*=O5/0@27JL$
M
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M
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M&VHC2I!EJ1D?0R,@'%EAB,TF/':0TP@M$--I)*"+Y$1:$0#F2226B2(B^1=
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M\3T21$ [0
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MM:&T*<<42&T$:EK4>A$1=3,S/P(@'#U,;T_J^\CTNWN=_<7;V::[MVNFFGQ
M<T+0XA+C:B6VLB4A:3U(R/J1D9>)& Y ,1^TK(KILR9K#+Q$1FVXZA"B(_ ]
M#,C <BL:]1QR3+9,YAJ*(1.),WC01J5V^OFT(C,] &2       #&EV$" ;13
MI3,8WU=MDGG$M[U_HIW&6I_80#) =;\AB*T;TEU#+*=-SCBB0DM3T+4ST+Q
M'Y$>,CNR74,MZDG>XHD)W*/0BU/3J9^ #L =?J&"?*,;J/4FGN$SN+?L(]-V
MWQTU^( U(8?-Q++J'%-*V.DA1*-"R_-5IX']A@.P  =+$N+*[I1GVWC8<-E[
MMK2O8ZG35"M#/11:EJ1]0'<     ZE2HR)#<1;S:93R5+98-1$XM+>FXTI,]
M3).XM=/#4!V@    .F-*BS&N_#>;D,;E([C2B6C<A1I46J3,M2,C(_D8#N
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M]D9.>)2GX\I\[+N+D&PB0AM1;"0C3S$HS-1^&TCU IC<Z\F9UE./\JXYB%%
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MCD6SY(+@;.L,JV59!/MK)+-/8OJ:CLSV&#8>2ZZA)JV-K0I1&2-RDD6A$9Z
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MR0@MRS\"Z:^) %'D5'DK$F503V;&-$DNP9#T=6]M,F.>CC>XNAFDST/0!LP
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MN#25<&EJV2CUE=':APHZ=3)MB.@FVT%KUT2E)$ Z+S(J/&H\>5?3V8#$N2S
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MZ:^) $?(Z*7>S,9C3V7K^N9:DSX#:MSK#,C7MJ<(OIWZ:D1]=.O@ V@
M   #5S\DHJRWJJ"?8,L7=V;R:F M1=^3Z5LW7C;1XF2$%N4?@0#:     -71
M9)19-'D2\?GLV,6))=@R'XZM[:9,<]KB-W@9I/H>G0!M  !%:'DG!LHR2UQ'
M'[N/8Y#1Z_BL)C>HV-J^VHC7MV&:5^51)49D?0P&VFY'15UQ68]-L&6;RY[Q
MU=>I1=^045'<=-"/$R0GJH_  AY)16-U9XY!GLR+RF1'<M8+2MSD8IB5+9[I
M%])K2DU)(^NG7P,@&T     :NZR2BQPH!WE@S .TF,UE<EY1)5(FRE;6F6R\
M5+4?@1?E\ &T     :N5D=%"NX&-2I[+=]:-O/P*\U??NM1B(W%DDOS4Z^)@
M-H  (=3<7871YC:9]#@+=RZVW)?LI3[TE;;2U;E-,$ZM264&?7:V1?+PZ ,N
M;R)@U;"O+&=?PF(&-O)B7LE;I$U%DKV[6G%>'</>DMA>;4]-->@#>QH,&(Y(
MD1(S4=Z8LGY;C;:6UNNDDD;W#(B-2MJ23JKKH6@#2MY]A;V*OYPU>1%8A'[Q
MNW1.%Z32.ZIA9I<\%$3B306W7<?AJ W\=]J4PU)85O8>0EQI9:EJA9:D?7YD
M8#L     :6RR_&*BR53V=K'C6B(+]NY$6LNXBOBGH[(41?2VD^FX^GCIX& [
ML=R.DRVEAY%CDUNQI)Z#<B3&==CB4J-!Z;B(RT4DR,C+4C(!M
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MT[O$P5?/N 8M9'"N=(IYC<*0FEG./N.M=XEQ&V%JD-$1F6BG&B6VE?YIGN^
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M(TJ+H8"6@ ".9OG%#Q_2IO<A6ZF&Y)CP64,-FZZY(EN$VVA*2T+J9ZF9F1:
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MSBAR^?D-?2+===QFP546;CC9MM^L;0E:T-F?51)W:&>FFOAJ74!)
M $<PW.*'/(=A88\MUR'6V$FH>=>;-HE2(1DEPT$KJ:-3T(S(M0$C
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M&)8\N8Y2YARB<+")-1R%CN.SKAZYGLM-HM(=2?9C*2M"S6IEQ6TT'I])?,M
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M9:Z'T%IYQSC7+%++E2.1LTBY'%].W%@PH=<W"2E;:M3DN.$9J4XLNBD%Y/D
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MQ4ND?>1)<CFAQ2$ZN-DE)[DI)9="T)6A]0&^U+3=KY?'7X: /I&1EJ74C\#
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MAX1-X[K[K%;"3+J95N=PFP-MQ)MRG#-2NV\7@M"M#3_:>H7'[2__ "]87_\
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MTSU27NVS :LVH[<0F=_;[2$]4D:=2/3KTT >^7&TNMK:66J%D:5%X=#+0^I
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M: 6QN.>(%\?6*YR\TR+(F&XA5M=76\PG8<:(E1*01-(0A*G$[223JNNWH6A
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MW'O"=5@F0OY3*O[?*+[T**:NFWCZ'W(=6VLG"8;V(01ZJ+52U=3^S56HM'>
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M>AI:C3H?3J0#*N<BQ_'6V7<@MH=4U(4;<=<Z0U&2XM*36:4FZI)&9)(U&1?
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M:]>I@C*]TM'36J^)E65;&G./9[2USAR&4.FN%+[O?CGN(]6G=B.XCP5M+7P
MAAY-A6'7/N8Q;&+6AKYN-PL'DE"J7HS:X;/:FFTCMLF6Q.Q!FE/E\OP 4G2?
MB]AQ'P-CL2!$O*^5D5X1TMP^;%;)DQ)$CTC+[FBM2+<O8V:3)9^70_ %>D.
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MH9&6J>H(E0
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M4EE^0UJDC9;6HM2,R+J7S 2[)<;?8P/G#-9.>TN8V5S40HMNW0,ML--/Q/\
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M4X>IFK3<9D?4%>B>?\XN>/N-)]]1=ANP<D1*],Z8CNQ8:)KZ&52'4?G)02O
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M"Z)(S-2EJ^!:F8(]"Q94:;&9FPW4OQ)+:7H[[9DI"VW")25),NAD9'J1@CM
M
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MC333#2&&$):8:22&VT$24)0DM"2DBZ$1%X$ Y@
M
M
M
M
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MET<H<KY-QX[*D0./[+(L=JX?XE<WD>3&C1X\=.XW-B7#-;JFTH-2TD1:)Z^
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M6U1E\=#!."Z00           !UMR&'5N--.H6XR9)>0E1&I!F6I$HB\#,OF
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M^I&1EXD8#D   # M;RDHFFGKNRBUK+[A,LN37VXZ5NJ\$)-Q22-1_ BZ@,\
M      '3*E183"I,Q]N/&1IO>>6EM"=QDDM5*,B+4ST =P#K??8C-*>DNH99
M3IN<<42$EJ>A:F>A>(#$L;RDIW(K5O918#LYPF(*)3[;"GW3T(D-$XHC6KJ7
M1/4!G@       Z)DV'7179UA(:B0F$FM^2^M+32$EXFI:C(B+[3,!VMN-O-H
M=:63C3A$I"TF2DJ2HM2,C+H9&0#K7*BMR&HCC[:)3Y*4RPI:2<6EO3<:4F>I
MDG4M=/ !W .IV5&9=98>>0V_)-28[2U$E;BDI-2B01GJHR(M3T^ #M
M !P>>9CLN2)#B6F&DFXZZX9)0A"2U-2C/H1$74S,!PBRXL^,U-@OMR8;Z2<8
MD,K2XTXA1:DI*DF9&1_ R )4J+"85*FOMQHR--[SRTMH3N,DEJI1D1:F9$ [
M@                    '0W-AO)?6U(:<1&6IN2I*TJ)I:"(U)69'Y3(CU,
MC <V)#$IAN3%=0]&>23C3S:B6A:%%J2DJ+4C(R\#(!V            B/(N
M5W)-'&QRXE/QZE$^)836(^S26W"<)TH[N]*ONU*))JTZ] $N
M     =1R8Q24PS>04M2#=3'W%W#;29)-1)UUVD9D6H#M  $!=XIK)_(K/(MY
M;6-M)K34K'J62\G\,K7'629=<990A)J<46I[G%*TUZ>"="I\"   UV052KVB
MLZ1$MV JRBOPRG1].\QZAM3?<;W$9;D[M4ZEX@,/#,5K<&Q2FQ"H-2JZEB-0
MF''-.XX322(W%[2(MRSU6K0B+4P&WDRHL)E4F8\W'CI,B4Z\HFT$:C)):J49
M%U,R(@$;SW JCD2JATMV\^U!B6$2TTBJ2VMQR$ON(0:C2HR2:M-VW0_D9 -A
ME^-1,RQ:XQ.>ZXQ!NHCT"2\QM)U+4A!MK-!K)1$K0^FI& [*JOJ,.QNOIV7B
MC4E)#CP([LITO*Q%;2RWW'%Z:GHDM3/Q,!M@'4<J,F2F$IY!3%H4ZB.:B[AM
MH,B4HDZZFDC,B,_M ?&I45]QYEA]MUZ,HD2&T+2I3:S22B2LB/5)F1D>A_ !
MW  #'F3H5>SZB?):BL:DGNOK2TC<KP+51D6I@.\C)1$I)ZD?4C+PT ?0
M     !CQI\&8MYJ'*9D.QE;)"&G$N*;7^BLDF>T^G@8#( 17%L!I\3O,IR&
MZ^]8Y;-1861O+(VT*9;)IM#24I(DI)/SU,S\3\- E0  Z?513E'")YOUA-D\
M<?<7=)HSVDO9KKMU+37P =P   -768Y24T^VM*R&B/87CZ)5M(2:C6^\VTEE
M"E&HSTVH022(M" 9T>5%EDX<5]M\FG%,NFTM*]CK9Z*0K:9Z*2?B1]2 =P
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MW<1J*O9XG/+X%;66)R7/Q1U4&<3??6R9=LVG5)-))^I/QU\05[,!E1OO!_\
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MR]G<7,[?#N,:*MMI&*5S-MDS]Q*7%U]2E3C,2*E&FKRVT[]Z_)UT/3XDI9F
MYE7\@X92YI5H4U"N8J)*6%GJMI9ZI<;49:$9H62D&9>.@(I7),3IN8_<3;XK
MG+*K+#\,QZ,["IC=<:CJL+59FN2KMJ29K)OR%UZ:$?B0*VDZ?=\#XMA'$.$+
M5F&:7TJ5"QQ=Z[V668<4CDO./J:+<;<="TI2E/7;X?220&ML_<5E%+QGFEW:
MX]$8Y$P.TB5%S4)><7 >]:^TAI]ESHLD.(<,T$KKTZ@4U\[FKG^%=Y%B"\.Q
MPLCQVM_>67(*?)7$_"MIGV$(VI6N09D:=^Y*-2/IIH9BFYL^=,YN7>-(/'5#
M62+3D.GDVI(N)#S;,-V*TAQ:5+93JM"=5%T3JKIX 4W6,\NYAEW%UID=935D
M+.Z&T?H;VNLYQQJN++ANI0\X;^AF:$H6E>WQ_-(SZ&81/^HS+J[CKD>[N*FG
MD9=Q[(KF5JJY3DFFFM6CC1-K:<(S7T2M1F6OCH1Z=2(4SF>:>5ZZRRW%<HQF
MH8R^MQ5>;8^Q7R7I,9Z&R[VEQGU=%&]KJDC1HDS+Y&1@4D53S5.R3(.+:;'Z
M^.ZC-Z=[(;]QQ2S57Q&6$&1().FIJ?4IG5734@*3ODFNR&XX_P GJ\3?5'R6
M962V*IY"^TLI*VE$@DN:EL49]"7KY3Z@BAO;/2\-*DQ)M)7RL8Y;QFM.MRZ@
MF/R&'UO:)2_)>8<5M=2:]5)5X(W%N21[-"RV-3[C<NFNTV;R\=KV^&,BNOP&
MLGMREG=-DX^N*U-?9/R$TMQL]4%YTE\^AJ%-]8\M\HW699%6<78C OL:PV:Q
M5W;DV:<2;,F.;3?;AF>C2.P2O.;OC\-? !VV?)G*]CRY?<<X-0TTFLQU%7)L
M+.SDOM.)CV#9+626V_J7]6W3H6WKJ9D0"..>X_*D..YT6/UQ\),7?X Y9>K6
M5R:"?**=@EG39V.Z?^'IW-/]H%,7%9/(Y>ZW.B8KJE5<J+5M6;JY+W>;J"W^
MG<9+;H;RBZN(,MI'X'\3'!N\EYJY"PW/JRLOJO'5XA:9 QCC4:!9+D7S2)JU
M(CRWF="0E"B+<:-NI?3KX&!394/)G*^6<EY'C%#04Q8ABMRBMM;65)?3+5'6
MV2]6FD]#<(NNI^7X?,P&HB^X/))?'U!9MTL,N0[;+?W(E4V]TXL>:A]Q+BS,
MCW[4-)2M6O@:OD!3T*"/&/#O)F<\;X?66,RAKY'%DW+)M1.M$R7#M6WI\U:2
MDFWIL)IM7D,CU4K3X:D8-2M&X]P%QC^+\IS;2IC'E& W#576US2G31,CV*VD
MU[JBU-6YPEJ4HD_ N@)2\ZU4]==$7:H;;M%,-G-;8,S:3(-!=PD&KJ:25KIK
M\ 1YVRKW-6^(XQ:6UG2Q3M*K.9.'OQ4*=VJKHC7JES$EU5KV3(_EUU^P%IL\
MZY]R;&(G)5E5TD.;!PRTI:6I-UQQ"I<FP2VJ63ID>B>V;J"1M_M IU99?98T
MYQN?+6(T+^0S\VC1*A,1^0^W CK:);<E"U;=9"%DHM#+8>B3T^0:;AU_D%?/
M7+2)U94?@3]C$3DKJ'WER&T(@.^B*.DTF3F].WNDO;MU5I\@)8.&<O6]%P]Q
M=(XYPZIAR<UN)U2Q1]]]F%'64F2DEDXHUKZJ;WKW;OB1%X J2L>X?)*C!<TG
MY=CT4\_Q"X9QU%76/K5"G39IH3&4VMTMR4GO-2B5UVI^!GH1*2#CKDKDNRY.
MLN,^1Z6HKY]?2MW:9=,^^^VZ3TA+*2(GNJ2+525$?7<G4M4F0#M]TKERWP9E
MOX,RPZ2HVVQ.2XILT0C47<6UM+S.$>W1*M"/K^0Q"/HY,Y&Q# \#QU5!52N2
MLM=;KL9KX\E[\-1 BQ6W52I*S22_NT'YT(^?0_@ G'$G)%SFJLCQW+ZQFHSK
M#YJ(%W%AN*>AN)?1W8\AA2R)1(=21Z)5UZ?;H0<N?<H7B'#N87+!F4PX"X,+
M;J:_4V)E$:-)%U,R6Z2O[ (49QYF>2<$\,YC0JBLVUAQAD3<2?'=WI,Z:T<:
M=)YLD'KN-3[BT_FZ%J"KI7R9?V')&4X9C%="GP,:QQFV.2\^IE3MO.-3D6,I
MS12&VEM)W&LTF9>/@"(I@_.N3N9C;8GR-%HB;A8^]E3%IBTQ<^.W%B.]MYAX
MUF?WJ>OTZ%T^.I&!2O)V<<A\A9CPGE&44%?4XE<7ZY^-G%E./S$LG'63:9:%
MI)&Y2='$K;_(9$8*E]K[C<MAN7&<1,>KW>%\>N3H;*>N4LKIPD/HBNS6&2\B
MF4..%HCZU%\NII)3?X&9*]S/+*B/<7X7CNT]=2T..H^GV +R!
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M%M=G$F-7]'G'*]C;U[L.#=7S<NI?<V[9#"8R4&M&AGTU^8(G'('_ - 64_\
M=%A_U9P$>8.)(6<<A5G"5:O%)5-BV#%^-3<BE.M*C3$H84W$**2%&I1N&K5:
M5$6S_G-2Q<6X4B8[?NX;E7"QY=(7<O+8S=,U+$)RGDOFXE][<X1$ZRA1D;.T
MC5MT+KU,6N_C[%\AJ^<.7\ELH+C%'?\ [NE335[=DGT,!;3VS0S/R*,DGJ1
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MBNK8D,K?(E(=:4:5),M/$C+0%I8J%H=0EQM1*;61*2HO R,M2,@1R
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MV,2;B920RC2[^:NSMW]ZUK?E.=#49K4>A$1:$E.A%\@&[
M              :.;A^/6&45F9389/9%3,2(M7+4I?W#<O0GMJ-=NY9%MW&6
MNG0O$P&\   !'\.PN@P2J=I\=86S$?E2)\A3KBWW794M9N.N+<<,U*,S/X_
M!(            1ZEPK'Z#(<ARJN86F]RER,Y<RG'%N&YZ)HV6$I)1F24H29
MD1) 2$  1YO"L?;S5[D'L+5E+U<FE]4MQ:DH@(>[_;0V9[4ZN>8S(M3 2$
M     'Q226DTJZI46AE]A@(C@G&.&<;M3DXK 4S*LW$NV=A)>=F392T:[.Z^
M^I:U$DE'M3KH6I]-3,!+P                        $%YJ+7AWD BZ&>.
M6W7_ .PG0(>8\$C1L^>X-8P+";"IN<1*LFY3F;]:5;$<A1XB42&4R2T.3ZE1
M'M/KKKKX*5H:8V+Y/R9Q_1Y)GF/7D-O#(W(LZNGXJ[!0X[*3-FMMN.'+,]Z%
M))220E!$7Q,S^D!87N$Y:O\ !+NP.@Y3J*2?60VY</"'*HITF:[MW*:D23-7
M9WEH;1$23/7X%Y@2&;=YIR]FO)])A&"Y+#Q.)9X/$RV2X_7M61HD/2S:6AON
M:>.Y"?,>A)(STW -)GW(G-#66\N)Q3*8=;0\7Q*BQ37R:QF2Y-*5 *0ZT;IZ
M&A*E(<49]5=4I3H6I@)#QMGO*;7(^,TN>7L&[IL[QI>2Q(T2"F"56\GMN=A"
MR4I;K9(5IN=/<9_+3J$9H^;<D;Y;QNAC\G4^=5E]:/U=IC]=5E#1 ;V+4R\Q
M+(U&\6I%N/>9:]"U\2+2683DO-W)M[,S?&[ZJK,"@9"_3-XK-A=Q<FK@NDV_
M*.6C5U,A778WT1KXGIXD5[F/N.RZ-=9EDM/F5'5U>&7#E1"XZG,M'/NF(+C;
M<E\Y"C[K9K,UFSVR_-,C+IJHM+6B\GY%9<AYQ609:/W;K</AY!1LJ9;WMR93
M2W"6I6FJM>GE,] 13EY8<E\AS_;MD[64QZV]O(]AV)2JUE\F+!+"U/R31JE*
MR=:V-DWHDDF6[X]"K5L^3+K#^1.2?Q7T]A7XCAT.X;0W&:8??EI2M2B4\DC7
ML6LNB34:4:]/M(W/$?\ .Z6W69AGN3U-EBF052+1VK:@E#?K'Y"$/,M,NH,R
M<;2A1]Q3JM2/PU^H!6>&<VY.YR[B^,%R93\@5>129L.VJZRJ_#T5RF&%.LN1
MY&JE/)4:>IFM1>)=>BB+325&=9-Q_P 0Y7;8S(36>KY.L:ZVR!<0[!-36R72
M[TTXY:DOMFE*=JBT/=IXZ /2O%#^0R\1:FY#EE?FJI+RW*[(:J.B(R_"T22-
MZ&E*1W"42]^S0B^GQ(S,RJ;-\HYHM^3L\Q; \IB4=;B5-"NHT5^M9F.27G&E
M.&QW'--B7#29*6>XT]-I>)@K6T&:JSSE?A+.9;28S]KBES)F-MZ]M#R$)2\2
M"/4]N]*MNO70!(.(<BYNY**HY4_'JN/Q]=S):?W.>A:/1ZN.\ZPVXB6C5:Y!
MJ;ZI5HC3K_ND)>@@1Y^]P]%1OY5Q+)?JX;LF?F<!B<^Y':4X^R3+B>VXHTF:
MTZ$7E5TZ%\@6$$SWG#(J7),SB8AE^/892\=*3&J\-FQ65/7ST=KO24$>J5LI
MUU;9['U*TUV^(+257?('*&?Y_C.-<;9)&Q*JR+!H^8]R97M6+B'9#^B4IWZ=
M3):$GKY2(E'H:M 197 F>6O)?$N-YG>(;3<3VWVYILIV-K=B278QK)/PW]K<
M9%T(SZ= )4QC,IK^H;DZJD\?+RZ'97-.Q)N.S%>8JVUQ$H4MWU!&K;HK>>SX
M)^8*E7/_ "#8X/,BP*+D^HP53%:J1$H'JM-C*EOM&OMH4H]R8[#A))M*MG11
M'IKX$2&C?Y.Y:S=[B"HQ*\A8S8Y[0SK"WEK@MSFVY$-E"S<:;=/4NN[:DU:%
MKUUT 9K,G(\>YWRB7HG(,QJN,([JC;:[*;&SC/FK5+39^0GG4]$)\-=" 8?&
M.4\D<D\>Y+=.<F5=JN52/D_5HJ&HTZBME$1J9<;)1&XTE"7$$IQ/G/S)Z%U"
M-<<93R+A? O'5-07$21>Y[:,5&,.OPD(9IH;BG5/K<(C/U"DF@U%O(OJ^.G4
MJ3S^5.4<,QWEK$\CMXUIFN"5\.UI,I9AM1TRHL])&1NQ2W-I6V?E^1Z_9J9$
M>YVK>5W/;/?W>9YE$MF[!REL5P8M8W%0B&\\R1Q4+(]W1]QE[N*ZZ(-/@KH6
M'J'#*_)JO'8L/,+IO(;]!N')M68J("'4K6:D$3*#42=J3)/CUTU!E2V18QBZ
MO='C,1VDKUPY.+64F4RJ(RIMQ[U1&;BTFC12_'S'U!>"MZSW-Y*X_6\@NYE1
MKQNQNBK7.+TL-(M(E.N2J,B4;^O=-\B(G30?W>TR/IKM(M+1HKSE[,^9LRI*
MS*XE3A6$VU63]8JM9D2)D22PEYV/WCT-LE$E6CG51&?R+0$=/$V2<M9K<9!E
MUWF4"'@>.WMY4NTBJYA*G&(9*)IQV7N0:"9-2%=/J2D]Q]>@1KC/FC);'F"@
MPY?(U7R)49"S9?B+-=5_AJ:F1 8[[?:<TU>;<T-*5*4KX_88%)-Q+DO-?)ZJ
MWE2)?U<;CJVL9;*,/?@Z.M5,5YV.3R9:-7%234W]"M&_C_N@*UD>YW)69#_(
MBLSI$8W'NSKCXO4PV5HJF3(*,<OO[NZ4C3[W9_A[>O\ N@M/9H,J$Y+K:ZV]
MQ_%$"UAL3X+E9D/<C2FD/M*VQT&6J%D9'H?V JK'LHN>&,9]PL' '45T7$[N
MFFT#*FT/1XWXZ\RB0TVVLC22"3T2G31(*M;/,WR%7)N4<>+?0>*GQG/OCB]I
M&_UYR5QM_<TW:=OIMUT!%><.Y1R9@=9PTBYNX=OQ[F[!4T>F:@HC/5KI,FN*
MM,@C-;REF7WIKT2770O!0++!H,GM\3XRNIM.;!/RN6Y$![U,=J4CLR):"5M2
MZ2B2KH6BBZE\- &_SOD/FH\FY@?Q3*853C_&**^<S6OUK,IR6B1"]0XP;RM#
M0D]BSW:&K4R(C20(])XI<KR+%Z3('&B9<MH$6>ME)ZDA4IE#II(S^!;M 1YR
MY(QG#LPRNJX<XHQJ'&NJ:YB7^69+!C-L,TK:7#?41OH21JDO:Z(:(_#Y$GR%
M>I 11'-L.'8<O<(0[",U+AO65R3L>0VEUI9>@29;D+(R/0^I= 6%09PZ?&J?
M<IB^))]!CZZ^EL(M?&+MLQ7KI*(TOM(3H2"<2X9Z%H1)(B+H0*G>98IC_'V2
M< W&*5[-;-;LF,=>7&;2TY(@SX>Q9/FDB-PR,C5JO7S*,_$P1B\O8SAN8WC?
M"7%V-0V\O<M(U_E.1PX[;+=&A3I/+?<?21&<EY/E;:(^J3^'0!ZAD1X\MAV+
M*:0_%?0IMYAU)+;6A9:*2I*M2,C(]#(P10/">/8^WRQS$XU4PFW*V[@IKUHC
M-)5')4+J31DGR:_';H"RB/,U9CM9F>$8+#PYG"L8;R>#:?S#3%2B*J5UD>F9
M7'0:D.O.*[>YY24D:?#:6J2M!R9/?J.4.:3J,.+DE-I104V$I#6O[O.(A.-=
MA:G$*W$I)%)-+!DKH1?4DS2&YQ^MJ+W*O;OA\J:C),5K<;G6S+CB#.+*E,QD
M--*4TZ7_ *@R\B5EN1IU^) )WPO%CXWS3S5A50TB/CT>737$2$P1)98DVD(W
M).U!:$G>:4]"^!$"2O*Q_P#F?+_^4N?_ !I@CQY@.69WC_ _!U)@5I'J;#*;
M>=4R)<N,F8VEMR7,42MBNOE,MW0RU/XZ TE6=<D9_BN18_Q+9<F5&.7D>F=O
M+_/;2OC(;F..2ULQ8C$5:B:0K:G[P_T2W%U(R,C3JY&E\HUO!&2V:6"NFLT<
MKK-4,]T5R1#0XV;K1G^8XG:X7RW: K*YKYOR/ <LL9%!R;3RGJJ7$;1QNBK)
MUY]AQ;3;Z'I^JMCR=RE;4J3HDO@?0"FTY$S;F5_.^4*S"\JB4=)Q_30[YJ(_
M6LS'9)JAJDK8)QSZ4K-"MRSW&7E))>)@C.>Y,Y+Y%MN/<0P>UAXE;7^)LYK?
M6CL--BG:Z;;:(S+3JB(DJ<-6XS/=M,M#U+10;GVD%(3Q"299H5**YMR?4T1I
M;-SUB]QH(_!.O@!+29CG7,61Y5R(7&]S!HJ'B]AI3D*7"1-<N9AQE2W6EK69
M&R@DIV)-'4ST/7KY0Q[+DWD[D/(..:GCR]BXFSFF,/WDYR3";L38D-&G<39.
M::FE1FA.X]NG4R,]" 7CD#,Z/QW:1[22F;9-4LAN;,2V327GTQ5$XX39=$DI
M6JMI>'@"/,?#N3\F8'CW#CEI>Q+'CS-3*@9I68*&'ZYYQ#AQ74R=34ZM2B^\
MWEM+P(OS@:2&OYBY*G85CV.)G,_S3D9V]A%Q8)BM;$LP75O29"6#3LT1'-O7
M0OM\01>/*V;*XXXZR+-FXY2GZB(IZ-'7KL7(6HFFB7M,CV;UIW:'KIJ"*2XG
MYGR61R)1X5D&=TN?-Y?729;*Z9AF.Y464-KU"XJ^R>CC*FR7L6OSJ-/@6AZE
MI"L<Y3]P]MBO'>8%F-6IGD2U=QIF ]4-:07.^\RF8:VU(-QPNTHR;Z(^G774
M]"K-Q/D7.&,/Y.J,SR^LC9%@MG^'1\VG0T1XBF74-K;6]%:4E.\]5))*#^HT
MEHHR\Q$*QCFW*K"BY8K$YE Y AX_C*[NER1%4W7EWE-NDN._#4G8HDF1=%$?
M3QUUT(M))CUC*N.8N%;>=V_73\ =E239;2RUW7F6'%;&T:)2G51Z)+H7@"+<
MY>R%[&,(E6C&5P,,>)UEI-[9Q_6MMDM7F2W'W$;CII(S0GKX>&FID1YCM^0\
MPY%X-Y>IW<PAY'%Q9<-3.51ZY,0K2ME-]Q;!Q_*3*TJ3IO).I'J77Z@:>G^(
MJ_)ZW :=G*[MN^GN1V7H\MF(B"EN*MELVF30A2B4:"U+?XJ^0,L?'V67.4\S
M6XVA;C3%4;2U)(U),V5D>TS+4M?L'W^JRF.@T(B>.I_YA^0Z'#&>[]5,Q%QC
MI5_],H=0<P939\E?NU(KVTU;LIV&40D**0RELU%W%*UZFG;JOIIIKH/L]3V/
MI]/H?>C*>:,8F^$WP_\ P?F^A_*NKUNZ?'RPCDG*<>6OY8UQO_I6W@E\5MMO
MFJ63:$H(\<0H]I$G4SF]3/3Q,?(SF9[7%_\ W?\ ]#]%IXQ'?<JC_P#KQ_\
MR+"'YY^Q
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M(@O%6-<I5UDA&<8WB-77U\(XK=E2-K_$I<TB2@GTF3:$-M*1OW(VDK4^FA=
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M/Y@'B4/^9Q02S#<[ZPJO=Z;9W%=KQ_.V:;M.@_-OVR5@
M
M                                           Q&*NLBSI=G&AL-64[
MME-F(;2E]XF4[6R<61;E$DNB=3Z ,L
M                                          !KX%%2U<VPLJZOCQ;"
MV<0]:2F6TH=DN-)V(4ZLBU6:4]$[O @&P
M
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M="T\0&5E')M)BV:8G@<J/(?O,O<?1 -I*>RTW$;-QQQU:E%X>!)21F?V B;
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ME:&9?+4!W@(9RCR72<48HYE=['DRXW?:AL1H2$K=<D2#,D)U6I*4ETZJ4?\
MM/0@'#,>3:7#,FP_$I\>1(N,TEN0ZY+!)[391R0;KCJU&6A)WIT(B,S 38
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M1_ @5M^.LS/D#$8.5*IYU"J;W2.LM&^U);[3BF]3+XI5MW)/XD")2
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M]"^8#IPK*(^;8G39=#CNQ(EU$:G1X[^WNH:?3N02MIF6NAEX& WH
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MD]O+;V7<9%E?X)8P)4YQZ"5=ZU;"F4-K,^BDI49[C/JKX:$ ]'^\[_P!O?\
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M>6-YAZ:6/D%9^+O^JD17C6RTX@G-$]%FZ:M"21="Z:ZF9)>E00
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MUVZJTZ?:!;-A\"PH>5QLK9R"8W+C8BC"F^RVVVZEMM!(*6ASKM=+3<1;3(C
MMK\$]O4K&LUK,XR[.;3-+''X[T/'&[%)(*(W)0;2S4O>XIU1H4I.IZ>.I]=
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M+;_%N 6<5SC)\AC9--?P_*GIDRRPMQM)0W)-BE27E..$K5:=%JVIVEITU,]
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M2=ED\V;*#3X[EZ[2TU^)@CN:FPWHA3V9#3D%2.ZF4A:5-&V1:FHED>FFGQU
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MFO3S&7U:@,V1QUE&6<)\,Y/4T:,VHL;A3G+C!ER7(JY:'W5))YHVE)4I3?\
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M2,M#/774"TCXRXGQ7BBNFP,:5,D.V;Q2K*?9252I4AY*=I*6H]J2T+]%)?:
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MWQ)B.*9YD?(U4F26190E*+'NOJ<CI(C2I7;;,NFY22,]QGIX)VET!$Z!
M
M
M
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MXNO3H>A:<7N?^(8^;_R[>RB.G*N_Z,X^QWLE+-6SL'()'9)S=Y=IK^KR_5T
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MK-<,MQJ-)%J9FI1GK\3,_$P%\^Z6+:3. \U:J"4J2F*R\Z3>N[TK$IEV1X?
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M*5J>A?,R!)8?N5D0:KD_A7(,I-#>"0;::BRD2"UB,RW$,G'6]KY2T-"E$:O
MDJ/Y@0I+))%;9X'[G;_&#;5@\^VH6ZJ1'(BB/2V[!"I*F3+RGJ:TJ,T^)*28
M*F]S7NIYEI*W&8Z(]G,XA?9@-14);-4E;,HFM"01==Q%H8" \/5W[U1N):Y7
M(N.U\F@MRF5&,MPEMW*'FI!NR6'G4%K]\E)Z&YHESIXZ /?MQ5Q;NIGTLY.^
M#8QWH<E'S:D(-M9?VDHP9>(O;\S>91G-+BSR%%:\-4>05Y/KZ(*VF37HK)%K
MX:-*TZ_H U*$Q++%I'MZP[!:GLIYG:S)*3KT(V6S4PY3Q$XOH2R+8;3>X^FX
MB+Q3T"_*JRQ*@]X^8-Y [!@.6515LTR926VU/V,A44DDQN+S.J49_3YC/4$X
M* B5,JVJ,\P+*\_Q_$G9&72%V==<PU.V[D[O(-N2U(21K[:E$:=R>B2W&9DE
M?4T_1JO9DQX$5B8]ZB8TRVB0^1:$XXE)$I>A_,^H,/SVO(L17!/.4LX[1S"S
MXT)DFA)NDDI;6A$O3=H6Y6G7XG\S!I)>0)%G#YWS,I^54N)P+[%JY,>9DD3U
M;,JK7":;?:C:D>BC=0YY4]5F70C,@&)DE1:X0GV^KB9A5G308=PBJS:PC+?I
MFW93BWF3<:=(S0?:6TV@UZ;5)W=-AF08F34$>FX2L+EC*JW+L9G\BP[2_=I8
MZV(,?5MQ,IOM&1$2#4IG:22V[=NW4C(!<O%E[B>1>ZW/+/#9D.?4.8W#3ZJO
M-"F''D.1R69*1Y5&70C,OR G!L_>8EISCK&6WDI6TO+*M*T+(C2I)MR=2,CZ
M&1D!"L^0Z^6ODSW%UF.L[)"\/KU^GBI))J;0Q%4\1)2775K>6A>(*QZ&YPK)
M<P]M,#C5<9[(::"O]Y"@))#T9AN(R4A$HTD1[C4F1]7CN,_SR,PG7 5GB-1S
M;R_037H,/(IN1&FAKUI;;E.--HDK=].C0E;206Y6WIIX@DK!]UC3COM^S5#2
M36HH\59D77RHG1U*/^PB,P(4WBF4XGE7N$XT.GMHUC"@<?\ H;1V.Z1H9=2P
M^IQM:R,MJDI5YBUU3\= 5K^',F@\;<DXC@&%Y-3\A<;Y(_/32FRR@K^E4M)N
MN&]HA*T)5^=O^M)*424::&%7X]3SKS%KC <BY"H,4G_O8Z<FILH2U77XRETD
MH?2^@M^TS+9W"\J>I&9:@K]&+*5+K*27-;:.;.AQ7'DLH(R-YUILU$DB+7ZC
M+0&'YYGG.0Y[+XAR?(<[KK2RG9G'?_<>#"BQ7J?;/2GN=QG[S:[H2M'/JW$>
MJU$HP:3F[4G\']VG4O\ WZ!_[9X@'K3B@R/BW"#+J1T%5H?_ -A- R\B7\2"
M]7>["2\PTY*9FP$MO+0E3B"-]T]$J,M2\R2/I\2!I+<<7'>YRX:.8M)1W.+V
M#D+4K86Q49_<9GJ6A::]0&DX<R:%QMR3B. 85DM/R%QODC\XJ4V6D)OZ4UI-
MUPWM$)6A*OSM_P!:4J,DHTT,/5V"\C8GR1#L)^(RW)L.KF.5LQY;#S"4RFDI
M4M">ZE.[0E)/5/3J#*F>3H\65[LN'V);3;[1UUNKMNI2M.Y$:0I)Z*(RU(RU
M(_@9:@O!YSF-S2X+F2(CK,:HJ^7'G;!UUGOQ(S'IFTMN/LI2>]E*U%N1IYM2
M+0%3==6<K'^<,U5G]%E\ZPQI$:ZB8]'5'92^1(],\9E]VKR(6DS3KYM2/KJ
MO#C+,\ XYXKXH:N4MU]KEE965U;Z2&MQV5+=::/:I3#9GJI;NIFL_J49_,$6
MUF;%C*P_((U/N_%GJV8W [9Z+]2MA9-[3^>XRT!'@NLM<.MN)>$,1Q$XZN58
M67,KDQ(Z"38QS1*?4ZX\9%N2DS-A>Y731/\ N'H:7WP/654[FCG:3,AQY,J/
M>P>P\ZTAQQO0Y*RVJ41FGS((^GQ+[ 25U\EF1<<9@9]"*DLO^J. CQED'H(_
MMCX&LYR&418V3Q?537D)-+<<GYJEDM9D>B-$ZJ3X'IU\ :XK/YV/!;6=A>=X
M-R'1XOF-1#FOXSZ_M+J)]?J;3J-5)4VC56]"#VGOU41%TW))"V_;_F\KD3B;
M'\IF5;-/)D(>8<APT=J)K%>6R:V$?FH7LW$GX'J6IZ:@2\^^Z:5)P'D.RM:]
MAQW^:&'R,50TT7UV+<IA&X^I?^H<2W_:"PV5S"QKBSW!<:Q<Z>BP\,JL'*GJ
M)\\DE"3/A]U#QFI?E):D*+51^.])>)@*CEQ6S]KM[<M1B1C;_(2Y..+<:Z-5
MB]B#-O4M4-FM!I,B_.(R 6E[@+N%+SCAW+\*R"GK<+:=MH];D;[*9E%%L/*1
MFM*$F@C4I.U*_!*DFK4MAF0AKZG \&L.'.0D95R=4.T619&U*:O:F.XU @WQ
M*(U)[)Z)4AS<CHC1/;\Q*T(C(+.]LO(>09-99IA^0R*B^EXR[#-.9X^AM,2S
M1);623<4TA"%.()O3<DOF6GEU426'[G7X59GO"U]DQH1@L"]D%;O2$[HK4AQ
M+"HRWM>FA;'%:GX$2C A2N1R:VVQCW/Y#B:FUX+-E43<&3&(BB/S&YB#?4R9
M%M/S*-1FGQWI/XD"O:/&=965^"8TJNAL1#>J*[N'':0UOVQD&6[:1:Z;CTU^
M8,J2YXF55%[@.'<CS53;."1DVK*Y<PB.$Q/<9,FU.&HMJ3W&RHE*_1U_-,%A
MI.0^5<8@8KB$/A"PK<3Q')<IE5]QEIUS91H,AA2%./I1)0ELS62^XE[X)3T4
MG0]I5?8-68CE&-^X&JSS.8[M',MJ??G$9AMJ.]+.0^;,E,=CR&EQTD[TH\IE
MN,E$7F()I@.;6^18;S%QWD+M)ECF.8\Z_&S*@::7'G(5!=)A+QMH2E;S9)(D
MF1:D:5%UV[C"S_:;=8M8<.X_6TDN&_=UT-!7K$4T&^RXXZ]VRD$DM249)/;N
MZZ DM=[D\_R3&K[C[$Z>^BX=6Y+-E'8YC.C,2D02B(;)!)]27;0:NZKS&:3\
M/,1;@(>8%O*=X#YO4JU:O#5E\)9W$9I$=B::I9:R6VF_(A+NF\DIZ$1Z%T!I
MZ&Q4R_J^_P#]?QO_ &T<&>#?>\N-/D<'6"HC;CL.//@/VK;6NIPT/%NU(O@2
MS0?V>/P A"*FTPO,/<[#L^,#AS<7B8.\SD+M>V@H2DK4X33+J222341*8(T*
M+IM))_09$7@EOLHCQT<&5TA#+:9#DV<EUY*$DXLD/JVDI1%J>FO34$E@^\#\
M.B1N,;6R0PU#CYA7^LFR$(-#<=)+6LG%J(]$:)-2DGT/3[ (86>2\;R#W&<%
M2Z142PQR1$MUPEL)0Y$6AMAW8ILM-NB5)U29?$M2 419HEIX=NW8CC46JJ^8
M7I%@ZZQWXD:.<9+;;KS*4GO92O0E(TZZD6@*]!^WFJ5+Y0S3-/Y@4673I\&)
M&NXN/1U1V4OIVG&>,R^[5]VAQ)FG7S&>O74$EZ8!            &MJ\>H*1
M^=*IJN)7R;1XY5D]$8;87)D*,S-QY2$D:UF:C\RM3Z@->6 8*FK;HTXS5E2L
MR?7M5Q0H_ID3"U^_2ULVDYU^O34!\O\  ,&RJPB6V2XY6V]G T]'+G1&9#K9
M$>XB)2TF>A'U(O#7J D1$1$1$6A%T(B 4QB?M_HX>:9QF&;0ZO(5Y)<-VM-'
MD1$/J@(8[FT^X\DSWKWEN2DMI;2ZG\"VM=>/T3MTUDCE9%7D++)Q&;93#9S$
M1S,U&TEXT[R1JHSVD>G4$8&18)A67OQ).58]774B K=#=GQ6I*FNNNB3<29D
M6O4R\ $%Y(X9;Y$Y!P/(YRX1XQB2)Y3ZB5'*2F84Q#:$-=M1=LD$2#U-6OPT
M+XD6UAU^*XS4T18Q6T\.+CA-J9.I:CMIB&VYKO2IHD[3)6I[M2Z_$$8^/X-A
MF*5\FIQJ@KZJLFF9S(D2,TRT_N(TGW$I21+Z'IYM>G0!UXWQ_@V'RI4W%,<K
M:69-Z2GX$5F,MQ.N[:9MI(]NO7;X:@,:-Q=QK"GG:Q,0IF;/U2;$IB*^,3R9
MB#W)>2O9N2LC\Q*(_'KX@-@K"\/6W:LKQ^N4U>K[MVVJ(P:9KA&9DJ01HT=/
M4SZKU ,8PS$L+BNPL2I(5)%?7W'VH$=N.3BRZ$I>PBW&1="U\ ';D6*XSE\#
M\,RFHAW-?KN*//8;D(2K])).$>A_:74!B_N'A'X"QBQXY6*QJ*M+L>H5#85#
M0X@S,EI9-&PE:F9[M-=0&:>-8Z=I*O#J89W,Z/Z*;8'':.2_%Z?<N.;=RF^A
M>11Z -52<9\=8W*CS\?Q.HK)\-3JHLN)!CLOM'((TN;'$()2=R3-)Z'X=/ !
MW_N!@OX7^!_NS5?@OJ?7_AWHH_IO6?\ R?M;-O<_W]-0$B 1.)Q=QM7V<6Z@
M8A31+>"M;L2;'@1FGFW'#U4M*T((R5K^=X@,O(L"PG+Y,29E6.UUS*@'K#>G
MQ6I*V^NNB3<29[=>NWP ;]"$-H2VVDD-H(DH0DM"(BZ$1$7@1 (Y<\>8%D5G
M^-7^,U=I;&P<0YLV&Q(=-@_S#4XA1F74_P#:?S =MQ@F%9!2Q<<N\>KY]#!2
MA$&ND16G(\=+222@FD&G1&U);2V:=.G@ RG<7QI^A/%7J>$O&3:*.=.J.T<+
MLD>I([.W9M(^I%H PH_'^"Q<</#V,;K$XJI1.+IO2,G#4X2B7O4R:32I6Y)*
MW&6NI .=U@N%Y&Y7NY!CU=:+J?\ YF',BLO^G+0BT;WI/:70NA=.A?(!]/!\
M,/'58A^[U<6*JW:TI1&2@ZK4:S,F23L(S4>[73QZ^(#LK<.Q.GH5XO54D&'C
M;J5MO5+,9I$1Q+I:+);1)VJW%]6XCU^(#%H./,#Q5]J7C6,U=3,9:5&:DPH;
M##R65JWJ1W$()6TU>8RUZF D$B/'F1W8DMI#\5]"FGV'4DMMQM9;5)4E1&1D
M9'H9& T>/X'A6)PIE=C./5]3 L#,YT>'%:90_J1IT<)"2W%H9D1*Z$70!R;P
M;"F8E7 :QRL1!I'O5TT9,-@FH<@U]SNQTDC1M>X]VY&AZ]0&^4E*TFE1$I*B
MT4D^I&1_ P$4JN+^-Z.8U8TV(T\"P8>7*8EQX$=IYM]TM%+0M*"4DS+IY3(!
MQY2Q.=G7'F18?6O-1IUU#<ALOR-W:0;FA;E;"4>A%\B 87&G%.+<;TU;'KZV
M!^\L>NBUMG?QH;4:3-.,VE"EK4G57G-.XR-1ZGXZF W*\!PAS)$YBYCM:K*D
MD1)N3B,G,(R+0E=W;NW$73=KKIT\ &6[BN,/SI]H]307+*UC'!LYBXS2GY40
MTDDV7EFG<MO0B+8HS+0!C?N+A6VG06.UI(QY9NT*2B,DF"M74SCD2=&S,^OD
MTZZ'XD D "-L\>X)'R1S,6,;K6\J=,U.7"8C)2S6KH:^[MW;C+H:M=3^8#8+
MQG'';9V_<J(:[Q^,<%^R5':.4N(H]394Z:=YMGI]!GH [::CIL=KVJG'ZZ-5
M53)J-F#"91'80;BC6HTMMDE):J,S/0O$!K;W \)R>PC6N28[6V]E#0IJ-*G1
M&9+B&UZZH)3B5'MZGT\.H#;5=564D!BJIH;%?614[(T*(VAAAM.IGHA"")*2
MU/X$ J*NX I97*6<<@9K%K+^NR5R JKJI<1$HXIP&4-FZI;R3(E*-)^5!:;?
M$S\ 6UGY#B6+Y;6IILGIX=O5(4E;<2:PV^TA2"T2I*5D>TR+H1D".$C#,0ET
MD;&I5#7O8[#-"HE2Y$97#:-K4T&ADTFA)IU/30@&/?X-C]Y'OE)AL0KS(*Q^
MFEWS$=KU_II#1MD1NFG51(Z*2E1FG4BZ .W!\2KL#Q&FPZI4I<"FBMQ&G7-"
M6X:"\SBMNA;EJU4K3XF XWN!X3D]A&M<DQVMM[*&A34:5.B,R7$-KUU02G$J
M/;U/IX=0&VJZJLI(#%530V*^LBIV1H41M###:=3/1"$$24EJ?P(!4D;@.GL>
M5\VY!S2-67M3D::]NLIY<1$HXYP&&FS=4MY)D2E*;/RH+Z3ZG\ 6UFW^)8OE
M545'DE/#M:=)I4B%,8;>90I!:)-"5$9)-)="-/@".I>$8:Y30\=<QZM705SB
M'H%6J(RJ*PZWKM6VT:-J5%N/11%KU,!V9+B&*YE#37Y92PKJ&V>]MF?';D)0
MH_%2-Y'M/IXI <V\4QAK'_W3;IH*<7[1L?@Q1FBA=HSU-'9V[-#/KIM\>H#&
MJ\$PJEH9&+U./5T/')9+*75,Q6DQ7B<+1?=;).U>XNA[B,!VMX=B33U3(:HJ
M]#]"@V:-U,5DEP6U)VFF,9)U:29=#)&@#=+0AQ"FW$DI"B-*DJ+4C(^AD9&
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M!I9>#89.QQ.'R\?KW<51IVZ4XK7HD:*-9&EDD[4F2CW$9%X]0&':<8\=7=;
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M+4U$9F ^XUB.+8;"56XG30Z6"M1N.,0&&XZ5K/\ .5L(MQ_:8#=
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M]"M-?AKH>@IMD<_XG(@\<S($&=+7R6\;%-&:2SW&.T:4OKD:N:$EDU>?8:O
M] *6P"
M
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M@RZ^'+<>:3&G()#I*86:#,C2:DJ2>G123^SQ(P930
M
M
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MRM56DN0XT3/:921I8C)(E*U2R2E$E1G\? %3M*4H224D24EX$70B!'T
M
M
M
M                                             =;K[+.SO.);[BB;
M;WJ).Y:O!):^)G\@' YL(FGWSDM$S%W>J<-:=K7;+56\]=$Z%U/7P =K;C;S
M:'F5I<:<22VW$&2DJ2HM2,C+H9&0#D     ZFI49]QYEEYMQZ.HD2&T*)2FU
M*22B)9$>J3,C(^OP =H#IE2HL)A<J:^W'C-Z&X\\M+;:=3T+52C(BZF [@
M   !U1I46:PB5#>;D1G"U;>943C:B(].BDF9'U(!V@.IV5&8=98>>0V])4:(
M[:U$E3BDI-1D@C/51DDC,]/@ [0                        &-/L:^JB.
M3[26S!@M:=V3)<2RTG<9)+<M9D1:F9$77Q 9)&1EJ7A\P'5&E19K")4-YN1&
M<+5MYE1.-J(CTZ*29D?4@');S+;C;*W$I==U)IM2B)2]I:GM(^IZ%U/0!S
M
M
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M2/\ (2@1M
M
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M@
M
M                                     .IZ-&D]OU#*'NRLG6>XDE['
M$^"TZD>BBUZ&0#M                       !ILLQ:FS7'IN+Y"RJ136*4
M(F,)6ILUH;<2YMW)T,B,TEKI\ &>NOBJKE52$=J$;!Q4MM^7:ULV$2?EH7@
MP<4Q:CPG':_%<;BE#I*QKLQ(Y&:M",S4HS4>IFI2E&I1GXF8#<
M              ZG(T=UUJ0ZRA;[!J-AU22-;9K+:K:9EJ6I=#T =H
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
E                                              #_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>px_25avadelpxy04pg01-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 px_25avadelpxy04pg01-4c.jpg
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M_\0! @ !  (" P$!              4&! <" P@!"0$! 0 # 0$! 0
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M$0 _ /?U H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M8;[:UCU>?NN?/TC=X/$\3'-OA:=?]77ZM?.L5:7DE H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MG_PX:F[];)\V/C8>T_TV\_X?'^T37%7^N<(?_KA_EN5KW/++^0\[V@]3J?\
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M*M6YYY?R/C>9[0>OU#S;3\]/<,?VAXR_Y6NG_$3K3N_5R?.CXGE^T_V?>_\
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M5W4E67>K]//55^^RY;[FG_>,UT2C)+WKC7D+'(0W*_8M=;=;R!'?2I4)]II
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M2Z)*@KW!)$\-5;5Q%_4H2I_MDJB\^W_1M&_]'@:JB*FY?16_.75$ZK0AM/\
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M'TE55N2B>^ICW%_QZ+#8?L"YQZ'D&1\>RG-&;FP-VMX+X=^+HV\B>^0$"_\
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M[-?YY^-LR?P'>?K<O[2&9@O^I<0_S;-_^QVL<W/+^0Y^K>OU#YVS_NNO.?\
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ML\NRW!"]%F K9D"Z&*^*$*^ZBIK0>3;]8KOBUW=LUW%&Y32;D^"K;\=54$?
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M2OR?VKSDZJ+[/<9/<S%[7_=C=>U'VG\C[[]:M_C]W_#1^UELS,B'YN<D=?\
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MCMOY3%-7'3YX[5HK0\8H% H% H%!4<WRRXV%RSV3'H;,_*\A?<CVN/*<)F,
M1VU>??>,4(MC8HFJ"FY55$2NC#BBZLW32VWF]WI73L>XC)ES739APQ$WS;%;
MIU32VVV.5;I[^$4FJ!;Y4E6[&\@D9%:A#+\:ELVR59H3W<;E2IO;]#*.X2(J
M-O\ =%4WCN'SM4Z==WU:)NMTSZ-T5KYN?O/3GV?MR[G%;AR?H<]LWQ?=%)MM
MLKXFJ/E6:9Y32>%)XLJRYY>X%TN%AY%@Q+9<8EM<OS,RVNN2(3EO8+8^BJZ
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M:::)6=V>^;XNKQCEY'3FZUNLFYMW.K3?CI%FF(BVV(Y6VV\HM\G;6:\WW%<
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M:OTD<N$4B*4TZ>6FG"G<8UQ_C^,QKDRTDBYR+SHEWGW9XITJ6  K8 ZX[JI
M(*HB/AHJ^[3)GNOF.RG*G"AONL;C=763-+(Q>I;9&BVWC69MB.4S/&9YL;%N
M,,8Q*X^L[<LR1(996+;1GRW9C<"*2HJLQ!=54;!=$\.NB::Z5EDW%]\4FGN1
MS\[=O^O;G>8_#OTVQ,ZKM-L6S?=\J^GK2Z1XGQ ,B'(D"5J$Q;J%I62ZMK&Y
M+_\ -:1==B/:KKN]WKIK5^LWZ=/DI7MIW59S[0[N=OX-;?5T:],>)H^1KYZ?
M)[B=3$[(MPOEQ>9*0>1,,Q;JP^9.1W&6&S:$$;)5$443)"T\:U>+=2(^3R>;
M^\<WAXK(FG@S-UDQ%)B9F)K7G/&.'<B<3XSQK#IQ7&W%,E2Q82%#.XRW9GH<
M)%0DCQNZJ]MO5$Z)[GC6S+N+LD4FGN12L]\N[J/7=SO;-%^FV*ZKM%L6Z[OE
M74YW.F-Q1B$3(0R!IN4O9DG<8MI.2Z5K8GN:[I+455V"ZNXEU3P5=41%JSN;
MYMT^Y7MIW5;,GM#N[]O.&9MXVZ)OTQXEUD?B3?SFW[I?<AXIQ+);R[>K@,MI
MV8+(7>)%E.QXEQ"-^Y#,:!4%U 3HFODZ>%,>YOLMI%/)Y/,FR]H=WM<,8K-,
MQ;71-UL778]7/1=/JU9N58#8LL*&_*<EVZX0!-J+<;5)<@R@8=TWL]QI4U;+
M1-17]32L,>>ZRM*3$]_%S]/ZQGV>J+8MOMOXS;?;%]M8Y74GMCO<9W'.)S<6
MA8>,,HEGMA-.VM8CAL2(C["JH/LO"N\74557?KJNJZZZK5C<7Q?-]>,\_*N+
MK>ZLW5VYU:K[ZQ?JB)MNB>=MUO*;?)V4BG)SM/'V,6K'YV->CG/@797#N[L]
MTY,F8X\B"9ONFNXB5$1$7IIITTJ79[[KHNY3'*G8QW'6=SFW%N>L678Z:-,1
M;;9$<HMMCA$?'VNO$^/+!A\J3<(+DR=<Y+015GW24Y-D-Q&E4@CMFZJJ#0JN
MNU/U==$JY<]V2*32(\G!GU'K6?>VQ9?%MEELZM-EL66S=/.Z8CG=/>D<IQ2R
MYC:TM5[9(V6W0DQGF3)F1'DLKJV\RZ"H0&*^"I]3P6L,>6['-8<G3^H9MEE\
M3%/&DQ,3%8NMGG;=$\)B5>8XBQ%JSW&SR%FSDO+K#U[GS);K\Z<D545MM]\E
MW*VB)MV)HFGU5K=.ZOU1/"*<N'"'JW^T>[G-9EMTV>%%T66VVQ%EFKG-MO+5
MY4W.PK'KA>#O<F,OI;]N<LLL ,@9?@.KJK3H)T5!55VKXIJM:HS71;3RU]UY
MV+JFXQX8Q6SZ,7QDCOMOCMB?C9&+8S;L/LK%@M3D@[?%W(PDMXY!@"KJ@(1]
M=H^ CY$J9,DY+M4\VKJ&_P F]S3FR1&J[GIC3'GI';/:F:U//*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!01F0WZVXO9)V0WAWLVVW-$_(-$U+0? 13
MIJ1+H(IY56L\=DWW1;'.79LMGDW>:W#BBMU\TC[NZ.<^16\7Y">O-X<Q_(+!
M,QB\%$]9P6)QM.#(A(2 1H;)$(N I#W&B\X=4]_3?DP:;=5LQ=%:>Z]??]&C
M!AC-ARVY[-6BZ;8F--_.E)YQ/'3='":(ZS<NQ;K<;<KUCFP,5OLDH./9)()I
M(\R2*D@BK2%W6D=V%V5,?/Z>%9W[6;8GC$W1SCN^[M=6Z]G+L..^F6V_-BMU
M9,45K9;PKQIINTUC52?1?;YRY'M%QN2,6*;<<8L#X1,CR*,K2L0WR05(4:4N
MXZC2&*O*V/F)2S:S=$<8B;N4=_W=AM?9R[-CLKELLRYHU8\<UK?''M]6W52=
M-?62.4<@NV>[LV#'K%*R>\E$]9RX\%QEH6(&_8+BN/$(D9DB]ML=2+1?U<,>
M#5;JNF+8K3W7)L.C1GQ3FS9;<%FK1$W1,ZK^=*1QB(_&NGA%8=<[E&T?-^Q7
MG'HC]]G9.2MV&TQU;:?>< "-U#)PD%M&4$NZ1+H*I2-M=JF+II%O.6>+H&7Z
MQEQ9KHQ6X/I+YK,1%:6TIQNU5C3':^,<IV=,2NN3W2%+M\JQR%M]ULA@CDT)
M^X!;8;0%47.ZK@=HQ7:2$BZIUTL[:[7%L3$UXQ/91;_9_-];QX,=UM\98U67
M\K9LXUNFO&W32=43QBGF=V.\AA<95QM63VI[%KY;(J7-^%-=9>$K<JDGI .L
MD0J(J*B?[%:F3!2(FV=43-/=[FO>]&G%;9DP9(SX[[M$76Q='I_)FV[C6>SO
M8..<JA>[K:XD['YUGM61 XYB]VEJT3,X6@[NA V1$R1MZN-BY\,4Z5EDVVF)
MF+HF;><=WX73O?9^<&*^ZS+9DOPT\6RVM;*S3G,4NB)X7:>4NF7R_#B7*6:V
M68>&6Z>EHN.6(30Q&9V\6B3M$2.DT#A(V;R#M0M?&K&UF8CC&J8KI\GW=C/'
M[-WWX[?TEOCWV>);AXZILI7G33%TQ%8MYT9N4\DN6.[2K/9<?FY))M,8)]_]
M -D/0HSNY0Z.D*N.F($0M!YRIUK''M]45FZ+:\(KVN?I_0XW&*W+ERVX8R73
M;CU:O3NBE>4>C;%8B;IX1*WVBZP;[:H5ZMCO?MUP8;E17414W-.BA"JHO5%T
M7JB]4KFNMFV9B></!W.WOV^6[%DBEUDS;,>6%$+EV,-R(_4<WYE!</4IY=N:
M]$2=W>Q^Y[NYV.[]Z[^FS=TKK^JS3G&JE=/D_#Y'TT>SEWAT\6WQ]'B>#QU:
M*:N?JZ]/I:/6HR<GY.2QW>?:[58)M_&Q,MR\FDPB9 8##PJX"(+IB3KB@G<[
M8==NB^6L<>WU6Q,S%M>7E:=AT'ZQBLR9,MF'Q9FW%%VKTYCA/*)TVUX:I[63
M?>16(@61C%[8_E%WR&.4^UP89ML"L$! RD.NOJ(-AH8H.[X1+M3K4LP5KJG3
M%O"?.T[3HMU\Y9W%\8+,-VFZZZ)GT^,:8MMK-T\)K3E$5=1\IV7YHQ\H:ARG
M)DN9ZHCV'8(3UN_<)I89"1((F) 2DJKH@HI5?JUVO37LK7LIWLX]G\WUN=O-
MUL6VV^).3\3PZ5U^6)B8IY9HYVKDRW/6N_R\D@OX]<\6;1Z_6R23;YM-.-JZ
MT;;C*D#HN"*H&U=5)%'3W9=MYK$6SJB[E+'<="R6Y<5N"Z,UF>:8[HK%9B:3
M$Q=QMFWMKV<7S%N1'[W>&;'?<>FXU<)\4KA9@G$TXDN*VHH>BM$6QT-XJ;)^
M<*+3)@TVZK;HNB.$^3[N]=_T6W!AG+AS6Y[;+M%^FL:;IY<^=LTFET<)8%NY
M>A7"XPB6RS&,/N\Q;79LJ,FEBR9F\FQ3M"2N@VX8*+3A#H2Z>&M9W;68B>,:
MHBLV^1U9_9N_'CN_26SGQVZ[\7'5;;SGC33,VQ-;K8G@V17$^1*!00V/9+;L
ME&YE;D<0+5<)-IDJZ.S63#)!<4.JZCN71%\M;,F.;*5[8K[[T-YL<FUT:Z?I
M++<D4^3=RKY4S6MYY0*!0*!0*"M9AE[>*L06V(#UWOEV?]#M%HBJ NR'D G"
M52<5!   5(S+H*5OQ8M=>-(CG+U^F]-G=W73-T8\>.-5]]U:6Q6D<(XS,S-(
MB.,HF-RE:$Q:\9'>H4JU2\>>6'>;*Z(N2VY:[$;:;V*HN=[N!VC%=I;O%.NF
M<[:[7%L375REW9.@9OK6/!BNMR1FC59?'"V;>-9FO&W32=43QBCNQOD)+I.G
M6;);0_B]]@Q4NA0IKK+PN6Y245?!UDB'0"3:X*]154J9,%(B;9U1,T]UKWW1
MO"LMRX,D9\=UVC5;%T4O^3,7<>/XO>P,>Y6"]7.UL3<?G6BR9%O^;%ZEJTK,
MU6P5U$( )395P!4VD<3SQ\*SR;;3$TNB9MYQW?A=6\]GIP8KYMRV9,F&GBV6
MUK96:<YX7:9X7:?5GFZ[AR]"@7*:7J68]AUIFI:KQE8DTD6--W"V2=HB1TVV
MS- <=$=!77QTJV[69B.,:IBL6^1GA]F[\F.W]);&?);KLQ<=5UO..--,73$5
MMMF:S#.RGD5ZR7=ZR6+'IN2SK=&&X7H8!,@D2*XI;/W4A[CIH!*#(><2)K6&
M/!JMK==%L3PBO;]W>Y=AT6,^&,N7-;@MONT6:J^G=%*\HX6Q6*W3PARNW)=O
M9ME@E8W!?R*YY2VK]BML8FV#=9;;1UUQQQY1!H6Q)$+=UW*@Z>XMV\S-T73I
MBWG*;?H62[)EMSW1ALP33)=-9I,S2(B+>-TSV4[.+@/*=E7$7\H<B2@F1IGJ
M=^P[1*>EW[@M)#04+:1D1"HJBZ**[J?5KM>FO96O93O93[/YOK<;>+K=-UOB
M1D_$\.E=?DBD37R\';8N1H\MN]M91;7\8NV.QQG76#,-M]!A&!F,AIUA2!T-
M )"V=1)-%I?MYBFF=47<O.PW?1+K)Q3M[XSV9ITV76Q,>G6(TS;=2;9XQ2O.
M)JQ\8Y.]>W:!:[M8)N/^O&')F-/S29,9S#0HX:;6C)6G4!4<[9]=NM7)M],3
M,3%U.?D;M_T'ZOBNR8\MN;PIBW+%NKT)GA'.(U6UX:H[6*'+L8[D!^HYJ84[
M</4S67;FEB%.[JL?N:%W$85U.TC^FS=TK+ZK-.<:J5T^3\/D;I]G+HQS'BV^
M/%GB>#QU:*:N=-.K3Z6CG1>[Q=H%AM4V]71WLVZWL.293NBKM;:%2)41.JKH
MG1$\:Y++9NF(CG+YG;;>_<9;<6.*W7S%L>>51Q;DAR^7:-9KWC\W&Y=UC'/L
M/IQLFDR,WM4_W(B[;H(8D;)^<B+73DV^FVL71=3A/D^[O>]O^B1M\5V7%EMS
MQCNTY--?0NGESCC;-)B+HX2PH7+\.9<HAI99C>&7*<MHMF6*311'YN\FA3M"
M2NBT;@J .D.U2T\*RG:S$3QC5$5FWR.C+[-WV8[H\2V<]EGB78>.JVRE>=-,
MW1$UFWG$.S(N50LEUND6%C\Z[VC'1;/*+Q$5I&H*.AW=! R0WB!M>XZC:>8/
MC4Q[;5$3-T1-W*._\##9>S\Y\5EU^6S'?FKX5EU:WTFG.(I;6>%NKUI9^1\A
MC;9=OM.,VE[*;Y<HBW1J%"=99$+<*H/I!NO$(H)*2"VGVRUCCP5B9NG3$33W
M7-LNC3ELOR9\D8,=EVB;KHNGT_DQ%O'A^-W.F1RG:%Q.TY+:84JY2[[(2!:;
M( BU,<G:F+C+B&J"WVE;/NF2[10575>FMC;7:YMF8C3QF>RC.SH&;ZUDP9+K
M;(Q1JOOYVQ9PI=%.-VJL:8CC-7V%RC:$QZ^WK(8C]CFXP7:OUHD*#LAETQ$V
MD!6R47$>0Q[1"NA*M2=M=JB+9KJY3]W<9>@9?K&+%ANC+;GXX[XK%LQ^-6O&
MW32=4=CNQ7/G[Y>'<<OUAEXU?O1DN,2),-IY)$)31M7 <9(A0P)41QLO.'5/
MU)EP:;=5LQ='+W6OJ'1[=OAC/ARVY\>K1,VQ,:;Z5I,7<:3'*Z.$TE=*YGSQ
M08=UN4:S6N=>)JDD.WQW9<A0%3/M, KA;13Q70>B5E;;-TQ$=K?M\%V?+;BM
M]:^8MCSS-(?+/=(][M$"]1!,(MQC,S&!=3:XC<@$<%"1%71="ZIK2^V;;IB>
MQ=S@NP9;\5W.RZ;9IRK$T9M8N<H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H%!KKF_3\W[W<_U;UC:/2=?@]KUE'UW>]KI79L_I/<GXI?6>ROV^*<]&6G
MG\*]"<O]U,NQ18V[TCU1E?P/'9ZN;_\ W]FE;=KZEWGL^-Z/LW3ZIGU<O$VW
M[2?O58<_M_F9XR[6GI'I.(^BZ>/>[D;P]_3=65OT^3\O[[?AK^^-[7EIW5?-
M2_\ H<[9Z-^:GE7N::>GY?Z5I\+=O?UU]_;I2ZOC8_-8QSZOWIL:?(VM/>M^
M^[>'._\ .B_^F:^D_-_$OA^/^HO[]/\ O:Z^_4W?J6T^5?\ &P]IM/U7%IY>
M-NOS[:? @>/>U\Y,!\/1N]F_J[733;ZQ;^#^INK;G]6_\CXGI]9K]7W7?39Z
MO\N>?P,;*]_YQ,AV[O1/GEA'?_8;NP.[7WM.WK66+Z*WYE[=T^G[OQ?*^K;R
MG]K_ /J3W,']H;MV/W;Y@9'Z3IX]G<QMU][=K6G:^K'S[7F>S?V?'7E]<V]/
M/Z7WDCF7;]0<3^B>'S@L?H_;\.WZ(]NT][M[JPQ>MDK\F[XW)TROC[_5_@YJ
M^?7;]^BMQ>VOLOWQ97P^U>^[N^%WO6<G;N]_=I6^?M<4_J_%#U\E?^IL6GOP
M^]X5GWEYX^_MQR+Z1IZ;Z7:?2-?A:>J8^FOO:[M*Y<_T=GFG\Z7S?6?L6SIZ
MNG+3_.O_ *'W@;=^:3&MVNWM/]K=X]KTI[M__*:4WOTUWW=B>UU/WKF\]OOZ
M+:_"UP':^B0YW/A^AN;OV7I7K,O_ );N_KUV?_6>[]Y];-?^JXI\J/[/A?%I
M^!L7!NUZ\Y-]+\?77W[=\+L>K8VW7WM-=*X\WJXZ=WWY?*=6KX&RT_X7#S^)
M?50^$^[\Y\7])U[GYOX_8W>.SUHYNV_]WM:_J5U[SU+J?+^\^E]J:?5L^GE]
M<NK_ )4?^+X7"T]OY[QT'7T+\Y%X\?@=[U,GZ_<WZ>_K2[Z/_P N/SF>YK]2
MGY7U'%[WC?Z-'#FO3UQG';U]&^;^/>G_ +'_ &Z6N[WNUNU][6KM/5L^==^:
MOLO]#MJ\_&SZ?\C_ $EWY.Z9Q@"L[O3=,@[6SX6SU2[KII_A=O\ 5TKEV_T=
M_P"3^<^<Z#]BW=?5_0?MH^]56I_;^CEB?HO^L;<=]%V>/I'IL773W]=U;[?M
M-U?ZWQ2]C#7_ *ASZN7^T5\VB_\ H;$Y;R&XXMQQD-\M!]JYQXZ!%=\5;<D.
M RAIKJFH[]R:]-?&N+:XXORVVSR?*>SFSQ[OJ.'%DBMEUW&.^(B;J>[1KC$K
M3=K1EED^;F,9-;;9*5V-ESU]E!)8F,N,KLD'K)>VO"XB+JV(IH1)Y:[<MT76
M3JNMF?Q:=GDY<GUO4=QBS;7+X^?!??;2<,8K9MFR8GC;'H6^C-ORIGC$2ZL4
M:ES.15XLF7OTG&,+E/W>WH+[I2IJEL<8B/.*NII"5Y>XF]=WF(0Z)TN68C%X
MD1Z5\4\WE]UGU"ZVSI_[PMQ:<NYMMQW>C&FSG%U]L=GBZ?1X</2F)XK)P7CM
MJLS>:/0&W1<^<MT@:N/O/?Z/#?5&DT=,DW(A+N/X1?;*M:-[DF[37Y,3[[R/
M:S>Y<\[:+YBG@8[N%ML<;K>/*(X<.7*.R(;<KSWPI0*!0*!0*#7.5[/SO<==
MW3_5;_V=?WSLQO#W]N[]36NW%]#?^3]]]9T^O[IWE/E8*^;5?]^C7>7:?G!R
MSQ]"7),$]+_8;M5W[O\ N]K7]2NS%]';\W(^LZ=]@P?*\#>T^]\.I/\ ,F[U
M](]'U[WS(RGTC;X]KML;-?\ OUIVGJ_EV/+]F?H(U<OK>VIYZW5^!D99V?F;
MQ+Z+IIZ^QOT39X;.RN[;[W:W_J5,7KY*_)N:NG5^N;_5_@[BOO\ ^E1%1.RO
MLX94LC]UVY#W]WPN_P"GRMN[W]=M;)^U6_D_%#MR5_ZBP:>7Z"GF\.S^E:.-
M-WSYY!](_P!>UL/?W?#T]4,Z:^]NW_JZUS[CZ.SN]+\YXW7/L6TIZOZ>G^==
M]ZBB\):>N,(0]?1_FW?O0=WAM]>CLV__ %K;^I77O/5O^=;^:^E]J?H=S3GX
M^#5_D37_ +U?==ES[?ST>U_U#\Y5KVZ_ ](]2KN_5W[/U=*EOT?E\.?SF&"O
MU./E?4<OO>/^"K[S=W$R7*O1]V[Y@.^D;?V/K4-FOZG=_7IL_4M^?]Y/96GU
M;!J_WR*?Y4U_NK_G7;^<7&7HFG<]<GV=GQ?U;)[FGO;=*Y,/JY*]WWX?,=)K
M]7WNKEX45\_BV4^%KESM_1*8[.G<]$8[>WQ]*]9AI_WN[^O79_\ 6>[]Y]9;
M7_JN:_*N_L^%/P:?@;%YZU_-+DGCM[<;N:?O?I;._73R;==?>KCV7TUOW=CY
M/V1_BN'SW>_HNI\+CR'HF<\==G_7O2;QV-OPMOJE_=I^KMI@^CO[O1_.A>C?
M8=Y7U=.*O^=;_2I4O9]&.P>BZ=[M6/L;?'O^LHVNGOZZUU1]JFO];XI?18Z_
M]2Y=7*N:OF\*]8</[/S;Y9]+_<_G!?O2=_[WZ*UIKKY.WMT]ZM.7UL=/DV_&
M\KJ5?K&PT_X."GGU7??8'#VOS@MG>_=?F%C78W>/:U?W;?>UTU]^LMUZL_/N
M=/M+]GOIR^N;BOG]% 8IO_.)CFNOHGSOSCT7]A^Y+MTT_P#KFGZM;LOT5WS,
M;U.H4_=^;O\ JVSK[_\ _2R,_P"S\Y\]VZ=CTG!_6'['_7W/A^]MV_K5C@]2
MS_S/B:NCU^K;7OT[S3_EQR^%?<IW_G?X\[/CZ'?_ $C3]Z[47;K[V_2N3']#
M?Y[?OOF.GT_=&[K\K!3SUO\ O([FFZS@>Q3%X\>X2X%^FR/6D.S."S/DQH,<
MGU8 R-O:!KHKNAB6Q%1%ZUGM+8]*[A6V.%>7%U^R^WLF,^XNFRV[%;;HNR16
MRVZ^[3JF*368_%X3&J8J@<;Q>YW2%EF*.6Z]8K@LJ&S*LKEVE(3]NN+2DIDP
MZ$AQSM:BV[M-S35"\$*MV3)$3;=6+KJ\:=L>\]/?;_%BOP;B+\6XW%MTVWZ+
M>&2R>6J)MB-7.VL6]W;"#L4F3R=@6<YGE<X9%QAV=ZT1K=">>999"'&244I0
M%6]5ENHC@KM_<T0-5'<E;;XC#DLLMCA6OWJ>Y\;TMW9;TK?;7:[>VEMV6,DW
M71;,SJNT:*\?H[?1Y^MZ7":2W#Q7:X5HX[QJ/!$P:=MT64:&XXZO=D,@X:HK
MA$J(I$N@IT3P1$2O.W-TW9;J][X'V@W%^;J&:Z_G%]UO*(X6W3$<O)V\Y[5P
MKF>"4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@C,BL%LRFQSL>O#2NV
MVX-*R^"+H2(O5"%>NA"J(0KY%2L\=\V71='.'9LMYDVF>W-BFEUDUC[NZ>4^
M16\7X]>L]X<O^0W^7D]W&(ML@OS@::"/"4D,@0&1$2<-4'N.EYQ:)6_)GU6Z
M;8BV*U]UZ^_ZS;GPQAPXK<%FK7=%LS.J_E$UGC$1QTVQPBJ.LO$,:TW"W(_?
M)MPQ2PR2G8[C<@6E8AR5W;"5Y![KJ-;R[*&7F=/'2L[]U-T3PB+KN<]_W=KK
MW7M)=FQWTQ6V9LMNG)EBM;[>%?1]6W52-5/6+WQ''NUQN7H]]FV[%[^^,S(\
M=C"TC$Q\=J&2.J/=:1U %'D;+SZ6;J;8CA$W6\I[ON[$VOM'=AQV:L5E^7#&
MG'DFM;(XT]'U;M-?1KZJ1RCCUV\7=G(,=OTK%[RD3U9+D06V70?@H:F+:MO"
M0B8*J]MP="'5?>TPQY]-NFZ-45K[KEV'68PX9PYL5N>S5KB+IF--_*M8XS$_
MC6SPFCA.XNM'J"PVC'9;]BGXNJG8;M'1MU]DW!4'E,7!47$>0B[HDFA+2W<W
M:IFZ*Q=SAEBZ_E\?+DS6QEMS_2636(FG&VE.-NFGHSV.+'%=G+$KKC-UG2[A
M+ODA;A=+X1HU-.?N FWVU!$%OM*V': 4VB@Z:+UUL[F[7%T1$4X1'91;_:#-
M&[QY\=MMEN*W19CYVQ9QK;->-VJLZIGC-?,[L=X["WR;E=,HNKV4WRZ1$M;\
MV:RRP(VY%)?1P:9$1024E(U^V6IDSUB(MC3$37W>]KWO6IR6V8]OCC!CQW:X
MMMF9]/Y4S=QK'9W,+'.*ALEUM<N?D$Z\VK'0<;Q>TRQ:%J"+H=K4C;$2?(&]
M6VR<^ *]*RR;G5$Q%L1-W.>_\#IWOM!X^*^VS%9COS4\6^VM;Z37E/"V)GC=
MIYRZ97#\25<I;?KN8&%7"?ZWN.);6BB/3=XNE]](5=%DW!1PV47:I:^%6-U,
M1'"-4135Y/N[6S'[27V8[9\*WQ[+/#MS<=464IR]6;HB:1=SHS,HXU<O=WEW
MFQY#-QN3=XP0;_Z"#)^FQFD(075T25MT1,A%T/.1*QQ[C3;$3;%U.,>1S;#K
MD8,5N++AMSQCNF['JF[T+IY\I]*V9B)FV>%4W'Q-FWNXVU9YTFW6;'&78P6A
MDD]'E-&PC+:/[M2)6M-XKK\+JM:IRUU5BLW=KSK^HSDC-.6VV^_-,3KGUK9U
M:IT]D:N4^3DK"\0QEN*M>O9OS)*X>N2Q':UZ(LWN]_\ ==O<['=^^]C79NZU
MO^M33E&JE-7D_#Y7L_\ 4EWAU\*WQ]'A^-QU:*:>7JZ]/HZ^=&5D_&'KR[3[
MI:;_ #; %^9;B9-&A"R8SF605L50G0(F7$;7M]P/M=.E8X]QIMB)B+M/+R-.
MPZ]]7Q68\F*S-X4S=BF[5Z$S-9Y3Z5M>.F>UD7WCEB6-ED8M<W\7N^/QUM]L
MG0VVY I ,0 H[K3Z$+@>8*CN^"2:I4LW%*ZHU1=QGS][3M.MW6>)&XLC/9FN
MUW6W3,>GQG5%UM)MGC-:<XX.L^*[*N(QL8:F2FYL.9ZXC7[>)STN_<)U9A$2
M*)&1&2$A)HHKMJ_6;M>JD<J4[*=S./:#-];NSS;;-MUOASC_ !/#I31WQ$1$
M4\L5<K5QE;FK5?X>2SG\BN>4@C-]N<D6V#=:;;5IH&VV4$&A;154-J?"55UJ
M7;B:Q-L:8MY0FXZ[DG+BNP6QALP37';%9I,S69F9XW3=VU[.!B_'<BRWAJ^7
M[(9N37"!%*WV8YP--I$BN**GHC0CW'3V"AO'YQ(E,F?5;IMMBV)XSY?N[C?]
M:MSX9Q8<-N"V^[7?IK.JZ.7/E;%9I;'"$?;>((=ON,$%O4Q_#K1,6Z67%3%I
M(T:9N)P%[PBCIMMD:DVV1:"NGCI6=VZF8GA&J8I-SJS^TE^3'=/AVQGR6Z+\
MO'5=;RGT:Z8FZ(I=='/R+S?++;LBL\ZQ79KOVVX,G'DM:Z*H.)HNBIU14\45
M/!>M<ME\V71='.'S>TW63;9K<V.:763$Q[BE6?BZ;#N<"Z7S*[A?W;$T\UC;
M<QM@!B$^TK*NN]H160Z@>:AN^_TU76NF_<Q,3$6Q;7GY?P/HMSU^R_%=CQ8+
M,,99B<NF;O3I-=,5GT+:]EKMB\3VF#;\?:@SI#5[L$]RZC?50#ER9$Q2],1]
M53SAD(6TT]Q!Z^;2=S,S=6.%T4I\7O,,GM#ER9,LWVVSCS619X?'3;%OT>GN
MFSG'N]Z7Q;"QQ2[7^;#N4A^VWV8Y<_5;R K<>7()3?-LT1"5'"7X*]$K5DS:
MXMB8XVQ2K@W_ %2=YBQ6W61%V*V+-45K=;;PMB8Y<._M6FM#Q2@4"@4"@4%:
MS'#V\J9@O1Y[UHOUH?67:+Q%$#=CND"MFB@XBB;9@2B8%T)*WXLNBO"L3SA[
M'3>I3M)NB;(R8\D:;[+JTNBM8XQQB8GC$QR1,;BRT%BUXQV]395UF9 ^LV\7
MIPA:EN3$4%:=;V)M;[/;#M *;1V^'CKLG<W:XNB*:>4.V_K^6-UCSXK;<=N&
M--ED<;8MXUB:\;M59U3/&:NW&^/4MLZ=>,FN[^4WR=$]5E,FM,L"W;MRDL<&
MF1$=#)=SA+U)42IDSUB(MC3$37W6&^ZSXMEN+!CC!CLNUZ;9NFM_RIF[CP_%
MCL8./<4C9;I:WYN03KO9,<W_ #8LLI&D9A*X"M(I& H;ZM@J@TKGP$7I663<
MZHFEL1-W.>_\#IWGM#.?%?%N*S'DS4\6^VM;Z37E/"W5/&[3ZT\W5/X@ASKE
M-#UU,:PRZS?6MWQ01:*+)F;Q<)>Z0JZ#;A@AN-"6A+KX:U;=U,1'"-412+O(
MSP^TE^/';/AVSGQVZ+,O'5;;2D>C73-T1-+;IXPS\HXY?O5X?O=AR*;C4ZY1
M@M][*"#+B3(K>[9^ZB7;=!#(0>#SA1:PQY]-M+K8NB.,>3[NYS;#K5N##&+-
MAMSVV7:K-58T73SY<[9I%;9X2^W;C. ];<?C8U/?QRYXLVK%BN480?)IEQM&
MG&W6WD('1<$44M_7<B%KXZK=Q-;M4:HNYPFVZ[DMR9;L]L9K,\UR6S6*S$UB
M8FWC;,=E.S@XCQ79?FB]C#DN4<V1,]</7_<(SUO'<1U)@D@[1,2$4%$31!3;
M5^LW:]5.RE.RG<L^T&;ZW&>+;=-MOAQC_$\.E-'?,4GCY>+LL?'$>*U?'<IN
M;^47;(HXP+I.E@W'18( 0#'::800:#0R5=G4B7<O6I?N*TTQIBWC'G8[OK=U
M\XHV]D8+,,ZK+;9F?3K$ZIF[C=/".?*(HQ\8XQ6QW:#=+O?YN0>HV'(>-,30
M9!(+#HHV:J30"KKJ@*-]P^NW7W:N3<:HF(MBVO/RMN_Z]]8Q78\>*W#XLQ=E
MFW5Z<QQCG/HVUXZ8[6*WQ#&;N3;27V:N$LW#URSB.UI(@S>ZKZ??4'N*PCJ]
MU&-=F[K67UJ:<HU4IJ\GX?*W3[273CF?"M\>;/#G-QU:*:>7JZ]/HZ^=%GF8
MDS='<B:O$Z1/LN0QFH9VATM(\9L&S;<5C;HHDYNW$OCJB*E:(RZ=-(I-O:\?
M%U&[#&&<5MME^&Z;M<>M=-8F-7?II2/(AL6XW=LEWC7F^9#-R67:XQP+"LX&
M02'&=VH?[D(]QTT 1-X_.5$K;DW&JVEML6UXSY7H;_K<9\5V+%AMP1DNU9-,
MS.NZ.7.?1MBLS%L<(E@PN((D*Y0VTO<QS"[9.6[6O$U%H8K$W>3HKW1%'2:!
MPE,&B+:A:>-93NIF)X1JF*3=Y'1E]I+[\=T^';&>^SP[LW'5=;2G+U8NF(I-
MW.CMR+BD;U=;I*@Y!.L]GR-&QRBSQ1:)F<C8(TJB9BIL$XVB ZK?PQ\:F/<Z
M8B)MB9MY3W?A8;+VAG!BLMOQ69+\-?"ONK6RLUY1PNI/&W5ZLL[(^/!N,RWW
M?&+L]BU]MT1;6U-A,LOB=N54+T<VGA(5$53<VOB*UCCSTB8NC5$S7W7-LNM>
M%9?CSXXSX[[M>FZ;H]/Y43;QX_C=[ID<66A,4M&-VF=*MLRPOI/M-[ A=F!.
M53)QYS>BBYW5</N@2;2W::)TTL;F[7-TQ$ZN$QV4;+/:#-]:R9\EMM]N6--]
MG*V;.%+8IQMTTC3,<8HY0^+K06.WVRY%+?OD[)R1V^W=] :D/.MB(LD"-B@M
MHR@#VA%-!5*D[F[5$VQ2+>4?=WIEZ_E^L8LN&V,5N#ACLBLVQ$^M6O&[56=4
M]KNQ7 9%CO+N1WZ_R\EOWHJ6Z'+F-M,)'A(?<5L6V1$5,R05<<+SBT2IESQ=
M;IMB+8Y^ZU]0ZQ;N,,8,.*W!CU:YBV9G5?2E9F[C2(Y6QPBLI#,L/BYA!BM%
M+?METMLD)UINL-11^-);110D0D42$A)1,"30A6L,66<<\JQ/.'+TSJ5VRONG
M3%]E]NF^R[E=;/PQ,<XF.,2K*<2%)M=\8O.2S[A?,F%B->[TH,L.' CJJ>BL
M--BC;+9B1"6U-5W*JUO^M4F*6Q$6\H\O>]C_ *CT9<4XL-EF/!JFRSC,:Y_'
MNF>-TQ-*5[H2\CC6R'=9LZ&XY @76S^H+K:XR"##\8 5M@^B:BXR!$V!?L>E
M:XW%U(B>,Q-8EP6=<S1BMLNB+[L>3Q;+YYVW5K='EMNF(F8[^*5P['7\3QV'
MC[US>NPP [,>5)  <1@/-;;5&T1%V"B"B^-:\N37=-U*5<74][;O-Q=FBR,>
MOC,16E>V>/?/%/5J>84"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@Q;E
M<8-HM\FZ7)\8UOAM&_*D.=!!IM%(B7ZB)65MLW32.;=@PWYLEN/'&JZZ:1'?
M,JYB?(V/9C,?ML )D.Y,LA,&%<XKL)YZ$X6T)+0NHF]HEZ;D][735*W9=O=C
MBLTIY./'N>OU'HFXV5D7WZ;K9G3JLNBZ(NCG9=3E=Y&+9^5\0OE\;LD%R3_I
M+CT>VW-V,ZW;IK\;5'6XTDDV.$.TO!>NG36LK]M?;;6?>[8\\-VY]GMWM\$Y
M;XM]&(FZV+HF^R+N4WV<[8FL??H7OE?$+!>W++<')/\ HILLW.Y-1G7+=!=D
MZ=H)4D4V-J>X?'PUZZ4LVU]UM8]R.V?-!M?9[=[G#&6R+?2B9MMFZ(OOBWUI
MLMYW4_[&7EG(F/X?+CVZ>$R;<Y#1R_0;9%<FOM0VE03D.@TB[&A5=-R_J:Z+
M6.+!=DBL4B/+P]QHZ=T7<;VR;[)MMLB=.J^Z+(FZ>5L3/.Z>YVW?D#&;18(&
M1K(<G0;LK86AJWM'*DS''A4P!AH$W$2BBKITTTZZ5+<%]UTV\J<Z]C#;='W.
M;/=@I%EV.NN;IBVVR(X3-TSPB/NAPA\C8E,Q29F135BV6VJZW<_2FS9D17V%
M07&'F23>+J$J)LTU553375*L[>^+XLIQGDRR]%W=FZMVNG5??2;=,Q,71/*Z
MV[E-OE[.->4N6+9[8\L68S%"7;[A;T!R9;KK'<@RFV7450=5MU$U;)$70DJ9
M,%UE*TF)[N+'J'2,^STS=-M]M_JW671?;,QSBL=L=S!QWE7$LFO#5EMYRFGI
M8NN6F3+BNQHMQ;C_ +J4-UQ$%U \5TZZ=?"L\FVOLMK-/+Y/.Z=[[/[O:X9R
MWZ9BVD7Q;=%UV.;N6N(]6O\ 0^2.5\0C9">/..255F4-MDW48SI6MFX.:;8K
MDI$V"ZNX4VZ]%7151:1MKYMU>[3MIWT6SV>W=VW\:(MXVZXLU1XDV1^/%G.;
M?NAW99R9C.'3DMUR29)E QZ;-&WQ'9B0X>JCZ1)5I%[;>J+U7KT\*F+;WY(K
M%/=GG/D:^G="W.]LUV:;8KIMUW1;KN^3;7G<M<27&GQ6)T)T)$.2V#T=]M4(
M'&G!0A(53HJ*BZHM<\Q,327B9,=V.Z;+HI=;-)B>R8YPIR\L8@F1+CO<E;DF
M>JBNOHSOJM+G\465IL[WDV^[TUUKI^K7Z=7DK3MIWT>__P!/;OZOX]+?5UZ-
M4>)X?R]'/3Y7;D_)^+XG<O5=R66_(9:&5<C@Q7I;4",:J@O2S:%4:!=%\>NB
M:Z:5,>WOOBL4]_GYF&PZ#NMYC\2S3$3.FW5=%LWW?)LB?6EE9+G]@QABW./^
MD7*3>-RVF!:6#G2I0 ".&;3;6NX!!4(B\-%K''@NOKV4YUX-&QZ/GW=U\1IL
MC'Z]U\Q9;;QI$3,]LSPB'P^1,3'$FLV&:KEBD;0CDVV9ONOF?:%@&43>KJGY
MFS377Q\*>!?KT4XK'1=W.[G:Z:9(YUF*1%*ZINY::<:]SE8L_P ;OUJN-V!U
MVWA9MWKJ)<VCARH6P.ZJOM.(BBBAYZ+X*GEZ+2_!=;,1SKRIQJF[Z/N-OELQ
MS$7^+ZDV3%UM_&GHS'/CP8V)\E8WF,T[=;AF1)W82=&8N,5V&4J"1;1DQT=1
M.XTJJGG)[M99=O=CBLT]SCQ[FWJ/0]SLK(OOTW6UTS-ET7:;_D74Y7>1TP>5
ML0N%_"P,.R45Z0Y!AW5R,Z%LDS6==\=B4J=LW$VDFB+HNGFJM6=M?%NKX.VG
MF;,OL]N\>#QIBWA$776:H\2VV>5UUG.(Y>;MHNU<KYTH%!'VJ]VJ]^FK:I(R
M4MTIVWS%%%1&Y4?1'&UU1-5%5T73I6=UDVTKVQ5U;C:Y<&GQ(TZ[8OM\MMW*
M?=2%8.4H% H% H%!!Y5EEHP^WMW"[*Z:R'@BPH<1HY$J3)<U46F6@12,U1%7
M2MN/%=DFD/2Z?T[+O<DV8Z<(U73=,6VVVQSFZ9Y0PK?R)BEPQB;EJS"AVFUD
MZU=4F-FQ(B/L:=QEYDDWBXBJB;--5U3375*RNP7Q?%M.,\O*Z,W1=UCW-NVT
MZK\E)LTS$Q=$\KK;N4V^7LXUY/N*Y]8LN<EQH82X%QA"#LBW72,Y!E(P[KVW
MD;=1-6RT70D_5TIEP764K28GNXG4.CY]G%MUTVWVW<(NLNB^VL<[:Q^-'<P,
M?Y6Q');RU9;><H')B/+:)DF*ZQ#N*1OW98;QH@N[--5T\G5.E9W[:^RVL^[Y
M/.Z=Y[/;O:X9RWQ;2VFNV+HF['J]77;'&VK[,Y6Q"#D!X^^[)569 0)=U",Z
M=LCS7=-D=Z4B=L'%W"FBKHBKHJI2-M?-NKW:=M.^B8O9[=Y-OXT1;QMFZ+-4
M>)=9'.ZVSG-O/S]CNRSDO&\.FA;KD,R5,["SI35NBNS%BPA)163([2+VVD5%
M\Y?<\*F+;W9(K%/=FG'N:^G=#W.]LUV:;;:Z8F^Z+=5_R+:\[O(R+]G^.6"U
MVVZFZ[<1O.WU-$MC)S94U#;[NK#3:*I(@>>I>")Y>J5C9@NNF8Y4YUX4:MIT
M?<;C+?CB(L\+UYOF+;;.-/2F>7'A3F^#R'B98DYFRS5"Q,Z@^1MF+[;XGVE8
M)E4WH[W%V;--=:>!?KT4XK/1=U&[C:Z?TD\N,4F*5U1=RTTXU[GW&L_Q_)X]
MQ>861;9%GT6[0+JR<&5$ P5P#=;=T40($4A+PT1?<6F3!=9,=M>5.-4WW1]Q
MM+K(FE\9/4NLG7;=QI,6S'.8GA,<V+B_)V+Y;<?5EN]+CR'FBE6XI\5Z(W.B
MBJ(KT4G11' 35/#KHNNFE99-O?9%9I[D\O.W[_H.YV>/Q+],Q$Z;M-T739=\
MF^GJRZAY7Q LB3'.Y*0BF+:@NJQG4MA7)/\ YD25IL5[5--ON]-=:OU:_3J\
ME:=M.^C.?9[=QM_'I;ZNO1JCQ-'R]'/3Y?=7&9+BV^(_/FNC'AQ6S?D/N+M!
MMIL5(B)5\$1$U6N:(F9I#P,>.[)?%ED5NNFD1WS/*%4Q/DS&LQFE;K:,R++)
MA)L-NXQ'8?I<)504D1NZB=QM55.J>[X5T9=O=CBLT]R:TGNE[?4>A;G96:[]
M-UM=-VBZ+M%WR;J<KG5&Y6Q"5D(8\VY)17I)VZ+=3C.A;'Y[>NZ,U*5-A.IM
M)-->JIHBJM6=M?%NKW:=M.^C._V>W=FW\:8MX6ZYLU1XEMD_CS9SBW[I,AY5
MQ+&;P[9;@4IQV&+)W:7%BNR(EN"3^Y%,=!%%I#\4U\G7PICVU]]M8IY/+YC9
M>S^[W6&,MFF(NKHBZZ+;LFGUM%L^M1G95GUBQ)8;,L)=PGSQ-V);[5&<G2C8
M:1%<>V-(NC8[DU)?U*PQ8+KZTI$1W\'-T_I&?>:IMFVRVSA-U]T66UGE;6>V
M>YQG<BXG"Q:'F S%EV>Y$TU:_1&S?D2WWU46V&613>3JJBILTU147731:L8+
MYOFRG&.?D98NB[J_=7;;3IOLK-VJ8B+8CG===RBWR]O"G-SM/(&,W;'Y^2)(
M.# M*NA=VI[1QI,-Q@=Q@^T:;A)$5%TT777IK4NP7VW1;SF>5.UCN.C[G#N+
M<%(NNR4T:9BZV^)Y3;='"8^Z75B?(=@S"5(M\$)D*YQF@E+ N<5R%(<B.JHA
M(;!U$4VB5--R?JZ:I5RX+L<5FDQY.+/J/1L^RMB^^;;K+ITZK+HOMBZ.=LS'
M*Z.Y;*YWAE!T39L6VPI%QG.BQ"B-'(DOGT$&FA4S)?>1$5:L1,S2&W%BNRWQ
M99%;KIB(COF>$0XVZ?$NL"+=(#B/09K+<F*\B*B&R\*&!(BHBIJ*HO6K=;-L
MTGG"YL-^')=COBEULS$QW3'"636+24"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@Q;D\[&MTR0S^[-,..-]-?.$%5.GU4K*V*S#=@MB[);;/*9CXV
MG>/,BN&0!CD^=R[$F7*>U&E2\7!FS@\KKC:..Q=&Q1Y%%=173SNE>CGQQ;JB
M,<TCM]+W^Y]]UG98]M.:RSI]UMMDW6QEKFI2)I%_'T>//N3&(\A7>7G>38M?
MB%813IC.+2D0!4BMS;928I(.BJ8BX#H:HJD.[KYM:\N"V,=MUO=%?=Y2X.H]
M&PV;'#N,/K:+)RQQ_'F=-_FF8FV>Z=/>AHV4YSDMMXNA0L@6SW#*H,V7=KDS
M#BR#,XC#;HH+;P* HJDNNU*VSCQV3DF;:Q;,4XR]"_8;':Y-]=?B\2W;WV6V
M6S?='K73'.)K/).1LUOF%CEUJS26%\DXU;0OUON3;00W9D)Y'1[;K;:*V#@.
MLJWN'H2*BZ)UK3.&W)IFR*:IIYI>;DZ7@WWU?)M;?"C/?.*ZV9FZ++HT\8F>
M,VS;=6D\8F)BLL.Y2>2<.QX>0[W?TN?HPMS+_BX1&&H;<1PA[H17$1'D-@25
M1-QPM^WJG7IG;&+)=X<13NFOQ^=T8+.G;W<?4L6+1JK;CRZKINFZ.4WQZM+Y
M[(B-->$NN[9#>I^?Y/9',];Q&U6EFW%;V29MQ*]Z6P;CI[I@$1;5%/@KHE+<
M=L8[9T:IFO?]YEM]GAQ[#!EC:SN+\DY-4UR<--T1$4LGM=+_ "#DY\76J_NS
M6XA2KHMLN.6,Q5-EJV ^\T-S".2$B(ZC;:)O3:*N;M-M6,%GBS;3LKI\OR6R
MSHVVCJ>3#%LW:<>NW#-W&<FFV?"F[AZM9Y<9TTYI>WWC)[=B6672+D4;+;3"
MMK\['+^UZ.;_ *2TPZ1L/#&1&SV$($)(*:[M%\*UW663?;$VZ9F>,.'-MMME
MW>#'=ANV]]U]MN3'.JFF;HI=;J]**Q,Q,5[*PP>/[Q,O$VSO/<MQ;[*D,C(D
M8VTS:!=,B9WFWHP/>3MKU73KYO7RUGGLBV)_1S'E])T]8VUF&S)$;"[%$32,
MLSFI'I4B?2]'C]]VX-R+=7IF>MY6^+L6Q29TZTD( V:VJ(_(CF&@(FY6CCJ.
MXNJ[DU6IFP12S3VTKY^'X6OJO1<46;6=O%)RVV6W\9G])=;;=$_E1?RY<%;9
MY SASC:VW*\WMJQWN5DWJ>Z7<F(W;A12<<W:B\/:3MHB#N-/JK6Z<&/Q9B(K
M&FL1WO7NZ/LHZC?9BQ3EQVX/$LLU75ONI'=.KCSI"SP[W-AXIE]Z@\D1\RDV
MRU2)+"QVK:J0GVV'7&W"2&G7<H=!<Z+MK1-D3?;$V:*SY>/OO'R[6R_=;?%?
ML[MM%^2V)K.7TXFZV)CT_/SCO8T+D;(96)V%91#"R^/?[18\FC[ -"&8ZUN<
M!--$"0RX+@$*=-RHGP:RG;VQ?-.-NF9C[O)+;EZ+M[-WET^EAG#ER8IX_BQ/
M"?+9=$VS$]W'F[<M8Y#B9O8;1;,Y?AV[)Y$Y 82VV]U8;<2,4@1;,VU(_#;J
M>JZ5,4XYQS,V<;:=L\6'3K^GW[++DR;6+KL%MG'Q,D:YNNT\8B>'?P;2@,28
MT&-&FREG3&6@;D3" &B><$40G%!M$$5)>N@IHGDKANF)GAP?%YK[;[[KK;=-
MLS-+>,TCNK/&:>56#OET3E-C&D>3U*>/O7$H^P=RR@FM,H>_3=IL)4VZZ5NT
M1X.KMU4^![,;3%^ZYST_2>-%E:_BZ+II3ESCFXW^_72#R'AM@BO(%KN\>\.S
MV5 24RA-QR95"5-P[5<+P7KY:MED3CNNGG%/AJNSVF+)T_<9KH]/'=BBV>[5
M-^KS\H4+'>4<DF8CFPW9P&\DMD&[WC')J-M['X$5R0P!;$3:I1WFMCB*G@H:
MZZZUUY-M;%]E.4S$3Y^'QP^GWO0-O9N]MX<5Q7WXL>2VL^C?=%MT\>=+[;JV
M^:[N=N1Y=>BR.QVJ3G4?"K=)QYFZ.S9#,!1DS7'4 @0IJ;4T'SMH5,>*W3,Z
M-<ZJ=O+W&O9=-PQM\N2W:SNKK<TV1;$Y/1MB*U]#CSX5ELK#7#>L##YY(WE@
MN$X07MD8P-NBAJ.T?1$1I=BHH]/<ZUPY?6]73Y/^U\AU.(MSS$89V]*>A.JL
M</Z_I<>:?K4\PH% H% H% H% H% H% H%!I#%LJS'()K=P8RN-\ZFIY-WCC>
M6W&C^CPP>5MQMLE1)"N-M_?4>U("7IIHM>IDQV6Q33Z-.%_W</<?H_4.G[/;
M639."[P9LK9N;9NNU7::Q,_B:;KO1T\)COJL'*&<WS&[I;H]@)"8M<<\@RAK
MMHX96=A]J.38:HNTB[CCB*FB_>EK3ML-M\3J[>$>?[OC>5T'I.#=8KYS<\D^
M%BFM(\6;;KHF>^(I;;^7"7S.^7IZ[6##L6EA GW\9,J1>>V$E8L""+:F339K
MM)QPG6P!2111-5T71*UX;+:3?=%8M[/++@Z9M,-N++N=Q;KMPZ;8LK-NJ^^M
M*S'&(MBV9FE)GA%43>)'(.%XCF3\VZC=FK;;7)V/WUUID):/"V:DR^R (V6Q
M1$A- ZH6B^%;+(QY+[:12L\8=VVLV&^W>WBVSPYOOBW)CB;M-*Q2ZVZ9U17C
M$Q7A3@R<:RF[YU?P*PSF@Q#'M(]ZGL]ITKE=59$SCM="V,L(8DXXFBF2H(^:
MA+6.3';CM]*/2NY>2._SRU;[I^'I^#]-;/C9N-ELUCP\=9I==WW74F(M[(XS
MQF(4>1E6;M8YDF<KGK$1;-.N@1<<DPH"L.A;I3C;4=7$0'U5T00!5"W;B3Q\
MO5&+'JMLT<XCC6>V.?<^CLZ?LIW&':?59N\6S'7)%^2L:[8F;J<;/1K6>%*0
MLV8\A7VTW^S.0D&)8+7'A7#-&7@$R"/>)*0V0W;54"95''BTTU$?<\=.+!;=
M;-><UBWW./P\GC],Z-@S8,D7>EDR3?9@F._%;KNFG;%WHVQY93F6W:_W'*K9
M@.,W!+/)DPG[O=KLC0/OLPF'6V ;8!U";WNN&J*1HNT15415\-6*VV+)ONBO
M&D1Y7F].V^#%M;]YGL\2+;K<=EE9B)NF)NF;ICC2V(Y1SF>Y!Y-<^1\*P',)
M,VX-SY=I!I[',@5ID9#[3JBAA(CB/;0VBU'>B:&BHNB*BUMQVXLF2VD4KSC^
MEZ6QP=.W^_V]MMDV1DF8R8ZW4B8K2;;JZJ7<Z<[9X5E-X]DMQSC)9%PL$T&L
M"LCCL(WFD;<*Z3T1$/:2HJ@PQKT(=%<+P503KJOQQCLI='I3\$?AEYV\V./8
M;:+,ULSN,L1=2:QX=G9Y[[^Z?5C^MROE<CYDH% H% H% H% H% H% H% H%
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M^LI[GP/K)X>U46Q'#5%M/ZOA::?V6P<*C1IU]Y1.:(F4F[I#DD2(NZ,U;8X
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M-AJ*)JDHYT=2(=/ME5P]?JK6^)KN;J_UOBE[6.^Z_P!H=Q;=RN\>V?F^'?\
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MZ:_JUS[CACLB/ZWYSQ.MQHV6TMMY1X\__%F/BMA1N%R65>,$9D$KK5NQR_+
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MTBZ^W>X9LMUW1DLI;6FJ=44BO97O>(_FUQ-_>K,_W%+_ )>OI_$S?X<?VH_
M_HOZ]U7_ '&W_.L_T3YM<3?WJS/]Q3/Y>GB9O\./[4?@/KW5?]QM_P ZS_1/
MFUQ-_>K,_P!Q3/Y>GB9O\./[4?@/KW5?]QM_SK/]%O7V:K7A]ON&0EB^6OY,
MXXS&22V];WH",BA.;5177#W;NOAX:5Y74+KYBW5;I]VK\U]N=QN\F/#]8V\8
M(B;J4OMOKR[HBCT17CORDH% H% H% H%!7<YPVV9_C4O%KPZ^S;YA-$XY%(
M>167!='13$T\137S:W8<LXKHNCF];I/4\O3MS;N,41-UM?6Y<8IV3'>ALGPZ
MV1"RO-6W7UNDVP/VUUDB%6$98;,Q4104+=KX^=I[U;<>69TV=D75>AL.IY+X
MP;68C1;FB^)[:S,1W\O<:IQS]U]GC^:W3\!"N_)_KO<^-]MO>75_G8OSY3?'
M>'VW-\7S:R75U]F*F<7&7OC$(.;XSK+@IJ8FFBJG7I6K/EG'?9,?(AYW6NI9
M-AN=MEQQ$S]4QV\>7I1=$]L)%BS1LBY=Y+L$TS"'=+! A2#:5$<%N0T;9**D
MA(BHA=-46L)OFS#CNCLNER7[F[;=)V6:VFK'FONBO*MLQ/%<K?QI8K;/Q.X,
M2)1/8?!=MEM$S;47&7FD957D0$U+0>FW:FODKFNW%TQ='#TIK+Y_-UW/ELSV
M3%M-S?%]W">$Q-?1X\O/5HAC]%]E_P#C&#\,<KU9^EG]7]Y^F7?Q/)_P7]R&
M]9O&%AG2<SE.R):.9S'CQ;L@FVB-A$85@%8U;7:JB6J[]W6O+C<W1%L</0Y/
MS7%U[/CMVUL1;_LLW76<^.J[5.KCW]U&3$X^LT.]8_?6GY*R\<MBV:$!&"MG
M'41'<XFS53T'Q143WJQG/=-MUORIJTY.LYK\.7#,6TS9/$NYUU>3CR]]$0.'
M,9MUDQVPL2IQ0\9NPWZ"9N-JX<D3-Q!=5&D10U->@HB^_6R[=WS===P]**.[
M-[3;G+FS9IMLU9\?A7<)I%M(CAQY\/+YE3QW&8&97[F/&+FXZU N-RAM/N1R
M$74%&$/S5(23Q'RC71DR3CMQ71SB)>YO=_?L<'3L^.(FZRR^8KR]:GD2!0FF
M/: MUN!25AK"3CB2JF[8,_8BJNGCI6%:[:9_K_><L99NZ#??/.=U7_X=4/E.
M)V[!I?#V*VEUYZWV^_.HRY)(3>7O;WEW* @GB:Z:#X5LQY9R1ENGG-KOV'4<
MG4+.H;C)$1=?ABNGEPI';7N7:Y</XU<['E5@?E31AY=<$NUR,'&D<;?1QMW:
MRJMJB#JVG0D)??KFMW5T76W</1BCYW![2;G%GP9HMMU;>S1;PFDQ28]+CSX]
ME$$,)J?SUD-N>4A8DX>U'<(%1"0')2@JHJHO71:VUIM[9_K_ 'GISEG'T+#?
M'.W<S/O658&08Y!Q'+.&,:MKCKL&VR;DPPY(42=44BHNI*(BFO7R(E9V9)R6
M9;IYS3XW3L][?O=IU'/?$1=?;CF:<O7]UKJ]?HVY(_\ C'D?A$>NRSZ6S]7^
M%]9M?XCL_P#@;?S;F[,WP^VV^V<@YFRZ^5SO&/28DEHR%6!"+$=0% 4%"15U
MZZDM>7ARS,V6=D7???G72NI9,F7:;68C1CS6W1/;Z5\5KQ^\P^.L/MMVQOC'
M+Y#KXW+';*+<)ILA1DTG1 :<[B**JNB)YNA)U]VL\^6;;LEG9=/Q2Z.M=2R8
M=SO=M;$:<V7TN_T+YF*<??X*YQEA]MS3"+E;KHZ^TS#S"=<6BC$(DKT61N!"
MW"2;55>O_;6[<99QY(F/D1#UNN]2R;'>V7XXB9NVUEG'NNMX]L<6P+AQC8;E
M,S":_(EB[FL6/!NB ;:"VW%95D59U;7:JBO7=NZUQV[BZ(MCAZ$\'RV'KV?%
M9M[8BVFUNNNLX3QFZ=4ZN/Q45%RU1[%S+@-DB$9Q;;C4N&P;JH3BMQT!L5)4
M1$550>O2NG5-V"^9[;H>[&XNW'1]WENI6_/;=-.5;JSP1?$.'6S,.,<;]9.O
MM>HLCD7N)Z.0CND0Y;VP3W"6H+N75$T7WZSW66<>6ZG;;3X';[2=3R;+J6;1
M$3XN"W'-?DW66UIQCCP_H0.2_P"J>T%]6W?@R5NQ\\/N_&]/8^OTG_S/SFU[
M5AEL>?L^>DZ^EWCXVU: 90A]'5@A[RDH[=V_5?'=IIY*\^[+/&SLU5?$;CJ>
M6VW)LZ1HNSSDK^-7EWTI[BF\,X?;<FXJXZN,]U]M['I4FXPA9(1$WAER!T<W
M"2J.B^33ZM=.[RS9FOB/QN'P0^@]I^I9-KU3>661$QFMMLNKW:+>7'FN5QXC
MQRYVC++,_*FC%S&8%PN9@XVAMNMFV:(RJMJB#JVG0D*N:W=71=;/#T(I#Y_#
M[1[C%EP98MMKMK=%O":3$Q,>EQY\>RBJ7%M&N;KZT.JB&!$**OCH,Q4KHM^@
MCY_WGN89KT7%/_\ N?W%*QG_ &9[/O\ .+C_ )"UTY.>;W'T.^^EZMYL;;DG
MA[&I5BOV/.2IJ0\AO)Y%-,7&D="6XXVZH-KVM$;U;3HJ*OOUY\;JZ+HNX>C&
ME\+9[2[FS/BS1;9JPXO"MX333$3%9X\^/F\BFWW](W*?_)P?Q3M=-GT6/Y[Z
M#:?P[8_\3/QVIWC;#K9>L5XORR4Z^%QQFUEZ"TV0HR?I\867.ZBBJKHB>;M)
M.ONUJW&6;;\EL<KI^*7F=<ZGDP;K?;>V(TY\GI5YQHNF8IQ]_A*5<X=QIVQ2
M,?*5.]#D7M<D,T<;[B3"-#V(O;T[>J>&FOOUK^MWZM7#EI<5OM+N8SQFTV:K
M<7@\IIII2O/UO@\B/Y%P^VVG&^3LOCNOE<LBLI-S6G"%602#$-IOMH@HJ:HO
MG:DO7W*SP99NNQV=EL_'+JZ+U+)FW.RVUT1IPY?1[_3OB9KQ][@J^/\ ]N.&
MO^47?P-FM]_T>7YWWWL[S[%U'_B8_/N4Z#^B_"__ (QF?PN173/TM_ZO[T/?
MR_Q/<_\ !3^9:O..XY!R[->:\:N3CK4&Y/6IA]R.HBZ@K&-=14A)->GE1:Y,
MF2<>/%='.*_&^;WN]OV6SZ;GLB)NLC+,5Y>M'F;':P.T1<BM^5-O2%N%KM'J
M..V1@K)1D)#W&FS53U3Q0D3WJXYS73;-O9,U?)7=7RW[>_;S%NG)D\2>==7+
MAQY?=5Y^P_\ 1IPA_P UG^%RZ]?+]+E^;]Z'ZEU+^)=3_P"'C\RQM2Z?]0MI
M_P"5)7X97!;]FGYWWGQ6W_\ ;^3_ (BW\QJ?$/T>\&?\SO\ X9)KOR_29?F_
M>A]OU+^(=3_46_F6-@<S8?;<9XJY%N,!U]Q[(94:XS1>(2$'BEQQT;VB*H.B
M>77ZM<FTRS?FLB?Q>'P2^7]F.I9-UU39V7Q$1AMNLMIW:+N?'FV$W@MIDY Y
MF#CTA+E-L@V%UH2!&$BD?=W".S7?KY=VGO5QSFF+='9$U?*W=6RVX(VT1;IM
MR^+Y=5*4Y\O<]UAP.*<>MT7$(C,F83>%N.O6M3-M2<)]%0N]HVFY.O3;MK*[
M<W3-T\/3YNC-[0[C+=N+IMMKN8B+^$\*?)X_'50<-PRV9[;N4,;N[K[,%_-9
MKIN12$'4)@F7!T4Q---4Z]*[,N6<4X[HYZ(?3]3ZGEZ=DV.?'$3=&ULCTN7'
M5'9,-F2^/K-,O607UU^2DO([8EFF@)@C81T$AW-ILU0]"\554]ZN&,]T6VV_
M)FKX_'UG-9AQ88BVF')XEO.NKR\>7O-?7JPQ,7Y+X3QV ;CD*V1[Y%8<?5"=
M(&K> HI**"BK]1$KKLOF_%ENGMT_&^IVN[OW?3>I9KXB+KYPW33EQR3R6TN(
M,;.PRL>65-]"EWI<C</N-]U):N"YL1>WIV]1\--??K1]:NU:N'+2\./:3<QG
MMS:;-5N+P>4TTTI7GZWP>1FW#C2Q7*?EEP?D2A>S""U;+D(&V@MLLM*RBLHH
M+H6A==VY-?)6%NXNB+8X>C-8<V'KN?%9@LB+:;:^;[>$\9F:^EQY>:CE;^-[
M';;EB]T8?E$_B=M*SVX3,% XY-BTI.H@(JGH*=144]ZEVXNF+H^5-4S=;SY<
M>?',6TW%_B7<^$UKZ/'EQ[:H]KA_&F;#:\>&5-6%:;T.1QC5QONE+!PW$ U[
M>BMZFO1$1??K.=U=JF[AQC2ZKO:3<W9[\VFS5DQ>#/":::1%8X^MP\WD94WB
MZP3RS,WI$M%SAN.U==IMHC8Q6E:#L:MKM547KNW5C&YNC3R]#DTXNOY\<;:(
MBW_99NFSA/'5-9U<?BHRHW'MFBY%:,E;?DK.LUI2Q16R,%:*,G7<:;-5/WT5
M$]ZL9SW3;-O9,U:+^LYK]ODP3%NG+D\6>==7DX\ONJS<(P^VX%C,+%;0Z\];
MX*NJRY*(3>7OO&\6Y0$$^$:Z:#X5CFRSEOFZ><M'5>I9.H;F[<9(B+KZ5T\N
M$1;VS/=WK!6EY10*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#PK(P;'2]O1
MJVK&_P! <>3("C]-OK ;<L[?]17Q[J^_1EV+'R \U:_;HPB;?R1NVOV]INWN
M.J@AO=CS&&D15Z:K(71/?6AV%R<;N7M\6DK$8F<"WJ-Z-I45!(;8^A(:IY4$
MV@]Y=$H=B)]FR3&CRO:,*0^VR(DZ9*X8@B A7-%)=RIT1535:$JKQ?\ ]$?*
M']+E_P!ELH=KU;[,?Z!<'_F)?Q[M$EMJB/S:Y#N8<63.>N)P(VWLJN-KDV*.
M(JOWAV4LTQ'3W67A;]_2C->O:9Q@< L7 5FGHB8YCR^BW5534.^VL$WB/R+O
M072^O1(6'VO),6Z\K<+VZQ.@_D)3D=;[!(1]J3,AI&+S=?-(@<45]Y:$.WD(
M]/;JP+4M-+<R**JZ>+,[IU]W6AV(KVQUNR\M<47&TW5BTB9[+5>Y&TXD2<U.
M:57S54,=K2DT1ZBNB)UH0G[)P9R[<.:<6S3/^1+'?K_C8LR#A,?>;@MJ1USX
M++3#6H$3ABADFFJZ:^2A5Z[HQ>,_9]Z\S^T,"]1*3<-4\B_Z=+HRE0N'R7Z&
M?+2:]$N)Z)]5F!K0GFS;CR=F&#^S'Q!C6&7!;+.RUZY1Y%[$NV<=F-<"':+F
MB]O<3Z*IIYR"*Z4&-?\ !LLX_P#:6XHL>6YM)S>4<F#)8F3>YWXX.2R0FE[K
MKQ;5(5(54OU*#8'*9JGMP\<:EHB6Z**:KHG4I_3K[NM#L6OVY'6W>$&'&3%Q
MM;W#1"!4)%46Y"*FJ>XJ42'9S2,F7[':L6YQ#?"P8^_(;!4(UC"Y$(UZ>305
M77W$6A'-I'&^+>7.2N$L>A.<G6"-QK,[$>!:)R PK,IIXA;C$Z,9#5U'-4V]
MQ5+WZ*L7.%@N&)YG[-&,W.2$NY64[?;Y$IK<K;CD67 :4AW(BZ+MZ:IK0AZM
MY;Q/&,XX\O>,9A/"UV*<V".W-QP&1C/ Z!L.[W%$>CJ!T5?.^#Y:,7E'%<@Y
M@]E_D+$>-\KNS&4<;9+(;A6@@/N$TRXZ#.]A"^^M*VKH*K2J39)J@+KU0RYO
M<=&+1F0^R/PME%^N>27>W37+K=Y3TZ:83G@%7Y!JX:B*+HB*2KHGDHM6Q>..
M-<5XJQ\\9P]AUBTG)<FD#[QOGWG1 27<?730!Z41H;V]_P!$-F_YAC?@4RBP
MIGM2*I9+[/VY==3!>ONJ];M:+"#SNV\@2O;-OD'#LDBXOD]RB,)9KG/;%QIQ
MCU<PBLMH;3J;BV&B>;XBOEH=C97$G#.=8KR#FW(V69E:,FN$ZUS;9? M9+WQ
MG&C+HH\V#38-D(M?!T1>OAUHE7#V U7\UN1)Y$O[J_7A1:++5&,67E6X^TMR
MG:./\MAXIE+TV<^9W!D7"E0O2^X -(XR]\$";/HG4?>H=C?7LR<09)QW=<QR
M2\Y1:LE;R=YM7W[.X3@>G1GGR?4]  !)"=)%$?!=4T2B2N/M"\68YRSAT3'K
MU>6K!=0F@YCUQ?($$IY-FB,;#(5<[@[O-!=W3<FNW11#3W"'(O+F!\P->SWR
MQ+"_>D1W'+/=A<](>;%F.<@%5Y40S;,&S31\>X):==M%EZ\HQ>#O9R54X YY
MT7_YFN7Z]M?HRE2K@Q-=]B&U.1=?1V,O-R;HFOWI0> 57W$[A!1>UL[VK+QC
M,WV:.-6[<\RX<MVV.VAMLA4DCL6UUMW1$\@*0 :>0M$7K1(YL#VFSO/&MVXS
MY&!DO6SV+3,:N)+T49"P"913]]%F&2?XE"&H\FQZXX&U#XAMT<A+E&TXA/>4
MEUVS=Y;D1/+]^,QTHK].;; C6JW1+7#'9$A,MQHX>XVR" *?J(E&#R3[=A;?
MS9JJ[42Z2E5571$T]&ZZT90F_;O&5(X@MQ0S0XT6_P 5;B +JHB462@*6G@F
MXA\?=2B0I?M=7?'+A[/_ !FW:G6G79CT%^TMM$*DL-JW. YM%.N@D;0K[BZ)
M18>QL<9EQ\>M,>X:^GM0X[<K=U7O"T*'K_WM:,7E[VE7(W'?.7%/,<A5:MS9
M/6J[O G466MRZK[JDW)=1/\ %HRA0./,?N<KV3N7<\426\9C)DS731-5*%!>
M$G5U]XBDZT.U.1;QC7T W65>9\UHX)L*0[_62W?NB&WQW]4>T\=GG>%#M5OD
MYB9&]ASCEN<A"\5S8<%"\>R[ZP<9_45LATH=K<G/XR9?LC&U;W$<<:M-@?EM
MMDA$L9'8JJ71?@ZINU]Q%HD<VE+'Q3R[R;POC,&3R?C[/',U(S%JM$U 85F6
MT1 W&[HQD-7A+<.WN*I+[M%;>YZXG9N_%O&&(Y'E=CLMRQUZ!"E3[U**''EH
MS$%A\8ZD!$1DHB2(2)T\52B0]1AM0!0--FB;=/#3R:41]H% H% H% H% H%
MH(S(_1%Q^Z^GP';K!]$?])MD=OO/26NV6YEMO5-Q&GFB.O55K/'75%)IQYNS
M9:_K&/1?&.[5;2Z9I%LUX73/9$<YEY\__!5_<9E/^Y#_ )>O8_3?XUO]K^A^
MI_\ \T_YGM_\Z/\ 1/\ \%7]QF4_[D/^7I^F_P :W^U_0?\ \T_YGM_\Z/\
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MFG#N:;M;L@N<^;9[];V4B),@JVO=C"9.")BX*]0(R42%4\>NO301*4R;V?,
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MNEWF.(3S@:%M$ %! $125?@JJKXJO2A5)\-\-X_PIC\W'<=G3)\2?,*X.NW
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M,>B_!?29^BQSCGL]:O/R-LUY[X<H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M$5&I$D45 -YPR=<4$7KMWF2#KUTTHC%3AGC0<GON8)86TO\ DL1ZWWJ0CSZ
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MQ9-VF8E^@[2=GO.E6;;)GMPWX\EUWI1,UB8X4HDOSG\@>7BNZ_*XM8?5\?\
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M-$3W$)5KBS6:+YM[I?)=4VL;7=Y<,<K+[K8\T3-/@3M:GFE H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M1J>C([3'H?[).NBZT*,^]YCCF2\O\/7BWWR_L,Y';)EPM%LB$VW:Y#7HQO\
M^F-D:%W%3S51!/J@IT\:"C\'<[9)>^2.1@O&/Y/<6)4AV3;HKK!&-HCVZ/)?
M""XVJH++SNG; $34STUU7K19AE>S%S9=+]+SH,QBWHHPW&XWEW(KD)%;[; B
MM,HD%PUZ-.-"A$K8IIIJNE"8;&P+VE\5SK)[=COJ.\6-C(!D'B=WNL9&8=U&
M)KW>R:$NA(B:HGZBJA*B*2C4GM#>TMZSQ+*,;P"+?H/J^Y-68\VAMJU;CE-.
M)Z3&&2!;@50UVJG4D\/-5%4L0]@(XU'BH\\8ML--[W'#701 1U555?!$2C%I
M3%?:APW*LJMMB9L]W@6'()+T#&<KG1NS;+E+CKM)MHU75-Q>:&J:Z]%05Z46
MBN<?<H+CV2\]Y1GUYDO8]BEW9CQ =-71CQ@*0#4>.UJ@HIDH@*)IN)4W+Y:"
M\\;<_P"/9_<YUBGV>YXC?8<%+RW!OS*1E?M1::2FRU5%%-4W:^'D5=%T%$-A
MWM1XEFF6P,<M]AO<>V7QR4QC612HBMP+B[!15=1I==R(FFFJIT7X>RA10_9Z
MYIR++N7,XM-ZM&1.Q[Q</_+RG-%Z+8HT1J0X,62.J"P9_ 0434B\=5ZT)A=<
M&]J:P9W<F8\#$[]#L8K-2ZY++8;&TP?0&3D'WI &0I][;553HJ:HG76A1WX/
M[4F'YKE5MQQ;)>++#R$G@Q6^7.,C,&YE&51-&C0EZJJ:)X]?-70E1%%$+=?;
M#Q*TW"\QG\3R!VV8[=G+/?;TS';<@Q5!Y6!<)P7%ZF0KM!="5$]WI0HF8U]L
M@^TS<&2O][[X8H-Q.W.NM)CS<1'&T5P44]R%UW]0\5)=VG2@Y89[46(9KE]N
MQN%8KW$M5^=D1L;R25$4+?<'8?[JC:HJDB)[NGF_;[*%'?=O:0MN/98S8LCP
MO)+-C\BZ>H6,KGPD8MSDU34!424M2:)151<'744543HN@HUMD><YA%S[VBEC
MWN6V.,8Y%+'VQ<5&X1'%%XC9#X(FIDI*>F[W^B45>^)>6XL&V<3\?7YJ=)O>
M88X%RBWY\T=9>DL-&Z\TX;AJXKN@;E71==R>[1&P.,N3[9RE%OEQLL"3%MEF
MNDBS!*D[-LIR+M4W&D B79YPZ*M!1N0O:;L> Y=?,,7%+Y?+I88;5SFO6MEM
MZ.$,VA><>=+?JVVT))N,ATUZ>_0HYX9[3^(YMF5EQ6'8[U;X62M/.8Y?;C%2
M/#FN104W@;\Y579M(-R:IN33RI0HXN>T]BS?'<[D=;+<5ML&_EC+D-.QZ04@
M4%>ZGWS;L\[W==:%&9GGM%V7#,RDX3;\7OV572U,LRL@*PQ/2A@,R1$V]Z;D
M5242$O(.BIYVNJ(*-9<Q\UY%B_M"X;:HUFR.7C]IBOR)5BM[2JEV>E0C4'&6
MP7[\D=7-'-RZ"0%IX:T6CTUDDV1'Q.[W&(11Y;5NDR&#5$WMN"P1BNBZIJ*I
M1B\Q>SM[1T<,=PG#\TAWU^Z9#*F1 S2X-D<"5=)$QUQM@'S)2/07&VM4^"6@
MZ;>J&4PV)E7M18;BV4W*QN6>[W"Q8_):@9/E4&-WK9;9;Y;!;=-%U7:7FGHG
MCT%"7I1*-X-N-O-@\R8N-."AMN J$)"2:HJ*G145*(Y4"@4"@4"@4"@4"@4"
M@4"@4"@KV>MP7<'R5JYR#B6X[7-&7*:#NN-,JP:&8AJFY1'5437K6[!7Q+:<
MZP]7I$WQO<,XXBZ[Q+*1/")G5%(F>RKP[Z@X5_+J[?[H7^7KZC7G^1'OOZ/^
MN=9_W7'_ )O_ (3U!PK^75V_W0O\O37G^1'OGUSK/^ZX_P#-_P#">H.%?RZN
MW^Z%_EZ:\_R(]\^N=9_W7'_F_P#A;X]F:WX-!N.1+B%_F7ITV8R2@F0EAHV*
M&YM45WGNU76O*ZA=DF+==L1[M7YG[=9M[DQX?K.*W%%;J:;]5>7DBCT77C/R
M<H% H%!J+(,=Y(LW)EPS?#+=;KM%NMMCP'69LDHQLE'-57HB+KKTZ_\ Y+Z-
MF3%=BBR^9BDU?=[/>].S]-LVNZOOQSCONNK;;JK6&3Z^Y^_)&Q_[Q/[FL=&W
M^5=[S3]4Z#_O&7_+A+<28K?<4QZX-9&+#5UNUUFW=V-%-76F4EDBHVAE\+3;
MXUKW66V^Z-/*(B'#[1]0P;S<63@K-F/'9CB;N$SI[:+]7(^88=VN<2RVN=>)
MY;(-OCNRY)IU5&F 5PUT^HE96VS=,1':W[?!?GRVXK/6OF+8\\S2&OXO*<US
MC"\YO-LWH5^L2/A<;$XZJ]M]K:8 KFW7SFG&W/@_;:5V3MH\6+(GA/:^IR>S
M]D=3Q[6S)JQY=.G)3G$UB9I7LNBZ.?8S(>9Y=:KU:K9G=DAP(5]=6';KG;)I
M2VAF]LG08>%UIDD[@@6PAW)JFB^.M83ALNMF;)F:=DQV.?+TO:9L.3)M,MU]
MV*-5UM]FF=-:3=;,771Z,S%8FG#B@8'*6;/8^YG4C&8;F$QW97I919IE<FXD
M*0Y'>?[)LB!;.T1J/<ZC6Z[;8]6C5.KS<.+T\W0-E;N(VEN:Z,\Q;359&B;K
MK8NMMU1=6*UB*Z>;9MPOEKMEF>R"6_I:66?22D ).ZM*B*BB((1$I:IM0455
M\E<-MDW7:8YOCL.TRY<T8;8].9I3EQ\M>$>ZB,!RU[-;$Y>GK>Y:R2;+B)!?
MU20V,5XFD1X?M7/-\\.NU>FM;,^+P[J5KPAW]8Z=&QSQBB^,GHV7:H]6=5L3
MZ/?;W3VK16AXQ0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0>*;5A=\;]KAW"R8-,'@WR3R"V7;+M^E2X0$A"7P4T?4
M0_4]ZC+L5[(;U*P&T<T\,7FR7&9FN<WYZ=BJ,1C?;N#%Q> A< T1=5 4WKIK
MYR[?%%T"YYT^?#7(G 5^S!F45FQO'7K+<9D-HI6L\;>L;MB@>)$9CI[J=?(M
M!4N6;?$Q;FK.+EG-XRW'<9S:##?M#N,!_M-$C"PY D(6HJ:*A ($NB)\+1"2
M@FN3K5Q7AF#<=VJ7*R[&<DM-I>FXAES<,@FQEE.JZD*<+2AHYJ2IVQ5%#]DB
M%YP>D>!KSFV0<38U=^0F3:RJ2P:RE>;[+KC0O&+#KC>B;2<:0#7HFNNNB:Z4
M27E[E+)(./\ +]QN?"CV16?E]^\-1+KBI0S*T7Q ) *0B:Z=LEUU,O'J0[==
M]%=O*=]9P;E/G>UWB!<'96?8['8QCT2*;XR"]7BTX6H^ -GNWEY-I>]J&"&0
MQ\#N7LWY?>XDU;/9<>G%<RB1W'G6@=9-G<0(B+H*GJ7^#JM!"W6VW2=PGD.9
M! E,VW+^30O-D9<9-'C@'W5%[8*+H*JJCK[H_4H-FYM&EER7[22ML.J+^$QP
M:(6SVN'ZN!-!5$T)>NG2@A\-B3$S;V7C..\@Q[!<!?(FST!?1741"54Z?JT%
MRX8R>+B_M!<K8+>8LUJ_Y1>UN-I%(YDPL)EI]Y7C=\!!1(=JKXJJ(G6B2IW%
M[K]PQWG+@T8TUGD&\W#(I\2,;!C'1EU@&6E-Y504[QIM3W45%35**K_!-JQ/
M),JX^LETO6=RLVQ,_2';#+8$K-9GX8ZDVYW!W,LN[$$-O7P$M%TH2J>2W\\=
MX<SCA*Y6JY?/AG+W+@\C<1PXZPB>:4)!NHFFUQ6] _9:BJ:I17Z"Y1:I-]Q"
M]62&:-R[E;94-APET07)#!-BJKY-%*C!X2X?Q['+O=<(X_RN[9XWG&.79))X
MH#(.66UR84@G0?)#35MDTZ$8]4(B\G6C).9)A^0Y7C_M+V^R0I#\\,EA7!F*
M#9[Y+,22\XXC::>>J BFB#KKHFGBE!*<6X_BG)EYOD_&<CS;(<N8Q2X6E)V3
MMAZNC'<&#82$4C3<+C;CBF@)YJ]515T6@N'LY<O1H%KPSA$\5NWSRM(S8>2*
M4;M-6I&7''!==(]-1=U1%\.ONKMU),.[A?)HF,>T%RM@EYBS&;_E%Z6XVD?1
MS)A8;+4AY7C=\! A(=JKXJJ)XT)1G!.,WG)/94S7%X#3C5XNCM^C067D)E3=
M>:1 !=^FB&J[57WZ$\U*Q*_N<E2N!^-[%9;A&R3CBX,3,P65&-@(+5K5O5#,
MD33O(VNB+IU5!\5HJ-R")/<X8]H=H8S^Y_.^ZRUVSU(%N;1:BFG5-$\E!L$K
M#=+_ ,\WVTPVC"1=N*2ML:0X)  R9(- .IJFB+JO6@DO9RY>CP+5AG")8K=4
MS.TA-AY&IQNTS:D9<<<!UTCTU%W5$7PZ^ZNFI)AYRO\ /N-\A,CF,_*)W,<?
M+F?G':9*/G:(L(7"1K1O:K8JA=&=J^&Y$3;I1DW1E426N=^U$21W5&1CD,6"
M1LE0U2"":"NG7K[E$=N<Q+KCOLV\0\JV9C3(./6[=+VNBJ:19K0QG@)%35-7
M%9U]Z@WQ[.F(EA7#&)VEX-D^1#2Y3]WPUD7$EDDA_P"$*.('_=HDM.Y-'DES
M?SR:1W29=X\=!LD;,A,O0FDVBNFA+[R456,:C3DN?LI$K#R#'BW07EV&G;W"
MVB;NG35$\ODH-8WR_I:>*LGXBEVNY?/*+GAW64R$-TF&H9*( X;B)HF\@5 3
M[;HJ=*#:7M'WW'+#R;<;W@LW(\:YOBMPF8WH$,WK;D D#:BWHFO<5L%0"U%0
M7;MVDJ:H(63EO*9>$\Q<+<E9W!DQH+%GFL7A8+!R$;N<J&8$P @JZKW'41$U
MZI[NBT'I/+'%D83?'1;,5=M4LD:(?OB*4<UVJ*:]?)I1B\)X!?AS'%.#.([1
M;KC\[,<R=+[=^]&-N.U;6YS\@GQ<7Q#8YX]/.%4]S4R<,CL-HL.;\CX/R/=L
MV@%D>0R+A:<?QAE)$2]1)[_>:=1LTVNN!YJGU\FU-232@]^8[:VK)C]ILK!N
MNL6Z''AM.2-.\01VA;0G-$1-RH/G>_1BDJ!0*!0*!0*!0*!0*!0*!0*!01N0
M]CU#=/2K>=VC>B/]ZUM@CAR@[9;F1 M$)7$\U$7QUK/'ZT4FG'FZ]EJ\>S3?
MX<ZK:7SPT\?6KY.;0V["?[A+K_NIC[JO6_2?XT>^_3:;W_FN/_-N_ ;L)_N$
MNO\ NIC[JGZ3_&CWRF]_YKC_ ,V[\!NPG^X2Z_[J8^ZI^D_QH]\IO?\ FN/_
M #;OP-@<6K8EDW+U/Q[,PDMC7=>EQ&XB24U+014%7=L\?U:X]SJI%;XO]U\O
MU^,^FSQ=W;NN,TBVZ;M/+O[VRZXGQY0*!0*#3^07KD?(.4+CA.(WZ+C\&TVR
M/.-QZ$$TWCD'HNN]4VZ:]-*]&RS%;BB^Z-59[Z/O=GM>G;;IEFZW.*[-=DR7
M6\+YMI2/(R_FESI_>)!_W*S]U6/B[?Y$_P!IH_>/0_\ <[_\ZY*</Y/?\GQR
MXEDK[4NZVF[3;2<QAM&!?&(0HCB@G057=X)6&ZQVV71IY3$2XO:788-KN+/
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M/@]QGLAO'7Q'<E"JQ<+YS?,VQJY,Y6PTSE^+7:9C=_*+JD9Z9 V*KS*+U0'
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MKSE\QK[_ '>Y%_\ #&/]W7L^-;\NW^P_6OWK@_WO!_Z2[\!\QK[_ '>Y%_\
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MA$X M(7WM$)%WKYO5*%&#>?: XLLN'V?.7KP<JP7\R9M#D*,_(=?>;UWM]L
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M*!0*!0*!0*!0*!0*!0*!0*!0*!0:2XN_3]SK_GL7_P"%'16[:(T_E"H/M&X
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MZI71N*Z+8O\ 6CXGO==C+;M,-NZI&XMFZV(C3PQ<-.J+>$3JU4GG,<9JVM7
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M]O&GFB%HK0\4H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MNF;KJ1,S=/DB(B*<([YE;*YWAE H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M)66R-$7ZNE!Y#PW"^($XRPGD;DW)4Q[D?(;@>3IEY249N$B2W(4R:$C0Q[2
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MVKJ"!JJIM1==%6B#OGM,\C,ED6>X]B<&=PQB=X]1W26Z\X-VD$#K;3C["(2
M@;G VH0+\)-5^%M*E<[YUY1:S^\8AQE9[-<H%OQIK*PG70GVS2+M$W%T!P4-
M20Q$ 1!ZKJJZ41@X1[1?)]ZR/CJ3D^,VJW8+R,4B):RBR'7K@$B(FTG34E0$
M STVALUV_;:IU*D^14_.'[3G'^!C]]L^$1'LMO(:;@])(D&*):^43%HOJ'1&
MI,$R.Z+[3J<MNJJ8OFN17;"H[BK\-N%&8;BEK[AD#*(G^"ON45RO<U>-,.]I
M7CZ.V;8^M(4BT1A3X3&4&+>T$3Q06MJ=/J4$MR;QACZ9S[._%M_A^D65NW2K
M?<8PF3*N&TRT3BJ;2B2*3J*2[52@CH#4C!+3[1O"D28_,Q.P6<KE86I1JZ44
M)4=#-L27R:.MI]4=WBJT'I;V=T1.#\#TZ?\ E$?]=%J(V;0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#S[F7)-SP3/(L+.\;LL7$;I*E$Q
M=6F2E33B,KH+AB*KH9;@U\WRK65N/5$TYOU+IG0\?4-C==M,V6[-CMMK9,Z;
M=4]D>2./:N-NRC%LZQF[W+BVU0+M>+>K;3+$Z)Z*R3IJBZ$IB"Z;-R]%\:PN
MLTS28>!GZ?NNG[G'9U"^_'9?69FV[5-/<F>U6K/F>>V[.[!@.98I8[; R1'W
M#& BN[@BM&YJJ(9!KN!/A)6461,33L>ON>F;'+L<N\VV?+?=@T^MP]:8CNKV
MJQ>K#?>;(^17BUHMMRW#+@[8K Q >]$8<C@\B&3I'JJ$C:E\ A3R:5G;.GGQ
MB8A[.UW>#H5V'%D]/#N;(RY)NC5,74X:8CRTYQ+*PC-.7,CMD^UV'#\?E1;/
M(2V7+OFH=R3&1$4CU<1#7IKNT\:PFRV/=CN_I:.J]+Z3M<EF3-N,ULY+==M(
MY6W=W#AYD3Q1F>38R60Y'ET&)\S[;>)3%YNI*<B9 D.(+81XH(I%V>X8#HB:
M(A*M9W66UC3W.[VAZ7MMUX.#;77>-?BMFRSA;;?;'&;KY^5IB9]R%_Y<Y-P[
M +4T4"UP963W!AF=;HDJ$JM.QWG-I$9B(Z$B(2Z*6M8X\6N>#YCV<Z#O.HY9
MUWWVXK)FVZ;;^,71'"D>]V*I@WM"<<3[0\]GMNM]JO"2"%F-!M[CS:QD %$U
M+:?G*2FFFOD2MEVWF)X15[?5O8SJ./+$;.^_)93C-V2(G56>'..%*/1D"/!C
MQA]7L-QX[NCJ T"-(JDB=5$43KI6B'Y/EOONN].9F8X<9JR:K2Z)L1BX0Y$"
M2.Z-*:-AX4Z:@X*B2?66@\>2^+^7KC@<+V<KEAS$NRVZY"$3D=R1'[+=C&8D
MK>#2_?1?5$[2@.B[>B_LJJMA9?9.3\%Y-SG*<&Q1<MM_)%M@QD<;E,QEMUSM
ML<H;2O"\J:LJ!;U(?+TZ41M+B'"I/'?&F-89-=%Z=:H8MS'&U56UD.$3KJ J
MHBJ*&9(*Z>%0:IL>!YH_=^9N/;K878N.9Y)N=Q@9>DAE8HC<(H,--HRBJXIB
M6JET1$VK[VM$=B.*\M97=>,,=S/%1QRR\6$+UQO)2V9 7.1"C>BQ/1 ;\Y!)
M$1QQ2Z)JJ=%1$4-U<MXD[G7&>58G'!')MSMS[<("T1%E@/<8U551$^^B'6H/
M,^-^SGF<6[\)S;A;C0;<LF=G[A/M*H2F9IW.,C^CGWU5<<V)LW::=:HO_('!
MUTRSVA[1EZQ>[A$FRR&KX9$WVDN+4:7$CJ3:DA$J#)%15!73:M!A\0\(Y';/
M9WRS",QB$QE^4I<>\VX\#QH:,#%AZN"1#HG9 QZ^7K04:Q^SCG'H_"[UT@&,
MR%/FR^155YI3V>L N$9'E0U[NO;V>;NT6@V!R'B?,7->%<C85DMAA6,8-P8?
MP.4V^A)/;BN$>UY=YZ;VT'0U0$0CT5/-6@BN,..KNXSDL^1PS;< G)8YEOM\
MMB>LB;)N$AE6W !O<0"R>O0B+S?=/55$2PK-Q+R+%PWV?;8_8S"=AU]<FY*R
MKS"K$CE,)Q#)4<T+S5UT;4EH)1SAO-R]IA+VD7_\$I7(,O)_>SM]=-P%C(.S
M?W-W=\_79IIY:"6M^&<C6'ECFG-+;C3-RCY! M[>-,3GV0B7!UF.#3K9^>JB
M*><B]Q!1?=ZZT%,XMXMSYG*,XRB-@WYN,;N^-RK4N)MW 9C4V\.#YKS0)H#0
M)U0==$'7S>A%H)?&.(^4,<XUX;R>SV 9N><:/W [CBSLAILY$2X2#(Q!U")O
M>@B*IHJ_"\JIM4KHN7$/*N2\8\PY)=,?&+GO)<VUNP<6:DM.''A6V6VX*&Z1
M"WOV*2KJJ?!\BKM2"ZS.-\W=YAQ_)0M!+8X?'QV*3,[K.@7-0>3L*._=KYP^
M<B;>OC53L./>',ID^RF_Q+D<?U-E$N/< %EXP<%MXYKDF.IDR1IM)=F[:JZ(
MON]*BH3@;C.]6G*K6YDG#=KQ9['8JM2,M&?WI$FX""M(]&9 B':X*EOUZ)NU
M0OM:J-1\;8]R;R3QO;>,[/C#?S)?RURZ3LQ66VB,-17M7VCC+Y^]-44%1?.\
M-/%4#;&;X5S/A^7\F1N/L9:R;'^66 ;"XK*:C%:I1,''>)T7%3<.CID/D^#U
MU114):R<,Y;B?(W"*Q8GI]@PNR3X-^N[;C8M-RY,=[7:!DCA"3AZ#H/AXT$O
M[06+9^YG7&G)&"XZN5%B,B<DVSMR&XCI>F@T+9(;FJ(/FEN71=.G3372"M^T
M1B_(.?BS9/S2Q,@=D6YD+1E$:Y-1I=JNCJ(3VY5T4F6S7H*Z"6FNO7I2%[M[
M/,]EEX%QY,M4:^X:]8$A9ME)R%64W/!@FSV*1H2IT#:1-DKFY==NBK04GAFS
M<_\ &;EFX@;Q> >&V:Z27YV:2)*$S)L\APW5!A@"0Q?4G%(=VNBZ(0[=24JG
MWCBGF^V63,.!\>QV/-PO,+Z5VB9J<IL&X<!]YIYQMYE?.4Q[(HNB:_"VH6J*
M@;!+BS+H'+^576!;#>Q9WCWYM6JXDZRG>G-BR -;-^Y%5 7SE1!]^B*]9>*N
M0(-E]GEF9929/"9D^1E.Y^/I":=<$@(E[FA:BBK][W4'?PRY?LHB<S\XV.$Y
M.R#)I,JW8='W"V;D:W,J$5!)Q104(B:$E7][H-?'[)N;8_Q?CN3V*3=IO*%K
MF1+L6).S(WJYF0C^XU:1=HHX([5(NZNNB^/2BU;$Y9X6S#-N<\+RZUP'6\-N
M(6US-&^\R*-G:I!2 !T5-"/45%M-B%U2B)CV@\7Y-D<F<<Y[QYB_SG+%1GG)
MC%)8BM]R0@ "$3K@+[J^:B^%!#VKAGDB1A'+^7Y?&8=Y1Y(@NQXUB@N@345I
MMH@981TBV*2ZB/PU1$$?.U5:"<X$N7.EACXMQWEW'+=GQ*U0EAR<A6XL/.IZ
M.R2MEV6C-=7#015/)KKY*@]%4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@TG.Y*NLBU\FW"5;+=(>P>64:THZR3B&WO5%[NX]571$^!MII
MK,>7\+]#Q=#Q6Y=E9;??$;JVM])I2?)P^.K#L'%KC-KB\J8B](7.+LRU>QLK
MTA&K,4NX AN@K8B)=L$=/MHIZIHG6LKI[.YT;SK\79;NG[F+?J^.9QZXMKET
MV32)K6FJ=,:N'>CL=L3^92[E9+6^X];I<QP<]GF\03K9=05729M;BHFC'=';
MX%J%:Z<>79Y'7O=W;L;+,N2(BZVV/J]M/0R8^6K-'R],U[.*8XGC-Y=D$V]R
MS<AOX+/DV& Q#-6V);+;9-(],%=W<>T+7<BIU\E9:--/+$.#VAOG9;>W%;2Z
M-U9;ENF[C-LS-=-D_BV^3BD96,X'S--ESK3=+K;7+$^Y;9P6TD@ 4@24B4D5
MM=Y)K\*D13L<F/?;[H=EMF2S'?XL1?;K]/T?)QX>9Y5Y/9Q"RW4['@EVN<R
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M9^:7#.6<+WR9=)!<;-X_=;;"R2X,.-*#LU4F,C(#8A-*0%M$2!%Z=?!= O\
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M.5 H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H"HBIHO5%\4H.DX<1V,4-QALXA)M*.0"K:BOD45332@[ ;;:
M;%EL!!H!0 ;%$04%$T1$1.B(B4'4Q"A16%BQ8[3$9==66P$&UW?"\T41.OEH
M$>'#B" 18[; -CVVQ: 000UUVH@HFB:]=*#DQ%C14-(S(,HX9.N(V* A.%\(
MET1-57RK0?(L.)";[,-AN.RI*:ML@+8[BZJN@HB:K0?&H,)@E)B,TT2F3JJ
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MQR+8F6[)CEQ"]V2&AO;(UQ;<-T7A53U54)PUT)5'KX4%SH% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MA)> %!Q'$38B B?XM"'WEB\<JY![2MNXJPK-Y.*6FZ6,9+SC;02 ;41D&X0
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M1 412(T-453)43R(E!>Z!047#N*,9PK*\JS6W%(?R'+I*R;D_(-%  W*0M-
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MV22W?6;YDT2W05R8FB%769TAG<8NB(B@DI(::(FG1=*$MF40H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MEC6.\3XM=+':H]NN%]LULEWB0P&TY3Z1A7N.*JKJJJ9+^JM$EMFB% H% H%
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M--FOBGNT1*RKI;8+\:+-F,1I,Q7$ALO.@V;RL@KKB-B2HI; %3+;X"FJ]*"
MN^;V^,%I*QO0+P=SDV\5$;E%C[+?<GE9&8"F2]T=1+M@'5U440ZT%&:]HW"'
MK1%OK3T<K6]DYXK*D^FQT;B *R5"=(/7:#+@1E,-R^<A)HM%HVO#N]JN%L:O
M<"='E69YKTEFX,N@Y&-C3=W!=%5%1TZ[M=*(@V>2>.Y%G=R%C+;,Y867O1GK
MH%PBE$!_;O[9.HYL0]OG;===.M!,1KO$NEF&]8\\S>(C[)/V]V*\!L2>BJ*
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MD.\R77>.U/'S>M&54)R?@]ZS[VNPM=AO<_&IT?'FGV\@M@D9Q'1!W9W%$@T
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M1I6]J:HJ: 1>5$4A)=*+1=N4_:/EX-E.(X[BF*EF*9C &?:SB2E8==[RJC*
M'9<U$DVDI*J:#]2B48N#^TM<L@Q/D>;D6*K9LSXWCO2KA9%D*K;R-@Z2"CB@
MJ@J$R0%YI)X*FNNB"C%XR]I+..0IUJNDGCEZR<;OQYCUURU^2;D6/Z TXZXX
M)=@$)O5OM_XVO7S52A1"Q/;"N:OP\LNF RX'#%RN"VJ'EIO;G4-"(>Z;*!IM
M3:6X1+IH2(1$FE"BU\G>T5D.%\G1^,,5PAS+;M/M@3[>467VS-USNJB$':).
MV*-J1%O\*%&;QS[2=GRCCS*\QRZV.8[<\&<<8R2TH7=,7!U1M&MR NYPQ5I
M/30TT5=.M"BG8I[6UZF9!C@YU@<C&,(S-[T?&L@)\G4(B,0 G$)L$4"4AU)%
M3:B[M"'K0HD<Z]IC,;%RCD/%.&<>.Y3>[2PP_%>CR2\X7([,@S=:%E=H"CNQ
M//ZEHGVU"C4OM'9WGD[D+AB?.P61$N%N=AW>W6\GC+TZYRB@OO0 ^]IM-AP
M94MJEN+P]TL-ZYU[05]P?",.GS<*D?G)S604*VX>;^U6GQ<1M4-WMZKJKC6T
M=B*6_P FBT2BY\19UF^<6NXNYUA4C#+K;9 Q>R^YW&Y.H(:FSN$5VBBBFOG"
MJ^!=%1 Q.;N9H7#UDMS[=L=ON3WZ4D#'[&P6PY#_ $U52027:*D ^:*DI$*(
MG75!$*WQW[05QO$+,DY.Q&7AERP>-Z=>")#?BDPK?=00-1'1U1T46]5WHJ**
M^X**/8_;"NSERLEUR[ 9-AXQR>6L*RY.3ZN:$A[.XZ*MB*CJBJ2"71$)1W[:
M+19>1/:,RS&.4IW%.(8$YE5Z:@-S(;C$M6R(G&T=)7&^TJ( (J]=_5=$\M$H
MH0>VME,O%@S"W<92'<?M3P1<KN1RU&*Q(=-!!M@^TJZJA"J[Q\U21%3JA*6C
M?G)O),3&N%KQR1;W%;%VT#*M!'YI^D7%L0B:I[N]T-4HCRV_ <XP]B9B&B=K
M(>2)C)+^S)+DXC@^^J%#CI^J5%[4[P'99F3\#\K<$WMM#O\ C<F?#;C+YW;>
M= C8T1?V,N.X:+0E2+EG3MQ]B"QXTRJNW.7?0QE60ZF7H\D[@V.GO"+0_6H=
MJT>T=@-HC9%[._&DUM5LXD%BF"P7;(V5>M\=U1+35"+4EW>ZNM"&?BE@>]F_
MVG;)Q]C=RE2./,[AJZMOEN=Q6GU1X07H@HI@ZRFA[=>V>U=536ASA8/9K$1]
MH+GK:*)_YJ2]$TZE.EJOUUHDO5]$*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0>5
MN4<(O'(/,>:8O9;!:+C(N&,V>.=]O#FQRS(Y(F?Z3% 6C<-WIJ* 8:$([E5.
ME&2,7*,JM61WW#L5*Y-GD?(%_&:_8D@^MW!M5CM[HBR5QVQD5P]'7=WG* D@
M^*T&=G')_*-LL5IDR3NEMSO%H5EE9O$@K:EL3#MTG^CAZ6CB&^\4AL#T;B%M
M;5476@E<FY!Y$P&;R7+OL^>5^8M]VNF%6]QJ&]C[]LBR&09?CFTTCXR88.(D
MIEXM"UW?!T5"-C<-2.2E+((.<QKEZD8<B.8U<+\5M*ZO \ROI8/):S)G8V\.
MYI>A;#1.NVA+SPQG69-,6_FJ9>7;MDD[!LHO$"WFTPD*V/!<8C -, VVAD#0
MD.]'B-55M55>JHA7H+BJ[Y''S+.>/KY?W<HC8T-GEP;S*!@)?_F\9UUUAWT<
M&P5!)KN-^;J@.(BJNB+1&H(W*/)-@MGSO?R-^\%>K/GTMJT3&(J0X;V)R^W"
M)E&6FW%3;KW=YEN3ZB45U9FYETR#/P:Z9S+O 6J\8'>(5^!F$,L';[--EQDM
MC?;4 -L9<?S-4Z"2D'B&ZN9<NNW&6)6/+VYKKEIL=SACE!J#9.2[<\TY&)"T
M!$$B?<9/4$'K[U$:2MW)7,$K&;O"O&0O6S*,82PX]>I#<6*II>;U?T$WQ$VM
MA;("MAIIMW$JZ:]:*D.6&+ZY"SO$7\@E.-8_^;\@N:LPTG2G9UV=;<<D.BP.
M]4)&W 'X(DVFB(BFA!.CE7,4WE6;;,<]:72SXG>;38[BR26INVO6IV(RY.E2
M^X;,GTLE>[S11P1M$':@KJ5$6GE^_96YE</$L?R1S$8T?'+QE#ET9:CNF_)M
MAL-LL%Z2!CVA[JNO"/4A3344ZT(4&S\P9]?0G7 [HD1),KC0V(C++.R.WDX,
MG<&V]XD1"[O+3<JJ*>"I17S&K5R/:>,;X>%WNZW1U,WNXW>/%] ;N_JF)<98
M2UMO=9[:RG207B%S5%\X0VZHBD=\ODF^SG/_ +V+\;L&_P 3 +9"R;T.&U<!
M;R"?,BS)AZ,Z(\J,[4;-%;;/X(IY0IUEO&>V17\#PZX7:1<;IEV=29EQM86S
MUM,E6=V,VP3BSU:C(!./=V2+8H1(F@[4UHK:7. Y3>?9PC2,H(['E2N8ZY?8
MT7LF"3#N41IT-5[H[1</NCM+Q$4U4==20JMS<R/%N7<QOMHR&4T[;+AQ_:[N
MR;44@O#5R)(+SDM>RBB: X2CV=@BO73PT*LG%F7\NY3G+-ZD1+@]@UQG7Z%>
M?3/5H6R$%MDNL6_T 6B29W$5A6I/?#0B+<FB(BT17^<[GD&477.;,]>'X.-8
M9)PL&[)'!GL3RO5T:-QV41MD[YBB':1MP4107775:$)#'LJYPR3,+Y/L*REL
M:W#)[(XY<1MJ6&WK;$?8M;K0MN)-[HOLBDKN HF)JJ(B"*T'7B^:90S\T[%?
MKC<)F90,I2%E]NOK%N=E17CL$N:+45V,R@+'><:[K#S?G[%VZZ=%"DR>4N4[
M5C[UZ',WYTF^X UF#0.1H7:M]SE7>)%48R"TB]MMMTFT!U3ZHJZ^X5>)67YA
M *]\8G?\@ON4!DQV[')EI]41+M)B-6=FZ/@^]-9"*#;7>5=R AEYH#THBFX_
MF66E>'^7)%V=E9##XC8OKT/M,)$DR&GIP"+H"VAHVC@>D$C9"N]5\Y T&BI^
M%EW,\&RV^V7N?=+?:<OO.-VRTY3=!M!7-M;J+IW%(R05>90"[8>BJ\WJ'<5/
M.5!T(N7#MTC85Q'F]WO,^0['L5]RE^==>VV<MU(LQY2>[8HC:NEMW;41!W>]
M0EKN)R#RFAWC%'[[>+4^[D&&0H4N[#:9-XC1,H<?"0JE$:*-M) $V@4-S?5%
MHJS,91R\7)DNUV-ZZW6QX9=K38[LKR6M(#]H*&R[/F3=Y-2EF%W>\T4<$;T'
M:@EJ5$05OS[EO)KQ?X&!7*Z.-Y%C+F1XFF0K:6W71"ZQF-\'T=O;'%R,Z;;0
M3$5>YL,NFZBM[<1Y-"O^'Q5&[7"Y7"/(FPI8W]N/'O#,B&^H.QY+<<&VU<8U
M%LB =%Z+Y:)*_40H% H% H% H% H% H% H% H% H-$^UG^C"#_S#9_PE*+#>
MU$>=<[0^=N6V.)XY$?&N#FS=<]<!=&YMQ+SHEM54\13J;B:_LDZ& T5O+)<6
MLF6XU<,2O<47[%<XQ0Y$9$041LDT10Z>:0+H0$GP21%3PHC3'!&4W7#+U,]G
M?/Y"ED>.-J[B%S=\T;M8.O94->BN,"FU11>@BJ=>V2T66_Z(T1[4W]G^/O\
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M50B,Q&61(O\ !U=-S_ZU1(9GM3,WO(>2>*^&N/6XZ7:VME=H420J>C"L=/\
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M[T0H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M0H?3;X*^-W/Y ?W5"A]-O@KXW<_D!_=4*'TV^"OC=S^0']U0H?3;X*^-W/Y
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M^<"S!7R;-"BZ_MNE>I&6/WQ,?_IT^^]^W/'_ %--O_Z.G^]\2]^T$XU>./\
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MXUPF(B'=+]EUO? -?.&);E)V0ZB>5 0@UKMVW#5=W0PN;TKB9E H% H% H%
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MDPK)JV2H.NFNHKI7!?D_2:H[V<1P>7K?[-7M*VW%;[Q= R>W1\ >-V2R&_\
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M:T44]80/C3/\(/V:4#UA ^-,_P (/V:4#UA ^-,_P@_9I0/6$#XTS_"#]FE
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MP5/H'<S?'L?^5R?Q2FF"I] [F;X]C_RN3^*4TP5/H'<S?'L?^5R?Q2FF"I]
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MZ".B)Y*"%N?"^ 7<<C&=">,<JGP[K>=)#H]R5;E$F"'0O,1%%-4'QHM4U;<
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M[_C=BRF"%MR* U<8#<AB8##Z;A1^*X+K1^3J)"GU4Z+JBJE$2E H% H% H%
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M<G6+J^UZ1Z'#CG,<:8UVHZ\C:^8*K\'RKXZ42CORGE; ,-LEHR*\W57;7?\
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M:STNT5N6WR+;:U9;9]#:N"/.H&HB)$G;[?[IJOZNM%EO:B% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MNXO-]]:)+3MMR[%)?&W"&%0Y+8Y;:,P%ZZVSMDC[ E-5%-PE'1-ZD"Z:]?\
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MKY=*#M&/&",D)N.RW!05!(C;0 QL+H0]L40=%\J:=:#H&UVH$C"%NB",%5*
M(QVD2,JKJJLH@_>U5>J[-*!<;7:[Q&]"O,"-<H6Y'$CS66Y#:&G@2"XA(B^^
ME!W.Q8;\0K>]%8<MQ-HP4$V@*,K2> =I4V;4\B:=*#A%@6^#""V084>+:VQ)
ML(##+;<9 /H0]H10="^VZ=?+0=42SV:!;SM,"V0XMH<0D=M[,=H(I]SJ6]I!
MVEKY=4H/L:TVB';O4\.VQ(UGT5%MS,=H(I(6FNYI!VEKHFNJ4'=Z)"6+Z L5
MA;?L[20E:!8_;3P#M*FS:GN::4'5;K7:K/%]"LT"-;86Y36/"9;CMJ:^)*+:
M"BK[ZT':[#AOOLRGXK+TN,JK%D.- ;K*EXJV9(I!KY=JI0=5QM5IO,<8EYM\
M6Y10-'08FL-R %Q/MA1P2T7IXI0=LB)#F1#MTN*Q(MS@(TY"=: XZMCT0.TJ
M*.U/(FG3R4'%B#;XT$;5&A1V;2#:LC;VV6QBHT7B':0=FB^5-.M!UQ+19X%O
M6TP+;$B6DMV^WL1VFXQ[_A;FA%!+7R[DH.86ZV-G&<;@1@<@HHP#!AL2C"OB
MC*H.K:+Y4#2@Z_4UE[*QO54+T97?258]%9[2O_OJALT[G^'IN]^@[#MUM<<D
MNNP8SCLT4;G.&PV1R 3P%XE'5Q$]P]:#KEV>S3[>EHGVR'*M Z;+>_':<C!M
M^#M:(5$=/)M1*#L<MUL>88BO0(KD6(HK$CFPT33"A\%6@4=H*GD442@YMQ(;
M4A^8U%9;F2DVRY(M CSXITT=-$W&GO$JT&-#L5@MJM%;;1 A&PIJP<:*RR;:
MNKJ:@0 BCN^VT7K0?8MEL<&:_<X%I@Q+G)3;)FQHK++[B+XH3@"A+KY>O6@S
M'&VGFG&'VP>CNBK;S+HHXV8$FBB0DBH2+Y45*##@V6QVM6UM=JA0":;[#9Q(
MS+!BUKKL0FQ1=NO736@RGF6)+)QY+3<B,ZFUUAX!<;,?<("145/>5* $>,U'
M2&U':"$@*RD06P1CM+T4.WIMVK^QTTH.FVVRUV6,D.RP(ULB(:N>CPF6XS?<
M7Q)1;045??6@^0+5:;44@[3;HEO.6:NRUB1VF.\:ZIN<[8IN\5\:#Y;K19K.
M+XV:V0[:,D^Y)2%':C=T_=/MB.[]6@X72V^M&@CN%&6,B[C8F0FI[9&GP2VN
MDB(H]?)5'Q(M[%4(;R"$.BBJ0 14T\-/OU!A1,;]72I,^W.6^%/F_P"N2XMG
MC,//?XYMN(JZ^6@[@LTQM]^4W-B!*E#VY<@;4PCKX::;731W4QTZ:$JT&5:[
M>-KBK$;]'1A"4VVHD1N"R&[QT::51U5>JK0=S<.$S(>F,166IDG3TF4VT //
M:>'<<%$(]/)N5:@^NPX;[[,I^*R]+C*JQ9#C0&ZRI>*MF2*0:^7:J4'5<;7:
MKQ'2'>;?&N4031T6)K#<AL7!\"07!)$7WTH*CR1QPUR(.)QCFA;8&-79J[N-
MBRCG=".&T&&PZ **J==>B#Y*"YPX5NMC:Q[/!C6R(KAO)%A,A'90W%U)=K:"
MBJONT'3;[19[0L@K1;8EN*6?<E%"CM1U=/QU-6Q'=^K0<8MEL<&:_<X%JA0[
MG)3;)FQHK++[B+XH3@"A+KY>O6@XO6''Y,E^;)LUO?FRMGI4EV(PXZ[V^HJ9
MD"J2IY%6@R4AP1D.S!B,),D"C<F3V6^ZZVG1 </;J8II\$E5*#IMUFLMG1]+
M-:X=M]*+?)]"CM1E=+QU-6Q'=^K09$F+$FL%%G1VI<5S3N1Y#8O-%HNJ;@-%
M%=%ZIJE!"'AMH<S>'GQ$[ZX@6MRR0XR;$BMQG3WD8B@[D/1=B>=M0?)5$U*A
MPI[*QKA%9F155"6/):!]I2'P50<0DU3R+I4'3 L]CM<MJ?;;/;X<QE=6WX\1
MAEQ/=1"; 5T7R]:"+PS#K1@EE<L=E)UR,_,E7)]^2H*\Y(FGO-24!%-$T01Z
M>"4$G<[/9[VRW'O=MB72.T6]EJ=';DB!>.HHX);?#R4&6 -M-@RR -,M"@--
M-BC;8 /@(B*(@HGN(E!C3+5:;B['D7*W1)TB&I+$>E1VGS9WIH6PG!)1UUZZ
M4 +5:6O1NU;HC?H*J4#9':'T9274E9T'[VJKU79IK0<@MUM;;E,MP8P,SMRS
MVA8;0)*DBH2O"@Z.*NJZJ>M!UPK-9;9L6V6N'!)IOL-E%C-,$+*+KVT)L47;
MKUVZZ4&;08_H%O0I1I"C[YR;9Y=EO=)%45-'UV_?$T54\_6@YQHT6%':APF&
MXL-@4;8C, +338)X" "B(B?4H.V@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%IQC_4G?\ZO^2-!-U%*
M!0*!0*!0*!0*!0*!0*!0*!0*!00>78=C6>61W',MMX7.RO&VZ[$<(P%3:)#!
M=6R$NBI[M!KOZ+/ /Y$Q?X>7_+T6I]%G@'\B8O\ #R_Y>A4^BSP#^1,7^'E_
MR]"JW8?Q3Q]@,65"Q"QM6N+.<!Z4VTX\:&XVBB*KW#)>B*OA1%C]2VSXN/UR
M^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_
M7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+
MC]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VS
MXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+
M;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/
M4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[-
M ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<O
MLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/U
MR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX
M_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^
M+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2V
MSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U
M+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0
M/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[
M- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<
MOLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/
MUR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/B
MX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML
M^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2
MVSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#
MU+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S
M0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+
M[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]
M<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN
M/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/
MBX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4M
ML^+C]<OLT#U+;/BX_7+[- ]2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[- ]
M2VSXN/UR^S0/4ML^+C]<OLT#U+;/BX_7+[-!DQXL>("A'!&P)=RHFJ]?#RT'
M=0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*"$S#*;9A&,73+;RCI6NT1SE2QCBCCJMAX[15115_52@IW$G.N$\TK=
MTPX)P>I?1_3/3V!8U]+[NS9M</7]R+6BT;,HA0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0:R]HG]!V>?T1(_[$HL/-O_TO3_Z(
M?_SH_P#?:++V_1B4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@\;>T=])O\YTG\UGS@^:7H<7M>K-?1>_L7N;=/+KXT911HS+?I>?
M-B[?/'YS?-7T8_6_IFOH_HNGG]S_  =/&B\%,XB_/EI>/S,^M]O^C>NO4^NF
MOWWL=W3_ .N;?U:$MF?_ /</_P#EW_RU$X/T=B=WT1COZ][MAW-WCNVIKK[^
MM&+NH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%!K+
MVB?T'9Y_1$C_ +$HL/-O_P!+T_\ HA__ #H_]]HLO;]&)0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!00>98K;<XQ:ZXC>#>;MEX
MCG$E'&(0>1MSQ4"(21%^J*T%+X@X'POA-;PN(R+@_P"N_1O3/6+S;VGHG=V;
M.VTUI^ZEKKKY*+5M"B% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%!H
M'C[EWEW.997<<8L47 8MSE0+E=7+D;<EF-!>)MYWMD.FHB.[SM$7WDZT5L"S
M<V\4Y!:KU>K-E,.7;,=#NWE\%<3T=K541Q1($(@54Z&"**^1:%$OAG(N%<AL
MS9.%7EF\Q[<Z,>8['0]@.&.]$U,10M4\HZI1%GH%!0>9N1EXJX[NN9LQ0GSX
MJL,0(#A$*/R)+P-"&HHJ]$)2Z>1*+#&MO-&&-\78]RAEERCV*TWN-&,E<(G!
M&8^&KD=M!%3-0(33H.N@JJ^6A1V2N=>)(6,-YG(RJ*F,O2RMS5P 7G .6V.\
MFQ$&R)50?.Z#II0HQYO)J2\EP(<7NECEX;EC-RDNR7WGO3GVH#'=U@B";%[?
M7O(YU'PZ+09V*\U\59O=7+)BV4P[E=&XY33CMJ8+V ^$6YP1%=NNI(BZHG54
MH45Z^>T;QFWA.7Y5BE^AWN1BL57'(X]X&SE.ZMQF]_;ZBZ[H"&&H^_0HM?%7
M(%MY,P6T97 DL2)$F.R-U;B;T:CW'L@<AA.YYWWLCV]?)1&?R#EK&!X/D&8R
M %T;+!?F-L&6P776P56FMR:Z;SVAK[]!J)SVBYY^SF7,\:T1DOK3PPI-H>=<
M&.Q*6>D-=Y:(>B"2.:>/736BT;$@\U<5W#%KCF<3*H3N-6AU(URN&XA%IY51
M!%0(4-5-539M%=WVNM"BD\A^TQA>,V#"LBQRYPKE:<LO;-O<FNH^(,6MD]L^
M4@( DI,;@':6BZFBZ+II0HN=ZYPXGQV;:+?>\JAPI5^C,3K4+O<V.Q)?[B\I
MH"@ 'IT)PA2A1'_G58L63YVSF]ULENQ'%CM3<=YAU\Y[!71O<*3A45 =Y:=K
M9Y/'W:"U85R%A?(L&1<L*O#%XA1'EC27&-R*VZB(NBB8B6BHNHKIHOD6B+-0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*"'RV\NX[BM\R!AH7W[3;Y<]IAQ5$#.*P;J"2HB
MJB*HZ*J4&I>/N6^1KM98V>\B6:Q8WQE(MJ70[TU<2=>;!T1)E":).BENV[==
MVO3QZ45=&.;>*9&*#G#650UQ590V\KBJF(!+--R-."0H8%IYVABG3KX4*+'B
M>7XYG-D8R3%)X7.R22<!B8V)@)$R:MFB(X(ET(53PHB;H%!I[G_F\>%+;CTM
MJ %RDWFX=AZ.9$*MP& WR7AV(JJH;@][KUHL0N.8\I\>\?I;BS'((MI2[;O5
MW>4B[H@B*1)VQ+04W)YRZ#U\:(B[SSMQ'CT.RW"\Y5%B0\A9259WB%XA?84M
MO<\UM=HZ]-QZ)1:,:3R@W:,YO\2^W6QQ\"M%CC7D9+3[SET#ON"'== 15OL$
MA>:H:K\'QW+M"2L?,_%F26Z]7>R93!E6W'01V]2D,@".V2*HF2N".HKM5$4=
M45>B=:)11>0?:;PFQ\=-YQA%U@WM)-S:M$;OI(;:1W<V<C<&P#U:9/N:=/%/
MJ*6C<MBOEIR6T0[]8I03K/<&T?ARV]=CC9>!)N1%^NE$4;G7E(^(>/I.6Q88
M7&Z%)C0;; =(@!Y^0?4=0U+HV+A]/<HL(#,>>X.,8UQKEJC%9L&;R8GK&?+<
M-&X4)^+Z2Z2;$U4Q^"FOE\E"BTSN;>*;;B4#.9N4PV\6NCA,6^?]\+O.@JH0
M"T(*YN%17>FSS?+I0HJ65>T;B6/\AX1BK=R@EC^3PG+C-NSBO*33+[2%;^V@
MCM_T@U\2UZ>YXT*+K^>'C-,U_-T61Q1S/?V?51=P2[JCN1ON*"-[U3P#?N7W
M*)15[%SA9+79+C=N4+_8;:+=]N%GMSMJ=D/L*W!031MY3#5) HJ[Q1-/@Z=5
MVT6C8^+Y5CV:V.+DF+7!JYV28A+'F,Z[2V$H$BH2(0JA(J*A(BI1$Q0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0>0./^#/2>+.2;_!L<J!RI?AR2SQG)
M9/QR?AR'MP-BRZ0MHCJ"@"YM\OCI1E5 N6B^99:LEO=DPF[66#9N+4PV7%EP
M#BOR;VC[;G9CLZ;GA:$%\\1U\$5/"@]<<>VX+9@^.14AC!?"UP1D1T:1DA<"
M,V)"8HB:$BIHJ+1BLM H-!^T3:LVR_(.-L-PJ&!O#=SR*7<I[#[MHCE9F5..
M$PFA7S72,D$-?.)$HL-08[8<XQ"QX7$R+&[C<HO&&=7)F9!M,"1)21 N#9.1
MYD-E017&4><<0-.HZIX*M%86)7O,XN"V)^P-9#:,'N689,YDY8Q";D7R*6@K
M;V&V]CJ A.;FW=H[>FW7P10E>,,2RV%%]GP)UBN4<K0/( W,9$1YLHGIC3O8
M1]%!$:[JK][W:;E^#K0=W&N(7J"WPAZUQBX^AP,>RYJ_1@ANM.BLE'=C+NHA
MM<>1=&T-44E7I0<L'MV:W+!^2\!Q^TWR;QT&*2F<9:RBU! N\6YD+FRV-DB?
MZ2@H1$AI\$]$'3750]!\#W)JX<4XRV%IFV9ZVP(MMEQ;C$*"Z4J'';:><$"T
M4@(T70_MJ)*L^U!;\ER;!K5@.*P7)D[++W;X$IU6778D:&T[Z0;THFQ)1:$F
MV]_NIKI0AHO(</Y+MG&7-6 7NR'<;J[?;1DL$K'"DG FE=94=R4,$2!2)&E;
M'>":[>ODZT5-7"V1,M_.WG-VQ7*;;AN0SL9:LC=OMBMWR/.LL<A<FI#-4T:8
M<7::IKN373SDZ!ROQ\C7[B/ \HS6P3KJ_C/(4.YO.-6I&;I,QV,3J^F/0 34
M#=(M"#[;S2+77=08'M%2^1,J?RFRC RH<;GV>T2,)L5FM?=@R!+8]-2Z[6C,
M'&#306]R**HG_>$.SDG$LJGR><B9L5PEC=9''JP=D1YU)21& 23VM 5'.TO1
MW;KM^VTH-U\3V>XV[EOF69)M[\.VSKA9RMS[C),L/@U!435DE1!-!7H2CY?&
MB-S40H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H*SR*Q(E<?99&AM&_+>LUQ;88:%3<<<.*X
M@B(IJJDJKHB)0>71X1:QOV<+5=<5QF:>33W,>OF:V)5?=ESV[6Z3KK*1GU5!
M).Z9=L03733151*,JH^]X]D&6MY?G%KQ6Y1,8RO-L4=M-FE0#;DK'M39-3);
MD5!)1:=(M5(DT7KK0>U6668[:-,-BTTFJH "@BBJNJ]$Z=56C%SH%!Y:YOPW
MDGE'E:99,1AQ6+-9,3EP7+A>X[Y0W9%]U!X(A@.WOHV+>T]?,5.M%A2'YV30
M[;BF=95B5ZFPW^-+EA\F,-N=??BW:$Z0$]+;<1.RVZT'<[IZ)MU7P1:*B+Z[
MG<CB_$<:BMY,N&S^.Q6TQ\9@#,;FWUTC1QB>:-F:,=I1)414\WSA\[HH3=[Q
M/+'+-E #8;B3K_$U@M[8C$?)3G,DUW(X^;JKHZ+N#X2:=4H)VXX>V[=L\9R;
M%KW+Q.7@N-PWHUBAKZ8X\P;>J11)! G8Y(CA!Y$'JFG2@B;DWR3E' V0MWBU
M7*_0+)D5LD8]/EVE(5[G6J*ZSW7'(8HI$K8IL[GB8HNJZ(M!Z\QJZ1KW8;?=
MX<&1;8DQD7F(,UCT62T!]4%QG[1=/M:,6E.>K3GV8<@<=XOA$*.HVUR;D,ZX
MWB,\_9FW66NQ'!Y6Q5%)=[J(&NO5%\*+#45M@YCC> <7VW(\7N]S=XUSB;#N
M34*WORW'H,5''@E,-J&ILHCFC;G@NSIUHH_C\ZVX#'RR3:,JL>1SLMR+)<#G
M6>T^G.6J/.1L&F;A#/X#<I!\T=OO_!UU"[7%[+XV7\%9[G.(2W906N?;[_'M
M-O\ 25C3IC3;<='6@3[TGV^U>C:[D3P6B*=D_P"<S(^6K/'R2)DTB79^2[?)
MBP6;?KC$;&V'A&/,1]IK7O*)+N,G--F[=HJ45(8[B62)?<7*78)OH[/*V07%
MY78;NP(;K:=J06X-$;)4\QQ?-U3HM!N/V9[3<[-@%SB76 _;I!9#>'FX\IHV
M#5IR2J@0B:(NU4^"J=%HDMRT0H% H% H% H% H*UR!DETQ##;SDMGLYWVX6R
M,<ENV@\W&WHVFI$3CJHB" ZF6FI:)YJ*NB4'9@>1/9=A&-Y7)9"/(OEKA7)U
MAI5)MLY; /*(J75412T36@U]R7RIFUKS:%QKQ9C\3(,P*V.9!<_6+ZQXS%O!
MWL (J*BI.N'YJ><FWHJHJ+JA7.P>T?QO*P#&\XRRYM8Q\X6I2MP9:FX8R+::
M-2VQ4 52V&J;?-120AZ:KI0HCN4?:3PW#[9'CXO=(%VS&<ML=AVEY7DUAW0V
ME%XD$1Z]EQ'4;4A+:J+II0HFX?+T&S3LS?Y"O-BMN/6.\,VFV/PWGW'P[[:F
M(3D(= =737S.GC[FJA*!SCQ.>(.YX&4Q"Q-B5ZO>N*(ZJ#+TW=I6]G<WJ*[D
M39U3KX4*.4KF_B>%CMMRV5E4)K';N;K5NGJI['7(Z*K@:(.X2'3J)(B^2A1D
M0^7^-;A;KC=8N11R@6F#'NMQ>(76^S!FAO8>43 243'PT36B43ERR[&[/C!9
MG<[@W%Q@([<PKBXA(VD=_;L/1$W>=O'R:]:"HGS]PZ&/.Y666Q/F^S-6U%.0
M7E$IJ CJM-BC>XU0"0E4$5-.NM%HS\DYFXNQ*VVB[Y!E$*);K^"/6=]")Y)+
M2H*]P$9$UV)N34U31->JT*.S(^7^,L1N-JM629/"MUPO0 ];F7C7SV7ET!PB
M%%%L"7P-Q1%>O7I1%>E\S0K)R%FE@RDHMHP_$+;;)SUY<5PC)ZZN=L4)!U1!
MW$("B"JZ]=:+1V\I\VXSQ_C&83H<V++RC%6XK;]I>5P429<FU=AMFHCU[@"1
MIM7P3Q2A1AVSEYS))O&CN-7*Q2;+EXS1NO?<D-3#?@, 3@6]O30NVXI(YW/!
M-/JT%IL?+O&F27VYXU8LFA3KY:!<<GQ&C52 &%T<(25$%Q 7X2MJ6GEHE'3B
M/-'%N>7A;!B.3Q+K>$865Z(SW!)645$544P%%5-?.%%W)Y4HM$-E_--EQ'EO
M%N-;C)C1POT1UY]UU'B?&2ZZ#$%IM %1^_'W$U77X/D\HHLEIY5X[ON6S<%M
M&0Q965V]7!E6T%+<AL+HZ FHH!FW_P"( $I#]LB41WYOR-A7'$*/<<UNS=JB
M2W%9C&;;KI.&([R1 9 RT$>I+IHB>-!$7_F_BC%V;9(OF41(K%YBMW"V&B.O
M(_$>707@[0'YGNKY/%=$HM'/)>:N*\/G1;;DF40X$N:RQ+BB:F8G&E$0M/;V
MQ(4;)17SU+:GE7JE"C,G<J\>V[+HN!3+\P&7S#:;C6E!=-XB?;[H? !11%'K
MN5=*(C[?SEQ+=6;W(MV5PY+&.-J_=S;[BHTP)]M7A\S[ZVA+M5QK<*+Y:+1-
M77D7![&=Q"[7R-$6T0&KM<2<)4!F%(-6VG")$5/OA)M 47<2^"=4HC*Q',\7
MSRS!?\1N;5TM).&RK[6X5!UO3<VX#B"8&FJ*HF*+HJ+X+0:;+VE84FT\K/6C
MT*7?L"<EG:[8G?3TB!"%ELI+Q**)IWG##:*HOF_]ZBT;&QWF/C;),?NF16W)
MH3]LL  5]EH1LMQMXJ2$2.B);#T7MDB*A_:JM"B:PW.<3Y!M*WS#KHU=;8+I
M1W'6D,";>;1%)MQMP1,"1%1=IBBZ*B^"T1KVU<F<C9/R%>;3B]@M3^%XS>0L
M%]27.<CWP5)L'#G-L[%;["(2]L57<[M7:J==I5KD<N8 F2SL&A7V+)S>&R^[
MZF%3WFY'95XVD-!V*X(IN-L24Q3JJ4*(/B#G+$>3[)"$;O!3,1MK=SO=HCJX
M Q1+3N;5>1$(6R) ,A(MJ^.E"B9LW-'%V0VV]WBS9-$EVW'05Z\OAW$1AE-?
MONA BFVNU=K@(0KY%H41$?VC^#Y;S,=C-()/2)*0VP5'A7NEH@D6YM-K:[DT
M=+1M?(5"BQS^4N/K7F,7 +AD$5C+YG;1BUFI;U-Y-S;9&@[ <<3JVV9(1_:H
MNJ41*97EV.8/97LARJ>%ML[! VY),3/SW2V@(BV)$1$JZ(@BJT%9E\X\3PL;
MMN7R<HBACMW)UJW3$%XN\['U[C:-B"N(8Z? 44+7II1:.5_YJXSQ_%K;E\S(
MX8V:^ X5CD:N&DHFA5201; C1 5-'"4?,7X6BT*,[C',96:\<6#-KLRS"DW:
M",Z2RSN[+2%JNB*:JNB(GE6B(VT\Z\2WRVWF[VO*8K]NQ]L7[N\HO-]EEPM@
MN;7&Q(P4NB&"$/OT6C Y9YHLO'V&Y3>;5(C3\CQQB"X5L>5P10[J:I%WJ":Z
M&(F2:+]KU5*%$)<_:1PJSY99&+C=8;''U[L#MXA9&H2%-^:W.&*C(-B"D@(*
M.&1$/33KHB=11>,HY=XTPQVU,Y/DT*WG>P%ZVJ9J8N,&J(+RDVA(#2JNB.N*
M(>_1'.X<J8!;LMCX#)OL=O,YA-MQ;0HNFZ1O-JZWKL!405%-=RKI05.V<]X1
M9<3QVY<CY79F+Q?([LEN19PFG;7P9>-I285UM7$$=$$NYHN[7R46BSW;F#C*
MQ7"RVJ[Y-#B3\A99E6EIPB^^QY*Z-.D2"HM@:KH!.J**O1.M$HP><.3?S2<=
MS\P:;8D7!MZ+%M\64K@M.O27A D)6T5?,:[CGO[=*+"M7/VC\)LN:P+?=KK#
MBX'=<=8OEKOYC(5R1)D3G(R-B @NC8@UO(B%-->JHE"B\Y'ROQSB-UM=DR/(
MX=ON=Y$'+<RX:JAM.%L!PC!"%MLB\T7'"$57HBT1<:!0*!0*!0*!0*!0*".O
MUEAY'9YECN!OMPI[:LOE$?<BO["\=KK)"8Z^'FKX4'1BV*X]A-AAXSBT!NV6
M."*C%B-;E0=Q*1*I&I$1$2JI$2JJKXT$Q0*!0*!0*!0*!0*!0*!00^53,C@6
M";*Q*V,W?(@$4@6^5(]#8,S,153=VEH@"JFJ::EIM3376@I7%F?Y5DMZR[#,
MYM\")EF'/00FR;*ZZ];7V[G'60UVE?$7$,$%4<$D]SW:*S>9^22XIP25E;,$
M;C-[\>%"C.N=ACTB6XC8D\YHNUL?A$OZG375 C,?Y+R&P8U-OG.D2UXE&CRF
M(T&[09BR[?-"4"$!MIH1@B*NWSUZ]5Z)03<+F/C"XXC.SR'D\-S$K:ZL>=<]
MQ"#3R**(V0D*'N+>.T=NI:IMUUHE'-.7.-5PK\XOSDA_,S=L]:[BV=S=M[?;
MV]SN:_\ A[-WO4$(YRM'O60\?C@]XL5PQ/+#N(R'I#[PSWD@-">V$V*:*8$O
MWX74U3IX>-%94'G+C6_G?;?B>01;Q?['$E3'K:VKC9&D054D$C!$-$5$15;W
M:4*,_C#.)&9\8V//;XVS!=N4(I\MMC=V&@$C5=-RD6B"/7K1$? Y]X>N=ONM
MU@Y=#>MMC8:E764B.HVPU(/MM:DH(BD1^:@#J6O32BT9C_-'%L;#&.07\HAC
MB$EWT9BY:FJ'(ZZM(T@J[W$0550V;D1-=-*%'V[<R\7V/%[9F=UR:)'QJ\EM
MM4Y5,O2%150NVV JXNU4\_S?-^VTHE$->N88D'/L0L, X<G#\ALURO\ *OZ.
M$X@Q8#*.@32@NW:J+N(EUZ>%%HG)7+G'L>"LX+['<$K(>3L#]\3N6EM=GI'P
M%5 4O-\-WO41J_&?:(FYEQKC>5V65C\7))M\B6G(K?<7I+,>,$MU[:RR2(I%
M(-H (/$?A+Y-M%HVJ[RQQRQF@<=NY'##,ST$;2IKW-Y#O%M2TV(XJ+JC:EN7
MW*(PH7-W%-PRD,)AY3$=RER0]!&VIW$<]*C$HN-*1 @H2**HB*7G?:ZT6B-Y
MAYDM/$TK#VKI(C1V,ANOHLYZ4CR]BVLM$4A\.TB^<!DT/7]GX+UT%$],Y:XX
MM^5PL'FY'$9RJXHRL6W&IH2E)'<R!'MV ;B*BMMF2$6J:(NM$364Y7CV%661
MD643@MUFC* O2G$,T0G"0 %!;$B)2)41$%%5:"KR.<>*(F,P,QD91%#'+FZ[
M'@S-KRJX^PBJ;7;1M7$<33X! A>]U2BT<KMS=Q39+%:,FN641&K'?FWGK/+%
M'74DA%41>[8M@1*3:FB$.W<B]%3HM"CE?.:N+,<C6B9>,GBL1K\P$NS&*./>
ME,.$("3:- :KU).GBGZBT*,IKECCE_,)& L9#%<R^*+BO6L-Y'N8#N.-B2#L
M)P!12-L24Q3Q2B,J-R1@LQNQO1[[&-G)(\F;9'=RB$B- !')#B$2(@BV*ZFI
MZ:4''"N2\$Y%&<>%7R/=_5IBW.%G>!MJYJH$HN")*![5V&B;2TZ*M!C9-RUQ
MUAN00<6R>_Q[;?;B+9Q8KPNKJ#QJVV1N""@V)$*BBN$**J4'3+YEXP@9:W@L
MS)8K.6.20@C;31Q#24Z(DVT1[-@D>\=B$7G+T35:%$_E>78Y@]E>R'*IX6VS
ML$#;DDQ,_/=+: B+8D1$2KHB"*K05B9SIQ- QRVY;*RF*&/WA7@MLM!>-7CC
M='0%L6U<0Q5>H*.[WJ+1E8KS'QCG%X=L.*9+$NEU9CI,-AA3T5CS=2$R% +;
MN3>@DJC]LB42CC9.9N+LDBWR98\GAS8N-LN2KRZTIZ,QF4)3>344[C2;5^^-
M;A\FM%HY8]S%QCE4*]7&PY-#EP<>;1^\R-3:".PHD:.DKHAJVJ"OGCJ/3QHE
M%/Q?VB\,R&[9K/*Z0V>.L59LRL9"J/AW'KNKP$CHN *@@F @/F>755T\"T3]
MEY_X<R&YVVSV?+H<FZ79U8\&*B/ 9/H2BC9H;8]LR5- %S:I_:ZT*)ICE/CV
M5FCG'D?((KF9-(6ZU(I;][8=PVQ/;VR<$?.)L3WBG54HB,MG.7$UXN<RS6W*
M8DBYP&),N5'%'446H*$3^BJ"(1-H*D0"JEMZZ:=:+1A\$\N0^8L'8R+6.S?&
MC<:O%MB]T@B.*ZYV04G$3<I-(!JJ>5:$H_ ^>L6RR]Y[:I]RA0APZ9*VKJZ.
MMI@@T+LQYQP4!$[IF&B>&WR^*BB\83R'A?(UO>NF%7AF[PX[G9D$TAMFV:IN
M1#;=$#%"3J*J.A)X:T1KE/: MQYYR1@[7HIW#$+>DNQ1D5[O7"1'AO29H&NW
M:",F -]/=5>O@A:)_B_FW">1,:9N#=[A#?8-JC7/)X8$;+4$G&4<?\YY$16F
MCW 1H1(.GG+K0HLF$\CX1R-%E3,*O3%W9@N(S+[2&!M$::@I Z(&@FB*H%MV
MEHNU5HBI\F<R-\?9U@>'I""6WE<HF;G)(B%8,<W68K+JHB*FAO/B&I=.E%HL
M5XY8X[L&3M87=[\Q&RE[:K=K473>5'&R=%?, D1-H*NJKI]=*(UQA?M CGV"
M6_(K1<;';[\M_CVJ[PI_IG8:C2YSK+#31 .XI+[#8FTJ^9N7SMJ=*+1LH.5.
M/G<S/CMF_P 9S-0$E]4"I=Q2;;[I-H>WMJX(><3:%O1.JI1%.Q;G_%/S8XIG
MO(]QA8Y)R@7ECQ [K@JK+Q@NP1$S40%!5PU3:.O5414HM%LR+EWC7%)]IME_
MR2)%FWQMM^UMHIO(\P\2 V[N9$Q%LR70'#5!)?!:(NM H% H% H% H% H% H
M*[FF$X_R!9OF_D[3TBSD\#[\5B2_$%[MHJ=MU6#!3;7=YP*NU>GN)034"!"M
M<&-;+;';BV^&T$>)%9% ::9:%   %.B"(HB(B4&10*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!05W/V'Y6"91&BM&_)>M$]MEEH5-PW#C.((B*=55571$2@IO$60
M.VW',"XZGV2ZQ[JSAMKN,BX.Q""W,DVRU'**X\2HHR1)-5:4.B>7R452>19U
M[XJYS'E4<:NN38O?<:6PO!8XZRY,>Y1Y*/M(8)\%MP404+W57W.H4G N-,JL
M%[]GN/D=D>)UA[,;ID#78)^- .ZQT=CMOEM(6R^"B(:Z[]43JE%0/)EGR.!=
M^0\1+$;Q<[I?\NL^06F\0K<Y*A#:VE;359 (NSM:*UM3PUT\-:"6S'%,EES<
M]0+#.D,S.2K!,9%(CK@/0FFT1QX4V*AM#X$744\M!W7EK/L7//9=EB7VU6BY
M\C 5\G6."KMR]1%$_=X0N-&BHKJ(A.MBOD\454H(;CS$<D)CC_UA8+P<=KDB
M[W"1ZY@&W*&&]&!6Y$MO9L;4BZJ7P-^NU:"V^TCA%RF\DXC;K&B-VKDJ/'P_
M(&FUV=N+;+@Q<D=!!TZHR+H=/M$T\J4(;;]HNUS;CP=F%JLL)V9-=@@W%@PV
MB==+:^UYH-MHJKHB>")X42&K.9L;R6S3^*,TL35SMMHL$&9#N;^/6MBYS8#\
M^$RT)^@O 0*+B K)DH^8GOZ)0A3\DQD\$P; 3PBWYK&SBV6RX%CDQVQLS0=:
MN4HWBM5UC 3@MD:GYOCM!5U1>B(5W\EVS,8UXSX,@PB?>;[RCC-BAV'U9%]-
MAP+I'81F5&-[5491MY>\BJNF@HOOT'#D? ,V>A<MV=BTS;E/+$L1C,R6F'#"
M:_:W63E=D]NCA"C9$HCJ7O:T&5,B7_D2/[2&16K%KS%C9/:[ 5@B7:WNQ)4E
M;?"<:<5IIQ%WDB@JCL55ZCY52@MBI/RO(> +Q9+%=+;;X4;(X<QV3 <BE#>*
MTC$!UX414:$W456R+3=XI1%*XMQS(7+MQ=CJX7<K+<^,8>2AF%PE1.S%<*XL
M.M,-QW_@R5>,M_F^1=1U35:*DN&L3R&V7;V?G9=AFPAMMHR<+NXY$<9]'<D&
M?:20J@FQ3^T0_'7I0EMS/#E6CG3CF_O6Z;*LS\&ZV4ID**[*;8F3G8O:[ZM"
MO:!4$EWEYJ(*KX(M$:KXZLF1A-XOXX?QZY1<IP"_7FZ91D+T1QN L1Y9FAM2
MS1!>]-](;T0%5?-75$0=:*V1SM=LNAWG'K?%EW^UX1,C3EGS\1@)<;D[= 1O
MT2,:*T]VVW$4]%VZ&7FDJ)U0D-(V>>YA7S2@WVP729/F<33;/ZEAP'Y4M)4F
M>""#S(@I-B:IVU(TT0B1%\:*R[QZ9BP3N/[E8KC<\KN/$5FQEB);H13T:NA^
MF,"V\XTA(V*.$.AJNWS%775$H-EX7A.4L7OE>RNL.QKG,Q3&;/;KLX!BP[.9
MM$N.Z3+RIH6QU1W[5Z=-:(J>$XY.Y!D8?B2XW<\=BXK@MSQ+-)=PAG";<E7"
M.Q#2,T:Z=[0VG).X-1T)%UW+15;M6$<D7CB6]Y9>;;=(.2LWG&&)MNCQ^[<7
M;1AK3,<WHT>0.QTR=)Z2 $*B:IY4TH-]\$6B&W%R7*8UPO\ <7LCN /2Y.26
M]NTNO.QF :[S$=MEA-ACM%3V)N4*)+6&0P[PF,>T1AHV6YG>[K-E7FV=J"^<
M>5#DQH;3?8>$5%QPB$OO8ZET7W%T#AR3AV4W:7RJ-HM$\D.!@\Q@8<42.4U:
M)#KTIJ,+H]IUUH40D;ZZD*#IU1*#9G!5IAD_EF9LW+(KI-R.5$&;,R:W!:">
M.WQ^T#D=@&6$4-A"V1[$U)OWM5$J5GTD[ARY99F(XED-DY0@7R%"EWEF*06B
MZXVABDER9(;4F38[6Y W_?1(11-%T1 S^.IQXZ_DW&5UQ6[EE!WK)+DQ?O5Z
MG .+/[TAB8LSX**\V8L(@*I[_-5$H*7:<&RRXX]AUCB6:3&N,GBB^63>\P<9
MMFY3!8%IE\R%$;,BUZ'U\5]VBHRV8O)NW'^7W($RRX9A;,!/%$M5WLK=OC1Q
M)0/T*,K$9DGW&3:7;IO\TO'K02O)6*Y#,M?,K42PS)"S\8Q"/;FV8;A*^]%,
MU=;900\XF^FX0ZCTU\E!V7K#)\CD_*L4R:;E46'DN3P+Y:ALEJ8F6R0R 1E9
M?<G$R;C*Q7&5!Y.Z""*(HHJ$M!N+G:[97:;!93Q^1<H%FDW9F/E5UL,5)UUB
M6LVW-SC#2MNJFKB-B1BV1"BZHBT2&G^+L>R$;[Q[-EVR\%'#-<RN$F9>(;C$
MST>7 ?1B3-'M@+9NJJ==HBI]!HJ*Q"+>\#M&!9%?\:O$JV):LRL90H5M>E2H
M<^X7ER1'(HXCO%)#0[ +314\?-76@W+QPQF&/^S3:6;+;W&\X@8VZMMMLMI6
MW4N#;)JRV;;FU==^U-I:>_1&@5L&99O&SR9&;R?(+C<>/F8IS<CMQP'BNK<]
M9,F## 6&1( 7=L =Z[M10B32BIO)V[UR'9>;KMC^.7IN-=,;QQBUMW"W2(;T
MH[>3Q/HPVX**XH(BIYNNJ^'BFH77+QGYCE]WR>T6:Y%:+EQ/>XD-9,%]@UEO
M3!V1U;,-1>,4U%OX1#U1-*(I,B!?,7QU^#=\4N]VD9MQ=9<:Q_T2 [)6-=(\
M)UEV!(T3='57'@>(CT1-J]=PZ45M3AG%[]CF=9O'OD1[NLV##;>-R-LNS*D0
M;=(:D]EU4T/:>F_:O1536B-3V^?=[=Q+Q7Q?D^.9 SBS\9RY9MZ#:9DIYV-%
MF.&Q;"%IM2#T@Q0G]=JHTB(GPZ*D.1<9EW#D'+0O#F4P<+Y'MMB"V1<>LS4]
M)+<5E6G(LKOL.%%<9(NZ@HK?FD2KU1*#;_M$V*ZW#@G(+-9X\B[W%AJW."RR
M"O2G@@SXSSI((IJ1=MLCT3QHD*)G[%SRS)<XR2T66XE;KQQ#*BVXGH+[3IRG
MI4PQC(!!N1XA(2[7PO#IX4%'OV'W>/=9-OR8\I@X[FN*XW;F(V.VAJZ=\H,5
M6)$*2K[+IQW&S+NCM4.BDJKN%**]CVZ)Z!;XD#NF_P"BLML=]U=7#[8H.XE3
M[9=-5HQ9- H%!H3G/VAKWQ+EUAQ"PX<>5W"_12D1VF)#C;ZN(Z3?;!IMAXC7
M0=>E%B%*^E)S=_<%>_K3_P"KZ+0^E)S=_<%>_K3_ .KZ%&!>?:_Y4QVWNW;(
M.$KE:K4RHH].G.S([ *X2 *$XY $4U)41-5\:%'J+"<B++L-Q_*SCI#.^6V)
M<BB(?<1I9; /*&_0=VW=IKHFM&*=H%!I?V@>=)_"C.-K;L<^<<K(9#\5N,D@
MHYB;*-;4!!:=4U-7-$32BQ#6_P!*3F[^X*]_6G_U?1:'TI.;O[@KW]:?_5]"
MC%N/M:\NV>"_<[MP9=H-MB@KLF9).:RRTV/B1F<!!%$]U5H4>B.*,Z<Y+X]L
M><NP4MKEX:<=*"+O?1OMO&UHAJ(:Z[-?@I1BN5 H-8<\\MO<+X.&8,VD;R9S
MF('HAOK%1$?!PM^]&W/#MZ:;?+18:;:]JGFE]H'F>!;TXRX*&VX"SB$A)-45
M%2WZ*BI1:.?TI.;O[@KW]:?_ %?0HX.^U3S2PT;SW MZ;9;%3<<-9PB(BFJJ
MJK;]$1$H4;DX&Y;>YHP<\P>M(V8PG/P/1 ?64BHP#9;]ZMM^/<TTV^2B2V?1
M"@4%!YJR3)L4XRO]XPR$_/RD6FX]L9B1SEO [*=!E7A: 34NR)D[IM5/-Z]*
M+"B\=9AAF!<?W)S',3R^3ZL?BNWIV99Y*7J[3[FYVW)B^D*)/GN'>ZJ%Y@Z(
MB:;4H+[S!+B1,!N2W'#Y.<VE[MLW''X0"X^<8C3>Z(*NXE;TWB@>=NT5%'3<
M@>/[E$N-EXMRQ8MHO['$X95C;N!V3(&O_,-!<)9[33+JJ2M$>T6A5=J_XV^B
MK!DN+9EE5HS#D;'['>;197,\LF01H'J]!O'H-HBG'E26+>_T=-'7!<0'$VEL
M77P6@D$QFX1</LO($.UY+D5JC\A!EN30KO:6(-S?%(_8=GQX$9=";W:&B;1+
MRZ(B*M!=9@3<DSKA7)\=PB;C=J9E9;**"_#]&%DWX6D9^6+":,>E.(A??-"7
M5?'Q4C5V&L<BY)GN.WC*8F63<@CV7*(V1%>+;Z-:XDYZ*Z+<> 3+0#M/S?-5
M5351V^*HA7HCA^V7.![.EBM4Z$_&NK=A>:<@O-&W(%Q1=T!6R1"0EU\-*(TU
M/P3+$]EWC0K5:Y\"\8U>+?>[]#A0A.[#%B2).]P(CPBCSK:NB\+3J:%IJM%[
M72[C=L#C5[(Y/S]6Y7/,#R*!?0L$=NXPKNW'V+<2@1R1%B/JB#HJ"JEIT3Q4
M,]9V<V\N).6.3<-GW9(UGO5LOEHM=M%UZ))EFJ1'CA#T;64R@H>@B@JJHJ#T
M&@BL0XWSJSPN+[!<+)+&YL8?F#,E.V9-1WKL3ST6,\ZJ;6W-K@AM-45%Z>2@
MR.'(U]OF:XA'<Q:\VZ/8N.I&,SY%XM[L2*Y<FGAW- ;H[2'KY?'W.BT&)CT"
M]2N">.,7#$[Q$ON*YM:!OS+]N=94D;ER'3='054VVP(4-Q4T'PH.V;B^3)E%
MTXZ3$[B63W'E$<UA92,52MS-C)T'DD>F+T0VP$@5KW5VIYW2@[H^)Y$LB'*#
M'IS9ESN_=S/T-T32U*JJ,DEV:I'Z_NGP/?H-S\^++@EQ[DK=NFW&VX_E46?=
M0ML9R;(:C>BRFNYVFD(U'>8BNB>5*)#5&8VC(3E<@<:ACMSD97FV76O(,<R)
MN&9P6[:#D%Q7')>FC7H@QG6R$E0D4M!14*BMR\[W;++1C-I=QM^XPK:_=XL?
M*;G8XR3;I$L[@N=UV.TH.KKO1L5,6S($75!6B0\^X[,>PE,+O^0V^^.QOSBY
M-< &;;G3O<J-*M[W;E.Q!; E-47N.*VVFFBJB=-**S+-.=X_OG$F39%9;E'A
M2YV?72-9&(3LFXQ(5T=9<C[HC2$8Z 2$:"GF(?73K06K@W#,FQJ^\9L7RS2(
M2P\3R GT=:)0AG<;RU+CQS-4T!T63TV+H714\BT24/8;+D9W+%>,UQZY1\LQ
MOD.5E5YR%R(86Y^T*]*?64,Q/,-9+;[;*!KNU14)$VT5AV;B[.9:<H8A#M;T
M*WXK8;[C.#DZ"MM3F\CGO7)$9<<01549%J,2B6@[M%H+]P#9V)N1/Y=(FY4_
M>H%@AX\_'R.TLV>(PT#JO)&9[3#".N1S$A(DW:"?BNJ425(]HES/K_>LQQ62
M.1.VL0LIX98[-;5DVBXQU=:=GNSWVV72W-.@NB*XWLT%40MW4L)?,,;O\B1G
MAL6:8Z4KD7&9L8PBN$3L2.U!1QX%0=2;#:6XT\T>OOT1M'G:[97:;!93Q^1<
MH%FDW9F/E5UL,5)UUB6LVW-SC#2MNJFKB-B1BV1"BZHBT(:<XNQ[(@RKC>X2
MK7>5C-Y=G,Z5.O$-R/,[$V$XD>1-'M@+;CRJGVHBI]!HK PK!<MEX/Q18VK/
M+MUU^:^?6YXY,=V.D.5<2 8WI"J*=K>JZANT5>JI0=&*XM.N.!Y$3Y9;)S+'
M^.KEC"VBYV=J%!8)V(C:P([K,=LY)"XT),^<:D.BZ[E6@SN0,&R^^PLF@6>Q
MRW)#O&^-,,-"P;8O/6ZY>DR(8J@HBNJT"CVT\[KIIX4'V]G<L\F<J9'9<;O#
M5KO$WC[U<$^UR(KLD+?/7TD@:<#4P:1//731$35?-T6@F+GC=^._Y"^EFED!
M\M8W<F71BN+NA,)$1R2*H/5H-"W.)YJ==5\:(C\/PJ>O(@XKE<S*F)MLS:=E
M<"'%M3"V)W5UZ0Q.<N(L*7;>:<5DQ)_5#79M31-"I'CW'+_$F\'NRK-,C^K[
MWG+UR)R*X'HP3%N",$\JBFQ'=P;%/X7337I1%^]EU9L'B2V8K=;9.M=[QMV7
M N;$^,Y&%7RE//?>B-$1T=ICYX:I0EK;)L?R.[8]SQ@4&QSWK_<+ZUDL%E8S
MK<2?;&BMSA-,R4'8;CHL.@C0KJJ]/=H-C<4OR,IY/SGD:!9Y]FQ:YP;/;(JW
M2*<!^;+@"^3SO9=1#T91T6=RIHJHJ"JZ4%?N;-T@<E\Y6YVT7!PLNQN"]89;
M$1YV*_ZOM<IAT.\ J*.=PQ 05=Q+X4% N> 9G>[7;[3:[/,9GN\(Q+4A&PXR
M*W%N5&=."1D@H+YB!#VR5%Z]>FM%;1X'ML6X9#>,T]893+N16V%9Y"9-:6+*
MTC;)&Z#30,,,"XY'52 RT5$W:(JII1)43F? ^1.1LJY.OE@=<M<'&++;+?:F
MCMIR'KNY!,KV80GE(" AD"VWN;$]Y:#Y*+#:'%_K.Z<HYKET^TR;=&OMBQ.1
M%*6PXSHX4:6;S**X*>>TIB+@>(KINHC5>.0KTO$>)XBY8;HW?,5Y"@N7B.Y!
M? $9._R):NM'LT<:%HQ(G!\T47JNE%7WBRX%C&3Y#QY?,7NBY#-RF^WN/?!M
MZG;EAW!3D,S3F=&QW@J1]!530O-5/'0C2]DQC*L;QOC2^7@<DL5G7$[ECTY+
M):0N4]B8]<5?[,B+)8>5L)+?FB:-Z[A%%5!5:*MV5VZ;QQ\S)'&\7*I&?VVQ
M6RT0(DZU%)MEYM925<&WSS$>W&?C(1$1[@5M/*O30CUHFNG7HOE2B% H% H/
M._,OM)9%QIR/"XZQO!G,MN4^WMW%@(LAT9)J9OH0 PU'>(MHLJ2JGD^I18A5
M_I2<W?W!7OZT_P#J^BT/I2<W?W!7OZT_^KZ%$9??;&Y.Q>"ESR3A>X6>W*8L
MI+N#\N*SW#15$=[L$4U5$71-:%'KBU35N5KA7%0[2RX[4A6]=VWN@AZ:]-=-
M:,670*#1//'M!7CB#(L;QNR8D64W#(VW2CL-2#:>5UMP6Q;;;;8>4U+=Y*+$
M*+]*3F[^X*]_6G_U?1:'TI.;O[@KW]:?_5]"C!O'M>\K8_;GKO?N$;G:[5'V
M]^=-=F1X[>\D =SCD 134B04U7Q6A1Z<P+)RS3"<>RXXR0COEOC7$HB'W4:6
M2T+FQ#VCNTUTUVI1BL5 H-/^T%S;*X1LEFNT.Q)?GKO-6"D99"QE%4;4T5%%
MIU2553332BQ#5_TI.;O[@KW]:?\ U?1:'TI.;O[@KW]:?_5]"CIE^U=S) BO
MSIW!%XC0HS9O29#Q3FVFVFQ4C,R*WH@B*(JJJ^%"C>G"?)CO+G'L#.'K:-I.
M:[):6$#RR$'T9XFM=Z@WKKMU^#1);"HA0*!0*!0*!0*!0*!0*#!O5YMF.VB=
M?KS(2):;8PY+G220B1MA@5,R5 1271$UT1%6@C;)FF/Y%<I-IM3SKLR+$AW!
MW?'>:;]'N(*XP0N& @2J*=1$E4?+I06"@4$1;LGL=VO5YQZWRD>N^/K'"[QT
M T[!36N^RBD0H*J3?G>:JZ>6@EZ" N>&V"\918LQN#!O7S&PEMV=Q7#1MGU@
MV+3Y=M%VJ1 .W54Z)03]!#Y7E-BPG'I^4Y-+2#8[:VCLN20D>U") %$$$4B(
MB(1$43555$H,FRW:-?K3#O,-M]J+-:%YIN6RY%?$2\CC3HB8%[Q)08F-9=C>
M81YLO&;BU<H]NF/6R:XSNT;F1=.ZTNY$ZCN3JG1475*":H.)F+8$X:[0!%(E
M7R(G55H(S&LDLN7V.%DF/2?3++< 5V'*0#;1P$)0W(+@B2)J*^*4'%,GL990
M6&C+1<D""EV."@GJ,(GE8%U2V[>IHHHF[7IX4%9S'FGC# +TUCV89"S:KN\R
MW)&.ZU(-$8=,FP,C;;( %2%4U(DHM%CMV6X[=[S*L%KGMR[G"B1;A)!G4VQB
MS]_HYHXB;"1Q&R4=I+TZ^5*(FJ!00_S7L:Y2F:+%UR4;>MG&:IGJD$GDD$T@
M;MG5Q$)5VZ]/'2@^L8S98^23,N:C:9!.B,VZ1,4S55BQC-QMM!5=J(A.$NJ)
MJOE\E!+T"@Q+K=(%CM<V]75\8MKML=V9.DGJHM1XX*XX:Z(JZ"(JO1*"%:SS
M&I$K%XC$AUUS,8[LVP&$9\FG8[# R2)PT#:UJV8J*.J*JO1.O2@LM!$9+D]C
MP^T.7S(I:0K6TXRP3RB;GWV2Z++0H+8D2J1F(^'U>E!+T"@B'LGL;&2Q</<E
MHF1S(CMR8@H)J2Q&#%HW5)$VHB&8BFJZKY/!:"7H(F7D]A@WR+C4J<VW?)D9
M^>Q"\Y3]$BJ(NO&J(J "*8IN-4U7HFNBT$=;.0\+O)Q&K;>&7W)]J+(8HZ&"
MG:@,6UD^>*:!N)$\[1:"1QC)[#F5BAY+C$X+C8IZ&42:TA(!HV9-ET-!)-"$
MA5%3Q2@EJ#!O5YMF.VB=?KS(2):;8PY+G220B1MA@5,R5 1271$UT1%6@[K?
M.C72!%N4(^Y#F,MR([BHH[FGA0Q70D14U1?!:"LW3D_!;,[?&KG=PCGC;T&-
M>M6WB[#]U05BM^:"[B<0A^!KIKUTH.?YRL&])<B+>6D>:O(8PYN!U &\N-]T
M8JFH;=ZIX==NY4'7<J)03=]O=JQJS3L@ODE(EGMK!RILHD(D;9:'<1: BDNB
M)X(BK09,.6Q/B1YT8E*-*;!YDE1150<%"%51=%3HOEH/LR7&@1'YTQQ&8D5L
MWY#Q?!!ML5(B7WD1-:#%L5[MN2V:!D%F>61:;FPW+@R% F^XP\*&![3021"%
M47JB+0=+V2V2/D<3$G92)D,Z*]<(\)!-26+&,&W'%)$VHB$X(]5U77IX+02U
M H(B^Y/8\:*UA>I:13O4YFTVP5$S5Z;(0B;:38*Z:H!+J6B)IXT#'LGL>5Q9
M,VP2TF1(DN1;GWA$P%),,U;>!-Z#KM)%'<G1?(M!+T"@4"@\I<W?]6/#/^;7
M^.>HL<GJVB%!H?VQU5/9\R;3RO6W7_>#%%AL#AG]$.!?\O6G\":HDKQ0*#RE
M[9"Z9#PXJ>/SA7^-B490]6T8E!K+VB%TX/SS3_TB1_V)181GLL_H!PG^:O\
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M-/;]7P\'"T5?"@VISM>CV8SA%J9ODO*\DER'K5;\=N@6%UYFV,*Y)[\X^@-
M+@EM3SC+:GAK1(:DPF5E?)4#A^Q7[,,@@A=+;E1WB3;+@<.;*.SW%N/'%]YK
MX9-BFTC3J77KH2ZE96*7GF?*N1GLILD2\R8$',I=EO'=NL(,?8QV&^L1UA+:
M;PN^E-"@O=U W$6OBBT'K"C$H% H% H/)^9?]=N _P! ._@]THR['K"C$H/,
M_MT_H39_IN%_%2*+#T%B_P#9FS?S&+_$C1$M0*#RE[0W_4EP9_/?_>VJ,HY/
M5M&)0:0]KW_IZR__ .=W_$HU%A;N"OT,8!_0%M_!@H2V#1"@\I>W)_9[ ?\
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MA6#D$9N#>0E29<PI,=G7MB1R'G"39KYA"J*.B:+T30M7.V<&\66BPWO&8F/
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M%P7"<U1 ,E11+JM$20^TA<XV+Y=-G8] E99BIV<DMMJO#,V!-CWZ6W%:5N6
M+L<;(B%P3#1%1%1=I=!1MF#<LX=PF7<KQ9H<',QCRW&+.S.5V+W00_1Q*4K0
MZ(>@[BV>;K1'FG'\NY++ACANX>C')O<K*H3$$2N[B%>(QQ)SFZ:^0$K:*XFI
MMEW/@(OCHB&383WM&31Q^R-)8X47/;M=;M8W8%PN0Q;1'>Q\E&8Z4XF^H+J"
M-ILU(CT\FJDHV1@.90>6N/(V1PP=MH79F3%DL-O";T60T;D9X6WVET+:8JK;
M@Z:IH736B-!8SR1D86_C]G)+S*-W ;=EEXY&99D&LF4.,.K;8X/*1BKI&X2.
M;7/A+I]6C)8LEYGSJY8)FMGN&,IC>7NX9(RW'CC7$G$2TN)V7G">%EM6I<5#
M1Q 'X9:(A#XT2C,Q[+;@Q(X=^=MG>;R278;S)B/1KP^Y&1B! C$CDEI&T&0<
M@#0OOG[D75%)>M!VXI[1EXFQ%N^:8DW9+-+Q69FEI<A7 ;@\[#MNSNMN K3*
M 9H8DWU_P5ZZZ"BQ\:\KY?E67EB&8XM&QZ8Y8(V40SBW!9^Z)-?5EMMQ.RUL
M<%45#ZKU3IT6@U1S?E=LM7*V1P\ES#*<?BQ,<@2,<BXU(G T=T>>D@G<:CB3
M2D9(V*=[:)>&M"%CN'M Y9@]GLUHR"SP[AE5GQN%?\[*=<H]J?$GA+='BL&*
M]Z6HMFZ;8H@IT%.I(E"BZIR_D&09>Y8^.<7#(K+:6K3(R&XOSA@.-MWUM)#/
MHS;C9"XK;!(^YN,>B[4ZT$=$YZN#^3QN]C2-<;7#)',*MN2)+0Y3MV C:%U8
MJ-Z)&<> F1/N:_;*B:Z4*(]CGO,BQVZ9;)PN,%C2>YC^, W=$<E7*\^L_5S0
M$"LBC#2JAD9$2JFWHBZI0HE>#;SEMXRCD\LS#T6[Q;S$C^K&IASXL4!M[*H,
M=PA!$ M>YH@#U+KUH2@(^)2&O:9*R?.S)CLC6/AEPVL[U+*(L\[N;2MJTI;5
MC[!0>SIMTZ4&%C?+UYM6'8/;N/\ $EN$G*/G3);CWF^.N+$&P3E%PCE/,F;J
M.;R41T3;T'54U*@F<3]HR?=&GKOE6*I9,<?Q:9FEHD1IP3I#D&VF#;S;H=MI
M!<+>)-HA>"Z+U\!1-<3\WN<@9"_BMZML*VWL[4SD5O;MER;NS2V]YU&2;D&V
M (U(:,@0PZHN[5*%$/(RO,;9[2=]CR8S981;\6BRI3AW T"/"%U]UR8,5&R%
M7B= F2'HNP1+=UVT$IQ[S5?<IO\ 8;=D^+)C]KS:WR+QA4P9@RW),:)VS()+
M8@/:<5ET'DT(AVKIKJE"COY+Y9RW$\K+$\0Q:/D$QC'Y.4S'),]8&R)"?1EP
M 'L.[S+5$#JG5>O1*"N99[3(6H+=,QZRQIMO7'8687GUE<X]MDA!N JXW&B-
M&A+(E=L#-030>B#JI$E"BP1>8\@OF;W&R8MC;-QQ"R0;;>+M?BF$$GT*[1')
M;21X:,JKCA(VJ"G<^KIK0HBK#[0-UE<97CE2\X[#3'V6HIV)FT70;A(DRISR
M,!!D#V05A\''&A<Z$B;EZ>;U%"=SOEECM.1Q;YAK(9[C<ZR1'+.Q<46%*9R-
MY&HKC4LV4VJA(8&A-Z(0^.B]!1T3_:$OMHQ:?(N^-PX686[*&,/EQW;CI9V'
MI3*26Y;\U645MA +:2JWKOT3IKT%&W+;D,UG#1R?+X35FDQX;LZZ1(\@9S3+
M; D9*#P""&*@.]-$\NE$:;:YSS.]6:4Q-Q0+%)R?&)^28!*&Y"XLAB,T)J#Y
M"TG8?%IUM]--PZ+IJBI1:*G:LKY2^9/!,AF"$B_SI*C%MYW=Q&;M%2R&XW*G
M/JVJB>Y2>)I4<7</1=R]"KD_[1T][&,0EVRP0F<LRCUJK\&[79FWVZ&-AD+%
MDJ4LQ7>KCJ(#""'774E1!6B494#GO(,RD8C&XUQ5B[%D]E=OSYW"XI!&$W$F
M!"D NC+G=4'"4/-TU\=-*%&9[2%\S"R6?"UQ%KNOR\MLT>0WZ84%']SZ*W%<
M(175I\T07%^U3KH5"%&OW+6<\>\A\B9%,M"7?&[/"Q-W(H)7(D&TC-!QMP(#
M9-*+Q&XX1D7WO79UZJF@7_.>:I^%<@VK%GX-G?M%PG6VVJB7IH;[K=3%H9 6
MWMJ?9:,M"52U).J=*%$;!Y[R!_+V[=,Q1EC#'<OF8$U>@G]R6=RC=U6W?1>R
M*(T2-*A:N:HOU.HHWK1"@I.6\0<9YW=!O67XU#N]U!D8P2I(DIHR!$0AT).B
M*1+^K00/T;."OR%MG[0_NZ+4^C9P5^0ML_:']W0J?1LX*_(6V?M#^[H5;/CQ
MV8D=J+&!&H[ "TRV/01 $VBB>\B)1';0*"HYCQ=Q]R!(BRLSQ^+>9$(":BN2
MA)2; U0B1-%3HJI05GZ-G!7Y"VS]H?W=%J?1LX*_(6V?M#^[H5/HV<%?D+;/
MVA_=T*MD6FTVZQ6N'9;1&"':H#(1H<5I- :9:%! !U\B(FE$9E H*WF& 8;R
M!%C0<SLT>\Q(CBO1FI2*2-N$.U2314ZJG2@I_P!&S@K\A;9^T/[NBU/HV<%?
MD+;/VA_=T*GT;."OR%MG[0_NZ%5\QC%<=PRT-6#%K<U:[,R1FU#CHJ-B3I*1
MJFJKXJNM$3% H% H% H% H% H% H%!ICF7B[.>39\&W09ECA8RP]$DM7=Z-(
M^<=KD1GQ=<=M[[9]O<X@".AH/ZM%0MTX1SUW,'W+9=[0&!2<TM_(#K+[4A;M
MZ9%5E'XZ&*]I&U1G4%TUU\=$H53^)\;\C8E<;GCD&]VE>*Y$B[3H<0HSZW="
MNZN.I&)S>C0M,O.J:.)N(TZ*B:] 8)P]><3O& 7&7<8TAK$,8?QR6#0N(3S[
MSC)HXWN338B-?;=:%43R_P )91F^372^XY(L9MW_ !XL:G)D$5V2_ !#=<1^
M 3?03+NZ+KIM)$/SO@T*LZW<7\DXGESEZPN^VIJU9#&LK&6A<H\B1(;>LD<8
MBN0$ Q!>^R* 2/>"^<BT&+=N&LRFP^6<<C7.V#C/()NW"W..-R/3X]QDM,,N
M"\H_>U906?-VHI:K^I0JQ<PX-S>]7#(X%DR"!$Q#/V+4SF0R&73N$<K4RW&,
MK<HKV_\ 2&FQ ^^B[?%*%4GDO"EYOCF8JS<HC+629#8;Y%!1<^\Q[($4#:+1
M/A$D?S=.GNT*NYKB_-[AS- Y%OLJQ1K992G#"DV>-)CWB?#EMDTS$N)F:M&#
M"*A(2:ZD*:"-!PY:XAR/,\KC93CC]F><.QR\;F0LDCNRXT=J6ZCR3(@-]$DH
MJ;%W:(H^6@@,JX,S[(<5PK VKC86;)CMOL\8[\4:3Z_M\VUHUWI%M>$MB=WM
M(B(X@Z)XZT*MF<OX1=.0,)?L-CEQX=[:EP;C;WIHF<57[?*;DB+R-^=L+9M7
M;UH*EE?$.4Y:>67";<;>Q=,JPV)C,@60>]':N+3C[KKH;M2["J]H"*JG[M!%
MSN#,@8S@\FMC&*WB#>F;4%_3)K8<Z5%>M48(AG;B'1$%YH!0A<+H2;M?)0J^
MKAD6X^U<M_B(ZD"SXXQ<;FV**D;URZ4BWQ27R*XD,W?J(@_J#L7KE'!K]E/S
M=O\ A\V)!S/$K@MQM!W(''(+PO,G'?CO]KSQ%P#^$&JHJ4%/OO&/+DBX6K-K
M/D-D3D9RR2L9R5^3%DMVTX4F4LIER(VV9&+L8E5![FJ.>*[?"@Z%]GR7!BW"
MUV>ZL>KGN.2X_C$^!HZLQ7'W%EN(.J(!*]JHCJNM"KA?.&L_OERPJ&].QYO'
ML2*SNQKRW%E!D<8K6VTDAF,\A]M6Y)-EKOT1!7J)*FM"KB[PAFEKEM91B]VM
M:9A;,OO^3VD;BU(. 5OR02:>C/\ :47$<$514(.FJ?JT*HOZ/&51L5P\0D8[
M>\OQ63>S=B7V"Y)L4V-?Y1230V]"= VBVDVH^75%U1:%6Q+#QM=+9F>+Y4^=
MKC,V7'IEFFVZTQBAQ5F39+$DW([.I(#>K9=%775:"5Y)PB?FWS1] ELQ?F[D
MMMR&5WQ(N['@=S>T&WP,MZ;57I0:RNGL]WI^%<9L:39KAD(9G=\OL\.\Q3E6
MEV'>6^TY#F-JBKNV^=W %=I"FB>6A5,3^*L[CP\*R/%G<9M7(.*+<0>@1H,B
M'C4F/=Q$'01EDU>$FT;:(30O.(5U1$71 PLHX6S*XY+#S*$N)WO(9]KAVS)_
MG/:3EQ1DPE)4FP&P-2 E1P@5I3$51!55UH52.8\49CE?(&-707L?M^(8Q/A7
M"US8L60SD4=B&(]R #H'V5CODBH2=-!73:6E!"73@W.\NR+)+OD]SL5J]:V*
MZX^W/QR+)CS)X7-!%D[F+KB@:1T!-H@6I=44M-$050[GL[9W=;%E,*Y2L8M$
MZ^V>SV6&Q8(<B/!:2SSTE*ZZ*H)&;@ZIKY.@^ ZJ*K/[4N--Y7B>,6-@WF;W
M<\CA6NW/1A(C1NY-O1IB.$"+M:]%-XG%7IT36A#:^0XE:\@PRYX.XBQ;/<;:
M]:-&435EAYA6$4-=4U 5\W7W*(TQ&X/Y%NMKO3>9Y!:Y%T'#I.!XT5O8?;8]
M&DH.^;,[JD7?/MMH0M>8B:Z>-%JWM98#ELLMOMCQH;L.*S&<<#5!(FFQ!537
MKHJITHCSKBO .5X5<K'<9\RR/6#"HU_")*@QGVKU<VKM'<1#G.%YBN JIT'5
M/%=554T+56L;XYSN7PP&4YH[$*WV#CN\6W%;);HTAFXJMV@)W%E]Y53NH#0M
M"+8^<J[NG@I5BL_"6?YEATVX97=+;%O=RPB)AV/1XK$EEN/!,FY3CLT'E(DD
M*0@!"VFU-OAY*)5LC.N/LTD7['\XXYN5MAY?9[?(LDIJ\M/.P9$&7VS5?O"[
MQ-IQI' 3P+P71*#5"\89SAV7XK@7&TR$LRWX)<8%RO=ZCR#B'Z?<V7'S;["K
ML>5TB=;$R)-HJ*Z_"H-M8)Q,]@V4VVZ1I[<FSVO#[;B+0$!#(<>MTEY\I!)J
MHH)HY\%%7K045W@'+X43&9%KE8]<KM89N1N%%OT1Z5;BCY)*]([H@.A=]E$0
M=/ T51W)XJ*I/&.%LSP]SBN5:;K;'Y.%P9=EOXRVY"@_ GO-..'$4-%1T4;5
M![GF]>ON4*N[CGA.[8!E6QJ'BLK"HDJ;,MUS<MA%E2),<<>;9.4JH&C).;4<
M\XB!$30?(*KUF.$3LDS/ \FC2FF(N)39LR6PXA*X\,N$<44;5.B*BGJN[R41
MKZP\'99;;[8[+-O-O>XHQ._2LJQ^$TPZ-W69(*0XU'?<5>UVF')+A(8^<?@J
M)Y"U;"XCPF=QW@%MQ&Y2FILV$]/=<DQT(6B]-G/RQT0^O07D%??2B+O0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"D<K81-Y Q=FPP)341]NY
MVVXDZ^A*"MV^6W((4V]=20-$H*=-XOSZ\\N6W.[G,Q^+;;"_,=MMPML62S?)
M,60RXTS!FFKBMFRVIH1+XEIYJ!JM%5*7[.^:Y4.>R\KNEDM5RRRT,VH6<:C2
M&(4J9%EI,:N,YMXE57]P(VNS7S"+JJT*LU_@;.,JCYY<\YNED^=.5N6"=;QM
MT9]ZV1I>.;^V+S4M5)UIU%07$7R*73P2A5)2>'<QG8; !MK$\>SNQY!$R:S-
MX] ?AV4S@"38,2T1>\XABZ[N,4%4W=$Z:J*KCP_@N1X-;LE7*IL*;>LER";D
M4@K8#K<5LIS; JT"/*I:"32Z:KX:>6A*EV'@[++;?;'99MYM[W%&)WZ5E6/P
MFF'1NZS)!2'&H[[BKVNTPY)<)#'SC\%1/(*LC#>$+[C3W%CLJZQ'TP*1DTBX
MHV#J+)^<)/JTC.[P[?=\_=^I0JL?(N"9G<,HLV?\;W&W0<MMD.79Y#-Z:>=A
M2($X@<U56%WB;3C:&">!>"Z)01?&W"3_ !UD>.7"/<VYEKL>)O8V\) 0R'I\
MJY!<7I*=5%&R)#T'5537Q7QH53',/'EXSR-CDNP';7+KC5T&ZL6V_M.2+3+^
M\N,*#X-ZDA"CF]LT1=I)X==4$*EBG!V264,,.X7*VK(QW)KMDD]N PY'BFW=
M6WA1F,UU1M 5WH*]$3HBT*NV\\'WZ_'RECTVZ00PKD @N4)T&WEN<2[M!'0%
M<151HXXE'0MJ><7AJE"KH_,SEMTX_O>,W6+B%BO-QF6IZ,]B]N=@QU9MDYB6
MYZ0JZ$9.=I=HH*("KXKXT*MZOM"^RXP2J@NB0$J>.A)I1&C,5X8S6V8?@&*W
MRZVM[Y@9(S=(4B$W(#TBU1X\AH1<1Q5TD$<A57;YB"GE6BU1=U]G>_.18ERA
MOV.ZY%:<CO\ >X-NO\5R599$#(S0G(\EM$4T<!1;,'!1="'P5%H5;MPRRR,?
MQJWVJ;'ML6>RWK,:L<7T&W=XE4B5EE5)13KY5U7QHC64;V>[9\X^7+G,E -O
MY+BA"C"P"]^$+K!I*/4O-4G'S[R)X>:FM%JC[7PIGEV8OSO(-_MS]TD8=)P"
MQN6EAX61ARA7N390OEJL@R%O<+>@(@]/&A5(V[BC-I#G'4_([C:_66&6F]6:
M8-O"0C+[=PC,Q8IM]WKN$64)W71-5\U-*".B>S[<SM%AL5RN\;T*!@]QPBX.
ML-F3BNW#M:2&D/1%0.WKH6BZT*H?@QC+[GRQ>KOD$F%=8F-XW#P\KU:HTN)#
M.7!FNF36LQ!5YX413>)K[V*D@I[XE<\XX7D9M><\E3)S 6O+L<B62(RHF1QY
M\!YZ0Q)-$T14;<,#%$77IY*%4!?N%,UG7RVY='^:=ZR679X%IRKYT6UVXQDE
M6_7_ $Z#IM-#/>2$V2B*^:JKTH56)WCG/K!R+<LGX_NMH@X[E*6KYRPKA&?=
M>C+:&TCHMO%HP;1'6$%LA<^#IJB^2@@H?!N6,9' M+MZ@+Q1:,H/-[?#!EX;
MPDY7')#<,CW=GT=M]Q7-VBF7ATH59[O"E[/B<L+9NT5K*85]>R:S7-6S.*W,
M2ZG<6!=#H2CH?;/3PUU373J*K#Q1@^7XM.RZ^YM,MLJ]Y7<&;BZW9P?;BL]J
M,W'V#WU4ETV>*^/C[U!()@T].93Y+]+9]5GC 8[Z#M+TCT@+@4SN[O@[-I;=
M/'6B*-BG!M]Q^+@S$BZQ'CQ6-ED>60 ZB/%D\GOLJVB^"-IT/=^I1:NBS^S[
M<&K/9+!>;M'.WQ,(N6$W(XP'W2<N3K1H^SW$TT!&_MO+0JLG#W'61X.CX9)
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MALMLO^D[%!L89-N@1*2$&OFHO6@IV&6*ZLR.*B&W/Q9@Y1G)ORUC&),K*;N
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MEJS)\1FS.4\QQ7)K_?+,WE>06NZ6=BUV$+BU.:8;C^C/#<>RXXPL1QI1=17
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MMLQ,E54U(11>@9?+7(UYXXMD6YVNR0KPT[WRD^GWF-9$#L AB#7I &KSKG5
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M!)D\=OHS]P<W;F]P&YO)O[V":=:#'>Y[O:6>(,7"7'LX<R4\-G8V=R:9;8N
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MZ/(?BJ:L$6\BU!3$25-"\HI1)46^<39M.NG+L6%*M?S9Y'MFV$Z\<@9\>Z!
M;@@#@BV3?HZ[2-3%5/P3:M%8>4\!7?+!RF),N<5B%?,7LMCBF"&X87&QR2E"
MXX! @JR1H"*FNJCJFB4*KEQ+A-UQ./<7K[C6(X[<99-"V&%Q'(X&TV*Z^D..
MMM$:[U501!T%.FJT%>Y"X]Y8SN\^HI-TL/YN5NMOO$:<3$AN_P !(#@/*S&0
M45E3(@T1\C0D$S3331*"2P_">2<+S*[QK?.M$CC2\WNX9'(.0,CURVY<T5QR
M(V (+* +Z[Q<4U+;TVT%2L'L]WR-8N.\>O=RAG"QBRY-8[\<0G4-T<B 6P*,
MIMI\!$7<I[?>1:%71B_!&4VO"LFQ&?9L)@S)>-2\<M&266$]'NLMY^.489$]
MTFDVH8[2>%ON:GJNODH59N0\%93=X>5QH]P@ =]PRUXK%4R>1!F6\C5QP]&U
MT:7=YJIJ7NI0JYWO@Z[N\D7'*XEDP_(K3D9VYZ[%E$(Y,V Y#9",^D+:T2&+
MS;:$F\PVN=>J4*MA<LX)-S_$PMMFF-VW([7.AWK'YSX*XPU<;:\CS2N"/50+
M10+3PUUT732@H]VXWY@RRQC=LGOMH'.[3D$#),8M407EL45;:TK'HQNDV,DA
MDB;A.DJ*HDOF]*#Y:.'<S]*M.07ZX6T\B=S1<SR%N+W_ $9MD;<Y;V8L4C!"
M/8*AYS@AKU]Q-15%7;A?/_S>S<&A1<5OD6[W>^7*X,W[TU!:&Y2"=AO176&U
M('F4,M_F^7S333J*N5\]GG(K_;+E:9]^9>*5A-FQANZN=TI3EXLDPIHRG45%
M^]D:!UWD?N]>JBKIF\'<AYG$Y#FYW)Q]B_Y<./O6QBW)*EVYF3CANF(R!DM@
M1M/;D$TT7S2+HNB:BJ5B\.Y)(QZV1';)B&+7.)E-FOLB/BT=Z-%=M]H?%Y0<
M-60)Q]55S9J BFNGNK00?+GL^Y?F^2Y?<K(5@E1<OC6QINXWP7RN5F.UIM(+
M>K;+B"#VF\E0Q7<J]%Z4*K9<^+LU<S'E*=;I5L7&>1[*W$0I!2$FQ;C%MQ6]
MI-H H*R6[>9;MWD0:"LSN#N2K9:6[9AUULP)?L-MF%9B5P25]Z*W1RBK-@JT
M.IEVW7!%MS8FNU57Q1!5EY%[/U[EX]R!CEBN$-N%D=AQNP6$I1.H328\+@&4
MC8VNF\23:H;O?1*%6X;&UFC=_P @]?NVX\64XR8L$-'DFBTC6DCTQ7/,55<T
M[?;\FNM$6&@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@:_K^% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H%!'7^S,Y#99UCD29,-B>R4=R3 >*-* 3315;='J)>^E!HKV<_0H
MN6<@VFPQ+GC>+PCMPP,,R!Z0Y<X[RM.*_-[<DW5;9DJH[-KI[E!5\WHE%E9_
M::R:]XOQ%='L=EG;[M<Y$.TLW!M5$XX3I -.."2:**[%(4)%115=4ZT(:PCK
M)]G;D3+L;Q:=,NN,#@,O,F;9>))RD&[6QXVU)#711%T17N;=-57W!2B\UB'F
M?F$,>Q-^3C^/ADW(DJ(&'0TE2UC-078BRWWIIH*JA"BMH(-_LE\=NA$HUSQQ
M=2DK@;^56\IU_F<D7T$=2X24&')0!(E'86CXCMVCW.FGO$6I5]P3VA>0,@R7
M%&[]C]JCXAEEUNEBAR(3[YW )-K0U[I@:;$;510=-=?$NB:(I*.NQ^TK?).:
MW/%99XQ>VO5MWGVQ_&IDN4C#UI9)\6IAO-@)(X(KH;/2A1DP^<>6(G&$;EW)
ML?L<?$Y+UH=%J)(DNR0MLY]6)+SFOFB0*31 /71"7=U2A1M#C7/KEGMSS93B
M,,8_CM\>L%IE-*:NR3@B/I#A[O-V[R004/?H-?1>;L_.]9]=I-DM(<:<=SKK
M#O$L7WUNSZ0(Q.LBPTOWO<9=L24U0?.Z?!H40.*^U)?+C;LD6Y6RS7:]6_%_
MGE:8N,SCF-BPAHVY!G*2*K<IA3 G4!%\W543IU%$O$Y\RYGB^/E\N-CM[R"_
MW>#8,49L$U]R"<RY"BB$Q7A1QDVO.[@>*JGD14*A14\\Y*RC+,<M^-Y3%:LV
M9XSR'C]HR!BTON'!DQY*D\TXVIZ&K;B?:.:]11?>0JZN\_7YI>MIB:?G3'C3
MH3J_Z 0H7I7C^[=?#X-$HU]B5VSEV%[14C,[?!F8_$2\.71IB=*](],C0D)J
M*P::*,=6D7S_ #2%>B)[A5@:YGRRQ8OC-AXRQB#+9L>"0,RO[5SF2%1FW&P*
MC#C'YQF_M$E0W-4T]^B4=N6^T?G;3TJ=@^/VJ1CT+$[=F\EV[2'FY*0IW4F!
M%G42=371/ 4T755Z)0HN_.M]NMQ]G7(<CQ[;%>GV9J8O><<;-J+)$#=0":Z]
MQ )4'R*OCTH0AY/(_+%N#'L$L-GL$S/FL==R>^]Q^8EL"VL/^CQF8Q;$<)]_
MPU<T$21?A)0;1Q;-XF7<>6_/H*-0HURMB7(0G.]MF.2M*9"\ZB= ;)%0ST\$
MUTHC1,/VF\C;QW/KA('&\@G8G;X5TA3,;D3';:XDN644X[Q2! ^X"IN0@\TA
M5%Z46BP7+FGDG&[9F=MR"QV9S.,7E6!(PPI$GU7*BY+*2,UY[HHZ)M$A"9*.
MBKU0=*%'1.YPY(M3$S&)MDLKG)4'*K5BS@-/RAL[C5]B+*BR$,A5X=$Z&*BO
MATZKI0HR,EYBY3L3]ZB0K)8[D_QY:(=YY&(9$ID'"F"Z^K%LW"J^8PR3N]_Z
MFWW0RYG/-R&X7*QP($5Z[ED6.V?'R+O(R_;LGCA+9DNHGG;FV@D;]GFZA[RT
M*(G&O:6.^<A0+.XMC+%+Y=Y>/VN'%FFYD<=Z*KH-2Y<94VBQ()I4%$T4$(55
M5H4>@Y\V/;8,JXRRV1(;3DA\_'1MH5,E_41*(T!9>>LYV6^Z93C]MAV3,K%=
ML@P<8C[[LH$M,=):,7#<* JNLDCB&SI[FGN%HF^)>6\VRW*(./9I:K7$&_XM
M%S6QO6AV0YVX4AUMGL2>^B??=7!+S/-3PU+QH.GGKFN\\32(SMKF8P;(15F2
M+)=I<IN]2]KBBH16V ( 113S7'5T4D44'I0B%UY9SV?@/&MQS>T0FIT^*L!(
MT*41-M&L^8Q%T,@ZIHCVNONT1KUWG'-[+$R;'<@LUJ?Y(M=^L^-6ANWOR!M$
MF3D;0/15,WA[HHT!$KOF]=O3375"T<)O-_(%NMQX_*LUH_.;#RRW8A,:1^2E
MG-+Q&63&EMEM5X0453<!(1)HOE5$H42N.<[7=,=DR,GQ&Z7?(K7?KGC-T;PR
M"]=(J2;48(3R(9"XVTXAILW]=46A13;?GV;X-G.=W<(D"X\?'G,.TWE]^1(]
M:L+<HT&.!1PT5KM,JX"J*]2W*B:::T'?9^1+Y95NUIXZQRU1;W?^2;_8#6XR
MIIQ7)##!/G.=7<9B1]KSFFO,Z:"B:T$Q;N;.0<EL^&6K'+):6^0<FE7R/,6<
M_(]31PQEY69)B32*^O>)01KS5VZKNUTZBC7W#^6-6?&<"NS]M&Y9%%PK*[NU
M>9<F23Z>B7$C-@A0]ABX6FID*FFG14HLK;:_:-R^U6VX7//;);!:=PIG/K"%
MG?D+K'?=;CMQ91/CT<-QT%W-BHBFOPM*)1?.-,\Y#N^:7_!N1+=:(ESLUOM]
MS!ZR.2'&B&XDZFPO2.J*';VKIXKU3HM!>LUO;V.8I=;Y&E6Z%(A,*XU*O;YQ
M;:!ZH@J^ZV)D(ZKIYHJJKT3QHC15C]HO*+QBKZ0HMCO&82,G@XC8[C;'92X^
M^]<HZ2AD.=T4D"#+:.=T4Z[AT2BT87%.?93B\NX-Y.W%D%D/*%VQV_OMO/NM
MQ9;L!HXPPU=Z]A7&MB(XB;4)$1$6@S;3RJN2WG#\\?Q,)=^EX_EMTLC<9Z2,
MM8-ND $=AMK<K9G+$ +<8+IJFW3JE!GV'G;,)'%SV>7"-CUVN5TE6ZV8M;K'
M*D^;<KHXC7HEQ&0&YEQ@C%3VKYR(NFWI0H3.;^0K3!NV.7&RV=SDZRY%9,>>
M;8?DC9GVLD%"B2 ,Q[H>*B:*A;=NO7PH42.2\S9?QZ5XMN<6VVE=[?AQY/$?
MMI2/0G[DS+6&<05>T-1WNQ]%T0M#6A1N6RNW1^SV]Z]LM1[TY&9.XL1U4F6Y
M1-BKH-J7510]4'7R41G4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4$
M9D606G%+#<<EOLA(MGM4=R7,?+KM::%271/$B7P$4ZDNB)UH-1\"YKG^6Y'R
M&UGP%"D0I=M?MEC(1%;=#N4/TMF.:H(DKJ-FWWMW_B:^%%E/<_YS?<#X\<FX
ML3;63W:=#LEHDO"CC;$B>Z@=U05%0E $)1145-VFJ*G2A#7-GY#S'AO+,VPO
M/KY(SJW6/&0S.V7!QIJ--[+;R1I#!;5VKJX6X-RKHB4%I7VAWTLMGN)8#>V[
MMD\Q(N+6!PHPSKA'&*DMV4(JYM!ML%37<6NJI[ZH**!QCR5D63?FNF9%?[TU
M<LBR')FCALA'".^U#3>#$T"T4!:$=H"TG157RHBT5>^.O:7M/(%\QJU+BUUL
ML++VK@6.76:K!1Y;]HU*4V':,B1 1%\]4^%YOOT2C*C>T(TS<[U9\FQ"YX_<
M+;99^106)3T-XI<6UHJO-_Z.\XC3W3X!K]5?#448]K]HLIECM&4W+!KS9L7O
M=RM-L@7.:4<0-N\[T"5M$U7LMD(H2^5#%4\=$%&P,&S^+G<S*F($!^-%Q>\R
M,><EOJ.V3*A(/?)L4ZH(D6WKXT10HOM'6]^Y93W<4NS&)89+NL#(,J-8ZP6G
MK0)+L!.YO,W50! $374QU\5T+1Q8]I:P1L:R:^93CMTQV?C4*'=CLTL6CDRH
M%S-&HKK*MFH^<X2 :%IVU7KY=!1*S.<"LV$!E62XA=;3>)MS9L=CQHRCOR[E
M-EB),)&-IPFU T5?/54^"6FO3444G+.;KEDMFP>3C*3<8N;G)%JP_+[1*%M)
M32*KAOQB)-R*!H@+O;5-4Z:^*4*+FQS[9'GX3"6B6*S<SDX"!*;6B2XNNLA?
M._<UT\/A4*-5XES!FV0XKS3)R>)?[-&LTJ[OP;VSZ(AVMN&+ A:VAU04DMB2
MD1=47JN[=HJE7>?[0UJPVTV&WC:+YECT7'+?D&37)D&%?@VZ0T")(EZ$($\7
M5PP;Z>*ZZ42CGF'M/6;%[K<HD+%[K?[1:;?;[U/O=O5CT5NW701)MY4=,2\#
M':.GG=?!$UH43WM!9G?,9X3OV5X:;PW!8[!Q;A'5L3C,R' 17]'?%$$M.B*7
M75/#5!#&R#G.7C;4""]A%VEY0EH?R._V%AZ&4BV6>*Z3)/NN*ZC;IFHJK;31
M*1:+X+0HV7!R*'>,7CY78VW+E G0 N=N:91!>D-.LH\T((XH(AFBHB(:IHOC
MI1&K'O:&9M=BRZY9-B-QM-WQ!+6[+LJ2(<QU]B]2/1HY,NQW2;4MZ%N!2U33
M3Q\"T?7?:%9AV^ZA<\0ND7+[/=[98Y>*H[$=EJ[?!W07&W0=5DA=3I\/H6J+
M[M"CD[[0336/L3UQ"Z'E!9(N&R\5!R,LMFZK&<E!]]5Q&C:(!1>XA;=%U\$H
M4?+[[0L;'9;S-SQ.Y)$L4>V2,\FLN1W6[ =XVJRTZB'ND$"$AN^CH2"*Z]?"
MA1,.<U6UIYZ"[99H71O,6L%&&JMJ9OOMC(;F(HDNC!1U5[KYVB*FE"CHQ3G6
MTY5DMMM+5DG0\?R-R>QB&3/$P<.Z.VA2])00;,G645 ,FE>$>X(JJ=>E"BT\
M@9A><.MK4^S8O*R8R5PI#<63$ABPTT.Y2,Y;K>JEX ((2DM$:\O7M)V^$Q"E
MV+$[I?8DC%V<XF.L.1&/0[0X;@.*ZCSHZN-]M?,#=N\G@JT6B5NG/V/VZWY=
M/;M4V6.,,V.3&::0$*Y-9,@)"*.A*FFIDH&A>"BM"BV\BYZUQYCK%^?M<F[/
M29L.VQ[;!5OTAR1/=1EL0[A *KN)$\4HC7]D]HL;A>;?:KOA5ULS#]]^9]RN
M#[T-]B)?S$C;BZ,O$;@D""JNB.P=R=5HM$I;N>;9<<G8M(8_<&L:N-QEV&Q9
M6XK"0)UW@(>^. ]SN")DTX#3A#M,A5/=T%&N</Y2R:\\;.W?.&<@M+B9@S A
MW2#)@B])*3=W6$B(B(6UF/M%E]%!-Z? 5>M!L9_GFTLY>5B"Q3WL89OC>(RL
MO;5E835_>1-(RM;^]L0B%LGMFP373WZ%'39>?(]URZ+CLG%;E;[1.O5PQB'D
M3[D8HKMUMBN[VT;!Q7=A(T6TU#3=T\BJ@H<P9GEF*9QQI%QB))O#=UE7<)N.
M0G([#EP5BW$;2*[((  6B7NDJFGAY5T2A#G9?:#QF[,0Y[MMFP+5,QRY9.,R
M4@ @E8I!1KA"4-V[O,*.Y5TVJ/5%H42.6Y[>'N!;OR/8+?)A7>1CCMWMT529
M61%5^,KK;I;_ #%5D21XA]P5'15Z4&KVN5>2F6^$Y062Z3IUZM=V.Y8Z$B"D
MB[G$@1"9F./$:-@"]PWM%(2U)$VZZ)07ISV@[7.L6-W3$,<N62W/(;6_?ULT
M0H[,B);(1(U(==)YP151=7M  *JN%T'R:BBW77D:UM\4S^4[&GIEL:LCU^@-
MN(H*Z(1B?;;-$ZBJJB 2>1:(U;;XO,&/\;7WD.Z9V5T9N6%S+T[$E1V0.VWP
MH92FG(1-MH*,-HNW8:+JHH7ET0JP<7\PW*_6L;!>L:NK.7V[&8.0Q6)#D1R1
M>8CK:MH\TH.[&W'76U38\0=2373KH*(J_<SLWC%LGBWRVWW#K]B\^Q-7.-:Y
M<!Z7VKS*;&*3,H%>8,#5"%X4ZH.J>-"B[XWRC,RG-[QBMMQ2?ZGL,Z1:KIDY
MNQAA!*CL@\@"'<[I*2&*= \W5-?'H&Q:(4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4$+EMHNU^QV?:;%>WL<O$@!]#O49IM]R.
MX!B:+VWD43%=NTQ7345714714#643BGDML\BRI_.XP<H7J/!ML&]Q[4WZ# M
ML!]7B:"*ZX?<)Y3<4S,NBJFW32BKSR7Q_;.3\'NF$7EXV&+BV&R8RB=QB0P8
MNM.BFJ:[3!%4=>J:IKUHC6-L]GW)I</,;CGF;%D><9-C[N(PKSZ$$9F%;'!5
M53L-FF\B<5'#75.OU56BU3N3<,72YXCQ];<?R(;5E_':0TM=[<B))8=6/$&(
M\AQU-.C@INTW]--/?H506+>SK<L?:Q-)N4C<I>.9//RF5*6$C!3"N#>Q6]@N
MJC9:^<JIJG7HE"KMQ[V=Y%D:PQEW( D!BMXO-W?TBJVLEN]@8*T*HZO;($/X
M?77W$H50>,>S%DECF6<;AFK$^R8Y:[U9+%""U!'>;CWEIQO>Z\#VKABKFXD5
M-/-Z:*JK0JO%SP2+B?LYW+C^ZJY>V+5C<J"91&%1Z0XU'-05EI%-=ZGMV)JO
MG:4$A[/^(/X1Q!BMEFM&U=7(B7"Z \BH^DRX$LET7=W7>"N;%U_8T)=%DX9A
MP[;R79KU<%GVSD:Y3I[X--]AR*S<&4:5L24C0B#343T3KY*%4)A/#7(&(6*Z
M6EK.H034@-VS&KE$Q^"P]#[*CI(?7J4APQ$0,3/;TW=2ZT$%#]F*7\V\@;N&
M3--9M>+Q;\CA72V6YJ';X%RM"$C#C4(3V*I[S[RZIN4M?%.HJS6_9TNDFT=R
M^94,_,Y^66_,+[>/0T;9>]6:BU$:9%Q-@"*Z"2DOU-.B"K%F^S?D;^9+=(V9
MMM88F:L\B)8'+<+CZW,2%7164CPJ@[4403;IUZIJG453B\'WYNX\I,QLH;#%
M.2(D_6V'"$GXMSN$9(_?5]'$4VVTW*C:;==4Z]-5%4/>?9QOSD&SLXMF?J28
M.)1<#RAY8 26Y]LC-HVKK0$XBLO*FY$7<NB*FBIIJHJSKK[.;<@;_$M5\]$M
M=TPV%A%O8>CJ\Y&:@*FQ\S1P>XJHG4=!Z^6A5?<@X\#(.)Y/&+T]6O2+,%F]
M9"WKM-M@6A=[>Y-4W"A*.[PZ:^6@I=XX=SZ:EGR&UYE$MG(<>R2,7O=W"V=R
M))MC[W>;5J.KZ=MUA>H%N5"775$1=*%5P?XKLQ\1GQ!&DO,6=;1ZE"<FBOHG
M:V=XD3:BDI>>0]$7JGA0:6Y$X<SR%Q]G=VNER8RG(;M8+7CUNM-BM2P=K<"<
MAM[&VW75<)4-2+S4T\$T%$1 S^0>*L\BX;E=VF7I<DY"RVZ8PP$BW6WM,18M
MGGM*R01>XZJ[=SC[RD>WZB)K06EC@J\2Y#%_R+)6IN7OY9:LLO$Z/"]'C/,V
M2.L6/#:9[I*"=O\ \12)==>BT*N_D+A.]Y3?[_<<9RE,?M>;P(UIS>&4,9;L
MF-#W@)QG",>TX3+AL%N$AVKKIJE"J0E\(6MWE?&>1XDU8T#';<%O]1(VI-OO
M16GV(CY&I_"9;DN"FHJOAUH58V(<3Y+@=^?*T7N#)P)F3/N5OL+EK9]9"Y/5
MQ[T;T]314;;><4VRV;]/-5=*"W8#;,J>XYM5LY.?2X95+A$.0JHL@BN2=RFS
MI&06_,$^UJ'1=-??HC6EC]GF^16HUOR#+TNUIQJS77'\&;2"+#\-F\,^CD[*
M,7-'S;906A04!-$UZ*M%JM>%\1O8GE.-9&=W&6./X3%P@HR,=OO'%>:=]*0N
MX6U"[6G;T7Q^%05_DS@F_9E><JG8YD\:S0LWML2V9"S,MWK%X4MV_M+%-7FD
M:0T/:XFB^&Y/.TT%5[Y*P%S/^/96#MSTM[DDK>23E:[R#ZOF,2E\S<.N[L[?
MA=-=>M$5')>"W;_=,ROC%^]!N]^NMCR#'Y(QD=]67''HX,M&8D>CPFHKN'S?
M-73WZ+5C1>";L\,.[9!DC<[+W<OM^9WRXM0^S'>&ULK'9A,-=Q5; 6]!$R(B
M\57WA5>>.L$<P0,I!R>D_P"<>1W+)!5&NSV!N1B2,+YQ;MFWX?37W$HB@S^"
MLCN&5W60]E;"8#?,CB95=,?&WIZ6<B C"MLI+5Y?O9DPVKGWO7S?-TU6BU2%
MIX/D6R]1[LM\%T6,WNN<=KT9150NL=QA(NO<7JWOU[FG7]BE"J-:X'R.SQ,;
MF8MEC,'*\:N5^F1)TF"LB(Y#R5Y7'V7&$>%5)OS% NYIN'JG7H*NO'/9UD6"
MS62T_.(7UM&,7S%R>]$4.Z=\D=])"#W5VHWX;-5U]U*%7;)]G-BY18MONE\[
MD)GCYGCUQ&X^TU=CNM/!.%5<5$T)I%1I?VU"JC8O:.;9C_)>4X_-<GY3)AV.
MP8[D$NU#9&Y#D*00S'FHLTC4FV6W"57'!1'#U0$Z(E%;WY-P$^0<-+&V[AZ%
M<67X<^#/>9&2UZ7;W@?;5]A5$7&R(-##PZT8M=N\"93-A76XW++(IYS*R.W9
MA;+E%MJQH,:X6R,,46CC(^2N-$WN!5[B$NNY=5UU+5R/V?+I.XTRW#KODX/9
M/D^0GEC>11H2QQAW CC.(K;'?)=!5A11>YKH7NT*K&/#SUON&)SL=O0VPL0Q
MF9C-M-8HODCTEIEMJ6HD:"7;5G>39:[]>JT*JPU[/=[N$#,9>19/%',LF?M,
MV+=K/; A1XDZPND_&EE')PT=><,E[RJ2:CYJ:>-"K.8X*O$M'KUDF1M3<TN>
M363)KU<(\/L139QU0&/#99[JJ"( JG<(E75=51:%7#G'"F,WS[B:WK$D.FQ=
MI,NXR&VW"B#:H3;<MYJ28IM1'7F8P )KYRZZ>%"&\*(4"@4"@4'D/VG$R^^\
MX<=X%CF6W+%X^01"9>D6^0^V FK[GWPFF76D-=!TZE1E#,^B5RC_ '\W_P#:
MS?ZRH5/HE<H_W\W_ /:S?ZRH54/F3A+E'B;CVYYW^>B_W;U<<8/0.Y-C=STF
M0VQ^Z>G.Z;=^[X/72A$O77$<J5.XJPB;.?<E39-AMCTF2^:N.NNN1&R(S,M5
M(B5=55?&C%<J!0>5O;,N>31G^-K1C=_G8^=ZNK\&1)M\AZ.JHZL9L2-&3!3V
M;U5$5:+#H^B5RC_?S?\ ]K-_K*BU/HE<H_W\W_\ :S?ZRH55GD3V>.4<"P>_
M9E^>Z_S_ %)#<F>A[IK/=[::[=_K ]NON[5H5>@/9IN5RO'!V'7*[S'[A<9$
M9XGYDMPWWW%24\**1FJDNB(B=5HDMK40H/._MHWV^8]P\S<,?N<NTSUO$1M9
M4!]R,\K9-/JH[VB$M%5$Z:T6%-MGLK\HW*VP[C^?>_M^EL-2.WI-+;W00]-?
M6*:Z:^Y1:LKZ)7*/]_-__:S?ZRH58MS]E?E&VVV9<?S[W]ST1AV1V])H[NT"
MGIKZQ7373W*%5R]BZ^WS(>'GKAD%SEW:>EXEMI*GON27D;%IA4'>Z1%HBJO3
M6B2]$40H%!5\_P "L?)&.GC&1'*"V./,R2]!?.*ZKD8^XWYX>1"1"T]U$7Q2
M@U1C7%W(?&60<@9!AIKD4F^R;.-F3);O)D$]%88!N6Y)<42+N@6X6E75=FB>
M312KUS=QY/Y,P&58+-+;@Y#&D1KI9)3Z*K(S8+B. CFB*NTDW JZ+IKKHNFB
MB&J)O$/+.;Q^0\QS9FUPLXR+&TQ/'[/;WS.*S%WH^Z3KQHO5QU-1\=$\:"U9
MIQQGO8XGR7$8\"=EG'K9QY5KG2#CQ7@FV\(;ZB\($NH$"*/F]4^LH5; .$>0
M["]Q<_? @=_%;WD5TORQI!$"-W<"1E64($4M27JBZ*B4&/A? ?(%DM7#4"6_
M&A2L(CYBQ>ID9]3-AS(0>&&XQYH[U%3$B\-*%57Q#V;N1[0ZZC^/V&U&WB-\
MQMR? FNNO7*XSF";9E2=[::(:EY.HIKK]J*%JVOF&&K9O93DXIE+[<.?CN,,
M$[):/>#=PL[(/,JV715^_,@@Z>/A1.U9_9]QZ5CO$6-!<E)R]75@KW=GG/W5
MR9=C*8XKGAYR=U 7ZE"5/M7"%_E<>\OX5>I#$-[.\DO-YLTEHU= &)JLG&)U
M$1%1=[7GBFO2A57L#X5RK&,4RI4X[Q&)DLVWQK5%B.3I\V/<FNX!3?2E=4Q;
M!Q 0F!#J)IYW3K0JP[3P'R1;\!CA#&! OE@S"+F6)XBY-?FP(L>&*@4#TQU%
M-!=W$:::HBZ=44B5!5GM\(<BSV+3D%Y& &4SN2K;G=]A1WR6/$MD #:1AMPA
M^^NB*ZZZ)KK[VJBK#9X8Y9CYO#C^B6IS"('(;^=A=4EF,TX\PE56NQV]NK8J
MN[5>I::=.M"J83BCDN/;>:L0;B6UZP9V_=[Q8KHDHPDE-N@M"W'<:4-H  B6
MX]?A>&J+T"+R#A7EF&W(9P\;3(;S'#;=AV5>GON-K ?B1TBN2&% %[@=LB1$
MTW;NNGDH5<LA]GW,4M^?6.P^C/VZZ8GC^,X\\^_VW''+*( :NIM79J@*J+JM
M"K:_)F!7G,N%+K@%O-EN^R[4Q%95PE1E9$;MGM4M.B$K>W=IY=:"F95B/,$F
M]+G6.6:UC?\ )<7/%;[99-P)&;;(1]QV/,;D(PO? $=)'&D 57IHJ^-!;;SQ
MG>0X&/BG&KKZ->V+"U9XMT52:%QYAH0)24=Q #VTA+351$O+I0>?\PXUOV%<
M;<FWZ3BEIPV!>FL2CVNQVF8<YM)-ONX(1/GVV^KA.!JH(OF^Z6JJ5.Y]C6?6
MU9G(F06Z!#R[+<UPMFTXXU-61%!+*ZK3"/2T9;7[^X9D2BWY@Z>*]*"XV[BK
M/9LBVY->XT*'?9O(#.97>VL25>:AVV/;78 ,B[VQ[SJ>:1*@BBZ^32B.KD/B
MCDBZ7K/;/BH6]W$^4?5OK2ZRWR:D6@H381I2C'1LO2.\RVG;T<#:?CTZT$XO
M$=_#GV/G3,EOYA!&;N3T(W-SI7^/!<M#9[%%?-2*:+NW?"2@K/#G CW'N3Q&
M;EAED>9L9RSA9\,UXKI+%TC]&_T/M[6W!;/8ZJGHNGF^^)E8>;^,\CS3(K'>
M(%BMN86:) G6YS';W,<A18LV8K:M7$=C;G<(!$@(=-VB^9HO5!"LV_A#.HUD
ME6]T8:O/<4_,4-'U5/7*.2"TUV?N6CH^?^M0JQKW@,MSF'ARP'+1'8]ACR,S
MML<T)M6\34'H#I]$5068^H"O373WM*#<7+&)7C,;+98-E1I7X&06:ZR.\?;3
MT:WS ?=T71=2VCT3RT&NW.(<T64\\(1-KG*K.<)J^J?^2ML-MJOP/W745^]_
MKT*L>P<09_%N>,X5<6K>'&V%Y/*RZV7QJ09W"6CCDE^-$..K:(! Y+/NN*>A
M"B;??#KB\4<C!A<G"7H,$6[;FD;(K5<AF*2S()7<Y[Q.-*TG:, 440=Q;EU\
M-.H=LCB3D3U].Q-@+>?'-US4,\E7XY!)-!KT@)KMO2*C?PU?;3:]W-$!>J:]
M$#,@<39FS-QJ4^$5$MN?7K*IB"_KI;KDLI6E'S>I_?AU'R4%GY6QK.)N68%F
MF$6V)>)6(OW1Z5;9LSU>CP7"$L1$!WM.Z$FY5ZCITH-+\@\2WBT<=\78E-N0
M-9S=LBF6FYE U5LH.6G(?NK32%U[;3>W<:I]IKXDB45Z:S3&RR' LAP^VJW$
M.ZVB;:89$FC32R8QL JHGVH[D\/)1BUAC& Y^=RX?NM_M\.W%@UKN]HO##,S
MTE51^'&B17&U1L4+N=A3(?M-=-5HK7:>SCDT/&L D7/&;/F5VQ^S2K!=L<N$
MYR)&!79A2H\MB0VVNI!N(7!(>HEHG7JA:O0A8%;Y?%[_ !R46/9X,ZSO6I^+
M;MSD:*4M@FW.PKB"1")&2@I(BKY=*,6LK;B'.]SP2]8#DR6>':8N(S<8MOHC
MQ/G=;DY&6+'F.&;8K';0$3<'BI$JZ:=$*B\HX1Y!O,2<Q:Y4:WR9''=IQ0)(
MR#15N-OF^DR&%4!0D9>;U:5SW"\*%41#X)S4[)GK$'&;/B3632\4DVG'K?.6
M3'8&R2^[+5QWLMIO,4W>:&B^'CJJBK=O&N)7C%I^>2+LC2-Y#DTJ\V[M'O58
MCT6*R*GT3:6YDM1H+[1"@4"@4"@4"@\K<V\F<W1>=K+Q1Q1<H40[O: FLLSF
M&"!7@66XZJNNMFJ?>V.B>[18=?JOV[__ %K'OVD7\6HO ]5^W?\ ^M8]^TB_
MBU#@IO)F<>V3Q/C:93EE\LPVLI+<-%B,1'G.Z\)$/FJP/30%H<'L^Q2GYUCM
MDV22%)DQ&'GB1-J*;C8D2HB>'5:,4A0*#S/[2/)G+&*Y_@N$\7W"-#F94+K.
MR6PRZV4CO VVJFZ!J*>=Y*+"*]5^W?\ ^M8]^TB_BU%X'JOV[_\ UK'OVD7\
M6H<%;SW)/;3XXQ.X9GD=[LB6:V]KTE8[,1UW[^\# [16..OG.#KU\*'!ZCXK
MOUSRGC7$LDO+@O7:[6F%-FN@ MB3[[ F:H(HB)JJ^"48K=0*#S[[5W)^=<8X
M]C,K YK4*XW:Z+!>)]AI\2 FE44^^B2#YWE2BPJGJOV[_P#UK'OVD7\6HO ]
M5^W?_P"M8]^TB_BU#@P+XY[<>/V6Y7^X7NP) M45^=*[;<0C[,9LG3VIZ.FJ
M[171*'!N'V:\ZR3D?B6UY9EDD)5[E/S&WGFV@8%18D&V";&T04T1/<HDMMT0
MH% H% H% H% H% H%!0N8\\D\:X+(RR*C&L>9;X[SDM#)EIB9,:CNN*C:H2J
M &1)[_N^%%A\B<T\:S\3F9M$O).X];Y26^8ZD29Z2U+(A$6BBJRDA#)3':G:
MZZT*.I_G/BV/C$/+SOR%9+A)<@Q%:BRW99RHZ*KK7H@,K(0FT%5-":3:G5>B
MI0HZ%Y1LX92K[N26MO"/FD&5=AQB4W</1W).T9JNDB-)'5OS$:V]W?Y-*"RX
M5G^*\A6^1<\3F',BQ'O19/>C28;C;VP7-I-RFVCZ@8DB[=%1:(^YIGN*<?6U
MFZY9/]"BR7ABQ1;9>E/O/DBEL;9C@XX:H(J2[1Z(FJT%;O7/7$^/1;7,NV0=
MF/>H(W:VD$2:\KD E5.^HM,$H FB[MZ)M\M%HS<GYFXQPYZUL9%D<>*=Y8;F
MP" 79#:PWB$ DN&P!BTP1$B(ZZH@ON]%HE'=D/+7'F*Y%!Q6^WMN-?;CV58C
MBT^\(I)/MLJ\ZTV;;*.%YH=TAW>2@U1R)SU=<.Q^>[&O5HDW1_-G,5BS6+?<
M'V;7!:1LWO2F4\Y^2P)><C1(+FY-B+HJ46C8<?DVV63YXW#,<BMRV;&Y,**O
MHD:6W(8.3%9<1IT"0U===-S<V#"%T5!ZDBT&:_S/QG'P]G.W;\VF-R)26YEY
M&9!2"G*2CZ-Z*+:R.\BBNK7:W(B:JFG6B.GAKD.1R?B<K*718&,5UN,.W+&%
MP .%$?)IDU1U=VXA3<6J)U7P3PHLLBV<R<:7B_7+&K?D#+ETM#<AZ=O!YJ,+
M4%422027 %EQ&57[XK;A;?+1&/9^<N++]9[U?[9D .6K'FADW9UR/*9-J,XF
MH/(VZT+CC1:>:;8D*^1:+1%1?:5X3F/M1V,I'NO/A&1'(<YI )[8C9ND<<4;
M:<[@;'7%%LM>A>-"B7?YMXOBY@.!2+^#64E,"V>AG'DBVDUT=S;)/JUV4-Q/
MW-%<\Y>@ZK0HS&^6>/7LT+CYN^-%E8F3"Q$;>[7I -]TF$D;.PKPAYRM(YO3
MW*(P[!S=Q?D^4#AMCOX2<B,I+;<58\ID3=@ZK(;!UUH&R-M$4B 35=OG>'6B
MT?+)S=Q?D;5Z?LU^25&Q^,Y/N<A(TL6AB,D0F\T9LH+P(H$FYE31?)0HJ&>^
MTCB-JXUNV:83.;N%PM\^#:RB38<UDFGYCH*O>8-MIT4]'[KC9$B"2CHBJO2A
M1:[OSOQ38&+-)O&0C#;OT<)UO1V-+1ST1PT:%]\.SNCM*:[=[Z .OEZ+0HSK
MAR[Q[;,L'!I5W5<J, =2W,1I3ZHVXTKXFKC31-H*@FNJG[WC1&=;N1L+N[N-
ML6VZA)=RZ,]/Q\ ;=UDQHH";I]0^]H*&/[KM77IX]*#&SCE3!>.#B-YC<S@%
M-!QUC9%E2D1IE11QPUC-.HV J8ZD>B=:#IF<P<=0<HMV&.WI',ENHQG($*/'
MDR.XU-_<7.XTT;8ME^S(T%/*J:T6B-A\^\47&WW:ZV^^G*MUC[*7*0S GF('
M)>]'; -(^KADYYNUK<ONT*.R1SOQ3%QR!E;V0(EEN<EV!"<&+,-XYD=%5QA8
MXLJ\+B:? ,$7W/%*%';.YOXMMV+6;,Y.0MKCV0*8V=]EB3(=D*SN[VUAIHWD
M[6TN[N;39IYVE"CC=><^*K+C]FRBX9$VW9,A%URSOA'E/&^U&U[SB,MM$X+;
M>GGF8((^5>J4*.63\X<68?)@Q;_D33#MRALW2$K+$F6V=ODD0-R>Y&:<!&E4
M5\\B04\5\4H4<[+S7Q=D%LOMYMF1,':\: 'KS)>;?C"RRZBJVZ/>;!7&W-J]
MLV]PG]KK0HZVN<.+7,4DYJM_%K'8<H+?,D/1I33S$IS38V['-I'@4MR*.YO1
M477PH44_./:3Q"T8I8<LQ6>W<+9<LDC6"YO/0YO<B,B:%.W,=L'1>;:5"!LQ
M12W(J"7@HHNSO,W&S.16O%#O7_GUW"(Y#B#%EEIZQ'?&%XT94&#='J(/$!>]
M0HP^7.3PXP3$YLM6FK->+T%MNTIUIZ0XU&6,^]JRW'13)PB:$!1!+Q^#K09<
MGFGC.+B%OSER^@>-W9U8UN>98DO2'GQ4D)H8S;1/[PV%O'MZCHNNE"BK9%S_
M (Y;<\XZQ^V36)F.9K&DS'+BS'E22VEL:@HRK(J*=QY3%W<*JWM\_9KK0HNT
M7E+ 9CEF98O32NY!ZS]4 3;P*_ZC(AG:;@3;V5 M=^FNB[=:(BI_._$UJ]1K
M<<D:C#D45FX6LG&)*"L*2:-M/O%VM([1FNT3?V(J_46BT2-\Y9X]QO*(F&7J
M^-1<BF*R(1E;>,&RE*HL"^\ $TRKJIHVCIBI>2B,.1S=Q?%S <#D7\&\I*8%
MK6&4>4@#->'<VR3_ &NR)N:^8BN><O1-5HM$SR-EP8'@F09@38O.6B"](C1S
MU07I*#M8:7;U^^.J =/=HBM\;\O6G+\=PQZ^FW:\ORUF>C%G0'40I=E-6Y[8
M*2%M[1)KM,MRCX:Z+17VX<_\2VRT6N_2L@_\GO*2#M\UF'-?:-J$^L9YPE:8
M+8V#B;=[FT5\454ZT*(7FOG_ !KC'')_JN?&FYLL%N?:+:;4F1&-M]Q ;-YV
M.*@V)IN5ON.!OTT1:$0MMUY<X]L&40L(O-]:CY1,5AL8BMO$ .R]>P#SP 33
M)NZ?>Q=,5+R:ZI1'7QYFMSR^[YU"GL,L,8Q?W;)!1E"W&RS&8>WN*2KJ9$ZO
MP41$31/?HJ]T0H% H/*7-W_5APS_ )M?XYVBQR>K:(4&A_;(_P"GS)O\];?P
M]BBPV!PS^B' O^7K3^!-425XH%!Y2]LC^T/#G_,)?QL2C*'JVC$H-9>T3^@[
M//Z(D?\ 8E%A&>RS^@'"?YJ_^%OT);@HA0>9_;I_0FS_ $W"_BI%%AZ"Q?\
MLS9OYC%_B1HB6H(G*/[,WG^8ROXDJ#S[["WZ$WOZ;F_Q4>BR],40H% H%!3N
M3N0K=QCBCF47)H9 )*B0F8Q/MQE<<F2 9Z&YT\P2)PM$7S15?#K03;V4XQ&2
MW+(O4!I+NJ#:5<E,CZ62Z:)'U).XO5/@:T$E(D1XC#DJ4Z#$9D5-UYTD   4
MU4B(M$1$3RK01D/*L7N%I>OT"]P)5BC;_2+FQ*9=B-]M-3WO":@.WRZETH*-
M:^84R.1*'%[2S<X,+*6,6DS2N<5AI8[D8)!SF"+47D'>*"PV2N'XIIX46C8#
M5^L3]V>L#%SB.7V,"/2+6#[92VVBTT,V4+>(KJFBJ-$=+ETQFZQF([TR!-AW
M-'1C-&ZR\U)2/JKJ BJJ.=O:N_37;IUH.AG,L,<9><CY!;#CPU:"03<R.H,J
M^*DT)JAZ#O054$7Q1.E!)6RZ6R]0FKG9IK%QMSZ*K$R(Z#[!HBZ*HN-J0KU3
M3HM!J9SVB,<^:6:95#AI+^9U[6Q';VI;!/2A],8A#+';KL9,W]14M=4%:+1M
M&)DF.S[:_>8-WA2K1%5P9-P8DM.1FE9_=$-T241V?;:KT\M$9-MN=MO$%FYV
MB8Q/MLD=\>9$=!]AP=534'&U4235/(M!K.P\NY#E&672QV' YLO'[)>W\=NN
M2>GP&F67XI"CKGH[C@O$(B8GYHJJHNB=>E%;#3),=5F/(2[PE8E]Y8CJ26MC
MR14(GNVN[0NV@DIZ?!T76B*CQUR]BV?X+!SE9,:S1)9NMN1)<QA7(Y@ZX  Z
M2$B"9@WW$']BOZM%HLJ9GAY/6Z,.0VQ9%W$7+2RDR/OE@:Z"3 []7$5?!0UH
MC,=OUB8NS-@>N<1N^R 5Z/:S?;&6XT.NI@RI;R%-%U5!H.H,GQIRXG:&[S!*
M[-HX3D 9+*R!%CHXJMH6Y$#[;IT\M!K^3S5$F3\IMV&0(V1O8TQ:'TD!=8D6
M'*]<2"9) DFI- K(@1*A%J9>8*:Z46B^OY%BI7)NPRKM;UO#CFUFV.2&%DDZ
MT@N:"RI;E(442Z#JG1:(?.#%IEY^;OK2WOY#'^_^JO2&3F-[4UW]G<ICHGEV
MT'%G+\2DOE&CWZW/20)L#9;F,&8D\:MMHHH:JBF:*(^ZO1*"29GP9$F3"CR6
MG9D/8DN.#@DZSW1W!W!1=1W#U'=XI0:IOO.OJO*+A:K5B-TON,6";&M639-
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MUWLMVR:'C&$3[]%&!?G(\F,3SKL]IQ056XZM&G>TWN)UTH+5SY!M\NRV:0_
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MJVC$H-(>U[_T]9?_ /.[_B4:BPMW!7Z&, _H"V_@P4);!HA0>4O;D_L]@/\
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M)N*RVP!$KVJHT""BK]]\NE%I#)_/=[6']S+?UWOY6B4AC3^8O:MN$"5 =X:
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MHOBBT1P"-';!IIMD!;9T[("*((:)HFU$3IHGN4&)>+S9;'%"3?IT>!#D.MQ
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M7#>!-.@3;H6&W"8&BB2*D8$5%1>J425_HA0>4?;G&0F+83(CQG97HU\[[C;
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M(WA^07^_1[C#Y-LM]N,*U-PV&&[))ML$KA%[+@IW'@5M-CB/*7G:+KUHCO\
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MXET>1%7TAB&!ML@:*NF@"X0IT\%HB&PKBKCWCI^;*PNPL6F3<$$93S:N.&0
MJD@"KIFH BKKL#0=?)03D'&K#;;Q=\@@P6F;S?O1TO$P47?)]";5IC?JJIY@
M*HITH*M9>%.*\="]MV3&(L)O(XSL"[MMJ[L=B2->XP(J:HVV6J^8UM'WJ+5P
MOG!O$^22(DJ]XM$EO0H;5MC[E= 4B1DVM 0@8B?;3H!&BD/D6A5*S^,L#NF0
M7#*9]C8>O]UM[EGN4U5-"?@/!VS:<%"05U#S-VW=MZ:Z40+C+ SB/0"L;"PY
M%H8QQYK4]"M$37LQOA? #<NGE]^@U[RQ[/UHY%NUA=@P+5;H\9&(]XO1C(6[
M!"@NM.LLPQ;,6=Q()-*Z^A$V"^:BZ]"U;:R/&['EUDF8YDD%NXV2X C<R$]K
ML,1)#3X*HJ*A"A(J+JBIJE$56[<)<4WV-8XEXQ>),CXVR$6S@[W"[4=I446C
M7?JZVBIKL>WCKUTU6BU7.YVNW7FV2[-=(P2K5.8<BS(CB:MN,/"H&!)[BBNE
M$5VS\8X'8(MHAVFRM1X]AC3(-I'>ZXK$:Y$AR0$G#)51Q4Z[E7WJ"-O/"7%6
M06FS6.[XQ%DVO'@5JS,;G06.T6FYM# Q(@+3S@(E$O*E%JO;##,5AJ-';%J.
MR MM- F@B )H(HGD1$2B*Y#X[PJWA;0AV9AD+1.?NUM0=_WF=+W]YX=2^$?<
M/77IUH(R[<-<8WW*%S2ZXW&DY.IQWBN"JZ)*]#459<4!- 5P-J(AJ.[;YNNG
M2A5(_FWP;5%]21]4OBY6GPO]NJBIZ9\+]TT7ZGO4$78^%.*\<F7:?9L6AQI-
M\CO0;HJH;H.Q)*ZO,HVX1 #;B_# !$5\J46K[CO"W%N*1+E!L6,Q8T2\1?5]
MT:-79"2(G7[TYWS-2%$+1/<31$Z(E"KJC\'<3Q,2EX+'Q>,&+SGQE2X6YY2<
M?;TV&KRN*[J.B(.A^:G1.E"J:_-UA"A<VSL<9QJ]0H]JNC;@JX,B%" FV&C0
ME5- $E05\??HC M'$'&UAQ_YK6G'8T>Q>FM70HNKAJ<V.8N-/&X9DX1 0#IN
M)?#3PH,F?QA@-S-UR?8H[YOW9G(G5)3\Z[1F^TW)70D\X0\W3PT\4H+;0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!05;/<"M'(5GC6JZORH3T";
M'NMJN=O<%F9#GQ%56GV2,3'<B$0^<!)HJ]*"F)[/6*#CQV5J]WUNY+?BRQK)
M1F-^MV[LXR+#C@O=G8HF [2 FU%=?J:%JA+1PY/QOD#!85A9E.X7B#EZOD_(
M;O,:E2YMPOS+L8XX@ B:D*GW3<<%$5%TU4J%5DQ7@'"<4NP7%B3<KE"AQYD*
MQ66Y24D6^TQKF6LIN&&P2%'$\Q5,S7;YNM"J,LOLV8A9FI["W[(+C'FX_-Q%
MAFX3&GPA6>X;=S,9$8';V]OWM2W>_KHF@JO4GCRQRG\.D..R4/!R4[.B.#H:
MK$*%]_U!=WWLM?-V^=]:B(2R<*8E8'\;D0WYQN8L5[.V]UYLD)<D<[DKNZ-I
MNVK^YZ::>7=1:NNS\&81:(5DMVLN;;[)9)^,M19;H&W(MUU(2D"_L;!2)=FB
M**BFGDH58T+@JS,8G>\*GY/D=WL%ZA-VH8]QG@\D*&SKL"**,B(JB+MWF)DJ
M(B*O2A5(7SA?$,A7+O61S##,[=!M%U 70%&V;8A]@V?O:[7$4]RJ6Y%5$Z>.
MH1V2<%V_++?!M5\S+*I%L8AA;KI#2Y +-U8!XGM9@HQHIENV$;7;)0T'7HE"
MJWYM@MCSW#;A@UX1UFRSVFV56(2-/->CN ZT;1*A(A ;8$.HJG3PHBOR>&<>
MN"SWKK=+K<+A<\6/"9\^3(:-]VWN&ZX3Q*C*)Z0I.EY^FW_!HM6+<>#+!)GV
MVY6F_P!_QR7!M\.SS'+)/2&MQA6W_5QEZ-EN($W#W&]A[25-=/ 56:)Q]CL6
M]9A>C!R4YG QF[[$DD)QB;B1/0A  045!)OX>JKJM$5[&^$[!C]GNF-2[Y?<
M@Q>YV];,%CO,_P!(A1+>J**,Q@;!M1VBNP3(B-!1$0NE%JP+9[/F)0;)D5GF
MW:]7E[([8%A?NMTEMR)T:U,B2-Q8Q]D1 !4E+J!*1=25:%5BQS![C9,XNN0O
M7-Q^Q':;;9K';%=<)&!A=Q7W' 71O>XJMZ$*:Z(NM$<Y_&5EGYZ'(!39S,YR
MWK:+G:FG6_5EQB:.H RV3;)34.\2CM,?)KKY0B<"X0Q;CZ\A>[?<+M='XD,[
M79&+O,]+8M=O<<1TH\,=@J(JJ".XU,]HH.[2BU?,^X2QWD"[R;S)O%YLLFXV
MU;'>F[++"*U<+?N,A:D";3F[:KAHBCM51)1+4>E"KKNG N%7>V93:93]P&+E
MT.S6ZZ*V^V)BSCR:1E97M+M)?_$UUW>1$H5?<@X)P_(\L?RF9,NC+%PD0IU[
MQZ/*0+/<I5L04C.RF% E)0V!J@F(EM'<B^45=MTX4QNZW'-9KMSNK,//(2PK
MY:&9#204<5IMGTIELF2(7]C2#N4E'JOF^X*N^Z<+X7>W,A*ZC)E,Y+:H-DN$
M<W11L6;6I''=:V@A"Z!DAH>J^<**B4*NEKAJVNX\>/7W)\AR%LKE!NZ3;M-"
M1)!ZV.MNLMMZ,B -JK:;T$-2ZKKKUH5;!G0HURA2;=,#N1);1QY#>NFYMT5
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M1(KHZ"GC0.(\2O>(1,O9OC3;1W?*[U>H';<1W="N#Z.,D6GP25/$?)042_\
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M2O-H"W>N#N$8;0J(23U>;2-M5=J+W==NBKT\:!*O%H@L!)FSXT:,Z"N-O//
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M5N5N&>-K68PES-OO!"5P.^K6NF]&]=RCT\=-*#*H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MUW.ITZ&NJZEXT!NV6YJ<[<VH; 7)\4;?F"V ON .F@DXB;E1-$T15H,>],6
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MPFVU12[/=<,#)13JB=.E"B8X*Y0SO*<G]2Y-*>OMKN-D;O8W4K%*L;-ON*N
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M(NFNF[SJ%5LSW K1R%:8UKNLB7!?@3&;G:[I;74CS8<Z-N1MYDR$QW(AD.A
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M #F!R)COSHM,9YBTNRY<6$X^H:R&X4@XZOAL4M ,FRVZ]=*(M- H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MZ>-!Q&-&!'!!D!%TB-U$%$0B--"4NG553QH.IZV6V0RS'D0V'8\8A..TXT!
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M7RT'#U3:O1';?Z#'] ?4B?B]H.R9&NXE(--JJJ]5U2@[DBQ1[6UAM/1Q4&-
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M]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM
M^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_>
M^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/
M)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK
M0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W
M@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#Y
MSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#Z
MZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G
M]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM
M^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_>
M^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/
M)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK
M0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W
M@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#Y
MSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#Z
MZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G
M]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM
M^<\G]X#ZZT#YSR?W@/KK0/G/)_> ^NM ^<\G]X#ZZT#YSR?W@/KK0/G/)_>
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M_P#M46B+D-F8=6YXLM[O3"F8@=W;1Q2>70TT5";\GF]/"B=BA91CV6<D9QS
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MAQX!VH]VQZ=S3R_!U55TU6BU6:)Q]BL+)+9EL:.^-]L]I''8#I/D38VT ($
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M;T04Z=:":XYP6!QMA-KP>URGYD"U"Z#,J5L[Y(^\X^N[8(CT5Q431/"B*0/
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M(;C?IV39/D"16I]UN L-$L>W@3<=L6X[;8)M0RW%IJ2^-!6L^]GVV9S=\BN
M9+=+' R]B$UE%K@)&)F<Y;$VQG")]IPPV@B 8MDB&B)K[XJL#G$MM/-<HRT;
MM-;AYE;V[?D-B%6O1)!LQUB-O(2@K@D+*J.@EIKU6@KS? :1\=Q>V1,SN\?(
ML,[S&.Y*V,7TEBW2&0C%#)I6NTXUVFP1%,=R$*$B^2A5/XMPWC.'3\5EV-^2
MVSB=KFVB''<(7$>2Y/-R'WWBVHJNFX"FJCHFI+TH581<'6$B O6<W5O-EY$3
M]R_U]14?1_@?N'7_ !O\*A5EXSQ0>)Y,[=+/E5W:Q4I4NX,8;N8]6M2K@I&_
MH2M*[VMYDZ#2&@B:ZIY4H->6KBG+EM?,]PQ9LL1RS-[\3=EFNNDT80(S@(4L
M38W&'?)R4Z*)HO4?"@WO<[%;;U8)>,W5LI=IGQ'+?,;=,E-V.\VK1H1Z[M2%
M5\[77RT1K9CA.?\ ,R\X/<>0+_<;1=8C%I8-]8B.Q+8P6ALMJ#";C>;56777
M-Q*/N+1:NR7P'BSD3(+=;ILJTVV[W"!?K3%MXLLA9;Q;6P;&7!T;\TG.V"N"
M>Y%ZZ::T*LBZ<//7S%8-HO.87>;E-JN8WVU9:?HP3(L\$441MH&A9[&TB%62
M%15"7WM P[WP9ZYB6 OGK?8^16:+/MTK)$..[/G0KL:.2&75=9(!1"1.SM'[
MV*:)X(J"K(M7","PSL&N-DO]PA2,+MOJ,E 6"2XVW>VZK$A";7:BFT*J3>U?
M'WE058^+< V'%;]"N<>]7*59K"EP3$<??)KT2T+=]R25:( %QSS3(&^Z1;!5
M4ZKUH595FXPO>+3.-K/C]]D!@^%Q+BS=HKCQ-NW)UYIMJ&CH-"@&+2JZYUTT
M+;HBT$UR!QPUF\NP7F)>)>/9/C+[[]HO, 6'76PFLK'DMJW);<;(7&UTZCJB
MHBI[BD5 /9ZM\*PXO:[)EEYM=XQ8[H,3(F2CG.?C7V0<B6T_O:5LE(BU$]FH
MDFY.M%JR[3P#CMHMD:UL72<;,;$Y^$ 9=G<L.Y/"^;ZZ B=T5'0?M?>H5<)W
ML^8Y.MIVT[K.%L\-B8 IIV=WH,%Q70D=0_=E5="^U]ZA5WW_ (&Q_(8F:0Y-
MTG-!FPV,9Q-]K5CYN]OL]G4%_=.VG<W:^]I0JSI7$SH+D4K',KNF/7?(;R%_
M=GPDC&H/-Q1B]@FWFC%QA4%#4"Z[D3KTTH(N+P#9;9%PD;-?;E NN%2YTQFZ
M@K!OR_7![YX/"3:@B/+^P%-B>'NT*I"3PG8)6*9/BI7&: 9)?I.4C/;)L9,*
MY2)(2P)A4#3:TXV.U"1=4U1:%40Y[/T298<HMUWRNZW&^Y5-MUUE9"\,4)3,
MZT]OL&TVTR#: G:%-BCT'HGNT*N[*> X.52?29.4W>(=TMT2SYFD0H[7KZ-!
MUV%)T:^]N%N(2-G;YA*"(B4*N[*>)[JU:^097'5W<M&5YN%K:9?)Q8[$ ;8R
MU#U8)@>X/W@27Q^%X:4&Q;K8+;>\?F8Q=@*5:+A#<MTQMPR4W([S:M&BGKNW
M**KYVNNO6B-9Q>!6%Q&;B-^S*_7N,20!L<N2ZPV]:?4Y;X;D7M-"B/"NG<=+
M57$1$6BU=T/@>T-PXRW6^W"ZY"F26_+[I?I'9&1-FVK1&&C$&T &! 4! !$T
M3P6A5!YWQ#?^0.6;K-.ZW&PX7.Q2+8KC)MY1O]/1R;*.1#(7@<)$[3B??!%-
MN[35=52@E<H]GC&,AGO.0KK<;'8KK%M]OR>PV\VQBW2)9T08C;AF!.-[01&B
M)LT4F_-Z>-"JRO\ %&/37,^2>Z^_#Y";89NT74 %EN-!& *,*(ZHNP$+4M="
MH*O;_9^A(Q?PR;*[MDDC(,?3%'I,Q(K1Q[>V1JUV499!$(-^NI[MQ:D6NM"K
M*E\)RGX..O1<VN\',L?AOVKYUQPB#+EVV4XAE&?;5I6E$-H=I=NH**%U+K0J
MV;%MS;%J9M,EYVX--QQBO/S%%QZ0(@@$3RB(H1&G4]!1%5?"B-7XAP%9<4N+
M,L[]=+Q"M$*9:\2M\\VC:L\2XJG?%DA!#,E1$;$W"54!$&BU2=KX:LMKMO'M
ML:N,LVN.W2>MIEV]TA3CN1U1[0?#1Q5\W2A5&2N!+2L9QZSWZX6G)6LAN>56
MJ_QT8.1#DWK493 @XV0&P8%M4335>G6A5WW7A0I3EFN=IS2^VG*;;;5L<[(P
M=8DSKC;B<[RA(5]HQWBXI$VX HH;E_4%67DG&MSVYAD&(W=]G-L@QUK'X,F2
M[V@9>B"\C,GNM!O%S<\I$0IT5-42@O-HMAV^Q0+/,DN7!R+$:B2)D@E-Z03;
M:-DXX2]5(]-Q*OE6B-<XUP9;L=LV+V,\@N%Q@X=>EO5A22C"$RTD=V.$-5!L
M=S8HZ1[E\Y2\NG2BU8O(WL_VWD&[7NX)DMUL,3)X<2#DEOMWHZLSDMQD48S5
MYIPA4-RBJ J;DZ>[J*I:[<0^OLSM^2WO*;K/L5JN;5^MN+/>C^A1[G':)IIP
M'!:1Y&P0E)&M^W<NJZ^%!&,< VIG&[CB_P X;GZ MX3(<7<'T<7K%/&0[*0X
MAHWYVKCQ[N[NU%=O3QH525RXB?O&,VVV7/,+O(RRSW!;S:\P7T8)T>80D!"#
M8-"SV" R F"!145T7R4'8Q@F90\@P0QRZ?<;!CPW9[(SG/H$FZ2IH ,076X[
M;;9-LJ3I"*Z;= 3SO&@R.7,/9R:P1;HR=U8O^,2AN]DDX^,<[D,@ )H@:"6J
M,FC@&0D#BH*T&N,&X%OCN"8P[D%ZN&-\@V>ZW:^1KE%.+,FQQO9N"^P^9MFP
MXX;1IW#$-$/X/3Q%4M']FBSVRT6:V8]E=XL\JV6RX8_,NL?T4Y<ZTW26<UQE
MQ763$"%TU4'6Q0DZ_J"J[8CQ9:<0N]LN\.;(D/6O%[=AK33W;V'$M;AN-O%M
M%%[A*:[M/-]ZB*EC7LYV?&;Y:;BQDMUE6?'!NK.-6%_T=8L"/>P(7VP-&D=/
M12\Q3-=$1$^J6KHF^S;;';/;K-:\LO%I98QWYG79R,D4BN%H$W' ;<1UDQ D
M)T_/;1"424:%4M<>!,>N-IR*T'<YK;&1V*U8W(,.UN:CV5#1IP-0TWGO\[7I
M[FE"JS8OC62VK-,POEVNSDO'[FMM8QJTJ\9M0H\*(@/EVU1  WGB,BVZZH(Z
M^Y1$!GW"-KSF^2KRW?KG84O,)NT93#MAM"U=;<T9$+3O< E D0R#N!H6PE'P
M6BU67&^/K1BV4Y%E%L<<$\ACVN(Y 7:D>.S967&&191$14U%SSMRKX=*(Z^0
M^/HN?P+<"7*59+Y9)H7.QWN!L](BRFQ)M5VN"0&!@9";9IH24%2OG! 7J+95
M3-;]&OUL@3K//R!'([T^X6^YFCK[+Q.LD(Z&B=I0%-B=$\$5"U=5Z]G^+>L<
MLV%.Y=>&<(M]L@6:YX^WZ+Z//CVPD,#(B94VG344[IM$FY$1$TH533_#=GEW
M[-I\VZ3'\>SR+Z/>\:7M)$20K#<99+;B!W1<[;2(GGZ(JJO[':$'&]G2P2+'
MD%IRR_W7)YM]ML:QA=YYLC*AVVWN=^*TPK38CN;=T>(S0MYHBEY=15QC^SU#
M<A9,%]RRZWJ[Y9(LDNZ7:2,4'D/'7D=CHV#30@(KH@DBHOUZ%7<[[/\ ;CRD
M;XUDUU:L3>2#FC6,CZ,4)+TI;WG%<)I7E U551ON;1555/>%4K;N%K';'L??
M:N$MPL=OETR2,)]K1R1=^_W&ST#X =]=NG7IUH53G%N/9-BV"6BRYG=COF5-
M"Z[=;FXZY([C[[QNJ(FXB$H-H:-AT3S12B-9<0<*W>W.VS)LUN5P1VT76]W.
MRXD\48H$-^XRI #(%6A4R4V'-X@;B[",EZ+THM4Q$]GN!9,=Q>TXIE5VL-ZQ
M5B; B9!%]'*4_ N3ZR'X\@#:5LQW[2;\WS"%"3K0JR,OX'C92Z;S&77JU/7"
MQAC.2/L%%=>NT%I#V+()U@D1U5,]YMB.X24>B+0JR+KPFW>;C:4FY;=SQ.UG
M;)"XLJQO0CD6402.0'V>ZT*DVANB!^>6O5.F@JS['Q2YCF82\@L^5W>-CLV?
M)O+^(B3!6\KA.1>^6\VB>1HS)7>R)H*.><GN4&5RUAT?+<8;?[ER8O&.2F[]
M8Y%C1D[B$Z&)H*,MR51IQ3$R#MNKM+7K1%!XHX7ND6RV&\YI)EQ\BM^37;+6
MXKKC#T@BNHN,B$UQD>V3NPM[BL[1W+HG2BU6VU\%X7;KKR#<G$>F-\CBK=YB
M.J*-M-.B[W@84$0A[AO&X2ZZ[M%3PH52_'N!73!V7X]PS"[90QVF(L!J[+'V
MQHT9"0$'LM-J;BHNCCAJJEHE$7:@4"@4"@4"@4"@I7+V67#!N,LIRRTL.2+I
M:[>\]"%EKO['U':#I@JHBMM$J..KY %5H*7Q_P N0X&+0(&7RKS<,G9Q63F]
MRDW* Q$D%;H[Y-FG:8400M?W$43SF]JJNJT55,WYNRAN-F=]Q.6+%GB8-:,H
MQUN1&;)QMZ[/G]\=0MVI(V@IL55%%\BT*-@<YYY?N/N&KOEU@1P[^Q'C#%DB
MP,D67'S 2>= M!0415ZJBHBJG1:$(3).59T9UV[0'+S;9C>%W6_Q\+N%J9%\
MGH;X,A(?)7.X+@$J?>17:3>I:IX4$9BG+N6Y%"X4<<:EP#RMUZ/DJW&&W'<G
M'&LZS%?C(FJ)'<=\\#!!W#[B4%XQ#G##LUR)O'K8Q<8Z3PDNX]=IT7L6Z\-P
M"0)!0'MRJXC>NJ[A%=OG)JG6A1LJB% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H*?RQ9+IDO&.7X]9&/2;O=+1-AP8^\6^X^^P8 .XU$4U
M5=-25$H--9U@G)$.X0;MCV,ED!W/CI_!)D5F9%BE!GO$#B/.%(< 3;^$/WM5
M75/?34J&NW#G(S^(7ZTQ[.CDV9QQCF-1@])C#ONMM,ED,ZJYHFQ%^&J[%\BK
M0;DYHQ&^9EPQD>(V)D7K]-M[;<6,1B"..LFVXK:$2H**6Q115737Q6A"K7G$
M\XS3+X^4/V$K*S/P.\6*0Q*E1WCBW*<^VK+3BLF6[41W*0(HIX+UZ4$;BV'9
M],M_"#=XQMZT%@XRK9?@=EQ73!@+*5O;D@K3A:HXXOFB.I#Y>G6@@>(^)[Y@
MTR MWP&=,R;"(5R]39&>1$Y;)DHVS9:"'"<?-&$E-'M-3:$6U\4H2]'8U/O%
MTL%NN&06OU)>Y+ .3[3W@E>C/$GG-]UM$$]/=2B)6@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4'!UUIALGGS%MH$W&X:H(BB>557HE!PC2
MHLQOO0WVY#.JCW&C$QU3Q3455*#D\\S&9<D2'!9CM"INNN$@ (BFJJ1+HB(B
M>6@YB0F*&"H0$B*)(NJ*B^"HM!]H.#3S+Z$K+@N(!$V:@2%M,%T(5T\%1?%*
M#G0*"*O62V/'G;6Q>9@Q7[U,"V6MLD(B?ENB1BV* A:>:!*I+H*>5:"0])C+
M)6&CP>EH".K'W)W$;5=J%MUUVZIIK0!DQS?<B@\!26A$W64)%,!/7:I#KJB+
MHNFOCI01]@R6QY1&DS+!,&=$B2G[>^\VA("28AJVZ"*2)NVDFFX=17R+02M
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M_(Y_XM0H?2P]GS\M6?D<_P#%J%#Z6'L^?EJS\CG_ (M0H?2P]GS\M6?D<_\
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M_(Y_XM0H?2P]GS\M6?D<_P#%J%#Z6'L^?EJS\CG_ (M0H?2P]GS\M6?D<_\
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MR)K[%"I^8#A/\@K)\B:^Q0J?F X3_(*R?(FOL4*GY@.$_P @K)\B:^Q0J?F
MX3_(*R?(FOL4*GY@.$_R"LGR)K[%"I^8#A/\@K)\B:^Q0J?F X3_ ""LGR)K
M[%"I^8#A/\@K)\B:^Q0J?F X3_(*R?(FOL4*GY@.$_R"LGR)K[%"I^8#A/\
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MC_Q*30EN^B(G*/[,WG^8ROXDJ#S[["WZ$WOZ;F_Q4>BR],40H% H% H% H%
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M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@H_,WZ(<]_Y>NWX$[0AK_V-_\
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M86_0F]_3<W^*CT67IBB% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H%!1^9OT0Y[_P O7;\"=H0U_P"QO_T^8S_GKE^'
MOT66^*(J'*WZ+LW_ * NOX$[0:O]C'] -B_G5Q_"W*++?]$*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#5?M)_H*S
MK^C#_P L*+#I]F/] N#_ ,Q+^/=H2VU1"@4"@4"@4"@4'G3VV_T%2_Z3@?Y9
M46&Z< _L)B_]$0/P9NB+%0*!0*!0*!0*!0*!0*#SUQ__ /A9YYR;DYS[]BF
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M_P"B% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H%!JOVD_T%9U_1A_Y846'3[,?Z!<'_ )B7\>[0EMJB% H% H% H% H
M/.GMM_H*E_TG _RRHL-TX!_83%_Z(@?@S=$6*@4"@4"@4"@4"@4'$T4@(1)0
M)45$--%5%7R]=4Z4%)XJXSMW%F-O6*'->NDV;.E72ZW>4B#(ERY9[E<<VZIJ
M@H =/';KY:"\4"@4"@4"@4"@4"@4"@4%%M7&4"W\H7[E.5/>GWB[08UJA1GA
M%&[?$8\YQME4ZJCIH)KKX+K^RHJ]40H% H% H% H% H% H% H% H% H% H%
MH%!K[G7]#&?_ - 7+\&.BPJ/LA?]/6(?_/'_ (E)H2W?1$3E']F;S_,97\25
M!Y]]A;]";W]-S?XJ/19>F*(4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4%'YF_1#GO_+UV_ G:$-?^QO\ ]/F,_P">
MN7X>_19;XHBH<K?HNS?^@+K^!.T&K_8Q_0#8OYU<?PMRBRW_ $0H% H% H%
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M:Z)0>3L,X8]L?C['X^+XCF-@M]BBDXXQ%\Q_:3QJX?GO6XR74B5?A495A/\
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MMLSZS#J_LODZ?N<."[);=.:8I,1/"MVGBSN*>5K?RM N,^WVYZWA;W@8,7S
MU-7!W:IL]RL=SMIP3$3-:N;VA]GLG2,EEE]\7ZXF>%>SSHWE;F^U\57&WVZX
M6F1<#N#)2 <8< !% /8J+NZZUGMMG.>)F)I1V>S_ +*Y>KX[[[,EMFB:<8GN
MJR.-N8[;R39KW>8-KD0FK(B*XV\8&3FK9.:"H^'P?+6.XVDX;HB9K5IZY[,Y
M.EYL6*^^+IR]T3PXQ'WVNX_M?8Y(D-1QQJ=N=,6Q^_,^)+I7;/2[HCUH?67_
M ,M]Q;;,^-9PCNN;"Y3YFMO%LVTPIUKD7$[L+A-%'-L$'M$ JB[_ '=]<>VV
MDYHF8FE'ROL_[,9.K69+[+XL\.G.)[:]WF.1>9K;QWDEGQN9:Y$U^\B!-/LF
MV !O>[.BH75=%ZTP;2<MLW1-*'1?9C)U+;Y,]M\6QCYQ,3W5<>2>:;;QOD%I
MQ^;:I$YZ[ +C3S#C8".YU6M%0NNNO6FWVDYK9NB:47H?LODZIM\F:W);9&.>
M4Q/=5L6Y31MMNEW$P5P(C+D@FQT0B1H%-437IJNE<=L5F(?)X,7BY+;(FFJ8
MCWYH\]1_:^QR1(:CCC4[<Z8MC]^9\272O8GI=T1ZT/U6_P#EON+;9GQK.$=U
MR_<K<V6OBF;;85PM4BX%<FG'@-AP 04:)!5%W?5KDVVSG/$S$TH^7]GO9;+U
M>R^ZS);9HF(XQ/:[N+.8[;RE&O,F!:Y%O&S(RKB/F!]SOHXJ(.WPT[?77W:Q
MW.TG#,1,UJU]?]F<G2;L=M]\7^+7E$\*4_"Q^/>;K9R%9\DO$*TR8;6.,B^\
MVZXV1/(3;KFT%'P7[UY?=K+/LYQ76Q,^LW=9]E<O3<V'%=DMNG--(I$\.-L<
M?[3NXZYFMO(MCOU\A6N1#:L0[G6GC;,G?O9N:"H^'0-.M3/M)Q71;,^LU]:]
MF,G3,^+%??%TY>V(GAQB/OLKBCEFW\K1+E,M]M?MP6UQIHT?,#WJZ)%TV>YM
MK'<[6<$Q$S6K1[0^SN3I%]EM]\7ZXF>$3V>=@\K<V6OBF;;85PM4BX%<FG'@
M-AP 04:)!5%W?5K/;;.<\3,32CI]GO9;+U>R^ZS);9HF(XQ/:[N,>8[;R;;K
MU<8%KD06[*C:N ^8&KG< ST';X:;/+[M8[C:3AF(F:U:^N^S.3I63'9??%_B
MUY1/"DQ'WVN6_;!QQQP&QQJ=N-4%/OS/BJZ>72NW]U7?*A];=_+;<1%?&L]Z
MYL7E?F6V\4OVEBX6M^XK=A?)M8Y@&ST=6T77?XZ]RN/;;2<]:32CY/V>]F<G
M5[<DV7Q9X=.<3VU[O,V6*[A0O=37Z]<+Y"7VB%!HO%,2M/-$Z\YUG0N7.SC<
M)%OQBS$\ZW#CPX9=KO*#9#N==+=NU^QM]7+EG;Q%EG":5F?*_2>H=1R]#LQ[
M3:4QWZ+;\M](FZZZ[CIK,3Z-L4I_VUN&!8'=< R&\6ZURNYQO*::D6FWOO./
M/PIFNUUIO>BKV23SNI^.G^$J\V?-&6V)GU^WRP\'J_5\74=OCOR6TW5LS%]T
M1$1?;V3-/QHY<OO0V)7&^4:#:D9Q<.;\*NN8,M6V%*:O0V2P-GW78K+$=$5Y
M]P?-5U[<G05\T41/'6O6F,<8+XLX^K6?N[GZ==9LL?1=SCVTS?=;.'7DY1=,
MW>K;'/3;3MYS*^9S@D[/,BLT.\.H7'D-EY^Y6UM]QER9.541D74;T56@34NA
MIYWC7)AS1BMF8]?LGNA\STGJUG3]ODNQ1_M-TQ%MTQ$Q99^-2OXT\N7)7N/K
M>QB?)678-B;AKBL6WP[@,!UPWF8%RDJ2=H%)2(1=!$<4=?J5NSW:\5M]WK5F
M//#U>LYKMYTW;[O<1^FNOOMU1$1-]EM.,]GHSZ-5-S3!+=A>(ED=TNYR>=GY
M 2;?<X<AXY<F:])T!B/&54W,[%[>SM:::_4KIPYIR7Z8C]%W>3RSWOH.E]6R
M;[=^!CQQ;T^+:76W6QIMMBWC==?V75XUU5JW;EV6)A^)/7^<QWKB+;;46W-:
MJ<BX2- :CMHFJJIN$B=$71-5\E>9BQ>)?ICE]Y^==.Z=]=W<8;)I;69FZ?Q;
M(XW73YK?AX*)P/#O$!S.HN03!GWL;Z17"4WJC92'(K+CB B^ B1*(^\E=6]F
MV=$VQ2-/WWTOM=EPY(VMV&W1C\'T8[=,771%?+/.6M(<CA>_Y%DD[DF^&S?+
MC?[@S;6@E2V6VH$8A99[JL?>V]=I+JXJ=*[IC/;;;&..$6QV1S?89;.L[?;X
M;-CBKCLPXYN]&R9F^ZMUU-7&[GV5;1Y,>CVJSX?Q[;;D5HL-W=]%N%R61L,+
M':XJOR$209:BI@ BKBKX:^.M<&WB;KKLDQ68_.F>'!\9T*V[-FW&]OL\3)CC
M5;;IYY<E^FWT8[IF9T_@8?&%GP)O*WKKQ#?6/FPD4H]_QUMR0ZBR45.Q) 7R
MW"NB**EX$GAUUK+<WY-%,L<>R?O-_7MSOIVL8^I8I\757'DI;'H_C63IX3WT
MYPBN5N,N/,:L=PR(($V9DMVE)%M,,;A*%)%UN!JC8B*.(FB$JFH_L15*V;;<
M9;[HMK%(Y\(Y0[?9[KO4-UGLPS?;;BQVZK[O#L]''9''L]RO?*0R_';GQ[P?
M$QR!.E$W'<BM9'=HRF<D(<A_?.>:T1204W$B>X'CY5K#%DC+N)NF/-'Q.7IN
M]Q]2ZU=GOMMXQ=..R::9NMMICMGLKP]VYAXI;<2QOE2P6[B.0+^/S[;+<RV-
M"E'-AM@V K"?,B-Q!>-S4/A:[?)U77++=??AF<O.)C3V3Y71U#/N]UTO+?U&
M*9++[?!FZV++IK/Z2V.$5MB./*E?,[;%A=EY;R7-[YF_?FK9[S(Q^QPQ?=9"
M"S!!M>\TC9#HXX1[]RZ]4I?FNP6V6V<*Q6?+5AN^J9NC;;;8MK2WQ,5N6^[3
M$S?-]?1NK'*(BE&"N<9$[PL[!:N9GDRWE<-:OFOWT]9:,)(U1==ZL+\+77=Y
MVNM9>#;X]:<*:J>Y^%T_NK;QUF+YLCPO"^L3C[/4U:?-K[.5."3GX?9>(,LP
MJZX@CT.!?+@./7Z*;[CP3"EM&3+[B.$2=T' W;ATUUT\*PMRW9[+XOYQ%8\C
MBP]2S=:VFYQ[FEUV*SQ<<Z8C1IF-5L4_%F)Y2W=7EOSHH% H% H% H% H% H
M% H% H% H-5\_P"J87;]%5/_ #RU^'3_ .:$KOV/KSYI?:^Q_P!LO_59?S6U
M*X'Q3S/Q5?[CB/(%[2Y/;\0S#)+K;(YKNVQ;S%?4FA)5Z)Z0![!T^$J)^QKV
M]S9&3'%/6MMB?<_H?L'M!L\>]V&+1'Z;;8,5\_UL5UO'^Q,5\D3/>V19U7\_
M>3)JNGS?M_3R?NYUQ7_9[?G2^2W/\"P?KLGYL+3FO'^*\@PXT#*X93(L1U7V
M %YUC1Q14575HA5>B^6M&'/?BFMLO%Z7UC==-ONOV]VF;HI/")X>[$M)8'P=
MQG?K_G$"Y6EQV-9;OZ%;027)'ML=@#VZBXBEYRKU+5:]/-O,MMMDQ/..Z'Z+
MU?VKZEM\&VOLR1$Y<>J[T;>,ZICN^)Z19:!AEMAI-&FA0 3770131.JUXTS5
M^1W73=,S/.7.HQ*#2F1W.18.4KU?(CGWV1;X-A%I/._TN>+[D%4%/*KS:AK_
M (5>GCMB[%%L]\S[W/X'Z'LL%NYZ9CQ71PB^_+^39IC)_P!V:^XI\&PO6Z+Z
M!:<?M64+8\>DM.1+H).N$+%WGMF<<1 ]QFHD1#J*ET1%UKINOK-9NFVMW9\V
M'OY=W&6[7DRY,'BYK9K9PCCAQ3$736*1%8X\:<YAM*=<DL'#]O:L%P*]S)<"
M':;'.W(V[,D31".T8=PDT+0M^AETT\Y>BK7!;;JS3JBG&9GR4?%XL'UCJ]\Y
MK/"MMOOOR6\XLBVMTQ-.SLX1QKP=O%4I(-KNV'.Q7X!XQ)5J' DJ+DH+9*#O
MQ%)6S<$ET4VTT)?@>[4W,5F+^>KX^UA[08_$RX]S%T7^/;6ZZ.%OB6SIOI6(
MF.R[E^,UYC]RLV$^B7N*-LNK9VJY2+/D%L=.-/EH(BZK=WBKU<<-U0'N*6HO
M>:H@I:5V7VW9*Q-8XQ6)Y1\V?NX/JMY@S;_5BN\3'/B8XOQWQ%UEO97!?V1%
MM9TTXV<:W1:P9%NN88U.XYN#$BU3Y%PLMT@^F.M$^<BX/HW(<!6G'!V).;4_
M'5$<\--*SBZ-49(XQ2Z/>Y? Z;,V*=S;O;)C);;9FLNTQ-(BRVML36(X^%-/
MR?.Y9--'*RN.6N--2?6EHBVV+#?78R20+O;QD-%JB^84IYULET7H-3'&BEO=
M,S[]L_>38XOJ>C;1,V^'DNOF8XSZ>'+IGSQCMMNCSK2../8O>[+=KI#M>.Q+
ME?XG9L]L=583)1K;/$GB,VV [KNY!5 ;%-HCXE6CQ-=LQ$S=2V>,\^</%G>V
M[O#DQX[LF:ZS#=6^^/2G5EQ>C2)NG3;2O&Z>,SRAW95!BWK/Y\AF)C%T:&TV
MW:YD>CF@D_-_U94 TVKIY_OZ5,<S;CCC='&?5]SFU]/RW8-A;$W9\<^)D^AX
M?BX_6XQQ[ESSQS2#C]M!0&!<KS B2A1/,*.*D]L33R&K0A[Z+I7-AYW3VQ$O
MG^D6^GEOGUK,5]T?.]6ON:IE0<@Q?%8D_E27'L\!B5#L+,B.^U&9!QEV1%G=
MQP"0442/3SB3Q\M==F2^8QQ6?6^_#Z?9[_=7X]C;=DOF+LTQ,3=-)B+\=(GO
MIV1V,?*_G/ZNN'SH6U;/F==_0O5BR47M=R!N[GI'D^#IM]_7R5<6BL::^O'/
MW6WI_P!6\2SZOXGVG%JUZ>=,O+3[OWG:;-HA9J5Z1+=>&GLE;9*4CIPLEM]Q
M=(8_877_ %F*(_\ A>:G97=H:#K4K=..G&/1\]LQ]Z?OL(NRW[+PO3QS&"9I
M2+\&2R/2U?U,DS^-Q].*5MF:)CEL[A>KE!QZS0)=QN%HBNY$T$%6D)FXLELM
MAN*ZXWYJN"\JH.JKM\*U[6EL3=,Q$3Z/N?C.#V<C'@QW9LMUMEN2Z,7I5XV3
MQRQ%(GCIT]W/FHV2/-9,YF.40[5;)EBGQ;,[+O4ILY%PM<27"!2EQP;#4O1A
M)7507 )%%5\E=6.-&FV9FL:N'9/'E[KZ38VSM8V^WNR9+<EEV:(LMF(LR76W
MSZ%TS/X\^CRNBDQ':MEJM<>5G-XFG"QF8TS>(Z+<+JB'>E1N%$5#9+8J:KT-
MKSDZKK7/==,8XBMW+LY<Y>'N-Q=9LL=L79[9G%=Z-GT7&_)PNX^Y<Z\2OS_S
M^;RMZ')9M&:R)EL:N3QM##?"%J5J[8(XIH1-,R/A .JFGO5<MGZ/37C92:=O
M'UOO,^H[2WZA.WBZV;]K%E^F*ZK=7TU9I2D776<IFFEDY\Q EY+D$2=.CP >
MBXRC3DYHI$!V0$ZXFS'F *C_ *.\0[#521-=/J+,$S%MLQ%?6\_*.7E:>D7W
MV;;%=9;-]+MQZLTOB-&*+KK)^7;'&.$]OG63BUR*U!OEN8M\:W2(%R,)S%J?
M*5:UD.,,ND4/41[8KN139VIM<W>[JNC<UK$UK6.WG[OX7D=?BZ;\5\WW7Q?9
M&F;[=.33%UT1KYUGNNKQMIW-61&;-;;8Z4;U==&+I9K[ZLR.W.G%NCH+%<?>
M&\12ZN$BBB*Z1>8ZFBB"E7?,W3/&L4FVL3RY_BS]W!]KDNS9<L:M>.<>7!JQ
MWQ%V./2BVV<%_P"+\VGI6<=5T0O.+8Q:'K!<XMTL>)+%>@M'V;*T+JN*R)$*
MOHXVFJ"NB@O7K7+DR7:HF)NY]KYOJ&_S6Y[+L>7<UB^>.2:4K\FD]O;Y$[QU
M9;7!XRM"6:!'BNW&SQ7I"QF@:5]]R(";S443<2_LEK5GOF<LUGE/WWF=:W67
M)U+)XM]UT69;HBLS.F(OGA'='D:[N-TM<S <+BQ)3;[S&,74GP9)#)D8]E)A
MU7$1=0V.*C9;O NGC79;;,9+IGY4?G/K,&#+9O\ <W76S$3GQ4KVZL\713OK
M;Z44[.*W\;8?/MUQC9&Y9[5CL([0W"2!9W"=],,R;=&1(5&6 1005$-!(O/+
M4M-*YMQEB8TUF[CV]CP>N=2QY<<X(R9,UWB3=JR131SC3;Z5T\><\8CT;>##
MO.-68.59\NV66 =^'&G;G"(HS*FMS&8O;?U4?W3<B??/A>_6=F2[P8B9FFJG
MN4;]MOLT]+LMR9+_  _'BR[TI^CT<;?FT[.2*L[&,QX'&ERQ,F"RV=,92Y2&
M2$I\IER.X5T],77>>TTW.=WX#J"G0M$K.^;YG)%WJQ'N?U:?=R=NYOW-V3>V
M;BO@V6SIB?4MF+H\'1V16.%NGUK*\XJS.5;E<Y.0 5EM\BXN83$"^DL5QI :
MG..:@+X&X"DBQ69": A+]\3IX5CMK8BWC--<T]S_ +:-'L_@Q6[>?%OBR-U=
MX7I1/&R(XZ9B)_UEUG.GJ^=TLG@%V;S#(,SD,/31N3#UOGM&JSVK>;4=VUK!
M5O[Z".;MP=GX;BFBZKN2K/B6Z;;.[W*\=56RZ-_AG;X=K$Q;HNBZV8]";ZW1
MF\2OHS2E)U>K;%O**,JW,8*:W6[Y8K?SP:R@V?2=56YMR$F(W;F6%'[ZC91^
MUH >80*2KT4EK&Z<G"+?5T^YRX_"T9[]]'AX]O7P)V]:?ZN;=%<MUWXNJ+]7
M&>,71;$<:(F*S8_FI#O3GHWYU"R-MMZ0A"ER6Z^LT;>CJJ+O[21]P]OX'8\[
M3;HM;)F[7,?B:?<I3G[_ ,+OR79_K5V*-7U3P)I'XGA^%6V[NU:Z3J];Q.'/
M@K/>;<PJY8B,A"BRYKV5"FJ*BP(\\^XVON#Z6TV*?XU;Z?I(O\FGW:?@>OIF
M-[9N:<;;8P?ESCBD_P"7=,^XR[D"LVO/<71Q0@Y3<;S>$1-406;9(?"X:'Y%
M7T=CI_\ 5*QMYV7?)BV/?Y?'+1@FN7:[BGI8+,./W<EMLXN'Y5_]E.7)G%)5
MBY!NF1E'3+8;I);9!DB3HK816CM7H2Z]P4(E$F^U\-Q23JNJ5JMF^+K(M]7X
M.?I5^[D\W!=NK,^TQX-7@W1Z4?B73KNC-XG9-(X7:O5MB.4484Z+8O4V575U
MN(UR2.0M!:9+/:2Y^LE&&@--%^Z**F1"0)YNQ2U\W6LXF[5;''1IX]U.+IQ9
M,_C8,<3=.U\&=<37P]'Z2LSV5I28GGJIVI%BXA.S\\BNML)_%<FG2<5<F259
MD6U^(P/;AB+?<(M3E,OIJ3>U>ZG7PK7-M,>F)]*V-7E\OP4]YR7X)Q[#P<=]
M,V"RW/IC5;?;=/&_C2.6.ZSE=6-'G1TC'K##PN(MLM-H8?EYC)B/)+9!J&\U
M'N<T6FI*@.I-MHF@"NJ(J(FE;(R73?-9GU/O1R==F]SW[R[Q,F28MVUMT:9F
M;HF[%CK-E?QI[9\[;V#0FX%C[ 1;/#7O.$;./)M@[ETZ_!'SU33=TKSLTUN[
M?=YO@^K99R9ZS=ENX1QR^O\ '/#N66M#R"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4%5Y-_1QEW]#7#\&<KHV_TMOGCXWM]"_B.W_6X_P Z'G7@
MS] ?)G^:N'_#4KV-Y]HQ^Y\;]7]K/X]LO/C_ &BU>Q__ &*OW]*?^[M5HZK]
M)'F>)_,G[;B_5_WKE"]L#^VMA_HO_P!X=KKZ5]'/G?3_ ,MOL67]9_=M3_LV
M_HEY _\ :/P%:T]0^FL^[M>9[<?Q7:?D_M'FO&/[26;^?1OXX:]O)ZL^9^N[
M_P"S9/F7?%+T?[4WZ0<'_P 1/PH:\7IOT=_W=C\E]@/X?NO/_<D]H;].> _X
MEN_XDY38_9[_ '?B/8S^";KSY/V4.KVC_P!->#_YF!_Q%VKL/H+_ '?B9^Q/
M\&W/GO\ V</2><_V*R3^BYWX.=>+A^DM\\/R'I7VW#^LL_.A^<6,?VDLW\^C
M?QPU]GD]6?,_K7?_ &;)\R[XI;Z]L+^UN/?T<?\ 'E7D]*]2[SOS+^6OV3-\
M^/S837LL?V&SS_N_@SM:NI?26//]O_MVU^[\:U%^SW^B7E+^9/?@+];-]]-C
M\_WW9[9?Q78_.C]I:RO9^_0IR7_F9O\ PXJQWWT^/W/C:?;'^,[+SV?M%C]C
MW^R60_TB'\0-:>J^O;YGD?S*^UX?F3^=*F>V%_:W'OZ./^/*NGI7J7>=]#_+
M7[)F^?'YL)GV8OT;9]_W_P $.M74?I;/N[7G^WG\1VON?GP\SV'_ &Y;/YVQ
M_&#7MW^K/F?L&\^@O^;=\3TI[6']L<)_Q'/PANO%Z9ZE[\B_EY]CW/GC\V3V
MD?TQ8'_B0_P\J;#Z"_W?B/8C^$;KSW_LW5[37Z6L)_S,;\.*KT_Z&_[NQG["
M_P *W/GN_9P],9A_9*_?T=,_B#KQ,7KQYX?CW3?M>+Y]GYT/S8L/^W+9_.V/
MXP:^TO\ 5GS/Z[WGT%_S;OB>@_;$_M+C7\Q>_CJ\CI7JW>=^6?RU^S9OGQ\2
M6]DW^R^=?^S_ ,2_6OJ?KV.+^8GVK:_E?G6HSV</T;<H?S)?P236S?\ TN/S
M_?AV>VW\1V/SO[]C)]G3]$O)/^9?_ 7*QW_TV/[NUI]M?XKL_/;^TA/>QW_9
MO)?Y\S_$K6GJOK6^9Y?\ROM.'YD_&JOMB?VEQK^8O?QU='2O5N\[V_Y:_9LW
MSX^)+>RQ_8;//^[^#.UKZE])8XO;_P"W;7[OQK7F*U?[4@_SAK_+2O<NY2_8
M]Q]%=YI^)Z8]KO\ M!A?^)*_C6:\3I?JWOQ_^7'V?<^>WXKCVF_THX+_ (C/
MX;3IWT-_W=A["?PS=>>?S'5[4GZ2<*_S+?X75Z;]%=]W8R]@?X=N?//YCT[D
M_P#9J\_S&5_$E7AX_6CSOQS8?:<?S[?CA^9]J_VI!_G#7^6E?;7<I?V#N/HK
MO-/Q/1GMC?[<Q;^:2?XP*\;I7JW>=^3?RT^@S_.M^*4C[(7^Q\X_]B_BY-8=
M4]:SW?O.7^9'TVV_+^.Q%^S-_8;D_P#F3?X-+K9U#Z3'Y_P.SVZ^V[+YT_G8
MV?[,/Z/N0O\ $_\ =7:PZC])9]W:YO;S^(;3S_W[4K['/^P\I_G<;^+.M?5?
M6M\SA_F7]/@^;=\<*][8W^W,6_FDG^,"MW2O5N\[U?Y:?09_G6_%*1]DW^R^
M=?\ L_\ $OUAU/U['+_,3[5M?ROSK7EV'_KD?_.A_E)7NSR?LV7U)\TO3OMB
M_P"T,,_Q)_\ E1J\/I7*[W/OOQS^6GT>Y\]G]]ZK;_<P^HG_ &5X#\2NYN5$
M*#4?!<R-:(-]XZF."S?\;NTT2BN+HZ[#DNJ^S( 5ZJ!H?C]37Q2O1WD3=,9(
MY71#[KVLQW9K\6]MBN/-CLX]D76QINMGRQ3[J+1:,_;OW(-UP^SQ@EVJRPFG
MKE>FG=P-3WG%08NU!5%78FY20^BHHJFJ5SW8-..+YYS/+R=[QMST>=OL,>YR
M73;?EOF+;)CG9$>O[_"E.-8E=*YGSS5V7_IMXV_FE]_!VZ[\7T%_GM?9]-_@
MN\^=A_.E)<EYS/QT;?C6+MM2<XR!7&[4W() CQFFDU=EOJO1&VTZHGVR]$1=
M%2M>WPQ?6Z[U;>?X')T/I./<Z\^XF;=OAI-]/6NF?5LM\MWP>1DX'C=IPBPR
M68TQ;W?9"N7&^W$2%R7.F$FXST0NB:^:V&NB?55569LDY+N5(Y1Y&GJ^^R[_
M #VS=;X6.*68[>5MEO9'W[I^]2%+SA_CSD#BR=RB#0Q;BQ;G7;1>")&+C$F1
M5-6&4<;)5$N^NW8A==WOZUTX8R8LT8^RO&.R?NA]#TJSJ'3NJ6["9U6S?$7V
M<[+K;J:KJ3'&-';3A1T76'RK>WL R2-8XM\CVRSQI\B%-E)"VW^2R@N/. J+
MJK0JO;Z>:1DOBE6V<-NNVM*S3O\ 1;=ODZ7@C=X+LMV*;\MUL76VZOT-L\+8
MG^M/K=\1#EPO<,U?RW.&[Q98D2$[=G7;F^S*[ILST881&0'3SP4?.W].O2F[
MMQQ9929Y</,Q]I\.RMVFVG%DNNNC'$6Q-M*V:KO2GNFO8F;/)XMO'%5]N%NM
M;-KQ9P)_KB#+:;:?:DM*0N=\4(U1W5$(/.W)J.FG1*U7QFMS1$S6[A1Y^YQ]
M3P]4Q67WSDS1HT76S,Q-LTIIY>CV3PISJUQ)L[<K#."Y>:MHY96)01IR2NK>
MR4UNAB[KT[:HT"*A=-.BUVQ?2_-%G/[JOK;-S-F\ZG;M9I?-LS;IY^C/IT\O
M&>7&O)L*^0K?"YWPI; RTQ<'K9=4R((PB!+;P;;]%5U!TZ=[H*K[GO5QV3,[
M>_5RK%//V_ ^6VF7)DZ'N?&F9MC)B\.ORZSKT_D\W?DR?.+FW$<><\Z%CEME
MY*^RO4#?=-(<=2_PFRW&-3'Z&"Z[Y4Q;]]JV/^S=%W&:/6S7VX8GR1&N[WXX
M2Y<Y27!LV.6N1*<A8[>K_!MN126C5G_R]Y'%-LW!5% #41$RU3IT7HM-G'I7
M3SF+9F/.GLI9$YLV2VV+LN+#??CB8KZ<4I,1VS'.(15ZL-AP/DO! P6,U:9E
M[=DPKQ:82=MF5;F8Y'WG6AZ;F23<)Z:KJO5:V67W9<5^OC3E/=+MVN\S]0Z;
MNIW<SDMQ1;=9?=QFV^;J:8G^M'..3Z_BEIOV799=,0S*X8F\P\$?-H,<&VP,
M@:W)(;)]/O*DWKH^*+X*J>761EFVRV+K8N^3]WWBSJ&7;[3!CW.WLW$3%<%T
MUFG'U9T^M2?Q)\R@P;:Q:.#XN20&7(^/Q\O:R&*VYN-T+6W/%ALBW><OFHA:
MKXIUKKNNU9],\]%/=H^GRY[LW6[L%\Q.2[;3BFG*<DX]4_#P^!M#E1V/=\@X
MSL<)T'IC^11[RT+9(6Z);6'77'$TU3;H2=?+7#MHFVW),_)I[[XSV?MNP[?>
MY;HI;&&['^5?=;$1Y^#:E<#XHH% H% H% H% H% H% H% H%!CSY7H,&5.[1
M/>C,N/=EO13/MBI;1U\JZ:)5MBLT;<./Q+[;*TU3$5GLJTIR;EELS7C#%+Q;
M2$3OMZM2PX:F)N]WTCSFO-\2!45"KU-OBG'ENB?Q8E^B="Z=DV/4\^*__58L
MNJZG"FGA/FGL;SKRGYLT-B&'1L[P#D#'7C[,A[*[P[;YB:H4>:RZ!LNHJ=4V
MDG7;U4=4\M>MERSBR67?U;?>?IG4NIW=/W^TS1QB-OBBZ/E6S$ZH][X:2Z>&
M\GF95R;?)5VCN1<B@6*':[\RZ@II<84AQMXAV]-I*B$GN:Z5=WCBS%$1RFZ9
MCS2V>TVPLVG3<5N.8NQ7YK[\<Q\BZV)M]V.3?]>0_+VK^*_[5\F_\P?^[-UW
M;GU,?S?OOL_:#[+LOU/]Z6T*X7QA0*#&<MUO>=5]V(RX^1-.$X38$:G'55:)
M55-=0554%^U\E9:I[VZW/DMBD73$<>WOY^_V][ZS @QG%>CQFF75%05QML0+
M:IDXJ:HB+HI$1?555J3=,I=FONBEUTS'G\E/BBGF<&[7;&6(\5J$PW&B'W8K
M(M (-.)KYP"B:"7G+U3W5JZIYU97;C+==-TW3,W129K-9CNGO=PQHX2')8,@
M,IT1;=?041P@;55$2+354%2+1%\-5J5FE&N;[IMBVLTCL[./-'M8QC;$B5+9
ML\)N5.)#FOA&:%Q\Q-'$5PD'4E0D0O.\O7QK.<ETQ2L\'5=O]S=;;;.2^8L]
M6-4TCA3AQX<.'F9C]O@27VY,F*R])9T[+SC8F8:$AIM)454T(4+IY4K&+IAH
MLS9++9MMNF(GG%>?9\3K]3VG8C7H$;MCNVAV0VIN<1XM$T\KB(:_X77QIKGO
M9?6<M:Z[J^>>ZGQ</-P?;E:K7>(Z1+O!CSXJ$CB,2V@?;0QU1"VN(J:IJO6E
MMTVS6)HF#<9<%VK'=-D]]LS$_ CW\,P^4VPU)Q^VO-1F^S&!R&P8MM;E+8"*
M"[1U)5T3IJM9QEOC\:??=5G4]W9,S;EOB;IK-+[N,]\\>,LF\V2->+:EN4EC
M(TXR_$>90=S#T5P76B!%14\U13IIX=*QLOFV:M6UW5V#)K]:L3$Q/;%T4F)]
M]EN0(+JR%=C-&LL$:EJ38KWFQ1407-4\X40E31?=K'5+1&:^*4NGT9K''E/?
M'<^/6^!)%1D167A5HHZBXV))V3TW-]47S5VIJ/AT2K%TP6YLEOJW3'&O/M[_
M #^5T+8;&MU2_+;(JWP1[8W)6&_2D#;MT[NW?IIT\?"KKNIIK-.YM^N9_"\'
M7=X?R=4Z?>Y,L8\<'W)(- ,EY!%UY!1#,6]=J$7BJ#N737PU6L:RT3?=-L6S
M,TCE'GYNABTVJ,R['C08[,=\>V^TVT  8:*FTA1$14T54T6K-TSVME^XRWS%
MUUTS,<IK/!A.8AB;TD)KMAMSDQOMHW(*(P3HHRB"WH2AJFQ!1!]Q$Z5GXM]*
M5GWW3;U+=6VS;&6^+9KPUW4X\^%>WM[T@MO@$S'CE%96/$(#BM*V*@T37P%
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MZ%_$=O\ K<?YT/.O!GZ ^3/\U</^&I7L;S[1C]SXWZO[6?Q[9>?'^T6KV/\
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M>P/\.W/GG\QZ=R?^S5Y_F,K^)*O#Q^M'G?CFP^TX_GV_'#\S[5_M2#_.&O\
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MJ)YZ^6LO%O[^[X.3;'4]U$Q,9+O1BV(X\HL]3^SV,N]6&SY%;RM5[AMS;>9
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M9?T^#YMWQPKWMC?[<Q;^:2?XP*W=*]6[SO5_EI]!G^=;\4I'V3?[+YU_[/\
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M&SZCFVMMUMFFE]*Q=;;?'"M.%T3RK+"3C_'@N*W1DK@S*-QI]U&;E.;:==9
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MZ%_$=O\ K<?YT/.O!GZ ^3/\U</^&I7L;S[1C]SXWZO[6?Q[9>?'^T6KV/\
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M>P/\.W/GG\QZ=R?^S5Y_F,K^)*O#Q^M'G?CFP^TX_GV_'#\S[5_M2#_.&O\
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MW!L'9'PM-?OK8$*)KXCTKNMQ1=BB8YU^!]E@Z7BS].QW6Q3+.2:S_4F;;?\
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MZN38M.KX+YR(**"_:KUK7CRS9R[X^!P['J67:5\.G&ZR[C%>-DUCW._O8L+
M+% EPYK!2.[!=BO,(;NX=T*"[;VT75.J=ITMWNEUJSGNF)CO^_-6[+UC/DLN
MMG32^+HGA\K)&2?^];%/)P?7\"LC]NOEIWR&[9D$OT^=%;=V@+IJ!/(WTU$'
MB#<Z/E4B\-U(S75B>VV*?=YDMZOFMR8LGHS?AMTVS3LXZ:]\VQ-+9[*6]R2#
M';<WD/SE:0V[@4/U<Z %M9<91WO"I!IU("4MI>1"+W:P\2=.GLK5R3O<D[?P
M)I-NK7Y8FFGA/=,4K'DA5OS26!8YVX[C=#L@@^U M)2D6+"&4B@XC";-_P"Y
MD;0]PRV 9".FM;_K5U:TBO?WO:_ZCSZHOBS'XE8FZ_3Z5^GC&KC3G$732(U7
M1$S5.73"+'=KK%O#HN,2XHL@B1B1H' BS&9S2.#HN[8ZRBI[RDGEK5;FNMB8
M^[E1YNWZKGPXKL44FVZO/C,:K+L=U//;=\$=R.<XMQ8[:Y:@&0U$<]-W(V[M
M7_S&8S-<T7;]J<=L0]P>E9_6;ZU\WP13[[KCK^ZC)&3T9NC1SCY%EUD?!=,S
MWSQ3.3XQ$RF)%C294J$Y"E-SXDJ"X+3S;[*$(JBF)BJ:&J*BC6O'DFR:QQKP
M>?L-_?M+[KK;;;HNMFV8NBL3$^:8[N]$/\?(\\Q,#);VQ<&XR0GIK3\='7VA
M=<>#N[HZBJ@KI(*B*=*V1G[-,4^[RN^SK.F)MG#BFV;M46S;=2V:1$T].O&D
M5K,\4VYCD"1<K;=IA.2I=JC/18JO*)#_ *3V^XZ0H*(KBHTB;O(BETZUJ\28
MB8CM>=;O<EN._';2VW)=%TT_JUI'S>/+S=R)B<<8S%<N)=IU^/=(\N')AO&A
M,)&GR')3K8"B)M'N.GMZ]$72MD[B^:>2GP<'=DZWN;XLXQ$XYMNB8CCJLMBV
MV9GOI$>='.\2V,V&X;-TNT6W>KXEHF0X\H6FY<. )@V+RHWOU(3(34#'<BUG
M]:NYTBM9GS5=5OM%GBZ;ILQW7:[LEMTVUFVZ^DS-O&G.(F*Q-%Z889BL-1HS
M8M1V0%MEH$01  3011$\$1$T2N69KQ?-WWW7W3==-9GC+LJ,"@4%>NV!8+?Y
MQ7.^XQ:;I<C$0.9-@1I+Y"":"BFZV1*B)X=:#5G/7'''EKX:S:X6S$;+#GQ[
M4^Y'E1[=%9>;-$30@,&T(53W46BPT+[".)8KD\'.2R2Q6^\E&=MB1EN,1B6K
M:.#*W('> MNNU-=/'2BR]?\ YJ.+?R(L'^ZH7\E1BMPB(B@BB"(IHB)T1$2@
M^T"@4"@4"@4"@4"@4"@4"@\@^T][-/(W+W(D7*,4<MPVQFU1X!)-D&R[WFGG
MW"\T6C331P>NM&42TO\ 06YL_?K)\M=_%Z+4^@MS9^_63Y:[^+T*GT%^;/WZ
MR?+7?Q>A5^A^*VV39L7LEHF;?3+? BQ)';7<'<89!LMJJB:IJG3I1@EZ!00V
M76=_(<4OE@BN U)ND"5"9==UV"<ADFQ(MNJZ(I==*VXK]%\73V2]#INYMVVZ
MQ9KHK&.^VZ:<_1F):MX[X8OV'<:Y;A4VX1'Y^0A*"+(9[O9;61%2.F_<(ET7
MJNB>%=V?=VY,MM\1-+?POM.M>T^#>]2V^ZLLNBW#-M8FE9TWZN'%,\&\87;B
MVP7*T7>9&FO39GI39Q-^T1[0-Z+W!%==1K7O-Q;FNB8CE#S_ &KZ]BZMGLR8
M[;K8MMT^E3OF>RJM\X\&Y!RED%NN]HN4.%'A0_1#;E=W>I]TW-4[8$FFA5NV
M>\MPVS$Q/-Z_LI[5[?I.WOQY++KINNU>C3NB.V8[DEQ3P_?,!PK)L8N,^))E
MWON^C/1^YVP[D=64W[Q%?'KT2L-SNK<N2VZ(G@X_:'VEP=1WN'/99=;&*E8F
ME9I=JX4EJBT^R7F=ONL&X.7RUD$60R^8CZ1JJ-&A*B:M)[E>A=U.R8F*2^XW
M/\Q-GDQ761BR>E;,?B]L>=M3F/AR^\CY/CU\M4^)$CV<4%YN5W=Y*CR.>;L$
MD\$\JI7!M-W;BLNB8GB^)]FO:;!TS;9L62RZZ<G+33Y-.V3E#AR^YSR+C>8V
M^X1(T"RC%%^._P!WO&L:6<@MNP5'J):)JJ=:FVW=N/%=9,36?P'0?:;!T_I^
M;;7V7779=5)BE/2LBWCQ<.5>&;]GO(&/9=;;A$C0K.W&!YB1W>Z2L2C?)1V"
M2=4)$354ZU=MN[<6.ZV8GC^!E[/^T^#IVPR[:^RZZ[)-U)BE.-D6]L^1MC(K
M:]>,?NUHCF+;]PAR(C3CFNP3?:)M%+3KHBKUTKS\=VFZ)[I?$;+/&#<8\DQ6
M++K;O>FKRM:?9+S.WW6#<'+Y:R"+(9?,1](U5&C0E1-6DZ]*]^[J=DQ,4E^U
M;C^8FSR8KK(Q9/2MF/Q>V/.V1SGPAD'*=[M=SM%QAPF(,0HS@2^[O4U<4]4[
M8$FFBUQ;/>6X;9B8GC+Y+V4]JMOTC!?CR6773?=7T:=U.V89_#G#]\XXQ[)+
M/=)\26]>M/1W(W<VAHT;?G[Q%?$O)6&[W5N:ZV8B>#E]I?:7!U/<8<N.RZV,
M7.M./&)X4GR,/C'A3(,'PG,L8GW&'(EY''<8B/,=U6VB..XRBN;A%=-31?-3
MPK+<;RW)DMNB)]%T=>]J=OO][M\]EET6X;HF8FE9]*+N''R.[C/AF_81Q_EN
M(S[A$D3<@;D!%?8[JM-J]%5A%/<(KT5=>B>%3<;NW)DMNB)]'\+7UWVGP;_?
M[?<V671;AFVL32LTOU<.*5X,XNN_%EENELO$R--=G2ADMG$[FT1%M 5%[@BN
MNJ5KWFYMS71,12CB]K.OX>KYK,F.VZV++:>E3OKV3*!YSX0R#E.]VNYVBXPX
M3$&(49P)?=WJ:N*>J=L"331:W;/>6X;9B8GC+T_93VJV_2,%^/)9==-]U?1I
MW4[9AG\1\/WSCS%,FL%RGQ)4B][O1G8_<V!N8)KS]XBOBODK#=;JW+?;=$3P
M<OM'[2X.I;K#FLLNMC%SK3CZ5>%):EMWLD9I"N$28=\M9#'>;>(4](U5&S0E
M1/O2>Y7H7=4QS$Q27W.?^8NSOQW6QBR<8F/Q>V/.VOS3PY?>3+[C]UM-PB0V
M;0)B\$KN[B4G0/S=@DG@/ETK@VF[MPVS$Q/%\1[+^TV#I>#+CR6773DY::=T
MQVR<K<.7W/LZQS*K;<(D6'9A8%]B1W>Z:LR5?7;L$DZHNB:JG6FVW=N+'=;,
M3Q_ >SWM-@Z=L<VWOLNNNRZJ3%*<;=/;+ARYPS?N0LUL&36RX0XL2T-L@\S)
M[O<)6I!/*H[!).J+IU5.M-KN[<6.;9B>++V<]I\'3=EEP9++KKLDS28I3C;I
M[9;:OL!VZV2Y6Q@Q;>FQ7XS9GKM$GFR!%73KHBK7GV7:;HGNE\-M,T8<UF2>
M5MUL^]-7E&W>R1FD*X1)AWRUD,=YMXA3TC54;-"5$^])[E>_=U3',3%)?MV?
M^8NSOQW6QBR<8F/Q>V/.V;SIPG?^5+O:;A:+C#A,V^,XPX$ON[B(W-R*G; D
MTTKAV>\MPVS$Q,U?'>R?M3@Z1BR69++KIONB?1IW>689O"W#]\XSM&1VZZSX
MDQR\]KT<HO<VAVVW 7?O$?*:>%8[O=6YKK9B)X.?VH]I<'5<V&_'9=;X5:ZJ
M<:S$\*3Y&'Q7PID&!8IF-@N-QAR9.1Q^Q$=C]U0;+L/-:N;Q%=-7$\$K+<[R
MW+?;=$3Z+H]H/:G;]1W6WS6676QANK-:<?2MGAQ\CNXMX9OV"85EF,W"X0Y$
MN_MN!%>8[JMMJY')E%/>(KXEKT3PJ;G=VY<EMT1/HM?7_:?!U#>X,]EEUMN&
M8K$TK-+HNX<4EP7Q7>.*[5=H%XFQIKEPD-OM%$[F@H ;50NX(]=?<K#>;FW-
M,3$4HY/:SV@P]7RX[\5MUNBV8]*G?Y)E#<Z<)W_E2[VFX6BXPX3-OC.,.!+[
MNXB-S<BIVP)--*V;/>6X;9B8F:N_V3]J<'2,62S)9==-]T3Z-.[RS#-X<X?O
MG'&/9)9[I/B2WKUIZ.Y&[FT-&C;\_>(KXEY*QW>ZMS76S$3P<_M+[2X.I[C#
MEQV76QBYUIQXQ/"D^1J*'[(N:QI<>25]M:HRX#BHGI"]!)%_>D]RO1GJF.8Y
M2^[R_P Q]E=9-OA9.,3\G\+;7-_#E]Y0N5AFV>X1(06D7A=&7W=25TVR3;VQ
M+PV>72O.V>[MPQ,3$S5\-[*^TV#I./+9DLNN\2E--.R)[Y\IR[PY?>0\PQW(
M[9/B18MF%L7FI/=[AJ$CNKMV"2>'NJE7:[NW%9=;,3Q/9SVFP=-VF;!DLNNG
M)6DQ2GJT[9<.8N&;]R-EE@O]JN$2)&M+8 \U)[N\E%_NZCL$D\/=5*;3=VXK
M)MF)XLO9KVGP=,VN7#DLNNG)/"E*>K3MEMV\0W+C:9]O:) =EQGF ,M=J$Z"
MBBKIUT15KSK)I=$OA-MEC%ELOGE;=$^]+R7#]D7-8TN/)*^VM49<!Q43TA?@
MDB_O2>Y7T,]4QS'*7[EE_F/LKK)M\+)QB?D_A;3YUX5OW*MRL\RT7")";MS#
MS+HR^[N(G3$D4>V!=.E<&RW=N&)B8F:OBO9/VHP=(QY+<EEUTWS$^C3LCRS#
M*X/X?OG%T+(HMVGQ)A7CT?T=8O<T#L"\);]XCX]Q--*QWFZMS3;,1/!I]JO:
M7!U:_#=CLNM\/5753C73RI/D8?$O"F0<?8]E]GN5QARGLBC@Q$<C]W:V0M/M
MJKF\1735U/#W%K+=;RW+=;,1/HNCVB]J<'4MQM\MEEUL8;JS6G'C;/"D_P!5
MD\0\.7WCO&,GL=SGQ)4B^#MC.1NZH-KV3;\_>(KXDG@E3=;NW+?;,1/!I]I/
M:;!U+<X,N.RZV,7.M./I1/"DSW,S@KBB\\5V^\0[Q-BS3N3S+S2Q.YH*- 0J
MA=P1\=>FE8;W<VYIB8BE'/[6^T.'J^3'=BMNMT1,3JIVSY)E&<Z\*W[E6Y6>
M9:+A$A-VYAYET9?=W$3IB2*/; NG2MFRW=N&)B8F:NSV3]J,'2,>2W)9==-\
MQ/HT[(\LPRN%N'[YQG:,CMUUGQ)CEY[7HY1>YM#MMN N_>(^4T\*QW>ZMS76
MS$3P:?:CVEP=5S8;\=EUOA5KJIQK,3PI/D:?9]D+-6GFW?7MK\PA+_YH7P77
M]Z2O1GJF/NE][=_,C93$QX63_N_A;=YUX<OG*DFPOV>?$A):1DB\DON:DLA6
ME3;VQ+P[:ZZUYVRW=N&)K$S5\)[)^TV#I%N6,MEUWB::::=FKOGRMS"FT1%?
M%$1*\U^?SS?:(4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4%-Y9Q:Y9OQMDV)6<F@NEX@.Q(IR2(&4<<3IO(
M1)43Z@K0:G]E/@S,N%(V5,Y>_ >*].03B>KG7'D1(HOH>_N--:?NHZ::^6BS
M+T51"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@@<KS7$\%M
M[5TR^[QK-;WGAC,ORS0!-XT54$?*JZ(I+[B(JKT2@RY^1V&UA;7+A<8\=N\2
M&H5J,W!TDR'Q(VVVE3X1$(D2:>1*"'Q3DS \XEOP,4OL:Z38S2/OQV5)'!:4
MMB'M,17;NZ:^[08,OF/B^ W;7I>40FV+P)';'U-5:>$'ECDHFB*/1U%#JOC0
MHDK1R-@M^R*?B5GO\.9DML)T)UK;=19#91RV.IM7356RZ'MUVKXT%GH% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
/H% H% H% H% H% H/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>px_25avadelpxy04pg02-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 px_25avadelpxy04pg02-4c.jpg
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M_\0 X  !  (" P$!              8'! 4" P@!"0$! 0$! 0$! 0
M      $" P0%!@<0  $# P," P(("08)" 4 &P(! P0 !081$@<A$S$B"$$4
M46$RTA465AAQD4)2DB-3E1>!T>'3U%=B,Y,DE+15=3>AL7*R<[,E.()#-'0U
MM39VP7=C5(3$A2:BHT1D165'"8.EQ68G*!F'$0$  @$!!@4# @,' @0%!0
M 1$" R$Q01($!:%28A,4<14&42)A@3+PD;%"(S,T<K+!@G,UT?&2PE/2@[-$
M%O_:  P# 0 "$0,1 #\ ]_4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4$'/F'CE
MOD%.+#O@)G1:(EJ[+_RE8]Y0>]V^UN5OS:;_ (O'I03B@4"@4$.Y#Y1PSBZW
M1KCF$Y8R3G?=[?%:;)Z1)>U346P!.NFY-571$^&@F- H(7A/*F%\B7:_VG$)
MQ7$\:-AFY2@;(8W=D]W0&S)$WJ/:+<HIIX=5H))?;Y;,:LMPR&]/^[6BUQW)
MDZ1M-SML,"IF6T$(ET1/ 45:"IHGJT]/LR2W%;S%L''2VB3T.>RVBK^<;D<1
M%/C)=*+2>9GR9A. XH.:9)=FF<>=V)#E,_YPDHW0)QH&.UNWJ8BJCITTZZZ=
M:(D=LN#%VML.ZQ4)(TYAJ2RCB;30'@0QW)UT71>J4&50*!0*!0*!0*!0*!0*
M"%Y)RIA>*Y=8<$N<XBRS(W "W6QALG'.TXIBCSB]!!O5LDU5=5]B+HN@8G*G
M,F$\.V^WW',WWP"Z/K'ALQ&5?=)01"</3440014W==>J:(M%I-X$Z)=(,6Y0
M'4?@S&FY$5\==IM/"A@2:Z+HJ*BT1D4"@C&>\@XGQGCSF3YE/2!:@-&6RVDX
MX\^0D8M- "*I&2 6B?%JNB=:#=6BYQ[U:8%YAH8Q+C'9EL"ZFUQ&Y (X*$FJ
MZ+H75*#-H% H(MR!R)B7&&/.9/F4](-L$T89T$G'7Y! 1BRT HJD9(!:>SIJ
MJHG6@W]LN#%VML.ZQD(8TYAJ2R+B;30'@0Q0DU71=%ZT&50*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#X1" J9J@@**
MI$JZ(B)XJJT'Y9RLANQ\@N^I5MS=9&\Y&. HB[E:'64+?X%C#LHV]K<Q<UY/
MQGR)QU;(L6!)P+,9 1)TYT'2DM'WVP,VW =$$%&WVS'<"ZZ+1F(=E^YDRL/4
M?8^&<<B07+&Y!2?D$V0#IRFM >>(6U!T0'4!:1-P%YCH4AO)?)_JNQN=DE\L
MF$6EG L8<?,I;Y^\.R8,?SK(T]Y:<4>WYRV-)MZIUVK0V)+(]3=O9]/+/-7T
M8B7.0JV]FRDXO;6Z(Z3*COTU[:;">^'9T^50IY8YISWF?,K9@#W*V,QK1!F3
MANF/7.&*@+T>2C7ZLP[SVTD11)$/:>B]4HU#U7SKSGE&&Y18.+>+[.S?.2LB
M'OM-RM5CQXZJ8BJBAMHI%VW"52<$0$=Q:HM&8A\X*YRRK+\JOW%?*EG9L?)6
M/A[P81=4CR(R*"$J"IN(A(CC9HH&0F!;AT1*$PKST.__ !;EG_>D3_KSJ+*_
M^=?^#&?_ .X+E_JQT2'C/CO"^$KCZ6[YD69A;HV9L#<RMT]9*-W%9+2+[H M
MHYJ6X]!V;-"3\=%XM)=I-VD^B2R#<U<*-'S$F;4KFNGNB,2"T!5_)1TG4_Y*
M'%:UD]2',N%Y#@4#/\.B6;CS*0B0;0*J134C"C+"O]Q'5\P]P'"!QH=15$33
MY5"EV<QY+Z@[;>[?9N',5M]UM\F,3\J\SW11&7@-1)I0<>8$>B@HKJ6[5>B;
M56B0B_"GJ$RK.K9G5CS2SQ[7R#@S+[LEIA#2,Z3".@0F"F:B3;C6T]KBH6OE
MTH3"ML*]2/J?Y,MC-QPK!+7+A0YHQ[G= :?]U+N*&C0B<E#U!#W.*VIJB*BZ
M"GB6H2_D7U!\Q6GFZ[\0\>8O;L@D-Q63M8N(ZV^+KT-J03KSA/@UVP4B\J[-
M4T\VOB2D(L?JD]1.4VN]V#'L(M\K,<6*0_D=R348\>+&U$@5@WA17MP&GE=+
M<B>4/;1:77Q7S7EO)_!]QSVRV&-,SNUE)B+9FW#:C29<40=3MJJF0[VW!404
MOE>7=IUHE*NG>H?U#\8W_'Y7-&(6R%B&12!81(*I[PP*D._:3<E]$,!/=L=3
MS::(J=="TL;GWGK(L$R&Q<:<:6=J^\DY"(NL,R-2889<(@#41-O4S4#7S&(@
M([BZ+1(A\X;YLS^[CF%KYFQ<L>G82P<NY7J,T8V]6V0[CC9*IN"KB-Z.BK1D
M)AU\O3<)A53OJKYTF6N5RQ9\&A+PS F>YNJ\1>^$WO0-RNH]JBZD(JX#"MB2
M[>NBT6EC\S>HZZXCB7'F88!&A3;;FSJ;OI-MTR;9,&R041EUO:X*FHGJI:*E
M$B&UY0YKRK"N<, XUM42 ]8LJ]V^D)$D'BE!WY1L%VB!T030114W 76A3S/S
M3DW+J>J6TW!K&HZY1:72C83 4"4+A;694OW9]Q.^FY3W.:JAAX>"46-RWO4/
MR'D-DX5P?(<^PFQ7'*;C.$;G9;U%=D1HCZ,O'JT(2$(55!1%U<+HJHM"$SYO
MY[NG&=OQ/%\)LS-WY#RQME+7;5$O=F&SVM@O; A(E-PMC0(2)T)57IHI(@X,
MY<Y:R;+;WQ[RSAZVN]V5D'SN\!LDA"KJ(0-/$CCK>YP5W-DVYHNU4TZ4)0[D
M'EOU8XJ5]REO!K1#P/'I+@.DZ?O#K\5IS9WTTDMN$!(J%N%D=$\4Z+0V-#ZF
M\]C<G^E?$\ZC1UB#=[Q%-V(I;^T^RU-9>!"T35$< D%=$U3KI18WISR=SE?.
M)\ XSL&'6IFZYIEL"'&M@2U7W9O8Q';U)!-M2(S> 03>*>*JOL4E)APCE?/%
M\GWBT\R8I$L8VYIDX=RBKH,EQXE\@H#K[9[1%5(@--OE14ZT)6AE%SD67&;S
M>8@@<JW094M@'=5;5QADG!0D14715'KHM$>+H/JM]1M]P>1G]GPJTEC%AD*-
M]NX@]V#%5#1L&CE(YY4-.X3>_35%7:FNIJFU]5F<0N2O3+A.<0&ECLWB\Q7C
MC*N_LOA$FM/-[M$W(#@$*%HFNFNE"-ZR.4^=9G$N"8)8L5M@WKD#*(<./9H#
MB$30HC3+>\P;42-2,Q!L$(=RZ]?+HI*=O"7+G,=\S>Z<<\NX:MMNL&.,P;Q;
MVU2&V)IN 'S1UYI>XFO;)MSQ%14?%4$O0M$*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!05OS]E?U*X<S&_ :-R1M[D2(6O
M5)$]4BM*GQB3J%_)18?GTWBW-Z^G\X(8FPO%)2ERDKU^H][[@CV%>_\ :-^W
M8FW_ !.NWXJ-+MY.><Y*]&N&YU'-3O6('#60^/\ C4*(:VQU5^,B[;J_@U\*
M)Q2'TZW<>2.7>5.=8T4W6AAQ;?:6#14(B)@%-L=?!42* _\ IT)498X \N<?
M\D<MY_R++AYA;$?2%9DD@TR\)L;VV>T9:]IXU]W;;;T1-OY7A16;>XDF1Z(<
M;?9%2:B98Z[)5-?*!#+:15_](Q3^6AQ3;U.Y?C&0X5PQ%LEWB3Y8^[R78L=X
M'76VB8C@A."*JH>9%'0M%U14]BT2''U 6B>/JSLZO98]@C-ZMK V[+&]R)&7
ML/1]NX7&=$<<%6B7N)MWZKTH1N6)PKQ'9[;S-,S+^,#6?Y=:8Q1[Q#5I"DJW
M(91ILC?66\I"";4Z(J(J(*JB]*)+6>AW_P"+<L_[TB?]>=197_SK_P &,_\
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M;MGY>NNO7QH(YCW"& 8SQ_=N,K=%D'B-Y5\ID61)<>-%D@#9]LR74/D(2;?
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M5JFL2'&I+,=L4% W:JA(J"FN\5ZT+97%O"''G#S,M,-@&W-GH(S+C+=61*<
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MSA?K$;0&^OEU'Q6B4C6%>H;.)]BY6@AE4++G,6L/TYC>6Q[=]'J9;/.#L5P
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M:)J(@)*B?*1*%)IA?J$X_P RLN47O2?8&L.%'<@B7N-[K*89,3,'.V!.:H:
M2"*+NUZ;>J:BF!A_.>)<R%=<+QYR\XIDDRVNR[1*N40(K[L1U%;"="U-P7!$
MB0AW::_!HBZ"G/TY\B7K-\0N%FRXT/.,+N#^/W]Y/_7N15VA(_":(HE\)B2Z
M(BHE"5Q40H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H%!U2?_9GO^@7_,M:P_JASU/Z9^BK>';7%O7$_P!$SQ4H
M<XIC#R"NTMCAJ*JB^Q4]E?J>^ZV6EW#GQWX\LOP?XITV'4=G]K/^G/GB?YRS
M\!X?M6"W9^\A.=N$LP)F-W %H6FS5%+5$5=Q+IIKT_!7G[EWS4ZS3C3Y8QC?
M/&WK[)^*Z/;=:=6,YSRJHN*J/_&?X^#2VR]Q,7S;E7)+B)E L\-FXR@:1%<5
MF+&)XD!"444E$>FJI73N'_M_3_\ F_Q<NS_^\=9_^W_@GO'^:P.1,0MF:6N)
M*A6V[ ;L6//$&Y';!PFT(A;-P40MNX="7RJE?F'[IX\Y'Y2XVR;GZ]P>:9\I
M<!P5T8F/8RPPZ_%EW$/+(?E(W\K:2$B"ORAVIX(2&:3'E3,;/;<[X<]1]O8D
M/\9-,2[;-DMQR0HC,L'&6C-K3447NGHB?F:)U5-0C-LY%FPWN=?4WC\=UJS3
M&8-DQ"5+:4?>'T5J'WA DZBV0MN*A)[=J]4)*#=>F;.>$V94:QP+I-O/-&:-
M.%?<@GQ7R><E&T4EUD7CUVM H+X+YU%"7\E$$J.:C<98_P /9'Q9D.+O%ZA0
MNJQ(0#"<=G..>\-]LF'Q%=&NVA#VT7]9XHB[D6BO<&)\CLVK),5X5O<6=*SQ
M,;B7*ZW 1:<AMJTSVG5==[N_<KK:IT!4523KUHRR>>/^'4O_ -XC?]XE?I?Q
MS_FQ],O\'X?\U_\ ;,O^K'_%NLWP&!GUBBVZ8^<.3%478TD!0U E':2$"JFJ
M*GLU3\->+M_<L^BU9SQCFB=DP^GWCLFGW/I\=/.9QG';$_IL_3BZ;#A$#!,*
MN=H@.G)<=9D/R9+B()..DSMZ"FNU$041$UK?4]PSZWJL,\HJIB(C^%N?1=GT
M^V=!J:6$SE,QE,S/&>7P8_"O_#2R?_7/^M.UT[__ ,[/_P O_;#C^(?^U:7_
M )O^_)5F)-KBOK#SB%=%[29I8XEQL;I]$>]R!EIUL5]I(K3I:?FAK7P'Z_@J
MBXJGT%ZM?]YQ?9_^52**LKF94^Y/&7V?0&,Z=/\ Z;!]E$C>@W-]YP3'G\:R
M2W9A<\)YBM.)PG+;*BQ'I$&YQ^VIMPG=@D.]23Y1_JT0DW[M$VEA((M]R#(^
M=/3U?LJB>XY'<<=N3]PC;%;T=<A255=B]0W)YMJ_)UTH);Z/#(\1SI%551,T
MNVB+KTU:C+THDH3GW)&*<6>KR1D^8R'8UJ+%6H8FPR4@E>==0A11#KIH!=:+
MP=V6\FXK YJXZY_GG)'BN\8]-M,2\%%>+W::T_)0NXT D8J>Y!'0=2354U1%
MH*U2T7E.$4Y+2TR4Q/\ BA]=/H_M>=+%L[7?[?AMW?J_@TZ_)ZT%Q<C\]+EW
M$7(F2<)1Y[#ME?@-2,I"&4<9+,C8+[L8C%'%<8 =CBF"$V&AITT5"4JGC>X8
M[<>:+[)QC+[UFUL^H%Q1;UD1.G+1[1"<9 GA$E; EZ=.A*2:KIJI7HGTA+KZ
M>L0_^V/_ ,DI-$E&^=__ #"\"_\ OMR_YHU"&7G*_P#^7_%J?_H*[?\ <RJ'
M!YZLI)]WK!%T\.5F-.G^ ]14LS6R7C)\B]4MDL;3DFYNQ\?DMQVD4G' @DW(
M< 13J1*V!((IU7P2@V7 "8CF?)6*W^-R'?LER+%[,ZX=MG6SL0X33[!1G(CD
MA$1$V$>X=-1+;T+6A*P?2HVY>+GROR)''2Q97E$@[.YUVO,1G'B[H_")=]$U
M^%%3V427H^B% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H.)B)@0'\DDVK[/'I5B:E)BXI%\5X]QS#9#DFQC(;
M)UM6B;=?<=;05)"54 ET1=13K7U.L[GK=5$1J5LG](A\'MO8NE[?E.6CS1<5
MMRF8_7<DDJ.U,C/PWE7MOMDTYL)0/:XBBNBIU1>O14KYN&<XY1E&^'V]33C4
MPG&=V45_>AC7$N(,V>_V0 D^YY+#.W78BD&;IQW0)LD$RU5%435-:^AUG<M;
MJL8QU*K'=44^/VWLO3=!EEEI7>=7>4SN^J48_8[=C%BMF.6=M6;5:(K,&$TI
M*9"Q&;1L$4EZJN@IJJ]5KYC[C)*#!<)3.,T9DNI$H"JJOQKI0<SBQ78Y1'&6
MSBD.PF"%%;45]BBJ::4'P8D4(XQ 8;&*"((,( HV@CX(@Z:(B4'P(4-HT<:C
MM X/@0@**G\J)0"A0BEC/*,TLX!5L)*@*NB"^(H>FJ)\6M!HH^#8_&SF9R(V
MTXN3S;>W:'7R<56QAM.=U  /!-2T4E^*@S<DQNU99:SLUY W(+A@X0MFK9;F
MUU3JE>OI.KU.FU/<T][YW<.WZ/7:,Z6K$SC,Q.R:W.6/X_;\9MR6NVJZL5#)
MQ.^Z3QZGX^8U5=.GA4ZKJL^HSY\ZO^$4UT/0Z?1Z7MZ=\MWMF9_Q<,DQJV95
M;QMMU[WNHN(]I'=-@E)!(=%4%1530EZ+6NDZO/IL^?"KJML6SW#M^EUNG[>K
M?+=[)F/UCA]7;C]@MV,6B/9+2!! C;^T)DIDG<,G"U)>J]26L=5U.?4:DZF?
M]4__ ";Z'HM+H]''1THK'&ZX[YO_ ,6!D.#8OE-VL%]O<!)%WQF24VRS!,VG
M6'3':2;FR%2 M!4@+4244U1=*\SW-ZL:,J.(K(:/=74VIY_^ETZ_RT'TF63:
M[!MB3.B)VU1%'1/!-/"@ZY$&!*[7O<9E[W=>XQW0$^V0_E#N1=%3X4H.U66B
M<%XFQ5T-4!Q4121%\=%\4H#;+3**C+8MH2J1("(**2^*KI[:#@Y$B/'W'F&W
M#TTW& DNB?&J4'%Z#"D1EA2(S3L-=-8Y@)-+HNJ>54T\>M!W=L-G:VIVM-NS
M1-NW3333X*#K8B18L<8D9AMF(**(L-@(-HB]51!1$3KK0<68,*, -QXS30-C
MVP%L!%!!5UVHB(FB=?"@[FVVV01MH!;;'Y("B"B?@1*#X;++A@X;8DXWU;(D
M15'7X%7PH"M-$X+Q *N@BH+BHFY$7Q1%\:#@D2*@(VC#?;$MXAL'1#_.1-/'
MXZ#F++0&3H-B+AZ;S1$0BT\-5]M!K;GC5DN]HNMCEPP&W7IEZ/<P8UCF\$@%
M;<U-I1)"457S(NOQT'W&\<LV(V&WXSCT0(-EMC(QH<9O54$ ]JJNJD2KJ1$2
MZD2JJ]5H-I0*!0/BH% H"KIU7PH% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H%!YO]8F*1/X9W;D://N4+([&S"BP?<YKT>-LD7!ELU-D%
M02+:Z2;O'P^"BPV3F1_P7FL\5\5XO=L^R%^.[DUSBS+MM*)")180O>90N:D9
M-Z-L B=>OY74,VZ^HML\<P&^X3B\C)I&?O28D"U^]-0'V)4051QIPG1(-1<$
M@,E)!1!4M532A28<2\G.<F6F[.W"R.XYD6/7-^RWRS//!*[,N.@DNQYM!%P%
M0NA(B=47Q315"A^9I& O>HLK;RCD\['\53$H[\-8DV3# K@L]T41>PA:JK>_
MQ3V46%WW),BXKQ"S8]QGB<W.";-UIMN9=FHYM-D1/J;\N9N5452) 1$7V#T3
M2B(=(]2Q-\?6+,(V'2I-]NV2)ALC&4E-@^Q=?UJ* /*VHN>9M!3H/RNNFE"F
MMO619A>>7> W<JL[F*W*<[EA7'&DG!/:%8L% 8,W&4%MQ5%5,>GEW?AH)/@?
M-F3\@WX_H3 )"\?E+G0(V6K<8RJK]O$]>]#V]QH7"'8*J2^*4*4QPQFJ8BG+
MG-'(&)R(LZ'=;C%E7U;D,V1WBE,"%C;CH6GZIP@07T38J+IT$:+*Z<0YQN]S
MO=RQ7.\+DX;E<>T'D5KM[TQJ:W-M[>J%HZV (VZ)=";(=4Z_!1*0^1S7R+GW
M#F797;>.I5GLKV.2Y-HNZ7B.CKCJZL/&T* #@)';5R0)KHI]O04U)*%)SZ;+
MQDMVXCQM,BL)64(EOA,6R2<MJ8MQB)&;49FC?5KN*J_JW/,E"5<<\<:65_D_
M Y:7*\QRS>]K!O3,:Y/LL]EF)Y49 5T;74!5=OQ_#0AO9G-9<>?2./XKAETR
M7CGCHF;7E>6K.;)Z*8B*N(VT\BN2B8$D[RH0[?;H.A**;O,.<\BM^;M8+Q[@
MSF;W&19(^2,2&;DQ;V5AR'B:W*K[:HB)H*BJ$JDI::>VA3N/F?+)_*-XXYQ;
M 7;S%QV;;(U_O_TDQ&8BQKFT#JO]IQO>:MH1_JP55) 5>GA0IPOW-F68IF-N
MM63\=RK=A%WOC>-6[*EN,5XW94AP@8=]R;13%IS:I(1'KM]FOEH4XW;G6_?7
M"[V+"N/[AEV/XQ,8MF37N#)9;<8EO[=S<:*:;Y"M;OUNA#MZZZ#YE%.G-/4#
M<<=O^0P\;P>;E&,82+99M?XTIF.D)7 1XA89<15D$TWYW=I#L_*T3K0I<EKN
M4*\VR'>+:\DBW7!AJ7#?'7:XP^". 2:^Q15%HBD/5,RY.M/'-E][DQ(=ZSFS
M6N><)\XKQ1982&W 0VU14U1?Q]:+#0X[>[GP;R)G6 E<;AD>'P,0=SNP0[I*
M5^5']R,VGX@2#15VND*J.J:#HG37<I!8,+FQJ9(XGC_0AA_%*+(F 7O**D#W
M:$W,VK^K3N[NYMU39X:_%0I2_%?,]_P&W79^_P"*S9^"S,UN,&Y9L4YHO=I,
MR4C3:>ZDBNDV"(*&>Y!3P35>E%IL,AND%N\>IU[*8TJ]V*WQ\> K6$QV(2L>
MYF?;:='?VD4RW+M%47VHM!.;SS+?,7N>.<>X!Q_)RFXR<6C9!%C)=&XRLPP+
ML=MQR0V:DHH*>?52,E1--5UHE+)XQSZW<H8+9LZM;!Q8EV;,O=750C:=9=-A
MT%)$1"VFV2(6B:IUT2B*)]1^"8]CUMO/(,C+\A'D2Y/M-X+;H]P<U;G(3:-Q
M845E!4A4EU/Q5$7\[Y18>D,<6[KCUI7($%+\L*/]*(&FU)G:'O:;>FF_=X41
M4/JH[KF V.(W)D16YV36>')<AO'&>5B0Z3;@H8*BIJBT6$=QYV=P;R[<L$:N
M]PO. 77&).2VZ+=I)2WX4VVF2/-MNGJJ-FV*DOQJGP:J%;%#R''.(K#ZI7LD
MNDC/G;C&NE_;*4X5ND6J;.]V6$D;Y MBV;:(B?)7733R[2K#]1V!XI;K3D?)
M%^S&_,9+*8%G![9'N#C33%U!K1AF%'91"+O.HA.>*HFY>GC1(7Q@19$6#XV6
M7(J92MLAK>D+1"]][ =[=ITW;]=VG37PHCS7:>&<:'U$3\)2[9 MBMN.Q;^P
MV5XE$:S2G=M5(]VJAM1$VT:MS]1F.XMCMPF7J+E^0'S5?GXKF!VB/.=1&7%>
M;9%EAH$%H65)#4E=7_E\1#.YSN,-K.<(MG-=YEV7C"38WW9!VI]]AI_)F2'N
M"_[KJ[VP;)":733<NGM6B0CD#*<VG\'X)B8WR<RWGF7)CUJR!QW_ ,67%2?<
M5'%<155'E -B:]=O2BK$XZMK_%/.MPXGMMQFS<(OF.AD=JC7&0<LX<V/)]U>
M;;<<52VN#^L+X]*(W/.<N7&S+AUN-)=8;D96VU(!IPVQ<;[!+M-!5$(=4\%H
M0[;;S3E5\Y#O6'63 G95AQNZA;+]E!W..PQ&8-M'%?[+C:&:HFJJV"KHFFI=
M:%-7C_J2<O-WLDN9ADRV\9Y5<RLF,9J[):,94Q3-MKN0T%'&0>,"$#(E_P"?
M04Z>,+Y>H-ZYRNL2#)R.YP,E,(-J!X1>=%J." RV;Q;0$47HG@B>%!L+5SU?
M6F\X@9Q@[N-97AEC<R;Z)2XL7!F7!!LS\LEEM!$MP;/DE_R:4*<>/O4!=\LR
MG&L?R7!Y&+PLUMKEUQ&Y.3F9HS&X[(ON(3;8"K7D7>.Y=53344W4*5CR=S/D
M'(EOQEVR8O-@<;R<UMD*WY@DYKMW'W283;@'$!$<%DR%5 B4A50ZZ%THM/7]
M&2@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%,^JVTW6^<#
M93:[+!D7*Y/E;NS#AM'(?/9<8QEM;;0B7044ET3P2BPK;FC$8MJYB:SC*[1D
MMQPJ\6)FWA,Q$Y(RHUSB.DJ-2 BF!*VX!)L4ETW]/8JH(;%,'C6:9P*WAV-W
MFV6"+>+C<)L&Z-N.S('OD=2+WPD4T;535=-Q?\M!.."K5=;;D/+;MR@R(;4[
M,9LF"<AHVA?CDVV@N-*:)O!=.A#TH2A7(5W'#/4@]EEZPJ]Y3CLG$&+:RY9[
M2MT )GT@;W52V@BH KKYM>J=.M!KN6;JQG]TP#)\OQ3*Y/#LR-<6YF-1XLN-
M<6KRV]VXYS8T1Q'-IH'ZC0_;KX*J*5$,9P_)&.->/X3&,W:#[GR_%N)6Z7&?
M67%M@FYH[(U%50 140W2\NOMH+SY)M%UF<_<*72)!D/VRW?6;Z0FM-&<>/W[
M< M]UP440WDFT-RIN7HE$5;CAN.<VV2[<4XIE6'S;I<)!<DV2ZQ#C6(H:(6L
ME=2)I'C7S-*TNBKX::KN*XEQYF-^X2Y=L]NM,D+\6>W*^6F!):-DYL>-*BR$
M5I#1%)'  ^VH]")-$H)# N=ZYAY.+/K=C-WL>-8UB=QMAG>8A1)$B[7!%W1F
M6U55-&Q^40_E)I[1U(D7'6.WXO28WBYVZ0SD3^,72$W;)#9,R/>'VY(MMJ#B
M(J*2D.FOPT.*2>G2]K=>)L<MSEJN5KDX_!BV:8W=8IPR.3$CMBZ3(GU-M"\J
M'HG5%3Q1:$L#F6U72X9]P_*@09$N- R%UZ<\PT;K;#2Q21#=(45 '7VETH0H
MO(L%L>/Y[G]IY Q3-+W]:+T_=<?/%#D+;Y\.Y;5-EP&G&VD<9)2[BNKU'XD3
M<5<F-XO*L?J1%8-NE-8K;^/(EHA3G6W"80XUQ'8PKZHHDZ@)JJ;MVG6B,SC&
MTWB'S1S;<)$%^-#N,BP%;)C[)A'D=FWN :M&J(AH!:(6U>E!YE@8I.D3L*=O
M&'97+YM@9K!E9UD<EB8];?= GN$*H:&3&Q05HFR!M$1!)=VW3<5=.-91?>&L
MYY!Q>;A=\O\ *RW)G,AQN5:(O=B26+IVT=$GR46VEC[5W[U3X]$ZT1",QP>R
MX_R3GS&?8QF5[A99.2X8X[B1R2ASFI;2 _%>;9< $<;+5"[ORA^!--Q7H;&L
MLM./YG9^#;'9Y81;3C$:Z-SGG!4(T)D_<F6'-RJ1.^0?;_S+1$4]4#5S"T<>
MWFW6BX7INPYM:+Q<(EIC',E)$A!(-PA;!/P"FNB:JG6A"+V^P9=R[D7)')SN
M/3L>@W##I6$X?;;TTD2?)[XF\X\ZRJKVT[J[0U714+QZ+017 [E>\BRGT_6<
M,0R"W#@,:X6W(KC<;<]'A-2EMB1]@NJFGBSKJ6B>84ZKJB%1]&LEO7'U^X,9
MQ&_,Y)DV:/S8UQD6]UFVA;?I$)!RED&B#M!&M%_"FFNM!-LUQS)))^IXF+-.
M=2\QK"-G4(SI),5F$H.>[Z#^MVKT+9KI02_'[)>VN>L5NCMME-VUCC-J"]-)
MAP6 F)-$E8)Q4VHZB==BKNHC>>E*TW6Q\#8M:[U!D6VY,%<>]#F-''?#?<9)
MCN;<023450DU3P6A*L"S?Z'YWS+-<ZP/+;_(M3HV;!G+99G)L*'!CH0R'F2,
MFQWOGYNX.OE541=%THJ](W*L>9G>-X-'LDX9.06)<E<?DH#!P8NNU DLDJF+
MF]1;(4\"7XJ(B?JCBW-_ ;/(M=KFW=VWY):9[\.V,'*DJQ&=(S46P157HGX*
M$-!C%MOW,_*=TY%NN/W/%L)@XX_B]ECWQA(MPER+@9%(D=A5)1 05035="\J
MHORD0*X9C9MDG%MF]+<[$;K&R:'<H\&^WLHY#90LD*;[U[XW*71#0A$! =/,
MNNG71%*D=\S!;;ZA<ARK-\&RK(;;C+,:UX#]$VAR="CJH;YLI%,FP[I.:"#@
MZ^7I^2-!Z=QZ\AD5CM]];ARK>W<& D#!N+7N\QE'$UV/-:KL-/:FM&566RU7
M4/5'?+T<&0-F<PV+&;N*M&D4I S]RM([IM4T'KMUUTHO! N:<TDYM9,IXQN_
M$UZ?SA\G8.)2FX@3H;K9&G8GMST0190=.X8Z^7Y)%\K:(<\FA7CC7DO$,[SN
MP3\RQYC"V<:DS;;%6ZN0[VRZCCSY,KU%'QU!'?%=RHO2@C,3CW.;9Q5;\Y@8
MU*9FV7D%W/;1A"!I/CX^\>U8+;*:[7-OZW8B:HGLW=**LGCIZY\G<U7#F#Z$
MN-DQ"U8^WC=D&\,+#DRY+TI94A\62550&_\ %:^"^SJBHA&XYMM5TN.7\1/V
M^#(EL0,I;D3G8[1N@PRC!HKCJBBH Z_E%TH0Q.+L=NAY5S;'GQ)$&->KUM@R
MGV3!MYIR%VU<:4D1#%%7Q'I04KQ+QYC$>9C6!9SB&;+G=BN*%,=;=E.8VP<-
MXW8\X35T6>R7E1-@^*KIK[2MUDE@SUK&^:RLULNP,SLTCRYK4!MUF=.L2(W[
MU[D6B*>X4\0UU'5/A2@TF,XG;AF<ON\<X9?[+A]SX^EQ;*S=HT[N2YA XBI'
M]Z5UQ=Z]!;W:JO5$T5*"P,=Q[(&<L],S[MIF Q9\7GQ[NZ4=T0AO'9F&Q"0J
MCHT2FBB@GHNO2B*PM[>46OCO".#Y.'7\LEPS-HLJYW%JWO.6M8"7%Y\9(R!1
M1VFDCR_$*EKI17NJC)0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#7,V"S,7N3DC,)L;[,CM0Y,]$
M_6G'8(C;;5?S14R71/AH-C0*!0*!0*!0*#6)CMC3(ERSW%KZR%"2UK<]OZ_W
M$75?1G=^9W%WZ?#0;.@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4%)<[<Q<@\2ZW:R8,.089%AMR;G?3FC&&.^[()E&E;VD2_^
MK75$_*^*BQ".RO4/R+8^)KUR=E?'S=G"*5L*QQ3GHZ$Z/<C1"<W "J&Q"%=%
M'KK0I,[[S+,L_(G&^#C:&W6<[BNRGYBO$)15:9[NT0V*A_!U5*%-)']2$:)"
MY;NV06?W:V\97%+:U[L\KKLXW7W(S6J$ HVIN"">U$W?%0IW\5<P\H9AD,*U
M9IQE*QZS7B$5TM5]CR!E1 CH*$(R%T':1H0H*:H>J_(VZD@I+.;^2Y'$G'=P
MSB+;@NCT)V,TD-UU61))+PM*JF(DO3=KX4(0G/.?<GMN26? ^-\-++,WGVEJ
M_7",4D8T>+$=3Y.\]-Q:_"HIU'Y2EH@I9_&^67;-L/@9'>\=EXM=)*&,FS7!
M%1YLVR4%5-4 E M-14@%=/91%)\C>H?EK \R9QG^& 2HEXN3MKQ6:=R%M;BH
M&(@0B@%L4D,5T-4TUHM),]S=EUHO?%F-Y3B+=HOV?O3V;I".7W2MR0W1!M14
M 47.X!"?BFGA0ID-\Z3CRSEC&_H5KM\;VQ;G'?\ >"W3"2*LC8:;/U:*J;=4
MW4*1WC+G3F7D.1C]Q3BP8N$7IX4<R +D#@M1MY ;J-$(DNU17II0I:/,.;7S
MCG +IFMAM#=[?M" _+@..DQK$W(+K@D(GU;1=Z]/DHM$0RX>H 9E_P"+\=PJ
MU-W>=R)'"Z2.Z^K7T?;-J&XZ2"!;B%!>3;T\S:I[:+2)N^HCER[9AE^-8'Q>
M&1Q<2N;]KDS0N0L*JMN&#9$#@#U-&U+0572A2?AR]=V^8<8XIGV)N*[>\=&_
M3I*R%)R+)_7(<= 0-I(*LZ;]W76@S.4.597'V5<>X['M;<]O-KLEI?D&\K2Q
MA4V0[@B@EO7];KHJIX4&?S%RI;.(,-<RB?$<N,QY]N!:;4PNUR7-?U4&T+0M
MJ:"1$NU>B=$5=$40K["O4%EEQO=XP7/\)/%N0H]H?OEAMYR.['N#+39$C:&@
MJHEJ*]1W?)/Y)#HHI@-^JAGZO<27N196@/DFX/P)C22"48#<68,)QT5V:GH1
MH6BZ=-:%+(XZY-F9WE_(&/K;6XELPRY-VF-.!U7#E/:.=[<"BB!L41\%7QH(
MCRSSAFN%<D6?C?",+#++M=[6MT;!9B1'/(Z\!BB$"CH(L[M5+VT*=&2<W\D8
M1QK#Y#S+C\;:C5V&#?[4DU'7HMN=40;E@0 0EJ:[-JZ>91]BT*;1GFR\Y%G6
M:8I@./M9!;</LPSENC<I$&9=9+*.Q832H*@B.:J*FI=-A?%0I K!ZD>:+[FD
MW!FN)0&]V<XRWZ.ET!3B,2MBBXNH()>0T)$$EH4R<C]3F>VO-LTL&/\ &QY'
M8L&>1+U<(DU6W6XR@1HX0*R>FJ :Z)K\FA2P;_SQ8H/!9\W6:,LNWN16W85O
MD%V7"DNR$BJP9"AZ*#JD)*.OR55.E"FQPWF.QY#PW'YANH);[4$%^;<X[1=Y
M63AF;;K8*J"I$I-J@)HFNJ?#0I5^*>J?(YE]QIS.,">QG <WD>Z8OD)2.\I.
M.$@LJ\&P=!<54\WEZ+N3<**M"G?F'J1SZR\D99A.)\<EE,+$ 9D7*5&FJT^D
M=Z.V^I]OLGU3>J(@[E72A3OROU1JQ@F"YG@..+?G\VGG:6+3)?\ =GV9H+VN
MSJ(FA$KOE1>B*FB^VA23\7<]?7M_),;R'')&*<AXLP4JXX]+<[J&QM11=;<V
M JCJHZZAX&*HI(M"D(F^JVYP^"+7S)]6&#DS[T5G.T^]F+8-BCR]Q'>TJJOZ
MK33;[:%+$;YI9G\D8+A]G@A*L6;6-V_L7975%UML6C= >T@JBZH*:ZETU^*A
M369EZ@H>)<Y8OP^=O!]B^ML^^757E H\B83H1VD;VJA*1 &NI)T-*%.OFGFW
M*^.<OQ?#,0Q(<JO&3,R'8\;WE8SFZ,J*HCY"1?+N)554\*$0B<OU770,$OF4
M-82[%R'"[I%M^;8W-DJ+L./,(VVY#3J-)O17 [>U033Q^3HJBD]E\V+.Y6Q/
MC;#K<W=XU\M:9!=;P3Q $.VNBILF@"!;B-$31%5.IA\-"DRY+Y LW%^%73-K
MZAN0K: [(S6G=??=)&VF@U]I&2)K^2FJKT2B*IX[]0.;7K,K/B?(_'LG% RF
M,<W'+@TZ4MH@ =^U]$!%!=%1-5T4244(40M:+32CZB^7KYE&6V+!.+0R&'BM
MUE6B1-"Y"RJE'=<; B!P!ZF@;M!UTH4E=X]03F-\S8CQ1D%E"&&36Z+)=N"R
M%(XUPF]T&X^Q T)%=:1K=N\2UH4Q9OJ&N$3&>6L@2P,D?&MV6U1F/>21)@H^
MC/<,NWY%T7=HB+\%"F5Q9RQS%G-XM"Y%QFE@PVZQ5F!D W!N0B-FQWF%1I$0
MOUBJ*?%K05Q9_6+E[EJ/,K[QD^'',:;]'7#(;?,[_N[F\055;-H==%,4ZD**
MJHF[5:+2U>>.=XO#^#VC+K;!;OKM[E-,6^,3RL <=QDWR>W(!+H@B*>'Y242
M(;#E/F$<#XA'E6S0 NT=]JWR(D5QU60-FXDWM+>(EX"YKX4*6/:9I7*U0;B0
M(V4N.U(5M%W(*N@AZ:]-=-:(JKG+G(.%YF'>]6T)MJR*><2XRC>5HHD=I6=[
MHB@$AJ@N*6BJGA\=%B#DWG-O N2L!XXAVYNXS<PDM-S'C>5I8D61(".VZ(H!
M;U)>XNBJGR/CZ"D-NGJ%Y5E<@9=A. <:!D[>)20C2Y87$8Y(+R*K9$+@(B*6
MP^@JOA0IL>0>>>0L1O."XI:,!"[9GE]J^D)%E6<C3D:6TWW'XZ'L4"1M!/4M
M4UTH4R9O+'.L#!DR5_B=!OK4^2U,LZW-K1JVQXP/#+[B(J+N-7 V::^7XZ#5
M<;^H;D7.,6O><W#CYNV8;;[)<[M;KN,]'6Y4NV:I[MMV(8H2@XBGMZ;:%.G)
M?5/*QGB7 ^4)6-MNAELMR/.@!))/=FF3<0B;-6_.2HWJB$B4*6$QS W+YBA\
M;1(C+MCFXT.4,WY'E3<V;J@(H"CIL44W;MU!5;GJUR:0Y)RZR<<3+GPW#N"6
MMS)F7O\ .W"4Q;1UN.H^"D2((KTU5!4Q)=$%/4$62S-BL3(ZJK$AL'6E(2 E
M!P4)-1)$5%T7P5-:(\HPO5_F*1KEE%QXS>>X[LUR<M5UO]OF=U8[@&(ZJV;0
MHJZ.!T4A'4D3<E&J2O._49EMJS^!A?'&$IF@W&RQLBC/-2UC.G#D;EW()-DF
MFB#IUUZ^%$IF!ZJ<6+B"7R@[:);-SAW#Z <Q8R1)*WE40DCHXHIY=B]Q3V:[
M4+R[DVT*?< Y[S&^93*XXSS"OJCR%(MKMVQJ*_)[D2< "2BV1B*J"IM754W=
M!/5!(=%%-$QZKI<["K/)MV, YR?=,B/%',0<DJ'8EM+J3A.=O=L03;15V="5
M4U\JT*3BW<X+$Y+S7CW-+:W: Q>U_6"%=&W2<;F6QH$<?<VD([5!"3HBKX%^
M;0INN$>1;YRK@S6;WBRMV*/<)#XVJ*#Q2"<ALEVT=-2 -%(Q-$1$\$1?;0E$
MN4>><BQS-EXXXRP]W-,NA0DNU[;%[L,Q(BZ*@^"J3A(0KIT^4*)N4M$%)-8>
M9[7?>&I7+ZVY^WQX=OES9-JEZ@X+T,256A-11"$R%.V:#U0DZ(NJ(*=/!W,0
M<P\=N9HL +?/BR),.;;VW5>$'8XBX.AJ(KY@,"\/;0F%-X]ZR,I>LT3-LHXU
M?B<;/RT@R,D@3/>!8<4MJJK1-"I:+T\1U7HBJO2BTE_(/J)S/'.2I6!8/@:Y
MF,.U,WQUR)+)I\H;B"I&((TYJB*8HFFJKKX42EI\4\G6'ES#8N8X^+C++IG'
MF0G].]&ELZ=QHU'HNB$)"J>(DB]/!")M0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!04SZL/\ R^9K_P!C
M#_U^-185]Z@__)U;/]W8Y_\ 8U"-Z"0,1S;%.?N$_KEFCV8?2$>5(M_?8]W]
MS:]T+5L?.>Y%U'KT\**D_'-JPV^7'U+6GD"0U$Q"5D)!<Y;SHQQ9%'Y) XCA
M=!,#02#5%\R)T7PH,CCRZ9]P9RGB?#MSR1G->-\M8>/&9:JA3H3339&WX$2]
MKRH*)N5O;Y@V[5&@FGK._P" -]_]ZMW^MMT2&FY"XOMF:W3%[Y@F:-8ESG9L
M?COPVQ>%%DVX0T'OM(NY 0B,>YM)%150A)-- G/IMY1O?*_'17G)66@R"U3W
M[/<7XR(C$EV,#9H\""JBFX710MJ[=R*J:(J(@E#_ %)_\3>!?_FI3_O8E"$?
M]4UIO-]Y?X8M&/W@\?O,QZZ-0[RT'=.,:^[>= W#NZ:IIJE%A#<"LU]Q_*O4
MC9LFOAY)?(F,&$N]NM]DY"K <(54-Q:;140^4OA06)Z0L4O]LPJP95/SJ1<+
M#<;<_'@X:Z C&ANK+54< ^ZJD7ZLNFQ/EK1)>E+C;X=VM\NUW%D9%OG,N1I;
M!]1<9>%0,5^)154HCR-Z0L";M7('(<NXSCN4G")#F'6,W>O:AA+?=<(=?D[B
M!--/#4OAHU+&XDQ/(+YSARI>;7G,G&+79LQ[]SLS("3-S;&4^XK;I$Z&U%$%
M#7:70J";Y(\T'K4Q%TW!%KZGO+O(D0=%=FZ=5HG!R]2+[)\D<"OBX"L_6G7N
M(2*.B.Q->OA0AC^KB5&CCQ;D$AT"Q^U9?".ZO(2$TV/1S4]-43R-N>-"'+.)
M,>\>L'C!BS.A(D6RRW"3=39)#1N+(8E"VAJ.NF[=T1?ST7VI0X/,4?&[I>H&
M<8YVB;;X3A75ZTGUU"7].C((OP=EIZC3UEZ05=NO'^09S*!1F9GDUTO3BKX[
M7#%O;^!" Z,RA?.&/WC)_5-A5GL63/8C<GL8?)N^1@1QUH6W9I$*"IMHN]$V
MKYJ$;EI\QW>RX5Z>KVSF$U,F1NSC9G)+RH+EQN+S21P<7:I;3)Q>\6U54-%)
M/"@KWT5BUB]CROC.]VM;/G]EGMSKQ'=5%>>C3F&UCGXKT!$VJ(]$W(OB:T);
M+BS_ ,V?,W_N5K_U>/0X*"Y OG(^,9QSY>\+G,PL=^D+?;LN-6@>F#$N/>8:
M<8WCTT4C E0D74QT^%"I]S3]5N.N-N%^+L?25D>,2;G'ODIJ"WWIERMT4DE/
MJ#::)^O*41@*KHFGCHE"$6QO(#O?IUYVPNVPI-O&S7/Z8M]KEM]B7'M,^6V_
MVW&TUV]L(YJ>G1-WP4$OYHO-FR#@'A&TV!]J1=;G<<?;M,=DQ5T3BPRC.HB"
MNNK;ABT7P$NE"$,Y5O\ R1BO,'.>3<>3H\)J#$M+=^WM([+6)*CQF$<C[@)$
M4"+4BU30>OLH)-FV)XWA>$^G*U8M.*XV9_)X%Q"Z/(C12"G.LR"<(== 3SZ(
M.OE1-%5515H):Q+BY#ZN,QN.//A*@6C#7(=XE1U0V?>2[>C2F*JBDFHZIKT4
M%3\E:)P5!;HD2X>D? 8%P!7($K/6&)0"NBDRXY)$T1?C%5HO%(N(AN6.^IO&
M^*[FR2)@ 9!;K7+=55<?M<P79L12U_P'=4^)43V4%=<G9RS>LOY,S2):;E-O
M$;)+:6-W]B-W+;$8QTS9)'7M=05T>V:(B?!KIK15U<\73)\FY9X7OW&3T9K)
M+G9Y]RL)SD0XY=V+[P@%JBHJFWJ ]/E*GAXT2&]]-&(63DKC'-LJR:Y.7C)^
M1WY,#,%-L&?='&$<!MIL!Z(0B\CPDFFFX41$VT26'Z(L65JV9;EUUEE<+Y'G
M#B<=YS5>S M#+:B#:KU02[@)M]B-C192GUL,/N<*+)!LG(D*\6]^<(^'8U-O
MK\2F8)^&B0X99RMR+9^:,#LMDNEDG\:9V^PMJBQ6R>N0P6V&2?==+H(B9&:M
M$*KY4^):" <*8GD%YYBY.OMMSJ3C=GLV;OO7*Q,@!,W-L)CSB@Z1.#M0A%05
M=I=%HLL;U#86_G7/MRC6IUUO(K1@0W['7(_5Q;C;9YO-B.GM,=X#\:I0A$<:
MR8LS]/\ Z@<L<82,]>KG$GOL"NHB[(=9-Q$7X-RKI0>E_3ABE_QO$;;/O>=2
M,GBWFT6MZV6>2 MA; 2/O5II4=-21!,0^2/0*)+QCB:YE<,+Q_!+S?0M/"^;
MY8_;KG(BL Y*:FLN,.(#SABFT7%[9 NY43:I$F@Z*:7)ZD[U8V>5\/P)RS7&
M^8WB6.3B<M-H8]\?!ZY1CAQU(%).C2 P>Y5Z:_'1(:6ZY0>2^A!6)"K[_C\Z
M-9)8EJA"L2<V30JB]45&7&TTH<7M?%)$=S';.TT\!N# BJ0@0DJ)V0Z]%HR\
M]^K/%86<9-Q3B$]U66+S/NL,7D_(>=BMHR73V(YMUHL*"Q1+]EN6\8\FY<IM
MWL,OLF&Q(Q[M4CV*.RC[JZ_E./FI%\![DHJS,,Q+(LF]1O+<FQYS)P^-:[M;
MG[A&C )C<6U5Q4;<W.MZ(* 2:Z%\O\8;KU#VBY9)ZB.*;38LA<QBX3+?<?=L
M@C(AN1]K;QJHHI@B[Q16_E?E4(7Z=NF6?BF?:+C>SR*XP;-+8EWIU$%V2Z,<
M]3,1(]%77PW+1%(<'?\ DKN/^YLG_P"O,H3O5E<++ R3@GTY8[=!4[;>,C&W
M2T%=J]J7*>9)47X40M4HK$XC+*9'+MXP"\@3F287@]ZPZ,\**G?;AR36*0IX
MZ;'A$/\ !0:#<X3R-F>#>D_'LGXXN=FB_5R3<8^51+H).R7'Y,]5C!' >F]1
M>0U0E3R]?90XO9F'W&?>,1L%VNB(-SGVZ'*FB(]L4??8 W$055=$W*O37I1E
MX:XCX[Y<Y1PS,,-Q^]VNR\77+*)@9 Z\V;MU)UM8[AHTB!M4%$6M$[@:KJFN
MFNIINN6F<UP;G9?X32(\6?B''@$R,X!?(K9;=XN V) 2$\@"A#JG71?P4&CO
M%GM&/\$\59LQ=';M;KWF\7)<PN+XH"#<'1('Q(1UT%I6'&]57J6I=-VE!<_(
MDJ->O5KQ)&LCP2)ENMUPF7!Q@T-&XCS#Z@IJ.NB$B+I\.Y/AHG!4>*Y%BR^K
M-WE)NS"WQ_>KW+QFTWO<BL?3ONK;9213_P"GD:KJJ::.[O$5HO!/?6QB9.GA
MF56J:5MN]TEEAT]YO75Z!<Q,T$]--1!1<U'V[UH0]3X]8K=C%AMF.6EOM6RT
MQ6841OVHU'!&QU7VKHG5?:M&7G;CN9$L?JSY=C7Q]N+*N%N@3H#D@T 3B,,,
MJXHD2HF@HHZ_!M7X*+P8OJAY6QW)> P+![C]+1<QND:S1G(8.*Z:,N=]X1;,
M1+75H6U'3KNT]M"&D],V7VP^0^4L4M5IFX_9;G&8O]EL]U92++9!IM(TC<VB
MJGF(VU147P2BRH; 6<LO>%\><<9/?F[9PSG-^DQW"A,B4P9L1YM49?<,4VHZ
MZ;?;7<J)\I479I17IFWNVNP^LF]'(?9M]I@80V*NON"TRTRTY&1-3-41$1$]
MJT9X.'I!NELAXUF%YE36(%DR3,)B8X,HPC))(@;T1@7%'<I)H*"/7RJGLH2]
M1T0H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H%!'\WPRQ\@XO<,/R1MQVR7,6QE RX3+BHRZ#PZ&/5/, T&L
MR?BW$<OP-GC>],/.8O':B1VF6WC!Y&X&SLZN)YE5-B:Z^-!\N'%F(7/)L6RZ
M6P\5YPYDXUD<%\T &S#MKO'70UT]JT& QPAQPVWF,>3:EGP\\EI/R.+,=<=:
M=D(X;HDVFJ*WM,U(5!445TT7HE%MJN.?3CQ7Q=>RR3&K:\Y>T FHTR?(.4<9
MHT42%E"T0=47:I:;M-4UT5=1:8Y_@6.\EXS)Q'*FG7K-*-IUYMATF3W,&C@:
M$/7Q2B(=G_IPXJY)=@2\AMKK=RMT=N$U<(3YQY!QFAVBVZ2:HXB)T123=\"Z
M46TZPW#,:P#'HF+8G "WV6&B]I@5(R(C7<1F9JI&9+U4B6B,#+N.,7S>\8S?
M;^R\Y<,2F_25F)IXVA"0A-EJ8BNAIJV/1?\ YZT#)>-\6RS*,:S"\LNG>\3<
M=>L[C;Q-@!O[=^\$Z$GD'QH, >'\)&\9E?4CO_2&>1%M^1%[PYM<CJTK*HVB
M+^K7:OB-%M"L;])7#&)W^V9-9K?-;NUHDM38;ASGC%'F20A4A5=%35.J>VA:
M\:(B6'<;XO@ERR2ZX\RZU,RN>=UO!.O&Z)2G",U4$+H*:N%T2@KG(O2/POE-
M^NF27>WS7+K=Y3TZ:X$YX!5^0:N&HBBZ(FY5T3V46VSS+TR\3YX]:'\B@RWG
M+';(UCMZMS'F]L*&IJT):+YB3>6I+U6A;C=/3%Q->,1L.$38,LL?QMR6]:V1
MF/"8G/<[CVXT74M2\-?"A;,L7ITXIQ_#;U@,6TN/XQ?W0D7"+*D.O%WFD1 -
MLU5" AVHJ**ZZT+9O%W!'''$#LR7AUO<&YSA[4BXS'2D2>PBH2-"1:((:HBJ
M@HFJHFNNB:"VPMW$6#6N5FTR+"/O<@[DR;>Z9(\)@Z!""*OD14><5=OM7\%!
MN<'PNP\>8M;\/QADV+);4<2,VZ:NG^N=-XU(RZJJF9+1$.Y+]/O&O+5ZBW_,
MX<F1<8<48+!,2G8X(P+ANHBB"Z:[G"ZT6V%#]-7%<+'[3BS<*6YCUFNRW^-;
MW9CKC+D]1 -SPJOG%!#:@KTT4OSEH6ER<9XH'(B\I,,O1\N<A?1LI]EXP9D1
M_!$>:3RFJ:#HJ_FC\"41SLW&^+6'-[]R%;F70R7)&V6;HZ;Q&T01Q$0VMKT%
M= 'PH-2O"G'YR,WDO0G7BY! 6\E%Q\R!Q 0T%6TU_5J*FI"H]473X*+;KL/!
M^!X[>L7O\)J8[<L-@.VJP')ENO"S&?[J$BB2Z$NUXP15\!T3\E*%MI&XMPZ+
MFF09V$0SO64PPMU\:=<)R'(CM@VTB%'+4-=C:"O3PU^%:(B6&>F+A[ \L3,K
M!9W$NS)&< ),AR1'B$>J*K+9JNBHB^534E'V:+1;20N'<%=OV79&_#<>GYQ"
M2VY"+CQJR[&1I&=HAKH"[13J/6A:/77TV<87O"['@-S8G2,<QQU]^U-%-=[K
M9254C%7$ZJ**2[47PH6DV!\1X!QK8YE@PVTC;X=Q14N#V\W9,A=JBBN/.$1K
MM0EVIKM'5=$35:(TK/I]XW8PFU\?MQ928W9[H%]@M>].=T9H*:HI.:ZJ/G+R
MT6V]E\5X=,Y$B\IG%<;S*)$.WMRVG2 "9,#;U-M/*1(+BHA+\7P)1&'8>&,#
MQS +GQI;H;JXM>/>?I%IY\W'W"F"@N$KJKNW:(FB^S1*+;I@<(8';I^&7)EF
M44S X[D3'3=E.'VV745%%Q%^7HBZ#KX)0MM<*XQQ3CZXY#<<79>BED\OZ1N4
M8GC<C))4C(B9:)=&]5-=4'V(B> I1'9Q_P ;XOQE;9]JQ1EUF'<I[UUE"^\;
MY+*D" &J*?5$T;'I0;V^V.T9-9YM@OT1N?9[BT4>9$>34'&S31473147VHJ+
MJB]4ZT%:<<^FWBCB^_%DV,VQXKV@FW%E37SDK&!U%$T90M$%215%25%+35-=
M%74MM+?O2'PKDE[N>0W2W33N=WE/SYC@3G@%7Y3A.N*(HNB)N)=$H6L&V\68
MA:LMM^:PV'AOULLS>-Q'2?,FTMS*[A$@5=%+7\I>M$:*)Z?>,X&-95B$* _'
ML&8R!EWB*W(<%-X.(X*,KKJV**GR4]G3PHMM=@OIBXEXYRB%F&+P9;%[@(\,
M9QV8\\VB2&C9/4"71?*9>/X:%LK[N/%JX"[QL4"26,N7%;T(E*=*0W.44'N
MZJ[A\J;=/@5?AH6E-EXTQ>Q9K=^08C;[F4WN+'@3YDAXW45B*#;8((KT'5&@
M4E3Q5-:(C<CT]<:2;!DV,.1)263++D-ZNT49;J#[X+G=W-=?(BKIJB>Q$3V4
M6WWC3T^<:\2WN3D&&0Y,>Y2XI0'B?E.R 5@W =5$$UTUW-CU_GH6E.4<?8WE
M][QK(+TTZY<L3E'.LY-.DV O.(**IB/0T\@]%HC6W'A_!+D]87G()L+CEY>R
M2VA'=-H$N4E]9+CAHB^9%<77:O3V>'2BVAN5^E'AS,\CN657ZWS';Q=7EDS'
M&YKS8*X2(B[1%=$3IX4+9V5>F?BG,H&/6V^P9;L3%X 6FT@W,=;4(K>FU"5%
M\R]/%:%I#@G#F#\<8Q=<0Q>,^Q9+R;KLYMZ0X\9$^R+![3)=1\@IX4+9>.\6
MXCB_'SW&-I8>#$WX\R&ZR;QF\K5P[BO?K?E(J]PM%3P]E$:MO@[ &['AV.C&
MD_1F"S@NN/@LEQ3"4VZKR*X6NIIO77:O3V>%%MM(_%F&Q.1Y7*L:(;68SHB0
M)<D721IQI! 44F_D[MK8#N^!*(@]Q]*/"5UR]W,9EB,I<A]9DFW"^X-N=D*N
MY3)A%TT4NJ@B[%_-TZ46UU(B"B"*:"G1$3P1*(B?'_&^+\96V?:L49=9AW*>
M]=90OO&^2RI @!JBGU1-&QZ4'![C/$Y'("<EOQW',H^CUM"F3I+'6&2JJBK*
M^5==5H-+9^!^-K-@EUXU:MSLG#+N^<J1;9<AU]&W3V=63)=[>U6Q(=I="Z^*
MK1;8.">G/C#CF)>6,8AR6)M\BNV^7=7))G."*\FA-L.IIVD\"U!$75$557:F
M@MD/^GWC"1QU"XN*VNCB]OE?2$38^X,L)F\S5Y']=V]>X0Z_FKIX(E"V_P W
MXQQ;D.W6>V92$B4Q8YC%R@F#YMN^]1A4!,R'J6J$NNOC1$QH*QY0X"XUY=F0
M[GE]O=*ZP0[#4^&\49\H^JEVG%'5"!%5535-4U714U6BVRG.$..E^I;;%M*+
M#P!XI.-PH[S@1VGS('%<<'5>Z>\$/<:JN[55\5H6VDWC/%)^?1^2GF7ARJ/;
MSM'>;>,&7(;F]5%QI%VDJ*XNB_@^!*(BQ>G#BXL"B\<>Y2DQR#<%O$)4ENI*
M9F*BIO!Y%W)T)4T_^?UHMNO.O35Q5R/D?UJRZ#+FW9668[A#,>9 VXZ;114;
M4>JIXJBI0MM;]P1QCD$'$[7*LR1[;A3_ +S8(D-PX[;:D0F8F@KYQ,@$C4O,
M1)KKU746LBB% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H%!3&9\]L85SCBW$URMH?1>2Q&71O2O*AM2I3TAAEKM;-%0G&@'7>GR_BZE
MIV6?GB$8\J3\E@C;K+QI..&3[#BO.RP!#VZ 2 @F9"(B.[34O&A2'89ZGLEG
MY-C$'D# WL4Q3.RV8A?"D=]'3<V]D7AV#IW=X;2\ORD7117<@IJ)OJ5YP@Y?
M$P1_B !RJX1W)L"W+=04W8K2FA.(2!LT3MEXEKTH4D.8\_\ )=ESJU\>8QQV
M%]R:78HM]G0?I 6'(SCVY'VMQ!L)&B3;NW=:%+AX\OF69%B\:ZYMCWU7R!QQ
MT7[/WQD]L -1 NX/1=PHA411N=>HKE_"\VCXB7%@/_35PEP,4D%<P KDW%<0
M1<$4 D#<)@>AJFFZBTEJ<V95 S#C/"\EQ1NU7C.6)CMTCE*[AV\XF]1$=H*+
MFY!1?%--:%-]Q]RQ*S7D?D+!'K6W#9PE^,PS-!Y7"DI)[G4@440=.W[%7QH(
M]A'J&8S3EO->+HEK;!S&6Y)6R8+ZD4UZ Z+#S:BHH@^<O+H2]$5:%(&7J6YQ
M'+AP)>'P3+SA_20VSZ5#>L/<H]W=LV::IIINUHM/2=TGWYC%)5TMEM"1DC<$
MI,>T..;0<EBUO2.K@HNFI>3=I1E1+GJJ:>X<L7(%IL(S<POMW3'8^+#(5%2X
MH:[A[FS73M[#3R^+@HM%ISSCU'YA:LFN^+\?X*67R<.B-RLWFLR5:C1G";WF
MRPNQ2-11"ZZ;E421 7:JT*;3(?4I!C8+Q_G>,6M+C S>[,6=R/)>5ER&;A&#
MJ%M$MQ-F!#[$7Q\%H4E,OEB5&YW@<.I:VRB3+(5Z*[*\J."2&Z';1K;HJ?J_
M'=[:"R)\V-;8,FXS#[<2&TY(D.+X"VT*F2_R(E$5'Z>>=0YSL5YN3ML"SS[1
M-2,<-MY9&L=YM#:<4E -%)4<'33\FBS"L&/5YF@-7O(I7&3TOC_'[D[:KM?;
M?-WDP;3@CJK9M(BKH8+HJHGF3S)1:3'D'U"Y/:,QQC$^-,0#,CRJQM9#;C67
M[DX3#JNDF@F"CHC;:'U)/'2B4M+C7(<SR;&_I+.\9^J=]]X=:^BO>!E?J00=
MCF\.GFU7I\5$0_U#<X)P;C%LO3%L"\7&Z3DALP7'ECIV@:-QQS<@&OET =-/
MRJ+$,GF#F5...+(_)EFM[=YCS"A+&CNNJP),3QWB>\1/\E4]E"DOS7.+;@F"
MW/.[RV9P+7$26ZPSHKAD>T0;%5T34C(115Z=:(K'BSFGD[,[_:H>5<8RK)C6
M1PRN5FR"-)&7';C(". LGH.WN(0H/R2553R::JA:1;)/5=D$6YW^[8?@+^0<
M7XE-^CK_ ).,A&B5T20'"8#:J*(ZHJ>/E42+8A)0IZ.L%\MN36.W9%9W>_:K
MK&9FPGM-%)F0". JI[%T7JGLHCS9>/5/G=NR3-8MMXT.]XI@MPD0KU=H<Y1<
M:8CN&/>(%9+3RMD:HG1$\51.M%IOL[]2=TMQ\?#QKBR98?(41Z9;8[TGW)\5
M90%5M4VF.X=Q(>I:(H^*T*9\WGK*<*XUNN<<JX0YCMW9G-VVQ8^S+"2[<'GP
M0@VN"BH":H:ET5=HJJ(JZ(HI]X]YVRZ]WB^8ER%@S^*97;+6=\AM]Q7XLB*@
MJJ 3B#HV>J?"NNA)Y2'112-\<>H7F?D8+-=[5Q0!8?<I@1G[VW<P46F1?[+[
MJ-F DO;T)=-.NE"DBF\^WL+KR]:K?CC,E_C**U-CZR319K9 3KN]$;79M 2)
M--=:%.=]]0DB)A/&&1V*R-3[SR1,A06;:<@@".<D='U0Q;53[3BH'R4Z=>E"
MF?%YPFR,RY4Q;Z%:1OCJW)<8\GOENF%[LK^PQV: FJ::HJT*0Z)ZK_I'A!>5
M85B9.\1;NU9+E9"DD@-&\:*)BYV]RH39"2>3QU3V4*2GE/G+(,:S2)QIQIB9
MYGG)PUNEPC=Y(\>)#1=!4R7\HOC4434?%21*%)=P[R>'*^()D1VB38KG'D.P
M+I:Y8EJU*8TW(V9"&\.J>;:FBZBO5%H2PN>.6PX7P(\N&"%RFN2V($*"XZK(
MN.O;B+4D$E\K8&7A[*$)?A.3Q<UP^Q9=#%&X]Z@QYPM(N[MJ^VADVJZ)JH$J
MBOQI1%:\M\V7[#LNLW&_'^+%EN>WB*=R]R.0,1AF$V1CO(RZ*I*V?12'33QZ
MHE%II<J]0^58KP]#Y'NN!2+7D#MV&ROX[<WE87=HXBO-FC:DH*0;1W@/M\1T
M(A39X]RMR^=KRJ\9YQJF,0+!9)EWA/%<&Y(RI,0.XD=>VBJ*$**N[3II00G$
M/5ID,MS&KEG_ !^]C^$99)&#:<ICRO>8R2#)0'>"MCH.X5U7<BH**J"6E"DZ
MRKU!0\9YXQWAHK<#L>\LM>^7=7E$X\J4CO8:1K8J%N4&^NY/E_%U%.GF7F_+
M>/<VQK!L.Q <KO&1QGY,>/[TL9W=&4B(1382+H D2JJT(A(N&N9(_*\2]QYE
MFD8WE>,RD@W^Q2S1TV'"W;2$]H:B2@:=11445]FBJ)A#N+_4A+Y6B<A#C>/
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MK2L8#9$O4>9WRW2S6(W)[9!LT!-7-NJ*OAK0I%>,N>.9>17<?N;/%8L83>9
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MCT0H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M1G$TBNO J$(O#;6Q(-4Z:H39HOQHM%;?T?8I?X&$X]ELS.I$S'Y\*7'B84X
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MT'$%YXA0]2$-O1%Z_'1)>@D5%1%1=47P6B% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M\A%55W(GBG3PHMLO).',&RK";)Q_=(KXX[CI1#M 1Y#C+[!V]I6&21T5W*J
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MBVV!G>'CCNB9@FH*&BDB*"J::*B*J*B:*:EL^6[IR'AG._)-\XKD,0I-BQ6
M=P!QH7W4M8!#;,F$,3'<TJ@XJE^2*^/A0<YF/8S@.->FV^0+B4[%7\A^EKQ>
M9*(T'OMQ**YO=354#M=HQZET1M=>NM!:MZF0[CZU+ =M= TL6(OE?7@--K0$
M4E11U471-.^T77\Y*)P5'PG?L:8]34G/CL:0<0Y!F7BWX/='%1&_?6G&U=<$
M5ZBK^JAIIT)W8G36BSN3'U<X"U<^1N/)L"<Y;7<YD-8=?R9Z*[#*6PX!$B="
MVJ:ZZ^.T/@H0]=P(,2V08UMM[(QX$-IN/%8!- ;9:%  !3X$%$1*,O-'"MYM
M.+\V^H"/D<IJ!,&;'NZG()!7Z-:20ZKG7KL 'FU7_I)198/JIY,QW).,,+CX
MP^Y?K)FEZ9<0;<!&]*M]J<4I --D@DIH[VQVDB:$FBT(:'@#*X<BQ<[X?$@R
M[1;P6X9#9K3<FO=Y3$2YQG15LFM2V[$!GP73S:T654<;0<IRN!P]QAG]Y;A\
M/9#)FW*Q,Q&01R1,@3) G$?>41)")TE1-%)-'1]NFT/06+WJTV#U6<S7F_2V
M85JAV.VNRI$@A!L6FXL-5UW>/1/"B<%<<0\;8ER!Z>[3:\JOB8K=;AE$Z7@%
MU5P&7PDH(-H#(D8*XBFR>HB2+N1-%0D2BRMG@OD[,K=D>;<5\NWB%<)F"MLR
M$RWN VR<5[;HDETM@[D0PZEH6NY#U5-:)+T4P^S)9;DQG!>CO"+C3K9(8&!I
MJ)"2:HJ*BZHJ41V4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@B4'CC%
M[=R#=.38K+R97=X3=MFO$\9,K':[6U!:5=J+^I#K_.M!A\F\287RY;H-KS2.
M](AV]\I488[YQU1P@4%U4/%-%HJ*VOTP\2V?$;_A$&#+&P9*Y$>NC)3'B,C@
M.=UG8:KJ.A>.GC0MTXMZ6.(L-FS+A8(4Z/+FP)=K>=6<\2I'G-JT[M55\I;5
M\I)X>-"TH/A; 3XN3AY83OU($4%(R/FCZ*DKWS=W==V[O>;_ )/"A:.YEZ8.
M(\Z=M\N]VZ2-S@16("W&-*<:DR8\5H66TDGU[I( H.\DWZ=-=-*%L_)/3MQ5
MD^)V+")MI.-C6.FXY:X<-]QC:;R+O(R15(R)54B(E557KK0MG\8<(8!Q [<W
ML)BR(QW<60F^\2')"$D934--Z]-.X5"VSY)XLPOEBR!8<T@++C,.=^)(:-69
M,=W312;<'JFJ="%=17VIT2B,'%.$^-L.PJ?@%JLH.8W=D/Z6:E$3[LM7!05)
MUQ5W:HB)MVZ;?$=%HMM5QMZ=>+.*;R_D&*VQWZ9= F6I<U\Y)QVC^4#.[H.O
M@I:;M.FNBK0MNK=P]@EMDWJ4U!-YR_WIG)[@,ATW1^DXSR2&W 15\J"XFNU.
MGL\.E"V.]PK@C\;-XCD>3V>071?R1$D.:F8:JG:Z_J^I+X4+3#'+!;<5L%LQ
MJS@3=JM$9J%";<)7#%E@$ $4BZJNB>-$4W>?2#PG?KQ<+[<;;-.XW.4].EF$
MY\!5Z0XKIJB(O1%(EZ46VUSOTQ<3<CY1,S#*(,M^]ST9&0XU,>9;5([0LAH
MKHGE!/"A:2'P[A#G&'\("CR/J5VT9['O#G?VC)26GZ[7=_C$U_!T\*%LO)^+
M<1R[ V.-[TP\YBT=J)':9;>,'>W V=E%<1=RZ;$U^&B(QQYZ;^+>+\C'*<1A
M2H]W%AR*AO2W7P[;VFY-IKI^31;2W,.-\7SNYXW=<B:>?D8K.&Z6EMMXVFDE
M@0$). *Z'M4$T0OC]BK1"X<;XO<^0+5R;)9>3++/#<ML5]MXP:**[W=0<:1=
MIHBO&J:^WK[$H(Y]W[C->-EXH. ^>(>\K-;:.0X4AN0KG<W@\J[D775/P*J>
MVBVQ\X].7%_(BV5<GA2GTL$%NU6Y&I;K6V*S\E"VKYE_PEZT+3G#<)Q;CZPL
M8UA]M:M=F84C%AK<1$X?RC<,U(S-=$U(R5=$1/!$HC!R'C?%LGRW',VNS+IW
M[%5=*T.-O$VV"OHB'O!.A>'MH(^/ O'80<TMC,64U;<^>23D$-N4X+*O(X3J
MFR.NC2J1+KM]FB>"(E%MJ,']+W$?'F40,PQF!+9O=M[ONKCLQYX$[[)L'J!+
MHOD,J%IO$XWQ>%R%.Y/89=3+;C &U27E>-65B@K9(B-?)1=6@Z_ST1&.3/3Q
MQARS=8U]RRWO?3$9M(ZS83Y1G'6!55$'=NJ$B:KHNF[3IKI1;;2_\+<>Y%A=
MGX_E6THV*6&0Q+MD*&\XQVW8R&@JIHNXM>X:EN55(EW*NO6A;++BK$%SR=R0
MVP^SD]T@+:KDZT^8,R(RB((CC:=%)$ -"_P4^"B-)(]/O&<OC6+Q1(@/.8A!
MD+-B-%(<60U()PW%,7==VJJZ:?\ 1)4HMK)A1&8$./!C(J1XK0,,HJJ2H#8H
M(ZJOCT2B*2C^D+@MF[K>9%C?G/D\4DV)<R0Y')TR4M2;0D0DU7Y*]%]NM%M,
MN3.$^/>6H,"%EUN(CM>OT=+AN+&D, 2(A )#TV+M3RDBITZ4+;?#..,/X_Q7
MZFXI;T@60D<5X$(B=><>%!<=<<)5(C)$1-RKT1$1-$1$HC'Q+BW$<)PA_CVP
ML/-XU)&4VZRZ\;CJC-14=T<7JFJ$NFGA0:.3P#QS+XYM?%CT64N(VB5[_"92
M4X+R/]QUU5)U%W*FYX^G\R46UF.M \T;+G4'!4"1.G0DT6B(OQYQWC/%^.!B
MN),NL6<'G9(MOND^?<>5%+S%UTZ4&*7%.%N9E?LZ?B./WS);;]"7='73*,[!
M46P4.TJ[4U%L454_^>M!JH_ _&[/'!<4OV]V;AO=.1'BRY#CKL=YPU<WL.ZH
M3:H1$2;5_*+75"5%+;"Q+TZ<8X3C5^QG'X<F.SDK!0[Q<5DF4]V,:**M"]TV
M J*NJ B:Z]=:%LRX\#<;W'#L=P<H#T:S8I(&;8G(DAQB7'DBI$KB/BN[4B-3
M+X2T7Q1*%M]F'&^+YU<<;NN0LO.S,4G!=;.33Q-(,IL@-%-!Z&FK8]%HB6T%
M5\E>G?BWE:\1L@RRV.K>& %ER7#?.,;[(+J(/;.A:>"%\K3IKII1;;DN'L"^
MG<2OS-O)A_"(YQ,;B,NF$2.VX"@J]K70BT_*+JJHBKJM"W.7Q-ALS+[SG#C#
MX7Z_VH[%=C;?,&GH3@B"HH(NB$B *(2=4TH-*YZ>^-3Q/&<.2)*;MF(3"N5@
MD-RG F1Y+CI/DJ/(N[13/=I\2? E"V#F/ICXBSW+Y>;93:Y$R\SB9*6B3'VF
M'/=V@9!-C9#HFUL==%2A;?YGPCQGGF,6[$;[8FAM%F'MV5(:K&=A#H**C!MZ
M**$@IN%=4+1-4542A;1VSTT<2VG!KU@$.UO):,B)ER\2BDN+.?.*XCS"D]KJ
MG;--PBB;?'5%U746LK';!:\5L-MQJRM*Q:+3&:APFB(G"%ED4 44B555=$ZJ
MM$;.@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@P9%ZL\2XQ;1*N
M$9B[34(H<!UYL)#P@BJ2MMD2$2(B==J4&=0*!0*!08)WFTMW5JQ'.8&]/LG)
M:MRNC[R3#:H).(WKNV(JHBEIIJM!G4"@P;K>;38HBS[U.8M\%"!OWB4Z#+?<
M<7: H1JB*1*N@IXJM!G4"@4&%=;O:K% =NE[G,6ZVL)J]+EN@PR"+T34S5$3
M5?"@Q[KDV.V.1;8=YNL2WR[P][K:F)3P,N27U37MM":HIEU3HGPHGM2@VM H
M% H% H% H%!'96>X1!CC+F9%;68ISDM OG+91M;BO7W9"W:=U/:'BGMH)%0*
M!083]XM,6XQ+1)G,-7:>AE"@FZ R'A:%2,FVU7<2"B:DJ)TH/@7FTN75RQ-S
MF#O3+*2GK>+H+(!@BVBX3:+N057HBJG6@SJ!08*WJSI=4L2W",E[5KWA+;WF
M_>E9UT[G:W;]NOY6FE!G4&$EXM*W5;$DYA;TC*RRMR.@LE(Z$@=U6T7<@;B1
M-RIIK09M H% H,6Y7.W6:"_=+O+9@6V**N29DIP666P3Q(S-41$_"M!WLO-2
M&FWV31QET4-LQZH0DFJ*GX4H.= H%!J[]DF/XM!&Y9+=(MHMY.A'&5.>".TK
MSJZ "$XJ)JOP4'<EYM"W4;&DZ.MZ)A9:6]'063[L)""N]M%W;-Q(F[335:#.
MH,*W7BTW=926J<Q.]Q?*),6,X+J-2 $2)HU!5VFB$*J*]4UH,9G*<;D7B?C[
M%WAN7RUM!(N5N%]M9,=EQ-1-UO=N$514754]J?"E!BCG6%F[:&0R"W&[?S=;
ML8C*:7WTHZ[7$CZ%^LVJFB[=>M!LF+S:9-SDV:-.8>N\(&W9D%MT3?9;>U[9
M. BJHH6U=NY.NG2@SJ!0*#00\XPZX9'*Q"!?8,G*8(*Y,M#,ALY;0CIN4VT5
M533<FOP:IK0;^@4"@4"@4"@4"@Z)DR);XKTZ?(;BPHXJX_)?,6FFP'JI$9*B
M(B?"JT"',BW"(Q/@O!)A2FP?C2&B0VW&G!0@,23HHDBZHJ4'?0:Z^W^R8Q:W
M[WD5QCVJT1MO?FS'199#>2 **9JB=25$3XZ#-9>9DLMR([@O1WA%QIULD,#
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MW5 70#N :*NTT3S>Q%T371"TD&0\K\ZX-CD1G*K78)/(&:WB):<'MUO-]8C
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MV=,@AWK$W'%ARV=HZQ]7M51S>8!U$=JZZI[:%.>"\Z<MM9/@J<HV>TQ\/Y1
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M6CCOB+DIPA50-$)$5%U3I1)1*WV+)+-S!SQDLO#9E^LETM4!NVP#94(]WVQ
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M*!0*!0*!0*!0*!0*!0*!0*!0*!04)Z9?_:^8/_HA7S_K-T65]T0H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M5AL5PQOD' LLO;[5BN45([N16F5++L*1F**:"B%M,EU0AU5-FNBA<'K._P"
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M511PAW%IIN7QH6VEBX>XNQG("RK'\3MMNOY;U&;'8$";5S5"5L4\K:JBJBJ
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MA\?=7!15)!3K^K'3X6ORJ&]>_&G)N*<KXNQE6)25=B&O:E17409,60*(I,O
MBKH2:HO1514ZHJHM$3"@\Y<$M)@/,G*O$+2=NR^\,Y58(X] ;8N BCX GYH*
M;+:?]&BR]&T0H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MNRGQ\?P.#0X/15$>=_55^H>XDN#*Z38^<VM&%3QT/<1>'7Q :+#T11&-<?\
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MY>N6;7F>1QK1<9.>WN2Q&?1Q3)A7!!#38!)HI"2>/LHLK6^\YP+]N(/Z+_\
M54*/O.<"_;B#^B__ %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"
M_;B#^B__ %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__
M %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG
M OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX@_HO
M_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX@_HO_P!50H^\
MYP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z
M+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/
MO.<"_;B#^B__ %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#
M^B__ %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"
MC[SG OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX
M@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX@_HO_P!5
M0H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX@_HO_P!50H^\YP+]
MN(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z+_\
M54*/O.<"_;B#^B__ %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"
M_;B#^B__ %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__
M %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG
M OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX@_HO
M_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX@_HO_P!50H^\
MYP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z
M+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/
MO.<"_;B#^B__ %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#
M^B__ %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"
MC[SG OVX@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX
M@_HO_P!50H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX@_HO_P!5
M0H^\YP+]N(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX@_HO_P!50H^\YP+]
MN(/Z+_\ 54*/O.<"_;B#^B__ %5"C[SG OVX@_HO_P!50H^\YP+]N(/Z+_\
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M1%(D373VT%<_>FX!^VT7_(2_ZBBTGF%Y[B7(EK<O>&7(;K:6GBBG+!MUH.\
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M'ECLD>\^H!^/;(C+\"X26H+K4=H#8;.V$A"T0BB@BZKJ@_"M$0KBB#;[SE?
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MV9(2$X+C J^1[T%M13:(JB?CHMLS.^!>,N1[G"N^46MQVX0V!A*]&DOQ5?B
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M,B4NJFNFBZI[*(CV,^GWB_$K#D&/6BV/>YY/&6WWA]^4\])<A]M6Q9%TR4@
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M=SG]HI]T]/B>V?<#O7VYB_NYS^T4^Z>GQ/;/N!WK[<Q?W<Y_:*?=/3XGMGW
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MHK[1545*\NKISIY5+43:6UR4H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H%!DQ/E%^"OM=K_JR^CCJ[F77Z!YR@
M4"@4"@4"@4"@4"@4"@4"@4"@4'3*_P 5_*E?,[E_M?S==/>P:_,/2\G>O?\
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M>[=OQ[W<#;IM]N[_ ):WJ?[6%_K"1OE5_ ECYMR3BG)++QY.QUG#9TB7%O\
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MI\/1\ISR=OUO?F97^C_13X>CY3GD[?K>_,RO]'^BGP]'RG/)V_6]^9E?Z/\
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M5T]!U1=$5/,I:=O*?/=LS'TRW;,\.MLF8W?1>QZYQ=RB]:W)$=Q'C>5L311
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M45*(\].^A7"R<N41C+;W'QN6:OQ+,V3:M,2-4VF:DBH[M'RIJ"%IXE1;6JO
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M^-&HW-IZ6+G8+9>^7>5,?;^A.)8S1/,6,W@<E-C$$Y.\F$,E!!;WH&JZ*I*
MD6U=!+D'J=YTA66W\RWC%K:/#-RN"P0A,*17 &$<-ON(XKB+NW-D*&0(!$FF
MT45%H4NCES+.7HY61[BJ3C,3'KI%]X*\9#)[#AOEYFVF@,A14< A45VEUUUV
M]-2*]MGJ;S*Y>GK+^03MT"-GN'W!BURFMINV]XG9,=I74 7-R:BZ::(XJ;AU
M1=%TH4S\3Y?YVAXM<N6>3;+:(?' 8ZMXM<6"2I*?F'VDB@JJZZ0)(W[M2$MJ
M*G@M"E$<G9IS+G5MXOR3D:U6R+C5ZOC-QQV5;MPO #AMHC+H$X?E(-#!5Z_"
MOLHK]$Z,O'=Z]2/-E_/+<ZXQL%L?XJPB4468<U#.7,;95.ZZ*HX"HB J.J@H
MFP537<NM&J1OU49I?^2,%XNRJPP(BX1?)+$EIJ42'(&]EW6UBN(JBBLBB&)$
M@]5]J=*$/7W&\7(XF%VMG+K;;[1DNUTKC;[,*! ;<5XU'M(*DGF#:1=5\RK1
MEYAR7$,9SGUJSL>RVV-76SO6 #.*_N0=X104210(514]BZT:X,3A0!XPY7YK
MXCMRI-Q.#;)5Y@6V=K(CZL@WHVX)+YD)J2+;OYZ FM"79C_-U]POTKQ^0<1Q
M^Q62X+?C@?1L.*\%OV&1;G%!7U<5Q=J>8G5Z=/!$H5M38.8^;<%PK)>2^7K'
M:8MB]QANXM:;>?Z]R?.- !EPNZXJ"(KW'=R:Z?)7HJ42F/A7-W,EASG#\?YK
MM-L8LO(S6_'I=KW [%DD@$##PD9Z]7&P(5ZHIHNY=%2A3'RWG/FW)\XS&Q<'
M6"!/LG'A*U>GIHD])F26U,3:9 7 55W-.B -^8MNN[4A&A2"^L"]<FWO ^/K
MC>[#&L=FF/1),V$ZXCDZ/D!-R$["Z%_B>UYODZZ]"T5-*+"U\UYHY2XKXLM\
M_.+);G^6K]<RM5DM5O(B@JA]0=-$=(ET3RJ(N=2(?!-="4X\8\R<I0N5&^'.
M;[7 BY!=817*PW&UKHTZ(B9DV2;B$DVM.Z$FBH0*FA:HM"D0PKFGU-<G7>]0
M\,LM@6T8_>O<IUQ?$VB6/W5#M[')/F4017#(=%]B=>BEIG7?G+G/+>4<MQ'B
M&V6,XF%2%BO6N[.BW/N!-&;;AMH;S6H;FR^1IM11W%J24*>IK>4XX$4KF#;=
MR)EM9C;"J30OJ*=Q (D15%"UVJOLHR\-YDQRE<O5_(:C6*Q7.\!")+7#N*(]
M$*Q"1B+QH9II(V*7X%]FE&N"Q<TYSYEO^<Y?CG"%EMTFR\=@JW^7<45QR1(:
M0M[+0HXWIYFW $1\Q;%7<FJ)1*?<P]4M['T]V+EW$(,-F^3+LW9[K;YHN/L,
MNBV^3J!L-M?,K8&"J702Z]:%+/X>N?.UVE7:;R];+7:;6^U&?L<2W+O> GMZ
MN-.*CKG^+% W;O$BZ+IKH)5+Z]B:# ,3)]-S(WX5<'QU%(KVJ?BH0EO !^G?
M-KA/RCB?$DM%VQY09.<_&[#H+.;<']6J.N(NHB8E_30E!+[ZG^3<3EY1QK=K
M5;Y?,$6]0K9B;4>,^$.=$G+Y7E;5Y5U44!1_6CU='\TJ+30^KESE1N_<7L36
M+7(:8D0UM\QE";1_(E5OOB0&YJ$?<C>Q%]GB5"%B\K\R\T<5<<X5=;M:K.?(
M%ZNCT"[6YL77H:AO<)@65%]%0C!&]54UZJM$B&_@7[U0P\*RFZY%:<:C9.T_
M%/'XSKZ-PFHCNOO)/.H_HO911V[S'7:74O+J-C1<0\W<CR^57>*.3_H2X2)5
MN*ZVJ]X\ZCD=1!-R@1(2BHJ*'[!(5'VH2*@F$,N'J8YNOL/(^3^/\=MCW#^+
M3EA/)+WK-EM 0;G=4<%47:X!KL'0$+KOT*BTEO*WJ.S"U0.)[KQ9:X=R_B,C
MFRW7(3)U7U**#4<3!UH1)#?(#)=4U3X*)3&RWF/GGC;"+? S"UVA[E;++\MH
MQ:-%ZPTB*#6KQ[750B[KJ- )$/CN+73112(\62,^E>L"5_$V#"AY:WCI,S$M
MI*<5X!:91MT=2+Y8_*3X?8E%X,KCKEZXV#@?D_/,8QG'[!=L?O0LQXMLANL0
MWE<=C-J;P=\B(D%TD':8BG31$H,W'/4)SE"RGC27R#9;.QA/)9L1;8U 0_>0
M[RL@+ZDKI[5)7VW-A:^153H2:T*3'FO/.?L2O=UDXB6*Q,2M</Z0A-7.1K=+
M@VTUO?$62=%54"$T1!0=4TT)571"0C^:^J'+8G"6!\GXG:X27C);B5MN-ME@
MZ\RCC'?;<%K8XV2;S9U#55T%?AH4S\DY!]3V$<9Y;G.76FQ1+A:Y,!^V0F *
M4VD"01-R1/M2-55HC9T55]AKU32AL;G(>=<DFYAP[C&#,PC3D"*U>+T4IMQX
MV+<8 Z79V.!M) "1U/7J*?'0I=V4W8K!C-ZOH"AG:X$J:(KX*L9DG$1?T:(\
M1<*\?<.9!PE>\_YHEQVKQEEVF0QR:X.J+\>20*0$R2KIW5-'7EU3S>!:BFE&
MI6U+Y.Q+@K@6SM<6W5<\<*=] XX[*>1\3G/$3QB:M(VJ-M(J[6Q^$1W==U$;
M+C/ESE*W\HM</\VV^W,7^[P"NV/W&T*O:< $,C9--Q(JHC3NB]%10_*0D*@J
M=/4IZC+OC66YA8[38$QK"[BK-REFTZCKC:N(V+0ME(7=M14(R3:NB]*+2U<\
M]0V0LXCQNUQ]:(\CD+D]EAVVQ)I*46$+C;:NFXJ*"EM-S:*JJ)HA$OAM4E''
MO-N?.2>0./N2K?!B\F83:W;Q'?@[BA3(R,(X!J.[V*XTJ[535#TT$A744T7"
M'*WJ2Y8=Q[)G[/8XW'AS'HMXFM(02'6V]RDXVV<@B3:J(VFB?*ZJBIX"6HS[
MG7U!\937LER:-B4C&(EQ2%,QRW2U>N0,$1(#A+W%,%-!U$E3HJIN;3PHM-AE
MLIF?ZV.+Y\?56)6,N/-*J:*H.,74AU_D6B<'I+-/_E.R'_=DW_5SHCP9Z3N3
M9'&-@SV/=41(+U@>RNQ"XJ(V[(MQG%)L-?$G#4!5/_I=&I;[T971W#Y_*^0Y
M<KC96RV1+M=2/J]L09$HR5%TU(A773X:$I5&]3'-5MM5GYBRC'+6UPM?;A]'
MMQ(Q&5SCQ^X;:/[MWF75H_E @FJ:;00A*A2P^4>7^1I7),/B#A.';Y.2I;_I
MB[W6ZJJQF8Y(BM@*"J=50@525"^6*(B=50B%7WF'/>4O3AFY0[1!AYICYS+-
MGD)XE1ENWA&=63(BHIKY]$VB*D6A"6FOEHM.'IQN/),?@*ZGDEHM$KC:%CUT
M?QL71[SDMP'))O-3&NXJ$T1(8JFT=1H2U\+G._X'Z6,=Y!Q"P6*T3I=]=MSE
MKBQ7@MXLJ4I2(6^^I]PE9'4B<7V_%0K:F> \R\S1N:;3QGRW:+7$:RRW.76T
M!:U(CB"VV\Z(&YW#0NC#@&B]=VBHNG124B%Z]2?.%W'.LXX[L=G=XSPV0Y;B
M*>CARG% MOO/E>;4E1%1Q031$$D3S+JM%IZ2X@RVZ9WQGC67WH&6[K=X8R90
M1A(&4-2)/()$2HG3VDM&4)S_ -5'%?&V63\+R0[C]-6U&5E)&B]UI/>&0?#0
ME,=?(X.O2BT[>._5#Q=R?E,;#\8.X+>)3;KK*2HJ,M*+ *X6I;RZZ(NG2A2R
M,Z_^4K(_]V3/^X.O?V[_ )6E_P!>/^,/C]Y_X&O_ .GG_P!LH/PTQ:+3QJQD
MI0FAF-M33ES&VA]X<99><+:IZ;EZ FB*OL2ON=^RU-7KITN::O&HO9$S$/RW
MXGAHZ':XZCECFB,^;*(CFF(RF:O?.Y$\=]0-ZN&4QHERM\<+).?".+;*'WV4
M=) $MZDJ%HJ^;RIK[-*^MU7XSI8=/.6&4\^,7MW37^'][\]T'YSKZO5XXZF&
M,:>>48[+YHO9$WQ_CL^C;<ZVNVQGL<N,>&PU<)5R%),H&Q%YU!0=$,T34M-/
M;7C_ !S6SRC5QG*9QC#9%[(?1_,^FTL,M#4QQB,LM3;E47.[?/%=M?BG]0=$
MZ%$N4*3;I[0OP9C1QY+!]1<:=%0,5^)4546@\,>HWCG@S <4A<7X%95G<MW*
M8P5M;CDY+N8 Z[N7W@D7Y)@O;;;5-5Z%IT4J-0W?+%CGY#R?P%PIF;IS8$2U
MQ960,(X6R5):;5M_>0JBEJD0QW(NJ(9:+UH,Y,<L_$/K*QNS8?#&V8SF=E,)
M]LCZC'W$$E- #P1.Y%:/3X56AP:WU%<<^GCBS!;GC5FLP.<DY&^C^/1&3<DW
M!DWGQTVZ*JMQQ1%; %3S^";BU)!#"YLR3(N.^".+.(+]<GK/.OT4&\JEMHKL
MB-;(B-[HVT%12T1T041+S=M0UVDM"$Y],N:\!P<B?P/!L;N>+Y@]'T1[( 1)
MUR9:3O+N,7#1#V_K5;01';U'HE$EZKHA0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!01#E
M?_A;F_M_\ NO1.J_^Q.T'GSTB\0\;7CBZPYQ><9ASLK&5,_\0EB3RHK$HQ;)
M&W%5M%%$3:NS7IKXT:EF<R(J^K3AQ4151([VJZ+I\I^B1N=7J76;@7+_ !GS
M=(@2)V)6/N6Z]G%#N%&%PCT-4Z)YA?/;JJ(I!HJIJE"&EXJRJ#E?-/)7J6=C
MR+9QA:K.L&-/DMJ!2%CMQT)0%/EEMCD6Q-53> KU6BH#@^5Y7A?(=D]3>5Q0
MC8?R=<KA:+FR#*(L"$3C8QW%+3PU:W[D'<8,FO7?03WUL0KIB\[&.5L=T&1(
MAW'$[D\B;D5BY1G4:35/;M<D*GQZ4(>C^'L0^H?%^*XH0=N3;[>RDP433_.W
MD[TC_P#"F=&4+YQYR<X?NEB9N^(R[O@MT%T+]>V1%QIC=J ,B!+M(U^40NJ"
M$/05)==I8AYUXFQV)R?RER?>^)K)(Q[C.^8S<;*'O (Q&*;<& :0 $2(1U=0
MGD "5 %/R=4&BHJO(LAWT^AZ8DQZX_Q4&Z_1_P!&=CKVTN"S]WCKNW?J]-/#
MS:[:"W,NL3^->H+T]8Z^O<>LUD8M[S@ZJ*G%:<9547XU&@U6-XO.S+DKU.8O
M;D_\1NL1V/!0O*)2%-U6Q4ET1$(D1%7X*#+X,]1B8YB^$\-1\0NEQY"A3CM%
MWMB-^[>[Q$=<-9.IHJ[@0PW@8@B:&JD*::B82;!47[\?)"Z+I]7F-%T73_%6
MKVT3@C'IWS:VX+S+R5QOD,.:UD^49(XMM9;9U;[3;DMPG#-5':';)#0M%W"N
MJ465)VO'.*N.)64X1S38LBD9I!N)#96+2\33%QAO*+;>Q%5$ZZ*XA]=PDB)U
M32BKDY8M=KX@R'@KD*WVJYQN.<?;*+*8F-D<Z",HN^@2!-?*[M><\BKX@H^Q
M*(V7IURJ#G'J>Y,RVUQI,:UW6UMNPPFMJR\30.1&Q-1]B&@[Q3\U4H3N6-ZS
M44N KZ@HJJLJW=$Z_P#XVW1(47&S.#S?GW 6+8A;YXS,"1B5DI2V.V$<8B0S
M-=R*2;=(B[273<I@GRETHK[ZH,3OT+FA<<Q\4"V\S,VF#-)$73WJ#-9 M/9Y
M>VRX2_X2T(>Z+= BVJWQ+7!!&H4)EN-&:3P%ID4 !_D1$HR\:\Q\@6/C#U>6
M?,LD8E/V>'CPM.A":%YY2?&4V.@F8(O4DU\U&HW,#CG&;WS+E_-&>XS8'\=P
MS+\<EV:RQY0)&"3<I#3"-.:)Y%529-QTA54%7--RZJM!!)?(K^2<"67TTP,>
MN*\J1[H-OD6XF-@BVS*<DH:JJZB6I"!(2)MT(E5!\0E7*UKQ7%>=[+;^<X$^
M\<;P\8B6W&ABH^31RH[#;1(G9,"4E=%U5%"W:D"EY=*"(X<VT'I0YF;BQW8\
M?Z=MR,1GD7NMM^]Q-HG_ (0IT*B\7IV_XY<\K]'$.QV=@Y%S>P^U/1XS:*KK
MA1(\>0H"*=5(D;44'VKTHSQ>7LFY6LF;8%PIAMLA3@NN)SX42\/NL;(H.L=M
M@0$T5=Q&@[]/8GCUHT_20D0A45\%31?Y:,/SOLF=_P $N.>4O3]D]HG%F=VE
MRV;"C;.]N6W=& A(XB^*CM;1T%1%W[M$ZT:2;E3$+K@_IZX2QF\LFS=HM^8?
MFQRU4V7):R)*MDG70@[NU4^%*#W71EX>Y-Y*M'$WJ_N&97R',G06K(S&%B
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MB(B)X(E 01155$1%7Q6@ZTBQDD++1D$E$.PG]J=Q13V*6FNE!]?CL2FB8DM
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MN5%+KXT:ED<"<EYWB]DXDQ/(+!;FL%RV*_ LEQB27';@$B*!O=R0"BC:"[[
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M7E3D^WPLNR6Q6>TX1<H3KD!R'(>>GG+:D=KS 7E%LD%Q?%231/AZ"5S40H%
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M2PN8<AY,[N185_#!,TPN^P$C62;"D JC)<:5'$G ]_BT%Q4(#'3:@HJ$I+Y
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M7:$]].V/7O%.&,4Q_(X3ENO4%A\)<)[;W&U*4\8Z[55.HDB^/MH2L^B% H%
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M6Q<WRUOGMGC>?)CN6<,'&_2@990-UU2X)%-P")5-&U'70%5:"B7\PSOD[#.
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ME0=X:$GF7S:^Q*#2X%DW(.3<!6?-[=E-HPE8+UVDY!-6T-.Q/=(LEX=0CMD
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M16YMKG-DQ+B/)N;=:--"$D]J*GC0=T.)%M\1B!!9"/"BM@Q&CM"@-MM-B@@
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MNP2\Y:_"'DT%>A4)=/J9SRYX?C^-6JV7.58QR>\LVZYWJW-%(G1K<($Z^L8
M$B[Q(*"*B*Z=?PT(5%&Y*RV'QAS#;+-D5_N5HQV+ G8=EMZ9?B7A EF(2&7'
MG6VB-6S'02TU5%7V:(A4QP^'F-GY3;X]F9Y?KS:LUP=R\2)DY\"EP+D;@L=^
M"J!M9VHJJ (BHB]5W:)1$ XXB7S#O2%DN<67*;PW<'V)(PHGO"#&MYQKJXV3
MD1!%" G455<7=U5?91>*73\1GY%ZF,4EGE=[@/SL-8NYE"D WM]V>:;.,.H+
M^H>(5==%=5(U7JGL#67C.;QQY:?41D6/N=B]_6:#"@RE'N=AR:#3"NH.BZD
MD1"FB^;3HM!VX!R?>,5OV31;+D.19OB$;%)]_P#?,KB267HUZM@DZ38.O--?
MJ'@ZHWUV]$1>BZAJ[-9<E3)/3]G.1YC=LCGY?,=NDR!<3 X<5^1 [J>Z (CV
MA03V*"*HKIJFGA0>N<JMIWC&KM:VYTFV'+B/-#<(!HW*84@5-[1*BHA)[*,O
M'O'<W)N.O2E R?&<AGE>\OE1K/:V)I@]!LYO721&-V(UM114Q4B+55\^A>S2
MC7%;F!?6KCGFPN*[GE5SR_'+UCJW^'*OKJ2)T6='E=AT!<1$56C%=R"OR>B)
MX*I$2OU$R<GMG$E]R#$)[]OOMA[%V;<C&K?<9AO ;[;FWQ!6MZD/MTH0J;.>
M7\GAW3E;/\;N3_T!A^,V2!9[>I;H*W3(B;D#,[:Z@;K .@G7_HJE!L+7;,WP
M/D3&>.KEGU\O]MY-L5U;E39KXG+MMVA14>*5 <45[0Z'HVWU05ZKNT30*YXZ
MNM^XL])]SY"L607%ZZW-URV6Z!*,7X%M=.[.QBD1F=BJCBB1.%KNW'ITTHO%
M8'!N:7-OE!S#[9DF29EA5RM!S7+CE,.2S(AWB.ZF\6W7VF_U+K9*J-]=JZ(B
M]%U)*]^2;_:<8P2_7J]WES'K?'B."5YCBCC\9Q[]4V;0$)(3F\A0!TZEHE$>
M:.+;_?;WR%E'',;*<V^K5SP]ZZ=_+A]WOD2X>] RC\)3'RLDVYN#1-->GY-&
MD[]&V.OVSANT7UR]7"<S>@=5JTRW1.# ]UFRFU]T!!10[NNYS4EU+X*)+I]6
MN/O7B%QLZW>;A;!7,;9;MD!P6Q0YQ%ME(BBOZ]CMKV2UT'>71=:$-1FV!SKK
MSK@^%LYA?+<ZQALUJ1D<20V%XD@U)1//(4%1",MI&0AJNFG376@B+G,>8GPI
MQU!O623X4S(KY/M%^RNW,D_=OHRTO.H79%L3/ON"@!W!%5315775:+2U_3=F
M-XO4G,L7DW*[W_&K!)AN8SD>0QG8UQDQ)S1D;+RN@V3A,.-D.]4U+77HFU$)
M+I]5KMS8M/&;]D8;E7MK/K(=LBR#[3+LL0D*T#AIU$"+1"+V)0A,K_;>2,OX
MAN<:Z2 PSD4F7GXK]FFEV6'XKBN,(LA43]6Z("+VO@)%05+Q7DF8<ZXER!R!
M>+[-LUG?M8X_:;1;)(HD63%B-OSI>W:HHXZZNC9*B$C:D/P+00^TADF ^C9,
MNQ[++NW=+HEK.&)R$[5M3Z31DPAH(BH X)+O%276B\5G<@0(?&N(V_$;WR/G
M%QOV1W9R7#6S$,W(Y@-QT1^+$06_U3 %H[Y4\JKIU1:(KW'N5<^<X7F6V#?Y
MY7BX\AI@-CR*[M_^,1+?*[3@N21+K[P(J8EN\PJO3Y*+14EE7?,^,[CRIQDN
M6W7((D/ YF8X[>KL^CUUA/L@ZP8>\"(J6KB(X'3RZ)I[54C7OO9UB/">-Y2Q
MGM\N64<HGC-L6;<7A>;M"W4>X\Y":T1!)07MJ2KN73=JA45KW[5>>-\QYL8A
MY1=KQ<K5@;4FVWRZ/H[<VE$'3!%? 0W*!)J):(OXM:#>R'<QSK)>(,27-KY8
MH608*-RO4JTR49E290L,FKBF0DB.$1:JYMW>*)IKK08UFY'E3N!+&SFV8Y#'
MR23?)EFAS,8:%[(KL$!]T.RVFPU0MFW<YT741U55+S!%$Y*SAC@7DX[=DU]6
M5C6208%ANUZW,7YB(_(BH3,I>A*8[B$MW7JOLT1 M;-K-EO#UMPR^1\UON0P
M&\OB#D[UWE(XA6R[B$1P%$!$4::<03:#302-:(E7#%WR#*LDY,RNY7&2_8%R
M%VQ8Y;W'-\1F-91[#CT<4Z(C[A*I*GBHT):?GQMN=GO"MIG:':7LH*4\R::M
ME(B1U*/JG@JH1+I^&A#$N/+F.67,.45A81)M'(6.X[.O#UYGLM-A=(=I7LQB
M$P-3)EPMJ@NGR4^%-*%*RXDY)R0,SP%^-EN39:YEHJUG5LO$&0%MA/R6$=9=
M@&K(-M-MN>0MA*)CUZ(O0K!8OG(L/&RY6'/KX],M^?.6!NP//B=J<MISD:)I
MQI1U)51?*2EY!Z"B+UH,_E3DV]W/D//H+>8Y%C4G#08C87:<>B/R(DNX)&5Y
MPKBK3+HF+CBHV(FJ(@]=.BZA);A=,WY6SKCFQ.91>L)CY%A9WB]Q+,XL1SWX
M'!0T1'$50\R_*TW;4TZ:JM$:#GC,QL<N^IB^>9R[DF'0HC*C9VD<QZ).;;!%
M2Z.BVB&;Z>8MY*@DJ_\ 00L+"Q"<_=/4ZU<I6GO4SC*#(>VIH/<>N(&6B>Q-
M5HG!*O4\NG N<+_^0@GXY#5"'C;D>XY!,XFC<+S73&7Q8[<;AD1F*HCD1N0Q
M&M*B7@O<&X*B#^:*45>'+G($B3R8&"W'+\@P[&K+88LUAW%8S\B7)NLM=0*0
ML=MQ>PV")^K7;N77K\ :J_<RY?=^/^(;7EMVNV*/96MW^N%XLD5U+TK5B566
MT8;;:(VUDDH&9@WY?%/+JE"D:SR_Y#F'IIS^)=[W>9T'#[["2R7:>PY"?N]J
MDR608;G"\V!.JT3BFI=/. *OAU"\,G#(L R?A;$XF5WBZQ)]XN#5VF7*0CDF
M<TK"O $@@$4,04M 14Z)^.B*?N%_Y&B8[F7+#.?7Q)6+<@R;);\>)]"M3D#W
MUEM6GFE'4TT>T'4M!1-$3KJA4XY!G9MF>8<PO6W,[MB]OXJM$5ZR0+.Z++,J
M7(MSTYUR8BBO<34.V*:]$T5-%3J%W\.7*X7GBC"KM=9+DRYS;+ D2Y;Y*;KK
MSD<"(S)>JJJKJJT9E0?J-SB-$O60ECF9YI'R+&+>V\5OQAG=8($TA)QOZ3=$
M$U1Y%'5")4'_ .]HL,ZYOYGR;R;B.+EFUYQ>WW7CJ-D5P^@'AC=RX'(VJ2(J
M*@ZJ::J/51':BHBJM!I;!R!GO(O'?!N*R<DG6BXY_*O+-_R.VF+-R*)CYO"@
M-NZ+L-T1#<XB:ZIKU1512I]Z9[9)LU[Y:M4RY2+Q(AY03!W.;M62_LC@B&ZH
MHB*>GRE1$U\:)*2<_P"16BU6*T6>;D60V2YWB:H0(>&M(]?+@+#9*ZRPFPU$
M1WB1&FFBZ)[=*$* A<BYY,X2OS</*KTS,M6?Q\?M5[N&K5["VNFSM;EHNBDX
M/<7>)^WRKTZ45)+FWR-8#YJXZLV;WRZO8_9;=DN/W6=)[ET8?1"DR&0=;$-0
M>0%#9IM1-$1/%5">8'G-]Y-Y<L\^WW%]C#[3A=ONUTMS#BHP[>+_ *N- \"=
M"V,H2CK\DDHBS^3K_:<8P*^WF]7MW'8+,8@^F8H([)8=>T;;5D%$D)Q3(4$=
M.J_CHCS'@G)^18MD'(<:W7?*[K9;1A$K*(L/D%I0N+5TBN*@*VBH*^[&)(7E
MT3V?DZT:?;#CN0P.2/3SE60Y?=LFG9;'N5VE1KJX#K$23(M /&,1!$>VVJ.H
M*AX>75--=*#*C\B9_)XU8L\/(93-_P MY+?P]F_N%WI,"W.OEJK&[P41#:">
MQ"714730,J^9!G'&\7E_C=,MNEZ9LN-,Y'C%^N+_ '+O%[R]IULY(H*GYTW
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M%O7MIY5+1=U"T0L?IXY"M[N#VFYYU%FX7Q]>&KG9+:-M[<E]EDS(4?>1W_&
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M)U7H<5X7C9%!(="(@'0OBH,*\\3-/<GX=R+CC\6SICS$Z%=K>U&$4G19K:"
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M=\DEM&_&L\&3<7F&=.ZXW$9)XA#<J)N5!T35:#%P?)AS3#K%EP1EAMWR#'N
M15/N*T,EM'$!21!U5$715TH-_0?$5%UT5%TZ+^&@^T$+XNY"C\GXFWEL2 Y;
MHC\J7&8COF)NJ$-\F-Y;41$W*"KHFNGAJM!L,>OV0W6^9';;OC;UFMEID-,V
MBZNR&G@N;+@*1.@ =6]BHB*A:^/PHJ($D147P77V4'S5%541>J>*?!00SC/D
M"+R39)]^A03@1HUTFVP =,7''$@N=KNEM1$'=I\G5=/A6@^\G<A1N-,<9O\
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MLA-=PL!W%W:EUZ]:*EUXXTQ+*>3<HP&ZQY*XEQOB,(</M;$R2R,5]\#<62A
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MC9EO[:D8=5]B(G1$H.S,>/L>S3-/4=?KTLA+MB$.WW/');4I]@8<QJSG([J
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MG9GSU<LM61*?X\L,(<19;DO,! <?M+TQXT!HA0B-T-"WHJ*.J=4TT"_>"O\
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MD][ XLIUYX6SV&R2JYVP4G"$%UT%?"BQ"<N9MAL>P!E3^1VP,9<78%[*9'&
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M9]CTO%LKA#/LLU![K*D39(;9(0&!@J$)"2:H0K_R4$0L' '%^-1;[%MEK?\
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MX\:\/E$E@Y&.8?;8)QDF4=0'"Z">S;\?1:%)C(S3&HV60<'=FI]:+C$<N46
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M_8G8<0]3%@S&7%C97<+U/=AP99 DN3'EL MJ5H"\S@B2H8;479\KHG6@VF8
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MAFM<=L38TQBV6RV\RS79=QE,^\P8*:D++\AK445ELR35%5$ZI\-!+LEQM]C
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MA(53HJ*BZHM$=M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M2XRV3L3N@C9]@E'5O<*();--4Z4&PH*DX:X-L/&ME@.7:!:[EG,9R8X>1,1
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M5Q-G?UV_%KTH4V4SF^YN9[=,.Q;!;GDENQ^7%M^0WN&_';2+(F"A#LCN*AN
M"+YSU1$T7V=5%+@HB%9#R+#QO/L9P>X0S$<HBW&3$NO<%&@.TM(^ZV0*FO\
MBUW:ZT$%Q3U)V3,<?P^]VFR22?RW(3QL;>3S?=BJR!.N2'%1-"$&D%Q13KYO
M'X2TK3C3G"[X1]9%R+'KM=\6E9W<;=.S$Y(.,Q')+[;##2-.$KA ""F[;M$=
M41-572BTM'//4#]4\COMBL&'W'*XV(169V9W* XRTU;6) *\*(CO5TT;3N$(
MZ:#KUZ%H2ELV*]VW)+);LAL[WO%JNL9F;">T5-[,@$<!51>J+HO5%\*(HW)/
M4\[CUQRC_P"X.YS<7PRZ#:LCR%B1'[+ F8 +@-%H;A*IIJ"?)145236BTDV=
M\X.8UD"XSB&)S\VNL.W#?+T-N<:9"%;G%782DYKW'31%(&13<2>%"GV_<]6A
MBQ8?<,)L\K+KYG@./8W8XQMQ73:CM]R0;[KJJ#2,Z[3UU\WQ(JH*8Q>HBP#Q
MRYFY6:<E\9N_U6<Q!4%+BF0]Q&_<M?DZ]=^[\SV;O+0I'>&LLR?*^<>2'<GM
MDZP2H5LLC(8[.D#*&&I X1]DFE5M0<7]9N%.NM"5A<J\J+QG]76F,?EY%/R6
MX?14&#!<;;=[ZMJ8_P"-T'1533JJ(GBM!&K=ZC+*F"Y7EV56.;C]UPR;]%7C
M'3)N5)6:XH"PVP;>@N(Z1H*%T3HJ_)\RBG"U\XWB\M9/C5SPBY8_R-:K.M[M
M^-O26#=G07%5L76'QT!"$]$,53RKTZJBH@IA^DK)<DO_ !-;&;]:9D=J(!'$
MR";)"5]*E)E23=<'S$X/;)$$NYXZII0EA<X93DF-\T<3%C]NG9 Z;.0&&-0I
M Q@EOI$!L"<5PA:1&D,CWFB[4UTZT(2"/ZBK ]QN6<E9IP7L;NN+)B"()7$L
MA[B D$5Z"I+KOU_-]F[RT*2+C3E(L[FWO'KU89.*YKCA,?2UAF.-R%%F6"FR
M\T^UY' )$7J/@OX4U#=9YD^08M:V)6-8K+RZZ29 QF[=">8C(&X2+N/.OD@@
MVFW;NT7JJ416I^I2 UQQ+SMW%[@-SM5_^JEXQI'&UEL7)#$# #TVN:;QTT1-
M5Z=/&BTE'&O+3^<W[(<2ON,R\3RO'4C/R;9,>9D]R+-%29=!QGRZZ)YQ_)U3
MJO70++HA0*!0*!0*!0*"#<RWR=CO%>6W:UL/2;HW;7V8#,9LWG5DRA[#2B#:
M*2[3<0ET]B4(>=++Q=F'$-^X1RF1>;C?H33P6"X6I8HHS:V[U%5'$161W=H'
M54B)WPVIUHTUV2X_?OX(<Y0AM<PY<SDN7*B1PCNDZ_'6X021UH$'4P5!54(4
M5.E!(?4CB-XG<L8Y9[0.EIY8BQ<9R!051, L]Q9GF^BIUW>[J0?]%%H0]9-M
M@TV+30H#8(@@ IHB"B:(B(GL2C+Q+>^+LSY/Q;FCD5J[72U#=+I+.)BXQ$_\
M4AXV(% (MXH]N5040$/RD]NNE&G=RC:\LS6[83.MEKF)"YBL%GL66$+#HE"D
M6^XQI;[KRH/DT;(V_-IJ**J>%!M^;XS;O(^56[/(633;-] QPXN@8X,Q8A2N
MP8RD(8GE[R.Z?XSIV_E)IMH0Q\7DS^-7>$^0[_9[BYC;>)2,=N1PXCTB1#EN
M$CS2.L@*FG<7RCTH(^.)Y!?.&8>1I9[['CV7D:9D%UMT-MV'?6K2\1(X]''1
M#1YI#1?+X:*NOE6@DDG&\,N7$/*^3X&SE]RN5PMC-N=N&4#)>=F@T2&"1>\/
M<-&^HEJGE_!0>J</ V\1L#;H$VX%NAB;9HHD)(P"*BHO5%3X*,O+D*Y0XW-M
MHF<.6K)K!?;S?5;Y%Q>XP'6+,=MW&DBX%O4FVW%TWM$!>;=^2OE,TT^2V"^K
MPASE#:M<TY,SDN7*A1QCNDZ_&6X021UL$'<8*@JNX4TZ4''G.+[_ )CRA"SR
M#E%QNSMN9'B^+9@FN6SLE#5'2VQ_U:[7NLGO:^7=I[*$+!PBV71KE3A^0]!D
M-L1N-FX\ITF' ;:?VLZMFJBB"::?(+K1$#S?&;)C?*'(47D)K-DM>6R69U@'
M#SDE#NK,B/VGXKK3*;"= M0VN+U%?8BIN*L^RXN./>H#"(-GA36\:M/'Q6Z*
M_*;-5;1J6*-M.N;=J.H*)N'Q^*B*HP^V7_%>+^&.09EDN#UOPJ_7P\@@-1G5
MG,0[K(?:23V%%#46^BEHFO5**[,QM]]S3CSU \EV^R7!BTYM(QV-CD%^*X$Z
M2Q9'66#D(PB*>P]VX>G@BZ^%!+LLO$KC?E+/+A>+'=9UOY Q:$Q8'[5">F]R
M=!BG'.*2-(NUQ=V_S:(@^/C1$%DXE,M^$\(9GD,?(H>+6BSSK7D4G&U?C7:W
MG)7<PZ0M)W>T9(HN=/#X=412I%?,4L#7$EJN>!6[)76;WG=JN<TLC;>=N3QM
M/=LY2H2*?;-!0D,O'VT'L"C+RUE&03>(>3.69=VQ^Z76+R+ M[V*2+9$<EMO
MS(<)R(<1PFT78>\T5-?R>OM1**Z,:P;),4R;TQ6>YP7O>;) R3Z9, )QN([+
MMXN(TZX.HBJ$7;\=%5.FM!Z2S #<Q&_MM 3CAVZ8(-@BD1$K!HB(B=55?@HC
MS9<,)R3)?1GCUEM=OE.WZW18%P6U-H;,UT8<ON.-MHJ;D<[>X@T3551-$552
MC7%PPS#\'Y B9L_A)9K,RF5BUPL#-TS,Y!1 6Z-F/NH.2.N\'-",47:FNNJT
M$CXKSU<IP*V<)IC5\MN40<9=L=ZES8)L08$F'$2('==-1U[RIN#8A+\/Q$5[
MCTR^9CCO$/"S.,W6WY9@V06^XY8],BFU#A1+$3J*:2%382O(:*UM715Z>U-2
MK4XEL5SE'SE;G8[L0[OE%V"$Y);-H' D1A;%P5)$W JK\H>E$4YCE^G7&T\&
M\<.XY>HF3X1E$4,D1Z ^D.*D<W6Q4I"#L7>A(8Z=-$+5=$34KU3R]C5QS'B_
M+<8M"(5UN=LDL0FU5!0WU!5 -55$3<2(.J^&M&7G[@ZQ8)>\IQ/OL9Z><8M$
M)V1'OYRCM%JFA'2.\SJ^B"*'JJ-"'B(IKIII1J6B@V2^)P;A\1;7,26WR<U)
M=CK&=1T(Z7!\E<(-NJ!HORE32@M3&;B>->J+D"!=+=/1<RB6,[#+:BN.0W&[
M=!<&0;CZ)M;0211\WBO3QTU)P51]$WF%Z;+?)?M4Y?H?//I:X1PC.+)"$S<W
M")U&E1"5$0D]E%6G>W7,UYNXSR&VPIS%EN.-7Q$DR8KK),I);1&^Z))Y"5.J
M"2HOA1%/\4X/BS+F-<:Y_%SQ,ZLUT_7V>.Y)<QQER+)-YB:&J=H8ZIM7>/74
ME5.BZT5WY[<+AA^/\Z\8S[!=Y5^RZ]R,@Q]Z!!>E19$&X&PXI]UL5$491M4<
M5?;T\46@]D8R)ACEG!P5!P8,9" D42149%%147JBI1EYDQZVW*Z1O4'Q&-NG
M1\MR.ZW^[VHWHQA!<BS&6ABK[R6@(KI*FB:^'7V+H:=.+WJY<FY#PQBUNQRZ
MVN5QP*2<SD7*&Y$8AOPH0Q18 STWJZX*[43KMT73Y6T+I]099D/#V4%@/O*9
M*D=OM+ U]\]W[[?O/8V^;N=CN;=OF_-\VE$A1'#EIQEWG8KCQU;,@:Q-W#)4
M9;AD+<U!=N)3&E<1MV7K\6Y!5!W[MJ:45\PAVX7CT?9/QS%LMS;R[&;=-C7*
M#(A/,J3[LZ1([;"D*=TA!-2$-53HGBJ4.+ER(K&:XYQ#R4Q$R1G#L469:<B=
MM#,B!>XPRH;+"2F4%.YV0<:47"'Y0ZI[:#'RC%<<=X'RB]\?P,JEO7^_VDY3
MV2MR'KA-]RELZ26A)%<)I1)4WJFJ[=%TTH)3R1B-_P HY-Y;MMJ@ONO7/C]F
M+;G.V2-/RA>(Q9!Q40-Y*FB)K1&HPS+_ *^<J<'% L=XA?52SW6WW]^=;WX\
M5B:=K%I64>,415$FEU7I\H?:NB%7)ZC"R\>(KZ6%>^)=$6/[TMJU^D/H_OA[
MU[MIUW]K=X?DZT2'GK#K3CIYMR%,XZM&0AB4GC:XQHTJ]L3C.3/5U%,8QRT4
MR1=438GB:'M32BI=C=JN[4STL$=NE(-NMUV"XJK#B)&([4T H\NW1M57HF_3
M6B*Z;FW.S\9X[PA,QZ\KF&,9M'>GN-0'W(7N7TDY("3WQ%0[9HZB!UZ^/AUH
MKW@J(J*BIJB^*49>1^%,&R$.4+KB%TMKL+%N,8E^MF+SW&C$7?K'/)YMP")$
M$MK&Y%VJOBE&I1NT+D-TXZPCTWKC5SC9Y8<ACE?9#D4QML:W0ISLHIHR5\A@
M0$.S3Y773Q'<%D8\C[/,?-.!SH4Z-<,Z:CN6.>L5TX!,!:G&S=.0** HA%MZ
MKU+R^-$5WPWB>'39^%8=ET+/AS[&9K4F1:9!R7<?MTZU&3C4CS)V@8/;HVK>
MOR]NNB[E++U;R:N3IQYE"X5O^M:6R5]$=KJ[[SVBV=O_ .F?F?X6E&7D_B6W
MV!_F+BBYXM;<G*6Q;[J.9W3(&IQL?2KEN5"$7).H"XA[^YLT!=01.M&EM^F:
MZ%;_ *Z8#<;=/A7^WY#=KE(61%<:BK'E241I0?)-AJ:>841>H]4Z=:)+/]4+
M<IO%,/OC4.3,@8]F-EO%V]S9*0\U!C$ZCCB-AU712%/PK0AT%(>R#U%X-E,*
M#,;LTS#9C@O28SK/;[\@7 !U"3R&HJB["\R?!04:QAUZ_@QQWD5PMU\:MN,9
M3>'\@9LR/1;U'@3Y#P>],HB(XB-J@J6U-=J^Q-50J_O3W8\':;R3+L.;R<W+
MT_&C3KGE_>61.2 V2-.L$^B&;8HZ3>XOS=/91):3U'2(MLS?B;(+O99=\QVU
MSKLY=8T."5R78[$;;#<T@J*^=4TW?!JGA0AQSGE&%E?#5XL_'F*7()]Z?;P^
MTVBXVIR$T+MS#:;G;1%$66FE,MZIM0D1%\:"+8UCV08UPGRQP(Y;7I5YQ>)/
M*R36(AM#=H%R:*2TX"HBHX\A*0$(DJIY1\4HKG>[H>;<7\$OV*VW%4L>:8O#
MN(2(;S+C:V^,0/N[2'JR)+M[OR=?;1&VY\[9<IX^SR SD$CB8[*_]'Q\;28J
MN9-[SY1?]R5#558T[.J_*^+?0A7.%VJ_8GQMQ%R#*L5S<MF%9'?#OUN]W=*Y
M,0;HZZTD@F51#)&M$4]$]M%9.8V^^YIQYZ@>2[?9+@Q:<VD8[&QR"_%<"=)8
MLCK+!R$81%/8>[</3P1=?"@MOG49]CE<6<B);Y4^RXC=NY?FX31OR&(LV-V%
M?[8(I*+:IYM/A2B0IO(RN67\<>HJ]6NR75MB_P!SLC]IC2X+[$I]D'HZ;P9(
M=RBJ#O\ #H/5=**M-RW7+^,W($I(4CW9[CV.PR^C+G;-]-_ZL2TT4_\ !3K1
M%8!&EP\*X8@\@1<@:XJ"RR@N42R!-;>^G.XONXRQB;7MJC_B4_.U]FM%8^+V
M"[IQGQZQ&LUUCA'YCBS?=9\=Y)S,%#<5')*$.J;45$<->F[VT%V^JA;C8,+L
M_*-C; [W@%VCW-KN>!1I6L-YM?B)7FU7_HT2$XX2P\L#XIQ7&7149L>"#]P0
MOE>^S%63(157JNCKA)0E6'*KCG'/-$;DN\VB=>./,EQI[%,@6VL'*<BOB^K[
M9N VJ%L<%>VBI_A>W1*"IH?%%\+@7(;I8\;NEMM#F<-Y79,:95QJ])CL519!
M&MZFX+Z-J1@JJ1>7<F[5-2I=9+#@UZP[E7*\(:S6Z7TL/N5D&YY7[R\$EN5'
M<=]VBJ^F\S;-M-PZ>7=TUW4&XQVTW9K+O3"XY DBW;L5GLW U9<08SI65@$%
MY=NC:J2;=#TZ]*(K/CCC[%8(VSB3D2-GA9= NYL':[<<DL=)L99/,7  1.R$
M?11(S1==VXO;15]\8PKS'Y4YSDLQ7&')<VUE:WY#1A'><"WF**)*B(0H6F[:
MM$><L>@#/O7&#]PMF62^7HN9PWL^FW5J<[;V!&4XGFW(K ]%!6B;3H"'N6BO
M2G L&=#R+EXYD5Z,$G,YST8GFS;1UI6VT0P4D3<*Z="3I1):OG'$',UY4XTL
M+\5YRRW*V9A;KE+!HS:829;&P;)PQ30%WHBAN5-23IUH0K?B#!LBQC,N%I-_
MMTQ,BFQLJN63SGVW#,9,IL6F!?<5%051EEL4W+^"BHS@_'V*1#8XDY&BYZ>3
MLWIUA;7:W))8\]'*6KS%P $3M PB*AN%JI(J*7X W><8U9<<Y0Y"C<AM9LEK
MRV0S.L X><E8=U9?CHT_%=:9\A.@6H*+B]17V(J;@F^5L0.+N3^&[@Q:[L[A
MMKL<ZPQ39BNS9+3KK;3;#3Z-IJAJBIXI\/P+H1&N0++>71]47:MLMQ+BWC?T
M>H1W221VXZ(?95!\^U?E;==/;14KN^.WB\\OV2&Q$>!J9Q?+MB2W&C%AN5(<
MV"!FJ;4+KU%5UHBM+!ER2V> >/IUENMKR3$LA:@WL9T-UF,T_'!QH0%\D03,
MQ_6"(Z^776BO4?-L>1,X?SJ+$9.1*>L5Q;98:%3<,RCFB"(BBJJJOL2B0J3%
M[9=&^1> GG(,D&8>#/,3'#9<$6'E@L)L=51T M4TVEHNM!5\2)=;=QW@L;*X
MM]B\7GE&2%G3%J;E,S%4W"*W*X+"(]V%<W;]/B_*VT5*N+>/PRSB/FS$XMJN
M=O@7F[37<=CWUIYN:2-QFGH1N>\>=5[C;:JJJJ_'K06!Z5'+IE&*WSEO(6@"
M_9W/!PS#718=H8"WLIUZ]#;>7^6B2Z?4J4E+O@29"EW7B(I4],R&P^\=]7O=
MQ]P1[W3];VE<W:[?^MMH0H;W;Z X3S"6W:+O#M?\3(<VUP;HP\-T<A(4<FM1
M?\YN$*:=574O;14_R.X.Y_+YJY1M=NG0L29P-['(LBY17(1RI@@Y(>4&W40M
M&OD%JGC0=G'MU<Y1R?A*)8;5<HT3CW')H9-<9\-R*RVY/M#4!@&7#1!<WD/<
M':OF#S)X+H$<M"Y#=..L(]-ZXU<XV>6'(8Y7V0Y%,;;&MT*<[**:,E?(8$!#
MLT^5UT\1W!M\\LUY>QCU--LVV6XY/N5I* (1W260(]C<K2(/G1-.JCKI06,%
MKN;OJ,LTH8;_ +G_  V6(LHFC%A))3]4:5Q4VH>G7;KKI1'9Z1[O_P#VG@83
M+M\^WW[$R?BWAJ=$=C-B])FR71!LW$1'%0=-Z#\G5-?%*$N?-9S<0Y-XXY:?
MMLNY8G8 NMMOY6]@I4B(-R8$&'^T&I*&]%$U]GX51*$*AOUFR._<:YWG8V2?
M$C9IG-KN-DMKT=Q)I6V*^TV$AQD44@[FBKHJ>S7JBHJE3/D+"[_E_(W,UGM4
M-TI%UPJ!'MCI 0,OR6C)Q&1<+0-Q*.WY737K1&#P=9<!OV78Q+5G/7,UQ:$X
MZZ&1G*=M5KEDPD9^/N?%$%315V"'RD%-=--*+*V/4GBU]R[B"]V[&XA7"\QG
M(=QCV\$U.0D&4V^;8HFJJ2@);13J2]$\:)"N8E^D<Q\IEG6/62YP<7QC$;E
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M"@4"@4&/&GP9AO-0Y3,AV,6R0#3@N$V?YIH*KM7IX+09%!%<6P&SXG?,IR&
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M? MMLN*R7/I1TH,Y&^^;*IVU:=(5%!^4/MU\:*]F494;ZP?_ "\9=_TK9_\
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MH>XBCH6Y$T6@S+SRWF5OR+%>,.,K#8V[F[B\6_I&O,IR)'<871D(,! TU<%
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M3X*(W&81N1>-^6\FSS$<1D9C;,UM$2( 0G&P<AW6VB332/H:IHP8KN(T\/\
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MX:->=K:V1]4#35>HCJ1&L7XUY*Q+CCC+)H^*NO9)@-_NTR?B0NMI)<MMT=<
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M:$2N$I 2[1VIHJHJT&%@'$/+I2^-;)R W9H>)\9J<R,_;'W9$F?*[2MQA(7
M%&^UNU<+P)?#QZ!V'P5G18),QU"@_2+_ "(N7@O?+M_1BR!=ZEV_\;HGR=/Y
M:%MY>.'\OG2.>'6"B;.1HD"/CNYXD5#BP'(Q]_R>1-Q)IINZ4+6]A=IF6##<
M>L<_8L^UVR%"D]I5)M7HT<&SVDJ(JIN%=%THCS]QOA_J9XYB7"%"L^(33O-U
MDWF[W&5,FK+??FN(1J1  IY4Z#THJUL5R;,;SRYGMAF@#6$8VS:V;6JQU!QZ
M9.C))>5'E70T;3RDB)TW)0:3FK"N0K_DN Y;QVQ;)-SQ"5/DNQKP\ZPP:3&
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MH@K>FXD37V=.M 3D+7DY>-OJ_=-$MWTG]8NPOT9KNT[7<^'V:_G>6@FM H%
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MB::%6OZ9[CDT//,IQEBUY?$XR>A,W&QEG$9QN7'FM$VU(:!U=P*CBN$:")>
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M617F2\_;<?Q*6D%V6W';_6>]&2+JV&N\43KJ*KT1%HD/-Q97E\W@-^TE>[U
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M9-KS>Z6''<U=&;?<?C-MNL/3@)#1Q3,D78I:DK>G55^5HB)0M-,7X4@XQR!
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MW+4:[\Q.<6VV(V]#8L*Y =\;?%T'=TAI@&FP!%31-Y*1*?LTT]M%=7(W,$/
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M2&AIN5LB^4>J>&[71*"V_2K>+ID_ >-/Y$13'4"7 %V1J:O18TEUAM"W>*"
M]O\  -$EYRQ> ,V[XIZ;92]T<;Y(N4Z1#/4D<LEK9][;(_\  >[CR?TT5JKK
M8+1DO$W*7.=ZE2&N6+1EQ!;+D,IUMV$+$F*#4=L$)$1$%XT'IJ.T=--M!.FN
M.,.R_P!4EA7(K,CA7K$8N5W>.CS[0K>B<52>5 -%'11%.VGE^*AP0*^8[G?*
M>8<LR;7@LC),PB9$4&T94-Z:MKMB&W2%2,TU&=(-^H-Z;MR?%YNM!ZLY?*\O
M>F?(7,D:[60GC(%=V?*6R:K *^FH:CT<W?)Z42-ZE\;';R)Z5M4T)<5D+I[=
M%M1*G_/1506;$<?LG!5MY7M#!1>0X6<-1H=T;><0T::)5%@6T+8B?E]!W+\.
MG2BK(RS$L>Y)OWJ,RK.'77K]A#2-8L12'&D@-Q6'W&%; 20='39'HJ=5(E3S
M%K1'"TV"V<O\J<,1N2HA7=NX<?A)G \XZV4AR.<OMNN&V0F2EHCB^;JJZ^%!
M<7HP?><X6;BN&1LP+M<8L5#)2V-(XAH*:^":FM$E4[6)0N*^;!O7+N*G?8&1
M98DO%>2XDQY5C3'W%6-%DL":!H!#YA(44=I;=XBB(5JL@;!./O55J*)KE#"]
M>G7Z40D_Y5UH)#!P_&^7.7PP[D4W'<9QOCVVO6.*D@HS;!R&(W=EAHJ#N!75
M\Q(H]!W(J"E!EYCQI@UZYQX;X[F&[D.#M8W,%DWYAO%*9B@^\RIR&2%3'< J
MB J#HB(GEZ4$]]&BJUQ=>+8!%[E:\END."V9*?;8%&304U\/,9+^%57VT25!
M7K&[1FF"\W\NY0^^G)&-Y.<>S7#WEUIVWM0Y#(1VFP$D1$7>K0[DU\J;="2B
MI7(X\Q'/?4-QX]EMH22_EV&1LDR-GNOLH]=49-.ZJ-F.S3M"FP=!73JGC0:O
MD+"<8RSE+U'77((2S)V.6&//LQ]UQL6)0VUM1<V@0H2IL33=JGCTZT&KNTF^
M9C>>&L9F8L[R+;&,!CW)K%W+FEJ!Z6X3\=U\GS^43;;(>7Y7_+0=E\P7*V,"
MX=X]Y5MST)LLZ6V1(!RVY+WT',5A1!)$<R3IW' %45%1$31$32@]MX1@F+<<
MV(<:PZ ENLH/.R!C(XX]^L?+<2[W2,E^!-2Z)THR_/BT8I8K-P7;N6;4R;'(
ML+.6X\.Z \YW.TV:D+ M[MB)KYUT'<OPZ=*-+'OS;0VCU::(B:S;<JZZ)U[S
MQ)_RKTH')/']T<L?'7)ESQ=,^XYM.#6V#>,=;F.PY-N%(Z.G.:1DA7Y'Y2(7
MR%W(B()"$OMMPQF[\_\  ]QP]HVL9/$9@VEE_57FHS422V#9JJDN\$382[EZ
MZ]5HBB,1Q#';/Q%QYR5;XI1\U=Y"BP'+J+SJ%[HVKA(T(;M@IJ KJ@Z^/73I
M1IOLCQO-^4,VY=>L^#OY1ED+)'+?9<N"]-6UVR-VV20Q@:C.D&_<VW\K<GQ>
M;K1$VYKP;)6K[:^5N3<27.L2#&8,3*+0Q..+,L<U&T.2^TD<T110T,MR;@74
MMVU$0J$._F[$&KY)Q7F*WXP6?<,QL689/&TEOP9ELA$)/#,!&R0M4:TW+YOD
M+NZ(A((>D\6RO#X?#MOS#'F7APBVV%)L.*2*4D(,",J]HMQ+JX(MJ"ZDNI)X
MKXT1XRQ6.L+D+AC-L<P6)@MAR6]/-VV5!N<B?*EPW71:<:EH\2KKH9:%TU$M
M-$T1**EUNQ2#Q1S4S<N7<5.]-9%E12L4Y-BS7C[<R2XJ1XTI@30/*2:D)"BB
MJ%IO%.@6=ZU8[4OB>UQGT56G<CMK9Z+HNTP?%=%]BZ+1(4CE?#_'MMS?G2Q0
M[43=EQ/%F;OCUO23(5F+/* V:O:$XJF6[5?UBE\I4_ 5N)<AC/K+Q9@8<?Q,
MZS6-A#=W<G7:Y/P66+<[^HV!VS!#=56A5#/Y"JFGY2H&APR4]8^).%>8Y;I*
MUA.32K/<Y7RG L=RD&![B\5%I-P /LWZ)TH/0WI0M).X5?>1)0+](Y_?KC>R
M=)-#6-[P;30K[=-R.&/_ $Z)*@<JX^Q+*LB]3>1WZ)WKOC",2;'(1XVT8?<;
M?<4M@D@DI*R ^9%Z:HGC16VM.'6'EWF'C&!R)&<NK$_B^VW":!/NLF]*$GA%
MTS:(#551=_RNJ]:#JNG'^(9I>N>G,J$VCXTM4>W8/&20ZRW;(=OAOK'5H-R(
MJ*L=OHNJ+N+VEK0<+/8[=R_R-P9#Y)CE=FKAA3KDYMYUULY)0RE]DW# A,E+
M8+B^;S+U7IK01 ;G?"X=QS 8D>1?,9/DJ796K*DOW-)\*.C#K$%9*] !YUXU
MW+T0O-^302#(L1SO$.%>:8]\Q$\,P>YNV.?CN/N7)FZA$E?2+ R1;<;-2\Z(
M)+O$=$043X:"3<U<781QQZ:%F8?;B@RLA>Q]Z\.D^\^4AQH2,2+NF2)YG370
M$1.OA0C>Y<\W1>)^1N0+@V2LP^5,+)B(C8KY[TR;<)1%!_*[)D>OYQT(>BL>
ML,GBS@QBS6IM!NN.8\ZX(B**A7!J,;[A;?;N?4B_EHBC?3YQ7Q_(PS!N87YT
ME>3Y!W2>LA+@8NW:;W7Q)ET#)2<0!#S"WHI=5/<BT65.A:8#/!%I]0D>4\YS
M,]EW><O/O#BO.O$^X/NRMH6S10%'-NW73I\A=*#>\C8-B^1Y;ZE;]=X:R+MC
M;-ME661W#!&'I ZNEL$D$E78@^9%T37X:#;XS9('&?(^"7;"F'(]UOO&LV]W
M4B>=D',N1PWI:N.(X1:J3H"NU/+T3ITH(YP[B')%Q_AQR#AN!/M7)J[G,O\
MGY7QAX[S!D2C;F-O1'3$AVBA NFI>55T55UH+^]:49F9QICL21KV)&56QIW:
M6Q=AM2170O8NB^-$A4V210X=R_G+&.,D=M%B:P^%-;A1WG7/=Y3AQHY.@9D1
MB:-ONGNW:IKJG@E%=G"W&^:-Y7A-WM?'#F-8#=[$Y:\RG?3;$]J]PI\-3&6;
M(F#C:D9">C:+MU1.FE! [79K?A_I]Y0RS&8YP<A?R=[$7KHTZ\IMV(G8KBL(
MBEM1"+R$6FXD+15H+.G8=CG$O,+F(\=$XQC.2\>W*1?(7?<DM.&Q'D]J46\B
M3<:M#HOAU+;HA+01:R81C^$^D*3R]B\ V.0[M;WK;-O2//&80YUW&(]L;4M@
M+V0V(8"A)N7KU6AQ37@'!<\Q[D[',BLW'CF$X%-L7N&0N)>H]U:GFC)/QII-
MB2&)F: GE!435?#4J$MSZL\%Q6_YUQ)-NL#WB7>K_#QZY&CKK:O6LGT-6/(2
M:>9X_,.A=?&B0Q,[XPP:]^I;CSCNZ6OWC#8&&FQ&M:OOB*-PG92,B3@FCA(.
MU%ZGU5.NM%4Q#N=[E<(\986Q!>OUDGYK.AR,?29[B-P",ZT;$$I!=&Q<-X__
M $O-XHE!Z3],>*9_A]VS>%?L3<PW"+C(C7#';"=Q9N@0WS$QDMMN-&I:%HV6
MAB/33\-$E5/*6#XQEW-'/$S((7O4FP8:%UM)[S!&9K-L94'= (4)1VZ(A:I\
M5%8/&N.VG$\]]/616)AT+WE5GNTB_P @Y#KAS71A&H(>\E31%7011-.@^U-:
M"(<:XYR;F=LL/(6)X,_.S8<D*[SN1UO; .21%TDD1#@NF&@*B^;KJJ(NB;25
M*#:Y3CF:\HY[R^5KP9_*LG@WSZ.LV3I>6K:Y8FH#QI&1J.Z0;T,&]==R)\'F
MZT$URGB^PY=Z@^+X7(]E[E[RS&??<WB^\.AWKK!MY-Z[F'$0=A,"GZI4%=/;
MUU#+Y! /XO\ J#)$37^')]?_ *T8_F2@B_&N)8_AF9>FZ^XW&*%=LK@W-S()
M"/.DLHO=DT0D(E%$3N*B"*(GA\&M!"DQ#';QP?8^7KDR4GD:[9R+-SNCCSBF
M8OO&IM$VI;%^0A_)W)KXZ45^CS4Z$_*D06)+3DV)L65& Q)UI'4W!O!%U'<G
M4=4ZT89% H% H% H% H% H*^X\X8P3C%N_LXQ#<1C)7D>NC4HT? A1#1&A%1
M1$;1'#3:NOC1;1[#?3)Q9@^5L9=9X\UZ5 -URS6^;+*1!MQOZ[RC-$FJ*NOB
M9%IX^*(M"VV@<$X-;.3)?*D%9S-^G$X[+@#)5+8Z^\R;!O''V^8U%P_E$HZD
MJHFM"VFQ?TP\6XAE\?,;,U< ?@/N2[5:G)KA6Z$^\BH9LLHB*FJ+IH9DGQ4+
M3GD;CO'>4L7>Q'*.^MH?=:?<]U<[+N]@MP^;0NFOQ41OG[/;9=G<L$V.,NT/
M1E@R(KZ=P'8Y-]L@-%\4(>BT%2X+Z6^)^/LI:RVS19DFX0U,K5'N$E9,:"3F
MNI, HHN[JNBN$:IXIUZT6TA/@_ WKAG-QDLR'W>0F!C9"VX]N;4 %1%64V^0
MAUU%=5T714H6E&%8C;<#Q>VXC9GI+UJM3:LPRFN]]]&E,C$%/1-4'=M%-.@H
MB>RB-=QQQIC7%EEEV'%O>/<)LYZYO>]O*^?O$@0 M"5$T'1L>E!RM_&^.6SD
M*[\FQO>/K->X;5NF[W5*-V&.WMV-Z=%_5#UU^'X:"$9/Z7^*,LR^1F-TBS ?
MN#S<J[VJ-*)FVSI#2ZBY(91-57Q5=I#JJJJ]555+:$9KZ?GN3>?KG=\@B38&
M!LX['@Q+M;I00G??D-$[;2(A*0=I7 -%#;UH6LK(/3YQID.#V/ G8+\&U8R2
M.6&9 >5F=$>55(W >5"U)PEWGN14(O-IJB:"W2SZ=.,X_'CW&K$:8W994L;G
M*FA*<&X/3P5%&0X\FFXDT31%';T^30MT6GTT\7VO#L@PQV/-N43*"9<O5RN$
MHGKB\Y$7='+O(@H*M$JJ&@^U==472A;HQGTR<<8M(NLV&_=Y<^]V:3CMSESI
MQ2'G84M!$UW**;300$14=$%$Z)0LO7IDXZO5@QO'UDWB UBL=Z':9D&>3,E(
M\ESN.@9*) 2$OBNQ%TZ4+6/A6%X[Q]C,'$L6B>YV6WBHLMJ2F9$9*9F9EJI$
M9*I*OXM$Z417^8\&VZ99>3'\1<5G+>1X@QYSL]\EABXV) "H@-D0)H9:Z(5%
MM-\/PN#BO']IP-I=(EOMC=M==8U;4R1K8ZZB^*$9*1Z_"M$4ZQZ*^&XVQ&';
MVV($A"(7%11%1=?R6TT_DHMIS9N+9<7G3)>6KB<9R-.M4.TV1H%(I#: @K)-
MQ"!!%54!0%$B515==*#GREP+Q]RY*A7/)&9,2^V\.S%O-K>]UF(SJI=M243$
MA1254W"NW5=--5U%M[QMQ?AW$]@7'<-AE&B..+(E/O&KTB0\J(.]UQ?%41$1
M$1$%/8E$0W-O3)QCGF27+)[L-QBS+RT+5WC6^8<6++-I$1MUUM$7<8:)IUVZ
MIJHJNM%M(+/PQAECR/&,I@I+^E,2LH8W:=[^YKW!L3%.X&U-QZ&OFZ?\E"T>
M>],G&+V",\?;;@W:XER.]P)P2U2X1ISB;2-IY171%3V**I[?E(BT+2/C+AK"
M^)7;T]B(RQ*_FP[</?9)RE5R,CFTD4^NI*Z9$JJNJT+3.\VJ+?;/<+'.W^XW
M.,]"D]LMA]J0V39[23P70ET6B*UG^G;CJY6/"L>EC/*WX$^LFQ[91"XJDX+I
M \2#YA4@'P0233053KJ6TPY"P*P\F8I,PW)N\MFG$R;_ +LYVG=8[HO!H6A:
M>8$UZ41J8_#^'QLM:S5KWKZ:9L@XR"J_JU]'@FB:CMUW]/E:T6VTX[X^Q_C#
M%HV'XQWTL\1QUUKWISO.[GW%<+4M!]J].E$1F%P)@EMY$N7)<$[A'O5V[[DR
M$W*(;>4B4R;+K_90>ID+AKYB444E5$1:+;&C>G7CN+BV,X>TD_Z'Q.Z_3MIU
MD_K??.X3GZPMGF'4EZ:)0MAY=Z8>+,TRN5EMT9GL2+D;3MZMT&8<:#<'&%11
M*0V";E75-=0,>OF^4JK0M)[CP]AUSRNZYC(&4EWO%C<Q>6@/J+26YY$0D =-
M1/1.A:T+;[!\-LW'V*VW#L?[OT/:@-N+[RYW7=KCA.KN+1-?,:^RB(?R1P#Q
M_P I7V%D>2!-9ND2.4!YVW2BB>]0C4E[$C:BJ0:D7R5%>NBKI1;=5O\ 3UQ[
M;+5A=GBI.2'@=Q<O%AW2=2]Z=?207>5!3>.]/#ITZ4+:P_2]Q>]F1YE)2YR7
M7+D=\<LS\XW+65R<<5U7R95-REN7713V^S33I0MDYGZ:>+LZRUS,+U&F-S)9
M,E>(,.44>#<2C:=M930HJEIM3Y!#KXKUZT+2^T<:8Q9,]O/(UO%\,@OL2/ F
M@KNL5&(@-MMHVUHB#HC0^W_GHB$Y#Z7^*\ES"3F,YB>Q(N$@)MVM<.8<>WS9
M39;D=>:!-V[=YEV&.I*J^*JM%MNL\X*P?D/*K1F=Y*?%OMH;&,#UNDK%21%!
MPG49?T%5(-Q%\E17KIKI0MF,\,X*%TS:Z28CLTN0 ;:R.+*=4V' 9 @%&Q1!
M4.AKU0M47145-*%M)Q]Z<N...+A,NUF&?-N<F(=M8E7.4LHXD%SQ8C>44 ?C
MT4M.FNBKJ+<XOIVX[AXOC.(M).^B,2NJ7ZTH4G5SWQ'"<_6%L\P:DOET2A;N
MXEXMF8'?^0\ENQQ7;IF>02;DP412+9;=Q%&;<4P#]8BN.*:#J/7Q6@[^0N"\
M(Y*R2T99?2GQ;W:&_=FY%ME+%5^+O5SL/*@JJAN(ODJ*^9>M"W;*X2PF9/SF
MXO),]YY"C-P\AT?T'M--JV/93;Y%VK\="VHR3TW<<9-8<9L<CZ0@NXE&2#9;
MQ;Y7N]Q;BH.U6R=VDA"OQATZZ::KJ+3S",*Q[CS&(.(XM'.-9;>)(PVXX;QJ
M3A*X9$9JJJI$2DOL^!$3I1'FSBOTK6N[R;YDG*5MG1I3^33+E;[2DQ!B3(".
M(4=9<<-W@:N*B;A)17KTHU;T-:.-\<LN>W_D>%[Q]8\E9CQKDKCNZ/VX@ VW
ML;T3:NUL=>M&4&R+TN<39/F$C,;E$EH]/D!.NMH8DDW;)LH%U1U]A$U4E554
MMI(BJJJJ=5U+;?77@S K[=\LO=Y9DSIV86\+-/5Y[4(\%M 46X@H*(TB$V#G
MM\XZ_#0MVVOA?$;7?\1R8'KA)N^%6YRSV9Z3)[B+$<!QK1Y-J;U$'%$5^)/@
MH6CMN]+_ !5:\S:S."Q/:<8G_3$:R!,,;2S<47<CX,"B*A(O@._9IY=NWI0M
MPN'I<XNNN82,PN'TG(.9<%O,RRN3C*UO3R/>KILJBJO7\G?MT\NFWI0M87('
M'^,\FXQ*Q'+(Y2+3*4'-6C5IYIYI=P.-FGR2%?Y%35%1454HB X_Z9.-\=6_
M.QGKM+EY-9WL>O,N=/*2\]$D;$,U(AZ.: *(2)HB)T2BVF!<4X8]QLWQ1.B'
M-P]J($$6)#BD]VVB0VR[@[50P)$(23P5*(U/%_!F%<32I]PQURX3+I<6@C/S
MKI+*4ZD9E=6V11$ $$?9Y=?CHMNOD;@3 >3K["R2_I.BWB)'*"[)M<HX92H1
M*JK'?4452#4B^3M+KIKI0MJ9GICXRF8-9L!_\1CVW'YCMPL\]B7LN$=Z0:FY
MM=V*FTE7PV^Q-.J:T+;#&_3QQKBV,Y3B%NC2W;%EZ(EW8E23?+41(4)LR\PD
MBENW*JKNT6A;#A^FOCR)AEOP8Y%UE6BVWEG(HSTF9OD^^1F>PT.] 1$:$.B-
MB*)[?&A:2'P[@[^39;E,Z*[-F9M":MM_BR'5**Y&9:!E! $1%!=H)YD+77JF
MBT&CXX].O'/&-[=R*Q#.F7=8Y0H4BZ2EE+"B&NJLQDVB@#[-5U+35->JZBTB
MPGBG%<!PF3@%@]Y^@):R5=]X>[K_ /GH[7-#T33IX=*(A<_TM\9W"P8MCI/7
M:/"P\9@V5V-.5I\/I%]9#RDX(:JJFO14TZ=*+;,?]-G'$O!QP.85SE6]FX+=
MX-R?G&Y<HDP@%O>P^2>5-H_(VJ.O737K0MDV[T[\:6_CV[\;+&ER[)?7UFW6
M7+E&].>FZB0R.ZNB"X*@*^441=.J+JNHM]XX]/N!<7Y$[E>/.7*1?9$!;9*E
M7&84I7FE-L]Q(0IY_P!4 IMT1$31$H6VG*7#F(\N,6H,E.9%F61\Y%MN%L?]
MVE-*Z@HX*&HFFT]@Z]->B:*E"VBSGTV<:Y\=J?N8W"#-M4!NSI,MTLF'Y-N9
M':,>21(?<'3Q5?,NO5:%K+QW'K/BEC@8WC\485FMC(QH44-50&P3X55555\2
M)5U5>J]:(BL'A[";=R?<.7(T=Y,ON4?W60:NZQD3MMM*8M:=#4&A15U^'VK1
M44OGI:XER',7\QN$*7W)LH;A<K,U)4+5+F"N[O/1]O4E554D0D0M5U3JM"V\
MSS@K!^0\JM&9WDIT2^VAH8P.VZ2L5)$4'"<%E]$%54-Q%\E171=-=*%M/FOI
MBXMSO*9.5W=F?'E7%6BO4&!,.+"N!,:;%D-BFJJFB=6R#KU^5UH6M&[X_:;[
M8)F,72.C]DGQ7($J*JDFZ.ZVK9#N1=R>5?%%UHBJ,*]+W&>!9)9\MM#EUD7N
MPH\-O=FS5D"+3[9M=K9L$4 !</8@HGCUUHMJVX%]+%LCV>UY1R9;9T3)X=U>
MNC%C.8APB4#%8KTB.WN'N#HOE0_#H:+X4)E:>?>FGC'D;)G,KOC,Z-<98MMW
M=NW2BBL7 &-$!)((BJ6B"*:@HKT3KTH6E0\4X>UF]CSV,P[&O&.VOZ!M49AS
M9":@(AH(=E$T\J.*B=?#3X*(R...-\<XLQXL9Q;WCZ,.2[-7WMU7W.Z_MW>9
M43IY4H(-"]+_ !?"S%O,E2YRGF9Y7ABT2IQO6T+B9J[WT:)-RDAKN\QJGPII
M1;=.6^E7BG,\BO.274;DS(OQ"]<8<.:3$,Y0^$CMH*ZN>/RE4>JKMU6A;8YS
MZ<.-\_;LWTL,^'-LD%NT,7"WRECR7K<V.Q([Y*)(X"HI:^77S+UZT+;N!PO@
MEJR3%,FM<5Z'+PR [:;'&9>)(P1G@< ^X!:J9*CI+N(M57JNJT+;/CSC?'.,
M;3.LN,>\>Y7">_=9'O;JOG[S)$!/:JHF@Z-CHE$0C)_2_P 499E\C,;I%F _
M<'FY5WM4:43-MG2&EU%R0RB:JOBJ[2'5555ZJJJ6VXY$X(P7DR]6:_WSWZ%=
M+*TL6.]:I*PU<B*JEV'%$57MZJ7R%%?,O6A;)E\+87-NV;WI])?OO($(;9D&
MU_0%C@RC"=E-OD+:GCUH6TV0^F[CC(\;QK''TN$(L296+8[Q!E*Q<FF"^4VK
MVU4(2^,.GLTU746RV/3[QS$L^&V*&Q+CV_!KBEXLH!),B6:CB/$;RGNWH1IN
M44T3V)HG2A:TJ(HBQ>D;B*P7BVW>,-TD#;):7)NW2IQ/0G9@$A-NNM**;B#3
MIU35.A;DHML[,O2WQ;G.2W?*+P-R9EWP0^E(D*:4>(\^TB"#Y-H*ZN#ITU7;
MKJNW5=:%N65^F+CC+UM)3I-XB%:;5%Q\%A7 VO>+;"%1;9?0A-"3JN[;MU5=
M:%I3%X<P>!D^*Y7;HST.;AEO.T6*,R\216XCC9M*A@NJF6UPO,I:JO5=5HC0
ML^G#CAC"K5@3:7#Z!LUX'(8>LK]?[\*$B;CV]0T-?+I_+1;8^:>F+BW.\IDY
M7=V9\>5<5:*]08$PXL*X$QIL60V*:JJ:)U;(.O7Y76A;LSOTU\=<A7\LBO#M
MUC2GF&(DZ/ GFQ&E1XH[6VW05#\J)^8H_#XZK0MQS7TT<;9O,@2Y17.U);[<
MQ9&XUIFE&CG;(NJ-1C;(33MHA+T'36A:R[?BV/VO&6<.@P&V\:8B?1K=N5%)
MKW39VU;+<JJ2**Z$I+JOMHBI<>]*/%F-7NSWVWN7<Y5@FI<+,Q(N!NQXJH:.
M=IMM1T1O<FY?RB]I+1;95L]+_%]LS%K,A2Y2GXTXKM$M,R<;]M9GF:N=\6B3
M<IH:[DW&O6A:<\B\;XYRA9(^/Y1[Q]'QIC-Q:]T=5ASOQT) U)$7IYUU2B-9
M<N&<-NMZS*_R_>_?\ZMH6:^[7]&_=6V183M#M786T4Z]>M%M&[WZ8N,K[%QN
M-(^DXSF,04L\27#FFQ(?MJ*2^[2#$=2;U,_D[5\R]=*%M#R;Q%'Q'TZ7SB_C
M6QR[Z4YP!@0''!?=%U^6V\;JF6Q$1O:I#\:)07-A6-1\.Q"Q8I%T[%F@1H(D
MGY2L-"!'^$E127\-$>;[?Z9(V?<G\FY'R+#N$"PW&ZQRL10YB1O?H[:$KXO-
MAO562)&E%5VEJBZ*E%M>\;BG$(6=0.08;+L>]6RTAC\%AIS;#;M[:JH C6GB
M.NB=:(B_(/IKXRY)R4\KOC4Z+=)+;;%U2VREBM7!IG1 &2*"N[1!%-145T%.
MO1*+:#<D\"'G?,V'QVK;)MW&U@QLX!7*V21@G#=;)X8S494524A39TV*.WQ^
M"A:Q7?3WQ@]QG&XH.VN?5B([[Y'=1U4FA-W$2R4?TU[J[R3733:NW3;TH6PH
M'ILXY@8+?\ WW.3;LG=CR+Y<),TG9\AR&X#K2JXH[1VJ"?)!-4\=:%I1FW%.
M*Y]A,; +_P"\_0$18RM>[O=I_P#S(=K>IZ+KT\>E$0'F_ +AR#R#Q-;F;*Y*
ML5ENC]VO5Y5$[,>/&%MP8Y*JZK[P32"J(GL2BPO0A$Q421"$DT(5ZHJ+[%HB
MGL7],?%6(9DSFEHB2_>8;KLFU6MZ23EM@R'_ );D=E4\JJGAN(D31-$Z)H6W
M7']+O$T7-$S1N'+WA-6[-6)9)+9PN"KN[XQM/E:]4'=L]FW;TH6W<W@O!I[V
M=/OI,[G(@,MY#MD:>6-KL[/E\GCU\:%LR'P[AT')<6RME)2W3$+0./6A#?4F
MO<1:)E.Z"IYSVFNI:T+1C'/3!Q9BN81\QM#-P;=@R3G6RT%,-;9$DN:ZN,LH
MB*GCIH1J/Q4+3/DWB_%N6[ QC67C(.UQYC=P (KRL&KS(.-HA$B+J.UPM4HC
M1X-P%QW@<'(8,*-)NJ92W[M>G[P^LQYZ(@$V,?<J#HV@DJ?G+TU5=$T+;#X[
M].7'7&61?6?'UN4BXLM.1K>$^:<AF''>74VV 1!3:O\ A[E_EH6VMGX/X_L^
M'9'@B1'IN-Y3,?N-VC3'E=(I$E&]R@:(*AM5H"!4ZB2:ZZT+:G!O3AQQ@#=Y
M6U#/F3KW!<M$BXW&4LB4U;W1VK'8)!% !$0=-!U\J=>E"TIL/%N'V'CH.+&H
MIS<.&/(B'%FN*ZXXS*<-UQ"--JZ[G%VJ.BCTTTTHB.<:^GKC_BR]NY%CY7&7
M=BC+;XSUSF%)2-"4D-6&01 % U1%3<A*GL7JNI;;WE'B;%.7+/#M&4>],_1T
MH9UOG6][W>6P^**.H&HFG5%ZHHK[%\42@Z+;PYA]JRG',PC+,*\XO9TQ^VF[
M()P"AHAIN>14U-Q>X2D>O5:%M&GINXQ_AZYQH[&EO8^L\[O'><DJLV/.--.Z
MR\B)M5$U3JBIHJZZZT+2/C+B?%>*+=-@8T4R0[<WDE7*?<I)2I4AX1VH1DNT
M4T3\T4^.@QY_#>&W'(<PR:3[W])YQ:OH*^;7U1OW-6!C_JAV^0M@)YNO7K0M
MCPN#L'M\W!Y\=)GO''K#L7']S^J=M\=A=Y-OG73\%"VA8]+O%,7,QS..Q/:<
M;GI>6K(W,-NTA<A7<D@6!1%0D+JB;]OLV[>E"W;G/IEXOS_)W\KO+,^--N"-
M)>8MOEG%BW#L:;%DMBBJJH@IU A7IKX]:%MIR+P-@G)LJQSKVLZ%.Q]LH\&5
M:Y117EBFB(3+AZ&J@J)[-"ZKUZT+95SX5PJ[7_*LCE#+2X9C:%QZ[BV_M:]Q
M5L&M&@VZ 6UL>O7_ ):%NJ-P=@\21@DEI)G=X[;=9QW61JFQ]!$N]Y?/T%/@
MH6\_\A^FL9_)$.S\>XO<85K?N\:_W;(YEP!+'$94E*0W"AIYE=-=/E:[=J"B
M("ZB6WH_&^),1Q3/,CY&M0R4R+*!$+CW7R<CBB*)%VVU3IN(45=RKIX#M3I1
M$ZHA0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*".9W%S2;BTZ-Q[.AVW+C[7T?,N0*[%#1X%=WB(&JZMH8I
MY5ZJE!YXX8S'U'YUG-[MUXR.QG8<*O:VC)6 B;'9(LFX!K%(6O!>WT4U&BRS
M^#_5'CF00F+3R3DD9G.[S=Y,:WP&HSC;#3"F#<=I3 % -Q:H*NN;E]JT)A:N
M9<\<3X!D<?%,LR1BWWV0@$L=6WG19%WY"OFT! TA(NJ=PDZ=?#K0I8@&#@"X
MV2$!(A"0KJBHO5%14HBJ;_ZEN%,7O4O';YE 1;S E_1\V*L662M/^W<0LJ.Q
M/::+M3X:+399MSQQ1QW<6K5EV1-P+@_!&Z1FA8D2$=B.&0 ;9L-F!*2@6T=V
MO37PH4Q<C]1/#N)L6.1?LE;C!D41BY6L$CR77"@RAW-/N VT1-@2>'<0?;\"
MT*;'+^;>+L$8LTK*,B9AP\@8<F6:4#;\IF2PT(&I@<=MP=%1P=NJ^;7IK0ID
M67E_C>_X1)Y&MM_CEAT'>,ZXNH;*,&WM16W&W!$Q/SCM#;J6X=NNY-2.O >9
M>-N38D^;AM^:FM6M-]Q!T'(CC#:HJHX82!;) 5!7SZ;?CH4PL(YZXIY&O\C&
M,/R ;C>HXFXK"1Y+0FVTNA&V;K0@8I\*%1:8N.^HOAO*LK#"K%D[4F_NF3,=
MHF)#33SH(JJ#;SK0MD73HB%YOR=:%-!Q[RY/G93S$_G-RC0L3P6Y-PX1[$:;
MCQ6^^AF9)J9F>P?AZ]!3KI0I-N.N9..N5_?DP6\?23EMV+-:*/(C&V+BJ@%H
M^V&J%M732A3;YQGV(\;V(LCS2YMVNTBX+ .F)N&X\:*0MMMMB1F2H*KH(KT1
M5\$6B*;Y;]0L1>%RY#X@O4>0+EVC6=RXO1SUC$XF]U%:D".AB*BOG%4T76BT
ML7#^<>+,ZCWN1C&1-3&,<:*1=S-MYCM1FT)2>1'FP4VT05\P:I^-*%.G ^?.
M)^2[T_CV&Y"$^\, 3J138D1B<;;70B:60VVAZ>*H/73KII0I0SGJ!Y,/@R9G
M0S8S>12LT7'VGAC K<: HBJ"T"ZHI)I\IS<O5?BT+3V%1EYFX3]4./7ULK+R
M5D<:/F]UODN):K>W'<:8:C(K;<=M7 !0'<>Y!5US<OM7PHLPM;.^<^+.-;Q$
ML&9Y"U;KM-$7&XR-/2"!HU41-WL@:-BJIT4]/A\*%)_'D,2V&I45T'XSX"ZR
M\V2&!MFFX2$DU145%U14HBF.:_4/A?'%OO\ CL._16N2XMN<DVVVNLO/@,@@
M0V@=)L%;$R1=P@9IKT]BIJ6(9D7G'$,+XMP?*>4K^$2Z9%:(,LE1DW'Y,AV,
MTX^8,1@)4%"<U704$=43X*%)?/Y4X^MF#M\D2[_&'"G@%R/=14C%W>2B@  B
MIDYN115M!W(J*BIT6B*WSOFNQ95PY><TXISN%93@2(K$B]3(C[WNI.O@';<C
MK'==!7-V@&K!(OL_.0M)3EG-V \;VNRQ<VR:*SD-V@A(B$D>0H/DK>G?)MH'
M"9:-Q.F]4]J:^5=!2*<4\ZPDX)M?*G+EZ8A.3Y4UEQ]&MHD82WFVF6&61(B5
M ;Z(B$6B*2KXK0I8MFY<XYOV$RN1;9?X[N'P4-9UQ)#;]W)M!4@<;,4<$_,.
M@*.XMR;475-2*NPSU Q>3.=8.,X/=VI_'J8Z_<7Q&,XQ(6YA)[2BZL@!<1 !
M144%$1=VO7V%I>]ZO5IQRTS+[?9C4"T0&B?F3'RV-MMCXJJ_\B(G55Z)UHB&
M81SCQ?R+#NLW$K\$UNR-%(N31LOQWVV 125U&GFP,@T3Y0BO7IXT6FKQOU)\
M*Y=D%OQC'\I;E7FZ)_F+)1Y3 FYJJ(WO>: 1<71=!)45?9XIJ*6E(D,Q([LJ
M0:-QV )UUQ? 0!-Q*NGP(E$5MA7J$XAY"R$L5Q/)&YM\T,F8QL2(W?1I%(^R
M3[8"YHB*6@KKHFOAUHM)UD60VC$['/R2_P CW2S6QDI$V3L-SMM!XEM;$B7\
M HM$0K">>^)N1+^6,8AD;=PO2,^\A&5F0QW&T%"+MD^V"$0HNI"*[DZ].BZ%
MIQ>Y_P"(8^;_ ,.WLHCCE7?]S6/L=[*2U+9V%D('91S=Y=JG\KR_*Z4*0F]\
MLYE!Y8Y/QR.['^A,,PUR^6F(3**AST8;?0WCU0R1%)1VB0IM^/K03[@S)[UF
MG$^,93D4A)5ZND8Y$Q\0!H2)7G$30 1!1$1$1-$H2FEYNL.PV>X7RX$HP+9&
M>FRB1-51F.VKAJB?]$5HCR //'J#@XI"Y_ND>U'Q+-N/8+%6@_S]NW$^4<7D
M>447=O':A*?4M"V;%Z&J7[EOJ(X?P:8ENR;(DASSB,7%J.D64\1QI6G:(%::
M(54D771%U1.JT2D\QS(K)EMCA9)CDT+A9+BWWH<QK7:8:JB]"1%145%$A)$5
M%31>M$0S/^>.*^,+M&L6:WWZ.NLIH9#<88TF02,&2@CA*PT:"*J))U7V46D\
MM=TMU[ML2\6B2W,M<]H),.6R6YMUET4(#%4\45%HBMLL]1W#6$7R?C>39*D*
M^6QQEJ;#]TF.D!2 %P=%;9(23:2$2BJZ>WK1:;S,^8>-\ Q^W9/D]_8C6>\"
M)VEYE#E%+ P$T-D&!,C#:0DIHFU-4U7JE$5[S7S<=NX8C<A\47:-*;NEPBP(
MUS[7>1L'C,7-&G43:X*CM47!Z?!18AN+-G^37#U(Y!QP\^V.*6;'&;C'C V/
M=.6^['17''%U)=$<(4%-!^+6@N*B*XS_ )XXKXPNT:Q9K??HZZRFAD-QAC29
M!(P9*".$K#1H(JHDG5?91:3RUW2W7NVQ+Q:)+<RUSV@DPY;);FW6710@,53Q
M146B*XR_U%\.X)>[AC>49(,*^VM6!F0?=9;IBLEL70T5MDA+R&)+M5=/;1:;
MG+^8N-\%QNW99DE_8CV.\"!VA]E#DE+!P$<0F09$S(=I(2DB:)JFJ]4HCJG\
MU\7VS#+;R%,R%D<.NT@(<&Z V^Z!2#W^0@;;(P5.V>[>*;=.NE%IJ/O'\-?5
M*3G'UD'ZM1K@5G66L:4A.3A;%U6VFU:0W/(2'N$533Q6A3=1>9>-)F".<ELY
M RF%,JH.W-P'6M'45![?:,$<4]51$! U7V4*8^.\X\797B=WS:QW\)./V "=
MO+O9?!^* BI;C8)M'=%05VJ@+NT7371:%,;#?4%Q#G^1-XKB>2-S[X\RLAB,
MK$ECN"(=PA GF@$C$?,0(NY$1>G1=!2Q)\^%:H,FYW*0W$MT-HY$N4\2 TTR
MT*D9F2Z(@BB*JJM$0;!.<.+N2I5P@X9D#=QFVP">E1U:?CN=@%05= 7VP4P1
M51%(-=-4U\4HM-)8O4YP?DM[M>/6;*VY%UO+B1X#)1I;*$\9; ;(W60$2,N@
M(2INZ:>*:BD(L_J6M$OU%7CC^X7QMK$V@:LEBC##>1Q_(3D-,NMN.*VI(HGW
M&Q5=K?MZ^*BB?S-=\+M/,U\O>:6Z]N8_.*%BUL:M\AM;=,=!](T20J,M]W<8
M"*DAF/D(E-$+2A34/>I"Y2_3#.SW&;PS/Y$LK<"+?7WHB@$>=/D V>C9 VV6
M@FNS;N#IUU\*+6U;F1\W\><;V?'5Y"R (-TO$-A]MI&G9#QH0#O>)N.V:@&[
M7S*B)KJB>%$IM\LY>XYPG%H&:9#?F6,<NO;^C)C(N2?>4>'>*M P)F2;?,JH
M.B)XT2D,X$Y3N?*=WY#G.W!F?CEKO*0\9*,UVF_H_81-DJJB&1&FA$I^WP1$
MZ466H]2?.R\4R<2LELN;4"Y76Y1GKTIQCD.-V)'"%]UM=I A*H[=-%/\U/;0
MB$[R#G?BK&,4L^:WK(6X]@R .Y97.R^;\H$TW$# MJ[H.J;E4$VZIKXI0I+L
M7RK'LUL<3),6N#5SLDT5*-+95=I;54214)$(2%45"$D147Q2B(OGO-G&7&5P
M:M6;WT;7<9$59\>.4>2\KC D0:BK+1CJI"J(.NM%II[5ZEN$KW>K-CUKRQB1
M=;]VTM[2-2$%7'BVMM.&3:"TZ1>5&W%0M=.G5-1389ESUQ+@&1L8GEF2,P+Z
M\@$<;MO/(R+J(H*^;0&#6Y%14[A)T\WAUH4[LXYPXNXXF1[?F.0-V^9+A_2,
M1M&9$A'HVY10@)ALQ5245VIKJM"FOOWJ+X<QB)8IM\R4(K6216;A:@6/*-TH
M4C7MON-@TIM@6BZ*X@ZZ+IX+0I9<.9$N,./<(#X28,ML'XTEDD-MQIT4(# D
MU11)%145*(\XW;U,6BU^HI,"GWQJ+A$*&4&0(0WC=/(G'T:%DW$;(MHHO10T
M#7Q5?86GQCU-6;%N7.0\=Y/OK%JQVS2($#&8C45UTR)P#.0Z:L-N&NGDW*2H
M*>Q*%+1SCG;BOCIFUOY7?PC-WID9=K[#+\OOQC1%1T?=VW$V*B^*^/LH4YWK
MG+BG'[!8\HNV2L,X]DF_Z&N(MOO-/*TFIHO:;)04? D<0=%Z+UH4VG'W)V$<
MI6I^\X/=1N<**ZL>3^K=8=:=TW(AMO"!IJG45TT7^1:(R<YY Q#C:QED6:W1
MNU6I#1D''$-PW'B151MMML2,R5!5=!%>B*O@E!HHW.'%LS I7)D7(6G<,@N
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M;<)=?U>XC71/R:+2>S\KO1<\8U8(.96\,5N5B=N"XHD1QV7,5>[LDM2A:5M
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M]S>ZA;(#KB,,:B;SKKJIKM;::$S+1.JZ#HGMH-))YXXGBX*QR0[DK'U0DO\
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ML3,:/Z>>(IK#+34TN16E.2 "+JJ)O:;C1-5Z"/BOL3X$H+RM=RQ+'_6-F 9
M[!@'<K1:V;,,H6VR?N,@HR"C&Y/,Z1*OR?,JZT3@C-L8:E6KU:@3(2%!^:X
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M<:+9[M&N,*!Q_P"XW1V.ZB@RZ+#Y.-F:*FTA$O,FNH^W2BM?PYDT'C;DG$<
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MKN75$73K0:X<!P48$:U#C-K2UPI7TA#A)"CHPS,Z_KVPV;1<ZKYT3=\= O>
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M!I[[Q5CM\R#!;RG^8PL!<D/6FSQ&FFXA$\R#+2**#Y!9V(0"&B:T5.Z(CL'
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MQ2\%TH4MBB% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M'G##I.>\4Y3C-O;5VZR(:R+6V"H)E.A$,F.(DJIHI.-".NOMH0I*-Q+R-=.
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M?VCOXQ^;0/JS!_:._C'YM ^K,']H[^,?FT#ZLP?VCOXQ^;0/JS!_:._C'YM
M^K,']H[^,?FT#ZLP?VCOXQ^;0/JS!_:._C'YM ^K,']H[^,?FT#ZLP?VCOXQ
M^;0/JS!_:._C'YM ^K,']H[^,?FT#ZLP?VCOXQ^;0/JS!_:._C'YM ^K,']H
M[^,?FT#ZLP?VCOXQ^;0/JS!_:._C'YM ^K,']H[^,?FT#ZLP?VCOXQ^;0/JS
M!_:._C'YM ^K,']H[^,?FT#ZLP?VCOXQ^;0/JS!_:._C'YM ^K,']H[^,?FT
M#ZLP?VCOXQ^;0/JS!_:._C'YM ^K,']H[^,?FT#ZLP?VCOXQ^;0/JS!_:._C
M'YM ^K,']H[^,?FT#ZLP?VCOXQ^;0/JS!_:._C'YM ^K,']H[^,?FT#ZLP?V
MCOXQ^;0/JS!_:._C'YM ^K,']H[^,?FT#ZLP?VCOXQ^;0/JS!_:._C'YM ^K
M,']H[^,?FT#ZLP?VCOXQ^;0/JS!_:._C'YM ^K,']H[^,?FT#ZLP?VCOXQ^;
M0/JS!_:._C'YM ^K,']H[^,?FT#ZLP?VCOXQ^;0/JS!_:._C'YM ^K,']H[^
M,?FT#ZLP?VCOXQ^;0/JS!_:._C'YM ^K,']H[^,?FT#ZLP?VCOXQ^;0/JS!_
M:._C'YM ^K,']H[^,?FT#ZLP?VCOXQ^;0/JS!_:._C'YM ^K,']H[^,?FT#Z
MLP?VCOXQ^;0/JS!_:._C'YM ^K,']H[^,?FT#ZLP?VCOXQ^;0/JS!_:._C'Y
MM ^K,']H[^,?FT#ZLP?VCOXQ^;0/JS!_:._C'YM ^K,']H[^,?FT#ZLP?VCO
MXQ^;09$*RQ8+Z/M&:FB*FA*BIU_ B5!LJ!0*!0*!0*!0*#2Y=E%JPG&+MEE[
M,@M5GC.2Y.Q$4R%M-4 $5412)=!%-?%:"G[+ZA<D<LF17G+>.+CCS=KL!Y7:
M#.2$B+.MZ?(;.0+:"Q(+77M$BEIJNG3J6EBX;REAV6XP&0-7RU@Y%@QYN0,-
M3F'0MI/LHZ02#0D0-B[A53V_)7X%HC-A\D<>S[,]D<+*K2]8(SHQI%T"='6*
MT\:H@MF[OVB1*J:(J]=:#MB<@8+/L<S)X.2VN3CEN(FY]V9F,.1&##35''1-
M0%?,GBOM3X:#Y$Y"P.?:)M_@Y/:I5CMJ"5PN3,Z.Y&CH:(0]UP340U14TW+0
M;6S7NSY%;6+Q8)\>YVF2BE'FPW0?8-$547:8*J+HJ:+\"T&&N8XDF1_4];[
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M&[VI>3O*NC6[3?\ DZT&YH% H% H% H% H% H% H% H% H% H% H% H% H%
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M!0*!0*!0-$TT]E H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M@4"@4'G3UM_\"I?^\X'_ %RHL+IP%57!,75>JK:8&J__ %LW1$BH% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MNG /_E$Q?_=$#_5FZ(D5 H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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4 H% H% H% H% H% H% H% H/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 12, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001012477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">AVADEL PHARMACEUTICALS PLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">SC 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">PREM14A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Nov. 12, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule011Flg', window );">Rule 0-11</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TxValtn', window );">Transaction Valuation</a></td>
<td class="nump">$ 2,101,825,233.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 290,262.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">(i) Title of each class of securities to which transaction applies:
Ordinary shares, nominal value $0.01 per share, of Avadel Pharmaceuticals plc.

(ii) Aggregate number of securities to which transaction applies:
As of the close of business on November 7, 2026, the maximum number of ordinary shares to which this transaction applies is estimated to be 110,456,049, which consists of (a) 97,817,589 outstanding ordinary shares (including restricted stock awards); (b) 12,419,785 ordinary shares subject to outstanding stock options to purchase ordinary shares; (c) 218,675 ordinary shares subject to outstanding time-based restricted stock unit awards; and (d) 44,029 shares of ordinary shares estimated to be issuable pursuant to Avadel's Employe Stock Purchase Plan (the "ESPP").

(iii) Per unit price of other underlying value of transaction computed pursuant to Rule 0-11 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"):
Estimated solely for the purpose of calculating the filing fee, as of November 6, 2025, the underlying value of the transaction was calculated based on the sum of: (a) the product of 97,817,589 outstanding ordinary shares (including restricted stock awards) and the per share transaction consideration of $20.00; (b) the product of 12,419,785 ordinary shares subject to outstanding stock options to purchase ordinary shares and $11.29 (which is the difference between the per share transaction consideration of $20.00 and the weighted average exercise price of $8.71); (c) the product of 218,675 ordinary shares subject to outstanding restricted stock unit awards and the per share transaction consideration of $20.00; and (d) the product of 44,029 shares of ordinary shares estimated to be issuable pursuant to the ESPP and the per share transaction consideration of $20. In accordance with Section 14(g) of the Exchange Act, the filing fee was determined by multiplying the sum calculated in the preceding sentence by 0.0001381. <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule011Flg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule011Flg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TxValtn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TxValtn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 12, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">290,262.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlTxValtn', window );">Total Transaction Valuation</a></td>
<td class="nump">2,101,825,233.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 290,262.06<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlTxValtn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlTxValtn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>18</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2529379d1_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="tm2529379d1_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="tm2529379d1_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="tm2529379d1_ex-filingfees.htm">tm2529379d1_ex-filingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="16">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>24
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2529379d1_ex-filingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "tm2529379d1_ex-filingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 18,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 8,
    "http://xbrl.sec.gov/ffd/2025": 6,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 16,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2529379d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2529379d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlPrevslyPdAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2529379d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlPrevslyPdAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2529379d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>25
<FILENAME>0001104659-25-110705-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-110705-xbrl.zip
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M+K:HZ04RZ#H)H6L.L#X#DQ<\^!FF1,/OAAU*DNL&KN_O@(39#D@HA?7@B,!
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M_P]02P$"% ,4    " !NKVQ;.!+]66$+  "F/   '0              @ $
M    =&TR-3(Y,S<Y9#%?97@M9FEL:6YG9F5E<RYH=&U02P4&      $  0!+
)    G L

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>tm2529379d1_ex-filingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2025-11-12</startDate>
            <endDate>2025-11-12</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-12</startDate>
            <endDate>2025-11-12</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-150">SC 14A</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-151">PREM14A</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-152">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-153">0001012477</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-154">AVADEL PHARMACEUTICALS PLC</dei:EntityRegistrantName>
    <ffd:OfferingTableNa contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ffd:OffsetTableNa>
    <ffd:Rule011Flg contextRef="offrl_1" id="ixv-157">true</ffd:Rule011Flg>
    <ffd:PrevslyPdFlg contextRef="offrl_1" id="ixv-182">false</ffd:PrevslyPdFlg>
    <ffd:TxValtn
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-183"
      unitRef="USD">2101825233.00</ffd:TxValtn>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-184"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-185"
      unitRef="USD">290262.06</ffd:FeeAmt>
    <ffd:TtlTxValtn contextRef="rc" decimals="INF" id="ixv-186" unitRef="USD">2101825233.00</ffd:TtlTxValtn>
    <ffd:TtlFeeAmt contextRef="rc" decimals="INF" id="ixv-187" unitRef="USD">290262.06</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="rc" decimals="INF" id="ixv-188" unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="INF" id="ixv-189" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="INF" id="ixv-190" unitRef="USD">290262.06</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_1" id="ixv-191">(i) Title of each class of securities to which transaction applies:
Ordinary shares, nominal value $0.01 per share, of Avadel Pharmaceuticals plc.

(ii) Aggregate number of securities to which transaction applies:
As of the close of business on November 7, 2026, the maximum number of ordinary shares to which this transaction applies is estimated to be 110,456,049, which consists of (a) 97,817,589 outstanding ordinary shares (including restricted stock awards); (b) 12,419,785 ordinary shares subject to outstanding stock options to purchase ordinary shares; (c) 218,675 ordinary shares subject to outstanding time-based restricted stock unit awards; and (d) 44,029 shares of ordinary shares estimated to be issuable pursuant to Avadel's Employe Stock Purchase Plan (the "ESPP").

(iii) Per unit price of other underlying value of transaction computed pursuant to Rule 0-11 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"):
Estimated solely for the purpose of calculating the filing fee, as of November 6, 2025, the underlying value of the transaction was calculated based on the sum of: (a) the product of 97,817,589 outstanding ordinary shares (including restricted stock awards) and the per share transaction consideration of $20.00; (b) the product of 12,419,785 ordinary shares subject to outstanding stock options to purchase ordinary shares and $11.29 (which is the difference between the per share transaction consideration of $20.00 and the weighted average exercise price of $8.71); (c) the product of 218,675 ordinary shares subject to outstanding restricted stock unit awards and the per share transaction consideration of $20.00; and (d) the product of 44,029 shares of ordinary shares estimated to be issuable pursuant to the ESPP and the per share transaction consideration of $20. In accordance with Section 14(g) of the Exchange Act, the filing fee was determined by multiplying the sum calculated in the preceding sentence by 0.0001381. </ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
